Advances Autism PDF

Chapter 1
Promoting Early Identification of Autism in the Primary

Care Setting: Bridging the Gap Between What We Know
and What We Do
Michael Siller, Lindee Morgan,
Meghan Swanson and Emily Hotez
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/53715
1. Introduction
During the last decade, research on Autism Spectrum Disorder (ASD) has made tremendous
progress with regard to early identification and diagnosis. These advances were made possible
by a growing number of rigorous research studies with large sample sizes that utilized a
combination of: (1) retrospective parent report and home video studies [1], (2) prospective
studies of infant siblings of children with ASD [2], (3) population-wide studies of ASD
screening tools [3], and (4) studies on the early stability of diagnostic classifications [4].
Advances in best practices related to early identification are reflected in a 2006 policy statement
published by the American Academy of Pediatrics [5], and a corresponding set of clinical
practice guidelines [6]. According to these guidelines, it is recommended that Primary Care
Providers (PCPs; e.g., family physicians, pediatricians) administer formal screening tests
during every well-child visit scheduled at 18 and 24 months, independent of known risk factors
or reported concerns. Moreover, PCPs are urged to promptly refer children for Early Inter
vention1 services as soon as ASD is seriously considered.
Even though the age of first diagnosis has gradually decreased during the last decade [7],
population based studies reveal that most children with ASD continue to be diagnosed after
three years of age [8]. Given that a reliable diagnosis of ASD is possible by 24 months, and that
about 90% of parents whose children are later diagnosed with ASD express documented
concerns before age 2 [9], the gap between best practice guidelines and community imple
1 Throughout this chapter, we use capital letters when referring to the publicly funded Early Intervention system
2013 Siller et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Recent Advances in Autism Spectrum Disorders - Volume I
mentation is tangible. This chapter outlines a sequence of four connected activities aimed at
improving early identification of ASD and promoting successful referrals for Early Interven
tion services. For each step in the sequence, this chapter (1) describes the barriers that autism
advocates, families, and PCPs face, and (2) showcases novel educational approaches that aim
to promote families access to prompt and appropriate Early Intervention services.
Figure 1. A sequence of four connected activities aimed at improving early identification of ASD and promoting suc
cessful referrals for Early Intervention services.
2. Raising Public Awareness about Autism

The prevalence of ASD in and of itself has heightened public awareness. What was once
considered a rare condition is now reported to affect 1 in 88 children [7]. Recent data from a
study that included population-wide screening procedures suggest that the true prevalence
of ASD may be even higher [10]. In the case of ASD, awareness is essential because awareness
promotes detection, and successful detection efforts result in earlier intervention, maximizing
optimal outcomes for this population. Given that there is an average 13-month lag from initial
evaluation to diagnosis, and that the average age of initial evaluation is 48 months with
diagnosis occurring at 61 months [11], ASD awareness efforts are far from complete. Impor
tantly, limited awareness of the behavioral characteristics of young children with ASD has
been noted for both parents and healthcare professionals. For example, data collected in 2004
by Porter Novelli and the Centers for Disease Control and Prevention show that 63% of parents
reported not knowing what behaviors most suggested ASD, and that 57% did not know the
best time to get help for children with ASD [12]. These data also indicated that healthcare
professionals need more information on developmental milestones and developmental
disabilities in that 30% recommended that concerned parents should wait to see if their childs
development progresses, and only 41% felt they had the necessary resources to educate
parents. Further, awareness campaigns continue to document a considerable gap between best
practice and the behaviors of healthcare professionals [13].
2.1. Barriers to public awareness about autism
Awareness efforts are critical to improve rates of detection, access to Early Intervention serv
ices, and promote optimal outcomes. It is clear that a lack of education and access to accurate
information are key barriers to ASD awareness efforts. Before addressing issues related to dis
semination of information, it is important to evaluate more emotionally-hinged barriers,
Promoting Early Identification of Autism in the Primary Care Setting: Bridging the Gap Between What We Know and
What We Do
http://dx.doi.org/10.5772/53715
namely the predominance of negative and stigmatizing stories about ASD in the media and so
cial stigma that may vary across cultures. It is unclear whether stigma and negative stereo
types interfere with peoples ability to access accurate information, whether a lack of accurate
information promotes stigma and stereotypes, or whether the two are reciprocally linked.
1.
Portrayals of ASD in the media
In addition to being a key source of entertainment and news, mass media tends to perpetuate
stereotypes and social beliefs in a way that defines and maintains an existing social order [14].
Portrayals of ASD in film (e.g., Rainman, Whats Eating Gilbert Grape?), fiction (e.g., The Curious
Incident of the Dog in the Night-Time [15]; Daniel Isnt Talking [16]), and non-fiction parent ac
counts of ASD (e.g., Real Boy: A True Story of Autism, Early Intervention, and Recovery [17]; Let Me
Hear Your Voice: A Familys Triumph Over Autism [18]) provide an index of the general increase
in ASD awareness. However, there is some disagreement as to whether these representations
have a positive or negative impact on awareness efforts [19, 20]. Claims of miracle cures for
ASD that victimize vulnerable families and contribute to unrealistic perceptions of the treata
bility of ASD are clearly harmful [21]. Jones and Harwood provided a content analysis of 1,228
articles about ASD published from 2002 to 2005 in the Australian media [20]. This analysis re
vealed some interesting patterns, including a limited amount of factual information in media
sources, and descriptions of people with ASD as either dangerous and uncontrollable or un
loved and poorly treated. Overall there was a predominance of negative stories about ASD in
cluding numerous references to the impact on families, difficulties with diagnosis, and
criminal cases. The authors submit that the implication of this type of coverage is likely a re
duction in peoples willingness to engage with individuals with ASD, creating barriers for so
cial and educational inclusion. Further research is needed to evaluate the impact of media
stereotypes of ASD on screening and early identification efforts.
2.
Cultural representations of ASD
Vast differences in attitudes and approaches to ASD have been reported for culturally and lin
guistically diverse groups. For example, it has been reported that families in Korea are hesi
tant to seek help for their childrens developmental problems, including ASD, because they are
seen as a mark of shame [22]. The effects of stigma have been evaluated for HIV/AIDS, mental
illness, ASD, tuberculosis, leprosy, and cancer [23]. Social stigma relating to a condition or dis
order can contribute to decreases in willingness to disclose disease status, health-seeking be
havior, quality of care received, and social support [24]. Stigma may also be inadvertently
perpetuated by healthcare professionals who maintain prejudice and negative stereotypes
about ASD and mental health conditions [25, 26]. Cultural interpretations of disability can of
ten be found in the context of religion. For example, a qualitative study indicated that Ortho
dox Jewish Israeli parents view their child with ASD as having a high spiritual status or
important religious mission [27]. In contrast, almost half of the Irish families interviewed by
Coulthard and Fitzgerald reported that having a child with ASD had prompted them to dis
tance themselves from religion [28]. Cultural perspectives may also influence families uptake
of services. For example, a general lack of trust in service providers has been described as one
factor related to African Americans underutilization of mental health services [29].
3.
Financial barriers to successful awareness campaigns
The most practical and often insurmountable barrier to effective awareness campaigns is that
of financial restriction. Incredible expense is associated with communicating a message to the
public, and campaigns with insufficient funding are often limited in their success. One study,
for example, reported that reliance on public service announcements often leads to suboptimal
time slots resulting in limitations in the delivery of the message to the intended audience [30].
Autism Speaks collaborated with the CDC and the Ad Council on the Learn the Signs. Act
Early. campaign, and initiated Light It Up Blue, a campaign to celebrate World Autism
Awareness Day. In conducting these and other awareness efforts, Autism Speaks spends more
than $15,000,000 annually [31].
2.2. Novel approaches to raising public awareness about autism
Bertrand and colleagues define health awareness campaigns as programs designed to com
municate educational messages to promote awareness and/or behavior change to a target
population through large-audience channels such as the Internet (websites and social net
working sites), television, radio, and print media (magazines, billboards, and posters) [32].
Support for the effectiveness of awareness campaigns are mixed with some associated with
positive behavior change [33], and others having little to no effect [34]. Further, recent events
demonstrate that negative awareness campaigns may be ineffective if they are perceived as
disturbing or offensive. In December 2007, the New York University Child Study Center
initiated an ASD awareness campaign in New York City that utilized advertisement notices
resembling ransom notes indicating that We have your son. We will make sure he will no
longer be able to care for himself or interact socially as long as he lives. Autism. The ads were
immediately met with significant backlash from the disability community as many families
and individuals with ASD called and emailed the center to report that the ads were offensive
and hurtful. It was suggested that ads such as this would contribute more to the spread of
stigma and fear than to improve awareness efforts, and as a result of this outcry the Child
Study Center cancelled the awareness campaign [35].
2.2.1. The Learn the signs. Act early. campaign
In 2004 the CDC launched an ongoing public health campaign entitled Learn the Signs. Act
Early (LSAE; [12]). The primary target audience for the campaign is parents of children aged
4 years or less, healthcare professionals (particularly pediatricians), and early educators,
including childcare providers and preschool teachers. Campaign objectives are to increase
awareness of developmental milestones and early warning signs, to increase knowledge about
the benefits of early action, to increase dialogue between parents and providers, and to increase
early action when developmental delay is suspected. Very effectively, this campaign incorpo
rated several key features considered crucial for promoting behavior change [36].
1.
Using a theoretical framework to conceptualize and guide behavior change. The Transtheoretical
Model was used to plot where the target audiences were in terms of a) their awareness
and monitoring of developmental milestones, and b) acting early when a delay is first
What We Do
http://dx.doi.org/10.5772/53715
suspected [37]. This model assumes that the change of health-related behaviors is a multistage process where individuals move from precontemplation, to contemplation, to
preparation, to action, and finally to maintenance. Results from surveys and focus groups
revealed that, even though many parents were aware of ASD, they were not aware of
relevant developmental milestones, and did not believe that ASD was particularly
relevant to them (i.e., precontemplation stage). Healthcare professionals and early
childhood educators showed more awareness of relevant developmental milestones, but
reported that they did not routinely monitor these milestones or communicate concerns
with parents [36].
2.
Influencing the information environment. The LSAE campaign developed a comprehensive

approach for providing parents of young children with accurate information. Campaign
materials include factsheets on developmental milestones (in English and Spanish), a
campaign website, print and web banner advertisements, television and radio public
service announcements, and a 24/7 live call center (1-800-CDC-INFO). The campaign was
launched with a satellite media tour with the CDC Director; the public service announce
ments aired in collaboration with various TV and radio networks; and the campaign
materials were distributed in partnership with local grassroots organizations, private
sector companies, and key advocacy organizations (e.g., Autism Society of America,
Autism Speaks, and First Signs). Similarly, complex information environments were also
created for healthcare professionals and early childhood educators.
3.
Creative message framing. One of the biggest challenges for public health campaigns is to
stand out in our societys very crowded information environment, so that the message of
the campaign gets sufficient exposure [36]. To increase the likelihood that the campaign
messages capture the target audiences attention, LSAE used a creative approach for
creating and delivering messages. For example, the resource kit for healthcare professio
nals featured a picture of a child with the background text, A 4-year-old child with autism
was once a 3-year-old child with autism, was once. Similarly, the TV public service
announcement was first aired in New Yorks Times Square, reaching more than 91 million
people.
4.
Creating a supportive environment to assist individuals with behavior change. To support the
target audiences transition from contemplation to action, LSAE developed several key
tools. For example, the campaign used familiar images such as a growth chart, but
modified it to encourage and support the tracking of emotional, cognitive, and social
development. Materials for physicians included fact sheets with milestones and red flag
warning signs by age as well as informational cards to encourage doctor-parent dialogue.
5.
Incorporating process analysis and exposure assessment. The campaign organizers utilized
surveys and focus groups to understand the target audience (e.g., their knowledge, beliefs,
attitudes, and behaviors) and how best to reach them. In addition, focus groups were also
used to develop, test, and refine potential campaign concepts and accompanying images.
Results revealed that fear-based messages that focus on the severity of ASD quickly turned
parents away. Thus, instead of focusing on ASD, messages targeted the parents natural
and strong desire to monitor their childs growth and development. Finally, outcome
surveys indicate 34% of parents reported some familiarity with the LSAE campaign.
Significant changes in target parent behaviors were detected in that more parents knew of
the behaviors likely to be associated with ASD, the best time to get help for ASD, and the
developmental milestones their child should be reaching [38]. Similarly, substantially more
healthcare professionals believe that they have the resources necessary to educate parents
about monitoring child development, and fewer advocated a wait and see approach,
indicating that the marketing campaign was effective [39].
3. Implementing autism-specific screening

Both the Social Security Act [40] and the Individuals with Disabilities Education Improvement
Act [41] reaffirm the mandate for PCPs to play a central role in the identification of develop
mental disabilities. Between birth and 2nd birthday, children are recommended to participate
in a sequence of 11 preventive pediatric healthcare visits (i.e., well-child visits). In the context
of these visits, healthcare professionals have a unique opportunity to develop a long-term,
trusting relationship with the children and their families. Parents expect that healthcare
professionals take an interest in their childs development and behavior, competently identify
strengths and weaknesses, and are able to help them access available community resources, if
necessary [6].
3.1. Limitations of developmental surveillance
Developmental surveillance is defined as a flexible, longitudinal, continuous, and cumulative
process whereby knowledgeable healthcare professionals identify children who may have
developmental problems ([5] p. 407). Surveillance includes eliciting and attending to the
parents concerns, maintaining a developmental history, making accurate and informed
observations of the child, identifying the presence of risk and protective factors, and docu
menting the process and findings. According to the AAP recommendations on developmental
surveillance and screening [5], healthcare professionals are recommended to implement
developmental screening during all well-child visits. At the same time, this policy statement
also asserts that developmental surveillance by itself is insufficient for detecting developmen
tal concerns in a large number of children. Instead, the AAP recommends using a combination
of developmental surveillance and formal screening tests. Research has shown that healthcare
professionals who rely solely on clinical judgment are much less accurate in estimating
developmental status than professionals who implement formal screening tests [42, 43]. That
is, the clinical impressions of healthcare professionals tend to have excellent specificity (i.e., if
children are identified, concerns tend to be valid). At the same time, their sensitivity in
detection developmental delays is quite poor, leading to many un-identified children and
revealing significant difficulties in detecting less obvious delays. For example, Hix-Small and
colleagues [44] conducted a study where global developmental delays (at 12 and 24 months)
were identified based on both, clinical impressions and a formal screening test (Ages and
Stages Questionnaire, ASQ;[45, 46]). Results revealed that 48% of children with true develop
mental delays would have been missed if only clinical impressions were used. Similarly, in a
What We Do
http://dx.doi.org/10.5772/53715
study that aimed to identify toddlers with ASD, Robins [47] screened a total of 4,797 children,
identifying 21 children who were later diagnosed with ASD. Of those 21 children, only 4 were
previously red-flagged by the childs pediatrician.
3.2. Recommended and implemented screening practices
The use of general developmental screening instruments has been recommended by the AAP
since 2001 [48]. Current recommendations for identifying children with developmental
disabilities (not specifically ASD) suggest population-wide screening at 9, 18, and 30 months
[5]. Empirical information on the extent to which these recommendations have been imple
mented is limited. Two national surveys of AAP members completed in 2002 and 2009 indicate
that implementation has been slow [49, 50]. When asked about their screening practices, only
23.0% (2002) and 47.7% (2009) of physicians reported that they always or almost always
administer a formal screening tool. Since many healthcare professionals may administer
standard screening tools in a non-standard manner (e.g., by asking some but not other items)
or only administer these tools to patients considered high risk, these numbers likely overes
timate true implementation [51]. Researchers who asked parents to report on the screening
practices of their healthcare professionals found that less than 27% of parents of children
between 10 to 35 months recalled completing a developmental screening questionnaire within
the last 12 months [52]. Only two survey-based studies have evaluated the implementation of
ASD-specific screening instruments. In a 2004 survey of 255 pediatricians licensed in Maryland
and Delaware, dosReis and colleagues reported that only 8% of the respondents screened for
ASD [53]. In a 2007 survey of 51 pediatricians licensed in Alabama and Mississippi, Gillis
reported that 28% reported using ASD-specific screening instruments [54]. Importantly, only
one pediatrician reported routine screening for ASD at 18- or 24-months, suggesting that many
healthcare professionals administer ASD-specific screening tests only to children who are
considered high risk.
3.2.1. Barriers to successful screening in the primary care setting
Well-child visits are often the only routine, formalized, and longitudinal contact a child has
with a healthcare professional and thus is an ideal place to implement population-wide
screening. Given this widely acknowledged responsibility, it is striking that many practices
do not implement developmental and ASD-specific screening measures as recommended by
the AAP. In the following we will consider several key barriers that interfere with healthcare
professionals ability to implement effective screening practices.
1.
Parental compliance with the preventive pediatric healthcare schedule
The Medical Expenditure Panel Survey provides nationally representative information on

preventive care for children between 0 and 5 years of age [55]. Results indicate that the average
compliance ratio is 71.3% (SD = 1.4%), indicating that on average, parents attend about 3 out
of 4 AAP recommended well-child visits. In addition, findings reveal large variation in wellchild visit attendance based on the families socioeconomic status, access to resources, and
geography. That is, the compliance ratio was significantly below average if the child was
10
without health insurance (M = 52.5%, SD = 3.8), lived below the poverty level (M = 62.8%, SD
= 2.4), lived with a single parent (M = 65.5%, SD = 2.7), was Hispanic or Black (M = 64.5%, SD
= 2.1, or M = 64.7%, SD = 2.9, respectively), or had parents without a high-school degree (M =
60.8%, SD = 3.1). Moreover, in terms of geography, the compliance ratio ranged between 90.9%
(SD = 5.0) in New England and 51.3% (SD = 3.4) in the West South Central Census division. To
account for this variability in parental compliance with the preventive pediatric care schedule,
practices may be able to screen about 30% more children by flexibly administering screening
measures during sick-visits, when necessary [56].
2.
Competing priorities, time, and reimbursement constraints
During the last decade, the AAP [5, 6, 57] has published three separate statements on the early
detection of developmental-behavioral problems. Recommended screenings include: (1)
screening for maternal postpartum depression (in the first year), (2) broad-band developmen
tal screening (at 9, 18, and 24/30 months), (3) ASD-specific screening (at 18 and 24 months), (4)
social-emotional screening (contingent upon abnormal developmental or ASD screeners), (5)
kindergarten readiness screening (at 4 years), and (6) mental health/psychological function
screening (age 5 years and thereafter). Implementing such a dense screening schedule in the
context of short well-child visits filled with competing priorities (e.g., vaccinations, medical
surveillance), and limited reimbursement options is often noted as a key challenge by health
care professionals [53].
3.
Availability of high-quality screening instruments
Given that screening tools are being developed, revised, and evaluated on an ongoing basis,
the AAP practice guidelines do not recommend any particular ASD-specific screening instru
ment [6]. Instead, the AAP guidelines include a review of several potential measures, leaving it
up to the healthcare professional to select an instrument that fits the particular needs of their
practice. To date, the ASD-specific screening measure that has been adopted most widely in
primary care settings is the Modified Checklist for Autism in Toddlers (M-CHAT; [47, 58, 59].
The M-CHAT is a 23-item yes/no parent report screener for ASD. Screening positive (i.e., fail
ing) is defined as failing any three items, or any two of six critical items. Failed items are re
viewed with a follow-up interview, typically administered by phone a few weeks after the
screener is completed. Most of the research evaluating the efficacy of this measure has focused
on the positive predictive value (PPV), defined as the number of true positive cases divided by
number of cases that screened positive. Robins reported on the screening results of 4,797 tod
dlers (screened during their 15-, 18-, or 24-month well-child visits) [47]. The numbers of tod
dlers who failed the M-CHAT questionnaire, failed the M-CHAT follow-up interview, and
were eventually diagnosed with ASD, were 466, 61, and 21, respectively. Thus, if the results of
the follow-up interview were considered, the M-CHAT revealed a PPV of.57. However, with
out the follow-up interview, the PPV of the M-CHAT was as low as.06. These estimates are
consistent with data reported by Kleinman and colleagues [59], who reported PPVs of.65 and.
11, depending on whether the follow-up interview was or was not considered. Based on these
findings, at least three conclusions seem warranted: (1) without administering the follow-up
interview, the M-CHAT is likely to over-identify children by a factor of 17:1; (2) over-identifica
What We Do
http://dx.doi.org/10.5772/53715
tion can be dramatically reduced by administering the follow-up interview (3:1); (3) even
though the sensitivity of the M-CHAT has not been evaluated, comparisons to prevalence esti
mates of ASD suggest that the M-CHAT is likely to miss a considerable number of children [7].
Assuming current prevalence estimates (1:88), the sample reported by Roberts [47] likely in
cluded about 55 children with ASD. Even after considering participant attrition as a factor (i.e.,
families who did not complete the follow-up interview or diagnostic evaluations), the number
of children with ASD actually identified by the researchers (n = 21) is considerably lower than
would be expected.
4.
Limited parent literacy
The extent to which limited parent literacy interferes with the implementation of broad-band
developmental and ASD-specific screening measures has not been investigated. However, da
ta presented by Davis and colleagues suggest that limited parental literacy has the potential to
pose significant obstacles, particularly in the context of practices that primarily serve indigent
or immigrant communities [60, 61]. Based on a convenience sample of 396 parents from one
large medical center (i.e., Louisiana State University Medical Center, Shreveport, LA), 11% and
16% of parents showed a reading level below 4th and 7th grade, respectively. Limited parental
literacy may be an important factor in explaining missing data problems, reported across
many population-based screening studies. For example, Hix-Small and colleagues reported
that only about 54% of the administered screening questionnaires were completed and re
turned [44].
5.
Need for practice-wide system change
The successful implementation of effective screening practices requires more than educational
opportunities for individual staff members. Instead, what is needed is a context that supports
organizational restructuring [51, 62]. That is, practices need to develop, evaluate, and refine
office-wide implementation systems that divide responsibilities among staff members at
multiple levels. For example, the screening instrument may be distributed by a member of the
front desk staff, scored by a nurse, reviewed with the family by a provider, and possible
referrals may be coordinated by a social worker. Developing such an office-wide implemen
tation system requires an internal champion to lead the charge, a process for collecting data
to monitor progress, and a seamless integration with the clinics electronic medical record
system. In order to be sustainable, the implementation system also needs to be sufficiently
robust to be workable in the context of busy periods (e.g., the onset of the winter viral season)
and staff turnover.
3.2.2. Novel approaches to support autism-specific screening practices
Research suggests that traditional methods of education, including printed educational
materials and didactic, lecture-based continuing medical education (CME) sessions, have little
to no effect on the behavior of healthcare professionals [63, 64]. During recent years, several
alternative approaches to the traditional CME format have been suggested. These approaches
include specialized modules on ASD that are included as part of pediatric residency training
programs (e.g., CDC Autism Case Training) [65, 66], and academic detailing where a focused
11
12
training session on early identification of ASD is presented to the entire office staff of individual
practices [67]. In the following section, we will describe a third approach that has been used
widely to improve the delivery of high-quality healthcare, although it has yet to be imple
mented with a focus on improving early detection of children with ASD.
The Breakthrough Series Collaborative Model
The Breakthrough Series Collaborative Model (BSCM) has been developed by the Institute of
Healthcare Improvement (IHI, www.ihi.org) [68], and used successfully to improve the
delivery of preventive services by pediatric practices [69], follow-up to newborn hearing
screening [70], and child mental health service use [71]. In this model, several healthcare
provider teams partner with external experts to overcome specific barriers that impede the
delivery of high-quality care within their organization. Figure 2 presents the key elements of
a Breakthrough Series model.
Figure 2. Breakthrough Series Model
The breakthrough series starts with the selection of a specific topic that is considered ripe for
improvement. Even though data on the efficacy of learning collaboratives to increase early
identification of ASD has not been published to date, we suggest that this would be a very
appropriate topic, (1) because of the high prevalence rates of ASD, and (2) because the existing
knowledge in this area is sound but not widely used. Once the topic is selected, a faculty team
is assembled that combines expertise in the subject area as well as an improvement advisor
who coaches teams on improvement methods. Organizations elect to join the collaborative
through an application process, appointing multi-disciplinary teams within the organization
(a champions committee). The multi-disciplinary teams from all organizations are then
brought together for Learning Sessions that combine the exchange of formal academic
What We Do
http://dx.doi.org/10.5772/53715
knowledge with practical voices from peers. In between the Learning Sessions, teams engage
in Action Periods during which they implement change in a cyclical fashion: a) teams develop
a PLAN to implement change, b) they DO the work to implement the chance, c) they STUDY
their progress by measuring clinical behaviors, and d) they ACT upon the results by refining
their approach (Plan-Do-Study-Act cycles of learning).
4. Communicating concerns about autism to parents

When multiple risk factors are present (e.g., the child has a family history of ASD, the childs
parents or other family members are concerned about behaviors related to ASD, the childs
pediatrician notes concerns about ASD, or the child fails an ASD-specific screener), the AAP
clinical practice guidelines recommend that the childs PCP simultaneously (1) provides
parental education on ASD, (2) refers the child for a comprehensive ASD evaluation, (3) refers
the child for an audiology evaluation, (4) refers the child to Early Intervention or Early
Childhood Education Services, and (5) schedules a targeted follow-up visit within one month
[6]. Accomplishing all five actions simultaneously is considered crucial to avoid costly delays.
Little is currently known about how parents experience autism-specific screening, parent
education, and referrals provided by the childs PCP in accordance with the AAP clinical
practice guidelines. By definition, these interactions between PCP and parent precede a formal
ASD diagnosis. Thus, PCPs typically communicate a certain level of uncertainty about the
childs ASD diagnosis, emphasizing that the child is considered to be at high risk for ASD,
and focusing on the need for a comprehensive evaluation to rule out ASD. Even at this
tentative level, communicating concerns about ASD requires initiating or engaging parents in
a difficult conversation. For some parents, this conversation confirms suspicions that lay
dormant for various amounts of time. For other parents, it comes out of nowhere and confronts
them with concerns they had not previously contemplated. In either case, parents might not
yet be emotionally ready to consider the possibility that their child has autism. Parents often
feel responsible for their childs behavior or delays, feel guilty about not noticing or acting
upon these concerns more promptly, and fear the stigma all too often associated with devel
opmental disabilities.
When prompted to reflect upon the time when their child was first diagnosed, many parents
of older individuals with ASD express significant levels of discontentment, in some cases
resentment and anger [72, 73]. In part, these strong emotions stem from the fact that most
families experience significant delays between the time when they first note concerns [73], the
time when they choose to share these concerns with their childs physician [9, 74], the time
when their child is first evaluated [11], and the time when the ASD diagnosis is first given [7,
11]. On average, parents report seeing four to five doctors before an ASD diagnosis is made,
which occurs on average at age of four or five years [7, 11, 72, 73]. Parental perceptions of delay
in diagnosis due to watchful waiting are associated with (1) lower satisfaction with the
diagnostic process, (2) lower satisfaction with the help physicians offer after the diagnosis, and
(3) lower parental confidence in the physicians ability to help [72, 73, 75].
13
14
Parents also express dissatisfaction with the manner in which their childs pediatrician
discussed developmental concerns and/or delivered the ASD diagnosis. For example, parents
report dissatisfaction if a diagnosis is made but next steps and outcomes are not discussed [26].
Similarly, most parents of children with autism express a preference for receiving a clear ASD
label rather than hearing about their childs autism tendencies or trends [73]. This
preference for sincere, prompt, and honest information, even if this means that the physician
has to admit a level of uncertainty, can also be found in other medical conditions. For example,
cancer patients reported the highest levels of satisfaction and the lowest levels of anxiety when
they felt that their healthcare professional prepared them adequately for the diagnosis, when
they felt they were being told everything, when the word cancer was used, and when their
need to discuss life expectancy had been satisfied [76]. Importantly, high levels of trust in the
physician has been linked to high levels of adherence to recommended behavior change [77].
4.1. Barriers to successful communication between healthcare provider and parents
The AAP clinical practice guidelines recommend that once ASD is seriously considered (i.e.,
due to a failed ASD-screener or multiple risk factors) the parent is promptly educated about
ASD and referred for Early Intervention services. Research on the implementation of general
developmental screening suggests that referral rates for children who fail such screeners vary
tremendously across providers (M = 61%; range: 27% to 100%; [51]). Similarly, two descriptive
studies on early identification of ASD in the healthcare setting found that referral to a clinical
specialist (e.g., a developmental pediatrician) is the most likely response when autism is first
suspected [53, 54]. In the absence of a simultaneous referral to Early Intervention, referral to a
clinical specialist can significantly delay childrens access to services due to long waiting lists.
In addition, the preference for referring families only to a clinical specialist reveals that, even
in the presence of a failed ASD-screener, PCPs may often not feel ready to discuss autism with
the childs parents. The reasons why PCPs use their own clinical judgment or uncertainty to
override the results from a positive screening test are currently poorly understood [78]. This
being said, considering a possible ASD-specific referral requires a delicate balancing act
between the PCPs clinical judgment, tolerance for uncertainty, trust in screening tests,
expectations about parental reactions, self-efficacy with regard to giving bad news and
confidence in the available service system. In the following we will describe select components
of this tenuous balancing act, and discuss how each factor challenges the PCPs ability to
effectively communicate with parents about autism.
1.
Limited, outdated, or incorrect information on ASD and effective interventions
In a recent survey, PCPs reported feeling less competent providing care to children with ASD
compared to children with other neurodevelopmental disorders and chronic conditions [79].
As described above, research on early identification and intervention in ASD has evolved
rapidly during the last decade. Thus, PCPs may not always have access to the most current
information. For example, they may be unaware of recent advances in early diagnosis, they
may hold misconceptions about early red flags (e.g., they may erroneously assume that
children with ASD never show affectionate behaviors), or they may not be familiar or feel
passionate about the effectiveness of early intervention services [80].
What We Do
http://dx.doi.org/10.5772/53715
2.
Doubts about the accuracy of ASD-specific screening tests
Available ASD-specific screening tests are far from perfect. As discussed above, if the M-CHAT
is administered without the follow-up interview, over-identification is likely to occur at a rate
of 17:1 [47]. Several authors have emphasized the utility of second-stage autism-specific
screeners in a referral setting to help prevent over-referral and effectively direct high-risk
children toward comprehensive ASD evaluations [61, 81, 82]. Even though the M-CHAT
follow-up interview has been developed to reduce the number of false positive screens, a
feasible process for implementing this interview in the context of childrens well-child visits
has not been developed. In the absence of an effective second-stage screening process, PCPs
may use their own clinical judgment to prevent over-referrals.
3.
Expectations about parental reactions
Even though timely referrals for a comprehensive ASD evaluation and Early Intervention
services are important first steps, not all parents choose to comply with their pediatricians
referrals and pursue further evaluations [51, 75, 83]. Importantly, parental compliance rates
with ASD-specific referrals tend to be lower in younger, and higher in older children. For
example, Pierce and colleagues showed that 40% of parents refused a comprehensive followup evaluation after failing the CSBS Infant Toddler Checklist at 12 months [3]. Similarly,
Pandey and colleagues reported that 37% of parents of younger children (16 to 23 months)
refused a referral for a comprehensive ASD evaluation after a failed M-CHAT follow-up
interview [84]. In older children (24 to 30 months), the refusal rate was only 21%. In making
decisions about a childs referrals, PCPs may gauge the likelihood of a parents compliance,
and thus be more reluctant to make ASD-specific referrals for younger than for older children.
4.
Lack of experience in delivering bad news in uncertain situations
Primary care providers may be reluctant to administer population-wide screening measures

for ASD if they have had little or no training in sharing bad news with patients. A review of
the relevant literature in cancer has revealed that delivering difficult news can be stressful and
physicians may struggle with handling their own emotions of sorrow, guilt, and feelings of
failure [85]. Unsurprisingly, physicians report a desire for more training in delivering bad news
[85], and physicians who have received such training have expressed increased competence
in having conversations where difficult information needs to be delivered [86-88].
4.2. Novel approaches to improve communication about autism with parents
How to communicate difficult news to patients has been widely studied, particularly related
to cancer. For example, Eid and colleagues [87] tested a standardized intervention to im
prove communication skills in hematology-oncology fellows and nurses. The fellows and
nurses were tested pre-intervention via mock clinical interviews where a patient had to be
informed of bad news concerning their cancer care. The intervention consisted of one 45-mi
nute interactive lecture that outlined specific methodology for delivering bad news and case
scenarios to highlight proper strategies. Fellows and nurses also had the opportunity to
watch and score the investigators displaying ideal as well as incorrect practices for deliver
15
16
ing bad news. A week after the intervention, fellows and nurses participated in another
mock clinical interview. Both interviews were then scored using a fidelity checklist to meas
ure skills taught during the intervention. Results indicated that fellows and nurses scored
higher on the post-intervention clinical interview when compared to the pre-intervention in
terview; qualitatively, they also reported that the intervention improved their communica
tion skills while delivering bad news. Similar research has demonstrated that improvements
in physician communication skills are associated with improved patient outcomes, includ
ing reductions in patient distress [88] and increases in patient satisfaction with the treating
physician [89].
Multi-media training materials on communicating with parents about failed ASD-screeners
Given the short history of ASD-specific screening, little research is currently available on
how to effectively communicate with parents about failed ASD-specific screening tests. In
recent years, at least two groups have developed multi-media training materials that sup
port PCPs in this area. As part of the Learn the Signs. Act Early. campaign, the CDC de
veloped an in-class curriculum for current and future healthcare professionals, often
presented in the context of hospital Grand Rounds (http://www.cdc.gov/ncbddd/actearly/)
[65]. As part of this curriculum, learners watch and discuss video examples on how to com
municate with parents about concerning screening results as well as various strategies for
delivering difficult news. Importantly, learners are also provided with information about
the stages of grief experienced by parents of children with disabilities. Similarly, as part of a
webcast series on the medical home, the Waisman Center of the University of WisconsinMadison developed a 10-minute webcast on sharing screening results with families (http://
www.waisman.wisc.edu/connections)[90]. The webcast covers topics such as the importance
of developmental screening, understanding the difference between screening and diagnos
ing, and considering specific language to use when sharing concerns. It also discusses why
sharing screening results can be difficult, and shares specific steps to follow when sharing
screening results.
5. Supporting parents between referral and onset of services

Prompt access to Early Intervention can alter the developmental trajectory of individuals
with ASD. A recent clinical trial tested the efficacy of a comprehensive developmental be
havioral intervention program (Early Start Denver Model) in a sample of toddlers with ASD
between 18 and 30 months [91]. Results from this study revealed significant treatment ef
fects on childrens IQ, adaptive functioning, and autism symptoms. In many ways, this com
prehensive treatment model for toddlers is consistent with the report of the National
Research Council, which recommends that services should begin as soon as a child is sus
pected of having ASD and include a minimum of 25 hours a week, during which the child is
actively engaged in systematically planned, and developmentally appropriate educational
activity [92-94].
What We Do
http://dx.doi.org/10.5772/53715
Comprehensive early intervention programs, consistent with the NRC recommendations or

evidence based intervention practices [92-94] are currently not widely available to families
of toddlers with ASD. Significant wait-times may delay childrens prompt access to services
[95]. In addition, programs are also not providing services at the recommended level of in
tensity. In a national survey of Early Intervention Coordinators, the vast majority of re
spondents indicated shortages of ASD-related personnel, including behavioral therapists
(89%), speech-language pathologists (82%), and occupational therapists (79%). Further, Ear
ly Intervention Coordinators of almost half of the reporting states (44%) indicated that chil
dren with ASD receive 5 or fewer weekly service hours.
Families ability to effectively utilize intervention services has also been linked to a range of
demographic variables, including race and ethnicity [9, 96], immigrant status and cultural
beliefs [97, 98], language [68, 99, 100], and SES [101]. Further, many families face geographic
barriers in accessing ASD diagnoses and services. Children have been shown to receive di
agnoses of ASD at older ages when the family lives in an area with few neurologists and
psychiatrists [102]. Similarly, families in remote or rural areas often travel a great distance to
reach services that are not available locally [103].
5.1. PCP behaviors that contribute to delays between referral and onset of services
The current chapter focuses on the gap between best practice and community implementa
tion with regard to early identification of children with ASD. To fully support the needs of
toddlers with ASD and their families, it is important to recognize that a similar gap between
what we know and do also exists with regard to early intervention practices. Thus, to ensure
that children with ASD have access to appropriate services, PCPs should be mindful of sev
eral pitfalls that may contribute to delays between referral and onset of Early Intervention
services.
1.
Parents need to be reminded about the referrals
As described above, King and colleagues collaborated with 17 primary care practices to im
plement the AAP policy statement on developmental surveillance and screening [51]. Al
though a referral-tracking system is not specifically addressed in this policy statement, King
and colleagues noted that more than half of the practices (9 out of 17) attempted to imple
ment such a system. Because most practices include multiple healthcare professionals, a
clinic-wide referral-tracking system is necessary to monitor which children had been refer
red and where they had been referred to. On the one hand, King reported that most clinics
found referral-tracking to be a time- and labor-intensive effort that was difficult to main
tain over the long-term (p. 357). On the other hand, clinics that were successful in imple
menting such a tracking system learned very quickly that many families didnt follow
through with the recommended referrals, enabling them to develop strategies for providing
additional reminders and supports. In addition, an effective referral-tracking system ena
17
18
bled the physicians to develop better communication with local referral resources and re
ceive more consistent feedback on the children they referred.
2.
Parents need to be educated about ASD
An additional lesson learned by clinics implementing an effective referral-tracking system

was that many families did not seem to understand the reason for their childs referral [51].
The parents limited understanding is concerning, not only because it reduces the chances
that the parent will follow through with the pediatricians referral but also because a com
prehensive ASD evaluation will progress more efficiently if parents are familiar with the be
havioral characteristics of children with ASD and if they can report accurately about their
childs behavioral red flags of ASD [6]. Finally, by educating the parents about ASD at the
time when the referral is made, families have the opportunity to prepare themselves emo
tionally for the evaluation and the possibility that their child may have autism.
3.
Early Intervention administrators need to be informed that ASD is suspected
In determining eligibility for Early Intervention services, evaluations may cover multiple
areas of development, including (1) physical, including vision and hearing, (2) cognitive, (3)
communication, (4) social or emotional, and/or (5) adaptive. The developmental profile of
many toddlers with ASD is strikingly uneven with possible strengths in physical and cogni
tive development and specific delays in several social and communication milestones. Given
that ASD symptoms may be observed in the absence of global developmental delays, it is
important that the evaluation team is specifically charged with the task to rule out ASD. If
ASD symptoms are not specifically addressed during the evaluation, toddlers with ASD
who also have strengths in global development may be missed and as a result may not be
considered eligible for services.
5.2. Novel approaches to prevent delays between referral and onset of services
Several recent projects aiming to implement general developmental or autism-specific
screening in the primary care setting found it necessary to create a dedicated staff position, a
developmental or autism specialist, to provide second-stage screening services to prevent
over-referral, and/or information, support, resources and referrals to families identified with
developmental concerns [61, 104]. Other projects provided families with access to a develop
mental/autism specialist by creating a partnership with a local research group [3, 56]. Al
though this is a rather novel approach in the context of developmental and autism
screening, the idea of a patient navigation program has been popular in other medical fields
for several decades.
5.2.1. The patient navigation program
The American Cancer Society supported the nations first patient navigation program in 1990
at the Harlem Hospital Center. Founded by Dr. Harold Freeman, patient navigation originally
aimed to promote access to timely cancer diagnosis and treatment and to ensure coordinated
What We Do
http://dx.doi.org/10.5772/53715
services by assisting patients and their families to navigate through the healthcare delivery
system [105]. Ideally, patient navigators are familiar with the specific healthcare system
through which the patient must navigate, culturally attuned to the patient, and connected to
decision makers in the healthcare system. Patient navigation has the potential to improve the
continuity of care [106], promote compliance with recommended referrals by fostering trust
between patient and healthcare providers [107], and facilitate access to evaluations and
services in underserved populations by connecting them to resources most appropriate for
each patients individual needs [107]. Although a successful patient navigation program bears
significant promise for promoting early identification of ASD, such a program has not been
implemented to date.
6. Conclusion
During the last decade, research on early identification, diagnosis and intervention for toddlers
with ASD has made tremendous progress. Moreover, during recent years, the topic of
community implementation of best practice strategies has risen to the forefront. In order to
develop a sustainable service infrastructure for toddlers with ASD, systems for public
awareness, early identification, and early intervention need to be scaled up in tandem with
updated priorities in public policy and funding allocation. Eventually, efforts to increase early
identification of children with ASD will only be successful if identified children have access
to effective Early Intervention services.
Acknowledgements
Preparation of this manuscript was supported by a grant from The FAR Fund. The themes of
this chapter were informed by a public policy roundtable entitled Toddlers with Autism in
New York City, held at the Roosevelt House Public Policy Institute at Hunter College in March
2011. Roundtable participants included: Peter H. Bell, Autism Speaks; Alice S. Carter, Univer
sity of Massachusetts at Boston; Susan L. Hyman, University of Rochester; Michael Ganz,
Harvard University; Barbara Kalmanson, ICDL Graduate School; Gary Mesibov, University
of North Carolina at Chapel Hill; Donna M. Noyes-Grosser, NYS Department of Health;
Marilyn Rubinstein, New York Presbyterian Hospital; Laura Slatkin, New York Center for
Autism; Wendy Stone, University of Washington; Fred R. Volkmar, Yale University; Amy
Wetherby, Florida State University. Information about the event is available online:
www.hunter.cuny.edu/autismroundtable.
Author details
Michael Siller1*, Lindee Morgan2, Meghan Swanson3 and Emily Hotez4
19
20
*Address all correspondence to: [email protected]

1 Psychology Department, Hunter College of The City University of New York, New York,
USA
2 Autism Institute, College of Medicine, Florida State University, Tallahassee, USA
3 Psychology Department, Hunter College of The City University of New York, New York,
USA
4 Graduate Center, The City University of New York, New York, USA
References
[1] Ozonoff, S., Iosif, A.M., Young, G.S., Hepburn, S., Thompson, M., Colombi, C., et al.
Onset Patterns in Autism: Correspondence between Home Video and Parent Report.
Journal of the American Academy of Child and Adolescent Psychiatry 2011;50(8):
796-806.
[2] Bhat, A.N., Galloway, J.C., and Landa, R.J. Social and Non-Social Visual Attention
Patterns and Associative Learning in Infants at Risk for Autism. Journal of Child Psy
chology and Psychiatry 2010;51(9): 989-997.
[3] Pierce, K., Carter, C., Weinfeld, M., Desmond, J., Hazin, R., Bjork, R., et al. Detecting,
Studying, and Treating Autism Early: The One-Year Well-Baby Check-up Approach.
The Journal of Pediatrics 2011;159(3): 458-465.
[4] Kim, S.H. and Lord, C. Restricted and Repetitive Behaviors in Toddlers and Pre
schoolers with Autism Spectrum Disorders Based on the Autism Diagnostic Obser
vation Schedule (ADOS). Autism Research 2010;3(4): 162-173.
[5] American Academy of Pediatrics. Identifying Infants and Young Children with De
velopmental Disorders in the Medical Home: An Algorithm for Developmental Sur
veillance and Screening. Pediatrics 2006;118(1): 405-420.
[6] Plauche Johnson, C., Myers, S.M., and Council on Children With Disabilities. Identi
fication and Evaluation of Children with Autism Spectrum Disorders. Pediatrics
2007;120(5): 1183-1215.
[7] Center for Disease Control and Prevention. Prevalence of Autism Spectrum Disor
ders Autism and Developmental Disabilities Monitoring Network, 14 Sites, Unit
ed States, 2008. MMWR Surveillance Summaries 2012;61(SS03): 1-19.
[8] Fountain, C., King, M.D., and Bearman, P.S. Age of Diagnosis for Autism: Individual
and Community Factors across 10 Birth Cohorts. Journal of Epidemiology and Com
munity Health 2011; 65(6): 503-510.
What We Do
http://dx.doi.org/10.5772/53715
[9] Center for Disease Control and Prevention. Prevalence of Autism Spectrum Disor
ders Autism and Developmental Disabilities Monitoring Network, United States,
2006. MMWR Surveillance Summaries 2009;58(SS10): 1-20.
[10] Kim, Y.S., Leventhal, B.L., Koh, Y.J., Fombonne, E., Laska, E., Lim, E.C., et al. Preva
lence of Autism Spectrum Disorders in a Total Population Sample. American Journal
of Psychiatry 2011;168(9): 904-912.
[11] Wiggins, L.D., Baio, J., and Rice, C. Examination of the Time between First Evalua
tion and First Autism Spectrum Diagnosis in a Population-Based Sample. Journal of
Developmental and Behavioral Pediatrics 2006;27(2): S79-S87.
[12] Daniel, K.L., Prue, C., Taylor, M.K., Thomas, J., and Scales, M. Learn the Signs. Act
Early: A Campaign to Help Every Child Reach His or Her Full Potential. Public
Health 2009;123, Supplement 1(0): e11-e16.
[13] Grimshaw, J.M., Shirran, L., Thomas, R., Mowatt, G., Fraser, C., Bero, L., et al. Chang
ing Provider Behavior - An Overview of Systematic Reviews of Interventions. Medi
cal Care 2001;39(8): Ii2-Ii45.
[14] Gataullina, L., Stereotypes in Media. 2003. Available from: http://serendip.bryn
mawr.edu/local/scisoc/sports03/papers/lgataullina.html.
[15] Haddon, M. The Curious Incident of the Dog in the Night-Time. 1st ed. New York:
Doubleday; 2003.
[16] Leimbach, M. Daniel Isn't Talking. 1st ed. New York: Nan A. Talese; 2006.
[17] Adams, C. A Real Boy: A True Story of Autism, Early Intervention, and Recovery.
New York: Berkley Books; 2005.
[18] Maurice, C. Let Me Hear Your Voice: A Family's Triumph over Autism. 1st ed. New
York: Knopf; 1993.
[19] Farnall, O. and Smith, K.A. Reactions to People with Disabilities: Personal Contact
Versus Viewing of Specific Media Portrayals. Journalism & Mass Communication
Quarterly 1999;76(4): 659-672.
[20] Jones, S.C. and Harwood, V. Representations of Autism in Australian Print Media.
Disability & Society 2009;24(1): 5-18.
[21] Baird, G., Cass, H., and Slonims, V. Diagnosis of Autism. British Medical Journal
2003;327(7413): 488-493.
[22] Grinker, R.R. Unstrange Minds: Remapping the World of Autism. New York, NY:
Perseus Books; 2007.
[23] Fife, B.L. and Wright, E.R. The Dimensionality of Stigma: A Comparison of Its Im
pact on the Self of Persons with HIV/AIDS and Cancer. Journal of Health and Social
Behavior 2000;41(1): 50-67.
21
22
[24] Brown, L., Macintyre, K., and Trujillo, L. Interventions to Reduce HIV/AIDS Stigma:
What Have We Learned? Aids Education and Prevention 2003;15(1): 49-69.
[25] Lyons, M. and Ziviani, J. Stereotypes, Stigma, and Mental-Illness - Learning from
Fieldwork Experiences. American Journal of Occupational Therapy 1995;49(10):
1002-1008.
[26] Nissenbaum, M.S., Tollefson, N., and Reese, R.M. The Interpretative Conference:
Sharing a Diagnosis of Autism with Families. Focus on Autism and Other Develop
mental Disabilities 2002;17(1): 30-43.
[27] Shaked, M. The Social Trajectory of Illness: Autism in the Ultraorthodox Community
in Israel. Social Science & Medicine 2005;61(10): 2190-2200.
[28] Coulthard, P. and Fitzgerald, M. In God We Trust? Organised Religion and Personal
Beliefs as Resources and Coping Strategies, and Their Implications for Health in Pa
rents with a Child on the Autistic Spectrum. Mental Health, Religion & Culture
1999;2(1): 19-33.
[29] Nickerson, K.J., Helms, J.E., and Terrell, F. Cultural Mistrust, Opinions About Men
tal-Illness, and Black-Students Attitudes toward Seeking Psychological Help from
White Counselors. Journal of Counseling Psychology 1994;41(3): 378-385.
[30] Rideout, V., Hoff, T. Shouting to Be Heard: Public Service Advertising in a New Me
dia Age. 2002: Menlo Park, CA.
[31] Autism Speaks. Autism Speaks 2010 Annual Report. 2010; Available from: http://
www.autismspeaks.org/sites/default/files/documents/as_annual_report_2010web_01.pdf.
[32] Bertrand, J.T. and Anhang, R. The Effectiveness of Mass Media in Changing HIV/
AIDS-Related Behaviour among Young People in Developing Countries. Preventing
HIV/AIDS in Young People: A Systematic Review of the Evidence from Developing
Countries 2006;938: 205-241.
[33] Sood, S. and Nambiar, D. Comparative Cost-Effectiveness of the Components of a
Behavior Change Communication Campaign on HIV/AIDS in North India. Journal of
Health Communication 2006;11: 143-162.
[34] Hornik, R.C. Public Health Communication: Evidence for Behavior Change. 4th ed.
Mahaw: Lawrence Erlbaum Associates, Inc.; 2002.
[35] Shulman, R. Child Study Center Cancels Autism Ads. The Washinton Post 2007, De
cember 20.
[36] Randolph, W. and Viswanath, K. Lessons Learned from Public Health Mass Media
Campaigns: Marketing Health in a Crowded Media World. Annual Review of Public
Health 2004;25: 419-437.
[37] Prochaska, J.O., Redding, C.A., and Evers, K.E. The Transtheoretical Model and
Stages of Change. In: K. Glanz, B.K., Rimer, F.M., Lewis (Eds.) Health Behavior and
What We Do
http://dx.doi.org/10.5772/53715
Health Education: Theory, Research, and Practice, San Francisco: Jossey-Bass; 2002.
p99-120.
[38] Novelli, P. Healthstyles 2007 Survey. Unpublished dataset. 2007.
[39] Novelli, P. Docstyles 2007 Survey. Unpublished dataset. 2007.
[40] Social Security Act, 42 U.S.C. Chapter 7, Subchapter V, 701-710. (1989).
[41] Individuals with Disabilities Education Improvement Act, Pub. L. No. 108-446.
(2004).
[42] Werner, E.E., Honzik, M.P., and Smith, R.S. Prediction of Intelligence and Achieve
ment at Ten Years from Twenty Months Pediatric and Psychologic Examinations.
Child Development 1968;39(4): 1063-1075.
[43] Sices, L., Feudtner, C., McLaughlin, J., Drotar, D., and Williams, M. How Do Primary
Care Physicians Manage Children with Possible Developmental Delays? A National
Survey with an Experimental Design. Pediatrics 2004;113(2): 274-282.
[44] Hix-Small, H., Marks, K., Squires, J., and Nickel, R. Impact of Implementing Devel
opmental Screening at 12 and 24 Months in a Pediatric Practice. Pediatrics
2007;120(2): 381-389.
[45] Bricker, D. and Squires, J. Ages and Stages Questionnaire: A Parent-Completed,
Child-Monitoring System. Baltimore, MD: Paul H. Brookes; 1995.
[46] Bricker, D. and Squires, J. Ages & Stages Questionnaires: A Parent-Completed,
Child-Monitoring System (ASQ). 2nd ed. Baltimore, MD: Brookes Publishing; 1999.
[47] Robins, D.L. Screening for Autism Spectrum Disorders in Primary Care Settings. Au
tism 2008;12(5): 537-556.
[48] American Academy of Pediatrics. The Pediatrician's Role in the Diagnosis and Man
agement of Autistic Spectrum Disorder in Children. Pediatrics 2001;107(5):
1221-1226.
[49] Sand, N., Silverstein, M., Glascoe, F.P., Tonniges, T., Gupta, B., and O'Connor, K. Pe
diatricians' Reported Practices Regarding Developmental Screening: Are Guidelines
Used? Do They Help? Pediatric Research 2004;55(4): 68a-68a.
[50] Radecki, L., Sand-Loud, N., O'Connor, K.G., Sharp, S., and Olson, L.M. Trends in the
Use of Standardized Tools for Developmental Screening in Early Childhood:
2002-2009. Pediatrics 2011;128(1): 14-19.
[51] King, T.M., Tandon, S.D., Macias, M.M., Healy, J.A., Duncan, P.M., Swigonski, N.L.,
et al. Implementing Developmental Screening and Referrals: Lessons Learned from a
National Project. Pediatrics 2010;125(2): 350-360.
23
24
[52] Bethell, C., Reuland, C., Schor, E., Abrahms, M., and Halfon, N. Rates of Parent-Cen
tered Developmental Screening: Disparities and Links to Services Access. Pediatrics
2011;128(1): 146-155.
[53] DosReis, S. and Weiner, C.L. Autism Spectrum Disorder Screening and Management
Practices among General Pediatric Providers. Journal of Developmental and Behavio
ral Pediatrics 2006;27(2): S88-S94.
[54] Gillis, J.M. Screening Practices of Family Physicians and Pediatricians in 2 Southern
States. Infants & Young Children 2009;22(4): 321-331 310.1097/IYC.
1090b1013e3181bc1094e1021.
[55] Selden, T.M. Compliance with Well-Child Visit Recommendations: Evidence from
the Medical Expenditure Panel Survey, 2000-2002. Pediatrics 2006;118(6): E1766E1778.
[56] Miller, J.S., Gabrielsen, T., Villalobos, M., Alleman, R., Wahmhoff, N., Carbone, P.S.,
et al. The Each Child Study: Systematic Screening for Autism Spectrum Disorders in
a Pediatric Setting. Pediatrics 2011;127(5): 866-871.
[57] American Academy of Pediatrics Task Force on Mental Health. Enhancing Pediatric
Mental Health Care: Strategies for Preparing a Primary Care Practice. Pediatrics
2010;125(Supplement 3): S87-S108.
[58] Robins, D., Fein, D., Barton, M., and Green, J. The Modified Checklist for Autism in
Toddlers: An Initial Study Investigating the Early Detection of Autism and Pervasive
Developmental Disorders. Journal of Autism and Developmental Disorders
2001;31(2): 131-144.
[59] Kleinman, J.M., Robins, D.L., Ventola, P.E., Pandey, J., Boorstein, H.C., Esser, E.L., et
al. The Modified Checklist for Autism in Toddlers: A Follow-up Study Investigating
the Early Detection of Autism Spectrum Disorders. Journal of Autism and Develop
mental Disorders 2008;38(5): 827-839.
[60] Davis, T.C., Mayeaux, E.J., Fredrickson, D., Bocchini, J.A., Jackson, R.H., and Mur
phy, P.W. Reading-Ability of Parents Compared with Reading Level of Pediatric-Pa
tient Education Materials. Pediatrics 1994;93(3): 460-468.
[61] Schonwald, A., Huntington, N., Chan, E., Risko, W., and Bridgemohan, C. Routine
Developmental Screening Implemented in Urban Primary Care Settings: More Evi
dence of Feasibility and Effectiveness. Pediatrics 2009;123(2): 660-668.
[62] Pinto-Martin, J.A., Dunkle, M., Earls, M., Fliedner, D., and Landes, C. Developmental
Stages of Developmental Screening: Steps to Implementation of a Successful Pro
gram. American Journal of Public Health 2005;95(11): 1928-1932.
[63] Freemantle, N., Harvey, E.L., Wolf, F., Grimshaw, J.M., Grilli, R., and Bero, L.A.
Printed Educational Materials: Effects on Professional Practice and Health Care Out
comes. Cochrane Database Systematic Reviews 2000(2): CD000172.
What We Do
http://dx.doi.org/10.5772/53715
[64] Farmer, A.P., Lgar, F., Turcot, L., Grimshaw, J., Harvey, E., McGowan, J., and Wolf,
F.M. Printed Educational Materials: Effects on Professional Practice and Health Care
Outcomes. Cochrane Database of Systematic Reviews 2008(3).
[65] Center for Disease Control and Prevention. Autism Case Training: A DevelopmentalBehavioral Pediatrics Curriculum. 2011; Available from: http://www.cdc.gov/
ncbddd/actearly/act/class.html.
[66] Bauer, S.C., Smith, P.J., Chien, A.T., Berry, A.D., and Msall, M. Educating Pediatric
Residents About Developmental and Social-Emotional Health. Infants & Young Chil
dren 2009;22(4): 309-320 310.1097/IYC.1090b1013e3181bc1094da1090.
[67] Honigfeld, L., Chandhok, L., and Spiegelman, K. Engaging Pediatricians in Develop
mental Screening: The Effectiveness of Academic Detailing. Journal of Autism and
Developmental Disorders 2012;42(6): 1175-1182.
[68] Institute of Healthcare Improvement The Breakthrough Series: IHIs Collaborative
Model for Achieving Breakthrough Improvement. IHI Innovation Series white paper.
Boston: Institute for Healthcare Improvement; 2003. (Available on www.IHI.org)
[69] Young, P.C., Glade, G.B., Stoddard, G.J., and Norlin, C. Evaluation of a Learning Col
laborative to Improve the Delivery of Preventive Services by Pediatric Practices. Pe
diatrics 2006;117(5): 1469-1476.
[70] Russ, S.A., Hanna, D., DesGeorges, J., and Forsman, I. Improving Follow-up to New
born Hearing Screening: A Learning-Collaborative Experience. Pediatrics 2010;126:
S59-S69.
[71] Cavaleri, M., Gopalan, G., McKay, M. M., Apel, A., Bannon, W. M., & Bigley, M. F.
Impact of a Learning Collaborative to Improve Mental Health Service Use among
Low-Income, Urban Youth and Families. Best Practices in Mental Health: An Interna
tional Journal 2006;2(2): 6779.
[72] Goin-Kochel, R.P., Mackintosh, V.H., and Myers, B.J. How Many Doctors Does It
Take to Make an Autism Spectrum Diagnosis? Autism 2006;10(5): 439-451.
[73] Howlin, P. and Moore, A. Diagnosis in Autism: A Survey of over 1200 Patients in the
UK. Autism 1997;1(2): 135-162.
[74] Veness, C., Prior, M., Bavin, E., Eadie, P., Cini, E., and Reilly, S. Early Indicators of
Autism Spectrum Disorders at 12 and 24 Months of Age: A Prospective, Longitudinal
Comparative Study. Autism 2012;16(2): 163-177.
[75] Harrington, J.W., Patrick, P.A., Edwards, K.S., and Brand, D.A. Parental Beliefs
About Autism. Autism 2006;10(5): 452-462.
[76] Schofield, P.E., Butow, P.N., Thompson, J.F., Tattersall, M.H.N., Beeney, L.J., and
Dunn, S.M. Psychological Responses of Patients Receiving a Diagnosis of Cancer.
Annals of Oncology 2003;14(1): 48-56.
25
26
[77] Kosinski, M., Rogers, W.H., Safran, D.G., Taira, D.A., Tarlov, A.R., and Ware, J.E.
Linking Primary Care Performance to Outcomes of Care. Journal of Family Practice
1998;47(3): 213-220.
[78] Marks, K.P., Glascoe, F.P., and Macias, M.M. Enhancing the Algorithm for Develop
mental-Behavioral Surveillance and Screening in Children 0 to 5 Years. Clinical Pe
diatrics 2011;50(9): 853-868.
[79] Golnik, A., Ireland, M., and Borowsky, I.W. Medical Homes for Children with Au
tism: A Physician Survey. Pediatrics 2009;123(3): 966-971.
[80] Heidgerken, A.D., Geffken, G., Modi, A., and Frakey, L. A Survey of Autism Knowl
edge in a Health Care Setting. Journal of Autism and Developmental Disorders
2005;35(3): 323-330.
[81] Warren, Z., Stone, W., and Humberd, Q. A Training Model for the Diagnosis of Au
tism in Community Pediatric Practice. Journal of Developmental and Behavioral Pe
diatrics 2009;30(5): 442-446.
[82] Kobak, K.A., Stone, W.L., Ousley, O.Y., and Swanson, A. Web-Based Training in Ear
ly Autism Screening: Results from a Pilot Study. Telemedicine and E-Health
2011;17(8): 640-644.
[83] Dietz, C., Swinkels, S.H.N., van Daalen, E., van Engeland, H., and Buitelaar, J.K. Pa
rental Compliance after Screening Social Development in Toddlers. Archives of Pe
diatrics & Adolescent Medicine 2007;161(4): 363-368.
[84] Pandey, J., Verbalis, A., Robins, D.L., Boorstein, H., Klin, A., Babitz, T., et al. Screen
ing for Autism in Older and Younger Toddlers with the Modified Checklist for Au
tism in Toddlers. Autism 2008;12(5): 513-535.
[85] Fallowfield, L. and Jenkins, V. Communicating Sad, Bad, and Difficult News in Med
icine. Lancet 2004;363(9405): 312-319.
[86] Baile, W.F., Buckman, R., Lenzi, R., Glober, G., Beale, E.A., and Kudelka, A.P. Spikes
a Six-Step Protocol for Delivering Bad News: Application to the Patient with Can
cer. The Oncologist 2000;5(4): 302-311.
[87] Eid, A., Petty, M., Hutchins, L., and Thompson, R. "Breaking Bad News": Standar
dized Patient Intervention Improves Communication Skills for Hematology-Oncolo
gy Fellows and Advanced Practice Nurses. Journal Of Cancer Education: The Official
Journal Of The American Association For Cancer Education 2009;24(2): 154-159.
[88] Roter, D.I., Hall, J.A., Kern, D.E., Barker, L., Cole, K.A., and Roca, R.P. Improving
Physicians' Interviewing Skills and Reducing Patients' Emotional Distress: A
Randomized Clinical Trial. Archives of Internal Medicine 1995;155(17): 1877-1884.
[89] Delvaux, N., Razavi, D., Marchal, S., Bredart, A., Farvacques, C., and Slachmuylder,
J.L. Effects of a 105 Hours Psychological Training Program on Attitudes, Communi
What We Do
http://dx.doi.org/10.5772/53715
cation Skills and Occupational Stress in Oncology: A Randomised Study. Br J Cancer

2004;90(1): 106-114.
[90] Waisman Center of the University of Wisconsin-Madison, Wisconsin Medical Home
Webcast Series. 2011. Available from: http://www.waisman.wisc.edu/connections.
[91] Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., Greenson, J., et al. Random
ized, Controlled Trial of an Intervention for Toddlers with Autism: The Early Start
Denver Model. Pediatrics 2010;125(1): E17-E23.
[92] National Research Council. Educating Children with Autism. USA: National Acade
my Press; 2001.
[93] Odom, S.L., Boyd, B.A., Hall, L.J., and Hume, K. Evaluation of Comprehensive Treat
ment Models for Individuals with Autism Spectrum Disorders. Journal of Autism
and Developmental Disorders 2010;40(4): 425-436.
[94] Boyd, B.A., Odom, S.L., Humphreys, B.P., and Sam, A.M. Infants and Toddlers with
Autism Spectrum Disorder: Early Identification and Early Intervention. Journal of
Early Intervention 2010;32(2): 75-98.
[95] Downs, R.C. and Downs, A. Practices in Early Intervention for Children with Au
tism: A Comparison with the National Research Council Recommended Practices.
Education and Training in Autism and Developmental Disabilities 2010;45(1):
150-159.
[96] Mandell, D.S., Wiggins, L.D., Carpenter, L.A., Daniels, J., DiGuiseppi, C., Durkin,
M.S., et al. Racial/Ethnic Disparities in the Identification of Children with Autism
Spectrum Disorders. American Journal of Public Health 2009;99(3): 493-498.
[97] Lindsay, S., King, G., Klassen, A.F., Esses, V., and Stachel, M. Working with Immi
grant Families Raising a Child with a Disability: Challenges and Recommendations
for Healthcare and Community Service Providers. Disability Rehabilitation
2012;34(23):2007-17.
[98] Welterlin, A. and LaRue, R.H. Serving the Needs of Immigrant Families of Children
with Autism. Disability & Society 2007;22(7): 747-760.
[99] Williams, M.E., Atkins, M., and Soles, T. Assessment of Autism in Community Set
tings: Discrepancies in Classification. Journal of Autism and Developmental Disor
ders 2009;39(4): 660-669.
[100] Kim, C., Disare, K., Pfeiffer, M., Kerker, B.D., and McVeigh, K.H. Effects of Individu
al and Neighborhood Characteristics on the Timeliness of Provider Designation for
Early Intervention Services in New York City. Journal of Developmental and Behav
ioral Pediatrics 2009;30(1): 38-49.
27
28
[101] Durkin, M.S., Maenner, M.J., Meaney, F.J., Levy, S.E., DiGuiseppi, C., Nicholas, J.S.,
et al. Socioeconomic Inequality in the Prevalence of Autism Spectrum Disorder: Evi
dence from a US Cross-Sectional Study. Plos One 2010;5(7).
[102] Kalkbrenner, A.E., Daniels, J.L., Emch, M., Morrissey, J., Poole, C., and Chen, J.-C.
Geographic Access to Health Services and Diagnosis with an Autism Spectrum Dis
order. Annals of Epidemiology 2011;21(4): 304-310.
[103] Gething, L. Sources of Double Disadvantage for People with Disabilities Living in
Remote and Rural Areas of New South Wales, Australia. Disability & Society
1997;12(4): 513-531.
[104] Shannon, P. and Anderson, P.R. Developmental Screening in Community Health
Care Centers and Pediatric Practices: An Evaluation of the Baby Steps Program. In
tellectual and Developmental Disabilities 2008;46(4): 281-289.
[105] Freeman, H.P. Patient Navigation: A Community Centered Approach to Reducing
Cancer Mortality. Journal of Cancer Education 2006;21: S11-14.
[106] Bradford, J.B., Coleman, S., and Cunningham, W. HIV System Navigation: An
Emerging Model to Improve HIV Care Access. AIDS Patient Care STDS 2007;21
Suppl 1: S49-58.
[107] Natale-Pereira, A., Enard, K.R., Nevarez, L., and Jones, L.A. The Role of Patient Navi
gators in Eliminating Health Disparities. Cancer 2011;117(15): 3543-3552.
Chapter 2
Indicators of Autism in Iranian Children

Sayyed Ali Samadi and Roy McConkey
http://dx.doi.org/10.5772/52853
1. Introduction
Autism occurs in every country of the world. However its prevalence varies greatly across
nations with higher rates being reported in more affluent, English speaking countries. The
lower rates in less developed countries have been attributed to a lack of knowledgeable per
sonnel in child assessment and diagnostic services and their slow response to parental con
cerns [1]. While this is certainly a major impediment to early identification, other social and
cultural factors may play a part. In particular, expectations of childrens development and
behaviours may mean that parents attach less significance to certain early indicators of Au
tism across different cultures [2]. If this were so, then screening and other assessment tools
developed in Western countries may not be sufficiently sensitive to detect early signs of Au
tism in other societies [3].
This chapter summarises the findings from two studies in Iran that identified the items that
best discriminated children who had a diagnosis of autism. In the first study, the Gilliam
Autism Rating Scale - Second edition GARS ll [4] was used. Comparisons are drawn be
tween three groups of children aged 3 to 16 years: those with a compared diagnosis of Au
tism; children with intellectual disabilities and those whose development was considered to
be normal.
The second study focussed on the Autism Diagnostic Interview- Revised (ADI-R) [5]. This
tool was developed for use by clinicians to assist in making a diagnosis of autism usually
after referral that follows from the use of a screening tool such as GARS. In all the perform
ance of 333 children (84%) with a confirmed diagnosis of Autism could be confirmed with
those of 64 (16%) who were not given this diagnosis although they had screened positive.
The findings from these two major studies together identify those indicators of autism that
appear to be more culturally specific to Iranian or similar cultures. However comparisons
are drawn with similar data from other countries to underline the universality of certain au
2013 Samadi and McConkey; licensee InTech. This is an open access article distributed under the terms of
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
30
tistic traits [6]. Nevertheless the implementation of tools for the identification of children
with autism has to be located within wider considerations; notably the education of parents
and professionals around indicators of atypical child development and the possible environ
mental influences on childrens behaviours.
2. Identifying children with autism in different cultures

Children with autism have deficits in three developmental domains: communication, social
isation and restricted interests along with repetitive behaviours [7]. These criteria are pre
sumed to hold across all cultures although there is growing evidence of cultural variations
in the way children may present with Autism. Indeed there are good theoretical grounds for
expecting this to be so. Theories on human development propose that children develop
through adapting to the multidimensional, intersecting environments within which they
live and grow, the most proximate of which are their parents and families [8]. Parental influ
ences on their childs development may therefore vary in different cultures depending on
their beliefs about normative development, the relative value their culture places on differ
ent behaviors and the meaning attributed to them[9;10]. For example, in Western societies
the absence of direct eye contact is an early indicator of ASD yet in Chinese and Japanese
societies, such eye contact is uncommon as looking directly into someones eyes is consid
ered shameful in these parts of East Asia [11].
Studies done in the Western societies around early signs of autism, [12] found that the most
common parental concerns were for delay in speech and language development, followed
by abnormal signs of socio-emotional behaviour and medical problems or delay in reaching
milestones. By contrast, Daley [13] found that with Indian parents, social difficulties - such
as lack of interest in people, poor eye contact and showing no interest in playing with other
children - were rated as the first parental concern with delay in speech as a secondary con
cern. These variations in cultural expectations are likely to exist among indigenous profes
sionals as well as parents.
The diagnosis of autism varies across different ethnic groups within countries. Mandell et al.
[14] in a study of over 2,500 eight year-olds in the USA, reported that children from Black,
Hispanic and other ethnic or racial groups were less likely than white children to have a
documented autism spectrum disorder. Valicenti-McDermott et al. [15] found that children
of Hispanic and African American origin, foreign-born children, and children born to for
eign mothers were more likely to be diagnosed at an older age than those from white Ameri
can parentage. Likewise in Holland, fewer children from Moroccan or Turkish immigrants
than native born Dutch children were referred for assessments for ASD [16]. Moreover pae
diatricians (n = 81) more often referred to autism when judging clinical vignettes of Europe
an majority cases (Dutch) than vignettes of minority cases.
Cultural influences may also explain to some extent the variation in prevalence rate of ASD
reported across different countries. A systematic review of 40 studies [17], reported rates
varying from 3.8 per 10,000 in Norway, 5.4 in France and 5.6 in Finland through to a high of

http://dx.doi.org/10.5772/52853
60 per 10,000 in Sweden. However in London, a more thorough study reported a prevalence
rate of 38 9 per 10,000 for autistic disorders and for other ASDs at 77 2 per 10,000; giving a
total prevalence for all ASDs of 116 1 per 10,000 [18]. A regression analyses of the prevalence
studies found that the most significant influence on ASD rates was the diagnostic criteria
used, followed by the age of child when identified, the country of origin and urban/rural lo
cation of the sample [17].
These same factors may also account for the variation in prevalence rates that have been re
ported within countries even when ascertainment method, age group and reporting period
are similar. In the USA, the prevalence of all ASDs in eight year old children varied across
eleven sites from 42 per 10,000 in Florida to 121 per 10,000 in Arizona and Missouri [19]. Us
ing special education data on students with ASD, Coo at al., [20] reported a prevalence of
43.1 per 10,000 among 49 years school children in the British Colombia Province of Canada
whereas in Quebec it is reported at less than half this, at 21.6 per 10,000 [21].
One explanation for differences in the prevalence and identification of ASD across cultures
and regions is varying awareness of the criteria associated with a diagnosis of ASD [6]. More
specifically, it appears that differences may be more likely to arise cross culturally due to
various factors such as when a symptom is perceived, by whom, and what behaviour is
noticed first, as well as whether it is perceived as problematic ([2], p. 538). Moreover cul
tural attitudes regarding typical behaviours and what is perceived to be normal or abnormal
development for that culture would also have an impact on diagnosis of an ASD. Hence
children may be more or less susceptible to a diagnosis of an ASD dependent on the cultural
expectations of parents and indigenous professionals. Thus screening and other assessment
tools for autism developed in Western countries may not be sufficiently sensitive to detect
early signs of autism in other societies and could possibly underestimate the prevalence of
the condition [3].
3. Screening and assessing children for autism

A two-stage process for identifying children with autism is operational in many countries
[22]. The first stage involves a universal screening of all children and various tools have
been developed for use with children at different ages. They consist of a series of items indi
cative of autism and use parents as the primary informants. For example the CHAT (Check
list for Autism in Toddlers) is a screening tool developed for use with infants aged 18
months developed in the UK [23] that has also been adapted for use in the USA (M-CHAT:
[24]) and which has shown promise for use in Arab countries [25]. More recently, ten item
screening tools have been developed for use with children, adolescents and adults based on
the Autism Quotient developed in the UK [26]. Those individuals who screen positive
their scores exceed a designated cut-off point - are then referred for more detailed diagnostic
assessment.
A range of diagnostic tools for autism also have been developed [27]. These are based on
DSM-IV/ICD-10 criteria for autism and information about the child is usually obtained
31
32
through a detailed, structured interview with parents. However a multi-disciplinary as

sessment by experienced clinicians is also recommended including a physical examination
along with developmental and/or psychometric evaluations. These will enable a differen
tial diagnosis to be made for autism from other conditions in which there is overlap of
symptomology [28].
Such assessments can be time-consuming and costly. Their efficiency is determined by the
referrals from the screening tests. If individuals are screened as positive for autism but are
not subsequently diagnosed as having autism (false positives) this can mean wasted efforts
by the diagnostic team. The converse is also concerning. Children may screen as negative for
autism but had they been assessed, they might have been given a diagnosis of autism (false
negatives). Thus the effectiveness of the screening test needs to be assessed in terms of its
sensitivity (true positives are identified) and its specificity (false negatives are avoided).
Thus the choice of items that are included in the screening test is crucial. To date, the screen
ing tools have been developed within Western societies and given the earlier comments
about cultural influences, it is conceivable that at least some of these items may not be suited
for use in other cultures. The risk then is that the efficiency of the screening tool is diminish
ed within that society [11]. Indeed the same argument may apply when screening individu
als from immigrant communities in Western countries.
4. Autism in Iran
The Islamic Republic of Iran, formerly known as Persia, is located in the Middle East. The
capital city is Tehran. Iranian society is distinct from other Islamic societies of the MiddleEast and Central Eurasia in terms of its long history of civilisation, its geographical location,
separate language (Persian) and religious denomination (Shia Muslim).
It is a vast country of 1.65 million sq km, extending in the north from the Caspian Sea to the
Persian Gulf, Strait of Hormuz, and Oman Sea in the south, and from Afghanistan and Paki
stan in the east to Iraq and Turkey in the west. Persians (51% population) are the largest eth
nic group in the Republic within the total population of 74.8 million. The main minorities
are Azeri (24%), Gilaki and Mazandarani (8%), and Kurds (7%). People are mainly Muslims
(89% Shia Muslims and 9% Sunni Muslims). Iran became an Islamic Republic in 1979 and is
divided into 31 provinces, each of which is headed by a governor-general appointed by the
Minister of the Interior.
Children with ASD will usually be diagnosed by medical doctors either privately or through
child and family clinics provided by voluntary organisations. State-funded special schools
are provided through the Iranian Special Education Organisation although many parents
may opt for private schooling. In addition, parents will arrange private therapy for their
children. For children more severely affected or with other conditions such as intellectual
disability, day centre placements are available through the Iranian State Welfare Organisa
tion. However, these services are only available in larger cities and probably only for more

http://dx.doi.org/10.5772/52853
affluent families. Provision for adult services is mostly through private or voluntary organi
sations that also rely heavily on parental fees.
Iran is one of the few countries that has a national screening programme for autism prior to
childrens entry to compulsory education at age 6. An analysis of data obtained on over 1.32
million children aged 5 years of age screened over a three-year period, yielded an overall
Iranian prevalence of 6.26 per 10,000 [1]. Although this rate is similar to that previously re
ported for certain European countries and for Hong Kong, it is much lower than those re
ported for Sweden, USA and England [29].
4.1. Indicators of autism in Iran
The main aim of the two studies reported in this chapter was to identify the most common
indicators of autism for Iranian parents whose children had been given a diagnosis of au
tism. As argued above, this investigation would identify items for use in screening tests that
would be culturally sensitive for an Iranian culture. However the initial pool of items would
be drawn from those behaviours that define autism internationally according to DSM-IV [7]
and ICHD-10 [30]. These were taken from two commonly used scales for autism the Gil
liam Rating Scale for Autism (GARS) and the Autism Diagnostic Interview revised (ADIR). Although developed in the USA and the UK respectively, they have been translated for
use in other countries.
The most common indicators of autism would be chosen as those that best discriminated
children with a diagnosis of autism from age peers who were normally developing; from
those who were considered to have an intellectual disability and from those who were ini
tially suspected of having autism but were not diagnosed as such following assessment.
The resulting set of indicators would have particular relevance for the development of fur
ther screening tools in Iran but these findings might have wider applicability to other Mus
lim cultures and non-Western societies.
4.2. Study 1: Screening for autism
The Gilliam Autism Rating Scale - Second edition GARS ll [4] was developed in the United
States of America and is based on DSM-IV diagnostic criteria for autism. It is widely used in
hospitals, school and clinics across the USA with good psychometric properties which sub
sequent evaluation studies have confirmed [40]. The main reservations concerning its use,
centre on the cut-off points that are taken to be indicative of autism. The consensus is that
these should be set at a lower level than recommended in the test manual [41].
This tool takes the form of a behaviour checklist developed for use with children and youth
aged 3 to 22 years. It consists of 42 items grouped into three subscales: Stereotyped Behav
iours, Communication, and Social Interaction which are combined into a standard score
called the Autism Index with higher scores indicative of ASD. A further 14 items contrib
ute data about the childs development during the first three years of life which are used to
supplement information about the childs current level of functioning. Reliability and validi
33
34
ty data for the English version of the test is available based on a normative sample of 1,107
individuals with ASD and 328 non-ASD persons and those with other developmental disa
bilities. Coefficients of reliability (internal consistency and test-retest) for the subscales and
Autism Index range from 0.80 to 0.90.
For the purpose of this study the first author translated the GARS II assessment tool from
English to Persian. The Iranian version was back-translated and reviewed for language clari
ty and appropriateness for use in Iranian culture. The tool was then pilot tested with 15 Ira
nian families with a child who had screened positive for ASD and included parents from
different socio-economic backgrounds. Five of the 42 questions were unclear to parents and
these items were reworded for greater clarity.
4.2.1. Recruiting samples
Three groups of children aged between 3 and 16 years were recruited: those who had been
given a diagnosis of autism; those diagnosed as having an intellectual disability and those
whose development was considered to be normal. Recruitment took place in four Provinces
of Iran in order to achieve a geographical spread.
Children with ASD in the age range 5 to 10 years generally received a confirmed diagnosis
from trained diagnosticians from the Iranian Special Education Organisation (see Samadi et
al [1] for further details) or were admitted to the ASD special schools based on being at high
risk of ASD which meant that they would be re-evaluated one year after their registration.
Other children with ASD above or below this age range, had received a confirmed diagnosis
from the paediatrician or neurologists based on DSM IV criteria.
All the children with an Intellectual Disability aged 5 to 16 had received an approved diag
nosis from ISEO and children under 5 received a confirmation of diagnosis from the paedia
trician based on their developmental assessments and clinical presentation (i.e. Down
Syndrome or other conditions associated with an intellectual disability).
Parents of children with ASD and ID were recruited from special schools (both public and
private) whereas parents of preschool children were recruited from mother and child clinics.
The normally developing sample were chosen from mother and child clinics, schools and
from membership of the Parents and Teachers Association which has branches in all the cit
ies in Iran.
4.2.2. Procedure
All parents were informed about the aims of the study initially through a written notifica
tion sent from the clinic or schools but these were repeated verbally when the first author
met the parents when their consent to participate was obtained. Parents of children with
ASD and children with ID were met individually, the written instructions for completing
the scales were explained to them and they were assisted to complete the ratings scales as
necessary. Also 30 parents of normally developing children in Alborz province were met
personally during eight days in two schools. The remainder of parents whose children were

http://dx.doi.org/10.5772/52853
developing normally were given the ratings scales at a group meeting and asked to return
them within two weeks and 97% did so.
4.2.3. Study participants
In all data was obtained on 532 children: 390 with autism; 55 intellectually disabled and 87
normally developing. Their mean age was 10.5 years (SD 3.1). However those with autism
were significantly older (mean age 10.9 yrs) than those in the other two groups (9.4 years).
As commonly found with autism; many more boys than girls were identified (81% v 19%);
The gender ratio for the children with ID was (49% male v 51% female) and normally devel
oping (64% male v 36% female).
The children were recruited from four provinces in Iran: Tehran (35%) Alborz (21%) Razavi
Khorasan (25%) and Western Azerbaijan (19%). Proportionately more children with ID came
from Tehran Province but children with autism and those developing normally came from
all four Provinces.
4.2.4. Item analysis
In seeking to identify the items that best discriminated the three groups from the 42 items
included in the GARS scale the items were arranged into those that the highest percentage
of children with autism displayed but with the least percentage of children with intellectual
disability and those who were developing normally. The top 16 items were then selected us
ing the following criteria:
Over one-third of children with ASD showed the behaviour AND
Normally developing children did not show the behaviour or it was shown by fewer than
12% of these children AND
The proportion of children with intellectual disability who showed the behaviour was
fewer than half of the proportion of children with a diagnosis of autism.
Our aim was to reflect the range of behaviours that can be indicative of the variation among
children with autism and yet maximised their distinctiveness.
Table 1 summarises the percentage of children within each group who were sometimes or
frequently observed to show these behaviours. These are ordered by those most commonly
seen in children with autism. The subscale from which the item came is also noted.
These 16 items were then tested for their scaling properties. The Chronbach alpha of internal
reliability was acceptably high at 0.89 (N=422).
A total score could be calculated for each child on these 16 items with a minimum score of 0
(all items scored as never or rarely seen) and a maximum of 16 (all items scored as some
times or frequently observed). Table 2 presents the summary statistics for the three groups
of children on this computed measure as well as for the total group. With this sample no
ceiling effects were present on the scale.
35
36
Subscale
Item
ASD
Intellectual
Non-disabled
Disability
Communication
Uses gestures instead of speech or uses signs to
67.0%
0%
2.3%
66.2%
21.8%
0%
Stereotyped
Makes high-pitched sounds (e.g. eee-eee-eee) or 65.4%
12.7%
6.9%
behaviour
other vocalizations for self-stimulation
Social Interaction
Does not imitate other people when imitation is 65.0%
3.6%
0%
60.5%
0%
4.6%
obtain objects
Social Interaction
Withdraws, remains aloof or acts stand-offish in

group situations
required or desirable such as in games or learning

activities
Social Interaction
Stares or looks unhappy or unexcited when

praised humoured or entertained
Social Interaction
Laughs, giggles, cries inappropriately
56.5%
21.8%
0%
Social Interaction
Behaves in a unreasonably fearful or frightened
55.6%
12.2%
0%
55.4%
9.8%
11.5%
Shows no recognition that a person is present (i.e. 50.0%
3.6%
0%
48.5%
16.4%
11.5%
46.7%
12.7%
4.2%
Uses the word I inappropriately e.g. does not say I 45.7%
14.5%
0%
12.7%
0%
manner
Communication
Does not initiate conversations with peers or

adults
Social Interaction
looks through people)

Stereotyped
Stares at hands, objects or items in the
behaviour
environment for at least 5 secs
Social Interaction
Avoids eye contact, looks away when someone

looks at him or her
Communication
to refer to self)
Stereotyped
Flicks fingers rapidly in front of eyes for periods of 43.6%
behaviour
5 secs or more
Stereotyped
Flaps hands or fingers in front of face or at sides
42.4%
9.1%
0%
Stereotyped
Smells or sniffs objects (e.g. toys, persons hand,
34.4%
3.6%
0%
behaviour
hair)
Stereotyped
Whirls, turns in circles
34.1%
14.5%
4.6%
behaviour
behaviour
*Communication items are scored on N=422 for whom these items were rated; otherwise n=532.
Table 1. The percentage of Iranian children in each sample who were sometimes or frequently observed to show the
selected behaviours.

http://dx.doi.org/10.5772/52853
Type of development
Mean
Std. Deviation
Median
Minimum
Maximum
Autism Spectrum
294
8.31
3.71
8.00
1.00
15.00
Intellectual Disability
41
1.41
1.67
1.00
.00
6.00
Normally developing
87
.51
.76
.00
.00
2.00
Disorder
Table 2. Mean, SDs, Median and range scores on 16 items for the three groups (N=422)
The between group differences were statistically significant (F=252.6; p<0.001) as was the
variation within each group as indicated by the Standard Deviations with normally devel
oping children showing the least variation and those with autism the most
Using the summary scores it was also possible to check if these indicators varied by age of
the child. The Pearson Product Moment correlation was small although significant r=0.138
(p<0.005) with older children having higher scores. As regards childs gender, boys had sig
nificantly higher scores than girls (Mean 6.46 v 4.72: F=11.06: p<0.005). Scores were also
higher when fathers were the sole informants (mean 7.69) compared to mothers (mean 5.56)
(F=4.98:p<0.01). Also those children residing in the Provinces of Tehran and Mashahd
(means 6.92 and 6.71) had higher scores than children in two other provinces Alborz (Mean
5.04) and Western Azarbayjan mean 4.61).
A regression analysis was then used to control for the inter-relationships among these var
iables and with the childrens grouping of autism, ID and normal development. Indeed it
was children with autism who had the highest Beta scores (=7.89: 95% Confidence Inter
val [CI] 7.25-8.49: t=24.91 p<0.001) and the effect of childs age and gender were not signif
icant. However children living in Tehran ( =1.53: CI 0.75-2.30: t=3.86 p<0.001) and
Mashahd Provinces (=1.45: CI 0.60-2.30: t=3.34 p<0.001) tended to score higher than in the
other two provinces.
Finally correlations were computed between the scores on the 16 items with the total scores
on the GARS ratings for the three subscales and the total score. All correlations were statisti
cally significant (p<0.001) but highest with the total score and social interaction subscale and
lowest with the communication subscale.
Correlations 16 items score with ...
Pearson Product Moment

Correlations
Stereotyped behaviours subscale
r=0.861**
Communication
r=0.445**
Social Interactions
r=0.902**
Total score on GARS 42 items
r=0.903**
Table 3. Correlations between 16 item scale and GARS scores
37
38
4.2.5. Conclusions
Based on the 42 items included in the GARS Scale, it was possible to identify 16 items based
on parental ratings that efficiently discriminated between children with autism and those
who were normally developing and those with intellectual disabilities. These items were
drawn in the main from the social interaction (N=7) and stereotyped behaviour subscales
(N=6) with fewer coming from the Communication domain (N=3). A further paper provides
further data on the utility of GARS with an Iranian population and on the sensitivity and
specificity of the 16 item as a screening tool [31].
4.3. Study 2: Diagnosing autism
In the second study the focus was in identifying the indictors that would distinguish chil
dren who were ultimately diagnosed with autism from those who were suspected of having
the condition but on further examination were thought not to have autism. To do this, we
accessed childrens assessments on the Autism Diagnostic Interview-revised (ADI-R). Al
though widely used by clinicians internationally, this tool has been criticised on the length
of time taken to administer and its focus on more severe forms of the condition [42]. Howev
er it was the tool chosen by the Iranian Special Education Organisation to assess children
who screened positive for autism in the national screening program.
ADI-R takes the form of a structured interview with parents and consists of 93 items ar
ranged in three functional domains: Language/Communication; Reciprocal Social Interac
tions and Restricted, Repetitive, and Stereotyped Behaviours and Interests. Items are scored
for the behaviour that the child has ever showed as well as those showed at present. It is the
latter items that were included in this study.
The Persian version ADI-R [32] had been standardised on a sample of 100 children with
ASD, 9 children with intellectual disability and 100 normally developing children. The sam
ple age range was from 4 to 14 and they were drawn from different provinces. A Chronbach
alpha of 0.85 (for present behaviours) was reported. The test retest reliability on a sample of
33 children (24 with autism and 9 ID) with a 4-6 week interval was 0.99 for items relating to
unusual social interaction, 0.99 for Language and Communication and 0.96 for Repetitive
and Stereotyped behaviours.
4.3.1. Procedure
The ADI-R assessments were obtained for 397 children who had screened positive for au
tism in the national screening programme for all six-years prior to school entry (see Samadi
et al.[1]). The ADI-R Persian version was administered by specialists from the Iranian Spe
cial Education Organisation in the form of structured interview with one or both parents
supplemented by observations of the child. Also included in this sample were older children
who had been admitted to schools for children with ASD, but who needed to be assessed to
reconfirm the diagnosis which may have been given by a professional other than those em
ployed by the Iranian Special Education Organisation or by means of other diagnostic tools.

http://dx.doi.org/10.5772/52853
Following the diagnostic interview, 333 children (84%) were confirmed in having autism; for
20 (5%) the diagnosis was uncertain and 44 (11%) were thought not to have autism. For the
purposes of this study the latter two groups were combined.
4.3.2. Study participants
Of the 397 children 80% were male and 20% female. Their mean age was 7.3 years (range 5
to 14 years). In all, 32% were only children and a further 43% had one sibling with 25% hav
ing two to six siblings. In 23 families (5.8%), there was another child with a developmental
disability although 30% of families reported having a person with mental or developmental
disabilities in the wider family circle.
The mean age of mothers was 35.4 years (range 24 to 53 yrs) and of fathers 40.8 years (range
25 to 77). Of the mothers, 120 (30.2%) had completed university education as had 147 fathers
(37%). A further 139 mothers (35%) and 123 fathers (31%) had completed high school. The
remaining 138 mothers (27.8%) and 127 fathers (32%) had been to middle or elementary
school. In 124 families (31%) the parents were related.
4.3.3. Item analysis
As in Study 1, the items relating the childrens present behaviours were arranged into those
that the highest percentage of children with autism displayed but with the least percentage
of children who were thought not to have autism. The top 13 items were then selected so as
to reflect the variation among children with autism but also discriminating those with the
condition from those unlikely to have it. The following criteria were applied to do this.
Over 50% of children with a diagnosis of ASD showed the behaviour AND
Fewer than 50% of those children not diagnosed as autism showed the behaviour AND
The percentage of autism children showing the behaviour was at least double the percent
age of those without autism.
The 13 items met these criteria are listed in Table 4. They are ordered by those most com
monly seen in children with autism. The sub-grouping is also noted.
One previous study in Iran had identified the indicators most commonly found in a sample
of 61 children (mean age 7 years) assessed clinically assessed as having autism [33]. They
were: stereotyped and repetitive behaviours; lack of make-believe play, failure to initiate
conversations, use of rituals, motor mannerisms, no spoken language, poor social reciprocity
and impaired peer relations. Most of these behaviours are reflected in this study.
The 13 items were tested for their scaling properties and the Chronbach alpha of internal re
liability was acceptably high at 0.866 (N=397).
A total score could be calculated for each child on these 14 items with a minimum score of 0
(all items scored as never or rarely seen) and a maximum of 14 (all items scored as ob
served). Table 5 presents the summary statistics for the two groups of children on this com
39
40
puted measure as well as for the total group. The differences on scores between the two
groups was significant (F=238.0 p<0.001).
Ref num
Communication 42
Item
Autism
Non-Autism
N=333)
(N=64)
80.2%
31.7%
Mis-uses pronoun I and refers to self by name rather 80.2%
38.3%
Does not attempt or limited attempt to express

interest by pointing
Communication 37
than with pronoun.

Social Interaction 50
Uncertain, odd or occasional use of gaze in social
78.0%
28.1%
73.4%
21.9%
interactions
Repetitive Behaviours 69
Play is linked to highly stereotypic use of objects or

attention; interested in infant toys such as music boxes
and rattles,.
Social Interaction 53-2
No spontaneous sharing or no sharing.
72.7%
21.9%
Stereotyped, inappropriate, very limited or no
71.6%
19.0%
68.7%
17.2%
Little or no coordination of eye gaze and vocalisations 67.0%
25.4%
responses to people except parents.

Little or no smiling at people though may smile at

things; no reciprocal smiling.
Social Interaction 56
or weakly integrated.
Special or circumscribed interests that can interfere
63.6%
15.6%
with social activities

Marked mannerisms of hands and fingers that may or 62.8%
3.1%
may not interfere with social activities

Lack of interest in other children; may watch them but 61.9%
20.0%
almost never tries to approach them.

Has one to two unusual sensory interests that may
58.3%
14.1%
50.8%
6.3%
take major amount of time.

Complex and stereotyped bodily movements
Table 4. The percentage of Iranian children in the two groups who were observed to show the selected behaviours
from the ADI-R.

http://dx.doi.org/10.5772/52853
Group
Mean
Std. Deviation Median
Minimum
Maximum
ASD
333
8.65
2.63
10.00
.00
13.00
Not ASD and uncertain
64
2.97
2.89
2.00
.00
12.00
Total
397
8.37
3.81
9.00
.00
13.00
Table 5. Mean, SDs, Median and range scores on 13 ADI-R items for the two groups
Using the summary scores it was also possible to check if these indicators varied by age of
the child. The Pearson Product Moment correlation was small although significant r=-0.162
indicating that younger children scored more highly on these 13 items (p<0.001).
However there were no statistically significant differences by childs gender, mothers age,
level of education, if the child had siblings, or if there was a another child with develop
mental problems in the family. This was further confirmed in a regression analysis to con
trol for inter-relationships among the possible predictor variables and with the childrens
diagnosis. It was children diagnosed with autism who had the highest Beta scores (=5.59:
95% Confidence Interval [CI] 4.57-6.40: t=15.57 p<0.001) but the childs age was also a sig
nificant additional variable ( =-0.20: CI 0.03-0.37: t=2.37, p<0.05) with younger children
scoring more highly irrespective of their diagnosis.
4.3.4. Conclusions
It was possible to identify 14 items on the ADI-R that could reasonably well discriminate be
tween those children who would receive a confirmed diagnosis of autism and those who did
not. However these items are also more likely to be found in younger children irrespective
of the diagnosis.
5. Comparison of indicators from study and study 2

Finally a common set of best indicators could be identified across the two studies al
though there was some variation in wording and overlap across the two chosen rating
scales see Table 6. Nonetheless these items reflect the three domains that typify autism
although with more emphasis on social interaction and repetitive behaviours than on
communication.
However on both scales there were additional items that served to distinguish children
with autism (see Table 7) and depending on the intended purpose, these items could be
used to supplement those listed in Table 6 for the purposes of screening children for au
tism (GARS items) or clarifying the diagnosis of autism from other developmental disabil
ities (ADI-R items).
41
42
Items common to GARS and ADI-R

GARS Items
ADI-R items
Withdraws, remains aloof or acts stand-offish in group
Lack of interest in other children; may watch them but
situations
almost never tries to approach them.

No spontaneous sharing or no sharing.
Avoids eye contact, looks away when someone looks at
Uncertain, odd or occasional use of gaze in social
him or her
interactions
Little or no coordination of eye gaze and vocalisations or
weakly integrated.
Uses the word I inappropriately e.g. does not say I to refer Mis-uses pronoun I and refers to self by name rather than
to self)
with pronoun.
Flaps hands or fingers in front of face or at sides
Marked mannerisms of hands and fingers that may or may
Flicks fingers rapidly in front of eyes for periods of 5 secs or
not interfere with social activities
more
Stares at hands, objects or items in the environment for at
least 5 secs
Smells or sniffs objects (e.g. toys, persons hand, hair)
Has one to two unusual sensory interests that may take

major amount of time.
Whirls, turns in circles
Complex and stereotyped bodily movements
Stares or looks unhappy or unexcited when praised
Little or no smiling at people though may smile at things;
humoured or entertained
no reciprocal smiling.
Table 6. Items common to GARS and ADI-R that best discriminated Iranian children with autism
Items on GARS only
Items ADI-R only
Uses gestures instead of speech or uses signs to obtain objects
Does not attempt or limited attempt to express
Does not initiate conversations with peers or adults
interest by pointing
Shows no recognition that a person is present (i.e. looks through Special or circumscribed interests that can interfere
people)
with social activities
Does not imitate other people when imitation is required or
Stereotyped, inappropriate, very limited or no
desirable such as in games or learning activities
responses to people except parents.
Makes high-pitched sounds (e.g. eee-eee-eee) or other
Play is linked to highly stereotypic use of objects or
vocalizations for self-stimulation
attention; interested in infant toys such as music
Laughs, giggles, cries inappropriately
boxes and rattles.
Behaves in a unreasonably fearful or frightened manner

Table 7. Items particular to GARS and ADI-R that best discriminated Iranian children with autism

http://dx.doi.org/10.5772/52853
6. Discussion
These two studies had a number of strengths. Sizeable samples of children with autism were
recruited alongside those who were normally developing and those who had intellectual
disability or another form of developmental disorder. In both studies, the selected items dis
criminated effectively the children with autism. Also the studies were located in Iran; a
country on which relatively little published research exists. Equally there are some limita
tions that need to be acknowledged. No independent verification of the childs diagnosis of
autism was possible and reliance was placed on either parental reports or data held by the
ISEO. This issue may be of relevance also to children with ID in that some of them may have
undiagnosed autism. However even within developed countries, it would have been a cost
ly, not to say difficult undertaking, to obtain independent verification of diagnoses and even
more improbable in a country such as Iran.
A further limitation is that the first study was retrospective for parents in that their child
had already been diagnosed and hence their ratings on GARS may have been influenced by
the increased awareness they had about the indicators of autism which they may not have
had prior to the diagnosis. Hence it would be important to replicate the study on a prospec
tive basis especially with parents who had limited contact with professionals or with parents
who had lower levels of education. The latter recommendation arises from the finding in
Study 1 that parents from two provinces had significantly lower scores on the 16 items. In
these two provinces professional services are more limited with fewer parents availing of
higher education. These factors were also proposed as reasons for the variations in preva
lence rates of autism across Iran that has been previously reported [1].
Nevertheless it would be a major undertaking to repeat the study with an unselected popu
lation of children although the existence of the Iranian national screening programme for
autism on school entry makes this a possibility for five year olds. An alternative approach is
to consider the items identified in these studies as the basis for a referral tool [26]. For exam
ple, when concern is expressed about a child by parents or preschool educators, or if a child
is already experiencing problems, then these items might serve as a guide for primary health
or social care personnel to help them decide as to whether a referral should be made for
more specialist assessment for autism.
However the issue of identifying children with autism in other cultures has to be set within
a broader context than screening. First increased opportunities need to be provided to pa
rents - and to mothers especially for them to become more knowledgeable about child de
velopment and indicators of potential problems particularly those of relevance to their
culture. The desire for increased information about autism is a common request of parents
in different cultures [34]. Modern technology provides a cost-effective means for doing this.
Second, the beliefs, knowledge and skills of professions involved in diagnosing develop
mental problems will need to be expanded in relation to autism so that they can undertake
appropriate and thorough assessments of the children and devise relevant intervention pro
gramme for them and their families [35]. The development of an indigenous knowledge
43
44
base in relation to autism is especially pertinent as reliance on assessment and intervention

tools from other cultures may prove inadequate. Equally there is an onus on professionals in
Western countries to become better attuned to the cultural issues they may face with immi
grant communities [9] as part of the endeavour to find more effective and efficient tools for
the diagnosis of autism spectrum disorders [42].
A third aspect arises from the previous two; namely the relationships between parents and
professionals. Recent guidance in relation to autism in the UK, emphases the need for pro
fessionals to take seriously parental concerns [36]. Also diagnostic information often has to
be obtained through sensitive and careful questioning about the childs typical behaviours
in natural settings as well as observations of the child in clinic or school contexts. This is best
done through a trusted relationship between parents and professionals. Moreover parents
may experience elevated levels of stress and poorer health because of their childs behaviour
and will personally benefit from support offered by professional advisers [37]. Thus profes
sionals may need to acquire wider communication and inter-personal skills in order to effec
tively support families.
These broader issues relating to the identification and diagnosis of autism are not peculiar to
Iran and future cross-cultural research would help to identify practical means of addressing
them, especially when health, social care and educational resources are limited [38].
The findings also have international application in another sense. They confirm the uni
versality of certain indicators of autism in children; most notably in Iranian culture of re
petitive and stereotyped behaviours and atypical social interactions. Items relating to
communication and language were apparently less indicative of autism. As yet there is
no directly comparable data with that obtained from other cultures although future re
search might provide this. However studies that have directly compared children in the
UK and USA with those from South Korea and Israel [6] found significant differences in
the extent to which items relating to socialisation, verbal communication and restricted
interests were reported although all were present across the four countries. It is likely
that this cultural variation in parental perceptions of autistic traits reflects the behaviours
in children that parents value or perceive as being unusual within their particular cul
ture. Future research could usefully explore this proposition further as it may also ac
count for differences between the perceptions of parents from different socio-economic
backgrounds.
It is possible though that some of the inter-cultural differences and perhaps the intra-coun
try variation may arise from other environmental factors. Walker et al [39] have identified
from international epidemiological studies the key risks that prevent children from attaining
their developmental potential, such as lack of cognitive stimulation, intrauterine growth re
striction, maternal stress and exposure to societal violence. It is possible that some of these
environmental factors could trigger particular behaviour patterns within children that fall
within the broad category of autism. To date much energy has been expended on identify
ing the genetic bases for autism and even if these were to be found, there may well be envi
ronmental factors that mediate the genetic disposition for autistic traits.

http://dx.doi.org/10.5772/52853
Finally cross-cultural research in autism has much to contribute to our wider understanding
of this condition and of the factors that may ameliorate its impact on children and families.
An essential starting point is to have a common tool for use across countries that not only
defines the similarities in children who have the condition but is also sensitive to the cultur
al variations that may be inherent in its manifestation in varying cultures. These studies in
Iran are a contribution to that endeavour and provide a model as to how it could be realised.
Acknowledgement
Our sincere thanks to Miss Ameneh Mahmoodizadeh from the Iranian Special Education
Organisation for her assistance with Study 2.
Author details
Sayyed Ali Samadi and Roy McConkey
*Address all correspondence to: [email protected].
Centre for Intellectual and Developmental Disabilities, Institute of Nursing Research, Uni
versity of Ulster, Newtownabbey, N. Ireland, UK
References
[1] Samadi SA, Mahmoodizadeh A & McConkey R. A national study of the prevalence
of autism among five-year-old children in Iran. Autism: The International Journal of
Research and Practice 2012; 16 (1), 4-15.
[2] Daley, TC. The need for cross-cultural research on the pervasive developmental dis
orders. Transcultural Psychiatry, 2002; 39 531550.
[3] Greenfield PM, Ward M & Jacobs J. You cant take it with you: why ability assess
ments dont cross cultures. American Psychologist, 1997; 52(10) 11151124.
[4] Gilliam JE. Gilliam Autism Rating Scale-Second edition. Austin, Texas: Pro-Ed; 2006.
[5] Lord C, Rutter M & Le Couteur A. Autism Diagnostic Interview-Revised: A revised
version of a diagnostic interview for caregivers of individuals with possible perva
sive developmental disorders. Journal of Autism and Developmental Disorders 1994;
24(5) 659-685.
[6] Matson JL, Worley JA, Fodstad JC, Chung K-M, Suh D, Jhin HK, Ben-Itzchak E, Za
chor DA, Furniss F. A multinational study examining the cross cultural differences in
45
46
reported symptoms of autism spectrum disorders: Israel, South Korea, the United
Kingdom, and the United States of America. Research in Autism Spectrum Disorders
2011; 5 15981604.
[7] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disor
ders DSM-IV-TR (Text Revision) 4th edition. American Psychiatric Association:
Washington, DC; 2000.
[8] Bronfenbrenner, U. The ecology of human development: Experiments by nature and
design. Cambridge, MA: Harvard University Press; 1979.
[9] Dyches TT, Wilder LK, Sudweeks RR, Obiakor FR & Algozzine B. Multicultural is
sues in autism. Journal of Autism and Developmental Disorders 2004; 34 211222.
[10] Rogers-Adkinson DL, Ochoa TA & Delgadom, B. Developing Cross-cultural compe
tence : Serving families of children with significant developmental needs. Focus on
Autism and Other Developmental Disabilities 2003; 18 4-8
[11] Wallis, KE & Pinto-Martin, J. The challenge of screening for autism spectrum disor
der in a culturally diverse society. Acta Pdiatrica 2008; 97 539540.
[12] DeGiacomo A & Fombonne E. Parental recognition of developmental abnormalities
in autism. European Child and Adolescent Psychiatry1998; 7 (3) 131-136.
[13] Daley, TC. From symptom recognition to diagnosis: children with autism in urban
Indian. Social Science and Medicine 2004; 58 1323-1335.
[14] Mandell, DS, Wiggins, LD, Carpenter, LA, Daniels, J., DiGuiseppi, C, Durkin, MS et
al. Racial/ethnic disparities in the identification of children with Autism Spectrum
Disorders American Journal of Public Health 2009; 99 493498.
[15] Valicenti-McDermott M, Hottinger K, Seijo R, Shulman S. Age at Diagnosis of Au
tism Spectrum Disorders Journal of Pediatrics 2012; 10.1016/j.jpeds.2012.05.012.
[16] Begeer S, El Bouk S, Boussaid W, Terwogt MM & Koot HM. Underdiagnosis and Re
ferral Bias of Autism in Ethnic Minorities. Journal of Autism and Developmental Dis
orders 2009; 39:142148.
[17] Williams JG, Higgins JPT & Brayne CEG. Systematic review of prevalence studies of
Autism Spectrum Disorders. Archives of Diseases in Children 2006; 91: 815.
[18] Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D and Charman,T.
Prevalence of disorders of the autism spectrum in a population cohort of children in
South Thames: the Special Needs and Autism Project (SNAP). Lancet 2006; 368
210-215.
[19] Autism and Developmental Disabilities Monitoring Network Principal Investigators
(2009) Prevalence of Autism Spectrum Disorders - Autism and Developmental Disa
bilities Monitoring Network, United States. MMWR. Surveillance summaries, 58 (10),
1-20. Atlanta: Center for Disease Control and Protection; 2006

http://dx.doi.org/10.5772/52853
[20] Coo H, Ouellette-Kuntz H, Lloyd JEV, Kasmara L, Holden JJA & Lewis MES. Trends
in Autism prevalence: Diagnostic substitution revisited. Journal of Autism and De
velopmental Disorders 2008; 38 1036-1046.
[21] Fombonne E, Zakarian R, Bennett A, Meng L & McLean-Heywood D. Pervasive de
velopmental disorders in Montreal, Quebec, Canada: Prevalence and links with im
munizations. Pediatrics 2006; 118 (1) 139-50.
[22] Baird G, Charman T, Cox A, Baron-Cohen S, Swettenham J, Wheelwright S. & Drew,
A. Screening and surveillance for autism and pervasive developmental disorders
Arch. Dis. Child. 2001;84 468-475.
[23] Baron-Cohen S, Allen J & Gillberg C. Can autism be detected at 18 months? The nee
dle, the haystack, and the CHAT. British Journal of Psychiatry1992; 161 839843.
[24] Robins DL, Fein D, Barton ML & Green, JA. The Modified Checklist for Autism in
Toddlers: An initial study investigating the early detection of autism and pervasive
developmental disorders. Journal of Autism Developmental Disorders 2001; 31 131
144.
[25] Seif Eldin A, Habib D, Noufal A, Farrag S, Bazaid, K, Al-Sharbat M. et al. Use of MCHAT for a multinational screening of young children with autism in the Arab coun
tries, International Review of Psychiatry 2008; 20 (3) 281 289.
[26] Allison C, Auyeung B. & Baron-Cohen S. Toward brief Red Flags for autism
screening: The Short Autism Spectrum Quotient and the Short Quantitative Checklist
in 1,000 Cases and 3,000 Controls. Journal of the American Academy of Child & Ado
lescent Psychiatry 2011; 51(2) 202-212.
[27] Lord C & Corsello C. Diagnostic instruments in autistic spectrum disorders. In: Volk
mar FR, Paul R, Klin A, Cohen D. (eds). Handbook of Autism and Pervasive Devel
opmental Disorders. 3rd ed. Vol II. Hoboken, NJ: John Wiley & Sons; 2005: p730771
[28] Johnson CP & Myers SM. Identification and evaluation of children with Autism
Spectrum Disorders. Pediatrics 2007; 120 (5) 1183-1215.
[29] Fombonne E. Epidemiology of pervasive developmental disorders. Pediatric Re
search 2009; 65(6) 591-598.
[30] World Health Organisation. Classification of Mental and Behavioural Disorders
ICD-10: Clinical Descriptions and Diagnostic Guidelines. World Health Organisa
tion. Geneva. Switzerland; 1992
[31] Samadi SA & McConkey R. The utility of the Gilliam Autism Rating Scale for identi
fying Iranian children with Autism. Paper submitted for publication.
[32] Sasanfar R & Toloie A. Standardising and Normalizing The Autism Diagnostic Inter
view- Revised on Iranian population. The Iranian Special Education Organisation.
Tehran, The Iranian Special Education Organisation Publication; 2006.
47
48
[33] Ghanizadeh A, Mohammadi MR, Sadeghiyeh T, Shooshtari AA & Akhondzadeh, S.

Symptoms of children with Autism Spectrum Disorder, a clinical sample Iranian
Journal of Psychiatry 2009; 4 165-169
[34] Samadi SA, McConkey R & Kelly G. The information and support needs of Iranian
parents of Children with Autism Spectrum Disorders. Early Childhood Development
and Care 2011; available online: DOI:10.1080/03004430.2011.616931
[35] Mandell DS, Ittenbach RF, Levy SE, Pinto-Martin JA. (2007) Disparities in diagnoses
received prior to a diagnosis of autism spectrum disorder. Journal of Autism and De
velopmental Disorders 2007; 37(9) 17951802.
[36] Baird G, Douglas HR & Murphy MS. Recognising and diagnosing autism in children
and young people: summary of NICE guidance. British Medical Journal 2011;
343:d6360 doi: 10.1136/bmj.d6360.
[37] Samadi SA & McConkey R. The personal impact on Iranian mothers and fathers who
have a child with an Autism Spectrum Disorder. Journal of Intellectual Disability Re
search 2012 (in press).
[38] Samadi SA, McConkey R & Kelly G. Enhancing parental wellbeing and coping
through a family-centred, short course for Iranian parents of children with an Au
tism Spectrum Disorder. Autism. The International Journal of Research and Practice
2012; DOI: 10.1177/1362361311435156.
[39] Walker SP, Wachs TD, Grantham-McGregor S, Black MM, Nelson CA, Huffman SL
et al. Inequality in early childhood: risk and protective factors for early child devel
opment. Lancet 2011; 378: 132538.
[40] Lecavalier L. An Evaluation of the Gilliam Autism Rating Scale. Journal of Autism
and Developmental Disorders 2005; 35 (6): 795-805.
[41] South M, Williams BJ, McMahon WM, Owley T, Filipek TA, Shernoff E, Corsello C,
Lainhart JE, Landa R, Ozonoff, S. Utility of the Gilliam Autism Rating Scale in Re
search and Clinical Populations. Journal of Autism and Developmental Disorders,
2002; 32 (6): 593-599.
[42] Feinstein A. A History of Autism: Conversations with the Pioneers. New York, Wi
ley; 2010.
Chapter 3
Prevalence of Pervasive Developmental Disorders

Croatia in Comparison with Other Countries of the
World
Tomislav Benjak and Gorka Vuleti
http://dx.doi.org/10.5772/51637
1. Introduction
Disabled persons live in every corner of the world and on all social levels. According to UN
estimations, disabilities are much more widespread than is believed: at least one in every 10
inhabitants of each country has a certain form of disability, totaling some 450 million people
around the world. [1] According to the 2001 census, Croatia had at that time 423 891 persons
with disabilities (10% of overall population) [2]. According to the Croatian Disabilities Reg
istry (the Registry), [3], Croatia has 518 081 disabled persons (ca. 12% of overall population).
As defined in the Act on the Croatian Disabilities Registry, disability is a limitation or reduc
tion (resulting from damaged health) the capacity to perform a certain physical activity or
psychological function normal for a person of a certain age, and refers to the abilities which
are manifested in complex activities and behaviors generally accepted as important compo
nents of everyday life [4]. Croatia has defined the collection of data on disabled persons in
the Act on the Croatian Disabilities Registry (Official Gazette No. 64/01). The Registry in
cludes data on the following types of physical and mental impairments: visual, hearing and
speech impairments, impairments of the locomotor, central and peripheral nervous systems,
other organs and organ systems, mental retardation, PDDs (autism), mental disorders, as
well as data on multiple impairments. PDDs (autism) have been separated as a special disa
bility category. The data on the above disorders is provided by expert evaluation bodies
within the education and social welfare system [4]. According to the references, PDD preva
lence has registered a continual rise. To illustrate, according to the CDC Report from Atlan
ta, USA, prevalence numbers 6.6 per 1000. [5, 6, 7, 8, 9]. The data on individuals with PDDs
in Croatia is registered in the above Registry. However, due to a short history (since 2002),
the extent of the potential increase could not be determined.
2013 Benjak and Vuleti; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
50
2. Epidemiology of PDDs globally

2.1. Classification systems
For the purpose of learning more about the epidemiology of autism, and, by extension,
about the changes in its prevalence, the following part will present two classification sys
tems that have been in international use for many years, together with clearly stated crite
ria and diagnostic instructions that need to be abided by so as to correctly diagnose
autism and PDDs. The two systems are: WHOs ICD-10 (International Statistical Classifica
tion of Diseases and Related Health Problems) and DSM (Diagnostic and Statistical Manual of
Mental Disorders) by the American Psychiatric Association (APA). ICD-10 defines autism
under a three-sign category of F84: Pervasive developmental disorders. This group in
cludes, codes and defines the following: childhood autism (F84.0), atypical autism (F84.1),
Retts syndrome (F84.2), other childhood disintegrative disorder (F84.3), overactive disor
der associated with mental retardation and stereotyped movements (F84.4), Aspergers
syndrome (F84.5), other pervasive developmental disorders (F84.8), as well as pervasive
developmental disorder, unspecified (F84.9) [10]. PDD is also defined by the APAs DSM
classification. DSM introduced the term of pervasive developmental disorder for the first
time in its third revision from 1980. The term pervasive was selected so as to accentuate
the fact that this psychopathological manifestation assumes all of childs spheres of func
tioning. In DSM Revision III from 1987 PDDs encompass a significantly wider spectrum
of symptoms, which has lead to an increased prevalence. The term infantile autism was
changed to autistic disorder. All non-autistic pervasive disorders are specially categorized
as pervasive developmental disorders not otherwise specified (PDDNOS). Out of a need
to maximize the quality of diagnostics and create clearer diagnostic criteria DSM-III has
grown into DSM-IV (DSM-IV-TR, APA, 2000). The latter classification calls for an intro
duction of a new term: autism spectrum disorders (ASDs), which now defines autism [11,
12]. ASDs ultimately include: autistic disorder (AD), Aspergers syndrome (AS) and
PDDNOS. An approximation of the two above classification systems is visible in a series
of elements. What is significant is that both currently acknowledge a separate category of
pervasive developmental disorders, though the two selections of clinical entities encom
passed by this category remain diverse. Table 1 outlays nosological categories belonging
to PDDs in the ICD-10 and DSM-IV-TR. By analyzing Table 1 a similarity can be noticed
between the above classification systems in determining clinical entities belonging to
PDDs. Solely hyperkinetic disorder related to mental retardation and stereotyped move
ments is left out of the DSM-IV-TR [13]. The American Psychiatric Association (APA) has
proposed new diagnostic criteria for the fifth edition of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-5) for autism. While final decisions are still months
away, the recommendations reflect the work of dozens of the nations top scientific and
research minds and are supported by more than a decade of intensive study and analysis.
The proposal by the DSM-5 Neurodevelopmental Work Group recommends a new cate
gory called autism spectrum disorder which would incorporate several previously sepa
rate diagnoses, including autistic disorder, Aspergers disorder, childhood disintegrative
Prevalence of Pervasive Developmental Disorders Croatia in Comparison with Other Countries of the World
http://dx.doi.org/10.5772/51637
disorder and pervasive developmental disorder not otherwise specified [14]. Croatia ap
plies ICD-10 codes for PDD diagnoses.
ICD-10 (WHO, 1992)
DSM-IV-TR (APA, 2000)
F 84.0
Childhood autism
299.00
Autistic disorder
F84.1
Atypical autism
F 84.2
Rett's syndrome
299.80
Retts disorder
F84.3
Other childhood disintegrative disorders
299.10
Childhood disintegrative
F 84.4
Overactive disorder associated with mental
PDDNOS
disorder
retardation and stereotyped movements

F84.5
Asperger's syndrome
299.80
Aspergers disorder
F84.8
Other pervasive developmental disorders
PDDNOS
F84.9
Pervasive developmental disorder, unspecified299.80
PDDNOS
Table 1. Overview of PDD categories in ICD-10 and DSM-IV-TR.
2.2. Epidemiological studies on autism

The first epidemiological study of autistic disorder was published in 1966. Viktor Loter, the au
thor, thereby informed the health public that the prevalence of autistic disorder was low,
namely four to five autistic children per 10 000 inhabitants [15]. Epidemiological studies in
1980s and 1990s registered a significant increase in the prevalence of autistic disorder in differ
ent parts of the world. Research done in Wales has shown that autism prevalence in respond
ents born between 1977 and 1979 was 3.3, while the prevalence in the population born between
1987 and 1989 9.2 [16]. The prevalence of autism in Iceland grew from 4.2 persons in respond
ents born between 1974 and 1983 to 13.2 in the population born between 1984 and 1993 [17]. A
stable growth in the prevalence of autism during the 1980s and 1990s was also registered in
California [18]. Having analyzed a sample of some 300 000 respondents born between 1988 and
1996, Honda noted that the incidence of autism grew from an earlier 54 to the present 88 per
sons, with the highest oscillation being registered in the 1990s [19]. Fombonne conducted a
meta-analysis of 32 epidemiological studies on autistic disorder carried out between 1966 and
2001. Data was collected on the prevalence of autistic disorder in 13 different countries on a
sample of nearly 5 million people. According to the epidemiological research of the same au
thor, 13 in 10 000 liveborn children are born with autism, 3 with Aspergers syndrome, and 60
with PDDs [20]. Similar data are found in studies of other authors (21,22). According to the
CDC Report, the prevalence rate for autism numbers 6.6 per 1000 [5, 6, 7, 8]. Autism more com
monly appears in boys, accounting for the ratio of 4.3:1 in favor of boys [13]. According the co
hort study of children in South Thames prevalance of ASD was about 1% [23] while in the past
year a new epidemological study rates closer to 2% [24]. Regarding the prevalence of PDDs in
EU countries, EUGLOREH 2007 stressed the diversity of the definition of autistic disorder and
51
52
methodology yielding and monitoring prevalence, which is confirmed by Table 2. Specially

stressed is the need to approximate the above segments [25].
Area
Year
Total children in
age range
Criteria used
Age range
Total rate
per 10 000
Aarhus (Denmark)
1972
46 500
Kanner
2-14
4.3
Camberwell (UK)
1979
34 700
Kanner
3-17
4.9
Cambridgeshire (UK)
1999
34 262
DSM-IV
5-11
57
Vsterbotten (Sweden)
1983
69 600
Rutter
0-20
5.6
Gteborg1 (Sweden)
1984
128 600
DSM III
4-18
Gteborg2 (Sweden)
1986
42 900
DSM III
0-10
7.5
Gteborg3 (Sweden)
1991
40 700
DSM III - R
4-13
11.5
Rhne (France)
1989
103 700
Rutter
5-9
10.8
Iceland
1996
38 746
Rutter
4-12
8.8
Nord-Trondelag (Norwey)
1998
n.a.
DSM-IV
3-14
3.8
Northern Finland
1997
152 732
DSM III R/DSM-IV
5-7
20.7
Ireland East
1997
549 255
DSM III /DSM III - R
0-25
4.94
Table 2. Overview of the prevalence of autistic disorder in EU countries.
The above data leads to the conclusion that the prevalence of autistic disorder in the last 50
years has increased as much as 15 times. Does that mean that the modern world is facing a
kind of an autism epidemic? Despite a series of studies conducted to establish a potential
cause of the same increase, and, by extension, possible etiology of the disorder, [26, 27, 28,
29, 30, 31, 32, 33, 34, 35, 36, 37, 38], many authors continue to believe that the prevalence of
autistic disorder in the 21st century remains as it was 50 years ago [13]. The same authors
argue that this increment is due to more precise diagnostics, changes in diagnostic criteria
and a greater sensitization of the public for the problems of autistic persons. This increase in
the prevalence of autism in the past decades was mostly registered in persons of preserved
intellectual capacity [39], which would argue that the prevalence in persons with typical au
tism has remained virtually unchanged.. At this moment it has still not been confirmed or
denied that various factors (pollutants, diet, etc.) have a certain effect on the incidence and
prevalence of autistic disorder but there is clear scientic evidence that no causal relationship
between vaccination and autism [40]. Consequently, no definitive causes of the incurred in
crease in the prevalence of the above disorder can still be determined [13].
3. Prevalence of PDDs in Croatia

Croatia monitors data on persons with PDDs within the scope of the Registry. PDDs are
therein separated as a special type of disability and monitored according to the ICD-10 un
http://dx.doi.org/10.5772/51637
der the three-sign category of F84. The onset of a systematic epidemiological monitoring of
data on PDDs goes back to the introduction of the Registry in 2002. The data on the above
disorders is provided by expert evaluation bodies within the education and social welfare
system. These expert evaluation bodies hire experts who are to thank for PDD diagnostics.
The Registry database, as up until 4 May 2012, contains data on 1109 persons with PDDs,
with the largest number of registered under the diagnosis F84.9 (Table 3).
Pervasive developmental disorders categories
Number of persons
F 84.0
Childhood autism
267
F84.1
Atypical autism
57
F 84.2
Rett's syndrome
24
F84.3
Other childhood disintegrative disorders
18
F 84.4
Overactive disorder associated with mental
30
retardation and stereotyped movements

F84.5
Asperger's syndrome
44
F84.8
Other pervasive developmental disorders
19
F84.9
Pervasive developmental disorder, unspecified
650
Total
1109
Table 3. View the number of registered people with pervasive developmental disorders in Croatia, according to ICD-10.
The prevalence of PDDs in the overall population of the Republic of Croatia is about 2-3/10 000,
while in children (population aged 0-18) ca. 1/1000, with three times higher incidence in boys.
In Register we see increase (2.6x) number of registrated person with ASD in last seven years
(304 registrated person until 01.01.2005. and 792 after that date). The largest number of persons
with PDDs, namely 759 (70%), belong to the 519 age group (Table 4). Primorsko goranska
county and City of Zagreb number the highest prevalence in childhood at just above 1/1000.
Age group
0-4
County of residence
5-9
BJELOVARSKO-BILOGORSKA
BRODSKO-POSAVSKA
DUBROVAKO-NERETVANSKA
10-14
10
GRAD ZAGREB
12
ISTARSKA
KARLOVAKA
15-19
20-29
30-39
40+
Total
27
13
54
10
30
48
17
45 11
15
33
13 13
11
258
13
13
0 2
59
22
28
53
54
Age group
0-4
County of residence
5-9
10-14
15-19
20-29
30-39
40+
Total
KOPRIVNIKO-KRIEVAKA
17
KRAPINSKO-ZAGORSKA
39
LIKO-SENJSKA
MEIMURSKA
10
23
OSJEKO-BARANJSKA
20
18
12
2 1
81
POEKO-SLAVONSKA
PRIMORSKO-GORANSKA
18
24
15
4 6
84
SISAKO-MOSLAVAKA
30
SPLITSKO-DALMATINSKA
21
4 33
18
23
7 8
147
IBENSKO-KNINSKA
37
VARADINSKA
29
VIROVITIKO-PODRAVSKA
15
VUKOVARSKO-SRIJEMSKA
10
38
ZADARSKA
17
48
ZAGREBAKA
11
51
Unspecified
TOTAL
33 11 224 56 232
136 64 143 62 42 18 32
1109
47
As amended on 5 May 2012

Table 4. Overview of persons with PDDs (F84) by county of residence, sex and age group.
4. Conclusion
All the above leads to the conclusion that there is a difference between the registered prevalen
ces of PDDs in Croatia and other countries of the world. According to the last available CDC
data, global prevalence reaches 6.6 per 1000, while in Croatia the rate is ca. 1 in 1000 children
(0-18 age group). This great discrepancy, that is under registration of PDDs, could be ex
plained by numerous factors. One of them could be the phenomenon of diagnostic substitution,
which was encountered in the USA before 1990 until which time PDDs, as a diagnosis, could
not secure children the right to special education. In 1990 the passing of the individuals with
Disabilities Education Act was the culmination of a long tradition of state and federal acts pro
moting the closing of institutions and encouraging state governments to support families in
their effort to care for and raise their disabled children in their own homes. Autistic children,
especially children with comorbid mental retardation and behavior disorders, who, otherwise,
http://dx.doi.org/10.5772/51637
would have been institutionalized in the past, consequently, started attending local schools
and were included in the data on school prevalence. Before passing of the above Act, children
were labeled as having mental retardation, learning disabilities, speech or emotional disorders
in order to be granted the right to certain services. The prevalence of autism has, after passing
of the same act, experienced a continual growth. This could partly be ascribed to the method of
funding the education of autistic persons, as well as to granting rights to supplementary serv
ices (e.g. whole-year schooling), as defined by the legal amendment. The effects of these factors
on the existing estimations are controversial and illustrative of the reason why the educational
administrative data presented in some media-covered studies may affect the display of the
number of autistic persons [9]. Whether this phenomenon of diagnostic substitution currently
has occurred in Croatia cannot be established with certainty. A proof in favor of its existence
could be the fact that there are a total of 141 persons who have official decisions on special edu
cation with autism stated under item Orientation list. On the other hand, according to the same
decision on special education, 6961 pupils/high school students with unspecified disorders in
verbal communication, 3 888 pupils/students with mental retardation (whereof some 65%
have light retardation) and a surprising number of 7 219 with multiple impairments have a
right to special education in regular schools. Some 50% pupils/students who exercise the right
to special education lack the above item of Orientation list so as to escape stigmatization [3].
Each group potentially includes persons with PDDs. A more accurate prevalence of PDDs in
Croatia will be available after following the American example and introducing legal regula
tions to separate autism as a special disability category and granting corresponding rights to
persons with PDDs and their families. One should also be reminded of the need of continual
professional training of physicians, special education teachers, psychologists and other profes
sionals in new findings in the areas of diagnostics, therapy and rehabilitation of persons with
PDDs. By securing this, the advancement of legislation, diagnostics, IT system and the quality
of diagnosis recording, as well as sensitizing the public to equation of opportunities for per
sons with PDDs, will also contribute to advancing the epidemiology of the above disorders.
Author details
Tomislav Benjak1* and Gorka Vuleti2
1 Croatian National Institute of Public Health
2 School of Public Health, School of Medicine, University of Zagreb, Croatia
References
[1] http://www.hsuti.hr/EasyWeb.asp?pcpid=32, accessed on 16 Januay 2009.
55
56
[2] "Stanovnitvo prema invalidnosti". (2001). Popis stanovnitva, kuanstava i stanova

31.oujak 2001./priredila Mirjana Lipovak, Zagreb, Central Bureau of Statistics, Re
public of Croatia.
[3] Croatian National Institute of Public Health. (2011). Izvjee o osobama s invaliditetom u
RH, http://www.hzjz.hr/epidemiologija/kron_mas/invalidi11.pdf., last accessed on 16
July 2012.
[4] Zakon o Hrvatskom registru o osobama s invaliditetom, NN, br.64/01, Act on the Croatian
Disabilities Registry, Official Gazette No. 64/01.
[5] Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000;
Centers for Disease Control and Prevention. (2007). Prevalence of autism spectrum
disorders. MMWR Surveill Summ., 56(1), 1-11.
[6] Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000;
Centers for Disease Control and Prevention. (2007). Prevalence of autism spectrum
disorders. MMWR Surveill Summ., 56(1), 1-11.
[7] Van Naarden, Braun. K., Pettygrove, S., Daniels, J., et al. (2007). Evaluation of meth
odology for collaborative multiple source survaillance network for autism spectrum
disorders: Autism and Developmental Disabilites Monitoring Network. 14 sites,
United States, 2002., MMWR Surveill Summ., 56(1), 29-40.
[8] Rice, C., Baio, J., Van Naarden, Braun. K., et al. (2007). A public health collaboration
for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol., 21,
179-190.
[9] Pediatrics. (2007, October). Identification and Evaluation of Children With Autism Spec
trum Disorders.
[10] World Health Organization. (1992). International Statistical Classification of Diseases
and Related Health Problems,10th Revision Volume , I, 285-287.
[11] American Academy of Pediatrics, Committee on Children With Disabilities. (2001).
The pediatricians role in the diagnosis and management of autistic spectrum disor
der in children. Pediatrics, 107, 1221-1226.
[12] American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental
Disorders (4th Edition), DSM-IV, Washington, DC, American Psychiatric Publishing.
[13] Glumbi, N. (2005). Odrasle osobe s autizmom, Beograd.
[14] American Psychiatric Association. (2012). DSM-5: The Future of Psychiatric Diagnosis.
DSM-5 Proposed Criteria for Autism Spectrum Disorder Designed to Provide More Accu
rate Diagnosis and Treatment, http://www.dsm5.org/Documents/12-03%20Autism
%20Spectrum%20Disorders%20-%20DSM5.pdf, last accessed on 16 July 2012.
[15] Lotter, V. (1966). Epidemiology of autistic conditions in young children. Social Psy
chiatry, 1, 124-37.
http://dx.doi.org/10.5772/51637
[16] Webb, E. J. V., Lobo, S., Hervas, A., Scoudield, J., & Fraser, W. L. (1997). The chang
ing prevalence of autistic disorder in a Welsh health district. Dev Med Child Neurolo
gy, 39, 150-2.
[17] Maggnusson, P., & Saemundsen, E. (2001). Prevalence of autism in Iceland. Journal of
Autism and Developmental Disorders, 31(2).
[18] Dales, L., Hammer, S. J., & Smith, N. J. (2001). Time trends in autism and in MMR
immunization coverage in California. Journal of American Medical Association, 285(9),
1183-1185.
[19] Honda, H., Shimizu, Y., & Rutter, M. No effect of MMR withdrawal on the incidence
of autism: a total population study. Journal of Child Psychology and Psychiatry, 46(6),
572-579.
[20] Fombonne, E. (2005). Epidemiology of autistic disorder and other pervasive develop
mental disorders. J Clin Psychiatry, 66(Suppl 10), 3-8.
[21] Baird, G., Charman, T., Baron-Cohen, S., et al. (2000). A screening instrument for au
tism at 18 months of age: a 6 year follow-up study. Journal of the American Academy of
Child and Adolescent Psychiatry, 39, 694-702.
[22] Bertrand, , et al. (2001). Prevalence of autism in a United States population: the Brick
Township, New Jersey invastigation. Pediatrics [5].
[23] Baird, G., et al. (2006). Prevalance of Disorders of the Autism Spectrum in a popula
tion. Lancet.
[24] Kim, Y. S., et al. (2011). Prevalence of autism spectrum disorders in a total population
sample. Am J Psychiatry, 168, 904-912.
[25] European Health Commission. (2007). http://ec.europa.eu/health/ph_information/
dissemination/diseases/autism_1.pdf, last accessed on 16 July 2012.
[26] Volkmar, F. R., & Pauls, D. (2003, Oct). Autism. Lancet, 362(9390), 1133-41.
[27] Larsson, H. J., Eaton, W. W., Madsen, K. M., Vestergaard, M., Olesen, A. V., Agerbo,
E., Schendel, D., Thorsen, P., & Mortensen, P. B. (2005, May). Risk factors for autism:
perinatal factors, parental psychiatric history, and socioecenomic status. AM J. Epide
miol., 161(10), 916-25, discussion 926-8.
[28] Bolton, P. F., Roobol, M., & Allsopp, Pickles. A. (2001, Sep). Association between idi
opathic infantile macrocephaly and autistic spectrum disorders. Lancet., 358(9283),
726-7.
[29] Courchesne, E., Carper, R., & Akshoomoff, N. (2003, Jul). Evidence of brain over
growth in the first year of life in autism. JAMA, 290(3), 337-44.
[30] Bolton, P. F., & Griffiths, P. D. (1997, Feb). Associations of tuberous sclerosis of tem
poral lobes with autism and atypical autism. Lancet., 349(9049), 392-5.
57
58
[31] Smeeth, L., Cook, C., Fombonne, E., Heavey, L., Rodrigues, L. C., Smith, P. G., &
Hall, A. J. (2004, Sep). MMR vaccination and pervasive developmental disorders: a
case-control study. Lancet., 364(9438), 963-9.
[32] Hviid, A., Stellfeld, M., Wohlfahrt, J., & Melbye, M. (2003, Oct). Association between
thimerosal-containing vaccine and autism. JAMA, 290(13), 1763-6.
[33] Fombonne, E., Zakarian, R., Bennett, A., Meng, L., & Mc Lean-Heywood, D. (2006,
Jul). Pervasive developmental disorders in Montreal, Quebec, Canada:prevalence
and links with immunizations. Pediatrics, 118, e139-50.
[34] Chih, B., Afrid, S. K., Clark, L., & Scheiffele, P. (2004, Jul). Disorder-associated muta
tions lead to functional inactivation of neuroligins. Hum Mol Genet., 13(14), 1471-7,
Epub 2004 May 18.
[35] Gillberg, C., & Wing, L. (1999). Autism : not an extremerly rare disorder. Acta Psy
chiatrica Scandinavica, 99(6).
[36] Blaxitl, M., et al. (2003). The changing prevalence of autism in California. Commenta
ry on Croen et al. 2002, Journal of Autism and Developmental Disorders, 33(2).
[37] Mc Carthy, P., Fitzgerald, M., & Smith, M. (1984). Prevalance of Childhood Autism in
Ireland. Irish Medical Journal, 77, 129-130.
[38] Fitzgerald, M. (1998, August). A prevalence and psychosocial study of autism in Ire
land. Stockholm. 14th International Congress of Child and Adolescent Psychiatry and Al
lied Professions, 192.
[39] Croen, L. A., Grether, J. K., Hoogstrate, J., & Selvin, S. (2002). The changing preva
lence of autism in California. Journal of Autism and Developmental Disorders, 32(3),
207-215.
[40] Centers for Disease Control and Prevention. (2012). Concerns about Autism-Vaccine
Safety, http://www.cdc.gov/vaccinesafety/Concerns/Autism/Index.html, last accessed
on 16 July 2012.
Chapter 4
Gut Microbiome and Brain-Gut Axis in Autism

Aberrant Development of Gut-Brain Communication
and Reward Circuitry
Elizabeth M. Sajdel-Sulkowska and
Romuald Zabielski
http://dx.doi.org/10.5772/55425
1. Introduction
The function of the gut microbiome and the bidirectional communication between the
gastrointestinal tract (GIT) and the brain is increasingly recognized in health and disease and
disruption in its composition is not unique to the autistic pathology. However, the bidirectional
communication between the gut and the brain, the gut-brain/brain-gut axis in autism has
been relatively understudied. In general, this communication between gut and brain occurs
through a direct neuronal pathway via the vagus nerve, the hormonal pathway of several
hormones involved in the regulation of food intake, such as cholecystokinin (CCK), ghrelin,
leptin and insulin, and by the immunological signaling pathway involving cytokines. Recent
studies indicate that the vagus nerve is involved in immunomodulation as suggested by its
ability to attenuate the production of proinflammatory cytokines in experimental models of
inflammation (de Jonge and Ullola, 2007). Furthermore, the gut microbiome emerges as a major
player not only in the maturation of GIT tissue and the gut brain axis but also in brain
maturation, through its effect on both the immune and endocrine systems. Many toxins,
toxicants, infectious agents, diet or stress, affect an individuals gut microbiome, which may
be especially sensitive during the critical developmental period. Disruption of the developing
microbiome may have profound consequences on the developing gut-brain axis including the
brain as well as long-term effects on both the physical and psychological development.
This chapter attempts to bridge basic animal studies with clinical findings pertaining to the
brain-gut and gut microbiome in autism, and includes a discussion of various strategies in
managing autistic symptoms. The discussion also includes possible changes in the reward
2013 Sajdel-Sulkowska and Zabielski; licensee InTech. This is an open access article distributed under the
terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
62
system(s) in autism as a consequence of altered gut microbiome. It is possible that aberrant

regulation of the reward system(s) underlines behavioral abnormalities in ASD that could be
targeted by future microbiome-targeting therapies.
2. Effect of perinatal infection and toxicants on the developing brain

In a continuing quest to understand the nature of gene-environment interactions in ASD, we
have recently completed two animal studies examining the effect of perinatal exposure of
thimerosal (TM) and lipopolysaccharides (LPS) on the developing rat central nervous system
(CNS). Both TM and infections (modeled by LPS exposure) have been implicated in autistic
pathology.
Organic mercury compounds are powerful toxicants with a range of harmful neurological
effects in humans and animals. TM, which is metabolized to ethyl mercury, has been discon
tinued as a preservative from infant vaccines but continues to be used in several vaccines
including a flu vaccine administered to pregnant and lactating mothers (Sulkowski et al.,
2012). Perinatal maternal exposure of two strains of rats, Sprague Dawley (SD) and spontane
ously hypertensive (SHR) rats, to thimerosal (200 ug/kg body weight) resulted in both sex- and
strain-specific abnormalities in the neonatal rats (Sulkowski et al., 2012). Behavioral abnor
malities included delayed startle response and decreased motor learning, with the effects being
both sex- and strain-specific. TM exposure also resulted in a significant increase in cerebellar
levels of an oxidative stress marker (3-nitrotyrosine) and a decrease in cerebellar type 2
deiodinase, responsible for local intrabrain conversion of thyroxine to the active hormone, 3,
3,5,-triiodothyronine (T3). These effects were associated with an increased expression of
several genes negatively regulated by T3 (Sulkowski et al., 2012); Khan et al., 2012) suggesting
that perinatal exposure to TM impacts the developing brain at the genetic level. As TM
exposure during the postnatal phase coincided with lactation, some of the TM was delivered
through the milk to the GIT and may have had an effect on the developing gut microbiome
known to be sensitive to heavy metal exposure (Lapanje et al., 2007). This effect may be in part
due to competition with zinc resulting in a disturbance in metallothionein function and general
chelating capacity for other metals. Thus, at least part of the neonatal impact of TM/mercury
could be mediated via its action on the gut microbiome.
In a related study (Xu et al., submitted) we examined the effect of E.coli lipopolysaccharides
(LPS) exposure during critical developmental periods on the developing brain employing the
animal model of infection. Clinical and epidemiological data suggest that maternal infection
during pregnancy and nursing increases the probability of neonatal brain injury and may have
a long-lasting impact on brain functions. Maternal infection during pregnancy has been linked
to neurological and neurobehavioral disorders in humans such as cerebral palsy (Schendel,
2001; Schendel et al., 2002), neonatal strokes (Ferrieo, 2004), schizophrenia (Watson et al.,
1999; Pearce, 2001) and affective disorders (Watson et al., 1999). Animal studies implicate
bacterial infection in the pathology of Parkinsons disease (Carvey et al., 2003), and notably,
schizophrenia and autism (Patterson, 2002). The triggering signals for cytokine production are
endotoxins, major components of the outer membrane of Gram-negative bacteria.
Gut Microbiome and Brain-Gut Axis in Autism Aberrant Development of Gut-Brain Communication
http://dx.doi.org/10.5772/55425
LPS exposure is one of the most acceptable models of infection; LPS is a sufficient trigger for
cytokine production. LPS administered to the pregnant mother are transferred to the fetus
through the placenta (Kohmura et al., 2000), and result in increased cytokines levels in the
amniotic fluid (Urakabo et al., 2001; Gayle et al., 2004) and the fetal brain (Urakabo et al., 2001).
Bacterial infection of lactating mothers also results in an increased level of cytokines in milk
(Bannerman et al., 2004). Pretreatment of suckling rats with LPS (10 mg/kg-day x 5 days the
dose which produces weak, transient signs of endotoxemia) results in reduced pancreatic
secretion and attenuates acute pancreatitis at adult age due to an increased concentration of
the antioxidative enzyme SO in the pancreatic tissue, and to the modulation of cytokines
production (Jaworek at al., 2007a, b). This late-effect of LPS is accompanied by dose-dependent
reduction of mRNA signal for CCK1 receptor on pancreatic acini as well as modified expres
sion of acinar pro-apoptotic heat shock protein-60 (HSP60) and Bax proteins (Jaworek et al.,
2007b, 2008). Early postnatal LPS exposure results in inceased expression of toll-like receptor
4 (TLR4) and caspase-3 and 9- proteins in the pancreatic tissue of adult rats (Bonior et al.,
2012). These studies clearly indicate that perinatal exposure to LPS may have long lasting
consequences on the GIT function, and as expected, though not studied in detail, on the braingut axis.
Perinatal maternal exposure of two strains of rats, SHR or SD rat dams to LPS (200 g/kg body
weight) resulted in increased rollover time, delayed startle, and decreased motor learning,
with the effects being both strain- and sex-specific. LPS challenge also resulted in a trend
towards an increase in cerebellar levels of 3-NT and a decrease in D2 activities in LPS-exposed
pups (Xu et al., submitted). Several genes were affected by LPS. Notably Type 2 deiodinase 2
(DIO2) and brain derived neurotrophic factor (BDNF) expression was significantly elevated,
while transthyretin (TTR) expression was decreased following LPS exposure. In vitro, acute
exposure of cerebellar cultures to LPS resulted in a decreased size of the dendritic area of
Purkinje cells. Our data thus demonstrate that perinatal infection impacts the developing
cerebellum in a sex- and strain-dependent manner via mechanisms involving oxidative stress,
enzymes involved in maintaining local TH homeostasis, and downstream gene expression.
Interestingly, gene changes observed in the brains of LPS-exposed rats were distinct from TMassociated gene effect suggesting that the underlying macromolecular mechanism may be
trigger-specific.
Perinatal LPS exposure could have a profound effect on the gut microbiome similar to the
effect of repeated treatment with antibiotics. Experiments in healthy mice have shown that
disrupting the normal balance of the gut microbiome with antibiotics caused changes in mice
behavior and was accompanied by changes in BDNF which has been linked to depression and
anxiety (Bercik et al., 2011; Neufeld et al., 2011). Perinatal LPS exposure most likely affects gut
motility as suggested by studies of irritable bowel syndrome (IBS), where mild bacterial
overgrowth-associated motility disorder can be reversed by antimicrobials (Scarpignato and
Pelosini, 1999). Animal studies have also shown that stress can change the composition of the
microbiome, where the changes are associated with increased vulnerability to inflammatory
stimuli in the GIT. Could gut dysbiosis be induced by recurrent infections? We have observed
an increase in neurotrophin levels in the cerebella of rats exposed to LPS (Sajdel-Sulkowska et
63
64
al, unpublished observation) and brain region-specific changes in neurotrophin levels in ASD
(Sajdel-Sulkowska et al., 2011). Together these observations suggest that a bacterial infection
could trigger the gut microbiome to induce cytokine overproduction leading to an imbalance
of brain neurotrophins and contribute to developmental abnormalities.
3. Effect of environmental perturbations on the developing components of

the brain-gut axis: Intestinal permeability, inflammation and gut
microbiome
As indicated above the perinatal development of the CNS structure and function greatly
depends on the gastrointestinal GIT function. Little is known about the regulation of embry
onic gut epithelium or the effect of prenatal infection. The two key developmental time-points
in the regulation of the GIT both occur postnatally, the first few days after birth when all gut
digestive functions are launched by first colostrum ingestion and the second at weaning when
the digestive system has to modify its function following a switch from mothers milk to solid
food. The first time-point is particularly relevant for all mammalian species since it is associated
with a complex of dynamic changes in the GIT structure and function leading to a temporary
drop in the gut permeability barrier. The secretion of digestive juices (e.g., gastric and
pancreatic juice secretion) is obviously close to null before birth. Our studies indicate that in
neonatal calves the exocrine pancreas secreted low but measurable amounts of pancreatic juice
from the first postnatal day. The secretion responded to colostrum feeding showing a clearcut cephalic phase associated with plasma pancreatic polypeptide (PP) elevation but no gastric
or intestinal phase. Further studies involving vagal blockades and pharmacological cholecys
tokinin receptor antagonists indicated that in neonatal calves pancreatic response to first
colostrum feeding is already controlled by a neuro-hormonal mechanism involving CCK and
long vago-vagal reflex (Zabielski et al., 2002). Thus, the brain-gut axis control of the exocrine
pancreas observed in one- and two-month old milk-fed calves is already present at birth, only
the magnitude of the response increases with age reaching its peak at four weeks. The other
GIT function in neonatal calves closely associated with the brain-gut axis control include
periodic activity of GIT motility (migrating motor complex, MMC) and secretion (pancreatic
juice periodic secretion) observed already two-three days after birth along with plasma PP
oscillations (Zabielski et al., 2002). Plasma PP, a marker of efferent vagal activity, increased
with age indicating that brain-gut axis further develops after birth (and may be potentially
sensitive to any environmental modifications).
Intestinal functions in neonates are far more complex than in adults due to intensive
developmental processes. The small intestine is one of the fastest body organs to grow in
size postnatally as well as the fastest organ in rebuilding its structure. Relatively little is
known regarding the development of the large intestine, a major organ inhabited by gut
bacteria. At birth, the small intestinal mucosa is lined by enterocytes ready for rapid uptake
of colostral macromolecules (open gut). These enterocytes, so called fetal type enterocytes,
are equipped with a system of vesicles and cisterns (apical canalicular system, ACS) which
http://dx.doi.org/10.5772/55425
form large size mobile vacuoles in the upper part of the cell enabling the transfer of intact
colostral molecules into the blood (Baintner 2002). Approximately two days after birth,
following substantial intake of colostral bioactive substances, the permeability of the gut
epithelium is dramatically reduced to macromolecules due to the rapid replacement of fetal
type enterocytes by adult type enterocytes, a phenomenon known as gut closure; the cell
replacement is made by a receptor-mediated apoptosis involving TGF-1 and TNF- as
mediators (Godlewski et al., 2005, Strzakowski et al., 2007). Consequently, adult type
enterocytes do not contain ACS and large vacuoles. Interestingly, in the gut of neonatal pigs
the cells undergoing apoptosis, which is followed by unzipping-zipping events markedly
disrupting epithelial cell continuity, are located on the entire length of the villi (Godlewski
et al., 2005; see also Fig. 1). In contrast, in adult animals the apoptotic cells are observed only
on the villi top, forming a so called extrusion zone. Therefore, in neonates there is a much
wider absorptive surface that is potentially subject to environmental stimuli as compared to
adults. Though, one population of fetal type enterocytes disappears within the first few days
after birth, there is still another population of fetal type enterocytes existing in the lower
small intestine, in piglets observed until approximately three weeks after birth. These
enterocytes are important for the intracellular digestion of nutrients by lysosomal en
zymes, and form digestive vacuoles as a result of non-selective macromolecule uptake. Their
massive loss in piglets is observed 2-3 weeks after birth. Nevertheless the protection by
intestinal mucus and colostral biologically active peptides and proteins, extensive apopto
sis and unzipping-zipping of a great number of epithelial cells at the same time may
potentially open epithelial gates for any xenobiotics and harmful bacteria, and thereby
facilitate their transfer into blood circulation.
Studies of preterm piglets and intrauterine growth retarded (IUGR) piglets demonstrated that
the gut barrier in both groups of animals is open for a longer time than in full-term-appropriate
weight piglets. Namely, the lower part of the small intestine of 28 day-old IUGR piglets still
contained fetal type enterocytes expressing digestive vacuoles indicating marked delay in gut
mucosa development (Mickiewicz et al. 2012 JPP). The gut epithelium continuity in IUGR and
preterm neonates is not as finely controlled as in control rats; abnormalities of the gut epithe
lium may facilitate exposure of the gut and in turn the whole organism to external factors or
xenobiotics. It is possible that gut permeability is altered in critically ill children and predispose
them to bacterial translocation via a mechanism that creates a hostile environment in the gut
and alters the gut microbiome favoring the growth of pathogens that promote bacterial
translocation (Papoff et al., 2012).
Recent studies indicate that the vagus nerve is involved in immunomodulation as suggested
by its ability to attenuate the production of proinflammatory cytokines in experimental models
of inflammation (de Jonge and Ullola, 2007). Furthermore, functional development of the
vagus nerve occurs at two stages with the neuronal population in the dorsal motor nucleus of
the vagus (DMNV) maturing ahead of the sensory neuron population of the vagal sensory
nucleus NTS (Islami et al., 2008). There appears to be an important link between the vagus
nerve and memory recall in infancy suggesting that social learning, modulated by autonomic
nervous system, may be jeopardized in preterm infants (Haley et al., 2010)
65
66
Fig. 1.
1. of
Figure
1. cells
Packetts
of apoptotic
cells
in Massive
the epithelium
of neonatal
Figure 1. Fig.
Packetts
apoptotic
in the epithelium
of neonatal
piglets.
apoptosis is evidenced
by scan piglets.
ning electron
microscope
(SEM) image
shortened microvilli,
several yet unzipped
spaces
between cells (SEM)
are present.
Massive
apoptosis
isbyevidenced
by scanning
electron
microscope
image by
(SEM images generously supplied by dr. Tomasz Skrzypek, Catholic University of Lublin, Poland)
shortened microvilli, several yet unzipped spaces between cells are present.
(SEM images generously supplied by dr. Tomasz Skrzypek, Catholic University of
In conclusion,
Lublin, maturation
Poland) of the autonomic nervous system may be delayed in preterm and
IUGR animals. Furthermore, delayed development of the GIT in preterm and IUGR animals,
including longer gut permeability, facilitates the toxic effect of external factors including
bacterial translocation. Furthermore, the immature gut seemingly fails to stimulate the
development of the vagus nerve. Importantly, there is some evidence pointing to altered gut
permeability (leaky gut) in autism and possibly genetic predisposition to abnormalities in tight
junctions in ASD (White, 2003; de Magistris et al, 2010).
4. Determinants of individual sensitivity of brain-gut axis and gut

microbiome to environmental toxins; intrinsic and extrinsic components
Studies of the human microbiome revealed that even healthy individuals differ remarkably in
the microbes of the gut. The gut microbiome is regulated by both extrinsic and intrinsic factors.
http://dx.doi.org/10.5772/55425
While much of this biodiversity remains unexplained, extrinsic factors such as diet, environ
ment, and early microbial exposure, and the intrinsic factors such as host genetics have been
implicated (Human Microbiome Project Consortium, 2012); our own studies (Sulkowski et al.,
2012) suggest that sex may play an important role. Diet-derived carbohydrates that are not
fully digested in the upper gut are metabolized by bacteria in the human large intestine. These
nondigestable carbohydrates influence microbial fermentation and total bacterial number in
the colon. Human milk, unlike milk of other mammalian species, contains high amounts of
oligosaccharides of yet unknown function, but one can speculate that dietary oligosaccharides
may play an important function in the development of the microbiome in human neonates.
Evidence exists that the amount and type of nondigestable carbohydrates influence the species
composition of the intestinal microbiome. Individual variation in the gut microbiome may, in
part reflect differences in dietary intake, but the response of the gut microbiome to dietary
change can also differ among individuals (Flint, 2012)
Furthermore, an outcome of the exposure to infectious microbes or their toxins is also influ
enced by both microbial and host genes. Some host genes encode defense mechanisms,
whereas others assist pathogen function. Extensive human diversity in cell lethality dependent
on toxin binding and uptake has been observed (Martchenko et al., 2012). Furthermore, there
is evidence that individuals may evolve their own specific microbiome (Clayton, 2012).
Results of our recent animal studies (Sulkowski et al, 2012; Khan et al, 2012, Xu et al, submitted;
see also Fig. 2) indicate that the sensitivity of the developing CNS to both environmental toxins
and infection, are both sex- and rat strain-dependent. It can be extrapolated that the sensitivity
of the human microbiome is also sex-dependent. Because of this individual variability in host
response it is not surprising that the results of human postmortem studies of ASD brains are
difficult to interpret.
5. Microbiome
The human GIT harbors a large number (1000 to 1150) of bacterial species and is involved in
maintaining homeostasis and well-being. Functions of this microbiome include the regulation
of the mucosal immune system, GIT motility, epithelial barrier regulation, gut secretion,
digestion and metabolism (Grenham et al., 2011). One of the main functions of gut microbes
is to extract nutrients from otherwise indigestible fibers (Tremaroli and Backhed, 2012). The
microbiome, absent at birth, is gradually colonized by facultative bacteria and anaerobic
bacteria (Grenham et al., 2011).
Several lines of evidence point to both brain-gut axis and gut microbiome abnormalities in
autism which are summarized in Fig 3. Children with ASD frequently present a variety of
gastrointestinal (GI) symptoms, although some claim that the data supporting increased GI
symptomology in autistic children not to be rigorous enough (Erickson et al., 2005). The socalled bacterial theory of autism proposes the GIT symptoms are associated with changes
in microbial composition and that these changes could be involved in the pathogenesis or
progression of several childhood diseases including autism (Somma et al., 2010).
67
Fig. 2.
RELATIVE GENE EXPRESSION
A. MALES
3.5
3
2.5
2
1.5
1
0.5
0
SWAP Odf4
DIO2 Cirbp
TTR
Pcp2
DIO3 BDNF RELN FoxP4
B. FEMALES
RELATIVE GENE EXPRESSION
68
3.5
3
2.5
2
1.5
1
0.5
0
SWAP Odf4
DIO2 Cirbp
TTR
Pcp2
DIO3 BDNF RELN FoxP4
Figure 2. The effect of LPS exposure on cerebellar gene expression. Gene expression was measured by quantita
tive RT-PCR in cerebellar tissue of rat pups exposed perinatally to LPS (200g/kg BW) and was normalized to cyclophi
lin A. Panel A: males, PanelFigure
B: females.
presented
as relative
gene expression
2. Data
Theare
effect
of LPS
exposure
on (meanS.E.M.; *, p< 0.05; +, p<
0.1; Xu et al., submitted).
cerebellar gene expression. Gene expression

was measured by quantitative RT-PCR in
tissue of
ratmicrobiome
pups exposed
It has been suggestedcerebellar
that an abnormal
gut
in some ASD children may be due to
perinatally
to
LPS
(200g/kg
BW) and was
certain antimicrobial drugs that play a key role in modifying the intestinal bacterial flora and
normalized to cyclophilin A. Panel A: males,
selecting potentially harmful bacteria normally kept at bay by the innate intestinal flora. And
Panel B: females. Data are presented as a
so, both Clostridia (Finegold,
and Desulfovibrio
(Finegold, 2011a) have been implicated
relative 2011b)
gene expression
(meanS.E.M.;
in autistic pathology.*, Clostridia
form
spores
and
the
spores could likely survive antibiotic
p< 0.05; +, p< 0.1; Xu et al., submitted).
treatment and subsequently flourish. Desulfovibrio is an anaerobic bacillus that does not
produce spores and is resistant to some antibiotics such as cephalosporins used in treatment
of common childhood diseases such as ear infections (Finegold, 2011a). An increase in
Bacteroides, a decrease in Firmicutes with an overall increase in biodiversity has been observed
in IBD, celiac disease and autism (Iebba et al., 2011). An increase in Clostridium histolyticum, a
recognized toxin producer with systemic effects, has been observed in fecal samples of ASD
children (Parracho et al., 2005). A strong correlation of gastrointestinal symptoms with autism,
and a decrease in Bifidobacteria and increase in Lactobacilli, was observed in fecal samples of
ASD children (Adams et al., 2011). An association between high levels of intestinal, mucoepi
thelial-associated Sutterella species and GI disturbances has been detected in intestinal biopsy
samples in children with autism (Williams et al., 2012). This latter study may provide the most
accurate picture of the gut microbiome as the data were derived directly from the gut.
A response to oral treatment with vancomycin, not absorbed from the GI tract, in autism
suggests the importance of gut flora in a disease (Finegold, 2011a). Evidence suggests that
ASD may be associated with altered innate immune response; thus children with GI problems
may reflect inflammation as a reaction to an endotoxin produced by gut bacteria (Jyonou
chi et al, 2002).
http://dx.doi.org/10.5772/55425
HEALTH
*Normal range of social and
feeding behaviors
*Functional social- and foodreward center(s)
*Normal gastrointestinal
functions
*Normal gut permeability and gut
motility
*Normal level of cytokines
*Age-appropriate level of brain
neurotrophins
*Balanced gut microbiome
STRIATUM
F-R
CTR
S-R
CTR
AUTISM
*Altered social and feeding
behaviors
*Altered function(s) of social and
food-reward center(s)??
*Gastrointestinal problems
*Increased gut permeability
leaky-gut; altered gut
motility
*Increased levels of cytokines
*Altered levels of brain
neurotrophis
*Increased biodiversity of
gutmicrobiome; dysbiosis
gutand
microbiome
brain
gut axis
autism.
S-R-CTR,
social
Figure 3.Figure
Altered 3.
gutAltered
microbiome
the brain gut and
axis inthe
autism.
S-R-CTR,
socialin
reward
center;
F-R CTR, food
reward
center. reward center; F-R CTR, food reward center.
Our most recent studies suggest altered expression of ghrelin, the activating enzyme (ghrelin
O-acyltransferase, GOAT) and the receptor in several brain areas of autistic children (SajdelSulkowska, unpublished observation). A decrease in ghrelin mRNA has been also observed
in the temporal gyrus of Alzheimer patients (Gahete et al., 2010) suggesting ghrelin may
contribute to the severity of AD pathology. Since we have measured the levels of ghrelin
mRNA, it can be assumed that the changes observed were due to the altered levels of brain
ghrelin.
The majority of circulating ghrelin is synthesized by gastric mucosa X/A-like cells in response
to negative energy status. These cells are not typical endocrine cells since the oxyntic mucosa
cells produce HCl in the stomach lumen and ghrelin as a hormone. Ghrelin is the most potent
orexigenic peptide, and plays an important role in glucose metabolism and also in GIT
cytoprotection. In addition to its ability to stimulate appetite, ghrelin stimulates the release of
growth hormone release via the growth secretagogue, GHS-R1a receptor. Ghrelin O-acyl
transferase, GOAT, is the enzyme that activates ghrelin. The ghrelin/GHS-R/GOAT system
may play an important role in metabolic disorders in children (Lim and Korbonits, 2012). In
addition to the ghrelin of GIT origin, and the hypothalamus being the main source of brain
ghrelin, ghrelin has been detected in the midbrain, hindbrain, hippocampus, spinal cord and
69
70
several organs outside the brain. While the systemic endogenous ghrelin exerts a tonic
stimulating effect on hypothalamic CRH (Rucinski et al., 2012), its function in the brain includes
the modulation of membrane excitability, control of neurotransmitter release, neuronal gene
expression, and neuronal survival and proliferation (Ferrini et al., 2009).
It has been reported that ghrelin of GIT origin interacts with bacterial toxins (Tiaka et al.,
2011) and exerts a protective role in experimental colitis; is it possible that the ghrelin of brain
origin plays a protective role as well? If so, changes in the level of brain-derived ghrelin could
be detrimental to the developing brain.
6. Existing and emerging therapeutic strategies in autism targeting the gutbrain axis and gut microbiome: Role of individual microbes and dietary
amino acids in maintaining gut-brain homeostasis
Existing therapies targeting the gut microbiome include diet, antibiotics, and probiotics.
Dietary restriction, including the removal of dairy casein-containing products, wheat and
gluten sources, sugar, chocolate, preservatives, and food coloring have all been found to be
therapeutic in autism. Interestingly, dairy casein-containing products stimulate ghrelin (a
hunger hormone) and reduce CCK (a satiety agent) production in the periphery and in the
brain. Gastrointestinal problems in autism appear to respond to antimicrobial agents. Treat
ments targeting Candida, and probiotics have been used to reduce disbiosis and control gut
permeability (Kidd, 2002). Other strategies include the removal of heavy metals (including
mercury) by chelation and sulfur-sulphydryl repletion. Supplementation with dimethylgly
cine, vitamin B6, magnesium, vitamin B3, C, folic acid, calcium and zinc, cod liver, digestive
enzymes, all appear to be beneficial in a number of autistic children (Kidd, 2002). Immune
therapies, including pentoxifyllin, immunoglobulin, transfer factors and colostrums appear to
work in a limited number of cases,
The initial promising use of secretin, a triggering factor for digestion, in the treatment of autism
has been more recently disclaimed. In multiple randomized controlled trials secretin offered
no significant benefit (Krishnaswami et al., 2011; Williams et al., 2012).
Abnormalities in the primary pathway for carbohydrate digestion and transporters, involving
disaccharidases and hexose transporters, have been reported and found to be accompanied by
dysbiosis as evidenced by a decrease in Bactoroidetes and an increase in the ratio of Firmicutes
to Bacteroidetes (Williams et al., 2011). These abnormalities respond to probiotic and dietary
responses (Williams et al., 2011). Probiotic therapy appears to influence microbiome compo
sition, intestinal barrier function and mucosal immune responses (Critchfield et al., 2011).
There is evidence to support alterations of fecal microbiome in autism, and in the majority of
cases treatment with vancomycin, an antibiotic that targets gram positive anaerobes and is
minimally absorbed by the gut, can improve symptoms (Sandler et al., 2000).
Recently therapies targeting the gut microbiome are emerging as a viable strategy in the
treatment of CNS disorders (Forsythe et al., 2010). Preclinical studies of selected probiotics in
http://dx.doi.org/10.5772/55425
healthy volunteers (Messaoudi et al., 2011) provided encouraging results for further studies
exploring the concept of microbial targeting of the GIT under pathological conditions includ
ing autism. Individually tailored probiotic formulations, enriched in specific strains of gut
bacteria, could one day be used in treatments of ASD even as an adjuvant to other treatments.
7. Possible connection of gut microbiome and behavior; microbiome and

behavioral abnormalities in ASD
The intestinal microbiome participates in the development of the HPA axis (Sudo et al., 2004)
and is critical to the development of appropriate stress response later in life, which occurs
during a narrow, critical developmental window. This process involves both the regulation of
the levels of brain derived neurotrophic factor (BDNF) and NMDA receptors (Sudo et al.,
2004). The microbiome also plays an important role in anxiety-like behavior (Messaoudi et al.,
2011), depressive behaviors (Neufield et al., 2011; Messaoudi et al., 2011), but the effects are
diminished in vagatomized animals, suggesting either the direct communication between the
bacteria and the brain (Bravo et al., 2011) or through the brain-gut axis. The latter possibility
is an indirect action of bacteria on an afferent vagal pathway via gut immune, endocrine and
enteric nervous system (ENS) controlling mechanisms.
Animal studies have also shown that stress can change the composition of the microbiome,
where the changes are associated with increased vulnerability to inflammatory stimuli in the
GIT (Gareau et al., 2006); here the microbiome plays an important role in memory dysfunction
(Gareau et al., 2011). Stress is known to inhibit gut contraction, one of the crucial defense
strategies against bacterial colonization of gut mucosa. Early psychological trauma of maternal
separation resulted in persistent mucosal barrier dysfunction in neonatal rats, including host
defense to luminal bacteria, by mechanisms involving peripheral CRH receptors (Gareau et
al., 2006).
Oral antibiotics disrupt the microbiome and favor environment for opportunistic bacteria.
Clostridium tetani, an anaerobic bacillus produces a potent neurotoxin, tetanus neurotoxin
(TeNT) that is transported by the vagus nerve from the GI to the CNS. In the brain TeNT
disrupts the release of neurotransmitters by the proteolytic cleavage of synaptobrevin, a
synaptic vesicle membrane protein. This inhibition may be related to a variety of behavioral
deficits characteristic of autism. Some children with autism treated with anti-clostridia
antibiotics have shown a reduction in stereotyped behavior (Bolte, 1998).
8. The role of the reward system in gut-brain communication, the

interaction between food-reward and social-reward systems; altered gutmicrobiome regulation of the reward loop in autism?
Autism is characterized by both severe deficits in social interaction and communication and
significant eating difficulties with a highly restricted range of food choices (Williams et al.,
71
72
2000). It seems logical to hypothesize that altered composition of the gut microbiome under a
leaky gut condition in autism interferes with the normal activity of the reward circuitry
including both social and feeding behavior, as illustrated in Fig. 3. In support of this hypothesis
are the neuroimaging, electrophysiological and neurochemical data suggesting a disruption
in reward seeking tendencies in ASD, and especially in social contexts (Kohls et al., 2012). It
has been proposed that this disruption is caused by abnormalities of the dopaminergicoxytocinergic wanting circuitry that includes the ventral striatum, amygdale, and the
ventromedial prefrontal cortex (Kohls et al., 2012). Indeed, Individuals with ASD are charac
terized by low responsiveness to social rewards (Dawson et al., 2005; Schultz, 2005; Neuhaus
et al, 2010). Recent studies of the left amygdala and orbito-frontal cortex, which are the main
components of the social brain, showed neuronal dysfunctions in these structures in autism
(Mori et al, 2012). Furthermore, brain levels of serotonin, the happy hormone are regulated
by gut bacteria as evidenced by studies involving germ-free animals (Clarke et al., 2012).
Abnormalities in blood serotonin levels are consistently altered in a subset of children with
ASD.
It is also possible that the abnormalities in vagus nerve functions may further contribute to
social deficits in autism (Goetz et al., 2010). ). It is thus of interest (Ito and Craig, 2008) that
there is a possibility that the vicerosensory information is sent via the vagus nerve directly to
the reward centers. The vagus nerve is involved in our emotional responses and in feelings of
compassion as shown in vagal stimulation, suggesting that the social bond is related to the
gut-brain axis (Goetz et al., 2010). Studies utilizing single-photon emission tomography (SPET)
provide evidence for the limbic system-vagal nerve connection (Barnes et al., 2003). Vagotomy
was for decades a method of choice in treating a number of gastric diseases in adults; it would
be of interest to address it in context of autistic pathology.
Furthermore, the intestinal microbiome regulates the HPA during both development and
adulthood (Sudo et al., 2004) and plays an important role in the stress response. Activation of
the HPA axis involves the release of endogenous opioids which are components of the brain
reward system (Adam et al., 2007).
In humans, sensory factors, such as taste and smell, have an important role in reward-related
feeding (Rolls, 2011); gustatory, olfactory, visual and somatosensory aspects of food are
regulated by the orbitofrontal cortex. Environmental cues, as well as cognitive, reward, and
emotional factors play an important role in food intake which may override the homeostatic
requirements (Berthoud, 2006). Environmental cues regulate endocannabinoid and opioid
systems which play an important role in reward-related feeding and have wide receptor
distributions within the CNS (Cota et al., 2006). Hypothalamic endocannabinoids increase food
intake through a leptin-regulated mechanism. The nucleus accumbens is a key limbic pathway
and may be implicated in regulation of hedonistic and homeostatic feeding (Berthoud, 2006).
Dopamine appears to be associated with reward-related food intake and with behaviors
required to maintain feeding essential for survival (Di Marzo et al., 2001).
The neural circuit mediating reward-related behavior is a complex network that includes the
midbrain, substantia nigra, the amygdala, the ventral striatum, the ventromedial prefrontal
http://dx.doi.org/10.5772/55425
cortex and ventral anterior cingulated cortex with the central relay located in ventral striatum
(Kohls et al., 2012).
It is interesting, that the ventral striatum is associated with both social-reward and food-reward
circuitry (Adam et al., 2007). Although it is generally assumed that the two centers are separate,
the observation of altered sucrose preference and positive correlation with ventral striatum
dopamine levels under conditions of social isolation stress in perinatal rats lends support to
the speculation of inter-connectivity of the two centers (Brenes and Fornaguera, 2008).
9. Conclusions
The leaky gut during development may be potentially more vulnerable to environmental
insults than the normally developing GIT. Consequently, alterations in the gut microbiome
may play an important role in autistic pathology. Evidence is growing that points to an early
developmental abnormality in establishing GIT and innate microbial milieu. The gut micro
biome, regulated by both intrinsic and extrinsic factors, may be further jeopardized by
recurrent infections and/or recurrent use of antibiotics. A developmentally abnormal gut
microbiome may in turn affect both the gut-brain axis and brain development and contribute
to the etiology of ASD. Abnormalities in the gut-brain axis may further lead to the aberrant
development of both the social and the food reward system(s) in autism. Future studies
targeting the gut-brain/brain-gut axis in autism and the gut microbiome are warranted, but
must take into consideration individual variation in gut microbiomes and intrinsic and
extrinsic sensitivities and sex. Results of these studies will likely contribute to our under
standing of ASD and advance new and viable therapies.
Author details
Elizabeth M. Sajdel-Sulkowska1* and Romuald Zabielski2
1 Dept. Psychiatry Harvard Medical School and BWH, USA
2 DDept. Physiological Sciences, Warsaw University of Life Sciences, Poland
References
[1] Adam TC, Epel ES. Stress, eating and the reward system. Physiology and Behavior
2007; 91:449-458.
73
74
[2] Adams JB, Johansen LJ, Powell LD, Quig D, Rubin RA. Gastrointestinal flora and
gastrointestinal status in children with autism comparisons to typical children and
correlation with autism severity. BMC Gastroenterology 2011; 11: 22.
[3] Baintner K. Vacuolation in the young. In Biology of the Intestine in Growing Ani
mals, Zabielski R, Gregory PC, Westrom B. (eds). Amsterdam, Elsevier, 2002, pp.
55-110.
[4] Barnes A, Duncan R, Chisholm JA, Lindsay K, Patterson J, Wyper D. Investigation
into the mechanisms of vagus nerve stimulation for the treatment of intractable epi
lepsy, using 99mTc-HMPAO SPET brain images. Eur J Nucl Med Mol Imaging. 2003;
30:301-305.
[5] Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri
J, McCoy KD, Verdu EF, Collins SM. The intestinal microbiota affects central levels of
brain-derived neurotrophic factor and behavior in mice. Gastroenterology. 2011;
141:599-609.
[6] Berthound HR. Homeostatic and non-homeostatic pathways involved in the control
of food intake and energy balance. Obesity. 2006; 14:197S-200S.
[7] Bolte ER. Autism and Clostridium tetani. Med Hypotheses. 1998; 51:133-144.
[8] Bonior J, Jaworek J, Kot M, Konturek SJ, Pierzchalski P. Long-lasting effect of infant
rats endotoxemia on heat shock protein 60 in the pancreatic acinar cells: involvement
of toll-like receptor 4. Int J Inflam. 2012; DOI: 2012:354904. Epub 2012 May 22.
[9] Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock
J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central
GABA receptor expression in mouse via the vagous nerve. Proc Natl Acad Sci. doi:
10.1073/pnas.1102999108.
[10] Brenes JC, Fornaguera J. Effects of environmental enrichment and social isolation on
sucrose consumption and preference: associations with depressive-like behavior and
ventral striatum dopamine. Neurosci Lett. 2008; 436:278-282.
[11] Carvey PM, Chang Q, Lipton JW, Ling Z. Prenatal exposure to the bacteritoxin lipo
polysaccharide leads to long-term losses of dopamine neurons in offspring: a poten
tial, new model of Parkinsons disease. Front Biosci 2003; 8:s826-37.
[12] Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG,
Cryan JF. The microbiome-gut-brain axis during life regulates the hippocampal sero
tonergic system in a sex-dependent manner. Mol Psychiatry. 2012: (Epub 10.1038/mp.
2012.77)
[13] Clayton TA. Metabolic differences underlying two distinct rat urinary phenotypes, a
suggested role for gut microbial metabolism of phenylalanine and a possible connec
tion to autism. FEBS Lett. 2012; 586;956-961.
http://dx.doi.org/10.5772/55425
[14] Cota D, Tschop MH, Horvath TL, Levine AS. Cannabinoids, opioids and eating be
havior: the molecular face of hedonism? Brain Res Rev. 2006; 51;85-107.
[15] Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P. The potential role of
probiotics in the management of childhood autism. Gastroenterol Res Pract. 2011;
2011:161358.
[16] Dawson G, Webb SJ, Wijsman E, Schellenberg G, Estes A, Munson J, Faja S. Neuro
cognitive and electrophysiological evidence of altered face processing in parents of
children with autism: implications for a model of abnormal development of social
brain circuitry in autism. Dev Psychopathol. 2005; 17:679-697.
[17] De Jonge WJ and Ullola L. The alpha7 nicotinic acetylcholine receptor as a pharmaco
logical target for inflammation. British J Pharmacol. 2007; 151:915-929.
[18] de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De
Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C. Alterations of the intesti
nal barrier in patients with autism spectrum disorders and in their first-degree rela
tives. J Pediatr Gastroenterol Nutr. 2010; 51:418-24.
[19] Di Marzo V, Goparaju SK, Wang L et al. Leptin-regulated endocannabinoids are in
volved in maintaining food intake. Nature 2001; 410:822-825.
[20] Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, mcDougle Cj. Gastro
intestinal factors in autistic disorder: a critical review. J Autism Dev Disorders 2005;
35:713-727.
[21] Ferriero DM. Neonatal brain injury. N Engl J Med 2004; 351:1985-1995.
[22] Ferrini F, Salio C, Lossi L, Merighi A. Ghrelin in Central Neurons. Neuropharmacol.
2009; 7:37-49.Finegold SM. Desulfovibrio species are potentially
[23] Fingold SM. Desulfovibrio species are potentially important in regressive autism.
Med Hypotheses 2011a; 77:270274.
[24] Finegold SM. State of the art : microbiology in health and disease. Anaerobe 2011b;
17:367-368.
[25] Flint HJ. The impact of nutrition on the human microbiome. Nutr Rev 2012; 70:S10S13.
[26] Gahete MD, Rubio A, Cordoba-Chacon J, Gracia-Navarro F, Kineman RD, Avila J,
Lugue RM, Castano JP. Expression of the ghrelin and neurotensin systems is altered
in the temporal lobe of Alzheimers patients. J Alzheimers Dis. 2010; 22:819-828.
[27] Gareau MG, Jury J, Yang PC, MacQueen G, Perdue MH. Neonatal maternal separa
tion causes colonic dysfunction in rat pups including impaired host resistance. Pe
diatr Res. 2006; 59:83-88.
75
76
[28] Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, Macqueen G,
Sherman PM. Bacterial infection causes stress-induced memory dysfunction in mice.
Gut. 2011; 60:307-317.
[29] Gayle DA, Beloosesky R, Desai m, Amidi F, Nunez SE, Ross MG. Maternal LPS indu
ces cytokines in the amniotic fluid and corticotrophin releasing hormone in the fetal
rat brain. Am J Regul Integr Comp Physiol 2004; 286:R1024-R1029.
[30] Godlewski MM, Supecka M, Woliski J, Skrzypek T, Skrzypek H, Motyl T, Zabielski
R. Into the unknown--the death pathways in the neonatal gut epithelium. J Physiol
Pharmacol. 2005; 56 Suppl 3:7-24.
[31] Goetz JL, Keltner D, Simon-Thomas E. Compassion: an evolutionary analysis and
empirical review. Psychol Bull. 2010; 136:351-374.
[32] Grenham S, Clarke, G, Cryan JF, Dinan TG. Brain-gut-microbe communication in
health and disease. Front Physiol. 2011; 2:94[33] Haley DW, Grunau RE, Weinberg J, Keider A, Oberlander TF. Physiological corre
lates of memory recall in infancy: vagal tone, cortisol, and imitation In Praterm and
full-term infants AT 6 months. Infant Behav Dev. 2010; 33:219-234.
[34] Human Microbiome Project Consortium. A framework for human microbiome re
search. Nature 2012; 486:215-221.
[35] Iebba V, Aloi m, Civitelli F, CucchiaraS. Gut microbiota and pediatric disease. Dig
Dis. 2011; 29:531-539.
[36] Islami H, Shabani R, Bexheti S, Behluli I, Sukalo A, Raka D, Koliqi R, Haliti N, Dauti
H, Krasniqi S, Disha M. In vitro examination of ontogenesis of developing neuronal
cells in vagal nuclei in medulla oblongata in newborns. Bosn J Basic Med Sci. 2008;
8:381-385.
[37] Ito S, Craig AD. Striatal projections of the vagal-responsive region of the thalamic
parafascicular nucleus in macaque monkeys. J Comp Neurol. 2008; 506; 301-327.
[38] Jaworek J, Konturek SJ, Macko M, Kot M, Szklarczyk J, Leja-Szpak A, Nawrot-Porab
ka K, Stachura J, Tomaszewska R, Siwicki A, Pawlik WW. Endotoxemia in newborn
rats attenuates acute pancreatitis at adult age. J Physiol Pharmacol. 2007a; 58:131-47.
[39] Jaworek J, Nawrot-Porabka K, Leja-Szpak A, Szklarczyk J, Macko M, Bonior J, Sta
chura J, Konturek SJ, Pawlik WW. Exposition of newborn rats to bacterial endotoxin
impairs pancreatic enzyme secretion at adult age. J Physiol Pharmacol. 2007b;
58:287-302.
[40] Jaworek J, Leja-Szpak A, Nawrot-Porabka K, Bonior J, Szklarczyk J, Kot M, Konturek
SJ, Tomaszewska R, Pawlik WW. Effect of neonatal endotoxemia on the pancreas of
adult rats. J Physiol Pharmacol. 2008; 59 Suppl 4:87-102.
http://dx.doi.org/10.5772/55425
[41] Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory re

sponses and cytokine production against common dietary proteins in patients with
autism. Neuropsychobiology 2002; 46:76-84.
[42] Khan A, Sulkowski ZL, Chen T, Zavacki AM, Sajdel-Sulkowska EM. Sex-dependent
changes in cerebellar thyroid hormone-dependent gene expression following perina
tal exposure to thimerosal in rats. Khan J Physiol Pharmacol. 2012; 63:277-83.
[43] Kidd PM. Autism, an extreme challenge to integrative medicine. Part 2; medical
management. Altern Med Rev. 20027:479-499.
[44] Kohls G, Chevallier C, Rrioani V, and Schultz RT. Social wanting dysfunction in au
tism: neurobiological underpinning and treatment intervention. J Neurodev Disor
ders. 2012; 4:10.
[45] Kohmura Y, Kirikae T, Kirikae F, Nakano M, Sato I. Lipopolysaccharide (LPS)-in
duced intra-uterine fetal death (IUFD) in mice is principally due to maternal cause
but not fetal sensitivity to LPS. Microbiol Immunol. 2000 ; 44 :897-904.
[46] Krishnaswami S, McPheeters ML, Veenstra-Vanderweele J. A systematic review of
secretin for children with autism spectrum disorders. Pediatrics. 2011; 127:1322-1325.
[47] Lim CT, Korbonits M. Paediatric endocrine aspects of ghrelin. Paediatr Endocrinol
Rev 2012; 9:628-638.
[48] Matchenko M, Candille SI, Tang H, Cohen SN. Human genetic variation altering an
thrax sensitivity. Proc Natl Acad Sci USA 2012; 109:2972-2977.
[49] Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, Bisson JF, Rougeot
C, Pichelin M, Cazaubiel M, Cazaubiel JM. Assessment of psychotropic-like proper
ties of probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium
longum R0175) in rat and human subjects. Br J Nutr. 2011; 105:755-764.
[50] Mickiewicz M, Zabielski R, Grenier B, Le Normand L, Savary G, Holst JJ, Oswald IP,
Metges CC, Guilloteau P. Structural and functional development of small intestine in
intrauterine growth retarded porcine offspring born to gilts fed diets with differing
protein ratios throughout pregnancy. J Physiol Pharmacol. 2012; 63:225-39.
[51] Mori K, Toda Y, Ito H, Mori T, Goji A, Fujii E, Miyazaki M, Harada M, Kagami S. A
proton magnetic resonance spectroscopic study in autism spectrum disorders:
Amygdala and orbito-frontal cortex. Brain Dev. 2012; doi: 10. 1016/j.braindev.
2012.09.016
[52] Neufeld KM, Kang N, Bienenstock J, FosterJ. Reduced anxiety-like behavior and cen
tral neurochemical change in germ-free mice. Neurogastroenterol Motil. 2011;
23:255-264.
[53] Neuhaus E, Beauchaine TP, Bernier R. Neurobiological correlates of social function
ing in autism. Clin Psychol Rev. 2010; 30:733-748.
77
78
[54] Papoff P, Caccarelli G, dEttorre G, Cerasaro C, Caresta E, Midulla F, Moretti C. Gut

microbial translocation in critically ill children and effects of supplementation with
pre- and pro biotics. Int J Microbiol. 2012; 29012:151393.
[55] Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between gut
microflora of children with autistic spectrum disorders and that of healthy children. J
Med Microbiol 2005; 54:987-991.
[56] Patterson PH. Maternal infection: window on neuroimmune interactions in fetal
brain development and mental illness. Curr Opin Neurobiol. 2002; 12:115-118.
[57] Pearce BD. Schizophrenia and viral infection during neurodevelopment: a focus on
mechanisms. Mol Psychiatry 2001; 6:634-646.
[58] Rolls ET. Taste, olfactory and food texture reward processing in the brain and obesi
ty. Intern J Obesity. 2011; 35:550-561.
[59] Rucinski M, Ziolkowska A, Szyszka M, Hochol A, Malendowicz LK. Evidence sug
gesting that ghrelin O-Aceyl transferase inhibitor acts AT the hypothalamus to inhib
it hypothalamo-pituitary-adrenocortical axis function in the rat. Peptides. 2012;
35:149-159.
[60] Scarpignato C, Pelosini I. Management of irritable bowel syndrome: novel ap
proaches to the pharmacology of gut motility. Can J Gastroenterol. 1999; 13 Suppl A:
50A-65A.
[61] Schendel DE. Infection in pregnancy and cerebral palsy. J Am Med Womens Assooc.
2002; 56:105-108.
[62] Schendel DE, Schuchat A, Thorsen P. Public health issues related to infection in preg
nancy and cerebral palsy. Ment Retard Dev Disabilit Res Rev 2001; 8:39-45.
[63] Schultz RT. Developmental deficits in social perception in autism: the role of amyg
dale and fusiform face area. In J Dev Neurosci 2005; 23:125-141.
[64] Sajdel-Sulkowska EM, Xu M, McGinnis W, Koibuchi N. Brain region-specific changes
in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD). Cer
ebellum 2011; 10:43-48.
[65] Somma F, Castagnola R, Bollino D, Marigo L. Oral inflammatory process and general
health. Part 1: The focal infection and the oral inflammatory lesion. Eur Rev Med
Pharmacol Sci. 2010;14:1085-95.
[66] Strzakowski AK, Godlewski MM, Hallay N, Kulasek G, Gajewski Z, Zabielski R. The
effect of supplementing sow with bioactive substances on neonatal small intestinal
epithelium. J Physiol Pharmacol. 2007; 58 Suppl 3:115-22.
[67] Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C, Koga Y. Postnatal
microbial colonization programs the hypothalamic-pituitary-adrenal system for
stress response in mice. J Physiol. 2004; 558:263-275.
http://dx.doi.org/10.5772/55425
[68] Sulkowski ZL, Chen T, Midha S, Zavacki AM, Sajdel-Sulkowska EM. Maternal thi
merosal exposure results in aberrant cerebellar oxidative stress, thyroid hormone
metabolism, and motor behavior in rat pups; sex- and strain-dependent effect. Cere
bellum 2012; 11:575-586.
[69] Tiaka EK, Manolakis AC, Kapsoritakis AN, Potamianos SP. Unraveling the link be
tween leptin, ghrelin and different types of colitis. Annals of Gastroentrology
2420-28.
[70] Tremaroli V, Bckhed F. Functional interactions between the gut microbiota and host
metabolism. Nature 2012; 489:242-249.
[71] Urakubo A, Jarskog Lf, Lieberman JA, Gilmore JH. Prenatal exposure to maternal in
fection alters cytokine expression in the placenta, amniotic fluid, and fetal brain.
Schizophr Res 2001; 47:27-36.
[72] Watson JB, Mednick SA, Huttunen M, Wang X. Prenatal teratogens and the develop
ment of adult mental illness. Dev Psychopathol. 1999; 11:457-466.
[73] White JF. Intestinal pathophysiology in autism. Exp Biol Med (Maywood).2003;
22:639-649.
[74] Williams BL, Hornig M, Parekh T, Lipkin WI. Application of novel PCR-based meth
ods for detection, quantitation, and phylogenic characterization of Sutterella species
in intestinal biopsy samples from children with autism and gastrointestinal distur
bances. Mbio. 2012; 3. E00261-11.
[75] Williams K, Wray JA, Wheeler DM. Intravenous secretin for autism spectrum disor
ders (ASD). Cochrane Database Syst Rev. 2012; 4:
[76] Williams PG, Dalrymple N, Neal J. Eating habits of children with autism. Pediatr
Nurs. 2000; 26:259-264.
[77] Xu M, Sulkowski ZL, Parekh P, Khan A, Chen T, Midha S, Iwasaki N, Koibuchi N,
Zavacki AM, Sajdel-Slkowska EM. Effects of perinatal lipopolysaccharide (LPS) ex
posure on the developing rat cerebellum; modeling the effect of maternal infection
on the developing human CNS Cerebellum (submitted).
[78] Zabielski R, Morisset J, Podgurniak P, Rom V, Biernat M, Bernard C, Chayvialle JA,
Guilloteau P. Bovine pancreatic secretion in the first week of life: potential involve
ment of intestinal CCK receptors. Regul Pept. 2002; 103:93-104.
79
Chapter 5
Why There Is no Link Between

Measles Virus and Autism
Stephen A. Bustin
http://dx.doi.org/10.5772/52844
1. Introduction
A report published in the Lancet in 1998 described the case histories of 12 previously normal
children who developed symptoms of autism or inflammatory bowel disease after having
received the measles, mumps, and rubella (MMR) vaccine [1]. This paper formed the basis
for Andrew Wakefields subsequent claim to have identified a new type of gastrointestinal
disease, termed autistic enterocolitis. Despite never explicitly asserting a link between the
MMR vaccine and this supposedly new, regressive form of autism, the paper sparked a ma
jor health scare in the United Kingdom. It is probable that the uncertainty and controversy
surrounding the relationship between measles and autism contributed to the fact that in
2004/05, about 1.9 million school children and 300,000 pre-school children were recorded as
incompletely vaccinated against measles in England, including more than 800,000 children
completely unvaccinated. Based on this, approximately 1.3 million children aged 2-17 years
were susceptible to measles [2]. In 2006, a 13-year old boy, who had not received the MMR
vaccine, became the first person in the UK for 14 years to die of measles and as a result of
almost a decade of low MMR vaccination coverage across the UK, by 2008 the disease had
once again become endemic.
In 2010 the Lancet fully retracted the 1998 publication from the public record, stating that it
had become clear that several elements of the 1998 paper by Wakefield et al are incorrect,
contrary to the findings of an earlier investigation.The circumstances surrounding this pub
lication were subject to an extensive investigation and received a huge amount of publicity.
Wakefield was found guilty of serious professional misconduct over the way he carried out
his research and was struck off the medical register in 2010. A long statement released on 24
May 2010 includes the following key statements:
2013 Bustin; licensee InTech. This is an open access article distributed under the terms of the Creative
82
In all the circumstances and taking into account the standard which might be expected
of a doctor practising in the same field of medicine in similar circumstances in or around
1996-1998, the Panel concluded that Dr Wakefields misconduct not only collectively
amounts to serious professional misconduct, over a timeframe from 1996 to 1999, but also,
when considered individually, constitutes multiple separate instances of serious profes
sional misconduct. Accordingly the Panel finds Dr Wakefield guilty of serious professio
nal misconduct and
Figure 1. The polymerase chain reaction, a method for copying the same stretch of DNA several million-fold. A. A PCR
reaction consists of double stranded DNA, two short DNA molecules (primers) whose sequence is complementary to
opposite strands of the DNA, a DNA synthesis enzyme (Taq polymerase) and four nucleotide building blocks
(dNTPs). The reaction mixture is heated to 95C to dissociate the sample DNA strands, then cooled to around 55C
to allow the two primers to bind to their targets on the individual strands. Next, Taq polymerase makes two new
strands of DNA at its optimal temperature of around 70C, using the original strands as templates, hence duplicating
the original DNA. This procedure is repeated many times, leading to more than one billion exact copies of the original
DNA segment. These can be detected by running the samples on a gel and staining with a DNA-binding dye. B. qPCR
obviates the need for gel electrophoresis by using fluorescence to detect copied DNA. The qPCR method used for the
detection of MeV uses a target-specific DNA molecule (probe) that has a fluorescent dye at one end (R) and a
quencher (Q) on the other. In the absence of target, the quencher prevents the dye from emitting light. In the pres
ence of target, the probe binds to its target and is degraded by the Taq polymerase. This separates the fluorescent
label and the quencher and so results in the emission of light. Both the PCR and light detection are automated and
detected in a single step by a dedicated instrument.
Why There Is no Link Between Measles Virus and Autism

http://dx.doi.org/10.5772/52844
Accordingly the Panel has determined that Dr Wakefields name should be erased from
the medical register. The Panel concluded that it is the only sanction that is appropriate to
protect patients and is in the wider public interest, including the maintenance of public
trust and confidence in the profession and is proportionate to the serious and wide-rang
ing findings made against him [3].
There was far less publicity about the attempts to use molecular techniques to corroborate a
link between measles virus (MeV) and autistic enterocolitis. The major technique used
was the fluorescence-based real-time polymerase chain reaction (qPCR), a ubiquitous techni
que used for the sensitive and specific detection of DNA (Figure 1).
2. Technology and target

2.1. qPCR
A key attraction of qPCR technology is its apparent simplicity: an assay consisting of
combining oligonucleotides, PCR enzyme and buffer with a nucleic acid template to pro
duce a qPCR reaction is perceived as undemanding. This practical simplicity is comple
mented by the absence of any requirement for post-assay handling, as well as the
development of user-friendly data analysis software that makes data generation and vis
ualisation in the shape of amplification plots remarkably simple. Indeed, qPCR is often
described as a mature technology and as the gold standard for nucleic acid quantifica
tion. Whilst it is true that the technology is capable of exquisite sensitivity and specifici
ty, coupled with high reproducibility and accuracy, it is essential to understand that
qPCR assays are made up of numerous, often divergent protocols that use different in
struments, enzymes, buffers and non-identical targets.
Whilst qPCR is the method of choice for the detection of DNA, the enzyme (Taq polymerase)
used to copy the DNA template does not work well with RNA. Hence, if the amplification
target is RNA, as it is for MeV, an enzymatic RNA-to-DNA conversion (reverse transcrip
tion, RT) step must be carried out before the DNA copying step can specifically amplify the
target of interest. This variant of the qPCR is termed reverse-transcription (RT)-qPCR and
the principle of this reaction is simple: RNA is reverse transcribed into single stranded
DNA, either in a separate reaction or as a one tube assay that uses a different enzyme (Tth
polymerase), as was the case with the experiments discussed below. There are several detec
tion chemistries, but in this case a very specific and widely used probe-based method was
used (Figure 1B). Importantly, the use of fluorescent reporter molecules permits concurrent
target amplification, detection and quantification as the assay proceeds [4]. Fluorescence is
detected using dedicated qPCR instruments, which have (i) a controllable heating block that
can hold a variety of temperatures and rapidly change between them, (ii) an excitation light
source to excite the fluorochrome, (iii) a detector to register photon emissions and (iv) soft
ware that allows analysis of the data. Fluorescence emissions are collected from each sample
tube and the levels of background fluorescence detected by the fluorimeter module of the
qPCR instrument are established, providing a baseline that defines the sensitivity of the in
83
84
strument. Instrument-specific algorithms are used to define a fluorescence threshold for

each sample. Finally, the algorithm searches the data from each sample for a point that ex
ceeds the baseline and plots a characteristic amplification plot.
Increases in fluorescent signal are proportional to the amount of DNA produced during
each PCR cycle and produce a characteristic quantification cycle (Cq) for every test. As a re
sult, the more initial target there is, the sooner the instrument can detect the fluorescence
and the lower the Cq. Conversely, a higher Cq denotes less initial target. This correlation be
tween fluorescence and amount of amplified product permits accurate quantification of tar
get molecules over a wide dynamic range in the presence of suitable standards.
The consistency and reliability of RT-qPCR assays depends on the appropriate execution of
a number of steps, principally those involving sample selection, template quality, assay de
sign and data analysis.
2.2. Measles virus
MeVs, from the family Paramyxoviridae, genus Morbillivirus, have a single negativestrand RNA genome enclosed in a viral envelope associated with three proteins: the ma
trix (M) lining the inner surface of the envelope and the fusion (F) and haemagglutinin
(H) transmembrane proteins. Negative sense means that the RNA is complementary to
mRNA and must be copied into the complementary plus-sense mRNA before proteins
can be made. Thus, besides needing to code for an RNA-dependent RNA-polymerase,
these viruses also need to package it in the virion so that they can make mRNAs upon in
fecting the cell. The MeV RNA-dependent RNA polymerase generates a full-length posi
tive copy of their genome, the replicative intermediate as well as individual RNA
copies that serve as mRNA for individual virus-specific proteins (Figure 2). Importantly,
at no stage of its replication cycle is MeV RNA ever reverse transcribed into DNA, i.e.
MeV does not exist as a DNA molecule, a fact that was established in 1964. This is a criti
cal issue, since if it can be demonstrated that a test is amplifying DNA and not RNA, this
provides indisputable proof of contamination.
2.3. What makes a publication credible?
Before describing the experiments in detail, it is worth reiterating what is expected of a plau
sible scientific publication. Its credibility depends on a number of conditions that include
Transparency of reporting
Reliability of protocols and techniques
Inclusion of appropriate controls
Reproducibility of the data
This is especially so for publications that utilises qPCR, since its sensitivity makes experi
ments susceptible to contamination, which leads to the reporting of false positive results.

http://dx.doi.org/10.5772/52844
The purpose of this chapter is to demonstrate that the qPCR data claiming to detect MeV in
the intestine of autistic children are unreliable and meaningless because of
Absence of transparency: the key publication shows no data; hence an expert reader can
not evaluate the reliability of its conclusions
Unreliable techniques and protocols: analysis of the qPCR data was incorrect
Disregard for controls: obvious evidenceof extensive contamination was disregarded
Lack of reproducibility: the data could not be duplicated by several independent investi
gators
The only conclusion possible is that the assays were detecting contaminating DNA. Since
MeV is an RNA-only virus and never exists in DNA form, these data must be ignored and it
it is my opinion that the authors should withdraw this publication from the peer-reviewed
literature.
Figure 2. MeV life cycle. The virus attaches to the surface of a host cell, the viral envelope fuses to the plasma mem
brane and the nucleocapsid is released into the cell. Negative-sense genomic RNA is transcribed into individual mes
senger RNAs as well as a full-length positive-sense RNA template, which is used to create negative-sense RNA. Viral
proteins are translated, assembled around the negative sense RNA and new viruses bud from the cells.
85
86
3. Timeline
3.1. April 2000
An Irish pathologist, John OLeary, reports scientific results in a series of children with au
tistic enterocolitis following an approach made by Andrew Wakefield before the US
Congress Committee on Government Reform [5]. He had compelling evidence in relation
to the presence of measles virus in children with autistic enterocolitis and could confirm
that his [Wakefields] hypothesis is correct. This statement was based on the detection of
MeV using the then rather novel reverse transcription (RT)-qPCR assay as well other meth
ods, in 24/25 children with autistic enterocolitis, compared to 1/15 control children.
OLeary also emphasised that he went to desperate lengths to prove the absence of con
tamination problems to outrule the possible generation of false positives. Importantly, he
stressed that nothing in [his] testimony should or must be construed as anti-vaccine; rather
it encourages safe vaccine strategies. This final qualification, although very clear, was bur
ied by the headline news of the link between MeV and autistic enterocolitis.
3.2. August 2000
A brief letter signed by JJ OLeary, V Uhlmann and AJ Wakefield appeared in the Lancet [6]. It
asserted that their data from molecular virological studies examining the role of measles vi
rus infection in children with autism and enterocolitis have been peer-reviewed, presented,
and published at four international scientific meetings. The letter contained references to oth
er publications, with reference 4 listing a publication by Uhlmann et al. entitled Identification
of measles virus genomes in ileo-colonic lymphoid hyperplasia in children as in press in the
Journal Laboratory Investigations. However, there is no record of such a publication.
3.3. April 2002
Speculation about a possible association between intestinal abnormalities in children with
developmental disorders and the MMR vaccine was encouraged by a publication that utilis
ed RT-qPCR assays to screen childrens intestinal biopsies for the presence of MeV [7]. A
comparison of terminal ileal samples from 70 normal controls and 91 children with a new
form of developmental disorder, ileocoloniclymphonodular hyperplasia, led to the claim
that whereas 75/91 of the affected children patients tested positive for MeV, only 5/70 con
trol patients did. The paper does not reveal whether the autistic children had been given the
MMR vaccination, but in the context of the source (Royal Free Hospital), authors (including
Wakefield), introduction (reference to Wakefields paper) and the discussion one is left with
the impression that they had. The prominently displayed take home message concludes
the data confirmed an association between the presence of measles virus and gut pathology
in children with developmental disorder. These results, if true, would constitute hard evi
dence linking MeV, gut pathology and autism and was indeed used to support the vaccina
tion/autism theory, even though the authors themselves never made that specific link.

http://dx.doi.org/10.5772/52844
3.4. May 2004

An abstract entitled TaqMan RT-PCR Detection of Measles Virus Genomic RNA in Cere
brospinal Fluid in Children with Regressive Autism and published on the website of the
Association of American Physicians and Surgeons lists two of the authors from the 2002
publication as co-authors, with JJ OLeary occupying the senior author position[8]. It reports
the detection of MeV in the cerebrospinal fluid of 19/28 children presenting as autistic re
gression closely following MMR vaccination compared with 1/37 controls. In five cases a
haemaglutinnin[sic] gene allelic discrimination assay was carried out and showed a result
consistent with a vaccine strain being detected. The abstract concludes with the sentence:
The findings confirm a highly significant statistical association between the presence of MV
RNA in CSF and autistic regression following MMR vaccination.
3.5. Summer 2004
A paper is published that includes six patients (three patients, three controls) whose data
were already published in the May 2004 abstract. It reports the detection of MeV in 3/3 pa
tients but 0/3 controls [9]. Interestingly, OLeary and Sheils are not listed as authors; instead
the publication only thanks them in the acknowledgements.
3.6. June 2007
The first of three omnibus autism proceedings took place at the US Court of Federal Claims,
where all vaccine claims are managed and are adjudicated by the Office of Special Masters.
The trials were designed to establish whether or not autism could be caused by thimerosal
containing vaccines, by MMR vaccine, or a combination of the two. I acted as an expert wit
ness for the US Department of Justice (DoJ), presenting evidence based on earlier reports I
had prepared for the UK High Court, who gave permission for the release to the US Secreta
ry of the Department of Health and Human Services of two reports authored by myself.
These documents had been filed by the three principal defendants in the UK MMR vaccine
litigation and constituted an exhaustive analysis of the raw data underlying the results re
ported by the 2002 OLeary publication. The evidence presented to the trial is a matter of
public record, with the transcript available from the autism omnibus proceedings[10].
3.7. February 2009-August 2010
The evidence presented at the 2007 trial was used in further trials that concluded in February
2009 that there was no credible link between the MMR vaccine and autism. These decisions
were upheld on appeal in July/August 2009 and then again in August 2010 were read [11].
4. Analysis of the 2002 OLeary paper

The analyses and conclusions shown below were reached after examining all the RT-qPCR
data disclosed following a court order. New experimental reports were generated using
87
88
identical analysis software, compared with those disclosed by the OLeary laboratory and
any differences were noted. Any ambiguous or discordant results and all results involving
negative controls were further investigated by scrutinising the raw data collected by the
qPCR instrument. This permitted a definitive resolution of all ambiguities. All disclosed op
erator sheets and laboratory notebook entries relevant to the RT-qPCR assay were red and
compared with the disclosed and the reanalysed data. Standard operating procedures were
examined and inconsistencies with actual procedures were noted.
1.
Transparency of reporting
The purpose of publishing a paper in the peer-reviewed literature is to provide ade
quate information that allows any competent scientist to follow the published protocol
and reproduce the published data. Hence it is essential that detailed descriptions of the
methods used and of the results obtained are included. It is not acceptable to publish
summarised results only without any supporting, relevant data.
a.
RNA was extracted from fresh frozen samples as well as formalin fixed, paraffin-em
bedded tissue (FFPE). However, there is no information on how the fresh samples were
frozen, how long they had been stored,what percentage of patient and control samples
were fresh frozen or FFPE and whether the same percentage was in each category. This
is essential, since it is well established that FFPE treatment modifies and destroys RNA,
or in Prof OLearys own words wax and fixation by itself breaks down RNA [5].
Hence it was well known at that time that RNA-derived data obtained from FFPE sam
ples must be analysed and interpreted with caution [12-14].
b.
No information is provided with respect to quantification or quality assessment of the

extracted RNA; indeed there is no mention of RNA quality. This is vital information
needed to assess the validity of any quantitative or negative result [15].
c.
The RT-qPCR results are summarised without providing any actual data; a table simply
states that 70/91 children with gut pathology were positive for MeV, as against 4/70 in
the control group.
d.
MeV copy numbers in the affected children are reported as ranging from 1 to 3x105 cop
ies of RNA/ng total RNA; no corresponding figure is provided for the four positive
samples from the control samples. There is also no indication of what the potential error
in those copy numbers might be.
e.
Despite claims that the authors looked at two viral gene targets, they used only the data
from the F-gene, which were discordant with the H-gene results.
2.
Reliability of protocols and techniques
a.
RNA was extracted from both fresh frozen and FFPE tissue samples and subjected to
RT-qPCR analysis. Two RNAs were targeted; a control mRNA specified by the GAPDH
gene and the MeV F-gene. As discussed earlier, since FFPE samples are characterised by
RNA degradation, the expectation is that the results obtained from the FFPE samples
should be different and, in terms of quantification, there should be less RNA present in

http://dx.doi.org/10.5772/52844
a FFPE sample. This is in fact the results the authors obtain for the control RNA, where
there was an approximately 4,000-fold reduction in RNA levels (Figure 3A). In contrast,
the results recorded for MeV RNA were the same regardless of its source (Figure 3B).
Figure 3. FFPE vs fresh samples. A. Effects of formalin fixation on control gene expression levels showing the differ
ence caused by the formalin fixation process. Due to the exponential nature of the PCR reaction, the difference be
tween the average quantification cycle recorded for fresh tissue and that for formalin-fixed tissue (25 vs 37) equates
to 212 or a 4,000-fold reduction of target. B. Absence of an effect of formalin fixation on MeV RNA, with the average
quantification cycles very similar.
Since any RNA present during formalin fixation would have been affected in an identical
manner, the obvious implication of these results is that whilst the control RNA was indeed
present prior to formalin fixation and so was degraded, the MeV target was not degraded
and entered the sample after formalin fixation. Consequently, no MeV RNA can have been
present in the tissue and the positive result must have been caused by a contaminant.
b.
Detection of an internal control following RNA extraction is a useful indicator of wheth

er the extraction has been successful: absence of amplification implies that it has not
been. Consequently, the OLeary laboratory standard operating procedures implement
ed such an assessment and prescribed the exclusion of such samples from further analy
sis (Figure 4A). Fortuitously from the investigators point of view and against the rules
89
90
of their own SOP, the authors did not discard all samples where the control had been
negative. Instead, they reported positive MeV results from samples that contained RNA
as well as in autistic patient samples that had been negative for their control (Figure
4B). Since, these samples do not contain RNA by their own definition, their test must be
detecting a contaminant.
Figure 4. Workflow according to the OLeary SOP. A. Following RNA extraction, only samples testing positive for
GAPDH should have been further analysed for two viral targets. Samples testing negative should have been discarded
and fresh RNA extractions attempted. B. MeV target detection from control+ve samples and control-ve samples show
ing that there is no difference in the quantification cycles.

http://dx.doi.org/10.5772/52844
c.
Two tests accidentally omitted including the RT step before the PCR test. In the case of
the control, the results are as expected: the assay works significantly less well (Figure
5A). This is because Taq polymerase is very inefficient at making DNA from RNA. In
contrast, the four MeV samples tested give the same result, regardless, indicating that
the test is detecting DNA (Figure 5B). Since MeV does not exist as DNA, the test is not
detecting MeV but a DNA contaminant.
Figure 5. Absence of RT step. A. Control RNA: in the absence of the RT step (no RT), no amplification is observed (a Cq
of 40/45 equates by definition to no amplification). B. Measles RNA: in the absence of the RT step, amplification is
observed with Cqs in the same range as in the presence of the RT step (RT).
d.
Successful qPCR amplification is characterised by a characteristic amplification plot,

as obtained from sample F4 in Figure 6A and highlighted by the solid arrow. However
a second sample (H2) is also recorded as generating a positive result (circled) even
though it is clearly not being amplified (dashed arrow). The correct result is obtained by
moving the threshold line(dotted arrow) so that well F4 continues to record a positive
results, whereas well H2 now records a Cq of 40, which in this setup equates to no am
plification (Figure 6B). This is a rather elementary mistake.
91
92
Figure 6. Inappropriate analysis. A. The data as reported by the OLeary laboratory. B. The re-analysed data showing
absence of amplification in well H2 (circled).

http://dx.doi.org/10.5772/52844
3.
Interpretation of control results
Figure 7. Contamination (1). A. The report submitted by the OLeary laboratory shows a single negative NTC (circled),
with well E4 next to the NTC not analysed, despite all other samples having been analysed in duplicate. B. A re-analysis
that includes well E4 shows that this well is contaminated (arrow) and generates a reading (circled), invalidating any
results from this run.
93
94
b.
Figure 8A shows a similar situation, with all analyses except the NTC in well B11 car
ried out in duplicate. Again, these were the data disclosed to the investigation, and I
had to await the release of the raw data runs to be able to re-analyse those results. This
time, a re-analysis of the data including well B12 shows both tests gave positive results,
ie both negative controls reported contamination of the test (Figure 8B). The only con
clusion from these data can be that the data are unreliable.
Figure 8. Contamination (2). A. The report submitted by the OLeary laboratory shows a single negative NTC at B11,
with well B12 next to it not analysed, despite all other samples having been analysed in duplicate. B. A re-analysis that
includes well B12 shows that both NTCs are contaminated (circled), invalidating any results from this run.

http://dx.doi.org/10.5772/52844
4.
Reproducibility of the data
There have been a number of studies attempting to reproduce the findings of the 2002 paper
[16-18]. All failed to do so; instead they provided strong evidence for contamination being
the cause of the positive findings. However, there were some technical differences between
the studies in the choice of tissue (intestine vs blood) or protocols (enzymes, qPCR chemis
tries). Therefore, whilst there was a strong suggestion that Prof OLearys laboratory was de
tecting contaminants, there was no proof. However, any lingering doubt evaporated with
the publication from a multi-centre group of authors that refuted any association between
persistent MeV RNA in the gut and autism[19]. Astonishingly, this publication includes the
two main authors of the Uhlmann paper, and despite publishing evidence that contradicts
their own, they have never retracted their original paper.
5. The MIQE guidelines

The problems inherent in the design and reporting of qPCR-based assays had been known
for a long time, but there had been no concerted effort to tackle this serious problem. The
2002 OLeary paper is not unique in omitting sufficient experimental detail, which impedes
the readers ability to evaluate critically the quality of the results presented, repeat the re
ported experiments, or integrate methodological advances into their own studies. Indeed, a
recent survey of qPCR-based publication demonstrates very clearly that this problem per
sists even in 2010 [20] and that the perceived quality of the publishing journal is not correlat
ed with the actual quality of the qPCR publication. The egregious use of qPCR in the
MeV/MMR/autism context provided the stimulus to initiate a push towards improving the
technical aspects of qPCR assay design and reporting. Consequently, guidelines tackling this
issue have recently been published which aim to promote consistency between laboratories,
and increase experimental transparency [21]. The Minimum Information for publication of
Quantitative real-time PCR Experiments (MIQE) guidelines outline the minimum data set
necessary to evaluate effectively RT-qPCR assays, and are designed to be used as a checklist
to both accompany manuscript submission and to be available alongside the published
manuscript to enhance critical appraisal.
The four key areas of standardisation that define any qPCR experiment are study design,
technical detail, analysis methods and statistics. MIQE addresses these under a set of cap
tions that describe a large number of individual elements: Experimental design, sample,
nucleic acids, reverse transcription, target, primers and probes, assay details, PCR cycling
and data analysis. At first sight, these look daunting, arduous and over-exacting. In prac
tice, it is clear that most, if not all of these parameters describe information that would be
obtained as a matter of course during the experimental design, optimisation and validation
stages. Importantly, there is a clear hierarchy with some parameters, labelled E (essential)
in the published guidelines, indispensable for an adequate description of the qPCR assay,
whereas other components, labelled D (desirable) more peripheral, yet constituting an ef
fective foundation for the realisation of best practice protocols. There is increasing recogni
95
96
tion that the MIQE guidelines provide the basis for much-needed standardisation as well as
encourage the publication of essential information that should be accessible to reviewer and
reader[22].
6. Conclusions
This exhaustive analysis of the experimental RT-qPCR data generated by the OLeary labo
ratory demonstrates:
Lack of transparency and completeness of reporting
Persistent and widespread contamination
The contamination is caused by DNA
Inept data analysis
As a result, the conclusions put forward by this paper are entirely incorrect and there is no
evidence whatever for the presence either of MeV genomic RNA or mRNA in the GI tracts
of any of the patients investigated during the course of the studies reported by OLeary et al.
Instead, it is clear that the data support the opposite conclusion: there is no evidence for any
MeV being present in the majority of patients analysed. Unfortunately, the authors do not
report whether any the patients had received the MMR vaccination. However, assuming
that a significant proportion had done so, it is also clear that there is no link between the
MMR vaccine and the presence of MeV in the intestine of autistic children.
Acknowledgement
This work was carried out for the MMR vaccine litigation trial at the High Court of Justice in
London and at the US Vaccine court. The author acted as an expert witness and was paid by
the solicitors acting for the principal defendants SmithKline Beecham Plc and Smith Kline &
French Laboratories Ltd, Merck & Co Inc and Sanofi Pasteur MSD Ltd. The author also act
ed as an expert witness for the US Department of Justice and was paid.
Author details
Stephen A. Bustin
Address all correspondence to: [email protected]
Faculty of Health, Social Care & Education, Anglia Ruskin University, Bishop Hall Lane,
Chelmsford, UK

http://dx.doi.org/10.5772/52844
References
[1] Wakefield AJ, Murch SH, Anthony A et al. Ileal-lymphoid-nodularhyperplasia, nonspecificcolitis, and pervasive developmental disorder in children. Lancet.
1998;351:637-641.
[2] Choi YH, Gay N, Fraser G, Ramsay M. The potential formeasles transmission in Eng
land. BMC Public Health. 2008;8:338.
[3] GMC. Dr Andrew Jeremy WAKEFIELD Determination on Serious Professional Mis
conduct (SPM) andsanction. http://www.gmc-uk.org/Wakefield_SPM_and_SANC
TION.pdf_32595267.pdf (accessed 29th August 2012)
[4] Bustin SA. Absolute quantification of mRNA using real-time reverse transcription
polymerase chain reaction assays. Journal of Molecular Endocrinology. 2000;
25:169-193.
[5] O'Leary JJ. House ofRepresentatives, Committee on Government Reform. 106th
Cong, 2nd Sess. 2000;Serial No. 106-180:123-137.
[6] O'Leary JJ, Uhlmann V, Wakefield AJ. Measles virus and autism. Lancet.
2000;356:772.
[7] Uhlmann V, Martin CM, Sheils O et al. Potential viral pathogenic mechanism for new
variant inflammatory bowel disease. Mol Pathol. 2002;55:84-90.
[8] Bradstreet JJ, ElDahr J, Walker S et al. TaqMan RT-PCR Detection of Measles Virus
Genomic RNA in Cerebrospinal Fluid in Children with Regressive Autism 2004;
2004.
[9] Bradstreet JJ, El Dahr J, Anthony A, Kartzinel JJ, Wakefield AJ. Detection of Measles
Virus Genomic RNA in Cerebrospinal Fluid of Children with Regressive Autism: a
Report of Three Cases. Journal of American Physicians and Surgeons. 2004;9:38-45.
[10] Claims USCoF. Autism Trial Transcript Day 8. 2007 ftp://autism.uscfc.uscourts.gov/
autism/transcripts/day08.pdf (accessed 29th August 2012)
[11] Claims USCoF. Autism Decisions and Background Information. 2009 http://
www.uscfc.uscourts.gov/node/5026 (accessed29th August 2012)
[12] Dakhama A, Macek V, Hogg JC, Hegele RG. Amplification of human beta-actin gene
by the reverse transcriptase- polymerase chain reaction: implications for assessment
of RNA from formalin-fixed, paraffin-embedded material. J Histochem Cytochem.
1996;44:1205-1207.
[13] Foss RD, Guha-Thakurta N, Conran RM, Gutman P. Effects of fixative and fixation
time on the extraction and polymerase chain reaction amplification of RNA from par
affin-embedded tissue. Comparison of two housekeeping gene mRNA controls. Di
agn Mol Pathol. 1994;3:148-155.
97
98
[14] Unger ER, Vernon SD, Lee DR, Miller DL, Reeves WC. Detection of human papillo
mavirus in archivaltissues. Comparison of in situ hybridization and polymerase
chain reaction. J Histochem Cytochem. 1998;46:535-540.
[15] Bustin SA, Mueller R. Real-time reverse transcription PCR (qRT-PCR) andits poten
tial use in clinical diagnosis. ClinSci (Lond). 2005;109:365-379.
[16] Afzal MA, Ozoemena LC, O'Hare A, Kidger KA, Bentley ML, Minor PD. Absence of
detectable measles virus genome sequence in blood of autistic children who have
had their MMR vaccination during the routine childhood immunization schedule of
UK. J MedVirol. 2006;78:623-630.
[17] D'Souza Y, Dionne S, Seidman EG, Bitton A, Ward BJ. No evidence of persisting
measles virus in the intestinal tissues of patients with inflammatory bowel disease.
Gut. 2007;56:886-888.
[18] D'Souza Y, Fombonne E, Ward BJ. No evidence of persisting measles virus in periph
eral blood mononuclear cells from children with autism spectrum disorder. Pedia
trics. 2006;118:1664-1675.
[19] Hornig M, Briese T, Buie T et al. Lack of association between measles virus vaccine
and autism with enteropathy: a case-control study. PLoS ONE. 2008;3:e3140.
[20] Huggett J, Bustin SA. Standardisation and reporting for nucleic acid quantification.
Accredit Qual Assur. 2011;16:399-405.
[21] Bustin SA, Benes V, Garson JA et al. The MIQE guidelines: minimum information for
publication of quantitative real-time PCR experiments. Clin Chem. 2009;55:611-622.
[22] Bustin SA. Why the need for qPCR publication guidelines?--The case for MIQE.
Methods. 2010;50:217-226.
Chapter 6
Vaccine Safety Study as an

Interesting Case of "Over-Matching"
M. Catherine DeSoto and Robert T. Hitlan
http://dx.doi.org/10.5772/53876
1. Introduction
Increasing levels of diagnosed cases of autism have alarmed parents and health officials,
but the cause has not been established. It has been hypothesized that vaccination itself,
or some component in vaccines, may be somehow related to the onset of autism in some
cases (Delong, 2011; Gallagher & Goodman, 2010). Researchers have sought to alleviate
such concerns. Although most studies report null effects, work continues to be published
that suggests some reason for concern (Hewiston et al., 2010). Some skepticism of the
safety of vaccines still exists, documented by scholars on either side of the issue (Austin,
Schandley & Palombo, 2010, Destafano, 2007). As it is, the topic of vaccine safety and
triggering of unintended outcomes is one of the most controversial topics in environmen
tal health and toxicology.
After initial safety studies, case- control designs are often employed to continue to investi
gate both side effects and efficacy of inoculation. Matching is a technique used to improve
signal to noise in research case-control designs. Matching cannot or should not be done
in a way that artificially increases the chance that within strata exposure is the same. This
happens when a matching variable is a strong predictor of exposure and is called over
matching. Here, we report a textbook case of overmatching within a widely cited article.
Focusing on the overmatching as a statistical concept, suggestions are made to standardize
when overmatching may have occurred. It is important for statisticians to note when a study
that fails to find an effect related to public health outcome has employed a design that
would be expected a priori to result in a lack of effect.
It has been noted that some children received exposure to mercury significantly in excess of
safety standards during the 1990s, before the level of thimerosal in vaccines was lowered
(Geier & Geier, 2006), this has been suggested to increase odds of various developmental
2013 DeSoto and Hitlan; licensee InTech. This is an open access article distributed under the terms of the
100
disorders (Geier & Geier, 2006). The research by Price et al. (2010) spans the birth cohort
years that saw a decline in thimerosal exposure and reports that thimerosal exposure was
not associated with risk outcome of autism. Indeed, many studies have been published that
find no negative effect of vaccination on developmental outcomes whatsoever (Parker,
Schwartz, Todd, Pickering, 2004; see Destafano, 2007 for a review), indicating a lack of cause
and effect between vaccination and autism. Here, we suggest that a recent widely cited
study was flawed, and urge statisticians to carefully and critically review outcomes research
on high stakes topics. It should be noted and understood that a flaw in such a study does
not mean that vaccines cause autism, nor does it follow that one would properly assume
that the flaw leads to the conclusion that vaccination is not safe. Rather the weight of scien
tific research as a whole should be deferred to.
Conditional logistic regression (CLR) is a statistical technique used when the researchers
have matched cases with controls on various parameters (e.g., age, gender). CLR is the of
ten-used and appropriate way to analyze matched data sets (Rahman, Sakamoto & Fukui,
2003). To be clear, matching means that (as an example) for every case that is male and
aged 12, there is a control selected from a pool of possible controls that is also male and aged
12. If this were done, the researchers matched on age and gender. A variant is to have two
or three times the number of controls within each condition, or stratum. (Meaning for every
male case who is age 12, there are three controls who are male and age 12.) The matched
unit is called a stratum. When analyzing the data, CLR analyses are done within strata.
When matching is done, only conditions (strata) that have cases and control pairs that vary
on the risk factor contribute to the estimate of the effect of the risk factor (Miettinen, 1968).
In other words, if exposure level within strata is the same, CLR cannot estimate the effect.
As such, matching is a key design feature.
Matching cannot or should not be done in a way that artificially increases the chance that
within strata exposure is the same; this happens when a matching variable is a significant
predictor of exposure and is called overmatching.
Proper design can have important implications and researchers are appropriately cognizant
of the possible perils of failing to take enough care in considering the matching design. If
matching is used, researchers are wise to give explicit consideration to ensure that the prob
lem of overmatching is avoided when attempting to accurately estimate risk of an exposure
of interest (Sasieni and Castanon, 2009; Al-Taiar et al., 2009; Vidal et al., 2008; Agudo & Gon
zalez, 1999; Cullison et al., 2007). And this problem has long been known (see for example,
West, Schuman, Lyon, Robison & Allred, 1984). In their consensus paper on outcomes re
search, the American Thoracic Society noted that, Overmatching, matching for a variable
that is associated with the exposure but not the outcome, will reduce the statistical power of
the study, (p. 364). Improper matching cannot later be undone via analysis and the effect of
the matched variables cannot be checked, once matching has been done (Rubenfeld et al.,
1999). How could this happen? Usually, this arises when a researcher fails to realize he or
she is essentially matching on the exposure variable, and inadvertently the researcher
matches the effect out.
Vaccine Safety Study as an Interesting Case of Over-Matching

http://dx.doi.org/10.5772/53876
To illustrate overmatching, a fictitious example will be briefly discussed, followed by an ac

tual example from the literature. Assume the question is whether radiation exposure in nu
clear plant workers contributes to cancer. A hundred cancer cases are found, and a control
group of 700 is identified. Then, each case is matched with one from the control group on
gender, smoking, job location, and age. The researchers match on these variables to increase
efficiency (because they think these variables might independently account for disease risk).
We will keep this as one to one matching for simplicity, but a 1:3 matching would essentially
work the same.
Figure1
In this example, overmatching would happen if the researchers are looking for effects of ra
diation but fail to consider that while which power plant the worker is employed might
have some independent influence on disease risk (which is why it is matched), location
could also be a major determinant of radiation exposure. For example, imagine Plant L often
had radiation leaks, while Plant S had better safety. If one then matches on where one
works, all of the variance unique to a particular plant is matched out. In such a case, an ef
fect for radiation even if huge could be missed. It will be clear if one considers that this
would be like testing if radiation was related to cancer in Japanese nuclear power plant
workers after controlling for location with one of the locations being Fukishima (Figure 1). If
participants who developed cancer were matched on where they worked the researchers
may not detect any true health effects of the radiation exposure from the nuclear meltdown
at Fukushima compared to working at other plants that did not have a meltdown. The re
searchers would have matched out any effects associated with where they worked.
EmploymentLocation
CancerRisk
AmountofExposure
vialeaks
Figure 1. Overlapping variance: Illustration of Overmatching on Radiation Exposure; In this fictitious example, match
ing on the nuclear power plant of employment in the design of the study would be overmatching because it would
remove the largely overlapping variance associated with radiation due to the Fukishima leak, obscuring the effect
101
102
A now classic paper by Marsh, Hutton and Binks (2002) refers to a real research example
and is entitled, Removal of radiation dose response effects: an example of over-matching.
It details how a true effect can be missed if the researchers overmatch. According to the au
thors, If the exposure itself leads to the confounder or has equal status with it, then stratify
ing by the confounder will also stratify by the exposure, and the relation of the exposure to
the disease will be obscured. This is called over-matching and leads to biased estimates of
risk, (p. 1235). After previous work had suggested that radiation did predict leukemia, the
more recent case-control study failed to indicate any relation between radiation and leuke
mia. The matched factors in the new study that showed no increased for leukemia as a result
of radiation included: date of birth, gender, and date of entry. Date of entry was a meas
ure of what years the workers worked in the industry. The data was properly analyzed giv
en the matched design by conditional logistic regression, yet failed to find a known effect.
This prompted the study of the statistics used, with a focus on the matching process. It was
noted that some things are appropriate to match on, for example, gender. Because of the
underlying difference of the risks of leukemia between the sexes, being male versus female
affects the outcome, and it is important not to accidently have more males in the case group
as this would be a confound. On the other hand, Marsh et al. clearly showed that radiation
exposure varied by year, that is some years were higher than others and this was indeed a
major source of radiation variation (see figure 3, Marsh et al., 2001). The general decline in
median dose shows that dose and time are associated. The situation seems to be one where
dose is partially explained by date of entry, both being related to time; in sum, this seems
to have had the effect that workers in the same matched set have broadly similar recorded
doses. The apparent over-matching on date of entry has distorted the parameter estimate of
the risk of leukemia on cumulative dose by introducing matching (at least partially) on
dose, (Marsh et al., 2002).
What is the take home message of this classic report on the problem of overmatching?
When researchers match on a variable closely associated with the risk factor exposure,
then actual effects will not be-- and cannot be-- detected. This danger is written about by
various other authors as well. Richard Monson in his text, Occupational Epidemiology
notes over matching is a problem in case control studies. Monson emphasizes that
there should be no possibility that the factor is part of the causal pathway linking expo
sure and disease under study. (p. 41). If this is even remotely possible, Monsoon advis
es matching should not be done on that variable. Monson discussed an example where
overmatching resulted in underestimating the effect of estrogen use on endometrial can
cer. Here the matching was on a correlate of intrauterine bleeding, which in effect con
trolled for a symptom of the cancer itself.
Price et al. do not mention overmatching as a potential concern. The risk factor of interest is
thimerosal exposure via its inclusion in vaccine ingredients. There are two things that have a
systematic and predictable effect on how much thimerosal exposure a child would receive:
1) the vaccine schedule a child is born into/national recommendations, and 2) which manu
facturer a given provider is using for the vaccines (e.g. for the same years, Smith, Kline and
Beecham were using thimerosal in their HepB vaccine, while Merck did not).

http://dx.doi.org/10.5772/53876
BirthYear
AutismRisk
AmountofExposure
Figure 2. Controlling for Birth Year is overmatching due to the overlap with Amount of Exposure; similar to the radia
tion risk for leukemia written about by Marsh, controlling for time is (at least partly) controlling for exposure, which
varies with birth year. The matching on birth year is matching on the exposure. This seems to have had the effect that
children in the same matched set have similar recorded exposures to thimerosal, removing much of the variance
Price et al. matched out both of these variations in exposure. This has the effect of ensuring
that the control group is nearly identical with the case group on the risk factor, which pre
vents its effect from being accurately measured. Considering cumulative exposure for the
first 7 months of life, the overall mean for the full data set is 102.88 micrograms/Hg and a
standard deviation of 42.2. The means for the cases and matched controls is 100.0 and 103.2
micrograms of Hg: this similarity (less than one tenth of the standard deviation) is forced by
the matching on the variables that define exposure. Birth year dictates which vaccine sched
ule a child is born under as well as which batch brands and formulations are available on
the market at a given time. Doctors within a practice will be using the same manufacturer
across children (vaccines are ordered in large batches room a given manufacturer; the Vac
cine Data Set used by Price et al. documents that the same providers use the same manufac
ture. Thus, this is a text book case of overmatching: variables were matched on that
essentially define exposure. It is well known that matching on a variable that is associated
only with exposure, not with disease, reduces statistical efficiency (Zondervan et al, 2002;
Rubenfeld et al., 1999; Day, Byar, & Green, 1980) and that care needs to be taken to avoid
this in a case-control research design.
Across the different years, the average cumulative exposure varies from 42.3 micrograms to
125.46 micrograms; while within the birth year stratas, the mean exposures do not vary by
more than 15 micrograms. Birth year is a variable that defines exposure due to changes in
recommendations regarding the vaccine schedule and changes in vaccine formulas that oc
103
104
curred at different times. The above panels suggest that variance within the matched varia
ble (year) is small compared to the variance between birth years: birth year is accounting for
much variance in thimerosal exposure.
Figure 3. The difference across birth years on the risk factor of interest
During the past decades, there have been three main exposure sources of thimerosal: DPT/
DTaP, then Hepatitis B and Hib vaccines, while flu shots are currently the primary source in
the USA today. The Hib/Hep B introductions came in during the late 1980s and early 1990s.
The recognition that the cumulative mercury burden may have been too high came in 1999,
and mercury levels dropped for most vaccines given to children in the USA. Some people
have raised concerns that the increase in autism is associated with the changes in thimerosal
exposure; that is, the increase in autism is thought to be a function of the increases in the
number and amount of mercury containing vaccines. Whether or not one finds this model
persuading, matching on birth year is questionable if the goal is to test the model that differ
ences in thimerosal exposure via vaccine schedule increase ASD risk since -- as most people
are aware -- birth year essentially dictates which vaccine guidelines a child is born into. It
could be that the authors intended to control for hypothesized changes in diagnostic criteria
trends across the six birth years. The problem is that diagnostic effects on risk is not meas
ured while birth year effects on exposure are clear.
Moreover, HMO is not known to be a significant predictor of the outcome of autism diagno
sis, so potential reasons to match on this variable are less clear. As Hansson and Khamis
(2008) write in their paper on matched-sample logistic regression, Generally, matching will
increase the efficiency of the study when the matching variable is a strong outcome determi
nant, but will actually reduce it when the matching variable is strongly related to the expo
sure variable (over-matching), (p.595-596). Meittinem (1969) states that, matching reflects

http://dx.doi.org/10.5772/53876
the notion that the probability P of response is related to M, (p. 340) meaning that when
one matches, one infers that the matching variable effects the probability of risk (here for au
tism). HMO / health care provider was a major determinant of thimerosal exposure, but we
are not aware of papers that identify HMO is an independent risk for autism. Thus, it
should not have been matched. What was needed was a design that compared persons with
different exposures. Studies with uniform developmental assessments of children with a
range of cumulative thimerosal exposures are needed, (Vertraeten et al., 2003). Here Price
Figure4.
et al., began with such a data set, but then matched on birth year and HMO, matching out
exposure differences and negating comparisons of different exposures (see Miettinen, 1969
for a mathematical discussion).
CumulativeTh
C
himerosalfirsst7months
asafu
unctionofHM
MO
Micrograms
20
00
18
80
16
60
14
40
12
20
10
00
80
8
60
6
40
4
20
2
0
ASD
Dcases
con
ntrols
HMO1
HMO2
HM
MO3a HMO3
3b
Figure 4. The apparent over-matching on HMO distorts the estimate of the risk of autism on thimerosol by introduc
ing matching on exposure. If one matches on provider, one is matching on the vaccine manufacturer. There are differ
ent manufacturers available, but a given provider will be using one or the other. This seems to have had the effect that
children in the same matched set have similar recorded exposures to thimerosal. Again, this removes this variance and
obscures the effect
The model Price et al. were trying to test was whether thimerosal exposure via the US
vaccination schedule was associated with any increased risk of autism. To do this, they
needed to compare persons with and without high levels of exposure. They did not do
this because due to the conditional logistic regression matched on both birth year and
HMO they have inadvertently made sure that cases were only compared to controls with
the same exposure. Because Price et al. did not mention the possibility of overmatching,
we assume this did not occur to the research team. We assume this was accidental, but
it does underscore the need to have a balanced research team that does not start with as
sumptions that might flaw the design. For example, assuming that the increase in autism
is only due to diagnostic changes would lead to controlling for birth year, which might
have been flagged by someone who does not share this assumption. It is harder to un
derstand why HMO would be matched. Overall, this is unfortunate because the question
105
106
Figure5.
of vaccine safety is high stakes. There are concerns that a proper test of the full vaccine
schedule has not been properly tested, and that the safety tests that exist have been de
signed by the vaccine industry itself. Such concerns about conflicts of interest may be
preventing otherwise willing parents to adhere to the full vaccine schedule. Vaccines
have been and will continue to be a huge benefit to humanity. But this paper is flawed.
Unfortunately, there is not an analytic fix for overmatching: it is design flaw.
Provider/HMO
ASD Risk
AmountofExposurevia
vaccinemanufacturer
Figure 5. Which manufacturer a given provider used for the vaccines varied by HMO. Manufacturers differed in their
thimerosal use. For example, in 2002, Smith, Kline and Beecham were using thimerosal in their HepB vaccine, while
Merck did not. While the data set is careful to note manufacturer and Hg in the associated batch and manufacturer,
but CLR matching on HMO results in comparing cases to controls who had the same levels of exposure
The Price et al. research is an interesting case of overmatching that we think is of general
interest in the field of epidemiology. To avoid misunderstanding, we wish to state that this
research does not support the argument that vaccines or thimerosal in vaccines cause au
tism. It is however, uninformative to the question.
2. Suggestions for avoiding the problem of publishing overmatched

results
One way to conceptualize the problem of overmatching in conditional logistic regression is
the preemptive removal of variance that should stay available for the hypothesized predic
tor variable to attempt to account for. The total variance in a data set can be defined using
the average squared distance from the mean score for each participant: s2= SS/df. A question
related to overmatching concerns how much of the total variance is taken out beforehand
(matched out)? How much is too much? 10%? 90%? 50%? We would propose that the per

http://dx.doi.org/10.5772/53876
cent removed before testing should normally be small compared to the total. Further, the re
moval of this variance should only occur when there is authentic need: when the potential
matching variable is likely related to the outcome of interest via a path that is distinct from
the risk variable of interest in a case-control design.
As elaborated above, matching is appropriate only if the matching variable is a strong pre
dictor of the outcome of interest, but it is not appropriate when the matching variable is
strongly related to the exposure risk variable. We offer three suggestions to help objectively
identify, and thus avoid, the problem of overmatching.
Empirical Support. Before matching, first and foremost, researchers should locate studies
that suggest the potential match is likely correlated to the probability of the outcome occur
ing. These should be cited to support the need to match on that variable. If there is no reason
to think the matching variable relates to the outcome, there is no reason to match it.
Remaining Variance. Next, once the participants have been selected as a matched data set,
researchers can check to get an idea how much variance in the exposure variable is actually
accounted for by the matching variable M. If only a small amount of the variance is left after
the various matching, matching on the variable(s) cannot be justified and an unmatched or
lesser matched set of participants is called for. Specifically, a check to see if too much of the
total variance in the outcome of interest is matched out could be done by requesting Partial
Eta Squared. Partial Eta Squared represents the proportion of the total variance that is ex
plained by the between factor when an ANOVA is performed. Specifically, one can take the
extra step of analyzing the variance in the risk factor of interest (e.g., thimerosal exposure)
as a function of the matched variable (e.g., HMO or BirthYear). In this example, using thi
merosal exposure as the dependent variable, the total SS is 23507522. The SS associated with
the Birth Year is 1485471. This gives Partial Eta Squared =.456, meaning that about 46% of
the total variance in thimerosal exposure is fully explainable based on Year of Birth. When
one matches on this, only about half (54%) of the variance is left.
HMO, the other variable matched on, removed about 30% of the variance.
The percent that should be left would depend on the research question and causal assump
tions, but we suggest that if a matched variable is removing more than a fourth (25%) of the
variance (corresponding to a large effect size, Cohen, 1977), matching is unlikely to be war
ranted for this reason alone and welcome commentary on this benchmark proposal.
Relative relations. Finally, there are times when it could be proper to match on a variable
that accounts for variance in the risk factor being tested. A recent case coincidentally also
related to vaccines helps to illustrate this more. It had been pointed out that the enormous
benefits of the flu vaccine among the elderly appeared to far surpass even the effect that a
total eradicating of flu from the vaccinated population could account for (Jefferson, 2006).
After additional investigation, much of the original effect appears to be due to the tendency
for seriously ill and/or less healthy elderly persons not to have the flu shot. To be clear, most
of the flu vaccine effect on mortality was found to be due to health of the participants inde
pendent of the flu shot (Jackson et al., 2006). In this case, if this had been a case control de
sign, the risk factor would be flu vaccine and the probability outcome of interest would
107
108
hospitalization or death. In such a case control study, it would be proper to match on preex
isting health, even though one would find that health accounts for some of the variability in
getting or not getting the risk factor (flu vaccine). BUT: health would also relate to the mor
tality outcome, and even more strongly. It is this strong relationship that is key. If the varia
ble is more strongly related to the outcome this serves to justify matching.
To objectively quantify this, one needs to know how strongly M is related to the Risk Factor
R; and then how strongly M is related to the probability of response P. A problem is that
different types of data can make precise comparisons of effect size hard to judge.
Assume that M would be HMO, R would be mcg Thimerosal exposure, and P would be
ASD diagnosis. It would be desirable to compare the size of this relationship M to R
with the relationship of M to P. It would be ideal if one could simple compute correla
tions for M and R and for M and P. However, in most cases this would not work: the
scales are not all continual, and even if one were to employ a Spearman correlation, it
would not be apparent how to code something like HMO to insure a linear relationship.
What if HMO 2 was associated with an increase in thimerosal, and HMO 1 and 3 both
had low levels? This would result in a low correlation due to the curvilinear relation
ship, even IF much of the variance were in fact associated with HMO. On the other
hand, the relationship between HMO and thimerosal (M and R) can be checked via AN
OVA easily enough since R is continual and M is categorical. ANOVA would not work
for testing association between M and P because both M and P are both categorical in
this case. Chi Square would be appropriate. However, regardless of the correct hypoth
esis test, all hypothesis tests are in fact unified by the p value.
The p value is a function of the size of the effect and the sample size. Different types of stat
istical tests have different probability distributions, but the total area under the curve has a
constant meaning across tests. The percent of area covered means the same thing in any test,
regardless of the precise shape of the curve associated with a particular statistical test (corre
lation, ANOVA, Chi-square). A small p value could be due to a large effect, or it could be
due to a very small effect and a very large sample. It should be stated that when sample
sizes are similar, it will not be unduly affected by sample size differences. Since the sample
will be the same for testing M to P or testing M to R, we propose the p values are the most
readily available means to index the comparison.
Compute a measure for the relationship of M and P and the associated p value. (e.g., HMO
and ASD: X2 (2) = 1.59, p =.45 )
Compute a measure for the relationship of M and R and the associated p value. (e.g., HMO
and Thimerosal exposure: F (2,1090) = 237, p <.0001).
The p value in all cases should be smaller for the M to R relationship, compared to the M to
P relationship test. This will serve to demonstrate that even if the Matching variable does
bear some relationship to the risk factor for the outcome probability, there is clearly a stron
ger relationship to the outcome itself, thus objectively justifying the matching. (e.g., the p
value of.45 indicates no relationship exists between the matched variable and the outcome
of interest, while the p value <.0001 indicates that matched variable is related to the expo

http://dx.doi.org/10.5772/53876
sure variable being tested. It is well known that matching on a variable that is associated on
ly with exposure, not with disease, reduces statistical efficiency in a case control design
(Zondervan et al, 2002; Rubenfeld et al., 1999; Day, Byar, & Green, 1980), and this in essence,
defines the problem of overmatching).
To sum, variables such as birth year, HMO, age, gender, address should first and foremost
be matched if and only if there is a truly justifiable rationale to expect they have an inde
pendent causal pathway to the outcome; matching will increase he efficiency of the study
when the matching variable is a strong outcome determinant, but will actually reduce it
when the matching variable is strongly related to the exposure variable (over-matching),
(Hanson & Khamis, 2008, p.595-596). Second, if the majority of the variance in the risk factor
being tested is removed by matching, before the hypothesis is tested, extreme caution in re
porting a lack of effect is warranted. Finally, recalling that sample size will be held constant,
testing the relationships of M to R and P and comparing the p values can be used to justify
matching in the context of the matching variable removing variance relating to the risk fac
tor. We would propose that overmatching has and will continue to be a problem in matched
case control designs, but suggest that employing the three checks above will serve to lessen
deleterious effects associated with publishing overmatched results.
We welcome comments on these proposals.
Acknowledgement
This work was partially funded by a small grant awarded to the second author, Robert T.
Hitlan from Safeminds. We thank Safeminds for their support.
Author details
M. Catherine DeSoto and Robert T. Hitlan
University of Northern Iowa, Cedar Falls, USA
References
[1] Austin D. W., Shandley K. A., Palombo E. A. 2010. Mercury in vaccines from the
Australian childhood immunization program schedule. J. Toxicol. Environ Health A,
73: 637-40.
[2] Agudo A. and Gonzlez C. A. 1999. Secondary matching: A method for selecting
controls in case-control studies on environmental risk factors. Int. J. Epidemiol., 1999:
1130-1133.
109
110
[3] Al-Taiara, A., Assabria, A., Al-Haboria, M., Azazya, A., Algabrib, A., Alganadib, M.,
Christopher J. M., Whittyc, and Jaffarc, S. 2009. Socioeconomic and environmental
factors important for acquiring non-severe malaria in children in Yemen: A casecon
trol study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1;
72-78.
[4] Bonner, P. C., Schmidt, W. P., Belmain, S. R., Oshin, B., Baglole, D., and Borchert, M.
2007. Poor housing quality increases risk of rodent infestation and lassa fever in refu
gee camps of Sierra Leone. Am. J. Trop. Med. Hyg., 77; 169175.
[5] Day, N. E., Byar, D. P., and Green, S. B. 1980. Overadjustment in case control studies.
Am. J. Epidemiol., 112: 696706.
[6] Delong, G. A. 2011. Positive association found between autism prevalence and child
hood vaccination uptake across the U.S. population. J. Toxicol. Environ. Health A, 74:
903-16.
[7] DeStefano F. 2007. Vaccines and autism: Evidence does not support a causal associa
tion. Clin. Pharmacol. Ther., 82: 756-759.
[8] Gallagher, C. M. and Goodman, M. S. 2010. Hepatitis B vaccination of male neonates
and autism diagnosis, NHIS 1997-2002. J. Toxicol. Environ. Health A, 73: 1665-1677.
[9] Geier D. A., and Geier M. R. 2006. An evaluation of the effects of thimerosal on neu
rodevelopmental disorders reported following DTP and Hib vaccines in comparison
to DTPH vaccine in the United States. J. Toxicol. Environ. Health A, 69: 1481-1495.
[10] Hansson, L. and Khamis, H. J. 2008. Matched samples logistic regression in case-con
trol studies with missing values: when to break the matches. Statistical Methods in
Medical Research, 17: 595607
[11] Hewitson, L., Houser, L. A., Stott, C., Sackett, G., Tomko, J. L., Atwood, D., Blue, L.,
White, E. R. 2010. Delayed acquisition of neonatal reflexes in newborn primates re
ceiving a thimerosal-containing hepatitis B vaccine: Influence of gestational age and
birth weight. J. Toxicol. Environ. Health A, 73: 1298-1313
[12] Jackson, L., Kackson M. et al. (2006). Evidence of bias in estimates of influenza vaccine ef
fectiveness in seniors. Int. J. Epidemiol. 35 (2): 337-344.
[13] Jefferson, T. 2006. Influenza vaccination: policy versus evidence. British Medical Jour
nal, 333: 912-915.
[14] Marsh, J. L., Hutton, J. L., and Binks, K. 2002. Removal of radiation dose response ef
fects: an example of over-matching. British Medical Journal, 325: 327-330.
[15] Miettinen, O.S. 1969. The matched pairs design in the case of all-or-none responses.
Biometrics, 24: 33952
[16] Monson, R. R. 1990. Occupational Epidemiology (2nd Ed.). BocaRaton, FL: CRC Press.

http://dx.doi.org/10.5772/53876
[17] Parker, S. K., Schwartz, B., Todd, J., and Pickering, L. K. 2004. Thimerosal-containing
vaccines and autistic spectrum disorder: A critical review of published original data.
Pediatrics, 114: 793-804.
[18] Price, C. S., Thompson, W. W., Goodson, B., Weintraub, E. S., Croen, L., A., Hinrich
sen, V. L., Marcy, M., Robertson, A., Eriksen, E., Lewis, E., Bernal, P., Shay, D., Davis,
R. L., and DeStefano, F. 2010. Prenatal and infant exposure to thimerosal from vac
cines and immunoglobulins and risk of autism. Pediatrics, 126: 655-664.
[19] Rahman. M, Sakamoto, M. D., and Fukui, T. 2003. Conditional versus unconditional
logistic regression in the medical literature J. of Clin. Epidem., 56: 101-102.
[20] Rubernfeld, G. D., Angus, D. C., Pinsky, M. R., Curtis, J. R., Coners, A. F., and Ber
nard, G. R. 1999. Outcomes research in critical care. Results of the american thoracic
society critical care assembly workshop on outcomes research. Am. J. Respir. Crit.
Care Med., 160: 358-367
[21] Sasieni, P., Castanon, A., and Cuzick, J. 2009. Effectiveness of cervical screening with
age: Population based case-control study of prospectively recorded data. British Med
ical Journal, 339: b2968.
[22] Vertraeten, T., Davis, R. L., DeStefano, F. 2003. Safety of thimerosal containing vac
cines: A two-phased study of computerized health maintenance databases. Pediatrics,
112: 1039-1048.
[23] Vidal, J. S., Vidailhet, M., Elbaz, A., Derkinderen, P., Tzourio, C., and Alprovitch, A.
2008. Risk factors of multiple system atrophy: A case-control study in French pa
tients. Movement Disorders, 23: 797-803.
[24] West, D. W., Schuman, K. L., Lyon, J. L., Robison, L. M., and Allred, R. 1984. Differ
ences in risk estimation from a hospital and a population-based case-control study.
Int. J. Epidemiol., 13: 235-239.
[25] Krina, T., Zondervan1, L. R., Cardon, L. and Kennedy, S. H. 2002. What makes a
good casecontrol study? Human Reproduction, 17: 1415-1423.
111
Chapter 7
Pro-Inflammatory Phenotype Induced by

Maternal Immune Stimulation During Pregnancy
Nicholas M. Ponzio, Mili Mandal, Stella Elkabes,
Pan Zhang, Junichi Sadoshima, Sayantani Basak,
Peiyong Zhai and Robert Donnelly
http://dx.doi.org/10.5772/53990
1. Introduction
There is consensus among investigators studying Autism Spectrum Disorders (ASD) that
the etiological basis involves environmental factors acting on the genetic susceptibility of the
individual [1-5]. Over 100 candidate genes that may contribute to ASD susceptibility have
been identified, and numerous environmental triggers have been suggested. Yet, the
cause of ASD eludes clear definition and most likely is, as in most diseases, multi-factorial.
However, several common immunological themes emerge from clinical and experimental
studies of ASD, including persistent neuroinflammation, immune dysregulation, or autoim
mune manifestations in many autistic children. Thus, in addition to genetic and environ
mental factors, there is compelling evidence that immune factors also play a role in ASD.
Abnormalities consistent with immune dysregulation, including abnormal or skewed T
helper (Th) cell subsets and cytokine profiles, decreased lymphocyte numbers, decreased T
cell mitogen responses, and an imbalance of serum immunoglobulin levels have been re
ported in children with ASD [6-11].
Recent results of transcriptomic analysis of autistic brains [5] provides strong evidence sup
porting a gene-environment etiology for ASD. These authors demonstrated consistent differ
ences in transcriptome organization in the cerebral cortex of autistic and normal brains, and
identified two discrete modules of co-expressed genes associated with autism. The first, a
neuronal module of 209 genes, was enriched for known autism susceptibility genes, and the
second module of 235 genes was enriched for immune genes and glial markers. Gene enrich
ment analysis showed that genes in the neuronal module were downregulated and enriched
2013 Ponzio et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
114
for gene ontology categories related to synaptic function, whereas the genes in the immuneglial module were upregulated, and showed enrichment for gene ontology categories impli
cated in immune and inflammatory responses. The finding of a genetic association for the
neuronal module genes, but a non-genetic association for the immune-glial module genes
strengthens the gene-environment etiology for ASD.
Compelling clinical data demonstrate that children of mothers exposed to certain infectious
organisms during pregnancy have significantly higher frequencies of neurological disorders
[12-21], including schizophrenia and ASD, the etiology of which have been linked to activa
tion of the maternal inflammatory/immune responses (reviewed in [9, 22]). Rodent studies
in which the maternal immune system is activated during pregnancy replicate these clinical
findings, and provide validated mouse models of ASD [14, 15, 19, 23-33]. We have used a
well-characterized prenatal mouse model to investigate questions related to the influence of
maternal immune stimulation during pregnancy as an environmental risk factor that affects
development of the brain and immune system in the offspring.
Injection of pregnant dams with polyclonal immune stimuli, [e.g., polyinosinic-polycytidylic
acid (poly(I:C), lipopolysaccharide (LPS)] or direct injection of the pro-inflammatory cyto
kines these polyclonal stimuli induce (e.g., IL-1, IL-2, IL-6) cause immune dysregulation and
behavioral abnormalities in their offspring in comparison to the offspring of pregnant dams
given a control [i.e., Phosphate Buffered Saline (PBS)] injection [30, 34-39]. The underlying
mechanisms that mediate these abnormalities have not been clearly defined, and are the fo
cus of ongoing studies by us and others. A unique and powerful advantage of this model is
the ability to examine subjects for the initiation and persistence of effects and mechanisms
over a continuum of time and development from the earliest embryonic stages through the
neonatal period and into adulthood.
While it is impossible for any animal model to completely replicate a human condition as
complex as ASD, the mouse model of maternal immune stimulation with poly(I:C) has been
recognized as an excellent prenatal model for numerous reasons presented in recent reviews
by Meyer and Feldon [40] and Patterson [41]. These include (i) face validity (resemblance to
the human symptoms) (ii) construct validity (similarity to the underlying causes of the dis
ease) and (iii) predictive validity (expected responses to treatments that are effective in the
human disease) [42]. Thus, offspring from poly(I:C)-injected dams exhibit behavioral
anomalies reminiscent of those seen in autistic and schizophrenic individuals. In addition to
their behavioral abnormalities, our studies show that as a result of in utero exposure to
products of maternal immune stimulation these offspring also exhibit a pro-inflammatory
phenotype that confers a vulnerability to develop immune-mediated pathology after birth
and into adulthood [43-45].
In this regard, the results obtained from our investigation of the poly(I:C) mouse model
have provided the scientific rationale for an ongoing translational research project to deter
mine if similar molecular pathogenic mechanisms are involved in a cohort of ASD children
who also exhibit diagnostic evidence of immune dysregulation [46]. Using DNA obtained
from the Autism Genetic Resource Exchange (AGRE) database, we initiated a parallel study
to determine if there were polymorphisms in selected maternal cytokine genes that occurred
Pro-Inflammatory Phenotype Induced by Maternal Immune Stimulation During Pregnancy

http://dx.doi.org/10.5772/53990
more frequently in mothers of these autistic children. Our results show that mothers of au
tistic children in this cohort have significant increases in pro-inflammatory cytokine gene
polymorphisms, thereby conferring the genetic capability to respond more vigorously to im
mune stimulation by producing the types and amounts of cytokines that promote inflamma
tory reactions. Thus, results obtained from our investigation of the experimental prenatal
mouse model of maternal immune stimulation during pregnancy have already shown bio
logical relevance in humans.
Th cell Type
Surface Markers
Signal Pathways
Transcription
Inducing Cytokines
Factor
Cytokines
produced
Th1
CD4; Tim-3
STAT1
T-bet
IL-12
IFN-, IL-2
Th2
CD4; T1/ST2
STAT3
GATA3
IL-4
IL-4,5,10,13
Th17
Not yet defined
STAT3
RORt
IL-1, IL-6
TNF-
TGF-
IL-1,6,17,21,22
Treg
CD4; CD25
FoxP3
FoxP3
TGF-
IL-10, TGF-
hi
Table 1. Properties of T helper (Th) cell subsets
The hypothesis we are investigating in the prenatal mouse model is that maternal immune
stimulation during pregnancy acts as a first hit that alters the developing immune system
in ways that result in more robust pro-inflammatory immune responses by offspring upon
subsequent (i.e. second hit) postnatal immune stimulation. Moreover, such fetal program
ming occurs in elements of both the innate and adaptive immune systems. Therefore, our
experiments investigate how maternal immune stimulation during pregnancy influences the
development and function of myeloid and lymphoid compartments of the immune system
beginning at the level of the progenitor cells, and progressing to functional outcomes in neo
nates and adult offspring. In the myeloid compartment, we are focusing on the functions of
Antigen Presenting Cells (APC), and on those innate immune elements that mediate acute
inflammatory responses. With respect to the adaptive immune system, we are focusing on
pro-inflammatory T helper (Th) cell subsets (Th1 and Th17) and anti-inflammatory Th cell
subsets [T regulatory (Treg) cells and Th2 cells]. To do this, we are using several well-charac
terized model systems to document the pro-inflammatory nature of the offspring of
poly(I:C)-injected vs. PBS-injected pregnant dams. The results of these studies are forming a
solid foundation to investigate how the pro-inflammatory phenotype exhibited by these off
spring also contributes to the etiology and neuroinflammation associated with ASD.
Th cell subsets are induced by different cytokines, use different cell signaling pathways, and
produce unique cytokine profiles mediated by cytokine-specific transcription factors (Table
1). Th17 and Treg cells are dependent on cytokines for their development, maintenance, and
function, and have been implicated in modulating the incidence and/or progression of vari
ous inflammatory and autoimmune phenomena, including rheumatoid arthritis (RA) [47],
Experimental Autoimmune Encephalomyelitis (EAE) [48-50], Inflammatory Bowel Disease
115
116
(IBD) [51-53], diabetes [54, 55], and atherosclerosis [56, 57]. Thus far, however, little is
known about the involvement of proinflammatory Th1 and Th17 cells in autism, and how
Th cell subsets interact with microglial APC in the brain [58].
Figure 1. Prenatal models of maternal immune stimulation during pregnancy
2. Prenatal models of immune stimulation using poly(I:C)

In the prenatal model of maternal immune stimulation with poly(I:C) (Figure 1), C57BL/6
(B6) females and males are mated, and appearance of a vaginal plug is considered day zero
of gestation (E0). At E12, pregnant females are given a single i.p. injection of poly(I:C) or
PBS alone as a control. Sera and amniotic fluids are harvested, and stored at -80oC prior to
measurement of cytokine levels by Luminex bead-based multiplex assay [59] that meas
ures up to 32 individual cytokines. In vitro and in vivo analyses are also performed on the
neonatal and adult offspring of these poly(I:C)-injected and PBS-injected pregnant dams to
assess the phenotype and function of their innate and adaptive immune system compo
nents. As also shown in Figure 1, we mate females that are immunologically nave (i.e., nonimmune), as well as females that possess immunological memory (i.e., immune) with
immunologically nave males. The phenotype of the offspring from these mating schemes
reflects the immune status of the of the pregnant dams, and the nature of the prenatal stimu
lus. Our results demonstrate that offspring of both non-immune and immune poly(I:C)-in

http://dx.doi.org/10.5772/53990
jected dams exhibit a pro-inflammatory phenotype in comparison to offspring of PBSinjected dams. In addition, however, T helper (Th) cells from offspring of immune poly(I:C)injected dams show a unique ability to preferentially differentiate to become proinflammatory Th17 cells.
Figures 2A and 2B show the significant increases in IL-6 at 2hr and 16hr after poly(I:C) injec
tion, and similar differences were also seen in levels of IL-1, IL-12, TNF-, and GM-CSF in
these samples [45, 60].
Figure 2. IL-6 levels in sera and amniotic fluids from B6 pregnant dams. Samples collected 2hrs after injection of
poly(I:C) or PBS were tested for IL-6 in sera (A) and amniotic fluids (B) using Luminex bead-based multiplex assay. Data
show mean SEM. (N=3-8; **p<0.01 using Tukeys HSD test )
In addition to testing sera and amniotic fluids from pregnant dams, we also analyze pheno
typic and functional characteristics of lymphoid cells from offspring. To avoid bias due to
litter effects [61], the number of subjects examined in our experiments not only reflects off
spring within a litter, but also offspring from multiple dams, so that the N in our studies
considers both the number of dams, as well as the number of offspring.
117
118
Use of immunologically nave pregnant dams: Immunologically nave mice are used by most in
vestigators in the standard prenatal model of immune stimulation during pregnancy. These
pregnant dams are injected with poly(I:C) on embryonic day 12 (E12), and control pregnant
dams are injected with PBS. The embryos and offspring from these dams are then used ex
perimentally to determine the influence of maternal immune stimulation on prenatal devel
opment and postnatal function. Since this model was originally developed to investigate
neurodevelopmental disorders, such as schizophrenia and autism, a majority of the studies
focus on the CNS and behavioral outcomes of offspring. These investigations have shown
that maternal immune stimulation during pregnancy with polyclonal stimuli [e.g., poly(I:C)
or LPS], infectious pathogens, or specific cytokines (e.g., IL-2 or IL-6) results in expression of
ASD-like behavioral manifestations, as well as structural or functional changes in cells in the
brain of the offspring [39-41, 61, 62].
However, in the prenatal models that use poly(I:C) as the immune stimulus, the type of
poly(I:C) (i.e., sodium or potassium salt), dose of poly(I:C) (2-20 mg/Kg), and time of in
jection during pregnancy (E9 through E18) can influence some of the parameters that
have been examined in these offspring, including open field exploration, sensorimotor
gating (e.g., prepulse inhibition of the startle response), and repetitive/perserverative be
havior ([63, 64]. It is thought that poly(I:C)-induced maternal cytokines are primarily re
sponsible for the abnormalities seen in offspring. However, downstream effects induced
by these maternal cytokines or trans-placental stimulation of fetal tissues by poly(I:C) it
self have not been completely ruled out.
Use of pregnant dams with immunological memory: In addition to the existing model using
immunologically nave dams, we also modified this mouse model of neurodevelopmental
disorders by using dams that possess immunological memory prior to mating [43, 44].
This experimental design more closely resembles the human scenario, where women pos
sess immunological memory resulting from immunizations and natural exposure to envi
ronmental antigens prior to pregnancy. Using dams with immunological memory yields a
more robust mouse prenatal model, which revealed outcomes in offspring that may be
significant not only in the etiology and/or pathogenesis of schizophrenia and autism, but
also in other disorders that are currently not being considered by use of these prenatal
mouse models.
In both of these models, we and others have previously shown that following injection
of poly(I:C), pregnant dams produce significantly higher levels of pro-inflammatory cyto
kines (e.g., IL-1, IL-6, IL-12, TNF-, and GM-CSF) than PBS-injected dams in sera as well
as amniotic fluids. Most of the studies involving structural/chemical changes and behav
ioral abnormalities that are observed after injection of poly(I:C) to pregnant dams have
been performed on adult offspring from immunologically nave pregnant dams. Recent
ly, Hsaio, et al. [65] observed alterations in the peripheral immune system of these off
spring. Our results indicate that the adult offspring of immunologically nave poly(I:C)injected pregnant dams also exhibit a more robust acute inflammatory response after
injection of the TLR2 ligand, zymosan [45, 60].

http://dx.doi.org/10.5772/53990
Figure 3. Enhanced production of Th17 cells in offspring poly(I:C)-injected (20mg/Kg) immune dams. Spleen
cells from 3wk old offspring of poly(I:C)- and PBS-injected dams were stimulated with 3ng/ml PMA and 100ng/ml ion
omycin for 16hr, the last 4hr of which were in the presence of 10ug/ml Brefeldin A to block cytokine secretion. Cells
were harvested, and stained with fluorochrome-conjugated mAbs to detect cell surface molecules and intracellular
cytokines by FACS analysis. The spleen cells analyzed in each of the panels were from offspring of PBS-injected immu
nologically nave dams (A); offspring of poly(I:C)-injected immunologically nave dams (B); offspring of PBS-injected
immune dams (C), and offspring of poly(I:C)-injected immune dams (D). Numbers in upper left quadrants are percen
tages of IL-17A+ (Th17) cells after gating on CD4+ cells. Results shown are representative of seven experiments com
paring 18 offspring from 12 different dams. Overall results of percentages of Th17 cells were: 15.17.8 in offspring
from immune poly(I:C)-injected dams vs. 0.80.5 in offspring from immune PBS-injected dams (p=0.05 using Tukeys
HSD test )
The offspring of poly(I:C)-injected (vs. PBS-injected) pregnant dams who possess immuno
logical memory prior to pregnancy exhibit a unique pro-inflammatory phenotype in which
there is preferential development of Th17 lymphocytes after T cell activation (Figure 3) [43,
44]. This preferential Th17 cell development is not seen at all in offspring of immunological
ly nave poly(I:C)-injected or PBS-injected pregnant dams. Given their role in immune-medi
ated disorders, it is likely that the potential to produce Th17 cells that we have discovered in
offspring of poly(I:C)-injected pregnant dams with immunological memory may also be an
important component in the neuroinflammatory pathogenesis of ASD-like changes that
have been observed in this prenatal mouse model. Thus, one hypothesis we have tested is
that the pro-inflammatory phenotype of offspring induced as a result of embryonic develop
ment in a pro-inflammatory cytokine environment in utero make them more susceptible
119
120
(i.e., vulnerable) to develop immune-mediated pathology. Indeed, we have obtained com

pelling results from in vivo experiments in adult offspring that strongly support this possi
bility. Using a model of EAE, in which mice are injected with an encephalogenic-peptide,
Myelin Oligodendrocyte Glycoprotein peptide (MOG35-55), we found that adult offspring of
poly(I:C)-injected pregnant dams exhibited a significantly higher frequency and earlier on
set of clinical symptoms of EAE compared to offspring of PBS-injected pregnant dams [45,
60]. Our zymosan induced results and the EAE experiments are described in subsequent sec
tions of this chapter.
Maternal vs. fetal sources of cytokines: In this prenatal model, a single i.p. injection of
poly(I:C) (or control PBS) is given on gestational day 12 (E12). Convincing evidence from
this model by us and others [30, 43, 44, 61, 66-68] has shown that pro-inflammatory cyto
kines (IL-1, IL-6, IL-12, TNF-, GM-CSF) produced as a result of maternal immune stim
ulation during pregnancy induce changes in the development of the immune system and
the brain of offspring that result in immunological and behavioral manifestations similar
to those seen in individuals with ASD. To what degree these changes are induced by cy
tokines produced by the mother or fetus has not been fully defined. However, our re
sults using IL-6 knock-out (KO) dams mated with wild type males [44], suggests that
there is a fetal source for at least some of the cytokines detected in the amniotic fluid of
poly(I:C)-injected pregnant dams.
In these experiments, our results from mating IL-6 knock-out (KO) B6 females (IL-6-/-)
and wild-type (WT) B6 males (IL-6+/+) show that despite a maternal genetic deficiency for
IL-6 production, fetal components of the heterozygous IL-6+/- placenta are a source of this
cytokine (Figures 4 and 5), and heterozygous neonates can also produce IL-6 [44]. Using
similar mating schemes in this prenatal model, however, Hsiao, et al. [66] did not find
IL-6 in amniotic fluid of poly(I:C)-injected pregnant IL-6 KO B6 dams. Our results sug
gest that poly(I:C) (a TLR3 agonist) stimulates fetal placental tissues directly, and contrib
utes to the levels of IL-6 found in amniotic fluid. This is relevant to the interpretation of
data about the source of IL-6 (as well as other cytokines) found in the amniotic fluids
and fetal tissues, such as the brain [9, 63, 69], and also because TLR3 is expressed in the
brain during fetal development [70].
Pregnant dams injected with
Sickness behavior ratio
PBS
1.00 0.10
Poly(I:C)
0.40 0.02*
21
Pregnant dams were analyzed for sickness behavior before and 2 and 24 hrs after poly(I:C) injection. All mice in a
group were analyzed by calculating a ratio, where each post injection sickness behavior score was divided by its preinjection score. The individual ratios were then used to calculate the means, standard errors, and significance values.
*p < 0.0001 (Tukeys HSD test).
Table 2. Sickness behavior scores of immune poly(I:C)- and PBS- injected pregnant dams

http://dx.doi.org/10.5772/53990
Figure 4. Source of cytokines in pregnant dams. Sera (N=6) and amniotic fluids (N=17) from IL-6 KO pregnant dams
were collected 24 hrs after injection of poly(I:C), and IL-6 levels determined by Luminex assay. (*p<0.0001 Tukeys HSD
test).
Figure 5. Source of cytokines in offspring. Spleen cells from WT B6 (N=5) and spleen and placental cells from
poly(I:C)-injected IL-6 KO females (N=5) were cultured with/without PMA and Ionomycin (P/I). Supernatants were col
lected 24hrs later, and tested for the presence of IL-6 by Luminex assay. (*p<0.02; **p<0.01; Tukeys HSD test)
Regardless of source, however, since in utero exposure to the products of maternal immune
stimulation during pregnancy appear to be part of the underlying mechanisms responsible for
the changes observed in offspring, it is important to be sure that the pregnant dam responds to
the immune stimulus if their offspring are used for experiments. We have addressed this issue
by monitoring locomotor activity in a novel environment in every pregnant dam before, and at
2hrs and 16hrs after injection as a reliable, non-invasive measure of response to poly(I:C). We
opted to use this method in lieu of more invasive procedures that would jeopardize pregnancy
in these dams and/or add a level of stress that could influence the cytokine levels and/or fetal
development. As shown in Figure 6 and Table 2, there is a consistent and dramatic decrease in
activity (indicative of sickness behavior [71-74]) in poly(I:C)-injected pregnant dams at 2hrs
post injection that is not seen in PBS-injected dams. Moreover, sickness behavior at 2hrs post
poly(I:C) injection correlates very nicely with the increased levels of pro-inflammatory cyto
kines seen at 2hrs in the sera and amniotic fluids of pregnant dams (Figure 2). Activity scores
121
122
are measured in every pregnant dam, including those that are brought to term and give birth.
In this way, we are confident that the offspring used for subsequent in vivo and in vitro experi
ments to characterize phenotypic and functional immunological parameters were exposed in
utero to a pro-inflammatory cytokine milieu.
Figure 6. Sickness behavior scores in poly(I:C)-injected pregnant dams. Dams were tested before, and at 2hrs &
16hrs after poly(I:C) or PBS injection. Activity was monitored in a novel environment, and mice were given positive
scores for locomotion, rearing, grooming, sniffing, and negative scores for periods of inactivity. The data in this figure
show scores for 6 individual poly(I:C)-injected dams at the 3 time periods.
Effects of maternal immune stimulation on Toll-Like Receptors (TLR): We are also examining the
effects of poly(I:C) exposure during pregnancy on the expression and function of TLRs dur
ing fetal development and in neonates and adult offspring. TLRs are part of a larger family
of membrane bound cell surface and intracellular Pattern Recognition Receptors (PRR).
Eleven TLRs have been discovered in humans (TLRs 1-11), and 12 TLRs have been found in
mice (TLRs 1-12). First discovered in Drosophila [75], this family of molecules is very hetero
genous, complex, and highly conserved among species. Individual TLRs bind to particular
microbial products, such as LPS, peptidoglycan, lipoproteins, and flagellin on bacteria, as
well as viral fusion protein, unmethylated CpG motifs, double- and single-stranded RNAs
[76, 77]. TLR expression by cells of the innate and adaptive immune systems allows these
cells to recognize and respond to extracellular and intracellular microbial pathogens. Down
stream cell signaling pathways are initiated when ligands bind to TLRs, leading to activa
tion of different transcription factors (e.g., NF-B and others), which stimulate expression of
pro-inflammatory cytokine genes (e.g., IL-1, IL-6, TNF, interferons).
Thus, TLRs play an early and important role at the interface between the environment and
host tissues by initiating immune responses against pathogens. In addition to expression on
cells of the innate and adaptive immune systems, TLRs are also expressed in/on many cell
types in various other tissues of the body, including the placenta, embryonic brain, and
hematopoietic progenitor cells. In the context of our experimental model of maternal im
mune stimulation during pregnancy, how the maternal response to poly(I:C) (a TLR3 ago
nist) during pregnancy affects the normal expression and function of TLR3, as well as other

http://dx.doi.org/10.5772/53990
TLRs in the developing embryos and offspring is an important question that allows the de
sign of experiments that address underlying mechanisms.
Modulation and desensitization of TLR expression, as well as cross-talk among TLRs has
been shown in cells from humans and rodents. There is increasing evidence of TLR expres
sion during embryonic development in the placenta, fetal brain and hematopoietic stem
cells [78-81]. In this regard, we have obtained results indicating modulation of TLR expres
sion in 4wk old neonates from poly(I:C)-injected dams (Figure 7). Using pathway-focused
gene expression profiling qRT-PCR arrays, spleen cells from offspring of pregnant dams in
jected with the TLR3 agonist, poly(I:C), showed a 3.3 to 4.7 -fold increase in constitutive ex
pression levels of TLR2, 4 and 7 over those seen in age-matched control B6 offspring. In
contrast, expression levels of TLR3 and 9 were <2-fold greater than controls. These results
indicate that exposure to poly(I:C) (or poly(I:C)-induced cytokines) during fetal develop
ment results in altered TLR expression that persists after birth, consequences of which may
relate to differential immune responses to micro-organisms and auto-antigens. These data
also suggest that TLR modulation, desensitization, and cross-talk also occur when fetal tis
sues are exposed to TLR agonists in utero.
Figure 7. Altered constitutive expression of TLRs in offspring of poly(I:C)-injected dams. RNA was extracted di
rectly from unstimulated spleen cells of 4wk old offspring of poly(I:C)- and PBS-injected dams, and tested for expres
sion of TLRs using the RT2 Profiler PCR Array system. Data are expressed as fold-changes in gene expression for TLRs in
offspring of poly(I:C)-injected dams over PBS-injected dams. The results show >3-fold upregulation for TLR2, 4, and 7
and <2-fold increase for TLR3 and 9 in offspring of poly(I:C)- compared to PBS-injected dams.
Recent studies have shown expression of TLRs by neural progenitor cells (NPC), neurons
and glial cells in the adult brain, which may be important in the responses of these cells to
injury or infection [76, 82-88]. Studies of TLR expression in the developing rodent brain have
revealed that TLR3 appears as early as embryonic day 12.5 (E12.5) in mouse cortices, but de
clines over time. By contrast, TLR2 expression appears around E15.5 and increases with time
[70, 88]. Moreover, in standard in vitro neurosphere assays (used to assess developmental
potential of NPCs), both TLR2 and TLR3 activation appear to regulate NPC proliferation.
These studies raise questions regarding the expression of other TLRs during brain develop
123
124
ment, and how that expression pattern is altered when dams are exposed to TLR agonists,
such as poly(I:C), during pregnancy. The structural and/or functional abnormalities seen in
the brains of offspring from poly(I:C)-injected pregnant dams may correlate with alterations
of the normal patterns of TLR expression in the developing brain. Therefore, disruption of
the normal TLR expression pattern might be involved in the observed structural and/or
functional changes in the brain of individuals with neurodevelopmental disorders, such as
schizophrenia and autism.
Cell Marker
Percent Positive Cells in Fetuses from

PBS-injected dams
poly(I:C)-injected dams
#1
#2
#1
#2
Sca-1+, c-kit+ (HSC)
0.3
0.3
1.5
1.3
Sca-1-, c-kit+ (CMP)
24.0
25.9
21.6
24.5
Sca-1 , c-kit (CLP)
9.6
8.0
23.1
23.1
Pregnant dams were injected at E12 and fetuses were obtained 24 hrs later. Fetal liver cells from individual fetuses
were analyzed by FACS for expression of markers that define HSCs and early common progenitor cells.
Table 3. Hematopoietic Stem Cells in Fetal Liver
TLR expression on hematopoietic stem cells (HSCs): As previously mentioned, maternal expo
sure to poly(I:C) during pregnancy induces production of pro-inflammatory cytokines, in
cluding significant increases in IL-6 in maternal circulation, amniotic fluid, placenta, and
fetal brain [51, 89-93]. Direct injection of IL-6 to pregnant dams also results in consequences
for the offspring, including structural abnormalities in the brain, as well as behavioral and
cognitive abnormalities [30, 34-36, 38]. However, IL-6 also affects the immune system; it is
an autocrine growth factor for thymic epithelial cells [94], stimulates fetal hematopoiesis
[95], and can alter the balance of Tregs and Th17 cells towards the pro-inflammatory Th17
phenotype [96-101]. Thus, IL-6 is a key player in the differentiation of cells in the immune
system, and may play a role in the immune dysregulation seen in ASD.
Recent studies have also revealed that HSCs not only respond to cytokine signaling to ini
tiate myelopoiesis and lymphopoiesis, but also can sense microbial pathogens directly via
TLR signaling [78]. Administration of nanomolar concentrations of the TLR4 agonist, LPS,
triggers emigration of monocytes from the BM into the bloodstream, indicating that circulat
ing levels of TLR ligands can also stimulate HSCs within hematopoietic tissues [102]. Addi
tionally, treatment of mice with TLR3 agonist poly(I:C) activates HSCs to proliferate [103].
Therefore, it is likely that in the prenatal model we are studying, HSCs are influenced not
only by the poly(I:C) induced cytokines elicited during pregnancy, but also by this TLR3 ag
onist as well. Therefore, we have examined placentas, fetal livers, and neonatal bone mar
row from poly(I:C)-injected (vs.PBS-injected) pregnant dams and offspring to characterize
the changes in HSCs, as well as lineage-specific progenitor cells. We examined cells from

http://dx.doi.org/10.5772/53990
these tissues for surface markers (Sca-1 and c-kit) that define HSCs, and the lineage-specific
progenitors for T cells (TCR, CD3), B cells (sIg, CD19), and myeloid cells (CD11b, CD11c).
An example of our results for HSCs in fetal liver is presented in Table 3. Pregnant dams were
injected at E12 with either PBS or poly(I:C), and fetuses were examined 24 hrs later. The data
show that in comparison to fetuses from PBS-injected dams, fetal livers from poly(I:C)-injected
dams had a 4- to 5-fold increase in the percentage of HSCs that were double-positive for Sca-1
and c-kit, and almost a 3-fold increase in the percentage of HSCs that expressed only Sca-1,
which are early Common Lymphoid Progenitors (CLP). By contrast, the percent of HSCs that
expressed only c-kit, which are early Common Myeloid Progenitors (CMP), was similar in all
fetal livers. These results are intriguing because they indicate hyper-proliferation of HSCs and
early CLP, which may forecast the preferential changes we have observed in mature T lympho
cytes in the adult offspring of poly(I:C)-injected dams [43-45, 60].
3. In vivo proof-of-concept experiments

In addition to our investigation of the consequences of maternal immune stimulation to preg
nant dams, embryonic tissues, and 2-4 wk old neonates, we have also extended our studies to
adult offspring of poly(I:C)-injected (vs. PBS-injected). Our guiding hypothesis is that as a re
sult of in utero exposure of the fetus to cytokines elicited by maternal immune stimulation (act
ing as a first hit), developmental programming of the immune system occurs in offspring,
which persists postnatally and into adulthood. In the case of this prenatal model, such fetal
programming results in development of a pro-inflammatory phenotype, such that upon
subsequent postnatal exposure to an immune stimulus (i.e., second hit) the offspring of
poly(I:C)-injected pregnant dams exhibit exacerbated responses in comparison to offspring of
PBS-injected dams. Such a scenario is also consistent with the multiple hit concept of mental
disorders [104, 105]. In the context of ASD, this would mean that abnormalities of behavior and
immune dysregulation in some children with ASD could reflect such developmental program
ming during embryonic development that is manifested postnatally upon encounter with a
second hit to their immune system. We tested this hypothesis by using adult offspring of
poly(I:C)-injected (vs. PBS-injected) pregnant dams in selected in vivo experimental models
that involve activation of their innate and/or adaptive immune systems.
Inflammatory response to TLR2 agonist, zymosan: We induced an antigen non-specific acute in
flammatory response in the peritoneal cavity with zymosan (TLR-2 agonist), and assessed
the qualitative and quantitative nature of the inflammatory response 4 hrs later [106].
Adult offspring from immunologically nave poly(I:C)-injected dams were injected i.p. with
PBS (control) or zymosan. Adult offspring from immunologically nave PBS-injected dams
were also injected with PBS or zymosan for comparison. Mice were euthanized at 4 hrs, and
2ml of cold PBS was used to flush their peritoneal contents. The number and type of perito
neal exudate cells were determined by manual counting and FACS analysis, and the perito
neal fluid was analyzed for the presence of cytokines.
125
126
As shown in Table 4, the >2 fold increase in total Peritoneal Exudate Cell (PEC) count in the
zymosan-injected poly(I:C) offspring was significantly higher than the count recovered from
zymosan-injected PBS offspring. In contrast, there were no significant differences in absolute
PEC numbers in control PBS-injected adult poly(I:C) or PBS offspring. The peritoneal cellu
lar infiltrate in offspring injected with PBS was primarily mononuclear cells (monocytes and
lymphocytes) (Figure 8A). In contrast, the acute cellular inflammatory response in the peri
toneal cavity of zymosan-injected offspring was mostly neutrophils (Figure 8B).
Offspring
Total PEC
Neutrophils
From
Injected with
(x106)
Percent
PBS-injected dams
PBS
0.8 0.3
<5.0
Absolute
IL-6 (pg/ml)
Sera
Peritoneal Fluid
<0.004
4 0.6
15 7.9
1176 586
number (x106)
Zymosan
6.3 1.8
70.0 10
4.40 1.9
420 200
Poly(I:C)-injected
PBS
1.0 0.4
<5.0
<0.005
8 2.7
6 2.5
dams
Zymosan
13.3 2.1**
81.0 6
10.8 2.0**
2692 514*
7808 1306*
Adult offspring from immunologically nave poly(I:C)-injected dams were injected i.p. with PBS (control) or zymosan.
Adult offspring from immunologically nave PBS-injected dams were also injected with PBS or zymosan for compari
son. Mice were euthanized at 4 hrs, and 2ml of cold PBS was used to flush their peritoneal contents. The number and
type of peritoneal exudate cells (PEC) were determined by manual counting and FACS analysis, and sera and perito
neal fluids were analyzed for the presence of cytokines. N = 5-8, ** P=0.016 (students t-test). *P< 0.05 (students ttest)
Table 4. Zymosan-induced acute inflammatory responses in offspring
Figure 8. Acute inflammatory response in zymosan-injected adult offspring. Adult offspring from poly(I:C)-inject
ed non-immune dams were injected i.p. with 1 ml of zymosan suspension or PBS (control). Four hours after injection,
peritoneal cavities were flushed with ice cold PBS. Cytospin slides were made from peritoneal exudate cells, and
stained with Wrights/Giemsa stain. (A) PBS-injected offspring from poly(I:C)-injected non-immune dams at 630X. (B)
zymosan-injected offspring from poly(I:C)-injected non-immune dams at 630X.

http://dx.doi.org/10.5772/53990
The percentage of neutrophils in zymosan-injected offspring from PBS-injected and poly(I:C)injected offspring (Table 4) were similarly high (i.e., 70% and 81%, respectively). However, be
cause the total number of PEC recovered from zymosan-injected offspring from poly(I:C)injected (vs. PBS-injected) dams was significantly higher, the absolute number of neutrophils
from zymosan-injected offspring was also significantly greater in offspring from poly(I:C)-in
jected dams. Given the huge infiltration of neutrophils into the peritoneal cavity in zymosaninjected offspring, we also examined the bone marrow for evidence of increased myeloid
activity, and found evidence of increased myeloid activity in mice showing PEC counts in ex
cess of 10 x 106 cells. As also shown in Table 4, significantly higher levels of IL-6 were observed
in fluid obtained from the peritoneal cavity of zymosan-injected poly(I:C) offspring vs. PBS off
spring at 4 hrs after zymosan injection. Although not shown in the table, levels of TNF- and
IL-10 were also significantly higher in these zymosan-injected poly(I:C) offspring.
Results from the myocardial Ischemia/reperfusion model: Based on the results we obtained using
injection of zymosan to mimic the acute inflammatory response induced by an infectious or
ganism, we wished to determine if the offspring of immunologically nave poly(I:C)-injected
dams would also mount a more robust inflammatory responses to endogenous molecules
created by non-infectious tissue injury. The persistent neuroinflammation observed in
brains of individuals with autism and in rodents from experimental models of neurodeve
lopmental disorders may be triggered by such endogenous stimuli. For these experiments,
we selected a well-characterized cardiac model in which ischemia/reperfusion causes a
sterile inflammatory response. After an acute myocardial infarction, reperfusion (by
thrombolytic therapy or primary percutaneous intervention) is currently the most effective
strategy to minimize myocardial damage and improve clinical outcome [107]. Paradoxically,
restoring blood flow to the ischemic heart tissue can also induce injury a phenomenon
called myocardial reperfusion injury (R/I). The modes of myocardial cell injury and death
following myocardial R/I are apoptosis, autophagy, and necrosis, and several underlying
mechanisms have been identified or proposed [108-112]. However, one well-studied cause
of myocardial R/I is the host inflammatory response that occurs during reperfusion. Despite
the fact that ischemia and reperfusion takes place in a sterile environment, activation of in
nate and adaptive immune responses occurs and contributes to injury (reviewed in [112]).
Contributing factors of reperfusion-induced inflammation include activation of Toll-like Re
ceptors (TLRs), complement activation, free radical generation, cytokine cascade initiated by
release of pro-inflammatory cytokines, and chemokine upregulation [113-116]. The presence
of these immune mediators leads to recruitment of neutrophils to the ischemic myocardium,
which exert cytotoxic effects themselves by release of proteolytic enzymes. Another paradox
of myocardial reperfusion is that it may also significantly enhance a healing process. Studies
have shown that Monocyte Chemoattractant Protein-1 (MCP-1) is also induced in the in
farcted area, which may regulate myeloid cell recruitment, leading to accumulation of mac
rophages and mast cells that secrete angiogenesis-stimulating factors, which facilitate
myocardial repair [117, 118].
For these experiments, adult offspring of immunologically nave poly(I:C)-injected and PBSinjected dams were anesthetized, intubated and ventilated; the heart was exposed by a thor
127
128
acotomy through the 4th and 5th ribs, and a suture was passed under the left coronary
artery. The left coronary artery was occluded for a period of 20 min, and reperfusion applied
for 24 hrs. Reperfusion was achieved by removal of the occlusion, the thoracotomy incision
was closed, and mice were allowed to recover under monitoring in an incubator. After 24 hr
of reperfusion, mice were assessed for cardiac injury as previously described [119, 120].
As shown in Figure 9, significantly greater cardiac damage was observed in offspring from
immunologically nave poly(I:C)-injected dams than in offspring from control PBS-injected
dams. We are currently assessing the underlying mechanisms responsible for the difference
in levels of damage in experimental and control offspring. Myocardial I/R induces infiltra
tion of inflammatory cells, such as neutrophils that secrete cytokines/chemokines, including
IL-6 and TNF, which in turn contribute to cell death, fibrosis and reduced myocardial con
tractility [121]. Therefore, it is likely that similar underlying inflammatory mechanisms also
occur in the myocardial I/R model as those described above for the acute inflammation in
duced by zymosan. In the zymosan and myocardial I/R models, the response is measured
within hours of the immune stimulus. This indicates that elements of the innate immune
system are the primary mediators of the pathology, and suggest that modification of these
components has occurred as a result of maternal immune stimulation during pregnancy.
Figure 9. Cardiac damage in offspring of poly(I:C)-injected vs. PBS-injected immunologically nave pregnant
dams. Adult offspring from poly(I:C)-injected (Exp) and PBS-injected (Control) dams were subjected to cardiac ische
mia (20 min) and reperfusion (24 hrs), and assessed for cardiac damage (indicated by infarct size). Offspring from
poly(I:C)-injected dams exhibited significantly greater cardiac damage (p=0.011; students t-test) than control off
spring. (N = 8 mice/group; 8 weeks of age)
Response to auto-antigens: In order determine if components of the adaptive immune system al

so mount more robust responses following immune stimulation we chose a well-characterized
EAE model of an immune-mediated disease, and used adult offspring of pregnant dams with
immunological memory. We have previously shown that T cells from offspring of poly(I:C)-in
jected pregnant dams with immunological memory (i.e., immune) preferentially differentiate
to become Th17 cells after in vitro activation [43-45, 60]. In contrast, T cells from offspring of
poly(I:C)-injected immunologically nave pregnant dams (i.e., non-immune) do not show such
Th17 cell preferential differentiation. Th17 cells have been shown to be involved in the neuro
pathology responsible for the clinical symptoms that develop in Experimental Autoimmune

http://dx.doi.org/10.5772/53990
Encephalomyelitis (EAE), a mouse model of multiple sclerosis [122-128]. Female offspring of

poly(I:C) (vs. PBS) -injected pregnant dams were injected s.c. in each hind flank with an ence
phalogenic-peptide (MOG35-55) in Complete Freund s adjuvant (CFA). I.p. injections of pertus
sis toxin were given after MOG immunization to enhance the immune response and promote T
cell migration into the brain [129]. Typically, 10 12 days after injection of MOG and pertussis,
90% of B6 mice develop progressively: weakness and paralysis in their tail, hindlimb paresis
and finally hindlimb paralysis. Controls that receive CFA and pertussis toxin, but no MOG, do
not develop clinical signs of EAE.
However, offspring of poly(I:C)-injected immune pregnant dams exhibited clinical signs of
EAE significantly earlier and with higher frequency than offspring of poly(I:C)-injected nonimmune dams (Figure 10). More than 70% of poly(I:C) immune offspring began to show
clinical signs of EAE by day 4 after MOG35-55 immunization compared to none seen in
poly(I:C) non-immune offspring. On day 7 after immunization, 25% of poly(I:C) non-im
mune offspring began to show symptoms, but this was still significantly lower than the
>70% seen in poly(I:C) immune offspring. By day 9, >60% of poly(I:C) non-immune off
spring showed clinical signs of EAE. In addition to the higher frequency of clinical signs of
EAE, poly(I:C) immune offspring also had significantly higher disease severity from days
4-7 post MOG35-55 immunization compared to poly(I:C) non-immune offspring [45, 60]. From
days 9-20, the development of EAE among offspring was very similar in both groups. How
ever, the earlier appearance of clinical symptoms affords a window of opportunity to inves
tigate underlying mechanisms in the EAE model that can be applied in future studies of
mechanisms of neuroinflammation and pathogenesis in experimental models of autism.
Figure 10. Frequency of mice showing clinical signs of EAE. Adult offspring of of poly(I:C)-injected dams with im
munological memory [vs. immunologically nave poly(I:C)-injected dams] were injected s.c. with MOG in CFA and i.p.
with pertussis toxin. Mice were scored for clinical signs of neurological impairment, and the percent of mice showing
clinical signs at the indicated times after immunization is shown in this figure.
129
130
These results are consistent with our hypothesis of fetal programming due to effects of ma
ternal immune stimulation during pregnancy, leading to increased susceptibility of off
spring to a second hit postnatal stimulus. This is likely due to an overall heightened
immune responsiveness to develop EAE by MOG-specific Th cells that preferentially differ
entiate to become Th17 cells in these pro-inflammatory mice and/or a lower antigen thresh
old for initiation of an immune response. Another contributing factor could be differential
responses of these pro-inflammatory offspring to TLR agonists on the mycobacteria in CFA
(TLR2) and pertussis toxin (TLR4) used as part of the MOG immunization protocol [130,
131]. Support for this possibility is shown in Figure 7, where offspring of poly(I:C)-injected
dams who possess immunological memory showed >3-fold higher expression of TLR2 and
TLR4 compared to controls.
Overall, our results are consistent with the concept of developmental programming of the
immune system [71, 132-136]. These changes persist into adulthood, and increase the vulner
ability of offspring from poly(I:C)-injected dams to develop immune-mediated diseases
when exposed to subsequent antigen specific, as well as antigen non-specific immune chal
lenges. There is considerable plasticity of the developing immune system, and maternal
stressors, such as immune stimulation during pregnancy, can modulate normal develop
ment [137]. Immune stimuli during the perinatal period of life can also act as a vulnerability
factor for later-life alterations of immune responsiveness [132]. Such fetal programming has
been described in relation to abnormalities of metabolism, growth, and behavior in offspring
[138-140], as well as in relation to allergic and autoimmune disorders [133-135, 141-143]. The
fetal programming of the developing immune system in this prenatal mouse model descri
bed herein is most likely mediated by cytokines and/or other inflammatory mediators pro
duced by immune stimulation in response to poly(I:C) given to the pregnant dam. However,
as we have previously shown, the sources of these products of immune stimulation are of
both maternal and fetal origin [44].
4. Summary and conclusions

The results from our investigation of the poly(I:C)-induced prenatal model of neurodeve
lopmental disorders further identifies and characterizes gene-environment interactions
(i.e., maternal immune response genes vs. environmental antigens) that influence fetal
development in ways that have consequences for health and disease of offspring. Further
characterization of this model presents excellent opportunities to define the underlying
mechanisms responsible for the alterations that occur during embryological development,
which persist and are manifested in adult offspring. We are using this model to examine
the peripheral immune system of offspring to identify mechanisms that explain the im
mune dysregulation that is characteristic in a significant cohort of children with Autism
Spectrum Disorders (ASD). The immunological changes we find in offspring of dams
that receive immune stimulation during pregnancy involve significant differences in cyto

http://dx.doi.org/10.5772/53990
kines and T helper (Th) lymphocyte subsets. Our investigation of this mouse model has
also provided a scientific basis for an ongoing translational research project to determine
if similar molecular pathogenic mechanisms are involved in the cohort of ASD children
who also exhibit evidence of immune dysregulation. Thus, mothers of autistic children in
this cohort have polymorphisms in the same cytokine genes that promote inflammatory
reactions in our mouse model, and their children with autism and immune dysregula
tion inherit the maternal pro-inflammatory phenotype.
Convincing evidence from this model has shown that pro-inflammatory cytokines pro
duced by maternal immune stimulation during pregnancy induce changes in the devel
opment of the immune system and brain of offspring that result in similar
immunological and behavioral manifestations as those seen in individuals with ASD.
Therefore, our results are relevant to the concept of developmental programming of the
immune system. In utero exposure to these cytokines produces offspring that exhibit a
pro-inflammatory phenotype, which persists throughout the neonatal period and into
adulthood. Subsequently, upon postnatal exposure to agents that stimulate the immune
system, offspring that exhibit this phenotype mount a more robust immune response in
which pro-inflammatory immune elements (i.e., Th17 cells and cytokines) predominate.
Th17 cells have been shown to mediate immunopathology in numerous disorders that
model human diseases, such as multiple sclerosis, arthritis, inflammatory bowel disease,
atherosclerosis, and diabetes. Our use of offspring that have Th cells with the potential
to preferentially differentiate into Th17 cells will also determine the contribution of Th17
cells to the etiology and pathogenesis of ASD.
The nature and timing of this second hit to the immune system may also be a critical de
termining factor in the manifestation of immune outcomes. Thus, if immune stimulation
occurs very early in life when organ systems, such as the brain, are still developing, it
may lead to neurodevelopmental disorders like ASD. Contrastingly, if the second hit oc
curs later in life, the outcome may be manifested as an autoimmune disorder. However,
possession of a pro-inflammatory phenotype as described in our model is not necessarily
a disadvantage. In certain clinical scenarios, such as malignancy or infection with patho
genic micro-organisms, a more robust immune response may provide survival advant
age. Indeed, our preliminary results in an infection model indicate that the offspring of
poly(I:C)-injected pregnant dams that exhibit a pro-inflammatory phenotype show in
creased survival time and lower pathogen burden than control offspring from PBS-inject
ed pregnant dams.
As with many other components of the immune system, the effector functions resulting
from developmental programming induced by maternal immune stimulation during preg
nancy have the potential to be a double-edged sword with outcomes that can be either detri
mental or beneficial. The future challenge in studying this prenatal model system will be to
sufficiently understand the underlying cellular and molecular mechanisms to enable the de
sign of effective therapeutic interventions to inhibit outcomes that are harmful, and enhance
those that are beneficial.
131
132
Author details
Nicholas M. Ponzio1, Mili Mandal2, Stella Elkabes3, Pan Zhang4, Junichi Sadoshima5,
Sayantani Basak6, Peiyong Zhai7 and Robert Donnelly8
1 Department of Pathology & Laboratory Medicine, University of Medicine and Dentistry of
New Jersey New Jersey Medical School and the Graduate School of Biomedical Sciences,
Newark, USA
New Jersey Graduate School of Biomedical Sciences, Newark, USA
3 Department of Neurological Surgery, University of Medicine and Dentistry of New Jersey
New Jersey Medical School and the Graduate School of Biomedical Sciences, Newark, USA
New Jersey New Jersey Medical School, Newark, USA
5 Department of Cell Biology & Molecular Medicine, University of Medicine and Dentistry
of New Jersey New Jersey Medical School and the Graduate School of Biomedical Sciences,
Newark, USA
New Jersey New Jersey Medical School, Newark, USA
7 Department of Cell Biology & Molecular Medicine, University of Medicine and Dentistry
of New Jersey New Jersey Medical School, Newark, USA
New Jersey New Jersey Medical School and the Graduate School of Biomedical Sciences,
Newark, USA
References
[1] Ashwood, P. and J. Van de Water, Is autism an autoimmune disease? Autoimmunity
Review, 2004. 3: p. 557-562.
[2] Pardo, C.A., D.L. Vargas, and A.W. Zimmerman, Immunity, neuroglia and neuroinflam
mation in autism. Int Rev Psychiatry, 2005. 17(6): p. 485-95.
[3] Connolly, A.M., et al., Brain-derived neurotrophic factor and autoantibodies to neural anti
gens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epi
lepsy. Biol Psychiatry, 2006. 59(4): p. 354-63.

http://dx.doi.org/10.5772/53990
[4] DiCicco-Bloom, E., et al., The Developmental Neurobiology of Autism Spectrum Disorder.
J Neurosci, 2006. 26(6): p. 6897-6906.
[5] Voineagu, I., et al., Transcriptomic analysis of autistic brain reveals convergent molecular
pathology. Nature, 2011.
[6] Ashwood, P., S. Wills, and J. Van de Water, The immune response in autism: a new fron
tier for autism research. J Leukoc Biol, 2006. 80(1): p. 1-15.
[7] Ashwood, P., et al., Associations of impaired behaviors with elevated plasma chemokines in
autism spectrum disorders. J Neuroimmunol, 2011. 232(1-2): p. 196-9.
[8] Ashwood, P., et al., Altered T cell responses in children with autism. Brain Behav Immun,
2011. 25(5): p. 840-9.
[9] Patterson, P.H., Maternal infection and immune involvement in autism. Trends Mol Med,
2011.
[10] Ashwood, P., et al., In search of cellular immunophenotypes in the blood of children with
autism. PLoS One, 2011. 6(5): p. e19299.
[11] Goines, P.E. and P. Ashwood, Cytokine dysregulation in autism spectrum disorders
(ASD): Possible role of the environment. Neurotoxicol Teratol, 2012.
[12] Croonenberghs, J., et al., Activation of the inflammatory response system in autism. Neu
ropsychobiology, 2002. 45: p. 1-6.
[13] Deykin, E. and B. MacMahon, Viral exposure and autism. Am J Epidemiol, 1979. 109: p.
628-638.
[14] Hagberg, H. and C. Mallard, Effect of inflammation on central nervous system develop
ment and vulnerability: review. Current opinions in Neurology, 2005. 18: p. 117-123.
[15] Hornig, M., et al., An infection-based model of neurodevelopmental damage. Proc Natl
Acad Sci, 1999. 96: p. 12101-12107.
[16] Lipkin, W. and Hornig M, Microbiology and immunology of autism spectrum disorders.
Novartis Foundation Symposium, 2003. 251: p. 129-143.
[17] Malek-Ahmadi, P., Cytokines and etiopathogenesis of pervasive developmental disorders.
Med Hypotheses, 2001. 56(3): p. 321-324.
[18] Pardo, C. and C. Eberhart, The neurobiology of autism. Brain Pathology, 2007. 17: p.
434-447.
[19] Patterson, P., Maternal infection: window on neuroimmune interactions in fetal brain devel
opment and mental illness. Curr Opin Neurobiology, 2002. 12: p. 115-118.
[20] Brown, A.S., Prenatal infection as a risk factor for schizophrenia. Schizophr Bull, 2006.
32(2): p. 200-2.
[21] Brown, A.S. and E.J. Derkits, Prenatal infection and schizophrenia: a review of epidemio
logic and translational studies. Am J Psychiatry, 2010. 167(3): p. 261-80.
133
134
[22] Jonakait, G., The effects of maternal inflammation on neuronal development: possible mecha
nisms. Int J Dev Neurosci, 2007. 25: p. 415-425.
[23] Bell, M. and J. Hallenbeck, Effects of intrauterine inflammation on developing rat brain. J
Neurosci Res, 2002. 70: p. 570-579.
[24] Carvey, P., et al., Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to longterm losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease.
Front Biosci 2003. 8: p. s826-s837.
[25] Fatemi, S., et al., Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly
in adulthood: implications for genesis of autism and schizophrenia. Clin Mol Neurobiol,
2002. 22: p. 25-33.
[26] Hornig, M., et al., Borna disease virus infection of adult and neonatal rats: models for neuro
psychiatric disease. Curr Top Microbiol Immunol, 2001. 253: p. 157-177.
[27] Pletnikov, M.V., et al., Rat model of autism spectrum disorders. Genetic background effects
on Borna disease virus-induced development brain damage. Ann NY Acad Sci, 2001. 939: p.
318-319.
[28] Pletnikov, M.V., et al., Developmental brain injury associated with abnormal play behavior
in neonatally borna disease virus-infected lewis rats: a model of autism. Behav Brain Res,
1999. 100(43-50).
[29] Shi, L., et al., Maternal influenza infection causes marked behavioral and pharmacological
changes in the offspring. J Neurosci, 2003. 23(1): p. 297-302.
[30] Smith, S.E., et al., Maternal immune activation alters fetal brain development through inter
leukin-6. J Neurosci, 2007. 27(40): p. 10695-702.
[31] Weissenbock, H., et al., Microglial activation and neuronal apoptosis in Bornavirus infect
ed neonatal Lewis rats. Brain Pathology, 2000. 10(260-272).
[32] Lancaster, K., et al., Abnormal social behaviors in young and adult rats neonatally infected
with Borna disease virus. Behav Brain Res, 2007. 176: p. 141-148.
[33] Rousset, C., et al., Maternal exposure to LPS induces hypomyelination in the internal cap
sule and programmed cell death in the deep gray matter in newborn rats. Pediatr Res, 2006.
59: p. 428-433.
[34] Dammann, O. and A. Leviton, Maternal intrauterine infection, cytokines, and brain dam
age in the preterm newborn. Pediatr Res, 1997. 42: p. 1-8.
[35] Conroy, S., et al., Interleukin-6 produces neuronal loss in developing cerebellar granule neu
ron cultures. J Neuroimmunol, 2004. 155: p. 43-54.
[36] Gilmore, J., et al., Prenatal Infection and Risk for Schizophrenia: IL-1beta, IL-6, and TNFal
pha Inhibit Cortical Neuron Dendrite Development. Neuropsychopharmacology, 2004.
29: p. 1221-1229.

http://dx.doi.org/10.5772/53990
[37] Nawa, H. and N. Takei, Recent progress in animal modeling of immune inflammatory
processes in schizophrenia: implication of specific cytokines. Neuroscience Research, 2006.
56: p. 2-13.
[38] Samuelsson, A., et al., Prenatal exposure to Interleukin-6 results in inflammatory neurode
generation in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial
learning. Amer J Physiol Regul Integr Comp Phyusiol, 2006. 290: p. R1345-1356.
[39] Ponzio, N.M., et al., Cytokine levels during pregnancy influence immunological profiles and
neurobehavioral patterns of the offspring. Ann N Y Acad Sci, 2007. 1107: p. 118-28.
[40] Alston, E.N., et al., Cardiac ischemia-reperfusion regulates sympathetic neuropeptide ex
pression through gp130-dependent and independent mechanisms. Neuropeptides, 2011.
45(1): p. 33-42.
[41] Patterson, P.H., Immune involvement in schizophrenia and autism: etiology, pathology and
animal models. Behav Brain Res, 2009. 204(2): p. 313-21.
[42] Crawley, J.N., Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol,
2007. 17(4): p. 448-59.
[43] Mandal, M., et al., Preferential development of Th17 cells in offspring of immunostimulated
pregnant mice. J Reprod Immunol, 2010. 87(1-2): p. 97-100.
[44] Mandal, M., et al., Maternal immune stimulation during pregnancy affects adaptive im
munity in offspring to promote development of TH17 cells. Brain Behav Immun, 2011.
25(5): p. 863-71.
[45] Mandal, M., et al. Maternal immune stimulation during pregnancy facilitates prenatal im
muno-developmental changes leading to a pro-inflammatory phenotype in offspring. in Inter
national Meeting for Autism Research. 2012. Toronto, Canada.
[46] Ramanathan, M., et al., Maternal cytokine regulation in the pathogenesis of autism. 9th
Annual International Meeting for Autism Research, 2010.
[47] Postigo, J., et al., Exacerbation of type II collagen-induced arthritis in apolipoprotein E-defi
cient mice in association with the expansion of Th1 and Th17 cells. Arthritis Rheum, 2011.
63(4): p. 971-80.
[48] Furuzawa-Carballeda, J., M. Vargas-Rojas, and A. Cabral, Autoimmune inflammation
from the Th17 perspective. Autoimmun Review, 2007. 6: p. 169+175.
[49] Bettelli, E., et al., Reciprocal developmental pathways for the generation of pathogenic effec
tor TH17 and regulatory T cells. Nature, 2006. 441: p. 235-238.
[50] Segal, B.M., Th17 cells in autoimmune demyelinating disease. Semin Immunopathol,
2010. 32(1): p. 71-7.
[51] Gayle, D.A., et al., Maternal LPS induces cytokines in the amniotic fluid and corticotropin
releasing hormone in the fetal rat brain. Am J Physiol Regul Integr Comp Physiol, 2004.
286(6): p. R1024-9.
135
136
[52] Hundorfean, G., M.F. Neurath, and J. Mudter, Functional relevance of T helper 17
(Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm Bowel
Dis, 2011.
[53] Liu, Z.J., et al., Potential role of Th17 cells in the pathogenesis of inflammatory bowel dis
ease. World J Gastroenterol, 2009. 15(46): p. 5784-8.
[54] Ankathatti Munegowda, M., et al., A Distinct Role of CD4(+) Th17- and Th17-Stimulated
CD8(+) CTL in the Pathogenesis of Type 1 Diabetes and Experimental Autoimmune Ence
phalomyelitis. J Clin Immunol, 2011.
[55] Emamaullee, J.A., et al., Inhibition of Th17 cells regulates autoimmune diabetes in NOD
mice. Diabetes, 2009. 58(6): p. 1302-11.
[56] Cheng, X., et al., The Th17/Treg imbalance in patients with acute coronary syndrome. Clin
Immunol, 2008. 127(1): p. 89-97.
[57] Gao, Q., et al., A critical function of Th17 proinflammatory cells in the development of athe
rosclerotic plaque in mice. J Immunol, 2010. 185(10): p. 5820-7.
[58] Bilbo, S.D., S.H. Smith, and J.M. Schwarz, A lifespan approach to neuroinflammatory and
cognitive disorders: a critical role for glia. J Neuroimmune Pharmacol, 2012. 7(1): p.
24-41.
[59] Hulse, R., et al., Optimization of multiplexed bead-based cytokine immunoassays for rat se
rum and brain tissue. J Neurosci Methods, 2004. 136: p. 87-98.
[60] Mandal, M., et al., Maternal immune stimulation during pregnancy shapes the immunolog
ical phenotype of offspring Submitted for publication, 2012.
[61] Meyer, U., J. Feldon, and S.H. Fatemi, In-vivo rodent models for the experimental investi
gation of prenatal immune activation effects in neurodevelopmental brain disorders. Neuro
sci Biobehav Rev, 2009. 33(7): p. 1061-79.
[62] De Miranda, J., et al., Induction of Toll-Like Receptor 3-Mediated Immunity during Gesta
tion Inhibits Cortical Neurogenesis and Causes Behavioral Disturbances. MBio, 2010. 1(4).
[63] Meyer, U., et al., The time of prenatal immune challenge determines the specificity of inflam
mation-mediated brain and behavioral pathology. J Neurosci, 2006. 26(18): p. 4752-62.
[64] Meyer, U., et al., Adult brain and behavioral pathological markers of prenatal immune chal
lenge during early/middle and late fetal development in mice. Brain Behav Immun, 2008.
22(4): p. 469-86.
[65] Hsiao, E.Y., et al., Modeling an autism risk factor in mice leads to permanent immune dys
regulation. Proc Natl Acad Sci U S A, 2012.
[66] Hsiao, E.Y. and P.H. Patterson, Activation of the maternal immune system induces endo
crine changes in the placenta via IL-6. Brain Behav Immun, 2011. 25(4): p. 604-15.
[67] Shi, L., et al., Activation of the maternal immune system alters cerebellar development in the
offspring. Brain Behav Immun, 2009. 23(1): p. 116-23.

http://dx.doi.org/10.5772/53990
[68] Bitanihirwe, B.K., et al., Late prenatal immune activation in mice leads to behavioral and
neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsy
chopharmacology, 2010. 35(12): p. 2462-78.
[69] Fortier, M.E., et al., The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats
via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol,
2004. 287(4): p. R759-66.
[70] Lathia, J.D., et al., Toll-like receptor 3 is a negative regulator of embryonic neural progenitor
cell proliferation. J Neurosci, 2008. 28(51): p. 13978-84.
[71] Dantzer, R. and K.W. Kelley, Twenty years of research on cytokine-induced sickness behav
ior. Brain Behav Immun, 2007. 21(2): p. 153-60.
[72] Henry, C., et al., Exaggerated sickness behavior and brain proinflammatory cytokine expres
sion in aged mice in response to intracerebroventricular lipopolysaccharide. J Immunol,
2007. 178: p. B13.
[73] Dantzer, R., et al., From inflammation to sickness and depression: when the immune system
subjugates the brain. Nat Rev Neurosci, 2008. 9(1): p. 46-56.
[74] Yirmiya, R. and I. Goshen, Immune modulation of learning, memory, neural plasticity and
neurogenesis. Brain Behav Immun, 2011. 25(2): p. 181-213.
[75] Belvin, M.P. and K.V. Anderson, A conserved signaling pathway: the Drosophila toll-dor
sal pathway. Annu Rev Cell Dev Biol, 1996. 12: p. 393-416.
[76] Okun, E., K.J. Griffioen, and M.P. Mattson, Toll-like receptor signaling in neural plastici
ty and disease. Trends Neurosci, 2011. 34(5): p. 269-81.
[77] Kawai, T. and S. Akira, Toll-like Receptors and Their Crosstalk with Other Innate Recep
tors in Infection and Immunity. Immunity, 2011. 34(5): p. 637-50.
[78] Baldridge, M.T., K.Y. King, and M.A. Goodell, Inflammatory signals regulate hemato
poietic stem cells. Trends Immunol, 2011. 32(2): p. 57-65.
[79] Carty, M. and A.G. Bowie, Evaluating the role of Toll-like receptors in diseases of the cen
tral nervous system. Biochem Pharmacol, 2011. 81(7): p. 825-37.
[80] Stridh, L., et al., Regulation of Toll-like receptor 1 and -2 in neonatal mice brains after hypo
xia-ischemia. J Neuroinflammation, 2011. 8: p. 45.
[81] Koga, K. and G. Mor, Toll-like receptors at the maternal-fetal interface in normal pregnancy
and pregnancy disorders. Am J Reprod Immunol, 2010. 63(6): p. 587-600.
[82] Lehnardt, S., et al., The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced
oligodendrocyte injury in the CNS. J Neurosci, 2002. 22(7): p. 2478-86.
[83] Babcock, A.A., et al., Toll-like receptor 2 signaling in response to brain injury: an innate
bridge to neuroinflammation. J Neurosci, 2006. 26(49): p. 12826-37.
137
138
[84] Ma, Y., et al., Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and
inducer of neuronal apoptosis. J Cell Biol, 2006. 175(2): p. 209-15.
[85] Ma, Y., et al., TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle,
2007. 6(23): p. 2859-68.
[86] Rolls, A., et al., Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol,
2007. 9(9): p. 1081-8.
[87] Tang, S.C., et al., Pivotal role for neuronal Toll-like receptors in ischemic brain injury and
functional deficits. Proc Natl Acad Sci U S A, 2007. 104(34): p. 13798-803.
[88] Okun, E., et al., TLR2 activation inhibits embryonic neural progenitor cell proliferation. J
Neurochem, 2010. 114(2): p. 462-74.
[89] Urakubo, A., et al., Prenatal exposure to maternal infection alters cytokine expression in the
placenta, amniotic fluid, and fetal brain. Schizophr Res, 2001. 47(1): p. 27-36.
[90] Bell, M., J. Hallenbeck, and V. Gallo, Determining the fetal inflammatory response in an
experimental model of intrauterine inflammation in rats. Pediatric Res, 2004. 56: p.
541-546.
[91] Uchide, N., et al., Induction of pro-inflammatory cytokine gene expression and apoptosis in
human chorion cells of fetal membranes by influenza virus infection: possible implications for
maintenance and interruption of pregnancy during infection. Med Sci Monit, 2005.
11(RA7-16).
[92] Peltier, M. and M. Brown, Experimental genital mycoplasmosis causes increased levels of
mRNA for IL-6 and TNF-alpha in the placenta. Am J Reprod Immunology, 2005. 53: p.
189-198.
[93] Ashdown, H., et al., The role of cytokines in mediating effects of prenatal infection on the
fetus: implications for schizophrenia. Mol Psychiatry, 2006. 11(1): p. 47-55.
[94] Meilin, A., Y. Sharabi, and J. Shoham, Analysis of thymic stromal cell subpopulations
grown in vitro on extracellular matrix in defined medium--V. Proliferation regulating activi
ties in supernatants of human thymic epithelial cell cultures. Int J Immunopharmacology,
1997. 19: p. 39-47.
[95] Suda, T., et al., Effect of interleukin 6 (IL-6) on the differentiation and proliferation of mur
ine and human hemopoietic progenitors. Exp Hematol, 1988. 16: p. 891-895.
[96] Croy, B., et al., Uterine natural killer cells: insights into their cellular and molecular biology
from mouse modelling. Reproduction, 2003. 126: p. 149-160.
[97] Stumhofer, J., et al., Interleukin 27 negatively regulates the development of interleukin 17producing T helper cells during chronic inflammation of the central nervous system. Nat Im
munol, 2006. 7: p. 937-945.
[98] Batten, M., et al., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the
development of interleukin 17-producing T cells. Nat Immunol, 2006. 7: p. 929-936.

http://dx.doi.org/10.5772/53990
[99] Veldhoen, M., et al., TGFbeta in the context of an inflammatory cytokine milieu supports de
novo differentiation of IL-17-producing T cells. Immunity, 2006. 24(2): p. 179-89.
[100] Dominitzki, S., et al., Cutting edge: trans-signaling via the soluble IL-6R abrogates the in
duction of FoxP3 in naive CD4+CD25 T cells. J Immunol, 2007. 179: p. 2041-2045.
[101] Kimura, A., T. Naka, and T. Kishimoto, IL-6-dependent and -independent pathways in the
development of interleukin 17-producing T helper cells. Proc Natl Acad Sci (USA), 2007.
104: p. 12099-12104.
[102] Shi, C., et al., Bone marrow mesenchymal stem and progenitor cells induce monocyte emi
gration in response to circulating toll-like receptor ligands. Immunity, 2011. 34(4): p.
590-601.
[103] Essers, M.A., et al., IFNalpha activates dormant haematopoietic stem cells in vivo. Nature,
2009. 458(7240): p. 904-8.
[104] Keshavan, M.S., Development, disease and degeneration in schizophrenia: a unitary patho
physiological model. J Psychiatr Res, 1999. 33(6): p. 513-21.
[105] Keshavan, M.S. and G.E. Hogarty, Brain maturational processes and delayed onset in
schizophrenia. Dev Psychopathol, 1999. 11(3): p. 525-43.
[106] Ajuebor, M.N., et al., Role of resident peritoneal macrophages and mast cells in chemokine
production and neutrophil migration in acute inflammation: evidence for an inhibitory loop
involving endogenous IL-10. J Immunol, 1999. 162(3): p. 1685-91.
[107] Yellon, D.M. and D.J. Hausenloy, Myocardial reperfusion injury. N Engl J Med, 2007.
357(11): p. 1121-35.
[108] Buja, L.M., Myocardial ischemia and reperfusion injury. Cardiovasc Pathol, 2005. 14(4):
p. 170-5.
[109] Kostin, S., Pathways of myocyte death: implications for development of clinical laboratory bi
omarkers. Adv Clin Chem, 2005. 40: p. 37-98.
[110] Kajstura, J., et al., Cause of death: suicide. J Mol Cell Cardiol, 2006. 40(4): p. 425-37.
[111] Takemura, G. and H. Fujiwara, Morphological aspects of apoptosis in heart diseases. J Cell
Mol Med, 2006. 10(1): p. 56-75.
[112] Eltzschig, H.K. and T. Eckle, Ischemia and reperfusion-from mechanism to translation. Nat
Med, 2011. 17(11): p. 1391-401.
[113] Frangogiannis, N.G., C.W. Smith, and M.L. Entman, The inflammatory response in myo
cardial infarction. Cardiovasc Res, 2002. 53(1): p. 31-47.
[114] Oyama, J., et al., Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-defi
cient mice. Circulation, 2004. 109(6): p. 784-9.
[115] Frangogiannis, N.G. and M.L. Entman, Chemokines in myocardial ischemia. Trends Car
diovasc Med, 2005. 15(5): p. 163-9.
139
140
[116] Arslan, F., et al., Bridging innate immunity and myocardial ischemia/reperfusion injury: the
search for therapeutic targets. Curr Pharm Des, 2008. 14(12): p. 1205-16.
[117] Ren, G., O. Dewald, and N.G. Frangogiannis, Inflammatory mechanisms in myocardial
infarction. Curr Drug Targets Inflamm Allergy, 2003. 2(3): p. 242-56.
[118] Frangogiannis, N.G., The role of the chemokines in myocardial ischemia and reperfusion.
Curr Vasc Pharmacol, 2004. 2(2): p. 163-74.
[119] Yamamoto, S., et al., Activation of Mst1 causes dilated cardiomyopathy by stimulating
apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest, 2003.
111(10): p. 1463-74.
[120] Matsui, Y., et al., Distinct roles of autophagy in the heart during ischemia and reperfusion:
roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res, 2007.
100(6): p. 914-22.
[121] Del Re, D.P., et al., Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective
against pressure overload in mice. J Clin Invest, 2010. 120(10): p. 3555-67.
[122] Kurnellas, M.P., et al., Plasma membrane calcium ATPase deficiency causes neuronal path
ology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis
and spinal cord injury. FASEB J, 2005. 19(2): p. 298-300.
[123] Murphy, A.C., et al., Infiltration of Th1 and Th17 cells and activation of microglia in the
CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Im
mun, 2010. 24(4): p. 641-51.
[124] Huppert, J., et al., Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
FASEB J, 2010. 24(4): p. 1023-34.
[125] Tesmer, L.A., et al., Th17 cells in human disease. Immunol Rev, 2008. 223: p. 87-113.
[126] Kebir, H., et al., Human TH17 lymphocytes promote blood-brain barrier disruption and cen
tral nervous system inflammation. Nat Med, 2007. 13(10): p. 1173-5.
[127] Matusevicius, D., et al., Interleukin-17 mRNA expression in blood and CSF mononuclear
cells is augmented in multiple sclerosis. Mult Scler, 1999. 5(2): p. 101-4.
[128] Almolda, B., et al., Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate
with the recovery phase of acute EAE in rat. PLoS ONE, 2011. 6(11): p. e27473.
[129] Hofstetter, H.H., C.L. Shive, and T.G. Forsthuber, Pertussis toxin modulates the immune
response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells
and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2
cells. J Immunol, 2002. 169(1): p. 117-25.
[130] Fujimoto, C., et al., Pertussis toxin is superior to TLR ligands in enhancing pathogenic au
toimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and
their cytokine production. J Immunol, 2006. 177(10): p. 6896-903.

http://dx.doi.org/10.5772/53990
[131] Stenger, S. and R.L. Modlin, Control of Mycobacterium tuberculosis through mammalian
Toll-like receptors. Curr Opin Immunol, 2002. 14(4): p. 452-7.
[132] Bilbo, S.D. and J.M. Schwarz, Early-life programming of later-life brain and behavior: a
critical role for the immune system. Front Behav Neurosci, 2009. 3: p. 14.
[133] de Moura, E.G., P.C. Lisboa, and M.C. Passos, Neonatal programming of neuroimmuno
modulation--role of adipocytokines and neuropeptides. Neuroimmunomodulation, 2008.
15(3): p. 176-88.
[134] Merlot, E., D. Couret, and W. Otten, Prenatal stress, fetal imprinting and immunity.
Brain Behav Immun, 2008. 22(1): p. 42-51.
[135] Phillips, D.I., External influences on the fetus and their long-term consequences. Lupus,
2006. 15(11): p. 794-800.
[136] Bale, T.L., et al., Early life programming and neurodevelopmental disorders. Biol Psychia
try, 2010. 68(4): p. 314-9.
[137] Barouki, R., et al., Developmental origins of non-communicable disease: Implications for re
search and public health. Environ Health, 2012. 11: p. 42.
[138] Hales, C.N. and D.J. Barker, The thrifty phenotype hypothesis. Br Med Bull, 2001. 60: p.
5-20.
[139] Khashan, A.S., et al., Higher risk of offspring schizophrenia following antenatal maternal
exposure to severe adverse life events. Arch Gen Psychiatry, 2008. 65(2): p. 146-52.
[140] Painter, R.C., T.J. Roseboom, and O.P. Bleker, Prenatal exposure to the Dutch famine and
disease in later life: an overview. Reprod Toxicol, 2005. 20(3): p. 345-52.
[141] Barrett, E.G., Maternal influence in the transmission of asthma susceptibility. Pulm Phar
macol Ther, 2008. 21(3): p. 474-84.
[142] Bellinger, D.L., C. Lubahn, and D. Lorton, Maternal and early life stress effects on im
mune function: relevance to immunotoxicology. J Immunotoxicol, 2008. 5(4): p. 419-44.
[143] Conrad, M.L., et al., Maternal TLR signaling is required for prenatal asthma protection by
the nonpathogenic microbe Acinetobacter lwoffii F78. J Exp Med, 2009. 206(13): p. 2869-77.
141
Chapter 8
Valproic Acid in Autism Spectrum Disorder: From an

Environmental Risk Factor to a Reliable Animal Model
Carmem Gottfried, Victorio Bambini-Junior,
Diego Baronio, Geancarlo Zanatta,
Roberta Bristot Silvestrin, Tamara Vaccaro and
Rudimar Riesgo
http://dx.doi.org/10.5772/54824
1. Introduction
Autism spectrum disorders (ASD) have attracted public attention by its high prevalence,
elevated social cost and large impact on the family [1]. Since the first descriptions of au
tism made by Hans Asperger in 1938 [2] and by Leo Kanner in 1943 [3, 4], much discus
sion has focused in the search for the triggering points of autism and identifying risk
factors has become a high priority of scientists. Nevertheless, even after almost seventy
years since the first reports, the etiology of autism remains unknown and its molecular
basis is not well understood. Environmental factors (such as virus, bacteria, drugs, etc.)
known to increase the risk of autism have critical periods of action during embryogene
sis. Congenital syndromes are found in high rates in patients with autism including so
matic changes originated early in the first trimester [5].
The link between rubella and autism came from epidemic rubella in which the incidence of
autism diagnosis in prenatally exposed offspring was more than 10-fold higher than normal.
The study describes 243 children exposed to congenital rubella, where 25% presented mental
retardation, 15% had reactive behavior and 7% was included in the autism spectrum [6].
Valproic acid (VPA) has traditionally been prescribed for epilepsy, but is increasingly used for
psychiatric condition, such as bipolar disease by its modulation on GABA neurotransmission
[7]. Furthermore, it has been also shown to be associated with an increased prevalence of
autism. In fact, prospective and retrospective studies demonstrate that exposure to VPA during
pregnancy is associated with approximately three-fold increase in the rate of major anomalies
2013 Gottfried et al.; licensee InTech. This is an open access article distributed under the terms of the
144
and a possible set of dysmorphic features with decreased intrauterine growth [8, 9], charac
teristics of Fetal Valprotate Syndrome (FVS) described in item 3. Histone deacetylase (HDAC)
inhibition by VPA and changes in gene expression may explain part of the teratogenicity of
this drug. In utero exposure of rodents to VPA has been proposed to induce a phenotype with
behavioral characteristics reminiscent of those observed in ASD and provides a robust animal
model for social cognitive impairment understanding and a potential screen for the develop
ment of novel therapeutics for this condition [10]. Other possible explanations include either
the effect of VPA through the increase of fetal oxidative stress, affecting mainly the brain in
comparison to other fetal organs, or its inhibitory action on the folic acid mechanism [11]. In
agreement, it is possible to duplicate a number of anatomic and behavioral features charac
teristic of human cases by exposing rat embryos to a teratogenic agents at the time of neural
tube closure [12].
Thus, in utero exposure to VPA has been used as a reliable model to increase the understanding
of behavioral effects evaluated by specific tests as sociability, social preference and stereotypic
behavior, also observed in human patients [9, 13, 14]. The present chapter summarizes the
current knowledge on the relationship between in utero exposure to VPA in humans and in
autism-like animal model phenotypes, highlighting the importance of this model to the
neurobiology of autism studies.
2. Valproic acid
The compound VPA (Figure 1A) is a fatty acid synthesized in 1882 [15] as an analogue of valeric
acid, found naturally in valerian (Valeriana officinalis), used at that time as an organic solvent.
The chemical names to VPA and derivatives are shown in Table 1. Antiepileptic properties of
VPA, which is structurally unrelated to other antiepileptic drugs, were discovered by chance
in 1962, when the French researcher Pierre Eymard in a serendipity discovery observed the
anticonvulsant properties of VPA while using it as a vehicle for a number of other compounds
that were being screened for anti-seizure activity [16]. He found that it prevented pentylene
tetrazol-induced convulsions in rodents. Since then, it has also been used for migraine and
bipolar disorder. The U.S. Food and Drug Administration (FDA) approved VPA in 1978 for
the treatment of seizure disorder and in 1986 approved its enteric-coated counterpart valproate
semisodium (Figure 1B) also named divalproex sodium (USA), for the same indication.
Valproate semisodium is a stable co-ordination compound comprised of sodium valproate
(Figure 1C) and valproic acid in a 1:1 molar relationship in an enteric coated form. An enteric
coating is a barrier applied to oral medication that controls the location in the digestive system
where it is absorbed. This compound dissociates to release valproate ions into the gastroin
testinal tract. Once in the blood, sodium valproate can be converted also in the acid form or
conjugated as valproate semisodium [17]. The acid form is currently used to quantify plasma
levels of all three.
Valproic Acid in Autism Spectrum Disorder: From an Environmental Risk Factor to a Reliable Animal Model
http://dx.doi.org/10.5772/54824
Valproic Acid
2-Propylvaleric acid, 2-Propylpentanoic acid or Di-n-dipropylacetic acid
Sodium Valproate
Sodium 2-propylvalerate
Valproate semisodium
Sodium hydrogen bis(2-propylvalerate)
Valproate Pivoxil
Hydroxymethyl 2-propylvalerate pivalate
Valpromide
2-Propylvaleramide
Table 1. Chemical names of VPA and derivatives
Figure 1. The molecular structure of VPA and derivatives showed in ball and stick view. A. Valproic acid. B. Valproate
semisodium, C. Sodium valproate. In A is possible to compare both chemical and ball and stick structures (used also to
illustrate derivatives).
The therapeutic concentration of sodium valproate (the sodium salt of VPA) during chronic
oral treatment ranges from 40-100 mg/mL (280700 mmol/L) in plasma and from 627 mg/g
(42190 mmol/g) in brain [18]. From this point, to simplify the reading throughout the text, the
VPA abbreviation will be used when referring to valproic acid and derivatives.
The VPA is marketed under brand names including: Convulex (Pfizer-UK and Byk MadausSouth Africa), Depakene (Abbott Laboratories-USA, Brazil and Canada), Depakine (Sanofi
Aventis-France and Sanofi Synthelabo-Romania), Deprakine (Sanofi Aventis-Finland),
Encorate (Sun Pharmaceuticals-India), Epilim (Sanofi Synthelabo-Australia), Valcote (Abbot
Laboratories-Argentina).
The VPA effects of clinical importance include GABAergic activity increase, excitatory
neurotransmission decrease, and modification of monoamines [19]. The biochemical and
biological effects of VPA are summarized in Table 2.
145
146
Target of action
Biological effects
Reference
HDAC (inhibition)
Open DNA transcription
[20]
Mitochondria
Energy metabolism impairment
[21]
Lymphocytes
Modification of the epigenotype
[22]
Neurons from substantia nigra
Reduction in firing rate
[23]
c-Jun N-terminal kinase (JNK)
Defective neurite formation
[24]
GSK3 inhibitor
Promotion of hair re-growth
[25]
Beta-catenin-Ras-ERK-p21Cip/WAF1 pathway
Differentiation and inhibition of proliferation in

neural progenitor cells
Constitutive androstane receptor (CAR) and
Up-regulation of CYP3A4 and MDR1 gene
pregnane X receptor (PXR)
expression
Matrix metalloprotease-9 inhibitor
Attenuation of blood-spinal cord barrier (BSCB)
PI3K/Akt/mTOR pathway
after spinal cord injury (SCI)

Skeletal muscle hypertrophy
[26]
[27]
[28]
[29]
Table 2. Biochemical and biological effects of VPA
3. Valproic acid as an environmental risk factor in the development of

autism
After the VPA license for use in 1978, the first adverse report of a fetus exposed to the drug
was published in 1980 [30]. Since then. particular attention has been directed to the occurrence
of neural tube defects in infants exposed to VPA in utero [31, 32]. The critical period for exposure
to teratogens shown to increase the risk of autism is early in the first trimester [33]. Some of
the critical teratogens related to autism risk are maternal rubella infection [6], ethanol [34],
thalidomide [35] and VPA [8, 9]. Approximately one in 250 pregnancies is known to be exposed
to antiepileptic drugs [36] and a significant proportion of these are exposed to VPA, either as
monotherapy or as part of a polytherapy drug regimen.
The timing for the teratogenic effect of VPA that increases the risk for autism cannot be
estimated directly, as the drug is typically taken throughout the entire pregnancy [33]. Many
children exposed in utero to VPA exhibit FVS, first described in 1984 [37] and characterized by
a major and minor malformations and developmental and behavioral delays [8, 12, 38-40].
Specific impairments observed in FVS includes neural tube defects, trigonocephaly, radial ray
defects, pulmonary abnormalities, coloboma of iris/optic disc, low verbal IQ and features of
ASD [41] and has been reported in a number of sibling pairs [12, 21, 37, 42-44] with different
degree of severity among affected siblings. Common facial features of FVS include epicanthal
folds, broad nasal bridge, short nose with antiverted nares, long upper lip, and low set,
posteriorly rotated ears [41].
http://dx.doi.org/10.5772/54824
The classical autism was first reported to be one of the behavioral outcomes of VPA exposure
[41] through several case reports [12, 39, 45]. The first epidemiological study with drugs as
environmental risk factors of autism was described in 2000, with 57 offspring of women taking
anticonvulsants (see ref [46], summarized in Tables 3 and 4).
Features
% of children
Poor social interaction
53
Poor communication skills
49
Short attention span
46
Insistence on routines
44
Hand flapping
25
Table 3. Autism features in children exposed in utero to anticonvulsants.
No of children
Neural tube defect
Genitourinary
Extremities
Eyes
Teeth
Diastasis recti
VPA exposure in mg (weeks of gestation)
1000 (0-5), 800 (5-40)
1200 (1-17), 1500 (17-26), 2000 (26-40)
1000 (0-40)
1000 (0-5), 800 (5-40)
1500 (0-40)
1000 (0-40)
1500 (0-40)
700 (0-40)
800 (0-40)
1000 (0-40)
1700 (0-40)
1200 (0-40)
Table 4. Congenital malformations in children exposed in utero to VPA
Fifty two children were ascertained through the Fetal Anticonvulsant Syndrome Association
(FACS) and five were referred to the Aberdeen Medical Genetics Service (AMGS). The number
of patients exposed in utero to each anticonvulsant alone was 34 (60%) to VPA, 4 (7%) to
carbamazepine, 4 (7%) to phenytoin, and 15 (26%) to more than one anticonvulsant. The
number of patients with behavioral problems was 46 (81%), with hyperactivity or poor
concentration was 22 (39%) and with attention deficit and hyperactivity disorder 4 (7%).
Autistic features were present in 34 patients (60%).
147
148
4. Animal model of autism induced by prenatal exposure to VPA

Considering human evidences of autism followed by early in utero exposure to teratogens,
such as thalidomide and VPA, the next step was to develop a model of autism induced by
prenatal exposure of animals to the same drugs, particularly VPA [47]. The in utero exposure
to VPA induced patterns of abnormal development across species as demonstrated in Table 5.
Patterns of abnormal development
Specie
References
Mice
[48, 49]
Rabbits
[50]
Rhesus monkey
[51]
Cardiac abnormalities
Mice
[52]
Neural tube defects (including spina bifida)
Mice
[53]
Cranial neural tube defects
Rats
[54]
Behavioral abnormalities
Rats
[55]
Skeletal abnormalities
Table 5. Patterns of abnormal development across species after in utero exposure to VPA.
The use of animal models allows a wide range of research possibilities including the search
for etiologic clues, molecular targets, and biomarkers. The main aspects to take into account
in developing animal models, is (i) to reproduce a circumstance that would lead to a certain
condition, for example, inducing a genetic disease by manipulating a specific gene; (ii) to
induce similar patterns found in the studied condition, for example, observing the same
behavioral alterations found in a particular impairment; (iii) to observe if the model has
similarities to a human features when exposed to certain treatment [56]. The time of induction,
dosage of VPA and the way of administration in rodents are variable in the literature, as
demonstrated in Table 6. It is important to observe that in rats, 600 mg/Kg VPA at 12.5 days
of pregnancy is the most investigated due to similarities in the features of autism. Besides the
higher number of studies describing prenatal exposure to VPA, there are some protocols
reporting also postnatal exposure and behavioral features of autism [57, 58].
The diagnoses of autism take into account behavioral alterations in three main areas: sociabil
ity, communication and behavioral stereotypies and narrow range of interests. Therefore, a
consistent animal model must show similar behavioral abnormalities, which might indicate
common neural alterations.
Our group has administrated a single intraperitoneal injection of 600 mg/kg VPA in pregnant
rats at the embryonic day 12.5, observing variations in social memory, and flexibility to change
strategy [84]. Females were kept separate and with free access to their own litters. Somatic
aspects observed during the pups' development, included body weight, ear unfolding and eye
opening which were unchanged between groups. In three-chambered-apparatus test, used to
http://dx.doi.org/10.5772/54824
Embryonic Day(s)
Procedure
(mg/Kg VPA)
References
Mice
9
IP (200, 400, 800)
[59]
SC (400)
[60]
9, 12.5, 14.5
IP (500)
[61]
11
OA (800)
[62, 63]
12, 13, 14
IP (100)
[64]
12.5
IP (500)
[65]
13
SC (600)
[66, 67]
Rats
7, 9.5, 12, 15
IP (400)
[68]
8, 9, 10, 11
OA (800)
[69]
IP (600)
[70]
OA (800)
[71-74]
9, 11
AO (800)
[75, 76]
11, 12, 13
IP (200)
[77]
1.5
IP (500)
[78]
1.5, 12, 12.5
IP (350)
[9]
12
IP (400)
[79]
12
IP (600)
[80-83]
12.5
IP (600)
[10, 14, 84-93]
12.5
SC (350)
[94]
12.5
IP (350)
[95]
12.5
IP (400, 500, 600)
[77]
12.5
IP (500)
[96]
Table 6. Prenatal exposure of VPA in rodents: Time of induction and dosage
observe social memory, preferences and interests, the VPA group spent less time in the
presence of a stranger rat and more time in the presence of an object, indicating a reduced place
preference conditioned by conspecific and an increased preference for the object, revealing
sociability impairments. As adults, they showed inappropriate social approach to a stranger
rat, decreased preference for social novelty, apparently normal social recognition, no spatial
learning deficits and normal resistance to change on Morris water maze.
149
150
5. Brain alterations induced by prenatal exposure to VPA

Once prenatal exposure to VPA became a reliable tool to model autism, more brain alterations
were investigated in rodents exposed to this teratogen, as summarized in Table 7.
Rodent
VPA (mg/kg)
Findings
References
500
Altered distribution of 5-HT neurons in the dorsal raphe nucleus.
[71]
350
Rat
500
400
600
500
Mice
500
Reduction in the number of motor neurons from hypoglossal and

oculomotor nuclei.
Reduction in the number of putative synaptic contacts in connection
between layer 5 pyramidal neurons.
Prolonged neuronal progenitor cells proliferation in embrionary
period.
Decreased number of purkinje cells, neuronal degeneration and
chromatolysis.
Reduction in the number of Parvalbumin -positive inhibitory neurons
in the neocortex.
Nissl-positive cell loss in the middle and lower layers of the prefrontal
cortex and in the lower layers of the somatosensory cortex.
[9]
[97]
[79]
[98]
[99]
[65]
Table 7. Brain alterations induced by in utero exposure to VPA
Behavioral outcomes started to be studied, demonstrating a number of anatomic and behav

ioral features characteristic of human cases by exposing rodents embryos to VPA at the time
of neural tube closure. One of the affected structures in the brains is the cerebellum. Magnetic
resonance imaging showed that patients with autism have reduced size of the cerebellum when
compared to controls, displaying smaller vermal lobules VI and VII. This abnormality is
probably an outcome of developmental hypoplasia and not likely shrinkage or deterioration
after full development had been achieved [100]. Similar alterations were found in brains from
rat model of autism induced by prenatal exposure to VPA [9]. Exposed rats showed a reduction
in the number of motor neurons of the earliest-forming motor nuclei (V, XII), and had the VI
th and III rd cranial nerve nuclei affected. In the same way, another work found diminished
number of cells in the posterior lobe of the cerebellum [86]. In this context, cerebellar anatomy
alterations in humans might be due to loss of neurons in the cranial nerve motor nuclei, as
demonstrated in rats.
The amygdala is likely to be also linked to autism, due to its involvement in social-emotional
behavior. Rats exposed to VPA in utero had longer lasting and harder to extinguish fear
memories, which could be explained by the hyperreactivity and hyperplasticity found in the
lateral amygdala [96, 101]. Another work found enhanced long-term potentiation (LTP) in the
http://dx.doi.org/10.5772/54824
medial prefrontal cortex of rats exposed to VPA, with enhanced synaptic plasticity and shortand long-term fear memories [82].
Synaptic impairments were already described in autism, which may be related to neuroligins
alterations. Neuroligins are a family of proteins which play a central role in synaptic matura
tion and were affected in rats after in utero exposure to VPA. Neuroligin 3 mRNA expression
was decreased in the hippocampus, especially in cornu ammonis (CA1) and dentate gyrus [62].
Synaptic plasticity is influenced by brain-derived neurotrophic factor (BDNF), a factor that
modulates several neurochemical parameters. High levels of BDNF have been reported in the
blood of patients with autism [102]. BDNF acts through TrkB-mediated activation of various
signal transduction pathways, including pathways that involve PI3K, mitogen-activated
kinase (MAPK), and phospholipase C- [103]. Infusion of BDNF in the nucleus accumbens of
aged rats restored synaptic plasticity and improved cognition [104] and some environmental
factors, such social isolation, results in low levels of BDNF in the hippocampus of rats [105].
Animals exposed to VPA in utero display decreased cortical BDNF mRNA expression. It is
important to notice that altered levels of the transcript will not necessarily mean an altered
protein expression [63]. Diminished BDNF may lead to altered synaptic development; once it
is known that this neurotrophic factor is involved in development and function of serotonergic
neurons [106].
Several hypotheses have arisen to explain the social deficits in autism. One of these proposals
points an alteration in opioidergic mechanisms as a likely causative of behavioral impairments
in this disorder [107]. Opioid peptides are involved in stress responses and affective states,
and blockage of their receptors causes dysphoria in humans. Enkephalins are part of the opioid
family and are distributed in brain areas, like the striatum and the nucleus accumbens,
involved in processing emotional information, anxiety and fear. Exposure to VPA reduced
proenkephalin mRNA expression in both the core and shell of the nucleus accumbens and dorsal
striatum of rats concomitantly to anxious-like behavior [91].
The monoamine system is also altered in patients with autism and their relatives. It was
demonstrated that children with autism have increased 5-HT (serotonin) synthesis capacity
when compared to children with typical development [108]. Besides, it is widely known that
sleep disorders are common in autistic children [109]. Interestingly, increased levels of
serotonin was found in pre-frontal cortex of rats prenatally exposed to VPA in association with
disrupted sleep/awake rhythm. The elevated levels of 5-HT were found during light phase of
animals circadian rhythm [74]. It was proved that serotonergic neurons have a silent firing
rate during REM sleep [110], indicating that the sleep disturbance found in the animals may
be related to increased levels of 5-HT found in their prefrontal cortex. In addition, higher levels
of 5-HT were also reported in the left side of hippocampus and in blood from rats [111].
However, using the whole hippocampus, it was demonstrated 46% decrease in 5-HT levels
from rats exposed to VPA in utero [70].
Recently, we observed hippocampal reactive astrogliosis in the group of rats exposed in
utero to VPA (see ref [84]). After 15 postnatal days, hippocampal astrocytes were intensely
immunoreactive to the astroglial marker Glial Fibrillary Acidic Protein (GFAP) (Figure 2).
151
152
Astrocytes are the major cell type in the central nerve system (CNS) and provide a variety of
critical supportive functions that maintain neuronal homeostasis, participating of the synapse
and the glutamatergic metabolism [112]. These cells become reactive in VPA group, charac
terized by up-regulation of GFAP and apparently show higher number of processes than the
control cells as demonstrated by the squares in A and B.
Seven Fresh-frozen post mortem tissues from individuals with autism and CSF from six living
autistic patients were investigated for cytokine protein profiling [113]. This study shows an
active neuroinflammatory process in the cerebral cortex, white matter, and notably in the
cerebellum. Immunocytochemical studies showed marked activation of microglia and
astroglia. The cytokine profiling indicated that the macrophage chemoattractant protein
(MCP)-1 and tumor growth factor-beta1, both derived from neuroglia were the most prevalent
cytokines in brain tissues. We presumed that microglia/macrophage-derived pro-inflamma
tory cytokines regulate the transition of astrocytes into reactive astrogliosis. Nevertheless, the
mechanisms which regulate the level of astroglial cell activity in the hippocampus from VPA
autism model need to be investigated.
Control
HippocampusP15
VPA
Figure 2. Astrocyte immunoreactive to GFAP in hippocampus from rats. A. Representative image from control group,
B. Representative image from VPA group. Scale bar = 50 m
Glutamatergic excitatory synapses are the major type of synapses in the brain and it was found
that glutamate metabolism is altered in autistic CNS, particularly the glutamate receptors
AMPA, NMDA and mGluR5 [114]. In agreement, rats exposed in utero to VPA show impair
ments in excitatory/inhibitory brain balance [78]. In this context, impairment in excitatory and
inhibitory signaling during certain periods of development is proposed to be involved in the
autism pathophysiology [115].
Although social impairments are one of the most important features observed in autism,
patients present several other symptoms, including motor disturbances. Motor stereoty
pies are part of the so called autism triad of impairments, but hypotonia, motor apraxia,
http://dx.doi.org/10.5772/54824
toe-walking, have already been reported [116]. Evaluation of motor cortex neurons of rats
exposed to VPA in utero showed no changes in length or volume of either basilar or api
cal dendrites, but presented greater dendritic arborization in comparison with controls.
This data indicates that pruning of neurons is abnormal in animals prenatally exposed to
VPA [95]. Evidence suggests that the same may happen in patients with autism, since
there are reports of increased brain weight in autopsy cases of autism [117]. However,
the involvement of the abnormal pruning in motor cortex neurons with motor disturban
ces in autism deserves further investigation. Individuals with autism are more likely to
present hearing deficits. In a study with a group of 199 children and adolescents, 3.5%
had profound bilateral hearing loss or deafness [118].
The superior olivary complex (SOC) plays different roles in hearing. It is located within the
lower brainstem and it is involved in encoding temporal features of sound and descending
modulation of the cochlear nucleus and cochlea for listening in background noise. Rats exposed
to VPA in utero showed reduced number of neurons and disrupted neuronal morphology in
the SOC. Neuronal cell bodies were smaller and more round, indicating that these anatomical
feature might have a role in the hearing difficulties that are a common in patients with autism
[87]. In a study with brains of patients with autism similar morphological alterations were
found, including soma size, shape and number of neurons in the SOC [119].
The cerebellum have been the focus of studies involving active and chronic neuroinflammatory
process in autistic patients, demonstrating the presence of proinflammatory chemokines such
as MCP-1 as well as antiinflammatory cytokines such as TGF-1 in this brain structure. These
findings support the idea that a chronic state of specific cytokine activation occurs in autism
[113]. Because neuroimmune responses are influenced by the genetic background of the host,
the role of neuroinflammation in the context of the genetic and other factors that determine
the autism phenotype remains an important issue to be investigated.
6. Concluding remarks and scientific challenges

The spectrum of autism comprises a multifactorial group of disorders, with phenotypic
diversity related to the symptoms and increasing prevalence. One of the major challenges of
cognitive neuroscience is to understand how changes in the structural properties of the brain
affect the plasticity exhibited whenever a person develops, ages, learns a new skill, make social
interaction or adapts to a disease. In ASD, it is necessary studies in this field attempting to
explain and understand the trigger of autism. In this context, it is not easy to find a single
animal model able to captures the entire molecular and cellular alterations observed in patients
with ASD.
Studies of in utero interventions in the search for animal models of autism, together with the
study of potential clinical markers to ASD are innovative and may generate strategies aiming
(a) the prevention of autism; (b) the construction of laboratory kits as new tools to improve
and anticipate diagnosis; (c) the study of neuroglial plasticity; (d) the search for new clues to
unravel the etiology of ASD. Challenged by these complexities, it is necessary to evaluate the
153
154
most representative animal model to which a research group may address its questions.
Considering that neuroimmune responses are influenced by the host, the role of possible
neuroinflammation triggered by environmental factors in utero followed by neuroglial
alterations in the litters remain an important issue to be investigated.
The present chapter summarizes findings obtained in rodents exposed in utero to VPA which
present important similarities to autism features, supporting it as a valuable experimental
model to study neurodevelopmental alterations induced by VPA as an environmental risk
factor.
Author details
Carmem Gottfried1*, Victorio Bambini-Junior1, Diego Baronio2, Geancarlo Zanatta1,
Roberta Bristot Silvestrin1, Tamara Vaccaro1 and Rudimar Riesgo2
1 Translational Research Group in Autism Spectrum Disorders (GETEA), Brazil
2 Postgraduate Program in Biochemistry at Department of Biochemistry, Institute of
Healths Basic Science, Brazil
References
[1] Wallace, S, Fein, D, Rosanoff, M, Dawson, G, Hossain, S, Brennan, L, et al. A global
public health strategy for autism spectrum disorders. Autism Res. (2012). Jun;, 5(3),
211-7.
[2] Asperger, H. Das psychisch abnormale Kind [The psychically abnormal child]. Wien
Klin Wochenschr. (1938).
[3] Kanner, L. Autistic Disturbances of Affective Contact. Nervous Child. (1943). , 1943(2),
217-50.
[4] Kanner, L, & Eisenberg, L. Early infantile autism, Psychiatr Res Rep Am Psychiatr
Assoc. 1957 Apr(7):55-65., 1943-1955.
[5] Bello, S. C. Autism and environmental influences: review and commentary. Rev
Environ Health. (2007). Apr-Jun;, 22(2), 139-56.
[6] Chess, S. Follow-up report on autism in congenital rubella. J Autism Child Schizophr.
(1977). Mar;, 7(1), 69-81.
[7] Haddad, P. M, Das, A, Ashfaq, M, & Wieck, A. A review of valproate in psychiatric
practice. Expert Opin Drug Metab Toxicol. (2009). May;, 5(5), 539-51.
http://dx.doi.org/10.5772/54824
[8] Ardinger, H. H, Atkin, J. F, Blackston, R. D, Elsas, L. J, Clarren, S. K, Livingstone, S, et

al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet. (1988).
Jan;, 29(1), 171-85.
[9] Rodier, P. M, Ingram, J. L, Tisdale, B, Nelson, S, & Romano, J. Embryological origin for
autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol.
(1996). Jun 24;, 370(2), 247-61.
[10] Foley, A. G, Gannon, S, Rombach-mullan, N, Prendergast, A, Barry, C, Cassidy, A. W,
et al. Class I histone deacetylase inhibition ameliorates social cognition and cell
adhesion molecule plasticity deficits in a rodent model of autism spectrum disorder.
Neuropharmacology. (2012). Sep;, 63(4), 750-60.
[11] Banji, D, Banji, O. J, Abbagoni, S, Hayath, M. S, Kambam, S, & Chiluka, V. L. Amelio
ration of behavioral aberrations and oxidative markers by green tea extract in valproate
induced autism in animals. Brain Res. (2011). Sep 2;, 1410, 141-51.
[12] Christianson, A. L, Chesler, N, & Kromberg, J. G. Fetal valproate syndrome: clinical
and neuro-developmental features in two sibling pairs. Dev Med Child Neurol. (1994).
Apr;, 36(4), 361-9.
[13] Alsdorf, R, & Wyszynski, D. F. Teratogenicity of sodium valproate. Expert Opin Drug
Saf. (2005). Mar;, 4(2), 345-53.
[14] Schneider, T, & Przewlocki, R. Behavioral alterations in rats prenatally exposed to
valproic acid: animal model of autism. Neuropsychopharmacology. (2005). Jan;, 30(1),
80-9.
[15] Burton, B. S. On the propyl derivatives and decomposition products of ethylacetoace
tate. American Chemistry Journal. (1882). , 18(3), 385-95.
[16] Meunier, H, Carraz, G, Neunier, Y, Eymard, P, & Aimard, M. Pharmacodynamic
properties of N-dipropylacetic acid]. Therapie. (1963). Mar-Apr;, 18, 435-8.
[17] Perry, P. J, Bever-stille, K. A, Arndt, S, & Gundersen, S. Correlation of valproate plasma
concentrations and dose in bipolar affective disorder. J Clin Psychopharmacol. (2000).
Apr;, 20(2), 277-9.
[18] Silva, M. F, Aires, C. C, Luis, P. B, Ruiter, J. P, Ijlst, L, Duran, M, et al. Valproic acid
metabolism and its effects on mitochondrial fatty acid oxidation: A review. J Inherit
Metab Dis. (2008). Apr 4.
[19] Chateauvieux, S, Morceau, F, Dicato, M, & Diederich, M. Molecular and therapeutic
potential and toxicity of valproic acid. J Biomed Biotechnol. (2010).
[20] Yildirim, E, Zhang, Z, Uz, T, Chen, C. Q, Manev, R, & Manev, H. Valproate adminis
tration to mice increases histone acetylation and 5-lipoxygenase content in the hippo
campus. Neurosci Lett. (2003). Jul 17;, 345(2), 141-3.
[21] Clayton-smith, J, & Donnai, D. Fetal valproate syndrome. J Med Genet. (1995). Sep;,
32(9), 724-7.
155
156
[22] Tremolizzo, L, Difrancesco, J. C, Rodriguez-menendez, V, Riva, C, Conti, E, Galimberti,

G, et al. Valproate induces epigenetic modifications in lymphomonocytes from
epileptic patients. Prog Neuropsychopharmacol Biol Psychiatry. (2012). Oct;, 39(1),
47-51.
[23] Lscher, W, Rohlfs, A, & Rundfeldt, C. Reduction in firing rate of substantia nigra pars
reticulata neurons by valproate: influence of different types of anesthesia in rats. Brain
Res. (1995). Dec;702(1-2):133-44.
[24] Yamauchi, J, Torii, T, Kusakawa, S, Sanbe, A, Nakamura, K, Takashima, S, et al. The
mood stabilizer valproic acid improves defective neurite formation caused by CharcotMarie-Tooth disease-associated mutant Rab7 through the JNK signaling pathway. J
Neurosci Res. (2010). Nov;, 88(14), 3189-97.
[25] Lee, S. H, Yoon, J, Shin, S. H, Zahoor, M, Kim, H. J, Park, P. J, et al. Valproic acid induces
hair regeneration in murine model and activates alkaline phosphatase activity in
human dermal papilla cells. PLoS One. (2012). e34152.
[26] Jung, G. A, Yoon, J. Y, Moon, B. S, Yang, D. H, Kim, H. Y, Lee, S. H, et al. Valproic acid
induces differentiation and inhibition of proliferation in neural progenitor cells via the
beta-catenin-Ras-ERK-WAF1 pathway. BMC Cell Biol. (2008). , 21Cip.
[27] Cerveny, L, Svecova, L, Anzenbacherova, E, Vrzal, R, Staud, F, Dvorak, Z, et al. Valproic
acid induces CYP3A4 and MDR1 gene expression by activation of constitutive andros
tane receptor and pregnane X receptor pathways. Drug Metab Dispos. (2007). Jul;, 35(7),
1032-41.
[28] Lee, J. Y, Kim, H. S, Choi, H. Y, Oh, T. H, Ju, B. G, & Yune, T. Y. Valproic acid attenuates
blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity
and improves functional recovery after spinal cord injury. J Neurochem. (2012). Jun;,
121(5), 818-29.
[29] Gurpur, P. B, Liu, J, Burkin, D. J, & Kaufman, S. J. Valproic acid activates the PI3K/Akt/
mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne
muscular dystrophy. Am J Pathol. (2009). Mar;, 174(3), 999-1008.
[30] Dalens, B, Raynaud, E. J, & Gaulme, J. Teratogenicity of valproic acid. J Pediatr. (1980).
Aug;, 97(2), 332-3.
[31] Mastroiacovo, P, Bertollini, R, Morandini, S, & Segni, G. Maternal epilepsy, valproate
exposure, and birth defects. Lancet. (1983). Dec , 24-31.
[32] Robert, E, & Rosa, F. Valproate and birth defects. Lancet. (1983). Nov 12;2(8359):1142.
[33] Arndt, T. L, Stodgell, C. J, & Rodier, P. M. The teratology of autism. Int J Dev Neurosci.
(2005). Apr-May;23(2-3):189-99.
[34] Nanson, J. L. Autism in fetal alcohol syndrome: a report of six cases. Alcohol Clin Exp
Res. (1992). Jun;, 16(3), 558-65.
http://dx.doi.org/10.5772/54824
[35] Stromland, K, Nordin, V, Miller, M, Akerstrom, B, & Gillberg, C. Autism in thalidomide

embryopathy: a population study. Dev Med Child Neurol. (1994). Apr;, 36(4), 351-6.
[36] Lindhout, D, & Omtzigt, J. G. Pregnancy and the risk of teratogenicity. Epilepsia. (1992).
Suppl 4:S, 41-8.
[37] DiLiberti JHFarndon PA, Dennis NR, Curry CJ. The fetal valproate syndrome. Am J
Med Genet. (1984). Nov;, 19(3), 473-81.
[38] Bescoby-chambers, N, Forster, P, & Bates, G. Foetal valproate syndrome and autism:
additional evidence of an association. Dev Med Child Neurol. (2001). Dec;43(12):847.
[39] Williams, G, King, J, Cunningham, M, Stephan, M, Kerr, B, & Hersh, J. H. Fetal valproate
syndrome and autism: additional evidence of an association. Dev Med Child Neurol.
(2001). Mar;, 43(3), 202-6.
[40] Chessa, L, & Iannetti, P. Fetal valproate syndrome. Am J Med Genet. (1986). Jun;, 24(2),
381-2.
[41] Kini, U, Adab, N, Vinten, J, Fryer, A, & Clayton-smith, J. Dysmorphic features: an
important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch
Dis Child Fetal Neonatal Ed. (2006). Mar;91(2):F, 90-5.
[42] Winter, R. M, Donnai, D, Burn, J, & Tucker, S. M. Fetal valproate syndrome: is there a
recognisable phenotype? J Med Genet. (1987). Nov;, 24(11), 692-5.
[43] Kozma, C. Valproic acid embryopathy: report of two siblings with further expansion
of the phenotypic abnormalities and a review of the literature. Am J Med Genet. (2001).
Jan 15;, 98(2), 168-75.
[44] Malm, H, Kajantie, E, Kivirikko, S, Kaariainen, H, Peippo, M, & Somer, M. Valproate
embryopathy in three sets of siblings: further proof of hereditary susceptibility.
Neurology. (2002). Aug 27;, 59(4), 630-3.
[45] Williams, P. G, & Hersh, J. H. A male with fetal valproate syndrome and autism. Dev
Med Child Neurol. (1997). Sep;, 39(9), 632-4.
[46] Moore, S. J, Turnpenny, P, Quinn, A, Glover, S, Lloyd, D. J, Montgomery, T, et al. A
clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. (2000).
Jul;, 37(7), 489-97.
[47] Rodier, P. M, Ingram, J. L, Tisdale, B, & Croog, V. J. Linking etiologies in humans and
animal models: studies of autism. Reprod Toxicol. (1997). Mar-Jun;11(2-3):417-22.
[48] Brown, N. A, Kao, J, & Fabro, S. Teratogenic potential of valproic acid. Lancet. (1980).
Mar 22;, 1(8169), 660-1.
[49] Bruckner, A, Lee, Y. J, Shea, O, & Henneberry, K. S. RC. Teratogenic effects of valproic
acid and diphenylhydantoin on mouse embryos in culture. Teratology. (1983). Feb;,
27(1), 29-42.
157
158
[50] Petrere, J. A, Anderson, J. A, Sakowski, R, Fitzgerald, J. E, & De La Iglesia, F. A.

Teratogenesis of calcium valproate in rabbits. Teratology. (1986). Dec;, 34(3), 263-9.
[51] Mast, T. J, Cukierski, M. A, Nau, H, & Hendrickx, A. G. Predicting the human terato
genic potential of the anticonvulsant, valproic acid, from a non-human primate model.
Toxicology. (1986). May;, 39(2), 111-9.
[52] Sonoda, T, Ohdo, S, Ohba, K, Okishima, T, & Hayakawa, K. Sodium valproate-induced
cardiovascular abnormalities in the Jcl:ICR mouse fetus: peak sensitivity of gestational
day and dose-dependent effect. Teratology. (1993). Aug;, 48(2), 127-32.
[53] Ehlers, K, Sturje, H, Merker, H. J, & Nau, H. Valproic acid-induced spina bifida: a mouse
model. Teratology. (1992). Feb;, 45(2), 145-54.
[54] Turner, S, Sucheston, M. E, De Philip, R. M, & Paulson, R. B. Teratogenic effects on the
neuroepithelium of the CD-1 mouse embryo exposed in utero to sodium valproate.
Teratology. (1990). Apr;, 41(4), 421-42.
[55] Vorhees, C. V. Behavioral teratogenicity of valproic acid: selective effects on behavior
after prenatal exposure to rats. Psychopharmacology (Berl). (1987). , 92(2), 173-9.
[56] Crawley, J. N. Mouse behavioral assays relevant to the symptoms of autism. Brain
Pathol. (2007). Oct;, 17(4), 448-59.
[57] Yochum, C. L, Dowling, P, Reuhl, K. R, Wagner, G. C, & Ming, X. VPA-induced
apoptosis and behavioral deficits in neonatal mice. Brain Res. (2008). Apr 8;, 1203,
126-32.
[58] Wagner, G. C, Reuhl, K. R, Cheh, M, Mcrae, P, & Halladay, A. K. A new neurobehavioral
model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism
Dev Disord. (2006). Aug;, 36(6), 779-93.
[59] Downing, C, Biers, J, Larson, C, Kimball, A, Wright, H, Ishii, T, et al. Genetic and
maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice. Toxicol
Sci. (2010). Aug;, 116(2), 632-9.
[60] Tung, E. W, & Winn, L. M. Valproic acid increases formation of reactive oxygen species
and induces apoptosis in postimplantation embryos: a role for oxidative stress in
valproic acid-induced neural tube defects. Mol Pharmacol. (2011). Dec;, 80(6), 979-87.
[61] Kataoka, S, Takuma, K, Hara, Y, Maeda, Y, Ago, Y, & Matsuda, T. Autism-like behav
iours with transient histone hyperacetylation in mice treated prenatally with valproic
acid. Int J Neuropsychopharmacol. (2011). Nov , 18, 1-13.
[62] Kolozsi, E, Mackenzie, R. N, Roullet, F. I, Decatanzaro, D, & Foster, J. A. Prenatal
exposure to valproic acid leads to reduced expression of synaptic adhesion molecule
neuroligin 3 in mice. Neuroscience. (2009). Nov 10;, 163(4), 1201-10.
[63] Roullet, F. I, Wollaston, L, Decatanzaro, D, & Foster, J. A. Behavioral and molecular
changes in the mouse in response to prenatal exposure to the anti-epileptic drug
valproic acid. Neuroscience. (2010). Oct 13;, 170(2), 514-22.
http://dx.doi.org/10.5772/54824
[64] Fucic, A, Stojkovic, R, Miskov, S, Zeljezic, D, Markovic, D, Gjergja, R, et al. Transpla

cental genotoxicity of antiepileptic drugs: animal model and pilot study on mother/
newborn cohort. Reprod Toxicol. (2010). Dec;, 30(4), 613-8.
[65] Hara, Y, Maeda, Y, Kataoka, S, Ago, Y, Takuma, K, & Matsuda, T. Effect of prenatal
valproic acid exposure on cortical morphology in female mice. J Pharmacol Sci. (2012). ,
118(4), 543-6.
[66] Gandal, M. J, Edgar, J. C, Ehrlichman, R. S, Mehta, M, Roberts, T. P, & Siegel, S. J.
Validating gamma oscillations and delayed auditory responses as translational
biomarkers of autism. Biol Psychiatry. (2010). Dec 15;, 68(12), 1100-6.
[67] Mehta, MV, Gandal, MJ, Siegel, SJ, & mGlu, . 5-antagonist mediated reversal of elevated
stereotyped, repetitive behaviors in the VPA model of autism. PLoS One.
2011;6(10):e26077.
[68] Kim, K. C, Kim, P, Go, H. S, Choi, C. S, Yang, S. I, Cheong, J. H, et al. The critical period
of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol
Lett. (2011). Mar 5;, 201(2), 137-42.
[69] Tashiro, Y, Oyabu, A, Imura, Y, Uchida, A, Narita, N, & Narita, M. Morphological
abnormalities of embryonic cranial nerves after in utero exposure to valproic acid:
implications for the pathogenesis of autism with multiple developmental anomalies.
Int J Dev Neurosci. (2011). Jun;, 29(4), 359-64.
[70] Dufour-rainfray, D, & Vourc, h P. Le Guisquet AM, Garreau L, Ternant D, Bodard S,
et al. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a
model for autism. Neurosci Lett. (2010). Feb 5;, 470(1), 55-9.
[71] Miyazaki, K, Narita, N, & Narita, M. Maternal administration of thalidomide or
valproic acid causes abnormal serotonergic neurons in the offspring: implication for
pathogenesis of autism. Int J Dev Neurosci. (2005). Apr-May;23(2-3):287-97.
[72] Nakasato, A, Nakatani, Y, Seki, Y, Tsujino, N, Umino, M, & Arita, H. Swim stress
exaggerates the hyperactive mesocortical dopamine system in a rodent model of
autism. Brain Res. (2008). Feb 8;, 1193, 128-35.
[73] Narita, M, Oyabu, A, Imura, Y, Kamada, N, Yokoyama, T, Tano, K, et al. Nonexplora
tory movement and behavioral alterations in a thalidomide or valproic acid-induced
autism model rat. Neurosci Res. (2009). Jan;, 66(1), 2-6.
[74] Tsujino, N, Nakatani, Y, Seki, Y, Nakasato, A, Nakamura, M, Sugawara, M, et al.
Abnormality of circadian rhythm accompanied by an increase in frontal cortex
serotonin in animal model of autism. Neurosci Res. (2007). Feb;, 57(2), 289-95.
[75] Kuwagata, M, Ogawa, T, Shioda, S, & Nagata, T. Observation of fetal brain in a rat
valproate-induced autism model: a developmental neurotoxicity study. Int J Dev
Neurosci. (2009). Jun;, 27(4), 399-405.
159
160
[76] Ogawa, T, Kuwagata, M, Hori, Y, & Shioda, S. Valproate-induced developmental

neurotoxicity is affected by maternal conditions including shipping stress and envi
ronmental change during early pregnancy. Toxicol Lett. (2007). Nov 1;174(1-3):18-24.
[77] Dendrinos, G, Hemelt, M, & Keller, A. Prenatal VPA Exposure and Changes in Sensory
Processing by the Superior Colliculus. Front Integr Neurosci. (2011).
[78] Rinaldi, T, Kulangara, K, Antoniello, K, & Markram, H. Elevated NMDA receptor levels
and enhanced postsynaptic long-term potentiation induced by prenatal exposure to
valproic acid. Proc Natl Acad Sci U S A. (2007). Aug 14;, 104(33), 13501-6.
[79] Go, H. S. Chan Kim K, Choi CS, Jeon SJ, Kwon KJ, Han SH, et al. Prenatal exposure to
valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat
brain via a mechanism involving the GSK-3beta/beta-catenin pathway. Neuropharma
cology. (2012). Jul 27.
[80] Stanton, M. E, Peloso, E, Brown, K. L, & Rodier, P. Discrimination learning and reversal
of the conditioned eyeblink reflex in a rodent model of autism. Behav Brain Res. (2007).
Jan 10;, 176(1), 133-40.
[81] Stodgell, C. J, Ingram, J. L, Bara, O, Tisdale, M, Nau, B. K, & Rodier, H. PM. Induction
of the homeotic gene Hoxa1 through valproic acids teratogenic mechanism of action.
Neurotoxicol Teratol. (2006). Sep-Oct;, 28(5), 617-24.
[82] Sui, L, & Chen, M. Prenatal exposure to valproic acid enhances synaptic plasticity in
the medial prefrontal cortex and fear memories. Brain Res Bull. (2012). Apr 10;, 87(6),
556-63.
[83] Murawski, N. J, Brown, K. L, & Stanton, M. E. Interstimulus interval (ISI) discrimination
of the conditioned eyeblink response in a rodent model of autism. Behav Brain Res.
(2009). Jan 23;, 196(2), 297-303.
[84] Bambini-junior, V, Rodrigues, L, Behr, G. A, Moreira, J. C, Riesgo, R, & Gottfried, C.
Animal model of autism induced by prenatal exposure to valproate: behavioral changes
and liver parameters. Brain Res. (2011). Aug 23;, 1408, 8-16.
[85] Felix-ortiz, A. C, & Febo, M. Gestational valproate alters BOLD activation in response
to complex social and primary sensory stimuli. PLoS One. (2012). e37313.
[86] Ingram, J. L, Peckham, S. M, Tisdale, B, & Rodier, P. M. Prenatal exposure of rats to
valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol
Teratol. (2000). May-Jun;, 22(3), 319-24.
[87] Lukose, R, Schmidt, E, & Wolski, T. P. Jr., Murawski NJ, Kulesza RJ, Jr. Malformation
of the superior olivary complex in an animal model of autism. Brain Res. (2011). Jun
29;, 1398, 102-12.
[88] Schneider, T, Labuz, D, & Przewlocki, R. Nociceptive changes in rats after prenatal
exposure to valproic acid. Pol J Pharmacol. (2001). Sep-Oct;, 53(5), 531-4.
http://dx.doi.org/10.5772/54824
[89] Schneider, T, Roman, A, Basta-kaim, A, Kubera, M, Budziszewska, B, Schneider, K, et

al. Gender-specific behavioral and immunological alterations in an animal model of
autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology.
(2008). Jul;, 33(6), 728-40.
[90] Schneider, T, Turczak, J, & Przewlocki, R. Environmental enrichment reverses behav
ioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic
approach in autism. Neuropsychopharmacology. (2006). Jan;, 31(1), 36-46.
[91] Schneider, T, Ziolkowska, B, Gieryk, A, Tyminska, A, & Przewlocki, R. Prenatal
exposure to valproic acid disturbs the enkephalinergic system functioning, basal
hedonic tone, and emotional responses in an animal model of autism. Psychopharma
cology (Berl). (2007). Sep;, 193(4), 547-55.
[92] Wang, Z, Xu, L, Zhu, X, Cui, W, Sun, Y, Nishijo, H, et al. Demethylation of specific Wnt/
beta-catenin pathway genes and its upregulation in rat brain induced by prenatal
valproate exposure. Anat Rec (Hoboken). (2010). Nov;, 293(11), 1947-53.
[93] Yochum, C. L, Bhattacharya, P, Patti, L, Mirochnitchenko, O, & Wagner, G. C. Animal
model of autism using GSTM1 knockout mice and early post-natal sodium valproate
treatment. Behav Brain Res. (2010). Jul 11;, 210(2), 202-10.
[94] Vorbrodt, A. W, Dobrogowska, D. H, Kozlowski, P. B, Rabe, A, Tarnawski, M, & Lee,
M. H. Immunogold study of effects of prenatal exposure to lipopolysaccharide and/or
valproic acid on the rat blood-brain barrier vessels. J Neurocytol. (2005). Dec;, 34(6),
435-46.
[95] Snow, W. M, Hartle, K, & Ivanco, T. L. Altered morphology of motor cortex neurons
in the VPA rat model of autism. Dev Psychobiol. (2008). Nov;, 50(7), 633-9.
[96] Markram, K, & Rinaldi, T. La Mendola D, Sandi C, Markram H. Abnormal fear
conditioning and amygdala processing in an animal model of autism. Neuropsycho
pharmacology. (2008). Mar;, 33(4), 901-12.
[97] Rinaldi, T, Silberberg, G, & Markram, H. Hyperconnectivity of local neocortical
microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex. (2008).
Apr;, 18(4), 763-70.
[98] Sandhya, T, Sowjanya, J, & Veeresh, B. Bacopa monniera (L.) Wettst ameliorates
behavioral alterations and oxidative markers in sodium valproate induced autism in
rats. Neurochem Res. (2012). May;, 37(5), 1121-31.
[99] Gogolla, N, Leblanc, J. J, Quast, K. B, Sudhof, T. C, Fagiolini, M, & Hensch, T. K.
Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J
Neurodev Disord. (2009). Jun;, 1(2), 172-81.
[100] Courchesne, E, Yeung-courchesne, R, Press, G. A, Hesselink, J. R, & Jernigan, T. L.
Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med. (1988).
May 26;, 318(21), 1349-54.
161
162
[101] Markram, H, Rinaldi, T, & Markram, K. The intense world syndrome--an alternative
hypothesis for autism. Front Neurosci. (2007). Nov;, 1(1), 77-96.
[102] Nelson, K. B, Grether, J. K, Croen, L. A, Dambrosia, J. M, Dickens, B. F, Jelliffe, L. L, et
al. Neuropeptides and neurotrophins in neonatal blood of children with autism or
mental retardation. Ann Neurol. (2001). May;, 49(5), 597-606.
[103] Huang, E. J, & Reichardt, L. F. Trk receptors: roles in neuronal signal transduction.
Annu Rev Biochem. (2003). , 72, 609-42.
[104] Li, M, Dai, F. R, Du, X. P, Yang, Q. D, Zhang, X, & Chen, Y. Infusion of BDNF into the
nucleus accumbens of aged rats improves cognition and structural synaptic plasticity
through PI3K-ILK-Akt signaling. Behav Brain Res. (2012). May 16;, 231(1), 146-53.
[105] Scaccianoce, S. Del Bianco P, Paolone G, Caprioli D, Modafferi AM, Nencini P, et al.
Social isolation selectively reduces hippocampal brain-derived neurotrophic factor
without altering plasma corticosterone. Behav Brain Res. (2006). Apr 3;, 168(2), 323-5.
[106] Martinowich, K, & Lu, B. Interaction between BDNF and serotonin: role in mood
disorders. Neuropsychopharmacology. (2008). Jan;, 33(1), 73-83.
[107] Shattock, P, & Whiteley, P. Biochemical aspects in autism spectrum disorders: updating
the opioid-excess theory and presenting new opportunities for biomedical interven
tion. Expert Opin Ther Targets. (2002). Apr;, 6(2), 175-83.
[108] Chugani, D. C, Muzik, O, Behen, M, Rothermel, R, Janisse, J. J, Lee, J, et al. Develop
mental changes in brain serotonin synthesis capacity in autistic and nonautistic
children. Ann Neurol. (1999). Mar;, 45(3), 287-95.
[109] Hoshino, Y, Watanabe, H, Yashima, Y, Kaneko, M, & Kumashiro, H. An investigation
on sleep disturbance of autistic children. Folia Psychiatr Neurol Jpn. (1984). , 38(1),
45-51.
[110] Jacobs, B. L, & Fornal, C. A. Activity of brain serotonergic neurons in the behaving
animal. Pharmacol Rev. (1991). Dec;, 43(4), 563-78.
[111] Narita, N, Kato, M, Tazoe, M, Miyazaki, K, Narita, M, & Okado, N. Increased monoa
mine concentration in the brain and blood of fetal thalidomide- and valproic acidexposed rat: putative animal models for autism. Pediatr Res. (2002). Oct;, 52(4), 576-9.
[112] Araque, A. Astrocytes process synaptic information. Neuron Glia Biol. (2008). Feb;, 4(1),
3-10.
[113] Vargas, D. L, Nascimbene, C, Krishnan, C, Zimmerman, A. W, & Pardo, C. A. Neuro
glial activation and neuroinflammation in the brain of patients with autism. Ann
Neurol. (2005). Jan;, 57(1), 67-81.
[114] Carlson, G. C. Glutamate receptor dysfunction and drug targets across models of
autism spectrum disorders. Pharmacol Biochem Behav. (2012). Feb;, 100(4), 850-4.
http://dx.doi.org/10.5772/54824
[115] Rubenstein, J. L, & Merzenich, M. M. Model of autism: increased ratio of excitation/

inhibition in key neural systems. Genes Brain Behav. (2003). Oct;, 2(5), 255-67.
[116] Ming, X, Brimacombe, M, & Wagner, G. C. Prevalence of motor impairment in autism
spectrum disorders. Brain Dev. (2007). Oct;, 29(9), 565-70.
[117] Bailey, A, Luthert, P, Dean, A, Harding, B, Janota, I, Montgomery, M, et al. A clinico
pathological study of autism. Brain. (1998). May;121 ( Pt 5):889-905.
[118] Rosenhall, U, Nordin, V, Sandstrom, M, Ahlsen, G, & Gillberg, C. Autism and hearing
loss. J Autism Dev Disord. (1999). Oct;, 29(5), 349-57.
[119] Kulesza, R. J. Jr., Lukose R, Stevens LV. Malformation of the human superior olive in
autistic spectrum disorders. Brain Res. (2011). Jan 7;, 1367, 360-71.
163
Chapter 9
Mnesic Imbalance or Hyperthymestic Syndrome as

Cause of Autism Symptoms in Shereshevskii
Miguel ngel Romero-Mungua
http://dx.doi.org/10.5772/54295
1. Introduction
Solomon Veniaminovich Shereshevskii (1886-1958) was a man studied by psychologist
Aleksandr Romanovich Luria, who thought that Shereshevskiis (S) remarkable memory
caused a psychological syndrome with cognitive deficits; consequently, Luria not only
described Ss memory, but also other aspects of his life such as his synaesthesia, mental
imagery, preferences, strengths, weaknesses and personality [1]. Likewise, more recently
the phrase hyperthymestic syndrome (hyperthymesia) has been coined in order to de
scribe the case of a woman (AJ) whose autobiographical memory is extraordinary, but
she has said it is a burden [2]. On the other hand, Kanners clinical description of au
tistic disorder suggested that excellent rote memory might be involved in its aetiology
[3]. In addition, some authors have thought that S could have had an Autism Spectrum
Disorder (ASD) [4,5]. So the question arises: if S could have had an ASD, then how
might his memory have given rise to such an ASD? For this reason, the present chapter
begins by reviewing the evidence for the diagnosis of autistic disorder in S using criteria
from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Re
vision (DSM-IV-TR) of the American Psychiatric Association [6] and from proposed crite
ria for its fifth edition [7], the chapter also compares his symptoms with those from a
famous case (DT) with Asperger syndrome [8,9]. It is concluded that S most likely had
autistic disorder. Next, I reviewed the literature to determine whether the assumption
that a superior memory may be the cause of autism symptoms would be acceptable or
not. However, the data seem to show that Ss job as a professional mnemonist was asso
ciated instead with a gradual decrease in the severity of some of his autism symptoms
[1], notwithstanding, there are great mnemonists without ASD [10,11]. Finally, an alterna
tive explanation regarding the possible relationship between superior memories and au
2013 Romero-Mungua; licensee InTech. This is an open access article distributed under the terms of the
166
tism spectrum disorders is given by the mnesic imbalance theory, which posits that a
faulty procedural memory is replaced, in some of its functions, by a relatively preserved
declarative memory, resulting in all three diagnostic symptoms of autism [12].
2. Diagnosis of autism spectrum disorder in Shereshevskii

2.1. Diagnostic criteria for autistic disorder by the DSM-IV-TR
Autistic disorder is the most clinically representative of the ASDs [13]. Currently its diagno
sis is based entirely on the observation of behaviors listed in the DSM-IV-TR diagnostic cri
teria [6]. Such criteria can be assessed by the Autism Diagnostic Interview-Revised (ADI-R),
which is conducted with the caregivers of individuals suspected of having autistic disorder
or other ASD [14]. Consequently, if one wants to make a retrospective diagnosis of ASD in
historical figures, then one might use the ADI-R, although it does not cover all ASDs, on bio
graphical texts. However, there are several difficulties in implementing this strategy. First,
since the biographical texts are not usually oriented to describe symptoms of psychiatric dis
orders, possibly such symptoms were not mentioned even though they had been present.
Second, some behaviors from historical figures have been considered autism symptoms
[15-17], but this attitude has been questioned because of doubts regarding whether the so
cio-cultural context was taken into account [18]. Third, it is necessary to find the motivation
behind behaviors in order to determine whether they are autism symptoms or not [19].
Fortunately, although the psychologist who wrote the psychobiographical text to be dis
cussed in the present chapter did not specifically search for autism symptoms, he pointed
out several of these symptoms in S. This historical figure lived in the twentieth century,
hence, his socio-cultural context was relatively similar to ours; the motivation behind behav
ior from S were examined in detail by the author of that text [1]. In addition, there are three
major cognitive theories that attempt to explain autism: mentalizing deficit, that is, deficit to
infer mental states [20]; weak central coherence, which is defined as disability to see the
overall picture but with ability to see details [21]; and finally, executive dysfunction, which
is the disturbed activity of the mental processes which control actions [22], although there is
a newer version of the first of them called empathizing-systemizing theory which surmises
that autism may be explained by a hyper-developed drive to analyze or construct systems
(systemizing) with a hypo-developed drive to infer mental states and to react to them with
appropriate emotions (empathizing) [23]. Thus, the presence of the cognitive deficits pre
dicted by such theories may be considered motivations associated with autism. Finally, in
the present work, the DSM-IV-TR diagnostic criteria will be mentioned in the order in which
they appear in that manual diagnostic [6]; every area of the core triad of impairments (social
interaction, communicative capacity and behavioral flexibility) is discussed in order to es
tablish whether S had autistic disorder.
Mnesic Imbalance or Hyperthymestic Syndrome as Cause of Autism Symptoms in Shereshevskii

http://dx.doi.org/10.5772/54295
2.1.1. Impairment in social interaction

A total of six (or more) items from criterion A (core triad) are required for the diagnosis of
autistic disorder, with at least two from subcriterion A1 (social interaction), and one each
from subcriteria A2 (communicative capacity) and A3 (behavioral flexibility), while each of
the three subcriteria contains four items [6]. On the other hand, S had impairment in the use
of nonverbal behaviors to regulate social interaction (item A1a). Since the biography of S ex
plicitly describes that some individuals always called him kalter nefesh, which is a phrase in
Yiddish that means cold soul, because for instance, he reacted cold-bloodedly to news that
other people said to him, so if someone said Fire! S did not understand that something
was being consumed by flames and consequently he did not show emotions. In this exam
ple, the impairment seems secondary to weak central coherence [21].
Besides, S had failure to develop peer relationships (item A1b), which was manifested in
various ways. For instance, he had a very good wife and a very intelligent son, but S
perceived them as through a haze; also he had difficulties understanding why his fellow
men wanted to have any job, which seems to be in accordance with hypo-developed em
pathizing [23].
Moreover, S showed a lack of socio-emotional reciprocity (item A1d), if his host asked him
How do you like these cigarettes? he answered So-so, fair... , that is, S did not respond
reciprocally to the kindness of others, which he explained as secondary to his inability to au
tomatically react appropriately because he neeeded to monitor all his own actions con
sciously [1]. It might be explained as a sort of self-consciousness disturbance through
mentalizing deficit [24] but it might also be explained more directly as secondary to hypodeveloped empathizing [23].
In conclusion, the data suggest that S met three of the four items from subcriterion A1, since,
unfortunately, the psychobiographical text does not provide enough data to make inferences
about item A1c: lack of shared enjoyment [1,6,14].
2.1.2. Impairment in communicative capacity
The biography of S shows evidence that he met item A2b (impairment to initiate or sustain
conversational interchange), as only about the time S was over fifty years of age did he learn
to follow a conversation and stick to the subject; moreover, S had marked difficulty under
standing abstract concepts because he understood only what he could visualize and, there
fore, he did not understand phrases such as to weigh ones words or the pressure is
higher [1]. This difficulty with abstract thinking (verbal) along with a higher tendency to
use visual mental representations seems most easily explained by the mnesic imbalance
theory [12] than by the three major cognitive theories, but also such a cognitive profile has
been extensively described by the thinking in pictures hypothesis [25,26]. Both theorical pro
posals will later be explained in detail.
On the other hand, S also met item A2c (stereotyped, repetitive or idiosyncratic language),
since he at least utilized some words that can be described as neologisms for the ADI-R [14].
For example, S used the word zhuk (Russian: beetle) when he meant chipped part, black bread,
167
168
darkness and negligence, whereas to him the word gis (Yiddish: to spill) assumed the mean
ings of sleeve and the reflection of a face in the polished surface of the samovar [1]. This is similar to
the phrases bread basket instead of home bakery, fifty five instead of grandmother, Annette and
Cecile in order to say red and blue, as well as the words Blum instead of a teller of truth and
hexagon instead of six, all which were spoken by children described by Leo Kanner, who has
always been considered as the first to clinically describe autistic disorder [3,27]. However, a
recent communication has suggested instead that Hans Asperger could have done so five
years earlier [28]. Furthermore, the pronominal reversal shown by S was not so typical of
autistic disorder, since he did refer to himself as he but did not show echolalia [1,14].
However, his pronominal reversal seems to be related to self-consciousness disturbance
shown by individuals with ASD [24].
In summary, there is evidence that S met items A2b and A2c, that is, two of the four items
from subcriterion A2, however, there are no data to establish whether S had a delay in spo
ken language with failure to compensate through gestures (item A2a), not to say that he had
a lack of varied and spontaneous social imitative or make-believe play (item A2d) [6],
though S always had problems with his ability to distinguish between his visual mental rep
resentations and the true word [1]; it is difficult, if not impossible, to develop make-believe
play without such an ability.
2.1.3. Impairment in behavioral flexibility
S had an encompassing preoccupation with an interest that was abnormal in intensity
and focus (item A3a), specifically, on very detailed and specific visual mental representa
tions. This unusual and circumscribed interest began in Ss early years, for instance,
when he was five years old he met a rebe (Yiddish: teacher) but S thought there was a
mistake, since that rebe in his visual mental representation was something white, whereas
the teacher was a swarthy man. Furthermore, his preoccupation on visual mental repre
sentations took up most of his time, for instance, when S read this sentence: N was
leaning up against a tree... he saw N (as a slim young man) standing near a big linden
tree with grass and woods all around... But then S continued reading: and was peering
into a into a shop window then he understood that N was not in a woods but on the
street; as a result, S needed to completely rebuild his visual mental representation. More
over, S was very anxious if he listened to words but their very detailed images did not
appear in his mind, for instance, with the word restaurant S needed to see its entrance,
people sitting inside, a Romanian orchestra tuning up, and a lot else, while with the
word airport a S would have seen all details such as the crowd and the police cordon.
Also, he did not admit that the words Mariya, Masha, Marusya and Mary (Russian var
iants of the same name) could all apply to the same woman because each word would
elicit visual mental representations, which were very distinct one from the other [1,6,14].
Apparently he showed an inflexible adherence to nonfunctional routines (item A3b). For
example, if S had to remember the phrase American Indian, then he needed to see a very
long rope across the ocean from a Russian street to America; these mental journeys were
made by him despite the fact that they made him feel exhausted, not by the amount of

http://dx.doi.org/10.5772/54295
data stored, but because S felt like he really had done those long journeys. Another time
he was asked to memorize a table whose numbers were arranged in a simple logical or
der: 1 2 3 4 2 3 4 5 3 4 5 6 4 5 6 7 etc. Then S produced visual mental representa
tions in which the number six could be represented by a man with a swollen foot and
the number seven by a man with a mustache. Later S remarked that if he had been
asked to memorize the letters of the alphabet arranged in a similar order, then he would
have proceeded with it in the same way because he would not have noticed such an ar
rangement [1]. Thus, the first example may be explained by executive dysfunction [22],
whereas the second may be explained by weak central coherence [21]. On the other
hand, his need of adherence to routines was not limited to his job as a professional mne
monist, for instance, when S participated in a lawsuit for which he practiced imagining
the judges table on the right, he entered the courtroom but the judge was sitting on the
left, thus, S lost his head and the case. The latter example may be explained by the mne
sic imbalance theory [12,29], which will be explained later.
Besides, S had a persistent preoccupation with parts of objects (item A3d) [6]. For instance,
although his synesthesia was present since childhood, even in adulthood he kept showing
much preoccupation because of the sensory experiences resulting from it. Thus, even when
S was talking with famous people, he would be so interested in their voices that he could
not follow what they said [1].
It can be concluded that S met items A3a, A3b and A3d from subcriterion A3, however,
there is insufficient information to determine whether S had stereotyped and repetitive
motor mannerisms (item A3c). So, one can claim that S fulfilled all the items required by
criterion A for the diagnosis of autistic disorder, such as is summarized in Table 1, al
though we cannot claim that S has had delays or abnormal functioning in social interac
tion, language or imaginative play prior to age 3 years (criterion B), but it appears that
he accomplished criterion C, in other words, he suffered neither Retts disorder nor
childhood disintegrative disorder [1,6].
item a
item b
item c
item d
total
1. Social interaction
2. Communicative capacity
3. Behavioral flexibility
Core triad
Table 1. Items from the triad of core symptoms for diagnosing autistic disorder: Each addition symbol (+) represents
an item met by Shereshevskii, whereas each subtraction symbol (-) represents an item for which there is insufficient
information to reach conclusions about it.
2.2. Proposed diagnostic criteria for autistic disorder in DSM-V

Currently the DSM-IV-TR guides the diagnosis of ASD [6], but soon its fifth edition
(DSM-V) will replace it [7]. For this new edition of the manual, the term Autism Spec
trum Disorders (ASD) is proposed instead of Pervasive Developmental Disorders
169
170
(PDDs), which includes Retts disorder, childhood disintegrative disorder, Aspergers dis
order and Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) [6],
however, according to the American Psychiatric Association (APA) the term ASD ex
cludes Retts disorder [7], although in a previous use of the term ASD also excludes
childhood disintegrative disorder [30]. On the other hand, the APA also proposes to stop
using these diagnostic categories and use the name ASD as a single diagnostic category
[7]. This proposal is based on the lack of reliability of the clinical distinctions among dis
orders [31], which is in accordance with the rejection of the assumption of normal early
language development in Aspergers disorder [32]. So, it has been suggested to continue
the use of the DSM-IV-TR and to regard all the PDDs, with the exception of Retts disor
der, as ASD [33]. However, a study found that only 25% of those diagnosed by DSM-IVTR with Aspergers disorder, 28% of those with Pervasive Developmental Disorder Not
Otherwise Specified (PDD-NOS) and 76% of those with autistic disorder met the pro
posed DSM-V criteria for ASD [34]. This supports the view that the PDD-NOS should
not be considered ASD because its diagnosis does not require compliance with the com
plete diagnostic triad of autism [35]. At first glance, one can assume that it is quite feasi
ble that if the proposed criteria require two symptoms instead of one on impairment in
behavioral flexibility (restricted, repetitive patterns of behavior, interests, or activities)
any individuals who actually have diagnosis of some ASD will not meet these new crite
ria; in addition, at present the criteria regarding the impairments in social interaction
and communicative capacity are not require to be completely fulfilled. Consequently, the
question arises whether S can meet these new criteria just as he met the necessary items
from criterion A for the diagnosis of autistic disorder. To answer one might embed the
criteria from the DSM-IV-TR among those from the proposed DSM-V criteria and see if S
meets the criteria of the latter; thereby items A1c, A1d and A2b of the DSM-IV-TR are
integrated into subdomain A1 (social-emotional reciprocity) of the proposed DSM-V cri
teria, because, indeed, the lack of shared enjoyment (item A1c) evaluates another aspect
of the same symptom assessed by item A1d (socio-emotional reciprocity), and item A2b
(to initiate or sustain conversational interchange) does too. On the other hand, subdo
main A2 (nonverbal communication) includes item A2a (delay in spoken language) since
this is evaluated by a failure to compensate through gestures [14]. Besides, subdomain
A3 (deficits in relationships) contains the item on social imitative or make-believe play
(A2d) because of the importance of these behaviors in early relationships [6]. Further
more, stereotyped, repetitive or idiosyncratic language (item A2c) is integrated into sub
domain B1 (Behavioral stereotypies) and the verbal rituals are integrated into the
apparently inflexible adherence to nonfunctional routines according to the ADI-R [14]. Fi
nally, criterion B of the DSM-IV-TR which requires abnormal functioning in social inter
action, communication or play is replaced by criterion C in the proposed DSM-V criteria
which only requires symptoms in early childhood [6,7].
Using the above method, one can see that S completely met the criteria proposed in the
DSM-V for ASD, that is, the new criteria seem to confirm the diagnosis of ASD even more
strongly than the DSM-IV-TR (Table 2).

http://dx.doi.org/10.5772/54295
Summarized proposed DSM-V criteria
Summarized DSM-IV-TR criteria
A. Social communication and interaction
A: 1. Socialization / 2. Communication
1. Social-emotional reciprocity
1c 1d 2b
2. Nonverbal communication
1a 2a
3. Deficits in relationships
1b 2d
B. Restricted and repetitive behavior
A: 3. Restricted and repetitive behavior
1. Behavioral stereotypies
2c 3c
2. Adherence to routines
3b
3. Interests and preoccupations
3a
4. Reaction to sensory aspects
3d
C. Symptoms in early childhood

D. Impaired everyday functioning
-------------------------
B. Dysfunction prior to age 3 years

------------------------C. No Retts or childhood disintegrative disorder
Table 2. Comparison between the proposed DSM-V criteria for ASD and those from the DSM-IV-TR for autistic
disorder: all text in italics represents each criterion and item met by Shereshevskii.
2.3. Some shared features with a case of synesthesia and Asperger syndrome
Daniel Tammet (DT) is a British writer born in 1979, who was diagnosed with Asperger syn
drome (Aspergers disorder) by researcher Simon Baron-Cohen [8], so this paragraph does
not discuss his diagnosis but the characteristics he has in common with S. Indeed DT has
been named the modern-day Shereshevsky since he not only has an ASD but also phe
nomenal memory and synaesthesia. For instance, DT memorized and recited 22,514 digits of
pi and has an extraordinary ability to learn to speak new languages [9]; similary S had the
ability to memorize long chains of digits and reproduce several stanzas of The Divine Comedy
fifteen years after having read it and despite not knowing Italian. However, both S and DT
showed impaired face memory. Besides, with respect to synaesthesia, DT experiences num
bers as having shapes, colour, textures, as well as some words with colour, while S also had
synesthetic reactions whenever he heard tones, voices and speech sounds. Such reactions
were puffs of steam, splashes, colourful visual flashes, flavours and even bodily sensations
[1,9]. On the other hand, DT also has visual mental representations when he hears certain
phrases, for instance, with fragile peace he imagines a glass dove, whereas with election
triumph he sees the politician holding a trophy [9].
DT solved mathematical problems such as the following one through mental imagery:
There are twenty-seven people in a room and each shakes hands with everyone else. How
many handshakes are there all together? To solve this problem DT began imagining two
men inside a bubble [9]; similarly, S solved the following problem: A husband says to the
wife Give me 7 of your mushrooms and I will have twice as many as you! To which the
wife replies: No, give me 7 of yours and we will have the same amount. How many mush
171
172
rooms does each have? In order to solve this problem S imagined himself with them (hus
band and wife) [1]. On the other hand, DT has also used mental imagery in order to better
understand emotions. For instance, in order to empathize with someone who is sad, DT has
imagined himself "sitting in the dark hollowness of number 6" [9]; similarly, S used his men
tal imagery, for example, during a very difficult performance S could see someone smiling
in the audience, which was turned into an image of a sharp spire, so that he felt as if hed
been stabbed in the heart [1].
There are some differences between the symptoms from DT and S. Thus, whereas the neolo
gisms from S were created by simple associations, the neologisms of DT such as pramble
(to go out for a ramble with a baby in a pram) and biplets (twins) were created following
more complex rules such as in the last neologism: a bicycle has two wheels and a tricycle
three and three sisters might be a triplets. In other words, the neologisms from S were cre
ated through semantic or perceptual association, whereas those from DT were through mor
phological or syntactic analysis. DT has also shown impairment to initiate or sustain
conversational interchange and both DT and S recognized that they were verbose and that
this affected the conversations with others. DT also has difficulty understanding language,
but whereas S believed that the phrase the pressure is higher meant that the gas was
moved upward and consequently it could not dissolve in water [Luria], DT believed that the
phrase John is not tall, he is a giant meant something impossible, although the phrase is
not structurally different from the sentence John does not have ten dollars, he has twenty,
that is, it seems S had more problems in understanding the meaning of the words them
selves but DT only with whole sentences. DT has shown problems to understand phrases
such as he is not inexperienced in such things and likewise S could have had the same
problems since he said he could not understand the negation of the negation [1,9].
3. Superior memorization as a cause of autism symptoms

3.1. Impaired and preserved memories in ASD
When Leo Kanner wrote his clinical description of autistic disorder, he pointed out excellent
rote memory in children with the disorder and hinted that such an overload may be in
volved in the development of the disorder [3]. More recently it has been proposed that a
mnesic imbalance may be the cause of all symptoms of autism, so the mnesic imbalance
theory posits that all three diagnostic symptoms of autism may be explained by faulty pro
cedural memory with relatively preserved declarative memory [12,29]. Procedural memory
can be defined as behavioral algorithms that operate at an unconscious level and declarative
(explicit) memory is information that is subject to conscious verbal reflection; whereas de
clarative memory includes episodic, semantic and working memory, procedural memory is
only one of the various non-declarative (implicit) memories, such as priming, emotional
conditioning and conditioned reflexes [36]. It is important to remember the latter because
there are authors who may be referring to different types of memory although with the
same term, for instance, procedural memory has been described as all implicit memory [37],

http://dx.doi.org/10.5772/54295
whereas, other authors have pointed out that it is only a subtype [12,36,38,39]. In addition, a
study in high functioning adults with ASD observed that memory for emotionally arousing
events was preserved over time [40], and this preservation is particularly important for
teaching new abilities to children with low functioning ASD [41].
The mnesic imbalance theory is supported by clinical studies that have shown bad proce
dural functioning [42-44], or good declarative functioning in individuals with ASD [45,46].
For instance, in a study utilizing the Serial Response Time Task (SRTT) with 10-element se
quences to evaluate procedural learning in children and adolescents with autistic disorder,
the results showed significant deficit in their procedural learning relative to Intellectual
Quotient (IQ)-matched controls [43]. In contrast, some studies have challenged this finding,
but it is important to note that all of these later studies had not use the same aforementioned
task but rather tasks with 4-element sequences or shorter, as well as other changes in the ap
plication of the tasks [47-49], while significant improvement has been found in this sort of
tasks in individuals with autistic disorder when the sequence length is short [50]. On the
other hand, this deficit in procedural learning of sequences might be related to the poor
short-term declarative memory shown on serial recall tasks in adults with ASD during a
study, because its experiments demonstrated that their poor performance was due to faulty
memory for the order of the items rather than because of memory deficit for the items them
selves [51]. In other words, the difficulties in procedural learning of unconscious algorithms
might lead to problems in learning explicit sequences, for instance, there are studies that
have found impairment in the delayed self-initiated execution of intentions at designated
events (called prospective memory), such as remembering to turn off the porch light at 11
pm or, to give a message to mom when she arrives [52-53].
Besides, a study utilizing a picture-naming task showed that boys with High Functioning
Autism (HFA) responded faster than control boys on lower-frequency words; then, its au
thors argued that the results support the notion of enhancement in declarative memory of
people with ASD [46]. This conclusion is based on the declarative/procedural model that as
sumes storage of grammar in procedural memory as well as of vocabulary in declarative
memory [38]. In addition, such a model is in accordance with a meta-analysis which found
that picture vocabulary tests are the peak of ability relative to verbal IQ in high functioning
individuals with ASD [54].
Furthermore, a study utilizing a composite measure as an index of procedural learning
showed significant negative correlation between procedural learning and autism symptoms
[42]. Moreover, in another study, a composite group that included children with autistic dis
order, both with non-functional verbal language and no spoken language, a significant posi
tive correlation was observed between autism symptoms and scores of an index of
declarative memory, which suggests that the imbalance between declarative and procedural
memory in ASD might be more important than the mere faulty procedural memory [44];
such an imbalance might contribute to a global cognitive imbalance. This assumption is in
accordance with results from a study in children with autism, which showed that those with
a lower verbal than nonverbal IQ profile showed greater social impairment than those with
out this profile; this result was independent of scores in verbal or full-scale IQ [55].
173
174
Nevertheless, the mnesic imbalance theory does not suggest that declarative memory has to
be above average in individuals with ASD; indeed, an impairment of episodic memory is in
accordance with this theory [12]. In addition, the mnesic imbalance theory suggests that al
though procedural learning is significantly lower relative to declarative learning in individ
uals with ASD, this procedural memory can be developed [12,50]. Anyway, in this theory
the imbalance between procedural and declarative memory is needed to account for the im
pairments in social interaction, communicative capacity and behavioral flexibility, as well as
for the islets of ability and neurobiological findings observed in people with ASD [12,56].
However, it is important note that there are several deficits in declarative memory in indi
viduals with ASD, but such deficits might be explained by overlap in the functioning of the
memories. For instance, S and DT showed impaired face memory [1,8], which might be due
to the difficulty to verbally describe all elements that make each face unique; consequently,
facial memory has to be implicitly acquired through perceptual categorization, which is a
type of procedural learning [57]. It is likely that some individuals with ASD see face learning
as a task that should be performed by conscious memorization of each element of the face,
which might explain the lack of developmental improvement in face learning that has been
observed in autism [58]. Besides, utilizing functional magnetic resonance imaging, a study
measured the activation over time of the amygdala in adults with ASD and the results
showed a delay in the decrease of amygdala activity relative to control adults, which could
be an action to improve face learning, since the participants with ASD had a reduction in the
number of errors during a second set of the task of facial memory [59], while another study
reported an association between increased amygdala activation and better facial memory in
healthy people [60]. Furthermore, in individuals with autistic disorder, a study showed defi
cit of their facial memory awareness, that is, when participants were asked to say how they
thought their performance in the task was, the answers did not correspond to reality [61].
The faulty perceptual categorization might be enough to explain the significant preference
in individuals with ASD for utilizing an approach oriented to process parts rather than the
gestalt during the Rey Osterrieth Complex Figure (ROCF) task [62]; this situation is equiva
lent to an increased number of elements, which might explain the difficulty for any individ
ual with ASD to memorize the ROCF despite their tendency to use visual mental
representations [26]. But the above mentioned deficit in facial memory awareness cannot be
explained only by poor perceptual categorization. Another study showed that, whereas in
typically developing adults the memory of actions is significantly better if the actions are
self-performed (enacted) than if only observed, in adults with Asperger syndrome is not the
case (Figure 1). These results were considered secondary to difficulties in encoding specific
motor and proprioceptive signals [63], but an alternative explanation might be that during
ones actions procedural knowledge is typically created and may aid declarative knowledge
during recall, whereas in people with ASD, impairment of procedural learning prevents the
appearance of such aid [12]. Consequently, if the latter explanation is used not only for mo
tor actions but also for mental actions, then one might have an account for the deficit in fa
cial memory awareness.

http://dx.doi.org/10.5772/54295
Impaired procedural memory is not only unable to aid declarative memory, but that declar
ative memory also has to replace faulty procedural memory in some of its functions, which
implies an overload for consciousness. This assumption is in accordance with a study that
showed that children with ASD, in comparison to the control group, had significant difficul
ty in divided attention (ability to simultaneously perform two independent tasks), which
was significantly related to everyday working memory [64].
The above findings are in accordance with a review of memory in ASD that pointed out a
deficit in episodic memory, but are not in accordance to its assumption of preserved memo
ry for non-social stimuli [65]. On the other hand, one must keep in mind that although there
are deficits in encoding and organization of episodic and autobiographical memory in peo
ple with ASD, their storage and retrieval are preserved [66,67].
Figure 1. Mean of correctly recalled items of the Free Recall Task of actions (Enacted and Observed) in Asperger and
Comparison groups: The bars represent means and the whiskers represent standard error (From Zalla et al., 2010).
3.2. Reduction of autism symptoms during the mnemonist job

In the first clinical description of autistic disorder, it was suggested that excellent rote mem
ory might be involved in its etiology, since some children described by him could recite ver
batim the questions and answers of the Presbyterian Catechism, the Twenty-third
Psalm, poems, as well as titles and composers of Victrola record pieces but were unable to
initiate or sustain conversations with others [3]. On the other hand, some authors have
thought that S could have had an ASD [4,5]; it has been surmised that his astounding memo
ry interfered with his comprehension of what he heard or read [5,68]. However, such an as
sumption might be inaccurate because his cognitive difficulties could be due to the ASD he
suffered, not to his memory. So, the mnesic imbalance memory posits a higher tendency to
175
176
use explicit (visual) mental representations in people with ASD to solve problems [12]. Simi
larly, a study of individuals with declarative memory deficits due to neurological damage
showed that creating mental imagery of events from a personal perspective may improve
episodic memory [69], therefore, people with ASD might try to improve their poor episodic
memory through mental imagery. In addition, another study found that mental imagery
was effective at enhancing the task of relearning after brain injury [70], so mental imagery
might be used against motor deficits secondary to faulty procedural memory [12]. Finally,
other study reported that understanding expressions (idioms) is associated with more so
phisticated and figurative mental images [71]; consequently, the creation of mental images
in people with ASD might be a small successful attempt in order to understand abstract
thinking as well as mental states of others, for example, mentalizing deficit in children with
autistic disorder was initially tested using the unexpected transfer test of false belief [20],
but both typically developing 3 year olds and children with autism significantly improve on
that test when they use thought bubbles, that is, visual representations of mental states
[72,73]. In addition, a review supports the Thinking in Pictures hypothesis, which posits
that a subset of individuals with ASD shows disposition towards using visual mental repre
sentations, although the authors of that theoretical proposal make the assumption that in
people with ASD, mental imagery creates difficulties for understanding [26]. In view of this
scenario, it is possible that neither his astounding memory nor his encompassing preoccupa
tion for very detailed and specific visual mental representations were the cause of the cogni
tive problems of S, but rather some other factor might be the cause of these three features in
S and such a factor might be the mnesic imbalance since procedural memory seems to be
required for the development of analogical inference, which is a sort of reasoning performed
primarily through unconscious algorithms that might be at the heart of abstract thinking
and verbal comprehension [74-76]. So, if it is difficult to perform reasoning through proce
dural memory then that might be tried through declarative memory using explicit (visual)
mental representations [12]. So, it is very likely that this was the reason why S often said I
can only understand what I can visualize [1].
It has been surmised that the mnemonist job could exacerbate autism symptoms in S [4].
However, the symptoms appear to have decreased precisely because of that job. For in
stance, the encompassing preoccupation with very detailed and specific visual mental repre
sentations that he did for his job was very exhausting, so S decided to make his visual
mental representations more and more simple; as a result, the word restaurant was no longer
represented by its entrance, people sitting inside, a Romanian orchestra tuning up, and a
lot else, but by an entrance way with a bit of something white showing from inside,
while with the word airport, S could see only a small segment of the Leningrad Highway.
This simplification of the visual mental representations allowed him to better understand
and to enjoy what he heard and read. Also, S showed a decrease of the apparently inflexible
adherence to nonfunctional routines, for example, if S heard the word America, he no longer
needed to do his mental journeys, but just to imagine Uncle Sam. In addition, S learned to
follow conversations and to understand when his behavior was not tactful [1]; similarly, a
man with autistic disorder named Peter Guthrie and another man with an ASD named Kim
Peek, who were used as models to create the character with autistic disorder in the movie

http://dx.doi.org/10.5772/54295
Rain Man also showed significant improvement in socialization and communication after
the increase in their public activity [77,78].
3.3. Relationship between great mnemonists and ASD
There are several cases of individuals with ASD that have been known for their astounding
memory, for example, Kim Peek learned more than 12,000 books and his encyclopedic
knowledge covering at least 15 interests such as world and American history, sports, mov
ies, geography, actors and actresses, literature and classical music. Peek as S had significant
difficulties with language comprehension, for instance, once when Peek was asked to lower
his voice he only slid lower into his chair [78,79]. Also, Peter Guthrie has an extraordinary
memory: he can say the day of the week for any date between past and future decades, has
memorized the Billboard record-sales charts and an extraordinary amount of data from al
manacs and newspapers; he reads, writes and pronounces English, Japanese, French, Arabic
and Spanish [77]. Moreover, a mental calculator described in his book the case of an elderly
man with ASD who could tell what day of the week any given date fell, because he remem
bered the day of the week and an event of dates that he had lived [80], while another author
described twins, John and Michael who also recalled a great amount of events from their
own life, but in addition, they could say the day of the week for any date in a period of
80,000 years [81]. It is interesting to note that although bad episodic memory in people with
ASD has been mentioned, these cases showed an extraordinary amount of autobiographic
remembrances, even S not only remembered the hundreds and thousands of series of num
bers, words or syllables, but also the whole scene in which the learning had initially been
carried out, so he said This was a series you gave me once when we were in your apart
ment... You were sitting at the table and I in the rocking chair... You were wearing a gray
suit and you looked at me like this... [1].
On the other hand, a woman named Jill Price (whose pseudonym in scientific literature is
AJ), remembers almost every day of her life since age 11. This feature is considered part of a
disorder for which the phrase hyperthymestic syndrome (hyperthymesia) has been coined
[2]. However, another author has considered the possibility that her hyperthymesia is only a
sort of obsessive compulsive disorder since she spends excessive amounts of time reliving
past events and although says this is a burden also says when I think of these things it is
kind of soothing [82]. On the other hand, S showed an apparent obsessed worry by his
memories when he said I both did and didn't want it to appear. However, this was a wor
ry about an apparent real-life problem, because S left his job as a journalist after meeting Lu
ria, then S became a professional mnemonist who performed on stage memory acts to
entertain audiences; he often gave several functions each evening and feared he began to
confuse the individual functions. Consequently, S tried to forget what he had memorized in
previous functions, but finally, he understood that memories only appear if he wanted it.
This latter situation was interpreted by Luria as S had learned to forget [1], but such as
sumption is inaccurate because it is different forget than to only remember when one wants
to. Thus, it is likely that S was finally able to answer the question Isnt it confusing to re
member so much? as the professional mnemonist without ASD Harry Lorayne, who acted
177
178
before S died and whose response was No! [83]; contrary to S, he had a very good empa
thy and extraordinary memory for faces, so he could memorize the name of 700 individuals
in only one function [10].
Hyperthymesia is also called Highly Superior Autobiographical Memory (HSAM); an au
thor with HSAM (and without ASD) has claimed that this is not a disorder, but is almost
like therapy, in that it helps you to better understand yourself and predict how youll func
tion [84]. It has been suggested that studying cases of hyperthymesia may provide the basis
of potential future treatments for patients with memory disorders [85]. Furthermore, other
cases of superior memory studied by science are those individuals without ASD that have
set a Guinness World Record by memorizing thousands of digits of pi, for example, Rajan
Mahadevan, whose memory allowed him to recited 31,811 decimals of the mathematical
constant pi, shows his ability to recite a random sequence of over 40 digits seen by him at
the rate of a digit per second during a digit span test [86], whereas Hideaki Tomoyori, could
recite the first 40,000 digits of pi, had an average visual digit span of 8, but 10 in the auditory
digit span [87]; likewise, Chao Lu established the Guinness World Record at 67,890 decimals
of pi and could remember a mean of 8.83 digits during the visual digit span task [88], where
as Dominic OBrien (with at least six World Memory Championship titles), memorized a
random sequence of 74 digits in the auditory digit span task [11]. These data indicate that
the digit span tasks are not useful to show the superior memory of some individuals with
out ASD, such as Hideaki Tomoyori and Chao Lu. This situation does not seem to be differ
ent in people with ASD since DT, who was diagnosed with Asperger syndrome and recited
22,514 digits of pi, had a mean of 11.5 digits on a visual digit span task [8]. In contrast, when
these individuals are allowed self-paced learning they can demonstrate their superior mem
ory; for instance, Tomoyori perfectly remembered the 25 digits from a 5 X 5 number matrix
studied for 233 seconds, that is, at a rate of 9.32 seconds per digit, whereas his control group
recalled only a mean of 18.30 digits of that matrix studied at an average of 395.6 seconds
(15.82 seconds per digit) [87]. Besides, Chao Lu also perfectly recalled all matrices, such as
one of 25 digits which he studied for 35 seconds (1.4 seconds per digit), whereas with a 7 X 7
number matrix he required 260 seconds (5.31 seconds per digit) and on a 9 X 9 matrix he
used 387 seconds (4.78 seconds per digit) [88]. Likewise, S also demonstrated his superior
memory through self-paced learning, for instance, he correctly recalled all 20 digits from ta
bles of numbers that he memorized in a mean of 37.5 seconds (1.8 seconds per digit), he
learned tables of 50 digits in 165 seconds (3.3 seconds per digit). He recalled the third verti
cal column of these later tables in 80 seconds, recalled the second vertical column in 25 sec
onds, which suggests that S did not memorize the tables as a mental photograph but as a
chain of data with a determined order [1]. This same pattern has been observed in Tomoyori
who also used mental imagery [87]. Indeed, according to the occipital activation that is ob
served in mnemonists with and without ASD, even if there is no success in the memorizing,
both groups use visual mental representations during recordings [89,90]. In addition, other
features of neurobiological similarity between people with ASD have been observed as well
as in those whose declarative memory has been significantly enhanced [56]. Even children
with Low Functioning Autism (LFA) may show qualitative similarity with the great mne
monists without ASD. For instance, some of them can learn to read whole sentences at pre

http://dx.doi.org/10.5772/54295
school age despite their very poor language comprehension [3,77,78,91], besides, the great
mnemonists can learn large amounts of text quickly [10,11]. Also the delayed echolalia in
children with LFA is a demonstration of good declarative memory [3,27]. On the other hand,
skills such as calendar calculation are common among the great mnemonists without ASD
and in some individuals with HFA or Asperger syndrome. Indeed DT, Kim Peek and Peter
Guthrie made calendar calculations [9,77,78]. To summarize, figure 2 illustrates the differen
ces and similarities between people whose declarative memory has been significantly en
hanced and that have an ASD regardless of whether or not they have an extraordinary
declarative memory.
Biological features
Decreased numbers of Purkinje cells, age changes in inferior olive,
increased packing and reduced size of cells in cerebral cortex,
changes in gray matter volume, increased activity in default mode network,
increased amygdala activation, increased hippocampal creatine and choline
Cognitive processing
Faulty procedural memory with relatively preserved declarative memory,
increased utilization of visual mental representations,
reading skills enhanced by good declarative memory
Behavioral manifestations
Completely fulfilled core triad of symptoms for diagnosing autistic disorder,
significant tendency to perform acts that demonstrate declarative knowledge
Figure 2. Shared characteristics between people with ASD and those whose declarative memory has been significant
ly enhanced (in blue text), and those only present in people with ASD (in red text). The blue arrows suggest a recipro
cal causal interaction among all shared characteristics, whereas one red arrow indicates unidirectional influence and
the other one bidirectional influence.
4. Mmesic imbalance and superior memory in autism spectrum disorders

Mnesic imbalance theory predicts a higher tendency in individuals with ASD to use visual
mental representations [12,56], these types of representations may be utilized to significantly
enhance declarative memory [11,83,92]. Luria recognized that this mental imagery was the
cornerstone of Ss extraordinary memory, whereas the synesthetic experiences were addi
tional information [1]. So for instance, a study of individuals with synaesthesia shows that
they have better memory than controls for data that induce synaesthesia, as well as for color
179
180
per se [93]. However, during the World Memory Championships the competitors currently
use mnemonic methods, not innate features as synaesthesia; one of these mnemonic meth
ods is the method of loci [94], which was used by S, who when he listened to a list of ob
jects to memorize he would distribute them along a street in his home town or the Gorky
Street visualized in his mind [1]. The method of loci is used by Buenos Aires waiters, who
memorize all the orders without written support [95].
Lorayne has pointed out that it is difficult to remember the abstract, he therefore recom
mends replacing it by tangible objects, for example, 7 might be represented by a flag, where
as 8 by an hourglass [10], while S used a man with a mustache to represent 7 and a very
stout woman to represent 8 [1]; OBrien said that 07 may become James Bond [11]. Finally, it
is very difficult to memorize meaningless words, but a solution is to convert those words
into intelligible images, for instance, the name Olczewsky was imagined by Lorayne as an
old man chewing, while he skied [83], while S visualized the word mavanasanava as his
landlady speaking (Polish: mwi = to speak) from the window, pointing into our guest
house (Russian: = our) and making a sign of negation (Latvian: nava = is not a) with
her other hand [1].
5. Conclusion
The astounding memory of Shereshevskii has been taken as a paradigmatic example of how
the development of a skill can affect the development of others. However, this chapter has
offered arguments against such a view and presented evidence that he had an ASD. In addi
tion, the relationship between memory and autism can be better understood if we reanalyze
the life of this extraordinary individual under the light of the mnesic imbalance theory.
Acknowledgements
The author would like to thank Edith Monroy for reviewing the language of the manuscript.
Author details
Miguel ngel Romero-Mungua
Outpatient Service, Dr. Samuel Ramrez Moreno Psychiatric Hospital, Health Secretariat,
Mexico

http://dx.doi.org/10.5772/54295
References
[1] Luria AR. The mind of a mnemonist: a little book about a vast memory. Solotaroff L
(Trans.) from the Russian. New York, NY: Basic Books; 1968.
[2] Parker ES, Cahill L, McGaugh JL. A case of unusual autobiographical remembering.
Neurocase 2006;12 (1) 35-49.
[3] Kanner L. Autistic disturbances of affective contact. The nervous child 1943; 2:
217-250.
[4] Elfakir A. Mmoire et autisme: de la neuropsychologie la psychanalyse. Le cas de
Cherechevski. LInformation psychiatrique 2005; 81 (9): 763-770.
[5] Wing L. Asperger's syndrome: a clinical account. Psychological medicine 1981; 11 (1):
115-129.
[6] American Psychiatric Association. Diagnostic and statistical manual of mental disor
ders (4th edition, text revision).Washington, DC: American Psychiatric Publishing;
2000.
[7] American Psychiatric Association. Neurodevelopmental disorders. In: DSM-5 draft
criteria closed for final public comment. Arlington,VA. American Psychiatric Associ
ation; 2012. http://www.dsm5.org/ProposedRevision/Pages/Neurodevelopmental
Disorders.aspx (accessed 26 September 2012).
[8] Baron-Cohen S, Bor D, Billington J, Asher J, Wheelwright S, Ashwin C. Savant mem
ory in a man with colour form-number synaesthesia and Asperger syndrome. Jour
nal of Consciousness Studies 2007; 14 (9-10): 237-252.
[9] Tammet D. Born on a blue day: inside the extraordinary mind of an autistic savant.
New York, NY: Free Press; 2007.
[10] Lorayne H. Secrets of mind power. Hollywood, FL: Lifetime Books; 1995.
[11] OBrien D. Learn to remember. San Francisco, CA: Chronicle Books; 2000.
[12] Romero-Mungua MA. Mnesic imbalance: a cognitive theory about autism spectrum
disorders. Annals of general psychiatry 2008; 7 (1) e20. http://www.annals-generalpsychiatry.com/content/7/1/20 (accessed 26 September 2012).
[13] Szatmari P. A mind apart: understanding children with autism and Asperger syn
drome. New York: The Guilford Press; 2004.
[14] Le Couteur A, Lord C, Rutter M. Autism diagnostic interview-revised (ADI-R). Los
Angeles: Western Psychological Services; 2003.
[15] Arshad M, Fitzgerald M. Did Michelangelo (1475-1564) have high-functioning au
tism? Journal of medical biography 2004; 12 (2): 115-20.
181
182
[16] Fitzgerald M. Einstein: brain and behavior. Journal of autism and developmental dis
orders 2000; 30 (6): 620-621.
[17] Fitzgerald M. Ludwig Wittgenstein: autism and philosophy. Journal of autism and
developmental disorders 2000; 30 (6): 621-622.
[18] Beveridge A. Diagnosis of historical figures. Journal of medical biography 2004; 12
(3): 126-127.
[19] Little C. Which is it? Asperger's Syndrome or giftedness? Defining the differences.
Gifted Child Today 2002; 25 (1): 58-63.
[20] Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a "theory of mind"?
Cognition 1985; 21 (1): 37-46.
[21] Frith U. Autism: explaining the enigma. Malden, MA: Blackwell Publishing; 1989.
[22] Ozonoff, S., Pennington, B. F. & Rogers, S. J. (1991). Executive function deficits in
high-functioning autistic individuals: relationship to theory of mind. Journal of child
psychology and psychiatry, and allied disciplines, 32 (7), 1081-1105.
[23] Baron-Cohen S. The extreme male brain theory of autism. Trends in cognitive scien
ces 2002; 6 (6): 248-254.
[24] Frith U, Happ F. Theory of mind and self consciousness: What is it like to be autis
tic? Mind and Language 1999; 14: 1-22.
[25] Kunda M, Goel AK. Thinking in pictures: a fresh look at cognition in autism. In: Love
B, McRae K, Sloutsky V (eds.) Proceedings of the 30th annual conference of the Cog
nitive Science Society. Austin, TX; 2008. p321-326.
[26] Kunda M, Goel AK. Thinking in Pictures as a cognitive account of autism. Journal of
autism and developmental disorders 2011; 41 (9): 1157-1177.
[27] Kanner L. Irrelevant and metaphorical language in early infantile autism. The Ameri
can journal of psychiatry 1946; 103: 242-246.
[28] Lyons V, Fitzgerald M. Asperger (1906-1980) and Kanner (1894-1981), the two pio
neers of autism. Journal of autism and developmental disorders 2007; 37(10):
2022-2023.
[29] Romero-Mungua MA. Es la memoria procesal deficiente la causa del comporta
miento estereotipado en el autismo? Psiquiatra, rgano Oficial de Difusin de la
Asociacin Psiquitrica Mexicana, A.C., 1998; 14 (2): 62-65.
[30] Gabis L, Huang W, Azizian A, Devincent C, Tudorica A, Kesner-Baruch Y, Roche P,
Pomeroy J. 1H-magnetic resonance spectroscopy markers of cognitive and language
ability in clinical subtypes of autism spectrum disorders. Journal of child neurology
2008; 23 (7): 766-774.
[31] Lord C, Petkova E, Hus V, Gan W, Lu F, Martin DM, Ousley O, Guy L, Bernier R,
Gerdts J, Algermissen M, Whitaker A, Sutcliffe JS, Warren Z, Klin A, Saulnier C,

http://dx.doi.org/10.5772/54295
Hanson E, Hundley R, Piggot J, Fombonne E, Steiman M, Miles J, Kanne SM, GoinKochel RP, Peters SU, Cook EH, Guter S, Tjernagel J, Green-Snyder LA, Bishop S, Es
ler A, Gotham K, Luyster R, Miller F, Olson J, Richler J, Risi S. A multisite study of
the clinical diagnosis of different autism spectrum disorders. Archives of general
psychiatry 2012; 69 (3): 306-313.
[32] Howlin P. Outcome in high-functioning adults with autism with and without early
language delays: implications for the differentiation between autism and Asperger
syndrome. Journal of autism and developmental disorders 2003; 33 (1): 3-13.
[33] Kurita H. How to deal with the transition from Pervasive Developmental Disorders
in DSM-IV to Autism Spectrum Disorder in DSM-V. Psychiatry and clinical neuro
sciences 2011; 65 (7): 609-610.
[34] McPartland JC, Reichow B, Volkmar FR. Sensitivity and specificity of proposed
DSM-5 diagnostic criteria for autism spectrum disorder. Journal of the American
Academy of Child and Adolescent Psychiatry 2012; 51 (4): 368-383.
[35] Mercadante MT, Van der Gaag RJ, Schwartzman JS. Non-Autistic Pervasive Develop
mental Disorders: Retts syndrome, childhood disintegrative disorder and pervasive
developmental disorder not otherwise specified. Revista brasileira de psiquiatria
2006; 28 (Suppl. 1): 12-20.
[36] Budson AE, Price BH. Memory: clinical disorders. In: Nature Publishing Group.
(Ed.). Nature encyclopedia of life sciences. London, UK: Macmillan Publishers Ltd,
2001; 11: 529-536.
[37] Magalln S, Narbona J Deteccin y estudios especficos en el trastorno de aprendizaje
procesal. Revista de Neurologa 2009; 48 (Suppl 2): 71-76.
[38] Ullman MT. The declarative/procedural model of lexicon and grammar. Journal of
Psycholinguistic Research 2001; 30 (1): 37-69.
[39] Romero-Mungua MA. Trastorno de aprendizaje no verbal frente a trastorno del es
pectro autista. Revista de Neurologa 2009; 49 (8): 448.
[40] Maras KL, Gaigg SB, Bowler DM. Memory for emotionally arousing events over time
in autism spectrum disorder. Emotion 2012; doi: 10.1037/a0026679.
[41] Lovaas OI. The autistic child. New York, NY: Irvington Publishers; 1977.
[42] Klinger LG, Klinger MR, Pohlig R. Implicit learning impairments in autism spectrum
disorders: Implications for treatment. In: Prez JM, Gonzlez PM, Com ML, Nieto C
(eds.) New developments in autism: The future is today. London, UK: Jessica Kings
ley; 2007. p76-103.
[43] Mostofsky SH, Goldberg MC, Landa RJ, Denckla MB. Evidence for a deficit in proce
dural learning in children and adolescents with autism: implications for cerebellar
contribution. Journal of the International Neuropsychological Society: JINS 2000; 6
(7): 752-759.
183
184
[44] Romero-Mungua MA. Memoria procesal deficiente y alteraciones de la comunica

cin en la patogenia del autismo infantil. Neurologa, Neurociruga y Psiquiatra
2002; 35 (4): 203-208.
[45] Beversdorf DQ, Smith BW, Crucian GP, Anderson JM, Keillor JM, Barrett AM,
Hughes JD, Felopulos GJ, Bauman ML, Nadeau SE, Heilman KM. Increased discrimi
nation of "false memories" in autism spectrum disorder. Proceedings of the National
Academy of Sciences of the United States of America 2000; 97(15): 8734-8737.
[46] Walenski M, Mostofsky SH, Gidley-Larson JC, Ullman MT. Brief report: enhanced
picture naming in autism. Journal of autism and developmental disorders 2008; 38
(7): 1395-1399.
[47] Barnes KA, Howard JH Jr, Howard DV, Gilotty L, Kenworthy L, Gaillard WD, Vai
dya CJ. Intact implicit learning of spatial context and temporal sequences in child
hood autism spectrum disorder. Neuropsychology 2008; 22 (5): 563-570.
[48] Brown J, Aczel B, Jimnez L, Kaufman SB, Grant KP. Intact implicit learning in au
tism spectrum conditions. The quarterly journal of experimental psychology 2010; 63
(9): 1789-1812.
[49] Nemeth D, Janacsek K, Balogh V, Londe Z, Mingesz R, Fazekas M, Jambori S, Danyi
I, Vetro A. Learning in autism: implicitly superb. PloS one 2010; 5 (7): e11731.
[50] Gordon B, Stark S. Procedural learning of a visual sequence in individuals with au
tism. Focus on autism and other developmental disabilities 2007; 22 (1): 14-22.
[51] Poirier M, Martin JS, Gaigg SB, Bowler DM. Short-term memory in autism spectrum
disorder. Journal of abnormal psychology 2011; 120 (1): 247-252.
[52] Altgassen M, Koban N, Kliegel M. Do adults with autism spectrum disorders com
pensate in naturalistic prospective memory tasks? Journal of autism and develop
mental disorders 2012; 42 (10): 2141-2151.
[53] Brandimonte MA, Filippello P, Coluccia E, Altgassen M, Kliegel M. To do or not to
do? Prospective memory versus response inhibition in autism spectrum disorder and
attention-deficit/hyperactivity disorder. Memory 2011;19 (1): 56-66.
[54] Mottron L. Matching strategies in cognitive research with individuals with highfunctioning autism: current practices, instrument biases, and recommendations. Jour
nal of autism and developmental disorders 2004; 34 (1): 19-27.
[55] Joseph R, Tager-Flusberg H, Lord C. Cognitive profiles and social-communicative
functioning in children with autism spectrum disorder. Journal of Child Psychology
and Psychiatry 2002; 43: 807821.
[56] Romero-Mungua MA. Mnesic imbalance and the neuroanatomy of autism spectrum
disorders. In: Eapen V (ed.). Autism A Neurodevelopmental Journey from Genes to
Behaviour. Rijeka: InTech;2011. p425-444.

http://dx.doi.org/10.5772/54295
[57] Ashby GF, Crossley MJ. Interactions between declarative and procedural-learning
categorization systems. Neurobiology of learning and memory 2010; 94 (1): 1-12.
[58] O'Hearn K, Schroer E, Minshew N, Luna B. Lack of developmental improvement on
a face memory task during adolescence in autism. Neuropsychologia 2010; 48 (13):
3955-3960.
[59] Kleinhans NM, Johnson LC, Richards T, Mahurin R, Greenson J, Dawson G, Aylward
E. Reduced neural habituation in the amygdala and social impairments in autism
spectrum disorders. The American journal of psychiatry 2009; 166 (4): 467-475.
[60] Kleinhans NM, Johnson LC, Mahurin R, Richards T, Stegbauer KC, Greenson J, Daw
son G, Aylward E. Increased amygdala activation to neutral faces is associated with
better face memory performance. Neuroreport 2007; 18 (10): 987- 991.
[61] Wilkinson DA, Best CA, Minshew NJ, Strauss MS. Memory awareness for faces in in
dividuals with autism. Journal of autism and developmental disorders 2010; 40 (11):
1371-1377.
[62] Tsatsanis KD, Noens IL, Illmann CL, Pauls DL, Volkmar FR, Schultz RT, Klin A.
Managing complexity: impact of organization and processing style on nonverbal
memory in autism spectrum disorders. Journal of autism and developmental disor
ders 2011; 41(2): 135-147.
[63] Zalla T, Daprati E, Sav AM, Chaste P, Nico D, Leboyer M. Memory for self-per
formed actions in individuals with Asperger syndrome. PloS one. 2010; 5(10): e13370.
[64] Yerys BE, Wallace GL, Jankowski KF, Bollich A, Kenworthy L. Impaired Consonant
Trigrams Test (CTT) performance relates to everyday working memory difficulties in
children with autism spectrum disorders. Child neuropsychology: a journal on nor
mal and abnormal development in childhood and adolescence 2011: 17 (4):391-399.
[65] Boucher J, Mayes A, Bigham S. Memory in Autistic Spectrum Disorder. Psychologi
cal bulletin 2012; doi: 10.1037/a0026869.
[66] Southwick JS, Bigler ED, Froehlich A, Dubray MB, Alexander AL, Lange N, Lainhart
JE. Memory functioning in children and adolescents with autism. Neuropsychology
2011;25 (6): 702-710.
[67] Crane L, Pring L, Jukes K, Goddard L. Patterns of Autobiographical Memory in
Adults with Autism Spectrum Disorder. Journal of autism and developmental disor
ders 2012; doi: 10.1007/s10803-012-1459-2.
[68] Schacter DL. Searching for memory: the brain, the mind, and the past. New York,
NY: Basic Books; 1997.
[69] Grilli MD, Glisky EL. Self-imagining enhances recognition memory in memory-im
paired individuals with neurological damage. Neuropsychology 2010;24 (6): 698-710.
[70] Liu KP, Chan CC, Lee TM, Hui-Chan CW. Mental imagery for relearning of people
after brain injury. Brain injury 2004;18 (11): 1163-1172.
185
186
[71] Nippold MA, Duthie JK. Mental imagery and idiom comprehension: a comparison of
school-age children and adults. Journal of speech, language and hearing research
2003; 46 (4): 788-799.
[72] Kerr S, Durkin K. Understanding of thought bubbles as mental representations in
children with autism: implications for theory of mind. Journal of autism and devel
opmental disorders 2004; 34 (6): 637-648.
[73] Wellman HM, Baron-Cohen S, Caswell R, Gomez JC, Swettenham J, Toye E, Lagattu
ta K. Thought-bubbles help children with autism acquire an alternative to a theory of
mind. Autism: the international journal of research and practice 2002; 6 (4): 343-363.
[74] Day SB, Gentner D. Nonintentional analogical inference in text comprehension.
Memory & cognition 2007; 35 (1): 39-49.
[75] de Gortari E. Introduccin a la lgica dialctica. Mxico, DF: Fondo de Cultura Eco
nmica; 1956.
[76] Gross WL, Greene AJ. Analogical inference: the role of awareness in abstract learn
ing. Memory 2007; 15 (8): 838-844.
[77] Dalphonse S. Dustin and me. The Washingtonian 1992, 27; (10): 50-55 & 136-138.
[78] Treffert DA, Christensen DD. Inside the mind of a savant. Scientific American 2005;
293 (6): 108-113.
[79] Foer J. Remember this. National Geographic 2007; (11): 32-57.
[80] Coto A. Entrenamiento mental. Madrid, ES: Editorial Edaf; 2006.
[81] Sacks O. The Twins. In: The man who mistook his wife for a hat and other clinical
tales. New York, NY: Harper Perennial; 1990. p195-213.
[82] Marcus G. Total recall: the woman who can't forget. Wired 2009; (17): e04.
[83] Lorayne H. How to develop a super-power memory. New York, NY: Frederick Fell;
1957.
[84] Henner M. Total Memory Makeover: Uncover Your Past, Take Charge of Your Fu
ture. New York, NY: Gallery Books; 2012.
[85] Ally BA, Hussey EP, Donahue MJ. A case of hyperthymesia: rethinking the role of
the amygdala in autobiographical memory. Neurocase 2012; doi: 10.1080/13554794.
2011.65422.
[86] Ericsson KA, Delaney PF, Weaver G, Mahadevan R. Uncovering the structure of a
memorist's superior "basic" memory capacity. Cognitive psychology 2004; 49 (3):
191-237.
[87] Takahashi M, Shimizu H, Saito S, Tomoyori H. One percent ability and ninety-nine
percent perspiration: a study of a Japanese memorist. Journal of experimental psy
chology. Learning, memory, and cognition 2006; 32 (5): 1195-1200.

http://dx.doi.org/10.5772/54295
[88] Hu Y, Ericsson KA, Yang D, Lu C. Superior self-paced memorization of digits in

spite of a normal digit span: the structure of a memorist's skill. Journal of experimen
tal psychology. Learning, memory, and cognition 2009; 35 (6): 1426-1442.
[89] Neumann N, Dubischar-Krivec AM, Braun C, Lw A, Poustka F, Blte S, Birbaumer
N. The mind of the mnemonists: an MEG and neuropsychological study of autistic
memory savants. Behavioural brain research 2010; 215 (1): 114-121.
[90] Maguire EA, Valentine ER, Wilding JM, Kapur N. Routes to remembering: the brains
behind superior memory. Nature neuroscience 2003; 6 (1): 90-5.
[91] Goldberg TE. On hermetic reading abilities. Journal of autism and developmental
disorders 1987; 17 (1): 29-44.
[92] Buzan T. Use your perfect memory. Ney York, NY: E.P. Dutton, Inc.; 1984.
[93] Yaro C, Ward J. Searching for Shereshevskii: what is superior about the memory of
synaesthetes? The quarterly journal of experimental psychology : QJEP. 2007; 60 (5):
681-695.
[94] Ericsson KA. Exceptional memorizers: made, not born. TRENDS in Cognitive Scien
ces 2003; 7 (6): 233-235.
[95] Bekinschtein TA, Cardozo J, Manes FF. Strategies of Buenos Aires waiters to enhance
memory capacity in a real-life setting. Behavioural neurology 2008; 20 (3): 65-70.
187
Chapter 10
Genetic Evaluation of
Individuals with Autism Spectrum Disorders
Eric C. Larsen, Catherine Croft Swanwick and
Sharmila Banerjee-Basu
http://dx.doi.org/10.5772/53900
1. Introduction
While the genetic component of Autism Spectrum Disorders (ASD) has been clearly estab
lished from various lines of study, the multitude of genes and chromosomal loci associated
with ASD has made identification of the underlying molecular mechanisms of pathogenesis
difficult to resolve. A range of diverse methodologies and study types have identified both
rare and common genetic variants in ASD candidate genes and chromosomal loci. Moreover,
the recent development of high-throughput next generation sequencing (NGS) technologies
and the increasing usage of chromosomal microarray analysis (CMA) has led to a significant
expansion in the number of single nucleotide variants (SNVs) and copy number variants
(CNVs) potentially affecting one or more genes that have been identified in ASD individuals.
This, in turn, has given critical insight into the molecular and cellular processes that may be
preferentially targeted for disruption by genetic lesions in ASD patients.
However, it is important to note that there is no genetic test available for the diagnosis of ASD.
Rather, genetic testing is primarily aimed at identifying genetic variants potentially responsi
ble for disease pathogenesis in a given individual diagnosed with ASD. Furthermore, the
utility of NGS and CMA in genetic evaluation of ASD individuals is dependent on proper
interpretation and reporting of test results. In this chapter we will discuss 1) genetic testing
technologies currently available for the identification of genetic variation in ASD cases, 2) the
genes and genomic loci targeted by single nucleotide and copy number variants that have been
linked to ASD susceptibility, 3) the bioinformatics tools that enable researchers to process the
enormous amount of genetic data associated with ASD, and 4) challenges that exist in the
interpretation and reporting of genetic evaluation results in ASD cases.
2013 Larsen et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
192
2. Genetic screening technologies for the evaluation of ASD cases

Autism spectrum disorders (ASD) are among the most highly heritable neurodevelopmental
disorders, and extensive research has been focused on identifying the underlying genetic ba
sis of these disorders. It has become apparent that ASD is a genetically heterogeneous disor
der, with hundreds of genes and chromosomal rearrangements identified that confer
varying degrees of risk for disease. Initially, susceptibility genes and genomic loci were
identified by costly, low-throughput techniques, such as automated Sanger sequencing and
conventional cytogenetic techniques. The need for lower-cost, higher-throughput genetic
screening technologies capable of identifying genome-wide variation in individuals with ge
netically complex diseases, such as ASD, has driven improvements in pre-existing techni
ques and the development of new technologies. The genetic screening technologies
presently available to clinical geneticists and researchers are capable of providing lowercost, high-throughput genetic data that have significantly expanded our knowledge of ge
netic variation, both in the general population and in ASD individuals in particular. The first
major high-throughput studies aimed at identifying CNVs and SNVs in ASD cohorts were
published in 2010 and 2011, respectively [1, 2]. Here we describe in greater detail two of
these genetic screening technologies that have become widely used in the genetic evaluation
of ASD cases: next generation sequencing (NGS) and chromosomal microarray (CMA).
2.1. Next generation sequencing
Next-generation sequencing (NGS) is a term used to describe a collection of high-through
put sequencing technologies that have enabled clinicans to screen larger amounts of genetic
material at lower cost than traditional sequencing technologies, such as automated Sanger
sequencing [3]. NGS is typically used to identify single nucleotide variants (SNVs), as well
as small insertions or deletions in candidate genes. However, NGS can also be used to iden
tify copy number variants (CNVs), as was recently demonstrated in a report detailing whole
exome sequencing in a cohort of ASD cases [4], as well as balanced chromosomal rearrang
ments, which are typically not detected by genome-wide microarrays [5, 6]. Since 2011, six
research articles have been published that have identified rare variants in both existing and
novel ASD susceptibility genes using NGS techniques [2, 4, 7-10], a fact that illustrates how
extensively these techniques have been adopted by the ASD research community. As a re
sult of these studies, the potential number of potential ASD-linked genes have increased
dramatically (Table 1). Furthermore, as demonstrated by the minimal overlap of candidate
genes across these studies, the results of these studies further illustrate the genetic heteroge
neity of ASD.
NGS techniques are typically divided into three categories, each with its own advantages
and disadvantages (summarized in Table 2). These techniques vary in terms of genetic cov
erage (the size of the sequenced target, which can range in size from one or a few genes to
the entire genome) and genetic resolution (sensitivity in detection of variants per sequencing
target). In general, the smaller the genetic coverage, the higher the genetic resolution. It
should be noted that, as the size of the target for sequencing increases, so does the number
Genetic Evaluation of Individuals with Autism Spectrum Disorders

http://dx.doi.org/10.5772/53900
of both false-positive and false-negative variants [11]; this is one of the many considerations
that must be taken into account in deciding which NGS technique to utilize.
Exome Report
Total # of genes
# of unique genes
# of overlapping genes
O'Roak 2011
21
21
Sanders 2012
170
166
O'Roak 2012
240
227
13
Neale 2012
173
168
Chahrour 2012
53
53
Iossifov 2012
363
338
25
Total
1020
973
47
Table 1. Six recent scientific articles describing rare genetic variants identified in ASD cases by next generation
sequencing (NGS) has led to a dramatic increase in the number of potential ASD candidate genes and further
illustrates the genetic heterogeneity of ASD. Overlapping genes are genes in which a rare variant was identified in
more than one exome report and are used as a measure of genetic heterogeneity.
Availability
Targeted gene Commercially
panels
Cost
~$5000
available
Advantages
Disadvantages
-Highest resolution of NGS
-Unable to detect variants
approaches
in genes not included in the
-Contains a number of well- panel

characterized ASD
susceptibility genes
(syndromic and nonsyndromic)
Whole exome
Available only in
sequencing
research settings
~$1000
-Estimated to detect the
-Unable to detect variants
majority of disease-
in non-coding regions
covering variants
Whole
Available only in
genome
research settings
sequencing
~$4000-$5000
-Greatest coverage of the
-Lowest resolution of NGS
genome (both coding and
techniques
non-coding regions)
193
194
Availability
Cost
Advantages
Disadvantages
-Higher cost than whole
exome sequencing
Table 2. A summary of the benefits and drawbacks of the three types of next generation sequencing (NGS) techniques in
the genetic evaluation of ASD cases. Cost estimates of whole-exome and whole-genome sequencing in [14].
2.1.1. Targeted gene panels

Targeted gene panels generally test for 50-100 genes that have been demonstrated to be strong
ly associated with a particular disease. Such gene panels are already extensively used to screen
individuals for a wide range of cancers and inherited diseases for which causative genes have
been identified. A number of commercially-available ASD gene panels have recently been de
signed to target both genes strongly associated with non-syndromic ASD as well as syndromic
genes (genes that cause syndromes in which a subset of affected individuals also develop ASD,
such as FMR1, MECP2, and CACNA1C, which cause Fragile X, Rett, and Timothy syndromes,
respectively). For example, the Greenwood Genetic Center offers a 62-gene syndromic gene
panel that covers the coding region and flanking intronic boundaries of ASD-linked 62 genes
for $5500 (http://www.ggc.org/images/pdfs/syndromicautism62-genengspanel.pdf). While
targeted gene panels offer the smallest coverage of the human genome of the three NGS ap
proaches, they offer the highest resolution. One of the major drawbacks to the use of targeted
gene panels for a genetically heterogeneous disorder such as ASD is the inability to detect mu
tations in genes outside of those included in the gene panel.
2.1.2. Whole exome sequencing
Whole exome sequencing, which is also known as targeted exome capture, is designed to spe
cifically identify variants in protein-coding regions of the human genome. Although these pro
tein-coding regions, called exons, constitute a very small percentage of the human genome, it is
estimated that they contain up to 85% of disease-causing mutations [12, 13]. However, whole
exome sequencing will fail to detect any potentially pathogenic variants in non-coding regions
of the human genome. This NGS method also provides lower resolution than targeted gene
panels. Nonetheless, whole exome sequencing is increasingly being used to identify potential
ly pathogenic rare single gene variants in individuals with ASD [2, 4, 7-10].
2.1.3. Whole genome sequencing
In contrast to whole exome sequencing, which only covers protein-coding regions of the
human genome, whole genome sequencing provide coverage of the entire genome, allowing
for the sequencing of both coding and non-coding genomic regions. As such, single nucleotide
changes and small insertions/deletions within non-coding regions of the genome can be
detected by this method. While whole genome sequencing covers the largest amount of the
human genome of all NGS techniques, it offers the lowest resolution of the three NGS
technologies. Whole genome sequencing is also more costly than whole exome sequencing,

http://dx.doi.org/10.5772/53900
although the differences in cost betwen these two techniques have fallen from 10- to 20-fold
[13] to 4- to 5-fold [14].
2.2. Chromosomal microarray
Microscopically-visible chromosomal rearrangments have long been implicated in the onset
and pathogenesis of neurodevelopmental disorders, includng ASD. Indeed, many of the most
strongly ASD-linked chromosomal deletions and duplications, collectively referred to as copy
number variants (CNVs), were discovered through the use of conventional cytogenetic
techniques such as G-banded karyotyping, fluorescent in situ hybridization (FISH), and
microsatellite analysis. For example, duplications of chromosome 15q11-q13 were first
implicated in ASD in the mid-1990s by these methods [15-17]. Likewise, these methods
identified chromosomal rearrangments on the long arm of chromosome 22 in ASD cases [18,
19]. However, conventional cytogenetic techniques are impractical in the identification of copy
number variation throughout the human genome in large case cohorts. While G-banded
karyotyping is capable of detecting large chromosomal deletions and duplications (~1 Mb and
larger), it lacks the sensitivity to detect smaller CNVs. Alternatively, the use of techniques such
as FISH is generally limited to screen a particular chromosomal region, so while they are useful
for examining copy number variation in a genomic loci of interest in larger case populations,
they are impractical for the purposes of identifying deletions and duplications throughout the
genome.
In the last decade, technological and computational advances have allowed clinical geneticists
and researchers to detect submicroscopic chromosomal deletions and duplications throughout
the human genome in large case cohorts that would not be detected by traditional cytogenetic
techniques. Chromosomal microarray (CMA) is a term frequently used to include all types of
array-based whole genome copy number analyses, with the two most widely used being arraycomparative genomic hybridization (aCGH) and single nucleotide polymorphism (SNP)
arrays. CMA has been demonstrated to provide a higher diagnostic yield than G-banded
karyotyping (15-20% compared to ~3%) due to its ability to detect submicroscopic deletions
and duplications, and it has been proposed that CMA should replace conventional cytogenetic
techniques as a first-tier diagnostic tool for individuals with congential abnormalities and
developmental disorders, including ASD [20]. High-throughput genome-wide aCGH and SNP
arrays are now regularly used in the detection of CNVs in large ASD cohorts [1, 21-24].
aCGH and SNP arrays employ similar methodologies in the detection of CNVs (Figure 1). The
first step involves labeling the DNA of the ASD patient with a fluorophore, thereby creating
a test sample. The test sample is then mixed with an equal amount of DNA from a normal
reference sample that has been labeled with a different fluorophore. This mixed DNA sample
is added to a glass slide containing thousands of oligonucleotide probes corresponding to
different chromosomal regions that cover the human genome; in the case of SNP arrays, the
oligonucleotide probes are specific for common polymorphisms found in the general popu
lation. The sensitivity of CMA has been greatly increased in recent years by the development
of arrays employing a larger number of smaller oligonulceotide probes; in doing so, clinical
geneticists and researchers are able to detect even smaller copy number changes than before
195
196
without compromising genomic coverage. The test and reference DNA samples hybridize with
the probes on the slide, and the fluorescence intensities of the test and reference DNA can then
be measured. Following analysis with software that is typically specific for the platform being
used, one or more algorithms are used to call the CNV. The ratio between the two fluorescence
intensities is used to identify copy number changes. For example, if the test-to-reference ratio
is 1 (yellow in the example below), then there is no change in copy number at the chromosomal
region corresponding to a given probe, If the test-to-reference fluorescence ratio is > 1 for a
particular probe (green in the example below), then the ASD patient carries a duplication in
the chromosomal region corresponding to that probe. If the test-to-reference ratio is < 1 (red
in the example below), then the patient carries a deletion at that site of the genome.
Figure 1. Chromosomal microarray (CMA) analysis involves hybridization of differently labeled test and reference DNA
samples with oligonucleotide probes, followed by computerized analysis and identification of copy number variants
(CNVs) based on changes in fluorescence intensity ratio.
Despite the recommended use of CMA as a first-tier genetic evaluation tool in place of conven
tional cytogenetic techniques, it should be noted that aCGH is unable to detect balanced chro
mosomal rearrangments and other chromosomal abnormalities that have traditionally been
detected by karyotype analysis [25]. In addition to their traditional utilization in the detection
of risk-conferring common polymorphisms, SNP arrays have the added advantage of being
able to detect copy number neutral genetic variation such as uniparental disomy and long con
tiguous streteches of homozygosity (LCSH) that cannot be detected by aCGH [25, 26].
3. Genetic variation in ASD

With the advent of NGS techniques and increasing usage of CMA screening, the number of
SNVs and CNVs that have been identified in ASD individuals has grown significantly. Based
on a survey of recently published exome sequencing studies of ASD cohorts, it was estimated
that the number of dosage-sensitive ASD susceptibility genes is approximately 370, with
roughly a third of these genes having been identified [10]. However, even this number might
be a conservative projection. As shown in Figure 2, the number of ASD susceptibility genes in

http://dx.doi.org/10.5772/53900
the Human Gene Module of the autism genetic database AutDB [27] has increased from 284
genes in September 2011 to 369 genes in June 2012. A large number of newer susceptibility
genes have been annotated from reports employing whole exome sequencing of ASD cases [2,
4, 7-10], illustrating the increasing usage of NGS techniques in the study of genetic variation
in ASD. In addition to the identification of novel ASD susceptibility genes, NGS techniques
have identified novel rare variants in previously identified ASD susceptibility genes. The
number of ASD-associated CNV loci has also increased significantly, with the CNV module
of AutDB expanding from 1034 CNV loci in September 2011 to 1173 loci in June 2012 (Figure
2). In this section we describe the genetic categories into which ASD susceptibility genes have
been classified, as well as describe recent studies that have yielded invaluable insight on the
functional profiles of ASD-associated genes and CNV loci.
Figure 2. The number of genes and CNV loci associated with ASD in the genetic database AutDB has increased over
the last four quarterly release dates.
3.1. Genetic categories of ASD susceptibility genes

The earliest ASD susceptibility genes were rare single gene variants in genes associated with
syndromes such as Fragile X syndrome and Rett syndrome. The discovery of single gene
mutations/disruptions in two neuroligin genes, NLGN3 and NLGN4, in ASD siblings [28]
initiated the search for additional ASD susceptibility genes in non-syndromic ASD cases. The
continued identification of rare genetic variants associated with both syndromic and nonsyndromic ASD, as well as of risk-conferring polymorphisms enriched in ASD populations
197
198
compared to unaffected controls in genetic association studies, has led to significant increases
in the number of ASD-linked genes. While the majority of ASD-associated genes have been
linked to disease on the basis of genetic studies in human populations, a number of additional
ASD-linked genes have been identified by alternate methodologies, such as gene expression
studies in post-mortem brain tissue of ASD individuals.
ASD susceptibilty genes in the Human Gene Module of AutDB are defined into four distinct
categories:
1. Rare. This category features genes implicated in rare monogenic forms of non-syndromic
ASD. Rare allelic variants within this category include single nucleotide variants, small
insertions and deletions, chromosomal rearrangements such as translocations and inversions,
and monogenic submicroscopic deletions and duplications. Among the genes within this
category are CACNA1H and SHANK1.
2. Syndromic. Syndromic genes were among the first genes for which rare genetic variants
linked to autism were identifed. In addition to well-characterized syndromic genes such as
FMR1 (Fragile X syndrome), MECP2 (Rett syndrome), and CACNA1C (Timothy syndrome),
genes such as CHD7 and SLC9A6 fall into the syndromic category.
3. Association. This category includes genes in which small risk-conferring common poly
morphisms have been identified from genetic association studies in idiopathic ASD popula
tions. Among the genes within this category are MET and MTHFR.
4. Functional. This category includes functional candidate genes that have not yet been
experimentally linked to ASD by genetic studies. Among the genes in this category are BCL2
and PDE4B, whose inclusion is based on changes in gene expression in post-mortem brain
tissue of ASD subjects.
As shown in Figure 3, while the number of both rare and common ASD-associated variants in
the Human Gene module of AutDB has increased over the last four quarterly release dates,
the number of rare variants has increased at a much greater rate than the number of common
variants. The number of rare variants increased from 1141 in September 2011 to 1675 in June
2012, an increase of ~146%. In contrast, the number of common variants rose form 508 to 575
over the same span of time, an increase of only ~113%. This disparity between the addition of
rare and common variants to AutDB is in part due to the increased usage of NGS and CMA
and subsequent identification of rare ASD-associated variants in large ASD cohorts.
It should be noted that a given gene can fall under multiple genetic categories, depending on
the affected population under investigation and the type of study. For example, both rare
variants and risk-conferring common polymorphisms have been identified in the CNTNAP2
gene in ASD individuals across multiple studies [2, 29-31] However, in addition to its role as
an ASD susceptibility factor, recent studies suggest that rare variants in CNTNAP2 are
responsible for two additional syndromes: cortical dysplasia-focal epilepsy syndrome [32] and
Pitt-Hopkins-like syndrome 1 [33]. Therefore, based on the combined evidence from all of these
aforementioned studies, CNTNAP2 is classified in AutDB as a syndromic gene, a rare gene,
and an association gene.

http://dx.doi.org/10.5772/53900
The classification of ASD-linked genes into genetic categories is a useful tool in assessing the
strength of the evidence for the connection of a given gene with ASD. Genes within the rare
and syndromic categories are generally considered to have the strongest link to ASD [34]. Due
to the frequent lack of replication in their association with ASD from one study to the next,
genes within the association category are considered to have a weaker link to ASD than genes
within the rare and syndromic categories. Genes within the functional category have no direct
documented connection to ASD and are therefore considered to be among the weakest ASD
candidate genes.
Figure 3. The number of rare and common ASD-associated variants in the Human Gene module of AutDB has in
creased over the last four quarterly release dates.
3.2. Functional profiles of ASD-associated genes and CNV loci

The increasing number of ASD-associated genetic factors, as shown in Figure 2, has only added
to the well-established genetic heterogeneity of ASD. In spite of the complexity caused by this
genetic heterogeneity, bioinformatic analysis of ASD-linked genes and CNV loci has yielded
valuable insight into the molecular interactions and cellular pathways preferentially targeted
by genetic lesions in individuals with ASD. Not only can this information be potentially used
to design therapeutic approaches targeting disrupted pathways, but it can also aid in assessing
the clinical importance of newly-discovered ASD candidate genes and CNV loci in which
pathogenic variants are identified by NGS and CMA, respectively. For example, a gene whose
encoded gene product resides within a known ASD-associated cellular process or interacts
with a known ASD-associated gene is a stronger candidate than a gene that fails to reside
within known ASD-associated cellular processes or interact with known ASD-associated
genes.
199
200
Recent large-scale ASD genetic studies have used a systems biology approach to translate ge
netic information into functional profiles that shed light on how genetic variation in ASD may
lead to disease onset and pathogenesis. Rare CNVs identified in large ASD cohorts have been
shown to be enriched for genes involved in cellular processes of relevance for ASD, including
cellular proliferation, projection, and motility, and GTPase/Ras signaling [1], neuronal cell ad
hesion and ubiquitin-mediated degradation [22], glycobiology [35], axon growth and path
finding [36], and synapse development, axon targeting, and neuron motility [37]. Gene
datasets from genome-wide association studies in ASD populations were demonstrated to be
enriched for Gene Ontology (GO) classifications for cellular processes including pyruvate me
tabolism, transcription factor activation, cell signaling and cell-cycle regulation [38]. A recent
report describing gene pathway analysis using single nucleotide polymorphism (SNP) data
from the Autism Genetics Research Exchange (AGRE) identified cellular pathways such as cal
cium signaling, long-term depression and potentiation, and phosphotidylinositol signaling
that reached statistical significance in both Central European and Han Chinese populations
[39]. More recently, whole exome sequencing studies in large ASD cohorts have demonstrated
that proteins encoded by genes in which potentially disruptive de novo mutations were identi
fied showed a higher degree of connectivity among themselves and to previously identified
ASD genes based on protein-protein interaction network analysis [4, 8]. Another exome se
quencing study in ASD individuals found that many of the genes in which potentially disrup
tive variants were identified associated with the Fragile X Mental Retardation Protein (FMRP),
the encoded product of the syndromic ASD gene FMR1 [10]. Taken together, these functional
maps suggest that specific cellular pathways and processes are preferentially targeted by ge
netic variation in ASD cases, and that association with the encoded products of well-character
ized ASD-linked genes offers evidence for pathogenic relevance.
Knowledge of ASD-associated genes can also be used to identify novel ASD candidate genes.
Following the construction of functional and expression profiles from a reference set of 84 rare
and syndromic ASD-linked genes, we generated a predictive map of novel ASD candidate
genes [40]. In total, 460 potential candidate genes were identified that overlapped both the
functional profile and the brain expression profile of the initial reference set. The power of this
predictive gene map was demonstrated by the capture of 18 pre-existing ASD-associated genes
that were not included in the reference gene dataset, with the remaining 442 genes serving as
novel ASD candidate genes. Since the publication of our predictive gene map, 12 of the novel
ASD candidate genes identified in [40] have been added to AutDB, demonstrating the
continued power of this analysis (manuscript in preparation).
4. Bioinformatics of ASD
With the rapid growth of genetic data obtained from ASD individuals, there has become a
critical need for databases specializing in the storage and assessment of this data. Here we
highlight several of the ASD-related genetics databases that are available to researchers.

http://dx.doi.org/10.5772/53900
4.1. AutDB
Our autism database AutDB (http://autism.mindspec.org/autdb/Welcome.do) is a webbased, searchable database of ASD candidate genes identified in genetic association stud
ies, genes linked to syndromic autism, and rare single gene mutations [27]. Evidence
regarding ASD candidate genes is systematically extracted from peer-reviewed, primary
scientific literature and manually curated by our researchers for inclusion in AutDB. To
provide high-resolution view of various components linked to ASD, we developed de
tailed annotation rules based on the biology of each data type and generated controlled
vocabulary for data representation. AutDB is widely used by individual laboratories in
the ASD research community, as well as by consortiums such as the Simons Foundation,
which licenses it as SFARI Gene.
AutDB is designed with a systems biology approach, integrating genetic information with
in the original Human Gene module to corresponding data in subsequent Animal Model,
Protein Interaction (PIN) and Copy Number Variant (CNV) modules. The Animal Model
module contains a comprehensive collection of mouse models linked to ASD [41]. While
the Animal Model module initially contained only genetic mouse models of ASD, it has
since been expanded to include induced mouse models of ASD in which a chemical or bi
ological agent linked to ASD has been administered. As core behavioral features of ASD
such as social interactions and communications can only be approximated in animal mod
els, the annotation strategy for this module includes four broad areas: 1) core behavioral
features of ASD, 2) ASD-related traits such as seizures and circadian rhythms that are her
itable and more easily quantified in animal models; 3) neuroanatomical features, and 4)
molecular profiles. To this end, we developed PhenoBase, a classification table for system
atically annotating models with controlled vocabulary containing 16 major categories and
>100 standardized phenotype terms. The PIN module of AutDB serves as a repository for
all known protein interactions of ASD candidate genes, documenting six major types of
direct interactions: 1) protein binding, 2) promoter binding, 3), RNA binding, 4) protein
modification, 5) direct regulation, and 6) autoregulation. Its content is envisioned to have
immediate application for network biology analysis of molecular pathways involved in
ASD pathogenesis. For the purposes of genetic evaluation of individuals with ASD,
knowledge of the protein interactions of ASD-associated genes can potentially aid in the
clinical assessment of novel ASD candidate genes based on their interactions, or lack
thereof, with known ASD-linked genes.
4.2. Gene scoring module of SFARI gene
As previously mentioned, AutDB is licensed to the Simons Foundation as SFARI Gene.
However, unlike AutDB, SFARI Gene includes a unique feature initiated by the Simons
Foundation called the Gene Scoring module (https://gene.sfari.org/autdb/GS_Home.do). The
Gene Scoring module is a web-based platform detailing the rank of ASD-associated genes in
the SFARI Gene Human Gene module [42]. With the increase in the number of genes linked
to ASD, a Gene Scoring initiative was launched to assess the ASD candidate genes based on a
set of standardized annotation rules. Following evaluation by an expert panel of advisors, the
201
202
gene assessment results are then integrated in the form of Gene Score Cards to display the
scores and the evidence in a graphical user interface for the ASD-linked gene. Recently, a
community-wide annotation functionality was incorporated into the Gene Scoring module,
allowing users to download the Gene Scoring dataset, score genes of their choice, and submit
their scores to SFARI for possible inclusion.
4.3. DECIPHER
DECIPHER (Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl
Resources) (http://decipher.sanger.ac.uk/) is an interactive web-based database that incorpo
rates a suite of tools designed to aid in the interpretation of submicroscopic chromosomal
deletions and duplications [43]. Genetic and phenotypic information is publically available
not only for individuals diagnosed with idiopathic ASD, but also for individuals diagnosed
with a recognized microdeletion or microduplication syndrome in which a subset of affected
individuals also develop ASD.
4.4. AutismKB
AutismKB (http://autismkb.cbi.pku.edu.cn/) is a web-based, searchable database hosted by the
Center for Bioinformatics, Peking University [44]. AutismKB is an evidence-based knowledge
resource for ASD genetics containing information on genes, copy number variants, and linkage
regions associated with ASD. Analysis of the gene content in AutismKB is available for users
in the form of GO term enrichment analysis using the DAVID functional annotation tool and
pathway enrichment analysis. Much like the Gene Scoring Module of SFARI Gene (see section
4.2), the genes within AutismKB are scored.
4.5. Autism Chromosome Rearrangement Database
The Autism Chromosome Rearrangement Database (http://projects.tcag.ca/autism/) is a webbased, searchable genetic database of chromosomal structural variation in ASD that is hosted
by The Centre for Applied Genomics at the Hospital for Sick Children in Toronto, Canada [21].
The content of this database, which is derived both from published research articles and inhouse experimental results, includes cytogenetic and microarray data from individuals with
ASD.
4.6. Autism Genetic Database
The Autism Genetic Database (http://wren.bcf.ku.edu/) is a web-based, searchable genetic
database developed by researchers at the University of Kansas [45]. In addition to ASDassociated genes and CNVs, this database also includes information on known non-coding
RNAs and chemically-induced fragile sites in the human genome.
Recent lines of evidence have placed non-coding RNAs under increased scrutiny with regards
to their potential pathogenic role in ASD. A number of small nucleolar RNAs (snoRNAs) reside
within the ASD-associated 15q11-q13 region. A mouse model engineered to mimic duplication
of the 15q11-q13 region observed in ~1% of ASD cases exhibited overexpression of the snoRNA

http://dx.doi.org/10.5772/53900
MBII52 (the mouse ortholog of the human snoRNA HBII52), which could potentially alter
serotonergic signaling and contribute in part to the ASD-associated traits exhibited by these
mice [46]. More recently, it was discovered that a non-coding RNA is transcribed from a genepoor region of chromosome 5p14.1 identified in genome-wide association studies of ASD
cohorts [47]. Expression of the non-coding RNA, designated MSNP1AS, was shown to be
higher both in individuals carrying the ASD-associated T allele and in post-mortem brain
tissue of individuals with ASD.
Spontaneous breakage during DNA replication at rare chromosomal fragile sites may also play
a role in the pathogenesis of neuropsychiatric disorders such as ASD. The chromosomal fragile
site FRAXA has been implicated in fragile X syndrome, and other fragile sites have been
identified that associate with ASD, such as FRA2B, FRA6A, and FRA13A [48].
5. Challenges of genetic evaluation in ASD

NGS and CMA have expanded the ability of clinical geneticists and researchers to identify
potential genetic causes of ASD. However, there are many challenges still present in the
field of genetic evaluation. A recent report in the American Journal of Medical Genetics
found that many children with ASD fail to get genetic evaluation, and that parents and
medical professionals need to be better educated about the potential benefits of genetic
evaluation [49]. Educating parents on genetic evaluation is especially critical in light of a
recent survey of nine parents regarding their childs participation in genetic research in
ASD [50], in which parents valued having had their child enrolled for a variety of rea
sons, including the potential use of genetic results in tailoring intervention and in family
planning, the establishment of connections with experts in the field of ASD, and network
ing with other families, among others.
Even with the increased sensitivity of genetic evaluation techniques, an underlying genetic
cause of ASD is still only identified in a minority (< 25%) of ASD cases [51]. One of the major
challenges in the clinical interpretation of NGS and CMA lies in differentiating between
pathogenic and benign genetic variants identified in ASD patients. The pathogenic relevance
of the vast majority of ASD-linked genetic variants remains unknown; such variants are
frequently classified as variants of unknown significance, or VOUS. While the identification
of a genetic lesion in an existing ASD susceptibility gene or CNV locus is suggestive of a
possible genetic cause of disease, variants in these genes and CNV loci have also been observed
in seemingly unaffected individuals. Furthermore, it is important to note that, while techno
logical advances have expanded the ability of clinical geneticists and researchers to identify
these potential genetic causes of ASD, there is no genetic test available for the diagnosis of
ASD. A recent report proposed a means of predicting a diagnosis of ASD based on the
identification of candidate SNPs [39]. The accuracy of the predictive classifier was found to be
71.7% in individuals of Central European descent from validation datasets. However, the
accuracy of the predictive classifier fell when tested in a Han Chinese cohort, a finding that
stresses how genetic heterogeneity across populations complicates the use of such an ap
203
204
proach. In addition, the overall accuracy of the predictive classifier is likely too low to serve
as an effective diagnostic tool.
A number of guidelines have already been proposed to aid clinicians and clinical geneticists
in the interpretation and reporting of CNVs. With the increasing use of high resolution NGS
technologies, similar guidelines will likely be proposed for the interpretation and reporting of
single nucleotide variants (SNVs). Furthermore, tools and prioritization schema have also been
developed to aid clinicians in the interpretation of genetic testing results. Here we discuss in
greater detail the challenges in interpreting genetic screening results in ASD cases, the
strategies that have been proposed for the interpretation and reporting of screening results,
and the resources available to aid in that interpretation.
5.1. Challenges in the interpretation of ASD genetic screening results
5.1.1. Technical limitations of NGS and CMA
As previously mentioned, as the size of the sequenced target increases, so does the poten
tial number of false-positive and false-negative variants identified [11]. Such sequencing
artifacts are particularly problematic for the detection of spontaneous, or de novo variants,
as false-positive variants would appear to be de novo in origin when they are observed in
an offsprings genome but not in parental genomes. Furthermore, the source of DNA used
in sequencing studies can introduce sequencing artifacts. DNA from lymphoblastoid cell
lines from individuals to be genetically evaluated is a commonly used template for se
quencing; however, the creation and culturing of these cell lines can introduce genetic
changes that would appear as de novo variants when such cell lines are compared between
parents and offspring. In order to remove or reduce the possibility of artifactual results,
subsequent variant validation should be performed. In the case of single gene variants
identified by NGS, a more targeted sequencing approach limited to the gene or region of
interest would confirm the variant previously identified. In the case of CNVs identified by
NGS or CMA, a targeted detection method such as quantitative real-time PCR or FISH is
frequently used to confirm their discovery.
5.1.2. Genetic heterogeneity
While the genetic basis of many human diseases can be traced back to one or a few genes,
the genetic basis of complex neuropsychiatric disorders such as ASD has proven to be far
more complicated, with hundreds of genes and genomic loci associated with varying risks
of disease. The recent utilization of NGS and CMA approaches in genetic evaluation of
ASD cases has led to the detection of genetic variation not only in both existing and novel
susceptibility genes and genomic loci. However, the strength of evidence for many of
these novel candidate genes or genomic loci is minimal, and some degree of replication in
follow-up studies will be required to fully assess the relevance of many of these newlyidentified variants.

http://dx.doi.org/10.5772/53900
5.1.3. Incompelete penetrance and variable expressivity

One of the major challenges in identifying potential causative genetic variation in ASD cases
lies in the fact that a potentially disruptive variant in a gene or genomic loci may not always
associate or segregate with disease. For example, a potentially pathogenic variant in a gene
may not only be present in an ASD individual, but it may also be present in seemingly
unaffected family members. Similarly, the pathogenic variant may also be observed in
seemingly unaffected individuals in the general population. This phenomenon, referred to as
incomplete penetrance, complicates the interpretation of genetic evalaution.
Alternatively, a genetic variant may result in a range of disease severity in affected individuals,
a phenomenon known as variable expressivity. For example, ~500 kb deletions and duplications
at the 16p11.2 locus are among the most heavily studied ASD-associated CNVs. However,
CNVs at this locus are also responsible for a range of other neurodevelopmental and neuro
psychiatric disorders, such as schizophrenia. CNVs at the 16p11.2 locus can also be inherited
from seemingly unaffected family members and have been observed in unaffected individuals
in the general population. This lack of correlation between genotype and phenotype as it relates
to ASD-associated genetic variation may be in part due to differences in gene-environment
interactions between individuals carrying such variation.
A recent report highlights some of the challenges inherent in the genetic evaluation of ASD
individuals. A putative disruptive variant in the ASD-associated SHANK3 gene was identified
in a boy with autism [52]. The variant, which was inherited from a healthy mother, was a small
insertion that would be predicted to result in a frameshift and premature stop. Based on this
evidence, as well as the relatively high penetrance of SHANK3 mutations in ASD and other
neuropsychiatric diseases, one could conclude that this variant in the SHANK3 gene was
pathogenically relevant in this autistic male. However, follow-up studies revealed that this
variant was unlikely to be present in the majority of SHANK3 transcripts due to alternative
splicing events. Furthermore, this variant was observed in 4 out of 382 control individuals
without neuropsychiatric conditions, a rate >1%. This report not only illustrates the necessity
of determining the frequency of a given potentially pathogenic variant in the general popula
tion but also warns against relying too heavily on computational, or in silico, predictions of the
effects of that variant on gene function.
5.2. Ethical considerations in the reporting of ASD genetic screening results
Informed consent, and the extent to which participants have been sufficiently informed as
to the purpose of a research or clinical study, has long been an issue in the field of genet
ic evaluation. For example, the extent to which research findings will be released and
made available is one that participants in genetic evaluation studies should be informed
of beforehand. In some cases, the participants themselves may not be able to gain access
to the findings of genetic evaluation. This is an issue that has only been compounded
with the rise of NGS and CMA and subsequent explosion in the amount of genetic data
generated by these techniques.
205
206
The sheer volume of genetic information generated by NGS and CMA not only leads to the
identification of potential genetic causes of a disease of interest, but also frequently leads to
the detection of other variants that are no directly related to the disease under investigation
but are related to other inherited human diseases. The extent to which these incidental findings
should be reported is a subject of some controversy, particularly in those situations in which
genetic predisposition to an adult-onset disease is discovered in a child being evaluated for
genetic causes of childhood developmental disorders. One such situation was described in a
recent news feature in Nature in which the family of a child who had undergone genetic testing
for developmental disability had to be informed that the child carried a genetic predisposition
to colon cancer after extensive debate between clinical geneticists and ethics reviewers as to
the extent to which such genetic information should be reported [53]. The degree to which
clinical geneticists should report incidental findings in research participants has been consid
ered by numerous authors [54-57], but as of yet there is not consensus. Many of these same
ethical concerns must be considered in the reporting of genetic evaluation results in individuals
with ASD.
Another consideration lies in the use of genetic evaluation to determine the recurrence risk in
the siblings of children with ASD and in family planning [50]. Given a recent estimate that the
recurrence rate of ASD in siblings may be as high as ~20% [58], the identification of inherited
variants that potentially impart susceptibility to ASD is of critical importance both in identi
fying at-risk siblings that have not yet begun to manifest symptoms of ASD and in making
informed decisions with regards to family planning.
5.3. Strategies for ASD genetic screening interpretation and reporting
The American College of Medicine Genetics released practice guidelines for the use of genetic
screening techniques in the evaluation of individuals with ASD in 2008 [59]. In the years that
have followed, additional practice guidleines and consensus statements discussing the use of
CMA in the genetic evaluation of ASD cases have been published [25, 26]. With its increasing
usage in the genetic evaluation of ASD cases, similar practice guidelines and consensus
statements regarding NGS will likely be forthcoming, and strategies for the interpretation of
NGS data in the evaluation of neurological diseases have recently been proposed [14]. In this
section we highlight some of the factors to consider in the interpretation of genetic screening
results in ASD cases.
5.3.1. Variant inheritance and segregation with ASD
One of the key determinants in the interpretation of ASD genetic screening results is the
mechanism of variant inheritance and how closely that variant segregates with ASD. Genetic
variation can either arise de novo or be transmitted from one or both parents. There has been
considerable interest in the ASD research community in the pathogenic relevance of de novo
variants, especially within the context of sporadic ASD cases.
As they have been subjected to less stringent evolutionary selection, de novo variants tend to
be more deleterious than inherited variants, making them excellent candidates for sporadi

http://dx.doi.org/10.5772/53900
cally-occurring disease [11]. An increased rate of de novo CNVs in sporadic cases compared to
familial cases has been reported [21, 60], and rare de novo CNVs at specific genomic loci were
found to associate with ASD in sporadic cases from the Simons Simplex Collection [24]. Exome
sequencing studies using ASD cohorts have reported an increased rate of de novo genedisrupting events (i.e. nonsense, splice-site, and frameshift mutations) in affected children
compared to their unaffected siblings [10].
Whereas ASD genetic research is increasingly focused on de novo genetic variation, it should
be remembered that the genetic basis of ASD was first established by studies demonstrating
the high heritability of the disease, a fact that illustrates the continued importance of identi
fying inherited genetic variation in ASD cases. A number of inherited single gene variants and
CNVs that segregate with disease in ASD families has been recently described [9, 61-64]; these
and other findings clearly demonstrate the importance of identifying inherited variants that
closely segregate with disease in affected families. It should be noted that determining the
extent of variant segregation in ASD families can be complicated by the phenotypic heteroge
neity that a given variant can cause from one affected family member to another. Furthermore,
a disease-causing variant may exclusively segregate with disease in males, even if the variant
does not reside on the X chromosome, as is the case with a SHANK1 mutation identified in a
four-generation ASD family [61]. Detailed family history and genetic evaluation of both
affected and unaffected family members is essential in determining the signficance of both de
novo and inherited variants in ASD cases.
5.3.2. Functional impact of variant
In addition to the mechanism of variant inheritance and variant segregation with disease,
another important consideration in interpretation of genetic screening results lies in the
functional impact of the variant. In many cases, especially with the use of high-throughput
screening technologies, variant function is predicted in silico. In the case of single gene
mutations, variation that results in disruption of gene function, such as nonsense mutations,
splice-site mutations, or frameshift mutations that introduce premature stop codons, are strong
genetic candidates, especially if such gene-disrupting variants are identified in a known ASD
suscepibility gene or a gene associated with an ASD-linked pathway. The interpretation of
missense mutations is more complicated and requires assessment of evolutionary conservation
using phyloP or Genomic Evolutionary Rate Profiling (GERP) conservation scores, as well as
scoring of the functional impact using Grantham or PolyPhen-2. However, as previously
mentioned [52], dependency on in silico predictions for variant function, even in well charac
terized ASD-linked genes, can lead to false conclusions. As such, experimental functional
assays are essential to accurately determine the impact of a given variant on gene expression
or function of the encoded gene product.
5.3.3. Clinical correlations of the variant with ASD
Another consideration in the interpretation of genetic screening results in ASD cases is the
degree of clinical correlation of a given variant with ASD. Hundreds of susceptibility genes
and CNV loci linked with ASD have been identified and catalogued in online genetic databases
207
208
such as AutDB, DECIPHER, and others. The identification of a novel, potentially pathogenic
variant in one of these known susceptibility genes or CNV loci would be strong evidence for
a causal role. To a lesser extent, a novel variant in a gene in an ASD-associated pathway or a
gene previously shown by gene expression studies to be differentially regulated in ASD tissue
would be a strong candidate. Another factor to consider is the frequency of a variant of interest
in healthy control populations; the absence or significantly reduced frequency of the variant
of interest in unaffected individuals would offer strong evidence for a causal role.
5.4. Resources for ASD genetic screening interpretation
A number of online resources are available to aid clinical geneticists in the interpretation of
genetic screening results in ASD individuals. Many of these resources are aimed at differen
tiating between rare, potentially ASD-specific variants and benign variants observed in the
general population. In this section we will describe some of these resources in greater detail.
5.4.1. Genetic variation in control populations
Differentiating between potentially pathogenic and benign genetic variants in ASD cases
requires knowledge of the degree of genetic variation that resides within seemingly unaffected
individuals in the general population. A number of online resources, several of which are
hosted by the National Center for Biotechnology Information (NCBI) [65], have been devel
oped to allow clinical geneticists to visualize genetic variation identified in the general
population. The genetic variation curated in these databases can range from single nucleotide
polymorphisms to chromosomal structural variation and has proven invaluable in assessing
the potential pathogenic relevance of novel genetic variants.
5.4.1.1. dbSNP (database of single nucleotide polymorphisms)
dbSNP (http://www.ncbi.nlm.nih.gov/snp) is a public domain database hosted by NCBI
collecting a range of polymorphic genetic variation, including single nucleotide polymor
phisms (SNPs), small-scale multi-base deletions or insertions (also called deletion insertion
polymorphisms or DIPs), and retroposable element insertions and microsatellite repeat
variations (also called short tandem repeats or STRs) [65].
5.4.1.2. 1,000 Genomes Project
The 1,000 Genomes Project (http://www.1000genomes.org/) is a consortium employing highthroughput NGS techniques for the purposes of characterizing over 95% of genetic variants
located in genomic regions accessible to sequencing and occurring at an allelic freuqency of
1% or higher in each of five major population groups [66].
5.4.1.3. dbVar (database of genomic structural variation)
dbVar (http://www.ncbi.nlm.nih.gov/dbvar/) is a searchable online database hosted by NCBI
containing genomic structual variation, defined by the database as inversions, balanced

http://dx.doi.org/10.5772/53900
translocations, and CNVs approximately 1 kb or larger in size, that has been observed in both
case and control populations [65].
5.4.1.4. Database of Genomic Variants
The Database of Genomic Variants (http://dgvbeta.tcag.ca/dgv/app/home?ref=NCBI36/hg18)
is an curated online database hosted by the Centre for Applied Genomic that contains struc
tural variation, defined by the developers of the database as genomic alterations that involve
segments of DNA that are larger than 50bp, in control individuals [67]. Users can search the
database for genetic variants such as CNVs, insertions, inversions, and regions of uniparen
tal disomy, as well as download database contents.
5.4.2. Genotype-phenotype association
The dbGaP public repository (http://www.ncbi.nlm.nih.gov/gap/) was created by the Na
tional Institutes of Health for the purposes of collecting individual-level genotype and phe
notype data and associations between them [68]. The studies collected in dbGaP include
genome-wide association studies, sequencing and diagnostic assays, and associations be
tween genotype and non-clinical traits. Users can browse association results, utilize the Phe
notype-Genotype Integrator (PheGenI) to search for phenotypic traits linked to GWAS data,
and download data.
6. Conclusion
The development of lower-cost, high-throughput genome-wide genetic screening technolo
gies has revolutionized the field of genetic evaluation and now provides clinical geneticists
and researchers the opportunity to detect genetic variation in ASD individuals like never be
fore. In doing so, the evidence for previously identified genetic susceptibility factors will ex
pand, and novel ASD candidate genes and genomic loci will be identified, resulting in a
better understanding of the genetic basis of ASD. However, precautions must be taken to
ensure that genetic screening results are interpreted and reported properly.
Acknowledgements
The authors would like to thank the other members of MindSpec, Inc. (Ajay Kumar, M.S.,
Idan Menashe, Ph.D., Wayne Pereanu, Ph.D., Rainier Rodriguez, and Sue Spence), as well as
the Simons Foundation. AutDB is licensed to the Simons Foundation as SFARI Gene.
Author details
Eric C. Larsen, Catherine Croft Swanwick and Sharmila Banerjee-Basu
MindSpec, Inc., U.S.A.
209
210
References
[1] Pinto D, et al. Functional impact of global rare copy number variation in autism spec
trum disorders. Nature 2010; 466(7304): 368-372.
[2] ORoak BJ, et al. Exome sequencing in sporadic autism spectrum disorders identifies
severe de novo mutations. Nature Genetics 2011; 43(6): 585-589.
[3] Metzker ML. Sequencing technologies-the next generation. Nature Reviews Genetics
2010; 11(1): 31-46.
[4] ORoak BJ, et al. Sporadic autism exomes reveal a highly interconnected protein net
work of de novo mutations. Nature 2012; 485(7397): 246-250.
[5] Talkowski ME, et al. Next-generation sequencing strategies enable routine detection
of balanced chromosome rearrangements for clinical diagnostics and genetic re
search. American Journal of Human Genetics 2011; 88(4): 469-481.
[6] Talkowski ME, et al. Sequencing chromosomal abnormalities reveals neurodevelop
mental loci that confer risk across diagnostic boundaries. Cell 2012; 149(3): 525-537.
[7] Sanders SJ, et al. De novo mutations revealed by whole-exome sequencing are
strongly associated with autism. Nature 2012; 485(7397): 237-241.
[8] Neale BM, et al. Patterns and rates of exonic de novo mutations in autism spectrum
disorders. Nature 2012; 485(7397): 242-245.
[9] Chahrour MH, et al. Whole-exome sequencing and homozygosity analysis implicate
depolarization-regulated neuronal genes in autism. PLoS Genetics 2012; 8(4):
e1002635.
http://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjour
nal.pgen.1002635
[10] Iossifov I, et al. De novo gene disruptions in children on the autistic spectrum. Neu
ron 2012; 74(2): 285-299.
[11] Veltman JA and Brunner HG. De novo mutation in human genetic disease. Nature
Reviews Genetics 2012; 13(8): 565-575.
[12] Cooper DN, et al. The nature of mechanisms of human gene mutation. In: Scriver CR
et al. (eds.) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill,
New York; 1995. 7th edition, p259-291.
[13] Choi M, et al. Genetic diagnosis by whole exome capture and massively parallel
DNA sequencing. Proceeding of the National Academy of Sciences U.S.A. 2009;
106(45): 19096-19101.
[14] Foo J-N, et al. Whole-genome and whole-exome sequencing in neurological diseases.
Nature Reviews Neurology 2012; doi: 10.1038/nrneurol.2012.148. http://
www.nature.com/nrneurol/journal/vaop/ncurrent/full/nrneurol.2012.148.html

http://dx.doi.org/10.5772/53900
[15] Baker P, et al. Brief report: duplication of chromosome 15q11-13 in two individuals
with autistic disorder. Journal of Autism and Developmental Disorders 1994; 24(4):
529-535.
[16] Bundey S, et al. Duplication of the 15q11-13 region in a patient with autism, epilepsy
and ataxia. Developmental Medicine & Child Neurology 1994; 36(8): 736-742.
[17] Cook EH Jr., et al. Autism or atypical autism in maternally but not paternally derived
proximal 15q duplication. American Journal of Human Genetics 1997; 60(4): 928-934.
[18] Carratal F, et al. A patient with autistic disorder and a 20/22 chromosomal translo
cation. Developmental Medicine & Child Neurology 1998; 40(7): 492-495.
[19] Goizet C, et al. Case with autistic syndrome and chromosome 22q13.3 deletion de
tected by FISH. American Journal of Medical Genetics 2000; 96(6): 839-844.
[20] Miller DT, et al. Consensus statement: chromosomal microarray is a first-tier clinical
diagnostic test for individuals with developmental disabilities or congenital anoma
lies. American Journal of Human Genetics 2010; 86(5):749-764.
[21] Marshall CR, et al. Structural variation of chromosomes in autism spectrum disorder.
American Journal of Human Genetics 2008; 82(2): 477-488.
[22] Glessner JT, et al. Autism genome-wide copy number variation reveals ubiquitin and
neuronal genes. Nature 2009; 459(7246): 569-573.
[23] Shen Y, et al. Clinical genetic testing for patients with autism spectrum disorders. Pe
diatrics 2010; 125(4): e727-735.
[24] Sanders SJ, et al. Multiple recurrent de novo CNVs, including duplications of the
7q11.23 Williams syndrome region, are strongly associated with autism. Neuron
2011; 70(5): 863-885.
[25] Manning M and Hudgins L. Array-based technology and recommendations for uti
lization in medical genetics practice for detection of chromosomal abnormalities. Ge
netics in Medicine 2010; 12(11): 742-745.
[26] Miller DT, et al. Oligonucleotide microarrays for clinical diagnosis of copy number
variation and zygosity status. Current Protocols in Human Genetics 2012; Chapter 8:
Unit8.12.
[27] Basu SN, et al. AutDB: a gene reference resource for autism research. Nucleic Acids
Research 2009; 37(Database issue): D832-836.
[28] Jamain S, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and
NLGN4 are associated with autism. Nature Genetics 2003; 34(1): 27-29.
[29] Arking DE, et al. A common genetic variant in the neurexin superfamily member
CNTNAP2 increases familial risk of autism. American Journal of Human Genetics
2008; 82(1): 160-164.
211
212
[30] Bakkaloglu B, et al. Molecular cytogenetic analysis and resequencing of contactin as

sociated protein-like 2 in autism spectrum disorders. American Journal of Human
Genetics 2008; 82(1): 165-173.
[31] Li X, et al. Association analysis of CNTNAP2 polymorphisms with autism in the Chi
nese Han population. Psychiatric Genetics 2010; 20(3): 113-117.
[32] Strauss KA, et al. Recessive symptomatic focal epilepsy and mutant contactin-associ
ated protein-like 2. New England Journal of Medicine 2006; 354(13): 1370-1377.
[33] Zweier C, et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive PittHopkins-like mental retardation and determine the level of a common synaptic pro
tein in Drosophila. American Journal of Human Genetics 2009; 85(5): 655-666.
[34] El-Fishawy P and State MW. The genetics of autism: key issues, recent findings, and
clinical implications. The Psychiatric Clinics of North America 2010; 33(1): 83-105.
[35] van der Zwaag B, et al. Gene-network analysis identifies susceptibility genes related
to glycobiology in autism. PLoS One 2009; 4(5): e5324. http://www.plosone.org/arti
cle/info%3Adoi%2F10.1371%2Fjournal.pone.0005324
[36] Sbacchi S, et al. Functional annotation of genes overlapping copy number variants in
autistic patients: focus on axon pathfinding. Current Genomics 2010; 11(2): 136-145.
[37] Gilman SR, et al. Rare de novo variants associated with autism implicate a large
functional network of genes involved in formation and function of synapses. Neuron
2011; 70(5): 898-907.
[38] Anney RJ, et al. Gene-ontology enrichment analysis in two independent family-based
samples highlights biologically plausible processes for autism spectrum disorders.
European Journal of Human Genetics 2011; 19(10): 1082-1089.
[39] Skafidas E, et al. Predicting the diagnosis of autism spectrum disorder using gene
pathway analysis. Molecular Psychiatry 2012; doi: 10.1038/mp.2012.126. http://
www.nature.com/mp/journal/vaop/ncurrent/full/mp2012126a.html
[40] Kumar A, et al. A brain region-specific predictive gene map for autism derived by
profiling a reference gene set. PLoS One 2011; 6(12): e28431. http://www.plosone.org/
article/info%3Adoi%2F10.1371%2Fjournal.pone.0028431
[41] Kumar A, et al. Animal model integration to AutDB, a genetic database for autism.
BMC Medical Genetics 2011; 4:15. http://www.biomedcentral.com/1755-8794/4/15
[42] Abrahams BS, et al. SFARI Gene 2.0: a community-driven knowledgebase for the Au
tism Spectrum Disorders (ASDs). Submitted to Nature Genetics, manuscript under
review.
[43] Firth HV, et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in
Humans Using Ensembl Resources. American Journal of Human Genetics 2009;
84(4): 524-533.

http://dx.doi.org/10.5772/53900
[44] Xu LM, et al. AutismKB: an evidence-based knowledgebase of autism genetics. Nu

cleic Acids Research 2012; 40(Database issue): D1016-22.
[45] Matuszek G and Talebizadeh Z. Autism Genetic Database (AGD): a comprehensive
database including autism susceptibility gene-CNVs integrated with known noncod
ing RNAs and fragile sites. BMC Medical Genetics 2009; 10: 102. http://www.biomed
central.com/1471-2350/10/102
[46] Nakatani J, et al. Abnormal behavior in a chromosome-engineered mouse model for
human 15q11-13 duplication seen in autism. Cell 2009; 137(7): 1235-1246.
[47] Kerin T, et al. A noncoding RNA antisense to moesin at 5p14.1 in autism. Science
Translational Medicine 2012; 4(128): 128ra40. http://stm.sciencemag.org/content/
4/128/128ra40.short
[48] Smith CL, et al. Genomic and epigenomic instability, fragile sites, schizophrenia and
autism. Current Genomics 2010; 11(6): 447-469.
[49] Levenson D. Too many children with autism miss genetics evaluations. American
Journal of Medical Genetics, Part A 2012; 158A(8): vii-viii.
[50] Trottier M,,et al. Parents perspectives on participating in genetic research in autism.
Journal of Autism and Developmental Disorders 2012; http://www.springerlink.com/
content/0q66420l3v518r31/?MUD=MP
[51] Gurrieri F. Working up autism: the practical role of medical genetics. American Jour
nal of Medical Genetics. Part C, Seminars in Medical Genetics 2012; 160C(2): 104-110.
[52] Kolvezon A, et al. Analysis of a purported SHANK3 mutation in a boy with autism:
clinical impact of rare variant research in neurodevelopmental disabilities. Brain Re
search 2011; 1380: 98-105.
[53] Hayden EC. The broken contract. Nature 2012; 486(7403): 312-314.
[54] McGuire AL, et al. Research ethics and the challenge of whole-genome sequencing.
Nature Reviews Genetics 2008; 9(2): 152-156.
[55] Caulfield T, et al. Research ethics recommendations for whole-genome research: con
sensus statement. PLoS Biology 2008; 6(3): e73. http://www.plosbiology.org/article/
info%3Adoi%2F10.1371%2Fjournal.pbio.0060073
[56] Wolf SM, et al. Managing incidental findings in human subjects research: analysis
and recommendations. The Journal of Law, Medicine & Ethics 2008; 36(2): 219-48.
[57] Bredenoord AL, et al. Disclosure of individual genetic data to research participants:
the debate reconsidered. Trends in Genetics 2011; 27(2): 41-47.
[58] Ozonoff S, et al. Recurrence risk for autism spectrum disorders: A baby siblings re
search consortium study. Pediatrics 2011; 128(3):e488-95. http://pediatrics.aappubli
cations.org.ezproxy.nihlibrary.nih.gov/content/128/3/e488.long
213
214
[59] Schaefer GB, et al. Clinical genetics evaluation in identifying the etiology of autism
spectrum disorders. Genetics in Medicine 2008; 10(4): 301-305.
[60] Sebat J, et al. Strong association of de novo copy number mutations with autism. Sci
ence 2007; 316(5823): 445-449.
[61] Sato D, et al. SHANK1 Deletions in Males with Autism Spectrum Disorder. Ameri
can Journal of Human Genetics 2012; 90(5): 879-887.
[62] Duong L, et al. Mutations in NRXN1 in a family multiply affected with brain disor
ders: NRXN1 mutations and brain disorders. American Journal of Medical Genetics.
Part B, Neuropsychiatric Genetics 2012; 159B(3): 354-358.
[63] Salyakina D, et al. Copy number variants in extended autism spectrum disorder fam
ilies reveal candidates potentially involved in autism risk. PLoS One 2011; 6(10):
e26049.
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.
0026049
[64] Shen Y, et al. Intra-family phenotypic heterogeneity of 16p11.2 deletion carriers in a
three-generation Chinese family. American Journal of Medical Genetics. Part B, Neu
ropsychiatric Genetics 2011; 156(2): 225-232.
[65] Sayers EW, et al. Database resources of the National Center for Biotechnology Infor
mation. Nucleic Acids Research 2011; 39(Database issue): D38-51.
[66] The 1000 Genomes Project Consortium. A map of human genome variation from
population-scale sequencing. Nature 467(7319): 1061-1073.
[67] Iafrate AJ, et al. Detection of large-scale variation in the human genome. Nature Ge
netics 2004; 36(9): 949-951.
[68] Mailman MD, et al. The NCBI dbGaP database of genotypes and phenotypes. Nature
Genetics 2007; 39(10): 1181-1186.
Chapter 11
Genetic Etiology of Autism

Agnes Cristina Fett-Conte,
Ana Luiza Bossolani-Martins and
Patrcia Pereira-Nascimento
http://dx.doi.org/10.5772/53106
1. Introduction
Autism Spectrum Disorders (ASD) are severe neurodevelopment disorders characterized by
impairment in social interaction and communication, and repetitive and stereotyped behav
iors. Motor deficits, aggressive behavior, abnormal sleep patterns, gastrointestinal problems,
epilepsy and intellectual disability are also observed. Manifestations are observed before
three years of age with early stimulation being recommended (Baird et al., 2006; Faras et al.,
2010; Bronsard et al., 2011; Miles, 2011; Angelidou et al., 2012). Due to the great phenotypic
variability of carriers and the subjectivity of the differential diagnostic criteria of "Pervasive
Developmental Disorders" (American Psychiatric Association, 2000), ASD is today consid
ered the most appropriate denomination. The general term, autism, is often used as a syno
nym for ASD.
ASD were described more than seven decades ago (Sanders, 2009) and many neurobiologi
cal changes have been illustrated in carriers, yet the diagnosis is still based on behavioral
aspects using diagnostic scales. However, even though there is a detailed checklist made
up of several scales, most are not translated and validated in different countries, which hin
ders standardized and efficacious diagnosis (Marteleto et al., 2008; Rapin & Goldman, 2008;
Sato et al., 2009; Biederman et al., 2010).
The prevalence of ASD varies by region, but it is believed to be around 1:150 individuals.
However, higher prevalences of up to 1:88 children have been described (Currenti, 2010; An
gelidou et al., 2012). The tentatives to explain such high prevalence rates involve changes in
diagnostic criteria, greater knowledge of the general population and the exposure of the ge
netic material of fetus to internal and external toxic agents (King & Bearman, 2009; Lintas &
Persico, 2009; Avchen et al., 2011).
2013 Fett-Conte et al.; licensee InTech. This is an open access article distributed under the terms of the
216
Although many environmental factors are related to the pathogenesis of autism, such as the ru
bella virus whose disruptive effects in the brain may result in autistic behavior, the participa
tion of genetic components is certain. The estimated concordance rate for identical twins ranges
from 60 to 90%, while among dizygotic twins and non-twin siblings the rate is from 5 to 31%
(Bailey, et al., 1995; Rosenberg et al., 2009; Hallmayer et al., 2011). Based on studies of twins, her
itability was estimated to be between 60 and 80% (Geschwind, 2011; Hallmayer et al., 2011).
In up to 10% of ASD cases it is possible to identify etiological, genetic or environmental fac
tors (syndromic autism). Thus, in about 90% of the cases there is no known cause (non-syn
dromic autism). A multifactorial etiology can be assigned to these idiopathic cases after the
exclusion of environmental and genetic causes, and using specific evaluations (VeenstraVanderweele et al., 2004). Scientific discoveries until now have shown that there are multi
ple genetic factors (polygenes) involved in the predisposition to ASD which, associated with
an external trigger (environmental factor), would result in the behavioral framework for au
tism. However, these factors alone also result in changes in the brain that lead to autistic be
havior. Thus, the same factors may be present in two children with one having autism and
the other not. There is no doubt that science has elucidated many biological mysteries about
autism, yet for every issue clarified, another, even more complex, appears.
2. Environmental etiology
Prenatal or perinatal infections by viral agents such as rubella and cytomegalovirus, as well
as exposure to toxic agents, such as thalidomide, valproic acid and alcohol, are some of the
best-known environmental causes of ASD (Chess et al., 1978; Christianson et al., 1994).
Allergenic environmental factors and autoimmune problems during pregnancy may also
be involved in the etiology of autism. The presence of circulating maternal antibodies
against fetal brain proteins suggests the possibility of their transposition in the blood-brainbarrier. Studies have demonstrated the presence of pro-inflammatory cytokines in the fetal
brain, such as TNF (tumor necrosis factor) which is preformed in maternal mast cells (Vojda
ni, 2008; Angelidou et al., 2012).
Even premature birth has been implicated as a cause of ASD. Babies from gestations of less
than 28 weeks have a high risk of neurological problems. A study in Atlanta, USA, showed
that children born in the 33rd gestational week have a greater risk for autistic characteristics
(Limperopoulos et al., 2008).
There is a link between oxidative stress and immune response (Viora et al., 2001). There are
suggestions that environmental factors trigger oxidative stress in individuals genetically
susceptible to autism, which would lead to losses in methylation and secondary neurologic
deficits (Dardeno et al., 2010). Increased levels of oxidative stress markers have already been
described in the cord blood of mothers who had premature births compared to those of
mothers who had full term births (Joshi et al., 2008).

http://dx.doi.org/10.5772/53106
Premature birth is associated with the formation of reactive oxygen species (Davis & Auten,
2010). Stress typically results in the release of corticotropin-releasing hormone (CRH) with
elevated levels of this hormone in plasma being associated with premature births (Warren et
al., 1992; Chrousos, 1995). CRH may stimulate the release of a cytokine, interleukin-6 (IL-6),
by mast cells, which are part of the immune system. IL-6, by injuring the blood-brain barrier
due to stress related to CRH and mast cells, increases its permeability (Esposito et al., 2001).
With the increased permeability, neurotoxic molecules can reach the brain and cause an in
flammatory process that contributes to the pathogenesis of ASD (Theoharides, 2008; Valent
et al., 2012). This process has suggested a new possibility for the etiology of ASD.
3. Overlapping genetic etiologies

Many genomic regions, with genes implicated as candidates, have been associated to the eti
ology of autistic behavior, although the results of some studies have not been replicated.
Even so, it is estimated that all proposed regions together would be involved in the etiology
of less than 1% of cases. In addition, scientific evidence shows that changes in regions re
ported in ASD have also been described in other neuropsychiatric diseases, which suggests
that there is an etiological connection with phenotypes attributed to other neurodevelop
ment abnormalities (Griswold et al., 2012). For example, some rare mutations associated
with increased risk for ASD and schizophrenia have already been reported in 15q13.3,
16p11.2 and 22q11.21 and in the NRXN1 gene (Weiss et al., 2008; Levinson et al., 2011; Sand
ers et al., 2011).
Moreover, many genes involved in nonsyndromic intellectual disabilities (ID) and in epilep
sy have also been implicated in the etiology of nonsyndromic ASD. These genes probably
belong to a continuum of neurodevelopment disorders that manifest in different manners
depending on associated genetic and environmental factors. The identification of changes is
crucial for patients and for counseling of families, as well as for the identification or exclu
sion of the presence of specific genetic diseases in patients with ASD (Betancour, 2011).
Many patients with chromosomal or monogenic diseases have autistic behavior as one phe
notypic manifestation of the disease. A scientific enigma to be elucidated refers to the possi
ble causes of the varying severity of symptoms or the presence/absence of manifestations in
carriers in the same family. They are not free from rare or common mutations associated
with behavioral phenotype in isolation. Thus, in autism, studies on gene interactions are
fundamental and what is called overlapped etiology can be an additive effect between dif
ferent genes, some of them more significants.
4. Genetic anticipation
Genetic anticipation studies are fundamental in the elucidation of inheritance mechanisms
for any genetically influenced condition, because, in addition to the clinical importance and
217
218
guidance in genetic counseling, these investigations can assist in the elucidation of the recur
rence risks in future generations (Constantino et al., 2010).
Following a promising approach in the investigation of complex disease etiologies, studies
on endophenotypes (intermediate phenotypes) may be used to direct the search for the
etiology of ASD (Weinberger et al., 2001). Manifestations related to autistic behavior are of
ten observed in varying degrees of severity in unaffected individuals of previous genera
tions in the same family, thereby characterizing the phenomenon of genetic anticipation in
ASD (Losh et al., 2008).
A Swedish study reported that the existence of individuals with schizophrenia and bipolar dis
order in the family is a risk factor for the occurrence of autism. The authors found an association
between schizophrenic parents or siblings with increased risk of ASD. Bipolar disorder also
proved to be a risk factor, but not as strong as schizophrenia (Sullivan et al., 2012).
Studies of autistic families have also shown a significant increase in the recurrence of ASD in
first-degree relatives of carriers. For example, siblings of individuals with ASD have a 22- to 25fold higher risk of having the disorder (Lauritsen et al., 2005; Abrahams & Geschwind, 2008).
There are significantly higher risks of ASD in offspring of parents with ASD and those with fam
ilial history of psychiatric problems. Depression and personality disorders have been reported
to be more common in mothers of children diagnosed with ASD than in mothers of children
with normal development (Daniels et al., 2008; Constantino et al., 2010). Even some non-affect
ed individuals of different generations in the same family may show subtle impairment in cog
nitive development, language changes or in social interaction; this is termed the broad autism
phenotype. This phenotypic diversity of autistic behavior and psychiatric manifestations in fam
ilies of the patients indicate that the genetic factors that influence ASD may be composed of dis
tinct elements that manifest differently between affected and non-affected family members
(Pickles et al., 2000; Szatmari et al., 2000; Goldberg et al., 2005).
In the molecular field, studies on genealogies with multiple affected family members and
studies on twins suggest that allelic variations are associated with increased susceptibility to
ASD and that there are etiological factors common to both ASD and milder autistic pheno
types (Lundstrom et al., 2010; Arking et al., 2008; Wang et al., 2009). Hence, epidemiological
studies have been developed with families in an attempt to clarify the relative proportions
of cases of autism and broad autism phenotypes in the population that might explain these
complex mechanisms of genetic transmission.
5. Associated syndromes and comorbidity in autism

Similar to intellectual disabilities or delay in motor developmental, the autistic behavioral
phenotype can occur alone or as part of the spectrum of phenotypic manifestations in a par
ticular condition of environmental, genetic or multifactorial etiology. In some situations, the
autistic behavioral phenotype is observed in individuals with only one other clinical mani
festation, such as epilepsy. This simultaneous occurrence (co-occurrence) has been discussed

http://dx.doi.org/10.5772/53106
much and is referred to in the literature either as an association or as comorbidity. Probably

the truth is, that in most cases, the different manifestations result from the same causal fac
tor, which suggests the term association is more appropriate than comorbidity.
Monozygotic and dizygotic twin studies indicate a variety of neuropsychiatric diagnoses as
sociated with ASD, including attention deficit and hyperactivity disorder (ADHD) and anxi
ety disorder (Lichtenstein et al., 2010). High frequencies of these diseases have been
reported in children with autism, as has bipolar disorder in adolescents and young adults
(Munesue et al., 2008; Simonoff et al., 2008). The wide range of clinical behavioral symptoms
among carriers may be justified and be a good argument to consider the diagnosis of ASD
alone, with all the possible manifestations expected in the spectrum, as no individual is ex
actly like another. In this way, families would be less anxious and confused on receiving
three or four diagnoses for the same child.
There are a number of diseases associated with autism, whose genetic etiology is well estab
lished, i.e. autistic behavior is one of the possible manifestations. The most common is Frag
ile X syndrome (FRAXA). This is the most frequent form of inherited mental retardation and
is considered a monogenic cause of ASD. Symptoms include neurodevelopmental delay,
anxiety, hyperactivity, and autistic-like behavior, which are accompanied by macroorchid
ism and distinct facial morphology. It is caused by the expansion of the CGG trinucleotide
repeat in the 5' untranslated region of the fragile X mental retardation 1 (FMR1) gene result
ing in loss of the Fragile X Mental Retardation Protein (FMRP), an RNA-binding protein
abundant in the brain and gonads of affected men. FMRP has multiple functions in the RNA
metabolism, including mRNA decay, dendritic targeting of mRNAs and protein synthesis.
In neurons lacking FMRP, a wide array of mRNAs encoding proteins involved in synaptic
structure and function are altered. As a result of this complex dysregulation, in the absence
of FMRP, spine morphology and functioning is impaired (De Rubeis et al., 2012). Frequen
cies of between 2% and 3% of FRAXA have been observed in studies on boys with ASD,
while in boys with FRAXA, the frequencies of ASD range from 20% to 40% (Kaufmann et al.,
2004; Shibayama et al., 2004). Tuberous Sclerosis, another monogenic disease that results
from mutations in the TSC1 and TSC2 genes, is observed in about 1% of individuals with
ASD and is regarded as the second most common genetic cause of the autistic phenotype
(Smalley, 1998).
The list of medical conditions associated with the autistic phenotype, including genetic syn
dromes, is growing. Examples of genetic conditions associated with autism and the gene re
gions involved are: Angelman Syndrome (UBE3A), Rett syndrome (MECP2),
neurofibromatosis (NF1), Timothy syndrome (CACNA1C), Smith-Lemli-Opitz syndrome
(DHCR7), CHARGE (CHD7), Cohen syndrome (VPS13B), Noonan syndrome (PTPN11), 2q37
deletion syndrome, Cornelia de Lange syndrome (NIPBL, SMC1A and SMC3), DiGeorge/
Velocardiofacial syndrome (22q11), Smith-Magenis (RAI1), Williams-Beuren syndrome
(7q11.23) and Phelan-McDermid syndrome (22q13.3) (Berg et al.,2007; Phelan, 2008; Dela
haye et al., 2009; Van der Aa et al., 2009; Laje et al., 2010; Betancour, 2011).
Many inborn errors of metabolism also seem to contribute to at least 5% of ASD cases as the de
ficiency of certain enzymes in metabolic diseases can result in the accumulation of substances
219
220
that may have toxic effects on brain development. An example is phenylketonuria, an autoso
mal recessive disorder that, if untreated, leads to excessively high levels of phenylalanine and
toxic metabolites, resulting in intellectual disabilities and ASD (Manzi et al., 2008).
Mitochondria are intracellular organelles that have the function of producing energy. In the
mitochondria ATP production, free oxygen radicals and reactive oxygen species (ROS) are
produced and then normally removed from the cells by anti-oxidant enzymes. When the
production of ROS and free radicals exceeds the limit, oxidative stress occurs, that is, ROS
combine with lipids, nucleic acids and proteins in the cells leading to cell death by apoptosis
or necrosis. Since brain cells have limited antioxidant activity, a high lipid content and high
requirement for energy, it is more prone to the effects of oxidative stress. Some patients with
ASD and mutations in mitochondrial DNA have already been reported (Fillano et al., 2002;
Dhillon et al., 2011). The first study involving bioenergetic metabolism disorders in ASD
was directed by Coleman & Blass (1995), who reported lactic acidosis in four children with
autism. Later Lombard (1998) proposed that mitochondrial oxidative phosphorylation can
cause abnormal brain metabolism in children with autism resulting in acidosis. A study by
Pons et al. (2004) described five children with ASD who had abnormal respiratory chain en
zyme activity, characterized by the A3243G mutation. Graf et al. (2000) described two broth
ers with autism associated with a mitochondrial DNA G8363A RNA(Lys) mutation.
All these diseases, in addition to peculiar and specific clinical signs and symptoms, have au
tism as a common manifestation. However, with so different genetic etiologies and proba
bly, the involvement of different interaction mechanisms, what do they have in common
that explains the autistic behavior? The autistic behavior is attributed to changes in neurode
velopment and all these diseases cause changes in the brain structure and/or functioning,
probably damaging cerebral areas that are linked to autistic symptoms.
In the clinical practice, the recognition of these conditions is fundamental, as it allows the
targeting of laboratory tests and assists in the initial breakdown of etiological heterogeneity
which categorizes specific cases of autism as syndromic or nonsyndromic. This definition is
important because of possible implications in the prognosis and recurrence risk (Miles, 2011;
Gurrieri, 2012).
6. Chromosomal alterations
Numerical and structural chromosomal alterations, visible by conventional cytogenetic tech
niques, occur in about 6 to 7% of ASD cases and have already been described in all autoso
mal and sex chromosomes. These findings justify karyotyping by GTG banding as part of
the etiological work-up protocol of carriers (Castermans et al., 2004; Shen et al., 2010).
Some human chromosomal aneuploidies are known to increase the risk for ASD; the most
common, as identified in studies of individuals with autism, are trisomy 21 (Down syn
drome), monosomy of chromosome X in women (Turner syndrome), uniparental X disomy
in men (Klinfelter syndrome), Y disomy and 45,X/46,XY mosaicism. Structural abnormalities
include 15q11-13 duplication and deletions of 2q37, 22q11.2 and 22q13.3 (Betancour, 2011).

http://dx.doi.org/10.5772/53106
Due to the high number of cases that have been described and the type of genes located in
them, the association of eight chromosomal regions is well established in autism including:
1q21, 7q11.23, 15q13, 15q11-13, 16p11.2, 17p11.2, 22q13.3 and 22q11.21. Rearrangements in
volving these regions are detected by classic cytogenetic techniques but it is recommended
that more sophisticated techniques, such as array comparative genomic hybridization (ar
ray-CGH), are used for their evaluation (Gillberg, 1998; Griswold et al., 2012).
As expected, unbalanced changes are more frequently found in dysmorphic individuals and
with delays in neuropsychomotor development due to the extent of damage because they
result in significant gains and losses of gene content. Balanced rearrangements, however, are
less frequent and can be related to mutations in DNA breakpoints. Some are so rare that it is
difficult and risky to consider them a cause of autism. However, some occur at high enough
frequencies to be considered risk factors for the disease. Identifying balanced changes is im
portant for genetic counseling, not only due to the etiologic implications, but also because
these changes may predispose descendants to unbalanced rearrangements (Carter, 2011;
Sherer & Dawson, 2011; Nowakowska et al., 2012).
However, chromosomic analysis detects only 3-5 megabase abnormalities. New technolo
gies using DNA or chromosomal microarrays can identify submicroscopic abnormalities.
Microdeletions and duplications, e.g., may be identified with microarrays in individuals
with ASD who previously had normal kariotype. Therefore, if cytogenetic analysis is nega
tive in clinically diagnosed ASD, molecular techniques are necessary.
7. Candidate genes
According to recent findings, some common mutations, epigenetic mechanisms, chromo
some alterations, rare single gene mutations, copy number variations (CNVs) and single nu
cleotide polymorphisms (SNPs) result in the autistic phenotype. Because of national and
international consortia, many linkage and genome-wide association studies have evolved
which elucidated candidate genes and susceptibility of genomic regions relevant to ASD. In
contrast to polygenic or complex genetic models for autism, suggested in the majority of cas
es, a few forms of ASD are known to be caused by single gene defects, such as in FRAXA
(Chiocchetti & Klauck, 2011; Dhillon et al., 2011).
According to a review by Betancour (2011) more than 100 candidate genes for autistic be
havior are also related to syndromic or nonsyndromic intellectual disabilities. Many are also
associated with epilepsy, with or without intellectual disabilities; this suggests that these
neurodevelopment disorders have risk factors in common with ASD.
Mutations in a single gene may be autosomal dominant, recessive or X-linked. Some, not al
ways related to syndromic cases, are highly penetrating and appear at sufficiently high fre
quencies to be considered monogenic causes of autism. Of the growing list, the most
important candidate genes are: NLGN3, NLGN4, SHANK2, SHANK3, NRXN1, NRXN3,
PTCHD1/PTCHD1AS, SHANK1, DPYD, ASTN2, DPP6, MBD5, CDH8 and CNTNAP2. It is
221
222
important to note that most of these act on neurotransmission in the central nervous system
(Sherer & Dawson, 2011).
There are reports of more than two hundred candidate genes in the literature. According to
Swanwick et al. (2011), they can be classified into four categories: 1) rare - genes involved in
rare monogenic forms of ASD. This type of allelic variant includes rare polymorphisms and
mutations directly related to ASD (NRXN1 and SHANK3); 2) syndromic - genes related to
syndromes with phenotypic manifestations in a significant subpopulation of carriers that in
clude autistic symptoms (FMR1 and MECP2); 3) association - genes with common polymor
phisms that confer a small, probably additive risk, for ASD, that were identified from
association studies derived from cases of unknown etiology (MET and GABRB1) and 4)
functional - genes with functions related to the biology of ASD that are not included in the
other categories (CASDP2 and ALOX5AP). Among these, the ones that belong to the first
two categories are the most strongly related to the pathogenesis of ASD (El-fishawy & State,
2010). There are indications that de novo point mutations occur in approximately 5 to 20% of
the cases (ORoak et al., 2011).
Persico and Bourgeron (2008) proposed that there are three main pathways involved in the
pathogenesis of ASD. The first entails genes that affect cell migration, the second disruptions of
the glutamate-GABA harmony and the third involves synaptic formation and maintenance and
dendritic morphology. All these pathways play a fundamental role in the central nervous sys
tem, particularly in the serotonergic process (Berkel et al., 2010; Durand et al., 2007).
Recent studies have given more support to evidence that a large subset of genes, involved in the
outgrowth and guidance of axons and dendrites, is implicated in the etiology of autism. How
ever, many studies are still needed in order to understand the role of isolated genes and gene re
gions in ASD and to identify the associations between them and to identify new candidate
genes that act within the molecular pathways (Hussman et al., 2011; Griswold et al., 2012).
But despite the large number of previously identified candidate genes, the number of pa
tients with changes in these genes does not reach 1% of the total cases, which further high
lights the extreme heterogeneity seen in the pathogenesis of ASD. The findings have led to a
paradigm shift in the concept of the genetic architecture of common neurodevelopmental
diseases, stressing the importance of individual patterns, rare mutations and overlapping in
genetic etiology. They have also converged on specific neurodevelopmental pathways, pro
viding insights into pathogenic mechanisms (Mitchell, 2011).
8. Single Nucleotide Polymorphisms (SNPs), Quantitative Trait Locus

(QTL) and risk for ASD
Of the techniques that supported the rapid advance in molecular genetics, comparative genom
ic hybridization (CGH) and single nucleotide polymorphism (SNP) genotyping array have al
lowed the qualitatively and quantitatively identification of the genes and genomic
rearrangements involved in the autistic phenotype (Alrcon et al., 2008; Whalley, 2011; Mefford

http://dx.doi.org/10.5772/53106
et al., 2012). The use of these molecular sequencing tools has also enabled the identification of
high frequencies of common variants in some genes, such as SNPs, in individuals with SD.
SNPs, causing about 50% of all currently known variations in genetic material, are the most nu
merous variants in the genome. Moreover, SNPs are considered genetic markers that can be
used to identify genes associated with complex diseases (Malhotra & Sebat, 2012).
Unlike CNVs, SNPs seem to be more penetrating in ASD. De novo SNPs, although less fre
quent, seem to have more deleterious effects and confer higher risk for autistic behavior
(Chahrour et al., 2012). Associations between some SNPs of mitochondrial and nuclear
genes and predisposition to ASD have been reported by several studies (Ramoz et al., 2004;
Silverman et al., 2008; Smith et al., 2009). Studies have shown SNPs in the GABRA2, GA
BRA3, GABRA4, SLC25A12, FOXP2, CNTNAP2, CNTNAP2 and BDNF genes (Li et al., 2005;
Segurado et al., 2005; Alrcon et al., 2008; Cheng et al., 2009; Scott-Van Zeeland et al., 2010;
Jiao et al.,2011). In the Genome-wide Association Studies (GWAS) involving 4305 individu
als with ASD and 6941 controls, strong association signals were revealed in six SNPs of two
genes encoding neuronal cell-adhesion molecules, cadherin 10 (CDH10) and cadherin 9
(CDH9). These findings were replicated in two independent cohorts and implicated neuro
nal cell-adhesion molecules in the pathogenesis of ASD (Wang et al., 2009).
It is possible that screening for SNPs may identify new biological mechanisms that are in
volved in predisposition to ASD. However, GWAS, although promising, has revealed few
common alleles and many results have still to be replicated (Ma et al., 2009; Manolio et al.,
2009; Klein et al., 2010). It is clear that SNPs may have variable expressions or reduced pene
trance. But, while it is apparent that rare variations can play an important role in the genetic
architecture of these diseases, the contribution of common variations to risk for ASD is less
clear (Jiao et al., 2011; Sherer & Dawson, 2011). Additionally, a strong Association between
SNPs in the 5p14.1 and 5p15.2 regions and ASD has also been reported (Wang et al., 2009).
However, the results of Stage 2 of the Autism Genome Project Genome-Wide Association
Study, which incremented 1301 ASD families to the investigation bringing the total to 2705
families analyzed (Stages 1 and 2), showed that no single SNP has a significant association
with ASD or selected phenotypes at the genome-wide level and concluded that common
variants affect the risk for ASD but their individual effects are modest (Anney et al., 2012).
These controversial results about the role of SNPs in the predisposition for ASD do not rule
out participation in the phenotype, but motivate the investigation of biological phenomenon
that would explain their participation. Probably a single SNP does not affect the risk, but
perhaps the additive effect of several SNPs, in specific combinations, with the participation
of environmental determinants cannot be discarded in etiologically complex diseases.
From another standpoint, the Quantitative Trait Locus (QTL) approach is one of the most
suitable methods to find susceptibility of loci. This approach follows the assumption that
ASD occur as a continuum of severity, a position supported by findings of elevated levels of
ASD symptoms in parents and siblings of cases compared to controls, and variations in ASD
traits that have been found in the general population. One study to identify the loci that un
derlie ASD symptoms in children with attention-deficit/hyperactivity disorder (ADHD) in
223
224
vestigated both the total level of ASD symptoms as well as scores of three ASD symptom
domains, thus taking into account potential differential genetic origins of different ASD
symptom domains. QTL linkage analyses for the different ASD domains were carried out
using 5407 SNPs spanning the entire genome. Findings suggest that some QTLs are ASD
specific, although the 15q QTL potentially has pleiotropic effects for ADHD and ASD (Nij
meijer et al., 2011). The genetic analysis of quantitative traits that are phenotypically linked,
such as in ASD and ADHD, can reduce the heterogeneity of diagnosis and indicate loci re
lated to susceptibility (Lu et al., 2011).
There is a QTL related to language delay located close to the 7q35-36 region. Interestingly
this region is mapped in the CNTNAP2 gene, a strong candidate for predisposition to autis
tic behavior; it is well known that communication abilities are qualitatively impaired in au
tistic individuals. The significant delay in language (age of first word) is observed in
about half of affected children (Alrcon et al., 2008). The relationship of SNPs in the
CNTNAP2 gene has already been described, as has the association of the gene and its SNPs
to language development delay in autistic and non-autistic individuals (Alrcon et al., 2008;
Arking et al., 2008; Tan et al., 2010; Stein et al., 2011; Whalley et al., 2011).
Additionally, the transcription factor encoded by the FOXP2 gene has already been linked to
the development of language. This factor binds to the promoter of the CNTNAP2 gene regu
lating its expression during development. There are reports of changes in the FOXP2 bind
ing site in patients with ASD, which suggests that a reduced expression of the CNTNAP2
gene may be the underlying etiology of one of the phenotypic characteristics of ASD (Vernes
et al., 2008; Poot, et al., 2009). In addition to these, it has been suggested that WNT2 and EN2
are related to language development in autism (Lin et al., 2012).
Promising results on the influence of genetic bases in neurobehavioral disorders have also
been obtained through studies on CNVs. All these emerging genetic technologies have
brought more valuable approaches to improve the understanding of the etiology of ASD.
Advances in the use of molecular biology tools have provided a promising manner to study
gene-gene and gene-environment relationships in disorders (Gurrieri, 2012; Li et al., 2012).
This combination of tools in the search for the etiology will reflect in the possibility of target
ing the diagnosis, prognosis, early interventions and genetic counseling. However, more da
ta and the reproducibility of findings are necessary to establish the genetic components of
these diseases.
9. Copy Number Variations (CNVs) in ASD

Copy Number Variations (CNVs), submicroscopic variations that are less than 500kb in size
in DNA, are widespread in normal human genomes. The most common CNVs tend to be
large (> 500Kb) and contain several genes, while rare or de novo CNVs are smaller (< 100Kb),
sometimes interrupting a single gene. On average, there are more than 1000 CNVs in the ge
nome, accounting for 4 million base pairs of genomic difference. Although SNPs outnum
ber CNVs in the genome by three orders of magnitude, their relative contributions to

http://dx.doi.org/10.5772/53106
genomic variation (as measured in nucleotides) are similar. Thus, in addition to 0.1% of ge
netic difference at the nucleotide sequence level, another 0.1% of genetic difference is appa
rent at the structural level (Malhotra & Sebat, 2012).
The rate of genome-wide nucleotide substitutions is estimated at 30100 per generation and
1 per exome. In contrast, the global rate of structural mutation events is lower: CNVs > 10
Kb in size occur at a rate of 0.010.02 per generation (Marshall et al., 2008; Conrad et al.,
2011; Levy et al., 2011; Sanders et al., 2011). Nucleotide substitutions probably account for
the majority of disease risk alleles, but based on sheer size and potential to impact genes (or
multiple genes), structural mutations are, on average, more pathogenic. Thus, CNVs, de novo
CNVs in particular, seem to be a class of variants that have large effect on disease risk (Mal
hotra & Sebat).
CNVs are gaining importance in the scenario of ASD. They represent a significant source of
genetic diversity and seem to significantly contribute to changed behavioral phenotypes (Se
bat et al., 2007; Rees et al., 2011). To have an idea, de novo CNVs have already been reported
to be three to five times more common in families of individuals with ASD than in controls,
and more often presenting the syndromic form of autism, that is, with the most severe phe
notypes (Miller et al., 2010; Pinto et al., 2010; Shen et al., 2010; Sanders et al., 2011). In fact,
CNVs, in particular de novo CNVs involving many genes, confer risk for ASD. However, al
though they are important in this respect, they rarely interrupt a single gene or have com
plete penetrance and many give a wide-ranging risk including risk for other problems such
as intellectual deficiency, epilepsy and schizophrenia (Geschwind, 2011; ORoak et al., 2011).
Up to 40% of CNVs in autism are inherited from apparently normal parents, consistent with
the suggestion of incomplete penetrance. Both de novo (non- inherited) or inherited CNVs
occur at the same locus in unrelated individuals, and some of them coincide with those seen
in other gene-related diseases associated with ASD, including developmental delay and in
tellectual deficiency (Cook & Scherer, 2008; Lee & Scherer, 2010). Thus, some apparently
have a pleiotropic effect.
De novo CNVs have been observed in from 7-10% of cases in simplex families, in 2-3% in
multiplex families and approximately 1% of normal controls. Rare de novo CNVs have al
ready been observed in 5.8-7.9% of carriers and in 1.7-1.9% of unaffected siblings in simplex
families (Levy et al., 2011; Sanders et al., 2011), while de novo mutations in coding regions
participate in < 20% of cases of ASD (Malhotra & Sebat, 2012). In addition, about 10% of
ASD cases with de novo CNVs have two or more CNVs (Sebat et al., 2007; Christian et al.,
2008; Marshall et al., 2008).
Many of the variations occur in gene regions that contain synaptic genes, and it seems that
some involve haploinsufficient regions or dominant inheritance. Others seem to express re
cessive forms as in the cases of the NHE926, PCDH10 and DLA1 genes identified in studies
of individuals with consanguineous parents. Other rare variations were found deleted in ho
mozygous (Bourgeron, 2009; Ramocki & Zoghbi, 2008; Morrow et al., 2010).
There are descriptions of de novo and inherited CNVs, sometimes in combination in a given
family, implicating many novel ASD genes such as SHANK2, SYNGAP1, DLGAP2 and the
225
226
X-linked DDX53-PTCHD1 locus, of an enrichment of CNVs disrupting functional gene sets

involved in cellular proliferation, projection and motility, and GTPase/Ras signaling, (Pinto
et al., 2010). Another pathway with many of these variations is that related to the develop
ment of synapses, and maintenance and motility of neurons, the NLGN-NRXN-SHANK
pathway (Bourgeron, 2009).
But, CNVs have been regarded as rare variants within the panorama of the etiology of
ASD and it is important to emphasize the care that should be taken in associating them in
the etiology, especially those not previously described. Accuracy is required in the study of
these changes during the formation of control groups. On the other hand, when it comes to
autism, on finding the same CNVs in carriers and controls is not a reason to dismiss their
participation in the phenotype, given the complexity of factors that may be acting jointly
and in combination in different cases.
10. Reduced penetrance and pleiotropic effects

Incomplete penetrance and variable expressivity are discussed greatly in the literature in an
attempt to explain the complexity of the biological phenomena involved in ASD (Zhao et al.,
2007; State & Levtt, 2011; Coleman & Colbert, 2012).
While some genomic regions seem to play very important roles in predisposition for autism
and others not so much, there are some for which there is much divergence in published da
ta. For example, the variations that involve 15q11-13, 16p11.2 and 22q11.2 are among the
most commonly found CNVs in patients with autism, however the resulting behavioral phe
notype varies from normal to strongly affected (Cook & Scherer, 2008; Adzhubei et al., 2011;
Devlin & Scherer, 2012). The explanation for the recurrence of rearrangements in these re
gions is that they are flanked by low repetition segments containing 99% of the identity,
which due to their genomic structure predisposes them to non-allelic homologous recombi
nation and a high mutation rate (Cottrell et al., 2011). However, another four regions in
which large deletions are observed (2q22.1, 3p26.3, 4q12 and 14q23) are not flanked by un
stable elements and also have a strong potential for involvement in the etiology of autism
(Nicholas et al., 2007; Cottrell et al., 2011; Griswold et al, 2011).
With the recent clinical and research use of high resolution array-based strategies for charac
terizing CNVs in children with developmental disabilities, there has been a significant in
crease in the diagnosis of interstitial 15q duplications, including small, atypical duplications.
The association between ASD and 15q duplications has been described in many case reports
since the 1980s and sparked interest in 15q11-13 as a candidate region in autism linkage
studies. Prevalence estimates of proximal 15q duplications in cohorts of patients with autism
range from 0.5% to 3%, depending on ascertainment criteria and methods used to identify
the duplications (Simon et al., 2010). This region contains receptors of an inhibitory neuro
transmitter, gamma-aminobuytric acid (GABA) that acts on a complex channel receptor
mainly permeable to chloride anions to reduce neuronal excitability. GABA signaling is also

http://dx.doi.org/10.5772/53106
established before glutamatergic transmission suggesting that GABA is the principal excita
tory transmitter during early development (Takayama & Inoue, 2004; Ben-Ari et al., 2007).
In multiplex families, i.e. those with more than one affected individual, different individuals
have similar microdeletions or microduplications and exhibit autistic, broad or normal phe
notypes (Fernandez et al., 2010; Kumar et al., 2008). The microduplication of 15q11-13,
which seems to have a major impact on the expression of ASD, is a good example of differ
ent effects in carriers. For example, Veltman et al. (2005) reported a female proband referred
for evaluation of a possible ASD. Genetic analyses indicated that the proband, her father
and one of her sisters, carried a paternally derived interstitial duplication involving
15q11-13. The proband showed evidence of ASD (PDD-NOS), borderline mental retardation,
mild hypotonia and joint laxity. Her father and her sister were of normal intelligence and
neither was thought to have an ASD, although speech/language difficulties and some autis
tic type behaviors were reported to have been present early in the development of the sister.
In studies of idiopathic cases, the most common change is the 16p11.2 microduplication/
microdeletion, comprising a region of around 600 Kb. Microduplication of 16p11.2 is present
in autistic and schizophrenic individuals but is also seen in normal individuals. This varia
tion is also observed in cases of ASD with and without dysmorphic signs (Fernandez et al.,
2010; Shinawi et al., 2010). Microdeletions of 16p11.2 seem to be more penetrating (around
100%) and are associated with the presence of major dysmorphic signs, while microduplica
tions have reduced penetrance (~50%) and are associated with minor dysmorphic signs (Ra
mocki & Zoghbi, 2008; Bourgeron, 2009; Fernandez et al., 2010).
One possible explanation for these cases, as already mentioned in previous sections, is that
probably there are other genetic components that are contributing to the disease in these
families that, depending on how they are associated in individuals, result in different phe
notypes (Griswold et al., 2012). But it is also very likely that different CNVs display different
penetrance depending on the sensitivity of the affected gene to dosage (number of copies),
the function of the gene and the affected region.
Endophenotypes (or intermediate phenotypes) are defined as heritable traits that form a
causal link between genes and observable symptoms. Brain based endophenotypes offer
several important advantages over clinical phenotypes in the search for pleiotropic genes in
ASD. They provide insight in the causal chains of action leading from gene to symptom ex
pression, they aid in forming etiologically more homogeneous subgroups of patients (Gould
& Gottesman, 2006).
In addition to the variability of simple and more complex genetic mechanisms proposed in
the expression of the ASD phenotype, environmental factors via epigenetic mechanisms
seem to be very important.
227
228
11. Epigenetic in autism

Particularly in light of recent findings on mutations in the genes that encode synaptic mole
cules associated with the communication between neurons, genetic factors are considered to
be the most important contributors to the pathogenesis of autism. Epigenetic mechanisms,
such as DNA methylation and modifications to histone proteins, regulate DNA structure
and gene expression, but without changing DNA sequence. Epigenetic abnormalities are as
sociated with several neurodevelopmental diseases. Many features of autism are consistent
with an epigenetic dysregulation, such as discordance of monozygotic twins, parental origin
and the gender-dependent effects of some alterations. Since epigenetic modifications are
known to be affected by environmental factors such as nutrition, drugs and mental stress,
ASD are not only caused by congenital genetic defects, but may also be caused by environ
mental factors via an epigenetic mechanism.
An example of this phenomenon in ASD is the mechanism of action of the SHANK3 gene.
SHANK3 is strongly suspected of being involved in the etiology of ASD since several muta
tions have been identified in a particular phenotypic group of patients with ASD. SHANK3
(also known as ProSAP2) regulates the structural organization of dendritic spines and is a
binding partner of neuroligins; genes encoding neuroligins are mutated in autism and As
pergers syndrome (Durand et al., 2007). It codes a synaptic scaffolding protein enriched in
the postsynaptic density of excitatory synapses and plays important roles in the formation,
maturation and maintenance of synapses. Haploinsufficiency of the SHANK3 gene causes a
developmental disorder, 22q13.3 deletion syndrome (known as Phelan-McDermid syn
drome), which is characterized by severe language and speech delay, hypotonia, global de
velopmental delay and autistic behavior. Five CpG-islands have been identified in the gene,
and tissue-specific expression is epigenetically regulated by DNA methylation. Cumulative
evidence in animal models has shown that several SHANK3 variants are expressed in the
developing rodent brain with their expression being regulated by the DNA methylation of
intragenic promoters (Uchino et al., 2006).
Additionally, oxidative stress in brain cells occurs due to environmental and genetic causes
and leads to decreased activity of the methionine synthase enzyme, which participates in
DNA methylation processes. So, when the activity of this enzyme is impaired, affected indi
viduals can exhibit attention deficits and other signs, including autistic symptoms, due to
defects in the expression of genes that are controlled by this epigenetic mechanism (Na
viaux, 2008; Dhillon et al., 2011).Therefore, environmental factors may activate intracellular
pathways during embryonic development thereby causing epigenetic changes in neural
function that would explain the relationship between environmental signals and genome in
the regulation of individual differences in behavior (Zhang & Meaney, 2010).
Studies carried out in Sweden involving 208 autistic children with Pervasive Developmental
Disorder-Not Otherwise Specified (PDD-NOS) and Aspergers syndrome (AS) obtained in
teresting results. The authors observed that advancing paternal age is associated with an in
creasing risk for ASD in offspring, that autistic-like traits in the normal population are
affected by both young and advancing paternal age and that autistic similarity within pairs

http://dx.doi.org/10.5772/53106
of twins seems to increase with advancing paternal age. It was suggested that this result
may be related to factors such as de novo mutations in germ lines, exposure to toxic agents
during life and epigenetic alterations (Lundstrom et al., 2010; Hultman et al., 2011). Advanc
ing maternal age was also reported as a risk factor for autism (Parner et al., 2012). However,
the explanations for these phenomena are still only speculative.
12. Exome sequencing

The development of the next generation sequencing has radically modified the scientific
landscape, making it possible to sequence all exomes of any person. The power of this ap
proach has been demonstrated by a number of studies which have identified pathogenic
mutations in diseases that have been difficult to make by traditional genetic mapping.
Exons are coding regions of the genome responsible for the development of functional ele
ments of the body, such as proteins. It has become clear that exome sequencing has great
potential with respect to sporadic diseases and the identification of de novo mutations.
Whole-exome sequencing (WES) of patient-parent trios has proven to be a successful screen
ing tool for the identification of candidate genes causing complex phenotypes such as in
ASD, learning disability, and schizophrenia (Choi et al., 2009; Bilguvar et al., 2010; Vissers et
al., 2010; Gilman et al., 2011; Pagnamenta et al., 2012; Sanders et al., 2012).
ORoak et al. (2012) studied all coding regions of the genome for parent-child trios exhibit
ing sporadic ASD, under the hypothesis that de novo mutations underlie a substantial frac
tion of the risk for developing ASD in families with no previous history of ASD or related
phenotypes (simplex families). They observed that these mutations are overwhelmingly pa
ternal in origin and positively correlated with paternal age, consistent with the modest in
creased risk for children of older fathers. It was also possible to estimate 384-821 loci which
could be considered pathogenic.
The analysis the homozygosity is used to define loci that may be involved in recessive ho
mozygous mutations that cause diseases characterized by genetic heterogeneity (Lencz et
al., 2007; Nalls et al., 2009). Starting from this concept, Chahrour et al. (2012) used homo
zygosity analysis to identify probands from non-consanguineous families that showed evi
dence of distant shared ancestry, suggesting potentially recessive mutations. The WES of 16
probands revealed validated homozygous, potentially pathogenic, recessive mutations that
segregated perfectly the disease in 4 of 16 families. The candidate genes that were found,
UBE3B, CLTCL1, NCKAP5L, and ZNF18, encode proteins involved in neuronal activities.
Neale et al. (2012) studied 175 trios to assess de novo mutations. They found strong evidence
that CHD8 and KATNAL2 are genuine autism risk factors. However, the small increase in
the rate of de novo events, when taken together with the protein interaction results, were con
sistent with an important but limited role for these mutations in ASD, similar to that docu
mented for de novo CNVs. According the authors, the data indicated that most of the
observed de novo events are unconnected to ASD; those that do confer risk are distributed
229
230
across many genes and are incompletely penetrant. The results support polygenic models in
which spontaneous coding mutations in any of a large number of genes increases risk by 5to 20-fold.
Iossifov et al. (2012) did not find significantly greater numbers of de novo missense muta
tions in ASD children versus unaffected, but gene-disrupting mutations (nonsense, splice
site and frameshifts) were twice as frequent in the first group. Based on this differential and
the number of recurrent and total targets of gene disruption they estimated between 350 and
400 autism susceptibility genes. Many of the genes are associated to the FMRP protein, rein
forcing links between autism and synaptic plasticity. They suggested that genes associated
to FMRP are especially targets of cognitive disorders that are dosage-sensitive.
Another aspect of exomes should also be considered. Mitochondria are cellular organelles
that function to control energy production necessary for brain development and activity. Al
though each individual is typically characterized by a single mitochondrial DNA type, the
fact is that each individual is a population of mitocondrial DNA genomes, and the presence
of multiple types within an individual is termed heteroplasmy. Although each individual is
typically characterized by a single mitocondrial DNA type, in fact to date, more than 400 mi
tochondrial mutations have been associated with human disease and most were observed in
heteroplasmic states, with pathogenic mutations coexisting with normal mitochondrial ge
nomes. This suggests that the heteroplasmic level is of particular interest, as the disease phe
notype becomes evident only when the percentage of mutant molecules exceeds a critical
threshold value. Although this value differs for different mutations and in different tissues,
it is usually in the range of 70%~90%. However, all the various techniques that have been
employed to detect heteroplasmy have disadvantages. WES allows rapid detection of not
only nuclear mutations but also mitochondrial mutations that also seem to be involved in
the etiology of ASD. In this context, Li et al. (2012) sequenced the mitochondrial genome of
131 healthy individuals of European ancestry. In 32 individuals they identified 37 hetero
plasmies at frequencies of 10% or higher at 34 different sites in the mitochondrial DNA indi
cating that variations commonly occur in mitochondrial DNA. These variations may impact
on energy levels and influence brain development and function. Next generation sequencing
should provide novel insights into genome-wide aspects of variation or heteroplasmy useful
in the study of human disorders including autism.
All these results show that there are a lot of regions/genes being identified by very advanced
methods, but no common etiology can be proposed. It is clear that whatever the proposed
model to explain ASD, all aspects such as environmental, oligogenic, de novo mutations,
polygenic, multifactorial, pleiotropic effects, combination of locus heterogeneity, heteroplas
my, among others, do not apply to all cases. Perhaps ASD emerge due to highly specific and
individual biological patterns. The possibility of distinguishing primary and secondary ef
fects will require a better understanding of the underlying biology and identification of the
association between genetic and environmental factors within the phenotypic context of
each family. The bottom line is that you must have a systemic view of the problem.

http://dx.doi.org/10.5772/53106
13. Conclusion
Knowledge about the biological mechanisms involved in the etiology of ASD has increased
significantly over the past three years. A genetic etiology of these disorders is certain, as cer
tain as is their complexity. An understanding of the genetic factors involved is crucial to es
tablish future intervention strategies. Although the current emphasis on deciphering ASD
has demonstrated the necessity of multidisciplinary approaches, clinical geneticists have an
important role in diagnosis and research of autism. The interpretation of this new genetic
data requires a set of skills. It is important to know how to get and to interpret genetic tests,
family pedigrees, to analyze dysmorphic, neurologic, and medical phenotypes, to interpret
heterogeneity, develop rational genetic models, and to design researchs.
Despite the numerous known or, at least, allegedly involved causes of predisposition for
ASD, the etiology is identified in a few cases (~ 10%) thereby highlighting the importance of
genetic testing in affected individuals. The discovery of an etiological agent in a given case
will, very probably, not interfere in treatment. However, this will reduce the distress of pa
rents by explaining the cause of the problem and clarify about the possibility of familial re
currence. On identifying the etiologic agent, genetic counseling can be better targeted. Thus,
a clinical-genetic evaluation of the patient is important as are the karyotypic analysis, molec
ular test for FRAXA, the investigation of inborn errors of metabolism, performing imaging
tests and multiplex ligation-dependent probe amplification (MLPA) for at least three hot
spots in ASD (15q11-13, 16p11.2 and 22q11.2). These are strategies available to better assess
the etiology ASD. Certainly, in the not too distant future, other more sophisticated genetic
research tools will be commercially available. The question that remains is whether the in
terpretation of results will accompany the speed of technical advances.
Acknowledgements
Financial support: Fundao de Amparo Pesquisa do Estado de So Paulo (FAPESP).
Author details
Agnes Cristina Fett-Conte1, Ana Luiza Bossolani-Martins2 and Patrcia Pereira-Nascimento2
1 Medical School FAMERP/FUNFARME, So Jos do Rio Preto, So Paulo, Brazil
2 IBILCE/UNESP, So Jos do Rio Preto, So Paulo, Brazil
231
232
References
[1] Abrahams, B. S., & Geschwind, D. H. (2008). Advances in autism genetics: on the
threshold of a new Neurobiology. Nat Rev Genet, , 9(5), 341-355.
[2] Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P.,
Kondrashov, A. S., & Sunyaev, S. R. (2010). A method and server for predicting dam
aging missense mutations. Nat Methods., , 7(4), 248-249.
[3] Alarcn, M., Abrahams, B. S., Stone, J. L., Duvall, J. A., Perederiy, J. V., Bomar, J. M.,
Sebat, J., Wigler, M., Martin, C. L., Ledbetter, D. H., Nelson, S. F., Cantor, R. M., &
Geschwind, D. H. (2008). Linkage, association, and gene-expression analyses identify
CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet., , 82(1), 150-159.
[4] Anney, R.; Klei, L.; Pinto, D.; Almeida, J.; Bacchelli, E.; Baird, G.; Bolshakova, N.;
Blte, S.; Bolton, P.F.; Bourgeron, T.; Brennan, S.; Brian, J.; Casey, J.; Conroy, J.; Cor
reia, C.; Corsello, C.; Crawford, E.L.; de Jonge, M.; Delorme, R.; Duketis, E.; Duque,
F.; Estes, A.; Farrar, P.; Fernandez, B.A.; Folstein, S.E.; Fombonne, E.; Gilbert, J.; Gill
berg, C.; Glessner, J.T.; Green, A.; Green, J.; Guter, S.J.; Heron, E.A.; Holt, R.; Howe,
J.L.; Hughes, G.; Hus, V.; Igliozzi, R.; Jacob, S.; Kenny, G.P.; Kim, C.; Kolevzon, A.;
Kustanovich, V.; Lajonchere, C.M.; Lamb, J.A.; Law-Smith, M.; Leboyer, M.; Le Cou
teur, A.; Leventhal, B.L.; Liu, X.Q.; Lombard, F.; Lord, C.; Lotspeich, L.; Lund, S.C.;
Magalhaes, T.R.; Mantoulan, C.; McDougle, C.J.; Melhem, N.M.; Merikangas, A.;
Minshew, N.J.; Mirza, G.K.; Munson, J.; Noakes, C.; Papanikolaou, K.; Pagnamenta,
A.T.; Parrini, B.; Paton, T.; Pickles, A.; Posey, D.J.; Poustka, F.; Ragoussis, J.; Regan,
R.; Renshaw, K.; Roberts, W.; Roeder, K.; Roge, B.; Rutter, M.L.; Schlitt, S.; Shah, N.;
Sheffield, V.C.; Soorya, L.; Sousa, I.; Stoppioni, V.; Sykes, N.; Tancredi, R.; Thompson,
A.P.; Thomson, S.; Tryfon, A.; Tsiantis, J.; Van Engeland, H.; Vincent, J.B.; Volkmar,
F.; Vorstman, J.; Wallace, S.; Wing, K.; Wittemeyer, K.; Wood, S.; Zurawiecki, D.;
Zwaigenbaum, L.; Bailey, A.J.; Battaglia, A.; Cantor, R.M.; Coon, H.; Cuccaro, M.L.;
Dawson, G.; Ennis, S.; Freitag, C.M.; Geschwind, D.H.; Haines, J.L.; Klauck, S.M.;
McMahon, W.M.; Maestrini, E.; Miller, J.; Monaco, A.P.; Nelson, S.F.; Nurnberger,
J.I.Jr,; Oliveira, G.; Parr, J.R.; Pericak-Vance, M.A.; Piven, J.; Schellenberg, G.D.;
Scherer, S.W.; Vicente, A.M.; Wassink, T.H.; Wijsman, E.M.; Betancur, C.; Buxbaum,
J.D.; Cook, E.H.; Gallagher, L.; Gill, M.; Hallmayer, J.; Paterson, A.D.; Sutcliffe, J.S.;
Szatmari, P.; Vieland, V.J.; Hakonarson, H. & Devlin, B. (2012). Individual common
variants exert weak effects on risk for Autism Spectrum Disorders. Hum Mol Genet.
2012 Jul 26. Epub ahead of print.
[5] Angelidou, A., Asadi, S., Alysandratos, K. D., Karagkouni, A., Kourembanas, S., &
Theoharides, T. C. (2012). Perinatal stress, brain inflammation and risk of autism-Re
view and proposal. BMC Pediatr., , 12(1), 89.
[6] Arking, D. E., Cutler, D. J., Brune, C. W., Teslovich, T. M., West, K., Ikeda, M., Rea,
A., Guy, M., Lin, S., Cook, E. H., & Chakravarti, A. (2008). A common genetic variant

http://dx.doi.org/10.5772/53106
in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am

J Hum Genet., , 82(1), 160-164.
[7] Avchen, R. N., Wiggins, L. D., Devine, O., Van Naarden, Braun. K., Rice, C., Hobson,
N. C., Schendel, D., & Yeargin-Allsopp, M. Evaluation of a records-review surveil
lance system used to 880 determine the prevalence of autism spectrum disorders.
((2011). J Autism Dev Disord, , 41(2), 227-236.
[8] Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter,
M. (1995). Autism as a strongly genetic disorder: evidence from a British twin study.
Psychol Med, , 25(1), 63-77.
[9] Baird, G., Simonoff, E., Pickles, A., Chandler, S., Loucas, T., Meldrum, D., & Char
man, T. (2006). Prevalence of disorders of the autism spectrum in a population cohort
of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet, ,
368(9531), 210-215.
[10] Ben-Ari, Y., Gaiarsa, J. L., Tyzio, R., & Khazipov, R. (2007). GABA: a pioneer trans
mitter that excites immature neurons and generates primitive oscillations. Physiol
Rev., , 87(4), 1215-1284.
[11] Berg, J. S., Brunetti-Pierri, N., Peters, S. U., Kang, S. H., Fong, C. T., Salamone, J.,
Freedenberg, D., Hannig, V. L., Prock, L. A., Miller, D. T., Raffalli, P., Harris, D. J.,
Erickson, R. P., Cunniff, C., Clark, G. D., Blazo, M. A., Peiffer, D. A., Gunderson, K.
L., Sahoo, T., Patel, A., Lupski, J. R., Beaudet, A. L., & Cheung, S. W. (2007). Speech
delay and autism spectrum behaviors are frequently associated with duplication of
the 7q11.23 Williams-Beuren syndrome region. Genet. Med., , 9(4), 427-441.
[12] Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Rob
erts, W., Szatmari, P., Pinto, D., Bonin, M., Riess, A., Engels, H., Sprengel, R., Scherer,
S. W., & Rappold, G. A. (2010). Mutations in the SHANK2 synaptic scaffolding gene
in autism spectrum disorder and mental retardation. Nat. Genet., , 42(6), 489-491.
[13] Betancour, C. (2011). Etiological heterogeneityin autism spectrum disorders:more
than 100 genetic and genomic disorders and still couting. Brain. Res, , 1380, 42-77.
[14] Biederman, J., Petty, C. R., Fried, R., Wozniak, J., Micco, J. A., Henin, A., Doyle, R.,
Joshi, G., Galdo, M., Kotarski, M., Caruso, J., Yorks, D., & Faraone, S. V. (2010). Child
Behavior Checklist Clinical Scales Discriminate Referred Youth With Autism Spec
trum Disorder: A Preliminary Study. J Dev and Behav Pediatr, , 31(6), 485-490.
[15] Bilgvar, K., Oztrk, A. K., Louvi, A., Kwan, K. Y., Choi, M., Tatli, B., Yalnizolu, D.,
Tysz, B., Calayan, A. O., Gkben, S., Kaymakalan, H., Barak, T., Bakirciolu, M.,
Yasuno, K., Ho, W., Sanders, S., Zhu, Y., Yilmaz, S., Diner, A., Johnson, M. H., Bro
nen, R. A., Koer, N., Per, H., Mane, S., Pamir, M. N., Yalinkaya, C., Kumanda, S.,
Topu, M., Ozmen, M., Sestan, N., Lifton, R. P., State, M. W., & Gnel, M. (2010).
Whole-exome sequencing identifies recessive WDR62 mutations in severe brain mal
formations. Nature., , 467(7312), 207-210.
233
234
[16] Bourgeron, T. (2009). A synaptic trek to autism. Curr Opin Neurobio., , 19(2),
231-234.
[17] Bronsard, G., Botbol, M., & Tordjman, S. (2011). Aggression in low functioning chil
dren and adolescents with autistic disorder. PLoS One, , 21(5), e14358.
[18] Carter, M., Nikkel, S., Fernandez, B., Marshall, C., Noor, A., Lionel, A., Prasad, A.,
Pinto, D., Joseph-George, A., Noakes, C., Fairbrother-Davies, C., Roberts, W., Vin
cent, J., Weksberg, R., & Scherer, S. W. (2011). Hemizygous deletions on chromosome
1p21.3 involving the DPYD gene in individuals with autism spectrum disorder. Clin
Genet, , 80(5), 435-443.
[19] Castermans, D., Wilquet, V., Steyaert, J., Van de Ven, W., Fryns, J. P., & Devriendt, K.
(2004). Chromosomal anomalies in individuals with autism: a strategy towards the
Identification of genes involved in. AutismAutism., , 8(2), 141-161.
[20] Chahrour, M. H., Yu, T. W., Lim, E. T., Ataman, B., Coulter, M. E., Hill, R. S., Stevens,
C. R., Schubert, C. R., Autism, A. R. R. A., Sequencing, Collaboration., Greenberg, M.
E., Gabriel, S. B., & Walsh, C. A. (2012). Whole exome sequencing and homozygosity
analysis implicate depolarization regulated neuronal genes in autism. Plos Genet., ,
8(4), e1002635.
[21] Cheng, L., Ge, Q., Xiao, P., Sun, B., Ke, X., Bai, Y., & Lu, Z. (2009). Association study
between BDNF gene polymorphism and autism by threedimensional gel-based mi
croarray. Int J Mol Sci., , 10(6), 2487-2500.
[22] Chess, S., Fernandez, P., & Korn, S. (1978). Behavioral consequences of congenital ru
bella. J. Pediatr, , 93(4), 699-703.
[23] Chiocchetti, A., & Klauck, S. M. (2011). Genetic analyses for identifying molecular
mechanisms in autism spectrum disorders. Z Kinder Jugendpsychiatr Psychother, ,
39(2), 101-111.
[24] Choi, M., Scholl, U. I., Ji, W., Liu, T., Tikhonova, I. R., Zumbo, P., Nayir, A., Bakka
lolu, A., Ozen, S., Sanjad, S., Nelson-Williams, C., Farhi, A., Mane, S., & Lifton, R. P.
(2009). Genetic diagnosis by whole exome capture and massively parallel DNA se
quencing. Proc the Nat Ac Sci U S A., , 106(45), 19096-19101.
[25] Christian, S. L., Brune, C. W., Sudi, J., Kumar, R. A., Liu, S., Karamohamed, S., Bad
ner, J. A., Matsui, S., Conroy, J., Mc Quaid, D., Gergel, J., Hatchwell, E., Gilliam, T. C.,
Gershon, E. S., Nowak, N. J., Dobyns, W. B., Cook, E. H., & Jr , . (2008). Novel submi
croscopic chromosomal abnormalities detected in autism spectrum disorder. Biologi
cal Psychiatry, , 15(63), 1111-1117.
[26] Christianson, A. L., Chesler, N., & Kromberg, J. G. (1994). Fetal valproate syndrome:
clinical and neuro-developmental features in two sibling pairs. Dev. Med. Child
Neurol. , 36(4), 361-369.
[27] Chrousos, G. P. (1995). The hypothalamic-pituitary-adrenal axis and immune-medi
ated inflammation. N Engl J Med, Vol. Vol. 18, (332), 1351-1362.

http://dx.doi.org/10.5772/53106
[28] Coleman, M., & Blass, J. P. Autism and lactic acidosis. ((1985). J. Autism Dev. Dis
ord., , 15(1), 1-8.
[29] Coleman, M., & Gillberg, C. (2012). The autisms. Oxford: Oxford University Press.
[30] Conrad, D. F., Keebler, J. E., De Pristo, M. A., Lindsay, S. J., Zhang, Y., Casals, F.,
Idaghdour, Y., Hartl, C. L., Torroja, C., Garimella, K. V., Zilversmit, M., Cartwright,
R., Rouleau, G. A., Daly, M., Stone, E. A., Hurles, M. E., Awadalla, P., 10, , & Ge
nomes, Project. (2011). Variation in genome-wide mutation rates within and between
human families. Nat. Genet., , 43(7), 712-714.
[31] Constantino, J. N., Zhang, Y., Frazier, T., Abbacchi, A. M., & Law, P. (2010). Sibling
recurrence and the genetic epidemiology of autism. Am J Psychiatry, , 167(11),
1349-1356.
[32] Cook, E. H., Jr , , & Scherer, S. W. (2008). Copy-number variations associated with
neuropsychiatric conditions. Nature, , 455(7215), 919-923.
[33] Cottrell, C. E., Bir, N., Varga, E., Alvarez, C. E., Bouyain, S., Zernzach, R., Thrush, D.
L., Evans, J., Trimarchi, M., Butter, E. M., Cunningham, D., Gastier-Foster, J. M., Mc
Bride, K. L., & Herman, G. E. (2011). Contactin 4 as an autism susceptibility locus.
Autism Res., , 4(3), 189-199.
[34] Currenti, S. A. (2010). Understanding and Determining the Etiology of Autism. Cell
Molec Neurobiol, , 30(2), 161-171.
[35] Daniels, J. L., Forssen, U., Hultman, C. M., Cnattingius, S., Savitz, D. A., Feychting,
M., & Sparen, P. (2008). Parental psychiatric disorders associated with autism spec
trum disorders in the offspring. Pediatrics, , 121(5), e1357-e1362.
[36] Dardeno, T. A., Chou, S. H., Moon, H. S., Chamberland, J. P., Fiorenza, C. G., & Man
tzoros, C. S. Leptin in human physiology and therapeutics ((2010). Front Neuroen
docrinol, , 31(3), 377-393.
[37] Davis, J. M., & Auten, R. L. (2010). Maturation of the antioxidant system and the ef
fects on preterm birth. Semin Fetal Neonatal Med, , 15(4), 191-195.
[38] De Rubeis, S., Fernndez, E., Buzzi, A., Di Marino, D., & Bagni, C. (2012). Molecular
and cellular aspects of mental retardation in the Fragile X syndrome: from gene mu
tation/s to spine dysmorphogenesis. Adv Exp Med Biol, , 970, 517-551.
[39] Delahaye, A., Toutain, A., Aboura, A., Dupont, C., Tabet, A. C., Benzacken, B., Elion,
J., Verloes, A., Pipiras, E., & Drunat, S. (2009). Chromosome 22q13.3 deletion syn
drome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3. Eur.
J. Med. Genet., , 52(5), 328-332.
[40] Devlin, B., & Scherer, S. W. (2012). Genetic architecture in autism spectrum disorders.
Curr Opin Genet Dev., , 22(3), 229-237.
[41] Dhillon, S., Hellings, J. A., & Butler, M. G. (2011). Genetics and mitochondrial abnor
malities in autism spectrum disorders : a review. Curr Genomics, , 12(5), 322-332.
235
236
[42] Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau,
F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsater, H., Sponheim, E., GoubranBotros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M. C., de Mas, P., Bieth, E.,
Roge, B., Heron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T. (2007).
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associ
ated with autism spectrum disorders. Nat. Genet., , 39(1), 25-27.
[43] Esposito, P., Gheorghe, D., Kandere, K., Pang, X., Conally, R., Jacobson, S., & Theo
harides, T. C. (2001). Acute stress increases permeability of the blood-brain-barrier
through activation of brain mast cells. Brain Res, , 5(888), 117-127.
[44] Faras, H., Ateeqi, N. A., & Tidmarsh, L. (2010). Autism spectrum disorders. Annals
of Saudi Medicine, , 30(4), 295-300.
[45] Fernandez, B. A., Roberts, W., Chung, B., Weksberg, R., Meyn, S., Szatmari, P., Jo
seph-George, A. M., Mackay, S., Whitten, K., Noble, B., Vardy, C., Crosbie, V., Lus
combe, S., Tucker, E., Turner, L., Marshall, C. R., & Scherer, S. W. (2010). Phenotypic
spectrum associated with de novo and inherited deletions and duplications at
16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J. Med.
Genet., , 47(3), 195-203.
[46] Fillano, J. J., Goldenthal, M. J., Rhodes, C. H., & Marin-Garcia, J. (2002). Mitochondri
al dysfunction in patients with hypotonia, epilepsy, autism, and developmental de
lay: HEADD syndrome. J. Child Neurol. , 17(6), 435-439.
[47] Geschwind, D. H. (2011). Genetics of autism spectrum disorders. Trends Cogn Sci, ,
15(9), 409-416.
[48] Gillberg, C. (1998). Chromosomal disorders and autism. J. Autism Dev. Disord, ,
28(5), 415-425.
[49] Gilman, S. R., Iossifov, I., Levy, D., Ronemus, M., Wigler, M., & Vitkup, D. (2011).
Rare de novo variants associated with autism implicate a large functional network of
genes involved in formation and function of synapses. Neuron., , 70(5), 898-907.
[50] Goldberg, W. A., Jarvis, K. L., Osann, K., Laulhere, T. M., Straub, C., Thomas, E., Fili
pek, P., & Spence, M. A. (2005). Brief report: Early social communication behaviors in
the younger siblings of children with autism. J Autism Dev Disord., , 35(5), 657-664.
[51] Gould, T. D., & Gottesman, I. I. (2006). Psychiatric endophenotypes and the develop
ment of valid animal models. Genes Brain Behav., , 5, 113-119.
[52] Graf, W. D., Marin-Garcia, J., Gao, H. G., Pizzo, S., Naviaux, R. K., Markusic, D., Bar
shop, B. A., Courchesne, E., & Haas, R. H. (2000). Autism associated with the mito
chondrial DNA G8363A transfer RNA(Lys) mutation. J. Child Neurol., , 15(6),
357-361.
[53] Griswold, A. J., , D., Sacharow, S. J., Robinson, J. L., Jaworski, J. M., Wright, H. H.,
Abramson, R., K., , Lybaek, H., Oyen, N., Cuccaro, M. L., Gilbert, J. R., & Pericak-

http://dx.doi.org/10.5772/53106
Vance, M. A. (2011). A de novo 1.5 mb microdeletion on chromosome 14q23.2- 23.3 in

a patient with autism and spherocytosis. Autism Res., , 4(3), 221-227.
[54] Griswold, A. J., , D., Cukier, H. N., Naes, L. D., Schmidt, M. A., Chung, R. H., Ja
worski, J. M., Salyakina, D., Konidari, eu., Whitehead, P. L., Wright, H. H., Abram
son, R. K., Williams, S. M., Menon, R., Martin, E. R., Haines, J. L., Gilbert, J. R.,
Cuccaro, M. L., Pericak-M, A., & Vance, . (2012). Evaluation of copy number varia
tions reveals novel candidate genes in autism spectrum disorders associated path
ways. Hum Mol Genet., , 21(15), 3513-3523.
[55] Gurrieri, F. (2012). Working up autism: the practical role of medical genetics. Am J
Med Genet C Semin Med Genet. , 160C(2), 104-110.
[56] Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., Miller, J.,
Fedele, A., Collins, J., Smith, K., Lotspeich, L., Croen, L. A., Ozonoff, S., Lajonchere,
C., Grether, J. K., & Risch, N. (2011). Genetic heritability and shared environmental
factors among twin pairs with autism. Arch. Gen. Psychiatry, , 68(1), 1095-1102.
[57] Hultman, C. M., Sandin, S., Levine, S. Z., Lichtenstein, P., & Reichenberg, A. (2011).
Advancing paternal age and risk of autism: new evidence from a populationbased
study and a meta-analysis of epidemiological studies. Mol Psychiatr.y, , 16(12),
1203-1212.
[58] Hussman, J. P., Chung, R. H., Griswold, A. J., Jaworkski, J. M., Salyakina, D., , D., Ko
nidari, I.., Whitehead, P. L., Vance, J. M., Martin, E. R., Cuccaro, M. L., Gilbert, J. R.,
Haines, J. L., & Pericak-Vance, M. A. (2011). A noise-reduction GWAS analysis impli
cates altered regulation of neurite outgrowth and guidance in autism. Mol. Autism, ,
2(1), 1.
[59] Iossifov, I., Ronemus, M., Levy, D., Wang, Z., Hakker, I., Rosenbaum, J., Yamrom, B.,
Lee, Y. H., Narzisi, G., Leotta, A., Kendall, J., Grabowska, E., , B., Marks, S., Rodgers,
L., Stepansky, A., Troge, J., Andrews, P., Bekritsky, M., Pradhan, K., Ghiban, E.,
Kramer, M., Parla, J., Demeter, R., Fulton, L. L., Fulton, R. S., Magrini, V. J., Ye, K.,
Darnell, J. C., Darnell, R. B., Mardis, E. R., Wilson, R. K., Schatz, M. C., Mc Combie,
W. R., & Wigler, M. (2012). De novo gene disruptions in children on the autistic spec
trum. Neuron., , 74(2), 285-299.
[60] Jiao, Y., Chen, R., Ke, X., Cheng, L., Chu, K., Lu, Z., & Herskovits, E. H. (2011). Pre
dictive models for subtypes of autism spectrum disorder based on single-nucleotide
polymorphisms and magnetic resonance imaging. Adv Med Sci., , 56(2), 334-342.
[61] Joshi, S. R., Mehendale, S. S., Dangat, K. D., Kilari, A. S., Yadav, H. R., & Taralekar, V.
S. (2008). High maternal plasma antioxidant concentrations associated with preterm
delivery. Ann Nutr Metab, , 53(3-4), 276-282.
[62] Kaufmann, W. E., Cortell, R., Kau, A. S., Bukelis, I., Tierney, E., Gray, R. M., Cox, C.,
Capone, G. T., & Stanard, P. (2004). Autism spectrum disorder in fragile X syndrome:
communication, social interaction, and specific behaviors. Am. J. Med. Genet A., ,
129(3), 225-234.
237
238
[63] King, M., & Bearman, P. (2009). Diagnostic change and the increased prevalence of
786 autism. Inter J Epidemiol, , 38(5), 1224-1234.
[64] Klein, R. J., Xu, X., Mukherjee, S., Willis, J., & Hayes, J. (2010). Successes of genomewide association studies. Cell, author reply 353-355., 142(3), 350-351.
[65] Kumar, R. A., Karamohamed, S., Sudi, J., Conrad, D. F., Brune, C., Badner, J. A., Gil
liam, T. C., Nowak, N. J., Cook, E. H., Jr , , Dobyns, W. B., & Christian, S. L. (2008).
Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet., , 17(4), 628-638.
[66] Laje, G., Morse, R., Richter, W., Ball, J., Pao, M., & Smith, A. C. (2010). Autism spec
trum features in Smith-Magenis syndrome. Am. J. Med. Genet. C Semin. Med. Gen
et., , 154C(4), 456-462.
[67] Lauritsen, M. B., Pedersen, C. B., & Mortensen, P. B. (2005). Effects of familial risk
factors and place of birth on the risk of autism: a nationwide register-based study. J
Child Psychol Psychiatry, , 46(9), 963-971.
[68] Lee, C., & Scherer, S. W. (2010). The clinical context of copy number variation in the
human genome. Expert Rev Mol Med., , 12, e8.
[69] Lencz, T., Lambert, C., De Rosse, P., Burdick, K. E., Morgan, T. V., Kane, J. M., Ku
cherlapati, R., & Malhotra, A. K. (2007). Runs of homozygosity reveal highly pene
trant recessive loci in schizophrenia. Proc Natl Acad Sci U S A., , 104(50),
19942-19947.
[70] Levinson, D. F., Duan, J., Oh, S., Wang, K., Sanders, A. R., Shi, J., Zhang, N., Mowry,
B. J., Olincy, A., Amin, F., Cloninger, C. R., Silverman, J. M., Buccola, N. G., Byerley,
W. F., Black, D. W., Kendler, K. S., Freedman, R., Dudbridge, F., Peer, I., Hakonar
son, H., Bergen, S. E., Fanous, A. H., Holmans, P. A., Gejman, P. V., & (2011, . (2011).
Copy number variants in schizophrenia: confirmation of five previous findings and
new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry, ,
168(3), 302-316.
[71] Levy, D., Ronemus, M., Yamrom, B., Lee, Y. H., Leotta, A., Kendall, J., Marks, S.,
Lakshmi, B., Pai, D., Ye, K., Krieger, A., Yoon, S., Troge, J., Rodgers, L., Iossifov, I., &
Wigler, M. (2011). Rare de novo and transmitted copy-number variation in autistic
spectrum disorders. Neuron., , 70(5), 886-897.
[72] Li, H., Yamagata, T., Mori, M., & Momoi, M. Y. (2005). Absence of causative mtations
and presence of autism-related allele in FOXP2 in Japanese autistic patients. Brain
Dev., , 27(3), 207-210.
[73] Li, M., Schnberg, A., Schaefer, M., Schroeder, R., Nasidze, I., & Stoneking, M. De
tecting heteroplasmy from high-throughput sequencing of complete human mito
chondrial DNA genomes. ((2012). Am J Hum Genet., , 87(2), 237-249.
[74] Li, X., Zou, H., & Brown, W. T. (2012). Genes associated with autism spectrum disor
ders. Brain Res Bull. Epud already print.

http://dx.doi.org/10.5772/53106
[75] Lichtenstein, P., Carlstrom, E., Rastam, M., Gillberg, C., & Anckarsater, H. (2010).
The genetics of autism spectrum disorders and related neuropsychiatric disorders in
childhood. Am J Psychiatry, , 1(11), 1357-1363.
[76] Limperopoulos, C., Bassan, H., Sullivan, N. R., Soul, J. S., Robertson, R. L., Jr , ,
Moore, M., Ringer, S. A., Volpe, J. J., & du, Plessis. A. J. (2008). Positive screening for
autism in ex-preterm infants: prevalence and risk factors. Pediatrics, , 121(4), 758-765.
[77] Lin, P. I., Chien, Y. L., Wu, Y. Y., Chen, C. H., Gau, S. S., Huang, Y. S., Liu, S. K., Tsai,
W. C., & Chiu, Y. N. (2012). The WNT2 gene polymorphism associated with speech
delay inherent to autism. Res Dev Disabil., , 5(33), 1533-1540.
[78] Lintas, C., & Persico, A. M. (2009). Autistic phenotypes and genetic testing: state-ofthe- 821 art for the clinical geneticist. J Med Genet, , 46(1), 1-8.
[79] Lombard, J., Autism, a., & mitochondrial, disorder?. (1998). Med. Hypotheses, , 50(6),
497-500.
[80] Losh, M., Childress, D., Lam, K., & Piven, J. (2008). Defining key features of the broad
autism phenotype: a comparison across parents of multiple- and single-incidence au
tism families. Am J Genet B Neuropsychiatri Genet., , 147B(4), 424-433.
[81] Lu, A. T., Yoon, J., Geschwind, D. H., & Cantor, R. M. (2011). QTL replication and
targeted association highlight the nerve growth factor gene for nonverbal communi
cation deficits in autism spectrum disorders. Mol Psychiatry. Epub ahead of print.
[82] Lundstrom, S., Haworth, C. M., Carlstrom, E., Gillberg, C., Mill, J., Rastam, M., Hult
man, C. M., Ronald, A., Anckarster, H., Plomin, R., Lichtenstein, P., & Reichenberg,
A. (2010). Trajectories leading to autism spectrum disorders are affected by paternal
age: findings from two nationally representative twin studies. J Child Psychol Psy
chiatry, , 51(7), 850-856.
[83] , D., Salyakina, D., Jaworski, J. M., Konidari, I., Whitehead, P. L., Andersen, A. N.,
Hoffman, J. D., Slifer, S. H., Hedges, D. J., Cukier, H. N., Griswold, A. J., Mc Cauley,
J. L., Beecham, G. W., Wright, H. H., Abramson, R. K., Martin, E. R., Hussman, J. P.,
Gilbert, J. R., Cuccaro, M. L., Haines, J. L., & Pericak-Vance, M. A. (2009). A genomewide association study of autism reveals a common novel risk locus at 5p14.1. Ann.
Hum. Genet., , 73(Pt3), 263-273.
[84] Malhotra, D., & Sebat, J. . (2012). CNVs: harbingers of a rare variant revolution in
psychiatric genetics. Cell, , 148(6), 1223-1241.
[85] Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D.
J., Mc Carthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., Cho, J. H., Gutt
macher, A. E., Kong, A., Kruglyak, L., Mardis, E., Rotimi, C. N., Slatkin, M., Valle, D.,
Whittemore, A. S., Boehnke, M., Clark, A. G., Eichler, E. E., Gibson, G., Haines, J. L.,
Mackay, T. F., Mc Carroll, S. A., & Visscher, P. M. (2009). Finding the missing herita
bility of complex diseases. Nature, , 461(7265), 747-753.
239
240
[86] Manzi, B., Loizzo, A. L., Giana, G., & Curatolo, P. (2008). Autism and metabolic dis
eases. J. Child Neurol., , 23(3), 307-314.
[87] Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M.,
Moessner, R., Pinto, D., Ren, Y., Thiruvahindrapduram, B., Fiebig, A., Schreiber, S.,
Friedman, J., Ketelaars, C. E., Vos, Y. J., Ficicioglu, C., Kirkpatrick, S., Nicolson, R.,
Sloman, L., Summers, A., Gibbons, C. A., Teebi, A., Chitayat, D., Weksberg, R.,
Thompson, A., Vardy, C., Crosbie, V., Luscombe, S., Baatjes, R., Zwaigenbaum, L.,
Roberts, W., Fernandez, B., Szatmari, P., & Scherer, S. W. (2008). Structural variation
of chromosomes in autism spectrum disorder. Am. J. Hum. Genet., , 82(2), 477-488.
[88] Marteleto, M. R., Lima, e., Menezes, C. G., Tamanaha, A. C., Chiari, B. M., Perissino
to, J., & (2008, . (2008). Administration of the Autism Behavior Checklist: agreement
between parents and professionals observations in two intervention contexts. Rev
Bras de Psiquiatr, , 30(3), 203-208.
[89] Mefford, H. C., Batshaw, M. L., & Hoffman, E. P. (2012). Genomics, Intellectual Disa
bility, and Autism. N Engl J Med., , 366(8), 733-743.
[90] Miles, J. H. (2011). Autism spectrum disorders-a genetics review. Genet. Med., , 13(4),
278-294.
[91] Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N.
P., Church, D. M., Crolla, , , J. A., Eichler, E. E., Epstein, C. J., Faucett, W. A., Feuk, L.,
Friedman, J. M., Hamosh, A., Jackson, L., Kaminsky, E. B., Kok, K., Krantz, I. D.,
Kuhn, R. M., Lee, C., Ostell, J. M., Rosenberg, C., Scherer, S. W., Spinner, N. B., Stav
ropoulos, D. J., Tepperberg, J. H., Thorland, E. C., Vermeesch, J. R., Waggoner, D. J.,
Watson, M. S., Martin, C. L., & Ledbetter, D. H. (2010). Consensus statement: chro
mosomal microarray is a first-time clinical diagnostic test for individuals with devel
opmental disabilities or congenital anomalies. Am J Hum Genet., , 86, 749-764.
[92] Mitchell, K. J. (2011). The genetics of neurodevelopmental disease. Curr Opin Neuro
biol, , 21(1), 197-203.
[93] Morrow, E. M., Yoo, S. Y., Flavell, S. W., Kim, T. K., Lin, Y., Hill, R. S., Mukaddes, N.
M., Balkhy, S., Gascon, G., Hashmi, A., Al-Saad, S., Ware, J., Joseph, R. M., Green
blatt, R., Gleason, D., Ertelt, J. A., Apse, K. A., Bodell, A., Partlow, J. N., Barry, B.,
Yao, H., Markianos, K., Ferland, R. J., Greenberg, M. E., & Walsh, C. A. Identifyin au
tism loci and genes by tracing recent shared ancestry. ((2010). Science, , 321(5886),
218-223.
[94] Munesue, T., Ono, Y., Mutoh, K., Shimoda, K., Nakatani, H., & Kikuchi, M. (2008).
High prevalence of bipolar disorder comorbidity in adolescents and young adults
with high-functioning autism spectrum disorder: a preliminary study of 44 outpa
tients. J Affect Disord, , 111(2-3), 170-175.
[95] Neale, B. M., Kou, Y., Liu, L., Maayan, A., Samocha, K. E., Sabo, A., Lin, C. F., Ste
vens, C., Wang, L. S., Makarov, V., Polak, P., Yoon, S., Maguire, J., Crawford, E. L.,

http://dx.doi.org/10.5772/53106
Campbell, N. G., Geller, E. T., Valladares, O., Schafer, C., Liu, H., Zhao, T., Cai, G.,
Lihm, J., Dannenfelser, R., Jabado, O., Peralta, Z., Nagaswamy, U., Muzny, D., Reid,
J. G., Newsham, I., Wu, Y., Lewis, L., Han, Y., Voight, B. F., Lim, E., Rossin, E., Kirby,
A., Flannick, J., Fromer, M., Shakir, K., Fennell, T., Garimella, K., Banks, E., Poplin,
R., Gabriel, S., De Pristo, M., Wimbish, J. R., Boone, B. E., Levy, S. E., Betancur, C.,
Sunyaev, S., Boerwinkle, E., Buxbaum, J. D., Cook, E. H., Jr , , Devlin, B., Gibbs, R. A.,
Roeder, K., Schellenberg, G. D., Sutcliffe, J. S., & Daly, M. J. (2012). Patterns and rates
of exonic de novo mutations in autism spectrum disorders. Nature. , 485(7397),
242-245.
[96] Nalls, M. A., Guerreiro, R. J., Simon-Sanchez, J., Bras, J. T., Traynor, B. J., Gibbs, J. R.,
Launer, L., Hardy, J., & Singleton, A. B. (2009). Extended tracts of homozygosity
identify novel candidate genes associated with late-onset Alzheimers disease. Neu
rogenetics., , 10(3), 183-190.
[97] Naviaux, R. K. (2008). Mitochondrial control of epigenetics. Cancer Biol. Ther., , 7(8),
1191-1193.
[98] Nicholas, B., Rudrasingham, V., Nash, S., Kirov, G., Owen, M. J., & Wimpory, D. C.
(2007). Association of Per1 and Npas2 with autistic disorder: support for the clock
genes/social timing hypothesis. Mol. Psychiatry, , 12(6), 581-592.
[99] Nijmeijer, J. S., Arias-Vsquez, A., Rommelse, N. N., Altink, M. E., Anney, R. J.,
Asherson, P., Banaschewski, T., Buschgens, C. J., Fliers, E. A., Gill, M., Minderaa, R.
B., Poustka, L., Sergeant, J. A., Buitelaar, J. K., Franke, B., Ebstein, R. P., Miranda, A.,
Mulas, F., Oades, R. D., Roeyers, H., Rothenberger, A., Sonuga-Barke, E. J., Steinhau
sen, H. C., Faraone, S. V., Hartman, C. A., & Hoekstra, P. J. (2011). Identifying loci for
the overlap between attention deficit/hyperactivity disorder and autism spectrum
disorder using a genome-wide QTL linkage approach. J Am Acad Child Adolesc
Psychiatry. , 7(49), 675-685.
[100] Nowakowska, B. A., de Leeuw, N., Ruivenkamp, C. A., Sikkema-Raddatz, B., Crolla,
J. A., Thoelen, R., Koopmans, M., den, Hollander. N., van Haeringen, A., van der Ke
vie-Kersemaekers, , Pfundt, R., Mieloo, H., van Essen, T., de Vries, B. B., Verde, A.,
Reardon, W., Fryns, J. P., & Vermeesch, J. R. (2012). Parental insertional balanced
translocations are an important cause of apparently de novo CNVs in patients with
developmental anomalies. Eur J Hum Genet, , 20(2), 66-170.
[101] ORoak, B. J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J. J., Girirajan, S., Karakoc, E.,
Mackenzie, A. P., Ng, S. B., Baker, C., Rieder, M. J., Nickerson, D. A., Bernier, R.,
Fisher, S. E., Shendure, J., & Eichler, E. E. (2011). Exome sequencing in sporadic au
tism spectrum disorders identifies severe de novo mutations. Nat Genet, , 43(8),
585-589.
[102] ORoak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko,
A., Lee, C., Smith, J. D., Turner, E. H., Stanaway, I. B., Vernot, B., Malig, M., Baker, C.,
Reilly, B., Akey, J. M., Borenstein, E., Rieder, M. J., Nickerson, D. A., Bernier, R.,
241
242
Shendure, J., & Eichler, E. E. (2012). Sporadic autism exomes reveal a highly intercon
nect protein network of de novo mutations. Nature., , 485(7397), 246-250.
[103] Pagnamenta, A. T., Lise, S., Harrison, V., Stewart, H., Jayawant, S., Quaghebeur, G.,
Deng, A. T., Murphy, V. E., Akha, E., Rimmer, A., Mathieson, I., Knight, S. J., Kini,
U., Taylor, J. C., & Keays, D. A. (2012). Exome sequencing can detect pathogenic mo
saic mutations present at low allele frequencies. J Hum Genet., , 57(1), 70-72.
[104] Parner, E. T., Baron-Cohen, S., Lauritsen, M. B., Jorgensen, M., Schieve, L. A., Year
gin-Allsopp, M., & Obel, C. (2012). Parental age and autism spectrum disorders. Ann
Epidemiol, , 22(3), 143-150.
[105] Persico, A. M., & Bourgeron, T. (2008). Searching for ways out of the autism maze:ge
netic, epigenetic and environmental clues. Trends Neuroscience., , 29(7), 349-358.
[106] Phelan, M. C. (2008). Deletion 22q13.3 syndrome. Orphanet. J. Rare Dis, , 27(3), 14.
[107] Pickles, A., Starr, E., Kazak, S., Bolton, P., Papanikolaou, K., Bailey, A., Goodman, R.,
Rutter, M., & (2000, . (2000). Variable expression of the autism broader phenotype:
Findings from extended pedigrees. J Child Psychol Psychiatry., , 41(4), 491-502.
[108] Pinto, D.; Pagnamenta, A.T.; Klei, L.; Anney, R.; Merico, D.; Regan, R.; Conroy, J.;
Magalhaes, T.R.; Correia, C. & Abrahams, B.S.; Almeida, J.; Bacchelli, E.; Bader, G.D.;
Bailey, A.J.; Baird, G.; Battaglia, A.; Berney, T.; Bolshakova, N.; Blte, S.; Bolton, P.F.;
Bourgeron, T.; Brennan, S.; Brian, J.; Bryson, S.E.; Carson, A.R.; Casallo, G.; Casey, J.;
Chung, B.H.;Cochrane, L.; Corsello, C.; Crawford, E.L.; Crossett, A.; Cytrynbaum, C.;
Dawson, G.; de Jonge, M.; Delorme, R.; Drmic, I.; Duketis, E.; Duque, F.; Estes, A.;
Farrar, P.; Fernandez, B.A.; Folstein, S.E.; Fombonne, E.; Freitag, C.M.; Gilbert, J.;
Gillberg, C.; Glessner, J.T.; Goldberg, J.; Green, A.; Green, J.; Guter, S.J.; Hakonarson,
H.; Heron, E.A.; Hill, M.; Holt, R.; Howe, J.L.; Hughes, G.; Hus, V.; Igliozzi, R.; Kim,
C.; Klauck, S.M.; Kolevzon, A.; Korvatska, O.; Kustanovich, V.; Lajonchere, C.M.;
Lamb, J.A.; Laskawiec, M.; Leboyer, M.; Le Couteur, A.; Leventhal, B.L.; Lionel, A.C.;
Liu, X.Q.; Lord, C.; Lotspeich, L.; Lund, S.C.; Maestrini, E.; Mahoney, W.; Mantoulan,
C.; Marshall, C.R.; McConachie, H.; McDougle, C.J.; McGrath, J.; McMahon, W.M.;
Merikangas, A.; Migita, O.; Minshew, N.J.; Mirza, G.K.; Munson, J.; Nelson, S.F.;
Noakes, C.; Noor, A.; Nygren, G.; Oliveira, G.; Papanikolaou, K.; Parr, J.R.; Parrini,
B.; Paton, T.; Pickles, A.; Pilorge, M.; Piven, J.; Ponting, C.P.; Posey, D.J.; Poustka, A.;
Poustka, F.; Prasad, A.; Ragoussis, J.; Renshaw, K.; Rickaby, J.; Roberts, W.; Roeder,
K.; Roge, B.; Rutter, M.L.; Bierut, L.J.; Rice, J.P.; Salt, J.; Sansom, K.; Sato, D.; Segura
do, R.; Sequeira, A.F.; Senman, L.; Shah, N.; Sheffield, V.C.; Soorya, L.; Sousa, I.;
Stein, O.; Sykes, N.; Stoppioni, V.; Strawbridge, C.; Tancredi, R.; Tansey, K.; Thiruva
hindrapduram, B.; Thompson, A.P.; Thomson, S.; Tryfon, A.; Tsiantis, J.; Van, Enge
land, H.; Vincent, J.B.; Volkmar, F.; Wallace, S.; Wang, K.; Wang, Z.; Wassink, T.H.;
Webber, C.; Weksberg, R.; Wing, K.; Wittemeyer, K.; Wood, S.; Wu, J.; Yaspan, B.L.;
Zurawiecki, D.; Zwaigenbaum, L.; Buxbaum, J.D.; Cantor, R.M.; Cook, E.H.; Coon,
H.; Cuccaro, M.L.; Devlin, B.; Ennis, S.; Gallagher, L.; Geschwind, D.H.; Gill, M.;
Haines, J.L.; Hallmayer, J.;Miller, J.; Monaco, A.P.; Nurnberger, J.I.Jr.; Paterson, A.D.;

http://dx.doi.org/10.5772/53106
Pericak-Vance, M.A.; Schellenberg, G.D.; Szatmari, P.; Vicente, A.M.; Vieland, V.J.;
Wijsman, E.M. & Scherer S.W. ((2010). ). Functional impact of global rare copy num
ber variation in autism spectrum disorders. Nature., Vol. 466, No. 7304, pp.368-372.
[109] Pons, R., Andreu, A. L., Checcarelli, N., Vila, M. R., Engelstad, K., Sue, C. M., Shun
gu, D., Haggerty, R., de Vivo, D. C., & Di Mauro, S. (2004). Mitochondrial DNA ab
normalities and autistic spectrum disorders. J. Pediatr, , 144(1), 81-85.
[110] Poot, M., Beyer, V., Schwaab, I., Damatova, N., Vant, Slot. R., Prothero, J., Holder, S.
E., & Haaf, T. (2009). Disruption of CNTNAP2 and additional structural genome
changes in a boy with speech delay and autism spectrum disorder. Neurogenetics, ,
11(1), 81-89.
[111] Ramocki, M. B., & Zoghbi, H. Y. (2008). Failure of neuronal homeostasi results in
common neuropsychiatric phenotypes. Nature., , 455(7215), 912-918.
[112] Ramoz, N., Reichert, J. G., Smith, C. J., Silverman, J. M., Bespalova, I. N., Davis, K. L.,
& Buxbaum, J. D. (2004). Linkage and association of the mitochondrial aspartate/
glutamate carrier SLC25A12 gene with autism. Am. J. Psychiatry, , 161(4), 662-669.
[113] Rapin, I., & Goldman, S. (2008). The Brazilian CARS: a standardized screening tool
for autism. Jornal de Pediatr (Rio J), , 84(6), 473-475.
[114] Rees, E., Moskvina, V., Owen, M. J., ODonovan, M. C., & Kirov, G. (2011). De novo
rates and selection of schizophrenia-associated copy number variants. Biol. Psychia
try, , 70(12), 1109-1114.
[115] Rosenberg, R. E., Law, J. K., Yenokyan, G., Mc Gready, J., Kaufmann, W. E., & Law,
P. A. (2009). Characteristics and concordance of autism spectrum disorders among
277 twin pairs. Arch. Pediatr. Adolesc. Med., , 163(10), 907-914.
[116] Sanders, J. L. (2009). Qualitative or Quantitative Differences Between Aspergers Dis
order and Autism? Historical Considerations. J Autism Dev Disord, , 39, 1560-1567.
[117] Sanders, S. (2011). Whole-exome sequencing: a powerful technique for identifying
novel genes of complex disorders. Clinical Genetics, , 79(2), 132-133.
[118] Sanders, S.J.; Ercan-Sencicek, A.G.; Hus, V.; Luo, R.; Murtha, M.T.; Moreno-De-Luca,
D.; Chu, S.H.; Moreau, M.P.; Gupta, A.R.; Thomson, S.A.; Mason, C.E.; Bilguvar, K.;
CelestinoSoper, P.B.; Choi, M.; Crawford, E.L.; Davis, L.; Wright, N.R.; Dhodapkar,
R.M.; DiCola, M.; DiLullo, N.M.; Fernandez, T.V.; Fielding-Singh, V.; Fishman, D.O.;
Frahm, S.; Garagaloyan, R.; Goh, G.S.; Kammela, S.; Klei, L.; Lowe, J.K.; Lund, S.C.;
McGrew, A.D.; Meyer, K.A.; Moffat, W.J.; Murdoch, J.D.; ORoak, B.J.; Ober, G.T.;
Pottenger, R.S.; Raubeson, M.J.; Song, Y.; Wang, Q.; Yaspan, B.L.; Yu, T.W.; Yurkie
wicz, I.R.; Beaudet, A.L.; Cantor, R.M.; Curland, M.; Grice, D.E.; Gunel, M.; Lifton,
R.P.; Mane, S.M.; Martin, D.M.; Shaw, C.A.; Sheldon, M.; Tischfield, J.A.; Walsh,
C.A.; Morrow, E.M.; Ledbetter, D.H.; Fombonne, E.; Lord, C.; Martin, C.L.; Brooks,
A.I.; Sutcliffe, J.S.; Cook, E.H. Jr.; Geschwind, D.; Roeder, K.; Devlin, B. & State, M.W.
((2011). ) Multiple recurrent de novo CNVs, including duplications of the 7q11.23
243
244
Williams syndrome region, are strongly associated with autism. Neuron., Vol. 70,
No. 5, pp. 863-885.
[119] Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey,
A. J., Ercan-Sencicek, A. G., Di Lullo, N. M., Parikshak, N. N., Stein, J. L., Walker, M.
F., Ober, G. T., Teran, N. A., Song, Y., El -Fishawy, P., Murtha, R. C., Choi, M., Over
ton, J. D., Bjornson, R. D., Carriero, N. J., Meyer, K. A., Bilguvar, K., Mane, S. M., Se
stan, N., Lifton, R. P., Gnel, M., Roeder, K., Geschwind, D. H., Devlin, B., & State,
M. W. (2012). De novo mutations revealed by whole-exome sequencing are strongly
associated with autism. Nature., , 485(7397), 237-241.
[120] Sato, F. P., Paula, C. S., Lowenthal, R., Nakano, E. Y., Brunoni, D., Schwartzman, J. S.,
& Mercadante, M. T. (2009). Instrument to screen cases of pervasive developmental
disorder: a preliminary indication of validity. Rev Bras de Psiquiatr, , 31(1), 30-33.
[121] Scott Van, Zeeland. A. A., Abrahams, B. S., Alvarez-Retuerto, A. I., Sonnenblick, L. I.,
Rudie, J. D., Ghahremani, D., Mumford, J. A., Poldrack, R. A., Dapretto, M., Gesch
wind, D. H., & Bookheimer, S. Y. (2010). Altered functional connectivity in frontal
lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci
Transl Med., , 2(56), 56ra80.
[122] Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B.,
Yoon, S., Krasnitz, A., Kendall, J., Leotta, A., Pai, D., Zhang, R., Lee, Y. H., Hicks, J.,
Spence, S. J., Lee, A. T., Puura, K., Lehtimki, T., Ledbetter, D., Gregersen, P. K.,
Bregman, J., Sutcliffe, J. S., Jobanputra, V., Chung, W,., Warburton, D., King, M. C.,
Skuse, D., Geschwind, D. H., Gilliam, T. C., Ye, K., & Wigler, M. (2007). Strong asso
ciation of de novo copy number mutations with autism. Science, , 316(5823), 445-449.
[123] Segurado, R., Conroy, J., Meally, E., Fitzgerald, M., Gill, M., & Gallagher, L. (2005).
Confirmation of association between autism and the mitochondrial aspartate/gluta
mate carrier SLC25A12 gene on chromosome 2q31. Am J Psychiatry., , 162(11),
2182-2184.
[124] Shen, Y., Morre, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B.,
Miller, K. J., Frazier, J. A., Silverstein, I., Picker, J., Weissman, L., Raffalli, P. S., J.este,
Demmer. L. A., Peters, H. K., Brewster, S. J., Kowalczyk, S. J., Rosen-Sheidley, B. C.,
Mc Gowan, Duda. A. W. 3., Lincoln, S. A., Lowe, K. R., Schonwald, A., Robbins, M.,
Hisama, F., Wolff, R., Becker, R., Nasir, R., Urion, D. K., Milunsky, J. M., Rappaport,
L., Gusella, J. F., Walsh, C. A., Wu, B. L., Miller, D. T., autismo, Consrcio., Clnica,
Gentica. . D. N. A., & Colaborao, Diagnostics. (2010). Clinical Genetic Testing for
Patients With Autism Spectrum Disorders l, Pediatrics, , 125(4), 727-735.
[125] Sherer, S. W., & Dawson, G. (2011). Risk factors for autism: translating genomic dis
coveries into diagnostics. Hum Genet, , 130(1), 123-148.
[126] Shibayama, A., Cook, E. H., Jr , , Feng, J., Glanzmann, C., Yan, J., Craddock, N., Jones,
I. R., Goldman, D., Heston, L. L., & Sommer, S. S. (2004). MECP2 structural and 30-

http://dx.doi.org/10.5772/53106
UTR variants in schizophrenia, autism and other psychiatric diseases: a possible as

sociation with autism. Am. J. Med. Genet. B Neuropsychiatr. Genet., , 128B(1), 50-53.
[127] Shinawi, M., Liu, P., Kang, S. H., Shen, J., Belmont, J. W., Scott, D. A., Probst, F. J.,
Craigen, W. J., Graham, B. H., Pursley, A., Clark, G., Lee, J., Proud, M., Stocco, A.,
Rodriguez, D. L., Kozel, B. A., Sparagana, S., Roeder, E. R., Mc Grew, S. G., Kurczyn
ski, T. W., Allison, L. J., Amato, S., Savage, S., Patel, A., Stankiewicz, P., Beaudet, A.
L., Cheung, S. W., & Lupski, J. R. (2010). Recurrent reciprocal 16p11.2 rearrange
ments associated with global developmental delay, behavioural problems, dysmor
phism, epilepsy, and abnormal head size. J Med Genet., , 47(5), 332-341.
[128] Silverman, J. M., Buxbaum, J. D., Ramoz, N., Schmeidler, J., Reichenberg, A., Hol
lander, E., Angelo, G., Smith, C. J., & Kryzak, L. A. (2008). Autism-related routines
and rituals associated with a mitochondrial aspartate/glutamate carrier SLC25A12
polymorphism. Am. J. Med. Genet. B. Neuropsychiatr. Genet., , 147(3), 408-410.
[129] Simon, E. W., Haas-Givler, B., & Finucane, B. (2010). A longitudinal follow-up study
of autistic symptoms in children and adults with duplications of 15q11-13. Am J Med
Genet B Neuropsychiatr Genet., , 153B(2), 463-467.
[130] Simonoff, E., Pickles, A., Charman, T., Chandler, S., Loucas, T., & Baird, G. (2008).
Psychiatric disorders in children with autism spectrum disorders: prevalence, comor
bidity, and associated factors in a population-derived sample. J Am Acad Child and
Adolesc Psychiatry, , 47(8), 921-929.
[131] Smalley, S. L. (1998). Autism and tuberous sclerosis. J Autism Dev Disord, , 28(5),
407-414.
[132] Smith, M., Spence, M. A., & Flodman, P. (2009). Nuclear and mitochondrial genome
defects in autisms. Ann. N. Y. Acad. Sci., , 1151, 102-132.
[133] State, M. W., & Levitt, P. (2011). The conundrums of understanding genetic risks for
autism spectrum disorders. Nat. Neurosci., , 14(12), 1499-1506.
[134] Stein, M. B., Yang, B. Z., Chavira, D. A., Hitchcock, C. A., Sung, S. C., Shipon-Blum,
E., & Gelernter, J. (2011). A common genetic variant in the neurexin superfamily
member CNTNAP2 is associated with increased risk for selective mutism and social
anxiety-related traits. Biol Psychiatry, , 69(9), 825-831.
[135] Sullivan, P. F., Magnusson, C., Reichenberg, A., Boman, M., Dalman, C., Davidson,
M., Fruchter, E., Hultman, C. M., Lundberg, M., Lngstrm, N., Weiser, M., Svens
son, A. C., & Lichtenstein, P. (2012). Family History of Schizophrenia and Bipolar
Disorder as Risk Factors for AutismFamily History of Psychosis as Risk Factor for
ASD. Arch Gen Psychiatry., Epub already print., 1(5)
[136] Swanwick, C. C., Larsen, E. C., & Banerjee-Base, S. (2011). Genetic Heterogeneity of
Autism Spectrum Disorders, In: Autism Spectrum Disorders: The Role of Genetics in
Diagnosis and Treatment, Deutsh, S. I and Urbano, M. R., Crocia: In Tech., 65-82.
245
246
[137] Szatmari, P., Mac, Lean. J. E., Jones, M. B., Bryson, S. E., Zwaigenbaum, L., Bartolucci,
G., Mahoney, W. J., & Tuff, L. (2000). The familial aggregation of the lesser variant in
biological and nonbiological relatives of PDD probands: A family history study. J
Child Psychol Psychiatry,. , 41(5), 579-586.
[138] Tan, G. C., Doke, T. F., Ashburner, J., Wood, N. W., & Frackowiak, R. S. (2010). Nor
mal variation in fronto-occipital circuitryand cerebellar structure with an autism-as
sociated polymorphism of CNTNAP2. Neuroimage. , 53(3), 1030-1042.
[139] Takayama, C., & Inoue, Y. (2004). GABAergic signaling in the developing cerebel
lum. Anat Sci Int, , 79(3), 124-136.
[140] Theoharides, T. C., Doyle, R., Francis, K., Conti, P., & Kalogeromitros, D. (2008).
Novel therapeutic targets for autism. Trends Pharmacol, , 29(8), 375-382.
[141] Uchino, S., Wada, H., Honda, S., Nakamura, Y., Ondo, Y., Uchiyama, T., Tsutsumi,
M., Suzuki, E., Hirasawa, T., & Kohsaka, S. (2006). Direct interaction of post-synaptic
density-95/Dlg/ZO-1 domain-containing synaptic molecule Shank3 with GluR1 aamino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor. J Neurochem., ,
97(4), 1203-1214.
[142] Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells,
M., Escribano, L., Hartmann, K., Lieberman, P., Nedoszytko, B., Orfao, A., Schwartz,
L. B., Sotlar, K., Sperr, W. R., Triggiani, M., Valenta, R., Horny, H. P., & Metcalfe, D.
D. (2012). Definitions, criteria and global classification of mast cell disorders with
special reference to mast cell activation syndromes: a consensus proposal. Int Arch
Allergy Immunol, , 157(3), 215-225.
[143] Van der , N., Rooms, L., Vandeweyer, G., van den, Ende. J., Reyniers, E., Fichera, M.,
Romano, C., Delle, Chiaie. B., Mortier, G., Menten, B., Destre, A., Maystadt, I., Mn
nik, K., Kurg, A., Reimand, T., Mc Mullan, D., Oley, C., Brueton, L., Bongers, E. M.,
van Bon, B. W., Pfund, R., Jacquemont, S., Ferrarini, A., Martinet, D., SchranderStumpel, C., Stegmann, A. P., Frints, S. G., de Vries, B. B., Ceulemans, B., & Kooy, R.
F. (2009). Fourteen new cases contribute to the characterization of the 7q11.23 micro
duplication syndrome. Eur. J. Med. Genet., (2-3), 94-100.
[144] Veenstra-Vanderweele, J., Christian, S. L., & Cook Jr, E. H. (2004). Autism as a para
digmatic complex genetic disorder. Annu. Rev. Genomics Hum. Genet. , 5, 379-405.
[145] Veltman, M. W., Thompson, R. J., Craig, E. E., Dennis, N. R., Roberts, S. E., Moore, V.,
Brown, J. A., & Bolton, P. F. (2005). A paternally inherited duplication in the PraderWilli/Angelman syndrome critical region: a case and family study. J Autism Dev Dis
ord. , 35(1), 117-127.
[146] Vernes, S. C., Newbury, D. F., Abrahams, B. S., Winchester, L., Nicod, J., Groszer, M.,
Alarcn, M., Oliver, P. L., Davies, K. E., Geschwind, D. H., Monaco, A. P., & Fisher, S.
E. (2008). A functional genetic link between distinct developmental language disor
ders. N Engl J Med., , 359(22), 2337-2345.

http://dx.doi.org/10.5772/53106
[147] Viora, M., Quaranta, M. G., Straface, E., Vari, R., Masella, R., & Malorni, W. (2001).
Redox imbalance and immune functions: opposite effects of oxidized low-density
lipoproteins and Nacetylcysteine. Immunology, , 104(4), 431-438.
[148] Vissers, L. E., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van
Lier, B., Arts, P., Wieskamp, N., del Rosario, M., van Bon, B. W., Hoischen, A., de
Vries, B. B., Brunner, H. G., & Veltman, J. A. (2010). A de novo paradigm for mental
retardation. Nature Genetics,. , 42(12), 1109-1112.
[149] Vojdani, A. (2008). Antibodies as predictors of complex autoimmune diseases and
cancer. Int J Immunopathol Pharmacol, Erratum in: Int J Immunopathol Pharmacol.,
Vol. 21, No.4., 21(3), 553-566.
[150] Wang, K., Zhang, H., , D., Bucan, M., Glessner, J. T., Abrahams, B. S., Salyakina, D.,
Imielinski, M., Bradfield, J. P., Sleiman, P. M., Kim, C. E., Hou, C., Frackelton, E.,
Chiavacci, R., Takahashi, N., Sakurai, T., Rappaport, E., Lajonchere, C. M., Munson,
J., Estes, A., Korvatska, O., Piven, J., Sonnenblick, L. I., Alvarez, Retuerto. A. I., Her
man, E. I., Dong, H., Hutman, T., Sigman, M., Ozonoff, S., Klin, A., Owley, T., Swee
ney, J. A., Brune, C. W., Cantor, R. M., Bernier, R., Gilbert, J. R., Cuccaro, M. L., Mc
Mahon, W. M., Miller, J., State, M. W., Wassink, T. H., Coon, H., Levy, S. E., Schultz,
R. T., Nurnberger, J. I., Haines, J. L., Sutcliffe, J. S., Cook, E. H., Minshew, N. J., Bux
baum, J. D., Dawson, G., Grant, S. F., Geschwind, D. H., Pericak-Vance, M. A., Schel
lenberg, G. D., & Hakonarson, . (2009). H. Common genetic variants on 5p14.1
associate with autism spectrum disorders. Nature, , 459(7246), 528-533.
[151] Warren, W. B., Patrick, S. L., & Goland, R. S. (1992). Elevated maternal plasma corti
cotropinreleasing hormone levels in pregnancies complicated by preterm labor. Am J
Obstet Gynecol, , 166(4), 1198-1204.
[152] Weiss, L. A., Shen, Y., Korn, J. M., Arking, D. E., Miller, D. T., Fossdal, R., Saemund
sen, E., Stefansson, H., Ferreira, M. A., Green, T., Platt, O. S., Ruderfer, D. M., Walsh,
C. A., Altshuler, D., Chakravarti, A., Tanzi, R. E., Stefansson, K., Santangelo, S. L.,
Gusella, J. F., Sklar, P., Wu, B. L., & Daly, M. J. (2008). Autism Consortium. Associa
tion between microdeletion and microduplication at 16p11.2 and autism. N Engl J
Med. , 358(7), 667-675.
[153] Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B.
K., Berman, K. F., & Goldberg, T. E. (2001). Prefrontal neurons and the genetics of
schizophrenia. Biol Psychiatry,. , 1(50), 825-844.
[154] Whalley, H. C., OConnell, G., Sussmann, J. E., Peel, A., Stanfield, A. C., Hayiou-Tho
mas, M. E., Johnstone, E. C., Lawrie, S. M., Mc Intosh, A. M., & Hall, J. (2011). Genetic
Variation in CNTNAP2 Alters Brain Function During Linguistic Processing in
Healthy Individuals. Am J Med Genet B Neuropsychiatr Genet., , 156B(8), 941-948.
[155] Zhang, T. Y., & Meaney, M. J. (2010). Epigenetics and the environmental regulation
of the genome and its function. Annu Rev Psychol., , 61, 439-449.
247
248
[156] Zhao, X., Leotta, A., Kustanovich, V., Lajonchere, C., Geschwind, D. H., Law, K.,
Law, P., Qiu, S., Lord, C., Sebat, J., Ye, K., & Wigler, M. (2007). A unified genetic
theory for sporadic and inherited autism. Proc Nati Acad of Sci U S A., , 104(3),
12831-12836.
Chapter 12
Advances in Autism Research

The Genomic Basis of ASD
Melanie Lacaria and James R. Lupski
http://dx.doi.org/10.5772/53689
1. Introduction
Many of the recent advances in autism research that have provided fundamental insight
into this condition have come from the application of genetic/genomic approaches; these
advances have been fomented by the advent of new technologies to interrogate the en
tire genome, such as array comparative genomic hybridization (aCGH), single nucleotide
polymorphism (SNP) microarrays, transcriptome sequencing, and whole genome or
whole exome sequencing (WGS/WES) [1]. With the recent advancement of these technol
ogies over more traditional, lower-resolution technologies such as cytogenetic analysis,
came the ability to interrogate the entire genome at a high-resolution. With the improve
ment of next-generation sequencing technology, as well as the reduction in the cost of
this technique, WGS is becoming more commonplace in the search for novel diseasecausing variants in individual patients. Alternatively, many studies have utilized WES,
as it is less costly than sequencing the entire genome and coding simple nucleotide var
iants (SNVs) can often be more readily interpreted given knowledge provided by the ge
netic code. While the reduced cost and more readily interpretable variation have proven
to be distinct advantages of this method over whole-genome sequencing, it is well
known that many other variants in non-coding or regulatory regions can be pathogenic,
and they typically cannot be discerned by whole-exome sequencing, which requires a
targeted-capture step to enrich for and focus analysis on the coding sequences of all an
notated protein-coding genes [2, 3]. Furthermore, repetitive or G-C rich regions or highly
homologous sequences are often excluded by WES, and copy number variations (CNVs)
usually cannot be accurately called due to the use of PCR-based sample preparation
methods. Nonetheless, the utility of WGS/WES in individual patient diagnosis and man
agement has been demonstrated by several recent reports [4-6].
2013 Lacaria and Lupski; licensee InTech. This is an open access article distributed under the terms of the
250
Some of the first studies providing a high-resolution view of the entire genome have re
vealed that a large number of CNVs are present in the genomes of healthy individuals, and
that CNVs account for a greater proportion of the nucleotide variation between two given
individual genomes than can be attributed to SNVs [7-9]. These structural alterations can
reach up to several megabases in length, but a much higher frequency is observed for small
er (<1 kb) CNVs [2]. And, as one would expect, the likelihood of CNVs becoming pathogenic
rises when they have an increased size and/or occur in gene-dense regions of the genome
[8]. Traditionally, structural variation (CNV) was not considered to play a causative role in
autism or ASD. However, recent studies have revealed that not only single-gene alterations,
but also CNVs can lead to autism or ASD. In fact, it is now becoming increasingly evident
that CNVs account for a larger proportion of new autism diagnoses than single-gene disor
ders. Recurrent CNVs at specific genomic loci have been associated with autism, including
15q11-q13, 16p11.2, 17p11.2, 22q13.3, 7q11.23, and 2q37, among others [1, 10-16]. While sev
eral of these loci are associated with known Centers for Mendelian Genomics, numerous
CNVs have also been observed in idiopathic autism, underscoring the importance of these
structural variations in the future of all types of autism research [17].
The application of next-generation sequencing technology to evaluate CNVs has also re
cently been described in a report that utilized whole-transcriptome sequencing analysis
of the genomes of a cohort of patients with autism spectrum disorder (ASD) [18]. This
approach allows for the evaluation of CNVs and overcomes some of the problems asso
ciated with CNV-calling in WES. With several large-scale projects currently underway,
the future of next-generation sequencing and whole-genome analysis in the study of au
tism will most definitely provide many new insights into the etiology of this disease.
Currently, Autism Speaks is working in collaboration with the company BGI to gener
ate the largest database of sequenced genomes of individuals with ASD, a project
known as the Autism Genome 10K. Similarly, the National Institute of Mental Health
in the US has funded another large-scale Autism Genome Project. Mendelian/
syndromic forms of autism are also currently being studied by the Genomic Disorders
consortium in the US by WES.
Among the variants identified in the large-scale studies of patients with autism report
ed to date, many gene networks/pathways have been implicated, including genes for
neuronal adhesion [18, 19], ubiquitin degradation [19], chromatin remodelling [5, 20],
sodium channels [13], proteolysis [21], cytoskeletal organization [21], signal transduction
[18], neuropeptide signalling [18], neurogenesis/synaptogenesis [18], neuronal migration
[22], basic metabolism, and RNA splicing [22], among others. While these pathways
may seem diverse, repeated hits in these networks support the many genes, com
mon pathway hypothesis [22]. Importantly, although the biological function of ASD
susceptibility genes identified via these whole-genome studies do not appear to lie
within the same network, they likely converge to disrupt neuronal function in brain re
gions that support language, social cognition, and behavioral flexibility, resulting in the
phenotypes commonly associated with ASD [22].
Advances in Autism Research The Genomic Basis of ASD

http://dx.doi.org/10.5772/53689
2. Chromosome engineering mouse models for ASD

Since ASD is known to be a highly heterogeneous disorder with both genetic and environmen
tal components, modeling the disease in rodents, where environmental and background ef
fects can be largely controlled and systematically manipulated and studied, is of great
advantage in the study of the pathomechanisms underpinning autism. Furthermore, numer
ous tools for genetic manipulation and for behavioral analysis that are currently available and
developed for genetic studies in rodents can be leveraged to facilitate this avenue of research.
Importantly, behavioral assays have been developed and validated to objectively quantify the
phenotypes relative to autism, including both core and associated autistic-like phenotypes,
such as abnormal social behavior, communication deficits, and repetitive behaviors, as well as
autism-associated anxiety-like behaviors, motor defects, learning and memory deficits, sleep
disorders, sensory hypersensitivity, and seizures, among others [23] (Table 1; adapted from
Crawley et al, where a full description of these behavioral tests can be found; [23]).
With the importance of CNVs in the etiology of ASD established, chromosome-engineered
mouse models were then generated for the study of autism or ASD. The first such mouse
strains were developed over a decade ago using a chromosome-engineering approach [24].
This technique allows for the creation of a targeted duplication or deletion in the desired lo
cation by first generating the rearrangement in mouse embryonic stem (ES) cells which can
then be established as mouse strains via Cre/loxP site-specific recombination [25, 26]. To gen
erate the desired rearrangement, two gene-targeting steps are required to prepare each end
point for a selectable recombination event (Figure 1). Importantly, the type of rearrangement
(deletion, duplication, inversion) depends on the relative orientation of the loxP sites; if the
sites are in the same orientation, the region between them can be deleted or duplicated, but
if they are in opposite orientation, an inversion results [25]. The cis or trans configuration is
also relevant; trans insertion (insertion in each chromosome homologue) of loxP sites ena
bles generation of both deletion and duplication in the same ES cells. Transient transfection
of the ES cells with a vector expressing Cre recombinase facilitates the recombination be
tween the targeted loxP sites, and cells containing the event can be selected for using hypo
xanthine aminopterin thymidine (HAT)-containing media due to the reconstitution of a
functional Hprt cassette as a result of the recombination [25]. The resulting mouse models
harbor either a chromosomal duplication or deletion of a defined region that is syntenic to
the copy number variable region in humans. Importantly, chromosome-engineered mouse
models are distinct from monogenic animal models in that they harbor structural chromoso
mal rearrangements resulting in specific, targeted CNVs with genomic intervals that may
span several megabases and contain numerous genes, many of which may be of unknown
function. In contrast, monogenic animal models primarily utilize a reverse-genetics ap
proach to knock-out or transgenically-overexpress the specific single gene of interest, limit
ing the study to that one particular gene. A publicly-available resource can facilitate
chromosome engineering for the targeted manipulation of the mouse genome; the mutagen
ic insertion and chromosome engineering resource (MICER) can be utilized to access vectors
to create chromosomal rearrangements or to study gene disruptions in a high-throughput
manner [27]. (http://www.sanger.ac.uk/resources/mouse/micer/).
251
252
Core features of autism
Analogous feature/assay in mice
Abnormal social interactions
Preference for social novelty

Social recognition
Home cage monitoring - nesting patterns
Direct social interactions / juvenile play
Social approach to a stranger mouse
Impaired social communication
Vocalizations during direct social interaction

Parental retrieval of separated pups
Ultrasonic vocalizations by separated pups
Response to olfactory cues
Repetitive or restrictive behavior
Perseverative holeboard exploration

Behavioral stereotypies/ home cage observation
Reversal of a position habit in maze tasks
Marble burying
Novel object exploration
ASD- Associated features
Analogous feature/assay in mice
Anxiety
Elevated plus maze

Light/dark exploration
Open field analysis
Theory of mind deficits
Social transmission of food preference

Avoidance of aggressive encounters
Intellectual disability
Morris water maze

Contextual and cued fear conditioning
T-maze
Motor defects
Rotarod test for motor learning

Wire hang
Dowel walking
Footprint analysis
Aggression
Resident intruder attack

Tube test for social dominance
Sleep disturbances
Circadian running wheel

Home cage monitoring - activity levels
Hypersensitivity to sensory stimuli
Pre-pulse inhibition
Acoustic startle
Hot plate test for nociception
Seizures
Sensitivity to audiogenic or drug-induced seizures
Table 1. Behavioral tests for the evaluation of autistic-like features in mice

http://dx.doi.org/10.5772/53689
Figure 1. Generating defined chromosome rearrangements. Defined endpoints of the desired interval for rear
rangement (A and B) are modified by gene targeting in embryonic stem (ES) cells to allow for introduction of a loxP
site (blue triangle), a non-functional portion of the HPRT cassette [5 or 3), and a positive selectable marker (Neo or
Puro). The targeted ES cells are then transiently transfected with a vector expressing Cre recombinase, which facilitates
recombination between the loxP sites, resulting in either deletion (Df) or duplication (Dp) of the intervening region. In
this example, reconstitution of the Hprt cassette via recombination between loxP sites lying in a shared intron be
tween the two halves confers resistance to hypoxanthine aminopterin thymidine (HAT), which can be used to select
for the deletion event. Two positive selectable markers (Puro and Neo) identify the duplication event. A full explana
tion of this technology and more examples of chromosome recombineering are outlined by Mills et al [25].
We will discuss specific examples of chromosome-engineered mouse models of ASD for

which the neurobehavioral phenotypes have been described using established rodent be
havioral assays, including mice harboring duplication or deletion of the genomic interval
syntenic to human chromosome 16p11.2, 15q11-q13, and 17p11.2, which all model CNVs
that have been identified in patient populations with autism [28-30]. Most of the CNV-based
animal models of ASD described to date have focused on syndromic forms of autism, as the
underlying genetic cause of these genomic disorders is often well-described.
By definition, genomic disorders result from structural changes in the genome, wherein the
genomic instability often reflects a susceptible genome architecture, that leads to disease
traits [31]. These structural rearrangements or CNVs commonly cause the disruption or
complete loss or gain of dosage-sensitive gene(s). Alternatively, CNVs can cause gene fu
sion, position effects, transvection effects, or the unmasking of a recessive allele or function
al polymorphism [32]. Genomic disorders are therefore distinct from traditional genetic
syndromes, which are typically caused by DNA sequence-based changes [33]. Within the
past decade, several technologies, including array comparative genomic hybridization
(aCGH), next-generation sequencing, and single nucleotide polymorphism (SNP) genotyp
253
254
ing platforms, have been utilized to detect and analyze CNVs in the genome and to investi
gate the mechanism by which these CNVs are generated [34]. CNVs can be formed by
several mechanisms, such as non-allelic homologous recombination (NAHR), non-homolo
gous end joining (NHEJ), or fork stalling and template switching (FoSTeS) [35]. NAHR,
which is often mediated by low copy repeats (LCRs) with high (~95%) sequence similarity
flanking the rearranged region, is the most common mechanism by which recurrent CNVs
are created. Often this mechanism can result in recurrent genomic rearrangements that are
observed in multiple patients with the same disorder, as in Charcot-Marie-Tooth disease
type 1A, Prader-Willi syndrome, and Smith-Magenis Syndrome, among many others [32,
33]. The genomic architecture rendering genomic instability at three loci that are enriched
for LCRs are shown in Figure 2.
Figure 2. The genomic structure of loci associated with CNV-based ASD. (A) Chromosomes 15q11-13, (B)
16p11.2, and (C) 17p11.2, are enriched for LCRs, or segmental duplications (indicated by red arrows), which facilitate
non-allelic homologous recombination (NAHR), resulting in the generation of CNVs (blue and red bars). This figure
was generated using the genome browser provided by UCSC (http://genome.ucsc.edu/index.html?org=Hu
man&db=hg18&hgsid=289381925].
3. ASD associated with CNVs on chromosome 16p11.2

In recent years, whole genome analyses of cohorts of patients with autism have identified
recurrent CNVs on chromosome 16p11.2, effectively linking reciprocal microduplications
and microdeletions at this locus with increased susceptibility to ASD [12, 36-39]. Important
ly, further studies have revealed that CNVs at this locus are responsible for ~1% of all ASD
diagnoses, making it the most common CNV to be associated with ASD identified to date

http://dx.doi.org/10.5772/53689
[13]. The 16p11.2 locus is flanked by two directly repeated segmental duplications of ~145
kb, which mediate the NAHR that results in the loss or gain of ~600 kb intermediate region
containing ~27 protein-coding genes [9, 12, 40].
Interestingly, the microduplication of this region has also been linked to schizophrenia, sug
gesting the presence of an underlying biological link between these two disorders [41, 42].
This phenomenon also gives a potential genetic basis for the hypothesis of Crespi et al,
which states that autism and schizophrenia represent diametric disorders of the social brain
[43]. Thus, schizophrenia and autism might reflect mirror traits of the opposing extremes of
behavioral phenotypes reflecting evolution of the social brain [43]. The phenotypes caused
by CNV at the 16p11.2 locus are extremely heterogeneous, and, in addition to ASD, they
have been reported to include metabolic disorders [44-47], cardiac anomalies [40, 48], de
pressive disorder [49], speech delay [50], mental retardation [40, 51, 52], vertebral anomalies
[52], syringomyelia [53], abnormal head size [36], and epilepsy [36, 40], as well as other vari
ous congenital anomalies and behavioral abnormalities [44]. As the phenotypes of many
more patients harboring CNVs in this genomic region are delineated, the full phenotypic
spectrum associated with this locus will likely become more well-defined, and the critical
genomic interval and dosage-sensitive genes responsible for the phenotypes will be deter
mined. Indeed, a more recent study described a patient pedigree for a family with multiple
generations of autism or ASD that also carry a smaller-sized deletion within the common
deletion of 16p11.2, thereby reducing the critical interval for ASD to a 118 kb region con
taining only 5 genes: MVP, CDIPT1, SEZ6L2, ASPHD1, and KCTD13 [54]. To date, none of
these genes have been significantly associated with an elevated risk for ASD, which indi
cates that the situation is likely much more complex [37, 55]. Furthermore, correlation be
tween the phenotypes of patients harboring different- or similar-sized CNVs is confounded
by extreme heterogeneity and variability of symptoms. For example, a family with three af
fected members harboring identical 16p11.2 deletions was recently described to have mini
mal symptom overlap between family members [56]. Subsequent studies have aimed at
using model organisms to identify the key dosage-sensitive genes within this region that
give rise to the abnormal phenotypes [29, 57, 58]. Among these, chromosome-engineered
mouse models harboring reciprocal deletion or duplication of the mouse chromosome syn
tenic to human chromosome 16p11.2 have been generated to study the physiological and be
havioral phenotypes associated with these chromosome abnormalities [29].
4. Animal models for human 16p11.2 CNVs

Mouse models were generated through a chromosome engineering approach for the
study of human 16p11.2 deletion and duplication CNVs [29]. It was observed that ~50%
of mice harboring the deletion CNV die shortly after birth, while duplication mice sur
vive to adulthood, suggesting that the deletion CNV results in a more severe phenotype
than the duplication [29]. A similar phenomenon has been observed in other genomic
disorders caused by reciprocal CNVs, including Smith-Magenis and Potocki-Lupski syn
dromes [15]. Expression of the genes within the 16p11.2 region corresponds to gene dos
255
256
age in four brain regions that may be relevant for autism, including the olfactory bulbs,
cortex, cerebellum, and brainstem [29].
In-cage neurobehavioral phenotypes were assessed in these mice to determine what, if any,
affect these CNVs had on autistic-like behaviors. As expected, deletion mice displayed the
most abnormal phenotypes, while duplication mice had fewer and milder symptoms. Inter
estingly, reciprocal phenotypes were sometimes observed for mice harboring reciprocal
CNVs. For example, the amount of time spent resting in the cage was lower in deletion mice
but higher in duplication mice relative to controls, indicating that 16p11.2 CNVs affect the
rate and timing of specific behaviors in a dosage-dependent manner. Deletion mice dis
played an abnormal ceiling-climbing behavior where they demonstrated marked stereotypic
and nonprogressive motor behaviors, similar to what is often observed in patients with au
tism or patients with lateral hypothalamic and nigrostriatal lesions in the brain. These ab
normal behaviors were accompanied by volumetric and morphological changes in several
brain regions, including the lateral hypothalamus. Importantly, the difference between dele
tion mice and duplication mice was greater than that between deletion mice and controls,
indicating that these effects are reciprocal or opposing in nature.
No significant abnormal social behavior was observed in these animal models in the 3chamber test for sociability, indicating either that these animals do not display social abnor
malities, or that further investigation into the social behavior of these animals is required.
Indeed, with the subtle nature of many social interactions in rodents, it is quite possible that
social abnormalities exist in these mice but have not yet been described. It is also distinctly
possible that the in-cage environment does not elicit a social deficit that might perhaps be
observed in the wild or natural environment of the animal. An extensive battery of tests for
social behavior will be required to rule out the possibility of further abnormalities.
Many of the genes mapped to the altered region have unknown function, and therefore,
unknown significance or contribution to the disease phenotype. In order to further delin
eate the function of the dosage-sensitive genes within the common duplication/deletion
region, zebrafish models were generated [57, 58]. The first study aimed to investigate the
diametric head size phenotypes linked to this locus, as in addition to ASD, deletion is
known to result in macrocephaly, and duplication gives rise to microcephaly [36, 57]. In
this study, zebrafish were utilized for an in vivo overexpression screen, which identified
the gene KCTD13 as the likely candidate for the neurodevelopmental phenotypes associ
ated with CNVs at 16p11.2. Interestingly, this gene was also one of the 5 genes found in
a minimal critical deletion interval for ASD [54]. Overexpression of this gene in zebrafish
resulted in microcephaly, while the reciprocal reduced expression of this locus by mor
pholino oligonucelotides resulted in macrocephaly, thereby mirroring the phenotypes
seen in humans harboring CNVs at this locus [57]. Further study revealed that the func
tion of this gene is likely conserved across species, and it is required to maintain the
proliferative status of cortical progenitor cells in mice [57]. Furthermore, this gene is af
fected in a complex genomic rearrangement identified in a patient with autism [57]. Tak
en together, these results indicate that KCTD13 is a likely candidate for further study of
the neurological phenotypes associated with CNV at this locus.

http://dx.doi.org/10.5772/53689
Another study was able to identify homologs of 21 of the known 16p11.2 human genes in
the zebrafish genome by family tree comparisons [58]. These genes were then targeted for
loss of function studies by injecting antisense morpholino oligonucleotides into early em
bryos [58]. Interestingly ~79% of the genes tested by this method were required for proper
brain, eye, or nervous system development, and two of the genes were determined to be
dosage-sensitive, with abnormal phenotypes present with a ~50% reduction in gene expres
sion [58]. The results of this study suggest that at least two genes, aldolase a (aldoaa) and ki
nesin family member 22 (kif22), are highly dosage-sensitive and are required for proper
brain function, making them likely candidates for future studies of the ASD associated with
CNV of this region [58].
These two studies indicate that while kctd13, kif22, and aldoaa are all potentially interesting
dosage-sensitive candidate genes, further investigation is needed to determine whether
these genes act together in a epistatic manner to contribute to the full neurological pheno
type, whether they modify each other via cis interactions, or whether other genes or genetic
elements in the 16p11.2 locus are also contributing to the phenotype. The current data,
which could not have been obtained without these important studies in model organisms,
cannot distinguish between these possibilities, but they provide a starting point for research
into the function of these genes and the molecular pathways underpinning the phenotypes
associated with 16p11.2 CNVs.
5. Prader-Willi and Angelman syndromes

Chromosome 15q11-13 is enriched for LCRs, providing a mechanism for LCR-mediated
NAHR, and generating a series of recurrent breakpoints along this chromosome. As a result,
interstitial deletion or duplication of this region is common. LCRs can also mediate triplica
tions, or, alternatively, the presence of supernumerary isodicentric chromosome 15 (idic(15))
can lead to crossing over between these LCRs, and ultimately, duplication of the region. A
bipartite imprinting center lies at this locus and directs the expression of a number of genes,
resulting in a tissue-specific parent-of-origin effect. As a result, many of the phenotypes
caused by these structural rearrangements also display parent-of-origin effects.
Paternally- or maternally-inherited deletions of human chromosome 15q11-13 result in
Prader-Willi syndrome (PWS) or Angelman syndrome (AS), respectively. Alternatively,
these disorders can be caused by uniparental disomy (UPD), or by balanced translocations
involving this region. Less frequently, imprinting errors, leading to aberrant methylation of
the PWS imprinting center can also cause PWS, and mutations or deletions in the gene
UBE3A can cause AS [11, 59]. The critical region for AS lies 35 kb telomeric to the PWS criti
cal region [60]. PWS is characterized by intellectual disability, hypotonia, hyperphagia, obe
sity, compulsive and repetitive behaviors, skin picking, tantrums, irritability. In addition,
congenital abnormalities are often observed, including hypogonadism, facial dysmorphism,
and small hands and feet, among others. PWS can also be associated with psychosis, mood
disorders, and ASD [61].
257
258
AS is a neurodevelopmental disorder that is characterized by severe developmental de

lay, intellectual disability, microcephaly, seizures, lack of speech, ataxia, and dysmorphic
facial features [11, 59]. Patients with AS are often described as having happy demeanors,
however hyperactivity, attention deficits, aggression, and repetitive or stereotypic behav
iors have also been described [59]. AS has been associated with ASD in several studies,
however, the severity of the cognitive impairments in most patients with AS may pre
clude an accurate diagnosis [11, 59].
6. Duplication of 15q11-13
It has been estimated that up to ~5% of cases of ASD can be attributed to maternal duplica
tion of the genomic region reciprocal to the PWS-AS critical region on chromosome
15q11-13, making it one of the most common chromosomal abnormalities observed in pa
tients with ASD [10, 62]. Due to the presence of imprinting at this locus (discussed above),
parent-of-origin effects are seen, and, for interstitial duplications, maternal origin confers an
increased risk for clinical phenotypes. Paternal duplications are much less common, and do
not appear to lead to ASD, as familial cases have been described where a seemingly normal
carrier mother transmits a paternally-derived duplication to their child [63]. However, a
small number of subjects with paternal duplication of 15q11-13 and various clinical pheno
types have been described [64]. Phenotypes are dosage-sensitive at this locus; one extra ma
ternal copy of 15q11-13 results in partial autism penetrance, while two extra copies (caused
by idic15 or interstitial triplication) result in a much higher penetrance of autism as well as
additional phenotypes that are typically more severe than those seen in patients with dupli
cations [62]. In the case of triplications, parent-of-origin effects are no longer observed, and
both paternal and maternal duplications are associated with poor clinical outcomes [65].
This loss of parent-of-origin effects is interesting, and it may be an indication of the underly
ing mechanism that may give rise to a predisposition for these phenotypes. Many heteroge
neous and complex phenotypes can be associated with increased copy number of this region
including intellectual disability, apraxia, dyslexia, seizures, hypotonia, developmental de
lay, gait abnormalities, hyperactivity, schizophrenia, and ASD [66]. Patients with ASD due
to duplication of 15q11-13 also display several stereotypic and repetitive behaviors, includ
ing rocking, licking, and hand-flapping, among others, that are often directed towards sen
sory stimulation, suggesting that the underlying cause of these phenotypes may be due to a
disregulation of sensory inputs or signaling [63, 64].
Interestingly, recent post-mortem evaluation of the brains of patients harboring maternal
duplication of 15q11-13 suggested that accumulation and deposition of abnormal intracel
lular and extracellular amyloid protein (A) in the specific regions and neuron types
in the brains of patients with maternal duplication of 15q11-13 may underlie or contrib
ute to some of the neurobehavioral phenotypes associated with ASD [67]. However, fur
ther studies are needed to confirm this hypothesis. Several animal models for the CNVbased syndromes associated with chromosome 15q11-13 have been developed to facilitate
research into these disorders.

http://dx.doi.org/10.5772/53689
7. Modeling 15q11-13 CNVs in mice

The first mouse model for PWS was generated by targeted deletion of part of the imprinting
center on chromosome 15q11-13 [68]. While these mice model several aspects of PWS, in
cluding hypersensitivity to sensory input in the form of increased acoustic startle response
and decreased prepulse inhibition, it is not known whether these mice exhibit other autisticlike behaviors, such as impaired social interactions or altered communication [69]. Further
behavioral characterization is needed to determine whether these mice accurately recapitu
late the neurobehavioral phenotypes seen in patients with PWS and/or ASD.
Mouse models for Angelman syndrome were initially generated by disrupting maternal ex
pression of Ube3a; these mice exhibit increased anxiety-like behavior that may be due to the
disruption of a glucocorticoid receptor transactivation in the brain [70]. They also display
various motor defects [71], abnormal cerebellum-driven licking behavior [72], sleep disturb
ance [73], abnormal EEG patterns, and cognitive defects in the conditioned fear and Morris
water maze tests [74]. However, these mice displayed hypoactivity and normal social seek
ing behavior, in contrast to what is seen in human patients with AS and/or ASD [75]. Impor
tantly, human patients with mutations in UBE3A typically have a milder phenotype than
those patients harboring interstitial deletions, so this mouse model may not accurately re
flect the majority of AS patients, who have a deletion containing this gene, as well as many
other genes at this locus. Indeed, when a larger 1.6 Mb deletion model was generated by
chromosome engineering that encompasses the genomic region from Ube3a to Gabrb3, the
phenotype of these mice was more severe than that of mice with deletion of Ube3a alone
[76]. Similar to Ube3a deficient mice, large deletion mice had significant motor impairment,
anxiety-like behavior, and abnormal EEG, but they also had learning and memory defects
and abnormal communication [76]. These larger deletion mice may be an appropriate model
for CNV-associated ASD, however further investigation into the social neurobehavioral phe
notypes is necessary.
Chromosome-engineered mouse models harboring a duplication of 6.3 Mb on mouse chro
mosome 7 syntenic to the duplication of human chromosome 15q11-13 associated with ASD
were developed to study the underlying mechanism behind the phenotypes associated with
this CNV in humans [28]. The core features of autism, including abnormal social interac
tions, stereotypic or ritualistic behavior, and impaired communication were all evaluated in
this mouse model, and patDp/+, but not matDp/+ mice were determined to have reduced so
ciability compared to wild-type mice. Ultrasonic vocalizations were evaluated in pups sepa
rated from the dam, and an abnormal USV pattern was observed in patDp/+ but not
matDp/+ mice. Specifically, patDp/+ mice appeared to have delayed development of com
munication, they emitted a greater number of USVs, and some pups emitted vocalizations at
abnormally high frequencies (>70 kHz). In order to evaluate communication between older
mice, pairs of mice 7-8 weeks of age were observed in a resident intruder paradigm and the
pattern of USVs was measured during this interaction. Vocal communication between pairs
of pat/Dp/+ mice was significantly reduced compared to the vocalization recorded between
WT pairs, giving further support to the notion that patDp/+ mice have a defect in social
259
260
communication. However, no defects in olfactory communication or function were observed

in these mice. Restricted behaviors and inflexibility were evaluated with a battery of behav
ioral tests, including the Morris water maze and the Barnes maze. These tests revealed that
patDp/+ mice do not respond as flexibly to a change in situation as wild-type or matDp/+
mice. No overt defects in learning and memory were observed in either the patDp/+ or
matDp/+ mice by the Morris water maze or conditioned fear test, although patDp/+ mice did
display generalized fear and elevated anxiety-like behavior. The abnormal neurobehavioral
phenotypes observed in this CNV-based model of ASD could not be attributed to gross mor
phological or histological changes in the olfactory bulb, cerebral cortex, hippocampus,
amygdala, corpus callosum, or cerebellum. Nor were any abnormalities in the number of
Purkinje cells detected in the cerebellum, suggesting that the underlying pathomechanism
responsible for these phenotypes is likely due to aberrations in molecular pathways that re
main to be determined.
The gene Ube3a (also known as E6-AP) codes for E3 ubiquitin-protein ligase, which belongs
to a family of E3 ligase genes that are involved in synaptogenesis and have recently been
linked to the pathogenesis of ASD [62]. Given the known association of the gene UBE3A
with AS and its maternal-specific expression pattern in neurons, a mouse model that overex
presses this gene was generated to test the hypothesis that Ube3a is responsible for many of
the phenotypes associated with duplication of 15q11-13 [62]. Transgenic overexpression of
Ube3a via bacterial artificial chromosome (BAC) recombineering in mice resulted in autisticlike neurobehavioral phenotypes, including defects in communication, abnormal social be
havior, and increased repetitive or stereotypic behavior [62]. Similar to the phenomenon
observed in human patients, these effects were also determined to be dosage-sensitive, as
the phenotypes were more penetrant in mice with three-fold overexpression of Ube3a than
in those observed in mice with two-fold overexpression of this gene. Furthermore, it was de
termined that glutamatergic synaptic transmission was suppressed, providing a potential
mechanism underlying the neurobehavioral phenotypes.
8. Smith-Magenis and Potocki-Lupski syndromes

Smith-Magenis syndrome (SMS) and Potocki-Lupski syndrome (PTLS) are two prototypical
genomic disorders caused by reciprocal deletion (SMS) or duplication (PTLS) resulting in
gene copy number variation on chromosome 17. SMS results from a de novo, recurrent, 3.7
Mb deletion in 17p11.2 del(17)(p11.2p11.2) in ~73% of cases, that is a consequence of
NAHR mediated by LCRs flanking the region [77-79]. However, many of the pleiotropic fea
tures of SMS appear to result from haploinsufficiency of a single gene lying in the middle of
the SMS critical region, retinoic acid induced 1 (RAI1), as determined by the identification of
non-deletion SMS patients with heterozygous point mutations in RAI1 [80-82]. Patients with
mutations in RAI1 manifest most of the phenotypes observed in subjects with a chromoso
mal SMS deletion, demonstrating that the reduced dosage of the RAI1 gene alone may cause
much of the SMS phenotype [81, 83].

http://dx.doi.org/10.5772/53689
Both SMS and PTLS manifest a broad range of opposing or overlapping phenotypes. SMS is
characterized by multiple congenital anomalies, including otolaryngologic, ophthalmologic,
brain, cardiac, craniofacial, and renal abnormalities, as well as intellectual disability (ID),
brachydactyly, sleep disturbance, hearing impairment, obesity, scoliosis, and other neurobe
havioral abnormalities [84, 85]. Specifically, SMS patients display aggressive and self-injuri
ous behaviour, including polyembolokoilamania [84], as well as characteristic repetitive
behaviors, including autoamppexation or self-hugging, which is an identifying feature of
the disorder [86, 87]. More recently, SMS patients have also been described as meeting the
criteria for autism spectrum disorder (ASD) [88].
The PTLS duplication was the first predicted reciprocal duplication to be described [89].
PTLS was identified and initially defined much later than SMS, ([89] versus Smith et al.
1986); as a result, fewer PTLS patients have been medically examined and fewer studies of
the clinical phenotypes are available in the literature. The clinical features that have been ob
served in patients with PTLS are distinct from those seen in SMS [15], although cognitive
and neurobehavioral abnormalities are present in both disorders. PTLS patients lack the
self-injurious behaviors, abnormal facies, and sleep disturbance, as well as some of the con
genital anomalies found in most individuals with SMS. The features observed in greater
than 90% of PTLS patients are developmental delay, neurobehavioral abnormalities, lan
guage impairment, cognitive impairment, poor feeding, hypotonia, and oropharyngeal dys
phasia [15, 90]. When evaluated by objective clinical assessment, the majority of PTLS
patients have autistic features such as decreased eye contact, atypicality, withdrawal, anxi
ety, and inattention, meeting criteria for a diagnosis of autistic spectrum disorder (ASD) or
pervasive developmental disorder not otherwise specified, and making ASD the most com
mon and consistent feature observed in PTLS. [14].
Most PTLS patients have no distinctive facial abnormalities but they can have a triangularshaped face. The other clinical features present in over half of patients include sleep apnea,
abnormal EEG, attention deficit, hypermetropia, and cardiovascular abnormalities [15].
These cardiovascular abnormalities can typically include both structural and conduction de
fects, such as atrial or ventricular septal defects, bicuspid aortic valve, dilated aortic root, di
lation of the pulmonary annulus, patent foramen ovale, or hypoplastic left heart [15, 91-93].
Upon molecular analysis, most [22 of 35] PTLS patients included in the first multidisci
plinary study were determined to carry a common recurrent 3.7 Mb duplication in
17p11.2 mediated by the same proximal and distal SMS-REPs which also mediate the re
ciprocal common recurrent SMS deletion [15]. Others have uncommon and sometimes
complex genomic rearrangements, all of which involve duplication in 17p11.2 [94]. The
smallest PTLS duplication identified to date occurred in a single patient and is 1.3 Mb in
size. This duplicated segment contains 14 genes, including both RAI1, the major contribu
ting gene for the reciprocal deletion causing SMS, as well as the steroid-metabolism reg
ulating gene, SREBP1. This patient demonstrates all typical PTLS phenotypes [94].
Whether, or to what extent, PTLS results from RAI1 gene over-dosage still remains to be
elucidated, although mouse studies (described below) have shown that it is likely re
sponsible for at least some of the symptoms [95].
261
262
9. RAI1: Retinoic acid induced 1

Spanning over 120 kb, the RAI1 gene consists of six exons, of which the third is the largest,
containing >90% of the coding region [80, 85, 96]. All of the point mutations identified in
SMS patients to date lie within this exon. Most of the mutations are frameshift or nonsense
mutations occurring in a specific heptameric poly C tract hotspot region within RAI1, and
thus likely cause loss-of-function alleles [82, 97].
The RAI1 transcript is 7.6 kb, encoding a 1906-amino acid, ~200 kDa protein with sever
al known domains, including an extended plant homeodomain (PHD) zinc finger in the
carboxyl-terminus (residues 1832-1903; [80]), a polymorphic polyglutamine (CAG) tract
in the N-terminus that is associated with the severity of the phenotype and medication
response in patients with schizophrenia, as well as the age-at-onset of spino-cerebellar
ataxia type 2 (SCA2) [96, 98], two polyserine tracts, two transactivation domains [99],
and two bipartite nuclear localization signals (NLS). Importantly, the PHD in Rai1 is
highly conserved in the trithorax family of nuclear proteins involved in transcriptional
regulation as well as in the formation of a chromatin remodeling complex, suggesting
that Rai1 may also function as a transcriptional regulator [100]. Further strengthening
this connection, Rai1 is known to be located in the nucleus and have transactivation ac
tivity [99], and it shares a similar genomic structure (>50% shared identity and similar
zinc finger domains) with another gene, TCF20, or stromelysin1 platelet-derived growth
factor (PDGF)-responsive element-binding protein (SPBP), which is known to act as a
nuclear transcriptional cofactor [101].
In the human brain, RAI1 is highly-expressed in the hippocampus and the cerebellar cor
tex, and it is globally-upregulated in the occipital, temporal, and parietal lobes according
to expression data from the Allen Brain Atlas (Allen Institute for Brain Science). In con
trast, it appears to be down-regulated in the cerebellar nuclei, corpus callosum, dorsal
thalamus, and frontal lobe, suggesting that its expression is confined to specific brain re
gions. Similar to what is seen in humans, Rai1 is also upregulated in the hippocampus
and cerebellum of adult mice [102]. Rai1 is critical for development, and the majority of
Rai1 mouse embryos are resorbed during development by E15.5 [99]. While Rai1 expres
sion is certainly necessary early in fetal development, according to expression data from
mouse embryos, peak Rai1 expression occurs at E18.5 and persists until P4 (Allen Brain
Atlas), indicating that it is also required for post-natal development. Although the pre
cise function of RAI1/Rai1 is not currently understood, it is known to be part of a dos
age-sensitive pathway that most likely regulates neuronal development and
organogensis, that, when perturbed, results in many of the phenotypes observed in both
SMS and PTLS. Importantly, RAI1 has been identified in a reconstructed human genenetwork (Prioritizer) as an important candidate gene for involvement in idiopathic au
tism, suggesting that this gene may function in a common pathway that may influence
ASD phenotypes in non-syndromic patients as well [103].
-/-

http://dx.doi.org/10.5772/53689
10. Modeling SMS and PTLS in rodents

Several mouse models interrogating the critical region for SMS and PTLS have been generat
ed in the past decade in order to have an appropriate animal model system to evaluate the
phenotypes in SMS and PTLS and to further study the molecular mechanism underlying
these disorders. The first of these strains was developed in 2003 using a chromosome-engi
neering approach described earlier in this chapter [24]. The resulting mouse models harbour
either a chromosomal duplication (Dp(11)17, modeling PTLS) or deletion (Df(11)17, model
ing SMS) of ~2 Mb that is syntenic to the SMS/PTLS critical region. Soon after, several small
er deletion strains (~590 kb 1 Mb) were created using retroviral insertion of loxP sites in ES
cells with one fixed end, with the intent to determine which other genes in the critical region
may contribute to the complex phenotypes in SMS [104, 105]. Once SMS patients with point
mutations in RAI1 were identified, a mouse model harbouring a truncated null allele for
Rai1 was generated via gene targeting to further study the function of this dosage-sensitive
gene and to compare the phenotype of this model with that of the deletion strains [99, 102].
Likewise, a mouse model harbouring the Rai1 transgene (TgRai1), and globally over-ex
pressing Rai1 at steady-state levels similar to those seen in Dp(11)17/+ mice, was constructed
to further study the function of this gene in PTLS [106].
Initial studies of Dp(11)17/+ mice determined that they have reduced weight, reduced ab
dominal and inguinal fat, and reduced spleen weight [24]. Upon analysis of some of the be
havioral traits of these mice, it was determined that they display anxiety-like behaviors,
have reduced maximum startle response during the pre-pulse inhibition test, and defects in
contextual fear conditioning [107], as well as several other abnormal social behaviors, in
cluding decreased nesting, abnormal sociability, and dominant behaviour [108]. Further in
vestigation into the neurobehavioral abnormalities in these mice found that they also have
decreased preference for social novelty, motor defects, and increased activity levels in the
open field [109]. Many of these behavioral phenotypes are reciprocal or opposing to those
seen in Df(11)17/+ mice, underscoring the dosage-sensitive nature of these disorders [109].
For example, a recent study investigating cerebellum-driven licking behavior in Dp(11)17/+
and Df(11)17/+ mice found that many of the quantitative licking behavior parameters ana
lyzed were altered in a directly-opposing manner [110]. Specifically, the interval between
visits to the waterspout, number of licks per visit, and variability in the number of licks per
lick-burst were all altered in duplication and deletion animals in opposite directions com
pared to wild-type mice (ex: longer versus shorter intervals, etc).
Recently, an extensive battery of behavioral tests were performed and Dp(11)17/+ mice were
observed to display complex social abnormalities, including defects in social recognition,
dominant and aggressive behavior, as well as abnormal response to social odors [30]. Fur
thermore, these mice were shown to have altered communication, anxiety-like behavior, dis
ordered circadian rhythm, learning and memory deficits, motor defects, and stereotypic,
repetitive behaviors, confirming that these mice model both the core and associated features
of autism. In addition, rearing these mice in an enriched environment mitigated or rescued
263
264
certain neurobehavioral abnormalities, suggesting a role for gene-environment interactions

in the determination of copy number variation-mediated autism severity [30].
The phenotypic changes observed in Dp(11)17/+ and Df(11017/+ mice are accompanied by
changes in gene expression; on average, transcripts in the critical interval are expressed at
138 + 29% of wild-type levels in Dp(11)17/+ mice, and at 66 + 15% of wild-type levels in
Df(11)17/+ mice [109]. The expression level of these genes can be normalized to roughly that
of wild-type mice by crossing Dp(11)17/+ and Df(11)17/+ mice to create a double heterozy
gote carrying two copies of the genes within the critical region in cis, (as opposed to the typi
cal trans orientation in wild-type mice). However, the presence of the structural variation
itself affects expression of genes outside the affected interval, resulting in genome regula
tion that may ultimately contribute to the phenotype. As a result, these double heterozy
gous mice display some abnormal behaviors, including elevated activity levels and
decreased preference for social novelty [109].
When Rai1 is over-expressed in mice (Rai1-Tg, modeling PTLS), these mice have growth re
tardation, are underweight, display anxiety-like behavior, social dominance, motor abnor
malities, and have increased motor activity in juvenile mice. Furthermore, there is a dosagedependent exacerbation of this phenotype [106]. These mice also display abnormal maternal
behavior, altered sociability, reduced reproductive fitness, and impaired serotonin metabo
lism [111]. Together these results suggest that Rai1-Tg mice display a complex neurobeha
vioral and metabolic phenotype similar to that of mice harboring the Dp(11)17 CNV,
suggesting that RAI1 is likely responsible for some, if not many of the phenotypes identified
in PTLS. Further support for this hypothesis is indicated by studies of Dp(11)17/Rai1 doubleheterozygous mice with normalized copy number of Rai1, but increased dosage of the sur
rounding interval; this study revealed that normalization of Rai1 copy number was able to
correct weight differences, and at least partially rescue phenotypes on behavioral tests for
locomotor activity, anxiety, and learning and memory [95].
11. Gene-environment interactions

While genetic defects play a part in the etiology of ASD, environmental effects have long
been thought to contribute to these disorders. For example, although the majority of
SMS/PTLS patients present with either deletion or duplication of the same ~3.7 Mb genedense region, there is significant variability in the clinical phenotype [112]. Furthermore,
while there are some significant differences in the incidence of the abnormalities in pa
tients with the common deletion/duplication compared to those patients with smaller or
larger-sized CNVs, a clear distinction between these sub-groups of patients cannot be
made; many of these phenotypes are therefore likely strongly influenced by genetic back
ground as well as environmental effects [83, 94]. While gene-environment interactions
may potentially explain the source of the variability seen in these syndromes, investiga
tion into the specific environmental factors that may affect outcomes for these genomic
disorders has yet to be undertaken.

http://dx.doi.org/10.5772/53689
Chromosome-engineered mouse models for ASD are ideal for the study of complex disease,
as they are mechanistically similar to human patients (targeted duplication/deletion synten
ic to human critical interval), they are polygenic (numerous genes are affected), the observed
phenotypes equate with common, clinically described features (neurobehavioral pheno
types, sleep disorder, etc), and they can be influenced by environmental factors. In addition,
autism is known to be highly variable, and it is suspected to be dependent on both genetic
and environmental factors, such as low birth weight and gestational age, prenatal exposure
to various agents, parental age at birth, diet, infection, xenobiotic and pesticide exposure,
among others [113]. Many of these environmental insults are amenable to study using
mouse models, as the interaction of these environmental factors with CNVs can be directly
tested in congenic mouse models to control for the effects of genetic background.
Molecular analysis of these mouse models, as well as patient samples, can also be utilized to
dissect the role of specific genes or CNVs responsible for the susceptibility to the influence
of environmental factors in these autism-related syndromes. Most importantly, the results of
these types of studies can provide useful insights as to how genes/CNVs can interact with
environmental factors in the context of complex human diseases; this may lead to strategies
to alleviate symptoms of not only rare genomic disorders, but also more common idiopathic
forms of autism or ASD. Furthermore, these models represent an important resource for fu
ture studies of the pathomechanisms underlying ASD, as well as potential treatments for
ASD. They may also foster further investigation into the genomic basis of autism and com
plex behavior, as well the underlying genetic mechanisms leading to these pathogenic
CNVs. In studying CNV-based models for complex genomic disorders and ASD, we have
come to realize that the ideal animal models of ASD should not only phenocopy relevant
human symptoms, but the phenotypes should also be based on similar underlying physio
logical and genetic mechanisms.
Author details
Melanie Lacaria1 and James R. Lupski1,2
1 Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX,
USA
2 Department of Pediatrics, Baylor College of Medicine, and Texas Childrens Hospital,
Houston, TX, USA
References
[1] Jacquemont ML, Sanlaville D, Redon R, Raoul O, Cormier-Daire V, Lyonnet S, et al.
Array-based comparative genomic hybridisation identifies high frequency of cryptic
265
266
chromosomal rearrangements in patients with syndromic autism spectrum disor

ders. J Med Genet. 2006 Nov;43[11]:843-9.
[2] Gonzaga-Jauregui C, Lupski JR, Gibbs RA. Human genome sequencing in health and
disease. Annu Rev Med. 2012;63:35-61.
[3] Bras J, Guerreiro R, Hardy J. Use of next-generation sequencing and other whole-ge
nome strategies to dissect neurological disease. Nat Rev Neurosci. 2012;13([7]):
453-64.
[4] Bainbridge MN, Wiszniewski W, Murdock DR, Friedman J, Gonzaga-Jauregui C,
Newsham I, et al. Whole-genome sequencing for optimized patient management. Sci
Transl Med. 2011 Jun 15;3[87]:87re3.
[5] O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, et al. Exome se
quencing in sporadic autism spectrum disorders identifies severe de novo mutations.
Nat Genet. 2011 Jun;43([6]):585-9.
[6] Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, et al. Patterns and rates of
exonic de novo mutations in autism spectrum disorders. Nature. 2012 May
10;485[7397]:242-5.
[7] Ku CS, Polychronakos C, Tan EK, Naidoo N, Pawitan Y, Roukos DH, et al. A new
paradigm emerges from the study of de novo mutations in the context of neurodeve
lopmental disease. Mol Psychiatry. 2012 May 29.
[8] Girirajan S, Campbell CD, Eichler EE. Human copy number variation and complex
genetic disease. Annu Rev Genet. 2011;45:203-26.
[9] Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong associ
ation of de novo copy number mutations with autism. Science. 2007 Apr
20;316[5823]:445-9.
[10] Bolton PF, Veltman MW, Weisblatt E, Holmes JR, Thomas NS, Youings SA, et al.
Chromosome 15q11-13 abnormalities and other medical conditions in individuals
with autism spectrum disorders. Psychiatr Genet. 2004 Sep;14([3]):131-7.
[11] Hogart A, Wu D, LaSalle JM, Schanen NC. The comorbidity of autism with the ge
nomic disorders of chromosome 15q11.2-q13. Neurobiol Dis. 2010 May;38([2]):181-91.
[12] Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, et al. Association be
tween microdeletion and microduplication at 16p11.2 and autism. N Engl J Med.
2008 Feb 14;358([7]):667-75.
[13] Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D, et al.
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams
syndrome region, are strongly associated with autism. Neuron. 2011 Jun 9;70([5]):
863-85.

http://dx.doi.org/10.5772/53689
[14] Treadwell-Deering DE, Powell MP, Potocki L. Cognitive and behavioral characteriza
tion of the Potocki-Lupski syndrome (duplication 17p11.2]. J Dev Behav Pediatr. 2010
Feb-Mar;31([2]):137-43.
[15] Potocki L, Bi W, Treadwell-Deering D, Carvalho CM, Eifert A, Friedman EM, et al.
Characterization of Potocki-Lupski syndrome (dup[17](p11.2p11.2]) and delineation
of a dosage-sensitive critical interval that can convey an autism phenotype. Am J
Hum Genet. 2007 Apr;80([4]):633-49.
[16] Berg JS, Brunetti-Pierri N, Peters SU, Kang SH, Fong CT, Salamone J, et al. Speech
delay and autism spectrum behaviors are frequently associated with duplication of
the 7q11.23 Williams-Beuren syndrome region. Genet Med. 2007 Jul;9([7]):427-41.
[17] Cho SC, Yim SH, Yoo HK, Kim MY, Jung GY, Shin GW, et al. Copy number varia
tions associated with idiopathic autism identified by whole-genome microarraybased comparative genomic hybridization. Psychiatr Genet. 2009 Aug;19([4]):177-85.
[18] Luo R, Sanders SJ, Tian Y, Voineagu I, Huang N, Chu SH, et al. Genome-wide Tran
scriptome Profiling Reveals the Functional Impact of Rare De Novo and Recurrent
CNVs in Autism Spectrum Disorders. Am J Hum Genet. 2012 Jun 21.
[19] Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, et al. Autism genomewide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009 May
28;459[7246]:569-73.
[20] Talkowski ME, Mullegama SV, Rosenfeld JA, van Bon BW, Shen Y, Repnikova EA, et
al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal
locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum
Genet. 2011 Oct 7;89([4]):551-63.
[21] Chahrour MH, Yu TW, Lim ET, Ataman B, Coulter ME, Hill RS, et al. Whole-exome
sequencing and homozygosity analysis implicate depolarization-regulated neuronal
genes in autism. PLoS Genet. 2012 8([4]):e1002635.
[22] Geschwind DH. Autism: many genes, common pathways? Cell. 2008 Oct 31;135([3]):
391-5.
[23] Crawley JN. Mouse behavioral assays relevant to the symptoms of autism. Brain
Pathol. 2007 Oct;17([4]):448-59.
[24] Walz K, Caratini-Rivera S, Bi W, Fonseca P, Mansouri DL, Lynch J, et al. Modeling
del[17](p11.2p11.2] and dup[17](p11.2p11.2] contiguous gene syndromes by chromo
some engineering in mice: phenotypic consequences of gene dosage imbalance. Mol
Cell Biol. 2003 May;23[10]:3646-55.
[25] Mills AA, Bradley A. From mouse to man: generating megabase chromosome rear
rangements. Trends Genet. 2001 Jun;17([6]):331-9.
[26] van der Weyden L, Bradley A. Mouse chromosome engineering for modeling human
disease. Annu Rev Genomics Hum Genet. 2006;7:247-76.
267
268
[27] Adams DJ, Biggs PJ, Cox T, Davies R, van der Weyden L, Jonkers J, et al. Mutagenic
insertion and chromosome engineering resource (MICER). Nat Genet. 2004 Aug;
36([8]):867-71.
[28] Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K, et al. Abnormal behavior
in a chromosome-engineered mouse model for human 15q11-13 duplication seen in
autism. Cell. 2009 Jun 26;137([7]):1235-46.
[29] Horev G, Ellegood J, Lerch JP, Son YE, Muthuswamy L, Vogel H, et al. Dosage-de
pendent phenotypes in models of 16p11.2 lesions found in autism. Proc Natl Acad
Sci U S A. 2011 Oct 11;108[41]:17076-81.
[30] Lacaria M, Spencer C, Gu W, Paylor R, Lupski JR. Enriched Rearing Improves Behav
ioral Responses of an Animal Model for CNV-based Autistic-like Traits. Hum Mol
Genet. 2012 Jul 15;21(14):3083-96.
[31] Lupski JR. Genomic disorders: structural features of the genome can lead to DNA re
arrangements and human disease traits. Trends Genet. 1998 Oct;14[10]:417-22.
[32] Lupski JR, Stankiewicz P. Genomic disorders: molecular mechanisms for rearrange
ments and conveyed phenotypes. PLoS Genet. 2005 Dec;1([6]):e49.
[33] Lupski JR. Genomic disorders ten years on. Genome Med. 2009;1([4]):42.
[34] Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, dis
ease, and evolution. Annu Rev Genomics Hum Genet. 2009;10:451-81.
[35] Gu W, Zhang F, Lupski JR. Mechanisms for human genomic rearrangements. Patho
genetics. 2008;1([1]):4.
[36] Shinawi M, Liu P, Kang SH, Shen J, Belmont JW, Scott DA, et al. Recurrent reciprocal
16p11.2 rearrangements associated with global developmental delay, behavioural
problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet. 2009 May;
47([5]):332-41.
[37] Kumar RA, Marshall CR, Badner JA, Babatz TD, Mukamel Z, Aldinger KA, et al. As
sociation and mutation analyses of 16p11.2 autism candidate genes. PLoS One.
2009;4([2]):e4582.
[38] Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural varia
tion of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008 Feb;
82([2]):477-88.
[39] Fernandez BA, Roberts W, Chung B, Weksberg R, Meyn S, Szatmari P, et al. Pheno
typic spectrum associated with de novo and inherited deletions and duplications at
16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med
Genet. 2010 Mar;47([3]):195-203.
[40] Ghebranious N, Giampietro PF, Wesbrook FP, Rezkalla SH. A novel microdeletion at
16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and
mild mental retardation. Am J Med Genet A. 2007 Jul 1;143A[13]:1462-71.

http://dx.doi.org/10.5772/53689
[41] McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, et al. Micro
duplications of 16p11.2 are associated with schizophrenia. Nat Genet. 2009 Nov;
41[11]:1223-7.
[42] Lupski JR. Insights for autism from Charcot-Marie-Tooth disease. SFARI. September
27, 2011.
[43] Crespi B, Badcock C. Psychosis and autism as diametrical disorders of the social
brain. Behav Brain Sci. 2008 Jun;31([3]):241-61; discussion 61-320.
[44] Jacquemont S, Reymond A, Zufferey F, Harewood L, Walters RG, Kutalik Z, et al.
Mirror extreme BMI phenotypes associated with gene dosage at the chromosome
16p11.2 locus. Nature. 2011 Oct 6;478[7367]:97-102.
[45] Yu Y, Zhu H, Miller DT, Gusella JF, Platt OS, Wu BL, et al. Age- and gender-depend
ent obesity in individuals with 16p11.2 deletion. J Genet Genomics. 2011 Sep
20;38([9]):403-9.
[46] Perrone L, Marzuillo P, Grandone A, del Giudice EM. Chromosome 16p11.2 dele
tions: another piece in the genetic puzzle of childhood obesity. Ital J Pediatr.
2010;36:43.
[47] Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, Andersson J, et al. A
new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Na
ture. 2010 Feb 4;463[7281]:671-5.
[48] Puvabanditsin S, Nagar MS, Joshi M, Lambert G, Garrow E, Brandsma E. Microdele
tion of 16p11.2 associated with endocardial fibroelastosis. Am J Med Genet A. 2010
Sep;152A([9]):2383-6.
[49] Degenhardt F, Priebe L, Herms S, Mattheisen M, Muhleisen TW, Meier S, et al. Asso
ciation between copy number variants in 16p11.2 and major depressive disorder in a
German case-control sample. Am J Med Genet B Neuropsychiatr Genet. 2012 Apr;
159B([3]):263-73.
[50] Rosenfeld JA, Coppinger J, Bejjani BA, Girirajan S, Eichler EE, Shaffer LG, et al.
Speech delays and behavioral problems are the predominant features in individuals
with developmental delays and 16p11.2 microdeletions and microduplications. J
Neurodev Disord. Mar;2([1]):26-38.
[51] Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH, van Haeringen A, Fransen van de
Putte DE, Anderlid BM, et al. Extending the phenotype of recurrent rearrangements
of 16p11.2: deletions in mentally retarded patients without autism and in normal in
dividuals. Eur J Med Genet. 2009 Mar-Jun;52[2-3]:77-87.
[52] Shimojima K, Inoue T, Fujii Y, Ohno K, Yamamoto T. A familial 593-kb microdeletion
of 16p11.2 associated with mental retardation and hemivertebrae. Eur J Med Genet.
2009 Nov-Dec;52([6]):433-5.
269
270
[53] Schaaf CP, Goin-Kochel RP, Nowell KP, Hunter JV, Aleck KA, Cox S, et al. Expand
ing the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients
with syringomyelia. Eur J Hum Genet. 2010 Feb;19([2]):152-6.
[54] Crepel A, Steyaert J, De la Marche W, De Wolf V, Fryns JP, Noens I, et al. Narrowing
the critical deletion region for autism spectrum disorders on 16p11.2. Am J Med Gen
et B Neuropsychiatr Genet. 2011 Mar;156([2]):243-5.
[55] Konyukh M, Delorme R, Chaste P, Leblond C, Lemiere N, Nygren G, et al. Variations
of the candidate SEZ6L2 gene on Chromosome 16p11.2 in patients with autism spec
trum disorders and in human populations. PLoS One. 2011;6([3]):e17289.
[56] Shen Y, Chen X, Wang L, Guo J, Shen J, An Y, et al. Intra-family phenotypic heteroge
neity of 16p11.2 deletion carriers in a three-generation Chinese family. Am J Med
Genet B Neuropsychiatr Genet. 2010 Mar;156([2]):225-32.
[57] Golzio C, Willer J, Talkowski ME, Oh EC, Taniguchi Y, Jacquemont S, et al. KCTD13
is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy num
ber variant. Nature. 2012 May 17;485[7398]:363-7.
[58] Blaker-Lee A, Gupta S, McCammon JM, De Rienzo G, Sive H. Zebrafish homologs of
genes within 16p11.2, a genomic region associated with brain disorders, are active
during brain development, and include two deletion dosage sensor genes. Dis Model
Mech. 2012 Nov;5(6):834-51..
[59] Veltman MW, Craig EE, Bolton PF. Autism spectrum disorders in Prader-Willi and
Angelman syndromes: a systematic review. Psychiatr Genet. 2005 Dec;15([4]):243-54.
[60] Lalande M, Calciano MA. Molecular epigenetics of Angelman syndrome. Cell Mol
Life Sci. 2007 Apr;64[7-8]:947-60.
[61] Dykens EM, Lee E, Roof E. Prader-Willi syndrome and autism spectrum disorders:
an evolving story. J Neurodev Disord. 2011 Sep;3([3]):225-37.
[62] Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP. Increased gene dos
age of Ube3a results in autism traits and decreased glutamate synaptic transmission
in mice. Sci Transl Med. 2011 Oct 5;3[103]:103ra97.
[63] Roberts SE, Dennis NR, Browne CE, Willatt L, Woods G, Cross I, et al. Characterisa
tion of interstitial duplications and triplications of chromosome 15q11-q13. Hum
Genet. 2002 Mar;110([3]):227-34.
[64] Wegiel J, Schanen NC, Cook EH, Sigman M, Brown WT, Kuchna I, et al. Differences
between the pattern of developmental abnormalities in autism associated with dupli
cations 15q11.2-q13 and idiopathic autism. J Neuropathol Exp Neurol. 2012 May;
71([5]):382-97.
[65] Ungaro P, Christian SL, Fantes JA, Mutirangura A, Black S, Reynolds J, et al. Molecu
lar characterisation of four cases of intrachromosomal triplication of chromosome
15q11-q14. J Med Genet. 2001 Jan;38([1]):26-34.

http://dx.doi.org/10.5772/53689
[66] Stewart LR, Hall AL, Kang SH, Shaw CA, Beaudet AL. High frequency of known
copy number abnormalities and maternal duplication 15q11-q13 in patients with
combined schizophrenia and epilepsy. BMC Med Genet. 2011;12:154.
[67] Wegiel J, Frackowiak J, Mazur-Kolecka B, Schanen NC, Cook EH, Jr., Sigman M, et
al. Abnormal intracellular accumulation and extracellular Abeta deposition in idio
pathic and Dup15q11.2-q13 autism spectrum disorders. PLoS One. 2012;7([5]):e35414.
[68] Yang T, Adamson TE, Resnick JL, Leff S, Wevrick R, Francke U, et al. A mouse model
for Prader-Willi syndrome imprinting-centre mutations. Nat Genet. 1998 May;19([1]):
25-31.
[69] Relkovic D, Doe CM, Humby T, Johnstone KA, Resnick JL, Holland AJ, et al. Behav
ioural and cognitive abnormalities in an imprinting centre deletion mouse model for
Prader-Willi syndrome. Eur J Neurosci. 2010 Jan;31([1]):156-64.
[70] Godavarthi SK, Dey P, Maheshwari M, Jana NR. Defective glucocorticoid hormone
receptor signaling leads to increased stress and anxiety in a mouse model of Angel
man syndrome. Hum Mol Genet. 2012 Apr 15;21([8]):1824-34.
[71] Mulherkar SA, Jana NR. Loss of dopaminergic neurons and resulting behavioural
deficits in mouse model of Angelman syndrome. Neurobiol Dis. 2010 Dec;40([3]):
586-92.
[72] Heck DH, Zhao Y, Roy S, LeDoux MS, Reiter LT. Analysis of cerebellar function in
Ube3a-deficient mice reveals novel genotype-specific behaviors. Hum Mol Genet.
2008 Jul 15;17[14]:2181-9.
[73] Colas D, Cespuglio R, Sarda N. Sleep wake profile and EEG spectral power in young
or old senescence accelerated mice. Neurobiol Aging. 2005 Feb;26([2]):265-73.
[74] Miura K, Kishino T, Li E, Webber H, Dikkes P, Holmes GL, et al. Neurobehavioral
and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neuro
biol Dis. 2002 Mar;9([2]):149-59.
[75] Allensworth M, Saha A, Reiter LT, Heck DH. Normal social seeking behavior, hypo
activity and reduced exploratory range in a mouse model of Angelman syndrome.
BMC Genet. 2011;12:7.
[76] Jiang YH, Pan Y, Zhu L, Landa L, Yoo J, Spencer C, et al. Altered ultrasonic vocaliza
tion and impaired learning and memory in Angelman syndrome mouse model with
a large maternal deletion from Ube3a to Gabrb3. PLoS One. 2010;5([8]):e12278.
[77] Bi W, Lupski JR. RAI1, the SmithMagenis, and PotockiLupski Syndromes. In: Ep
stein CJ, Erickson RP, Wynshaw-Boris A, editors. Inborn Errors of Development;
2008.
[78] Liu P, Lacaria M, Zhang F, Withers M, Hastings PJ, Lupski JR. Frequency of nonallel
ic homologous recombination is correlated with length of homology: evidence that
271
272
ectopic synapsis precedes ectopic crossing-over. Am J Hum Genet. 2011 Oct 7;89([4]):
580-8.
[79] Shaw CJ, Withers MA, Lupski JR. Uncommon deletions of the Smith-Magenis syn
drome region can be recurrent when alternate low-copy repeats act as homologous
recombination substrates. Am J Hum Genet. 2004 Jul;75([1]):75-81.
[80] Bi W, Saifi GM, Shaw CJ, Walz K, Fonseca P, Wilson M, et al. Mutations of RAI1, a
PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome.
Hum Genet. 2004 Nov;115([6]):515-24.
[81] Slager RE, Newton TL, Vlangos CN, Finucane B, Elsea SH. Mutations in RAI1 associ
ated with Smith-Magenis syndrome. Nat Genet. 2003 Apr;33([4]):466-8.
[82] Bi W, Saifi GM, Girirajan S, Shi X, Szomju B, Firth H, et al. RAI1 point mutations,
CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome.
Am J Med Genet A. 2006 Nov 15;140[22]:2454-63.
[83] Edelman EA, Girirajan S, Finucane B, Patel PI, Lupski JR, Smith AC, et al. Gender,
genotype, and phenotype differences in Smith-Magenis syndrome: a meta-analysis of
105 cases. Clin Genet. 2007 Jun;71([6]):540-50.
[84] Greenberg F, Lewis RA, Potocki L, Glaze D, Parke J, Killian J, et al. Multi-disciplinary
clinical study of Smith-Magenis syndrome (deletion 17p11.2]. Am J Med Genet. 1996
Mar 29;62([3]):247-54.
[85] Greenberg F, Guzzetta V, Montes de Oca-Luna R, Magenis RE, Smith AC, Richter SF,
et al. Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene
syndrome associated with del[17](p11.2]. Am J Hum Genet. 1991 Dec;49([6]):1207-18.
[86] Finucane BM, Konar D, Haas-Givler B, Kurtz MB, Scott CI, Jr. The spasmodic upperbody squeeze: a characteristic behavior in Smith-Magenis syndrome. Dev Med Child
Neurol. 1994 Jan;36([1]):78-83.
[87] Arron K, Oliver C, Moss J, Berg K, Burbidge C. The prevalence and phenomenology
of self-injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil
Res. 2010 Feb;55([2]):109-20.
[88] Laje G, Morse R, Richter W, Ball J, Pao M, Smith AC. Autism spectrum features in
Smith-Magenis syndrome. Am J Med Genet C Semin Med Genet. 2010 Nov
15;154C([4]):456-62.
[89] Potocki L, Chen KS, Park SS, Osterholm DE, Withers MA, Kimonis V, et al. Molecu
lar mechanism for duplication 17p11.2- the homologous recombination reciprocal of
the Smith-Magenis microdeletion. Nat Genet. 2000 Jan;24([1]):84-7.
[90] Soler-Alfonso C, Motil KJ, Turk CL, Robbins-Furman P, Friedman EM, Zhang F, et al.
Potocki-Lupski syndrome: a microduplication syndrome associated with orophar
yngeal dysphagia and failure to thrive. J Pediatr. 2010 Apr;158([4]):655-9 e2.

http://dx.doi.org/10.5772/53689
[91] Yusupov R, Roberts AE, Lacro RV, Sandstrom M, Ligon AH. Potocki-Lupski syn
drome: an inherited dup[17](p11.2p11.2] with hypoplastic left heart. Am J Med Genet
A. 2011 Feb;155A([2]):367-71.
[92] Sanchez-Valle A, Pierpont ME, Potocki L. The severe end of the spectrum: Hypoplas
tic left heart in Potocki-Lupski syndrome. Am J Med Genet A. Feb;155A([2]):363-6.
[93] Jefferies JL, Pignatelli RH, Martinez HR, Robbins-Furman PJ, Liu P, Gu W, et al. Car
diovascular findings in duplication 17p11.2 syndrome. Genet Med. 2012 Jan;14([1]):
90-4.
[94] Zhang F, Potocki L, Sampson JB, Liu P, Sanchez-Valle A, Robbins-Furman P, et al.
Identification of uncommon recurrent Potocki-Lupski syndrome-associated duplica
tions and the distribution of rearrangement types and mechanisms in PTLS. Am J
Hum Genet. 2010 Mar 12;86([3]):462-70.
[95] Walz K, Paylor R, Yan J, Bi W, Lupski JR. Rai1 duplication causes physical and be
havioral phenotypes in a mouse model of dup[17](p11.2p11.2]. J Clin Invest. 2006
Nov;116[11]:3035-41.
[96] Toulouse A, Rochefort D, Roussel J, Joober R, Rouleau GA. Molecular cloning and
characterization of human RAI1, a gene associated with schizophrenia. Genomics.
2003 Aug;82([2]):162-71.
[97] Truong HT, Dudding T, Blanchard CL, Elsea SH. Frameshift mutation hotspot identi
fied in Smith-Magenis syndrome: case report and review of literature. BMC Med
Genet. 2010;11:142.
[98] Hayes S, Turecki G, Brisebois K, Lopes-Cendes I, Gaspar C, Riess O, et al. CAG re
peat length in RAI1 is associated with age at onset variability in spinocerebellar atax
ia type 2 (SCA2]. Hum Mol Genet. 2000 Jul 22;9[12]:1753-8.
[99] Bi W, Ohyama T, Nakamura H, Yan J, Visvanathan J, Justice MJ, et al. Inactivation of
Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse
models for Smith-Magenis syndrome. Hum Mol Genet. 2005 Apr 15;14([8]):983-95.
[100] Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R, et al. ALL-1 is a
histone methyltransferase that assembles a supercomplex of proteins involved in
transcriptional regulation. Mol Cell. 2002 Nov;10([5]):1119-28.
[101] Rekdal C, Sjottem E, Johansen T. The nuclear factor SPBP contains different function
al domains and stimulates the activity of various transcriptional activators. J Biol
Chem. 2000 Dec 22;275[51]:40288-300.
[102] Bi W, Yan J, Shi X, Yuva-Paylor LA, Antalffy BA, Goldman A, et al. Rai1 deficiency in
mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous
mice display minimal behavioral phenotypes. Hum Mol Genet. 2007 Aug 1;16[15]:
1802-13.
273
274
[103] van der Zwaag B, Franke L, Poot M, Hochstenbach R, Spierenburg HA, Vorstman JA,
et al. Gene-network analysis identifies susceptibility genes related to glycobiology in
autism. PLoS One. 2009;4([5]):e5324.
[104] Yan J, Bi W, Lupski JR. Penetrance of craniofacial anomalies in mouse models of
Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all
null alleles are alike. Am J Hum Genet. 2007 Mar;80([3]):518-25.
[105] Yan J, Keener VW, Bi W, Walz K, Bradley A, Justice MJ, et al. Reduced penetrance of
craniofacial anomalies as a function of deletion size and genetic background in a
chromosome engineered partial mouse model for Smith-Magenis syndrome. Hum
Mol Genet. 2004 Nov 1;13[21]:2613-24.
[106] Girirajan S, Patel N, Slager RE, Tokarz ME, Bucan M, Wiley JL, et al. How much is
too much? Phenotypic consequences of Rai1 overexpression in mice. Eur J Hum Gen
et. 2008 Aug;16([8]):941-54.
[107] Walz K, Spencer C, Kaasik K, Lee CC, Lupski JR, Paylor R. Behavioral characteriza
tion of mouse models for Smith-Magenis syndrome and dup[17](p11.2p11.2]. Hum
Mol Genet. 2004 Feb 15;13([4]):367-78.
[108] Molina J, Carmona-Mora P, Chrast J, Krall PM, Canales CP, Lupski JR, et al. Abnor
mal social behaviors and altered gene expression rates in a mouse model for PotockiLupski syndrome. Hum Mol Genet. 2008 Aug 15;17[16]:2486-95.
[109] Ricard G, Molina J, Chrast J, Gu W, Gheldof N, Pradervand S, et al. Phenotypic con
sequences of copy number variation: insights from Smith-Magenis and Potocki-Lup
ski syndrome mouse models. PLoS Biol. 2010;8[11]:e1000543.
[110] Heck D, Gu W, Cao Y, Qi S, Lacaria M, Lupski JR. Opposing phenotypes in mouse
models for Smith-Magenis deletion and Potocki -Lupski duplication syndromes sug
gest gene dosage effects on fluid consumption behavior. Am J Med Genet Part A.
2012;9999:1-7.
[111] Girirajan S, Elsea SH. Abnormal maternal behavior, altered sociability, and impaired
serotonin metabolism in Rai1-transgenic mice. Mamm Genome. 2009 Apr;20([4]):
247-55.
[112] Potocki L, Shaw CJ, Stankiewicz P, Lupski JR. Variability in clinical phenotype de
spite common chromosomal deletion in Smith-Magenis syndrome [del[17]
(p11.2p11.2]]. Genet Med. 2003 Nov-Dec;5([6]):430-4.
[113] Duchan E, Patel DR. Epidemiology of autism spectrum disorders. Pediatr Clin North
Am. 2012 Feb;59([1]):27-43, ix-x.
Chapter 13
Autism Spectrum Disorders: Insights from Genomics

John J. Connolly and Hakon Hakonarson
http://dx.doi.org/10.5772/54357
1. Introduction
The field of genetics has made considerable scientific progress in the past several years
and continues to evolve at a rapid pace. This progress parallels developments in genom
ic technology, where instrumentation and methodology are becoming increasingly so
phisticated and cost-effective. Here, we review recent developments in understanding
autism spectrum disorder (ASD) from a genomics perspective. A large catalog of com
mon and rare variants has now been associated with ASD, and we are beginning to see
some of these discoveries translate into pharmacogenomic intervention. This review pro
vides an overview of genome-wide association studies (GWAS) and common genetic var
iants, followed by an overview of the status of rare variant research, which have risen to
prominence with the proliferation of next-generation sequencing and techniques for iden
tifying copy number variants. While these approaches need not be mutually exclusive,
they provide a useful structure for organizing relevant genetic factors. Although there is
much work to be done before these discoveries will enter the clinic, the past decade has
seen us make major inroads in elucidating the causes of ASD and making tentative steps
towards developing treatments.
1.1. Defining the autism phenotype
Autism is known to be highly heterogeneous, and this phenomenon has made definitions of
the phenotype somewhat problematic. The American Psychiatric Association recently pro
posed revisions to its Diagnostic and Statistical Manual of Mental Disorders V (DSM-5) cri
teria for ASD (see Wing et al., 2011) [1], acknowledging the long-observed overlap between
social and communication dimensions (previously separate). Thus, ASD will be defined by
1) persistent deficits in social communication and social interaction across contexts, and 2)
restricted, repetitive patterns of behavior, interests, or activities. These should impair every
2013 Connolly and Hakonarson; licensee InTech. This is an open access article distributed under the terms
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
276
day functioning, not be accounted for by general developmental delays, and be present from
early childhood.
For large-scale genome analyses, DSM criteria have been considered insufficiently precise,
and cases are often selected using scores from the Autism Diagnostic Interview (ADI-R) [2],
Autism Diagnostic Observation Schedule (ADOS) [3], and/or Social Responsiveness Scale
(SRS) [4]. These instruments offer a more robust psychometric platform, and cases defined
as autism are required to meet strict threshold criteria (e.g. all sub-dimensions of the ADIR and ADOS). Individuals not quite meeting these criteria may be subsumed under the
broader autism phenotype, which also typically includes Asperger syndrome, childhood
disintegrative disorder and pervasive developmental disorder not otherwise specified. A di
agnosis of Rett syndromewhich has a reportedly distinct pathophysiology, clinical course,
and diagnostic strategy (Levy, Mandell & Schultz, 2009) [5] and will likely be removed in
the impending publication of DSM-Vis typically exclusionary. Intellectual impairment,
which is often co-morbid with ASD (Dawson et al., 2007; Blte et al., 2009) [6,7] is not an ex
clusionary criterion, but is co-varied in statistical analyses. Given the broad range of IQ tests
and their associated psychometric properties, this requires considerable finesse.
Standardization of diagnostic criteria has facilitated the accumulation of large ASD samplesets, where institutions can share (de-identified) data. In this vein, initiatives such as the Au
tism Genome Project include data from several thousand ASD individuals, greatly
increasing statistical power of relevant analyses.
1.2. Heritability of ASD
Although Skuse (2007) [8] cautions that heritability estimates of ASD may have been skewed
by the co-inheritance of (low) intelligence or other variables, there is little doubt that genetic
factors play a key role in autism. In the most widely-cited twin study, Bailey et al. (1995) [9]
report that monozygotic twins are 92% concordant on a broad spectrum of cognitive or so
cial abnormalities, compared with only 10% for dizygotic twins. Parents and siblings of indi
viduals with ASD often exhibit subsyndromal levels of impairment (Piven et al., 1997) [10],
and having an affected sibling is the single biggest risk factor for developing an ASD. In an
analysis of 943,664 Danish children (Lauritsen et al., 2005) [11], the strongest predictors of
autism were siblings with ASD, who conferred a 22-fold increased risk, while Fombonne
(2005) [12] suggested that this risk may be even greater.
1.3. Early genetic studies insights from Rett syndrome and Fragile X
Early efforts to identify the genetic causes of ASD utilized linkage and association ap
proaches. Linkage studies, more prominent in the 1980s and 1990s, typically focus on fami
lies or larger pedigrees and are well powered to identify rarer genetic variants. The most
common linkage approach is the affected sib-pair design (see ORoak & State, 2008) [13],
which examines the transmission of genomic segments through generations. Linkage stud
ies helped define the locus containing FMR1, which is mutated in fragile X syndrome (e.g.
Richards et al., 1991) [14], Approximately 30% of children with fragile X syndrome meet cri

http://dx.doi.org/10.5772/54357
teria for autism (Rogers et al., 2001; Harris et al., 2008) [15,16]. Similarly, linkage studies have
been important to identifying MECP2 as the major cause of Rett syndrome (e.g. Curtis et al.,
1993) [17].
Association studies take a different approach. Rather than track transmission of specific ge
nomic regions through generations, association studies scan the breadth of the genome.
Here, the goal is to determine post-hoc whether identified variants are more or less common
in affected individuals. Early association studies (i.e. pre HapMap) were complementary
with the linkage approach, and in many designs, linkage primed target loci for this more
fine-grained analysis.
These early insights have played an important role in shaping our current understanding of
ASD. Functional studies of FMR1 and MECP2 have highlighted the importance of synaptic
dysfunction (Ramocki & Zoghbi, 2008) [18] as a unifying factor that could extend into the
more common forms of autism and, as discussed below, remain highly relevant to our un
derstanding of the broader ASD phenotype.
2. Genome wide association and common variants

Aside from notable successes with fragile X and Rett syndrome, early linkage and associa
tion studies have been inconsistent in resolving more complex genetic correlates of ASD,
and candidate genes have often not being replicated between studies. These challenges may
in part be accounted-for by their relatively low resolution/coverage, making it difficult to
detect candidate loci other than those of major effect. A shift in technology was required to
get beyond such challenges, which was engendered by the introduction of high-resolution
single nucleotide polymorphism (SNP) arrays. SNP arrays provided coverage of many thou
sand (now several million) common SNPs, which could be examined at a relatively low cost
across large sample sets.
Genome-wide association studies (GWAS) examine the frequency of SNPs in case versus
control populations, and can adopt either a case-control or family-based design. The former
allows researchers to avoid the often complex process of acquiring diagnostic/phenotype da
ta from a patients family, and can incorporate very large numbers of control datasets that
may be more readily available. The latter controls for the often confounding phenomenon of
population stratification, where variants more common to specific racial groups may either
be erroneously identified as causal, or obscure actual causal variants. A major caveat with
family-based designs is the often unfounded assumption that unaffected family members do
not share causal variants.
GWAS test for common variants (>1% population frequency), with the assumption that ASD
are at least in part caused by the coinheritance of multiple risk variants, each of small indi
vidual effect (odds ratios typically between ~1:1 and ~1:5). This assumption is known as the
common disease-common variant (CDCV) model (Risch & Merikangas, 1996) [20].
277
278
2.1. The 5p14.1 locus

A 2009 paper from our laboratory (Wang et al., 2009 [21]) was the first to identify common
variants for ASD on a genome-wide scale. Our group examined 780 families (3,101 individu
als) with affected children, a second, independent group of 1,204 affected individuals, and
6,491 controls. All were of European ancestry. We identified six genetic markers on chromo
some 5 in the 5p14.1 region that confirmed susceptibility to ASD. This locus has been repli
cated in two additional independent cohort studies (Ma et al., 2009; St Pourcain et al., 2010)
[22, 23], lending further support for 5p14 as associated with ASD risk.
As shown in Figure 1, the region straddles two genes, CDH9 and CDH10. Both genes encode
type II classical cadherins, transmembrane proteins that promote cell adhesion. Cadherins
represent a large family of transmembrane proteins that mediate calcium-dependent cell
cell adhesion, and have been shown to generate synaptic complexity in the developing brain
(Redies, Hertel & Hbner, 2012) [24]. The association of cadherins is consistent with the cort
ical-disconnectivity model of autism (e.g. Gepner & Fron, 2009) [25], which postulates that
ASD may result from an increase or decrease in functional connectivity and neuronal syn
chronization in relevant neural pathways. While this hypothesis may yet be confirmed, a re
cent study by Kerin et al. (2012) [26] suggests a more complex mechanism to explain
association between ASD and the 5p14.1 locus.
Basing their analyses on the genomic region surrounding the rs4307059 locus, the authors
used a bioinformatics approach (i.e. Genome Browser) to examine relevant expressed se
quence tags (ESTs) and RNA (by Tiling Array within the 100-kb linkage disequilibrium at
the GWAS peak). Only one functional elementa single noncoding RNAwas located. The
3.9-kb RNA corresponded to moesin pseudogene 1 (MSNP1), and has 94% sequence identity
to the mature mRNA of the protein-coding gene MSN. Located on the X chromosome
(Xq11.2), MSN spans 74 kb and contains 13 exons. It produces a 4-kb mRNA, and encodes
the 577amino acid moesin protein. The noncoding RNA at 5p14.1 was encoded by the op
posite (antisense) strand of MSNP1, and was therefore named moesin pseudogene 1, anti
sense MSNP1AS.
Follow-up analyses by the group largely confirm that MSNP1AS is expressed in the brain,
providing important functional validation. Using custom TaqMan Gene Expression assays
to target the region, they showed that while MSN was widely expressed in all tissues tested,
MSNP1AS was expressed variably. Sites of greatest expression were the adult temporal cere
bral cortex, adult peripheral blood, and fetal heart, as well as three immortalized cell lines.
Moreover, postmortem analyses (qPCR on total RNA) of fresh-frozen, superior temporal
gyri of ASD-control pairs (n=10) found a 12.7-fold increase of MSNP1AS expression in the
temporal cortex of individuals with ASD. Individuals with ASD also showed a 2.4-fold in
crease in MSN expression in the same region. Interestingly, there was no evidence of in
creased expression for either CDH9 or CDH10.
The group next used genotypedetermined from three associated SNPs from the original
Wang et al. paperas the independent variable in expression analyses. All three SNPs,
rs7704909, rs12518194, and rs4307059, have a high degree of linkage disequilibrium (LD)

http://dx.doi.org/10.5772/54357
(r2>0.98). Using resequencing to compare relevant genotypes, they identified highly signifi
cant differences in MSNP1AS expression. Thus, the T/T genotype at rs7704909 corresponded
to a 23.3 fold increase in MSNP1AS RNA compared to the C/C genotype. For the rs4307059,
the T/T versus C/C genotype corresponded to a 22.0-fold increase in MSNP1A expression.
For rs12518194, the A/A versus G/G genotype corresponded to a 10.8 fold increase in
MSNP1A expression. Again, there was no evidence of increased/decreased expression dif
ferences for CDH9 or CDH10 in relation to genotype or case/control status.
Figure 1. Genome-wide association results at the 5p14.1 region. a, A Manhattan plot shows the log10(p values) of
SNPs from their combined association analysis. b, The 5p14.1 region in the UCSC Genome Browser, with conserved
genomic elements in the PhastCons track. c, Genotyped (diamonds) and imputed (grey circles) SNPs are plotted with
their combined p values. Genotyped SNPs are colored on the basis of their correlation with rs4307059 (red: r2 0.5;
yellow: 0.2 r2 < 0.5; white: r2 < 0.2). Estimated recombination rates from HapMap are plotted to reflect local linkage
disequilibrium. Adapted from Wang et al., 2009 [21]. Reprinted with permission from Nature Publishing Group.
Although Western blot analyses did not identify significant differences in moesin protein
levels between cases and controls, overexpressing MSNP1AS in human cell lines was shown
to significantly reduce levels of the moesin protein. The authors speculated that relevant al
terations in moesin may occur only during specific development landmarks, which may im
279
280
pact neurodevelopment. This would explain why moesin levels are not elevated in the ASD
samples per se, in spite of the marked differences in MSNP1AS expression. Further work is
needed to confirm this hypothesis, and quantification of moesin protein levels at key devel
opmental stages would certainly contribute in this respect.
Taken as a whole, these results provide compelling support for 5p14.1 as a risk locus for
ASD. Although sample sizes for some analyses were small (10 ASD-control pairs for post
mortem studies), this quite rigorous series of experiments draws a clear path from GWAS
result through functional validation. As such, these results help allay criticism of the GWAS
approach as a means of candidate discovery. Thus, a 2010 review by McClellan and King
(2010) [27] singled out the 5p14.1 locus as an example of the perils of cryptic population
stratification. These comments seemed somewhat misguided in the light of rigorous meth
odologies developed by the GWAS community for controlling stratification (e.g. EigenStrat)
[28], replication [22, 23], and now functional validation by the Kerin et al. group [26].
Similarly, replication/validation of the 5p14.1 locus provides an important demonstration of
the legitimacy of associations in intergenic regions. Again, McClellan and King had disput
ed the utility of such results, questioning how genome-wide association studies come to be
populated by risk variants with no known function? It is important to emphasize that the
GWAS approach typically does not tag the disease variant, but rather its approximate loca
tionthrough linkage disequilibrium, this is typically 100kb or less. Moreover, as in the
Kerin et al. paper, the significant SNP may be tagging an intergenic regulatory element,
which has functional consequences far beyond the associated region, in this case the MSN
locus on the X-chromosome.
Finally, these expression analyses provide a reminder about the capabilities of different ge
nomic technologies. In the past twelve months, a number of high-profile next-generation se
quencing (NGS) studies have been able to examine genomic correlates of ASD with
unprecedented resolution. These types of studiesreviewed in greater depth belowhave
been interpreted as the future of ASD genetics and, to a large extent, this may be true. How
ever, we note that DNA sequencing in the 5p14.1 region would not have identified the noncoding RNA at this locus. Thus, although NGS platforms used for RNA-sequencing are
becoming increasingly sophisticated (Ozsolak & Milos, 2011) [29], microarray studies retain
a place in guiding genomic discovery.
2.2. Other replicated common variants from candidate gene studies
A number of other common variants from candidate gene studies have been proposed as
ASD risk factors. These include Contactin Associated Protein 2 (CNTNAP2), located on chro
mosome 7q35, which has been identified as a candidate for the age at first word endopheno
type (Alarcn et al., 2002) [30]. A follow-up by the same group (Alarcn et al., 2008) [31]
using linkage, association, and gene-expression analyses, found CNTNAP2 to be the only
autism-susceptibility gene to reach significance across all approaches. An independent link
age analysis by Arking et al. (2008) [32] also highlighted CNTNAP2 as a significant ASD can
didate gene. CNTNAP2 is part of the neurexin family, which have repeatedly been
associated with autism (see below). Interestingly, Vernes et al. (2008) [33] showed that

http://dx.doi.org/10.5772/54357
CNTNAP2 binds to FOXP2, which is a well-established correlate of language and speech

disorders (Lai et al., 2001) [34], and are commonly observed in ASD.
Another locus indentified by the candidate gene approach is Engrailed 2 (EN2), a homeo
box gene that is critical to the development of the midbrain and cerebellum. Like other
homeobox genes, it regulates morphogenesis. EN2 is a human homolog of the engrailed
gene, which is found in Drosophila. En2 mouse mutants have anatomic phenotypes in
the cerebellum that resemble cerebellar abnormalities reported in autistic individuals
(Cheng et al., 2010) [35]. In three separate datasets, Benayed et al. (2005, 2009) [36, 37]
have reported and replicated a significant association between EN2 and both broad and
narrow ASD phenotypes. Wang et al. (2008) [38] also found an association between EN2
and ASD in a Chinese Han sample, although Zhong et al. (2003) [39] failed to find evi
dence of an underlying association.
The oncogene MET is also strongly linked to ASD etiology, having been supported by a
number of studies in the past decade (e.g. IMGSAC, 2001; Campbell et al., 2006, 2008; Sousa
et al., 2009) [40-43]. Recently, Eagleson et al. (2011) [44] reported a role for Met signaling in
cortical interneuron development in vitro in a mouse model.
2.3. Unexplained variance
For the most significant discovery SNP identified in the Wang et al. study above (rs4307059),
the risk allele frequency was 0.65 in cases with an odds ratio of 1.19. This is comparable with
common variant discoveries in other psychiatric disorders including schizophrenia (Gless
ner et al., 2009) [45], bipolar disorder (Ferreira, 2008) [46], and attention-deficit/hyperactivity
disorder (Arcos-Burgos et al. 2010) [47]. While it is important not to undermine the signifi
cance of these findings, it should be noted that the predictive value of such ratios is relative
ly low (Dickson et al. 2010) [48], often explaining less than 5% of the total risk (review at
http://www.genome.gov/gwastudies). However, it is also possible that these common SNPs
may be tagging a rarer causative variant (i.e. synthetic association), where the effect sizes
may be markedly underestimated by the GWAS variant as we recently reported (Dickson et
al. 2010) [48]. In one example, Wang et al. (2010) [49] examined the NOD2 locus as a cause of
Crohns disease. Using resequencing data, they found that three causal variants explain >
5% of the genetic risk, where GWAS had estimated the risk at ~1%. This finding has two po
tentially important implications. First of all, it highlights the need for careful phenotyping of
cohorts, which is important to ensure that the phenotypes produced by rare-variants are not
being filtered-out and missed as a consequence. A long range haplotype analysis of the
GWAS data at respective loci is recommended in an attempt to enrich for individuals with
rare-causative variants, who can be selected from the cohort and sequenced for confirmation
(Wang et al., 2010) [49].
Second, the results of our Crohns disease study suggest that in certain circumstances, there
may be an explicit relationship between tagged variants and underlying rare variants. Thus,
the distinction between loci harboring common versus rare variants is not necessarily con
crete. Indeed, the same locus may harbor both common and rare variants (Anderson et al.,
281
282
2011). In recent years, we have seen an increased emphasis on the former, which is reflected
in an upsurge in the number of copy number variation (CNV) and NGS studies.
3. Rare variants CNVs and next-generation sequencing

3.1. Copy number variation in ASD
CNVs are insertions, deletions, or translocations in the human genome that are universal in
the general population (e.g. Pinto et al., 2010) [50]. CNVs can be detected by the same SNP
arrays used in GWAS, and vary in length from many megabases to 1 kilobase or smaller.
They are often not associated with any observable phenotype.
One of the most widely-known CNVs is Down syndrome, which is characterized by an ex
tra chromosome 21. Rett syndrome is also caused by a CNV, which includes a deletion in
MECP2. CNVs can be inherited or occur de novo, the cause of which is thus far unknown.
Common disease-causing CNVs are infrequent but rare CNVs, with a frequency of less than
1%, have been identified for a range of disorders including ADHD (e.g. Williams et al., 2010)
[51], schizophrenia (e.g. Glessner et al., 2010; Levinson et al., 2011) [52, 53], bipolar disorder
(e.g. Chen et al., 2010) [54] and many others.
Sebat et al. (2007) [55] provided some early insights into the genomic features of CNVs in
ASD. Firstly, they noted that de novo CNVs were individually rare from 118 ASD cases,
none of the identified variants were observed more than twice, with the majority seen just
once. This confirmed the widely-held assumption that many different loci can contribute to
the same ASD phenotype. The sheer volume of loci identified by this approach (multiple lo
ci on 20 chromosomes) affirms the extraordinarily complexity of ASD.
A number of subsequent studies have greatly expanded the number of candidate loci using
the CNV approach. Our laboratory (Bucan et al., 2009) [56] reported 150+ CNVs in 912 ASD
families that were not found in 1,488 controls. Critically, 27 of these loci were replicated in
an independent cohort of 859 ASD cases and 1,051 controls. Some of the rare variants we
identified had previously been associated with autism, including NRXN1 and UBE3A, (Guil
matre et al., 2009) [57]. Samaco et al. (2005) [58] previously identified significant deficits in
ube3a expression in mecp2-deficient mice, suggesting a shared pathological pathway with
Rett syndrome (as well as Angelman syndrome, and autism). Similarly, Kim et al. (2008) [59]
associated NRXN1 with a balanced chromosomal abnormality at chromosome 2p16.3 in two
unrelated ASD individuals. Rare variants in the coding region included two missense
changes.
Glessner et al. (2009) [52] identified and reported CNVs in two major gene networks, includ
ing neuronal cell adhesion molecules (such as NRXN1) and the ubiquitin gene family (such
as UBE3A). Interestingly, four of the most prominent genes enriched by CNVs in ASD cases
(UBE3A, PARK2, RFWD2 and FBXO40) all of which were uncovered independently - are
part of the ubiquitin gene family. Ubiquitination can alter protein function after translation,
and degrade target proteins in conjunction with proteasomes. The ubiquitinproteasome

http://dx.doi.org/10.5772/54357
system operates at pre- and post-synapses, whose functions includes regulating neurotrans
mitter release, recycling synaptic vesicles in pre-synaptic terminals, and modulating changes
in dendritic spines and post-synaptic density (Yi & Ehlers, 2005) [60]. As well as implicating
an ASD-ubiquitination network, we also identified a second pathway involving NRXN1,
CNTN4, NLGN1, and ASTN2. Genes in this group mediate neuronal cell-adhesion, and con
tribute to neurodevelopment by facilitating axon guidance, synapse formation and plastici
ty, and neuronglial interactions. We also note that ubiquitins are involved in recycling celladhesion molecules, which is a possible mechanism by which these two networks are cross
linked.
In a similar approach, Pinto et al. (2010) [50] further confirmed the importance of rare CNVs
as causal factors for ASD. The group did not observe a significant difference between cases
and controls in terms of raw number of CNVs or estimated CNV size. However, the number
of CNVs in genic regions was significantly greater in ASD cases. Again, loci enriched for
CNVs include a number of genes known to be important for neurodevelopment and synap
tic plasticity, such as SHANK2, SYNGAP1, and DLGAP2. Between 5.5% and 5.7% of ASD
cases have at least one de novo CNV, further confirming the significance of de novo genetic
events as risk factors for autism. Similar to the Glessner study, the Pinto group mapped
CNVs to a series of networks involved in the development and regulation of the central
nervous system functions. Implicated networks include neuronal cell adhesion, GTPase reg
ulation (important for signal transduction and biosynthesis), and GTPase/Ras signaling, also
involved in ubiquitination.
Finally, Gai et al. (2011) [61] took a slightly different approach, focusing exclusively on inher
ited CNVs. While underlying loci were not necessarily common to those identified by the
Glessner and Pinto groups, enrichment in pathways involving central nervous system de
velopment, synaptic functions and neuronal signaling processes was again confirmed. The
Gai et al. study also emphasized the role of glutamate-mediated neuronal signals in ASD.
Collectively, these CNV studies suggest that certain hotspots on the genome are particularly
vulnerable to ASD, which include loci on chromosomes 1q21, 3p26, 15q11-q13, 16p11, and
22q11. These hotspots are part of large gene networks that are important to neural signaling
and neurodevelopment and have additionally been associated with other neuropsychiatric
disorders. In particular, a number of CNV studies in schizophrenia have highlighted struc
tural mutations incorporating chromosomes 1q21, 15q13, and 22q11 (e.g. Glessner et al.,
2010) [62], which are significantly enriched in cases versus controls, with NRXN1 being a
standout in this regard. From a phenotype perspective, autism and schizophrenia seem very
different, both in behavioral manifestation and age of onset, and it may seem counter-intui
tive that associated loci should overlap. Some authors have addressed this peculiarity by
proposing that schizophrenia and autism may in fact be different poles of the same spec
trum. Thus, Crespi and Braddock (2008) [63] suggest that social cognition is underdeveloped
in ASD and over-developed in the psychotic spectrum, with a similar polarization of lan
guage and behavioral phenotypes. Although speculative, this hypothesis has gained some
traction. In the next several years, genomic, imaging, and model-systems approaches will
283
284
likely shed further light on the relationship between autism, schizophrenia and other neuro
psychiatric disorders.
3.2. Sequencing familial forms of ASD
To this point, we have focused primarily on the complex interactions of polygenic networks
as the major cause of ASD. However, this is not exclusively the case. Paralleling the recent
spate of CNV studies is a renewed focus on rare disorders. These include familial forms of
complex diseases that are potentially monogenic or with less complex inheritance pattern.
At the outset of this chapter, we emphasized the overlap with fragile X syndrome, where
one third of cases are co-morbid for ASD. As mentioned, fragile X is caused by a failure to
express the protein coded by FMR1. However, mutations in FMR1 do not always result in
fragile X and can result in a phenotype more representative of ASD. Thus, Muhle et al. (2004)
[64] found that 7-8% of idiopathic ASD cases may have mutations at the FMR1 locus. Like
wise, although mutations in MECP2 are the common cause of Rett syndrome, certain muta
tions at the same locus have been associated with idiopathic autism (Carney et al. (2003).
X-linked genes encoding neurologins NLGN3, NLGN4 and SHANK3 (a neuroligin binding
partner) are other prominent examples of distinct rare genetic causes. A parallel can be
drawn between these studies and studies of mental retardation and epilepsy, which include
many rare syndromes that collectively account for a substantial proportion of the two disor
ders (Morrow et al., 2008). Indeed it is perhaps more than coincidence that autism is heavily
co-morbid with these two conditions, with ~40% of ASD cases meeting diagnostic criteria for
mental retardation and epilepsy respectively (Blte et al., 2009; Danielsson et al., 2005) [7,65].
It is also noteworthy that many of these monogenic-related genes are also major players in
neurodevelopment and synapse activity. Other prominent examples include TSC1, TSC2
(Osborne et al., 1991; Franz, 1998) [66, 67], NF1, and UBE3A (see Morrow et al., 2008) [68].
The identification of monogenic or possibly oligogenic autisms is likely to accelerate in
the next several years as NGS becomes more widely available. In our group, we recently
encountered a family of two parents, six healthy siblings, and two siblings with severe
autism suggestive of autosomal recessive inheritance. Unsuccessful attempts using link
age and CNV approaches failed to identify a causal locus, but whole-exome sequencing
at 20x coverage identified four genes, including one with a non-synonymous SNP in the
protocadherin alpha 4 isoform1 precursor (PCDHA4) gene, which presents a strong can
didate gene, currently under validation. Protocadherins are part of the cadherin family
that facilitates neuronal cell adhesion and this discovery is consistent with the functional
properties of the PCDH family.
Known syndromes with ASD features include fragile X, neurofibromatosis type 1, down
syndrome, tuberous sclerosis, neurofibromatosis (which confers a 100-fold increased risk for
ASD Li et al. (2005) [69], Angelman, Prader-Willi and related 15q syndromes, and at least
several dozen others (see Zafeiriou et al., 2007, for a comprehensive review) [70]. Table 1
from Volkmar et al. (2005) [71] lists the most commonly associated syndromes with median
rate and range. It is likely that many more unidentified rare syndromes with Mendelian
causes have ASD phenotypes. As of September 2012, the Online Mendelian Inheritance in

http://dx.doi.org/10.5772/54357
Man (OMIM) database listed over 7,000 known or suspected Mendelian diseases (MD), with
~3,500 (~50%) of these having an identified molecular basis (http://omim.org/statistics/
entry). Since OMIM derives its data from published data, these figures likely under-repre
sent rare disorders, which may go unreported. As such, there may be several times more
Mendelian disorders that have no defined genetic etiology to date. Given the large-represen
tation of autism phenotypes in known syndromes, we can assume a similar trend in unre
ported ASD syndromes.
The proportion of ASD accounted for by rare variants remains to be determined. Irrespec
tive, as with many other aspects of scientific inquiry, the study of these events will continue
to play an important role in explicating the pathogenesis of ASD. El-Fishawy and State
(2010) [72] point to hypercholesterolemia and hypertension (Brown, 1974; Lifton et al., 2001)
[73,74] as examples where rare mutations have been successful in driving a molecular un
derstanding of the disease as opposed to identifying risk factors in the general population.
Rare mutations, particularly when they are Mendelian, carry large effects and are typically
located in genic regions. These characteristics make the resolution of underlying networks
distinctly less complex and, moreover, are amenable to modeling in other systems.
Recent groundbreaking studies by Marchetto et al. (2010) [75] and Muotri et al. (2010) [76],
who created a cell culture model of Rett syndrome, are potentially exciting developments in
this regard. Here, the researchers used skin biopsies from four Rett syndrome patients, each
carrying a different MECP2 mutation, to culture induced pluripotent stem cells (iPS). Once
the iPS cells developed into neurons, they showed a decreased number of neurons and den
dritic spines, consistent with neurodevelopmental disruptions. Intervention with insulinlike growth factor 1 (IGF1), which is known to regulate neurodevelopment, was
subsequently shown to reverse Rett-like symptoms in a mouse model of the disease. This
innovative approach is an exciting model of how rare gene approaches can stimulate our
understanding of the pathophysiology and potential reversibility of ASD.
Syndrome
Number of Studies
Median Rate
Range %
Tuberous sclerosis
11
1.1
03.8
Fragile X
0.0
08.1
Down syndrome
12
0.7
016.7
Neurofibromatosis 1
01.4
Table 1. Associated disorders and their rate in autism (from Volkmar et al., 2005 in Zafeiriou et al. 2007) [70,71]
3.3. Large-scale next-generation sequencing

In April 2012, Nature simultaneously published three papers that used exome sequencing to
probe genomic correlates of ASD. This represented something of a landmark for both ASD
and NGS research, as it demonstrated the viability of NGS on a large scale the three stud
ies combined examined 600 trios (parents and offspring), plus a 935 further ASD cases. Col
285
286
lectively, these papers suggest that several hundred or more genes may be considered
autism candidates, and again highlight the staggering complexity of the phenotype.
ORoak et al. (2012) [77] sequenced 677 individual exomes from 209 families primarily
from the Simons Simplex Collection [78]. In 189 new probands, they validated 120 severely
disruptive de novo mutations, 39% of which occur in a highly interconnected b-catenin/chro
matin remodeling protein network. The group observed a strong paternal bias (41:10) in the
rate of de novo mutations, which supports the hypothesis that the germline mutation rate in
coding regions is markedly more prominent among males. These de novo events were more
common in older fathers, marking paternal age as a significant risk factor for ASD.
Among the identified de novo loci, 62 were identified as top candidate mutations based on
severity and/or supporting evidence from the literature. Interestingly, probands with these
mutations were broadly distributed in terms of IQ score, with only a modest (non-signifi
cant) association with intellectual impairment. Recurrent protein-disruptive mutations were
identified in two genes: netrin G1 (NTNG1) and chromodomain helicase DNA binding pro
tein 8 (CHD8). NTNG1 is known to play a role in axon guidance and dendritic organization
(Nishimura-Akiyoshi et al., 2007) [79]. CHD8 regulates -catenin and p53 signaling, and has
not previously been associated with ASD. This gene was emphasized as particularly note
worthy, after follow-up protein-protein interaction (PPI) analyses, showed that -catenin
and p53 signaling may be features of an ASD-relevant network. In total 49 of proteins in the
PPI network were highly interconnected, with a number of underlying genes also previous
ly associated with neurodevelopment.
Neale et al. (2012) [80] exome-sequenced 175 trios and also focused on de novo mutations. As
per the ORoak study, there was a correlation between paternal age and de novo events for
offspring (P<0.0001), and also for maternal age (P=0.000365). Across the sample set, the
group observed 161 point mutations, of which 101 were missense, 50 silent, and 10 non
sense. Two conserved splice site rare single nucleotide variants and six frameshift inser
tions/deletions (indels) were also observed. Three genes were found to harbor two de novo
mutations: BRCA2 (two missense), FAT1 (two missense) and KCNMA1 (one missense, one
silent).
The group next performed PPI analyses to determine whether interactions between genes
associated with de novo mutations, as well as existing ASD candidates, was of etiological im
portance. This pathway approach, which additionally incorporated data from Sanders et al.
study (below) [81], found that the distribution of functional de novo mutations is not ran
dom. The average distance for non-synonymous variants was significantly larger for con
trols versus cases (3.78 vs. 3.66; P=.033). This suggests that a proportion of these de novo
events contribute to autism. A model whereby de novo variants in up to 20% of cases, confer
a 10- to 20-fold increased risk was supported.
In the third of these Nature papers, Sanders et al. (2012) [81] performed exome sequencing
on 238 families, including 200 quartets (parents, 1 affected and 1 unaffected sibling) from the
Simons Simplex Collection [78]. Comparing de novo non-synonymous single nucleotide var
iants (SNVs) between affected and unaffected siblings, the group observed a significantly

http://dx.doi.org/10.5772/54357
(P=.01) higher proportion among the probands (125 total) versus their unaffected sibling (87
total). From simulations, the authors concluded that two or more de novo nonsense/splicesite mutations should be considered significant. The gene sodium channel, voltage-gated,
type II, subunit gene (SCN2A) was the only such gene with two ASD individuals found
to harbor relevant nonsense mutations. Mutations in SCN2A have been associated with epi
lepsy (Kamiya et al., 2004; Ogiwara et al., 2009) [82, 83] and idiopathic ASD in multiplex fam
ilies (Weiss et al., 2003) [84]. Neither of the probands has a history of seizures.
Combining the exomes from their study with those from ORoak et al. (n for probands =
414), the groups identified two additional genes that each contained two loss-of-function
mutations: the katanin p60 subunit A-like 2 (KATNAL2) and chromodomain helicase DNA
binding protein 8 (CHD8). ORoak et al. also evaluated these three novel candidates using
exome sequencing on 935 cases and 870 controls. Three additional loss-of-function muta
tions each were observed in KATNAL2 and CHD8 in individuals with ASD, while none were
identified in controls.
It is important to note, however, that for de novo events in general, there was no evidence to
support the hypothesis that multiple events in any individual conferred an increased risk of
ASD. As such, the two de novo hit hypothesis is not supported.
In a fourth independent exome sequencing study involving 343 families from the Simons
Simplex Collection Iossifov et al. (2012) [85] also reported a relatively equal distribution of de
novo mutations in cases and controls. Again however, loss-of-function mutationsnonsense,
splice site, and frame shiftswere more common in individuals with ASD (59 versus 28). Of
the 59 likely gene disruptions (LGD) in ASD cases, none occurred more than once, al
though twoNRXN1 and PHF2had been identified in a previous CNV study by the same
group (Gilman et al, 2011) [86]. Intriguingly, the 59-strong LGD shared considerable overlap
with a set of 842 proteins that interact with the fragile X protein, FMRP. In total, 14 of the 59
appeared on the FMRP list (P=.006). Furthermore, 13 of 72 CNV candidates from the groups
previous CNV paper were also on the list (P=.0004), meaning 26 of the combined 129 total
were FMRP-related (P<1x10-13).
The authors subsequently screened for de novo mutations in upstream targets of FMR1. One
was identified a deletion in GRM5 that removes a single amino acid and causes an addi
tional substitution at the same site. GRM5 encodes the glutamate receptor mGluR5 (Bear et
al, 2004) [87] and, as noted below, mGluR5 antagonists are currently in clinical trial (Jacque
mont et al., 2011) [88] having indicated success in mouse models (Dlen et al., 2007) [89]. Fur
ther elucidating the relationship between FMR1/FRMRP and these ASD candidates is clearly
an important next step in maximizing the impact of these findings. These are discussed fur
ther in the section below.
Collectively, all four of these exome sequencing studies converge upon the conclusion that
ASD is highly heterogeneous, with several hundred or more loci potential risk variants. Sim
ulations by the Neale et al. group confirm the statistical implausibility that hundreds of var
iants with high penetrance are possible, and a model where de novo variants in up to 20% of
cases, confer ~10- to 20-fold increased risk is supported. The studies also converge on the
287
288
conclusion that paternal age (and possibly maternal age) is a significant ASD risk factor, but
the frequency and size of de novo mutations per se is not. Evidence for three candidate genes
CHD8, KATNAL2, and SCN2Awould seem quite strong, though further functional stud
ies are needed to help define pathogenesis. Perhaps most exciting is the association between
GRM5 and existing/novel candidates. As we have learned from GWAS, larger sample sets
are clearly needed to fully harness the power of NGS in relation to such a complex pheno
type. While these studies have been important in proposing novel candidates and confirm
ing existing hypotheses of ASD, we await with anticipation results from the sequencing of
all 2,648 families from the Simon Simplex Collection.
4. Toward a treatment?
Ultimately, the primary goal of genome research should be to propose targets for interven
tion. As mentioned above, a number of translational studies have begun to probe the metab
otropic glutamate receptor, mGluR5, as a potential target for fragile X syndrome treatment.
These studies have a theoretical basis in the hypothesis that protein-synthesis-dependent
functions of metabotropic receptors are exaggerated in fragile X syndrome (Bear, Huber &
Warren, 2004) [87]. Thus, the fragile X protein, FMRP, is thought to work in functional oppo
sition to mGluR5 (and mGluR1). Where FMRP is absent, mGluR-dependent protein synthe
sis becomes over-activated, resulting in neurological and behavioral abnormalities.
Dlen et al. (2007) [89] crossed Fmr1 mutant with Grm5 mutant to produce Fmr1 knockouts
who also had a selective reduction in mGluR5 expression. They found that a 50% reduction
in mGluR5 gene dosage rescued a range of deficits in Fmr1 mutants. Relevant measures in
cluded protein synthesis in hippocampus, density of dendritic spines (layer 3 pyramidal
neurons), visual responsiveness, and cognitive performance (inhibitory avoidance a hippo
campus-dependent memory). This provides confirmation that mGluR5 and FMRP are func
tionally oppositional. Moreover, it suggests possible pharmacological avenues by which this
genetic disease may be treated.
A range of translational studies have begun to target this pathway. These include efforts to
inhibit the activity of individual mGluR5 (Jacquemont et al., 2011; Berry-Kravis et al., 2009)
[88,90], and FMRP-regulated proteins (Paribello et al., 2010) [91], NMDA (Wei et al., 2012)
[92], and GSK3 (lithium, Berry-Kravis et al., 2008) [93], which have shown promise in open
label and (in some instances) clinical trials (see Berry-Kravis et al., 2011 for review) [94].
Moreover, these compounds may have clinical application to the broader ASD phenotype.
Silverman et al. (2012) [95] recently reported that the mGluR5 antagonist, GRN-529, de
creased ASD-related symptoms of autism in two different mouse models of the disease (re
petitive grooming/repetitive jumping). In addition to the Iossifov et al. (2012) [85]
sequencing study discussed above, Kelleher et al. (2012) [96] recently showed that idiopathic
autism cases may have higher burden of mGluR5 variants. The group found that in 209 idio
pathic cases, there was significant enrichment for rare functional variants in the mGluR5
pathwaynamely the genes TSC1, TSC2 and SHANK3, and HOMER1relative to controls

http://dx.doi.org/10.5772/54357
(n=300). It is likely that drugs targeting the mGluR5 pathway, if/when approved for fragile X
syndrome, will lead to human clinical trials for ASD. This translational approach which
delineates a direct route from gene discovery, through functional validation to treatment, is
clearly the blueprint by which genome research can have tangible clinical impact.
5. Conclusions
ASD are clearly highly heritable disorders and advances in gene-finding technology in the
past decade have rapidly accelerated gene discovery. As is typically the case, successive de
velopments have made the problem more complex such that there are huge numbers of can
didate genes, most of which remain to be replicated. In spite of this complexity, we can
observe a number of patterns beginning to unfold 1) the relative scarcity of causal common
variants, 2) the growing list of causal rare variants, and 3) the emergence of monogenic dis
orders with primary and secondary ASD phenotypes.
The monogenic autisms are particularly interesting from a treatment perspective, as they
provide a mechanism for studying ASD phenotypes in model systems and are an obvious
target for drug intervention. They are also amenable to clinical testing and the decreasing
cost of research technologies means that this capacity is more widely available to clinicians.
In fact, as the resolution of clinical instruments becomes more sophisticated, it is likely that
the clinic will become a primary workplace for syndromic discovery.
A key requirement in driving gene discovery is the necessity of high-quality phenotype da
ta. ASDs are notoriously heterogeneous, and are fractionated in terms of symptoms and tra
jectory. Mandy & Skuse (2008) [97] reviewed seven factor analysis studies of ASD
symptoms, and found that all but one dissociated social and non-social factors. In a nonclinical sample of 3,000 twin pairs, Happ et al. (2006) [98] examined autistic-like traits and
found consistently low correlations (r = 0.1-0.4) between each of the core deficits on the au
tism spectrum. Endophenotypes, sub-components or sub-processes of the broader pheno
type, may provide a productive avenue to disentangling some of this complexity. By
filtering out all but a few discrete measures, we can theoretically increase the signal-to-noise
ratio in genotype-phenotype associations. A number of endophenotypes for ASD have been
associated with disease genes, including head circumference (associated with the HOXA1
A218G polymorphism, Conciatori et al., 2004) [99]; age at first word (associated with a quan
titative trait locus on 7q35, Alarcn et al. 2005) [100]; delayed magnetoencephalography
evoked responses to auditory stimuli (Roberts et al., 2010) [101]; and enhanced perception
(Mottron et al., 2006) [102]. The endophenotype approach is arguably more consistent with
rare-/mono-genic discovery, where a mutated network may not yield a diagnosis of autism
per se, but nevertheless cause associated abnormalities. Note, this approach does not dimin
ish the pleiotropic effects of genes involved in neurodevelopment, and only serves to make
the point that the relevant genotype may associate with some but not all ASD features.
The converse, of course, is also true, as a large number of candidate genes contribute to the
majority of known ASD. With ~80% of genes expressed in the brain it is likely that this num
289
290
ber will continue to grow, and here again careful phenotyping is critical to identifying func
tional consequences. Ultimately, the primary goal is not to determine the frequency of
variation/mutation in cases versus controls, but to determine the pathway(s) and gene net
works that lead to pathology. We will also need to identify other major biological players
such as epigenetic factors, RNA regulatory elements, and environmental exposures, which
are critical components of the ASD equation. While daunting, the elucidation of these ele
ments will doubtlessly take us closer to developing effective treatments for ASD. Given the
current rate of progress, we have cause for cautious optimism in this regard.
Author details
John J. Connolly1 and Hakon Hakonarson1,2
1 Center for Applied Genomics, The Childrens Hospital of Philadelphia, Philadelphia, USA
2 Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia,
USA
References
[1] Wing L, Gould J, Gillberg C. Autism spectrum disorders in the DSM-V: better or
worse than the DSM-IV? Res Dev Disabil. 2011 Mar-Apr;32(2):768-73.
[2] Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised
version of a diagnostic interview for caregivers of individuals with possible perva
sive developmental disorders. J Autism Dev Disord. 1994 Oct;24(5):659-85.
[3] Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, et al. Autism di
agnostic observation schedule: a standardized observation of communicative and so
cial behavior. J Autism Dev Disord. 1989 Jun;19(2):185-212.
[4] Constantino JN, Davis SA, Todd RD, Schindler MK, Gross MM, Brophy SL, et al. Val
idation of a brief quantitative measure of autistic traits: comparison of the social re
sponsiveness scale with the autism diagnostic interview-revised. J Autism Dev
Disord. 2003 Aug;33(4):427-33.
[5] Levy SE, Mandell DS, Schultz RT. Autism. Lancet. 2009 Nov 7;374(9701):1627-38.
[6] Dawson M, Soulieres I, Gernsbacher MA, Mottron L. The level and nature of autistic
intelligence. Psychol Sci. 2007 Aug;18(8):657-62.
[7] Bolte S, Dziobek I, Poustka F. Brief report: The level and nature of autistic intelli
gence revisited. J Autism Dev Disord. 2009 Apr;39(4):678-82.
[8] Skuse DH. Rethinking the nature of genetic vulnerability to autistic spectrum disor
ders. Trends Genet. 2007 Aug;23(8):387-95.

http://dx.doi.org/10.5772/54357
[9] Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as

a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995
Jan;25(1):63-77.
[10] Piven J, Palmer P, Jacobi D, Childress D, Arndt S. Broader autism phenotype: evi
dence from a family history study of multiple-incidence autism families. Am J Psy
chiatry. 1997 Feb;154(2):185-90.
[11] Lauritsen MB, Pedersen CB, Mortensen PB. Effects of familial risk factors and place
of birth on the risk of autism: a nationwide register-based study. J Child Psychol Psy
chiatry. 2005 Sep;46(9):963-71.
[12] Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009
Jun;65(6):591-8.
[13] O'Roak BJ, State MW. Autism genetics: strategies, challenges, and opportunities. Au
tism Res. 2008 Feb;1(1):4-17.
[14] Richards RI, Holman K, Kozman H, Kremer E, Lynch M, Pritchard M, et al. Fragile X
syndrome: genetic localisation by linkage mapping of two microsatellite repeats
FRAXAC1 and FRAXAC2 which immediately flank the fragile site. J Med Genet.
1991 Dec;28(12):818-23.
[15] Rogers SJ, Wehner DE, Hagerman R. The behavioral phenotype in fragile X: symp
toms of autism in very young children with fragile X syndrome, idiopathic autism,
and other developmental disorders. J Dev Behav Pediatr. 2001 Dec;22(6):409-17.
[16] Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I, et al. Autism
profiles of males with fragile X syndrome. Am J Ment Retard. 2008 Nov;113(6):
427-38.
[17] Curtis AR, Headland S, Lindsay S, Thomas NS, Boye E, Kamakari S, et al. X chromo
some linkage studies in familial Rett syndrome. Hum Genet. 1993 Jan;90(5):551-5.
[18] Ramocki MB, Zoghbi HY. Failure of neuronal homeostasis results in common neuro
psychiatric phenotypes. Nature. 2008 Oct 16;455(7215):912-8.
[19] Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor
H polymorphism in age-related macular degeneration. Science. 2005 Apr
15;308(5720):385-9.
[20] Risch N, Merikangas K. The future of genetic studies of complex human diseases.
Science. 1996 Sep 13;273(5281):1516-7.
[21] Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, et al. Common genet
ic variants on 5p14.1 associate with autism spectrum disorders. Nature. 2009 May
28;459(7246):528-33.
[22] Ma D, Salyakina D, Jaworski JM, Konidari I, Whitehead PL, Andersen AN, et al. A
genome-wide association study of autism reveals a common novel risk locus at
5p14.1. Ann Hum Genet. 2009 May;73(Pt 3):263-73.
[23] St Pourcain B, Wang K, Glessner JT, Golding J, Steer C, Ring SM, et al. Association
between a high-risk autism locus on 5p14 and social communication spectrum phe
notypes in the general population. Am J Psychiatry. 2010 Nov;167(11):1364-72.
291
292
[24] Redies C, Hertel N, Hubner CA. Cadherins and neuropsychiatric disorders. Brain
Res. 2012 Aug 27;1470:130-44.
[25] Gepner B, Feron F. Autism: a world changing too fast for a mis-wired brain? Neuro
sci Biobehav Rev. 2009 Sep;33(8):1227-42.
[26] Kerin T, Ramanathan A, Rivas K, Grepo N, Coetzee GA, Campbell DB. A noncoding
RNA antisense to moesin at 5p14.1 in autism. Sci Transl Med. 2012 Apr 4;4(128):
128ra40.
[27] McClellan J, King MC. Genetic heterogeneity in human disease. Cell. 2010 Apr
16;141(2):210-7.
[28] Li Q, Yu K. Improved correction for population stratification in genome-wide associ
ation studies by identifying hidden population structures. Genet Epidemiol. 2008
Apr;32(3):215-26.
[29] Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat
Rev Genet. 2011 Feb;12(2):87-98.
[30] Alarcon M, Cantor RM, Liu J, Gilliam TC, Geschwind DH. Evidence for a language
quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum
Genet. 2002 Jan;70(1):60-71.
[31] Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM, et al. Link
age, association, and gene-expression analyses identify CNTNAP2 as an autism-sus
ceptibility gene. Am J Hum Genet. 2008 Jan;82(1):150-9.
[32] Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M, et al. A common
genetic variant in the neurexin superfamily member CNTNAP2 increases familial
risk of autism. Am J Hum Genet. 2008 Jan;82(1):160-4.
[33] Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, Groszer M, et al. A
functional genetic link between distinct developmental language disorders. N Engl J
Med. 2008 Nov 27;359(22):2337-45.
[34] Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. A forkhead-domain
gene is mutated in a severe speech and language disorder. Nature. 2001 Oct
4;413(6855):519-23.
[35] Cheng Y, Sudarov A, Szulc KU, Sgaier SK, Stephen D, Turnbull DH, et al. The En
grailed homeobox genes determine the different foliation patterns in the vermis and
hemispheres of the mammalian cerebellum. Development. 2010 Feb;137(3):519-29.
[36] Benayed R, Choi J, Matteson PG, Gharani N, Kamdar S, Brzustowicz LM, et al. Au
tism-associated haplotype affects the regulation of the homeobox gene, ENGRAILED
2. Biol Psychiatry. 2009 Nov 15;66(10):911-7.
[37] Benayed R, Gharani N, Rossman I, Mancuso V, Lazar G, Kamdar S, et al. Support for
the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disor
der susceptibility locus. Am J Hum Genet. 2005 Nov;77(5):851-68.
[38] Wang L, Jia M, Yue W, Tang F, Qu M, Ruan Y, et al. Association of the ENGRAILED
2 (EN2) gene with autism in Chinese Han population. Am J Med Genet B Neuropsy
chiatr Genet. 2008 Jun 5;147B(4):434-8.

http://dx.doi.org/10.5772/54357
[39] Zhong H, Serajee FJ, Nabi R, Huq AH. No association between the EN2 gene and au
tistic disorder. J Med Genet. 2003 Jan;40(1):e4.
[40] Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, et al. A genetic
variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci
U S A. 2006 Nov 7;103(45):16834-9.
[41] Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P. Genetic evidence implicating
multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum dis
order. Autism Res. 2008 Jun;1(3):159-68.
[42] Sousa I, Clark TG, Toma C, Kobayashi K, Choma M, Holt R, et al. MET and autism
susceptibility: family and case-control studies. Eur J Hum Genet. 2009 Jun;17(6):
749-58.
[43] A genomewide screen for autism: strong evidence for linkage to chromosomes 2q,
7q, and 16p. Am J Hum Genet. 2001 Sep;69(3):570-81.
[44] Eagleson KL, Campbell DB, Thompson BL, Bergman MY, Levitt P. The autism risk
genes MET and PLAUR differentially impact cortical development. Autism Res. 2011
Feb;4(1):68-83.
[45] Glessner JT, Hakonarson H. Common variants in polygenic schizophrenia. Genome
Biol. 2009;10(9):236.
[46] Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, et al. Col
laborative genome-wide association analysis supports a role for ANK3 and CAC
NA1C in bipolar disorder. Nat Genet. 2008 Sep;40(9):1056-8.
[47] Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D, et al. A com
mon variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and
predicts effectiveness of stimulant medication. Mol Psychiatry. 2010 Nov;15(11):
1053-66.
[48] Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB. Rare variants create
synthetic genome-wide associations. PLoS Biol. 2010 Jan;8(1):e1000294.
[49] Wang K, Dickson SP, Stolle CA, Krantz ID, Goldstein DB, Hakonarson H. Interpreta
tion of association signals and identification of causal variants from genome-wide as
sociation studies. Am J Hum Genet. 2010 May 14;86(5):730-42.
[50] Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional im
pact of global rare copy number variation in autism spectrum disorders. Nature.
2010 Jul 15;466(7304):368-72.
[51] Williams NM, Zaharieva I, Martin A, Langley K, Mantripragada K, Fossdal R, et al.
Rare chromosomal deletions and duplications in attention-deficit hyperactivity dis
order: a genome-wide analysis. Lancet. 2010 Oct 23;376(9750):1401-8.
[52] Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, et al. Autism genomewide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009 May
28;459(7246):569-73.
[53] Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, et al. Copy Number Variants
in Schizophrenia: Confirmation of Five Previous Findings and New Evidence for
293
294
3q29 Microdeletions and VIPR2 Duplications. Am J Psychiatry. 2011 Mar;168(3):

302-16.
[54] Chen X, Li X, Wang P, Liu Y, Zhang Z, Zhao G, et al. Novel association strategy with
copy number variation for identifying new risk Loci of human diseases. PLoS One.
2010;5(8):e12185.
ation of de novo copy number mutations with autism. Science. 2007 Apr
20;316(5823):445-9.
[56] Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, Sonnenblick LI, et al. Ge
nome-wide analyses of exonic copy number variants in a family-based study point to
novel autism susceptibility genes. PLoS Genet. 2009 Jun;5(6):e1000536.
[57] Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, et
al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared
biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psy
chiatry. 2009 Sep;66(9):947-56.
[58] Samaco RC, Hogart A, LaSalle JM. Epigenetic overlap in autism-spectrum neurode
velopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and
GABRB3. Hum Mol Genet. 2005 Feb 15;14(4):483-92.
[59] Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y, et al. Disruption
of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet. 2008 Jan;
82(1):199-207.
[60] Yi JJ, Ehlers MD. Ubiquitin and protein turnover in synapse function. Neuron. 2005
Sep 1;47(5):629-32.
[61] Gai X, Xie HM, Perin JC, Takahashi N, Murphy K, Wenocur AS, et al. Rare structural
variation of synapse and neurotransmission genes in autism. Mol Psychiatry. 2011
Mar 1.
[62] Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, Hou C, et al. Strong synap
tic transmission impact by copy number variations in schizophrenia. Proc Natl Acad
Sci U S A. 2010 Jun 8;107(23):10584-9.
brain. Behav Brain Sci. 2008 Jun;31(3):241-61; discussion 61-320.
[64] Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics. 2004 May;
113(5):e472-86.
[65] Danielsson S, Gillberg IC, Billstedt E, Gillberg C, Olsson I. Epilepsy in young adults
with autism: a prospective population-based follow-up study of 120 individuals di
agnosed in childhood. Epilepsia. 2005 Jun;46(6):918-23.
[66] Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad
Sci. 1991;615:125-7.
[67] Franz DN. Diagnosis and management of tuberous sclerosis complex. Semin Pediatr
Neurol. 1998 Dec;5(4):253-68.

http://dx.doi.org/10.5772/54357
[68] Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, Hill RS, et al. Identifying autism
loci and genes by tracing recent shared ancestry. Science. 2008 Jul 11;321(5886):
218-23.
[69] Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, et al. The HMGCoA reductase inhibitor lovastatin reverses the learning and attention deficits in a
mouse model of neurofibromatosis type 1. Curr Biol. 2005 Nov 8;15(21):1961-7.
[70] Zafeiriou DI, Ververi A, Vargiami E. Childhood autism and associated comorbidities.
Brain Dev. 2007 Jun;29(5):257-72.
[71] Volkmar FR. Handbook of Autism and Pervasive Developmental Disorders. 3 ed.
New Jersey: John Wiley & Sons; 2005.
[72] El-Fishawy P, State MW. The genetics of autism: key issues, recent findings, and clin
ical implications. Psychiatr Clin North Am. 2010 Mar;33(1):83-105.
[73] Brown MS, Goldstein JL. Expression of the familial hypercholesterolemia gene in het
erozygotes: mechanism for a dominant disorder in man. Science. 1974 Jul 5;185(4145):
61-3.
[74] Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension.
Cell. 2001 Feb 23;104(4):545-56.
[75] Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y, et al. A model for neural
development and treatment of Rett syndrome using human induced pluripotent
stem cells. Cell. 2010 Nov 12;143(4):527-39.
[76] Muotri AR, Marchetto MC, Coufal NG, Oefner R, Yeo G, Nakashima K, et al. L1 ret
rotransposition in neurons is modulated by MeCP2. Nature. 2010 Nov 18;468(7322):
443-6.
[77] O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic autism
exomes reveal a highly interconnected protein network of de novo mutations. Na
ture. 2012 Apr 4.
[78] Fischbach GD, Lord C. The Simons Simplex Collection: a resource for identification
of autism genetic risk factors. Neuron. 2010 Oct 21;68(2):192-5.
[79] Nishimura-Akiyoshi S, Niimi K, Nakashiba T, Itohara S. Axonal netrin-Gs trans
neuronally determine lamina-specific subdendritic segments. Proc Natl Acad Sci U S
A. 2007 Sep 11;104(37):14801-6.
exonic de novo mutations in autism spectrum disorders. Nature. 2012 Apr 4.
[81] Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. De
novo mutations revealed by whole-exome sequencing are strongly associated with
autism. Nature. 2012 Apr 4.
[82] Kamiya K, Kaneda M, Sugawara T, Mazaki E, Okamura N, Montal M, et al. A non
sense mutation of the sodium channel gene SCN2A in a patient with intractable epi
lepsy and mental decline. J Neurosci. 2004 Mar 17;24(11):2690-8.
295
296
[83] Ogiwara I, Ito K, Sawaishi Y, Osaka H, Mazaki E, Inoue I, et al. De novo mutations of
voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurol
ogy. 2009 Sep 29;73(13):1046-53.
[84] Weiss LA, Escayg A, Kearney JA, Trudeau M, MacDonald BT, Mori M, et al. Sodium
channels SCN1A, SCN2A and SCN3A in familial autism. Mol Psychiatry. 2003 Feb;
8(2):186-94.
[85] Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, et al. De novo gene
disruptions in children on the autistic spectrum. Neuron. 2012 Apr 26;74(2):285-99.
[86] Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D. Rare de novo var
iants associated with autism implicate a large functional network of genes involved
in formation and function of synapses. Neuron. 2011 Jun 9;70(5):898-907.
[87] Bear MF, Huber KM, Warren ST. The mGluR theory of fragile X mental retardation.
Trends Neurosci. 2004 Jul;27(7):370-7.
[88] Jacquemont S, Curie A, des Portes V, Torrioli MG, Berry-Kravis E, Hagerman RJ, et
al. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated
with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med. 2011
Jan 5;3(64):64ra1.
[89] Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, et al. Correction
of fragile X syndrome in mice. Neuron. 2007 Dec 20;56(6):955-62.
[90] Berry-Kravis E, Hessl D, Coffey S, Hervey C, Schneider A, Yuhas J, et al. A pilot open
label, single dose trial of fenobam in adults with fragile X syndrome. J Med Genet.
2009 Apr;46(4):266-71.
[91] Paribello C, Tao L, Folino A, Berry-Kravis E, Tranfaglia M, Ethell IM, et al. Open-la
bel add-on treatment trial of minocycline in fragile X syndrome. BMC Neurol.
2010;10:91.
[92] Wei H, Dobkin C, Sheikh AM, Malik M, Brown WT, Li X. The therapeutic effect of
memantine through the stimulation of synapse formation and dendritic spine matu
ration in autism and fragile X syndrome. PLoS One. 2012;7(5):e36981.
[93] Berry-Kravis E, Sumis A, Hervey C, Nelson M, Porges SW, Weng N, et al. Open-label
treatment trial of lithium to target the underlying defect in fragile X syndrome. J Dev
Behav Pediatr. 2008 Aug;29(4):293-302.
[94] Berry-Kravis E, Knox A, Hervey C. Targeted treatments for fragile X syndrome. J
Neurodev Disord. 2011 Sep;3(3):193-210.
[95] Silverman JL, Smith DG, Rizzo SJ, Karras MN, Turner SM, Tolu SS, et al. Negative
allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and res
cues social deficits in mouse models of autism. Sci Transl Med. 2012 Apr 25;4(131):
131ra51.
[96] Kelleher RJ, 3rd, Geigenmuller U, Hovhannisyan H, Trautman E, Pinard R, Rathmell
B, et al. High-throughput sequencing of mGluR signaling pathway genes reveals en
richment of rare variants in autism. PLoS One. 2012;7(4):e35003.

http://dx.doi.org/10.5772/54357
[97] Mandy WP, Skuse DH. Research review: What is the association between the socialcommunication element of autism and repetitive interests, behaviours and activities?
J Child Psychol Psychiatry. 2008 Aug;49(8):795-808.
[98] Happe F, Ronald A, Plomin R. Time to give up on a single explanation for autism.
Nat Neurosci. 2006 Oct;9(10):1218-20.
[99] Conciatori M, Stodgell CJ, Hyman SL, O'Bara M, Militerni R, Bravaccio C, et al. Asso
ciation between the HOXA1 A218G polymorphism and increased head circumfer
ence in patients with autism. Biol Psychiatry. 2004 Feb 15;55(4):413-9.
[100] Alarcon M, Yonan AL, Gilliam TC, Cantor RM, Geschwind DH. Quantitative ge
nome scan and Ordered-Subsets Analysis of autism endophenotypes support lan
guage QTLs. Mol Psychiatry. 2005 Aug;10(8):747-57.
[101] Roberts TP, Khan SY, Rey M, Monroe JF, Cannon K, Blaskey L, et al. MEG detection
of delayed auditory evoked responses in autism spectrum disorders: towards an
imaging biomarker for autism. Autism Res. 2010 Feb;3(1):8-18.
[102] Mottron L, Dawson M, Soulieres I, Hubert B, Burack J. Enhanced perceptual func
tioning in autism: an update, and eight principles of autistic perception. J Autism
Dev Disord. 2006 Jan;36(1):27-43.
297
Chapter 14
The Genetic Architecture of Autism and Related

Conditions
Michael Gill, Graham Kenny and Richard Anney
http://dx.doi.org/10.5772/54854
1. Introduction
Autism is a behaviourally defined developmental disorder characterised by impairments in
social communication, restricted interests and repetitive behaviours [1]. Abnormalities in these
three developmental areas tend to cluster together in affected individuals. In DSM-IV, Autism
is part of a larger continuum of disorders collectively called Pervasive Developmental Disor
ders. Autism spectrum disorders (ASD) refer to Autism, Pervasive developmental disorder,
not otherwise specified, and Asperger syndrome. All individuals with ASDs have qualitative
abnormalities of social development in combination with disorders of communication and/or
stereotyped repetitive interests and behaviors. The social skills that develop naturally in typ
ically-developing children do not do so in children with ASD. In addition, there are several
behaviors and co-morbid symptoms that relate to each of the three classical impairments. Re
cent studies have reported rates of co-occurring intellectual disability in the range of 25-50%.
Neither developmental delay nor cognitive impairment are required for an ASD diagnosis.
Fombonne and colleagues recently estimated the prevalence of strictlydefined autism at ap
proximately 15-20 per 10,000 people [2]. When the definition of autism is relaxed to include
Autism Spectrum Disorders, the prevalence estimated expands to approximately 60 in in
10,000 children [2, 3].
Little is known of the biological basis of ASD and the future development of rational knowl
edge based treatments will depend on a comprehensive understanding of innate biological
predisposition and its interaction with environmental factors. The identification and charac
terisation of the genetic variation and genes involved in ASD is a route towards this goal. This
chapter outlines the various approaches that have been applied to this task, in the context of
rapidly evolving technology and human genome resources, and summarises the state of
2013 Gill et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
300
knowledge at this time, anticipating future developments, and outlining the implications for
clinical management.
2. Autism is a heritable disorder

There is unequivocal evidence to support the role of genetic liability as the basis of familiality
in the aetiology of ASD. In their seminal work, Folstein and Rutter [4] observed that 4 of 11
(36%) pairs of identical twins were concordant for strictly defined autism whilst none of 10
pairs of fraternal twins were concordant. In a large follow-up study, which included these
original twins, Bailey and colleagues observed a more striking concordance rate in identical
twins (60%) with no concordance in the fraternal twins [5]. This highly cited study underlined
ASD as the most heritable of the neurodevelopmental and psychiatric disorders with herita
bility estimates of 91 - 93%. A recent review of over 30 twin studies of ASD [6] noted that the
early twin studies, which relied upon a strict diagnosis of autism, show a median identical and
fraternal concordance of 76% and 0% respectively. The expansion of these and other studies
to include a broader definition of ASD revealed a median concordance rate of 88% and 31%.
In both cases, these data reveal that ASD is underpinned by a strong genetic component. More
recently, Hallmayer and colleagues [7] using more stringent clinical diagnostic tools, such as
the Autism Diagnostic Interview (ADI; [8]) and the Autism Diagnostic Observation Schedule
(ADOS; [9]) in a group of 202 twin pairs from the California Twin Registry, identified similar
concordance rate of ASD as previously attained; with identical twin boys showing a concord
ance rate of 77% and fraternal twin boys 31%.
3. Genetic linkage and association

The heritability estimates above calculated from twin studies imply that there is unknown
genetic variation in children with ASD that confers risk. Several models may fit the observed
family and twin data including, at the extremes, a common disorder-common-variant model,
with many DNA variants of small effect combining together to create risk; and a multiple rare
variant model where ASD is in reality a large collection of different and individually rare
disorders. The true picture is only slowly emerging, and as with many other common disor
ders, common low penetrant and rare higher penetrant DNA variants combine to jointly con
tribute to risk. Molecular genetic methods have developed exponentially over the last few
decades with ever increasing knowledge of the structure and function of the human genome.
For disorders with largely unknown aetiology, such as ASD, using human genetic studies to
identify risk genes is a gateway to an understanding of underlying biology. Such studies may
focus on individuals or families each using different but related genetic strategies to track
down risk or causative genetic variation. These methods include genetic linkage, genetic as
sociation, and direct examination of structural and copy number variation.
The basis of genetic linkage is the physical co-location of genes or other DNA variation. Such
DNA variation is more likely to be transmitted together (or linked) than those that are further
The Genetic Architecture of Autism and Related Conditions

http://dx.doi.org/10.5772/54854
apart. Linkage studies take advantage of this non-random assortment of genetic variation. A
linkage study calculates whether a known genetic variant and a disease mutation (represented
by the disease trait) are linked and if so, roughly localises the causative mutation. Following
the successes of using these approaches in the discovery of multiple loci implicate in Mendelian
disorders, researchers were encouraged to apply linkage methodology to more complex traits,
such as ASD where Mendelian principles may apply, at least in a proportion of families. How
ever, in ASD, only a few scans have highlighted loci with significant linkage, highlighting loci
including chromosome 7q, 2q and 3q.
In 1998, the International Molecular Genetic Study of Autism Consortium (IMGSAC) [10] re
ported modest evidence for linkage. This included significant linkage arising on chromosome
7q32-q34. Supplemented analyses of IMGSAC families provided additional support for link
age at 7q22, 16p13, and 2q31 [11, 12]. The long arm of chromosome 7 has received particular
attention with additional support reported for 7q21 [13], 7q22 [14], 7q31 [15, 16], 7q32 [17] and
7q36 [16].
Few individual families exist where ASD segregates in an obvious Mendelian fashion that is
large enough to provide significant evidence for linkage by themselves. Most linkage studies
required the assumption that a significant proportion of the families in the sample might be
linked to a given locus and few were sufficiently large to accommodate even modest locus
heterogeneity. Under a common disorder - common variant model, multiply affected families
will occur but linkage methods would be considerably underpowered. The effects of DNA
variation with low penetrance are more easily identified using a genetic association study
design in a sample of cases drawn from a population.
Fine-mapping and candidate gene association studies at implicated regions on 7q have impli
cated a number of potential susceptibility genes including RELN, MET, CNTNAP2 and EN2.
Persico and colleagues [18] studied five DNA variants or polymorphisms across the RELN
gene locus, including a GGC repeat variant located close to the RELN gene translation initiator
codon. Located at 7q22, RELN encodes an extracellular matrix protein Reelin, which plays a
pivotal role in the development of laminar structures including cerebral cortex, cerebellum
and hippocampus. Using a genetic association approach, Persico and colleagues identified a
nominally significant association with this 5-UTR GCC-triplet-repeat polymorphism [18].
This finding was further supported by some studies [19-25] but not others [26-31]. MET, located
at 7q31 received considerable attention following a high-profile association reported by Camp
bell and colleagues. The MET gene encodes a protein involved in MET (Mesenchymal epithelial
transition factor) receptor tyrosine kinase signalling which has been implicated in brain growth
and maturation offering biological plausibility to its candidature. As with other candidate
genes in ASD, the original findings have been supported in some [32], but not other studies
[33] [34]. A similar scenario played out for the EN2 homeobox gene located at 7q36 [35, 36].
Arking and colleagues [37] observed an association at CNTNAP2 in the NIHM/AGRE collec
tion. The main association observed was for rs7794745 located in intron 2 of the gene (Discovery
P = 0.00002, Validation P = 0.005). The CNTNAP2 (7q35) gene encodes the contactin-associated
protein-like 2 protein, which is a member of the neurexin family and thought to play a role in
axonal differentiation and guidance. Li and colleagues also found mild support for CNTNAP2
301
302
where they observed a weak association with a haplotype containing the SNP rs7794745 [38].
More recently, a large GWAS of 2705 families identified a strong association for the SNP
rs1718101 in the CNTNAP2 gene with a subset of individuals without intellectual disability
and of European ancestry (P = 7.78 x 10-9) [39].
The Paris Autism Research International Sibpair (PARIS) study [15], that supported the find
ings on 7q, noted additional loci at 2q31-q32, 16p13 and 19p13, that overlapped to some extent
with regions identified in the IMGSAC analyses. Fine mapping of the 2q31-q32 led to addi
tional evidence implicating the genes SLC25A12, STK39 and ITGA4 as putative risk genes for
ASD. As with most candidate genes examined in small samples, these associations were vali
dated by some [40-42] but not all studies [43-46]. The positional candidature of the 2q31-q32
was further supported by a case study of a young Irish male with high-functioning autism
with a complex translocation traversing chromosome 2q32 (46,XY,t(9;2)(q31.1;q32.2q31.3))
[47]. Fine mapping and mutation analysis identified an association with a polymorphism
within the splice donor sequence of exon 16 of the ITGA4 gene and ASD (rs12690517; P = 0.008)
[48].
In a study of Finnish families, Auranen and colleagues [49, 50], who included individuals with
autism, infantile autism, Asperger syndrome (AS) and developmental dysphasia reported a
significant linkage to 3q25-q27. This was supported by suggestive evidence at 3q25-q27 in a study
of AS also in the Finnish population [51] as well as linkage at 3q25-q27 in a single large extended
Utah pedigree of Northern European ancestry [52].
Interestingly, the advent of large collaborative studies by the Autism Genome Research
Exchange (AGRE), the Autism Genome Project (AGP) and the National Institute of Men
tal Health (NIMH) has not yielded stronger evidence in favour of specific loci. Liu and
colleagues using data from 110 multiplex families from the AGRE collection [16] ob
served only suggestive linkage on chromosomes 5p13, Xq26-qtel, and 19q12 alongside
modest support for previously reported linkage on 7q (7q31 and 7q36) and 16p13. A fol
low-up analysis including 235 additional AGRE multiplex families was again limited to
only suggestive loci at chromosomes 17q11, 5p13, 11p11-p13, 4q21-q22 and 8q24 [53]. In a
much larger collection of 1168 multiply-affected families from the AGP (including fami
lies previously included in the AGRE, CPEA, IMGSAC, PARIS and Seaver linkage stud
ies), Szatmari and colleagues identified suggestive linkage to chromosome 11p12-p13 and
a large region on chromosome 15q23-q25 [14]. Of the regions that were featured promi
nently in previous linkage analyses, there was only modest support for previously high
lighted linkage regions on chromosome 2q31 (female autism-probands) and 7q22 (male
ASD-probands) from families of European ancestry [14]. A similarly large linkage study
of 1031 families, including 1553 affected offspring, Weiss and colleagues identified sug
gestive linkage at 6p27 and significant linkage at 20p13 [54].
Early association studies examined whether specific variation in genes was associated with
the disease and focused on candidate loci identified from linkage and cytogenetic studies (po
sitional candidate genes) as well as in genes within biological processes that we perceived as
having a role in ASD. In the mid-1990s Risch and Merikangas [55] demonstrated that where
genetic variants have only small effect on risk the association study is a more powerful ap

http://dx.doi.org/10.5772/54854
proach than linkage to identify genetic risk. However, the transition from candidate gene to
genome-wide association studies was not realised until technological advances firstly enriched
the maps of common variation across the genome and secondly enabled the interrogation of
these variants en masse as part of genome-wide SNP arrays.
Wang and colleagues [56] performed one of the first GWAS on individuals in European an
cestry individuals from the AGRE collection, the Autism Case Control Collection and unaf
fected controls from the Childrens Hospital of Philadelphia control collection. Neither familybased nor case-control analysis alone yielded genome-wide significant findings. However, in
a combined analyses the authors identified genome-wide significant association on chromo
some 5p14.1 (rs4307059; P =3.4 x 10-8) and a number of additional association signals on chro
mosome 13q33.3, 14q21.1 and Xp22.32. The 5p14.1 association was validated in the
Collaborative Autism Project (CAP) and Centre for Autism Research and Treatment (CART)
study. The authors found a modest to strong replication of the association signal on chromo
some 5p14.1. In a reciprocal study with the CAP and CART study as the discovery sample
followed by validation using the AGRE dataset was published in parallel by Ma and colleagues
[57]. The authors examined approximately 500k SNPs, more than in the Wang report and albeit
not genome-wide significant, they retained the association signal on chromosome 5p14.1.
A second independent GWAS was reported by Weiss and colleagues [54]. In the initial scan
the authors did not find any GW-significant associations. However, as with the previous
GWAS, additional supplementation of their family-based studies with a case-control set de
rived from 90 probands without parental data garnered some additional signal for the top hits.
A replication consortium of greater than 2000 trios was genotyped for 45 SNPs across all of
the top associated regions. The only marker that showed evidence of replication resides on the
short arm of chromosome 5 at 5p15. Although, like Ma and colleagues, this report has consid
erable overlap with the AGRE families reported by Wang and colleagues, the authors did not
observe strong association at 5p14.1. The chromosome 5p association lies in close proximity
to TAS2R1. The TAS2R1 gene encodes a G-protein coupled receptor that is involved in bitter
taste recognition. The authors highlight a more biologically plausible ASD candidate gene
approximately 80 Kb telomeric, SEMA5A. SEMA5A encodes a gene important in axonal guid
ance and has been shown to be down regulated in the occipital lobe cortex, lymphoblast cell
lines and lymphocytes from individuals with autism.
Two additional GWAS followed by the Autism Genome Project (AGP) [39, 58]. In the first
report of 1369 families, Anney and colleagues identified a single GW-significant finding on
chromosome 20 at position 20p12 within the MACROD2 (MACRO-domain containing 2) gene
locus (rs4141463; P = 2.1 x 10-8; OR = 0.56). Weak statistical support was observed for MAC
ROD2 in an AGRE validation sample, albeit showing the same direction of effect for the risk
allele. In a follow-up study using an additional 1301 families the authors showed little if any
signal of association (rs4141463; P = 0.206, OR=0.91). In a combined analyses the association at
MACROD2 was less compelling (rs4141463; P = 1.2 x 10-6; OR=0.77). The role of MACROD2 is
largely unknown although structural variation in this gene and specifically the region har
bouring the ASD association signal have been implicated in schizophrenia [59, 60] and epilepsy
[61]. However, this same region has been identified as a hotspot for deletions in the genome
303
304
identified as a region of large rare deletions [62]. MACROD-like proteins are highly conserved
across evolutionary time, which may indicate an essential role. The MACRO-domain is an
ADP-ribose binding module [63] and has been implicated in the ADP-ribosylation of proteins,
an important post-translational modification that occurs in a variety of biological processes
such as DNA repair [64], heterochromatin formation, histone modification and sirtuin biology
[65-67] as well as long-term memory formation [68]. The association signal observed at
rs4141463, albeit tagged to the MACROD2 gene, resides in an intronic region near an intragenic
non-protein-coding-RNA, NCRNA00186 (MACROD2-AS1). Two MACROD2-AS1 transcripts
have been reported of 673bp and 1230bp in length, located on the reverse strand between exon
5 and 6 of MACROD2. Anti-sense RNAs typically interact with mRNA, resulting in transcrip
tional or post-transcriptional effects and have been linked to brain development and plasticity
[69]. However, unlike MSNP1AS described for the 5p14.1 association observed by Wang and
colleagues, a function for this non-coding RNA has not yet been reported.
The strongest association signal observed by the AGP combined analyses was rs1718101 (P =
7.8 x 10-9; OR=2.13 (1.63-2.80)), a SNP within the CNTNAP2 gene which was previously impli
cated in ASD through linkage analyses. This association was observed in a secondary analysis
which was restricted to ASD individuals of European ancestry with a higher IQ. Anney and
colleagues suggest that with the current data few if any common variants have an impact on
risk exceeding (an effect size of) 1.2 (or below its inverse). In an attempt to seek evidence for
or against common variants having an impact on risk, the authors constructed an allele-score.
The allele-score method, as previously described by Purcell and colleagues [70], calculates a
score for each individual based on number of risk associated alleles that the individual pos
sesses. This score is then used to either calculate the predictive value of the score between cases
and controls or estimate the amount of variance that this score predicts for the disease. Allelescores derived from the transmission of common alleles from the families described in the AGP
stage 1 GWAS [58] could significantly predict case-status in the independent Stage 2 sample.
The authors concluded however that despite the limited findings for individual loci from
GWAS studies to date, en masse the top results exert a detectable impact suggesting that as the
sample sizes increase, additional significant loci will emerge. Putting together samples of the
size seen in successful GWAS studies in other disorders (n>20,000) is challenging for a disorder
with a complex phenotype such as ASD.
4. Structural variation: Chromosomal abnormalities in autism

Autism has been frequently associated with chromosome abnormalities, such as deletions,
duplications, inversions, or translocations; with abnormalities on the long arm of Chromosome
15 and with numerical and structural abnormalities of the sex chromosomes. Reddy in a survey
of chromosomal abnormality in autism found one in 14 of 421 individuals (3.33%) [71]. These
fourteen cases broke down into 4 supernumerary chromosome markers, 4 deletions, 3 inver
sions and 3 duplications. Several reviews have since confirmed that such abnormalities can be
identified in ~3-5% of these patients [72, 73]. The regions commonly reported include 2q37,

http://dx.doi.org/10.5772/54854
5p14, 5p15, multiple locations on chromosome 7, 11q25, 15q11-q13, 16q22.3, 17p11.2, 18q21.1,
18q23, 22q11.2, 22q13.3 and Xp22.2p22.3.
Many studies have converged on particular chromosomal abnormalities in autism, the most
common of which are maternally inherited duplications at 15q11-13. These duplications are
found in as many as 13% of patients diagnosed with autism.
Another relatively common chromosomal variant is the 22q11.2 microdeletion syndrome, or
velocardiofacial syndrome (VCFS) that occurs in ~1/4000 live births. This syndrome is also
identified in the context of learning disability or in schizophrenia and has a complex pheno
typic expression affecting multiple organs. The physical features include a typical facial ap
pearance, (long face, narrow palpebral fissures, flattened malar eminences, prominent nose
and small mouth); anatomical and/or functional abnormalities of the palatal shelves such as
cleft palate and velopharyngeal insufficiency; lymphoid tissue hypoplasia and heart defects.
A wide range of childhood onset developmental symptoms and disorders are described in
association with the VCFS mutation [74] including attention deficit hyperactivity disorder
(ADHD), oppositional defiant disorder, phobias, anxiety, obsessive compulsive disorder and
autism spectrum disorders.
5. Copy number variation

The human genome has both sequence and structural variation, the majority of which has no
functional consequences and is unrelated to any disorder. Structural variation may be bal
anced, such as is the case for inversions and balanced translocations or may alter DNA copy
number. The later, referred to as copy number variants (CNVs) extend from the duplication
or deletion of a single base pair to whole chromosome abnormalities. The term CNV is gen
erally used to indicate the larger changes. Initially, large CNVs were identified with classical
chromosomal staining and light microscopy. As many of these abnormalities were initially
identified in sub-telomeric regions, there was interest in knowing if such deletions, duplica
tions and other re-arrangements might occur throughout the genome. This hypothesis was
confirmed with the development of high resolution array based comparative genomic hy
bridization (aCGH) [75].
In the arrays, comparative hybridization is performed with DNA immobilized on a platform
such as a glass slide. Initially the DNA arrays consisted of human DNA cloned into bacterial
artificial chromosomes (BAC arrays) representing the human genome at approximately 1Mb
intervals. The present arrays consist of 25-base pair oligonucleotides (probes). In the last dec
ade the resolution of the arrays have improved to the extent that the number of smaller CNVs
identified in the genome that were previously invisible to microscopy has increased enor
mously. Deletions and duplications at least as small as 10kb are now known to occur through
out the genome.
Interestingly, some CNVs appear to differ from single nucleotide polymorphisms (SNPs) in
terms of locus specific mutation rates. Rates for genomic re-arrangements range from 10-4 to
305
306
10-5, a rate that is considerably more frequent than point mutations [76]. This high mutation
rate, coupled with reduced fecundity in some carriers, and the fact that comparatively, they
affect a larger proportion of the genome, make CNVs a potentially important source of new
and recent mutation in neurodevelopmental disorders.
6. CNVs in autism
As discussed above, autism is a phenotypic feature of many genomic disorders. Betancur [77],
in her review, lists 103 disease genes and 44 genomic loci where autism or autistic like behaviors
have been described. ASD is diagnosed in ~30% of males with Fragile X syndrome and in
reverse, Fragile X mutations are found in as many as 78% of individuals with ASD [78]. Sim
ilarly, mutations in MECP2, the Rett Syndrome gene, have been found among cases of autism
that do not have the classical Rett phenotype and autism patients have an increased risk for
neurofibromatosis and other rare monogenic diseases like tuberous sclerosis and Jouberts
Syndrome, again inversely patients with these disorders have an increased risk for having
autism [79, 80].
The genes and loci listed in the Betancur study are all causally implicated in learning
disability (LD), indicating that these two neurodevelopmental disorders share some ge
netic risk factors. Early use of aCGH in non-syndromic autism suggested the method
had promise in detecting hitherto unrecognized CNVs. For example Jacquemont et al
[81] identified 6 deletions and 2 duplications in 29 patients presenting with syndromic
ASD where previous high resolution karyotyping was reported as normal. Another
study showing the potential for CNV analysis was a large linkage study [14] using a
10k SNP array where intensity data was used to determine copy number. The authors
highlight some individual findings including a family with two sisters with ASD, both
of whom had a ~300kb deletion on Ch. 2p16 that included the coding exons of the neu
rexin 1 gene (NRXN1). A second finding was a recurrent 1.1Mb duplication at Ch. 1q2.1
in four affected individuals from three families, a third was a ~900kb de novo duplica
tion at 17p12 in an affected sib-pair, and with the same region appearing as a maternal
ly inherited deletion in two male siblings, with a paternally inherited deletion in a
further female. Duplications in this region cause Charcot-Marie-Tooth 1A (CMT1A) and
hereditary neuropathy with pressure palsies when deleted, and overlapping deletions
are seen in Smith-Magenis syndrome that includes autism symptoms in many cases [82].
A key development was the report of de novo copy number variants in autism [83] using
aCGH. These authors showed that individually rare CNVs, and in particular ones that affect
neurodevelopmental genes, were enriched in cases. They further suggested that the rate of de
novo CNVs differed between simplex cases, where they occurred in 10% of families in the
sample, and familial cases where they occurred in 3% of families, suggesting that sporadic and
familial cases of ASD might have different underlying genetic mechanisms, although not all
studies since then have found this distinction. Several studies of CNVs in large autism case
and family series have followed. Marshall et al. [84] examined 427 ASD families using a 500k

http://dx.doi.org/10.5772/54854
SNP array and karyotyping by standard clinical diagnostic method. A de novo rate of 7.1%
and 2.0% in simplex and multiplex families respectively was observed, supporting the previ
ous findings [83]. Families occasionally showed more than a single de-novo event where both
may combine to produce risk. A further set of loci were identified in two or more unrelated
families, increasing the evidence supporting a pathogenic role. As with the LD literature, at
some loci, both deletions and duplication were found suggesting a more complex mechanism
than simple over or under-expression of gene products. Of the 196 inherited CNVs confirmed
experimentally, 90 were of maternal and 106 of paternal origin. The authors list numerous
potential ASD candidate genes where a structural change was either de-novo, found in two or
more unrelated ASD cases, or, in the case of the X-chromosome, transmitted from an unaffected
mother. Given their rarity, very few individual CNVs in this study provided statistical evi
dence to support their role in autism. For example, 4 CNVs from 427 cases were found at the
DPP6 a subunit that affects the function of Kv4.2 channels at the same site of expression as
SHANK3 and NLGN gene products. Only one similar CNV was found in 1652 controls (Fisch
ers exact test p = 0.016). In keeping with previous cytogenetic findings and the emerging
overlap in disorders involved, CNVs were found in ASD cases that involved known loci or
genes in disorders such as Waardenburg Type IIa, Speech and language disorder, learning
disability and VCFS. A further study [85] found a total of 51 CNVs in 46 cases and not in the
controls. 42 of these were familial and 9 de novo with recurrence in two or more cases at three
loci. In total, case specific CNVs were found in 11.6% of cases, although, in keeping with the
Marshall et al [84] study, none were individually associated with case status with the majority
being observed in only a single case. Pinto et al [86] compared CNVs in 996 ASD cases of
European ancestry to 1,287 matched controls, using the Illumina 1M SNP array. Cases were
found to carry a higher global burden of rare, genic CNVs, especially so for loci previously
implicated in either ASD and/or intellectual disability. Nearly 6% of the cases had de-novo
mutations with some having two or more events. Novel candidate genes were identified that
were de-novo in cases and not controls, including SHANK2, SYNGAP1 and DLGAP2. In keep
ing with previous studies only one novel CNV (maternally inherited X-linked deletions at
PTCHD1) occurred statistically more frequently in cases compared to controls (7 vs 0). PTCHD1
involvement in autism and LD was further extended and confirmed in a focused examination
of the PTCHD1 locus in cohorts of autism and LD cases and extending the study of CNVs to
sequence data, identifying additional maternally inherited missense mutations in 8 probands
not seen in controls [87]. In the Pinto et al study[86], certain gene sets were found to be enriched
for case deletions but not duplications. These included sets involved in cell and neuronal de
velopment, projection, motility and proliferation; GTPase/Ras signaling known to be involved
in regulating dendrite and spine plasticity; and kinase activity/regulation. There was addi
tional overlap with gene sets thought to be involved in LD including microtubule cytoskeleton,
glycosylation and CNS development/adhesion. More recently, Salyakina and colleagues [88]
have shown the value of extended multiply affected families in a CNV study of 42 families.
They found 5 deletions and 7 duplications that co-segregated with ASD, two overlapping with
known autism CNVs on 7p21.3 and 15q24.1 and two near regions on 3p26.3 and 12q24.32
previously associated with schizophrenia.
307
308
As the resolution of the probe arrays improves, smaller CNVs will be detected, and the boun
daries of previously identified CNVs will become more refined [89]. Nord et al. [90], examined
genomic DNA of 41 children with autism and 367 healthy controls for rare CNVs using a very
high-resolution aCGH platform. They found that cases were more likely than controls to have
CNVs as small as ~10kb, likely to affect genes involved in transcription, nervous system de
velopment, and receptor activity. They found that expression of CNTNAP2, ZNF214, PRODH
and ARID1B genes affected by CNVs were decreased in probands compared with controls
suggesting reduced expression as a potentially aetiological factor during development.
Larger samples, particularly those based on families, will also enable the improved estimation
of the overall effects of de-novo mutations and the assessment of rare recurrent events as
disease associated mutations [91]. These authors studied 1124 autism families containing pro
bands, unaffected parents and an unaffected sibling using the Illumina 1M SNP array. In a
related paper [92] they were able to confirm de novo CNVs identified using the SNP array
with those detected using a Nimblegen 2.1M aCGH platform. A combined total of 58 rare de
novo CNVs were identified across the two studies with each array type identifying 95% of the
total. However, the sensitivity for smaller CNVs was low for both arrays. Overall, the burden
of rare de novo CNVs in the Sanders et al [91] study was greater in probands than in siblings
for total number, size and gene content. Using the rate in siblings as a control to evaluate
findings in the cases, there was strong individual statistical support for recurrent de novo
duplications at 7q11.23, the locus at which deletions cause Williams-Beuren syndrome; dele
tions at 16p11.2 and duplications at 16p11.2. In addition the authors observed 8 loci at which
rare transmitted CNVs, present only in probands, overlapped with one of the 51 regions in
probands containing one or more rare de novo CNVs. However, the rare transmitted CNVs
were not more likely to be in cases than in unaffected siblings, even when subdivided into
genic, exonic, brain-expressed or previously identified as ASD related. This suggested that the
excess burden in their sample was due to rare de novo events, although when the gene sets
were applied to gene pathway analysis, more pathways showed enrichment in the case set
compared to the sibling set. To date, the number of definitive replicated findings for ASD from
all studies has been small, with the data suggesting an extreme heterogeneity model with no
single risk variant occurring in more than 1% of cases.
7. Mutation rates and models of risk in autism

Given the replicated finding that de-novo mutations are more frequent in simplex cases com
pared to familial cases, Zhao et al [93] have suggested a model of autism risk in which families
fall into two groups; those in which the overall risk for autism is low, representing the majority
of families, and those in which the risk is higher due to a disease mutation with a dominant
mode of transmission with greater penetrance in males compared to females. Under this mod
el, sporadic cases of autism occur in low-risk families due to a de novo mutation of relatively
high penetrance, whereas familial autism occurs due to the inheritance of an existing mutation
from a clinically unaffected or asymptomatic parent. In another model, Girirajan et al. [94]
proposed the necessity in some families for a second mutation to lead to severe neurodeve

http://dx.doi.org/10.5772/54854
lopmental disorder. In this study, individuals with childhood developmental delay are en
riched approximately fourfold for a rare 520-kb 16p12 deletion. In nearly all cases examined
(22/23), the deletion was inherited. Thus, 16p12 deletions appear to be an example of inherited
predisposition to neurodevelopmental disorder with dominant transmission. However, these
individuals were more likely to carry a second large (>500 kb) CNV compared to matched
controls, and clinical features of those with a second large CNV were typically more severe
than those with the 16p12 deletion alone. Itsara et al. [95] suggest that multiply affected autism
pedigrees segregate an existing inherited mutation of low penetrance which by itself is rarely
sufficient to cause disease. Secondary mutations, such as de-novo mutations are required to
manifest as disorder. Whether or not these second hits are disease specific remains to be ex
amined. The authors propose that the excess of de novo CNVs among cases may be due to a
depletion of second-hits in the unaffected sibling due to the initial low penetrant mutation
segregating in the family. The abundance of inherited low penetrance mutations and the high
rate of de novo CNVs in the population enable multiple cases to appear within families with
apparently unusual patterns of inheritance.
8. Next-generation sequencing studies

There is an increasing literature describing the occurrence of single nucleotide mutation in
ASD. Unlike the common polymorphisms described earlier, these variants are often rare or
private to an individual and considered to have a large impact on the gene's function. Early
studies have focused on candidate genes with strong a priori evidence to suggest causation,
such as the Neuroligin and Shank encoding genes. Sanger sequencing of the exons of families
with ASD have identified many putatively causative mutation in these synaptic proteins [96,
97]. As with the transition from candidate gene association studies to GWAS, the advent of
more sophisticated high-throughput next-generation sequencing approaches have enabled
many genes to be screened in a single experiment. This has extended to the systematic scanning
of the whole exome of individuals with ASD to identify putative risk mutations.
In April 2012, three key manuscripts were published in Nature describing a considerable
exome sequencing effort of 622 family trios and 250 unaffected siblings [98-100]. In these stud
ies the focus was on de novo mutation in the exome of individuals with ASD. De novo mutations
are those changes that occurred in the child which are not inherited from the parent. Given
the natural mutation rate, the number of families studied and the number of genes under
investigation it was estimated that three independent mutations would provide strong evi
dence implicating a gene in ASD, whilst two independent mutations would be suggestive but
not definitive. Unfortunately in these studies no gene was burdened with three independent
mutations, whilst several revealed two independent de novo mutations. Follow-up analyses
across the studies of the two-hit genes in a cohort of over 2600 individuals with ASD and over
1600 typically developing controls identified additional non-synonymous mutations in KAT
NAL2 (katanin p60 subunit A-like 2), CHD8 (Chromodomain-helicase-DNA-binding protein
8), GRIN2B (Glutamate [NMDA] receptor subunit epsilon-2), LAMC3 (Laminin subunit gam
ma-3), SCN1A (sodium channel, voltage-gated, type I, alpha subunit) and SCN2A (sodium
309
310
channel, voltage-gated, type II, alpha subunit). Despite the early caution regarding the number
of de novo events observed per gene, the burgeoning evidence from focused re-sequencing of
these suggests that other families with ASD have damaging loss-of-function mutation in these
genes.
9. Implications of genomic studies for clinical practice

Genetic findings to date in autism include known genetic syndromes such as Rett and Fragile
X; chromosomal structural variation such as duplications on ch15 and deletions on ch22 and
increasing numbers of CNVs, many de novo, in a small proportion of cases, especially those
with co-morbid developmental abnormalities. Common variants are only slowly emerging
from genome-wide studies but sample sizes are still relatively modest compared to other dis
orders. The diagnosis remains as a clinical one, but genetic testing has diagnostic, prognostic
and family planning implications, and in the coming years may also be of importance with
respect to potential treatments for specific conditions such as Rett and Fragile X. Therefore, a
clinical genetics evaluation should be considered in ASD children in order to identify syn
dromic forms of autism, identify familial cases, and drive diagnostic testing. Genetic testing
using aCGH has been recommended by the American Academy of Pediatrics [101] and the
American College of Medical Genetics [102, 103], particularly to evaluate aetiological hetero
geneity and identify syndromes. For the vast majority of cases with an identified genetic cause,
there is no specific benefit in terms of treatment, but the diagnosis itself may be of value to
parents seeking an explanation for the symptoms they see in their child. Acceptance of the
disorder may be easier in the presence of a known cause as echoes of social causation and
blame can still be heard. Family investigation may also be warranted, particularly where the
proband has an identified genetic causation as recurrence risk in siblings may have implica
tions for family planning. If a genetic cause of pathogenic significance is identified, the recur
rence risk for sibs may be established according to the particular genetic diagnosis. In the
majority of cases, no genetic alteration is found, and an empirical risk for siblings of 10-20%
can be provided. Establishing a clear de novo origin for a given mutation may enable a low
risk estimate in siblings although there are caveats relating to the exact origin of the mutation.
Finally, and re-stating the main goal of genetic research in ASD, a better understanding of
underlying biology may lead to novel and unexpected treatment possibilities. Early signs of
this are emerging in human trials for treatments aimed at the specific mutations found in Rett
and Fragile X syndromes.
Author details
Department of Psychiatry, School of Medicine, Trinity College Dublin, Ireland

http://dx.doi.org/10.5772/54854
References
[1] Lord C. Epidemiology: How common is autism? Nature. 2011 Jun 9;474(7350):166-8.
PubMed PMID: 21654793.
Jun;65(6):591-8. PubMed PMID: 19218885. Epub 2009/02/17. eng.
[3] Fernell E, Gillberg C. Autism spectrum disorder diagnoses in Stockholm preschoolers.
Res Dev Disabil. 2010 May-Jun;31(3):680-5. PubMed PMID: 20149593. Epub 2010/02/13.
eng.
[4] Folstein S, Rutter M. Genetic influences and infantile autism. Nature. 1977 Feb
24;265(5596):726-8. PubMed PMID: 558516. Epub 1977/02/24. eng.
a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995 Jan;
25(1):63-77. PubMed PMID: 7792363. Epub 1995/01/01. eng.
[6] Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new
twin studies. Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):255-74.
PubMed PMID: 21438136. Epub 2011/03/26. eng.
[7] Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic Her
itability and Shared Environmental Factors Among Twin Pairs With Autism. Arch Gen
Psychiatry. 2011 Jul 4. PubMed PMID: 21727249. Epub 2011/07/06. Eng.
[8] Le Couteur A, Rutter M, Lord C, Rios P, Robertson S, Holdgrafer M, et al. Autism
diagnostic interview: a standardized investigator-based instrument. J Autism Dev Dis
ord. 1989 Sep;19(3):363-87. PubMed PMID: 2793783. Epub 1989/09/01. eng.
cial behavior. J Autism Dev Disord. 1989 Jun;19(2):185-212. PubMed PMID: 2745388.
Epub 1989/06/01. eng.
[10] International Molecular Genetic Study of Autism Consortium (IMGSAC). A full ge
nome screen for autism with evidence for linkage to a region on chromosome 7q. In
ternational Molecular Genetic Study of Autism Consortium. Hum Mol Genet. 1998
Mar;7(3):571-8. PubMed PMID: 9546821. Epub 1998/04/18. eng.
[11] International Molecular Genetic Study of Autism Consortium (IMGSAC), Bailey A.
Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q.
Hum Mol Genet. 2001 Apr 15;10(9):973-82. PubMed PMID: 11392322. Epub 2001/06/08.
eng.
[12] International Molecular Genetic Study of Autism Consortium (IMGSAC), Monaco AP.
A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q,
311
312
and 16p. Am J Hum Genet. 2001 Sep;69(3):570-81. PubMed PMID: 11481586. Epub
2001/08/02. eng.
[13] Barrett S, Beck JC, Bernier R, Bisson E, Braun TA, Casavant TL, et al. An autosomal
genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet.
1999 Dec 15;88(6):609-15. PubMed PMID: 10581478. Epub 1999/12/03. eng.
[14] Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, et al. Mapping
autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet.
2007 Mar;39(3):319-28. PubMed PMID: 17322880. Epub 2007/02/27. eng.
[15] Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E, et al.
Genome-wide scan for autism susceptibility genes. Paris Autism Research Internation
al Sibpair Study. Hum Mol Genet. 1999 May;8(5):805-12. PubMed PMID: 10196369.
Epub 1999/04/10. eng.
[16] Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D, et al. A genomewide
screen for autism susceptibility loci. Am J Hum Genet. 2001 Aug;69(2):327-40. PubMed
PMID: 11452361. Epub 2001/07/14. eng.
[17] Schellenberg GD, Dawson G, Sung YJ, Estes A, Munson J, Rosenthal E, et al. Evidence
for multiple loci from a genome scan of autism kindreds. Mol Psychiatry. 2006 Nov;
11(11):1049-60, 979. PubMed PMID: 16880825. Epub 2006/08/02. eng.
[18] Persico AM, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, et al. Reelin
gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychia
try. 2001 Mar;6(2):150-9. PubMed PMID: 11317216. Epub 2001/04/24. eng.
[19] Skaar DA, Shao Y, Haines JL, Stenger JE, Jaworski J, Martin ER, et al. Analysis of the
RELN gene as a genetic risk factor for autism. Mol Psychiatry. 2005 Jun;10(6):563-71.
[20] Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR, et al. Reelin gene alleles
and susceptibility to autism spectrum disorders. Mol Psychiatry. 2002;7(9):1012-7.
[21] Serajee FJ, Zhong H, Mahbubul Huq AH. Association of Reelin gene polymorphisms
with autism. Genomics. 2006 Jan;87(1):75-83. PubMed PMID: 16311013. Epub
2005/11/29. eng.
[22] Ashley-Koch AE, Jaworski J, Ma de Q, Mei H, Ritchie MD, Skaar DA, et al. Investigation
of potential gene-gene interactions between APOE and RELN contributing to autism
risk. Psychiatr Genet. 2007 Aug;17(4):221-6. PubMed PMID: 17621165. Epub 2007/07/11.
eng.
[23] Li H, Li Y, Shao J, Li R, Qin Y, Xie C, et al. The association analysis of RELN and GRM8
genes with autistic spectrum disorder in Chinese Han population. Am J Med Genet B
Neuropsychiatr Genet. 2008 Mar 5;147B(2):194-200. PubMed PMID: 17955477. Epub
2007/10/24. eng.

http://dx.doi.org/10.5772/54854
[24] Holt R, Barnby G, Maestrini E, Bacchelli E, Brocklebank D, Sousa I, et al. Linkage and
candidate gene studies of autism spectrum disorders in European populations. Eur J
Hum Genet. 2010 Sep;18(9):1013-9. PubMed PMID: 20442744. Pubmed Central PMCID:
2987412. Epub 2010/05/06. eng.
[25] Kelemenova S, Schmidtova E, Ficek A, Celec P, Kubranska A, Ostatnikova D. Poly
morphisms of candidate genes in Slovak autistic patients. Psychiatr Genet. 2010 Aug;
[26] Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M. Absence of asso
ciation between a polymorphic GGC repeat in the 5' untranslated region of the reelin
gene and autism. Mol Psychiatry. 2002;7(7):801-4. PubMed PMID: 12192627. Pubmed
Central PMCID: 1913931. Epub 2002/08/23. eng.
[27] Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, et al. Analysis of reelin
as a candidate gene for autism. Mol Psychiatry. 2003 Oct;8(10):885-92. PubMed PMID:
14515139. Epub 2003/09/30. eng.
[28] Devlin B, Bennett P, Dawson G, Figlewicz DA, Grigorenko EL, McMahon W, et al.
Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the
CPEA network. Am J Med Genet B Neuropsychiatr Genet. 2004 Apr 1;126B(1):46-50.
[29] Li J, Nguyen L, Gleason C, Lotspeich L, Spiker D, Risch N, et al. Lack of evidence for
an association between WNT2 and RELN polymorphisms and autism. Am J Med Genet
B Neuropsychiatr Genet. 2004 Apr 1;126B(1):51-7. PubMed PMID: 15048648. Epub
2004/03/30. eng.
[30] Dutta S, Sinha S, Ghosh S, Chatterjee A, Ahmed S, Usha R. Genetic analysis of reelin
gene (RELN) SNPs: no association with autism spectrum disorder in the Indian pop
ulation. Neurosci Lett. 2008 Aug 15;441(1):56-60. PubMed PMID: 18597938. Epub
2008/07/04. eng.
[31] He Y, Xun G, Xia K, Hu Z, Lv L, Deng Z, et al. No significant association between RELN
polymorphism and autism in case-control and family-based association study in Chi
nese Han population. Psychiatry Res. 2011 May 30;187(3):462-4. PubMed PMID:
20554015. Epub 2010/06/18. eng.
[32] Jackson PB, Boccuto L, Skinner C, Collins JS, Neri G, Gurrieri F, et al. Further evidence
that the rs1858830 C variant in the promoter region of the MET gene is associated with
autistic disorder. Autism Res. 2009 Aug;2(4):232-6. PubMed PMID: 19681062. Epub
2009/08/15. eng.
susceptibility: family and case-control studies. Eur J Hum Genet. 2009 Jun;17(6):749-58.
313
314
[34] Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, Tsujii M, et al. Further

evidence for the role of MET in autism susceptibility. Neurosci Res. 2010 Oct;68(2):
137-41. PubMed PMID: 20615438. Epub 2010/07/10. eng.
the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder
susceptibility locus. Am J Hum Genet. 2005 Nov;77(5):851-68. PubMed PMID:
16252243. Epub 2005/10/28. eng.
tistic disorder. J Med Genet. 2003 Jan;40(1):e4. PubMed PMID: 12525552. Pubmed Cen
tral PMCID: 1735256. Epub 2003/01/15. eng.
genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk
of autism. Am J Hum Genet. 2008 Jan;82(1):160-4. PubMed PMID: 18179894. Epub
2008/01/09. eng.
[38] Li X, Hu Z, He Y, Xiong Z, Long Z, Peng Y, et al. Association analysis of CNTNAP2
polymorphisms with autism in the Chinese Han population. Psychiatr Genet. 2010 Jun;
[39] Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, Baird G, et al. Individual common
variants exert weak effects on the risk for autism spectrum disorders. Hum Mol Genet.
2012 Aug 8. PubMed PMID: 22843504. Epub 2012/07/31. Eng.
[40] Segurado R, Conroy J, Meally E, Fitzgerald M, Gill M, Gallagher L. Confirmation of
association between autism and the mitochondrial aspartate/glutamate carrier
SLC25A12 gene on chromosome 2q31. Am J Psychiatry. 2005 Nov;162(11):2182-4.
[41] Kim SJ, Silva RM, Flores CG, Jacob S, Guter S, Valcante G, et al. A quantitative associ
ation study of SLC25A12 and restricted repetitive behavior traits in autism spectrum
disorders. Mol Autism. 2011;2(1):8. PubMed PMID: 21609426. Epub 2011/05/26. eng.
[42] Turunen JA, Rehnstrom K, Kilpinen H, Kuokkanen M, Kempas E, Ylisaukko-Oja T.
Mitochondrial aspartate/glutamate carrier SLC25A12 gene is associated with autism.
Autism Res. 2008 Jun;1(3):189-92. PubMed PMID: 19360665. Epub 2009/04/11. eng.
[43] Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T, et al. Brief report:
High frequency of biochemical markers for mitochondrial dysfunction in autism: no
association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Au
tism Dev Disord. 2006 Nov;36(8):1137-40. PubMed PMID: 17151801. Epub 2006/12/08.
eng.
[44] Rabionet R, McCauley JL, Jaworski JM, Ashley-Koch AE, Martin ER, Sutcliffe JS, et al.
Lack of association between autism and SLC25A12. Am J Psychiatry. 2006 May;163(5):

http://dx.doi.org/10.5772/54854
[45] Blasi F, Bacchelli E, Carone S, Toma C, Monaco AP, Bailey AJ, et al. SLC25A12 and
CMYA3 gene variants are not associated with autism in the IMGSAC multiplex family
sample. Eur J Hum Genet. 2006 Jan;14(1):123-6. PubMed PMID: 16205742. Epub
2005/10/06. eng.
[46] Chien WH, Wu YY, Gau SS, Huang YS, Soong WT, Chiu YN, et al. Association study
of the SLC25A12 gene and autism in Han Chinese in Taiwan. Prog Neuropsychophar
macol Biol Psychiatry. 2010 Feb 1;34(1):189-92. PubMed PMID: 19913066. Epub
2009/11/17. eng.
[47] Gallagher L, Becker K, Kearney G, Dunlop A, Stallings R, Green A, et al. Brief report:
A case of autism associated with del(2)(q32.1q32.2) or (q32.2q32.3). J Autism Dev Dis
ord. 2003 Feb;33(1):105-8. PubMed PMID: 12708586. Epub 2003/04/24. eng.
[48] Conroy J, Cochrane L, Anney RJ, Sutcliffe JS, Carthy P, Dunlop A, et al. Fine mapping
and association studies in a candidate region for autism on chromosome 2q31-q32. Am
J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):535-44. PubMed PMID:
18846500. Epub 2008/10/11. eng.
[49] Auranen M, Vanhala R, Varilo T, Ayers K, Kempas E, Ylisaukko-Oja T, et al. A ge
nomewide screen for autism-spectrum disorders: evidence for a major susceptibility
locus on chromosome 3q25-27. Am J Hum Genet. 2002 Oct;71(4):777-90. PubMed PMID:
12192642. Epub 2002/08/23. eng.
[50] Auranen M, Varilo T, Alen R, Vanhala R, Ayers K, Kempas E, et al. Evidence for allelic
association on chromosome 3q25-27 in families with autism spectrum disorders origi
nating from a subisolate of Finland. Mol Psychiatry. 2003 Oct;8(10):879-84. PubMed
PMID: 14515138. Epub 2003/09/30. eng.
[51] Ylisaukko-oja T, Nieminen-von Wendt T, Kempas E, Sarenius S, Varilo T, von Wendt
L, et al. Genome-wide scan for loci of Asperger syndrome. Mol Psychiatry. 2004 Feb;
[52] Coon H, Matsunami N, Stevens J, Miller J, Pingree C, Camp NJ, et al. Evidence for
linkage on chromosome 3q25-27 in a large autism extended pedigree. Hum Hered.
[53] Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, et al. A ge
nomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet. 2003
Oct;73(4):886-97. PubMed PMID: 13680528. Epub 2003/09/19. eng.
[54] Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association
scan reveals novel loci for autism. Nature. 2009 Oct 8;461(7265):802-8. PubMed PMID:
19812673. Epub 2009/10/09. eng.
[55] Risch N, Merikangas K. The future of genetic studies of complex human diseases. Sci
ence. 1996 Sep 13;273(5281):1516-7. PubMed PMID: 8801636. Epub 1996/09/13. eng.
315
316
[56] Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, et al. Common genetic
variants on 5p14.1 associate with autism spectrum disorders. Nature. 2009 May
genome-wide association study of autism reveals a common novel risk locus at 5p14.1.
Ann Hum Genet. 2009 May;73(Pt 3):263-73. PubMed PMID: 19456320. Epub 2009/05/22.
eng.
[58] Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, et al. A genome-wide scan
for common alleles affecting risk for autism. Hum Mol Genet. 2010 Oct 15;19(20):
[59] Xu B, Woodroffe A, Rodriguez-Murillo L, Roos JL, van Rensburg EJ, Abecasis GR, et
al. Elucidating the genetic architecture of familial schizophrenia using rare copy num
ber variant and linkage scans. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16746-51.
[60] Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, et al. De novo
CNV analysis implicates specific abnormalities of postsynaptic signalling complexes
in the pathogenesis of schizophrenia. Mol Psychiatry. 2012 Feb;17(2):142-53. PubMed
PMID: 22083728. Epub 2011/11/16. eng.
[61] Lesca G, Rudolf G, Labalme A, Hirsch E, Arzimanoglou A, Genton P, et al. Epileptic
encephalopathies of the Landau-Kleffner and continuous spike and waves during
slow-wave sleep types: Genomic dissection makes the link with autism. Epilepsia. 2012
Sep;53(9):1526-38. PubMed PMID: 22738016. Epub 2012/06/29. Eng.
[62] Bradley WE, Raelson JV, Dubois DY, Godin E, Fournier H, Prive C, et al. Hotspots of
large rare deletions in the human genome. PLoS ONE. 2010;5(2):e9401. PubMed PMID:
20195527. Pubmed Central PMCID: 2828468. Epub 2010/03/03. eng.
[63] Karras GI, Kustatscher G, Buhecha HR, Allen MD, Pugieux C, Sait F, et al. The macro
domain is an ADP-ribose binding module. EMBO J. 2005 Jun 1;24(11):1911-20. PubMed
PMID: 15902274. Epub 2005/05/20. eng.
[64] Timinszky G, Till S, Hassa PO, Hothorn M, Kustatscher G, Nijmeijer B, et al. A macro
domain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat
Struct Mol Biol. 2009 Sep;16(9):923-9. PubMed PMID: 19680243. Epub 2009/08/15. eng.
[65] Hoff KG, Wolberger C. Getting a grip on O-acetyl-ADP-ribose. Nat Struct Mol Biol.
2005 Jul;12(7):560-1. PubMed PMID: 15999106. Epub 2005/07/07. eng.
[66] Liou GG, Tanny JC, Kruger RG, Walz T, Moazed D. Assembly of the SIR complex and
its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacety
lation. Cell. 2005 May 20;121(4):515-27. PubMed PMID: 15907466. Epub 2005/05/24. eng.
[67] Chen D, Vollmar M, Rossi MN, Phillips C, Kraehenbuehl R, Slade D, et al. Identification
of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. J Biol Chem. 2011
Apr 15;286(15):13261-71. PubMed PMID: 21257746. Epub 2011/01/25. eng.

http://dx.doi.org/10.5772/54854
[68] Cohen-Armon M, Visochek L, Katzoff A, Levitan D, Susswein AJ, Klein R, et al. Longterm memory requires polyADP-ribosylation. Science. 2004 Jun 18;304(5678):1820-2.
[69] Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, de
velopment, plasticity and disease. Nature reviews Neuroscience. 2012 Aug;13(8):
[70] Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, et al. Com
mon polygenic variation contributes to risk of schizophrenia and bipolar disorder. Na
ture. 2009 Aug 6;460(7256):748-52. PubMed PMID: 19571811. Epub 2009/07/03. eng.
[71] Reddy KS. Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum
Disorder. BMC medical genetics. 2005 Jan 18;6:3. PubMed PMID: 15655077. Pubmed
Central PMCID: 548305.
[72] Gillberg C. Chromosomal disorders and autism. J Autism Dev Disord. 1998 Oct;28(5):
[73] Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L.
Identification of novel autism candidate regions through analysis of reported cytoge
netic abnormalities associated with autism. Mol Psychiatry. 2006 Jan;11(1):1, 18-28.
[74] Gothelf D, Schaer M, Eliez S. Genes, brain development and psychiatric phenotypes in
velo-cardio-facial syndrome. Dev Disabil Res Rev. 2008;14(1):59-68. PubMed PMID:
18636637.
ease, and evolution. Annual review of genomics and human genetics. 2009;10:451-81.
[76] Lupski JR. Structural variation in the human genome. The New England journal of
medicine. 2007 Mar 15;356(11):1169-71. PubMed PMID: 17360997. Epub 2007/03/16.
eng.
[77] Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 ge
netic and genomic disorders and still counting. Brain Res. 2011 Mar 22;1380:42-77.
113(5):e472-86. PubMed PMID: 15121991. Epub 2004/05/04. eng.
[79] Marui T, Hashimoto O, Nanba E, Kato C, Tochigi M, Umekage T, et al. Association
between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population.
American journal of medical genetics Part B, Neuropsychiatric genetics : the official
publication of the International Society of Psychiatric Genetics. 2004 Nov 15;131B(1):
317
318
Brain & development. 2007 Jun;29(5):257-72. PubMed PMID: 17084999. Epub
2006/11/07. eng.
chromosomal rearrangements in patients with syndromic autism spectrum disorders.
Journal of medical genetics. 2006 Nov;43(11):843-9. PubMed PMID: 16840569. Pubmed
[82] Smith ACM, Boyd K, Elsea SH, Finucane BM, Haas-Givler B, Gropman A, et al. SmithMagenis Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneRe
views. Seattle (WA)1993.
ation of de novo copy number mutations with autism. Science. 2007 Apr 20;316(5823):
445-9. PubMed PMID: 17363630. eng.
[84] Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural variation
of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008 Feb;82(2):477-88.
[85] Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, Karamohamed S, et al. Novel sub
microscopic chromosomal abnormalities detected in autism spectrum disorder. Biol
Psychiatry. 2008 Jun 15;63(12):1111-7. PubMed PMID: 18374305. Epub 2008/04/01. eng.
[86] Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional impact
of global rare copy number variation in autism spectrum disorders. Nature. 2010 Jul
15;466(7304):368-72. PubMed PMID: 20531469. Pubmed Central PMCID: 3021798. Epub
2010/06/10. eng.
[87] Noor A, Whibley A, Marshall CR, Gianakopoulos PJ, Piton A, Carson AR, et al. Dis
ruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual
disability. Sci Transl Med. 2010 Sep 15;2(49):49ra68. PubMed PMID: 20844286. Pubmed
[88] Salyakina D, Cukier HN, Lee JM, Sacharow S, Nations LD, Ma D, et al. Copy number
variants in extended autism spectrum disorder families reveal candidates potentially
involved in autism risk. PloS one. 2011;6(10):e26049. PubMed PMID: 22016809. Pubmed
[89] Celestino-Soper PB, Shaw CA, Sanders SJ, Li J, Murtha MT, Ercan-Sencicek AG, et al.
Use of array CGH to detect exonic copy number variants throughout the genome in
autism families detects a novel deletion in TMLHE. Human molecular genetics. 2011
Nov 15;20(22):4360-70. PubMed PMID: 21865298. Pubmed Central PMCID: 3196886.
Epub 2011/08/26. eng.
[90] Nord AS, Roeb W, Dickel DE, Walsh T, Kusenda M, O'Connor KL, et al. Reduced tran
script expression of genes affected by inherited and de novo CNVs in autism. European

http://dx.doi.org/10.5772/54854
journal of human genetics : EJHG. 2011 Jun;19(6):727-31. PubMed PMID: 21448237.

Pubmed Central PMCID: 3110052. Epub 2011/03/31. eng.
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syn
drome region, are strongly associated with autism. Neuron. 2011 Jun 9;70(5):863-85.
[92] Levy D, Ronemus M, Yamrom B, Lee YH, Leotta A, Kendall J, et al. Rare de novo and
transmitted copy-number variation in autistic spectrum disorders. Neuron. 2011 Jun
[93] Zhao X, Leotta A, Kustanovich V, Lajonchere C, Geschwind DH, Law K, et al. A unified
genetic theory for sporadic and inherited autism. Proceedings of the National Academy
of Sciences of the United States of America. 2007 Jul 31;104(31):12831-6. PubMed PMID:
[94] Girirajan S, Eichler EE. Phenotypic variability and genetic susceptibility to genomic
disorders. Human molecular genetics. 2010 Oct 15;19(R2):R176-87. PubMed PMID:
[95] Itsara A, Wu H, Smith JD, Nickerson DA, Romieu I, London SJ, et al. De novo rates and
selection of large copy number variation. Genome Res. 2010 Nov;20(11):1469-81.
PubMed PMID: 20841430. Pubmed Central PMCID: 2963811. Epub 2010/09/16. eng.
[96] Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, et al. Mutations
of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with
autism. Nat Genet. 2003 May;34(1):27-9. PubMed PMID: 12669065. Epub 2003/04/02.
eng.
[97] Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, et al.
ated with autism spectrum disorders. Nat Genet. 2007 Jan;39(1):25-7. PubMed PMID:
17173049. Epub 2006/12/19. eng.
exomes reveal a highly interconnected protein network of de novo mutations. Nature.
2012 Apr 4. PubMed PMID: 22495309. Epub 2012/04/13. Eng.
exonic de novo mutations in autism spectrum disorders. Nature. 2012 Apr 4. PubMed
PMID: 22495311. Epub 2012/04/13. Eng.
novo mutations revealed by whole-exome sequencing are strongly associated with au
tism. Nature. 2012 Apr 4. PubMed PMID: 22495306. Epub 2012/04/13. Eng.
[101] Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum
disorders. Pediatrics. 2007 Nov;120(5):1183-215. PubMed PMID: 17967920. Epub
2007/10/31. eng.
319
320
[102] Schaefer GB, Mendelsohn NJ. Genetics evaluation for the etiologic diagnosis of autism
spectrum disorders. Genetics in medicine : official journal of the American College of
Medical Genetics. 2008 Jan;10(1):4-12. PubMed PMID: 18197051. Epub 2008/01/17. eng.
[103] Roesser J. Diagnostic yield of genetic testing in children diagnosed with autism spec
trum disorders at a regional referral center. Clinical pediatrics. 2011 Sep;50(9):834-43.
Chapter 14
The Genetic Architecture of Autism and Related

Conditions
http://dx.doi.org/10.5772/54854
1. Introduction
Autism is a behaviourally defined developmental disorder characterised by impairments in
social communication, restricted interests and repetitive behaviours [1]. Abnormalities in these
three developmental areas tend to cluster together in affected individuals. In DSM-IV, Autism
is part of a larger continuum of disorders collectively called Pervasive Developmental Disor
ders. Autism spectrum disorders (ASD) refer to Autism, Pervasive developmental disorder,
not otherwise specified, and Asperger syndrome. All individuals with ASDs have qualitative
abnormalities of social development in combination with disorders of communication and/or
stereotyped repetitive interests and behaviors. The social skills that develop naturally in typ
ically-developing children do not do so in children with ASD. In addition, there are several
behaviors and co-morbid symptoms that relate to each of the three classical impairments. Re
cent studies have reported rates of co-occurring intellectual disability in the range of 25-50%.
Neither developmental delay nor cognitive impairment are required for an ASD diagnosis.
Fombonne and colleagues recently estimated the prevalence of strictlydefined autism at ap
proximately 15-20 per 10,000 people [2]. When the definition of autism is relaxed to include
Autism Spectrum Disorders, the prevalence estimated expands to approximately 60 in in
10,000 children [2, 3].
Little is known of the biological basis of ASD and the future development of rational knowl
edge based treatments will depend on a comprehensive understanding of innate biological
predisposition and its interaction with environmental factors. The identification and charac
terisation of the genetic variation and genes involved in ASD is a route towards this goal. This
chapter outlines the various approaches that have been applied to this task, in the context of
rapidly evolving technology and human genome resources, and summarises the state of
2013 Gill et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
300
knowledge at this time, anticipating future developments, and outlining the implications for
clinical management.
2. Autism is a heritable disorder

There is unequivocal evidence to support the role of genetic liability as the basis of familiality
in the aetiology of ASD. In their seminal work, Folstein and Rutter [4] observed that 4 of 11
(36%) pairs of identical twins were concordant for strictly defined autism whilst none of 10
pairs of fraternal twins were concordant. In a large follow-up study, which included these
original twins, Bailey and colleagues observed a more striking concordance rate in identical
twins (60%) with no concordance in the fraternal twins [5]. This highly cited study underlined
ASD as the most heritable of the neurodevelopmental and psychiatric disorders with herita
bility estimates of 91 - 93%. A recent review of over 30 twin studies of ASD [6] noted that the
early twin studies, which relied upon a strict diagnosis of autism, show a median identical and
fraternal concordance of 76% and 0% respectively. The expansion of these and other studies
to include a broader definition of ASD revealed a median concordance rate of 88% and 31%.
In both cases, these data reveal that ASD is underpinned by a strong genetic component. More
recently, Hallmayer and colleagues [7] using more stringent clinical diagnostic tools, such as
the Autism Diagnostic Interview (ADI; [8]) and the Autism Diagnostic Observation Schedule
(ADOS; [9]) in a group of 202 twin pairs from the California Twin Registry, identified similar
concordance rate of ASD as previously attained; with identical twin boys showing a concord
ance rate of 77% and fraternal twin boys 31%.
3. Genetic linkage and association

The heritability estimates above calculated from twin studies imply that there is unknown
genetic variation in children with ASD that confers risk. Several models may fit the observed
family and twin data including, at the extremes, a common disorder-common-variant model,
with many DNA variants of small effect combining together to create risk; and a multiple rare
variant model where ASD is in reality a large collection of different and individually rare
disorders. The true picture is only slowly emerging, and as with many other common disor
ders, common low penetrant and rare higher penetrant DNA variants combine to jointly con
tribute to risk. Molecular genetic methods have developed exponentially over the last few
decades with ever increasing knowledge of the structure and function of the human genome.
For disorders with largely unknown aetiology, such as ASD, using human genetic studies to
identify risk genes is a gateway to an understanding of underlying biology. Such studies may
focus on individuals or families each using different but related genetic strategies to track
down risk or causative genetic variation. These methods include genetic linkage, genetic as
sociation, and direct examination of structural and copy number variation.
The basis of genetic linkage is the physical co-location of genes or other DNA variation. Such
DNA variation is more likely to be transmitted together (or linked) than those that are further

http://dx.doi.org/10.5772/54854
apart. Linkage studies take advantage of this non-random assortment of genetic variation. A
linkage study calculates whether a known genetic variant and a disease mutation (represented
by the disease trait) are linked and if so, roughly localises the causative mutation. Following
the successes of using these approaches in the discovery of multiple loci implicate in Mendelian
disorders, researchers were encouraged to apply linkage methodology to more complex traits,
such as ASD where Mendelian principles may apply, at least in a proportion of families. How
ever, in ASD, only a few scans have highlighted loci with significant linkage, highlighting loci
including chromosome 7q, 2q and 3q.
In 1998, the International Molecular Genetic Study of Autism Consortium (IMGSAC) [10] re
ported modest evidence for linkage. This included significant linkage arising on chromosome
7q32-q34. Supplemented analyses of IMGSAC families provided additional support for link
age at 7q22, 16p13, and 2q31 [11, 12]. The long arm of chromosome 7 has received particular
attention with additional support reported for 7q21 [13], 7q22 [14], 7q31 [15, 16], 7q32 [17] and
7q36 [16].
Few individual families exist where ASD segregates in an obvious Mendelian fashion that is
large enough to provide significant evidence for linkage by themselves. Most linkage studies
required the assumption that a significant proportion of the families in the sample might be
linked to a given locus and few were sufficiently large to accommodate even modest locus
heterogeneity. Under a common disorder - common variant model, multiply affected families
will occur but linkage methods would be considerably underpowered. The effects of DNA
variation with low penetrance are more easily identified using a genetic association study
design in a sample of cases drawn from a population.
Fine-mapping and candidate gene association studies at implicated regions on 7q have impli
cated a number of potential susceptibility genes including RELN, MET, CNTNAP2 and EN2.
Persico and colleagues [18] studied five DNA variants or polymorphisms across the RELN
gene locus, including a GGC repeat variant located close to the RELN gene translation initiator
codon. Located at 7q22, RELN encodes an extracellular matrix protein Reelin, which plays a
pivotal role in the development of laminar structures including cerebral cortex, cerebellum
and hippocampus. Using a genetic association approach, Persico and colleagues identified a
nominally significant association with this 5-UTR GCC-triplet-repeat polymorphism [18].
This finding was further supported by some studies [19-25] but not others [26-31]. MET, located
at 7q31 received considerable attention following a high-profile association reported by Camp
bell and colleagues. The MET gene encodes a protein involved in MET (Mesenchymal epithelial
transition factor) receptor tyrosine kinase signalling which has been implicated in brain growth
and maturation offering biological plausibility to its candidature. As with other candidate
genes in ASD, the original findings have been supported in some [32], but not other studies
[33] [34]. A similar scenario played out for the EN2 homeobox gene located at 7q36 [35, 36].
Arking and colleagues [37] observed an association at CNTNAP2 in the NIHM/AGRE collec
tion. The main association observed was for rs7794745 located in intron 2 of the gene (Discovery
P = 0.00002, Validation P = 0.005). The CNTNAP2 (7q35) gene encodes the contactin-associated
protein-like 2 protein, which is a member of the neurexin family and thought to play a role in
axonal differentiation and guidance. Li and colleagues also found mild support for CNTNAP2
301
302
where they observed a weak association with a haplotype containing the SNP rs7794745 [38].
More recently, a large GWAS of 2705 families identified a strong association for the SNP
rs1718101 in the CNTNAP2 gene with a subset of individuals without intellectual disability
and of European ancestry (P = 7.78 x 10-9) [39].
The Paris Autism Research International Sibpair (PARIS) study [15], that supported the find
ings on 7q, noted additional loci at 2q31-q32, 16p13 and 19p13, that overlapped to some extent
with regions identified in the IMGSAC analyses. Fine mapping of the 2q31-q32 led to addi
tional evidence implicating the genes SLC25A12, STK39 and ITGA4 as putative risk genes for
ASD. As with most candidate genes examined in small samples, these associations were vali
dated by some [40-42] but not all studies [43-46]. The positional candidature of the 2q31-q32
was further supported by a case study of a young Irish male with high-functioning autism
with a complex translocation traversing chromosome 2q32 (46,XY,t(9;2)(q31.1;q32.2q31.3))
[47]. Fine mapping and mutation analysis identified an association with a polymorphism
within the splice donor sequence of exon 16 of the ITGA4 gene and ASD (rs12690517; P = 0.008)
[48].
In a study of Finnish families, Auranen and colleagues [49, 50], who included individuals with
autism, infantile autism, Asperger syndrome (AS) and developmental dysphasia reported a
significant linkage to 3q25-q27. This was supported by suggestive evidence at 3q25-q27 in a study
of AS also in the Finnish population [51] as well as linkage at 3q25-q27 in a single large extended
Utah pedigree of Northern European ancestry [52].
Interestingly, the advent of large collaborative studies by the Autism Genome Research
Exchange (AGRE), the Autism Genome Project (AGP) and the National Institute of Men
tal Health (NIMH) has not yielded stronger evidence in favour of specific loci. Liu and
colleagues using data from 110 multiplex families from the AGRE collection [16] ob
served only suggestive linkage on chromosomes 5p13, Xq26-qtel, and 19q12 alongside
modest support for previously reported linkage on 7q (7q31 and 7q36) and 16p13. A fol
low-up analysis including 235 additional AGRE multiplex families was again limited to
only suggestive loci at chromosomes 17q11, 5p13, 11p11-p13, 4q21-q22 and 8q24 [53]. In a
much larger collection of 1168 multiply-affected families from the AGP (including fami
lies previously included in the AGRE, CPEA, IMGSAC, PARIS and Seaver linkage stud
ies), Szatmari and colleagues identified suggestive linkage to chromosome 11p12-p13 and
a large region on chromosome 15q23-q25 [14]. Of the regions that were featured promi
nently in previous linkage analyses, there was only modest support for previously high
lighted linkage regions on chromosome 2q31 (female autism-probands) and 7q22 (male
ASD-probands) from families of European ancestry [14]. A similarly large linkage study
of 1031 families, including 1553 affected offspring, Weiss and colleagues identified sug
gestive linkage at 6p27 and significant linkage at 20p13 [54].
Early association studies examined whether specific variation in genes was associated with
the disease and focused on candidate loci identified from linkage and cytogenetic studies (po
sitional candidate genes) as well as in genes within biological processes that we perceived as
having a role in ASD. In the mid-1990s Risch and Merikangas [55] demonstrated that where
genetic variants have only small effect on risk the association study is a more powerful ap

http://dx.doi.org/10.5772/54854
proach than linkage to identify genetic risk. However, the transition from candidate gene to
genome-wide association studies was not realised until technological advances firstly enriched
the maps of common variation across the genome and secondly enabled the interrogation of
these variants en masse as part of genome-wide SNP arrays.
Wang and colleagues [56] performed one of the first GWAS on individuals in European an
cestry individuals from the AGRE collection, the Autism Case Control Collection and unaf
fected controls from the Childrens Hospital of Philadelphia control collection. Neither familybased nor case-control analysis alone yielded genome-wide significant findings. However, in
a combined analyses the authors identified genome-wide significant association on chromo
some 5p14.1 (rs4307059; P =3.4 x 10-8) and a number of additional association signals on chro
mosome 13q33.3, 14q21.1 and Xp22.32. The 5p14.1 association was validated in the
Collaborative Autism Project (CAP) and Centre for Autism Research and Treatment (CART)
study. The authors found a modest to strong replication of the association signal on chromo
some 5p14.1. In a reciprocal study with the CAP and CART study as the discovery sample
followed by validation using the AGRE dataset was published in parallel by Ma and colleagues
[57]. The authors examined approximately 500k SNPs, more than in the Wang report and albeit
not genome-wide significant, they retained the association signal on chromosome 5p14.1.
A second independent GWAS was reported by Weiss and colleagues [54]. In the initial scan
the authors did not find any GW-significant associations. However, as with the previous
GWAS, additional supplementation of their family-based studies with a case-control set de
rived from 90 probands without parental data garnered some additional signal for the top hits.
A replication consortium of greater than 2000 trios was genotyped for 45 SNPs across all of
the top associated regions. The only marker that showed evidence of replication resides on the
short arm of chromosome 5 at 5p15. Although, like Ma and colleagues, this report has consid
erable overlap with the AGRE families reported by Wang and colleagues, the authors did not
observe strong association at 5p14.1. The chromosome 5p association lies in close proximity
to TAS2R1. The TAS2R1 gene encodes a G-protein coupled receptor that is involved in bitter
taste recognition. The authors highlight a more biologically plausible ASD candidate gene
approximately 80 Kb telomeric, SEMA5A. SEMA5A encodes a gene important in axonal guid
ance and has been shown to be down regulated in the occipital lobe cortex, lymphoblast cell
lines and lymphocytes from individuals with autism.
Two additional GWAS followed by the Autism Genome Project (AGP) [39, 58]. In the first
report of 1369 families, Anney and colleagues identified a single GW-significant finding on
chromosome 20 at position 20p12 within the MACROD2 (MACRO-domain containing 2) gene
locus (rs4141463; P = 2.1 x 10-8; OR = 0.56). Weak statistical support was observed for MAC
ROD2 in an AGRE validation sample, albeit showing the same direction of effect for the risk
allele. In a follow-up study using an additional 1301 families the authors showed little if any
signal of association (rs4141463; P = 0.206, OR=0.91). In a combined analyses the association at
MACROD2 was less compelling (rs4141463; P = 1.2 x 10-6; OR=0.77). The role of MACROD2 is
largely unknown although structural variation in this gene and specifically the region har
bouring the ASD association signal have been implicated in schizophrenia [59, 60] and epilepsy
[61]. However, this same region has been identified as a hotspot for deletions in the genome
303
304
identified as a region of large rare deletions [62]. MACROD-like proteins are highly conserved
across evolutionary time, which may indicate an essential role. The MACRO-domain is an
ADP-ribose binding module [63] and has been implicated in the ADP-ribosylation of proteins,
an important post-translational modification that occurs in a variety of biological processes
such as DNA repair [64], heterochromatin formation, histone modification and sirtuin biology
[65-67] as well as long-term memory formation [68]. The association signal observed at
rs4141463, albeit tagged to the MACROD2 gene, resides in an intronic region near an intragenic
non-protein-coding-RNA, NCRNA00186 (MACROD2-AS1). Two MACROD2-AS1 transcripts
have been reported of 673bp and 1230bp in length, located on the reverse strand between exon
5 and 6 of MACROD2. Anti-sense RNAs typically interact with mRNA, resulting in transcrip
tional or post-transcriptional effects and have been linked to brain development and plasticity
[69]. However, unlike MSNP1AS described for the 5p14.1 association observed by Wang and
colleagues, a function for this non-coding RNA has not yet been reported.
The strongest association signal observed by the AGP combined analyses was rs1718101 (P =
7.8 x 10-9; OR=2.13 (1.63-2.80)), a SNP within the CNTNAP2 gene which was previously impli
cated in ASD through linkage analyses. This association was observed in a secondary analysis
which was restricted to ASD individuals of European ancestry with a higher IQ. Anney and
colleagues suggest that with the current data few if any common variants have an impact on
risk exceeding (an effect size of) 1.2 (or below its inverse). In an attempt to seek evidence for
or against common variants having an impact on risk, the authors constructed an allele-score.
The allele-score method, as previously described by Purcell and colleagues [70], calculates a
score for each individual based on number of risk associated alleles that the individual pos
sesses. This score is then used to either calculate the predictive value of the score between cases
and controls or estimate the amount of variance that this score predicts for the disease. Allelescores derived from the transmission of common alleles from the families described in the AGP
stage 1 GWAS [58] could significantly predict case-status in the independent Stage 2 sample.
The authors concluded however that despite the limited findings for individual loci from
GWAS studies to date, en masse the top results exert a detectable impact suggesting that as the
sample sizes increase, additional significant loci will emerge. Putting together samples of the
size seen in successful GWAS studies in other disorders (n>20,000) is challenging for a disorder
with a complex phenotype such as ASD.
4. Structural variation: Chromosomal abnormalities in autism

Autism has been frequently associated with chromosome abnormalities, such as deletions,
duplications, inversions, or translocations; with abnormalities on the long arm of Chromosome
15 and with numerical and structural abnormalities of the sex chromosomes. Reddy in a survey
of chromosomal abnormality in autism found one in 14 of 421 individuals (3.33%) [71]. These
fourteen cases broke down into 4 supernumerary chromosome markers, 4 deletions, 3 inver
sions and 3 duplications. Several reviews have since confirmed that such abnormalities can be
identified in ~3-5% of these patients [72, 73]. The regions commonly reported include 2q37,

http://dx.doi.org/10.5772/54854
5p14, 5p15, multiple locations on chromosome 7, 11q25, 15q11-q13, 16q22.3, 17p11.2, 18q21.1,
18q23, 22q11.2, 22q13.3 and Xp22.2p22.3.
Many studies have converged on particular chromosomal abnormalities in autism, the most
common of which are maternally inherited duplications at 15q11-13. These duplications are
found in as many as 13% of patients diagnosed with autism.
Another relatively common chromosomal variant is the 22q11.2 microdeletion syndrome, or
velocardiofacial syndrome (VCFS) that occurs in ~1/4000 live births. This syndrome is also
identified in the context of learning disability or in schizophrenia and has a complex pheno
typic expression affecting multiple organs. The physical features include a typical facial ap
pearance, (long face, narrow palpebral fissures, flattened malar eminences, prominent nose
and small mouth); anatomical and/or functional abnormalities of the palatal shelves such as
cleft palate and velopharyngeal insufficiency; lymphoid tissue hypoplasia and heart defects.
A wide range of childhood onset developmental symptoms and disorders are described in
association with the VCFS mutation [74] including attention deficit hyperactivity disorder
(ADHD), oppositional defiant disorder, phobias, anxiety, obsessive compulsive disorder and
autism spectrum disorders.
5. Copy number variation

The human genome has both sequence and structural variation, the majority of which has no
functional consequences and is unrelated to any disorder. Structural variation may be bal
anced, such as is the case for inversions and balanced translocations or may alter DNA copy
number. The later, referred to as copy number variants (CNVs) extend from the duplication
or deletion of a single base pair to whole chromosome abnormalities. The term CNV is gen
erally used to indicate the larger changes. Initially, large CNVs were identified with classical
chromosomal staining and light microscopy. As many of these abnormalities were initially
identified in sub-telomeric regions, there was interest in knowing if such deletions, duplica
tions and other re-arrangements might occur throughout the genome. This hypothesis was
confirmed with the development of high resolution array based comparative genomic hy
bridization (aCGH) [75].
In the arrays, comparative hybridization is performed with DNA immobilized on a platform
such as a glass slide. Initially the DNA arrays consisted of human DNA cloned into bacterial
artificial chromosomes (BAC arrays) representing the human genome at approximately 1Mb
intervals. The present arrays consist of 25-base pair oligonucleotides (probes). In the last dec
ade the resolution of the arrays have improved to the extent that the number of smaller CNVs
identified in the genome that were previously invisible to microscopy has increased enor
mously. Deletions and duplications at least as small as 10kb are now known to occur through
out the genome.
Interestingly, some CNVs appear to differ from single nucleotide polymorphisms (SNPs) in
terms of locus specific mutation rates. Rates for genomic re-arrangements range from 10-4 to
305
306
10-5, a rate that is considerably more frequent than point mutations [76]. This high mutation
rate, coupled with reduced fecundity in some carriers, and the fact that comparatively, they
affect a larger proportion of the genome, make CNVs a potentially important source of new
and recent mutation in neurodevelopmental disorders.
6. CNVs in autism
As discussed above, autism is a phenotypic feature of many genomic disorders. Betancur [77],
in her review, lists 103 disease genes and 44 genomic loci where autism or autistic like behaviors
have been described. ASD is diagnosed in ~30% of males with Fragile X syndrome and in
reverse, Fragile X mutations are found in as many as 78% of individuals with ASD [78]. Sim
ilarly, mutations in MECP2, the Rett Syndrome gene, have been found among cases of autism
that do not have the classical Rett phenotype and autism patients have an increased risk for
neurofibromatosis and other rare monogenic diseases like tuberous sclerosis and Jouberts
Syndrome, again inversely patients with these disorders have an increased risk for having
autism [79, 80].
The genes and loci listed in the Betancur study are all causally implicated in learning
disability (LD), indicating that these two neurodevelopmental disorders share some ge
netic risk factors. Early use of aCGH in non-syndromic autism suggested the method
had promise in detecting hitherto unrecognized CNVs. For example Jacquemont et al
[81] identified 6 deletions and 2 duplications in 29 patients presenting with syndromic
ASD where previous high resolution karyotyping was reported as normal. Another
study showing the potential for CNV analysis was a large linkage study [14] using a
10k SNP array where intensity data was used to determine copy number. The authors
highlight some individual findings including a family with two sisters with ASD, both
of whom had a ~300kb deletion on Ch. 2p16 that included the coding exons of the neu
rexin 1 gene (NRXN1). A second finding was a recurrent 1.1Mb duplication at Ch. 1q2.1
in four affected individuals from three families, a third was a ~900kb de novo duplica
tion at 17p12 in an affected sib-pair, and with the same region appearing as a maternal
ly inherited deletion in two male siblings, with a paternally inherited deletion in a
further female. Duplications in this region cause Charcot-Marie-Tooth 1A (CMT1A) and
hereditary neuropathy with pressure palsies when deleted, and overlapping deletions
are seen in Smith-Magenis syndrome that includes autism symptoms in many cases [82].
A key development was the report of de novo copy number variants in autism [83] using
aCGH. These authors showed that individually rare CNVs, and in particular ones that affect
neurodevelopmental genes, were enriched in cases. They further suggested that the rate of de
novo CNVs differed between simplex cases, where they occurred in 10% of families in the
sample, and familial cases where they occurred in 3% of families, suggesting that sporadic and
familial cases of ASD might have different underlying genetic mechanisms, although not all
studies since then have found this distinction. Several studies of CNVs in large autism case
and family series have followed. Marshall et al. [84] examined 427 ASD families using a 500k

http://dx.doi.org/10.5772/54854
SNP array and karyotyping by standard clinical diagnostic method. A de novo rate of 7.1%
and 2.0% in simplex and multiplex families respectively was observed, supporting the previ
ous findings [83]. Families occasionally showed more than a single de-novo event where both
may combine to produce risk. A further set of loci were identified in two or more unrelated
families, increasing the evidence supporting a pathogenic role. As with the LD literature, at
some loci, both deletions and duplication were found suggesting a more complex mechanism
than simple over or under-expression of gene products. Of the 196 inherited CNVs confirmed
experimentally, 90 were of maternal and 106 of paternal origin. The authors list numerous
potential ASD candidate genes where a structural change was either de-novo, found in two or
more unrelated ASD cases, or, in the case of the X-chromosome, transmitted from an unaffected
mother. Given their rarity, very few individual CNVs in this study provided statistical evi
dence to support their role in autism. For example, 4 CNVs from 427 cases were found at the
DPP6 a subunit that affects the function of Kv4.2 channels at the same site of expression as
SHANK3 and NLGN gene products. Only one similar CNV was found in 1652 controls (Fisch
ers exact test p = 0.016). In keeping with previous cytogenetic findings and the emerging
overlap in disorders involved, CNVs were found in ASD cases that involved known loci or
genes in disorders such as Waardenburg Type IIa, Speech and language disorder, learning
disability and VCFS. A further study [85] found a total of 51 CNVs in 46 cases and not in the
controls. 42 of these were familial and 9 de novo with recurrence in two or more cases at three
loci. In total, case specific CNVs were found in 11.6% of cases, although, in keeping with the
Marshall et al [84] study, none were individually associated with case status with the majority
being observed in only a single case. Pinto et al [86] compared CNVs in 996 ASD cases of
European ancestry to 1,287 matched controls, using the Illumina 1M SNP array. Cases were
found to carry a higher global burden of rare, genic CNVs, especially so for loci previously
implicated in either ASD and/or intellectual disability. Nearly 6% of the cases had de-novo
mutations with some having two or more events. Novel candidate genes were identified that
were de-novo in cases and not controls, including SHANK2, SYNGAP1 and DLGAP2. In keep
ing with previous studies only one novel CNV (maternally inherited X-linked deletions at
PTCHD1) occurred statistically more frequently in cases compared to controls (7 vs 0). PTCHD1
involvement in autism and LD was further extended and confirmed in a focused examination
of the PTCHD1 locus in cohorts of autism and LD cases and extending the study of CNVs to
sequence data, identifying additional maternally inherited missense mutations in 8 probands
not seen in controls [87]. In the Pinto et al study[86], certain gene sets were found to be enriched
for case deletions but not duplications. These included sets involved in cell and neuronal de
velopment, projection, motility and proliferation; GTPase/Ras signaling known to be involved
in regulating dendrite and spine plasticity; and kinase activity/regulation. There was addi
tional overlap with gene sets thought to be involved in LD including microtubule cytoskeleton,
glycosylation and CNS development/adhesion. More recently, Salyakina and colleagues [88]
have shown the value of extended multiply affected families in a CNV study of 42 families.
They found 5 deletions and 7 duplications that co-segregated with ASD, two overlapping with
known autism CNVs on 7p21.3 and 15q24.1 and two near regions on 3p26.3 and 12q24.32
previously associated with schizophrenia.
307
308
As the resolution of the probe arrays improves, smaller CNVs will be detected, and the boun
daries of previously identified CNVs will become more refined [89]. Nord et al. [90], examined
genomic DNA of 41 children with autism and 367 healthy controls for rare CNVs using a very
high-resolution aCGH platform. They found that cases were more likely than controls to have
CNVs as small as ~10kb, likely to affect genes involved in transcription, nervous system de
velopment, and receptor activity. They found that expression of CNTNAP2, ZNF214, PRODH
and ARID1B genes affected by CNVs were decreased in probands compared with controls
suggesting reduced expression as a potentially aetiological factor during development.
Larger samples, particularly those based on families, will also enable the improved estimation
of the overall effects of de-novo mutations and the assessment of rare recurrent events as
disease associated mutations [91]. These authors studied 1124 autism families containing pro
bands, unaffected parents and an unaffected sibling using the Illumina 1M SNP array. In a
related paper [92] they were able to confirm de novo CNVs identified using the SNP array
with those detected using a Nimblegen 2.1M aCGH platform. A combined total of 58 rare de
novo CNVs were identified across the two studies with each array type identifying 95% of the
total. However, the sensitivity for smaller CNVs was low for both arrays. Overall, the burden
of rare de novo CNVs in the Sanders et al [91] study was greater in probands than in siblings
for total number, size and gene content. Using the rate in siblings as a control to evaluate
findings in the cases, there was strong individual statistical support for recurrent de novo
duplications at 7q11.23, the locus at which deletions cause Williams-Beuren syndrome; dele
tions at 16p11.2 and duplications at 16p11.2. In addition the authors observed 8 loci at which
rare transmitted CNVs, present only in probands, overlapped with one of the 51 regions in
probands containing one or more rare de novo CNVs. However, the rare transmitted CNVs
were not more likely to be in cases than in unaffected siblings, even when subdivided into
genic, exonic, brain-expressed or previously identified as ASD related. This suggested that the
excess burden in their sample was due to rare de novo events, although when the gene sets
were applied to gene pathway analysis, more pathways showed enrichment in the case set
compared to the sibling set. To date, the number of definitive replicated findings for ASD from
all studies has been small, with the data suggesting an extreme heterogeneity model with no
single risk variant occurring in more than 1% of cases.
7. Mutation rates and models of risk in autism

Given the replicated finding that de-novo mutations are more frequent in simplex cases com
pared to familial cases, Zhao et al [93] have suggested a model of autism risk in which families
fall into two groups; those in which the overall risk for autism is low, representing the majority
of families, and those in which the risk is higher due to a disease mutation with a dominant
mode of transmission with greater penetrance in males compared to females. Under this mod
el, sporadic cases of autism occur in low-risk families due to a de novo mutation of relatively
high penetrance, whereas familial autism occurs due to the inheritance of an existing mutation
from a clinically unaffected or asymptomatic parent. In another model, Girirajan et al. [94]
proposed the necessity in some families for a second mutation to lead to severe neurodeve

http://dx.doi.org/10.5772/54854
lopmental disorder. In this study, individuals with childhood developmental delay are en
riched approximately fourfold for a rare 520-kb 16p12 deletion. In nearly all cases examined
(22/23), the deletion was inherited. Thus, 16p12 deletions appear to be an example of inherited
predisposition to neurodevelopmental disorder with dominant transmission. However, these
individuals were more likely to carry a second large (>500 kb) CNV compared to matched
controls, and clinical features of those with a second large CNV were typically more severe
than those with the 16p12 deletion alone. Itsara et al. [95] suggest that multiply affected autism
pedigrees segregate an existing inherited mutation of low penetrance which by itself is rarely
sufficient to cause disease. Secondary mutations, such as de-novo mutations are required to
manifest as disorder. Whether or not these second hits are disease specific remains to be ex
amined. The authors propose that the excess of de novo CNVs among cases may be due to a
depletion of second-hits in the unaffected sibling due to the initial low penetrant mutation
segregating in the family. The abundance of inherited low penetrance mutations and the high
rate of de novo CNVs in the population enable multiple cases to appear within families with
apparently unusual patterns of inheritance.
8. Next-generation sequencing studies

There is an increasing literature describing the occurrence of single nucleotide mutation in
ASD. Unlike the common polymorphisms described earlier, these variants are often rare or
private to an individual and considered to have a large impact on the gene's function. Early
studies have focused on candidate genes with strong a priori evidence to suggest causation,
such as the Neuroligin and Shank encoding genes. Sanger sequencing of the exons of families
with ASD have identified many putatively causative mutation in these synaptic proteins [96,
97]. As with the transition from candidate gene association studies to GWAS, the advent of
more sophisticated high-throughput next-generation sequencing approaches have enabled
many genes to be screened in a single experiment. This has extended to the systematic scanning
of the whole exome of individuals with ASD to identify putative risk mutations.
In April 2012, three key manuscripts were published in Nature describing a considerable
exome sequencing effort of 622 family trios and 250 unaffected siblings [98-100]. In these stud
ies the focus was on de novo mutation in the exome of individuals with ASD. De novo mutations
are those changes that occurred in the child which are not inherited from the parent. Given
the natural mutation rate, the number of families studied and the number of genes under
investigation it was estimated that three independent mutations would provide strong evi
dence implicating a gene in ASD, whilst two independent mutations would be suggestive but
not definitive. Unfortunately in these studies no gene was burdened with three independent
mutations, whilst several revealed two independent de novo mutations. Follow-up analyses
across the studies of the two-hit genes in a cohort of over 2600 individuals with ASD and over
1600 typically developing controls identified additional non-synonymous mutations in KAT
NAL2 (katanin p60 subunit A-like 2), CHD8 (Chromodomain-helicase-DNA-binding protein
8), GRIN2B (Glutamate [NMDA] receptor subunit epsilon-2), LAMC3 (Laminin subunit gam
ma-3), SCN1A (sodium channel, voltage-gated, type I, alpha subunit) and SCN2A (sodium
309
310
channel, voltage-gated, type II, alpha subunit). Despite the early caution regarding the number
of de novo events observed per gene, the burgeoning evidence from focused re-sequencing of
these suggests that other families with ASD have damaging loss-of-function mutation in these
genes.
9. Implications of genomic studies for clinical practice

Genetic findings to date in autism include known genetic syndromes such as Rett and Fragile
X; chromosomal structural variation such as duplications on ch15 and deletions on ch22 and
increasing numbers of CNVs, many de novo, in a small proportion of cases, especially those
with co-morbid developmental abnormalities. Common variants are only slowly emerging
from genome-wide studies but sample sizes are still relatively modest compared to other dis
orders. The diagnosis remains as a clinical one, but genetic testing has diagnostic, prognostic
and family planning implications, and in the coming years may also be of importance with
respect to potential treatments for specific conditions such as Rett and Fragile X. Therefore, a
clinical genetics evaluation should be considered in ASD children in order to identify syn
dromic forms of autism, identify familial cases, and drive diagnostic testing. Genetic testing
using aCGH has been recommended by the American Academy of Pediatrics [101] and the
American College of Medical Genetics [102, 103], particularly to evaluate aetiological hetero
geneity and identify syndromes. For the vast majority of cases with an identified genetic cause,
there is no specific benefit in terms of treatment, but the diagnosis itself may be of value to
parents seeking an explanation for the symptoms they see in their child. Acceptance of the
disorder may be easier in the presence of a known cause as echoes of social causation and
blame can still be heard. Family investigation may also be warranted, particularly where the
proband has an identified genetic causation as recurrence risk in siblings may have implica
tions for family planning. If a genetic cause of pathogenic significance is identified, the recur
rence risk for sibs may be established according to the particular genetic diagnosis. In the
majority of cases, no genetic alteration is found, and an empirical risk for siblings of 10-20%
can be provided. Establishing a clear de novo origin for a given mutation may enable a low
risk estimate in siblings although there are caveats relating to the exact origin of the mutation.
Finally, and re-stating the main goal of genetic research in ASD, a better understanding of
underlying biology may lead to novel and unexpected treatment possibilities. Early signs of
this are emerging in human trials for treatments aimed at the specific mutations found in Rett
and Fragile X syndromes.
Author details
Department of Psychiatry, School of Medicine, Trinity College Dublin, Ireland

http://dx.doi.org/10.5772/54854
References
[1] Lord C. Epidemiology: How common is autism? Nature. 2011 Jun 9;474(7350):166-8.
PubMed PMID: 21654793.
Jun;65(6):591-8. PubMed PMID: 19218885. Epub 2009/02/17. eng.
[3] Fernell E, Gillberg C. Autism spectrum disorder diagnoses in Stockholm preschoolers.
Res Dev Disabil. 2010 May-Jun;31(3):680-5. PubMed PMID: 20149593. Epub 2010/02/13.
eng.
[4] Folstein S, Rutter M. Genetic influences and infantile autism. Nature. 1977 Feb
a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995 Jan;
[6] Ronald A, Hoekstra RA. Autism spectrum disorders and autistic traits: a decade of new
twin studies. Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):255-74.
[7] Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic Her
itability and Shared Environmental Factors Among Twin Pairs With Autism. Arch Gen
Psychiatry. 2011 Jul 4. PubMed PMID: 21727249. Epub 2011/07/06. Eng.
[8] Le Couteur A, Rutter M, Lord C, Rios P, Robertson S, Holdgrafer M, et al. Autism
diagnostic interview: a standardized investigator-based instrument. J Autism Dev Dis
ord. 1989 Sep;19(3):363-87. PubMed PMID: 2793783. Epub 1989/09/01. eng.
cial behavior. J Autism Dev Disord. 1989 Jun;19(2):185-212. PubMed PMID: 2745388.
Epub 1989/06/01. eng.
[10] International Molecular Genetic Study of Autism Consortium (IMGSAC). A full ge
nome screen for autism with evidence for linkage to a region on chromosome 7q. In
ternational Molecular Genetic Study of Autism Consortium. Hum Mol Genet. 1998
Mar;7(3):571-8. PubMed PMID: 9546821. Epub 1998/04/18. eng.
[11] International Molecular Genetic Study of Autism Consortium (IMGSAC), Bailey A.
Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q.
Hum Mol Genet. 2001 Apr 15;10(9):973-82. PubMed PMID: 11392322. Epub 2001/06/08.
eng.
[12] International Molecular Genetic Study of Autism Consortium (IMGSAC), Monaco AP.
A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q,
311
312
and 16p. Am J Hum Genet. 2001 Sep;69(3):570-81. PubMed PMID: 11481586. Epub
2001/08/02. eng.
[13] Barrett S, Beck JC, Bernier R, Bisson E, Braun TA, Casavant TL, et al. An autosomal
genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet.
1999 Dec 15;88(6):609-15. PubMed PMID: 10581478. Epub 1999/12/03. eng.
[14] Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, et al. Mapping
autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet.
2007 Mar;39(3):319-28. PubMed PMID: 17322880. Epub 2007/02/27. eng.
[15] Philippe A, Martinez M, Guilloud-Bataille M, Gillberg C, Rastam M, Sponheim E, et al.
Genome-wide scan for autism susceptibility genes. Paris Autism Research Internation
al Sibpair Study. Hum Mol Genet. 1999 May;8(5):805-12. PubMed PMID: 10196369.
Epub 1999/04/10. eng.
[16] Liu J, Nyholt DR, Magnussen P, Parano E, Pavone P, Geschwind D, et al. A genomewide
screen for autism susceptibility loci. Am J Hum Genet. 2001 Aug;69(2):327-40. PubMed
PMID: 11452361. Epub 2001/07/14. eng.
[17] Schellenberg GD, Dawson G, Sung YJ, Estes A, Munson J, Rosenthal E, et al. Evidence
for multiple loci from a genome scan of autism kindreds. Mol Psychiatry. 2006 Nov;
11(11):1049-60, 979. PubMed PMID: 16880825. Epub 2006/08/02. eng.
[18] Persico AM, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, et al. Reelin
gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychia
try. 2001 Mar;6(2):150-9. PubMed PMID: 11317216. Epub 2001/04/24. eng.
[19] Skaar DA, Shao Y, Haines JL, Stenger JE, Jaworski J, Martin ER, et al. Analysis of the
RELN gene as a genetic risk factor for autism. Mol Psychiatry. 2005 Jun;10(6):563-71.
[20] Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR, et al. Reelin gene alleles
and susceptibility to autism spectrum disorders. Mol Psychiatry. 2002;7(9):1012-7.
[21] Serajee FJ, Zhong H, Mahbubul Huq AH. Association of Reelin gene polymorphisms
with autism. Genomics. 2006 Jan;87(1):75-83. PubMed PMID: 16311013. Epub
2005/11/29. eng.
[22] Ashley-Koch AE, Jaworski J, Ma de Q, Mei H, Ritchie MD, Skaar DA, et al. Investigation
of potential gene-gene interactions between APOE and RELN contributing to autism
risk. Psychiatr Genet. 2007 Aug;17(4):221-6. PubMed PMID: 17621165. Epub 2007/07/11.
eng.
[23] Li H, Li Y, Shao J, Li R, Qin Y, Xie C, et al. The association analysis of RELN and GRM8
genes with autistic spectrum disorder in Chinese Han population. Am J Med Genet B
Neuropsychiatr Genet. 2008 Mar 5;147B(2):194-200. PubMed PMID: 17955477. Epub
2007/10/24. eng.

http://dx.doi.org/10.5772/54854
[24] Holt R, Barnby G, Maestrini E, Bacchelli E, Brocklebank D, Sousa I, et al. Linkage and
candidate gene studies of autism spectrum disorders in European populations. Eur J
Hum Genet. 2010 Sep;18(9):1013-9. PubMed PMID: 20442744. Pubmed Central PMCID:
2987412. Epub 2010/05/06. eng.
morphisms of candidate genes in Slovak autistic patients. Psychiatr Genet. 2010 Aug;
[26] Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M. Absence of asso
ciation between a polymorphic GGC repeat in the 5' untranslated region of the reelin
gene and autism. Mol Psychiatry. 2002;7(7):801-4. PubMed PMID: 12192627. Pubmed
[27] Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, et al. Analysis of reelin
as a candidate gene for autism. Mol Psychiatry. 2003 Oct;8(10):885-92. PubMed PMID:
14515139. Epub 2003/09/30. eng.
[28] Devlin B, Bennett P, Dawson G, Figlewicz DA, Grigorenko EL, McMahon W, et al.
Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the
CPEA network. Am J Med Genet B Neuropsychiatr Genet. 2004 Apr 1;126B(1):46-50.
[29] Li J, Nguyen L, Gleason C, Lotspeich L, Spiker D, Risch N, et al. Lack of evidence for
an association between WNT2 and RELN polymorphisms and autism. Am J Med Genet
B Neuropsychiatr Genet. 2004 Apr 1;126B(1):51-7. PubMed PMID: 15048648. Epub
2004/03/30. eng.
[30] Dutta S, Sinha S, Ghosh S, Chatterjee A, Ahmed S, Usha R. Genetic analysis of reelin
gene (RELN) SNPs: no association with autism spectrum disorder in the Indian pop
ulation. Neurosci Lett. 2008 Aug 15;441(1):56-60. PubMed PMID: 18597938. Epub
2008/07/04. eng.
[31] He Y, Xun G, Xia K, Hu Z, Lv L, Deng Z, et al. No significant association between RELN
polymorphism and autism in case-control and family-based association study in Chi
nese Han population. Psychiatry Res. 2011 May 30;187(3):462-4. PubMed PMID:
20554015. Epub 2010/06/18. eng.
[32] Jackson PB, Boccuto L, Skinner C, Collins JS, Neri G, Gurrieri F, et al. Further evidence
that the rs1858830 C variant in the promoter region of the MET gene is associated with
autistic disorder. Autism Res. 2009 Aug;2(4):232-6. PubMed PMID: 19681062. Epub
2009/08/15. eng.
susceptibility: family and case-control studies. Eur J Hum Genet. 2009 Jun;17(6):749-58.
313
314
[34] Thanseem I, Nakamura K, Miyachi T, Toyota T, Yamada S, Tsujii M, et al. Further

evidence for the role of MET in autism susceptibility. Neurosci Res. 2010 Oct;68(2):
the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder
susceptibility locus. Am J Hum Genet. 2005 Nov;77(5):851-68. PubMed PMID:
16252243. Epub 2005/10/28. eng.
tistic disorder. J Med Genet. 2003 Jan;40(1):e4. PubMed PMID: 12525552. Pubmed Cen
tral PMCID: 1735256. Epub 2003/01/15. eng.
genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk
of autism. Am J Hum Genet. 2008 Jan;82(1):160-4. PubMed PMID: 18179894. Epub
2008/01/09. eng.
[38] Li X, Hu Z, He Y, Xiong Z, Long Z, Peng Y, et al. Association analysis of CNTNAP2
polymorphisms with autism in the Chinese Han population. Psychiatr Genet. 2010 Jun;
[39] Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, Baird G, et al. Individual common
variants exert weak effects on the risk for autism spectrum disorders. Hum Mol Genet.
2012 Aug 8. PubMed PMID: 22843504. Epub 2012/07/31. Eng.
[40] Segurado R, Conroy J, Meally E, Fitzgerald M, Gill M, Gallagher L. Confirmation of
association between autism and the mitochondrial aspartate/glutamate carrier
SLC25A12 gene on chromosome 2q31. Am J Psychiatry. 2005 Nov;162(11):2182-4.
[41] Kim SJ, Silva RM, Flores CG, Jacob S, Guter S, Valcante G, et al. A quantitative associ
ation study of SLC25A12 and restricted repetitive behavior traits in autism spectrum
disorders. Mol Autism. 2011;2(1):8. PubMed PMID: 21609426. Epub 2011/05/26. eng.
[42] Turunen JA, Rehnstrom K, Kilpinen H, Kuokkanen M, Kempas E, Ylisaukko-Oja T.
Mitochondrial aspartate/glutamate carrier SLC25A12 gene is associated with autism.
Autism Res. 2008 Jun;1(3):189-92. PubMed PMID: 19360665. Epub 2009/04/11. eng.
[43] Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T, et al. Brief report:
High frequency of biochemical markers for mitochondrial dysfunction in autism: no
association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Au
tism Dev Disord. 2006 Nov;36(8):1137-40. PubMed PMID: 17151801. Epub 2006/12/08.
eng.
[44] Rabionet R, McCauley JL, Jaworski JM, Ashley-Koch AE, Martin ER, Sutcliffe JS, et al.
Lack of association between autism and SLC25A12. Am J Psychiatry. 2006 May;163(5):

http://dx.doi.org/10.5772/54854
[45] Blasi F, Bacchelli E, Carone S, Toma C, Monaco AP, Bailey AJ, et al. SLC25A12 and
CMYA3 gene variants are not associated with autism in the IMGSAC multiplex family
sample. Eur J Hum Genet. 2006 Jan;14(1):123-6. PubMed PMID: 16205742. Epub
2005/10/06. eng.
[46] Chien WH, Wu YY, Gau SS, Huang YS, Soong WT, Chiu YN, et al. Association study
of the SLC25A12 gene and autism in Han Chinese in Taiwan. Prog Neuropsychophar
macol Biol Psychiatry. 2010 Feb 1;34(1):189-92. PubMed PMID: 19913066. Epub
2009/11/17. eng.
[47] Gallagher L, Becker K, Kearney G, Dunlop A, Stallings R, Green A, et al. Brief report:
A case of autism associated with del(2)(q32.1q32.2) or (q32.2q32.3). J Autism Dev Dis
ord. 2003 Feb;33(1):105-8. PubMed PMID: 12708586. Epub 2003/04/24. eng.
[48] Conroy J, Cochrane L, Anney RJ, Sutcliffe JS, Carthy P, Dunlop A, et al. Fine mapping
and association studies in a candidate region for autism on chromosome 2q31-q32. Am
J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):535-44. PubMed PMID:
18846500. Epub 2008/10/11. eng.
[49] Auranen M, Vanhala R, Varilo T, Ayers K, Kempas E, Ylisaukko-Oja T, et al. A ge
nomewide screen for autism-spectrum disorders: evidence for a major susceptibility
locus on chromosome 3q25-27. Am J Hum Genet. 2002 Oct;71(4):777-90. PubMed PMID:
12192642. Epub 2002/08/23. eng.
[50] Auranen M, Varilo T, Alen R, Vanhala R, Ayers K, Kempas E, et al. Evidence for allelic
association on chromosome 3q25-27 in families with autism spectrum disorders origi
nating from a subisolate of Finland. Mol Psychiatry. 2003 Oct;8(10):879-84. PubMed
PMID: 14515138. Epub 2003/09/30. eng.
[51] Ylisaukko-oja T, Nieminen-von Wendt T, Kempas E, Sarenius S, Varilo T, von Wendt
L, et al. Genome-wide scan for loci of Asperger syndrome. Mol Psychiatry. 2004 Feb;
[52] Coon H, Matsunami N, Stevens J, Miller J, Pingree C, Camp NJ, et al. Evidence for
linkage on chromosome 3q25-27 in a large autism extended pedigree. Hum Hered.
[53] Yonan AL, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA, et al. A ge
nomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet. 2003
Oct;73(4):886-97. PubMed PMID: 13680528. Epub 2003/09/19. eng.
[54] Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association
scan reveals novel loci for autism. Nature. 2009 Oct 8;461(7265):802-8. PubMed PMID:
19812673. Epub 2009/10/09. eng.
[55] Risch N, Merikangas K. The future of genetic studies of complex human diseases. Sci
ence. 1996 Sep 13;273(5281):1516-7. PubMed PMID: 8801636. Epub 1996/09/13. eng.
315
316
[56] Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, et al. Common genetic
variants on 5p14.1 associate with autism spectrum disorders. Nature. 2009 May
genome-wide association study of autism reveals a common novel risk locus at 5p14.1.
Ann Hum Genet. 2009 May;73(Pt 3):263-73. PubMed PMID: 19456320. Epub 2009/05/22.
eng.
[58] Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, et al. A genome-wide scan
for common alleles affecting risk for autism. Hum Mol Genet. 2010 Oct 15;19(20):
[59] Xu B, Woodroffe A, Rodriguez-Murillo L, Roos JL, van Rensburg EJ, Abecasis GR, et
al. Elucidating the genetic architecture of familial schizophrenia using rare copy num
ber variant and linkage scans. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16746-51.
[60] Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, et al. De novo
CNV analysis implicates specific abnormalities of postsynaptic signalling complexes
in the pathogenesis of schizophrenia. Mol Psychiatry. 2012 Feb;17(2):142-53. PubMed
PMID: 22083728. Epub 2011/11/16. eng.
[61] Lesca G, Rudolf G, Labalme A, Hirsch E, Arzimanoglou A, Genton P, et al. Epileptic
encephalopathies of the Landau-Kleffner and continuous spike and waves during
slow-wave sleep types: Genomic dissection makes the link with autism. Epilepsia. 2012
Sep;53(9):1526-38. PubMed PMID: 22738016. Epub 2012/06/29. Eng.
[62] Bradley WE, Raelson JV, Dubois DY, Godin E, Fournier H, Prive C, et al. Hotspots of
large rare deletions in the human genome. PLoS ONE. 2010;5(2):e9401. PubMed PMID:
[63] Karras GI, Kustatscher G, Buhecha HR, Allen MD, Pugieux C, Sait F, et al. The macro
domain is an ADP-ribose binding module. EMBO J. 2005 Jun 1;24(11):1911-20. PubMed
PMID: 15902274. Epub 2005/05/20. eng.
[64] Timinszky G, Till S, Hassa PO, Hothorn M, Kustatscher G, Nijmeijer B, et al. A macro
domain-containing histone rearranges chromatin upon sensing PARP1 activation. Nat
Struct Mol Biol. 2009 Sep;16(9):923-9. PubMed PMID: 19680243. Epub 2009/08/15. eng.
[65] Hoff KG, Wolberger C. Getting a grip on O-acetyl-ADP-ribose. Nat Struct Mol Biol.
2005 Jul;12(7):560-1. PubMed PMID: 15999106. Epub 2005/07/07. eng.
[66] Liou GG, Tanny JC, Kruger RG, Walz T, Moazed D. Assembly of the SIR complex and
its regulation by O-acetyl-ADP-ribose, a product of NAD-dependent histone deacety
lation. Cell. 2005 May 20;121(4):515-27. PubMed PMID: 15907466. Epub 2005/05/24. eng.
[67] Chen D, Vollmar M, Rossi MN, Phillips C, Kraehenbuehl R, Slade D, et al. Identification
of macrodomain proteins as novel O-acetyl-ADP-ribose deacetylases. J Biol Chem. 2011
Apr 15;286(15):13261-71. PubMed PMID: 21257746. Epub 2011/01/25. eng.

http://dx.doi.org/10.5772/54854
[68] Cohen-Armon M, Visochek L, Katzoff A, Levitan D, Susswein AJ, Klein R, et al. Longterm memory requires polyADP-ribosylation. Science. 2004 Jun 18;304(5678):1820-2.
[69] Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, de
velopment, plasticity and disease. Nature reviews Neuroscience. 2012 Aug;13(8):
[70] Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, et al. Com
mon polygenic variation contributes to risk of schizophrenia and bipolar disorder. Na
ture. 2009 Aug 6;460(7256):748-52. PubMed PMID: 19571811. Epub 2009/07/03. eng.
[71] Reddy KS. Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum
Disorder. BMC medical genetics. 2005 Jan 18;6:3. PubMed PMID: 15655077. Pubmed
Central PMCID: 548305.
[72] Gillberg C. Chromosomal disorders and autism. J Autism Dev Disord. 1998 Oct;28(5):
[73] Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L.
Identification of novel autism candidate regions through analysis of reported cytoge
netic abnormalities associated with autism. Mol Psychiatry. 2006 Jan;11(1):1, 18-28.
[74] Gothelf D, Schaer M, Eliez S. Genes, brain development and psychiatric phenotypes in
velo-cardio-facial syndrome. Dev Disabil Res Rev. 2008;14(1):59-68. PubMed PMID:
18636637.
ease, and evolution. Annual review of genomics and human genetics. 2009;10:451-81.
[76] Lupski JR. Structural variation in the human genome. The New England journal of
medicine. 2007 Mar 15;356(11):1169-71. PubMed PMID: 17360997. Epub 2007/03/16.
eng.
[77] Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 ge
netic and genomic disorders and still counting. Brain Res. 2011 Mar 22;1380:42-77.
113(5):e472-86. PubMed PMID: 15121991. Epub 2004/05/04. eng.
[79] Marui T, Hashimoto O, Nanba E, Kato C, Tochigi M, Umekage T, et al. Association
between the neurofibromatosis-1 (NF1) locus and autism in the Japanese population.
American journal of medical genetics Part B, Neuropsychiatric genetics : the official
publication of the International Society of Psychiatric Genetics. 2004 Nov 15;131B(1):
317
318
Brain & development. 2007 Jun;29(5):257-72. PubMed PMID: 17084999. Epub
2006/11/07. eng.
chromosomal rearrangements in patients with syndromic autism spectrum disorders.
Journal of medical genetics. 2006 Nov;43(11):843-9. PubMed PMID: 16840569. Pubmed
[82] Smith ACM, Boyd K, Elsea SH, Finucane BM, Haas-Givler B, Gropman A, et al. SmithMagenis Syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneRe
views. Seattle (WA)1993.
ation of de novo copy number mutations with autism. Science. 2007 Apr 20;316(5823):
445-9. PubMed PMID: 17363630. eng.
[84] Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural variation
of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008 Feb;82(2):477-88.
[85] Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, Karamohamed S, et al. Novel sub
microscopic chromosomal abnormalities detected in autism spectrum disorder. Biol
Psychiatry. 2008 Jun 15;63(12):1111-7. PubMed PMID: 18374305. Epub 2008/04/01. eng.
[86] Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional impact
of global rare copy number variation in autism spectrum disorders. Nature. 2010 Jul
15;466(7304):368-72. PubMed PMID: 20531469. Pubmed Central PMCID: 3021798. Epub
2010/06/10. eng.
[87] Noor A, Whibley A, Marshall CR, Gianakopoulos PJ, Piton A, Carson AR, et al. Dis
ruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual
disability. Sci Transl Med. 2010 Sep 15;2(49):49ra68. PubMed PMID: 20844286. Pubmed
[88] Salyakina D, Cukier HN, Lee JM, Sacharow S, Nations LD, Ma D, et al. Copy number
variants in extended autism spectrum disorder families reveal candidates potentially
involved in autism risk. PloS one. 2011;6(10):e26049. PubMed PMID: 22016809. Pubmed
[89] Celestino-Soper PB, Shaw CA, Sanders SJ, Li J, Murtha MT, Ercan-Sencicek AG, et al.
Use of array CGH to detect exonic copy number variants throughout the genome in
autism families detects a novel deletion in TMLHE. Human molecular genetics. 2011
Nov 15;20(22):4360-70. PubMed PMID: 21865298. Pubmed Central PMCID: 3196886.
Epub 2011/08/26. eng.
[90] Nord AS, Roeb W, Dickel DE, Walsh T, Kusenda M, O'Connor KL, et al. Reduced tran
script expression of genes affected by inherited and de novo CNVs in autism. European

http://dx.doi.org/10.5772/54854
journal of human genetics : EJHG. 2011 Jun;19(6):727-31. PubMed PMID: 21448237.

Pubmed Central PMCID: 3110052. Epub 2011/03/31. eng.
Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syn
drome region, are strongly associated with autism. Neuron. 2011 Jun 9;70(5):863-85.
[92] Levy D, Ronemus M, Yamrom B, Lee YH, Leotta A, Kendall J, et al. Rare de novo and
transmitted copy-number variation in autistic spectrum disorders. Neuron. 2011 Jun
[93] Zhao X, Leotta A, Kustanovich V, Lajonchere C, Geschwind DH, Law K, et al. A unified
genetic theory for sporadic and inherited autism. Proceedings of the National Academy
of Sciences of the United States of America. 2007 Jul 31;104(31):12831-6. PubMed PMID:
[94] Girirajan S, Eichler EE. Phenotypic variability and genetic susceptibility to genomic
disorders. Human molecular genetics. 2010 Oct 15;19(R2):R176-87. PubMed PMID:
[95] Itsara A, Wu H, Smith JD, Nickerson DA, Romieu I, London SJ, et al. De novo rates and
selection of large copy number variation. Genome Res. 2010 Nov;20(11):1469-81.
PubMed PMID: 20841430. Pubmed Central PMCID: 2963811. Epub 2010/09/16. eng.
[96] Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, et al. Mutations
of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with
autism. Nat Genet. 2003 May;34(1):27-9. PubMed PMID: 12669065. Epub 2003/04/02.
eng.
[97] Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, et al.
ated with autism spectrum disorders. Nat Genet. 2007 Jan;39(1):25-7. PubMed PMID:
17173049. Epub 2006/12/19. eng.
exomes reveal a highly interconnected protein network of de novo mutations. Nature.
2012 Apr 4. PubMed PMID: 22495309. Epub 2012/04/13. Eng.
exonic de novo mutations in autism spectrum disorders. Nature. 2012 Apr 4. PubMed
PMID: 22495311. Epub 2012/04/13. Eng.
novo mutations revealed by whole-exome sequencing are strongly associated with au
tism. Nature. 2012 Apr 4. PubMed PMID: 22495306. Epub 2012/04/13. Eng.
[101] Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum
disorders. Pediatrics. 2007 Nov;120(5):1183-215. PubMed PMID: 17967920. Epub
2007/10/31. eng.
319
320
[102] Schaefer GB, Mendelsohn NJ. Genetics evaluation for the etiologic diagnosis of autism
spectrum disorders. Genetics in medicine : official journal of the American College of
Medical Genetics. 2008 Jan;10(1):4-12. PubMed PMID: 18197051. Epub 2008/01/17. eng.
[103] Roesser J. Diagnostic yield of genetic testing in children diagnosed with autism spec
trum disorders at a regional referral center. Clinical pediatrics. 2011 Sep;50(9):834-43.
Chapter 15
Genetic and Environmental Factors in Autism

Esra Guney and Elvan Iseri
http://dx.doi.org/10.5772/53295
1. Introduction
Autism is a neurodevelopmental disorder characterized by impaired social interaction, and
verbal and nonverbal communication as well as limited and repetitive behaviours. Although
symptomatology of autism may be noticed around early months, diagnosis generally occurs
around 24-36 months, however in some cases diagnosis may be delayed to adulthood [1].
Since behavioural symptoms and the degree of functional impairment are variable, the au
tistic disorder is described as a heterogenous symptom cluster of varying etiological and
pathological basis [2]. Described as a multifactorial disorder created by interaction of neuro
logic, immunologic, environmental, and genetic factors, autistic disorder has no definite
cause [3, 4]. In many cases in whom the etiology remains unclear are diagnosed as idiopath
ic autism or non-syndromic autism [5, 6]. Seventy percent of cases with idiopathic autism
have basic symptoms without physical abnormalities whereas 30% have complex autism in
which dysmorphic features are detected such as microcephaly and/or structural brain mal
formations [7]. Autism is associated with other syndromes such as Fragile X syndrome,
Down Syndrome, and tuberosclerosis in 5-25% of the cases ([8, 9]. Although phenotypic het
erogeneity is the biggest challenge for research efforts directed to identify autism etiology
[10], currently it is widely accepted that environmental and genetic factors play essential
role in genesis of autistic disorder thanks to a recent advance in research techniques related
to biological factors and widespread studies in this field [11, 12].
2. Genetics
Autistic disorder is a multifactorial genetic disorder not following classical Mendelian inher
itance. Impairment in social interaction and verbal communication as well as genetic differ
entiation in rigid-repetitive behaviours indicates that different features in autistic disorder
2013 Guney and Iseri; licensee InTech. This is an open access article distributed under the terms of the
322
may be caused by different genes associated with distinct brain regions and be related to
cognitive impairment and functional abnormalities [13].
Genetic studies in the field of autistic disorder have mainly focused on molecular genetic
studies, assessment of chromosomal abnormalities, twin studies and family studies. In fami
lies having an autistic child the recurrence rate has been reported as 3-8% [14, 15, 16]. The
studies on twins and adopted children are important in identifying the actual importance of
genetic factors. Concordance among twins enables to measure heritability, and thus to as
sess what percentage of the phenotype is affected by genetic factors. Monozygotic (identical)
twins share 100% of the genetic material whereas dizygotic (fraternal) twins share 50% of
the genetic material. Monozygotic twins higher rate of concordance compared to dizygotic
twins may be used for calculation of heritability. Twin studies generally showed a higher
concordance rate for monozygotic twins compared to dizygotic twins. The concordance rate
of monozygotic twins is at least 60% when diagnostic criteria for autism (DSM-IV) are used
whereas the number is as high as 71% for autism spectrum and 92% for a broader spectrum
of verbal/social interaction disorders [11, 12, 16, 17]. On the other hand, the concordance rate
of dizygotic twins has been reported as 1-30% [9, 17-20]. Twin studies demonstrated an
average autism inheritance of 90% [21]. On the basis of these studies autism is considered to
be among the most inherited psychiatric diseases [22, 23].
Although autism has a high inheritance rate, its mode of inheritance remains unclear. Multigene interactions and multiple loci are believed to play role in genetic susceptibility to the dis
ease [24]. There are 3 basic approaches in this area: 1) in whole genome scanning method, it is
aimed to predict the localization of a disease, about chromosomal localization of which we
have no preliminary information, by starting from common genetic determinants in a com
munity composed of multiplex families (families with more than one involved member). 2) cy
togenetic studies guide molecular studies by showing inherited or de novo chromosomal
anomalies in involved persons or families. 3) candidate gene studies examine the relationship
of genes known to affect brain development in associated regions or alternatively, a selected
precursor gene considered to hypothetically contribute to autism pathogenesis.
It has been demonstrated that structural chromosomal variations comprising also copy
number variations play an important role in etiology of autism. De novo copy number varia
tions have been identified in 7-10% of sporadic autism cases [25, 26].
In studies employing genome scanning method to reveal genetic etiology of autism, cogent
evidence for an association with chromosomes 2, 7, 1, and 17, especially long arm of chro
mosomes 2 (2q) and 7 (7q) has been obtained. Other chromosomes less associated with au
tism are chromosomes 1, 9, 13, 15, 19, 22, and X chromosome [14, 16, 27]. Although a lot of
genomic regions have been explored for etiology, consistent results for a limited number of
regions such as 7q11, 7q31, 22q11 have been obtained [16, 28, 29]. Particularly 15q11-q13 re
gion on chromosome 15 has been widely related to autism. It has been suggested that dupli
cations in this region of chromosome 15 may contribute to autism development. There exist
in this area a series of potential candidate genes containing gamma aminobutyric acid A
(GABAA) receptor gene complex [30]. These duplications inherited maternally have been re
ported to be present in 1-3% of individuals with idiopathic autism [31, 32].

http://dx.doi.org/10.5772/53295
Another region related to autism is a deletion region located on chromosome 16p11. This re
gion has also been demonstrated to be in relationship with Asperger Syndrome, mental re
tardation, and developmental abnormalities [33, 34].
It has been showed that, in individuals with autism, there is a significant increase in the fre
quency of allelic variations of HOXA1 gene (7p15). HOXA1 and HOXB1, which have a criti
cal role for development of fetal caudal medullary structures, are only expressed at the third
week following fertilization, a period when neural tube is formed, and they appear to be
partly associated with development of superior olivary, facial and abducens nuclei. It has
been suggested that HOXA1 has a role in autism tendency and is associated with early
phase of brain stem development in autism etiology [16, 35]. On the other hand, there are
studies where no significant association with HOXA1 gene variants and autism could be
demonstrated [36, 37].
Engrailed-2 (EN-2) which is the human homologue of drosophila engrailed gene and located
on the long arm of Chromosome 7 (7q36) is a homeobox gene having a critical role in mid
brain and cerebellar development. Temporal and spatial pattern of engrailed gene expres
sion occurs simultaneously with the development of cerebellar precursor cells. Thus, it has
been suggested to be important to determine correct cell number in cerebellum [38]. Petit
and his colleagues (1995) reported a significant association between Pvull polymorphism at
the 5 region of EN-2 gene and autism [39]. However, this association could not be con
firmed in a later family study [40].
MET oncogene coding pleiotropic MET receptor thyrosine kinase is located on the long arm
of Chromosome 7. MET signalization has a role in neocortex and cerebellar growth and ma
turation, and immune functions. MET gene and its ligand, hepatocyte growth factor (HGF),
have been related to autism. Studies conducted by Campbell and his colleagues ([41,42]
showed that C allele in the promoter region of MET gene decreases MET promoter activity
by two fold and decreased MET gene expression is associated with autism tendency.
Another gene on Chromosome 7 is CNTNAP2 (contactin-associated-protein-like 2) gene.
CNTNAP2 gene has been associated in various studies with autism, language delay, and
epilepsy [43-45].
FOXP2 (forkhead box P2), a forkhead transcription factor gene, is a member of family fork
head known as the key regulators of embryogenesis; it encodes a transcription factor con
taining polyglutamine and is associated with development of lingual functions. In a study in
Chinese society, FOXP2 gene located in the 7q31 region was linked with autism pathogene
sis [46]. However, other studies did not replicate these findings [47, 48].
Another gene investigated for autism relationship is Wingless-Int (Wnt2) gene located on
the long arm of Chromosome 7 (7q31-33). Wnt genes encode glycoproteins rich in cysteine,
which regulate various cellular movements during the embryonic development [49]. It has
been shown that Wnt has a role in regulation of activity-dependent dendritic branching in
hippocampal pyramidal neurons [50]. Wnt2 gene was linked with autism in a study by Was
sink and his colleagues [51].
323
324
Reelin is an important extracellular matrix glycoprotein that has an important role in devel
opment of neuronal migration, lamination, and connection during embryonic brain develop
ment and is associated with a signal pathway forming the basis of neuro-conduction,
memory formation, and synaptic plasticity [52]. It is responsible for lamination in embryonic
period whereas it has a role in cell signalization and synaptic plasticity in adulthood period
[53]. Decrease in reelin expression has been associated with autism. RELN gene, which is lo
cated in 7q22 region and encodes reelin protein which is important in neurodevelopment,
involves a polymorphic GGC repeat in 5 region. Long GGC alleles of RELN gene cause
blunt gene expression; therefore, they are considered to be linked with autism [52]. There
are studies reporting a significant relationship between RELN alleles with larger numbers of
CGG repeats and autism [52, 54] while there are also negative studies in terms of such a rela
tionship [55]. Besides the genetic complexity in the etiopathogenesis of this disorder, nonreplication of the results of different studies should also be taken into consideration.
Neuroligins are cellular adhesion molecules located at the postsynaptic side of the synapse.
Neuroligins and neuroxins, neuronal cell surface proteins, form an asymmetrical intercellular
connection by adhering to each other. Interaction of neuroligins with beta neuroxins forms
functional synapses [56]. Neuroligin family is composed of 5 members, i.e. NLGN1, NLGN2,
NLGN3, NLGN4, and NLGN4Y. Although all of the neuroligin family is linked with autism
spectrum disorder [57], the most robust evidence comes from NLGN3 (Xq13) and NLGN4
(Xp22.3) genes. Jamain and colleagues [58] found that mutations in NLGN3 and NLGN4, two
X-linked neuroligin genes, are associated with autism spectrum disorders [58]. Following this,
it has been demonstrated that a 2-base-pair deletion in NLGN4 gene causes premature stop co
don in mental-retarded men with or without autism. This finding indicates that NLGN4 gene is
not only associated with autism, but also with mental retardation [59]. Since mutations in neu
roligin genes impair the functions of synaptic cell adhesion molecules, they are considered to
be related with autism and neurodevelopmental defects in mental retardation [60]. Since neu
roligins are abundant particularly in excitatory synapses, a defect in synaptogenesis has been
suggested to result in derangement in cognitive development and communication [59]. None
theless, some other studies revealed negative results [61].
Genetic studies examining the relationship of neuroxins, the connection partners of neuroli
gins, with autism revealed that a mutation in neuroxin 1beta gene results in autism susceptibil
ity [62]. Structural variants of neuroxin 1alpha gene have also been linked with autism [63].
Another protein adhering to neuroligins is SHANK3. Some forms of autism are considered
to stem from a single gene, and particularly from a rare allele having a major effect. Doctor
Joseph Buxbaum has reported that one of these genes is SHANK3 gene located on Chromo
some 22 (22q13) which is responsible for 1% of autism and some forms of mental retarda
tion, microcephaly, and delay in expressive language [34]. SHANK proteins are believed to
be the primary regulator of postsynaptic density thanks to their ability to form multimeric
complexes with postsynaptic receptors, signal molecules, and cellular skeleton proteins
found in dendritic spikes. Postsynaptic density is the measurement of how synapses are
linked to each other. A mutation in SHANK3 gene has been reported to be related with au
tism spectrum disorders [64]. Role of various mutations in Neuroligin/neuroxin/SHANK3

http://dx.doi.org/10.5772/53295
complex in development of autism spectrum disorders provide potential evidence for syn
aptic alterations in etiology of the disorder.
A large-scale study by Wang and his colleagues [65] revealed a significant relationship be
tween a single nucleotide polymorphism located in the 5p14.1 region and autism spectrum
disorders. The associated single nucleotide polymorphism is located in a region placed be
tween cadherin 10 (CDH 10) and cadherin 9 (CDH 9) genes. CDH 9 and CDH 10 encode
type II classic cadherins of the cadherin family, which are transmembraneous glycoprotiens
responsible for calcium-dependent cell-cell adhesion. This finding shows the role of neuro
nal cellular adhesion molecules in autism pathogenesis [65].
Neurotrophins have many functions such as neuronal survival, target innervation, and synap
togenesis in development of peripheral and central nervous system. Neurotrophins exert their
biologic functions by binding to a Trk tyrosine kinase receptor which is a high-affinity recep
tor. Neurotrophin family has 4 members. These are nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin-3 and neurotrophin-4. BDNF is the most important
member of neurotrophin family. BDNF has many roles in neuronal differentiation such as neu
ronal survival, dendritic and axonal growth/branching, synapse formation, and neuronal plas
ticity [66, 67]. Various studies have investigated the relationship between BDNF gene and
autism. Nishimura and colleagues [68] detected an increase in BDNF expression in autistic in
dividuals. Subsequent studies confirmed the potential role of BDNF gene mutations in autism
pathogenesis [69]. A recent study in which serum BDNF levels significantly increased in autis
tic children found no significant impact of genetic variations of BDNF gene on autism risk;
however, a significant relationship between neurotrophic tyrosine kinase receptor type 2
(NTRK2) and autism was reported [70]. A large-scale study on patients diagnosed with autism
spectrum disorder and mental retardation without autism diagnoses showed that, when com
pared to control group, autism spectrum disorders and mental retardation had a significant in
crease in serum neurotrophin 4 and BDNF (both are Trk B ligands) [71, 72]. On the other hand,
no changes were observed in NGF (trk A ligand) and neurotrophin 3 (Trk C ligand) levels. In
light of these findings, it has been suggested that trkB ligands may be overexpressed or secret
ed in central nervous system of autistic or mental retarded children during infantile period. It
has also been suggested that the effect of BDNF and neurotrophin- 4 on activity-dependent
dendritic growth and branching [66] may be related to early and transient brain development
seen in autistic infants [67, 73]. This increase in BDNF expression and/or secretion was suggest
ed to be linked with the role of Metil-CpG-binding protein 2 (MeCP2) gene in BDNF transcrip
tion [74]. A mutation in MeCP2 gene encoding a protein functioning as a general
transcriptional receptor is responsible for Rett Syndrome. It has been shown that MeCP2 selec
tively bind to BDNF promoter III and suppresses BDNF gene expression. MeCP2 has an impor
tant role in regulation of neuronal activity [75]. It has been suggested that MeCP2 mutations
located on Xq28 locus may be a risk factor for autism by affecting BDNF expression and den
dritic differentiation in cortex. In a study investigating MeCP2 gene mutation in autistic indi
viduals for that purpose, 2 girls exhibited de novo mutations [67, 76].
Another gene linked with autism is the Fragile X mental retardation 1 (FMR1) gene encoding
Fragile X mental retardation protein (FMRP). FMR1 is associated with autism secondary to
325
326
Fragile X syndrome [28]. However, fragile X mutations may be found in 7-8% idiopathic au
tism patients [77]. FMRP is a selective RNA-binding protein; it transports RNAs to dendrites
and regulates local translation of synaptic mRNAs as a response to activation of metabotropic
glutamate receptors. This protein is considered to have a role in synaptic plasticity and devel
opment of synaptic connections between neural cells. Impaired mRNA translation in the ab
sence of FMRP leads to an alteration in protein-synthesis-dependent plasticity [28, 78].
Autism risk is higher than general population in neurofibromatosis, tuberosclerosis, or Cow
den Syndrome, a rare syndrome which is characterized by multiple tumor-like growths
called hamartomas and affects the intellectual abilities. These diseases develop due to domi
nant mutations in tumor suppressor genes NF1, TSC1/TSC2, and PTEN. Mutations in these
autism-associated genes affect synaptic protein level by impairing cellular translation. Alter
ations in protein level results in abnormal synaptic functions [28].
Angelman syndrome and Prader-Willi syndrome mainly develop due to genetic deletions in
15q11-q13 locus or disomy (condition where two copies of a chromosome comes from a sin
gle parent) belonging to a single parent [79]. Deficiencies in paternal genes cause PraderWilli syndrome; Angelman Syndrome which is more commonly associated with autism may
be caused by deletion or mutation in maternal ubiquitin protein ligase gene UBE3A or
ATP10C [80, 81]. Other rare single gene defects associated with autism are found in Wil
liams Syndrome, Sotos Syndrome, hipomelanozis Ito, and Moebius Syndrome [82-85].
Since serotonin reuptake inhibitors have favourable effects on rituals and routines in autistic
individuals and serotonin transporter gene has important role in serotonergic neurotrans
mission, serotonin transport gene has been investigated as candidate gene in autism. One of
the polymorphisms examined in this gene is the one that is formed by long (L) and short (S)
alleles owing to different number of insertion/deletion repeats of a 44-base-pair sequence in
the transcriptional control region. Cook and his colleagues [86] reported a significant rela
tionship between autism and short allele while Klauck and his colleagues [87] revealed a
significant relationship between autism and long allele. A subsequent study did not dupli
cate these findings [88]. A different polymorphism investigated at the serotonin transport
gene is the variable number of tandem repeats (VNTR) polymorphism due to repeat of a 17base-pair region at 2nd intron of the gene 9,10, and 12 times. This polymorphism could not
be related to autism [89]. Evidence has been accumulated on the relationship of many sero
tonin genes, notably serotonin receptor (HTR) 1B, HTR2A, HTR3A, and HTR5A, with au
tism [90-93].
Glutamate is the main excitatory neurotransmitter associated with cognitive functions such
as memory and learning. Autism has been hypothesized as a hypoglutamatergic disorder by
virtue of neuroanatomic studies and the similarities glutamate antagonists generate in
healthy persons [94]. It has been demonstrated in genome scanning studies that one of the
candidate regions for autism is 6q21 region [95]. This region contains glutamate receptor 6
(GluR6) gene. A study by Jamain and his colleagues [96] found a significant relationship be
tween GluR6 gene and autism. It has been thought that GluR6 dysfunction may contribute
the deterioration of communication and learning process in autism and any dysregulation of
GluR expression may be related to an increase in the rate of epileptic disorder in autistic

http://dx.doi.org/10.5772/53295
children [96]. Other glutamatergic receptor genes associated with autism are metabotropic
GluR8 and GRIN2A (glutamate receptor, ionotropic, N-methyl-D-aspartate 2A) [97, 98].
Gama aminobutyric acid (GABA) is the major inhibitor neurotransmitter in the brain. GABAA
receptors are formed by different homologous subunits. Among GABA receptor subunit genes,
GABRA4 with 4p12 location has been shown to play a role in etiology of autism and increases au
tism risk by interaction with GABRB1 [99]. Other genes associated with autism in some other
studies are GABRG3, GABRA5, GABRB3 located on 15q11-q13, and GABRA2 located on 4p
[100-102]. Contrary to these findings, there are other studies with negative results in terms of the
relationship between GABA receptor genes and autism in various ethnic groups [103].
Proenkephalin, prodinorphine of opioid metabolism; tyrosine hydroxylase, dopamin beta
hydroxylase (DBH), D2, D3, and D5 dopamin receptors, monoaminooxidase A (MAOA) and
B genes of monoaminergic system have no major role in etiology of autism shown in studies
[104, 105]. However, a recent study revealed a significant relationship between MAOA gene
and autism [106].
Mutations detected in autism in conjunction with all other genetic factors explored so far
have been reported to explain no more than 20% of cases with autism spectrum disorder.
Thus, a gene-dosage model has been proposed according to which the susceptibility for au
tism is determined by the sum of effects of threshold genetic and non-genetic factors [107,
108]. For autism etiology, it has been suggested that the detected chromosomal abnormali
ties in combination with other undetected loci cause autism. It has been considered that the
inconsistencies between the results of the studies aimed to determine the role of genetic fac
tors may be the product of genetic heterogeneity, clinical heterogeneity, and sample size and
ethnic differences among different studies [109].
3. Environmental risk factors

In addition to effects of a number of genes of small effect, various environmental factors are
believed to be responsible for susceptibility to autism. Development of autism seems to be
dependent on interaction of susceptibility genes with each other and with the environment
[110]. It has been claimed that among environmental factors related to autism are toxins (en
vironment-polluting matters, insecticides, thimerosal in vaccines, lead), viruses (prenatal ex
posure to influenza, rubella, and cytomegalovirus infections), and premature birth with
premature retinopathy [111-115]. Although there has been a debate regarding the relation
ship of autism with thimerosal in measles, rubella, and mumps vaccines; further careful
evaluation of data could not support the relationship between autism and vaccines [116,
117]. The relationship between exposure to Rh immune globulin, which contained the pres
ervative thimerosal until 2001 in the United States, and autism has also been investigated;
however, no significant association has been revealed between exposure of antepartum RhIg
preserved with thimerosal and an increase in risk of autistic disorder. The latter findings are
in accordance with the consensus that exposure to ethymercury in thimerosal is not the
cause of increased prevalence of autism [118].
327
328
Other factors related to intrauterine environment are maternal hypothyroxinemia [119], ma

ternal influenza [120], and high levels of sex hormone exposure related to infertility treat
ment [121].Thalidomide and anticonvulsant exposure in pregnancy is correlated to an
increase in autism risk [122, 123]. Rasalam and his colleagues [124] showed that 8.9% of chil
dren exposed to sodium valproate in intrauterine life later develop autistic spectrum disor
ders such as autism or Asperger syndrome. Recently, Hadjikhani [125] have suggested that
serotonin reuptake inhibitor use in pregnancy increases autism risk by causing hyperseroto
ninemia and indirectly affecting amygdala and oxytocin levels.
In many studies, the pre-perinatal complication rates in autistic disorder have been studied
and a higher pregnancy-related complication rate has been demonstrated in autistic children
[126, 127]. In a recent meta-analysis [128], the most strong risk factors for autism were ad
vanced maternal and paternal age, maternal gestational hemorrhage, gestational diabetes, ma
ternal prenatal drug use (particularly psychoactive drugs), and birth in a foreign country
following immigration of mother. Both advanced maternal and paternal age are associated
with autism. The underlying mechanism is unclear. Maternal age may be related to autism due
to increased risk of chromosomal abnormalities in ova of increased age or because of unstable
trinucleotide repeats [128]. The relationship between paternal age and autism is considered to
result from imprinted genes (genes showing different expression patterns depending on the
parent it originates), de novo spontaneous mutations that accumulate with advancing age in
spermatagonia, or confounder effects of sociocultural environmental factors [129]. Another po
tential risk factor for autism is maternal birth abroad [130]. It has been suggested that this factor
may result from absence of immunization that mother would develop against widespread in
fectious agents of the country in which she gives birth. Another possible explanation is about
the potential role of maternal stress because of immigration [131]. A more detailed investiga
tion on the relationship between mother immigration and autism is needed. It has been demon
strated in some studies that gestational hemorrhage increases autism risk by causing fetal
hypoxia [130]. Among other factors considered to cause hypoxia and associated with increased
autism risk in some studies are fetal distress, maternal hypertension, prolonged labor, cord
complications, low Apgar score, and cesarean section [132]. Gestational diabetes is another risk
factor, with unknown biologic mechanism [128].
Some studies demonstrated that prenatal stress increases autism risk [133, 134]. However,
due to limitations that these studies are based on retrospective expressions of mothers and
these mothers are generally susceptible for experiencing stressful life events outside preg
nancy period, these studies need to be supported by further studies. Spontaneous abortions,
pre-perinatal complications, congenital anomalies, and neurologic/immunologic abnormali
ties are among the negative impacts of prenatal stress. Prenatal stress also has various nega
tive effects on brain development such as a delay in myelinization, an increase in sensitivity
of amygdala to glucocorticoids, and abnormal development in dopaminergic system
[135-137]. Autistic disorder is associated with a functional derangement in brain areas relat
ed to social cognitive functions in which amygdala and orbitofrontal cortex plays an impor
tant role. Orbitofrontal cortex is susceptible to effects of prenatal stress especially in the
middle of gestation. Normal functioning of orbitofrontal cortex - amygdala axis is very im

http://dx.doi.org/10.5772/53295
portant for social cognitive function. Therefore, it has been suggested that damage in orbito
frontal region may cause main deficits in autism that underlies inadequate responses to
other peoples mental status and that impairs self-organization of social-emotional behav
iours [137, 138]. Prenatal stress may impair brain development by many mechanisms includ
ing: a) fetal hypoxia due to reducing of uterine and placental circulation, b) impairment of
hypothalamus-hypophysis-adrenal axis by stimulation of secretion of maternal stress hor
mones that can cross placenta, c) generation of pregnancy and birth complications, d) epige
netic effects on expression of stress response-related genes [137].
It has been reported that exposure of environmental stress factors at 21-32nd weeks with a
prominent peak at 25-28th weeks is associated with an increase in possibility of development
of autism [134]. When data regarding progressively worsening developmental process are
considered [139], it has been argued that postnatal environmental exposures in genetically
susceptible children may be etiologically important [140]. Expression and the impact of
many genes is influenced by environmental factors. Thus, the effect of environmental factors
in etiology of autism is believed to be indirect by influencing genetic functions [140, 141].
4. Conclusion
In line with studies aimed to understand the neurobiology of autism, the presence of altera
tions in regional brain anatomy and functional neuronal communicative network has been
currently proved. The main role among factors underlying abnormal brain development be
longs to genetic factors. Evidence regarding that autism is a primarily genetic disorder is
progressively increasing. Although environmental factors alone can explain a few cases,
they are believed to increase autism risk by interacting with genetic susceptibility. Although
data collected so far contribute to the ever-increasing body of knowledge about neurobiolo
gy of autism, they do not influence diagnosis and treatment of autism. Use of these data is
aimed in future in differentiation of autism from other neurodevelopmental disorders and
in diagnostic and therapeutic processes.
Author details
Esra Guney1* and Elvan Iseri2
1 Ankara Pediatric & Pediatric Hematology Oncology Training and Research Hospital,
Child and Adolescent Psychiatry Department, Ankara, Turkey
2 Gazi University Medical Faculty, Child and Adolescent Psychiatry Department, Ankara,
Turkey
329
330
References
[1] Filipek PA, Accardo P, Baranek GT, Cook EH Jr, Dawson G, Gordon B et al. The
screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999;
29:439- 484.
[2] Krause I, He XS, Gershwin ME, Shoenfeld Y. Brief Report: Immune factors in autism:
A critical review. J of Autism and Developmental Disorders 2002;32:337-345.
[3] Ashwood P, Wills S, Water JV. The immune response in autism: a new frontier for
autism research. Journal of Leukocyte Biology 2006;80:1-15.
[4] Chauhan A, Chauhan V. Oxidative stres in autism. Pathophysiology 2006;13:171-181.
[5] Boddaert N, Zilbovicius M, Philipe A, Robel L, Bourgeois M, Barthelemy C et al. MRI
findings in 77 children with non-sendromic autistic disorder. PLos One 2009;4: e4415.
[6] Gillberg C, Coleman M. Autism and medical disorders: a review of the literature.
Dev Med Child Neurol 1996;38:191-202
[7] Miles JH, Takahashi TN, Bagby S, Sahota PK, Vaslow DF, Wang CH et al. Essential
versus complex autism: definition of fundamental prognostic subtypes. Am J Med
Genet A 2005;135:171-180.
[8] Rutter M, Bailey A, Bolton P, Le Couteur A. Autism and known medical conditions:
myth and subtance. J Child Psychol Psychiatry 1994;35:311-322.
[9] Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of
the literature. Mol Psychiatry 2007;12:2-22.
[10] Newschaffer CJ, Fallin D, Lee NL. Heritable and non-heritable risk factors for autism
spectrum disorders. Epidemiol Rev 2002;24:137-153.
[11] Folstein S, Piven J. Etiology of autism: genetic influences. Pediatrics 1991;87:767-73.
[12] Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E et al. Autism as
a strongly genetic disorder: evidence from a British twin study. Psychol Med
1995;25:63-77.
[13] Happe F, Ronald A, Plomin R. Time to give up on a single explanation for autism.
Nat Neurosci 2006;9:1218-1220.
[14] Shao Y, Wolpert CM, Raiford KL, Menold MM, Donnelly SL, Ravan SA et al. Genom
ic screen and follow-up analysis for autistic disorders. Am J Med Genet
2002;114:99-105.
[15] Fisher S, Vargha-Kadem F, Watkins K, Monaco A, Pembrey M. Localization of a gene
implicated in a severe speech and language disorder. Nat Genetic 1998;18:6-170.
[16] Gadia CA, Tuchman R, Rotta NT. Autism and pervasive developmental disorders.
Jornal de Pediatria 2004;80(2 suppl): 83-94.

http://dx.doi.org/10.5772/53295
[17] Folstein S, Rutter M. Infantile autism: a genetic study of 21 twin pairs. J Child Psy
chol Psychiatry 1977;18:29-321.
[18] Ritvo ER, Freeman BJ, Mason-Brothers A, Mo A, Ritvo M. Concordance for the spec
trum of autism in 40 pairs of affected twins. Am J Psychiatry 1985;142:74-77.
[19] Trottier G, Srivastava L, Walker CD. Etiology of infantile autism: a review of recent
advances in genetic and neurobiological research. J Psychiatr Neurosci
1999;24:103-115.
[20] Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a
new neurobiology. Nat Rev Genet 2008;9:341-355.
[21] Lichtenstein P, Carlstrm E, Rastam M, Gillberg C, Anckarsater H. The genetics of
autism spectrum disorders and related neuropsychiatric disorders in childhood. Am
J Psychiatry 2010;167 (11):1357-63.
[22] Losh M, Sullivan PF, Trembath D, Piven J. Current developments in the genetics of
autism: from phenome to genome. J Neuropathol Exp Neurol 2008;67:829-837.
[23] Freitag CM. Genetics of autism. J Intellect Disabil Res 2008;52: 817.
[24] Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J et al. A genomic
screen of autism: evidence for a multilocus etiology. Am J Hum Genet
1999;65:493-507.
[25] Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T et al. Science
2007;316: 445-449.
[26] Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J et al. Structural varia
tion of chromosomes in autism spectrum disorder. Am J Hum Genet 2008;82:477-488.
[27] Gutknecht I. Full genome scans with autistic disorders: a review. Behav Genet
2001;31:113-23.
[28] Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F et al. Key role
for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends in
genetics 2010;26(8):363-372.
[29] Cusco I, Medrano A, Gener B, Vilardell M, Gallastegui F, Villa O, et al. Autism spe
sific copy number variants further implicate the phosphatidylinositol signaling path
way and the glutamatergic synapse in the etiology of the disorder. Hum Mol Genetic
2009;18(10): 1795-1804.
[30] Bass MP, Menold MM, Wolpert CM, Donnelly SL, Ravan SA, Hauser ER et al. Genet
ic studies in autistic disorder and chromosome 15. Neurogenetics 2000;2(4):219-26.
[31] Cook E Jr, Lindgren V, Leventhal B, Courchesne R, Lincoln A, Shulman C et al. Au
tism or atypical autism in maternally but not paternally derived proximal 15q dupli
cation. Am J Hum Genet 1997a;60(4): 928-934.
331
332
[32] Schroer RJ, Phelan MC, Michaelis RC, Crawford EC, Skinner SA, Cuccaro M et al.
Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet
1998; 76(4):327-36.
[33] Kumar RA, Karamohamed S, Sudi J, Conrad DF, Brune C, Badner JA. Recurrent
16p11.2 microdeletions in autism. Hum Mol Genet 2008;17:628-638.
[34] Amstadter AB. Selected summaries from the XVII world congress of psychiatric ge
netics, San Diego, California, USA, 4-8 November, 2009. Psychiatric Genetics
2010;20(5):229-268.
[35] Ingram J, Stodgell C, Hyman S, Figlewics D, Weitkamp L, Rodier P. Discovery of al
lelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disor
ders. Teratology 2000;62:393-405.
[36] Li J, Tabor HK, Nguyen L, Gleason C, Lotspeich LJ, Spiker D et al. Lack of association
between HoxA1 and HoxB1 gene variants and autism in 110 multiplex families. Am J
Med Genet 2002;114: 24-30.
[37] Talebizadeh Z, Bittel DC, Miles JH, Takahashi N, Wang CH, Kibiryeva N et al. No
association between HOXA1 and HOXB1 genes and autistic spectrum disorders
(ASD). J Med Genet 2002;39:e70.
[38] Kuemerle B, Zamjani H, Joyner A, Herrup K. Pattern deformities and cell loss in En
graled2 mutant mice suggest two separate patterning events during cerebellar devel
opment. J Neurosci 1997;17:7881-7889.
[39] Petit E, Herault J, Martineau J, Perrot A, Barthelemy C, Hameury L et al. Association
study with two markers of a human homeogene in infantile autism. J Med Genet
1995;32:269-74.
[40] Zhong H, Serajee FJ, Nabi R, Mahbubul Huq AHM. No association between the EN-2
gene and autistic disorder. J Med Genet 2003;40:e4.
[41] Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S et al. A genetic
variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci
USA 2006;103 (45):16834.
[42] Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P. Genetic evidence implicating
multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum dis
order. Autism Res 2008;1(3):159.
[43] Arking DE, David JC, Brune CW, Teslovich TM, West K, Ikeda M et al. A common
genetic variant in the neuroxin superfamily member CNTNAP2 increases familial
risk of autism. Am J Hum Genet 2008; 82(1):160-164.
[44] Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM et al. Link
age, association, and gene-expression analyses identify CNTNAP2 as an autism-sus
ceptibility gene. Am J Hum Genet 2008;82(1):150-9.

http://dx.doi.org/10.5772/53295
[45] Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, Parod JM, et al.
Recessive symtomatic focal epilepsy and mutant contactin-associated protein-like 2.
N Engl J Med 2006;354(13):1370-7.
[46] Gong X, Jia M, Ruan Y, Shuang M, Liu J, Wu S et al. Association between the FOXP2
gene and autistic disorderin Chinese population. Am J Med Genet B 2004;127(1):
113-116.
[47] Newbury DF, Bonora E, Lamb JA, Fisher SE, Lai CS, Baird G et al. FOXP2 is not a
major susceptibility gene for autism or spesific language impairment. AmJ Hum
Genet 2002;70(5):1318-27.
[48] Wassink TH, Piven J, Vieland VJ, Pietila J, Goedken RJ, Folstein SE et al. Evaluation
of FOXP2 as an autism susceptibility gene. Am J Med Genet B 2002;114(5):566-569.
[49] Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell
Dev Biol 1998;14:59-88.
[50] Yu X, Malenka RC. Beta-catenin is critical for dendritic morphogenesis. Nat Neurosci
2003; 6:1169-1177.
[51] Wassink TH, Piven J, Vieland VJ, Huang J, Swiderski RE, Pietila J et al. Evidence sup
porting WNT2 as an autism susceptibility gene. Am J Med Genet 2001;105:406-413
[52] Persico AM, Levitt P, Pimenta AF. Polymorphic GGC repeat differentially regulates
human reelin gene expression levels. J Neural Transm 2006;113(10):1373-82.
[53] Costa E, Chen Y, Davis J, Dong E, Noh JS, Tremolizzo L et al. Reelin and schizophre
nia: a disease at the interface of the genome and the epigenome. Mol Interv 2002;
2(1): 47-57.
[54] Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR et al. Reelin gene al
leles and susceptibility to autism spectrum disorders. Mol Psychiatry 2002; 7(9):
1012-7.
[55] Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M et al. Absence of
association between a polymorphic GGC repeat in the 5 untranslated region of the
reelin gene and autism. Mol Psychiatry 2002;7: 801-4.
[56] Song JY, Ichtchenko K, Sudhof TC, Brose N. Neuroligin is a postsynaptic cell- adhe
sion molecule of excitatory synapses. Proc Natl Acad Sci USA 1999;96:1100-1105.
[57] Blundell J, Blaiss CA, Etherton MR, Espinosa F, Tabuchi K, Walz C et al. Neuroligin 1
delletion results in impaired spatial memory and increased repetitive behavior. J
Neurosci 2010; 30(6): 2115-29.
[58] Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC et al. Mutations
of the X linked genes encoding neuroglina NLGN3 ve NLGN4 are associated with
autism. Nat Genet 2003;34: 27-29.
333
334
[59] Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP et al. Xlinked mental retardation autism are associated with a mutation in the NLGN4 gene,
a member of the neuroligin family. Am J Hum Genet 2004;74: 552-557.
[60] Chih B, Afridi SK, Clark L, Scheiffele P. Disorder-associated mutations lead to functi
nal inactivation of neuroligins. Hum Mol Genet 2004;13:1471-1477.
morphism of candidate genes in Slovak autistic patients. Psychiatr Genet 2010;20(4):
137-9.
[62] Feng J, Schroer R, Yan J, Song W, Yang C, Bockholt A et al. High frequency of neu
rexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett
2006;409(1):10-3.
[63] Yan J, Noltner K, Feng J, Li W, Schroer R, Skinner C et al. Neuroxin 1 alpha structural
variants associated with autism. Neurosci Lett 2008;438(3): 368-70.
[64] Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F et al.
ated with autism spectrum disorders. Nat Genet 2007;39(1):25-7.
[65] Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS et al. Common genetic
variations on 5p14.1 associate with autism spectrum disorders. Nature 2009;459:
528-533.
[66] Shieh PB, Ghosh A. Neurotrophins: new roles for a seasoned cast. Current Biology
1997;7: 627-630.
[67] Polleux F, Lauder JM. Toward a developmental neurobiology of autism. Mental Re
tardation and Developmental Disabilities Research Review 2004;10:303-317.
[68] Nishimura K, Nakamura K, Anitha A, Yamada K, Tsujii M, Iwayama Y et al. Genetic
analyses of the brain-derived neurotrophic factor (BDNF) gene in autism. Biochem
Biophys Res Commun 2007;356(1):200-6.
[69] Cheng L, Ge Q, Xiao P, Sun B, Ke X, Bai Y et al. Association study between BDNF
gene polymorphism and autism by three-dimensional gel-based microarray. Int J
Mol Sci 2009;10(6):2487-2500
[70] Correira CT, Coutinho AM, Sequeira AF, Sousa IG, Loureno Venda L, Almeida JP et
al. Increased BDNF levels and NTRK2 gene association suggest a disruption of
BDNF/TrkB signaling in autism. Genes, Brain and Behavior 2010;9(7):841-8.
[71] Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL et al. Neu
ropeptides and neurotrophins in neonatal blood of children with autism or mental
retardation. Ann Neurol 2001;49: 597-606.
[72] Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okado N et al. Serum neuro
trophin concentrations in autism and mental retardation: A pilot study. Brain Dev
2004;26:292-295.

http://dx.doi.org/10.5772/53295
[73] Lainhart JE, Piven J, Wzorek M, Landa R, Santangelo SL, Coon H et al. Macrocephaly
in children and adults with autism. J Am Acad Child Adolesc Psychiatry
1997;36:282-290.
[74] Chen WG, Chang Q, Lin Y, Meissner A, West AE, Griffith EC et al. Derepression of
BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science
2003;302: 885-889.
[75] Shahbazian M, Young J, Yuva-Paylor L, Spencer C, Antalffy B, Noebels J et al. Mice
with truncated MeCP2 recapitulate many Rett syndrome features and display hyper
acetylation of histone H3. Neuron 2002;35:243-254.
[76] Carney RM, Wolpert CM, Ravan SA, Shahbazian M, Ashley-Koch A, Cuccaro ML et
al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pe
diatr Neurol 2003;28: 205-11.
[77] Muhle R, Trentacoste
2004;113:472-486.
SV,
Rapin
I.
The
genetics
of
autism.
Pediatrics
[78] Kelleher RJ, Bear MF. The autistic neuron: troubled translation? Cell 2008;
135:401-406.
[79] Sutcliffe JS, Nurmi EL, Lombroso PJ. Genetics of childhood disorders: XLVII. Autism,
part6: duplication and inherited susceptibility of chromosome 15q11-q13 genes in au
tism. J Am Acad Child Adolesc Psychiatry 2003;42:253-256.
[80] Akefeldt A, Gillberg C, Larsson C. Prader-Will syndrome in a Swedish rural country:
epidemiological aspects. Dev Med Child Neurol 1991;33:715-721.
[81] Fang P, Lev-Lehman E, Tsai TF, Matsuura T, Benton CS, Sutcliffe JS et al. The spec
trum of mutations in UBE3A causing Angelman Syndrome. Hum Mol Genet
1999;8:129- 135.
[82] Morrow JD, Whitman BY, Accardo PJ. Autistic disorder in Sotos Syndrome: a case
report. Eur J Pediatr 1990;149:567-569.
[83] Reiss AL, Feinstein C, Rosenbaum KN, Borengasser Caruso MA, Gold-smith BM.
Autism associated with Williams Syndrome. J Pediatr 1985;106: 247-249.
[84] Zappella M. Autism and hypomelanosis of Ito in twins. Dev Med Child Neurol
1993;35: 826-832.
[85] Stromland K, Sjgreen L, Miller M, Gillberg C, Wentz E, Johansson M et al. Mobius
sequence a Swedish multidiscipline study. Eur J Paediatr Neurol 2002;6:35-45.
[86] Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A et al. Evidence of link
age between the serotonin transporter and autistic disorder. Mol Psychiatry 1997b;
2(3): 247-250.
[87] Klauck SM, Poustka F, Benner A, Lescch KP, Poustka A. Serotonin transporter gene
(5-HTT) variants associated with autism? Hum Mol Genet 1997;6(13): 2233-2238.
335
336
[88] Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Conciatori M et al.

Lack of association between serotonin transporter gene promoter variants and autis
tic disorder in two ethnically distinct samples. Am J Med Genet 2000;96(1):123-127.
[89] Betancur C, Corbex M, Spielewoy C, Philippe A, Laplanche JL, Launay JM et al. Sero
tonin transporter gene polymorphism and hyperserotoninemia in autistic disorder.
Mol Psychiatry 2002;7(1): 67-71.
[90] Orabona GM, Griesi-Oliveira K, Vadasz E, Bulco VL, Takahashi VN, Moreira ES et
al. HTR1B and HTR2C in autism spectrum disorders in Brazilian families. Brain Res
2009;1250:149.
[91] Cho IH, Yoo HJ, Park M, Lee YS, Kim SA. Family-based association study of 5HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disor
der in Korean trios. Brain Res 2007;1139: 3441.
[92] Anderson BM, Schnetz-Boutaud NC, Bartlett J, Wotawa AM, Wright HH, Abramson
RK et al. Examination of association of genes in the serotonin system to autism. Neu
rogene 2009;10(3): 209-16.
[93] Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C et al. Evidence
for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination
of platelet serotonin levels. Hum Genet 2007;121:24356.
[94] Carlsson ML. Hypothesis: is infantile autism a hypoglutamatergic disorder? Rele
vance of glutamate serotonin interactions for pharmacotherapy. J Neural Transm
1998;105:525-535.
[95] Philippe A, Martinez M, Guilloud- Bataille M, Gillberg C, Rastam M, Sponheim E et
al. Genome wide scan for autism susceptibility genes. Paris Autism Research Interna
tional Sibpair Study. Hum Mol Genet 1999;8: 805-812
[96] Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B et al. Linkage and as
sociation of the glutamate receptor 6 gene with autism. Mol Psychiatry 2002;7(3):
302-310.
[97] Serajee FJ, Zhong H, Nabi R, Huq AH. The metabotropic glutamate receptor 8 gene
at 7q31: partial duplication and possible association with autism. J Med Genet
2003;40:e42.
[98] Barnby G, Abbott A, Sykes N, Morris A, Weeks DE, Mott R et al. Candidate-gene
screening and association analysis at the autism susceptibility locus on chromosome
16p:evidence of association at GRIN2A and ABAT. Am J Hum Genet 2005;76(6):
950-966.
[99] Ma DQ, Whitehead PL, Menold MM, Martin ER, Ashley-Koch AE, Mei H et al. Iden
tification of significant association and gene-gene interaction of GABA receptor sub
unit genes in autim. Am J Hum Genet 2005;77(3): 377-388.

http://dx.doi.org/10.5772/53295
[100] Menold MM, Shao Y, Wolpert CM, Donnelly SL, Raiford KL, Martin ER et al. Associ
ation analysis of chromosome 15 GABAA receptor subunit genes in autistic disorder.
J Neurogenetics 2001;15 (3-4): 245-259.
[101] Cook EH, Courchesne RY, Cox NJ, Lord C, Gonen D. Linkage disequilibrium map
ping of autistic disorder, with 15q11-13 markers. Am J Hum Genet 1998;62(5):
1077-1083.
[102] Kakinuma H, Ozaki M, Sato H, Takahashi H. Variation in GABA-A subunit gene
copy number in an autistic patient with mosaic 4p duplication (p12p16). Am J Med
Genet B 2008;147(6): 973-975.
[103] Tochigi M, Kato C, Koishi S, Kawakubo Y, Yamamoto K, Matsumoto H et al. No evi
dence for significant association between GABA receptor genes in chromosome
15q11-13 and autism in a Japannese population. J Hum Genet 2007;52(12): 985-989.
[104] Martineau J, Herault J, Petit E, Guerin P, Hameury L, Perrot A et al. Catecholaminer
gic metabolism and autism. Dev Med Child Neurol 1994;36(8): 688-97.
[105] Philippe A, Guilloud- Bataille M, Martinez M, Gillberg C, Rastam M, Sponheim E et
al. Analyses of ten candidate genes in autism by association and linkage. Am J Med
Genet 2002;114(2): 125-128.
[106] Yoo HJ, Lee SK, Park M, Cho IH, Hyun SH, Lee JC et al. Family-and populationbased association studies of monoamine oxidase A and autism spectrum disorders in
Korean. Neurosci Res 2009;63:1726.
[107] Cook E, Scherer SW. Copy number variations associated with neuropsychiatric con
ditions. Nature 2008;455:919-923.
[108] Constantino JN, Todd RD. Intergenerational transmission subthreshold autistic traits
in the general population. Biol Psychiatry 2005;57:655-660.
[109] Shastry BS. Molecular genetics of autism spectrum disorders. J Hum Genet 2003;48:
495-501.
[110] Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE et al. The epi
demiology of autism spectrum disorders. Annual Review of Public Health 2007;28:
235-258.
[111] Chess S. Follow up report on autism in congenital rubella. J Autism Child Schzophr
1997;7:69-81
[112] Iversson SA, Bjerre I, Vegfors P, Ahlfors K. Autism as one of several disabilities in
two children with congenital cytomegalovirus infection. Neuropediatrics
1990;21:102-103.
[113] Kern JK, Geier DA, Audhya T, King PG, Sykes LK, Geier MR. Evidence of parallels
between mercury intoxication and the brain pathology in autism. Acta Neurobiol
Exp 2012;72(2):113-53.
337
338
[114] Tsuchiya KJ, Hashimoto K, Iwata Y, Tsujii M, Sekine Y, Sugihara G et al. Decreased
serum levels of platelet-endothelial adhesion molecule (pecam-1) in subjects with
high-functioning autism: A negative correlation with head circumference at birth. Bi
ol Psychiatry 2007;62(9):1056-58.
[115] Chase JB. Retrolental fibroplasia and autistic symptomatology. American foundation
for the blind. Newyork, NY; 1972.
[116] Taylor B, Miller E, Farrington C, Petropoulos M, Favot-Mayaud I, Li J et al. Autism
and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal
association. The Lancet 1999;353:2026-2029.
[117] Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization
coverage in California. JAMA 2001;285:1183-1185.
[118] Miles JH, Takahashi TN. Lack of association between Rh status, Rh immune blogulin
in pregnancy and autism. American Journal of Medical Genetics 2007;143A:1297
1407.
[119] Roman GC. Autism: Transient in utero hypothyroxinemia related to maternal flavo
noid ingestion during pregnancy and to other environmental antithyroid agents. J
Neurol Sci 2007; 262(1-2):15-26.
[120] Smith SE, Li J, Garbett K, Mirnics K, Patternson PH. Maternal immune activation al
ters fetal brain development through interleukin-6. Journal of Neuroscience 2007;27:
1069510702.
[121] Croughan M, Schembri M, Bernstein N, Chamberlain N, Purcell N, Camarano L. Ma
ternal and childhool outcomes following infertility and infertility treatments. Paper
presented at the American Society for Reproductive Medicine Annual Scientific
Meeting, New Orleans, October 2125, 2006.
[122] Zwaigenbaum L, Szatmari P, Jones MB, Bryson SE, Maclean JE, Mahoney WJ et al.
Pregnancy and birth complications in autism and liability to the broader autism phe
notype. J Am Acad Child Adolesc Psychiatry 2002;41:572-579.
[123] DeLong GR. Autism: new data suggest a new hypothesis. Neurol 1999;52: 911-916.
[124] Rasalam AD, Hailey H, Williams JH, Moore SJ, Turnpenny PD, Lloyd DJ et al. Char
acteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med
Child Neurol 2005;47: 551-555.
[125] Hadjikhani N. Serotonin, pregnancy and increased autism prevalence: Is there a link.
Med Hypotheses 2010;74(5): 880-3.
[126] Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. Perinatal fac
tors and the development of autism: a population study. Arch Gen Psychiatry
2004;61(6):618-27.

http://dx.doi.org/10.5772/53295
[127] Larsson HJ, Eaton WW, Madsen KM, Vestergaard M, Olesen AV, Agerbo E et al.
Risk factors for autism: perinatal factors, parental psychiatric history, and socioeco
nomic status. Am J Epidemiol 2005;161(10): 926-8.
[128] Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive
meta-analysis. The British Journak of Psychiatry 2009;195:7-14.
[129] Reichenberg A, Bresnahan M, Rabinowitz J, Lubin G, Davidson M. Advancing pater
nal age and autism. Arch Gen Psychiatry 2006;63:1026-32.
[130] Kolevson A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism: a
review and integration of finding. Arch Pediatr Adolesc Med 2007;161:326-33.
[131] Gillberg C, Schaumann H, Gillberg IC. Autism in immigrants: children born to in
Sweden to mothers born in Uganda. J Intellect Disabil Res 1995;39:141-4.
[132] Previc FH. Prenatal influences on brain dopamine and their relevance to the rising
incidence of autism. Med Hypotheses 2007;68: 46-60.
[133] Ward AJ. A comparison and analysis of the presence of family problems during
pregnancy of mothers of autistic children and mothers of normal children. Child
Psychiatr Hum Dev 1990;20(4): 279-88.
[134] Beversdorf DQ, Manning SE, Hillier A, Anderson SL, Nordgren RE, Walters SE et al.
Timing of prenatal stressors and autism. J Aut Dev Disord 2005;35(4):471-478.
[135] Glover V. Maternal stress or anxiety in pregnancy and emotional development of the
child. The British Journal of Psychiatry: the Journal of Mental Science
1997;171:105-106.
[136] Mulder EJ, Robles de Medina PG, Huizink AC, Van den Bergh BR, Buitelaar JK, Viss
er GH. Prenatal maternal stress: Effects on pregnancy and the (unborn) child. Early
Human Development 2002;70 (1-2):3-14
[137] Kinney DK, Munir KM, Crowley DJ, Miller AM. Prenatal stres and risk for autism.
Neurosci Biobehav Rev 2008;32(8): 1519-32.
[138] Bachevalier J, Loveland KA. The orbitofrontal-amygdala circuit and self-regulation of
social-emotional behavior in autism. Neuroscience and Biobehavioral Reviews
2006;30(1): 97-117.
[139] Dawson G, Munson J, Webb SJ, Nalty T, Abbott R, Toth K. Rate of head growth de
celerates and symptoms worsen in the second year of life in autism. Biological Psy
chiatry 2007;61:458464.
[140] Dawson G. Early behavioral intervention, brain plasticity, and the prevention of au
tism spectrum disorder. Development and Psychopathology 2008;20:775-803.
[141] London E, Etzel RA. The environment as an etiologic factor in autism: a new direc
tion for research. Environmental Health Perspectives 2000;108 (supll 3): 401-404.
339
Chapter 16
Discovering the Genetics of Autism

Abdullah K. Alqallaf, Fuad M. Alkoot and
Mashel S. Aldabbous
http://dx.doi.org/10.5772/ 53797
1. Introduction
Autism is a complex neurodevelopmental disorder. It is characterized by social isolation,
language deficits and repetitive or stereotyped behaviors. Autism spectrum disorder (ASD)
has received a great deal of attention in the recent years not only due to the increasing rate
of affected children but also because of the social and economical impact of the disorder on
their families. Various studies and researches have been proposed to deal with and tackle
the ASD. They can be divided into three categories as follows.
1.
The basis and causes of the disorder. Different hypotheses have been proposed in an at
tempt to determine and discover the originality of autism. Genetic risk factors repre
sented by abnormal chromosomal variations and rearrangements, and non-genetic
factors represented by environmental agents that have been claimed to contribute to
ASD, such as exposure of children to vaccines, infection, certain foods or heavy metals.
2.
The methodologies and techniques for characterizing and diagnosing the disorder. Sev
eral instrumental diagnostic protocols are commonly used in autism research such as
the Autism Diagnostic Interview-Revised (ADI-R) and the Autism Diagnostic Observa
tion Schedule (ADOS). The advances in neuro-imaging techniques such as the function
al-Magnetic Resonance Imaging (f-MRI) have allowed scientists to model the structural
and functional differences in the human brain tissues of the individuals with ASD. The
clinical genetics evaluation provide reliable alternative to the interview-based protocols
and screening approaches. It allows geneticists to link an estimate of approximately
40% of the cases to genetic contributors.
3.
The treatments and therapies of autistic patients. The available approaches for treat
ments include applied behavior analysis (ABA), developmental models, structured
2013 Alqallaf et al.; licensee InTech. This is an open access article distributed under the terms of the
342
teaching, speech and language therapy and social skills therapy. When behavioral treat
ment fails, many medications are used to treat ASD symptoms.
Figure 1 demonstrates the interaction of the autism spectrum disorders researches and studies.
Figure 1. A puzzle-like representation of the interaction process of the researches and studies for autism spectrum
disorders.
The advancements of the technologies in the field of genetics provide the opportunities for
researchers and scientists to explore in depth the biological information and to convert it in
to meaningful biological knowledge through computational-based models.
In this chapter, we will investigate the genetics origins of autism and demonstrate the latest
techniques and technologies available for diagnosing the complex disorder. We will also
propose a robust approach for detecting and identifying the targeted disorder based upon the
advantages and strengths of the publically available and commercial approaches while avoid
ing their weaknesses. The proposed approach is divided into two steps. The preprocessing
step is a feature-extraction method used to clearly map and detect the genetic variations and
structural rearrangements followed by a statistical-based model as feature-selection to evalu
ate and measure the statistical and biological significance of the predicted variations. The
classification step is to discover the relationship among the tested samples into groups and/or
subgroups, and to provide insight into the complex pattern of the genome.
The results suggest that autism is associated with an increased amount of alterations in un
stable segments of the genome. The experimental results also show that using high-resolu

http://dx.doi.org/10.5772/ 53797
tion custom-tiled samples improve the accuracy of our proposed approach in determining
previously reported and new genetic contributors that warrant investigation.
This chapter aims at utilizing research to bring benefits to individuals and families affected
by autism spectrum disorders and to improve the quality of their life. And this can be done
by clear mapping and identifying the biomarkers associated with ASD at the early child
hood stages which are essential to provide better treatments and therapies. Finally, the pro
posed approach presented in this chapter is broadly applicable to case-control studies of
genetic diseases beyond the ASD.
The chapter is organized as follows. In section 2, we demonstrate the genetic data generat
ing techniques, data modeling and chromosomal variations that are associated with the tar
geted disorder, ASD. Section 3 is devoted for the methods used to analyze the genetic data
trying to discover the variant regions along the genome and to identify the tested samples.
In section 4, we apply molecular test to evaluate the predictive power of the proposed ap
proach. Finally, discussion and conclusion based on the results are presented in section 5.
2. Genetic data
2.1. Genomic structural variations and ASD susceptibility
Genetic alterations in the form of chromosomal rearrangements are genomic structural var
iations that lead to changes in the DNA copy number such as duplications and deletions of
the DNA copies. However, copy number changes do not include other genomic structural
variations such as inversions, insertions and reciprocal translocations. Figure 2 demonstrates
different types of chromosomal rearrangements.
Figure 2. a schematic representation of types of chromosomal rearrangements [67].
343
Rare Variants
Mendelian Syndromes
Chromosome region
Gene
Phenotype
6q23.3
AHI1
Joubert syndrome
7q35-q36.1
CNTNAP2
Recessive EPI syndrome, ASD, ADHD, TS, OCD
9q34.13
TSC1
Tuberous Sclerosis type I
10q23.31
PTEN
Cowden disease*
11q13.4
DHCR7
Smith-Lemli-Opitz syndrome
12p13.33
CACNA1C
Timothy syndrome
15q11.2
UBE3A
Angelman syndrome
16p13.3
TSC2
Tuberous Sclerosis type II
17q11.2
NF1
Neurofibromatosis
Xp21.2
DMD
Duchenne muscular dystrophy
Xp21.3
ARX
LIS, XLID, EPI, ASD
Xp22.13
CDKL5
X-linked infantile spasm syndrome
Xq27.3
FMR1
Fragile X syndrome
Xq28
MECP2
Rett syndrome
1q21.1
NBPF9
ASD, ID, SCZ, ADHD, EPI
2p16.3
NRXN1
ASD, ID, language delay, SCZ.
3p13
FOXP1
ID, ASD, SLI
6q16.3
GRIK2
Recessive ID
7q11.23
FKBP6/CLIP2
ASD, ID, language delay
7q31.1
FOXP2
SLI
11q13.3-q13.4
SHANK2
ASD, ID
15q11-q13
MAGEL2/ NDN
ASD, EPI, ID
16p11.2
VPS35/ORC6
ASD, ADHD, ID, EPI, SCZ
16p13.3
A2BP1
ID, ASD, EPI, SCZ, ADHD
17q11.2
SLC6A4
ASD, OCD
17q12
ACCN1/PNMT
ASD, SCZ, EPI
22q11.21
Common Alleles
344
DiGeorge syndrome, SCZ, ASD, ID.BPAD
22q13.33
SHANK3
ASD, Phelan McDermid syndrome**
Xq13.1
NLGN3
ASD
Xp22.11
PTCHD1
ASD, ID
Xp22.32-p22.31
NLGN4X
ASD, ID, TS, ADHD
1q42.2
DISC1
SCZ,BPAD
2q31.1
SLC25A12
ASD
3p25.3
OXTR
ASD
7q31.2
MET
ASD, Diabetes II
7q22.1
RELN
ASD
7q36.3
EN2
ASD
12q14.2
AVPR1A
ASD
17q21.32
ITGB3
ASD
Table 1. Chromosomal regions and genes that are implicated in risk for ASD, and associated genetic disorders and
syndroms [68& 69].Abbreviations: LTD, long-term depression; LTP, long-term potentiation; PPI, prepulse inhibition; E/I,
excitatory/inhibitory; PSD, postsynaptic density; ASD, autism spectrum disorders; SCZ, schizophrenia; ADHD, attention
deficit hyperactivity disorder; ID, intellectual disability; XLID, X-linked intellectual disability; LIS, lissencephaly; EPI,
epilepsy; OCD, obsessive compulsive disorder; TS, Tourette syndrome; SLI, speech and language impairment; USV,
ultrasonic vocalization; TF, transcription factor; ECM, extracellular matrix; GPCR, G-protein-coupled receptor;BPAD,
Bipolar affective disorder. *A rare autosomal dominant inherited disorder characterized by multiple tumor-like
growths, increased risk of certain forms of cancer, and diverse clinical features including neurologic features such as

http://dx.doi.org/10.5772/ 53797
autism and Lhermitte Duclos disease [39& 40].** A genetic syndrome caused by disruption of the SHANK3 gene which
codes for the shank3 protein. The protein most important role is in the brain. It is involved in processes crucial for
learning and memory. It also has an important role in brain development. It is also known as 22q13.3 deletion
syndrome and is highly associated with autism.Human (Homo sapiens) Genome Browser Gateway, http://
genome.ucsc.edu/cgi-bin/hgGateway.
A set of chromosomal regions and genes that are implicated with ASD are listed in Table
1. Some of the regions are associated with known Mendelian syndromes. In some individ
uals affected with these syndromes, ASD occurs as a secondary diagnosis. In other re
gions and genes, genetic variations causing ASD include a wide range of possibilities each
with very low frequency among the cases (rare variants). In some cases the rare variants
are found only once in the population. In contrast to rare variants we see that in other
chromosomal regions and genes only few common genetic variations (common alleles)
account for ASD susceptibility.
2.2. Data Generating
Figure 3 illustrates the process of generating DNA copy number data using Microarraybased comparative genomic hybridization (array CGH) technology.
Figure 3. Principles of the aCGH technology. (a) DNA from the sample to be tested and reference DNA are labeled
with a green uorescence dye (Cy3) and red (Cy5), respectively, and competitively co-hybridized to an array containing
genomic DNA targets that have been spotted on a glass slide. The resulting ratio of the uorescence intensities is pro
portional to the ratio of the copy numbers of DNA sequences in the test and reference genomes measured in a loga
rithmic scale. (b) The slides are scanned using a specic microarray scanner shown in (c). (d) The output of the
scanning process is the ratio of the fluorescence intensities for each spot represented as a point in the relative copy
number profile [66].
345
346
2.3. Data Modeling

As illustrated in Figure 3, aCGH technology is an experimental approach for genome-wide
scanning of differences in DCN samples. It provides a high-resolution method to map and
measure relative changes in DCN simultaneously at thousands of genomic loci. In a biologi
cal experiment, unknown (test) and reference (normal) DNA samples are labeled with fluo
rescent dyes Cy3 and Cy5, respectively. Then, they are combined and competitively cohybridized to an array containing genomic DNA targets that have been spotted on a glass
slide. The resulting ratio of the uorescence intensities is proportional to the ratio of the
copy numbers of DNA sequences in the test and reference genomes measured in a logarith
mic scale for a certain genomic location. These intensity ratios are informative about DNA
copy number changes. We expect to see duplication (gain) for positive ratio, deletion (loss)
for negative ratio and normal state for neutral ratio. Due to the logarithmic scale and the
probes performance, the data can be approximated as a piecewise function of short and long
intervals with different intensity levels that are not equally-spaced along the genome. More
over, microarray experiments suffer from many sources of error due to human factors, array
printer performance, labeling, and hybridization efficiency.
Figure 4. Graphical representation of the generated data using aCGH technology. The red stars represent the raw da
ta as described in (1). The grey solid line represents the true value of 4 variant segments that need to be estimated
with intensity levels Ai measured in log2(ratio) and bounded by the breakpoints n i-1 and n i, respectively.
According to the data description and properties generated by microarray technology, the
DCN cell line can be approximated as a one-dimensional piecewise constant (PWC) discretetime signal contaminated with some error. A good model of the genetic data generated by
the aCGH technology can be model as follows.
y[n] = x[n] + e n ,
n = 1, 2, ..., N .
(1)

http://dx.doi.org/10.5772/ 53797
where y[n] is the contaminated genetic signal and x[n] is the true value of the genetic varia
tion to be estimated at genomic location n of the length N. n is assumed to be modeled as
additive wihte Gaussian noise with zero mean and some variance 2.
As described in (1), Figure 4 illustrates the genetic data in the form of DNA copy number
generated by aCGH technology where 4 variant segements are presented with different in
tensity levels.
3. Methods
3.1. Data Filtering
Although the recent advantecment in microarray technologies and sequencing now make it
easy to measure the genetic variations with high-resolution through scanning large number
of samples, small changes, particularly at the low copy repeat (LCRs) regions, remain diffi
cult to detect due to different noise conditions. Thus, the challenging problem is to differen
tiate between the true biological signaling and the noise measurements.
Various methods have been proposed as preprocessing techniques to tackle this problem.
These methods have been motivated by either well-known signal processing techniques or
statistical-based models.
METHOD
SMOOTHING TECHNIQUES
COMPUTATIONAL
COMPLEXITY
SIGMA FILTERING (Alqallaf et al., 2007)
O(N)
SMOOTHING AND EDGE DETECTION (Huang et al., 2004)
O(N)
WAVELETS (Hsu et al., 2005)
O(N log N)
STATISTICAL-BASED MODELS
CIRCULAR BINARY SEGMENTATION (Olshen et al., 2004)
O(N2)
HIDDEN MARKOV MODELS (Fridlyand et al., 2004)
O(C2N)
SPARSE BAYESIAN LEARNING (Pique-Regi et al., 2008)
O(N log N)
Table 2. Comparison based on the computational complexity of the proposed denoising techniques.
In Table 2, we present a comparison study based on the computational cost of the most re
cent and successful approaches. As can be noticed that the smoothing techniques are well
suited to process very large amount of data such as the genetic signals compared to the stat
istical-based models. However, these techniques include important features such as the var
iant regions boundaries in the smoothing process.
Here we present our previously proposed method (Alqallaf et al., 2007), Sigma filter (SF). It
is a nonlinear method used as a feature extraction to detect the variant segments edges and
347
348
to smooth the rest of the genetic data. The filter is conceptually simple but effective noise
smoothing algorithm. Based on the assumption of the aCGH data modeling, the SF algo
rithm is well suited to denoise the tested samples before further analysis. SF algorithm is
motivated by the sigma probability of the Gaussian distribution, and it smooths the noise by
averaging only those neighborhood variant segments which have the intensities within a
fixed sigma range of the center data point. Consequently, variant segmets edges are pre
served, and subtle details are retained.
3.2. Statistical significance
Few studies in the literature have addressed the power of class discovery of the recurrent
copy number variations (CNVs) across multiple samples of the genetic data [52& 53]. How
ever, they did not consider denoising the data prior to applying the statistical analysis.
To reduce the dimensionality of the detected variant regions, we apply a simple statisticalbased approach to measure the significance of the candidate gemonic regions. The approach
is based on the frequency difference between the case and control samples at each gemonic
location. It is used as a feature selection algorithm to select a small subset of variant seg
ments as features for classification. Figure 5 is an illustration of three RCVNs with different
sizes of filtered DCN data for multiple samples of normal control (C i) and autistic (A i) indi
viduals, respectively. After selecting the informative segments of the genome, we then ap
plied comparative classification algorithms on the reduced data.
Figure 5. Schematic representation of 3 recurrent copy number variant segments (RCNVs) with different lengths. The
x-axis represents the genomic position and the y-axis represents the indices of the samples, Ci is for normal-control
samples and A i is for autistic samples, respectively. The vertical dashed lines represent the RCNVs boundaries. The dark
red and dark blue bars represent duplication and deletion for the corresponding chromosomal regions.
3.3. Data classification

Based on the collected and processed genetic data, we apply a system of classifiers that are
used to identify autistic individuals based on their genetic information. This system will
help improve detection, identification and diagnosis of autism, which will benefit both the
patients and the society in general and will lead to early diagnosis and treatment.
Generally classifiers are used by researchers faced with the task of classification based on a
given data. Classifiers are mathematical models that are able to perform the task of classifi

http://dx.doi.org/10.5772/ 53797
cation or decision making, based on a previously provided data. Classifiers ability to spot
trends and relationships in large data sets makes it well suited for many applications. In the
field of medicine classifiers can be used to classify accurately diseases, genes, tumors, and
other medical phenomena [54; 55; 56; 57; 58; 59& 60]. Although some attempts were made to
use classifiers in genetics [61]. Our attempt is to use three comparative classifiers, namely, kNearest Neighbor, Neural Network, and Support Vector Machine, to help in diagnosing pa
tients with ASD.
The leave-one-out cross-validation (LOOCV) is applied to evaluate the proposed classifiers
by measuring the classification performance to accurately identify the association between
the tested samples and the targeted disorder, ASD. The LOOCV involves using a single var
iant segment from the original sample as the validation data, and the remaining segments as
the training data. This is repeated such that each variant segment in the sample is used once
as the validation data.
3.3.1. k-Nearest Neighbor Classier
The k-Nearest Neighbor (k-NN) classier [64] is a well known nonparametric classier. To
classify a new input x, the k nearest neighbors are retrieved from the training data. The in
put x is then labeled with the majority class label corresponding to the k nearest neighbors.
For the k-NN classier, we used the Euclidean distance as the distance metric, and the best k
between 1 and 10 was found by performing LOOCV on the training data.
3.3.2. Neural Network
Neural networks are another type of classifier or mathematical models used for classifica
tion, regression or decision making. Their structure is inspired by the human neural system
and brain. It consists of many neurons, interconnected at different stages. The direction of
flow of information is usually from the input stage to the output stage. Each neuron has an
input and an output, where an activation function converts a neurons input to its output.
The output of each neuron is connected to the next stage through a weighted connection. A
learning function determines the value of the weights of all the connections. The weights are
updated based on a mathematical function that relates the network together. Therefore, a
neural network is considered as an adaptive network that changes its structure during the
learning or training phase, based on mathematical functions that relate input data to the cor
responding class labels. The sum of all neurons at the different layers and the weighted in
terconnections make up a complex network that is commonly referred to as a black box.
Before its use to classify a test sample, the neural network is trained on a given data set with
known classes or labels. During the training phase the weights are updated to minimize the
output error. The selected value of the minimum acceptable error determines when the
training stops. For a difficult data where it is impossible to reach the set minimum error, the
maximum number of epochs is used as criteria for stopping the training process.
349
350
3.3.3. Support Vector Machine

The Support Vector Machine (SVM) belongs to a new generation of learning system based
on recent advances in statistical learning theory [65]. A linear SVM, which is used in our sys
tem, aims to nd the separating hyper-plane with the largest margin, dened as the sum of
the distances from a hyper-plane (implied by a linear classier) to the closest positive and
negative exemplars. The expectation is that the larger the margin, the better the generaliza
tion of the classier. In a non-separable case, a linear SVM seeks a trade-off between maxi
mizing the margin and minimizing the number of errors.
Figure 6. Comparison study of the performance of the three tested classifiers. The x-axis represents the number of
segments and the y-axis represents the percentage average LOOCV accuracy.
Figure 6 illustrates the LOOCV classication accuracies using the tested classifiers, k-NN,
NN, and SVM. The x-axis is associated with the number of selected top-ranked variant seg
ments and the y-axis shows the average LOOCV accuracy.
4. Validation of the predicted variant segments

To evaluate our predictive power of our method in detecting and identifying patients with
ASD, we use molecular test, quantitative Polymerase Chain Reaction (qPCR). It is a very
sensitive and precise tool used for the quantification of nucleic acids. It can detect and
quantify very small amounts of specific nucleic acid sequence. It is based on the method of
PCR, developed by Kary Mullis in the 1980s. It allows the amplification of specific nucleic
acid sequence (DNA) more than a billion-fold. Using qPCR allows scientists to quantify the
starting amount of a specific DNA sequence in the sample before the amplification by PCR
method [62].

http://dx.doi.org/10.5772/ 53797
Quantitative PCR is an indispensable tool for researchers in various fields including funda
mental biology, molecular diagnostics, biotechnology, and forensic sciences. Critical points
and limitations of qPCR-based assays must be considered to increase the reliability of the
obtained data. For the detection of qPCR four technologies are commonly used all of which
are based on the measurement of fluorescence during the PCR. One principle is based on
intercalation of double-stranded DNA-binding dyes (simplest and cheapest). The other
three principles are based on the introduction of an additional fluorescence-labeled oligonu
cleotide (probe). Detectable fluorescence are only released either after cleavage of the probe
(hydrolysis probes) or during hybridization of one (molecular beacon) or two (hybridization
probes) oligonucleotides to the amplicon. The introduction of an additional probe increases
the specificity of the quantified PCR product and allows the development of multiplex reac
tions. Other technologies have been described for the detection of qPCR [63].
The qPCR method quickly became the first choice when it comes to quantitative analysis of
nucleic acid because of many reasons. It is highly sensitive and it allows the detection of less
than five copies (one copy in some cases) of a target sequence. It has good reproducibility. In
addition, it has broad dynamic quantification range, at least 5 log units. It is also easy to use
and has reasonable good value for money (low consumable and instrumentation costs).
For the purpose of this chapter, we are focusing on one of the many applications of qPCR,
which is indispensable for research and diagnostics, the genetic variations.
Array
CBS
SF
14
20
10
20
20
21
13
21
Table 3. Representation of the number of events (CNVs) detected by the circular binary segmentation (CBS) and
sigma filtering methods, respectively, for 22 qPCR confirmed CNVs.
Table 3 shows that the number of qPCR-confirmed CNVs detected by the sigma filtering
(SF) method is considerably higher than those detected using the circular binary segmenta
tion (CBS), ranging from 4.5% to 36% more for 4 different array experiments. The results
show that applying the averaging window of 2Kb allow the algorithms to be well suited for
detecting variations in high-density microarray data, especially at the LCR-rich regions.
5. Conclusion
The etiology of Autism spectrum disorders involves genetic and environmental risk factors.
In this chapter, we have discussed the genetics basis of the complex disorder, autism. With
the recent advances in the new screening technologies to investigate the entire genome such
351
352
as array comparative genomic hybridization (aCGH) and whole genome sequencing, pro
vide the opportunities insight into the pattern of the genetic variations and reveal their roles
in the genetic diseases. In this study, we have demonstrated an overview for the analysis of
genetic variations in the form of DNA copy number changes and their association with au
tism susceptibility.
Through mathematical-based models and computational-based approaches, we analyze the
genetic data trying to discover and identify the relationship between the structural chromoso
mal rearrangements along the genome and the targeted disorder, ASD. In conclusion, the results
show strong evidence that the genetic variations contribute in the complex disorder, autism.
Author details
Abdullah K. Alqallaf1*, Fuad M. Alkoot2 and Mashel S. Aldabbous3
1 Electrical Engineering Department, College of Engineering and Petroleum, Kuwait Uni
versity, Kuwait
2 The Higher Institute of Telecommunication and Navigation, Public Authority for Applied
Education and Training, Kuwait
3 Department of Biological Sciences, College of Science, Kuwait University, Kuwait
References
[1] Freeman, J. L., Perry, G. H., Feuk, L., Redon, R., Mc Carroll, S. A., Altshuler, D. M.,
Aburatani, H., Jones, K. W., Tyler-Smith, C., & Hurles, . (2006). Copy number varia
tion: new insights in genome diversity. Genome Research, 16(8), 949-961.
[2] Lee, J. A., & Lupski, J. R. (2006). Genomic rearrangements and gene copy-number al
terations as a cause of nervous system disorders. Neuron, 52(1), 103-121.
[3] Stankiewicz, P., & Lupski, J. R. (2002). Molecular-evolutionary mechanisms for ge
nomic disorders. Current Opinion in Genetics & Development on ScienceDirect,, 12(3),
312-319.
[4] Christian, S. L., Brune, C. W., Sudi, J., Kumar, R. A., Liu, S., Karamohamed, S., Bad
ner, J. A., Matsui, S., Conroy, J., & Mc Quaid, D. (2008). Novel submicroscopic chro
mosomal abnormalities detected in autism spectrum disorder. Biological Psychiatry,
63(12), 1111-1117.

http://dx.doi.org/10.5772/ 53797
[5] Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M.,
Moessner, R., Pinto, D., & Ren, Y. (2008). Structural variation of chromosomes in au
tism spectrum disorder. American Journal of Human Genetics,, 82(2), 477-488.
[6] Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B.,
Yoon, S., Krasnitz, A., & Kendall, J. (2007). Strong association of de novo copy num
ber mutations with autism. Science,, 316(5823), 445-449.
[7] Kirov, G., Gumus, D., Chen, W., Norton, N., Georgieva, L., Sari, M., ODonovan, M.
C., Erdogan, F., Owen, , & Ropers, H. H. (2008). Comparative genome hybridization
suggests a role for NRXN1 and APBA2 in schizophrenia. Human Molecular Genetics,
17(3), 458-465.
[8] Sharp, A. J., Hansen, S., Selzer, R. R., Cheng, Z., Regan, R., Hurst, J. A., Stewart, H.,
Price, S. M., Blair, E., & Hennekam, R. C. (2006). Discovery of previously unidentified
genomic disorders from the duplication architecture of the human genome. Nature
Genetics, 38(9), 1038-1042.
[9] Sharp, A. J., Mefford, H. C., Li, K., Baker, C., Skinner, C., Stevenson, R. E., Schroer, R.
J., Novara, F., De Gregori, M., & Ciccone, R. (2008). A recurrent 15q13.3 microdele
tion syndrome associated with mental retardation and seizures. Nature Genetics,
40(3), 322-328.
[10] Cantor, R. M., & Geschwind, D. H. (2008). Schizophrenia: genome, interrupted. Neu
ron,, 58(2), 165-167.
[11] Stefansson, H., Rujescu, D., Cichon, S., Pietilainen, O. P., Ingason, A., Steinberg, S.,
Fossdal, R., Sigurdsson, E., Sigmundsson, T., & Buizer-Voskamp, J. E. (2008). Large
recurrent microdeletions associated with schizophrenia. Nature,, 455(7210), 232-236.
[12] Stone, J. L., ODonovan, M. C., Gurling, H., Kirov, G. K., Blackwood, D. H., Corvin,
A., Craddock, N. J., Gill, M., Hultman, C. M., & Lichtenstein, P. (2008). Rare chromo
somal deletions and duplications increase risk of schizophrenia. Nature,, 455(7210),
237-241.
[13] Walsh, T., Mc Clellan, J. M., Mc Carthy, S. E., Addington, A. M., Pierce, S. B., Cooper,
G. M., Nord, , Kusenda, M., Malhotra, D., & Bhandari, A. (2008). Rare structural var
iants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Sci
ence, 320(5875), 539-543.
[14] Estivill, X., & Armengol, L. (2007). Copy number variants and common disorders:
filling the gaps and exploring complexity in genome-wide association studies. PLoS
Genetics, 3(10), 1787-1799.
[15] Greer, M. K., Brown, F. R., Pai, G. S., Choudry, S. H., & Klein, A. J. (1997). Cognitive,
adaptive, and behavioral characteristics of Williams syndrome. American Journal of
Human Genetics,, 74(5), 521-525.
[16] Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E. J., del Campo, M., Bamforth, S.,
Peregrine, E., Loo, W., Lilley, M., & Perez-Jurado, L. A. (2005). Severe expressive-lan
353
354
guage delay related to duplication of the Williams-Beuren locus. The New England
Journal of Medicine, 353(16), 1694-1701.
[17] van der , N., Rooms, L., Vandeweyer, G., van den, Ende. J., Reyniers, E., Fichera, M.,
Romano, C., Delle, Chiaie. B., Mortier, G., & Menten, B. (2009). Fourteen new cases
contribute to the characterization of the 7q11.23 microduplication syndrome. Europe
an Journal of Medical Genetics, 52(2-3), 94-100.
[18] Depienne, C., Heron, D., Betancur, C., Benyahia, B., Trouillard, O., Bouteiller, D.,
Verloes, A., Le Guern, E., Leboyer, M., & Brice, A. (2007). Autism, language delay
and mental retardation in a patient with 7q11 duplication. Journal of Medical Genetics,,
44(7), 452-458.
[19] Balciuniene, J., Feng, N., Iyadurai, K., Hirsch, B., Charnas, L., Bill, B. R., Easterday,
M. C., Staaf, J., Oseth, L., & Czapansky-Beilman, D. (2007). Recurrent 10q22-q23 dele
tions: a genomic disorder on 10q associated with cognitive and behavioral abnormal
ities. American Journal of Human Genetics,, 80(5), 938-947.
[20] Laumonnier, F., Roger, S., Guerin, P., Molinari, F., MRad, R., Cahard, D., Belhadj, A.,
Halayem, M., Persico, A. M., & Elia, M. (2006). Association of a functional deficit of
the BKCa channel, a synaptic regulator of neuronal excitability, with autism and
mental retardation. American Journal of Psychiatry,, 163(9), 1622-1629.
[21] Cook, E. H., & Jr , . (2001). Genetics of autism. Child and Adolescent Psychiatric Clinics
of North America,, 10(2), 333-350.
[22] Helbig, I., Mefford, H. C., Sharp, A. J., Guipponi, M., Fichera, M., Franke, A., Muhle,
H., de Kovel, C., Baker, C., & von, Spiczak. S. (2009). 15q13.3 microdeletions increase
risk of idiopathic generalized epilepsy. Nature Genetics, 41(2), 160-162.
[23] Papolos, D. F., Faedda, G. L., Veit, S., Goldberg, R., Morrow, B., Kucherlapati, R., &
Shprintzen, R. J. (1996). Bipolar spectrum disorders in patients diagnosed with velocardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in
bipolar affective disorder? American Journal of Psychiatry,, 153(12), 1541-1547.
[24] Niklasson, L., Rasmussen, P., Oskarsdottir, S., & Gillberg, C. (2001). Neuropsychiatric
disorders in the 22q11 deletion syndrome. Genetics in Medicine,, 3(1), 79-84.
[25] Antonell, A., de Luis, O., Domingo-Roura, X., & Perez-Jurado, L. A. (2005). Evolu
tionary mechanisms shaping the genomic structure of the Williams-Beuren syn
drome chromosomal region at human 7q11.23. Genome Research, 15(9), 1179-1188.
[26] Vorstman, J. A., Morcus, M. E., Duijff, S. N., Klaassen, P. W., Heineman-de, Boer. J.
A., Beemer, F. A., Swaab, H., Kahn, R. S., & van Engeland, H. (2006). The 22q11.2 de
letion in children: high rate of autistic disorders and early onset of psychotic symp
toms. Journal of the American Academy of Child & Adolescent Psychiatry,, 45(9),
1104-1113.
[27] Hertz-Picciotto, I., Croen, L. A., Hansen, R., Jones, C. R., van de Water, J., & Pessah, I.
N. (2006). The CHARGE study: an epidemiologic investigation of genetic and envi

http://dx.doi.org/10.5772/ 53797
ronmental factors contributing to autism. Environmental Health Perspectives,, 114(7),

1119-1125.
[28] Redon, R., Ishikawa, S., Fitch, K. R., Feuk, L., Perry, G. H., Andrews, T. D., Fiegler,
H., Shapero, M. H., Carson, A. R., & Chen, W. (2006). Global variation in copy num
ber in the human genome. Nature, 444(7118), 444-454.
[29] Shen, F., Huang, J., Fitch, K. R., Truong, V. B., Kirby, A., Chen, W., Zhang, J., Liu, G.,
Mc Carroll, S. A., & Jones, K. W. (2008). Improved detection of global copy number
variation using high density, non-polymorphic oligonucleotide probes. BMC Genet
ics,, 9(27).
[30] Conrad, D. F., Pinto, D., Redon, R., Feuk, L., Gokcumen, O., Zhang, Y., Aerts, J., An
drews, T. D., Barnes, C., & Campbell, P. (2010). Origins and functional impact of
copy number variation in the human genome. Nature,, 464(7289), 704-712.
[31] Perry, G. H., Ben-Dor, A., Tsalenko, A., Sampas, N., Rodriguez-Revenga, L., Tran, C.
W., Scheffer, A., Steinfeld, I., Tsang, P., & Yamada, N. A. (2008). The fine-scale and
complex architecture of human copy-number variation. American Journal of Human
Genetics,, 82(3), 685-695.
[32] Berg, J. S., Brunetti-Pierri, N., Peters, S. U., Kang, S. H., Fong, C. T., Salamone, J.,
Freedenberg, D., Hannig, V. L., Prock, L. A., & Miller, D. T. (2007). Speech delay and
autism spectrum behaviors are frequently associated with duplication of the 7q11.23
Williams-Beuren syndrome region. Genetics in Medicine,, 9(7), 427-441.
[33] Potocki, L., Bi, W., Treadwell-Deering, D., Carvalho, C. M., Eifert, A., Friedman, E.
M., Glaze, D., Krull, K., Lee, J. A., & Lewis, R. A. (2007). Characterization of PotockiLupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical
interval that can convey an autism phenotype. American Journal of Human Genetics,,
80(4), 633-649.
[34] Carvalho, C. M., & Lupski, J. R. (2008). Copy number variation at the breakpoint re
gion of isochromosome 17q. Genome Research,, 18(11), 1724-1732.
[35] Mukaddes, N. M., & Herguner, S. (2007). Autistic disorder and 22q11.2 duplication.
World Journal of Biological Psychiatry,, 8(2), 127-130.
[36] Barabash, A., Marcos, A., Ancin, I., Vazquez-Alvarez, B., de Ugarte, C., Gil, P., Fer
nandez, C., Encinas, M., Lopez-Ibor, J. J., & Cabranes, J. A. (2009). APOE, ACT and
CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alz
heimers disease. Neurobiol Aging,, 30(8), 1254-1264.
[37] Miller, D. T., Shen, Y., Weiss, L. A., Korn, J., Anselm, I., Bridgemohan, C., Cox, G. F.,
Dickinson, H., Gentile, J., & Harris, D. J. (2009). Microdeletion/duplication at
15q13.2q13.3 among individuals with features of autism and other neuropsychiatric
disorders. Journal of Medical Genetics, 46(4), 242-248.
[38] Shinawi, M., Schaaf, , Bhatt, S. S., Xia, Z., Patel, A., Cheung, S. W., Lanpher, B., Nagl,
S., Herding, H. S., & Nevinny-Stickel, C. (2009). A small recurrent deletion within
355
356
15q13.3 is associated with a range of neurodevelopmental phenotypes. Nature Genet

ics, 41(12), 1269-1271.
[39] Tsuchiya, K. D., Wiesner, G., Cassidy, S. B., Limwongse, C., Boyle, J. T., & Schwartz,
S. (1998). Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis
and other features of a Cowden-like syndrome. Genes Chromosomes & Cancer,, 21(2),
113-118.
[40] Zhou, X. P., Woodford-Richens, K., Lehtonen, R., Kurose, K., Aldred, M., Hampel,
H., Launonen, V., Virta, S., Pilarski, R., & Salovaara, R. (2001). Germline mutations in
BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cow
den and Bannayan-Riley-Ruvalcaba syndromes. American Journal of Human Genetics,
69(4), 704-711.
[41] Fombonne, E. (2003). Epidemiological Surveys of Autism and Other Pervasive Devel
opmental Disorders: An Update. Journal of Autism and Developmental Disorders, 33(4),
365-382.
[42] Kuehn, B. (2007). CDC: Autism Spectrum Disorders Common. Journal of the American
Medical Association,, 297(940).
[43] Abrahams, B., & Geschwind, D. (2008). Advances in autism genetics: on the thresh
old of a new neurobiology. Nature Reviews Genetics., 9(5), 341-355.
[44] Alqallaf, A., Tewfik, A., & Selleck, S. (2009). Genetic variation detection using maxi
mum likelihood estimator. IEEE International Workshop on Genomic Signal Processing
and Statistics., 978-1-42444-761-9, Minnesota, USA.
[45] Kallioniemi, A., Kallioniemi, O., Sudar, D., Rutovitz, D., Gray, J., Waldman, F., & Pin
kel, D. (1992). Comparative genomic hybridization for molecular cytogenetic analysis
of solid tumors. Science,, 258(5083), 818-821.
[46] Wang, Y., & Wang, S. (2007). A novel stationary wavelet denoising algorithm for ar
ray-based DNA copy number data. International Journal of Bioinformatics Research and
Applications, 3(2), 206-222.
[47] Willenbrock, H., & Fridlyand, J. (2005). A comparison study: applying segmentation
to array CGH data for downstream analyses. Bioinformatics, 21(22), 4084-4091.
[48] Rissanen, J. (1978). Modeling by Shortest Data Description. Automatica, 14, 465-471.
[49] Larson, R., & Castie, J. (1982). Principles of Dynamic Programming. 1-2, Marcel Dek
ker Inc., NY.
[50] BioDiscovery Inc. (2012). Nexus: Copy Number Professional software package (Bio
Discovery), Inc., El Segundo, CA) available from:, http://www.biodiscovery.com.
[51] Venkatraman, E., & Olshen, A. (2007). A faster circular binary segmentation algo
rithm for the analysis of array CGH data. Bioinformatics, 23(6), 657-663.

http://dx.doi.org/10.5772/ 53797
[52] Grant, G., Manduchi, E., Cheung, V., & Ewens, W. (1999). Significance testing for di
rect identity-by-descent mapping. Annals of Human Genetics, 63(5), 441-454.
[53] Diskin, S., Eck, T., Greshock, J., Mosse, Y., Naylor, T., Stoeckert, C., Weber, B., Maris,
J., & Grant, G. (2006). STAC: A method for testing the significance of DNA copynumber aberrations across multiple array-CGH experiments. Genome Research, 16(9),
1149-1158.
[54] Rohlfing, T., Russakoff, D., & Maurer, C. (2004). Performance based classifier combi
nation in atlas based image segmentation using expectation maximization parameter
estimation. IEEE transaction on medical imaging,, 23(8), 983-994.
[55] Guler, I., & Ubeyli, E. (2005). ECG beat classifier designed by combined neural net
work model. Pattern Recognition, 38, 199-208.
[56] Sampat, M. ., Bovik, A., Aggarwal, J., & Castleman, K. (2005). Supervised parametric
and non parametric classification of chromosome images. Pattern Recognition, 38,
1209-1223.
[57] Bruijne, M., & Nielson, M. (2004). Shape particle filtering for image segmentation.
Medical Image Computing and Computer-Assisted Intervention (MICCAI),, 1, 168-175.
[58] Shin, H., & Sohn, S. (2005). Selected tree classifier combination based on both accura
cy and error diversity. Pattern Recognition, 38, 191-197.
[59] Tsymbal, A., Cunningham, P., Pechenizkiy, M., & Puuronen, S. (2003). Search strat
egies for ensemble feature selection in medical diagnosis. 16th IEEE symposium on
computer based medical systems,, 124-129.
[60] Kook, H., Gupta, L., Molfese, D., & Fadem, K. (2005). Multi-stimuli multi-channel da
ta and decision fusion strategies for dyslexia prediction using neonatal ERPS. Pattern
Recognition, 38(11), 2174-2184.
[61] Moon, H., Ahn, H., Kodell, R., Lin, C., Baek, S., & Chen, J. (2006). Classification meth
ods for the development of genomic signatures from high-dimensional data. Genome
Biology, 7(12), 121.
[62] Valasek, M., & Repa, J. (2005). The power of real-time PCR,. Advances in Physiology
Education, 29(3), 151-159.
[63] Klein, D. (2002). Quantification using real-time PCR technology: applications and
limitations. Trends in Molecular Medicine, 8(6), 257-260.
[64] Dasarathy, B. (1991). Nearest Neighbor Norms: NN Pattern Classification Techni
ques. IEEE. Computer Society Press.
[65] Vapink, V. (1998). Statistical learning Theory. Wiley-Interscience.
[66] Shinawi, M., & Cheung, S. (2008). The array CGH and its clinical applications. Drug
Discovery Today, 13(17-18), 760-770.
357
358
[67] Schwab, M., Alitalo, K., Klempnauer, K., Varmus, H., Bishop, J., Gilbert, F., Brodeur,
G., Goldstein, M., & Trent, J. (1983). Amplified DNA with limited homology to
MYC cellular oncogene is shared by human neuroblastoma cell lines and a neuro
blastoma tumour. Nature,, 305(5931), 245-248.
[68] Aldinger, K., Plummer, J., Qiu, S., & Levitt, P. (2011). SnapShot: Genetics of Autism.
Neuron,, 72, 418.
[69] Sanders, S., et al. (2011). Multiple Recurrent De Novo CNVs, Including Duplications
of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism.
Neuron, 70, 863-885.
Chapter 17
Co-Occurrence of Developmental Disorders:

Children Who Share Symptoms of Autism,
Dyslexia and Attention Deficit Hyperactivity Disorder
Ginny Russell and Zsuzsa Pavelka
http://dx.doi.org/10.5772/54159
1. Introduction
Children with autism spectrum disorders (ASD) have a higher risk of suffering from several
other conditions. In this chapter I review the extent to which autistic individuals can also expe
rience a range of other difficulties, but my focus will be on the common neurodevelopmental
disorders. The most common of these include dyslexia, attention deficit hyperactivity disorder
(ADHD), dyspraxia, specific language impairment, and dyscalculia. There is considerable
symptom overlap in particular between ADHD and dyslexia, and like autism both are descri
bed as developmental disorders by psychiatric classification systems (American Psychiatric
Association, 2000; World Health Organization., 1992). Overlapping conditions are termed comorbidity by medical practitioners. Co-morbidity may reflect the greater difficulties experi
enced by children with a combination of deficits. Sometimes it is apparent that many children
with a developmental disorder could be classified in several ways. Here I will firstly examine
the research evidence that examines how often symptoms of dyslexia and ADHD occur in the
population of autistic children, and second, review the various theories that have tried to ex
plain why such co-occurring difficulties are so common.
Comorbidity, a term used in medical literature to mean a dual diagnosis, or multiple diag
noses, can reflect an inability to supply a single diagnosis that accounts for all symptoms.
Children with ASD have been shown to have higher rates of epilepsy, with 30% of cases
having epilepsy comorbid (Danielsson, Gillberg, Billstedt, Gillberg, & Olsson, 2005). Other
conditions that are commonly co-morbid with ASD include hearing impairment (Kielinen,
Rantala, Timonen, Linna, & Moilanen, 2004) mental health and behavioural problems (Brad
ley, Summers, Wood, & Bryson, 2004), including anxiety, and depression (Evans, Canavera,
2013 Russell and Pavelka; licensee InTech. This is an open access article distributed under the terms of the
362
Kleinpeter, Maccubbin, & Taga, 2005). It has also been shown that parents of autistic chil
dren are twice as likely themselves to have suffered from psychiatric illness than parents of
non-autistic children (Daniels et al., 2008).
Most of these problems are distinct from those examined in this chapter: the common devel
opmental disorders of childhood which are also found to co-occur with autism, particularly
ADHD and dyslexia.
Before reviewing the evidence that suggests many children share difficulties symptomatic of
these conditions, and the theories of why this may be, I will briefly describe how dyslexia
and ADHD manifest themselves.
2. Dyslexia
Dyslexia is conceptualized by both educational bodies and the psychiatric classification sys
tems as a learning difficulty that primarily affects the skills involved in accurate and fluent
word reading and spelling. Characteristic features of dyslexia are difficulties in phonological
awareness, verbal memory and verbal processing speed. Dyslexia is developmental delay in
literacy and generally slow and inaccurate reading and spelling. The definition of dyslexia has
changed over time, and such changes have often been based on the research identifying a range
of associated difficulties that occur with dyslexia. Estimates of the prevalence of dyslexia have
been complicated because dyslexia cut-offs are contested (Coltheart & Jackson, 1998) and dys
lexia manifests itself differently in various languages according to levels of phonic regularity
(Miles, 2004). Research over the last 40 years has focused on phonological skills. These are the
reading and de-coding skills used when breaking down language into its component sounds
and reassembling the parts in order to read or to spell a word.
Like autism, dyslexic difficulties are considered to exist in a continuum throughout the general
population (Fawcett, 2012). There is much interest in the association of cognitive ability with
changing symptom profiles and diagnosis. The definition of dyslexia is in flux, and has been re
cently redefined by many national bodies, for example in the UK, the British Psychological So
ciety, focusing on literacy learning at the 'word level' without attainment discrepancy:
Dyslexia is evident when accurate and fluent word reading and/or spelling develops very incompletely or with great
difficulty (British Psychological Society, 1999)
This definition implies that the problem is severe and persistent despite appropriate learn
ing opportunities. This UK definition differs from the ICD-10 diagnosis of developmental
dyslexia or Specific Reading Disorder, which requires a discrepancy between actual read
ing ability and the reading ability predicted by a childs IQ. So an intellectual disability,
(generally considered IQ below 70) can co-occur with the British Psychological Society defi
nition of dyslexia. This new definition includes the so called garden variety dyslexic chil
Co-Occurrence of Developmental Disorders: Children Who Share Symptoms of Autism, Dyslexia and Attention Deficit
Hyperactivity Disorder
http://dx.doi.org/10.5772/54159
dren who have difficulties with reading and spelling as well as other generalized intellectual
disabilities. The implications of including this group as dyslexic mean that more children
with an intellectual disability would also be classified as dyslexic. As ASD includes a large
group with intellectual disability the extension is likely to increase the number of children
who may be classified as having both conditions. This is important as the clinical and educa
tion label may determine the interventions a particular child receives.
In addition to these characteristics, dyslexic children may experience visual and auditory
processing difficulties, similar to hyper or hypo sensitivity often associated with ASD. Like
the islets of ability seen in many children with ASD, some dyslexic children may also have
strengths in particular areas, such as design, logic, and creative skills.
3. ADHD
ADHD is known as Hyperkinetic Disorder in ICD-10; there are three subtypes of ADHD
according the DSM. In the first, a child will primarily have problems with attention which
may manifest as an inability to remain on task for long periods, lack of response to instruc
tion or distractibility. In the second sub-type, symptoms of hyperactivity and impulsivity
dominate, which is characterized by wriggling, squirming, being unable to sit still, inter
rupting and finding it difficult to wait. Children may also be climbing in inappropriate sit
uations and always on the move when free to do so. The third sub-type is simply the coexistence of both attention problems and hyperactivity, with each behavior occurring
infrequently alone and symptoms starting before seven years of age.
According to ICD-10, eventually, assessment instruments should develop to the point where
it is possible to take a quantitative cut-off score to assess ADHD. Like dyslexia and autism,
the symptoms are behavioural in nature, and are part of a continuously distributed pattern
that extends into the population at large.
The persistence of ADHD symptoms is not so marked as for autism. Around 70 to 50 per
cent of those individuals diagnosed in childhood do not continue to have symptoms into
adulthood (Elia, Ambrosini, & Rapoport, 1999). There is evidence suggesting to some extent
symptoms of ADHD are expressed in reaction to home (Mulligan et al. 2011) and other envi
ronmental contexts. Individuals with ADHD also tend to develop coping mechanisms to
compensate for some or all of their impairments. ADHD is diagnosed more often in boys
with the reported ratio varying from 2:1 to 4:1 (Dulcan, 1997; Kessler et al., 2005) though
some studies suggest this may be partially due to referral bias where teachers are more like
ly to refer boys than girls (Sciutto, Nolfi, & Bluhm, 2004). Treatments for ADHD involve a
combination of medication, usually methyphenidates which are well established in improv
ing symptoms of inattention, and behavioral intervention in education and at home. The is
sue of girls being overlooked on identification is a common thread for research in dyslexia,
ADHD and autism. Our own results suggest there is some evidence to back up the claim
that boys with ASD symptoms are given the diagnosis more frequently than girls with
363
364
equivalent ASD symptoms (Russell, Steer, & Golding, 2011). This may be because the disor
ders tend to be conceptualized as male leading to referral bias.
Because ASD, Dyslexia and ADHD are all behaviorally defined, so symptoms are behaviours.
All three conditions are conceived as particular behaviours along a spectrum, where traits have
a continuous distribution and extend into the general (non-disordered) population. An arbitra
ry cut off point determines who is considered to be within the various categories and who is
not. The clinician giving a diagnosis will be responsible for judging where this cut off may
come, guided by diagnostic criteria and standards within disciplines as well as perceived im
plications: the benfits versus any possible risks of assigning a diagnosis. This is perhaps best es
tablished for autism: Constantino and Todd (2003) measured autistic traits in a large
community sample, and found no jump in the threshold of autistic behaviours between nor
mal individuals and those with an autism spectrum diagnosis, rather they found a continuous
distribution. These findings concurred with those in a Scandinavian study (Posserud, Lunder
vold, & Gillberg, 2006). One of our own studies has likewise shown that autistic traits do ex
tend into the subclinical population (Figure 1). As with dyslexia and ADHD, there is not a
sharp line separating severity in those with a diagnosis from less severe traits in those without
(London, 2007). In both dyslexia, ADHD and the autism spectrum, some children have more
severe difficulties than others, and the symptoms extend into the population of children (and
adults) as a whole. For dyslexia, there are many people who may have mild dyslexic difficul
ties but perhaps might not qualify as dyslexic. For autism spectrum disorders, many people
without an autism diagnosis do have autistic-type behaviours but the severity and frequency
of those behavioural symptoms is less severe than in those deemed to qualify for a diagnosis.
Figure 1. The distribution of an ASD composite trait in the general population from Russell et al.(2012)
http://dx.doi.org/10.5772/54159
The imposition of a cut off between normality and abnormality is therefore an arbitrary but
convenient way of converting a dimension into a category as Goodman and Scott (1997, p.
23) point out.
4. Evidence of symptom overlap ASD and ADHD

Various studies have looked for ADHD or ADHD symptoms in samples of children with
autism or ASD. Rates of ADHD have ranged from 28% to 78% of these samples (Ronald,
Edelson, Asherson, & Saudino, 2010). Studies that look at ADHD symptoms have reported
even higher numbers: for example, Sturm, Fernell, & Gillberg, (2004) looked at a sample of
around 100 high functioning children with ASD and found 95% had attention problems,
75% had motor difficulties, 86% had problems with regulation of activity level, and 50% had
impulsiveness. About three-quarters had symptoms compatible with mild or severe ADHD,
or had deficits in attention, motor control, and perception, indicating a considerable overlap
between these disorders and high-functioning ASD in children.
In an large analysis of nine hundred forty-six twins, Reierson and colleagues (2008) assigned
DSM-IV ADHD diagnoses, and measured autistic traits using the Social Responsiveness
Scale. The study showed that there are clinically significant elevations of autistic traits in
children meeting diagnostic criteria for ADHD. These findings confirm results in earlier
studies (Clark, Feehan, Tinline, & Vostanis, 1999). Santosh and Mijoovic (2004) which found
children with ADHD had elevated levels of impairment in all three autistic symptom do
mains, namely social deficits, communication and stereotyped behaviors. Clark et al found
65-80% of parents of children with ADHD reported difficulties in social interaction (particu
larly in empathy and peer relationships) and in communication (particularly in imagination,
and maintaining conversation). So the presence of autistic traits in children with ADHD ap
pears common (Ronald et al., 2010).
In an analysis conducted with Lauren Rodgers at the Peninsula Medical School in the UK
using data from the Millennium Cohort Study, a cohort of around 19,000 children who were
all born between 2000 and 2002, we noted 44 children had a dual diagnosis of both ASD and
ADHD (proportion of total population 0.3%) by age seven. The prevalence of children with
identified ADHD in the ASD sample was 17%. Conversely, the prevalence of children with
ASD in the ADHD sample was higher at 27%. Both figures indicate substantial overlap be
tween these conditions.
Various European research groups have examined co-morbid disorders in adults with diag
nosed ASD. An international team lead by Hofvander studied a group of 122 adults with
normal IQ from specialist clinics in three European cities: Gothenburg, Paris and Malm
(Hofvander et al., 2009). Here the overwhelming majority had symptoms of ASD. Nonverbal
communication problems were also very common, described in 89% of all their subjects. In
this study over half the participants, (52%) were diagnosed with co-morbid ADHD. Interest
ingly, participants diagnosed with pervasive developmental disorder. Not Otherwise Speci
fied (PDD-NOS) diagnosis had significantly more symptoms of inattention and
365
366
hyperactivity/impulsivity compared to subjects diagnosed with Aspergers syndrome. How

ever, the prevalence of the categorical diagnosis of ADHD did not differ significantly be
tween the groups, nor were gender differences apparent. Although the study presents clear
evidence of many cases where patients display symptoms of both ADHD and ASD, the clin
ical setting may have led to selection bias as patients with complex needs may be more like
ly to seek help.
Because behaviours associated with both conditions lie on a spectrum extending into the
normal range, some studies have found a range of frequency and severity of symptoms. In
Mulligan et al.s (2009) study, for example, 75 of children with ADHD had severe autism
traits, and over half showed sub-clinical autism symptoms. Kadesj and colleagues (Kades
j, Gillberg, & Hagberg, 1999), looked at comorbidity of ADHD in Swedish school-age chil
dren and found only 1% of children meeting the threshold for ADHD had comorbid
Aspergers Syndrome (AS). The estimates of co-morbidity of ADHD symptoms with ASD
symptoms vary widely because of differing methods of case ascertainment. An additional
problem is that the estimate of the prevalence of ASD itself has increased so much in west
ern countries, making ASD itself a moving target (Figure 2).
Patricia Howlin (2000) reviewed the estimated rates of co-existing psychiatric disorders in
subjects with high functioning ASD and found these estimates varied from 9% to 89% - very
substantial differences. However it is possible to generalise; thirty years of research have
confirmed that attention deficits and hyperactivity are relatively common in children and
adults with ASD even if the exact extent of overlap is dependent on methodology and ascer
tainment (Hofvander et al., 2009, Sturm, Fernell, & Gillberg, 2004).
Figure 2. The rising prevalence of autism spectrum disorders over 50 years. (Data from Autism Speaks and CDC, USA)
Recent trends have made categorical diagnosis an integral part of everyday clinical and re
search practice (Sonuga-Barke & Halperin, 2010). Christopher Gillberg (2010) points out that
clinicians have become focused on dichotomous categories of disorder and that clinics have
become increasingly specialized and overlook difficulties not within their immediate juris
http://dx.doi.org/10.5772/54159
diction. Gillberg has argued that co-existence of disorders is the rule rather than the excep
tion in child psychiatry and developmental medicine. He has coined the acronym ESSENCE
(referring to Early Symptomatic Syndromes Eliciting
Neurodevelopmental Clinical Examinations). This describes cases where a combination of
symptoms including inattention, hyperactivity, social and reading difficulties are observed.
Major problems in at least one ESSENCE domain before age 5 years often signal major prob
lems in the same or overlapping domains years later.
To summarize, although ADHD and ASD are separate and recognizable, there is good evi
dence that these conditions co-occur, constituting an amalgam of problems.
5. Comorbidity between dyslexia and ASD

There is only a small literature on the overlap in symptomology between autism spectrum
disorders with those of dyslexia. Officially, as for ADHD, ASD is an exclusionary criterion
for diagnosis of dyslexia and vice versa, but ASD also shows overlap with dyslexia in both
cognitive and behavioural features (Reiersen & Todd, 2008, Simonoff et al., 2008). A propor
tion of children share symptoms between dyslexia, ADHD and ASD.
The number of children that do share symptoms of ASD and dyslexia is likely to be small
(Wright, Conlon, Wright, & Dyck, 2011). The frequency of reading disorder in combination
with disorder of written expression (i.e. dyslexia) was around 14% in a sample of adults
with Aspergers Syndrome (AS) so according to this result around one in seven individuals
with AS will have co-occurring dyslexia (Hofvander et al., 2009). However the proportion of
individuals with dyslexia who have co-occuring AS is likely to be low as Aspergers Syn
drome is much a rarer condition than dyslexia.
A common problem for children with dyslexia is misinterpretation of spoken language,
which can also manifest itself in comprehension. This produces further overlap with prag
matic language impairment (PLI) which itself is virtually indistinguishable from communi
cation difficulties associated with high functioning autism. Pragmatic language difficulties
may involve literal interpretation so run on the spot would have a child looking for a big
black spot to run on, for example. Children with PLI will often fail to interpret the core
meaning or saliency of events. This causes a penchant for routine and 'sameness' (also seen
in autism and Asperger's Syndrome) as PLI children struggle to generalize and take hold of
the meaning of novel situations. Obvious and concrete instructions are clearly understood
and carried out, whereas simple but non-literal expressions such as jokes, sarcasm and gen
eral social chatting are difficult and may be misinterpretated. PLI may therefore impact on
the social abilities of the child who has difficulty interpreting jokes. Current thinking is that
PLI is not a problem rooted in language skills but one of social communication and informa
tion processing. Griffiths (2007) identified difficulties of this type in dyslexic students,
showed they were impaired in making inferences from a story and choosing the right
punch-line for a joke. This of course can have implications for written language and exami
nations under stress, as well as for a range of social interactions.
367
368
It is not just that ASD is co-morbid with dyslexia and ADHD. Other studies have noted high
comorbidity with other developmental disorders. Dyspraxia and dyscalculia and conditions
with shared symptoms such as specific language impairment are frequently comorbid with
autism. Also dyslexia and ADHD themselves co-occur Willcutt and colleagues (Willcutt,
Doyle, Nigg, Faraone, & Pennington, 2005) showed that 40% of a sample of twins with ei
ther dyslexia or ADHD was co-morbid for the other disorder. Reading difficulties were
measured with both rating scale and an objective task in a study by Cheung et al. (2012) and
correlations were observed among ADHD, reading difficulties and IQ. Over half, (53%-72%)
of the overlapping familial influences between ADHD and reading difficulties were not
shared with IQ. In a school based study Kadesj and colleagues found 40% of children with
ADHD showed reading problems and 29% writing problems (2005).
Overall, the literature suggests, there is good evidence to suggest that some children do suf
fer from symptoms of both dyslexia and ASD, although this is not so well established, and
does not occur so frequently as co-morbidity between ADHD and ASD.
6. Reasons for co-occurrence of ASD with other developmental disorders

Several theories have been put forward to explain the shared symptoms of the various de
velopmental conditions in other words why specific learning and language and social dis
orders are not specific. It is likely that all the explanations below play a part in cooccurrence; the causality of co-morbidity is most probably due to a complex web of
interacting factors.
7. Genetic explanations
One of the most persuasive explanations is that a genetic predisposition may lead to abnor
mal neurological development, which in turn may manifest in various different aberrant be
haviors and developmental delays. As autism, ADHD and dyslexia and other
developmental conditions are all highly heritable, so they all have a large genetic compo
nent, the theory seems plausible. The same genetic anomaly may lead to several disorders or
psychiatric conditions. In other words one genotype may lead to several (related) pheno
types. This is known as pleiotropy. Researchers have suggested that co-occurrence of au
tism and ADHD (and other developmental disorders) may reflect such common genetic
causes (Reierson et al, 2008). In this model, the origins of both sets of difficulties are due to
common genetic anomalies that predispose children to delayed or atypical neurological de
velopment. Certainly, specific genetic anomalies have been associated with a range of psy
chopathologies in adulthood. However, the genetic picture is complex and exact pathways
are not established. It is estimated there are more than a thousand gene variations which
could disrupt brain development enough to result in social delays (Sanders et al., 2012).
Such a genetic predisposition is almost certainly complex and multi factorial. So far, over
100 candidate genes have been associated with ASD, most of which encode proteins in
http://dx.doi.org/10.5772/54159
volved in neural development, but exact mutations within the candidate genes have yet to
be identified (Freitag, 2007). Furthermore, different individuals may have mutations in dif
ferent sets of genes and most of the discovered gene variations are likely to have a low pene
trance, thus not all carriers will develop the disorder. There may be interactions among
mutations in several genes, e.g. between regulatory genes and coding regions, or between
the environment and mutated genes, altering their expression. The effect of a mutation or
deletion can depend on processes relating to gene expression and regulation as well as the
subsequent effects on the expression of other genes.
The advent of genomics and the emphasis placed on this has led to much research to identi
fy genetic predispositions to ASD. The field of psychiatry as a whole has been geneticised
according to some social theorists. This refers to the potential reclassification of psychiatric
conditions in the light of findings from molecular biology. For example, a particular sub-cat
egory of DSM-IV schizophrenia has been linked to a substitution of a single base in the se
quence of DNA of a particular gene localised to a precise place on a particular chromosome,
leading to a substitution of one amino-acid for another in an enzyme involved in neuro
transmission. Hedgecoe (2001) provides a discussion of the geneticisation of schizophrenia.
The debate as to whether the old psychiatric systems of classification should be overhauled
in the light of new genomic knowledge which illuminates genetic aetiologies is ongoing
(Ericson & Doyle, 2003).
A second theory is that an environmental insult or a stressful event in the life of the fetus or
in a young childs life, may trigger a genetic predisposition to be expressed. Thus this consti
tutes a gene- environmental interaction theory. An example might be the high testosterone
levels in the womb that have been observed in some studies. Baron-Cohens Cambridge
group, for example, has carried out work that has suggested high levels of fetal testosterone
may be linked to the development of autistic traits (Ingudomnukul, Baron-Cohen, Wheel
wright, & Knickmeyer, 2007). According to the gene-environment explanation, the elevated
testosterone might lead to the differential expression of genes controlling the neurological
development of the child. Another example that has been quite widely publicized concerns
Omega 3 fatty acids. These have been implicated by Richardson (2006), who has argued that
attention-deficit/hyperactivity disorder, dyslexia, developmental coordination disorder
(dyspraxia) and conditions on the autism spectrum may all share common origins triggered
by problems with phospholipid (fatty acid) metabolism. However this is just one genetic /
environmental explanation for co-occurrence that vies with several others, and the available
evidence is subject to interpretation.
In the majority of cases, the gene-environment hypothesis seems highly plausible. It may
be that autism and co-occurring developmental conditions may all be caused by a genet
ic predisposition which is triggered by an early environmental influence (Trottier, Srivas
tava, & Walker, 1999).
369
370
Many environmental factors have been implicated in ASD but the effect of each is poorly
established. After the well publicized paper that linked autism to the MMR vaccination, re
search has repeatedly refuted a link between the MMR jab and ASD (Rutter, 2005). Deykin
and MacMahon (1979) found increased risk due to exposure to, and clinical illness from,
common viral illnesses in the first 18 months of life. In this study, mumps, chickenpox, fever
of unknown origin, and ear infections were all significantly associated with ASD risk. Epide
miological studies have shown there is a higher rate of adverse prenatal and postnatal
events in children with ASD than in the general population (Zwaigenbaum et al., 2002).
Newschaffer and colleagues (2007) review named associated obstetric conditions that in
cluded low birth weight, gestation duration, and caesarean section. It is possible that such
an underlying cause partially could explain both autism and the associated conditions (Ko
levzon, Gross, & Reichenberg, 2007). There is evidence to suggest adverse prenatal and peri
natal events are also associated with ADHD and cognitive development. Some studies have
suggested that the risk of autism may be increased with advancing maternal age (Bolton et
al., 1997). Paternal age too has frequently (but not always) associated with autism. There are
more mutations in the gametes of older men, and this higher rate of mutation in the genetic
material from the paternal side may explain the higher levels of neurodevelopmental disa
bilities in their offspring. An alternative explanation is that fathers who themselves have au
tistic traits are less likely to have children young. Using anticonvulsants during pregnancy
also appears to increase the risk of ASD (Moore et al., 2000). These drugs are used to combat
epilepsy which is commonly often comorbid with ASD. Parental occupational exposure to
chemicals during the preconception period has also been higher in ASD families than con
trols in some studies (Felicetti, 1981).
Environmental risk factors have received widespread media coverage within the last few
years, perhaps because of the strong degree of public concern (Russell & Kelly, 2011). In
most health and disease categories, a secondary function of diagnosis is to group together
people who have a common aetiology. However, the specific effects of genetic factors and
environmental risk factors that might play a part in abnormal neural development are large
ly unresolved. Goodman and Scott (1997) stress that current understanding of aetiology for
childhood developmental conditions will probably look ridiculously simplistic or misguid
ed in years to come. Despite, or perhaps because of, the uncertainty, there is an underlying
concern among people involved with children who are diagnosed with developmental con
ditions that environmental influences may be partially to blame for rising incidence. Novel
prenatal and perinatal medical practices, changing diet, shifting family structures and child
hood social activities have all been the subject of lay theories to explain rising prevalence not
just of ASD, but developmental disorders in childhood more generally, including ADHD
and dyslexia (Russell & Kelly, 2011).
9. The influence of childcare and the childs environment

A third possibility is that environmental factors alone may be enough to trigger not just au
tistic behaviors, but also other maladaptive behaviors such as inattention. Autistic behaviors
http://dx.doi.org/10.5772/54159
were observed in a study of abandoned Romanian children, conducted by Michael Rutter

and colleagues (1999). As well as cases with known genetic causes, in some cases, underly
ing social factors may predispose autistic symptoms. In this study, Rutter and colleagues
noted a very high instance of autism (6%) in the Romanian baby cohort, which they put
down to poor early care. These children exhibited typical symptoms of autism at four years
old, but unlike cases of autism without maltreatment, symptoms by age 6 were much mild
er. This case is an illustration of how children who share severe autistic symptoms at young
ages may have differing developmental trajectories. In this study, the symptoms of autism
may have been triggered primarily by the early neglect, rather than by a genetic predisposi
tion, for if a genetic predisposition was involved it would effect 6% or more of the babies, a
very high proportion.
It is not just aetiological environmental factors that seem to lead to increased risks of dis
playing autistic behaviours. Aetiological causes can be distinguished from proximate deter
minates which occur at the same time as symptoms, for example, social situations or
fluorescent lights may exacerbate the expression of ASD symptoms. There are also those in
fluences in the environment that are sometimes referred to in psychiatry as maintenance fac
tors, including stigmatisation and labelling. Although their influence in perpetuating ASD
and other developmental disorders is unclear, an influence in maintaining symptomatic be
haviours of autism and co-morbid conditions can not be discounted. Biological causes and
behavioural outcomes are mediated by experiential and environmental factors.
10. Cognitive causes and developmental consequences

The competing psychological theories that have been put forward concerning the psycho
logical mechanisms of ASD include weak central coherence theory, deficits in executive
function and the extreme male brain theory, all were reviewed by Happ in 1994.
The extreme male brain theory as developed by Baron-Cohen (2002) suggests that autis
tic individuals can systematizethat is, they can develop internal rules of operation
but are less effective at empathizing and handling events that are unexpected or social.
The theory was developed from the earlier theory of mind
(Baron-Cohen, Leslie, &
Frith, 1985). This suggested that autistic people lack the ability to understand other peo
ples mental states, put themselves in another persons place or imagine what they might
be thinking or experiencing. This lack of mentalising is discussed by Frith and Happ in
their discussion of dyslexia, autism and downstream effects of specific impairments
(1998). The theory of mind lines up with the mirror neuron theory of autism (Iacoboni
& Dapretto, 2006) which was based on the discovery that the macaque monkey brain
contained mirror neurons that fired not only when the animal is in action, but also
when it observes others carrying out the same actions.
An alternative psychological theory for autism is provided by Frith whose weak central co
herence theory (Frith, 2003; Happ & Frith, 2006) describes the ability to place information
in a context in order to give it meaning. Most people pull together numerous stimuli to form
371
372
a coherent picture of the world, allowing them to see the bigger picture. In central coher
ence theory, the failure to appreciate the whole accounts for the piecemeal way in which
people with ASD acquire knowledge. People with ASD may also show relative strengths in
some areas, known as islets of ability; and this accounts for savant skills. Related to central
coherence is the theory that autistic behaviours are due to interference in executive function
(Hill, 2004). Executive functions coordinate the flow of information processing in the brain
and are the mechanisms of transferring attention from one thing to another flexibly and
easily. They allow people to plan strategically, solve problems and set objectives. Their ab
sence means autistic people show an inability to plan and attain overarching goals. This
manifests as easily distractible behaviour and reliance on routines. Such psychological theo
ries of ASD are useful models but have also been subject to criticism. Bailey and Parr (2003)
describe such theories of psychological mechanisms as narrow cognitive conceptualisa
tions (p. 27), because they cannot accommodate the presence of sub-clinical autistic traits in
the general population.
These theories seem very distinct from some psychological theories that explain dyslexic
type and attention and hyperactive difficulties. The exception to this is that, deficits in exec
utive function have been suggested as causal for ADHD, as they affect both cognitive and
motivational systems (Willcutt et al., 2005). Frith and Happ (1998) focusing on dyslexia and
autism, argue that psychological mechanisms could act as gateways to impairment in other
domains. These downstream developmental effects have not yet been fully considered, they
suggest. Although they focus on autism and dyslexia, ADHD and other developmental dis
orders could easily be included in their model. As they point out, both dyslexia and autism
have genetic origins, an anatomical basis and extremely variable behavioral manifestations.
Their idea is that in addition to the genetic and anatomical origins, an additional develop
mental pathway may contribute to later difficulties. They argue that specific impairments
seen in dyslexia or autism (such as dyslexic phonological or autistic mentalising difficulties)
may have a gatekeeping function and subsequently lead to difficulties in other areas. Thus
impairments in domain-specific functions may have wide ranging developmental effects.
The idea put simply is that during development, one behavior exacerbates problems in oth
er domains. It is perhaps easier to understand given a few concrete examples. Frith and
Happ suggest that the core autistic difficulty of social engagement may lead to missed op
portunities for learning, including learning vocabulary. This may effect language acquisition
and in turn the development of language based skills evident in dyslexia. An easier pathway
to understand might be via gatekeeping function of inattention. If a child is inattentive (a
core symptom of ADHD) then the likelihood is they may struggle to focus on learning to
read. Hence difficulties symptomatic of dyslexia may be expected. Conversely perhaps read
ing difficulties are primary, in which case inattention might come from frustration and in
ability to deal with task demands. This direction of causality seems likely in the sub-group
of ADHD children whose problems only appear at school, and who are more likely than
other groups to show reading problems according to Taylor (2011). Furthermore, an inatten
tive child may find it difficult to socialize normally, and may have difficulties following in
struction. This may lead to the impairment in social skills symptomatic of autism.
http://dx.doi.org/10.5772/54159
In a similar way, it is possible to theorize that each domain of behavioural impairment in the
triad for autism might lead to another. In a review of evidence for single genetic or cognitive
causes for autism, Happ, Ronald, and Plomin (2006) note that twin studies suggest combi
nations of largely non-overlapping genes act on each area of impairment. Their own study
found only modest correlations between the three domains of behavioural traits in the triad
(namely deficits in social skills and communication and stereotyped behaviour or restricted
interests). In the general population, correlations ranged from 0.1- 0.4 for the relationship of
each domain to the other. This evidence shows that the three types of autistic traits may be
clustered or linked or co-inherited, but with a weak association. These low correlations
could be attributed to developmental pathways factors as well as genetic links. Such residu
al downstream developmental effects are easy to conceptualise. If a young boy is very aso
cial for example, then his communication skills will not be practised with peers, so he is
unlikely to develop as quickly in measures of communication as a more sociable child. The
weak correlation between repetitive behaviours is harder to explain. Speculation is possible:
repetitive behaviours have been shown to have both self-stimulatory as well as calming
functions (Turner, 1999). Repetitive behaviours can therefore be interpreted as responses to
unwanted stimuli, e.g. social stimuli with which autistic people have difficulty. Williams
(1994) has given a first person account of use of repetitive behaviours to ameliorate the
stress of social situations. Conversely, the need for stimulatory repetitive behaviours, con
centrating on drawing lines or circles for example, may interfere with social opportunities.
Weak associations do not confirm or deny genetic co-inheritance. Developmental pathways
where one type of behaviour leads to another may also provide a partial explanation.
In a different but related developmental scenario, Cheslack-Postava and Jordan Young
(2012) suggest that a childs upbringing is highly gendered, and proposed a gendered em
bodiment model for autism. They cite numerous studies illustrating that the nature of pa
renting in particular depends on the gender of the child. This they use to describe a
gendered theory of development of autism, although the model could also explain the large
predominance of boys with other developmental disorders. Cooper (2001) suggests boys are
socialized to encourage competition and activity thus a conflict between passivity required
at western schools and masculine identity is generated. Some behaviours associated with
ADHD when used excessively in school environments, climbing trees for example, are en
couraged more often in boys than girls. Cheslack-Postava and Jordan Young suggest such
gendered social processes interact with biology to promote certain disordered behaviours.
This they call the pervasive developmental environment.
As well as downstream developmental models, some theorists have suggested one cognitive
deficit may underlie several symptomatic behaviours. Although the cognitive/psychological
theories of dyslexia and autism seem quite distinct, some research does suggest children
with both ADHD and dyslexic difficulties show a distinctive deficit in rapid naming speed,
so it may that processing speed underlies the link (Bental & Tirosh, 2007).
A second example is provided by executive function which is impaired in both autism and
ADHD (Willcutt et al, 2005). According to some models, an underlying impairment in execu
tive function prevents children from coordinating information processing in the brain, and
373
374
prevents the transfer attention from one thing to another. It is easy to understand how this ab
sence may translate into symptoms of either autism, due to inability to plan with strategic over
arching vision, and hence reliance on routines, or as inattention and distractibility
symptomatic of ADHD. Executive functions are neuropsychological processes needed to sus
tain problem-solving toward a goal. Executive functions allow a resolution of conflict when
two responses are simultaneously called for by stimuli. In the laboratory, the Stroop task is an
example. The conflicting combination of a word like red written in green ink creates conflict
when the task is to say the color of the ink (green), due to the overlearned reading response that
automatically elicits the response based on the meaning of the word (red). Executive function
allows for the inhibition of the overlearned response and the execution of a response that is
more appropriate given the context. Research has confirmed the involvement of deficits in ex
ecutive functions that are essential for effective self-regulation in people with ADHD. The
mental processes most often listed as being part of the notion of executive function are quite di
verse so there is no standardized definition. They include: inhibition, resistance to distraction,
self-awareness, working memory, emotional self-control, and even self-motivation. Bramham
and colleagues (2009) found that both adults with ASD and ADHD had impaired executive
function, although they did have distinctive profiles. Nyden and colleagues found that chil
dren with Aspergers Syndrome and dyslexia did not differ in tests of executive function: they
could not establish any test of executive function that captured the differences in these disor
ders (1999).
Russell Barkley (2012) conceptualizes executive control as the methods of self-regulation. He
writes entertainingly on how a person might use executive functions to resist the temptation
to buy a tempting pastry from a shop:
avert your eyes from the counter, walk to a different section of the shop away from the tempting goodies, engage
yourself in mental conversation about why you need to not buy those products, and even visualize an image of the
new slenderer version of yourself you expect to achieve in the near future. All of these are self-directed actions you are
using to try and alter the likelihood of giving into temptation and therefore increase your chances of meeting your goal
of weight loss this month. This situation calls upon a number of distinct yet interacting mental abilities to successfully
negotiate the situation. You have to be aware that a dilemma has arisen when you walked into the shop (self-aware
ness), you have to restrain your urge to order the pastry to go with the coffee you have ordered (inhibition), you redirected your attention away from the tempting objects (executive attention or attentional management), you spoke to
yourself using your minds voice (verbal self-instruction or working memory), and you visualized an image of your
goal and what you would look like when you successfully attain it (nonverbal working memory, or visual imagery).
You may also have found yourself thinking about various other ways you could have coped effectively with these
http://dx.doi.org/10.5772/54159
temptations (problem-solving), and may have even used words of encouragement toward yourself to enhance the like
lihood that you would follow your plan (self-motivation).
Barkley explains that these and other mental activities are usually included in the under
standing of human self-regulation, and it is difficulties in these areas (which are processes in
executive function) that may lead to ADHD. Children with ADHD are distractible and selfregulation, the ability to override incoming stimuli, to see the bigger picture and lack the
ability to see the consequences of their future actions. Children with ASD have difficulties
transferring attention from one thing to another because they also lack overview (and impli
cations of their actions in the future).
Gooch, Snowling and Hulme (2011) note that deficits in time perception (the ability to judge
the length of time intervals) have been found in children with both dyslexia and ADHD.
These researchers found children with comorbid dyslexia and attention problems performed
poorly on measures of executive function as well as on phonological tasks. However, their
results were interpreted as the effect of independent underlying cognitive causes. Although
deficits in duration discrimination were associated with both dyslexia and attention prob
lems, they concluded the results supported the claim that the two disorders are products of
different cognitive defects originating from shared genes with pleiotropic effects.
Developmental models explain comorbidity of developmental disorders by shared cognitive
deficits, either as gateways as in Frith and Happs (1998) model, where one difficulty leads
to another later in life, or as underlying shared deficits, for example impaired executive
function causing both autism and ADHD. The alternative model suggests that cognitive dif
ficulties associated with each disorder are distinct, but multiple cognitive deficits arise from
similar genetic/environmental origins. All these theories have some empirical support.
11. Diagnostic substitution and the influence of society and culture

When symptoms of two or more conditions are shared, whatever the psychological mecha
nisms (whether or not there are shared underlying cognitive deficits, and /or genetic and
neurological differences) then the area of functioning that is highlighted as a problem may
depend on which tests are administered. In our recent research we followed a six year old
child who was assessed by three educational psychologists and one multidisciplinary team,
each blind to the findings of the others. One concluded that the child had dyspraxia, two
that the child had dyslexic difficulties, and a third that borderline AS was likely. We inter
preted these differences in the use of diagnostic labels as dependent on settings that varied
during assessments, and assessment methods that exposed different types of behaviour
(Russell, Norwich, & Gwernan-Jones, 2012). This work suggests that which diagnosis is as
signed depends to some extent on social and cultural factors as well as actual symptoms. If a
child has symptoms of several disorders, then one context or test may draw out symptoms
associated with one disorder, whereas another setting may expose symptoms of another.
375
376
Thus for co-occurring symptoms it is difficult to differentiate between disorders and the
likelihood that a co-morbid disorder will be missed is increased. This emphasizes the need
for assessment in multiple settings and reassessment over time.
One of the most compelling cross cultural descriptions of how autism is regarded across
various cultures was the book Unstrange Minds. Written by the anthropologist Roy Grinker
(2008), Grinker explains how the category of ASD is contingent on the culture through
which it is expressed- the condition is associated with differing levels of stigma in different
cultures. In the US, several studies have also shown that clinicians may diagnose ASD when
resources are targeted at the diagnosis, whereas previously, under other circumstances, they
may have diagnosed another category of childhood disorder. Paul Shattuck has written
about the extent to which increases in the administrative prevalence of autism have been as
sociated with corresponding decreases in the use of other diagnostic categories, mental re
tardation and learning disabilities (2006). This process of diagnostic substitution he argues,
may partially explain the rise in prevalence in autism in the US.
Our own work suggests that since the 1980s, the recorded prevalence of both ASD and
ADHD in the UK has increased dramatically. We examined data from both the Millennium
Cohort Study, (the large cohort of around 19,000 children who have been followed from
their birth through to seven years old and beyond), and another cohort, called the British
Cohort Study, where children were born thirty years previously. Both cohorts were repre
sentative of the UK as a whole, and medical reports of both ASD and ADHD were given
when children were age seven for in 2007-9 and ten in 1980. The results from 2007 contrast
ed with the 1980 sample at age 10. Only 11 children in the 1970 British Cohort Study were
reported as having ADHD in their medical exam, giving an estimated prevalence of 0.083%.
The autism diagnosis was rarely used with just 3 children assigned the label; 0.023% of chil
dren. A number of other child psychiatric diagnoses were available and many of these were
diagnosed during the medical exams. Details of these alternative labels are given in Table 1.
1980 Diagnosis (ICD 9 codes)
N of children
Percentage of total examined %
Autism (299.0/1/8/9)
0.023
ADHD (314.00/01, 314.9)
11
0.083
Disturbance in emotions (313)
0.053
13
0.098
81
0.614
Delays in development: Reading

(315.0)
Delays in learning & development
(315.2/8/9/5)
Delays in language
(315.3)
62
(1 autism co-morbid)
Impulse control (312.3/9)
Mild mental retardation
34
(317)
Other specified delays in
development (318)
(1 ADHD co-morbid)
22
(1 ADHD co-morbid)
0.462
0.007
0.258
0.166
http://dx.doi.org/10.5772/54159
Unspecified delays in development
N of children
25
(319)
(1 ADHD co-morbid)
Total
259
0.379
1.961
Table 1. Named conditions using ICD-9 categories for 10 year old children in 1980 (n=13201).
Among the 14,043 children in the 2007 cohort, 209 (1.49%) were reported to have ASD, and
180 (1.28%) were reported having been given an ADHD diagnosis by a clinician (unweight
ed figures). There was disproportional stratification in the Millennium Cohort, meaning that
all analyses were weighted to account for the clustering and over-inclusion of participants
from disadvantaged areas. After weighting, 1.7 % of children were reported as having an
ASD (95% CI, 1.4-1.99). 1.3% of these were boys, and 0.25% girls, giving boy girl ratio of ap
prox 5:1 for ASD. Surprisingly, the figure for ADHD was lower. After weighting, 1.4% of the
population were reported as having ADHD (95% CI, 1.2-1.7). Of these, 2.3% were boys and
0.25% girls, giving a gender ratio of approximately of 1 girl to every 4 boys with ADHD.
One interpretation of the historical shift is that diagnostic substitution has occurred: children
with similar symptoms in 1980 may have been more likely to receive generalised labels of
delays in learning & development than ASD or ADHD. So changing diagnostic practice,
cultural factors and context may do much to explain both co-morbidity and rising preva
lence. The steep rise in children assigned these diagnoses cannot be totally explained by the
substitution mechanism- twice as many children were given either ASD or ADHD diagno
ses in 2009 as the total number diagnosed with any type of developmental disorder in 1980.
Context also has a big part to play in the identification of difficulties, in terms of what is con
sidered to be disordered. Social constructionists have also pointed out that the conceptuali
zation of difficulties associated with both dyslexia and ASD as disorders is itself a product
of social and cultural standards, and of course the definition of each disorder has changed
over time. This has prompted calls for the term autism spectrum conditions to replace au
tism spectrum disorders (2009). Our own analysis of the Millennium Cohort has shown a
strong association between ADHD and poverty, reflecting findings from US studies which
have also found differing levels of ADHD amongst various ethnic groups- Hispanic children
were more likely to be identified with ADHD in a study by Akinbami et al. (2011). It is un
clear whether this is entirely due to greater awareness and access to health care in some
groups, differential reporting about the same level of difficulties between ethnic groups or
whether children in different groups have truly varying symptom levels (Boyle et al., 2011).
A study by Cuccaro et al. (1996) showed the nature of diagnosis of developmental disorders
varied according to the socio-economic status of the childs family; autism was more likely
to be identified in children of higher income families, although no biases of SES were found
for identification with ADHD. Cooper (2001) points out that the behaviour symptomatic of
ADHD becomes problematic where high value is placed on ability to remain sedentary and
sustain attention on tasks, in other words, in schools. Hulme and Snowling (2009) describe
how differences of this nature must therefore be thought of as both biological and as a prod
uct of the social and environmental world.
377
378
12. Conclusion
Two conclusions can be drawn. First, co-morbidities between developmental disorders are
common, and second, the causes of these overlapping difficulties are likely to be complex,
multifactorial and interacting. Firstly, the high overlap between symptoms of different de
velopmental disorders has been identified in a number of studies and there is an interna
tional consensus on this overlap. Studies from Canada, the UK, USA and Scandinavia all
show how hard it is provide an unequivocal diagnosis, leading to the quote from Kaplan
and her colleagues (2001) in developmental disorders co-morbidity is the rule, not the exception.
This was informed by the groups work studying a population-based sample of 179 children
receiving special support in Calgary: If the children met the dyslexia criteria, there was a
51.6% chance of having another disorder. If the children met the ADHD criteria there was an
80.4% chance of having another disorder. They criticize the term comorbidity, as it implies
unsubstantiated presumption of independent aetiologies. The authors argue that discrete
categories do not exist in real life.
Secondly, in considering the reasons for co-morbidities, a complex bio-psycho-social model
is required that leads to symptoms that may result in diagnosis. The nature of the diagnosis
itself may depend on social context as well as an individual childs behaviour. A hint of this
complexity is achieved in Figure 3, which is a schematic diagram of various potential causal
pathways. It is plausible that the same underlying genetic or neurological mechanisms may
underlie co-occurrence of dyslexia, ADHD and ASD. The reverse pathways are not at first so
obvious. But recent advances in systems biology have shown that the environment of the
cell affects gene expression and protein synthesis at molecular levels. Thus environmental
influences can alter core biology: for example Mack and Mack (1992) describe how tweak
ing rats whiskers changes gene expression in the sensory cortex. In systems theory, genetic
influences are conceptualised more like a set of piano keys on which notes may be played or
not played, played slowly or quickly, and there is enormous variation in the music pro
duced even with the same basic set of keys. So the cellular environment can affect genetic
expression. A simplified model underlying much behaviour genetics research envisages a
direct linear relationship between individual genes and behaviours. The reality is likely to
be far more complex with gene networks and multiple environmental factors impacting
brain development and function, which in turn will influence behaviour (Hamer, 2002). Kar
miloff-Smith (2007) emphasizes how learning and experience effects gene expression in hu
mans. Such scholars demonstrate that the social can affect the biological as well as the more
intuitive path of genetic origin leading to neurological development leading to aberrant be
haviour. Diagnosis itself may influence behaviour too, through differential treatment and in
terventions. Thus the pervasive developmental environment is composed of many related
factors, environmental stresses, and genetic predispositions, and the social contexts all of
which may interact to produce developmental outcomes that themselves may contribute to
predicting ongoing child development.
Snowling (2012) suggests a new dimensional classification of disorder, where deficits in dif
ferent components of learning are seen as additive, impacting on the potential for remedia
http://dx.doi.org/10.5772/54159
tion, rather than classing children into dichotomous disorder categories. Taylor (2011)
notes that for many children, it is better to think of changes in cognitive style, learning and
motivation rather than symptoms. Both conclude that it is important to examine children for
evidence of co-occurring disorders, and not simply continue to examine the areas which we
expect to be impaired according to categorization. The practical application of assessing chil
dren for a range of difficulties is that children will be best helped not by any all encompass
ing diagnosis, but by individual analysis of their strengths and weaknesses. Future research
may be wise to focus on the individual profiles of children across a broad range of areas,
looking at the unique strengths, as well as the weaknesses of the individual children, so that
parents and educators may adapt their support accordingly, regardless of the diagnostic la
bel a child receives.
Figure 3. Schematic of interacting causal mechanisms for co-morbidity.
Author details
Ginny Russell1 and Zsuzsa Pavelka2
1 University of Exeter Medical School, ESRC Centre for Genomics in Society, UK
2 University of Milan, Italy
379
380
References
[1] Akinbami, L. J., Liu, X., Pastor, P. N., & Reuben, C. A. (2011). Attention deficit hyper
activity disorder among children aged 5-17 years in the United States, 1998-2009.
NCHS Data Brief, (70), 18.
Disorders (4th ed., text revision [DSM-IV-TR]
[3] Bailey, A., & Parr, J. (2003). Implications of the broader phenotype for concepts of au
tism. Novartis Foundation symposium, 251, 2635; discussion 3647, 10911, 28197.
[4] Barkley, R. A. (2012). Executive Functions: What They Are, How They Work, and Why
They Evolved (1st ed.). Guilford Press.
[5] Baron-Cohen, S, Leslie, A. M., & Frith, U. (1985). Does the autistic child have a theo
ry of mind? Cognition, 21(1), 3746.
[6] Baron-Cohen, Simon. (2002). The extreme male brain theory of autism. Trends Cogn
Sci, 6(6), 248254.
[7] Baron-Cohen, Simon, Scott, F. J., Allison, C., Williams, J., Bolton, P., Matthews, F. E.,
& Brayne, C. (2009). Prevalence of autism-spectrum conditions: UK school-based
population study. The British Journal of Psychiatry, 194(6), 500509.
[8] Bental, B., & Tirosh, E. (2007). The relationship between attention, executive func
tions and reading domain abilities in attention deficit hyperactivity disorder and
reading disorder: A comparative study. Journal of Child Psychology and Psychiatry,
48(5), 455463.
[9] Bolton, P. F., Murphy, M., Macdonald, H., Whitlock, B., Pickles, A., & Rutter, M.
(1997). Obstetric complications in autism: consequences or causes of the condition?
Journal of the American Academy of Child and Adolescent Psychiatry, 36(2), 27281.
[10] Boyle, C. A., Boulet, S., Schieve, L. A., Cohen, R. A., Blumberg, S. J., Yeargin-Allsopp,
M., Visser, S., et al. (2011). Trends in the prevalence of developmental disabilities in
US children, 1997-2008. Pediatrics, 127(6), 10341042.
[11] Bradley, E. A., Summers, J. A., Wood, H. L., & Bryson, S. E. (2004). Comparing rates
of psychiatric and behavior disorders in adolescents and young adults with severe
intellectual disability with and without autism. Journal of Autism and Developmental
Disorders, 34(2), 15161.
[12] Bramham, J., Ambery, F., Young, S., Morris, R., Russell, A., Xenitidis, K., Asherson,
P., et al. (2009). Executive functioning differences between adults with attention defi
cit hyperactivity disorder and autistic spectrum disorder in initiation, planning and
strategy formation. Autism, 13(3), 245264.
http://dx.doi.org/10.5772/54159
[13] British Psychological Society. (1999). Working party of the division of educational
and child psychology of the British Psychological Society: Dyslexia, literacy and psy
chological assessment. British Psychological Society : Leicester.
[14] Cheslack-Postava, K., & Jordan-Young, R. M. (2012). Autism spectrum disorders: To
ward a gendered embodiment model. Social Science & Medicine (1982), 74(11), 1667
1674.
[15] Cheung, C. H. M., Wood, A. C., Paloyelis, Y., Arias-Vasquez, A., Buitelaar, J. K.,
Franke, B., Miranda, A., et al. (2012). Aetiology for the covariation between combined
type ADHD and reading difficulties in a family study: The role of IQ. Journal of Child
Psychology and Psychiatry,, 53(8), 864873.
[16] Clark, T., Feehan, C., Tinline, C., & Vostanis, P. (1999). Autistic symptoms in children
with attention deficit-hyperactivity disorder. European Child & Adolescent Psychiatry,
8(1), 5055.
[17] Coltheart, M., & Jackson, N. E. (1998). Defining Dyslexia. Child and Adolescent Mental
Health, 3(1), 1216.
[18] Constantino, J. N., & Todd, R. D. (2003). Autistic traits in the general population: A
twin study. Archives of general psychiatry, 60(5), 52430.
[19] Cooper, P. (2001). Understanding ADHD: A brief critical review of literature. Chil
dren & Society, 15(5), 38795.
[20] Cuccaro, M. L., Wright, H. H., Rownd, C. V., Abramson, R. K., Waller, J., & Fender,
D. (1996). Professional perceptions of children with developmental difficulties: The
influence of race and socioeconomic status. Journal of Autism and Developmental Disor
ders, 26(4), 461469.
trum disorders in the offspring. Pediatrics, 121(5), e13571362.
[22] Danielsson, S., Gillberg, I. C., Billstedt, E., Gillberg, C., & Olsson, I. (2005). Epilepsy in
young adults with autism: a prospective population-based follow-up study of 120 in
dividuals diagnosed in childhood. Epilepsia, 46(6), 91823.
[23] Deykin, E. Y., & MacMahon, B. (1980). Pregnancy, delivery, and neonatal complica
tions among autistic children. American Journal of Diseases of Children, 134(9), 860-864.
[24] Dulcan, M. (1997). Practice parameters for the assessment and treatment of children,
adolescents, and adults with attention-deficit/hyperactivity disorder. Journal of the
American Academy of Child and Adolescent Psychiatry, 36(10 Suppl), 85S121S.
[25] Elia, J., Ambrosini, P. J., & Rapoport, J. L. (1999). Treatment of attention-deficithy
peractivity disorder. New England Journal of Medicine, 340(10), 780788.
[26] Ericson, R. V., & Doyle, A. (2003). Risk and Morality. University of Toronto Press.
381
382
[27] Evans, D. W., Canavera, K., Kleinpeter, F. L., Maccubbin, E., & Taga, K. (2005). The
fears, phobias and anxieties of children with autism spectrum disorders and Down
syndrome: Comparisons with developmentally and chronologically age matched
children. Child Psychiatry and Human Development, 36(1), 326.
[28] Fawcett, A. (2012). Introduction to Dyslexia and Co-occuring Difficulties. Dylexia and
co-occuring difficulties. Bracknell, UK: British Dyslexia Association.
[29] Felicetti, T. (1981). Parents of autistic children: Some notes on a chemical connection.
Milieu Therapy, 1, 1316.
[30] Freitag, C. M. (2007). The genetics of autistic disorders and its clinical relevance: A
review of the literature. Molecular Psychiatry, 12(1), 222.
[31] Frith, U. (2003). Autism: Explaining the Enigma (2nd Ed.). Oxford, UK: Wiley-Black
well.
[32] Frith, U., & Happ, F. (1998). Why specific developmental disorders are not specific:
On-line and developmental effects in autism and dyslexia. Developmental Science, 1(2),
267272.
[33] Gillberg, C. (2010). The ESSENCE in child psychiatry: Early Symptomatic Syndromes
Eliciting Neurodevelopmental Clinical Examinations. Research in developmental disa
bilities, 31(6), 15431551.
[34] Gooch, D., Snowling, M., & Hulme, C. (2011). Time perception, phonological skills
and executive function in children with dyslexia and/or ADHD symptoms. Journal of
Child Psychology and Psychiatry, 52(2), 195203.
[35] Goodman, R., & Scott, S. (1997). Child Psychiatry. (2nd ed.). Oxford, UK: Blackwell
Publishing.
[36] Griffiths, C. C. B. (2007). Pragmatic abilities in adults with and without dyslexia: A
pilot study. Dyslexia, 13(4), 276296.
[37] Grinker, R. R. (2008). Unstrange minds: Remapping the world of autism. Cambridge, MA:
Basic Books.
[38] Hamer, D. (2002). Genetics: Rethinking behavior genetics. Science, 298(5591), 7172.
[39] Happ, F. G. (1994). Current psychological theories of autism: The theory of mind
account and rival theories. Journal of Child Psychology and Psychiatry, 35(2), 21529.
[40] Happ, F., Ronald, A., & Plomin, R. (2006). Time to give up on a single explanation
for autism. Nature Neuroscience, 9, 12181220.
[41] Happ, Francesca, & Frith, U. (2006). The weak coherence account: detail-focused
cognitive style in autism spectrum disorders. Journal of Autism and Developmental Dis
orders, 36(1), 525.
[42] Hedgecoe, A. (2001). Schizophrenia and the narrative of enlightened geneticization.
Social Studies of Science, 31(6), 875911.
http://dx.doi.org/10.5772/54159
[43] Hill, E. L. (2004). Executive dysfunction in autism. Trends in Cognitive Sciences, 8(1),
2632.
[44] Hofvander, B., Delorme, R., Chaste, P., Nydn, A., Wentz, E., Sthlberg, O., Her
brecht, E., et al. (2009). Psychiatric and psychosocial problems in adults with normalintelligence autism spectrum disorders. BMC Psychiatry, 9, 35.
[45] Howlin, P. (2000). Outcome in adult life for more able individuals with autism or As
perger syndrome. Autism, 4(1), 6383.
[46] Hulme, C., & Snowling, M. J. (2009). Developmental disorders of language learning and
cognition. Chichester, UK: Wiley-Blackwell.
[47] Iacoboni, M., & Dapretto, M. (2006). The mirror neuron system and the consequences
of its dysfunction. Nature reviews. Neuroscience, 7(12), 94251.
[48] Ingudomnukul, E., Baron-Cohen, S., Wheelwright, S., & Knickmeyer, R. (2007). Ele
vated rates of testosterone-related disorders in women with autism spectrum condi
tions. Hormones and Behavior, 51(5), 597604.
[49] Kadesj, B., Gillberg, C., & Hagberg, B. (1999). Brief Report: Autism and Asperger
syndrome in seven-year-old children: A total population study. Journal of Autism and
Developmental Disorders, 29(4), 327331.
[50] Kaplan, B. J., Dewey, D. M., Crawford, S. G., & Wilson, B. N. (2001). The term comor
bidity is of questionable value in reference to developmental disorders: Data and
theory. Journal of Learning Disabilities, 34(6), 555565.
[51] Karmiloff-Smith, A. (2007). Atypical epigenesis. Developmental Science, 10(1), 8488.
[52] Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M. J., et
al. (2005). The World Health Organization adult ADHD self-report scale (ASRS): a
short screening scale for use in the general population. Psychological Medicine, 35(2),
245256.
[53] Kielinen, M., Rantala, H., Timonen, E., Linna, S.-L., & Moilanen, I. (2004). Associated
medical disorders and disabilities in children with autistic disorder: A populationbased study. Autism, 8(1), 4960.
[54] Kolevzon, A., Gross, R., & Reichenberg, A. (2007). Prenatal and perinatal risk factors
for autism: A review and integration of findings. Archives of Pediatrics & Adolescent
Medicine, 161(4), 32633.
[55] London, E. (2007). The role of the neurobiologist in redefining the diagnosis of au
tism. Brain pathology (Zurich, Switzerland), 17(4), 40811.
[56] Mack, K. J., & Mack, P. A. (1992). Induction of transcription factors in somatosensory
cortex after tactile stimulation. Molecular Brain Research, 12(1-3), 141147.
[57] Miles, T. R. (2004). Some problems in determining the prevalence of dyslexia. Elec
tronic Journal of Research in Educational Psychology, 2(2), 512.
383
384
[58] Mulligan, A., Anney, R. J. L., ORegan, M., Chen, W., Butler, L., Fitzgerald, M., Buite
laar, J., et al. (2009). Autism symptoms in Attention-Deficit/Hyperactivity Disorder:
A familial trait which correlates with conduct, oppositional defiant, language and
motor disorders. Journal of Autism and Developmental Disorders, 39(2), 197209.
[59] Mulligan, A., Anney, R., Butler, L., ORegan, M., Richardson, T., Tulewicz, E. M.,
Fitzgerald, M. Gill, M. (2011). Home environment: association with hyperactivity im
pulsivity in children with ADHD and their non-ADHD siblings. Child: Care, Health
and Development [e-pub ahead of print].
[60] Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E.,
Mandell, D. S., Miller, L.A., Pinto-Martin, J, Reaven, J., Reynolds, A.M., Rice, C.E.,
Schendel, D., Windham, G.C.(2007). The epidemiology of autism spectrum disorders.
Annual Review of Public Health, 28, 235-58.
[61] Nydn, A., Gillberg, C., Hjelmquist, E., & Heiman, M. (1999). Executive function/
attention deficits in boys with Asperger syndrome, attention disorder and reading/
writing disorder. Autism, 3(3), 213228.
[62] Posserud, M.-B., Lundervold, A. J., & Gillberg, C. (2006). Autistic features in a total
population of 7-9-year-old children assessed by the ASSQ (Autism Spectrum Screen
ing Questionnaire). Journal of Child Psychology and Psychiatry, 47(2), 16775.
[63] Reiersen, A. M., Constantino, J. N., Grimmer, M., Martin, N. G., & Todd, R. D. (2008).
Evidence for shared genetic influences on self-reported ADHD and autistic symp
toms in young adult Australian twins. Twin Research and Human Genetics, 11(6), 579
585.
[64] Reiersen, Angela M, & Todd, R. D. (2008). Co-occurrence of ADHD and autism spec
trum disorders: phenomenology and treatment. Expert Review of Neurotherapeutics,
8(4), 657669.
[65] Richardson, A. J. (2006). Omega-3 fatty acids in ADHD and related neurodevelop
mental disorders. International Review of Psychiatry, 18(2), 155172.
[66] Ronald, A., Edelson, L. R., Asherson, P., & Saudino, K. J. (2010). Exploring the rela
tionship between autistic-like traits and ADHD behaviors in early childhood: Find
ings from a community twin study of 2-year-olds. Journal of Abnormal Child
Psychology, 38(2), 185196.
[67] Russell, G., Golding, J., Norwich, B., Emond, A., Ford, T., & Steer, C. (2012). Social
and behavioural outcomes in children diagnosed with autism spectrum disorders: A
longitudinal cohort study. Journal of Child Psychology and Psychiatry, 53(7), 735744.
[68] Russell, G., & Kelly, S. (2011). Looking beyond risk: A study of lay epidemiology of
childhood disorders. Health, Risk & Society, 13(2), 129.
[69] Russell, G., Norwich, B., & Gwernan-Jones, R. (2012). When diagnosis is uncertain:
variation in conclusions after psychological assessment of a six-year-old child. Early
Child Development and Care, (early on-line version).
http://dx.doi.org/10.5772/54159
[70] Russell, G., Steer, C., & Golding, J. (2011). Social and demographic factors that influ
ence the diagnosis of autistic spectrum disorders. Social Psychiatry and Psychiatric Epi
demiology, 46(12), 12831293.
[71] Rutter, M. (2005). Incidence of autism spectrum disorders: changes over time and
their meaning. Acta paediatrica, 94(1), 215.
[72] Rutter, M., Andersen-Wood, L., Beckett, C., Bredenkamp, D., Castle, J., Groothues,
C., Kreppner, J., et al. (1999). Quasi-autistic patterns following severe early global
privation. English and Romanian Adoptees (ERA) Study Team. Journal of Child Psy
chology and Psychiatry, , 40(4), 537549.
A. J., Ercan-Sencicek, A. G., et al. (2012). De novo mutations revealed by wholeexome sequencing are strongly associated with autism. Nature.
[74] Santosh, P. J., & Mijovic, A. (2004). Social impairment in hyperkinetic disorder - rela
tionship to psychopathology and environmental stressors. European Child & Adoles
cent Psychiatry, 13(3), 141150.
[75] Sciutto, M. J., Nolfi, C. J., & Bluhm, C. (2004). Effects of child gender and symptom
type on referrals for ADHD by elementary school teachers. Journal of Emotional and
Behavioral Disorders, 12(4), 247253.
[76] Shattuck, P. T. (2006). The contribution of diagnostic substitution to the growing ad
ministrative prevalence of autism in US special education. Pediatrics, 117(4), 102837.
bidity, and associated factors in a population-derived sample. Journal of the American
Academy of Child and Adolescent Psychiatry, 47(8), 921929.
[78] Snowling, M. J. (2012). Editorial: Seeking a new characterisation of learning disor
ders. Journal of Child Psychology and Psychiatry 53(1), 12.
[79] Sonuga-Barke, E. J. S., & Halperin, J. M. (2010). Developmental phenotypes and caus
al pathways in attention deficit/hyperactivity disorder: Potential targets for early in
tervention? Journal of Child Psychology and Psychiatry, 51(4), 368389.
[80] Sturm, H., Fernell, E., & Gillberg, C. (2004). Autism spectrum disorders in children
with normal intellectual levels: Associated impairments and subgroups. Developmen
tal Medicine and Child Neurology, 46(7), 4447.
[81] Taylor, E. (2011). Commentary: Reading and attention problems how are they con
nected? Reflections on reading McGrath et al. (2011). Journal of Child Psychology and
Psychiatry, 52(5), 558559.
[82] Trottier, G., Srivastava, L., & Walker, C. D. (1999). Etiology of infantile autism: A re
view of recent advances in genetic and neurobiological research. Journal of Psychiatry
and Neuroscience, 24(2), 103-15.
385
386
[83] Turner, M. (1999). Annotation: Repetitive behaviour in autism: A review of psycho

logical research. Journal of Child Psychology and Psychiatry, 40(6), 839849.
[84] Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005).
Validity of the executive function theory of attention-deficit/hyperactivity disorder:
A meta-analytic review. Biological Psychiatry, 57(11), 13361346.
[85] Williams, D. (1992). Nobody nowhere: The extraordinary autobiography of an autistic (1st
ed.). New York, NY: HarperCollins.
[86] World Health Organization. (1992). International Classification of Diseases and related
health
problems
(ICD-10).
Geneva,
WHO.
Retrieved
from
www.who.int/
classifications/icd/en/greenbook.pdf p.179
[87] Wright, C., Conlon, E., Wright, M., & Dyck, M. (2011). Sub-lexical reading interven
tion in a student with dyslexia and Aspergers disorder. Australian Journal of Educa
tional & Developmental Psychology, 11, 1125.
[88] Zwaigenbaum, L., Szatmari, P., Jones, M. B., Bryson, S. E., MacLean, J. E., Mahoney,
W. J., Bartolucci, G., et al. (2002). Pregnancy and birth complications in autism and
liability to the broader autism phenotype. Journal of the American Academy of Child and
Adolescent Psychiatry, 41(5), 5729.
Chapter 17
Co-Occurrence of Developmental Disorders:

Children Who Share Symptoms of Autism,
Dyslexia and Attention Deficit Hyperactivity Disorder
Ginny Russell and Zsuzsa Pavelka
http://dx.doi.org/10.5772/54159
1. Introduction
Children with autism spectrum disorders (ASD) have a higher risk of suffering from several
other conditions. In this chapter I review the extent to which autistic individuals can also expe
rience a range of other difficulties, but my focus will be on the common neurodevelopmental
disorders. The most common of these include dyslexia, attention deficit hyperactivity disorder
(ADHD), dyspraxia, specific language impairment, and dyscalculia. There is considerable
symptom overlap in particular between ADHD and dyslexia, and like autism both are descri
bed as developmental disorders by psychiatric classification systems (American Psychiatric
Association, 2000; World Health Organization., 1992). Overlapping conditions are termed comorbidity by medical practitioners. Co-morbidity may reflect the greater difficulties experi
enced by children with a combination of deficits. Sometimes it is apparent that many children
with a developmental disorder could be classified in several ways. Here I will firstly examine
the research evidence that examines how often symptoms of dyslexia and ADHD occur in the
population of autistic children, and second, review the various theories that have tried to ex
plain why such co-occurring difficulties are so common.
Comorbidity, a term used in medical literature to mean a dual diagnosis, or multiple diag
noses, can reflect an inability to supply a single diagnosis that accounts for all symptoms.
Children with ASD have been shown to have higher rates of epilepsy, with 30% of cases
having epilepsy comorbid (Danielsson, Gillberg, Billstedt, Gillberg, & Olsson, 2005). Other
conditions that are commonly co-morbid with ASD include hearing impairment (Kielinen,
Rantala, Timonen, Linna, & Moilanen, 2004) mental health and behavioural problems (Brad
ley, Summers, Wood, & Bryson, 2004), including anxiety, and depression (Evans, Canavera,
2013 Russell and Pavelka; licensee InTech. This is an open access article distributed under the terms of the
362
Kleinpeter, Maccubbin, & Taga, 2005). It has also been shown that parents of autistic chil
dren are twice as likely themselves to have suffered from psychiatric illness than parents of
non-autistic children (Daniels et al., 2008).
Most of these problems are distinct from those examined in this chapter: the common devel
opmental disorders of childhood which are also found to co-occur with autism, particularly
ADHD and dyslexia.
Before reviewing the evidence that suggests many children share difficulties symptomatic of
these conditions, and the theories of why this may be, I will briefly describe how dyslexia
and ADHD manifest themselves.
2. Dyslexia
Dyslexia is conceptualized by both educational bodies and the psychiatric classification sys
tems as a learning difficulty that primarily affects the skills involved in accurate and fluent
word reading and spelling. Characteristic features of dyslexia are difficulties in phonological
awareness, verbal memory and verbal processing speed. Dyslexia is developmental delay in
literacy and generally slow and inaccurate reading and spelling. The definition of dyslexia has
changed over time, and such changes have often been based on the research identifying a range
of associated difficulties that occur with dyslexia. Estimates of the prevalence of dyslexia have
been complicated because dyslexia cut-offs are contested (Coltheart & Jackson, 1998) and dys
lexia manifests itself differently in various languages according to levels of phonic regularity
(Miles, 2004). Research over the last 40 years has focused on phonological skills. These are the
reading and de-coding skills used when breaking down language into its component sounds
and reassembling the parts in order to read or to spell a word.
Like autism, dyslexic difficulties are considered to exist in a continuum throughout the general
population (Fawcett, 2012). There is much interest in the association of cognitive ability with
changing symptom profiles and diagnosis. The definition of dyslexia is in flux, and has been re
cently redefined by many national bodies, for example in the UK, the British Psychological So
ciety, focusing on literacy learning at the 'word level' without attainment discrepancy:
Dyslexia is evident when accurate and fluent word reading and/or spelling develops very incompletely or with great
difficulty (British Psychological Society, 1999)
This definition implies that the problem is severe and persistent despite appropriate learn
ing opportunities. This UK definition differs from the ICD-10 diagnosis of developmental
dyslexia or Specific Reading Disorder, which requires a discrepancy between actual read
ing ability and the reading ability predicted by a childs IQ. So an intellectual disability,
(generally considered IQ below 70) can co-occur with the British Psychological Society defi
nition of dyslexia. This new definition includes the so called garden variety dyslexic chil
http://dx.doi.org/10.5772/54159
dren who have difficulties with reading and spelling as well as other generalized intellectual
disabilities. The implications of including this group as dyslexic mean that more children
with an intellectual disability would also be classified as dyslexic. As ASD includes a large
group with intellectual disability the extension is likely to increase the number of children
who may be classified as having both conditions. This is important as the clinical and educa
tion label may determine the interventions a particular child receives.
In addition to these characteristics, dyslexic children may experience visual and auditory
processing difficulties, similar to hyper or hypo sensitivity often associated with ASD. Like
the islets of ability seen in many children with ASD, some dyslexic children may also have
strengths in particular areas, such as design, logic, and creative skills.
3. ADHD
ADHD is known as Hyperkinetic Disorder in ICD-10; there are three subtypes of ADHD
according the DSM. In the first, a child will primarily have problems with attention which
may manifest as an inability to remain on task for long periods, lack of response to instruc
tion or distractibility. In the second sub-type, symptoms of hyperactivity and impulsivity
dominate, which is characterized by wriggling, squirming, being unable to sit still, inter
rupting and finding it difficult to wait. Children may also be climbing in inappropriate sit
uations and always on the move when free to do so. The third sub-type is simply the coexistence of both attention problems and hyperactivity, with each behavior occurring
infrequently alone and symptoms starting before seven years of age.
According to ICD-10, eventually, assessment instruments should develop to the point where
it is possible to take a quantitative cut-off score to assess ADHD. Like dyslexia and autism,
the symptoms are behavioural in nature, and are part of a continuously distributed pattern
that extends into the population at large.
The persistence of ADHD symptoms is not so marked as for autism. Around 70 to 50 per
cent of those individuals diagnosed in childhood do not continue to have symptoms into
adulthood (Elia, Ambrosini, & Rapoport, 1999). There is evidence suggesting to some extent
symptoms of ADHD are expressed in reaction to home (Mulligan et al. 2011) and other envi
ronmental contexts. Individuals with ADHD also tend to develop coping mechanisms to
compensate for some or all of their impairments. ADHD is diagnosed more often in boys
with the reported ratio varying from 2:1 to 4:1 (Dulcan, 1997; Kessler et al., 2005) though
some studies suggest this may be partially due to referral bias where teachers are more like
ly to refer boys than girls (Sciutto, Nolfi, & Bluhm, 2004). Treatments for ADHD involve a
combination of medication, usually methyphenidates which are well established in improv
ing symptoms of inattention, and behavioral intervention in education and at home. The is
sue of girls being overlooked on identification is a common thread for research in dyslexia,
ADHD and autism. Our own results suggest there is some evidence to back up the claim
that boys with ASD symptoms are given the diagnosis more frequently than girls with
363
364
equivalent ASD symptoms (Russell, Steer, & Golding, 2011). This may be because the disor
ders tend to be conceptualized as male leading to referral bias.
Because ASD, Dyslexia and ADHD are all behaviorally defined, so symptoms are behaviours.
All three conditions are conceived as particular behaviours along a spectrum, where traits have
a continuous distribution and extend into the general (non-disordered) population. An arbitra
ry cut off point determines who is considered to be within the various categories and who is
not. The clinician giving a diagnosis will be responsible for judging where this cut off may
come, guided by diagnostic criteria and standards within disciplines as well as perceived im
plications: the benfits versus any possible risks of assigning a diagnosis. This is perhaps best es
tablished for autism: Constantino and Todd (2003) measured autistic traits in a large
community sample, and found no jump in the threshold of autistic behaviours between nor
mal individuals and those with an autism spectrum diagnosis, rather they found a continuous
distribution. These findings concurred with those in a Scandinavian study (Posserud, Lunder
vold, & Gillberg, 2006). One of our own studies has likewise shown that autistic traits do ex
tend into the subclinical population (Figure 1). As with dyslexia and ADHD, there is not a
sharp line separating severity in those with a diagnosis from less severe traits in those without
(London, 2007). In both dyslexia, ADHD and the autism spectrum, some children have more
severe difficulties than others, and the symptoms extend into the population of children (and
adults) as a whole. For dyslexia, there are many people who may have mild dyslexic difficul
ties but perhaps might not qualify as dyslexic. For autism spectrum disorders, many people
without an autism diagnosis do have autistic-type behaviours but the severity and frequency
of those behavioural symptoms is less severe than in those deemed to qualify for a diagnosis.
Figure 1. The distribution of an ASD composite trait in the general population from Russell et al.(2012)
http://dx.doi.org/10.5772/54159
The imposition of a cut off between normality and abnormality is therefore an arbitrary but
convenient way of converting a dimension into a category as Goodman and Scott (1997, p.
23) point out.
4. Evidence of symptom overlap ASD and ADHD

Various studies have looked for ADHD or ADHD symptoms in samples of children with
autism or ASD. Rates of ADHD have ranged from 28% to 78% of these samples (Ronald,
Edelson, Asherson, & Saudino, 2010). Studies that look at ADHD symptoms have reported
even higher numbers: for example, Sturm, Fernell, & Gillberg, (2004) looked at a sample of
around 100 high functioning children with ASD and found 95% had attention problems,
75% had motor difficulties, 86% had problems with regulation of activity level, and 50% had
impulsiveness. About three-quarters had symptoms compatible with mild or severe ADHD,
or had deficits in attention, motor control, and perception, indicating a considerable overlap
between these disorders and high-functioning ASD in children.
In an large analysis of nine hundred forty-six twins, Reierson and colleagues (2008) assigned
DSM-IV ADHD diagnoses, and measured autistic traits using the Social Responsiveness
Scale. The study showed that there are clinically significant elevations of autistic traits in
children meeting diagnostic criteria for ADHD. These findings confirm results in earlier
studies (Clark, Feehan, Tinline, & Vostanis, 1999). Santosh and Mijoovic (2004) which found
children with ADHD had elevated levels of impairment in all three autistic symptom do
mains, namely social deficits, communication and stereotyped behaviors. Clark et al found
65-80% of parents of children with ADHD reported difficulties in social interaction (particu
larly in empathy and peer relationships) and in communication (particularly in imagination,
and maintaining conversation). So the presence of autistic traits in children with ADHD ap
pears common (Ronald et al., 2010).
In an analysis conducted with Lauren Rodgers at the Peninsula Medical School in the UK
using data from the Millennium Cohort Study, a cohort of around 19,000 children who were
all born between 2000 and 2002, we noted 44 children had a dual diagnosis of both ASD and
ADHD (proportion of total population 0.3%) by age seven. The prevalence of children with
identified ADHD in the ASD sample was 17%. Conversely, the prevalence of children with
ASD in the ADHD sample was higher at 27%. Both figures indicate substantial overlap be
tween these conditions.
Various European research groups have examined co-morbid disorders in adults with diag
nosed ASD. An international team lead by Hofvander studied a group of 122 adults with
normal IQ from specialist clinics in three European cities: Gothenburg, Paris and Malm
(Hofvander et al., 2009). Here the overwhelming majority had symptoms of ASD. Nonverbal
communication problems were also very common, described in 89% of all their subjects. In
this study over half the participants, (52%) were diagnosed with co-morbid ADHD. Interest
ingly, participants diagnosed with pervasive developmental disorder. Not Otherwise Speci
fied (PDD-NOS) diagnosis had significantly more symptoms of inattention and
365
366
hyperactivity/impulsivity compared to subjects diagnosed with Aspergers syndrome. How

ever, the prevalence of the categorical diagnosis of ADHD did not differ significantly be
tween the groups, nor were gender differences apparent. Although the study presents clear
evidence of many cases where patients display symptoms of both ADHD and ASD, the clin
ical setting may have led to selection bias as patients with complex needs may be more like
ly to seek help.
Because behaviours associated with both conditions lie on a spectrum extending into the
normal range, some studies have found a range of frequency and severity of symptoms. In
Mulligan et al.s (2009) study, for example, 75 of children with ADHD had severe autism
traits, and over half showed sub-clinical autism symptoms. Kadesj and colleagues (Kades
j, Gillberg, & Hagberg, 1999), looked at comorbidity of ADHD in Swedish school-age chil
dren and found only 1% of children meeting the threshold for ADHD had comorbid
Aspergers Syndrome (AS). The estimates of co-morbidity of ADHD symptoms with ASD
symptoms vary widely because of differing methods of case ascertainment. An additional
problem is that the estimate of the prevalence of ASD itself has increased so much in west
ern countries, making ASD itself a moving target (Figure 2).
Patricia Howlin (2000) reviewed the estimated rates of co-existing psychiatric disorders in
subjects with high functioning ASD and found these estimates varied from 9% to 89% - very
substantial differences. However it is possible to generalise; thirty years of research have
confirmed that attention deficits and hyperactivity are relatively common in children and
adults with ASD even if the exact extent of overlap is dependent on methodology and ascer
tainment (Hofvander et al., 2009, Sturm, Fernell, & Gillberg, 2004).
Figure 2. The rising prevalence of autism spectrum disorders over 50 years. (Data from Autism Speaks and CDC, USA)
Recent trends have made categorical diagnosis an integral part of everyday clinical and re
search practice (Sonuga-Barke & Halperin, 2010). Christopher Gillberg (2010) points out that
clinicians have become focused on dichotomous categories of disorder and that clinics have
become increasingly specialized and overlook difficulties not within their immediate juris
http://dx.doi.org/10.5772/54159
diction. Gillberg has argued that co-existence of disorders is the rule rather than the excep
tion in child psychiatry and developmental medicine. He has coined the acronym ESSENCE
(referring to Early Symptomatic Syndromes Eliciting
Neurodevelopmental Clinical Examinations). This describes cases where a combination of
symptoms including inattention, hyperactivity, social and reading difficulties are observed.
Major problems in at least one ESSENCE domain before age 5 years often signal major prob
lems in the same or overlapping domains years later.
To summarize, although ADHD and ASD are separate and recognizable, there is good evi
dence that these conditions co-occur, constituting an amalgam of problems.
5. Comorbidity between dyslexia and ASD

There is only a small literature on the overlap in symptomology between autism spectrum
disorders with those of dyslexia. Officially, as for ADHD, ASD is an exclusionary criterion
for diagnosis of dyslexia and vice versa, but ASD also shows overlap with dyslexia in both
cognitive and behavioural features (Reiersen & Todd, 2008, Simonoff et al., 2008). A propor
tion of children share symptoms between dyslexia, ADHD and ASD.
The number of children that do share symptoms of ASD and dyslexia is likely to be small
(Wright, Conlon, Wright, & Dyck, 2011). The frequency of reading disorder in combination
with disorder of written expression (i.e. dyslexia) was around 14% in a sample of adults
with Aspergers Syndrome (AS) so according to this result around one in seven individuals
with AS will have co-occurring dyslexia (Hofvander et al., 2009). However the proportion of
individuals with dyslexia who have co-occuring AS is likely to be low as Aspergers Syn
drome is much a rarer condition than dyslexia.
A common problem for children with dyslexia is misinterpretation of spoken language,
which can also manifest itself in comprehension. This produces further overlap with prag
matic language impairment (PLI) which itself is virtually indistinguishable from communi
cation difficulties associated with high functioning autism. Pragmatic language difficulties
may involve literal interpretation so run on the spot would have a child looking for a big
black spot to run on, for example. Children with PLI will often fail to interpret the core
meaning or saliency of events. This causes a penchant for routine and 'sameness' (also seen
in autism and Asperger's Syndrome) as PLI children struggle to generalize and take hold of
the meaning of novel situations. Obvious and concrete instructions are clearly understood
and carried out, whereas simple but non-literal expressions such as jokes, sarcasm and gen
eral social chatting are difficult and may be misinterpretated. PLI may therefore impact on
the social abilities of the child who has difficulty interpreting jokes. Current thinking is that
PLI is not a problem rooted in language skills but one of social communication and informa
tion processing. Griffiths (2007) identified difficulties of this type in dyslexic students,
showed they were impaired in making inferences from a story and choosing the right
punch-line for a joke. This of course can have implications for written language and exami
nations under stress, as well as for a range of social interactions.
367
368
It is not just that ASD is co-morbid with dyslexia and ADHD. Other studies have noted high
comorbidity with other developmental disorders. Dyspraxia and dyscalculia and conditions
with shared symptoms such as specific language impairment are frequently comorbid with
autism. Also dyslexia and ADHD themselves co-occur Willcutt and colleagues (Willcutt,
Doyle, Nigg, Faraone, & Pennington, 2005) showed that 40% of a sample of twins with ei
ther dyslexia or ADHD was co-morbid for the other disorder. Reading difficulties were
measured with both rating scale and an objective task in a study by Cheung et al. (2012) and
correlations were observed among ADHD, reading difficulties and IQ. Over half, (53%-72%)
of the overlapping familial influences between ADHD and reading difficulties were not
shared with IQ. In a school based study Kadesj and colleagues found 40% of children with
ADHD showed reading problems and 29% writing problems (2005).
Overall, the literature suggests, there is good evidence to suggest that some children do suf
fer from symptoms of both dyslexia and ASD, although this is not so well established, and
does not occur so frequently as co-morbidity between ADHD and ASD.
6. Reasons for co-occurrence of ASD with other developmental disorders

Several theories have been put forward to explain the shared symptoms of the various de
velopmental conditions in other words why specific learning and language and social dis
orders are not specific. It is likely that all the explanations below play a part in cooccurrence; the causality of co-morbidity is most probably due to a complex web of
interacting factors.
7. Genetic explanations
One of the most persuasive explanations is that a genetic predisposition may lead to abnor
mal neurological development, which in turn may manifest in various different aberrant be
haviors and developmental delays. As autism, ADHD and dyslexia and other
developmental conditions are all highly heritable, so they all have a large genetic compo
nent, the theory seems plausible. The same genetic anomaly may lead to several disorders or
psychiatric conditions. In other words one genotype may lead to several (related) pheno
types. This is known as pleiotropy. Researchers have suggested that co-occurrence of au
tism and ADHD (and other developmental disorders) may reflect such common genetic
causes (Reierson et al, 2008). In this model, the origins of both sets of difficulties are due to
common genetic anomalies that predispose children to delayed or atypical neurological de
velopment. Certainly, specific genetic anomalies have been associated with a range of psy
chopathologies in adulthood. However, the genetic picture is complex and exact pathways
are not established. It is estimated there are more than a thousand gene variations which
could disrupt brain development enough to result in social delays (Sanders et al., 2012).
Such a genetic predisposition is almost certainly complex and multi factorial. So far, over
100 candidate genes have been associated with ASD, most of which encode proteins in
http://dx.doi.org/10.5772/54159
volved in neural development, but exact mutations within the candidate genes have yet to
be identified (Freitag, 2007). Furthermore, different individuals may have mutations in dif
ferent sets of genes and most of the discovered gene variations are likely to have a low pene
trance, thus not all carriers will develop the disorder. There may be interactions among
mutations in several genes, e.g. between regulatory genes and coding regions, or between
the environment and mutated genes, altering their expression. The effect of a mutation or
deletion can depend on processes relating to gene expression and regulation as well as the
subsequent effects on the expression of other genes.
The advent of genomics and the emphasis placed on this has led to much research to identi
fy genetic predispositions to ASD. The field of psychiatry as a whole has been geneticised
according to some social theorists. This refers to the potential reclassification of psychiatric
conditions in the light of findings from molecular biology. For example, a particular sub-cat
egory of DSM-IV schizophrenia has been linked to a substitution of a single base in the se
quence of DNA of a particular gene localised to a precise place on a particular chromosome,
leading to a substitution of one amino-acid for another in an enzyme involved in neuro
transmission. Hedgecoe (2001) provides a discussion of the geneticisation of schizophrenia.
The debate as to whether the old psychiatric systems of classification should be overhauled
in the light of new genomic knowledge which illuminates genetic aetiologies is ongoing
(Ericson & Doyle, 2003).
A second theory is that an environmental insult or a stressful event in the life of the fetus or
in a young childs life, may trigger a genetic predisposition to be expressed. Thus this consti
tutes a gene- environmental interaction theory. An example might be the high testosterone
levels in the womb that have been observed in some studies. Baron-Cohens Cambridge
group, for example, has carried out work that has suggested high levels of fetal testosterone
may be linked to the development of autistic traits (Ingudomnukul, Baron-Cohen, Wheel
wright, & Knickmeyer, 2007). According to the gene-environment explanation, the elevated
testosterone might lead to the differential expression of genes controlling the neurological
development of the child. Another example that has been quite widely publicized concerns
Omega 3 fatty acids. These have been implicated by Richardson (2006), who has argued that
attention-deficit/hyperactivity disorder, dyslexia, developmental coordination disorder
(dyspraxia) and conditions on the autism spectrum may all share common origins triggered
by problems with phospholipid (fatty acid) metabolism. However this is just one genetic /
environmental explanation for co-occurrence that vies with several others, and the available
evidence is subject to interpretation.
In the majority of cases, the gene-environment hypothesis seems highly plausible. It may
be that autism and co-occurring developmental conditions may all be caused by a genet
ic predisposition which is triggered by an early environmental influence (Trottier, Srivas
tava, & Walker, 1999).
369
370
Many environmental factors have been implicated in ASD but the effect of each is poorly
established. After the well publicized paper that linked autism to the MMR vaccination, re
search has repeatedly refuted a link between the MMR jab and ASD (Rutter, 2005). Deykin
and MacMahon (1979) found increased risk due to exposure to, and clinical illness from,
common viral illnesses in the first 18 months of life. In this study, mumps, chickenpox, fever
of unknown origin, and ear infections were all significantly associated with ASD risk. Epide
miological studies have shown there is a higher rate of adverse prenatal and postnatal
events in children with ASD than in the general population (Zwaigenbaum et al., 2002).
Newschaffer and colleagues (2007) review named associated obstetric conditions that in
cluded low birth weight, gestation duration, and caesarean section. It is possible that such
an underlying cause partially could explain both autism and the associated conditions (Ko
levzon, Gross, & Reichenberg, 2007). There is evidence to suggest adverse prenatal and peri
natal events are also associated with ADHD and cognitive development. Some studies have
suggested that the risk of autism may be increased with advancing maternal age (Bolton et
al., 1997). Paternal age too has frequently (but not always) associated with autism. There are
more mutations in the gametes of older men, and this higher rate of mutation in the genetic
material from the paternal side may explain the higher levels of neurodevelopmental disa
bilities in their offspring. An alternative explanation is that fathers who themselves have au
tistic traits are less likely to have children young. Using anticonvulsants during pregnancy
also appears to increase the risk of ASD (Moore et al., 2000). These drugs are used to combat
epilepsy which is commonly often comorbid with ASD. Parental occupational exposure to
chemicals during the preconception period has also been higher in ASD families than con
trols in some studies (Felicetti, 1981).
Environmental risk factors have received widespread media coverage within the last few
years, perhaps because of the strong degree of public concern (Russell & Kelly, 2011). In
most health and disease categories, a secondary function of diagnosis is to group together
people who have a common aetiology. However, the specific effects of genetic factors and
environmental risk factors that might play a part in abnormal neural development are large
ly unresolved. Goodman and Scott (1997) stress that current understanding of aetiology for
childhood developmental conditions will probably look ridiculously simplistic or misguid
ed in years to come. Despite, or perhaps because of, the uncertainty, there is an underlying
concern among people involved with children who are diagnosed with developmental con
ditions that environmental influences may be partially to blame for rising incidence. Novel
prenatal and perinatal medical practices, changing diet, shifting family structures and child
hood social activities have all been the subject of lay theories to explain rising prevalence not
just of ASD, but developmental disorders in childhood more generally, including ADHD
and dyslexia (Russell & Kelly, 2011).
9. The influence of childcare and the childs environment

A third possibility is that environmental factors alone may be enough to trigger not just au
tistic behaviors, but also other maladaptive behaviors such as inattention. Autistic behaviors
http://dx.doi.org/10.5772/54159
were observed in a study of abandoned Romanian children, conducted by Michael Rutter

and colleagues (1999). As well as cases with known genetic causes, in some cases, underly
ing social factors may predispose autistic symptoms. In this study, Rutter and colleagues
noted a very high instance of autism (6%) in the Romanian baby cohort, which they put
down to poor early care. These children exhibited typical symptoms of autism at four years
old, but unlike cases of autism without maltreatment, symptoms by age 6 were much mild
er. This case is an illustration of how children who share severe autistic symptoms at young
ages may have differing developmental trajectories. In this study, the symptoms of autism
may have been triggered primarily by the early neglect, rather than by a genetic predisposi
tion, for if a genetic predisposition was involved it would effect 6% or more of the babies, a
very high proportion.
It is not just aetiological environmental factors that seem to lead to increased risks of dis
playing autistic behaviours. Aetiological causes can be distinguished from proximate deter
minates which occur at the same time as symptoms, for example, social situations or
fluorescent lights may exacerbate the expression of ASD symptoms. There are also those in
fluences in the environment that are sometimes referred to in psychiatry as maintenance fac
tors, including stigmatisation and labelling. Although their influence in perpetuating ASD
and other developmental disorders is unclear, an influence in maintaining symptomatic be
haviours of autism and co-morbid conditions can not be discounted. Biological causes and
behavioural outcomes are mediated by experiential and environmental factors.
10. Cognitive causes and developmental consequences

The competing psychological theories that have been put forward concerning the psycho
logical mechanisms of ASD include weak central coherence theory, deficits in executive
function and the extreme male brain theory, all were reviewed by Happ in 1994.
The extreme male brain theory as developed by Baron-Cohen (2002) suggests that autis
tic individuals can systematizethat is, they can develop internal rules of operation
but are less effective at empathizing and handling events that are unexpected or social.
The theory was developed from the earlier theory of mind
(Baron-Cohen, Leslie, &
Frith, 1985). This suggested that autistic people lack the ability to understand other peo
ples mental states, put themselves in another persons place or imagine what they might
be thinking or experiencing. This lack of mentalising is discussed by Frith and Happ in
their discussion of dyslexia, autism and downstream effects of specific impairments
(1998). The theory of mind lines up with the mirror neuron theory of autism (Iacoboni
& Dapretto, 2006) which was based on the discovery that the macaque monkey brain
contained mirror neurons that fired not only when the animal is in action, but also
when it observes others carrying out the same actions.
An alternative psychological theory for autism is provided by Frith whose weak central co
herence theory (Frith, 2003; Happ & Frith, 2006) describes the ability to place information
in a context in order to give it meaning. Most people pull together numerous stimuli to form
371
372
a coherent picture of the world, allowing them to see the bigger picture. In central coher
ence theory, the failure to appreciate the whole accounts for the piecemeal way in which
people with ASD acquire knowledge. People with ASD may also show relative strengths in
some areas, known as islets of ability; and this accounts for savant skills. Related to central
coherence is the theory that autistic behaviours are due to interference in executive function
(Hill, 2004). Executive functions coordinate the flow of information processing in the brain
and are the mechanisms of transferring attention from one thing to another flexibly and
easily. They allow people to plan strategically, solve problems and set objectives. Their ab
sence means autistic people show an inability to plan and attain overarching goals. This
manifests as easily distractible behaviour and reliance on routines. Such psychological theo
ries of ASD are useful models but have also been subject to criticism. Bailey and Parr (2003)
describe such theories of psychological mechanisms as narrow cognitive conceptualisa
tions (p. 27), because they cannot accommodate the presence of sub-clinical autistic traits in
the general population.
These theories seem very distinct from some psychological theories that explain dyslexic
type and attention and hyperactive difficulties. The exception to this is that, deficits in exec
utive function have been suggested as causal for ADHD, as they affect both cognitive and
motivational systems (Willcutt et al., 2005). Frith and Happ (1998) focusing on dyslexia and
autism, argue that psychological mechanisms could act as gateways to impairment in other
domains. These downstream developmental effects have not yet been fully considered, they
suggest. Although they focus on autism and dyslexia, ADHD and other developmental dis
orders could easily be included in their model. As they point out, both dyslexia and autism
have genetic origins, an anatomical basis and extremely variable behavioral manifestations.
Their idea is that in addition to the genetic and anatomical origins, an additional develop
mental pathway may contribute to later difficulties. They argue that specific impairments
seen in dyslexia or autism (such as dyslexic phonological or autistic mentalising difficulties)
may have a gatekeeping function and subsequently lead to difficulties in other areas. Thus
impairments in domain-specific functions may have wide ranging developmental effects.
The idea put simply is that during development, one behavior exacerbates problems in oth
er domains. It is perhaps easier to understand given a few concrete examples. Frith and
Happ suggest that the core autistic difficulty of social engagement may lead to missed op
portunities for learning, including learning vocabulary. This may effect language acquisition
and in turn the development of language based skills evident in dyslexia. An easier pathway
to understand might be via gatekeeping function of inattention. If a child is inattentive (a
core symptom of ADHD) then the likelihood is they may struggle to focus on learning to
read. Hence difficulties symptomatic of dyslexia may be expected. Conversely perhaps read
ing difficulties are primary, in which case inattention might come from frustration and in
ability to deal with task demands. This direction of causality seems likely in the sub-group
of ADHD children whose problems only appear at school, and who are more likely than
other groups to show reading problems according to Taylor (2011). Furthermore, an inatten
tive child may find it difficult to socialize normally, and may have difficulties following in
struction. This may lead to the impairment in social skills symptomatic of autism.
http://dx.doi.org/10.5772/54159
In a similar way, it is possible to theorize that each domain of behavioural impairment in the
triad for autism might lead to another. In a review of evidence for single genetic or cognitive
causes for autism, Happ, Ronald, and Plomin (2006) note that twin studies suggest combi
nations of largely non-overlapping genes act on each area of impairment. Their own study
found only modest correlations between the three domains of behavioural traits in the triad
(namely deficits in social skills and communication and stereotyped behaviour or restricted
interests). In the general population, correlations ranged from 0.1- 0.4 for the relationship of
each domain to the other. This evidence shows that the three types of autistic traits may be
clustered or linked or co-inherited, but with a weak association. These low correlations
could be attributed to developmental pathways factors as well as genetic links. Such residu
al downstream developmental effects are easy to conceptualise. If a young boy is very aso
cial for example, then his communication skills will not be practised with peers, so he is
unlikely to develop as quickly in measures of communication as a more sociable child. The
weak correlation between repetitive behaviours is harder to explain. Speculation is possible:
repetitive behaviours have been shown to have both self-stimulatory as well as calming
functions (Turner, 1999). Repetitive behaviours can therefore be interpreted as responses to
unwanted stimuli, e.g. social stimuli with which autistic people have difficulty. Williams
(1994) has given a first person account of use of repetitive behaviours to ameliorate the
stress of social situations. Conversely, the need for stimulatory repetitive behaviours, con
centrating on drawing lines or circles for example, may interfere with social opportunities.
Weak associations do not confirm or deny genetic co-inheritance. Developmental pathways
where one type of behaviour leads to another may also provide a partial explanation.
In a different but related developmental scenario, Cheslack-Postava and Jordan Young
(2012) suggest that a childs upbringing is highly gendered, and proposed a gendered em
bodiment model for autism. They cite numerous studies illustrating that the nature of pa
renting in particular depends on the gender of the child. This they use to describe a
gendered theory of development of autism, although the model could also explain the large
predominance of boys with other developmental disorders. Cooper (2001) suggests boys are
socialized to encourage competition and activity thus a conflict between passivity required
at western schools and masculine identity is generated. Some behaviours associated with
ADHD when used excessively in school environments, climbing trees for example, are en
couraged more often in boys than girls. Cheslack-Postava and Jordan Young suggest such
gendered social processes interact with biology to promote certain disordered behaviours.
This they call the pervasive developmental environment.
As well as downstream developmental models, some theorists have suggested one cognitive
deficit may underlie several symptomatic behaviours. Although the cognitive/psychological
theories of dyslexia and autism seem quite distinct, some research does suggest children
with both ADHD and dyslexic difficulties show a distinctive deficit in rapid naming speed,
so it may that processing speed underlies the link (Bental & Tirosh, 2007).
A second example is provided by executive function which is impaired in both autism and
ADHD (Willcutt et al, 2005). According to some models, an underlying impairment in execu
tive function prevents children from coordinating information processing in the brain, and
373
374
prevents the transfer attention from one thing to another. It is easy to understand how this ab
sence may translate into symptoms of either autism, due to inability to plan with strategic over
arching vision, and hence reliance on routines, or as inattention and distractibility
symptomatic of ADHD. Executive functions are neuropsychological processes needed to sus
tain problem-solving toward a goal. Executive functions allow a resolution of conflict when
two responses are simultaneously called for by stimuli. In the laboratory, the Stroop task is an
example. The conflicting combination of a word like red written in green ink creates conflict
when the task is to say the color of the ink (green), due to the overlearned reading response that
automatically elicits the response based on the meaning of the word (red). Executive function
allows for the inhibition of the overlearned response and the execution of a response that is
more appropriate given the context. Research has confirmed the involvement of deficits in ex
ecutive functions that are essential for effective self-regulation in people with ADHD. The
mental processes most often listed as being part of the notion of executive function are quite di
verse so there is no standardized definition. They include: inhibition, resistance to distraction,
self-awareness, working memory, emotional self-control, and even self-motivation. Bramham
and colleagues (2009) found that both adults with ASD and ADHD had impaired executive
function, although they did have distinctive profiles. Nyden and colleagues found that chil
dren with Aspergers Syndrome and dyslexia did not differ in tests of executive function: they
could not establish any test of executive function that captured the differences in these disor
ders (1999).
Russell Barkley (2012) conceptualizes executive control as the methods of self-regulation. He
writes entertainingly on how a person might use executive functions to resist the temptation
to buy a tempting pastry from a shop:
avert your eyes from the counter, walk to a different section of the shop away from the tempting goodies, engage
yourself in mental conversation about why you need to not buy those products, and even visualize an image of the
new slenderer version of yourself you expect to achieve in the near future. All of these are self-directed actions you are
using to try and alter the likelihood of giving into temptation and therefore increase your chances of meeting your goal
of weight loss this month. This situation calls upon a number of distinct yet interacting mental abilities to successfully
negotiate the situation. You have to be aware that a dilemma has arisen when you walked into the shop (self-aware
ness), you have to restrain your urge to order the pastry to go with the coffee you have ordered (inhibition), you redirected your attention away from the tempting objects (executive attention or attentional management), you spoke to
yourself using your minds voice (verbal self-instruction or working memory), and you visualized an image of your
goal and what you would look like when you successfully attain it (nonverbal working memory, or visual imagery).
You may also have found yourself thinking about various other ways you could have coped effectively with these
http://dx.doi.org/10.5772/54159
temptations (problem-solving), and may have even used words of encouragement toward yourself to enhance the like
lihood that you would follow your plan (self-motivation).
Barkley explains that these and other mental activities are usually included in the under
standing of human self-regulation, and it is difficulties in these areas (which are processes in
executive function) that may lead to ADHD. Children with ADHD are distractible and selfregulation, the ability to override incoming stimuli, to see the bigger picture and lack the
ability to see the consequences of their future actions. Children with ASD have difficulties
transferring attention from one thing to another because they also lack overview (and impli
cations of their actions in the future).
Gooch, Snowling and Hulme (2011) note that deficits in time perception (the ability to judge
the length of time intervals) have been found in children with both dyslexia and ADHD.
These researchers found children with comorbid dyslexia and attention problems performed
poorly on measures of executive function as well as on phonological tasks. However, their
results were interpreted as the effect of independent underlying cognitive causes. Although
deficits in duration discrimination were associated with both dyslexia and attention prob
lems, they concluded the results supported the claim that the two disorders are products of
different cognitive defects originating from shared genes with pleiotropic effects.
Developmental models explain comorbidity of developmental disorders by shared cognitive
deficits, either as gateways as in Frith and Happs (1998) model, where one difficulty leads
to another later in life, or as underlying shared deficits, for example impaired executive
function causing both autism and ADHD. The alternative model suggests that cognitive dif
ficulties associated with each disorder are distinct, but multiple cognitive deficits arise from
similar genetic/environmental origins. All these theories have some empirical support.
11. Diagnostic substitution and the influence of society and culture

When symptoms of two or more conditions are shared, whatever the psychological mecha
nisms (whether or not there are shared underlying cognitive deficits, and /or genetic and
neurological differences) then the area of functioning that is highlighted as a problem may
depend on which tests are administered. In our recent research we followed a six year old
child who was assessed by three educational psychologists and one multidisciplinary team,
each blind to the findings of the others. One concluded that the child had dyspraxia, two
that the child had dyslexic difficulties, and a third that borderline AS was likely. We inter
preted these differences in the use of diagnostic labels as dependent on settings that varied
during assessments, and assessment methods that exposed different types of behaviour
(Russell, Norwich, & Gwernan-Jones, 2012). This work suggests that which diagnosis is as
signed depends to some extent on social and cultural factors as well as actual symptoms. If a
child has symptoms of several disorders, then one context or test may draw out symptoms
associated with one disorder, whereas another setting may expose symptoms of another.
375
376
Thus for co-occurring symptoms it is difficult to differentiate between disorders and the
likelihood that a co-morbid disorder will be missed is increased. This emphasizes the need
for assessment in multiple settings and reassessment over time.
One of the most compelling cross cultural descriptions of how autism is regarded across
various cultures was the book Unstrange Minds. Written by the anthropologist Roy Grinker
(2008), Grinker explains how the category of ASD is contingent on the culture through
which it is expressed- the condition is associated with differing levels of stigma in different
cultures. In the US, several studies have also shown that clinicians may diagnose ASD when
resources are targeted at the diagnosis, whereas previously, under other circumstances, they
may have diagnosed another category of childhood disorder. Paul Shattuck has written
about the extent to which increases in the administrative prevalence of autism have been as
sociated with corresponding decreases in the use of other diagnostic categories, mental re
tardation and learning disabilities (2006). This process of diagnostic substitution he argues,
may partially explain the rise in prevalence in autism in the US.
Our own work suggests that since the 1980s, the recorded prevalence of both ASD and
ADHD in the UK has increased dramatically. We examined data from both the Millennium
Cohort Study, (the large cohort of around 19,000 children who have been followed from
their birth through to seven years old and beyond), and another cohort, called the British
Cohort Study, where children were born thirty years previously. Both cohorts were repre
sentative of the UK as a whole, and medical reports of both ASD and ADHD were given
when children were age seven for in 2007-9 and ten in 1980. The results from 2007 contrast
ed with the 1980 sample at age 10. Only 11 children in the 1970 British Cohort Study were
reported as having ADHD in their medical exam, giving an estimated prevalence of 0.083%.
The autism diagnosis was rarely used with just 3 children assigned the label; 0.023% of chil
dren. A number of other child psychiatric diagnoses were available and many of these were
diagnosed during the medical exams. Details of these alternative labels are given in Table 1.
N of children
Autism (299.0/1/8/9)
0.023
ADHD (314.00/01, 314.9)
11
0.083
Disturbance in emotions (313)
0.053
13
0.098
81
0.614
Delays in development: Reading

(315.0)
Delays in learning & development
(315.2/8/9/5)
Delays in language
(315.3)
62
(1 autism co-morbid)
Impulse control (312.3/9)
Mild mental retardation
34
(317)
Other specified delays in
development (318)
(1 ADHD co-morbid)
22
(1 ADHD co-morbid)
0.462
0.007
0.258
0.166
http://dx.doi.org/10.5772/54159
Unspecified delays in development
N of children
25
(319)
(1 ADHD co-morbid)
Total
259
0.379
1.961
Table 1. Named conditions using ICD-9 categories for 10 year old children in 1980 (n=13201).
Among the 14,043 children in the 2007 cohort, 209 (1.49%) were reported to have ASD, and
180 (1.28%) were reported having been given an ADHD diagnosis by a clinician (unweight
ed figures). There was disproportional stratification in the Millennium Cohort, meaning that
all analyses were weighted to account for the clustering and over-inclusion of participants
from disadvantaged areas. After weighting, 1.7 % of children were reported as having an
ASD (95% CI, 1.4-1.99). 1.3% of these were boys, and 0.25% girls, giving boy girl ratio of ap
prox 5:1 for ASD. Surprisingly, the figure for ADHD was lower. After weighting, 1.4% of the
population were reported as having ADHD (95% CI, 1.2-1.7). Of these, 2.3% were boys and
0.25% girls, giving a gender ratio of approximately of 1 girl to every 4 boys with ADHD.
One interpretation of the historical shift is that diagnostic substitution has occurred: children
with similar symptoms in 1980 may have been more likely to receive generalised labels of
delays in learning & development than ASD or ADHD. So changing diagnostic practice,
cultural factors and context may do much to explain both co-morbidity and rising preva
lence. The steep rise in children assigned these diagnoses cannot be totally explained by the
substitution mechanism- twice as many children were given either ASD or ADHD diagno
ses in 2009 as the total number diagnosed with any type of developmental disorder in 1980.
Context also has a big part to play in the identification of difficulties, in terms of what is con
sidered to be disordered. Social constructionists have also pointed out that the conceptuali
zation of difficulties associated with both dyslexia and ASD as disorders is itself a product
of social and cultural standards, and of course the definition of each disorder has changed
over time. This has prompted calls for the term autism spectrum conditions to replace au
tism spectrum disorders (2009). Our own analysis of the Millennium Cohort has shown a
strong association between ADHD and poverty, reflecting findings from US studies which
have also found differing levels of ADHD amongst various ethnic groups- Hispanic children
were more likely to be identified with ADHD in a study by Akinbami et al. (2011). It is un
clear whether this is entirely due to greater awareness and access to health care in some
groups, differential reporting about the same level of difficulties between ethnic groups or
whether children in different groups have truly varying symptom levels (Boyle et al., 2011).
A study by Cuccaro et al. (1996) showed the nature of diagnosis of developmental disorders
varied according to the socio-economic status of the childs family; autism was more likely
to be identified in children of higher income families, although no biases of SES were found
for identification with ADHD. Cooper (2001) points out that the behaviour symptomatic of
ADHD becomes problematic where high value is placed on ability to remain sedentary and
sustain attention on tasks, in other words, in schools. Hulme and Snowling (2009) describe
how differences of this nature must therefore be thought of as both biological and as a prod
uct of the social and environmental world.
377
378
12. Conclusion
Two conclusions can be drawn. First, co-morbidities between developmental disorders are
common, and second, the causes of these overlapping difficulties are likely to be complex,
multifactorial and interacting. Firstly, the high overlap between symptoms of different de
velopmental disorders has been identified in a number of studies and there is an interna
tional consensus on this overlap. Studies from Canada, the UK, USA and Scandinavia all
show how hard it is provide an unequivocal diagnosis, leading to the quote from Kaplan
and her colleagues (2001) in developmental disorders co-morbidity is the rule, not the exception.
This was informed by the groups work studying a population-based sample of 179 children
receiving special support in Calgary: If the children met the dyslexia criteria, there was a
51.6% chance of having another disorder. If the children met the ADHD criteria there was an
80.4% chance of having another disorder. They criticize the term comorbidity, as it implies
unsubstantiated presumption of independent aetiologies. The authors argue that discrete
categories do not exist in real life.
Secondly, in considering the reasons for co-morbidities, a complex bio-psycho-social model
is required that leads to symptoms that may result in diagnosis. The nature of the diagnosis
itself may depend on social context as well as an individual childs behaviour. A hint of this
complexity is achieved in Figure 3, which is a schematic diagram of various potential causal
pathways. It is plausible that the same underlying genetic or neurological mechanisms may
underlie co-occurrence of dyslexia, ADHD and ASD. The reverse pathways are not at first so
obvious. But recent advances in systems biology have shown that the environment of the
cell affects gene expression and protein synthesis at molecular levels. Thus environmental
influences can alter core biology: for example Mack and Mack (1992) describe how tweak
ing rats whiskers changes gene expression in the sensory cortex. In systems theory, genetic
influences are conceptualised more like a set of piano keys on which notes may be played or
not played, played slowly or quickly, and there is enormous variation in the music pro
duced even with the same basic set of keys. So the cellular environment can affect genetic
expression. A simplified model underlying much behaviour genetics research envisages a
direct linear relationship between individual genes and behaviours. The reality is likely to
be far more complex with gene networks and multiple environmental factors impacting
brain development and function, which in turn will influence behaviour (Hamer, 2002). Kar
miloff-Smith (2007) emphasizes how learning and experience effects gene expression in hu
mans. Such scholars demonstrate that the social can affect the biological as well as the more
intuitive path of genetic origin leading to neurological development leading to aberrant be
haviour. Diagnosis itself may influence behaviour too, through differential treatment and in
terventions. Thus the pervasive developmental environment is composed of many related
factors, environmental stresses, and genetic predispositions, and the social contexts all of
which may interact to produce developmental outcomes that themselves may contribute to
predicting ongoing child development.
Snowling (2012) suggests a new dimensional classification of disorder, where deficits in dif
ferent components of learning are seen as additive, impacting on the potential for remedia
http://dx.doi.org/10.5772/54159
tion, rather than classing children into dichotomous disorder categories. Taylor (2011)
notes that for many children, it is better to think of changes in cognitive style, learning and
motivation rather than symptoms. Both conclude that it is important to examine children for
evidence of co-occurring disorders, and not simply continue to examine the areas which we
expect to be impaired according to categorization. The practical application of assessing chil
dren for a range of difficulties is that children will be best helped not by any all encompass
ing diagnosis, but by individual analysis of their strengths and weaknesses. Future research
may be wise to focus on the individual profiles of children across a broad range of areas,
looking at the unique strengths, as well as the weaknesses of the individual children, so that
parents and educators may adapt their support accordingly, regardless of the diagnostic la
bel a child receives.
Figure 3. Schematic of interacting causal mechanisms for co-morbidity.
Author details
Ginny Russell1 and Zsuzsa Pavelka2
1 University of Exeter Medical School, ESRC Centre for Genomics in Society, UK
2 University of Milan, Italy
379
380
References
[1] Akinbami, L. J., Liu, X., Pastor, P. N., & Reuben, C. A. (2011). Attention deficit hyper
activity disorder among children aged 5-17 years in the United States, 1998-2009.
NCHS Data Brief, (70), 18.
Disorders (4th ed., text revision [DSM-IV-TR]
[3] Bailey, A., & Parr, J. (2003). Implications of the broader phenotype for concepts of au
tism. Novartis Foundation symposium, 251, 2635; discussion 3647, 10911, 28197.
[4] Barkley, R. A. (2012). Executive Functions: What They Are, How They Work, and Why
They Evolved (1st ed.). Guilford Press.
[5] Baron-Cohen, S, Leslie, A. M., & Frith, U. (1985). Does the autistic child have a theo
ry of mind? Cognition, 21(1), 3746.
[6] Baron-Cohen, Simon. (2002). The extreme male brain theory of autism. Trends Cogn
Sci, 6(6), 248254.
[7] Baron-Cohen, Simon, Scott, F. J., Allison, C., Williams, J., Bolton, P., Matthews, F. E.,
& Brayne, C. (2009). Prevalence of autism-spectrum conditions: UK school-based
population study. The British Journal of Psychiatry, 194(6), 500509.
[8] Bental, B., & Tirosh, E. (2007). The relationship between attention, executive func
tions and reading domain abilities in attention deficit hyperactivity disorder and
reading disorder: A comparative study. Journal of Child Psychology and Psychiatry,
48(5), 455463.
[9] Bolton, P. F., Murphy, M., Macdonald, H., Whitlock, B., Pickles, A., & Rutter, M.
(1997). Obstetric complications in autism: consequences or causes of the condition?
Journal of the American Academy of Child and Adolescent Psychiatry, 36(2), 27281.
[10] Boyle, C. A., Boulet, S., Schieve, L. A., Cohen, R. A., Blumberg, S. J., Yeargin-Allsopp,
M., Visser, S., et al. (2011). Trends in the prevalence of developmental disabilities in
US children, 1997-2008. Pediatrics, 127(6), 10341042.
[11] Bradley, E. A., Summers, J. A., Wood, H. L., & Bryson, S. E. (2004). Comparing rates
of psychiatric and behavior disorders in adolescents and young adults with severe
intellectual disability with and without autism. Journal of Autism and Developmental
Disorders, 34(2), 15161.
[12] Bramham, J., Ambery, F., Young, S., Morris, R., Russell, A., Xenitidis, K., Asherson,
P., et al. (2009). Executive functioning differences between adults with attention defi
cit hyperactivity disorder and autistic spectrum disorder in initiation, planning and
strategy formation. Autism, 13(3), 245264.
http://dx.doi.org/10.5772/54159
[13] British Psychological Society. (1999). Working party of the division of educational
and child psychology of the British Psychological Society: Dyslexia, literacy and psy
chological assessment. British Psychological Society : Leicester.
[14] Cheslack-Postava, K., & Jordan-Young, R. M. (2012). Autism spectrum disorders: To
ward a gendered embodiment model. Social Science & Medicine (1982), 74(11), 1667
1674.
[15] Cheung, C. H. M., Wood, A. C., Paloyelis, Y., Arias-Vasquez, A., Buitelaar, J. K.,
Franke, B., Miranda, A., et al. (2012). Aetiology for the covariation between combined
type ADHD and reading difficulties in a family study: The role of IQ. Journal of Child
Psychology and Psychiatry,, 53(8), 864873.
[16] Clark, T., Feehan, C., Tinline, C., & Vostanis, P. (1999). Autistic symptoms in children
with attention deficit-hyperactivity disorder. European Child & Adolescent Psychiatry,
8(1), 5055.
[17] Coltheart, M., & Jackson, N. E. (1998). Defining Dyslexia. Child and Adolescent Mental
Health, 3(1), 1216.
[18] Constantino, J. N., & Todd, R. D. (2003). Autistic traits in the general population: A
twin study. Archives of general psychiatry, 60(5), 52430.
[19] Cooper, P. (2001). Understanding ADHD: A brief critical review of literature. Chil
dren & Society, 15(5), 38795.
[20] Cuccaro, M. L., Wright, H. H., Rownd, C. V., Abramson, R. K., Waller, J., & Fender,
D. (1996). Professional perceptions of children with developmental difficulties: The
influence of race and socioeconomic status. Journal of Autism and Developmental Disor
ders, 26(4), 461469.
trum disorders in the offspring. Pediatrics, 121(5), e13571362.
[22] Danielsson, S., Gillberg, I. C., Billstedt, E., Gillberg, C., & Olsson, I. (2005). Epilepsy in
young adults with autism: a prospective population-based follow-up study of 120 in
dividuals diagnosed in childhood. Epilepsia, 46(6), 91823.
[23] Deykin, E. Y., & MacMahon, B. (1980). Pregnancy, delivery, and neonatal complica
tions among autistic children. American Journal of Diseases of Children, 134(9), 860-864.
[24] Dulcan, M. (1997). Practice parameters for the assessment and treatment of children,
adolescents, and adults with attention-deficit/hyperactivity disorder. Journal of the
American Academy of Child and Adolescent Psychiatry, 36(10 Suppl), 85S121S.
[25] Elia, J., Ambrosini, P. J., & Rapoport, J. L. (1999). Treatment of attention-deficithy
peractivity disorder. New England Journal of Medicine, 340(10), 780788.
[26] Ericson, R. V., & Doyle, A. (2003). Risk and Morality. University of Toronto Press.
381
382
[27] Evans, D. W., Canavera, K., Kleinpeter, F. L., Maccubbin, E., & Taga, K. (2005). The
fears, phobias and anxieties of children with autism spectrum disorders and Down
syndrome: Comparisons with developmentally and chronologically age matched
children. Child Psychiatry and Human Development, 36(1), 326.
[28] Fawcett, A. (2012). Introduction to Dyslexia and Co-occuring Difficulties. Dylexia and
co-occuring difficulties. Bracknell, UK: British Dyslexia Association.
[29] Felicetti, T. (1981). Parents of autistic children: Some notes on a chemical connection.
Milieu Therapy, 1, 1316.
[30] Freitag, C. M. (2007). The genetics of autistic disorders and its clinical relevance: A
review of the literature. Molecular Psychiatry, 12(1), 222.
[31] Frith, U. (2003). Autism: Explaining the Enigma (2nd Ed.). Oxford, UK: Wiley-Black
well.
[32] Frith, U., & Happ, F. (1998). Why specific developmental disorders are not specific:
On-line and developmental effects in autism and dyslexia. Developmental Science, 1(2),
267272.
[33] Gillberg, C. (2010). The ESSENCE in child psychiatry: Early Symptomatic Syndromes
Eliciting Neurodevelopmental Clinical Examinations. Research in developmental disa
bilities, 31(6), 15431551.
[34] Gooch, D., Snowling, M., & Hulme, C. (2011). Time perception, phonological skills
and executive function in children with dyslexia and/or ADHD symptoms. Journal of
Child Psychology and Psychiatry, 52(2), 195203.
[35] Goodman, R., & Scott, S. (1997). Child Psychiatry. (2nd ed.). Oxford, UK: Blackwell
Publishing.
[36] Griffiths, C. C. B. (2007). Pragmatic abilities in adults with and without dyslexia: A
pilot study. Dyslexia, 13(4), 276296.
[37] Grinker, R. R. (2008). Unstrange minds: Remapping the world of autism. Cambridge, MA:
Basic Books.
[38] Hamer, D. (2002). Genetics: Rethinking behavior genetics. Science, 298(5591), 7172.
[39] Happ, F. G. (1994). Current psychological theories of autism: The theory of mind
account and rival theories. Journal of Child Psychology and Psychiatry, 35(2), 21529.
[40] Happ, F., Ronald, A., & Plomin, R. (2006). Time to give up on a single explanation
for autism. Nature Neuroscience, 9, 12181220.
[41] Happ, Francesca, & Frith, U. (2006). The weak coherence account: detail-focused
cognitive style in autism spectrum disorders. Journal of Autism and Developmental Dis
orders, 36(1), 525.
[42] Hedgecoe, A. (2001). Schizophrenia and the narrative of enlightened geneticization.
Social Studies of Science, 31(6), 875911.
http://dx.doi.org/10.5772/54159
[43] Hill, E. L. (2004). Executive dysfunction in autism. Trends in Cognitive Sciences, 8(1),
2632.
[44] Hofvander, B., Delorme, R., Chaste, P., Nydn, A., Wentz, E., Sthlberg, O., Her
brecht, E., et al. (2009). Psychiatric and psychosocial problems in adults with normalintelligence autism spectrum disorders. BMC Psychiatry, 9, 35.
[45] Howlin, P. (2000). Outcome in adult life for more able individuals with autism or As
perger syndrome. Autism, 4(1), 6383.
[46] Hulme, C., & Snowling, M. J. (2009). Developmental disorders of language learning and
cognition. Chichester, UK: Wiley-Blackwell.
[47] Iacoboni, M., & Dapretto, M. (2006). The mirror neuron system and the consequences
of its dysfunction. Nature reviews. Neuroscience, 7(12), 94251.
[48] Ingudomnukul, E., Baron-Cohen, S., Wheelwright, S., & Knickmeyer, R. (2007). Ele
vated rates of testosterone-related disorders in women with autism spectrum condi
tions. Hormones and Behavior, 51(5), 597604.
[49] Kadesj, B., Gillberg, C., & Hagberg, B. (1999). Brief Report: Autism and Asperger
syndrome in seven-year-old children: A total population study. Journal of Autism and
Developmental Disorders, 29(4), 327331.
[50] Kaplan, B. J., Dewey, D. M., Crawford, S. G., & Wilson, B. N. (2001). The term comor
bidity is of questionable value in reference to developmental disorders: Data and
theory. Journal of Learning Disabilities, 34(6), 555565.
[51] Karmiloff-Smith, A. (2007). Atypical epigenesis. Developmental Science, 10(1), 8488.
[52] Kessler, R. C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M. J., et
al. (2005). The World Health Organization adult ADHD self-report scale (ASRS): a
short screening scale for use in the general population. Psychological Medicine, 35(2),
245256.
[53] Kielinen, M., Rantala, H., Timonen, E., Linna, S.-L., & Moilanen, I. (2004). Associated
medical disorders and disabilities in children with autistic disorder: A populationbased study. Autism, 8(1), 4960.
[54] Kolevzon, A., Gross, R., & Reichenberg, A. (2007). Prenatal and perinatal risk factors
for autism: A review and integration of findings. Archives of Pediatrics & Adolescent
Medicine, 161(4), 32633.
[55] London, E. (2007). The role of the neurobiologist in redefining the diagnosis of au
tism. Brain pathology (Zurich, Switzerland), 17(4), 40811.
[56] Mack, K. J., & Mack, P. A. (1992). Induction of transcription factors in somatosensory
cortex after tactile stimulation. Molecular Brain Research, 12(1-3), 141147.
[57] Miles, T. R. (2004). Some problems in determining the prevalence of dyslexia. Elec
tronic Journal of Research in Educational Psychology, 2(2), 512.
383
384
[58] Mulligan, A., Anney, R. J. L., ORegan, M., Chen, W., Butler, L., Fitzgerald, M., Buite
laar, J., et al. (2009). Autism symptoms in Attention-Deficit/Hyperactivity Disorder:
A familial trait which correlates with conduct, oppositional defiant, language and
motor disorders. Journal of Autism and Developmental Disorders, 39(2), 197209.
[59] Mulligan, A., Anney, R., Butler, L., ORegan, M., Richardson, T., Tulewicz, E. M.,
Fitzgerald, M. Gill, M. (2011). Home environment: association with hyperactivity im
pulsivity in children with ADHD and their non-ADHD siblings. Child: Care, Health
and Development [e-pub ahead of print].
[60] Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E.,
Mandell, D. S., Miller, L.A., Pinto-Martin, J, Reaven, J., Reynolds, A.M., Rice, C.E.,
Schendel, D., Windham, G.C.(2007). The epidemiology of autism spectrum disorders.
Annual Review of Public Health, 28, 235-58.
[61] Nydn, A., Gillberg, C., Hjelmquist, E., & Heiman, M. (1999). Executive function/
attention deficits in boys with Asperger syndrome, attention disorder and reading/
writing disorder. Autism, 3(3), 213228.
[62] Posserud, M.-B., Lundervold, A. J., & Gillberg, C. (2006). Autistic features in a total
population of 7-9-year-old children assessed by the ASSQ (Autism Spectrum Screen
ing Questionnaire). Journal of Child Psychology and Psychiatry, 47(2), 16775.
[63] Reiersen, A. M., Constantino, J. N., Grimmer, M., Martin, N. G., & Todd, R. D. (2008).
Evidence for shared genetic influences on self-reported ADHD and autistic symp
toms in young adult Australian twins. Twin Research and Human Genetics, 11(6), 579
585.
[64] Reiersen, Angela M, & Todd, R. D. (2008). Co-occurrence of ADHD and autism spec
trum disorders: phenomenology and treatment. Expert Review of Neurotherapeutics,
8(4), 657669.
[65] Richardson, A. J. (2006). Omega-3 fatty acids in ADHD and related neurodevelop
mental disorders. International Review of Psychiatry, 18(2), 155172.
[66] Ronald, A., Edelson, L. R., Asherson, P., & Saudino, K. J. (2010). Exploring the rela
tionship between autistic-like traits and ADHD behaviors in early childhood: Find
ings from a community twin study of 2-year-olds. Journal of Abnormal Child
Psychology, 38(2), 185196.
[67] Russell, G., Golding, J., Norwich, B., Emond, A., Ford, T., & Steer, C. (2012). Social
and behavioural outcomes in children diagnosed with autism spectrum disorders: A
longitudinal cohort study. Journal of Child Psychology and Psychiatry, 53(7), 735744.
[68] Russell, G., & Kelly, S. (2011). Looking beyond risk: A study of lay epidemiology of
childhood disorders. Health, Risk & Society, 13(2), 129.
[69] Russell, G., Norwich, B., & Gwernan-Jones, R. (2012). When diagnosis is uncertain:
variation in conclusions after psychological assessment of a six-year-old child. Early
Child Development and Care, (early on-line version).
http://dx.doi.org/10.5772/54159
[70] Russell, G., Steer, C., & Golding, J. (2011). Social and demographic factors that influ
ence the diagnosis of autistic spectrum disorders. Social Psychiatry and Psychiatric Epi
demiology, 46(12), 12831293.
[71] Rutter, M. (2005). Incidence of autism spectrum disorders: changes over time and
their meaning. Acta paediatrica, 94(1), 215.
[72] Rutter, M., Andersen-Wood, L., Beckett, C., Bredenkamp, D., Castle, J., Groothues,
C., Kreppner, J., et al. (1999). Quasi-autistic patterns following severe early global
privation. English and Romanian Adoptees (ERA) Study Team. Journal of Child Psy
chology and Psychiatry, , 40(4), 537549.
A. J., Ercan-Sencicek, A. G., et al. (2012). De novo mutations revealed by wholeexome sequencing are strongly associated with autism. Nature.
[74] Santosh, P. J., & Mijovic, A. (2004). Social impairment in hyperkinetic disorder - rela
tionship to psychopathology and environmental stressors. European Child & Adoles
cent Psychiatry, 13(3), 141150.
[75] Sciutto, M. J., Nolfi, C. J., & Bluhm, C. (2004). Effects of child gender and symptom
type on referrals for ADHD by elementary school teachers. Journal of Emotional and
Behavioral Disorders, 12(4), 247253.
[76] Shattuck, P. T. (2006). The contribution of diagnostic substitution to the growing ad
ministrative prevalence of autism in US special education. Pediatrics, 117(4), 102837.
bidity, and associated factors in a population-derived sample. Journal of the American
Academy of Child and Adolescent Psychiatry, 47(8), 921929.
[78] Snowling, M. J. (2012). Editorial: Seeking a new characterisation of learning disor
ders. Journal of Child Psychology and Psychiatry 53(1), 12.
[79] Sonuga-Barke, E. J. S., & Halperin, J. M. (2010). Developmental phenotypes and caus
al pathways in attention deficit/hyperactivity disorder: Potential targets for early in
tervention? Journal of Child Psychology and Psychiatry, 51(4), 368389.
[80] Sturm, H., Fernell, E., & Gillberg, C. (2004). Autism spectrum disorders in children
with normal intellectual levels: Associated impairments and subgroups. Developmen
tal Medicine and Child Neurology, 46(7), 4447.
[81] Taylor, E. (2011). Commentary: Reading and attention problems how are they con
nected? Reflections on reading McGrath et al. (2011). Journal of Child Psychology and
Psychiatry, 52(5), 558559.
[82] Trottier, G., Srivastava, L., & Walker, C. D. (1999). Etiology of infantile autism: A re
view of recent advances in genetic and neurobiological research. Journal of Psychiatry
and Neuroscience, 24(2), 103-15.
385
386
[83] Turner, M. (1999). Annotation: Repetitive behaviour in autism: A review of psycho

logical research. Journal of Child Psychology and Psychiatry, 40(6), 839849.
[84] Willcutt, E. G., Doyle, A. E., Nigg, J. T., Faraone, S. V., & Pennington, B. F. (2005).
Validity of the executive function theory of attention-deficit/hyperactivity disorder:
A meta-analytic review. Biological Psychiatry, 57(11), 13361346.
[85] Williams, D. (1992). Nobody nowhere: The extraordinary autobiography of an autistic (1st
ed.). New York, NY: HarperCollins.
[86] World Health Organization. (1992). International Classification of Diseases and related
health
problems
(ICD-10).
Geneva,
WHO.
Retrieved
from
www.who.int/
classifications/icd/en/greenbook.pdf p.179
[87] Wright, C., Conlon, E., Wright, M., & Dyck, M. (2011). Sub-lexical reading interven
tion in a student with dyslexia and Aspergers disorder. Australian Journal of Educa
tional & Developmental Psychology, 11, 1125.
[88] Zwaigenbaum, L., Szatmari, P., Jones, M. B., Bryson, S. E., MacLean, J. E., Mahoney,
W. J., Bartolucci, G., et al. (2002). Pregnancy and birth complications in autism and
liability to the broader autism phenotype. Journal of the American Academy of Child and
Adolescent Psychiatry, 41(5), 5729.
Chapter 18
Pre-Existing Differences in
Mothers of Children with Autism Spectrum
Disorder and/or Intellectual Disability: A Review
Jenny Fairthorne, Amanda Langridge,
Jenny Bourke and Helen Leonard
http://dx.doi.org/10.5772/54488
1. Introduction
The autism spectrum disorders (ASD) represent a group of severe and chronic neuro-devel
opmental disorders often simply referred to as autism. [1] Using the criteria provided by the
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, ASD are diagnosed by
impairments within the three strands of DSM-4: social interaction, communication and repetitive
behaviours or interests. [2] The aetiology of autism is complex. [3] Research has implicated a
strong genetic basis [4-7] involving multiple genes [5, 7, 8] and possible gene-environment
interactions. [9-13] Advances in chromosomal microarray analysis and gene sequencing
technologies have improved diagnoses and suggest that aetiologies of ASD will continue to
be uncovered. [9] In addition, a child presenting with autistic symptoms may be found to have
a certain genetic mutation which accounts for their true underlying biological diagnosis. For
example, a diagnosis of Rett syndrome would be confirmed when a girl with ASD and
intellectual disability was found to have a mutation of the MECP2 gene on the X-chromosome.
[14] Children with ASD and intellectual disability have been found to have an expansion of
the FMR1 gene confirming a diagnosis of Fragile X syndrome. [15]
Autism and intellectual disability commonly coexist with 30-80% of persons with ASD
reported as also having ID. [16, 17] Currently, the relationship between ASD and comorbid ID
is poorly understood. [18] However, it is known that phenotypically, persons with these
disorders can be grouped into the three categories of ASD without ID, ASD with ID and ID
only. [18] Intellectual disability (ID) is characterized by an intelligence quotient (IQ) of less
than 70 which is associated with limitations in at least two areas of adaptive skill and which
2013 Fairthorne et al.; licensee InTech. This is an open access article distributed under the terms of the
388
is manifest before 18 years. [19] The level of ID is generally grouped into the five levels of mild,
moderate, severe, profound and unspecified by IQ score. In research it is common to stratify
ID to the following three levels defined by the American Psychiatric Association [2] (Table 1).
Descriptor/level of ID
IQ score
Mild or moderate ID
35-40 up to 69 points
Severe or profound ID
< 35-40 points
Unspecified ID
< 70*
*Here the person has been assessed as having ID but has not been assessed adequately to determine the level.
Table 1. Levels of intellectual disability
In terms of aetiology, ID can be broadly divided into cases of known biomedical cause and
those of unknown cause. The biomedical causes may be divided into genetic and non-genetic
causes. Further subdivisions are given in Figure 1.
Figure 1. Commonly known aetiologies of intellectual disability
In addition to genetic and non-genetic causes of ASD and ID, relationships with sociodemographic factors such as a mothers education, [20, 21] immigration, [17, 22] and ethnicity,
[23] have also been identified. Other reported associations involve aspects of a mothers health
including physical characteristics [24] physical [25, 26] and mental health [27, 28] and health
behaviours. [29, 30]
It has also been reported that milder autistic traits are present in other family members of
individuals diagnosed with ASD. This phenomenon has been coined the Broad Autism
Pre-Existing Differences in Mothers of Children with Autism Spectrum Disorder and/or Intellectual Disability: A Review
http://dx.doi.org/10.5772/54488
Phenotype [31] and includes qualitatively similar, but milder traits in areas such as language,
personality and social behaviour. Some researchers believe that identification of the Broad
Autism Phenotype in family members might provide a complementary strategy for detecting
genes which contribute to the likelihood of ASD. [32, 33] When comparing family members of
a child with ASD to persons from the general population, subtle differences within the Broad
Autism Phenotype could be associated with specific brain regions, particular neural pathways,
and ultimately with particular genes. [33]
The above factors have been used as guides in choosing terms for our literature search to
examine pre-existing characteristics of mothers of children with autism and mothers of
children with intellectual disability of unknown cause. Inherent characteristics of mothers of
children with a specific disability could be associated with the genetic, environmental or
genetic-environmental aetiology of their childs condition. It is therefore important to separate
pre-existing factors, particularly in relation to mental health, from morbidities such as
depression [34] which might develop due to the more intense demands of caring for a child
with ASD and/or ID.
The aim of this study is to review research on the pre-existing characteristics which differen
tiate mothers of children with ASD and/or ID of unknown cause from each other and from
mothers of children without these disabilities. Such an investigation may help to further clarify
the determinants of ASD and/or ID including the role of genetic and modifiable risk factors.
Improving our understanding of the genetic and environmental causes of ASD and ID may
reduce the future burden of these disabilities [35] by hastening the development of effective
prevention and treatment strategies.
2. Literature search and selection

The papers considered for this review resulted from a search of the Medline, Web of Knowl
edge, Scopus and Google scholar databases. Combinations of the search terms below were
chosen.
Terms associated with ASD and/or ID: autis*, pervasive development disorder*, intellectual
disability, mental retardation, disab*;
Terms associated with ASD and/or ID aetiology: immigra*, migra*, ethnic*, age, sociodemographic, prenatal, perinatal, auto*, immun*, anti*, psych* and phenotype*; and
Terms associated with mothers of children with ASD and/or ID: traits, characteristics,
parents, mothers, children, persons.
A paper was included in the review if:
It was accepted for publication between 1st January 1990 and 31st October, 2012 inclusive;
It was a full text article in English;
It described new research and was published in a peer-reviewed journal;
389
390
It described the results of a cohort, case-control, correlation or cross-sectional study of at

least 15 subjects;
It compared a characteristic of parents or mothers of children with ASD and/or ID with
parents or mothers of children without disability or with a population norm;
It assessed characteristics that were pre-existing and not likely to be a result of caring for a
child with ASD and/or ID; and
It used methods of ascertainment and measurement of the characteristic(s) of interest that
were assessed as unlikely to lead to bias.
Eighty papers were retained for the review. We stress that these papers do not represent the
entire literature pool in the area. Had we chosen different search terms or used different
combinations of terms in our searches, the basis for our review would possibly have been
different. The three categories for our analyses were; socio-demographic factors, immigrant status
and ethnicity and health and physical characteristics and we sorted papers by these categories. An
additional 61 articles were used to provide background information and possible explanations
of some of the reported associations.
3. Socio-demographic factors
There are a number of considerations which impinge on the effect of socio-demographic factors
on the prevalence of ASD and/or ID. Firstly, in persons with ASD with ID and those with just
ID, the features overlap to some degree. A child with ASD with ID, particularly in the past,
may often have been diagnosed with only ID as there have been secular changes in the
identification of children with ASD. Secondly, persons who could be diagnosed with ASD
without ID are most often able to function independently and may remain undiagnosed in a
range of scenarios. Thirdly, the process through which children are assigned a diagnosis of
ASD is much more complex than for ID. Whilst elsewhere, the gold standard might be the
considered judgement of an expert clinician who had seen many patients with autism [36], in
Western Australia, a diagnosis of ASD in a child requires an assessment by a team comprising
a paediatrician, psychologist, and speech pathologist. Waiting times for this assessment can
be prolonged in the Western Australian public system [37] and even longer in the US. [38] One
effect of these considerations is that in some countries a child whose parents are socioeco
nomically disadvantaged may oft times be diagnosed with ID when a diagnosis of ASD could
be more appropriate.
3.1. Socio-economic status
Thirteen articles researched the parental socio-economic status (SES) of children with ASD
and/or ID [17, 20, 21, 39-48] and all but two [42, 43] supported a different association of SES
with ASD than ID. Children with ASD were more likely to be from higher SES families but
children with ID were more likely to be from lower SES families.
A range of measures of high SES were consistently associated with ASD. In a large telephone
interview study in the US, family wealth was used as a measure of SES. [40] The researchers
http://dx.doi.org/10.5772/54488
found that children from higher income families were more likely to have a diagnosis of ASD.
Similarly, others using family income as a marker for SES, found a significant association
between high family SES and ASD in the offspring. [47] Further analyses, using the dual
markers of high family income and high maternal education, found a particular association
between high SES and ASD without ID. [47] Using population data and deriving SES from
mothers place of residence at time of the childs birth, Australian researchers also found that
ASD, ASD with ID and particularly ASD without ID were associated with higher SES. [17]
The overall association between high SES and ASD without ID could result from the increased
empowerment of parents of high SES to pursue a diagnosis where their children have a milder
variant of ASD. [49] In families of low SES, higher functioning children with autistic traits
might be informally labelled by family and contemporaries as unusual, difficult or emotionally
damaged. In a comparable way, lower functioning children with autistic traits might be
formally or informally given a diagnosis of ID. Others have suggested that children of lower
SES parents might be more likely to be diagnosed at a later age than those of higher SES and
hence not be included in studies of ASD and SES with lower ages of cut-off. [49]
Further evidence of the possible social contributions to the likelihood of an ASD diagnosis was
found in a large multi-based national study in the US. [39] Undiagnosed children who met the
criteria for ASD had a lower SES than children who had been previously diagnosed. [39] Arealevel SES indicators derived from census data were used in another study where the research
ers elucidated that increasing SES and the increasing prevalence of ASD were associated in a
dose-response fashion. [39]
King et al. [41] provided evidence that an interaction of social factors was affecting the
likelihood of an ASD diagnosis. They examined factors influencing the likelihood of an ASD
diagnosis using data on around five million births in Californian cohorts from 1992 to 2000.
They found that an interaction between high and low level SES measures influenced the
likelihood of an ASD diagnosis. Medi-Cal is a program providing medical assistance to the
needy in California and these researchers used family use of Medi-Cal as a binary measure of
SES. Property values in the area of a mothers residence were also used as a measure of SES.
These researchers reported that children whose families were enrolled with Medi-Cal births
and living in wealthier neighbourhoods were two and a half times more likely to receive a
diagnosis of ASD than their counterparts living in poorer areas. [41] This could indicate that
for parents of limited resources, living in a higher SES neighbourhood had benefits in terms
of the likelihood of their child being diagnosed with ASD. Possibly, this results from the
parents increased access to support persons such as paediatricians and child health nurses
and to educational programs such as parent classes and interventions for children, compared
to that of similar parents in less affluent areas.
In contrast, a Danish study accessing linked population data, used maternal education and
parental wealth as a measure of SES and found no association between SES and ASD diagnosis.
[42] In neighbouring Sweden, a population-based study published in 2012, used low income,
manual occupation and less education as measures of low SES. The researchers concluded that
low, not high SES, was a risk factor for ASD. [43] There may be a number of reasons for the
differing findings of these studies. The universal health-care and routine screenings offered in
391
392
Denmark and Sweden may eliminate the ascertainment bias associated with high SES which
may exist in other Western countries. [43]
By comparison with ASD, low SES was often identified as a risk factor for ID [21, 44-46, 48]
and especially mild or moderate ID. [17, 20, 48] One of these studies was a cross-sectional study
of over five million children. [48] It concluded that children with mild or moderate ID had an
increased risk of exposure to social conditions which were detrimental to their development.
[48] Another study examined SES and ID prevalence in the 1966 and 1985-6 Finnish birth
cohorts. [46] The researchers concluded that the association of low SES with ID was present in
both cohorts. Plausible hypotheses for this persisting association are that there had been no
improvements in antenatal and obstetric care in those of lower SES over the twenty years in
question or, alternatively, there is a prominent genetic involvement in the aetiology of ID.
Another, is that the higher risk of exposure to a developmentally unfavourable environment
has persisted over the 20 year interval in the children of mothers of lower SES. [48]
In total, ten studies [20, 21, 23, 41, 45, 47, 50-53] used education alone as a measure of SES. All
four of the studies investigating ASD reported positive associations between high maternal
education and the risk of ASD in the offspring. Three of these studies were from California
and each reported that parents of children with ASD were more educated than the general
population. [21, 41, 50] The fourth reported that mothers with more than 16 years education
were more than twice as likely to have a child with ASD without ID than mothers of a child
with only 12 years education. [47] The relationship was reversed with maternal education and
ID where all research ascertained a negative association between high maternal education and
the risk of ID in the offspring. For instance, with children with unspecified ID [20, 21, 23, 45,
51, 53] and developmental delay without ASD [24](which may include those with known
genetic syndromes), seven studies concluded that their mothers were of a lower educational
status. One of these, a population study, established that mothers of children with ID were less
likely to have more than 13 years of education. [23]
The association of maternal education with varying levels of ID has been investigated includ
ing for severe ID and on the basis that risk factors for Down syndrome differed from those of
other forms of ID, children with Down syndrome were excluded. Mothers of children with
severe ID were found to be more likely to have a lower educational status than mothers in the
general population. [52] Comparable results were found for mothers of children with mild or
moderate ID [20, 21] of unknown cause. These mothers had increased odds of a lower
educational status than mothers in the general population. One of these studies used Califor
nian service agency records and a sample of more than 27 000 mothers of children with mild
or moderate ID or severe or profound ID. [21] Less maternal education was also associated
with an increased risk of severe or profound ID in the offspring.
3.2. Marital status
Four papers, describing five studies, examined marital status in relation to the odds of ASD
and/or ID. [17, 20, 46, 54] At the time of their childs birth, it is uncertain whether a womans
marital status is associated with her odds of a child with ASD. However, mothers of children
with ID were more likely to be without partners.
http://dx.doi.org/10.5772/54488
In Australia, a retrospective cohort study, using linked health registries assessed marital status
in terms of living with a partner. They reported that at their childs birth, women living with
a partner were 35% more likely to have a child with ASD and particularly ASD with ID. [17]
On the other hand, a similar Canadian study found that mothers not living with a partner at
the time of their childs birth were 19% more likely to have a child with ASD than those mothers
who were living with a partner. [54]
With ID, women without a partner had increased odds of having a child with ID [17] and
particularly mild or moderate ID. [20] Similarly, a cohort study using UK data, concluded that
compared to typically developing children, those with early cognitive delay were less likely
to have their biological parents living together during the first five years of their lives compared
to families with a typically developing child. [55] However, in Finland, the negative association
between living with a partner and the odds of ID in the offspring, present in a 1966 birth cohort,
was absent in the 1985-6 cohort. [46] The reduction of the association in the second cohort may
have been a reflection of the improved SES of single mothers over the 20 year period.
3.3. Parental age
In most studies, increasing maternal age, sometimes along with increasing paternal age, was
associated with ASD. A minority of studies found relationships only with paternal age or found
no association with either maternal or paternal age. Contrasting results were reported with ID
where teenage mothers were more likely to have children with mild or moderate ID were older
mothers and particularly likely to have children with severe or profound ID. Socio-demo
graphic and biological explanations are offered.
All ten studies investigating the association of maternal age with the prevalence of ASD found
that advanced maternal age was associated with an increasing prevalence of ASD [17, 29, 47,
56-61] and sometimes ASD without ID. [17, 47] Four of these studies, reported an additional
association with paternal age. [17, 56, 58, 61] For instance, a population-based study using data
from multiple sites throughout the US, found associations with both maternal and paternal
age after adjustment for the other parent's age, birth order and maternal education. [58]
Five of the cited studies specifically reported an association between paternal but not maternal
age and ASD in the offspring. [58, 62-65] One of these studies was a small Japanese case-control
study of 84 father-child dyads. The researchers reported that advanced parental age was
associated with nearly twice the risk of ASD without ID. [65] Another was a population-based
Israeli cohort study which used data from a medical registry. [63] The remaining studies used
population data from Sweden and another, population data from Denmark. [62, 64] After an
adjustment for maternal age, the Swedish researchers identified a linear association of
increasing paternal age and the risk of ASD. These researchers commented that if no adjust
ment was made for paternal age it would appear as though maternal age, rather than paternal
was the risk factor for ASD. They added that paternal age could be a risk factor as generally
the male was considered to be the origin of new mutations in the gene pool and their produc
tion increased with age. [62]
393
394
By comparison, three studies from Northern Europe, and UK identified that neither of
advancing maternal nor advancing paternal age was a risk factor for ASD. [42, 43, 66] One of
the studies from Denmark and another from Sweden used linked data from national registries.
[42, 43] The third was a much smaller UK study of around 5 000 participants and parents
provided data by completing self-reports. As with broader measures of SES, the results from
Denmark and Sweden might reflect the model of health service provision in Scandinavia.
Moreover, there is evidence that children with ASD are diagnosed later in younger mothers.
[67] Thus there may be a bias of ascertainment in some studies where younger children are
included. In the UK study, [66] younger mothers may been included more often since they
were recruited when pregnant. Further, a diagnosis of ASD was not required for their child
but instead, a parent completed the Social and Communication Disorders Checklist. In other
studies from the US, [41, 47, 58, 59] Canada [29] and Australia, [17, 57] ASD may be underascertained in the children of younger parents, possibly as a result of their lesser confidence
to be pro-active in the diagnostic process.
Maternal age had a dual association with ID of unknown cause. Firstly, teenage mothers were
more likely to have children with mild or moderate ID. [17, 20, 21] Secondly, older women
were more likely to have children with severe or profound ID. [21, 68] The results of a Finnish
cohort study which investigated ID of both known and unknown cause [46] was discounted
because of the inclusion of ID of known cause. With Down syndrome, the most common cause
of ID, it is known that the risk increases very abruptly with advancing maternal age. [69] This
might explain the researchers finding of an association between increased maternal age and
ID in the offspring seen in the 1966 birth cohort. [46] The finding that the association no longer
existed in 1985-6 cohort may have been because of the introduction or increased uptake of
prenatal screening for Down syndrome.
The association of parental and particularly maternal age with ASD and/or ID suggests that
both social and biological forces are operating. Younger parents may find a diagnosis of ASD
more difficult to obtain for their children because of inexperience and navigational require
ments of local systems. Thus, some of the ID diagnoses of their children may be undiagnosed
cases of ASD. Further, the excess of older mothers of children with ASD and to a lesser extent
ID may result from increased de novo mutations in older women and their partners [70] or the
increase of epigenetic mechanisms which are associated with ageing. [71]
3.4. Parity
Parity describes the number of live-born children and stillbirths at more than 20 weeks
gestation of a woman. [72] Two strong relationships of low parity with ASD and high parity
with ID have been demonstrated in the majority of studies.
In women of lower parity, the risks of ASD, [29, 41, 73] ASD with ID [17] and ASD without ID
[17, 74] were found to be increased in a number of studies. One of these was a Canadian cohort
study using linked data-bases and with nearly 1 000 case mothers. [29] The authors identified
that nulliparous women (that is women having their first child) were at the greatest risk of
having a child with ASD. Moreover, a national, population-based study in the US reported
http://dx.doi.org/10.5772/54488
that older nulliparous women with older partners were around three times more likely to have
a child with ASD. [58]
However, two studies found other associations between parity and the risk of ASD. The first,
a Danish case-control study nested in population data, found no association. [42] The second,
a prospective cohort study using linked health data of more than 110 000 mothers in the US,
asserted that mothers of parity greater than two were more likely to have a child with ASD
than other mothers. [25] Possibly, socio-demographic factors were also operating in this
circumstance. In relation to SES and the odds of ASD, it is possible once again that the disparate
findings of this same Danish study may have been due to less ascertainment bias which set
them apart from other studies in the area. [42] The second study involved nearly 120 000 nurses
who were followed via their completion of mailed questionnaires over sixteen years. [25]
Hence, all mothers were educated and due to their involvement with nursing, could be
expected, on average, to have more knowledge of ASD than other mothers. Further, parity was
assessed as a binary variable with the two values of greater than two and less than or equal to
two. Commonly, other studies have defined parity as either a continuous variable or one with
more than two possible values and this difference might account for variations in study
findings.
Mothers of higher parity had increased odds of having a child with mild or moderate ID. [17,
20, 21] One of the research groups concluded that fourth or subsequent children had an
increased risk of mild-moderate ID. [20] A Finnish study of two birth cohorts, twenty years
apart, found that high parity persisted as a risk factor for ID over time. [46] A large cohort
study compared the parity of the mothers of Californian children with ID to the parity of
mothers of typically developing children born between 1987 and 1994. [21] These researchers
reported that mothers of parity of three or more were 30-50% more likely to have a child with
mild or moderate ID or unspecified ID. [21] Both this study and another Californian study
reported that mothers of children with severe or profound ID had an elevated but not
significantly increased parity compared to mothers of typically developing children. [21, 52]
3.5. Summary
Socio-demographic factors often operate quite differently for ASD and ID. For example, high
parental SES was positively associated with the risk of ASD and negatively associated with
the risk of ID in the offspring. Marital status, as defined by living with a partner, has different
associations. At the time of their childs birth, there was no consistent association of marital
status with mothers of a child with ASD compared to the mothers of typically developing
children. On the other hand, mothers of a child with ID were less likely to be living with a
partner than mothers of typically developing children. Parity appeared to have reverse
associations for ASD and ID. Compared to mothers of typically developing children, mothers
of low parity were more likely to have a child with ASD and mothers of high parity were more
likely to have a child with ID. Similar patterns exist for maternal age. Mothers of an advanced
age were more likely to have a child with ASD than mothers of typically developing children.
In contrast, mothers of a younger age were more likely to have a child with ID than mothers
395
396
of typically developing children. However, an additional association exists with older mothers
being also more likely to have a child with severe ID.
An under-ascertainment of ASD due to social factors and, to a lesser extent an over-ascertain
ment of ID could be contributing to the socioeconomic effects seen with ASD and ID. For
instance, in terms of the severity of ASD, researchers in California, with birth cohorts from
1992 to 2000, divided the children with ASD into two groups of equal size where the less severe
group comprised children in the top 50% of cases according to level of functioning and the
most severe group was the lower 50%. [41] They found that the children from the less severe
group were more often found in neighbourhoods which housed wealthier and more educated
individuals. Conversely, the same researchers reported that where low SES was measured by
a Medi-Cal payment for the birth, the ratio of more severe to less severe cases was always
greater than one. The researchers interpretation was that the most difficult to diagnose cases
of ASD, that is the less severely affected, were under-ascertained in lower SES populations. [41]
The association of high SES with ASD also might be compounded by some of the characteristics
known to be related to mothers of children with ASD. Older women with the support of a
partner and with fewer children would seem more likely to achieve a more complex diagnosis
requiring more assessments for their child than younger single mothers. Socio-demographic
associations with ASD in most Western countries do not appear to operate as strongly and
might even be absent in some Northern European countries. This might be due to a different
social welfare structure in this region and specifically related to the universal screening for
developmental disability. In addition to these and other social factors which could bias
ascertainment, biological factors may be operating with older parents.
4. Immigrant status and ethnicity

Immigrant describes mothers who give birth while residing in a country which is not their own
country of birth. Ethnic describes mothers who belong to a minority racial group in their
country of residence which may or may not be their country of birth. To some extent, the groups
of immigrant and ethnic mothers overlap. When examining social forces in relation to ASD
and ID, it is important to take into account the often complex process associated with making
a diagnosis of ASD.
4.1. Immigrant status
4.1.1. Immigrant mothers and autism
In all of the eight studies of immigrant mothers of children and ASD, [17, 22, 30, 57, 62, 75-77]
the research concluded that immigrant mothers were more likely to have a child with ASD
and particularly ASD with ID. [17, 22] In relation to immigrant mothers from Asia one of these
studies was conducted by an Australian research group from New South Wales and used birth
records and active surveillance to ascertain children with ASD. The group found that immi
grant mothers born in South-East or North-East Asia were more likely to have a child with
http://dx.doi.org/10.5772/54488
ASD than other immigrant mothers. [57] A Western Australian study, using linked population
data, also found that immigrant mothers from South-East or North-East Asia were at increased
risk of having a child with ASD with ID. [17] A similar situation was described in Sweden
where immigrant mothers from East Asia were more than three times as likely to have a child
with ASD. [76]
Black immigrant mothers and immigrant mothers from developing countries were also found
to be more likely to have a child with ASD compared to other immigrant mothers. One study
from the UK [75] and another from Sweden [76] reported that black immigrant mothers [75]
and immigrant mothers from sub-Saharan Africa [76] were much more likely to have a child
with ASD compared to non-immigrant mothers. Further, a small Swedish case-control study
compared the prevalence of autistic disorder and pervasive development disorder not
otherwise specified (PDDNOS) in black African children with at least one parent born in Somali
to the prevalence in children without a Somali background. [77] The researchers reported that
these 17 black mothers were from three to four times more likely to have a child with ASD
compared to the mothers without a Somali background. [77]
There is evidence that the intensity of the mothers skin colour is related to her risk of having
a child with ASD. A Swedish study compared the risk of ASD in the children of immigrants
from each of North, East and other parts of Africa. [22] The mothers from North Africa were
predominantly Moroccan and hence were probably fairer than the other two groups of
mothers. For example, the East African group was predominantly from Somalia and Ethiopia
while the ethnicity of the group from other parts of Africa was not described. The risk of ASD
in the North African group was elevated (1.5) but not significantly higher than that of nonimmigrant parents. On the other hand, the risk in the East African mothers and mothers from
other parts of Africa of having a child with ASD was 1.9 and 3.5. [22]
Immigrant mothers from distant countries and those who emigrated during pregnancy were
more likely to have a child with ASD than other immigrant mothers. For instance, researchers
from the UK and Denmark found that immigrant mothers born outside of Europe were more
likely to have a child with ASD. [62, 75] Similarly, a Swedish study found that immigrant
mothers who were not from either of the US or Europe were nearly three times as likely to
have a child with ASD compared to mothers from Nordic countries. [30] Another Swedish
study ascertained that immigrant mothers who emigrated during pregnancy were even more
likely to have a child with ASD than mothers who emigrated at other times. [22]
There is evidence that immigrant mothers are at different risks of ASD without ID and ASD
with ID. Two Swedish studies found that immigrant mothers, excepting those from neigh
bouring Northern Europe, were less likely to have a child with ASD without ID [22] and
Asperger syndrome [76] compared to non-immigrant mothers. One of these studies, along
with an Australian study, reported that immigrant mothers were more likely to have a child
with ASD with ID. [17, 22] In addition, the Swedish study found that the African immigrant
mothers were more likely to have a child with ASD with ID compared to non-immigrant
mothers. [22] Similar results were found in a small Swedish case-control study, where all
seventeen of the Somali children with autism presented with ASD with ID. [77]
397
398
Another group of researchers reported that certain immigrant mothers were less likely to have
a child with ASD than non-immigrant mothers. The US study conducted a national telephone
survey which chose respondents who resided with their biological child and the childs other
parent. [78] These researchers reported that non-immigrant Hispanic children had about twice
the prevalence of ASD of immigrant Hispanic children. [78] These results were at variance to
those in the previous studies of immigrant mothers. The lower likelihood of ASD in immigrant
Hispanics compared to non-immigrant Hispanics could be explained by the relative ease of
access of Mexican Hispanics to the US. With many countries, immigrants must meet stringent
criteria prior to entry and some of these relate to the health of their offspring, their age, wealth,
education and occupation. However, Mexican Hispanics would be less likely to experience the
same stress, climatic change and exposure to new infections as most other immigrants groups.
Moreover, immigrant parents from some of the other studies have usually relocated from more
distant locations. For example, one reported findings which related to immigrants from Somali
to Sweden, [77] another to non-European immigrants to Britain [75] and another to immigrants
to the isolated continent of Australia. [57]
Overall, immigrant mothers and particularly black or Asian immigrant mothers, mothers from
distant, developing countries and those who travelled while pregnant were at a higher risk of
having a child with ASD. The mothers at highest risk of a child with ASD were from groups
who would be expected to experience the most stress. For example, those relocating from a
developing country and those pregnant at the time might be expected to experience higher
stress than mothers who are relocating from a developed country or are not pregnant. This
stress, along with the environmental changes associated with immigration, may have specific
and negative effects on the developing fetal central nervous system. [22]
The risk of immigrant mothers having a child with ASD might be further exacerbated by an
increased exposure to novel viruses [75] and intrauterine infections. [57] Other hypotheses to
explain this association relate to low vitamin D levels [75, 79] and these have been further
fuelled by animal studies. One study of rat pups with gross vitamin D deficiencies reported
that they had structural brain abnormalities which were similar to those in children with ASD.
[80] Furthermore, ASD was particularly common in black or Asian immigrant women and
darker women more often have a vitamin D deficiency. [80] Generally, immigrant mothers are
more likely to have a child with ASD with ID and less likely to have a child with ASD without
ID. This may indicate different aetiologies for these subgroups.
Along with these biologicallybased hypotheses, social factors may affect the likelihood of
an immigrant mother having a child diagnosed with one of ASD, ASD with ID or ASD
without ID. For instance, a diagnosis of ASD without ID would be particularly difficult
where the childs parents were in an unfamiliar country, with a different language and
where unusual behaviours might be explained by cultural differences. [22] In Australia,
excluding the relatively small group of refugees, and in the US, Asian immigrants and
their children are more often of a higher SES than other immigrant mothers. [81, 82] This
might explain why the association with ASD was greater in this group than in other
immigrant groups.
http://dx.doi.org/10.5772/54488
4.1.2. Immigrant mothers and intellectual disability

Compared to ASD, there was a reverse scenario identified with ID. Overall, immigrant mothers
were 20-50% less likely to have a child with mild or moderate ID than non-immigrant mothers.
[17, 20, 21] In Australia, Asian immigrant mothers were less likely to have a child with mild
or moderate ID than non-immigrant mothers. [17, 20] As with ASD, the reversal with mild or
moderate ID might be due to their higher SES compared to other immigrant groups. [81-83]
Differing results were found with the association of ID in the children of Mexican immigrants
in a similar manner to the unexpected lower likelihood of Hispanic immigrant mothers having
a child with ASD. A study of children with severe or profound ID, and born in California,
found that immigrant mothers from Mexico, who would have been likely to be Hispanic, were
nearly twice as likely to have a child with severe or profound ID compared to parents born in
the US. [52] The idiosyncrasies associated with this immigrant group, compared to those
immigrants from more distant locations, might explain this finding. They are likely to be less
empowered than their non-immigrant counterparts and, as mentioned previously, their
immigration was likely to be less regulated. Hence, from a socio-demographic viewpoint, they
are more likely to present with low SES which is a risk factor for ID.
4.2. Ethnicity
In many studies, immigrant status and ethnicity were not differentiated. Therefore, within the
ethnic group of mothers, there would have been mothers who, due to their country of birth,
were both ethnic and immigrant. A recurrent trend of the research is that mothers from
minority ethnic groups were less likely to have a child with ASD and more likely to have a
child with ID than mothers who were not from minority ethnic groups.
Epidemiologists have found that mothers from ethnic minorities and particularly Aboriginal
mothers were less likely to have a child with ASD. For example, in the US, the Hispanic mothers
were less likely to have a child with ASD compared to non-Hispanic mothers. [23, 59, 84] In
New York, the prevalence in Latinos was around half that in non-Latinos. [40] Some of these
mothers from minority ethnic groups would have also been immigrant and, as reported,
immigrant mothers usually have higher rates of ASD. This means that mothers from ethnic
minority groups and who are native to their country might be expected to have the lowest
likelihood of a child with ASD. This is the case in both Australia and Canada, where Aboriginal
mothers had about half the odds of having a child with ASD compared to non-Aboriginal
mothers [17, 29]
Compared to ASD, there was a reverse situation with ID since overall mothers from ethnic
minority groups were more likely to have a child with ID. Asian mothers giving birth in
California were 40% more likely to have a child with severe or profound ID although this result
was not significant. [21] Hispanic mothers were more likely to have a child with either mild
or moderate ID or severe or profound ID than Caucasian mothers. Again, in each of the ID
groups, the results narrowly failed to achieve significance. [21] By comparison, Australian
Aboriginal mothers were more than three times more likely to have a child with mild or
moderate ID and were 60% more likely to have a child with severe or profound ID. [17, 20]
399
400
The higher rates of ID and the lower rates of ASD found in most ethnic minority and particu
larly indigenous communities may relate to the differing gene frequencies of these groups
from the general population. However, differences could be exacerbated by environmental
factors such as maternal alcohol consumption [85] without this being specifically identified as
an aetiological factor. [86] Another consideration could be that marginalized groups are less
empowered than others to pursue a diagnosis of ASD in contrast to a diagnosis of ID and that
the infrastructures established for diagnostic assessment do not meet their needs. This second
factor may also account for the lower prevalence of ASD and higher prevalence of ID with
respect to the Australian Aboriginal community. [87]
In two Californian studies, contrasting findings were found for the previously described
associations of ethnicity with ASD. Firstly, a cohort study found that Hispanic mothers were
no less likely to have a child with ASD with ID than white mothers. [52] The same study also
reported that Californian black mothers were more than five times as likely to have a child
with ASD with ID as white mothers. [52] Furthermore, Californian Asian mothers were almost
four times as likely to have a child with ASD with ID as white mothers. [52] Again, this may
be a reflection of the higher proportion of immigrants in these groups. A second explanation
in relation to the Asian mothers could be the fact that Asian mothers in US tend to have a
higher SES than most other ethnic mothers. The second of the two Californian studies reported
that Asian mothers giving birth in California were 30% less likely to have a child with mild or
moderate ID. [21] This may also be a reflection of their higher SES.
4.3. Summary
Generally, immigrant mothers, and especially black and Asian immigrant mothers, were more
likely to have a child with ASD compared to non-immigrant mothers. Furthermore, immigrant
mothers were more likely to have a child with ASD with ID and less likely to have a child with
ASD without ID compared to non-immigrant mothers. Immigrant mothers from distant or
developing countries and mothers who emigrated when they were pregnant were even more
likely to have a child with ASD. By contrast, in the US, Hispanic immigrant mothers were less
likely to have a child with ASD than non-immigrant Hispanic mothers. Furthermore, nonimmigrant mothers and particularly Aboriginal mothers were more likely to have a child with
ID and especially mild or moderate ID than mothers who were not ethnic.
5. Health and associated characteristics

5.1. Mental health
The World Health Organisation describes mental health as a state of mental well-being. [88] This
state of well-being can be enhanced by the prevention of mental disorders and the treatment
and rehabilitation of those with mental disorders. Compromised mental health has been
reported in the mothers of children with ASD and to a lesser extent in the mothers of children
with ID compared to mothers of children without these disorders. For example, researchers
found that mothers of a child with ASD were more likely to have a pre-existing psychiatric [62,
http://dx.doi.org/10.5772/54488
64, 89] or personality [62, 89, 90] disorder than mothers of typically developing children.
Further, parents of a child with ASD were more likely to have increased rates of disorders
which were related to affective disorder, [42] obsessive compulsive disorder, [27] anxiety, [27]
paranoia, [27] and somatization [27] than the parents of typically developing children. One of
these studies was conducted by a Californian team and recruited 269 parents of children with
ASD via an existing university research program and control parents of typically developing
children who were students (or their contacts) at the university. Self-reported mental health
measures were obtained via questionnaire. [27] Other reported associations with parents of a
child with ASD were increased rates of schizophrenia, [42, 89, 91] psychosis [42] and depres
sion, [27, 64, 89] compared to the parents of typically developing children. Mothers of a child
with ASD were more likely to have had pregnancies complicated by depression [92, 93] than
mothers of typically developing children. Another research group explored mental health by
comparing the rates of mental disorders in parents of people with ASD to those in parents of
people with Down syndrome. [94] Parents of a child with ASD were more likely to have had
an anxiety disorder than the parents of children with Down syndrome.
Studies have most commonly investigated the mental health of mothers of children with
disabilities rather than the developmental outcomes in children born to mothers with mental
health diagnoses. In one case-control study, the latter approach was employed and linked data
from population-based registries was used to compare the likelihood of ASD with ID or ID in
the children of more than 3 000 mothers with schizophrenia, bipolar disorder or unipolar major
depression to the likelihood of these disorders in control mothers. Of these, around 1 300
mothers had bipolar disorder and these were assessed as nearly ten times more likely to have
a child with ASD with ID than mothers without these disorders. [95] However, there were only
four children with a mother with pre-existing bipolar disorder so these large odds are
associated with particularly wide confidence intervals and only just reached significance.
The same study found that children of mothers with either schizophrenia, unipolar major
depression or bipolar disorder or a combination of these disorders were about three times as
likely to have a child with ID as mothers without these disorders. [95] Furthermore, mothers
with ID themselves were more likely to have a child with ID compared to mothers with no
history of psychiatric disorder or ID. [95]
5.2. Personality traits
Personality traits have been more often identified in the parents of children with ASD. For
instance, parents of children with ASD were more likely to manifest a range of subtle autisticlike characteristics than parents of typically developing children. These characteristics have
been grouped together as the Broad Autism Phenotype and include social cognition deficits,
such as reasoning about the emotions of others, [96] autistic-like traits, [97] and impaired
aspects of executive function. [98, 99]
A questionnaire entitled the Autism Spectrum Quotient (AQ) [100] was designed to assess the
Broad Autism Phenotype in the five domains of social skills, communication, attention to
detail, attention switching and imagination. [101] Researchers from the UK conducted a casecontrol study comprising parents of children with and without ASD from more than 1 500
401
402
families. Parents of children with ASD were more likely to exhibit autistic-like traits in all
domains except that of attention to detail [102] than parents of typically developing children.
Furthermore, these researchers and others found that a Broad Autism Phenotype occurred
more commonly in parents of children with simplex ASD [97, 102] (where only one family
member has ASD) and multiplex ASD [100, 103] (where more than one family member has
ASD) than in parents of typically developing children. A dose-response effect was also
described with parents in multiplex ASD families expressing a Broad Autism Phenotype
significantly more often than parents in simplex ASD families. [32]
Some factors associated with maternal mental health may have a deleterious effect on the fetus
and increase the likelihood of a child developing ASD or ID. For example, mothers with
schizophrenia may remain on antipsychotic drugs during their pregnancies and these drugs,
perhaps along with lower levels of maternal self-care (such as diet and medical care) and
genetic factors related to the disease may adversely affect the development in the fetus. The
milder autistic features in the parents of children with ASD might also be attributable to genetic
factors associated with ASD. [33] In their affected children, these factors, along with additional
genetic factors from the other parent, may sometimes produce the clinical phenotype of ASD.
5.3. Physical characteristics
Here are a group of diverse findings pertaining to the physical attributes of the mothers of
interest. One study identified that mothers of children with ASD were significantly taller,
particularly those of children with ASD without ID compared to the mothers of typically
developing children. [17] This study population comprised more than 300 000 mothers and
the mean heights of mothers of children with ASD with ID and mothers of children with ASD
without ID were 164.3 and 164.9 cm. These means were significantly higher than the mean of
the mothers of typically developing children (163.4cm). Another study found that mothers of
children with ASD were both taller and heavier than mothers of typically developing children.
[93] Similarly, a Canadian population study found that among non-smoking women, taller
and heavier women were more likely to have a child with ASD compared to the mothers of
typically developing children. [29]
Compared to the mothers of children with ASD, differing associations between maternal
height and the mothers of children with ID were identified. Using population data, researchers
identified that shorter women and those of medium height were more likely to have a child
with mild or moderate ID than other mothers. [20] Further, the shortest group of women were
more likely to have a child with severe or profound ID than other women. [20] Others found
that mothers of children with mild or moderate ID, with a mean height of 162.1 cm were
significantly shorter then than the mothers of typically developing children whose mean was
164.3 cm. However, the mothers of children with severe or profound ID were not significantly
shorter than the mothers of typically developing children. [17] However, associations have
also been described between SES and height, [104] and so the observed height differences
between the mothers of children with ASD and ID may be a reflection of the different mean
SES of these groups.
http://dx.doi.org/10.5772/54488
5.4. Health behaviours

Smoking during pregnancy has been associated with both ASD and ID in the offspring. In one
study, mothers who smoked during pregnancy were reported to be more likely to have a child
with ASD than mothers who did not smoke. [30] In 2011, a Swedish nested case-control study
using medical registry data, found that mothers who smoked during early pregnancy were
70% less likely to have a child with ASD but almost twice as likely to have a child with Asperger
syndrome. [76] This raises the possibility that Asperger syndrome has a distinct aetiology from
other forms of ASD.
On the other hand, differing results were found in a US population-based, case-cohort study
which explored the association of mothers who smoked during pregnancy and ASD. [105]
Data from more than 6 000 000 mothers and their children were adjusted for potential
confounders such as maternal age, education, and marital status. The definition of smoking
during pregnancy was not described in the paper, so presumably this encompasses all mothers
who had admitted to smoking one or more cigarettes during their pregnancy. The researchers
reported that mothers who smoked during pregnancy were no more likely to have a child with
ASD than mothers who did not smoke. Two large recently published cohort studies published
in 2010 and 2011 also found no association between mothers who smoked during pregnancy
and ASD. [29, 106] However, the first study examined only associations between maternal
smoking and ASD generally [29] Hence, any associations between the relatively small group
of mothers of children with Asperger syndrome may have been lost in the broader analysis.
In addition, smoking was defined as any smoking during pregnancy which may have lessened
the likelihood of an association with ASD. These were different outcomes to the second study,
where mothers of children with ASD with ID and ASD without ID were considered separately
and mothers who smoked ten or more cigarettes a day were a distinct group from the less
intense smokers. [106] The first research group suggested that associations found with other
studies were attributable to a confounding by maternal socio-demographic characteristics. [29]
The findings of associations between smoking during pregnancy and ID are also limited. A
population study in the US ascertained that mothers who smoked 20 or more cigarettes a day
were more likely to have a male child, but not a female child, with ID than mothers who did
not smoke during pregnancy. [107] A large Finnish cohort study found that mothers who
smoked after 2 months of pregnancy were no more likely to have a child with ID than mothers
who did not smoke after this time. [46] This definition of smoking is broader than that of the
first study so the likelihood of identifying an association between maternal smoking and ID
may be reduced. Further, smoking during the first two months of pregnancy or gender of the
fetus was not considered for inclusion in the model. An alternative study, with a more stringent
definition of maternal smoking and which addressed these omissions, would be more likely
to discern an association between smoking and ID.
Mothers who consume excessive alcohol during pregnancy were assessed as more likely to
have a child with ID (but not ASD). This cause of ID is termed fetal alcohol syndrome (FAS)
or fetal alcohol spectrum disorder (FASD). Fetal alcohol syndrome is at the most severe end
of the spectrum and is diagnosed by characteristic facial features, brain dysmorphology,
intellectual and other disabilities. [108] The milder diagnosis of FASD [109] does not require
403
404
the presence of all of the characteristic physical features required for FAS. [110] Studies from
Sweden and the US attributed between 2-10% of mild or moderate ID to FAS or FASD. [111,
112] While the US study considered that a further 3% of severe or profound ID was caused by
FAS or FASD. [112]
In a Western Australian record linkage study heavy prenatal alcohol exposure was found to
be an important cause, accounting for 2.5% of non-genetic intellectual disability. [85] Underascertainment, particularly of FASD, may result from non-disclosure of alcohol consumption
during pregnancy due to the associated stigma. [113] In addition, perhaps due to inadequate
training, [114] clinicians may lack awareness and confidence in making this diagnosis. [113]
Also, clinicians may be concerned at the psychological effect on the mother of a FASD diagnosis
and may not pursue this in situations where it is not conclusive or they feel it would not be
beneficial to the mother or child.
Large cohort studies and linked data have provided researchers with the opportunity to
study whole populations of mothers and their children with and without ASD and/or ID.
Data can also be adjusted for a range of possible confounders such as SES and age. This
enables the identification of new risk factors for ASD and/or ID and the elimination of
others. For example, the association of smoking during pregnancy with ASD and/or ID in
the offspring has weakened in the most recent studies using linked population data.
Persisting associations are an increased risk of Asperger syndrome or PDD-NOS in mothers
who smoked during pregnancy and an increased risk of ID in the male children of mothers
who smoked heavily during pregnancy. Maternal alcohol consumption during pregnancy
remains a risk factor for ID.
The remaining associations of maternal smoking with ASD and ID in the offspring could result
from the effect of this exposure on overall fetal development and particularly growth restric
tion, [115, 116] preterm birth [115] and low birth-weight [117] Moreover, sub-optimal fetal
growth has been associated with mild or moderate ID in Caucasian children. [118] The
association of maternal alcohol consumption with ID might be due the multiple effects of
alcohol on the fetus and placenta. [119] For example, alcohol can induce oxidative stress in
placental villous tissue. Other demonstrated effects are an increase in neural tube defects and
increased heart rate and cortisol levels in the exposed infant.
5.5. Physical health
The research literature has provided evidence that maternal physical health, both prior to and
during pregnancy is related to the likelihood of a mother having a child with ASD and/or ID.
Various pre-existing conditions in the mother and related or unrelated complications of her
pregnancy increase the likelihood of a mother having a child with ASD and/or ID compared
to mothers who do not have the condition.
Pre-pregnancy obesity is an example of a condition which increases the likelihood of a
woman having a child with ASD and/or ID. Obese women were more likely to have a
child with ASD, [24, 54, 120] or ID [24, 46] than women who were not obese. One of these
studies was a Finnish study which used linked data from the birth cohorts of 1966 and
http://dx.doi.org/10.5772/54488
1985-6 and included around 250 mothers of children with ID in each of the cohorts. [46]
In both cohorts, mothers with obesity prior to their pregnancies were more likely to have
a child with ID than women without pre-pregnancy obesity. However, the association of
ID with pre-pregnancy obesity was an increasing risk reflected in the greater odds in the
latter cohort(2.4) compared with the original cohort(1.8). [46] Another of the research
groups reported that women with an early age of menarche were more likely to have a
child with ASD than other women. [120] Early menarche, along with pre-pregnancy
obesity, could indicate the possibility of maternal hormonal involvement in the risk of ASD
and ID. [120] Then again, the relationship with ID may be resulting from confounding by
the association between socioeconomic disadvantage and obesity in highly developed
countries. [121] In the light of the increasing prevalence of obesity in these countries, these
associations with ASD and ID are an important future research direction. [122]
Women with an auto-immune disorder or anomalies of the immune system were more likely
to have a child with ASD and/or ID than women who did not. [25, 26, 123] Furthermore, the
majority of associations in this area were with ASD rather than ID. For example, in a casecontrol study using linked data with more than 1 200 cases, mothers with an auto-immune
disorder were 60% more likely to have a child with ASD than mothers without an auto-immune
disorder. [26] These findings were supported by a small case-control study of 61 mothers of
children with ASD. [123] Other studies have found that women with a particular auto-immune
disease were more likely to have a child with ASD than women who did not have the disease.
For instance, a case-control study with 407 cases found that women with psoriasis were more
likely to have a child with ASD than mothers without this disorder. [124] Another research
group used linked population data with more than 3 000 mothers of a child with ASD and
nearly 700 000 control mothers. They reported that women with rheumatoid arthritis or celiac
disease were more likely to have a child with ASD than mothers who did not have one of these
disorders. [125]
One study found that women with pre-existing diabetes were more likely to have a child
with ASD than women without pre-existing diabetes [29] However, a study used linked
data from the national birth and inpatient registries and reported that women with preexisting diabetes were no more likely to have a child with ASD than other mothers. [30]
In relation to ID, a group of US researchers investigated a possible association with diabetes
by comparing more than 160 000 mother-child dyads. The researchers identified that
mothers with pre-existing diabetes were more than 10% more likely to have a child with
ID. [126] Diabetes during pregnancy was also associated with both ASD and ID. For
instance, two studies found that mothers with diabetes during pregnancy were more likely
to have a child with ASD [25] and ASD with ID [127] than mothers without the disor
der. The first of these was a Canadian population study which included nearly 800 cases
of ASD and more than 66 000 births. Mothers who developed gestational diabetes were
associated with a 76% increased risk of ASD compared to women who did not develop
the condition. [25] The second was an Australian population study which found that
mothers who had diabetes during pregnancy were nearly three times as likely to have a
child with ASD with ID than mothers without diabetes. [127] More attenuated results were
405
406
ascertained by Californian researchers who conducted a case-control study and com

pared the mothers of more than 500 children with ASD, 172 mothers of children with
developmental disabilities other than ASD to typically developing children. [24] They
found that mothers with gestational diabetes were more likely (but not significantly more
likely) to have a child with ASD than mothers without the disorder. The lack of signifi
cance may be due to the reduced power of this smaller study. Two studies identified an
association between gestational diabetes and ID or a condition similar to ID. [24, 127] One
was a large retrospective cohort study using linked registry data. Here the researchers
found that mothers with diabetes during pregnancy were nearly 70% more likely to have
a child with mild or moderate ID [127] compared to mothers without this disorder. The
other research group found that mothers with diabetes during pregnancy were nearly two
and a half times more likely to have a child with a developmental disability other than
ASD than mothers without diabetes during pregnancy. [24]
Further, differences have been identified relating to the immunological status of mothers
of children with ASD prior to their pregnancies. An independent case-control study
identified fetal brain antibodies in mothers of children with ASD but not in controls
mothers. [128] This study found that mothers of children with ASD were significantly more
likely to have an auto-antibody reactivity pattern for human fetal brain proteins than
mothers of typically developing children.
Cytokines are regulators of immune response and maternal immune dysfunction has been
associated with the neurological development of the fetus. [129] A case-control study identified
that mothers of children with ASD and/or ID were more likely to have aberrant cytokine
profiles compared to the mothers of typically developing children. [130] In this study, the
concentration of serum cytokines at mid-pregnancy in the mothers of children with ASD with
ID, developmental disabilities other than ASD and typically developing children were
compared. Mothers of a child with ASD with ID were more likely to have higher concentrations
of three particular cytokines than mothers of a typically developing child. In addition, mothers
of a child with a developmental disability other than ASD were more likely to have higher
concentrations of a different set of three different cytokines (to the ASD group) than mothers
of typically developing children. [130]
Auto-immune diseases and other immune dysfunction might impinge on the immature
nervous system of the developing fetus. This could have a deleterious effect on future cognitive
function [131] and increase the likelihood of ASD and ID. [130]
Hypertension or high blood pressure is either a temporary or sustained elevation of the blood
pressure in the arteries. [132] Moreover, the elevation is at a level where cardiovascular or
other damage may occur. Hypertension during pregnancy was associated with an increased
risk of ASD in the child. Three studies provided evidence that women who experienced
hypertension during pregnancy were more likely to have a child with ASD [24, 30, 54] than
women who had not suffered hypertension. In one of the studies, Swedish researchers
conducted a nested, matched case-control study with data from over 400 children with ASD
and over 2 000 controls. [30] Records of childrens hospitalisation over 10 years were linked to
birth records. The researchers concluded that mothers who suffered a hypertensive disease
http://dx.doi.org/10.5772/54488
during pregnancy were 60% more likely to have a child with ASD than other mothers. In
contrast, a large cohort study of more than 650 000 nurses found that mothers with hyperten
sion during pregnancy were no more likely to have a child with ASD than mothers without
with hypertension during pregnancy. [25] Possibly, these nurses, with their increased medical
knowledge, sought treatment before their blood pressure reached a level which would have
been damaging to the unborn child.
Hypertension and oedema are two common symptoms of pre-eclampsia or toxaemia [132]
which is a condition occurring in about 8% of first pregnancies. [133] Women who experience
this condition, along with those who suffer oedema, were more likely to have a child with ASD
and/or ID. Three groups of researchers found that women with pre-eclampsia [25, 29, 134] and
those suffering oedema [92] during their pregnancies were more likely to have a child with
ASD than women without these conditions during their pregnancies. In contrast, a much
smaller case-control study, found that woman with pre-eclampsia had reduced (though not
significantly so) likelihood of a child with ASD. [60] Pre-eclampsia was also associated with
ID. [135] This association was found by researchers in a population-based, retrospective cohort
study in South Carolina. Here, women who suffered pre-eclampsia were nearly 60% more
likely to have a child with ID.
Associations of maternal epilepsy have been demonstrated with both ASD and ID. Women
who experienced epilepsy during pregnancy were more likely to have a child with ASD with
ID [127] or mild or moderate ID. [127] These Australian researchers conducted a retrospective
cohort study of nearly 3 000 mothers of children with ASD and/or ID of unknown cause and
around 237 000 mothers of typically developing children using linked population data from
medical registries. They established that mothers with epilepsy during pregnancy were more
than four and a half times as likely to have a child with ASD with ID [127] and more than three
and a half times as likely to have a child with mild or moderate ID compared to mothers
without epilepsy during their pregnancies. [127] A case-control study in US had only 61 control
mothers of a child with ASD. [123] Here, mothers who had experienced seizure prior to their
pregnancies were nearly six times as likely to have a child with ASD. However, possibly due
to the small size of the study, results did not reach significance.
In addition to epilepsy, mothers who experienced a range of other conditions during pregnancy
were found to be more likely to have a child with ASD than other mothers. Overall, health issues
during pregnancy were associated with a higher risk of ASD. Researchers reported that women
who had allergies, [124] asthma, [124] bleeding, [30] or high body temperature [93] during their
pregnancies were more likely to have a child with ASD than women who had not experienced
these conditions during their pregnancies. Asthma during pregnancy was also associated with
ID, with pregnant women with asthma being more likely to have a child with mild or moderate
ID than mothers without this condition during pregnancy. [127]
Other conditions during pregnancy have been associated with ID. For instance, an Australian
population study found that women who had renal or urinary conditions during pregnancy were
more than twice as likely to have a child with mild or moderate ID as women without these
conditions during pregnancy. [127] Furthermore, women who suffered anaemia during their
pregnancies were more than five times as likely to have a child with severe or profound ID than
407
408
women without anaemia during pregnancy. [127] Two research groups ascertained that
infections during pregnancy were associated with ASD. They found that women whose pregnan
cies were complicated by urinary tract infection, [93] or any bacterial or viral infection [93, 136]
were more likely to have a child with ASD than mothers who did not experience an infection.
Infections during pregnancy were also associated with ID. For example, one study reported
that mothers who suffered trichomoniasis during pregnancy were more likely to have a child
with ID than mothers without this condition during pregnancy. [137] A cohort study used
Medicaid claims and linked infant records to investigate the association of treated and
untreated urinary tract infections during pregnancy with later ID in the child. [138] The
researchers reported that pregnant women with untreated urinary tract infections were 30%
more likely to have a child with ID than pregnant women without these infections. Moreover,
mothers with untreated urinary tract infections were 22% more likely to have a child with ID
than mothers with antibiotic treated urinary tract infections. [138]
There is always a risk that the use of certain medications during pregnancy may have adverse
effects on a developing fetus. This use is likely to be related to a womans health and the
decision to use a particular medication at this time must be difficult. Sometimes, medications
initially considered safe have been later implicated to adversely affect the future health of the
unborn child. For instance, six studies found that the children of mothers who used antidepressants, [64, 139] anti-convulsants, [140] psycho-active drugs, [64] prescribed medications
[54, 93] and medications generally [141] had a higher risk of a child with ASD. One of these
was a population-based case-control study in Stockholm. [64] Using registry data, the re
searchers assessed that mothers who took psycho-active drugs or anti-depressants during their
pregnancies were more than four times as likely to have a child with ASD.
It is also possible that the increased use of prescribed medications in mothers of children with
ASD may have resulted from a bias in data collection. In one of the studies which found an
increased use of prescribed medications, case mothers were recruited via their response to an
advertisement in a support agency newsletter or via their membership of a support agency.
[93] Each of these methods might have resulted in a bias in the direction of a high SES. This,
in turn, may have produced an increased use of prescribed medications in the case mothers.
On the other hand, the study which found an increased use of medications generally was a
population study using medical registries. [141] The reported associations are likely to be
mediated by a complex interaction of factors. For instance, in addition to possible SES bias,
there could be a genetic association such as the familial link of depressive disorders or epilepsy
with ASD. Another possibility is an environmental effect which results from the physiological
impact of maternal medication use on the uterine environment.
5.6. Summary
Before the birth of their affected children, certain socio-demographic, health and physical
attributes differentiate mothers of children with ASD and/or ID from those of mothers in the
general population. Further, these attributes often vary by the disability group of their child.
In Tables 2 to 4, these differences are grouped into categories according to their associations
with groups of mothers. An examination of Table 2 shows that with socio-demographic factors,
http://dx.doi.org/10.5772/54488
the relationships with ASD and ID are most often reversed. High SES was most often associated
with the ASD groups of mothers and low SES, most often associated with ID.
Different associations of marital status were found with each of ASD and ID. With ASD, the
only two studies found in the area had opposing results. With all but one study, single mothers
were at increased risk of unspecified ID and mild or moderate ID, compared to women who
were living with a partner.
In the majority of the studies, increased maternal age, along with increased paternal and
parental age, were associated with ASD and ASD without ID. With ID, two associations
emerged. Younger mothers had an increased risk of bearing a child with mild or moderate ID.
But severe or profound ID was associated with increased maternal age.
Lower parity had a consistent positive association with ASD in most studies. With mild or
moderate ID and unspecified ID, the relationship was reversed and the association was with
greater parity. However, with severe or profound ID, there was no association.
In Table 3, the associations with immigrant status and ethnicity are summarized. Most often,
immigrant mothers are more likely to have a child with ASD or ASD with ID than nonimmigrant mothers. On the other hand, ASD without ID was associated with non-immigrants,
excepting those immigrants from nearby countries. The Mexican/Hispanic immigrant mothers
in the US were a separate group since these mothers were less likely to have a child with ASD
than Mexican/Hispanic non-immigrant mothers.
With ethnicity, the associations differed from those with immigrant status, in spite of the overlap
between the groups. Except for Asian and black mothers, mothers from ethnic minority groups
were at a lower risk of children with ASD compared to Caucasian mothers. With the exception of
Asian mothers, the relationship with ID was reversed since mothers from ethnic minority groups,
and particularly Aboriginal mothers, were at an increased risk of a child with ID.
Table 4 shows the many associations of health and behavioural traits with ASD and highlights
the quite small proportion common to both ASD and ID. With mental health, ten research
groups reported associations with ASD. Contrastingly, only one study found an association
with the mothers of children with ID. Autistic-like traits were associated only with the parents
of children with ASD.
As with other socio-demographic factors, ASD and ID had an overall reverse association with
height. Taller and heavier women were more likely to have offspring with ASD and shorter
women to have offspring with ID. The associations with maternal smoking during pregnancy
were minimal. Excessive alcohol consumption during pregnancy was only associated with
offspring with ID. Obesity though was associated with both ASD and ID.
Both ASD and ID had associations with immune function, though the association with ASD
was broader. Both pre-existing diabetes and diabetes during pregnancy were associated with
ASD and/or ID. Further, abnormal levels of cytokines during pregnancy were also associated
with each of ASD and ID. Other associations were with only ASD and were auto-immune
disorder generally, psoriasis, rheumatoid arthritis, celiac disease and maternal fetal brain
antibodies.
409
410
Seven studies associated hypertension, oedema and pre-eclampsia with ASD whereas only
one study associated pre-eclampsia with ID. Epilepsy and asthma had associations with both
of ASD and ID but no other associations during pregnancy were common to both disorders.
Medication use during pregnancy was only found to be associated with ASD.
ASD
Category
ASD without
Undifferentiated ASD
ID
SES
+veassoc
Unspecified ID
Severe ID
+veassoc [17,39-41,47]
+veassoc
-veassoc
-veassoc
[17]
[17,20,48]
[21,44-46,48]
-veassoc [20,21]
-veassoc
-veassoc
[20,21,32,44,45,51,
[21,52]
No assoc[42]
Sweden
Education as a
Mild ID
ID
[17,47]
In Denmark &
ID
ASD with
-veassoc[43]
+veassoc [47]
+veassoc [21,41,50]
measure of SES
53]
-veassoc (DD)[24]
Marital status
+veassoc [17]
+veassoc
at childs birth
-veassoc [54]
[17]
-veassoc [20]
-veassoc (early
(Women with
cognitive delay )
partners)
Age Maternal
-veassoc[17]
[55]
+veassoc
+veassoc
-veassoc
[17,47]
[17,21,29,47,56-61]
[17,20,21]
Paternal &
No assoc [46]
+veassoc
[21,68]
+veassoc [17,56,58,61]
maternal
Only paternal
+veassoc [65]
Maternal &
+veassoc [58,62-65]
No assoc [42,43,66]
paternal
(Denmark,
Sweden & UK)
Lower parity
+veassoc
+veassoc [29,41,73]
+veassoc
-veassoc
[17,74]
-veassoc [25]
[17]
[17,20,21]
-veassoc [21,46]
No assoc
[21,52]
No assoc [42]
Age & lower
+veassoc [58]
parity
ASD, autism spectrum disorder; ID, intellectual disability; Mild ID, Mild or moderate ID; Severe ID, Severe or profound ID;
SES, socio-economic status; +ve, positive; -ve, negative; assoc, association.
Table 2. Associations of socio-demographic factors in the mothers of children with ASD and/or ID
http://dx.doi.org/10.5772/54488
ASD
Category
ASD without ID
ID
ASD with ID
Mild ID
Immigrant
+veassoc[17,22,30,57,62,7
+veassoc [17,22]
status
5-77]
Severe ID
veassoc[17,20,2
(Immigrant vs
1]
non-immigrant)
North Europe &
-veassoc (except
+veassoc in
UK
other North
Somalis[77] & Africans
Europeans)[22,76]
[22]
US
-veassoc immigrant
+veassoc
Hispanic vs non-immigrant
Mexican
Hispanics [78]
immigrants in
California [52]
Asian
+veassoc in SE & NE Asians
-veassoc for
[17,57]+veassoc in East
Asians in Aus&
Asians[76]
US [17,20]
Ethnicity(Non-
-veassoc in Hispanics
+veassoc in
+veassoc in
Caucasian vs
[23,59,84] & Latinos [40]
Aboriginals
Aboriginals
[17,20]
[17,20]
Caucasians)
-veassoc in Aboriginals
[17,29]
+veassoc in Asians [52]
No assoc in Hispanics
-veassoc in
+veassoc in Blacks [52]
[52]
Asians [21]
ASD, autism spectrum disorder; ID, intellectual disability; Mild ID, Mild or moderate ID; Severe ID, Severe or profound ID;
+ve, positive; -ve, negative;assoc, association; SE, south eastern; NE, north eastern; Aus, Australia; NHW, non-Hispanic
white.
Table 3. Associations of immigrant status and ethnicity in the mothers of children with ASD and/or ID
411
412
ASD
Category
ASD without ID,
ID
Unspecified ID[Mild ID], [Severe ID]
Schizophrenia [42,89,91]
Schizophrenia [95] or
Depression [27,64,89]
Unipolar major depression [95] or
[Asperger syndrome]
[ASD with ID]
Mental health
Bipolar disorder [ASD
Bipolar disorder [95]
with ID] [95]

Psychiatric, [62,64,89] personality disorders,
ID in mother [95]
[62,89,90] affective [42] & obsessive compulsive

disorders,[27] anxiety, [27,94] & paranoia
[27]Somatization, [27] psychosis,[42]
depression,[ 27, 64, 89] & depression during
pregnancy [92,93]
Autistic-like traits [97,100,102,103]
Personality
traits
Physical
Taller[ASD without ID]
Taller and heavier [93] Taller and heavier (non-
Shorter, medium height
characteristics
[17 [17]Taller[ASD
smoking mothers only) [29]
[20]Shortest[Severe ID] [20] &
with ID] [17]
shorter[Mild ID] [17]
Health
Smoking[Asperger
Smoking [30]Smoking(-veassoc) [76]
In male children with 20 cigs/day in
behaviours
syndrome] [76]
Smoking(no assoc) [29,105,106]
mother[107]Smoking (no assoc)[46]
During
Alcohol[85]Alcohol[Mild ID] [111, 112]
pregnancy
Physical health
Alcohol[Severe ID] [112]

Obesity[ASD with ID]
Obesity [24,54,120]
Obesity [24,46]
[24]
Early menarche[120]
Immune
Diabetes during
Diabetes[24,29] & diabetes during
Diabetes[126] & diabetes during
function
pregnancy [ASD with
pregnancy[25]
pregnancy(Mild ID)[127] & (DD no
Higher conc of 3 cytokines[130]
Higher conc of 3 other cytokines(DD)
ID] [127]
ASD)[24]
[130]
Any auto-immune disorder, [256,26,123]
psoriasis,[124] & rheumatoid arthritis[125]
celiac disease, [125] &fetal brain antibodies
[128]
ASD, autism spectrum disorder; ID, intellectual disability; Mild ID, mild or moderate ID; Severe ID, severe or profound ID;
UTI, urinary tract infection,
Table 4. Associations of mental health, personality traits, physical characteristics, health behaviours and physical
health in the mothers of children with ASD and/or ID
http://dx.doi.org/10.5772/54488
Category
ASD
ID
ASD without ID[ASD Undifferentiated ASD
Unspecified ID[Mild ID], [Severe
with ID]
ID]
Hypertension[24,30,54] Oedema[92]
Other areas
during
pregnancy
Pre-eclampsia[25,29,134]
Epilepsy[ASD with ID)
Pre-eclampsia[135]
Epilepsy(Mild ID)[127]
[127]
Allergies,[124] bleeding,[30] & high
Renal/urinary conditions,[127] [Mild
temperature[93] UTI[93] & any
ID][126] Anaemia [Severe ID]
infection[93,136]
[127]Trichomoniasis[137] &
untreated UTI[138]
Asthma [124]
Asthma (Mild ID) [127]
Anti-depressants,[64,139]
prescribed[54,93] & other
medications[141] Anticonvulsants[140] &
psycho-active drugs[64]
ASD, autism spectrum disorder; ID, intellectual disability; Mild ID, mild or moderate ID; Severe ID, severe or profound ID;
UTI, urinary tract infection.
Table 5. Associations of health during pregnancy in the mothers of children with ASD and/or ID
6. Conclusion
This chapter provides a review of the research pertaining to the pre-existing characteristics
of mothers of a child with ASD and/or ID. Some consistent and enduring associations have
emerged across the published reports. With socio-demographic factors, these are the con
trasting associations of maternal education, age, immigrant status and ethnicity with ASD
and ID. With maternal health; aspects of mental health, personality traits, immune function
and the use of medication during pregnancy have stronger associations with the mothers of
children with ASD than ID. Some of these differences may be reflections of distinct aetiolo
gies for ASD and/or ID of unknown cause and provide directions for future research. As
such, primary and secondary prevention strategies may be refined and/or developed which
will contribute to lower prevalence, reduced levels of severity and better outcomes for af
fected children.
413
414
Author details
Jenny Fairthorne*, Amanda Langridge, Jenny Bourke and Helen Leonard*
Centre for Child Health, University of Western Australia, Australia
References
[1] Filipek, P., et al., The screening and diagnosis of autistic spectrum disorders. Journal
of Autism and Developmental Disorders, 1999. 29(6): p. 439-84.
[2] American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disor
ders, Fourth Edition, 2000, American Psychiatric Association: Washington, DC.
[3] Rutter, M., Aetiology of autism: findings and questions. Journal of Intellectual Disa
bility Research, 2005. 49(4): p. 231-38.
[4] Robinson, P., et al., Genetically determined low maternal serum dopamine hydroxy
lase levels and the etiology of autism spectrum disorders. American Journal of Medi
cal Genetics, 2001. 100(1): p. 30-6.
[5] Trajkovski, V., Etiology of autism. Journal of Special Education, 2004. 5(1-2): p. 61-74.
[6] Bass, M., et al., Genetic studies in autistic disorder and chromosome 15. Neurogenet
ics, 2000. 2(4): p. 219-26.
[7] Brune, C., et al., 5-HTTLPR genotype-specific phenotype in children and adolescents
with autism. American Journal of Psychiatry, 2006. 163(12): p. 2148-56.
[8] Newschaffer, C., et al., The epidemiology of autism spectrum disorders. Annual Re
view of Public Health, 2007. 28(21): p. 235-58.
[9] Mefford, H., M. Batshaw, and E. Hoffman, Genomics, intellectual disability, and au
tism. New England Journal of Medicine, 2012. 366(8): p. 733-43.
[10] Stoltenberg, C., et al., The autism birth cohort (ABC): a paradigm for gene-environ
ment-timing research. Molecular Psychiatry, 2011. 15(7): p. 676-80.
[11] Kubota, T., et al., Novel etiological and therapeutic strategies for neurodiseases: epi
genetic understanding of gene-environment interactions. Journal of Pharmacological
Sciences, 2010. 113: p. 3-8.
[12] Dodge, K. and M. Rutter, Gene-environment interactions: state of the science, in
Gene-environment interactions in developmental psychopathology, K. Dodge and
M. Rutter, Editors. 2011, Guilford Press: New York.
http://dx.doi.org/10.5772/54488
[13] Maher, P., Methylglyoxal, advanced glycation end products and autism: Is there a
connection? Medical Hypotheses, 2012.
[14] Young, D., et al., The diagnosis of autism in a female: Could it be Rett syndrome? Eu
ropean Journal of Pediatrics, 2008. 167(6): p. 661-9.
[15] Oberl, I., et al., Instability of a 550-base pair DNA segment and abnormal methyla
tion in Fragile X syndrome. Science, 1991. 252(5009): p. 1097-102.
[16] Fombonne, E., Epidemiology of pervasive developmental disorders. Pediatric Re
search, 2009. 65(6): p. 591-8.
[17] Leonard, H., et al., Autism and intellectual disability are differentially related to soci
odemographic background at birth. PLoS ONE, 2011. 6(3): p. e17875.
[18] Matson, J. and M. Shoemaker, Intellectual disability and its relationship to autism
spectrum disorders. Research in Developmental Disabilities, 2009. 30(6): p. 1107-14.
[19] Leonard, H. and X. Wen, The epidemiology of mental retardation: challenges and op
portunities in the new millennium. Mental Retardation and Developmental Disabili
ties Research Reviews, 2002. 8(3): p. 117-34.
[20] Leonard, H., et al., Association of sociodemographic characteristics of children with
intellectual disability in Western Australia. Social Science and Medicine, 2005. 60(7):
p. 1499-513.
[21] Croen, L., J. Grether, and S. Selvin, The epidemiology of mental retardation of un
known cause. Pediatrics, 2001. 107(6): p. e86.
[22] Magnusson, C., et al., Migration and autism spectrum disorder: population-based
study. British Journal of Psychiatry, 2012.
[23] Pinborough-Zimmerman, J., et al., Sociodemographic risk factors associated with au
tism spectrum disorders and intellectual disability. Autism Research, 2011. 4(5).
[24] Krakowiak, P., et al., Maternal metabolic conditions and risk for autism and other
neurodevelopmental disorders. Pediatrics, 2012. 129(5).
[25] Lyall, K., et al., Pregnancy complications and obstetric suboptimality in association
with autism spectrum disorders in children of the Nurses' Health Study II. Autism
Research, 2012. 5(1): p. 21-30.
[26] Keil, A., et al., Parental autoimmune diseases associated with autism spectrum disor
ders in offspring. Epidemiology, 2010. 21(6): p. 805-8.
[27] Hodge, D., C. Hoffman, and D. Sweeney, Increased psychopathology in parents of
children with autism: genetic liability or burden of caregiving? Journal of Develop
mental and Physical Disabilities, 2011. 23(3): p. 227-39.
415
416
[28] Morgan, V., et al., What impact do obstetric complications have on the risk of ad
verse psychiatric outcomes for the high risk children of mothers with schizophrenia
and other psychoses? Schizophrenia Research, 2008. 102(Supplement 2): p. 167-8.
[29] Burstyn, I., F. Sithole, and L. Zwaigenbaum, Autism spectrum disorders, maternal
characteristics and obstetric complications among singletons born in Alberta, Cana
da. Chronic Diseases in Canada, 2010. 30(4): p. 125-34.
[30] Hultman, C., P. Sparen, and S. Cnattingius, Perinatal risk factors for infantile autism.
Epidemiology, 2002. 13(4): p. 417-23.
[31] Losh, M., et al., Neuropsychological profile of autism and the broad autism pheno
type. Archives of General Psychiatry, 2009. 66(5): p. 518-26.
[32] Losh, M., et al., Defining key features of the broad autism phenotype: a comparison
across parents of multiple and single incidence autism families. American Journal of
Medical Genetics, 2008. 147(4): p. 424-33.
[33] Piven, J., The broad autism phenotype: a complementary strategy for molecular ge
netic studies of autism. American Journal of Medical Genetics, 2001. 105(1): p. 34-5.
[34] Harvey, J., M. O'Callaghan, and B. Vines, Prevalence of maternal depression and its
relationship to ADL skills in children with developmental delay. Journal of Paediat
rics and Child Health, 1997. 33(1): p. 42-6.
[35] Hertz-Picciotto, I., et al., The CHARGE Study: an epidemiologic investigation of ge
netic and environmental factors contributing to autism. Environmental Health Per
spectives, 2006. 114(7): p. 1119-25.
[36] Spitzer, R. and B. Siegel, The DSM-III-R field trial of pervasive developmental disor
ders. Journal of the American Academy of Child and Adolescent Psychiatry, 1990.
29(6): p. 855-62.
[37] Western Australian Autism Diagnosticians' Forum. Diagnosis in Western Australia
2012; Available from: http://waadf.org.au/Waitlist_times_1_December_2011.pdf.
[38] Shattuck, P. and S. Grosse, Issues related to the diagnosis and treatment of autism
spectrum disorders. Mental Retardation and Developmental Disabilities Research
Reviews, 2007. 13(2): p. 129-35.
[39] Durkin, M., et al., Socioeconomic inequality in the prevalence of autism spectrum
disorder: evidence from a US cross-sectional study. PLoS ONE, 2010. 5(7): p. e11551.
[40] Liptak, G., et al., Disparities in diagnosis and access to health services for children
with autism: data from the National Survey of Children's Health. Journal of Develop
mental and Behavioral Pediatrics, 2008. 29(3): p. 152-60.
[41] King, M. and P. Bearman, Socioeconomic status and the increased prevalence of au
tism in California. American Sociological Review, 2011. 76(2): p. 320-46.
http://dx.doi.org/10.5772/54488
[42] Larsson, H., et al., Risk factors for autism: perinatal factors, parental psychiatric his
tory, and socioeconomic status. American Journal of Epidemiology, 2005. 161(10): p.
916-25.
[43] Rai, D., et al., Parental socioeconomic status and risk of offspring autism spectrum
disorders in a Swedish population-based study. Journal of the American Academy of
Child and Adolescent Psychiatry, 2012.
[44] Gissler, M., et al., Social class differences in health until the age of seven years among
the Finnish 1987 birth cohort. Social Science and Medicine, 1998. 46(12): p. 1543-52.
[45] Zheng, X., et al., Socioeconomic status and children with intellectual disability in
China. Journal of Intellectual Disability Research, 2012. 56(2): p. 212-20.
[46] Heikura, U., et al., Variations in prenatal sociodemographic factors associated with
intellectual disability: a study of the 20-year interval between two birth cohorts in
Northern Finland. American Journal of Epidemiology, 2008. 167(2): p. 169-77.
[47] Bhasin, T. and D. Schendel, Sociodemographic risk factors for autism in a US metro
politan area. Journal of Autism and Developmental Disorders, 2007. 37(4): p. 667-77.
[48] Emerson, E., Deprivation, ethnicity and the prevalence of intellectual and develop
mental disabilities. Journal of Epidemiology and Community Health, 2012. 66(3): p.
218-24.
[49] Harris, J., Autism risk factors: moving from epidemiology to translational epidemiol
ogy. Journal of the American Academy of Child and Adolescent Psychiatry, 2012.
51(5).
[50] Van Meter, K., et al., Geographic distribution of autism in California: a retrospective
birth cohort analysis. Autism Research, 2010. 3(1): p. 19-29.
[51] Yaqoob, M., et al., Mild intellectual disability in children in Lahore, Pakistan: aetiolo
gy and risk factors. Journal of Intellectual Disability Research, 2004. 48(7): p. 663-71.
[52] Jelliffe-Pawlowski, L., et al., Risks for severe mental retardation occurring in isolation
and with other developmental disabilities. American Journal of Medical Genetics,
2005. 136(2): p. 152-7.
[53] Singhi, P., et al., Psychosocial problems in families of disabled children. British Jour
nal of Medical Psychology, 1990. 63(2): p. 173-82.
[54] Dodds, L., et al., The role of prenatal, obstetric and neonatal factors in the develop
ment of autism. Journal of Autism and Developmental Disorders, 2011. 41(7): p.
891-902.
[55] Hatton, E., et al., Changes in family composition and marital status in families with a
young child with cognitive delay. Journal of Applied Research in Intellectual Disabil
ities, 2010. 23(1): p. 14-26.
417
418
[56] King, M., et al., Estimated autism risk and older reproductive age. American Journal
of Public Health, 2009. 99(9): p. 1673-9.
[57] Williams, K., et al., Perinatal and maternal risk factors for autism spectrum disorders
in New South Wales, Australia. Child-care, Health and Development, 2008. 34(2): p.
249-56.
[58] Durkin, M., et al., Advanced parental age and the risk of autism spectrum disorder.
American Journal of Epidemiology, 2008. 168(11): p. 1268-76.
[59] Windham, G., et al., Birth prevalence of autism spectrum disorders in the San Fran
cisco Bay area by demographic and ascertainment source characteristics. Journal of
Autism and Developmental Disorders, 2011. 41(10): p. 1362-72.
[60] Stein, D., et al., Obstetric complications in individuals diagnosed with autism and in
healthy controls. Comprehensive Psychiatry, 2006. 47(1): p. 69-75.
[61] El-Baz , F., et al., Risk factors for autism: an Egyptian study. Egyptian Journal of
Medical Human Genetics, 2011. 12: p. 31-8.
[62] Lauritsen, M., C. Pedersen, and P. Mortensen, Effects of familial risk factors and
place of birth on the risk of autism: a nationwide register-based study. Journal of
Child Psychology and Psychiatry, 2005. 46(9): p. 963-71.
[63] Reichenberg, A., R. Gross, and M. Weiser, Advancing paternal age and autism. Ar
chives of General Psychiatry, 2006. 63(9): p. 1026-32.
[64] Eriksson, M., et al., First-degree relatives of young children with autism spectrum
disorders: some gender aspects. Research in Developmental Disabilities, 2012. 33(5):
p. 1642-8.
[65] Tsuchiya, K., et al., Paternal age at birth and high-functioning autistic-spectrum dis
order in offspring. British Journal of Psychiatry, 2008. 193(4): p. 316-21.
[66] Robinson, E., et al., Brief report: no association between parental age and extreme so
cial-communicative autistic traits in the general population. Journal of Autism and
Developmental Disorders, 2011. 41(12): p. 1733-7.
[67] Frenette, P., et al., Factors affecting the age at diagnosis of autism spectrum disorders
in Nova Scotia, Canada. Autism, 2011: p. 1-12.
[68] Drews, C., et al., Variation in the influence of selected sociodemographic risk factors
for mental retardation. American Journal of Public Health, 1995. 85(3): p. 329-34.
[69] Hook, E. and A. Lindsj, Down syndrome in live births by single year maternal age
interval in a Swedish study: comparison with results from a New York State study.
American Journal of Human Genetics, 1978. 30(1): p. 19-27.
[70] Liu, K., N. Zerubavel, and P. Bearman, Social demographic change and autism. De
mography, 2010. 47(2): p. 327-43.
http://dx.doi.org/10.5772/54488
[71] Hultman, C., et al., Advancing paternal age and risk of autism: new evidence from a
population-based study and a meta-analysis of epidemiological studies. Molecular
Psychiatry, 2011. 16(12): p. 1203-12.
[72] Mosby's Medical Dictionary 2009: Elsevier. 8th edition.
[73] Glasson, E., et al., Perinatal factors and the development of autism: a population
study. Archives of General Psychiatry, 2004. 61(6): p. 618-27.
[74] Schmidt, K., et al., Brief report: Aspergers syndrome and sibling birth order. Journal
of Autism and Developmental Disorders, 2012.
[75] Keen, D., F. Reid, and D. Arnone, Autism, ethnicity and maternal immigration. Brit
ish Journal of Psychiatry, 2010. 196: p. 274-81.
[76] Haglund, N. and K. Klln, Risk factors for autism and Asperger syndrome. Autism,
2011. 15(2): p. 163-83.
[77] BarnevikOlsson, M., C. Gillberg, and E. Fernell, Prevalence of autism in children
born to Somali parents living in Sweden: a brief report. Developmental Medicine and
Child Neurology, 2008. 50(8): p. 598-601.
[78] Schieve, L., et al., Association between parental nativity and autism spectrum disor
der among US-born non-Hispanic white and Hispanic children, 2007 National Sur
vey of Children's Health. Disability and Health Journal, 2012. 5(1): p. 18-25.
[79] Fernell, E., et al., Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of
Somali origin who have children with and without autism. Acta Pdiatrica, 2010.
99(5): p. 743-7.
[80] Cannell, J., Autism and vitamin D. Medical Hypotheses, 2008. 70: p. 750-9.
[81] Zhou, M. and Y. Sao Xiong, The multifaceted American experiences of the children
of Asian immigrants: lessons for segmented assimilation. Ethnic and Racial Studies,
2005. 28(6): p. 1119-52.
[82] Grulich, A., M. McCredie, and M. Coates, Cancer incidence in Asian migrants to
New South Wales, Australia. British Journal of Cancer, 1995. 71(2): p. 400-8.
[83] Ip, D., C.-T. Wu, and C. Inglis, Settlement experiences of Taiwanese immigrants in
Australia. Asian Studies Review, 1998. 22(1): p. 79-97.
[84] Pedersen, A., et al., Prevalence of autism spectrum disorders in Hispanic and nonHispanic white children. Pediatrics, 2012.
[85] OLeary, C., et al., Intellectual disability: population-based estimates of the propor
tion attributable to heavy prenatal alcohol exposure. Developmental Medicine and
Child Neurology, 2012.
[86] O'Leary, C., Fetal alcohol syndrome: diagnosis, epidemiology and developmental
outcomes. Journal of Paediatrics and Child Health, 2004. 40(1-2): p. 2-7.
419
420
[87] Wilson, K. and L. Watson, Autism spectrum disorder in Australian Indigenous fami
lies: issues of diagnosis, support and funding. Aboriginal and Islander Health Work
er Journal, 2011. 35(5): p. 17-8.
[88] World Health Organisation. Mental health. 2012 [2012 September 3]; Available from:
http://www.who.int/topics/mental_health/en/.
[89] Daniels, J., et al., Parental psychiatric disorders associated with autism spectrum dis
orders in the offspring. Pediatrics, 2008. 121(5): p. 1357-62.
[90] Mouridsen, S., et al., Psychiatric disorders in the parents of individuals with infantile
autism: a case-control study. Psychopathology, 2007. 40(3): p. 166-71.
[91] Sullivan, P., et al., Family history of schizophrenia and bipolar disorder as risk fac
tors for autism. Archives of General Psychiatry, 2012: p. 1-5.
[92] Zhang, X., et al., Prenatal and perinatal risk factors for autism in China. Journal of
Autism and Developmental Disorders, 2010. 40(11): p. 1311-21.
[93] Wilkerson, D., et al., Perinatal complications as predictors of infantile autism. Inter
national Journal of Neuroscience, 2002. 112(9): p. 1085-98.
[94] Piven, J., et al., Psychiatric disorders in the parents of autistic individuals. Journal of
the American Academy of Child and Adolescent Psychiatry, 1991. 30(3): p. 471-8.
[95] Morgan, V., et al., Intellectual disability and other neuropsychiatric outcomes in
high-risk children of mothers with schizophrenia, bipolar disorder and unipolar ma
jor depression. British Journal of Psychiatry, 2012.
[96] Gokcen, S., et al., Theory of mind and verbal working memory deficits in parents of
autistic children. Psychiatry Research, 2009. 166(1): p. 46-53.
[97] Hurley, R., et al., The broad autism phenotype questionnaire. Journal of Autism and
Developmental Disorders, 2007. 37(9): p. 1679-90.
[98] Wong, D., et al., Profiles of executive function in parents and siblings of individuals
with autism spectrum disorders. Genes, Brain and Behavior, 2006. 5(8): p. 561-76.
[99] Hughes, C., M. Leboyer, and M. Bouvard, Executive function in parents of children
with autism. Psychological Medicine, 1997. 27(1): p. 209-20.
[100] Bishop, D., et al., Using self-report to identify the broad phenotype in parents of chil
dren with autistic spectrum disorders: a study using the Autism Spectrum Quotient.
Journal of Child Psychology and Psychiatry, 2004. 45(8): p. 1431-6.
[101] Baron-Cohen, S., et al., The Autism Spectrum Quotient (AQ): evidence from Asperg
er syndrome/high-functioning autism, males and females, scientists and mathemati
cians. Journal of Autism and Developmental Disorders, 2001. 31(1): p. 5-17.
http://dx.doi.org/10.5772/54488
[102] Wheelwright, S., et al., Defining the broader, medium and narrow autism phenotype
among parents using the Autism Spectrum Quotient (AQ). Molecular Autism, 2010.
1(1): p. 10.
[103] Bernier, R., et al., Evidence for broader autism phenotype characteristics in parents
from multiple incidence autism families. Autism Research, 2011.
[104] Marques-Vidal, P., et al., Secular trends in height and weight among children and
adolescents of the Seychelles, 1956-2006. BioMed Central Public Health, 2008. 8(1): p.
166.
[105] Kalkbrenner, A., et al., Maternal smoking during pregnancy and the prevalence of
autism spectrum disorders, using data from the autism and developmental disabili
ties monitoring network. Environmental Health Perspectives, 2012. 120(7): p. 1042-8.
[106] Lee, B., et al., Brief report: maternal smoking during pregnancy and autism spectrum
disorders. Journal of Autism and Developmental Disorders, 2011: p. 1-6.
[107] Braun, J., et al., The effect of maternal smoking during pregnancy on intellectual dis
abilities among 8 year old children. Paediatric and Perinatal Epidemiology, 2009.
23(5): p. 482-91.
[108] Spohr, H., J. Willms, and H. Steinhausen, Fetal alcohol spectrum disorders in young
adulthood. Journal of Pediatrics, 2007. 150(2): p. 175-9.
[109] Spohr, H. and H. Steinhausen, Fetal alcohol spectrum disorders and their persisting
sequelae in adult life. Deutsches Arzteblatt, 2008. 105(41): p. 693-8.
[110] Malbin, D., Fetal alcohol spectrum disorder (FASD) and the role of family court judg
es in improving outcomes for children and families. Juvenile and Family Court Jour
nal, 2004. 55(2): p. 53-63.
[111] Hagberg, B. and M. Kyllerman, Epidemiology of mental retardation-a Swedish sur
vey. Brain and Development, 1983. 5(5): p. 441-9.
[112] Yeargin-Allsopp, M., et al., Reported biomedical causes and associated medical con
ditions for mental retardation among 10 year old children, metropolitan Atlanta,
1985 to 1987. Developmental Medicine and Child Neurology, 1997. 39: p. 142-9.
[113] Quattlebaum, J. and M. O'Connor, Higher functioning children with prenatal alcohol
exposure: Is there a specific neurocognitive profile? Child Neuropsychology, 2012: p.
1-18.
[114] Eyal, R. and M. O'Connor, Psychiatry trainees' training and experience in fetal alco
hol spectrum disorders. Academic Psychiatry, 2011. 35: p. 238-40.
[115] Cnattingius, S., The epidemiology of smoking during pregnancy: smoking preva
lence, maternal characteristics, and pregnancy outcomes. Nicotine and Tobacco Re
search, 2004. 6(Suppl 2): p. S125-S140.
421
422
[116] Naeye, R., Effects of maternal cigarette smoking on the fetus and placenta. British
Journal of Obstetrics and Gynaecology, 1978. 85(10): p. 732-7.
[117] Wakschlag, L., et al., Maternal smoking during pregnancy and severe antisocial be
havior in offspring: a review. American Journal of Public Health, 2002. 92(6): p.
966-72.
[118] Leonard, H., et al., Relation between intrauterine growth and subsequent intellectual
disability in a ten-year population cohort of children in Western Australia. American
Journal of Epidemiology, 2008. 167(1): p. 103-11.
[119] Ornoy, A. and Z. Ergaz, Alcohol abuse in pregnant women: effects on the fetus and
newborn, mode of action and maternal treatment. International Journal of Environ
mental Research and Public Health, 2010. 7(2): p. 364-79.
[120] Lyall, K., et al., Maternal early life factors associated with hormone levels and the
risk of having a child with an autism spectrum disorder in the Nurses Health Study
II. Journal of Autism and Developmental Disorders, 2011. 41(5): p. 618-27.
[121] McLaren, L., Socioeconomic status and obesity. Epidemiologic Reviews, 2007. 29(1):
p. 29-48.
[122] Mokdad, A., et al., The spread of the obesity epidemic in the United States,
1991-1998. Journal of the American Medical Association, 1999. 282(16): p. 1519-22.
[123] Comi, A., et al., Familial clustering of autoimmune disorders and evaluation of medi
cal risk factors in autism. Journal of Child Neurology, 1999. 14(6): p. 388-94.
[124] Croen, L., et al., Maternal autoimmune diseases, asthma and allergies, and childhood
autism spectrum disorders: a case-control study. Archives of Pediatrics and Adoles
cent Medicine, 2005. 159(2): p. 151-7.
[125] Atladttir, H., et al., Association of family history of autoimmune diseases and au
tism spectrum disorders. Pediatrics, 2009. 124(2): p. 687-94.
[126] Mann, J., et al., Children born to diabetic mothers may be more likely to have intel
lectual disability. Maternal and Child Health Journal, 2012: p. 1-5.
[127] Leonard, H., et al., Maternal health in pregnancy and intellectual disability in the off
spring: a population-based study. Annals of Epidemiology, 2006. 16(6): p. 448-54.
[128] Braunschweig, D., et al., Autism: maternally derived antibodies specific for fetal
brain proteins. Neurotoxicology, 2008. 29(2): p. 226-31.
[129] Ashwood, P., S. Wills, and J. Van de Water, The immune response in autism: a new
frontier for autism research. Journal of Leukocyte Biology, 2006. 80(1): p. 1-15.
[130] Goines, P., et al., Increased midgestational IFN-g, IL-4 and IL-5 in women bearing a
child with autism: a case-control study. Molecular Autism, 2011. 2(13): p. e1-e11.
http://dx.doi.org/10.5772/54488
[131] Derecki, N., E. Privman, and J. Kipnis, Rett syndrome and other autism spectrum
disorders-brain diseases of immune malfunction? Molecular Psychiatry, 2010. 15(4):
p. 355-63.
[132] McDonough, J., Stedman's Concise Medical Dictionary, 1994: Williams & Wilkins.
[133] Rudra, C. and M. Williams, Monthly variation in preeclampsia prevalence: Washing
ton State, 1987-2001. Journal of Maternal-Fetal and Neonatal Medicine, 2005. 18(5): p.
319-24.
[134] Mann, J., et al., Pre-eclampsia, birth weight, and autism spectrum disorders. Journal
of Autism and Developmental Disorders, 2010. 40(5): p. 548-54.
[135] Griffith, M., J. Mann, and S. McDermott, The risk of intellectual disability in children
born to mothers with preeclampsia or eclampsia with partial mediation by low birth
weight. Hypertension in Pregnancy, 2011. 30(1): p. 108-15.
[136] Atladttir, H., et al., Maternal infection requiring hospitalization during pregnancy
and autism spectrum disorders. Journal of Autism and Developmental Disorders,
2010. 40(12): p. 1423-30.
[137] Mann, J., et al., Trichomoniasis in pregnancy and mental retardation in children. An
nals of Epidemiology, 2009. 19(12): p. 891-99
[138] McDermott, S., et al., Urinary tract infections during pregnancy and mental retarda
tion and developmental delay. Obstetrics and Gynecology, 2000. 96(1): p. 113-9.
[139] Croen, L., et al., Antidepressant use during pregnancy and childhood autism spec
trum disorders. Archives of General Psychiatry, 2011. 68(11): p. 11104-12.
[140] Rasalam, A., et al., Characteristics of fetal anticonvulsant syndrome associated autis
tic disorder. Developmental Medicine and Child Neurology, 2005. 47(8): p. 551-5.
[141] Maimburg, R. and M. Vth, Perinatal risk factors and infantile autism. Acta Psy
chiatrica Scandinavica, 2006. 114(4): p. 257-64.
423
Chapter 20
Clinical Implications of a Link Between Fetal Alcohol

Spectrum Disorders (FASD) and Autism or Aspergers
Disorder A Neurodevelopmental Frame for Helping
Understanding and Management
Kieran D. OMalley and Susan D. Rich
http://dx.doi.org/10.5772/54924
1. Introduction
The teratogenic effect of alcohol was first observed by paediatrician Paul Lemoine in Nantes,
France in 1968, when he linked facial dysmorphic and growth features with maternal use of
alcohol (wine) in pregnancy. His initial series was 127 infants. Subsequently the syndrome
Fetal Alcohol Syndrome was defined in 2 classic papers in 1973 by David smith and Ken Jones
in Seattle. Their initial case series were 8 patients. The recognition that prenatal alcohol
exposure did not just cause dysmorphic facial features and growth delay was made by Sterling
Clarren in Seattle in 1978 with the introduction of the term Fetal Alcohol Effect ( FAE) to
describe children with alcohol exposure but no facial features. This descriptive clinical term
was changed to Alcohol Related Neurodevelopmental Disorder (ARND) by the Institute of
Medicine in 1996.
2. A conceptual understanding of the spectrum of effects of prenatal alcohol

exposure
In the same vein as Autistic Spectrum Disorders, Fetal Alcohol Spectrum Disorders (FASD,)
initially described by Streissguth & OMalley in 2000 is an umbrella term to describe the
continuum of complex neuropsychiatric, cognitive, behavioral, social, language, communica
tion and other multi-sensory deficits. There are, however, two conditions within this spectrum
which describe the range of conditions caused by prenatal alcohol exposure. They are Fetal
2013 OMalley and Rich; licensee InTech. This is an open access article distributed under the terms of the
452
Alcohol Syndrome (FAS) a dysmorphic syndrome, and Alcohol Related Neurodevelopment

Disorder (ARND) a non dysmorphic condition and by far the more common of the two
conditions.
However within FASD there are physical sequellae aside from the facial dysmorphology,
which are associated with all levels of prenatal alcohol exposure (Stratton et al 1996). These
Alcohol Related Birth Defects (ARBD), as they are called, can occur as early as the first few
weeks post conception.So, before most women know they are pregnant (Sulik, et al., 1983).
The central nervous system (CNS) and brain are the most sensitive and vulnerable structures
to the effects of alcohol and can be affected by moderate to heavy alcohol use at any point in
gestation. There is no safe amount of alcohol (threshold) during pregnancy and the Surgeon
General of the United States currently recommends all childbearing age women to avoid
alcohol if there is a potential for pregnancy (US Surgeon General, 2005).
Early, frequent, and/or binge exposures with moderate to high blood alcohol concentrations
can lead to a range of reproductive outcomes including infertility, miscarriage (spontaneous
fetal loss), still birth, sudden infant death syndrome, and a wide range of physical and
neurodevelopmental (functional) birth defects. Varying degrees of Fetal Alcohol Syndrome
(FAS) may be seen clinically at this range of exposure (Jones & Smith 1973, Streissguth et al
1987, 1991). Alcohol-Related Neurodevelopmental Disorder (ARND, Stratton et al., 1996) are
the neurodevelopmental/functional birth defects that manifest in individuals with FAS, as well
as those who do not meet full criteria for FAS but have documented evidence of prenatal
alcohol exposure. ARND can be associated with inattention, poor decision making, impulsiv
ity, processing and working memory issues, other areas of executive dysfunction, mood
instability, social communication deficits, and difficulties understanding consequences of their
actions. These deficits are best evaluated by a thorough neuropsychological exam, including
the Vineland Adaptive behavioral scales, IQ testing, and assessment of executive functions,
such as BRIEF., FASD includes two conditions FAS which is dysmorphic and ARND, which
is non-dysmorphic (See Table 1.).
Both FAS, dysmorphic and ARND. non-dysmorphic conditions can be associated with
physical sequellae resulting from alcohol exposure in pregnancy. The Institute of Medicine
describes these physical manifestations collectively as Alcohol Related Birth Defects (ARBD),
including abnormalities in the developing eye, ear, teeth, heart, kidney, and skeletal system
(Stratton et al, 1996; OMalley & Streissguth, 2000; Chudley et al, 2005; BMA, 2007). Like the
typical FAS facial features, ARBD occur in the first 8 weeks of embryonic development
(organogenesis). Many of these conditions may not be diagnosed or evident at the time of a
patients psychiatric evaluation (Iich 2005, Nowick Brown et al 2011).
The major difference between dysmorphic (i.e., FAS) and nondysmorphic (ARND) phenotypes
is whether or not the collective cardinal (dysmorphic) facial features are present. The facial
features correlate to heavy maternal blood alcohol concentration (e.g., the equivalent of 5 to 6
servings of alcohol) during the earliest points in gestation (late 3rd week to early 4th week of
embryonic development) (Sulik, 1983). Both the facial features and ARBD are due to early
embryonic changes, disruptions in cell migration, and cell death (apoptosis) due to the
Clinical Implications of a Link between Fetal Alcohol Spectrum Disorders (FASD) and Autism or Aspergers
http://dx.doi.org/10.5772/54924
teratogenic effects of alcohol. Thus, the clinical relevance of both ARBD and the facial features
in FAS is that of biomarkers for heavy binge exposure early in pregnancy and sometimes,
but not always, may predict a worse neurodevelopmental prognosis (Riley and McGee, 2005,
Coles et al 2011). Since both FAS and ARND have neurodevelopmental (CNS) involvement,
essentially ARND is FAS without the characteristic facial features. (Rich& OMalley 2012).
A. Fetal Alcohol Syndrome (FAS), a specific dysmorphic phenotype, requires documentation of all of the
following clinical features.
may or may not have a clear history of documented maternal alcohol use in pregnancy;
dysmorphic facial features based on racial norms (including all of the following: small palpebral fissures at or
below 10th percentile, smooth philtrum, thin vermillion border) this requires a clinical dysmorphologist with
an understanding of FAS diagnosis;
growth problems: confirmed prenatal or postnatal height or weight, or both, at or below the 10th percentile,
documented at any one point in time (adjusted for age, sex, gestational age, and race or ethnicity).
Central Nervous System (CNS) abnormalities:
I. Structural:
A. Head circumference (OFC) at or below the 10th percentile adjusted for age and sex.
B. Clinically significant brain abnormalities observable through imaging.
II. Neurological problems not due to a postnatal insult or fever, or other soft neurological signs outside normal
limits.
III. Functional Performance substantially below that expected for an individuals age, schooling, or
circumstances, as evidenced by:
A. Global cognitive or intellectual deficits representing multiple domains of deficit (or significant
developmental delay in younger children) with performance below the 3rd percentile (2 standard deviations
below the mean for standardized testing) or
B. Functional deficits below the 16th percentile (1 standard deviation below the mean for standardized testing)
in at least three of the following domains:
1. cognitive or developmental deficits or discrepancies
2. executive functioning deficits
3. motor functioning delays
4. problems with attention or hyperactivity
5. social skills
6. other clinically relevant neurodevelopmental issues (i.e., sensory problems, pragmatic language
problems, memory deficits, etc.)
B. Alcohol Related Neurodevelopmental Disorder (ARND) is a non-dysmorphic condition with the following
features:
must have a documented history of maternal alcohol use during pregnancy;
453
454
none or not all pathognomonic dysmorphic facial features are present;

no evidence of growth delay, low birth weight, decelerating weight over time, nor other height and weight
issues;
Central Nervous System (CNS) abnormalities:
I. Structural:
A. Head circumference (OFC) at or below the 10th percentile adjusted for age and sex.
B. Clinically significant brain abnormalities observable through imaging.
II. Neurological problems not due to a postnatal insult or fever, or other soft neurological signs outside normal
limits.
III. Functional Performance substantially below that expected for an individuals age, schooling, or
circumstances, as evidenced by:
A. Global cognitive or intellectual deficits representing multiple domains of deficit (or significant
developmental delay in younger children) with performance below the 3rd percentile (2 standard deviations
below the mean for standardized testing) or
B. Functional deficits below the 16th percentile (1 standard deviation below the mean for standardized testing)
in at least three of the following domains:
1. cognitive or developmental deficits or discrepancies
2. executive functioning deficits
3. motor functioning delays
4. problems with attention or hyperactivity
5. social skills
6. other clinically relevant neurodevelopmental issues (i.e., sensory problems, pragmatic language
problems, memory deficits, etc.)
(Jones & Smith 1973, 1975, Stratton et al 1996, Chudney et al 2005, BMA 2007, OMalley 2008, Novick Brown et al
2011, OMalley & Mukarjee 2010, CDC 2011,HHS)
Table 1. Characteristic Diagnostic Features of FAS (dysmorphic) and ARND ( non dysmorphc)
Among both phenotypes, FAS is the less common condition, accounting for only 20-25% of
the affected infants and children exposed to all levels of alcohol exposure. By comparison, nondysmorphic ARND is the more common clinical presentation of affected infants and children,
accounting for 75 to 80% of affected infants exposed to all levels of alcohol in pregnancy. While
maternal alcohol use is the leading known preventable cause of mental retardation and birth
defects, only 20-25% of patients with either dysmorphic FAS or nondysmorphic ARND have
a total IQ below 70. In other words, 75 to 80% of patients with FASD are estimated to have a
developmental disability or other CNS impairment (acquired brain injury) but are not mentally
retarded (Streissguth et al., 1996; Mukarjee et al., 2006). Hence FASD (FAS and ARND) are
NOT mental retardation conditions, but are complex neurodevelopmental disorders with
http://dx.doi.org/10.5772/54924
initial developmental, cognitive, and neurobehavioral outcomes, and higher lifetime risk of
psychiatric co-morbidities and substance use disorders.
The dysmorphic facial appearance of an individual is much less an impact than the complex
behaviors, psychopathology and developmental disability caused by alcohols neurotoxicity.
Thus, an individuals level of functioning is affected more by behavioral functioning, intellect,
cognitive and communication abilities, executive functioning, temperament, social related
ness, emotional regulation, and performance than what his or her face looks like. FAS, the
dysmorphic presentation of ARND, is in fact a protective factor for what Ann Streissguth called
secondary disabilities of FASD ( Streissguth et al 1996).
Neuroimaging studies suggest that alcohol exposure may be specific rather than global in its
teratogenicity, including specific vulnerability in the cerebellum, basal ganglia, and corpus
callosum. As well, studies have shown deficits in cognitive functions such as learning and
memory, visual-spatial functioning, executive functioning, attention, sequencing, processing
and motor control. (Mattson et al 2011) These functional birth defects are evidenced by
impairment in the brain and central nervous system. Riley and colleagues have shown that
functional birth defects are present in children with moderate to heavy prenatal alcohol
exposure, even in absence of characteristic (dysmorphic) facial features (Bookstein et al 2001,
Riley and McGee, 2005, Coles et al 2011).
It is a critical issue in clinical diagnosis of FASD to understand that the severity of the acquired
brain injury is not always correlated with the presence of facial dysmorphology (and FAS facial
features commonly change significantly in adolescence and adulthood). Therefore facial
features are minimally useful to assess and treat neurocognitive and neurobehavioral deficits
associated with prenatal alcohol exposure. (Streissguth, et al., 1991; Steinhausen, et al., 1993,
Nowick Brown et al 2011, Kodituwakku et al 2011, OMalley 2011, Rich & OMalley 2012).
The first 30 to 40 years of research in FASD has been driven by animal teratology and the
pursuit of minute changes in facial dysmorphology as biological markers for the level of
prenatal alcohol exposure. Nevertheless, it is becoming quite clear that it is the central nervous
system brain dysfunction that is the kernel of the problem and the guide to diagnostic
understanding and management. It is not the face that tells the clinician about the underlying
brain dysfunction but the complex mixture of developmental disability and psychiatric
disorder. FASD, whether dysmorphic FAS or non dysmorphic ARND are developmental
psychiatric disorders which, as Susan Rich and Kieran OMalley describe in their 2012 paper.
These conditions can present a neurodevelopmental mixture of mood dysregulation and
autonomic arousal with language and social skills deficits, cognitive and executive decision
making dysfunctions and multisensory functional and perceptual deficits
2.1. The link between FASD and autism or Aspergers disorder
As far back as 1990, child neuropsychologist Jo Nanson in Saskatoon, Canada, described 6
cases of FAS with autism. As well, the interest in prenatal risk factors contributing to autism
has been pursued by a number of authors and this potential aetiological link was published
in 1991 by International autism researcher Cathy Lord and colleagues. More recently, since
455
456
2009-2010, adult psychiatrist in London, Raja Mukarjee, has painstakingly clinically analysed
the clinical presentation of Autistic Spectrum Disorder in patients with FASD.
In the international paediatric and child psychiatric field the last 5 years have brought a wealth
of clinical case descriptions and case studies indicating the presence of ADHD co-morbidly
with PDD or Autistic Spectrum Disorder. Clinicians and researchers such as Professor Jeremy
Turk in the UK have commented on as much as a 25-30% co-morbid link between ADHD and
PDD/ASD. Furthermore the complexity of diagnostic issues within FASD have been recently
illustrated in a 2011 on line book chapter by Natalie Novick Brown, Kieran OMalley and Ann
Streissguth in which the developmental psychiatric presentations of FASD were shown to
include sometimes unrecognized Autistic Spectrum Disorder or Aspergers Disorder.
2.2. Aetiological theories postulated for this link
It is important to place the possible link between prenatal alcohol exposure and Autism
spectrum disorder or Aspergers Disorder in a historical context. Environmental agents,
diseases and postnatal interventions have had, it is fair to say, a rather mixed and controversial
past, as recently pointed out by Cathy Lord, So Hyun K im and Adriana Dimartino in 2011.
Although as far back as 1971 American child psychiatrist Stella Chesss case review of rubella
and thalidomide cases implicated these prenatal infectious and medication exposures as
aetiological, the series were small. European researchers Gilberg and Gilberg in 1983 have
more rigorously identified a cluster of adverse prenatal complications which may contribute
to a clinical presentation of Autism Spectrum disorder in early childhood.
However the most studied, but as well the most problematic, was the potential association
between MMR vaccine and Autism Spectrum Disorder. It is not the remit of the chapter to
completely review this, ultimately, false trail. Nevertheless it offers a salutary lesson in the
emotional reactions that possible environmental agents or interventions can elicit to the public
at large, but also the medical profession.
Alcohol has been in society for ever and the acknowledgement of prenatal alcohol and its
tertatogenic effect is still relatively a new phenomenon. So it is prudent to not scaremonger,
but scientifically and clinically carefully piece out the veracity of this possible link.
The science of alcohol teratology continues to advance in leaps and bounds and one of the core
findings has been the effect of prenatal alcohol on the dynamic balance of the developing
neurotransmitters. In parallel with the more focused autism research on the role of serotoni
nergic neurotransmitters has been the identified effect of alcohol on the embryological
serotoninergic neurotransmitter system. This research branches into the study of the serotonin
transporter gene, by groups such as Bonnin et al in 2011, but again parallel work on epigenetics
in alcohol has begun to unravel probable trans-generational shifts in genetic transcription
through effects on DNA methylation (Haycock 2009).
Another strand of research in alcohol teratogenesis has been identifying brain areas a more
sensitive to alcohol damage. Areas such as the corpus callosum, hippocampus, prefrontal
cortex, temporal lobe collectively and individually contribute to a clinical presentation of social
http://dx.doi.org/10.5772/54924
disconnectedness, lack of social cognition and awareness, impulsivity, and inability to

understand another persons cognitions or feelings (alexithymia). (Bookstein et al 2001).
The underlying organic brain dysfunction at a cellular, neurotransmitter and structural level
related to prenatal alcohol exposure sometimes shares significant congruence with ongoing
neuroscience research in Autism Spectrum Disorder and Aspergers Disorder, and awaits
collaborative work between the two academic fields.
There is also accumulating research which highlights the biological roots of fundamental
functional problems in FASD which relate to sustained impact on working memory, (Congdon
et al 2012)
2.3. Neuropsychological framework of understanding ASD and Aspergers and its
relationship to patients with FASD
1.
The psychological deficit in the child must be present before the onset of the disorder and
so very early in development.
2.
Be pervasive among individuals with the disorder.
3.
Be specific to autism
4.
Different psychological theories

a.
theory of mind theory
b.
the executive theory
c.
the praxis/imitation theory
d.
the emotion theory
e.
the emphathizing-systematizing or extreme male brain theory ( Hobson 1989,

Russell 1997, Baren Cohen et al 2000, Pennington 2009)
2.4. Clinical presentations of Aspergers disorder or autism spectrum disorder with FASD
This is the arena where the divergence between the classic presentations of Autism Spectrum
Disorder and Aspergers Disorder are seen, and offer a way to untangle the different aetiolog
ical routes to these syndromes.
FASD begin at birth and can be seen in infancy. The Mental Health Classification system, Zero
to three (DC 0-3R, 2005) has a diagnostic category of Regulatory Disorders which aptly
describes the immediate clinical presentations of Dysmorphic FAS or non dysmorphic ARND.
It is the category of Regulatory Disorder, underresponsive type which is the harbinger of
autism Spectrum Disorder or Aspergers Disorder diagnoses in early child hood.So the classic
time presentation of Autism Spectrum Disorder or Aspergers Disorder is different in the FASD
population.
457
458
The stereotypic movements, flapping, posturing are less commonly part of the FASD presen
tation. However they present more commonly a Developmental Co-ordination Disorder which
is diagnosed often Dyspraxia in countries such as Ireland.
The essence of the overlapping clinical presentations comes in the expressive and receptive
language area. The qualitative impairments in social awareness, social cognition, social
communication are not uncommonly very hard to differentiate whether using clinical
assessment by an experienced child psychiatrist or psychologist or using standardized
instruments such as ADOS among others. In many countries the ambivalence to accept the
true prevalence of FASD( ! in 100 live births) leads school systems and physicians to hide
many FASD patients under a Autism Spectrum Disorder or Aspergers Disorder diagnosis
because of the expediency of receiving school learning disability services. This is slowly
changing, pioneered in countries such as Canada and the USA. Now the UK are acknowledg
ing that FASD are the current biggest challenge for teaching as these pupils display complex
learning disabilities with co morbid psychiatric disorders for which there is no regular
curriculum ( Professor Barry Carpenter UK, 2012).
This chapter will include psychiatric clinical analysis of patients with FASD who present
autism spectrum Disorder or Aspergers Disorder features. with formal cognitive testing done
and not uncommonly differing autism assessments which have proved equivocal. The comorbid ADHD is a more frequent issue in the FASD population and this has critical importance
in both understanding and management. For example a successful medication treatment of
pervasive distractibility visual and auditory can have a positive effect on the childs social
functioning as he/she can now attend sufficiently to read faces and verbal and non verbal cues.
Medication is a change in the FASD patients who present with Autism spectrum disorder or
Aspergers Disorder features. The more commonly accepted efficacy of SSRI does not neces
sarily hold true for FASD children or adolescents with and can lead to unmasking a bipolar
diathesis, or in older patients contributing to Extra pyramidal symptoms.. This is especially a
problem in Ireland which has a high prevalence of Affective Disorder which is quite common
in the mothers who drink alcohol during pregnancy and so this genetic vulnerability can be
brought forth by too aggressive use of SSRI for that autism or Aspergers Disorder. As well the
psychostimulants can lead to an over focus in the FASD/ ASD group with increased persev
eration which can become a source of severe rage if challenged. As well the psychostimulants
are more likely to run the risk of bringing a schizoid change in the patient. Atypical agents
such as risperidone with its differential effect on 5HT receptor can also prove problematic in
management of Autism or Aspergers with a prenatal alcohol exposure history. In this case the
longer and prolonged use of the medicine can make the clinical situation worse by unmasking
an affective instability. (Rich & OMalley 2012)
Seizure disorders can be related to prenatal alcohol exposure and the effect of alcohol on the
GABA ergic system is one hypothesis. (Daniel Bonthius et al 1992, OMalley and Barr
1998).unexplained explosive episodes, rage attacks in FASD patients with autism Spectrum
disorder or Aspergers Disorder may have origins in seizure disorders which are not related
to the lower level of cognitive functioning or IQ as is the accepted rule.
http://dx.doi.org/10.5772/54924
Little comment is made on the family stress in this complex mix population but a family centred
therapeutic approach is the kernel of management and Identity issues have a completely
different resonance in an adolescent who is bright, has ARND, Aspergers disorder and is trying
to cope with the early loss of a birth mother to cirrhosis of the liver at 36 when her/she is aware
that the ARND has its roots in the birth mothers drinking during pregnancy. In Ireland the 3/
4 generations of families with FASD creates a transgenerational challenge to unraveling
disorganized parenting from disconnected parenting due to fundamental social communica
tion disorders. (Cummings et al 2000)
Recent international guidelines have included FASD among the environmentally-induced
neurodevelopmental disorders. (Sage Handbook of Developmental Disorders, 2011) Such a
neurodevelopmental diagnostic framework for children and adolescents with FASD improves
outcome and prognosis in many cases, notably for those with persistent aggressive and
antisocial behaviors. Neither the dysmorphic, Fetal Alcohol Syndrome (FAS) nor the nondysmorphic,Alcohol Related Neurodevelopmental Disorder (ARND) condition is currently
diagnosable as an Axis I disorder.
Therefore Susan Rich and Kieran OMalley, 2012, have recently proposed an alternative
psychiatric formulation based on a neurodevelopmental model. This was suggested in order
to improve clinical understanding and treatment of these complex developmental psychiatric
patients. Such a paradigm shift would better identify the large numbers of children who fall
through the cracks in diagnostic coding, becoming stuck in a revolving door through psychi
atric hospitals and institutions. (Brown et al 2011).
These complex cognitive and psychiatric deficits often predispose affected individuals to a
high degree of sensitivity to medications, increased risk of overmedication, treatment with
medication combinations, susceptibility to changes in dosing regimens, and paradoxical
responses to certain drugs.
Increasing clinical experience in using a neurodevelopmental formulation (compared to the
traditional multi-axial system) to guide the measured, educated use of psychotropics for
treatment of FASD can facilitate dramatic improvements in functioning of this challenging
population.
Early and/or multidisciplinary intervention and treatment can prevent or minimize disruptive
and risky behaviors, reduce academic failure, improve placement outcomes and reduce
chronic involvement in the legal and probation system. ( OMalley 2011b, Rich & OMalley
2012)
3. The domains of alcohol-related neurodevelopmental disorder

Although nearly every type of Axis I and II disorder in both DSM IV TR and ICD 10 Classi
fications, as well as most disorders from the 0-3 coding manual can be expressed by individuals
with effects of prenatal alcohol exposure, there have been efforts to better characterize the
common clinical features associated with ARND. While neurodevelopmental deficits may
459
460
exist in a range of severity, all cases of individuals with FAS have some degree of ARND. The
following neurodevelopmental domains have been found to be disrupted in clinical psychi
atric cases of both FAS and ARND (Figure 1). As indicated in the diagram, prenatal alcohol
exposure can lead to mood dysregulation and autonomic arousal, cognitive and executive
dysfunctions, language and social skills deficits, and multi-sensory functional and perceptual
deficits. Some individuals can have one or more domains of impairment, as indicated by the
overlapping areas in the Venn diagram. (Rich et al 2009, Solomon et al 2009, Rich & OMalley
2012)
Figure 1. Mood dysregulation and/or Autonomic Arousal:
It is slowly being recognized that the autonomic or involuntary (parasympathetic and

sympathetic) nervous system is affected by prenatal alcohol exposure, Animal research
indicated this many years ago but human studies are beginning to unravel its effect from the
infancy, early child hood and through to adolescence. Regulatory Disorders are prime clinical
examples of this effect of prenatal alcohol exposure. The classic dichotomy in temperament is
seen in the predisposition for a hyporesponsive infant or child, shy, inhibited, cautious and,
anxious or hyperreponsive, a dis-inhibited, impulsive, intense infant or child. the effect of
alcohol on the CNS produces a highly mood dysregulated child, having random or easily
provoked episodes of frustration, irritability, aggression, and anger. Infants and toddlers with
FASD can present with Regulatory Disorder Type I, II, or III (DC Zero to Three, 2005). The
type of mood dysregulation may be related to brain irritability as epileptiform activity and
spike and wave forms can be seen in sleep deprived or 24-hour EEGs for some individuals.
This phenomenon is akin to a faulty thermostat which instead of controlling temperature
controls emotional and arousal regulation. Thus the patient is unable to adjust their emotional
http://dx.doi.org/10.5772/54924
or arousal state appropriately in response to sometimes minor challenges i.e. failure of

examination, break up from boyfriend. This can lead to emotional incontinence with uncon
trollable crying or laughing, or maybe intermittent unpredictable explosive episodes.
These developmental psychiatric disorders presenting from infancy reflect the impact of
prenatal alcohol on the developing neurotransmitter system. This teratogenic effect on the
serotonin, GABA ergic Glutaminergic and other neurotransmitter systems can lead to anxiety
disorders, mood disorders (such as depression), aggression, and possibly later substance
abuse. As infants and toddlers, they are often temperamentally difficult to settle and do not
seem to enjoy/bond with their parents, birth, foster or adoptive These infants may have
pervasive sleep problems (with disruptions in the sleep/wake cycle, initial insomnia and
decreased non REM sleep).As well they can display a whole range of regulatory problems in
hyper or hyposensivity to auditory, visual,, olfactory, gustatory or tactile stimuli.
As young children, the sensory integration issues involving sensitivity to sounds, environ
mental noise, lights, fans, easily irritated by voices, loud music, smells, tastes, even touch
continue, and are often misunderstood as deliberate defiance.
This is commonly a clinical arena in which so called autistic features are noticed. In other
words, the young child with ARND may either seek out tactile stimulation (touch and/or
movement) or may, alternatively, be sensitive to touch and/or easily over-aroused by vigorous
proprioceptive stimuli (e.g., movement on swings, roller coasters, etc.).
Generally, transition periods are a challenge, not unlike autistic children. These children
require intensive one-on-one adult attention being unable to self-soothe easily, and having
difficulty in free /creative play. However, self regulation techniques can be taught and guide
play therapy has a role in integration of the childs exploration of self expression.
3.1. Cognitive and executive dysfunction
Brain structural, neurophysiological or neurotransmitter abnormalities belie the cognitive
deficits in ARND. These include: working memory deficits, difficulty with executive func
tioning (organization, concentration, auditory processing, processing speed, problem solving,
attention and impulse control.); deficits in IQ compared with their biological parents; mathe
matics disorders, reading disorders (e.g., dyslexia), spelling issues, and other learning
disabilities with or without mental retardation due to a hypoaroused, misconnected, or
disconnected prefrontal cortex, individuals with ARND may have a variety of deficits in
cognitive areas,. A variety of developmental disabilities (speech/language issues, visual
integration, gross and/or fine motor skills deficits (i.e., poor handwriting), spasticity, hyper
flexibility, etc.) can also be seen in many individuals with ARND.
Disruptions in cognitive functioning often lead to a failure to understand consequences, poor
judgment, and limited insight into the origins or the impact of ones behaviors. This subse
quently leads to significant and debilitating deficits in basic day to day functional abilities. The
child with ARND therefore, rather than thinking through actions, acts impulsively often in a
nave/ primitive manner (as though driven by basic instinct rather than measured intellect).
461
462
Self care is another area of concern. able to care for oneself (e.g., hygiene, meal preparation,
scheduling appointments), manage a household (take on responsibilities for chores, balance a
checkbook, etc.) and perform other activities of daily living may be limited depending on the
extent of a persons ARND.
Time, homework and money management difficulties lead to multitudes of practical daily
living problems. Children with ARND are seen as willful, lazy and showing clear oppositional
defiant features. The level of IQ does not offer a guide to these cognitive issues and often can
suggest a greater capability than is possible. Children with ARND not uncommonly present
a mixture of autistic features with ADHD and so are doubly challenged. Medication can have
a vital role in this group as they are misunderstood as having faulty theory of mind deficits,
whereas their distractibility and lack of focus makes them unable to fully participate in social
situation.
It is more common sense in the later grades/years in school to guide the student towards a
vocational training certificate rather than a diploma/ A level, Leaving Certificate track and to
master the basic life skills to be productive, employed in a semi-skilled trade (e.g., construction
worker, brick mason, landscape worker, plumbers assistant, etc.). However, for many
individuals with a higher degree of functioning and with appropriate academic/examination
support it may not be unreasonable to expect completion of secondary/ high school and even
the entering of a two or four year college or university programme. This is especially true for
FAS or ARND patients with an autistic profile and average or above average intellectual
functioning.
On the other hand, more cognitively impaired patients with FAS or ARND may have frequent
rudimentary behaviors (skin picking, pica, compulsive self harm or inappropriate/selfstimulating sexual behaviors). These can be a primitive expression of emotional distress, not
unlike non verbal autistic children. The central alexithymia, (inability to understand others
feelings or have words for ones own feelings) irrespective of IQ level is a fundamental clinical
construct in FASD.(Greene et al 1991)
3.2. Language and social skills deficits
The traditional view of language deficits come from the wealth of studies in expressive/
articulation problems and the more complicated so called receptive language problems where
the person has fundamental problems in the processing of language. this latter deficits was
described by wernicke as long ago as 1874 in his classic treatise on sensory aphasia. It is in this
area that patients withFASD truly show their autistic type clinical features. misuse of language
integral to social cognition and communication are quite common problems in adolescents or
young adults with ARND. It is important to understand that prenatal alcohol-induced organic
brain damage underpins the language deficits. At times, these patients are misdiagnosed with
Autistic Spectrum Disorder or Aspergers Disorder. The term social language disorder better
fits this population. This does not preclude the fact that medication may engender a positive
effect on language functioning, and specifically social communication. Individuals with
ARND suffer from indiscriminate or immature behaviors (e.g., telling inappropriate jokes in
the classroom or workplace, blurting out what they think of a person even if it is quite
http://dx.doi.org/10.5772/54924
insulting /silly or negative). These behavior problems range from silly or irritating socially
inappropriate behaviors to overtly aggressive and sometimes risky behaviors. Severe social
functioning problems may result in lack of long term friendships, being labeled by peers as
weird or odd, and/or appearing withdrawn, socially-isolated, and avoidant. At times,
ARND may lead to socially indiscriminate behaviors (i.e., individuals engaging in early or
promiscuous sexual activity, gang membership, and peer pressure).
The clinical understanding of the effect of pseudo word decoding and alexithymia in man
agement and understanding is critical to the psychiatrist, psychologist and educator. These
children and adolescents can be seen in an autistic or defiant light but have specific decoding
struggles which effect their receptive).
Case Examples: Two female adolescents with ARND were diagnosed with Autism and
Atypical Autism respectively after fulfilling the ADOS criteria. However both had clear
documented history of prenatal alcohol exposure. One normal I.Q. I4 year old girl with
Atypical Autism had a clinical presentation of ASD and ADD and deteriorated with psychos
timulant medication which markedly increased her perseveration. She responded to low dose
liquid fluoxetine, and as her attention problems, especially visual, ameliorated, so her autistic
features deceased. The other girl 15 years old, with moderate intellectual functioning, had very
debilitating social anxiety triggered by oversensitivity to facial cues. She eventually settled for
a while with a GABA ergic agent.( Lyrica, pregabulin), but now needs a specialized therapeutic
community placement. She had a history of many unexplained physical problems which were
Alcohol Related Birth Defects.
3.3. Multi-sensory functional and perceptual deficits
Sensory integration issues, including hypo or hypersensitivities to noise, touch, proprioceptive
stimuli, smells, tastes, and light may all be seen in children prenatally exposed to alcohol. This
may lead to infants and toddlers seeming to be easily agitated, over-stimulated, and overaroused. Adolescents and adults may cope by avoiding or over-reacting in situations or
environments which provoke their sensitivities. Adolescents or adults who misread or
misunderstand social cues may result in paranoid behaviors, such as over-reactions to the tone
of someones voice or an otherwise harmless look in their direction.
Prenatal alcohol exposure can have very disabling outcomes for alcohol-exposed children and
their families due to the interaction between psychosocial risk factors (Mukarjee et al, 2006),
cognitive deficits, and neuropsychiatric sequelae ( OMalley 2011b). In addition to a higher
prevalence of chronic exposure to domestic violence, neglect, child abuse, adjudicated youth
have higher rates of psychiatric illness, learning disabilities, and academic failure.
The sensory functional and perceptual deficits are commonly hidden and included in a
generic autistic diagnosis frame. However they are fundamental to understanding the
acquired brain damage caused by alcohol, which pervades brain structures, neurotransmitters
and electrophysiology (Hagerman 1999, OMalley 2008, OMalley & Mukarjee 2010).
Case example: A 21 year old previously adopted male Caucasian patient presented with a long
history of autism and psychotic features. He had been hospitalized a number of times and had
463
464
need restraint because of his reactivity to the environment. He had not responded to high doses
of SSRIs (which produced increased suicidality thoughts), and atypical, especially risperidone
which made him more affectively unmanageable. When he was assessed in the community
his clear history of sensory reactivity to tactile, olfactory, gustatory, visual and auditory stimuli
was unraveled as was his history of significant prenatal alcohol exposure. Which had been
ignored in previous assessments. A combined multi-modal approach addressing his sensory
reactivity combined with low dose buspirione was much more effective and he did not need
psychiatric hospitalization. As well he did not present any facial features as adult or as a young
child. He had been labeled as having unusual paranoid features but these were really his
correct sensitivity to what he perceived as a hostile challenging environment. His adoptive
parents recounted many stories of his oversensitivity to noise, light,fabrics food when he was
growing op and just saw him as over fussy.
4. A neurodevelopmenatal approach to management

4.1. General diagnostic problems
Although psychiatrists and mental health professionals treat patients with FASD, there is
presently no consistent way within DSM-IV TR to code for either the dysmorphic phenotype
(Fetal Alcohol Syndrome, FAS) or the non-dysmorphic condition (Alcohol-related Neurode
velopmental Disorder, ARND). Therefore, treatment of affected individuals is inadequate due
to lack of diagnostic clarity, and lack of scientifically tested or accepted psychiatric treatment
protocols. FAS, the leading non-hereditary cause of mental retardation and preventable birth
defects, is buried in Appendix G of the DSM-IV TR as a congenital malformation (760.71) and
the ICD-10 includes Fetus and newborn affected by maternal use of alcohol (P04.3) but excludes
FAS (Q86.0) (DSM IV-TR, 2000). (Nowick Brown et al 2011, OMalley 2011b, Rich & OMalley
2012).
At the current time because there is no appropriate DSM-IV TR or ICD 10 diagnostic frame
work, most psychiatrists and mental health professionals attempt to apply inadequate Axis I
diagnoses which are often poorly suited to the clinical understanding of this population. This
results in individuals being given a laundry list of psychiatric diagnoses, from ADHD, autism,
pervasive developmental disorder and bipolar disorder, to conduct disorder, reactive attach
ment disorder, personality disorders, and oppositional defiant disorder.
In a large study of secondary disabilities in 415 persons with ARND [FAS or Fetal Alcohol
Effect (FAE)], a majority (94%) had a history of co-occurring mental health problems. Among
both adults and children, attention deficits were the most frequently reported problems (61%)
reported whereas in adults alone, depression was most frequently reported (52%) (Stratton et
al., 1996). A smaller study has shown that the proportion of subjects with a history of psychi
atric disorders (74%) was greater than expected from the general population, including alcohol
or drug abuse (60%), major depressive disorder (44%), avoidant personality disorder (29%).
Researchers have shown a link between ADHD symptoms and FASD over the past several
years, indicating an acquired (non-genetic) etiology for a subtype of children with ADHD.
http://dx.doi.org/10.5772/54924
Infants and toddlers with FASD can present with Regulatory Disorder Type I, II, or III (DC
Zero to 3, 2005). Autistic behaviors have been noted in both younger children as well as school
age children prenatally exposed to alcohol (Streissguth et al, 1996; Streissguth & OMalley,
2000, Mukarjee et al 2012).
You could build a case that nearly all disorders developing during childhood listed in the DSM
IV-TR may be induced by exposure to alcohol in utero. Co-morbidities of FASD include other
behavioral, mood, anxiety, and conduct problems. The link between ADHD and FASD is
finding more universal acceptance and the link between autism and Aspergers disorder and
FASD will not be far behind. (OMalley 2011a).The lifetime prevalence of mental health or
psychiatric disorders in individuals with FASD is as high as 90% (Streissguth et al 1996, HHS,
2000), highlighting the importance of correct diagnosis and clinical management. Accurate,
informed diagnosis is critical in psychiatry to avoid over-medication or inappropriate treat
ment, leading to worsening of symptoms and poor outcomes.
The current standard of care or treatment as usual for individuals with FASD is inadequate
due to lack of diagnostic clarity, lack of accepted psychiatric treatment protocols, and further
complicated by the presence of Alcohol Related Birth Defects (ARBD) which are multisystem
organ involvement (i.e., seizure disorders; renal, eye, cardiac, g.i. problems and skeletal).
Early accurate diagnosis and intervention may be effective in preventing the development of
secondary disabilities (i.e., academic or school failure, conduct disorders and antisocial
behaviours leading to legal problems, sexually inappropriate behaviours, lack of steady
employment and housing).
4.2. The utilization of a neurodevelopmental formulation
The utilization of a neurodevelopmental formulation can guide the development of effective
multiisystem and multimodal intervention strategies, including appropriate psychopharma
cologic management (OMalley 2008).
1.
Thus, shifting diagnostic paradigms in children with prenatal alcohol exposure to the
dysmorphic (FAS) and non-dysmorphic (ARND) phenotypic expression of in utero
alcohol exposure would allow psychiatrists, pediatricians, and other medical professio
nals to have a richer, clearer and more holistic interpretation and understanding of the
wide range of neurocognitive, neurobehavioral, and neuropsychiatric disorders affecting
the individual rather than simply the degree of facial dysmorphology.
2.
The social or environmental context includes childhood exposure to domestic or com

munity violence, child abuse/neglect, early institutionalization, community violence, and
other early life events that may contribute to development of reactive attachment disorder
(RAD), post traumatic stress disorder (PTSD), developmental trauma disorder and other
psychiatric (Axis I and II) co-morbidities.
The interaction of the childhood experience on the expressed FASD phenotype cannot be
overlooked. Therefore, the neurodevelopmental biological vulnerability profile of FASD
during infancy, toddlerhood, childhood, and adolescence predisposes an individual to adverse
465
466
psychological outcomes resulting from early institutionalization, parental loss, physical/

emotional/sexual abuse, neglect, and other forms of trauma(Cummings et al 2000,Elias et al
2011, Rich & OMalley 2012).
3.
3.The implications of FASD on development, behavior, academic and adaptive function

ing over the life span can be best understood in the context of the interaction of social and
familial factors with an individuals neurodevelopmental deficits. Early institutionaliza
tion, neglect, abuse, and family violence may engender different nosological (diagnostic)
presentations in this patient population, depending on the quality and degree of under
lying neurodevelopmental impairment. So co-occurring diagnosis of Reactive Attachment
Disorder or Post Traumatic Stress Disorder, Developmental Trauma Disorder are quite
appropriate and herald the psychiatric and care complexities of the patient. It is therefore
of vital importance that care must be taken to tease out symptoms based on acquired
developmental versus social history in order to develop a holistic, appropriate under
standing of the interplay between brain-based and environmental (post-natal) origins of
psychopathology.
4.
Deficits in emotional regulation and mood, implicit ability to comprehend the nuances of
social situations, auditory or visual information processing, functional working memory,
and/or other executive functions put individuals at risk for further psychopathology in
the face of environmental stressors. These neurodevelopmental (CNS) and psychiatric
sequellae persist through the life course and may progress to worsening conditions with
devastating outcomes and poor prognosis (Streissguth and OMalley, 2000, Rich &
OMalley 2012).
A neurodevelopmental formulation provides the best option for clinical understanding of these types of FASD complex cases, but
especially if autistic features are the presentation, and the patient has borderline or low intellectual function or a marked split ( 12-15
points) between verbal and performance I.Q. (OMalley 2008, Chapter 1)
4.3. The practical utility of a neurodevelopmental approach

The challenges in the treatment of FASD currently relate to their clinical presentations having
an array of apparent psychiatric co-morbidity, and a general lack of diagnostic clarity. In
practice in both North America and Ireland/ UK clinicians who recognize the clinical signifi
cance of FAS or ARND, are given a number of psychiatric diagnoses (ADHD, Autism,
Aspergers disorder, intermittent explosive disorder, conduct disorder, mood disorder, etc.). It
is becoming increasingly evident that early onset dysregulation, social communication and
forensic issues are presenting complex mixtures of biological and environmental vulnerabili
ties which display developmentally changing clinical presentations. The autistic presentation
coupled with ADHD symptoms and intermittent unexplained explosive episodes is particu
larly perplexing and hard to manage. Thus, given that both conditions are common presenta
http://dx.doi.org/10.5772/54924
tions of FAS and ARND (Fitzgerald M, 2010). Clinicians using a neurodevelopmental approach
will have more success in understanding and treatment of FASD.
Multi-modal treatment can improve the developmental, social, academic, and mental health
trajectory of these children (OMalley 2008, Nowick Brown et al 2011). Brain organization and
function is affected in many individuals with FASD/ARND and can be enhanced by appro
priate multi-modal treatment strategies.
As with Autistic Spectrum Disorders, FASD diagnosis and treatment involves early interven
tion with a multimodal team approach (genetics, developmental pediatrics, psychologists,
psychiatrists, PT/OT, speech, special education) (OMalley 2008, 2011b, Kodituwakku et al
2011).
A capacity for consequential thinking is a key requirement for decisional capacity. This is
an expectation for adolescents or young adults in the school, work legal system, who have
been involved in antisocial and/or violent acts. Unfortunately, due to the neurocognitive
deficits associated with ARND, these individuals are often mentally and emotionally discon
nected from the consequences of their actions, misread social cues, are easily frustrated and
provoked, and are unable to navigate logical decision making. So called high functioning
autistic patients fit this neurocognitive profile and have the added challenge of unexpected
response to medication because of unrecognized brain damage (Coles et al 2009, Kodituwakku
et al 2011, Hosenbucus et al 2012).
4.4. The specific use of medication in FASD with or without autistic features
Clinical experience has shown that proper medication combined with comprehensive, early
intervention services will improve their neurodevelopmental and psychiatric outcomes. To
that end, psychotropic medication can be viewed as an integral part of multi-modal manage
ment program for dysmorphic and non-dysmorphic ARND (FAS Diagnosis, 2005; Byrne
2008, Coles 2009; Novick Brown, et al., 2011).
4.4.1. Off Label or off license use of psychopharmaceuticals in patients with FASD
No National Institute of Mental Health (NIMH), NICE (UK), or industry-sponsored studies
exist on the safety and efficacy of medication in children, adolescents, or adults with FASD,
so this continues to be a barrier to measured and safe treatment for all individuals.
There is literature on the pharmacological management of ADHD, Autism, Fragile X, aggres
sion and addictive disorders (Hagerman 1999, Lee et al 2001, Glancy et al 2002 a, b, Vocci et al
2005, Turk 2012), which is often mis-extrapolated to apply to individuals with FASD. Since
there is no definitive diagnosis in the current DSM-IV TR for FASD outside of 760.71 (which
is embedded in the ICD-9 codes in the Appendices under both FAS and toxic exposure to
alcohol in utero), no impetus exists for large scale clinical trials in psychiatric and mental
health research. Such controlled clinical studies are needed to determine best practices, or
even smaller studies to determine safety and efficacy, or to gain FDA or NICE guideline
approval for use of the medications in this unique neurodevelopmental psychiatric patient
467
468
population (Turk 2009). Presently, there currently are no FDA, AACAP, APA guidelines for
medication usage in adolescents or young adults with FASD who present with neuropsychi
atric disorders. Therefore, all medications are used off label or off license in this population.
4.4.2. Caution in use of medication in ARND

While research is scarce in patients with FASD, this population may be even more vulnerable
than those with brain injury sustained in the postnatal period, childhood, adolescence, or
adulthood. Individuals with FASD, whether FAS or ARND, have had fetal whole-body
exposure during prenatal development, leading to the potential for unrecognized Alcohol
Related Birth Defects ( ARBD) in a number of organ systems (kidney, heart, liver/g.i. system,
eye, immune system, neurological) (Stratton et al 1996). These underlying problems with
physical organs and structures may lead to unanticipated side effects to even low doses of
medication.
For example
i.
cardiac problems such as conduction anomalies, structural defects, and pathologic

murmurs may be linked with adverse events with stimulant medications.
ii.
Overt seizure disorders and irritability of the brain (associated with random and
triggered electrical discharges) may be present due to neuro-anatomical changes in
the ARND brain. Therefore, safety issues related to decreased seizure threshold for
certain medications should be considered prior to treatment of this population.
(OMalley & Barr 1998, Hagerman 1999,Bonthius et al 2001
iii.
Other medical complications associated with alcohol-related birth defects (ARBD)

need to be considered prior to beginning medication.
iv.
Therefore, caution in use of medications should be given due to the unique vulner
ability of these patients for severe and catastrophic side effects of certain medications
due to:
differential or paradoxical medication response ;
prenatal alcohol-induced neurochemical or structural CNS changes (i.e., acquired
brain injury);
complications related to multisystem organ involvement (absorption, metabolic or
elimination problems related to kidney, gastro-intestinal or liver problems related
to ARBD);
an increased incidence of seizure disorders in this population (i.e., lower seizure
thresh hold);
overall greater risk of side effects from multiple drug combinations, higher doses
of medications, and sensitivity to psychopharmaceuticals.
http://dx.doi.org/10.5772/54924
4.4.3. Psychopharmacological targeting of neurodevelopmental deficits to improve current function and

general prognosis
It is well recognized that patients with acquired brain injury respond differently to medications
than individuals with no brain injury.
International clinical experience with this population indicates that individuals with alcoholinduced brain damage (FAS and ARND) often respond to medications similarly to those with
other types of acquired or traumatic brain injury.
A prudent therapeutic approach in this group of patients is to streamline the numbers of
medications the person is taking in order to reduce drug-drug interactions and prevent
complications from over-medication (Stratton et al, 1996; OMalley & Storoz 2003; Byrne
2008; OMalley 2008).
Medications need to be started at low doses and increased slowly with the goal of maximizing
efficacy and minimizing side effects to the sensitive/vulnerable central nervous system. This
can be achieved more often than not by simplifying the medication regimen, reducing the
drug-drug interactions, and providing targeted therapy combined with medication manage
ment.
Psychotropic agents do improve brain organization and function (i.e., neuron glue) and y
can facilitate cognitive processes by dampening the spontaneous or random firing of mislaid
pathways in the brain. As well, psychotropic medications may improve mood, behavior, and
performance in individuals with FASD by altering the physiology of the injured brain
structure and function. Among these medications are the atypical antipsychotics, such as
risperdal, ziprazidone, aripiprizole, and olanzapine. Uses of lamotrigine, carbamazepine,
valproic acid, lyrica, frisium have also been anecdotally helpful in patients with generalised
anxiety, aggressively, impulsivity, and mood dysregulation. We believe that correctly chosen,
appropriately managed medications can have a positive effect on cognitive functioning and
decision making. (Hosenbus et al 2012, OMalley 2010, Turk 2012).
4.4.4. General principles regarding medication usage in FASD
The principles guiding use of medications in the organically compromised brain (targeted
medications, lower doses, and gradual increases in dosing) combined with psychotherapy and
comprehensive community supports, psychiatrists can improve the complex neurodevelop
mental issues in these individuals.
Medications may have positive or negative outcomes as patients with FASD are more sensitive
to the CNS effects of medications.
i.
For example, selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine,

paroxetine, or citalopram, used not infrequently in Autism, may be more likely to
precipitate agitation, activation, or suicidality in these brain- damaged adolescents
due to augmentation of a pre-existing, organically-driven impulsivity.
469
470
At the same time, given that individuals with FASD may have deficiencies and/or differences
in neurotransmitter systems such as serotonin and dopamine, low doses of sertraline and
fluoxetine have proven anecdotally beneficial for some patients
ii.
Adolescents and young adults with ARND and co-occurring seizure disorders have
a prenatally kindled organic brain dysfunction as a result of alcohol-induced damage
to the corpus callosum, cerebellum or hippocampus. There is anecdotal clinical
evidence that antiepileptics (i.e., carbamazepine, valproic acid, lamotrigine, neuro
ntion) can be effective in preventing this kindling effect. The prenatal effects of alcohol
can also result in a change in the balance of the developing neurotransmitters. Animal
research has shown that prenatal alcohol can induce decrease in inhibitory neuro
transmitter GABA in the hippocampus, and this neurochemical imbalance can
underpin development of seizures (Hannigan et al 1996, Riley et al 2006). The effects
of antiepileptics should be weighed carefully since some medications for seizures
may also increase anxiety, affective/mood liability, and reduce learning and cogni
tion.
4.4.5. The future for medication use in FASD including those with common presentations of ADHD,
mood disorders and/or autism
i.
Obviously multicenter, randomized controlled clinical trials (ideally international)

are needed in this vulnerable and clinically complex population. (Turk 2009)
ii.
There is a need for scientific testing and evaluation of new clinical instruments which
combine cognitive, language, and behavioral response as the gold standard for
assessing medication efficacy and safety in patients with FASD. Currently there are
no validated clinical instruments to evaluate the developmental, cognitive, language
and behavioral response of a patient with FAS or ARND to psychotropic medication.
There is a non-specific neuropsychiatric rating scale, but most drug rating scales (with
the exception of those used in Alzheimers disorder) evaluate clinical symptoms
related to psychiatric disorder (i.e., Connors Questionnaire, Beck Depression
Inventory, Hamilton Rating Scale, CBCL).
iii.
It is long recognized that the use of multiple psychotropic medications is a risk for
toxicity and acute confusional state, even in absence of underlying neurocognitive
problems. The mechanism of multidrug interaction leading to toxicity relates to
individual drugs competing for absorption through the liver cytochrome P450 2D6
enzyme system. In turn, certain medication blood levels increase (i.e., paroxetine is
well known to increase blood levels of other psychotropic medications). In a recent
lecture at the First European Conference on FASD in Rolduc, Holland (Nov 3rd to
5th 2010), Ken Warren, Acting Director of NIAAA, mentioned concern about medi
cation interactions, but no data was given or studies forthcoming.
http://dx.doi.org/10.5772/54924
5. Discussion
This chapter has attempted to highlight the overlapping clinic al presentations of patients with
FASD, whether dysmorphic FAS or non dysmorphic ARND. Autism and Aspergers Disorder
probably rank next to ADHD as the commonest clinical phenotype of FASD.
The lack of DSM or ICD Axis I codes for these individuals means that treating psychiatrists do
not usually identify either disorder (dysmorphic or nondysmorphic conditions related to
prenatal alcohol exposure as aetiological factors to be considered in diagnosis. The organic
brain hypothesis will then inform management at many levels.
Nevertheless, the arrival of DSM V will hopefully herald new diagnostic categories which will
capture more correctly some of these patients with FASD who show what are deemed ;autistic
features. Two proposed diagnostic categories, Social Communication Disorder and Alcohol
Related Neurobiological Disorder are in serious consideration. It is hoped that Alcohol Related
Neurodevelopmental Disorder (ARND), already well recognized, will replace the new
category it more correctly captures the essence of the developmental psychiatric disorder
(DSM 5 Symposium 2012).
Currently the generic treatment as usual prevents individuals with FASD from receiving
appropriate multisystem and multimodal services, and further results in predictably poor
outcomes for affected individuals and ultimately costly consequences for communities.
Brain imaging such as MRI, fMRI or SPECT scans studies may begin to map more specific areas
of brain dysfunction related to prenatal alcohol exposure and psychiatric clinical presentation
(Riley, et al 2005, Kodituwakku et al 2011, Coles et al 2011). Historically our scientific knowl
edge of damaged or diseased brain structure associated with infections such as syphilis, AIDS
or lesions associated with cerebrovascular accidents has informed our diagnostic accuracy and
informed treatment progress. Therefore it is not unrealistic to expect that correlations between
the structural and functional deficits in individuals exposed at certain points during pregnancy
could dramatically improve our understanding of brain function.
Finally, the ability to distinguish FASD with an autistic clinical presentation from a geneticallyacquired or non-organic cause of this neurodevelopmental condition. This aetiological
knowledge ultimately better describes the pathophysiology and neuropsychiatric phenomen
ology of the patients clinical diagnosis. The neurodevelopmental clinical frame expands the
clinicians understanding that the autistic presentation is actually a phenotype form of this
specific acquired brain injury, The prenatal alcohol exposure creates a chemical, structural,
and even electrical CNS environment that is hard wired very different from the other
aetiological pathways for autism. The child or adolescent psychiatrist (ideally trained in
developmental psychiatry) has a long recognized central role as the case supervisor for
patients with patients with FASD, and is in the better position to manage the unfolding and
clarification of the neurodevelopmental formulation, differential diagnosis, psychiatric comorbidities, and psychopharmacology. Increased understanding of these complex patients
through a neurodevelopment formulation, unraveling such issues as the hidden aetiology to
471
472
the autism presentation will improve holistic clinical outcomes including the appropriate,
targeted use of medication by the treating child/adolescent psychiatrists.
Author details
Kieran D. OMalley1 and Susan D. Rich2
1 Charlemont Clinic/ Our Ladys Childrens Hospital Crumlin, Dublin, Ireland
2 , USA
References
[1] Baren Cohen S, Ring, HA, Ballimore ET, Wheelwright, S,Ashwin C, Williams
SCR(2000). The amygydala theory of autism. Neuroscience and Biobehavioural
Reviews., 24, 3355-3344.
[2] Blumstein, A, Farrington, D. O, & Mortea, S. D. (1985). Delinquent Careers: Innocence,
Desistance and Persistence in an Annual Review of Research, , 6
[3] Bonthius, D, Woodhopuse, J, Bonthius, N. E, Taggrad, D. A, & Lothman, E. W. (2001).
Reduced seizure control and hippocampal cell loss in rats exposed to alcohol during
brain growth spurt. Alcohol Exp Clin Res., 25, (1) 70-82
[4] Bookstein, F. L, Sampson, P. D, Streissguth, A. P, & Connor, P. L. (2001). Geometric
morphometrics of corpus callosum and subcortical structures in fetal alcohol effected
brain. Teratology: , 4, 4-32.
[5] British Medical Association Board of Science(2007). Fetal Alcohol Spectrum Disorders:
A Guide for Professionals. Publisher: BMA, London.
[6] Byrne, C. (2008). April). Psychopharmacology Basics for FASD. Workshop Presenta
tion, 3rd Biennial Conference Adolescents and Adults with FASD. Vancouver, Canada.
[7] Carpenter, B. (2012). st Intercountry Adoption Conference, Plenary Talk, Education
Issues in FASD, Cork, Jan 21st
[8] CDCFAS: Guidelines for Referral and Diagnosis (CDC, HHS, NOFAS, (2005). th
Printing. National Center Birth Defects and Developmental Disabilities, Centers for
Disease Control and Prevention, Department of Health Human Services, and NOFAS,
USA.
[9] Chess, S. (1971). Autism in children with congenital Rubella. Journal of Autism and
Developmental Disorders. 1(1), 33-47
http://dx.doi.org/10.5772/54924
[10] Clarren, S. K, & Smith, D. W. (1978). The Fetal Alcohol Syndrome: A review of the world
literature. New England Journal of Medicine. , 298, 1063-1067.
[11] Clarren, S. K, Astley, S. J, & Bowden, D. M. (1988). Physical Anomalies and Develop
mental Delays in Nonhuman Primate Infants Exposed to Weekly Doses of Ethanol
During Gestation. Teratology , 37, 561-569.
[12] Chudley, A. E, Conry, J, Cook, J. L, Loock, C, & Rosales, T. le Blanc N ((2005). March 1)
Fetal Alcohol Spectrum Disorder: Canadian Guideline for Diagnosis. Can. Med. Assoc.
Journal, 172 (5 supplement).
[13] Coles, C. (2009). IHE Consensus Developmental Conference. FASD: Across the
Lifespan. Management Strategies. Westin Hotel, Edmonton, Alberta, Canada.
[14] Coles CD & Zhihao L ( (2011). Functional neuroimaging in the examination of effects
of prenatal alcohol exposureNeuropsychology Review, in press.
[15] Cummings, E. M, Davies, P. T, & Campbell, S. B. (2000). developmental psychopathol
ogy and Family Process. Theory,Research and Clinical Implications. The Guilford
Press, London, New York.
[16] DSM 5 Symposium ( (2012). The making of DSM S. Part 1. AACAP, 59th annual meeting
Oct 25th, San Francisco..
[17] Elias, S. E, Coughlan, B. J, & OMalley, KD. (2012). Fetal alcohol spectrum disorders:
children, parents and carers of living with the disorder: a mixed methods approach,
Poster Presentation SSBP International Conference, Leuven Belgium, Oct 10th to 12th
[18] Fitzgerald, M. (2010). Violent and Dangerous to Know. Nova Science Publishers, New
York. Available at www.amazon.com.
[19] Gardner H Spiegelman DBaka S ((2011). Perinatal and neonatal risk factors for autism:
A comprehensive meta analysis. Pediatrics, , 128(2)
[20] Gilberg, C, & Gilberg, C. I. (1983). Infantile autism. A total population study of reduced
optimality in the pre, peri and neonatal period. Journal of Autism and Developmental
Disorders, t, 32(4), 153-166.
[21] Glancy, G. D, & Knott, T. F. Part I: the Psychopharmacology of Long-Term AggressionToward an Evidence-Based Algorithm. Canadian Psychiatric Association Bulletin,
Psychiatry and the Law.
[22] Glancy, G. D, & Knott, T. F. Part II: The Psychopharmacology of Long-Term Aggres
sion-Toward an Evidence-Based Algorithm, Canadian Psychiatric Association Bulletin.
Psychiatry and the Law.
[23] Greene, T, Ernhardt, C. B, Ager, J, Sokol, R, Martier, S, & Boyd, T. (1991). Prenatal
Alcohol Exposure and Cognitive Development in the Preschool Years. Neurotoxicol
ogy and Teratology, , 13, 57-68.
473
474
[24] Hagerman, R. J. (1999). Neurodevelopmental Disorders. Diagnosis and Treatment.

Oxford University Press, New York, Oxford., 3-47.
[25] Hannigan, J, & Randall, S. (1996). Behavioural pharmacology in animals exposed
prenatally to alcohol. In Abel, EL, editor, Fetal alcohol syndrome. From mechanism to
prevention. CRC Press, New York,, 191-213.
[26] Hobson, R. P. (1989). Beyond Cognition. A theory of autism. In Dawson G, ed,.Autism,
nature, diagnosis and treatment. Guilford Press, New York,, 222-448.
[27] Hosenbocus, S, & Chahal, R. (2012). a review of executive function deficits and
paharmacological management in children and adolescents. J can acad. Child adolesc.
Psychaitry, 21,(3)
[28] National Institute on Alcohol Abuse and Alcoholism (NIAAA(2000). June). Highlights
from Current Research: 10th Special Report to the U.S. Congress on Alcohol and Health
from the Secretary of Health and Human Services. US Department of Health and
Human Services, Public Health Service, National Institutes of Health.
[29] Jones, K. L, & Smith, D. W. (1973). Recognition of the Fetal Alcohol Syndrome in early
infancy, Lancet, , 2, 999-1001.
[30] Jones, K. L, & Smith, D. W. (1975). The Fetal Alcohol Syndrome, Teratology, 1975,12:
1-10.
[31] Kodituwaddu FW & Koditowakku EL ((2011). From research to practiceAn integrative
framework for the development of interventions in children with featl alcohol spectrum
disorders. Neuropsychology Review,, 21, 204-223.
[32] Lee, R, & Coccaro, E. (2001). Feb) The Neuropsychopharmacology of Criminality and
Aggression. Canadian Journal of Psychiatry, , 46
[33] LemoineP Harousseau H, Borteyru JP ( (1968). Les infants de parents alcoholi
ques.Anomalies observes a propos de 127 cas. Quest Med. , 21, 476-482.
[34] Lord, C. Mulloy, C Wendelboe M., Schopler E((1991). Pre and perinatal factors in high
functioning females and males with autism. J autism Dev Disorder, , 21(2), 197-209.
[35] Lord C Kim SHDimartino A ((2011). Autism Spectrum Disorders. General Overview.
Chapter 14, Editors Howlin P, Charman T, Ghaziuddin M, The Sage Handbook of
Developmental Disorders, Published London, California, New Delhi, Singapore
[36] Mukarjee, R, Hollins, S, & Turk, J. (2006). Psychiatric comorbidity in fetal alcohol
syndrome. Psychiatric Bulletin. , 30, 194-195.
[37] Mukarjee, R, Hollins, S, & Curfs, L. (2012). Fetal Alcohol Spectrum Disorders. Is it
something we should be more aware of? J R Coll.Physicians, Edin. 21, 2, 42, 143-150
[38] Nanson, J. (1991). Autism in Fetal Alcohol Syndrome. A report of 6 cases. Alcoholism.
Clinical and Experimental Research
http://dx.doi.org/10.5772/54924
[39] Novick BrownN, OMalley, KD, Streissguth, AP ((2010). FASD: Diagnostic Dilemmas
and Challenges for a Modern Transgenerational Management Approach. In Editors,
Abubado, S, Cohen D, Prenatal Alcohol Use and Fetal Alcohol Spectrum Disorders: A
Model Standard of Diagnosis, Assessment and Multimodal Treatment, Bentham
Online Publishing, USA.
[40] OMalley, K. D, & Barr, HM. (1998). Fetal Alcohol Syndrome and Seizure Disorder.
Letter to editor, Can J Psychiatry.
[41] OMalley, K. D, & Storoz, L. (2003). Fetal Alcohol Spectrum Disorder and ADHD.
Diagnostic implications and therapeutic consequences. Expert Review of Neurothera
peutics. , 3(4)
[42] OMalley, K. D. (2008). (Ed.) ADHD and Fetal Alcohol Spectrum Disorders. 2nd Printing,
Nova Science Publishers, New York., CHAPTERS 1, 4, 6, 11
[43] OMalley, K. D. (2010). Fetal Alcohol Spectrum Disorders. in Enyclopedia of Psycho
pharmacolgy, Springer-Verlag, Berlin, Heidelberg.
[44] OMalley, K. D, & Mukarjee, R. (2010). Fetal Alcohol Stndrome, Alcohol Related
Neurodevelopmental Disorder, Syndrome Phenotypes, Society Study of Behavioural
Phenotypes, UK,www.ssbp.co.uk
[45] OMalley, K. D. (2011a). ADHD and FASD. From animal research to clinical experience.
Invited talk, International CADDRA meeting Toronto, October 16th
[46] OMalley, K. D. (2011b). Fetal Alcohol Spectrum Disorders. Chapter The Sage Hand
book of Devevelopmental Disorders. Howlin P, Charman T, Ghazziuddin M, Editors.
Published, London, California, New Delhi, Singapore, 24, 479-496.
[47] Orphan Drug ActUS Congress; Designation of Drugs for Rare Diseases or Conditions;
SEC. 526 [360bb]. (a)(1)
[48] Pennington, B. F. (2009). Diagnosing Learning Disorders. A Neuropsychological
Framework. 2nd Edition, The Guilford Press, London, New York
[49] Rich, S. D. (2005). Fetal Alcohol Syndrome: Preventable Tragedy. Psychiatric News,
Residents Forum. Page 12., 40(9)
[50] Rich, S. D, Sulik, K. K, Jones, K. L, Riley, E. P, & Chambers, C. (2009). Nov). Fetal Alcohol
Spectrum Disorder: A Paradigm for Neurodevelopmental Formulation and Multidis
ciplinary Treatment. Presented at the American Academy of Child and Adolescent
Psychiatry Annual Conference, Honolulu, Hawaii.
[51] Rich SD & OMalley KD(2012). A neurodevelopmental formulation for the psychiatric
care of Fetal Alcohol Spectrum Disorders. Journal of psychiatry and the Law, Accepted.
[52] Riley, E. P, & Mcgee, C. L. (2005). Fetal Alcohol Spectrum Disorders: an overview with
emphasis on changes in brain and behavior. Experimental Biology and Medicine, , 230,
357-365.
475
476
[53] Russell, J. (1997). Autism is an executive disorder. Oxford University Press, New York
[54] Sokol, R. J, Delaney-black, V, & Nordstrom, B. (2003). Dec 10). Fetal Alcohol Spectrum
Disorder JAMA, , 290(22)
[55] Solomon, M, Hessl, D, Chiu, S, Olsen, E, & Hendren, R. (2009). March 1). Towards a
Neurodevelopmental Model of Clinical Case Formulation., Psychiatric Clinics of North
America. , 32(1), 199-211.
[56] Stratton, K, Howe, C, & Battaglia, F. (1996). Fetal Alcohol Syndrome. Diagnosis,
Epidemiology, Prevention, and Treatment, Institute of Medicine, National Academy
Press, Washington DC, USA.
[57] Steinhausen, H-C, Willms, J, & Spohr, H-L. (1993). Sept). Long-Term Psychophatho
logical and Cognitive Outcome of Children with Fetal Alcohol Syndrome. Journal of
the American Academy of Child and Adolescent Psychiatry, 32:5, , 990-994.
[58] Streissguth, A. P, Aase, J. M, Clarren, S. K, & Randels, S. P. LaDue RA, Smith DF ((1991).
April 17). Fetal Alcohol Syndrome in Adolescents and Adults, Journal of the American
Medical Association, , 265(15), 1966.
[59] Streissguth, A. P. and LaDue RA ((1987). Fetal Alcohol Teratogenic Causes of Devel
opmental Disabilities. In S. Schroeder (Ed.), Toxic Substances and Mental Retardation,
Washington, DC: American Association on Mental Deficiency, , 1-32.
[60] Streissguth, A. P, Barr, H. M, Kogan, J, & Bookstein, F. L. (1996). Understanding the
occurrence of secondary disabilities in clients with fetal alcohol syndrome ( FAS) and
fetal alcohol effects( FAE) Final Report CDC Grant R04, USA
[61] Streissguth AP & OMalley KD ((2000). Neuropsychiatric Implications and Long Term
Psychiatric Consequences of Fetal Alcohol Spectrum DisordersSeminars in Clinical
Neuropsychiatry, , 5(3)
[62] Sulik, K. K, Johnston, M. C, & Webb, M. A. (1983). Fetal Alcohol Syndrome: Embryo
genesis in a Mouse Model. Science, , 214, 936-38.
[63] Turk, J. (2009). Behavioural Phenotypes in Relation to ADHD. ADHD in Practice. UK.,
1(3)
[64] Turk, J. (2012). Behavioural Phenotypes. Royal College of Learning Disability Psychia
trists residential meeting, Manchester, Sepember 27th
[65] Vocci, F. J, Acri, J, & Elksahef, A. (2005). Medication Development for Addictive
Disorders: The State of The Science. Am J. Psychiatry, , 162(8), 1432-1440.
[66] US Surgeon General (2005, Feb 21). U.S. Surgeon General Releases Advisory on Alcohol
Use in Pregnancy: Urges women who are pregnant or who may become pregnant to
abstain from alcohol. http://www.surgeongeneral.gov/pressreleases/sg02222005.html.
US Department of Health and Human Services, Office of the Surgeon General.
http://dx.doi.org/10.5772/54924
[67] Bonnin A ,Goedein N ,Chen K, Wilson ML, King J, Shih JC, Blakely RD, Deneris ES,
Levitt P ( 2011) A transient placental source of serotonin for fetal forebrain. Nature,
April
477
Chapter 22
Empowering Families in the Treatment of Autism

Jennifer Elder
http://dx.doi.org/10.5772/54303
1. Introduction
It is well known that autism is a complex, currently incurable disorder with an unclear etiol
ogy, and that individuals with autism typically have normal life expectancies which require
parents, and later siblings, to provide varying levels of lifelong care. Because of the complex
ity of the disease, it is critically important to help families understand the disorder, manage
stress, and sift through information that frequently includes erroneous media views and un
substantiated claims of treatment efficacy. This chapter will help families and advising pro
fessionals by providing them with an overview of several topics: first, the common reactions
and beliefs about autism and individuals with autism that are held by family members; sec
ond, the family-centered as well as complementary and alternative treatment approaches
that are currently available; and finally, the best recommendations for helping families
adapt to an autism diagnosis and maintain healthy functioning as caregiversall while
planning for, and addressing the lifelong needs of, individuals with autism.
2. Common reactions and beliefs held by family members

Families are faced with enormous challenges in caring for children with autism over a life
time. The first challenge is obtaining the initial diagnosis, which can be difficult despite the
fact that autism is better understood today than it was in the past. Indeed, it is common for
families to consult a variety of professionals such as pediatricians and primary health care
providers before receiving a conclusive diagnosis. Once the diagnosis is made, however, pa
rents face a second, far greater challenge: mourning the loss of their perfect childwhich
can be a long and arduous process that involves coming to terms with the fact that their
child, whose physical appearance is normal or even unusually attractive, has a complex, in
curable, and frequently debilitating condition. After the family advances through stages of
2013 Elder; licensee InTech. This is an open access article distributed under the terms of the Creative
504
grieving that can be characterized using Elizabeth Kbler-Rosss five stages of griefDenial,
Anger, Bargaining, Depression, and Acceptance (DABDA)they eventually arrive at a
new normal with family harmony reestablished [1].
The first stage of grieving, denial, is common in parents of children with autism, and
can persist even after a child receives a diagnosis. Because fathers are typically less in
volved in day-to-day care than mothers, they may experience denial more intensely due
to fewer opportunities to observe the symptoms. For example, a father may be more
likely to say, he doesnt have autism; hes just quiet, which is supported by stories of
other family members who were also late to develop yet still turned out fine. How
ever, as the symptoms of autism become more conspicuous, caregivers notice differences
between their child and other, typically developing children whom they encounter in
playgrounds, preschools, and family gatherings. Frequently, it is extended family mem
bers who identify the autistic symptoms, share their concerns with the primary caregiv
ers and try to convince the caretakers to seek further assessment and follow up as
needed. This action is critical to accurate and timely diagnosis, early intervention (< age
3), and improved prognosis for overall quality of life.
The next stage, anger, may result in family members asking Why us? or Why did this
have to happen to him? During this time, family tension is high and anger may also be ex
pressed toward intervening professionals, especially if there has been a prior lack of, or slow
responsiveness to, parental concerns. For example, one parent stated, That pediatrician
should have listened to me when I expressed concern about David not speaking at four
years old; instead, he told me not to worry about it. This failure to identify the signs sooner
can lead to destructive self-blame, resulting in self-talk such as, If only I had recognized the
signs sooner or I knew we should have sought other opinionscomments that may be
responded to with active listening (e.g. You sound as though you are experiencing a lot of
regret) and nonjudgmental advice (e.g. Many parents struggle at this time. What is impor
tant is that you are seeking the necessary assistance now.) In addition to self-blame related
to behavior, it is also common in this stage for parents to evaluate their genealogy to deter
mine who was genetically responsible for the disorder. Unfortunately, there is no conclusive
genetic test for autism and while genetics likely plays a role, environmental factors may also
contribute to its development.
The third stage, bargaining, can place families at great risk because it involves frantically
seeking ways to reverse the diagnosis even if those ways are implausible. For example, it is
common for parents to directly bargain with a higher power (e.g. If you cure my child, I
will be a better parent) or indirectly, with a lesser power such as the health care profession
(e.g. If I find the right doctor or medication, my child will be cured). As they desperately
seek a magic bullet, parents may interrogate health care providers about the most useful
medications despite the fact that no single medication is effective for all symptoms. In addi
tion, parents may surf the Internet and read testimonials regarding treatments that are not
empirically sound; consequently, well-informed professionals need to advise families
against these treatments as some are risky and can lead to financial burden. (The most com
mon treatment approaches will be described later in this chapter.)

http://dx.doi.org/10.5772/54303
The fourth stage, depression, can take many forms. Parents may at times feel over
whelmed and powerless in their ability to facilitate their childs development or ameliorate
difficult, disruptive behaviors such as severe tantrums or self-abuse. Indeed, negative be
haviors may intensify to such a degree that families curtail their usual plans or avoid a de
sired activity all together, leading to feelings of hopelessness that is expressed in statements
such as, I cant do anything right or why bother. In addition, because many children
with autism have sleep disturbances (e.g., difficulty falling asleep; waking up and becoming
active in the middle of the night), parents must be vigilant at night, causing exhaustion and
sometimes even deeper depression. At this point, it is important for caregivers to recognize
that they may need professional help such as counseling or prescribed medications in order
to optimally provide for their child and family.
Many families who advance to acceptance, the final stage, describe having gained spiritual
strength, which helped them maintain hopean essential ingredient to successful griev
ing. In this stage, families recognize that there is no instant cure for their childs autism, but
there are credible interventions that can help. Ultimately, families discover that they can be
powerful advocates for their children, and after receiving proper education, can implement
home interventions that positively affect the family unit and even improve their childs con
dition. Once they gain confidence in these new approaches, they can serve other families
struggling through the grieving process by contributing empathy and wisdom to local fami
ly support group meetings. Because grieving is rarely a linear process, these meetings can
also help families as they revisit earlier stages by limiting the time they spend in previous
ones, thus facilitating a more permanent acceptance.
3. Families as primary interveners

3.1. Parent training
Historically, development of more family-focused interventions has resulted in a shift from
didactic teaching and family therapy models to interactive approaches, in which parents are
active participants in all levels of the training process [2, 3]. Although parents were once
viewed as the cause of their childs problems [4-6], they are now recognized for the key roles
they can play in ongoing child training and skill generalization [7-9], which has led to better
child prognosis and long-term quality of life.
Because there are now clearer linkages between core constructs such as social reciprocity (e.g.
social turn-taking), joint attention (e.g. sharing interest in, and mutually commenting on, an
object), and language acquisition, developing these skills can improve a childs communica
tive capacity. In fact, researchers stress that teaching parents to target pivotal skills such as
joint attention may produce positive, sustained effects on social and language development
[10]. Similarly, evidence suggests that interventions that require parents to synchronize with
the childs attentional focus (i.e. become interested in what the child is interested in) may be
more effective than parent-directed approaches (e.g., instructing the child to play with a toy
in a certain way) for children who have difficulty responding to, or initiating, joint attention
505
506
[11]. However, there is a need to closely examine the individual parent-training intervention
components thought to be linked with these core constructs to determine which components
are most effective for a particular child. This would allow researchers to better identify the
most convenient and efficient means of teaching these constructs and related intervention
components.
3.2. Research development in parent training
The author and co-investigators have been following a systematic sequence of research that
began in the early 1980s with the development of a play-based, in-home intervention that
was initially tested in-depth, over 8-12 weeks, with four mother-child dyads using intrasub
ject (single subject experimental) methodology [12]. In this initial study, Elder found that
mothers figure prominently as recipients of training and other interventions and that even
when the focus was on the dyad, mothers took over and fathers stayed in the back
ground, with inadequate diffusion of new learning through the mothers. This lack of father
involvement piqued the interest of Elders research team, who collaborated on new studies
directed at fathers. Although a systematic review of the literature revealed only three inter
vention studies that included fathers, evidence indicated that fathers interaction styles dif
fered from mothers, possibly resulting in unique contributions to their childs social and
language development [13].
Building on Lambs (1987) seminal work related to fathers and their influence on child de
velopment, Elder et al. developed and tested a Father Directed In-Home Training (FDIT) in
tervention with a total of 36 father-child and mother-child dyads under controlled
conditions in two NIH/NINR-funded studies [7, 8]. The study was designed so that data
from individual training components could be analyzed rather than an entire intervention
package. These training components were based on the theoretical constructs in social inter
action theory and characterized by the broad concept of social turn-taking. Because the
team had previously observed many fathers sitting passively or aggressively directing inter
actions and not allowing their child time to respond, the research team created four inter
vention components: (a) following the childs lead (FCL), which involved allowing the child
with autism to direct play, (b) imitating/animating (I/A), which entailed attending to and
imitating the ADS child's sounds and/or actions in an animated manner, (c) expectant wait
ing (E/W), which required signaling the child and waiting for a response, and (d) comment
ing on the child (CC), which emphasized remarking on the childs actions at appropriate
times during play [12]. Fathers were instructed to watch videotaped examples and read
written directions about integrating these components into play sessions. After mastering
the skills, fathers taught mothers the same techniques using the research teams educational
approach, resulting in both parents reporting that training had helped them relax during the
in-home play sessions.
After the intervention, fathers significantly increased their use of the skills taught and chil
dren with autism responded with greatly increased initiating rates as well as frequencies of
child non-speech vocalizations. In follow-up interviews, fathers revealed that the training

http://dx.doi.org/10.5772/54303
had enhanced their paternal role and the quality of overall family functioning [14]. (Details
of these studies can be found in published articles [7, 8]).
3.3. Including siblings
Most children with autism have difficulty with inconsistency as evidenced by their strong
adherence to routines and rituals. Therefore, it may be difficult, perhaps even impossible,
for these children to effectively modify their interactions if family members are not consis
tent in their approach. Furthermore, incongruence within the family can distress children
with autism, who may express their feelings by engaging in a variety of aberrant behaviors
such as tantrums, aggression, and other behavioral expressions of frustration. Present re
search indicates that training non-affected, typically developing siblings, or other individu
als who have ongoing contact with the child with autism, could be beneficial. However,
little is known about the effects of training siblings to use theoretically-derived strategies
such as those Elder and others have implemented with parents. Also unknown is the effect
that training typically developing siblings might have on their own behavior, anxiety, and
overall quality of life. Although it seems likely that training would positively affect them,
training effects on siblings should be addressed in clinical trials.
In a search of the literature related to non-affected, typically developing (TD) siblings of
children with autism, few studies are found describing these children, their relationship
with their sibling with autism, or what effect having a sibling with autism has on them
[15]. Of the extant reports, the findings are inconsistent, making it difficult to character
ize the siblings, identify those who are vulnerable to poor adjustment outcomes, or de
velop interventions that benefit both the sibling and the entire family [15]. It is clear,
however, from both the literature and clinical experience, that TD siblings are often
faced with unique challenges related to their affected siblings autism. Also, because chil
dren with ADS rarely have physical disfigurement, it is often difficult for those who are
not familiar with autism to understand why these children act the way they do; this, in
turn, adds to the stress that TD siblings and the family experience [16-18]. Initial find
ings are promising because they show that when TD siblings care for their ADS siblings
early in life, this can positively affect not only the child with autism but also the inter
vening sibling [19-22]. This clearly indicates that training and evaluating siblings is an
area of research with enormous potential and clinical relevance.
Another important consideration that lends support for training siblings is evidence that
children with autism learn best in naturalistic environments such as their homes. In a classic
work, Baer, Wolf, and Risley (1968) state that skills taught to children in one setting cannot
be expected to generalize to other settings without planned, systematic implementation. In
fact, these researchers assert that no deliberate behavior changes, particularly related to lan
guage acquisition and socialization, should be made that are not reinforced regularly in the
childs primary environment; otherwise, trainers must continue to intervene to maintain the
behavior change [23]. If one ascribes to this view, clinic-taught interventions cannot be ex
pected to generalize well to home settings unless: (a) the trainer is always present (an im
practical and costly idea), (b) family members are taught to assist with generalization, or (c)
507
508
ideally, intervening family members and children with autism are trained in familiar home
environments where naturally reinforcing (caregiving) activities are more likely to occur. Al
so, children with autism are more likely to exhibit abnormal language in unfamiliar settings
than at home [11]. For these reasons, it is important that AD children acquire communica
tion skills in naturalistic settings where they are most likely to encounter interactions and
opportunities to utilize communication skills that are similar to the contexts of their daily
routines [11].
4. Using new technologies to train families

The use of the Internet has grown substantially over the last few years, with an estimated
260 million people now online in North America [24]. In addition, between 2000 and 2010
the proportion of Internet users who are black or Latino has nearly doubled, causing the In
ternet population to closely resemble the racial composition of the nation as a whole. Health
information is one of the most important subjects researched online, and this is reflected in
the autism community, where many families are heavily dependent upon Internet services
for education, updates on autism treatment, and peer support via parent chat rooms [15].
However, despite the great interest in using the Internet as a resource for learning about au
tism, online parent training interventions are rare. Recently, considerable evidence has be
come available demonstrating that web-based feedback systems may increasingly provide
feasible and cost-effective patient education [25] because they are available 24 hours a day
and can be used repeatedly to enhance learning. Further, with wide-spread internet technol
ogy, it may now be possible to provide much needed training to families living remotely
and to those representing previously underserved minorities. Clearly, there is an urgent
need for clinicians and researchers who have manualized training interventions to adapt
them for online use and systematically evaluate their effectiveness through clinical trials.
5. Managing family stress

Until the 1980s, the diagnosis of autism was generally not well-known and most children
diagnosed with autism were eventually institutionalized. Today, the majority of these chil
dren live with their families, who face enormous challenges in planning for and providing a
lifetime of care. Families often experience significant financial burden [26], insecurity re
garding long-term family planning, and stress related to the childs social impairments and
adverse behaviors that often interfere with family functioning [27, 28]. Because additional
care giving has been shown to predict parental distress [29] and parents of children with au
tism may experience greater stress than parents of children with other disabilities, interven
tions and techniques that can reduce stress are needed [30-34].
Although caring for a child with ASD can adversely affect quality of life for both parents
[35], most research related to parental stress has focused on mothers [36] who have reported

http://dx.doi.org/10.5772/54303
higher stress levels than fathers [31, 37-40]. However, in two other studies comparing moth
ers and fathers stress levels, no differences were found [32, 41]. The author and team also
found that both mothers and fathers scored very high, over the 90th percentile on the Parent
ing Stress Index pre-intervention with no statistical significance between the mothers and
fathers scores [14].
In 2008, Davis and Carter provided more insight regarding how mothers and fathers may
react to their childs autism. They noted that although mothers had a higher rate of stress
and depression, fathers reported more difficulty interacting with the children. In addition,
mothers were more involved with everyday activities and thus, more often affected by their
childs inability to perform activities of daily living and self-regulate emotions. In contrast,
fathers reacted more to overt behaviors such as tantrums, aggression, and/or loud/peculiar
vocalizations, which are particularly difficult to manage and can be embarrassing in public
settings. Because the core disability associated with autism is social, it can be stressful for
parents to deal with a child who may not like to be held, will not respond to their affection,
or even make eye contact.
Although only a few studies have explored effects of child intervention on changes in paren
tal stress levels, [14, 28, 42, 43] results are promising. Parent involvement that results in im
proved child outcomes can empower parents and lower stress in both mothers and fathers.
Also, it is important to consider that although fathers may not appear to be as overtly
stressed as mothers, there is evidence that they also experience high levels of stress; there
fore, interventions should include both mothers and fathers. Finally, although little is
known about stress in siblings, it is likely that their stress is also high and that they could
benefit from being included in an intervention.
6. Alternative and complementary therapies: Helping families

6.1. Select credible treatment options
A report from the American Academy of Pediatrics Council on Children with Disabilities
states that treatment goals for children with autism are to: (a) maximize the child's ultimate
functional independence and quality of life by minimizing the core features, (b) facilitate de
velopment and learning, (c) promote socialization, (d) reduce maladaptive behaviors, and
(e) educate and support families [44]. While standard treatments meet these goals and thus,
are generally accepted by the autism research community, the variety of novel approaches
are less accepted due to their lack of empirical support. As a result, families, who often be
come desperate to identify a ready cure for the disorder, must be equipped with the knowl
edge to avoid scams by fully evaluating the potential of new therapeutic approaches.
While it is not possible to cover the multitude of novel and complementary treatments
for autism, the author will provide a critical review of some of the most popular strat
egies, ferreting out those that are empirically validated from those that are unsubstantiat
ed. This section will include a discussion of findings from the authors previously
509
510
published, randomized clinical trial that evaluated the effects of the popular Gluten-Free,
Casein-Free diet on individuals with autism, and subsequently recommend directions for
future research.
6.2. Dietary intervention and nutritional supplements in autism
Increasingly, parents are using alternative treatments, such as dietary interventions or sup
plements, which they learn about from internet sites or anecdotal reports from other pa
rents. Perhaps the most well-known dietary intervention is the gluten-free casein-free
(GFCF) diet that restricts consumption of wheat and dairy products, and which adherents
claim can cure autism [45]. This diet is so popular that a person can simply type, GFCF
and autism into Googles search engine, and hundreds of sites appearfrom the GlutenFree Trading Co. to GFCF Diet Success Stories with endorsements such as the following:
Three weeks ago, I decided to give it [GFCF diet] a try. After three days without dairy,
Wow! Suddenly we had an alert child! He was talking more, making sense of the world, and
engaging with us! When I phased out wheat and gluten, he got even better. He is happier;
his behavior is better; his muscle tone seems to be improving; his eye contact is great; he is
speaking like a normal 4 year old! [46] Although testimonies like these abound on the In
ternet, there is limited empirical data to support the claims, resulting in a lack of data that
health care providers can use to effectively guide parents in making informed decisions.
This dietary intervention, which has clearly raced ahead of science, poses health risks as
well as financial and social drawbacks. While it is less costly than when it was originally in
troduced, the GFCF diet can still add financial strain to families and may even compromise
nutritional health (e.g., insufficient calcium) in children with autism who already have re
stricted food repertoires. There are also social costs to the children, who cannot eat foods un
less they are prepared at home, ruling out the possibility of eating cake, for example, at a
birthday party. Similarly, families experience a social cost because they have to prepare dual
meals plans that often consist of time-consuming recipes. Thus, unless families have addi
tional financial or social assistance, the GFCF diet can represent a significant burden to a
family already struggling with caring for a child with autism.
Despite the continuing popularity of this diet, only five controlled studies have been pub
lished since 1999. Three of these studiesKnivsberg [47], Whiteley [48], and Johnson[49]
were not double-blind. That is, parents not only knew when their children were receiving
the GFCF diet but were also responsible for implementing it. Of these three single blind
studies, Knivsberg [47] and Whiteley [48] reported positive findings but have been criticized
for their reliance on reports from parents who were not blinded to the dietary intervention.
However, it should be noted that Knivsberg [47] conducted a year-long study and some pro
ponents of the GFCF diet suggest that the short duration of other clinical trials may have
been responsible for the insignificant findings.
The other two studies were double blind randomized control trials. In the first study, Elder
[50] partnered with researchers and staff at the University of Floridas (UF) General Clinical
Research Center [now part of UFs Clinical Translational Science Institute Research (CTSI)]
to conduct the first double-blind placebo controlled clinical trial of the GFCF diet that was

http://dx.doi.org/10.5772/54303
published in The Journal of Autism and Developmental Disorders (2006). The researchers evalu
ated the effects of the GFCF diet on: (a) autistic symptoms as measured by the Childhood
Autism Rating Scale (CARS), Ecological Communication Orientation Scale (ECOS), and be
havioral frequencies of child social and language behaviors, and (b) urinary peptide levels
of gluten and casein. After videotaping the participating 13 children, aged 2 to 16 years, dur
ing in-home play sessions for 15 minutes before the diets introduction, at the end of the first
6-week period, and at the completion of the 12-week protocol, Elder [50] found that group
analysis showed no significant differences in any of the outcomes measured or urinary pep
tide levels of gluten and casein. Even when they were told that the findings were insignifi
cant, parents of nine children kept the children on the diet, indicating that a strong parent
placebo effect may exist and be responsible for perpetuating the diets popularity.
In the second study by Hyman [51], children were given the GFCF diet and provided with
food challenges; that is, snacks that contained gluten or casein, and which were disguised so
that the participants could not identify if the snacks were GFCF. As in the other clinical tri
als, these investigators used a variety of well-established outcome measures but like Elder
[50], found no significant differences or empirical support for the diet. Despite the insignifi
cant findings, the GFCF diet continues to be popular with parents, leading to the authors
published recommendations about how to properly advise families regarding diet: first, pa
rents may use the GFCF diet as long as the child does not have a severely restricted food
repertoire that could lead to a nutritional deficiency; and second, the family has the social
and financial resources to continue the diet [7].
Similar to dietary interventions, nutritional supplements are frequently used by parents to
to treat their childs symptoms although there is little sound empirical evidence to support
their efficacy in autism. Vitamins C, D, and the B vitamins are generally known to improve
immunity, brain function, and overall nervous system activity [52-55]. As a result, they are
often included in special autism supplements, which are specifically blended to treat au
tism-related symptoms. Other supplements that are frequently used include probiotics and
digestive enzymes, which may help treat gastrointestinal problems such as acid reflux and
constipation, and melatonin, a natural sleep aid that may help reduce nighttime sleep dis
turbances [56]. Finally, Omega-3 fatty acids, which have been shown to enhance neurologi
cal health in the general population, are currently being evaluated in several clinical trials
for the treatment of autism [57]. Despite the lack of empirical support for these supplements,
most are generally considered harmless if administered in age-appropriate doses.
6.3. Other approaches
Because of speculation that oxygen flow to the brain is reduced in children with autism,
hyperbaric treatments, in which individuals with autism are placed in a chamber and ex
posed to very high oxygen levels, have become popular. In 2009, the US ABC news network
broadcast a story, The Search for a Cure describing preliminary results from a trial by Dr.
Daniel A. Rossignol, himself a father of two children with autism. He and his colleagues
evaluated hyperbaric treatment in 56 children with varying degrees of autism ranging in age
from 2 to 7 years [58, 59]. Reports were positive, indicating that 30 percent of the children
511
512
who received the treatment had greatly increased functioning, while only 8 percent in the
control group did. In response to this study, Paul Ott, a M.D., autism expert, and author of
Autisms False Prophets commented on the questionable efficacy of the treatment and empha
size its potential to financially drain families [60]. For example, a one-hour treatment can
cost $100 to $900, and generally at least 40 are recommended. Despite his warning, however,
the ABC report concluded on an approving note by stating, While its positive effects re
main unclear, hyperbaric chamber therapy does not present the dangers that other therapies
do, thus encouraging parents to consider using an unproven and expensive treatment.
Although hyperbaric treatments are one of the latest alternative therapies to become popu
lar in the autism community, parents have long used other unsubstantiated, pharmaceutical
approaches. For example, antibiotics have often been prescribed for children with autism
who have frequent respiratory or gastrointestinal infections; similarly, antifungal agents,
such as nystatin and fluconazole, have been prescribed for children who suffer from an
overgrowth of gastrointestinal yeast (e.g. Candida) [61]. In both situations, the medications
are prescribed due to the erroneous belief that an infection or imbalance is the root cause
of the disorder. Other speculative treatments include the intravenous administration of se
cretin, a gastrointestinal hormone, and immunoglobulin-G, an immune system antibody,
which are popular because of a few, uncontrolled studies that demonstrated improvement
[62]. Despite their questionable efficacyseveral gold standard clinical trials have invalidat
ed the use of secretinalternative treatments are high in demand, generating countless arti
cles on the Internet, and sparking heated discussion on autism message boards [63]. This
prevailing popularity, which shows no sign of slowing in the future, is a testament to the
struggle many parents experience in caring for a child with autism.
Another popular, yet more controversial treatment is chelation therapy, which removes
mercuryan alleged contributor to autismfrom the body. When using this therapy, pa
rents typically have a medical doctor treat their child for lead poisoning or they may also
buy unregulated chelation agents from Internet sites. Unlike hyperbaric treatment and other
interventions that are intended to complement evidence-based treatments, advocates of che
lation therapy espouse it as a cure. Yet, to date, there is no proven link between mercury
exposure and autism [64]. Joecker, a researcher from the Mayo Clinic warns that not only is
chelation therapys efficacy unproven, but also that it can be associated with serious side ef
fects, including potentially deadly liver and kidney damage and as a result should be assid
uously avoided [65].
7. Interventions with empirical validation

After the preceding discussion of popular yet largely unproven interventions, the author
would be remiss not to provide at least a brief overview of interventions that are empirically
sound. Because autism presentations can vary greatly among individuals, each intervention
should be customized to meet the needs of the individual child, and be accompanied with
the early speech/language and occupational therapy that are typically indicated.

http://dx.doi.org/10.5772/54303
In addition to the special education and pharmacological interventions that may be necessa
ry, traditional treatment approaches include providing a child with speech, behavioral, oc
cupational, and physical therapy as indicated in some cases. Although public schools in the
United States are required by law to provide such services, the frequency, type, and quality
of these services vary considerably. Consequently, parents need to actively participate in
meetings where Individualized Educational Plans (IEP), or the equivalent, are developed to
specifically address a childs behavioral or learning needs. Furthermore, parents should
maintain close contact with educational personnel to help evaluate their childrens progress
and determine the future direction of treatment.
If the future direction includes medications, parents must carefully analyze the costs and
benefits by questioning their health care provider regarding possible improvements and
side effects. Although medications do not cure autism, sometimes they can alleviate behav
ioral symptoms that distress the child and interfere with therapeutic efforts such as inten
sive education and socialization [66-68]. These behavioral symptoms include hyperactivity,
self-injury, aggression, compulsions (repetitive behaviors), mood lability, anxiety, and sleep
disturbances [69].
In addition to medication, parents may consider using a behavioral intervention, which re
searchers have refined over time and developed into a highly successful treatment ap
proach. In particular, two comprehensive behavioral early interventionsLovaas Model
based on Applied Behavior Analysis (ABA) and the Early Start Denver Modelhave been
shown to be helpful in improving symptoms related to autism [70, 71]. Mounting evidence
also supports the use of other commonly used therapies such as Floortime, Pivotal Response
Therapy and Verbal Behavior Therapy [72-74]. For up-to-date information regarding behav
ioral interventions, visit the website for Autism Speaks, an internationally recognized organ
ization within the autism community, at http://www.autismspeaks.org/what-autism/
treatment. By visiting this site, parents will learn about the many valid treatments available
that are safe, effective, and capable of producing a better quality of life for children with au
tism and their families.
8. Relationship of family training intervention research to NIHs

priorities and NIMHs sponsored work-group recommendations
Finding ways to improve quality of life for ADS children and their families is one of the top
priorities of NIH and congressionally mandated research as noted in the Combating Autism
Act of 2006 [75, 76]. A report from a NIMH-supported work group of well-known autism
authorities addresses what has traditionally been problematic in the field of autism [77];
namely, that fragmented and isolated individual study approaches have not been effective
in systematically advancing the most effective behavioral interventions [78]. In response,
Smith et al. proposed a developmental process for designing and conducting studies on psy
chosocial interventions in autism, which provides a way to systematically validate and dis
seminate interventions; the process includes the following steps: (a) conduct initial efficacy
513
514
studies that may utilize intrasubject methodology to provide in-depth information about in
dividual responses over time, (b) manualize the intervention and pilot-test it with larger
numbers of participants, (c) conduct clinical trials to test the efficacy under controlled condi
tions, and (d) conduct effectiveness studies to evaluate outcomes in community settings.
The author and team have been following a developmental sequence that is consistent with
that of the NIMH work group and especially part of the final stepevaluating outcomes in
community settings. Delivering the training to all family members including siblings, and
providing training interventions using state of the art internet technology would greatly ex
pand our ability to deliver comprehensive family-centered training in the community, and
produce significant gains that would improve the quality of life for individuals with autism
and their families.
Author details
Jennifer Elder
University of Florida College of Nursing, Gainesville, Florida, USA
References
[1] Ross EK-R, Kessler D. Finding the meaning of grief through the five stages of loss.
New York: Scribner; 2007 2007. 256 p.
[2] Gross D, Fogg L, Tucker S. The efficacy of parent training for promoting positive pa
rent-toddler relationships. Research in Nursing and Health. 1995;18(6):486-99.
[3] Webster-Stratton C, Herbert M. What really happens in parent-training? Behavior
Modification. 1993;17:407-56.
[4] Bettelheim B. Feral Children and Autistic Children. american Journal of Sociology.
1959;64(5):455-7.
[5] Eisenberg L. THE FATHERS OF AUTISTIC CHILDREN*. American Journal of Or
thopsychiatry. 1957;27(4):715-24.
[6] Kanner L. Autistic disturbances of affective contact. Nervous Child. 1943;2:217-50.
[7] Elder J, Donaldson S, Kairella J, Valcante G, Bendixen R, Ferdig RE, et al. In-home
training for fathers of children with autism: A follow up study and evaluation of four
individual training components. Journal of Child and Family Studies. 2010;20(3):
263-71.

http://dx.doi.org/10.5772/54303
[8] Elder J, Valcante G, Yarandi H, White D, Elder TH. Evaluating in-home training for
fathers of children with autism using single-subject experiementation and group
analysis methods. Nursing Research. 2005;54(1):22-32.
[9] Rogers SJ. Evidence-based interventions for language development in young chil
dren with autism. Social & communication development in autism spectrum disor
ders. T. S. Charman, W. ed. New York: Guildford Press; 2006. p. 143-79.
[10] Mundy P, Sigman M, Kasari C. A longitudinal study of joint attention and language
development in autistic children. Journal of Autism and Developmental Disorders.
1990;20(1):115-28.
[11] Wetherby AM. Understanding and measuring social communication in children with
autism spectrum disorders. New York: The Guildford Press; 2006. pp. 3-34.
[12] Elder J. In-home communication intervention training for parents of multiply handi
capped children. Scholarly Inquiry for Nursing Practice. 1995;9:71-92.
[13] Flippin M, Crais ER. The need for more effective father involvement in early autism
intervention. Journal of early intervention. 2011;33(1):24-50.
[14] Bendixen R, Elder J, Donaldson S, Kairella J, Valcante G, Ferdig RE. Perceived stress
and family dynamics in fathers and mothers of children with autism following an inhome intervention. American Journal of Occupational Therapy. 2011.
[15] Smith L, Elder J. Siblings and family environments of persons with autism spectrum
disorder: a review of the literature. Journal of child and adolescent psychiatric nurs
ing: official publication of the Association of Child and Adolescent Psychiatric
Nurses, Inc. 2010;23(3):189-95. Epub 2010/08/28.
[16] Lobato DJ, Kao BT. Integrated Sibling-Parent Group Intervention to Improve Sibling
Knowledge and Adjustment to Chronic Illness and Disability. Journal of Pediatric
Psychology. 2002;27(8):711-6.
[17] Fisman S, Wolf L, Ellison D, Freeman T. A longitudinal study of siblings of children
with chronic disabilities. Canadian journal of psychiatry Revue canadienne de psy
chiatrie. 2000;45(4):369-75. Epub 2000/05/17.
[18] Hastings RP, Kovshoff P, Ward H, J. N, Espinosa F, Brown T, et al. Systems Analysis
of Stress and Positive Perceptions in Mothers and Fathers of Pre-School Children
with Autism. Journal of Autism and Developmental Disorders. 2005;35(5):635-44.
[19] Blacher J, Begum G. The Social and the Socializing Sibling: Positive Impact on Chil
dren with Autism. Exceptional Parent. 2009;39(5):56-7.
[20] Hodapp RM, Urbano RC. Adult siblings of individuals with Down syndrome versus
with autism: findings from a large-scale US survey. Journal of Intellectual Disability
Research. 2007;51(12):1018-29.
[21] Maynard AE, Martini MI. Learining in cultural context: Family, peers, and school.
New York: Kluwer Academic/Plenum Publishers; 2005.
515
516
[22] Orsmond GI, Kuo HY, Seltzer MM. Father involvement with adolescents and adults
with autism. 13th World Congress of the International Association for the Scientific
Study of Intellectual Disabilities; Cape Town, South Africa2008.
[23] Baer D, Wolf M, Risley T. Some current dimensions of applied behavior analysis.
Journal of Applied Behavior Analysis. 1968;1:92-7.
[24] Internet World Stats, (2010).
[25] Gentles JS, Lokker C, McKibbon AK. Health information technology to facilitate com
munication involving health care providers, caregivers, and pediatric patients: a
scoping review. J Med Internet Res. 2010;12(2):e22.
[26] Fletcher PC, Markoulakis R, Bryden PJ. The costs of caring for a child with an autism
spectrum disorder. Issues in comprehensive pediatric nursing. 2012;35(1):45-69. Epub
2012/01/19.
[27] NINDS, (2009).
[28] McConachie H, Diggle T. Parent implemented early intervention for young children
with autism spectrum disorder: a systematic review. Journal of evaluation in clinical
practice. 2007;13(1):120-9. Epub 2007/02/09.
[29] Lecavalier L, Leone S, Wiltz J. The impact of behaviour problems on caregiver stress
in young people with autism spectrum disorders. Journal of Intellectual Disability
Research. 2006;50(Pt 3):172-83. Epub 2006/01/25.
[30] Davis NO, Carter AS. Parenting stress in mothers and fathers of toddlers with autism
spectrum disorders: associations with child characteristics. Journal of Autism and
Developmental Disorders. 2008;38(7):1278-91. Epub 2008/02/02.
[31] Herring S, Gray K, Taffe J, Tonge B, Sweeney D, Einfeld S. Behaviour and emotional
problems in toddlers with pervasive developmental disorders and developmental
delay: associations with parental mental health and family functioning. Journal of In
tellectual Disability Research. 2006;50(12):874-82.
[32] Hastings RP, Kovshoff H, Brown T, Ward NJ, Espinosa FD, Remington B. Coping
strategies in mothers and fathers of preschool and school-age children with autism.
Autism. 2005;9(4):377-91.
[33] Jones J, Passey J. Family Adaptation, Coping and Resources: Parents of Children
with Developmental Disabilities and Behaviour Problems. Journal of Developmental
Disabilities. 2005;11(1).
[34] Rao PA, Beidel DC. The Impact of Children with High-Functioning Autism on Paren
tal Stress, Sibling Adjustment, and Family Functioning. Behavior Modification.
2009;33(4):437-51.
[35] Giarelli E, Souders M, Pinto-Martin J, Bloch J, Levy SE. Intervention pilot for parents
of children with autistic spectrum disorder. Pediatric nursing. 2005;31(5):389-99.
Epub 2005/11/22.

http://dx.doi.org/10.5772/54303
[36] Phetrasuwan S, Miles MS, Mesibov GB, Robinson C. Defining Autism Spectrum Dis
orders. Journal for Specialists in Pediatric Nursing. 2009;14(3):206-9.
[37] Sharpley C, Bitsika V, Efremidis B. Influence of gender, parental health, and per
ceived expertise of assistance upon stress, anxiety, and depression among parents of
children with autism. Journal of Intellectual & Developmental Disability. 1997;22(1):
19-28.
[38] Beckman P. Comparison of mothers' and fathers' perceptions of the effect of young
children with and without disabilities. American Journal on Mental Retardation.
1991;95:585-95.
[39] Bristol M, Gallagher J, Schopler E. Mothers and Fathers of Young Developmentally
Disabled and Nondisabled Boys: Adaptation and Spousal Support. Developmental
Psychology. 1988;24:441-51.
[40] Wolf L, Goldberg B. Autistic children grow up: An eight to twenty-four year followup study. Canadian Journal of Psychiatry. 1986(31):550-6.
[41] Trute B. Gender Differences in the Psychological Adjustment of Parents of Young,
Developmentally Disabled Children. Journal of Child Psychology and Psychiatry.
1995;36(7):1225-42.
[42] Hastings RP, Johnson E. Stress in UK families conducting intensive home-based be
havioral intervention for their young child with autism. Journal of Autism and De
velopmental Disorders. 2001;31(3):327-36. Epub 2001/08/24.
[43] Wong VC, Kwan QK. Randomized controlled trial for early intervention for autism: a
pilot study of the Autism 1-2-3 Project. Journal of Autism and Developmental Disor
ders. 2010;40(6):677-88. Epub 2009/12/19.
[44] Myers SM, Johnson CP. Management of children with autism spectrum disorders.
Pediatrics. 2007;120(5):1162-82. Epub 2007/10/31.
[45] Christison GW, Ivany K. Elimination diets in autism spectrum disorders: any wheat
amidst the chaff? Journal of developmental and behavioral pediatrics : JDBP.
2006;27(2 Suppl):S162-71. Epub 2006/05/11.
[46] Group GDS. Gluten Free Casein Free Diet Success Stories. Gluten Free Casein Free
Diet website: The GFCF Diet Support Group; 2012 [cited 2012 August 14]; Available
from: http://www.gfcfdiet.com/successstories.htm.
[47] Knivsberg A, Reichelt K, Hoien T, Nodland M. A randomised, controlled study of di
etary intervention in autistic syndromes. Nutrition Neuroscience. 2002;5(4):251-61.
[48] Whiteley P, Rodgers J, Savery D, Shattock P. A Gluten-Free Diet as an Intervention
for Autism and Associated Spectrum Disorders: Preliminary Findings. Autism.
1999;3(1):45-65.
517
518
[49] Johnson C, Handen B, Zimmer M, Sacco K, Turner K. Effects of Gluten Free / Casein
Free Diet in Young Children with Autism: A Pilot Study. Journal of Developmental
and Physical Disabilities. 2011;23(3):213-25.
[50] Elder J, Shankar M, Shuster J, Theriaque D, Burns S, Sherrill L. The Gluten-Free, Ca
sein-Free Diet In Autism: Results of A Preliminary Double Blind Clinical Trial. Jour
nal of Autism and Developmental Disorders. 2006;36(3):413-20.
[51] Hyman JM, Zilli EA, Paley AM, Hasselmo ME. Working memory performance corre
lates with prefrontal-hippocampal theta interactions but not with prefrontal neuron
firing rates. Frontiers in Integrative Neuroscience. 2010;4.
[52] Martin A, Cherubini A, Andres-Lacueva C, Paniagua M, Joseph J. Effects of fruits
and vegetables on levels of vitamins E and C in the brain and their association with
cognitive performance. The journal of nutrition, health & aging. 2002;6(6):392-404.
[53] Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about
vitamin D functions in the nervous system. Trends in Endocrinology & Metabo
lism. 2002;13(3):100-5.
[54] Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins
A and D take centre stage. Nat Rev Immunol. 2008;8(9):685-98.
[55] Reynolds E. Vitamin B12, folic acid, and the nervous system. The Lancet Neurology.
2006;5(11):949-60.
[56] Golnik AEIM. Complementary Alternative Medicine for Children with Autism: A
Physician Survey. Journal of Autism and Developmental Disorders. 2009;39(7):
996-1005.
[57] Amminger GP, Berger GE, Schfer MR, Klier C, Friedrich MH, Feucht M. Omega-3
Fatty Acids Supplementation in Children with Autism: A Double-blind Randomized,
Placebo-controlled Pilot Study. Biological Psychiatry. 2007;61(4):551-3.
[58] Brownstein J. Hyperbaric Autism Treatment Shows Possible Promise2009. Available
from: http://abcnews.go.com/Health/AutismNews/story?id=7070353&page=1.
[59] Rossignol DA, Bradstreet JJ, Van Dyke K, Schneider C, Freedenfeld SH, O'Hara N, et
al. Hyperbaric oxygen treatment in autism spectrum disorders. Medical gas research.
2012;2(1):16. Epub 2012/06/19.
[60] Offit P. Autism's False Prophets: Bad Science, Risky Medicine, and the Search for a
Cure. New York, NY: Columbia University Press; 2008.
[61] Shute N. Alternative biomedical treatments for Autism: How good is the evidence?
2010:[3 p.]. Available from: http://www.scientificamerican.com/article.cfm?id=alter
native-biomedical-treatments&page=2&WT.mc_id=SA_emailfriend.
[62] Unproven Treatments for Autism2010 August 13, 2012. Available from: http://
www.webmd.com/a-to-z-guides/unproven-treatments-for-autism-topic-overview.

http://dx.doi.org/10.5772/54303
[63] Krishnaswami S, McPheeters ML, Veenstra-VanderWeele J. A Systematic Review of

Secretin for Children With Autism Spectrum Disorders. Pediatrics. 2011;127(5):e1322e5.
[64] Weber W, Newmark S. Complementary and alternative medical therapies for atten
tion-deficit/hyperactivity disorder and autism. Pediatric clinics of North America.
2007;54(6):983-1006; xii. Epub 2007/12/07.
[65] Hoecker JL. Is chelation Therapy an effective autism treatment?2010. Available from:
http://www.mayoclinic.com/health/autism-treatment/AN01488.
[66] Malone RP, Gratz SS, Mary Anne D, Hyman SB. Advances in Drug Treatments for
Children and Adolescents with Autism and Other Pervasive Developmental Disor
ders. CNS Drugs. 2005;19(11):923-34.
[67] Rapin I. The Autistic-Spectrum Disorders. New England Journal of Medicine.
2002;347(5):302-3.
[68] West L, Waldrop J. Risperidone use in the treatment of behavioral symptoms in chil
dren with autism. Pediatric nursing. 2006;32(6):545-9. Epub 2007/01/30.
[69] King BH, Bostic JQ. An Update on Pharmacologic Treatments for Autism Spectrum
Disorders. Child and Adolescent Psychiatric Clinics of North America. 2006;15(1):
161-75.
[70] Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized,
Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver
Model. Pediatrics. 2010;125(1):e17-e23.
[71] Anderson SR, Romanczyk RG. Early Intervention for Young Children with Autism:
Continuum-Based Behavioral Models. Research and Practice for Persons with Severe
Disabilities. 1999;24(3):162-73.
[72] Wieder S, Greenspan SI. Climbing the symbolic ladder in the DIR model through
floor time/interactive play. Autism. 2003;7(4):425-35. Epub 2003/12/18.
[73] Simpson RL. Evidence-Based Practices and Students With Autism Spectrum Disor
ders. Focus on Autism and Other Developmental Disabilities. 2005;20(3):140-9.
[74] Sundberg ML, Partington JW. Teaching language to children with autism or other
developmental disabilities. Danville, CA: Behavior Analysits, Inc.; 1998.
[75] Combating Autism Reauthorization Act, Stat. S.1094 (2011).
[76] Committee IAC. Summary of Advances in Autism Spectrum Disorder Research: Cal
endar Year 20102010. Available from: http://iacc.hhs.gov/summary-advances/2010/.
[77] Smith T, Scahill L, Dawson G, Guthrie D, Lord C, Odom S, et al. Designing research
studies on psychosocial interventions in autism. Journal of Autism and Developmen
tal Disorders. 2007;37:354-66.
519
520
[78] Committee IAC. 2011 IACC Strategic Plan for Autism Spectrum Disorder Research.
Department of Health and Human Services Interagency Autism Coordinating Com
mittee website2011 [cited 2012 May 15].
Chapter 23
Collaboration Between Parents of

Children with Autism Spectrum Disorders and
Mental Health Professionals
Efrosini Kalyva
http://dx.doi.org/10.5772/53966
1. Introduction
When mental health professionals and parents of children with autism spectrum disorders
start working together, they bring into this relationship their own personal needs, concerns,
priorities and responsibilities, which must be taken into consideration in order to create a
mutually satisfactory and functional partnership. A partner is a person that one works with
in order to achieve a common goal through shared decision-making and risk-taking. Some
partnerships last for a short period of time and include casual encounters, while others last
long and evolve through numerous official and unofficial encounters [1]. For a partnership
model to work, all involved parties must understand how they feel about each other [2] and
to recognize that family operates as a system. When parents and mental health professionals
disagree, it is essential to resolve any conflict timely in order to avoid serious confrontations
or even legal litigations [3].
Minuchin [4] was the first who introduced the theory of family systems and stated that
individuals affect the context where they live and are in turn affected by it through a
series of repeated interactions. So, whatever affects one family member affects the whole
family in direct or indirect ways. Elman [5] describes families as the mobile that hangs
over a babys crib, with the pressure exerted on one end causing movement throughout.
The relationships between family subsystems (spouses, parents and children, and sib
lings) determine the balance of the entire family [6] and interventions at any subsystem
must aim to preserve this balance. For example, an intervention aiming at fostering the
mother-child bond could affect the mothers relationship with her husband or her other
children if the necessary actions are not taken. Family subsystems describe the interac
2013 Kalyva; licensee InTech. This is an open access article distributed under the terms of the Creative
522
tions within the family context, whereas cohesion and adaptability describe the way in
which family members interact.
Cohesion is inherent to the notions of engagement and disengagement. Some families with
high levels of engagement do not have clear boundaries between the subsystems, are overly
engaged in the therapeutic process and overprotective [4] and as a result do not allow the
individual with autism spectrum disorders to develop a sense of autonomy. On the other
hand, families with extremely low levels of engagement adopt rigid boundaries and do not
interact with the child sufficiently. So, the child with autism spectrum disorders is left free,
but without experiencing the necessary love and support. The degree to which a family ad
justs to the diagnosis of autism spectrum disorders depends to a large extent on the pre-ex
isting family cohesion and stability, while the disruption of family cohesion due to the birth
of a child with autism spectrum disorders can lead to increased stress [7]. In order to deal
with stress, families employ either internal coping strategies that include passive evaluation
or active reframing or external coping strategies through social and spiritual support [8].
Adaptability refers to the familys ability to change its functioning when a stressful event
occurs [9]. Family adaptability depends on the severity of autism spectrum disorders, as
well as on the accumulation of the demands made on parents [10]. Rigid families do not
change to face the stress, while chaotic families become unstable and face changes incon
sistently. The families that do not manage to adapt successfully are at risk of becoming
isolated and dysfunctional [11]. According to family systems theory the disruption of
communication among family members is a sign of dysfunction of the whole system and
not of a specific individual. Therefore, mental health professionals should aim at chang
ing interaction patterns and not just individuals, without incriminating anyone. Many
family members tend to blame the individual with autism spectrum disorders for the dif
ficulties that they experience, but with the appropriate guidance they perceive that mis
communication is often to blame [12].
Most studies conducted with families of individuals with disabilities are based on the as
sumption that families are homogeneous [13], but there are many features that differentiate
families between them. For example, unemployed parents of a child with autism spectrum
disorders have access to different resources than high-income parents [1]. Moreover, single
mothers of children with autism spectrum disorders experience heightened stress, since they
lack the practical, financial and moral support of their partner [14]. Cultural and contextual
factors can also affect the ways that families cope with disabilities. First generation Ameri
cans with Chinese origin are afraid that their children with autism spectrum disorders will
be stigmatized if they use sign language or other alternative forms of communication [15].
Parental reactions to their childs disorders must be viewed and interpreted within the so
cial, historical, and ecosystemic context of every family [16]. Parents initially experience a
stage of shock [17], which is followed by a range of reactions that could eventually lead
through consecutive reorganizations to adjustment to reality [18]. However, many parents
regress to previous stages when they realize that their children with autism spectrum disor
ders face difficulties that will not disappear and that they need constant care. In order to
support parents of children with autism spectrum disorders, mental health professionals
Collaboration Between Parents of Children with Autism Spectrum Disorders and Mental Health Professionals
http://dx.doi.org/10.5772/53966
must know the characteristics of the disorder and set realistic goals both for children with
autism spectrum disorders and their families [19].
Many researchers have established that parents of children with disabilities and mental
health professionals must cooperate in order to design and implement an effective therapeu
tic process [20-23]. Therefore, parental involvement in the planning of proper therapeutic in
tervention for children with autism spectrum disorders was the primary target of many
programs since the beginning of the 1980s [24]. Parents have been treated as partners, con
sultants, advocates, and supporters by the mental health professionals who offer these serv
ices. Parents often seek to work together with mental health professionals as they try to help
their children overcome the difficulties that they face [25-26]. So, empowering the coopera
tion between parents and mental health professionals has been a cornerstone for many con
temporary care systems for individuals with disabilities [27]. In order to achieve this
empowerment, it is important to increase parental autonomy and engagement in decisionmaking regarding the therapeutic goals [28].
It is expected that the cooperation between parents and mental health professionals will
result to better services for the children with disabilities, since the knowledge and the ex
perience that each person brings into this relationship are unique [29]. The problem is
that many mental health professionals cannot treat parents as equal partners in this proc
ess [30]. Through their training, mental health professionals develop an area of expertise
that places them almost automatically at the role of the expert. Sharing responsibility
with parents, without having a clear hierarchy, creates a new structure that is opposite
to the traditional nature of the relationship between parents and mental health professio
nals. However, the position and the authority of the mental health professionals have
been challenged and transformed according to contemporary political and theoretical
models, as can be seen below:
1.1. Professional as experts
This is the traditional cooperation model that is prominent in doctor-patient relation
ships, where the professionals use their position and their knowledge to decide what
will happen. Parental participation is of secondary importance and compliance with the
professionals suggestions is self-evident. Parents are informed about the decisions that
were taken without being allowed to express their opinions, feelings, needs, or wishes.
Children are treated as the passive recipients of a therapy, while parents are thought not
to have the time, the disposition, the skill or the knowledge to help their children. This
relationship is very bureaucratic and rigid, because it disadvantages parents by making
them dependent on the professional [31]. Moreover, when mental health professionals do
not engage parents actively in their childs treatment there may be a disagreement be
tween the therapeutic goals they set [31-32]. The exclusion of parents from the therapeu
tic process has been highly criticized since the beginning of the 1970s, since the
relationship between parents and mental health professionals becomes impersonal and
the sense of trust is lost [33]. Therefore, parents started gradually being involved in the
therapeutic process [34] and a lot of emphasis was placed on this involvement [35]. It
523
524
should be pointed out, that even though this kind of relationship is outdated, there are
still mental health professionals who impose themselves on parents.
1.2. The transitional relationship
Mental health professionals started treating parents as co-therapists and realizing that the
house can be used as a learning setting. They shared and transfered their skills to pa
rents to help them become more able, more confident, and more skilled. Parents partici
pate as co-teachers or co-trainers or co-therapists [18]. Mental health professionals
have to adapt their methods in order to incorporate and to support their cooperation
with parents. So, they have to discover ways to communicate with parents and to en
gage them in the therapeutic process. Parents who cooperate with mental health profes
sionals become more able, more knowledgeable and more assertive [36]. The main
drawback of this model is the underlying assumption that all parents have the motive
(and are able) to use this professional knowledge to help their child. It ignores the differ
ences that exist in parenting styles, family relationships, family resources, family values
and cultural contexts. For example, some parents may not feel comfortable acting as
teachers of their children [37]. Many interventions have focused solely on mothers and
have left out fathers creating disruption to the family system. This relationship is not tru
ly cooperative, since mental health professionals make the basic decisions and are still in
control [31].
1.3. Parent as consumers
The consumer model [31] stated that parents should have new rights and be given part
of the control. Parents are viewed as consumers, who have the right to choose the appro
priate services and interventions for their children. It is the first time that mental health
professionals recognize that parents possess specialized knowledge that they lack. Pa
rents use their knowledge to decide what they want and what they need for their child.
Mental health professionals guide parents to make more effective and appropriate deci
sions. Parents may choose not to attend some of the suggested services that they do not
consider suitable. Decision-making is reached after mutual exchange of ideas and with
mutual respect. The objective is to reach a mutual agreement on the treatment that the
child will follow. This model can be quite effective in various intervention settings [38].
The cooperation is very important, since parents have a greater sense of control. The
services that adopt this model must be very flexible to provide individualized support
[39]. This model presupposes that parents are capable to express and to assert their
needs and the needs of their children. However, some parents cannot prioritize their
needs or assume the responsibility of making important decisions. The concept of pa
rents as consumers who share resources may not be very realistic in a restrictive finan
cial context that offers minimal services. In this case the consumers do not necessarily
buy the best services and many parents cannot afford the increased financial demands of
the most effective therapies. This model is similar to counseling that is offered to parents
to help them resolve some personal issues.
http://dx.doi.org/10.5772/53966
1.4. he empowerment model

This model has added a social and systemic dimension to the consumer model [39], since
parents have the right to choose the services that they will offer to their child and mental
health professionals realize that family is a system and a social network. Every family com
prises of interconnected social relations within the context of the family itself as well as
within the wider social groups (extended family, friends, associates, cultural groups). The
system and the network affect the ways in which the family members view the individual
with disabilities. Given that each family has different advantages, parents have a unique ad
justment method and mental health professionals need to understand and respect that. Men
tal health professionals should also help parents realize that they can monitor their childs
progress and interfere when they identify a problem.
1.5. The negotiation model
Partners use negotiation to reach common decisions and to resolve any disagreements that
may arise. Negotiation can lead either to a common decision or to disagreement. Disagree
ments can come up for various reasons, such as the priorities that are set by each interested
party [40]. The negotiation model states that the ways that parents and mental health profes
sionals view a situation or a problem, the options that they have to resolve it, and the extent
to which they can face it, are affected by their roles as well as the social, financial, and
structural frames where they function. Therefore, according to this model, cooperation may
be dysfunctional under the three following conditions:
1.
Either parents or mental health professionals do not have the intention or the skill to
work with each other and to enter a cooperative relationship. Personal experiences may
decrease the likelihood to cooperate [1].
2.
Either parents or mental health professionals make all decisions and are not willing to
share responsibility [41].
3.
If the interests, the views, the priorities and the values of parents and mental health
professionals are contradictory, then their relationship may become competitive even
if they apply various conflict resolution strategies.
Some organizations are eager to engage parents in the therapeutic process not because they
recognize parental rights but because of staff shortage or scarce financial resources [36]. Pa
rents should be involved in decision-making regarding their children because mental health
professionals need their cooperation to do their job properly. Parents will also have a chance
to establish and generalize at home the skills that their children have mastered [38]. In order
for parents and especially mothers to function as therapists, they must devote a lot of
time to meeting with mental health professionals to receive the proper training [42]. Parents
of children with disabilities need guidance and support to be effective in their role [43-45];
otherwise, they will loose their self-esteem and become ineffective [46].
For the negotiation model to work, it has to operate at five different levels: personal, in
terpersonal, organizational, institutional, and ideological [40]. The sense of cooperation
525
526
encourages the productive combination of knowledge, skills, and sensitivities from both
parents and mental health professionals. The six elements that characterize a cooperative
relationship and differentiate it from other types of relationships are [47]: a) cooperation
is optional; b) cooperation demands equity among the participants; c) cooperation is
based on mutual goals; d) cooperation depends on shared responsibility and decisionmaking; e) people who cooperate share their resources; and f) people who cooperate are
equally responsible for the outcome.
Within this model, mental health professionals should have a clearly defined relationship
with parents that has four predetermined goals [48]: a) include parents in decision-making
about their child; b) train parents to participate in decision-making about their child; c) help
parents therapeutically to deal with some issues that stop them from functioning more effec
tively; and d) render parents capable to work effectively and meaningfully with their child
through empowerment.
The negotiation model has many functioning aspects that facilitate the development of a co
operative relationship between parents and mental health professionals, since it is develop
mental and parents are not viewed as static agents. They are encouraged to develop and
improve their skills to become more effective and to work on their personal issues. In order
to meet with the demands of this new role, mental health professionals are often called to
take on multiple roles and to become more flexible. They may need to act as mediators be
tween the parents and other agents, as well as to fight for the rights of the parents and their
children with disabilities especially in times of financial and moral crisis.
1.6. How do parents feel about mental health professionals?
Individuals with autism spectrum disorders depend on their families for daily care and sup
port that are essential for the successful implementation of any therapeutic intervention [49].
Therefore, it has been acknowledged that the needs of all the family members should be tak
en into consideration when designing an intervention [50]. Many highly recommended
treatments for autism spectrum disorders [see 49, for more information] such as Applied
Behavioral Analysis [51], TEACCH [52] and Portage [53] stress the importance of active
parental participation in the therapeutic process, which results from the proper cooperation
with mental health professionals. However, many parents claim that their participation in
their childrens therapy is minimal and restrained to six-monthly briefing meetings, while
they are not informed that they could be more actively involved in the treatment process
[54]. Parents must be treated as partners during the planning, implementation, and evalua
tion of the therapeutic approach and not just as observers or clients [55].
Many parents complain because they have to wait a long time to diagnose their children
with autism spectrum disorders and they need to visit up to four different mental health
professionals [54]. In a small scale study where parents of 25 children with autism spectrum
disorders were interviewed, it was found that these parents have to take their children to
different therapeutic settings, which is extremely time consuming. They work together with
an average of six mental health professionals for a total of approximately 37 hours per week
[56]. Since parents are often exposed to many diverse opinions and suggestions expressed
http://dx.doi.org/10.5772/53966
by mental health professionals, they end up being confused and they need guidance to
make the right choices and decisions [1]. Therefore, mental health professionals who work
therapeutically with the parents of children with autism spectrum disorders should assume
also a counseling role [57].
Parents need to be extremely persistent in order to ensure the services and the provi
sions that are necessary for their children with autism spectrum disorders [58-59]. Pa
rents started questioning the power of mental health professionals when they formed
groups to fight for their rights. An extreme example of disappointment with mental
health professionals was the creation of a centre of counseling and support for the pa
rents of children with special needs that was created by parents and to which mental
health professionals had no access [2]. The parents who founded this centre stressed that
it provided them with the opportunity to talk and to share their experiences giving
them, thus, the strength to deal with their daily problems.
Despite the fact that parents were overall satisfied with the mental health professionals they
had worked with in the past, they generally felt that they had to fight in order to access the
services that their children needed. They reported that many mental health professionals
failed to communicate with each other and with the parents and this created a heightened
sense of dissatisfaction. This was due to the fact that most children were monitored simulta
neously by several mental health professionals who seemed to work in isolation without
sharing information and common therapeutic goals. Furthermore, many parents supported
that the services they received did not suffice to address their childrens multiple and com
plex needs [3]. Moreover, some parents claim that they are tired of being accused for the
problems that their children face [60] and that constant criticism does not help them become
better and more effective parents. Paradoxically, although some mental health professionals
view mothers as guilty, they involve them at the same time in their childrens therapy [61].
Crawford and Simonoff [62] studied the attitudes of parents of children attending schools
for emotional and behavioral disorders. Many parents believed that they felt stigmatized
and isolated because of the problems that their children were facing. Although the stigma
accompanying mental health problems or other disorders, such as autism spectrum disor
ders is well recognized, there is limited research on the topic. Parents feel lonely and with
out any support, but they hesitate to share their concerns with others, because they are
afraid that they will be further stigmatized and held responsible for their childrens prob
lems. So, it is not surprising that parents were excited to meet with other parents who face
similar problems and can offer them valuable support.
Parents of children with special needs are often dissatisfied with the way that mental health
professionals behave and with the attitudes that they express. However, most relevant re
search has not studied the actual interaction between parents and mental health professio
nals, but they are based on parental anecdotal evidence that is usually negative [63-64]. If
the behaviors that parents report are accurate, then they constitute a breach of the professio
nal code of ethics [65] and should be seriously taken into consideration. On the other hand,
many parents appreciate that mental health professionals try to understand the family dy
namics and to address the individual needs of every family member [66] and there are also
527
528
quite a few parents who mention that mental health professionals have done their best to
help them and their children with autism spectrum disorders [54].
The mental health professionals who interact with children with autism spectrum disorders
and their families come from different educational and theoretical backgrounds, as well as
from different disciplines: specialized professionals (such as psychologists, speech thera
pists, and social workers), doctors, teachers or students. Despite the fact that the contribu
tion of mental health professionals to the planning and effectiveness of the treatment has
been widely acknowledged, more research is needed on identifying how they deal with
practical problems that arise during the course of their interactions with parents of children
with autism spectrum disorders. The role of mental health professionals and therapists has
been approached primarily by the psychoanalytic perspective and most studies have fo
cused only on the role of the teacher of children with autism spectrum disorders.
1.7. How do mental health professionals feel about parents?
The beliefs and the assumptions that mental health professionals hold regarding parental
contribution to the appearance and maintenance of their childrens problematic behaviors
and disorders greatly affect their choice of offered therapies and the intervention strategies
that they use when interacting with the specific families [67]. Even the term professional
has been controversial, since some refer to the traditional definition of professional (e.g.,
doctors, lawyers, architects, university professors), while others use this term to refer to
most working people (e.g., nurses, social workers, and teachers) [68]. The term mental
health professionals is now used to include all the educated people who have received the
appropriate training to work with individuals with disabilities. It is used to make the dis
tinction between trained staff and volunteers, carers, or untrained helping staff who work
with individuals with disabilities.
There are different sources of socially acceptable power for mental health professionals
[69]: physical power, power to provide resources, power of profession, power of specializa
tion and personal power. For many years now, the role of mental health professionals is pre
determined to provide them with the power and the right to use their knowledge and their
experience as they wish. They have resources at their disposal that they can share with chil
dren with disabilities and their families, as well as the specialized knowledge that they have
acquired through their training. Mental health professionals are usually considered experts,
since they are knowledgeable about an area or a topic. In case that some parents disagree or
refuse to cooperate with mental health professionals, the latter have the right to stop provid
ing their services. Mental health professionals can have considerable power and so many pa
rents treat them with respect.
The attitudes and perceptions of mental health professionals regarding their relation with
the parents of children with disabilities have not been adequately researched [70]. Smets [71]
explored staff attitudes regarding parental involvement in a service for individuals with in
tellectual disabilities and found that staff believed that parents were either unaware or indif
ferent to their childrens problems. Staff believed that parents were limited to the role of the
external observer and they were happy to defer the responsibility of caring for their child to
http://dx.doi.org/10.5772/53966
another person. However, the researcher stressed that the perception of the staff did not cor
respond to reality and to the actual needs of the families of the service users.
Some mental health professionals recognize the importance of working together with the
parents, but they claim that they are not adequately trained or prepared to do so and they
receive no support from their services [72-74]. To address this issue, it is important to better
understand the skills and the behaviors that mental health professionals need in order to
learn how to cooperate with parents [75-76]. Interpersonal skills, such as sensitivity towards
the parents, clarity and respect are usually highly appreciated by parents who work togeth
er with mental health professionals in early intervention settings [77].
1.8. Cooperation between parents and mental health professionals
Cooperation is a term that was recently introduced to literature looking at the relationship
between parents and mental health professionals, but is quite difficult to accomplish in prac
tice given that it means different things to different people. Cooperation can be viewed as
basic principle or theoretical viewpoint that is based on fundamental power exchange [78].
However, there are many organizational, geographical or financial obstacles in the coopera
tion between different groups of mental health professionals or between mental health pro
fessionals and service users that is, parents of children with disabilities [79-81]. The
potential cooperation between mental health professionals and parents is based mainly on
the anticipation that there will be an increase in the number and quality of offered services.
However, many mental health professionals feel threatened when they have to choose who
will have access to each service, especially when the choices are limited [82].
The cooperation between parents and mental health professionals is not just desirable
but also mandatory, since it is enforced by law in many countries [20, 83]. It has been
widely accepted that a healthy cooperative relationship between parents and mental
health professionals can lead to timely conflict resolution and benefit children with disa
bilities [84-85]. This cooperation is even more vital in early intervention programs, which
are family-centered [86] and through parental empowerment [87] there is a greater sense
of parental accomplishment [88].
Most relevant studies show that parents and mental health professionals are familiar
with cooperative relationships through their interpersonal experiences [89-90]. Functional
cooperative relationships are characterized by trust, respect, communication and shared
vision that are essential to make decisions that will lead to increased communication
[91], inclusion [92], and appropriate service provision for children with disabilities [93].
Some research also shows that teachers prefer to have a closer and more meaningful re
lationship with parents of children with disabilities [94]. The existence of supportive rela
tionships among parents and mental health professionals is the most important
determinant of a successful cooperative relationship [75].
Despite the existing legislations in some European countries and the wishes of both pa
rents and mental health professionals, it is often extremely difficult to create successful
and functional cooperative relationships [95-96]. For example, in the context of family-
529
530
centered early intervention cooperation remains an utopia [86]. Although mental health
professionals seem to favor cooperative relationships with parents, research shows that
there is a big gap between theory and practice [97]. Relevant studies [98] that were con
ducted using either focus groups or interviews and questionnaires showed that the basic
problem is that mental health professionals do not treat parents as equal partners and
continue to maintain control. So, the failure to establish cooperative relationships is due
to the fact that that there are no trusting and empowering relationships between parents
and mental health professionals [11, 99].
This failure to create cooperative relationships could also be caused by the inadequate defi
nition of cooperation [100] that hinders the quest for a common goal through functional in
teractions [101-103]. There are six factors that are essential for the establishment of a
cooperative relationship between parents of children with disabilities and mental health
professionals and form the basis of the partnership protocol that will be presented later on
in the chapter [104]. These factors are:
a.
communication: parents stressed that communication with mental health professionals

must be honest, frequent and open, with no hidden agendas. Mental health professio
nals should inform parents also about unpleasant developments in the therapeutic
process but without becoming rude or aggressive and without using jargon. Parents
want to have access to information regarding other services that are available for their
children. Communication should be a two-way process, with both parents and mental
health professionals listening to each other without being critical. Mental health profes
sionals seem to agree about the necessity of open and honest communication with the
parents that can form the basis of a trusting relationship.
b.
commitment: mental health professionals should not view what they do as a simple job
that pays for their expenses and treat children with disabilities just as another client or
case that is filed. They must value the individual and pay attention to the relationship
with the whole family of the child with disabilities. It is noteworthy that some parents
thought that mental health professionals should greet them if they meet somewhere in
public as a sign of respect and professional commitment. Many mental health professio
nals recognized the importance of commitment and argued that they often have to deal
with parents who do not want to be involved with the therapeutic process or get in
volved in decision-making regarding their child. However, this should not stop them
from making the effort to work closely with the parents.
c.
equity: mental health professionals must make conscious efforts to empower the fami
lies that they work with, recognizing the importance of parental knowledge instead of
devaluing it. Parents should be encouraged to express their opinions and to be fully en
gaged in decision-making in the context of a constructive exchange of ideas. Attention
is needed to keep the very thin line between empowering the parents and giving them
too much independence that could jeopardize the therapeutic process.
d.
skills: parents tend to admire the mental health professionals who make the difference
by offering practical help both to them and to their children with disabilities and who
http://dx.doi.org/10.5772/53966
are skilled and well trained. Mental health professionals should have high expectations
from the children that they work with if they are going to try hard to make some prog
ress and reach the goals that they have set. Parents appreciate the mental health profes
sionals who have the strength and the will to be constantly updated about the new
developments in their areas of expertise. Most mental health professionals referred to
the skills that they expect from their colleagues but not from parents (this partly reflects
their lack of trust in a cooperative relationship with the parents).
e.
trust: this term has three different meanings according to the context where it is used. It
means reliability in the sense that mental health professionals should honor their prom
ises any way they can. It is equal to security, in the sense that parents need to feel that
their children with disabilities are safe both physically and emotionally when in the
company of mental health professionals. The third dimension of trust is the discretion
that mental health professionals should possess regarding the information that they
share with colleagues about a child.
f.
respect: a sign of respect is that mental health professionals treat the child with disabili
ties as a human being and not as a label or a diagnosis, that they are polite, considerate,
punctual, and up-to-date with recent developments in the field. Several parents men
tioned that these simple rules of courtesy and proper behavior are often overlooked in
daily encounters. Many mental health professionals admit that the lack of respect to pa
rents can cause severe damage to the therapeutic relationship.
It is interesting to note that parents and mental health professionals seem to agree on
what they think constitutes a desirable and proper cooperative relationship. They may
differ in the importance that they place on each factor and in whether they identify it as
essential or not for the success of the cooperation. Both sides recognize that for a cooper
ative relationship to work, both parents and mental health professionals should do their
best keeping in mind the interests of the child with disabilities. This study [104] empha
sizes that it is imperative to conduct further research to create guidelines to delineate the
relationship between parents and mental health professionals, rendering it thus more sat
isfactory and more effective. This is the aim of the present study that aspires through the
use of a partnership protocol to delineate the relationship between parents of children
with autism spectrum disorders and mental health professionals a need that was iden
tified also by other researchers [16, 105].
Because of the heterogeneity of the symptoms and characteristics of autism spectrum disor
ders, the diagnosis usually does not provide useful suggestions for the appropriate treat
ment [106]. Successful therapeutic interventions develop when parents and mental health
professionals work together as a coordinated and cooperative team [107]. In order to deal
with the needs of children with autism spectrum disorders and their families the program
COMPASS was created [54], which aims at the cooperation between staff and parents to de
sign the most appropriate therapeutic intervention for each child. The greatest challenge
that mental health professionals who work with the families of children with autism spec
trum disorders have to face is to ensure that these children attend the therapeutic interven
tions that best suit their unique and complicated needs [108]. Parental attitudes and parental
531
532
satisfaction are widely used as indications of the success of early intervention programs
[109]. Since parents are the ones caring for their children with autism spectrum disorders,
their views should be seriously taken into consideration by mental health professionals. Pa
rental concerns and preferences can be used to improve offered services, while parental sat
isfaction can be translated into a measure of success of a therapeutic intervention [110].
The interaction between parents of children with autism spectrum disorders and mental
health professionals is crucial in special needs education because of the high incidence of au
tism spectrum disorders in the school population and the lack of resources [111-112]. How
ever, this interaction is often fragmentary and characterized by confusion, disappointment,
and tension that result to low levels of cooperation and decreased quality of service provi
sion to the child with autism spectrum disorders [111].
The relationship between parents of children with autism spectrum disorders and teachers
is also worth exploring [113-114], especially given that many children with autism spectrum
disorders have communication deficits and cannot express themselves and their needs
[115-116]. Research so far suggests that trust is built almost exclusively on personal interac
tions, encounters, and exchanges. Every encounter between parents and teachers turns into
an opportunity to expand and to strengthen the bonds of trust between the interested par
ties. Of course, if parents suspect that teachers are not worthy of their trust, then the bonds
that are created are very fragile. Many parents seek to create a strong bond with their childs
teachers, because they believe that this will benefit their child [11, 117]. In order to build up
their trust, both parents and teachers should state clearly and openly their expectations from
this relationship in an effort to minimize misunderstandings [118].
Mental health professionals often have to announce bad news to parents regarding their
childs diagnosis and prognosis, which cause drastic and often negative changes in their
lives [119-120]. Since parents have the unquestionable right to know the truth about their
childs condition, the question is not whether the mental health professionals will share the
news but how they will do it [120]. Many mental health professionals have been criticized
for the abrupt way in which they communicate upsetting news to the parents [46] and the
detrimental effects this can have on the parents is a matter of great concern [121]. However,
if the briefing is done properly, then this can be extremely useful for them, since they will be
able to understand their childs needs and design the appropriate treatment plan [122].
Despite the significant increase in knowledge about the causes and course of autism spec
trum disorders [123] and the appreciation of the importance or early diagnosis [124], there
have been no noteworthy changes in the information that parents receive in their first con
tact with mental health professionals. Some studies [125-126] have looked at the interaction
between parents and mental health professionals during the dissemination of the assess
ment conclusions. It was found that mental health professionals are aware of the dilemma of
delivering upsetting news and seek the active participation of the parents in a joint articula
tion of the problem. Some mental health professionals ask parents first to express their opin
ions about their childs problems and then they share the diagnosis to corroborate the
parents perspective [127]. Other mental health professionals present a series of related gen
eral and specific symptoms that lead to a specific diagnosis and then allow parents to state
http://dx.doi.org/10.5772/53966
the final diagnosis [126]. Usually, mental health professionals try to bridge the gap between
their views and parental views by modifying the diagnostic label, so as to comply with pa
rental wishes and to balance the levels of optimism and pessimism [125].
Parental satisfaction is an important element for the evaluation of the services that are of
fered to children with disabilities and their families [128] and can be related to other family
variables, such as stress or depression [129], increased empowerment [130] or increased
school involvement [131]. Some qualitative studies have shown that parents who are not sat
isfied with their relationship with mental health professionals experience stress and do not
feel welcome in the decision-making process regarding their children [59]. There are also
some documented cases of parents who were so unsatisfied with the early intervention pro
grams their children attended that they removed them from the program [132]. On the other
hand, there are many qualitative studies of families that come from different cultural back
grounds and report that parents who are satisfied with the services provided to their chil
dren tend to engage more in their training [133].
Research on parental satisfaction asks parents to evaluate the quantity or the quality of the
services that their children receive, as well as the nature of their relationship with mental
health professionals [128, 131]. However, there is still a basic gap in identifying a widely ac
cepted definition of parental satisfaction and which intervention model can be implemented
to increase this satisfaction [77]. In a survey of satisfaction among 290 parents of children
with autism spectrum disorders [134], it was found that most individualized educational
plans were not developed in cooperation with mental health professionals, they did not re
flect the views and the concerns of the family and they were not successfully coordinated by
the many different people who run the services. In another similar study [108] it was report
ed that most of the 539 parents had difficulty finding about the available services and ac
cessing them. They also claimed that they were not given any choice, that they had to fight
for what they wanted and that ultimately the received services differed greatly from what
they had originally asked for. Finally, more than half of the parents who participated in an
other study [135] complained that they were not fully informed about the available services
or the structural changes that were taking place in different agencies and that they were un
happy with their cooperation with mental health professionals. All these problems seem to
be even more prominent for the families of children with autism spectrum disorders who
have to interact with various mental health professionals, such as pediatricians, psycholo
gists, speech therapists and many others [136].
1.9. The present study
The concept of boundaries is inherent in human relations and cooperation and represents
the rules and limitations that can create a sense of safety [137]. In strictly professional rela
tionships the involved parties have a clearly defined role that they hesitate to deviate from.
However, in many mental health services professionals may fulfill various practical, infor
mative, and emotional needs of the individuals who use these services and their families
[105]. Despite the fact that the codes of ethics of different professional bodies offer guide
lines for the behaviors that protect mental health professionals against extreme cases of con
533
534
flict of interest or client exploitation for own purposes, there are no guidelines for the
delineation of daily interactions between mental health professionals and service users [138].
The code of ethics in special needs education does not address sufficiently the boundaries in
relationships between mental health professionals and parents of children with disabilities
[105] and this can hinder the establishment of a cooperative relationship between them [11].
So, it is imperative to create a form for the negotiation of the boundaries in daily interactions
between parents and mental health professionals in order to make decisions about how,
when and why the involved parties will interact [105]. This is how the partnership protocol
that will be presented in this chapter was created on the basis of the codes of ethics of the
British Psychological Society [139], the American Psychological Association [140], and the
Health and Care Practitioners Council [141]. The aim of this study was to explore whether
this partnership protocol could change the perceptions of parents of children with autism
spectrum disorders and mental health professionals about their relationship. More specifi
cally, it was hypothesized that parents of children with autism spectrum disorders would
hold more positive attitudes about mental health professionals after the implementation of
the partnership protocol. Mental health professionals would also express more positive atti
tudes towards the parents of autism spectrum disorders after the implementation of the
partnership protocol.
2. Methods
2.1. Participants
The participants of this study were 40 mental health professionals working in the private sector
with children with autism spectrum disorders and their families (18 men and 22 women): 5
psychiatrists, 10 speech therapists, 12 occupational therapists, 7 psychologists and 6 special ed
ucators. Their age ranged from 26 to 55 years old (mean age = 42 years and 2 months) and they
have been working with children with disabilities from 3 to 30 years (mean years of professio
nal experience = 17 years). The mean time that they have been working therapeutically with a
child with autism spectrum disorders was 2 hours per week. Forty mothers and fathers of chil
dren with autism spectrum disorders from Northern Greece also took part in the study. There
were 33 mothers and 7 fathers, aged 29 to 42 years old (mean age = 34 years and 7 months). Ten
mothers were housewives, 17 were private employees, 9 were public employees, and 4 were
self-employed. One quarter of the parents had one child, 24 had two children and 6 had three
children. Most parents lived with their spouses, while 4 mothers were divorced and raised
their children alone. All the parents had a child diagnosed with autism spectrum disorders
from a public child psychiatric or child developmental clinic. The mean age of their childs di
agnosis was 4 years and 8 months. Out of the 40 children with autism spectrum disorders there
were 7 girls and 33 boys and their age ranged from 3.5 to 14 years old. Ten children attended
special schools, 22 attended inclusion classes and the remaining 8 were in mainstream schools.
The parents were in contact with more than 5 mental health professionals from the time they
started seeking for a diagnosis and visited someone to help their children with autism spec
trum disorders for an average of 5 years and 3.5 hours per week.
http://dx.doi.org/10.5772/53966
2.2. Measures
2.2.1. Partnership protocol
The partnership protocol (please see Appendix) is a document that aims to delineate the re
lationship between mental health professionals and the parents of children with autism
spectrum disorders. It defines partnership as a functional relationship characterized by a
common goal, mutual respect and desire for negotiation. The protocol is two pages long in
order to be handy and to offer condensed information in the 11 following areas: 1) coopera
tion between parents and professionals, 2) negotiation of boundaries in parent-professional
relationship, 3) parental expectations/feelings/needs, 4) parental accuracy and reporting of
knowledge, 5) parental understanding of their childs condition, 6) parental participation in
decision-making, 7) parents as therapists, 8) parental briefing, 9) disclosure of information to
parents or third parties, 10) family discord and 11) negotiation of parent-professional disa
greement. The partnership protocol was piloted with five parents and seven mental health
professionals.
2.2.2. Parent measures
The parents completed a brief questionnaire at baseline, which included the following infor
mation: gender, age, educational level, profession, number of children, age of child with au
tism spectrum disorders, gender of child with autism spectrum disorders, age of diagnosis
of child with autism spectrum disorders, agency of diagnosis of the child with autism spec
trum disorders, years of cooperation with mental health professionals, weekly contact fre
quency with mental health professionals and number of mental health professionals with
whom they have cooperated so far. Then, parents were asked to define the relationship be
tween parents and mental health professionals; to specify what they expect from coopera
tive mental health professionals; to mention the problems that they face from uncooperative
mental health professionals; to describe what they do in case of disagreement with mental
health professionals; to define negotiation and to judge if it is necessary for a successful ther
apeutic relationship; and to document the three advantages and the three disadvantages of
their relationship with mental health professionals.
Parents were asked after the intervention to state whether the protocol was useful or not jus
tifying their answers; whether any points needed further clarification; which were the most
important points of the protocol; how often they used it; if it helped them define the nature
of the relationship that they had with the mental health professionals; what happened in
case of disagreement with mental health professionals; whether the protocol helped them re
solve any disagreement with mental health professionals; and whether anything had
changed in their relationship with mental health professionals.
In order to measure parental views about mental health professionals, the Helping Behavior
Checklist (CBCL) [142] was used, since it was based on the codes of ethics of six internation
al organizations of mental health professionals. The first part, which was used in this study,
consists of 16 statements that parents have to rate on a 4-point scale (where 1 = almost al
ways true and 4 = almost never true), such as the mental health professional clearly ex
535
536
plained to me what I had to do to help my child, the mental health professional did not
involve me in any decision-making regarding my childs therapy and the mental health
professional held me responsible for my childs problems. Scores are reversed in some
items and the total score for the scale varies from 16 to 64. This questionnaire is highly corre
lated to parental satisfaction about their childs progress since they started working with the
specific mental health professional. Test-retest reliability varies from 0.48 to 0.89 for a period
of 2-3 weeks [142]. The Cronbach of the scale for this study was high = 0.89 and deemed
satisfactory.
2.2.3. Mental health professionals measures
The mental health professionals filled in a brief questionnaire at baseline with demographic in
formation: age, gender, profession, years of professional experience, as well as weekly frequen
cy of sessions with children with autism spectrum disorders. Then they were asked to define
the relationship between parents and mental health professionals and what they expect from
cooperative parents; to mention the problems that they face from uncooperative parents; to
state whether their cooperation with parents is necessary for successful intervention; to de
scribe what they do in case of disagreement with parents; to define the concept of negotiation
and to judge if it is necessary for a successful therapeutic relationship; and to document the
three advantages and the three disadvantages of their relationship with parents.
Mental health professionals were asked after the intervention to state whether the protocol
was useful or not justifying their answers; whether any points needed further clarification;
which were the most important points of the protocol; how often they used it; if it helped
them define the nature of the relationship that they had with parents; what happened in
case of disagreement with parents; whether the protocol helped them resolve any disagree
ment with parents; and whether anything had changed in their relationship with parents.
The views of mental health professionals about the parents of children with autism spec
trum disorders they worked with were measured using Providers Beliefs About Parents Ques
tionnaire (PBAP) [143], which is based on some concerns that parents expressed about the
attitudes or the behaviors of some mental health professionals who worked with their chil
dren with disabilities. It consists of 37 statements that mental health professionals have to
rate on a 4-point scale (where 1 = completely disagree and 4 = completely agree). There are 5
subscales: a) parental incrimination, which consists of nine statements, such as the most
common cause of severe emotional disorder in children is their parents behavior or the
most common cause of emotional problems in children is their parents emotional inadequa
cy; b) necessity of informing parents, which consists of ten statements, such as it is usu
ally advisable to offer parent unlimited access to their childs files or all parents must be
informed on how exactly a therapy is expected to help their child; c) recognition of paren
tal status, which consists of seven statements, such as parents of children in need of men
tal health services are usually emotionally involved to such an extent, that they do not
accurately report their childs behavior or parents possess special knowledge that mental
health professionals lack; d) attitudes towards drug use, which consists of six statements,
such as drugs usually help to deal with autism or the possible merit of drug therapy
http://dx.doi.org/10.5772/53966
should be taken into consideration in most cases of autism; and e) providing guidance to
parents, which consists of four statements, such as it is not usually recommended to in
form parents about what they can do exactly to help their child or it is therapeutically ac
ceptable to brief parents directly about what they should do to help their child with autism.
Scoring is reversed for some statements and the total score varies from 37 to 148. External
validity ranges from 0.60 to 0.87 for each subscale [143] and test-retest reliability for the
whole scale is 0.89 for a period of 2-3 weeks. Cronbach for this study was very high for the
whole scale ( = 0.93) and is deemed extremely satisfactory.
2.3. Procedure
The researcher approached mental health professionals who were working privately with
children with autism spectrum disorders in Northern Greece and briefed them about the
study. She identified potential participants from the professional phone book and the lists of
professional bodies in the area and then randomly pulled 100 papers with names from a
container. She contacted them and 68 expressed an initial interest in the study, while 45
ended up agreeing to participate. The next step was to ask these mental health professionals
to draw a list with the children with autism spectrum disorders they were working with at
that time and the researcher randomly selected one family. The mental health professionals
were given the task to brief the families and in case the parents expressed an interest the re
searcher met with them as well. There were some families who did not want to participate
in the study, so another family was selected in their place until every mental health profes
sional was matched to a family of a child with autism spectrum disorders. The parent from
each family who participated was the one who was more in charge of the childs therapy
and was in more frequent and direct contact with the mental health professional. This was
deemed essential in order to follow the partnership protocol and to explore its effectiveness.
Before the beginning of the intervention the researcher informed the participants that they
could withdraw at any time without penalty and that all the information that they provided
would be confidential. Then, she gave out the baseline questionnaires that were filled out
individually in the office of the mental health professionals and in the presence of the re
searcher. The next step was to present the partnership protocol to the participants in detail,
to go through it with them and to answer any questions they might have. The intervention
started when all participants reassured the researcher that they had fully understood the
content of the partnership protocol and it lasted for six months. During this time the re
searcher called the participants monthly to check the progress of the data collection and to
ask if there were any issues that needed to be addressed. Meanwhile, five parents discontin
ued the intervention at different points due to time restraints (one parent), health problems
(two parents), or because they stopped taking their child to the particular mental health pro
fessional. So, the researcher asked the corresponding mental health professionals to stop us
ing the protocol and the final number of participants was decreased to 40 parents of children
with autism spectrum disorders and 40 mental health professionals.
Data collection was completed after a series of face-to-face meetings with every participant,
who was asked after the intervention to fill in the same questionnaire as in baseline and to
537
538
answer some additional questions about the protocol. The answers of the participants in the
open-ended questions were explored with thematic analysis, which led to the categories that
are presented. A second rater with experience with this type of analysis looked at approxi
mately half of the data and the interrater reliability was extremely satisfactory (95.7%).
3. Results
Data analysis revealed that after the intervention parents of children with autism spectrum
disorders were more satisfied with their cooperation with mental health professionals. Fol
lowing the implementation of the partnership protocol mental health professionals tended
to blame parents less for their childrens problems, gave them more information about their
childrens situation and directions on how they should behave, while they also recognized
more their parental status.
3.1. Parents of children with autism spectrum disorders
3.1.1. Baseline data
The characteristics of a satisfactory cooperative relationship between parents and mental
health professionals according to parents were: honesty, mutual briefing, mutual trust and
setting common goals. Parents believed that cooperative mental health professionals pro
vide constant briefing on the childs progress (90%); implement the therapy with consistency
(68%); are honest with parents (49%); recognize parental skills (40%); understand parental
wishes and problems (35%); and really want to help (10%). Uncooperative mental health
professionals, on the other hand, do not brief parents about their childs progress (88%); do
not implement the therapy consistently (73%); are dishonest with parents (50%); do not un
derstand parental wishes and aspirations (43%); withhold information related to the therapy
(23%); and are not knowledgeable about autism spectrum disorders (20%).
The vast majority of the parents (88%) thought that it is essential to cooperate with mental
health professionals in order for the therapy to succeed and approximately 75% reported
that they should actively participate in their childs therapy. The rest of the parents consid
ered that nothing can be done to alter the predetermined course that their children with au
tism spectrum disorders will follow. When a disagreement occurred with mental health
professionals, most parents insisted and discussed with them when they believe that they
were right, while they backed down when they were not certain. Parents defined negotia
tion as: clear expression of views from both sides; understanding with the childs progress
as a common goal; arrangement of a time frame for the accomplishment of some results; and
expression of realistic expectation from both parties. Indeed, almost 2/3 of parents (68%) re
ported that negotiation is essential for a successful therapeutic relationship. The advantages
and the disadvantages that parents identified in their relationships with mental health pro
fessionals are presented in Tables 1 and 2 respectively.
http://dx.doi.org/10.5772/53966
1. Encouragement about the childs progress
14
35
2. Genuine interest in the child and the family
10
25
3. Cooperation between parents and mental health professionals
17.5
4. Provision of practical advise to parents
12.5
5. Regular verbal communication with parents
7.5
6. Provision of support in all the areas of the childs development
2.5
Table 1. Advantages of Working with Mental Health Professionals According to the Parents of Children with Autism
Spectrum Disorders
1. Dishonesty about the childs progress
12
30
2. Lack of genuine interest in the child and the family
22.5
3. No understanding of parental needs
17.5
4. Inability to realize what is promised
12.5
5. Insensitivity to familys needs
10
6. Overcharging for the therapy
7.5
Table 2. Disadvantages of Working with Mental Health Professionals According to the Parents of Children with
Autism Spectrum Disorders
3.1.2. Post-intervention data

Most parents (87%) stated that the partnership protocol was useful, because it provides a
clear context for the relationships between parents and mental health professionals, it de
fines the roles of both parties, it promotes the positive cooperation that contributes to the
childs progress and it familiarizes parents with their rights. The remaining 13% claimed
that the protocol is not useful because it is binding and difficult to adhere to. Some parents
said that the protocol should also clarify which qualifications mental health professionals
should hold in order to work with children with autism spectrum disorders and what pa
rents can do if mental health professionals do not follow the protocol.
The most important points of the partnership protocol were: ensured cooperation, honest re
lationships, understanding of parental limitations, parental participation in decision-mak
ing, and recognition of parental needs and emotions. Parents referred to the protocol every
time that something changed in their childs therapy or a problem came up, as well as in
case of disagreement with mental health professionals. The changes that parents observed in
their relationship with mental health professionals after the implementation of the protocol
were: parents and mental health professionals cooperated more effectively (32%); mental
health professionals offered psychological support to parents (25%); mental health profes
539
540
sionals took parental needs and expectations into account (19%); parents learned how to act
as therapists for their children at home (13%); a time frame was set for the therapy (9%); and
mental health professionals did not treat parents just as an income source (3%).
3.1.3. The attitudes of parents of children with autism spectrum disorders towards mental health
professionals
Paired-samples t-test was use to compare differences in parental attitudes towards mental
health professionals before and after the implementation of the partnership protocol. Before
the intervention ( = 31.95, SD = 8.64) parents expressed statistically significant less positive
attitudes towards mental health professionals (t(1, 39) = 107.25, p < 0.001, 2 = 0.73) than after
the intervention ( = 28.65, SD = 7.67).
3.2. Mental health professionals
3.2.1. Baseline data
The characteristics of a satisfactory cooperative relationship between parents and mental
health professionals according to mental health professionals were: the exchange of ideas
about the child, shared decision-making, mutual trust and respect, will to negotiate, and fre
quent contact. Mental health professionals believed that cooperative parents provide accu
rate information about their children (78%); follow their advise (68%); are honest about their
childs condition (50%); are interested to learn more about their child (43%); do not have un
reasonable expectations for their childs progress (42%); and actively participate in their
childs treatment. Uncooperative parents, on the other hand, provide inaccurate information
about their children (80%); question the mental health professional (60%); do not understand
their childs condition (53%); do not keep certain agreements (45%); have irrational demands
for their childs progress (38%); do not participate in their childs therapy (25%); and do not
behave consistently (20%).
The vast majority of mental health professionals (93%) claimed that it is necessary to cooper
ate with parents for the success of the therapeutic intervention, since parents: possess valua
ble knowledge about their child that can be used in therapy, can complement the therapists
work and spend a lot of time with the child. In order to ensure parental cooperation, mental
health professionals make parents feel more comfortable; brief them regularly about their
childs progress; show sensitivity to the childs problems; express positive attitudes towards
the child and the parents; promote parental beliefs that their child can improve with the
proper therapy and support; take parental needs and wishes into account; engage parents in
decision-making; gain parental trust; and try to specialize in autism spectrum disorders.
When mental health professionals disagree with parents, they tend usually to have an open
and honest discussion with them, to engage them in decision-making, to be discrete, and to
present their arguments. They may even resort to another mental health professional and in
the end they make the final decisions if they cannot reach an agreement with the parents.
Mental health professionals defined negotiation as exchange of ideas with the childs inter
est in mind, defining the boundaries of the cooperation, determining the expectations from
http://dx.doi.org/10.5772/53966
the therapy, setting mutual goals, discussing new possibilities, and compromising, if neces
sary. The advantages and the disadvantages that mental health professionals identified in
their relationships with parents are presented in Tables 3 and 4 respectively.
1. Interest in their childs therapy
38
95
2. Willing to devote time to their child
35
88
3. Realistic expectations about their childs progress
27
68
4. Active participation in their childs therapy at home
22
55
5. Source of important information for the child
19
48
6. Willing to cooperate with mental health professionals
14
35
7. Trust mental health professionals
10
25
8. Wish a better future for their child
23
9. Encourage other family members to participate in therapy
15
Table 3. Advantages of Working with Parents of Children with Autism Spectrum Disorders According to Mental
Health Professionals
1. No understanding of the childs condition
33
83
2. Emotional overload
30
75
3. Provision of inaccurate information
29
73
4. Refusal to engage actively in therapy
25
63
5. Exaggerated and unrealistic expectations
25
63
6. Unwillingness to cooperate
20
50
7. Lack of trust in mental health professionals
18
45
8. Feelings of parenting inadequacy
16
40
9. Insecurity for their childs future
15
38
10. Parental disagreements about their child
13
33
11. Rejection of the diagnosis of autism spectrum disorders
10
25
12. Experience of guilt over the childs condition
20
13. Crossing the boundaries (e.g., calling in the middle of the night)
15
14. Insisting on their views, even when they are wrong
10
Table 4. Disadvantages of Working with Parents of Children with Autism Spectrum Disorders According to Mental
Health Professionals
3.2.2. Post-intervention data

Most mental health professionals (80%) claimed that the partnership was useful, because it
sets the boundaries of the cooperation, it promotes negotiation, it emphasizes mutual re
spect, it clarifies the need for parental involvement in the therapeutic process and mental
health professionals have a reference point in case of disagreement. The remaining 20% stat
541
542
ed that the protocol is not useful because it is binding and parents who are not educated
cannot understand it. Some mental health professionals said that the protocol should clarify
how much time mental health professionals should devote to parents, what happens when
parents do not follow the protocol, and for which third parties mental health professionals
should get the consent of the parents before they disclose information about their children.
The most important points of the partnership protocol were: the negotiation of the bounda
ries of the relationship between parents and mental health professionals, the clarification of
the roles of both sides, and the emphasis placed on active parental involvement in their
childs therapy. Mental health professionals referred to the protocol every time there was a
disagreement with parents. The changes that mental health professionals observed in their
relationship with parents after the implementation of the protocol were: parental expecta
tions became more relevant to the childs condition (93%); parents realized that the whole
family should be part of the therapy (80%); initial tensions were normalized (75%); parents
felt that their expectations and emotions were taken into account (65%); parents were more
committed to the therapy (58%); parents were more open to new suggestions and treatments
for their child (35%); parents made less calls of hypothetical crises (23%).
3.2.3. The attitudes of mental health professionals towards parents of children with autism spectrum
disorders
Analysis with MANOVA revealed that there was a statistically significant change in four
out of the five subscales that measured the attitudes of mental health professionals towards
the parents of children with autism spectrum disorders, even after being controlled for age,
gender, and years of professional experience. More specifically, there were statistically sig
nificant changes in parental incrimination (F(1, 39) = 5.56, p < 0.05, 2 = 0.12); necessity of in
forming parents (F(1, 39) = 5.03, p < 0.05, 2 = 0.11); recognition of parental status (F(1, 39) = 4.83, p
< 0.05, 2 = 0.10); and providing guidance to parents (F(1, 39) = 5.35, p < 0.05, 2 = 0.12). There
was no statistically significant difference in the attitudes that mental health professionals ex
pressed towards drug use before and after the intervention (F(1, 39) = 0.96, p > 0.05, 2 = 002).
Means and standard deviations are presented in Table 5.
Baseline
Post-intervention
(SD)
(SD)
Parental incrimination
26.69 (3.54)
22.24 (3.44)
5.56*
Necessity of informing parents
14.15 (3.24)
17.93 (2.74)
5.03*
Recognition of parental status
14.06 (2.52)
19 (2.04)
4.83*
Attitudes towards drug use
6.11 (2.18)
8.41 (1.54)
0.96
Providing guidance to parents
3.25 (1.07)
8.17 (2.34)
5.35*
* < 0.05
Table 5. Means and Standard Deviations of the Attitudes of Mental Health Professionals Towards Parents of Children
with Autism Spectrum Disorders Before and After the Intervention
http://dx.doi.org/10.5772/53966
4. Discussion
The research hypotheses were confirmed, since both parents of children with autism spec
trum disorders and mental health professionals expressed more positive attitudes about
each other after the implementation of the partnership protocol. Most participants felt that
the partnership protocol was particularly useful and they also identified some points that
could be further clarified, while they also pointed out the exact nature of the changes that
they have observed in their interactions.
4.1. The attitudes of parents of children with autism spectrum disorders towards mental
health professionals
Most parents of children with autism spectrum disorders believed from the beginning that it
was imperative to work together with mental health professionals in order to enhance their
childs progress, while the rest believed that their childs progress was predetermined and
there was nothing they could do to change that. Parents define a cooperative relationship as
a relationship that is characterized by honesty, mutual briefing, mutual trust, and setting
common goals [27]. The information that parents receive from mental health professionals is
more important to them than sympathy or psychological support [144-145].
Parents describe cooperative mental health professionals as constant providers of update
regarding their childs progress, consistent, honest, understanding, willing to help, and
aware that parents possess certain skills. So, the parents in this study have identified es
sentially the defining characteristics of cooperative relationships [77]. Parents cannot co
operate with mental health professionals who do not brief them, are inconsistent and
insincere, ignore them, withhold information and are not well trained in agreement
with other research [24, 28, 117].
The implementation of the partnership protocol helped the parents of children with autism
spectrum disorders to redefine their cooperative relationship with mental health professio
nals. They learned to function as therapists at home, facilitating thus the therapeutic process
[25-26]. They received emotional support from mental health professionals and they set a
time frame for some therapeutic goals, which could help them feel less stressed [146]. Most
parents reported that after the intervention mental health professionals treated them as
more equals, briefed them about their childs progress, engaged them more actively in the
therapeutic process, and took their feelings and opinions into consideration. This change
may be due to the fact that a trusting relationship was created through the protocol, which
helped the parents express themselves more freely and become more assertive. Trust is im
perative for the creation of a constructive cooperative relationship between mental health
professionals and parents of children with disabilities [104]. Many parents actively seek to
create this bond of trust, since they feel that it will benefit their child [11, 117].
An additional change that was reported by the parents of children with autism spectrum
disorders was that the mental health professionals started briefing them more about the
ways in which the proposed therapy will help their child and encouraged them to get ac
543
544
tively involved in decision-making regarding their childs treatment. Active participation in

their childs therapy can help parents develop a sense of efficacy and personal control that
can help them become even more effective parents [87] and less stressed and concerned
[147]. When parents feel heard and respected, then they can cooperate better with mental
health professionals to do what is best for their child and this is something that mental
health professionals should aim at [66].
4.2. The attitudes of mental health professionals towards parents of children with autism
spectrum disorders
Mental health professionals tended to incriminate parents of children with autism spectrum
disorders less after the implementation of the protocol. This is very important, since it af
fects greatly the choice of suggested therapies and strategies that mental health professio
nals employ when interacting with the parents of children with autism spectrum disorders
[67]. Since parents of children with autism spectrum disorders have been repeatedly blamed
for the problems that their children face [148], the partnership protocol encourages the crea
tion of a relationship that frees parents from guilt and treats them as equal partners. After
the implementation of the partnership protocol, mental health professionals realized that it
is essential to inform parents about their childs condition and the course of the therapy. The
needs of all family members are taken into consideration [50] and, therefore, frictions are de
creased [3, 11, 99]. So, it is possible to create a strong cooperative relationship that can bene
fit both parties [40, 47], while children with autism spectrum disorders can also benefit from
parental empowerment [149].
The mental health professionals who adopted the protocol said that they recognized more
the validity of parental knowledge and information regarding their child with autism spec
trum disorders. This change is very positive, since parents of children with autism spectrum
disorders know a lot of things about their children that are useful when planning the appro
priate intervention [61]. The acknowledgement of the usefulness of parental knowledge by
mental health professionals is essential to the cooperative process [60] and is, thus, empha
sized in the partnership protocol.
Moreover, mental health professionals understood that they need to provide more clear and
more detailed information to parents about the management and upbringing of their chil
dren with autism spectrum disorders. The partnership protocol stressed that parents can be
trained to satisfy the needs that arise from their parenting role and this is instrumental for
various therapeutic approaches [16]. Parents who receive specific guidance on how to deal
with challenging and unwanted behaviors believe that they can control them better [150]
and so they feel less stressed [146]. However, it is worth pointing out that some parents can
not or do not want to fulfill their instructional role [151] and this is something that mental
health professionals should respect.
The statistical analysis revealed that the perceptions that mental health professionals hold
about the parents of children with autism spectrum disorders were not affected by their age,
gender, or years of professional experience. Therefore, it is likely that they are affected by
http://dx.doi.org/10.5772/53966
their training and by the social representations that they hold about parents of children
with autism spectrum disorders [152], as well as by cultural and social factors [18].
Almost all the mental health professionals believed that their cooperation with the parents
of children with autism spectrum disorders was essential to the successful course of the
therapy [86, 128], since they bring their own knowledge and experience into the therapeutic
process [29]. Therefore, they claimed that in order to ensure this cooperation they try to earn
parental trust and to make them feel comfortable, while taking into account their needs and
wishes. By briefing parents about their childs progress, they engage them more actively in
decision-making regarding the treatment course [93]. However, it is worth mentioning that
at the beginning of the study parents complained that mental health professionals do not try
enough to cooperate with them. This could be due to a wider communication problem that
has been documented also in other studies, since good intentions alone are not enough to
establish cooperation [86, 94]. Finally, mental health professionals claimed that they tried to
increase their knowledge through training in order to be able to better deal with the prob
lems of children with autism spectrum disorders. This needs to be done if mental health pro
fessionals are to design an intervention that is based on the childs needs and skills and is
more likely to be successful [49].
Mental health professionals define cooperation as a relationship that is characterized by ex
change of views about the child, shared decision-making, mutual trust and respect, desire to
resolve disagreement, frequent contact and discussion on equal terms (there is no expert)
[15, 59, 89, 93]. This definition that they provided includes some of the key characteristics of
the negotiation model [40].
Parents should provide accurate information about their child that is essential for the es
tablishment of a cooperative relationship with mental health professionals [77]. Other
wise, mental health professionals have to waste a lot of valuable time and resources to
find out what they need to design an effective intervention [1]. Parents who are unaware
of their childs actual condition may place irrational demands on both their child and
mental health professionals and fail to keep agreements and deadlines, jeopardizing their
childs progress [111]. Finally, there are some parents who question the training of men
tal health professionals and their suitability to work with their child, but may continue
to cooperate because they have no other options or because they believe they can moti
vate the mental health professional [11, 99].
Mental health professionals noted that after the implementation of the partnership protocol
parents started to have more realistic expectations that made them realize the importance of
engaging the whole family in the therapeutic process [54]. Parents understood that they
have to follow the advice of mental health professionals to help their children and became
more open to new treatment suggestions [104]. These behaviors are indicative of greater
trust for the mental health professionals, who need initially to recognize the shock that pa
rents experience [17] and to help them reach the stage of full acceptance [16]. Parents also
seemed to have responded positively to the efforts made by mental health professionals to
take their feelings and views into account when designing the intervention [75]. Finally,
mental health professionals reported that the parents were better able to judge when they
545
546
needed to communicate in order to resolve an actual crisis, probably as a result of their ac

tive therapeutic engagement [98].
4.3. Evaluation of the partnership protocol
Most parents of children with autism spectrum disorders and mental health professionals
who used the partnership protocol said that it was useful, because: a) it clarifies the relation
ship between the two parties; b) it defines the roles of both parties; c) it promotes effective
cooperation; d) it advances negotiation; and e) it values mutual respect. All these elements
were rated by many studies [28, 101, 103] as essential for the creation of a functional and
effective cooperative relationship among parents and mental health professionals. It is ex
tremely important to point out that both parents and mental health professionals recognize
similar benefits from the implementation of the protocol, corroborating the finding that the
needs of parents and mental health professionals are closer that one would think, but they
need to be clearly defined in order to be satisfied [100].
The parents of children with autism spectrum disorders reported that the partnership proto
col informs them of their rights and helps them fight for provisions and services. Parental
participation is instrumental in reassuring the existence of options for adults with autism
spectrum disorders [153]. Parents become empowered [39, 86] and thus able to negotiate
with mental health professionals [40]. Mental health professionals said that they could use
this protocol to resolve conflicts or disagreements with parents. This is important, since
some mental health professionals do not know how to resolve interpersonal conflicts [3] and
they become increasingly stressed [147].
The four parents who thought that the partnership protocol is not useful justified their opin
ion by saying that it is binding and difficult to adhere to. It is a fact that the implementation
of a protocol or any form of agreement requires commitment from all involved parties.
Therefore, it is likely that some parents of children with autism spectrum disorders are ex
hausted from the constant care of a child with multiple and complex needs and do not pos
sess the required strength to enter this process [146]. Moreover, it is plausible that some
parents prefer to hold a more distant role from the therapeutic process [54]. The eight men
tal health professionals who considered the partnership protocol not to be that useful
thought as well that it is binding and that parents who are not educated cannot understand
it. It seems that they do not want to be committed to a predetermined cooperative relation
ship with the parents because they have adopted the expert model. Even if some parents are
not educated or able to understand some points, it is the role of mental health professionals
to explain everything to them in simple and understandable language [56].
Approximately 20% of the parents of children with autism spectrum disorders identified
two things that needed further clarification in the partnership protocol: a) which qualifica
tions mental health professionals should hold in order to work with children with autism
spectrum disorders and b) what parents can do if mental health professionals do not follow
the protocol. The first point partly reflects the insecurity that results from insufficient brief
ing regarding the options that parents have to choose the suitable mental health professional
after the diagnosis [55]. They could also result from limited options due to place of residence
http://dx.doi.org/10.5772/53966
or financial restraints [99]. The second clarification is indicative of feelings of inferiority or

intimidation. This partnership protocol has no legal power and it is not a contract with legal
ratifications. The whole point of the protocol is to introduce parents to the concept that they
can discuss any conflict or disagreement with mental health professionals on equal terms.
Mental health professionals also wanted to know what will happen in case that parents of
children with autism spectrum disorders do not follow the protocol. This is something that
should be discussed and agreed upon from the beginning between the two parties. Most dis
agreements are peacefully resolved, while very few have ended up in court [3]. Moreover, it
is important that some mental health professionals realize that some parents will not want
to cooperate with them [76]. The second question was how much time mental health profes
sionals should spend with parents of children with autism spectrum disorders and this is
again to be negotiated between them from the beginning.
The most important positive outcomes of the partnership protocol are: ensured cooperation,
honest relationships, understanding of parental limitations, parental participation in deci
sion-making, and recognition of parental needs and emotions. It seems that what parents
really need is to feel like equal partners in the therapeutic process and this is something that
the partnership protocol offers. Parents who are involved in decision-making about their
child and are supported by mental health professionals feel happier [2, 33, 154]. The most
important positive outcomes of the partnership protocol are: the negotiation of the bounda
ries of the relationship between parents and mental health professionals, the clarification of
the roles of both sides, and the emphasis placed on active parental involvement in their
childs therapy. Mental health professionals need to define their relationships with parents
as much as parents do [28, 77-78] and they use the protocol to do so.
4.4. Limitations
The aim of this study was to create a partnership protocol to delineate the relationship between
parents of children with autism spectrum disorders and mental health professionals with the
ultimate goal to improve the childs condition [84]. The need for this protocol derived from per
sonal experience and from meticulous literature search [16, 105]. Although the findings were
positive and encouraging, there are some limitations that should be taken into consideration:
1.
The mental health professionals were working in the private sector and so they might
be more willing to follow the protocol in order to keep their clients things could be
different if they worked in a public setting.
2.
The mental health professionals who agreed to participate in the study might have been
the ones who work better with parents, and the parents who participated might have
been the ones who were happy with mental health professionals to begin with. Howev
er, analysis showed that all the participants identified some problems at baseline.
3.
Some confounding variables, such as the training of mental health professionals or the
educational level of the parents were not taken into consideration when analyzing the
findings. For example, it was found that single mothers of children with autism spec
trum disorders experience more stress than married mothers [14].
547
548
4.
Despite the fact that the participants were reassured that data would be kept confiden
tial, they might be skeptical about expressing very negative attitudes [155].
5.
There was no official follow-up, although the researcher had informal contacts with the
participants and was informed that many of them continued to follow the partnership
protocol after the six-month period.
6.
There are many other factors that could have affected the collaboration between parents
of children with autism spectrum disorders and mental health professionals that are re
lated to external factors (e.g., financial crisis), internal factors (e.g., depressive mood) or
child-specific factors (e.g., severity of the autism spectrum disorders) that were not ex
amined in the present study and could inform further research.
4.5. Practical implementation and future research

This research confirmed the findings of previous studies [77, 104, 147] that the relationship
between parents of children with autism spectrum disorders and mental health professio
nals is quite challenging. However, the aim was not just to identify the existing problems,
but to propose also some possible solutions. It seems that the implementation of the partner
ship protocol had a positive effect on the delineation of the relationship of the involved par
ties and helped them overcome some the existing obstacles by becoming more cooperative
and willing to negotiate for the childs benefit.
As mentioned in the introduction, mental health professionals and parents of children with
disabilities hold their personal beliefs regarding the kind of relationship that they should
have. The partnership protocol helped them understand their rights and obligations, since
they might hesitate to discuss them openly. There are many mental health professionals
who do not know how to set limits to their relationships with parents and many parents
who do not know how to express their opinions or their questions regarding their child to
mental health professionals. Therefore, the partnership protocol may be suggested by men
tal health professionals as a means to negotiate their relationship with parents, while it
serves also as an opportunity to discuss further and to resolve any conflicts. However, it
should be stressed that the partnership protocol is not a legally binding document and so
parents and mental health professionals should follow it because they believe in its value. It
can be implemented in any therapeutic framework, where it is essential for parents of chil
dren with disabilities and mental health professionals to work together. It could also be used
to train mental health professionals who will work with children and adolescents with disa
bilities and their families [156].
This is the first study in Greece, and worldwide, that introduced the use of a partner
ship protocol to resolve possible conflicts that arise between mental health professionals
and parents of children with autism spectrum disorders. Therefore, future studies should
be conducted with parents of children with other disabilities, as well as with parents of
children with chronic illnesses and with other mental health professionals, such as doc
tors, nurses, or teachers.
http://dx.doi.org/10.5772/53966
5. Conclusion
This study confirmed the findings of previous international research regarding the prob
lematic relationships between mental health professionals and the parents of children
with disabilities. It was found that Greek mental health professionals are troubled by the
parents demands and their unwillingness to actively engage in their childs treatment.
Greek parents of children with autism spectrum disorders claim that mental health pro
fessionals are not interested in involving them in decision-making regarding their childs
therapy. Similar complaints have been expressed in other studies that have explored the
relationship between mental health professionals and parents of children with autism
spectrum disorders [77, 104, 147].
Despite the fact that the difficulties that were documented in this study have been identified
a long time ago and in several contexts, there has been no published coordinated effort to
resolve them. This partnership protocol was based on the codes of ethics of international or
ganizations of mental health professionals, it is written in simple language and it was con
sidered to be useful by most participants. The implementation of the partnership protocol
helped mental health professionals and parents of children with autism spectrum disorders
to define their interpersonal relationship and to overcome many of the difficulties and the
problems that they had identified at the beginning of their cooperation. They started to com
municate more honestly, to respect each other more and to resolve their conflicts more effec
tively. Even though these findings are encouraging, more longitudinal studies with varied
participants are needed to explore further the effectiveness of the partnership protocol.
Acknowledgement
I would like to thank all the participants and Dr Angeliki Gena who was the primary super
visor of my second PhD that is the basis of this research. I extend my gratitude also to my
family and especially my husband and colleague Vlastaris Tsakiris for his constant support
throughout this lengthy process.
Appendix
Parent-Professional Partnership Protocol
When professionals and parents of children with autism come together for the first time,
they bring with them their own worries, concerns, priorities, and responsibilities, which
must be woven together into a relationship that could be characterized as a partnership. The
roles of the parent and the professional impose certain rights and duties, obligations and an
ticipated behaviours, as well as expectations. It is extremely difficult to define the exact na
ture of this partnership, since every parent and every family has its own idiosyncrasies and
549
550
each professional possesses unique characteristics and ways of working and relating. The
aim of the present document is to provide some guidelines that could be adopted and im
plemented by both interested parties in an attempt to define their partnership and it is based
on the principles of the negotiating model. The negotiating model defines partnership as a
working relationship that is characterized by a shared sense of purpose, mutual respect and
the willingness to negotiate.
Cooperation between parents and professionals
Professionals need parental cooperation in order to be able to do their job effectively. Pa
rents should recognize that professionals have specialist knowledge and abilities, but they
cannot substitute the role of the caregiver. Since both parents and professionals are interest
ed in the childs progress, they need to cooperate to achieve the best results.
Negotiation of boundaries in parent-professional relationship
Parents and professionals should clarify and negotiate the nature and the limits of their part
nership. It would be advisable to make a contract that is not formal or legally binding. It just
sets out mutual expectations and intended behaviours. Depending on the situation it may be
appropriate to put this in writing and each party should retain their own copy. It is advisa
ble to repeat this process at later stages according to the progress of the child. Parents
should refrain from contacting the professional on a regular basis about things that do not
concern the child with autism and professionals should be punctual and fulfil their obliga
tions towards the family and the child.
Parental expectations/feelings/needs
Professionals should identify and evaluate the needs of the family, which cannot be separat
ed from the needs of the child. The child has a relationship with all the other family mem
bers and the relationships within the family have an interactive effect with each other.
Parents should verbalise and express their urging needs to professionals so that a solution
can be sought. These expectations, feelings, and needs should be incorporated into the treat
ment when the professional believes that is plausible and suitable.
Parental accuracy and reporting of knowledge
Parents possess a unique and special knowledge and understanding about their child that is
valuable for the design of a better intervention. The home is the best available place to con
solidate the knowledge that the child acquires and it can also offer multiple opportunities
for learning. Parents should be honest with professionals and try to overcome the difficulty
they may experience to talk publicly about the condition and the difficulties of their child. If
the professional is misled or told half the truth, it is very likely that the suggested treatment
will not be the appropriate one.
Parental understanding of their childs condition
Professionals should use simple language when talking to parents, since they do not have
expert knowledge that allows them to familiarise themselves with terms used among profes
sionals. Parents should also express their queries and seek to clarify any misconceptions or
http://dx.doi.org/10.5772/53966
worries they might have. If parents believe that they are not being listened to, they should
make sure that the attitude of the professional changes. Professionals must not focus on the
child alone, but they should advise parents on how to care for their child with autism. Even
if parents have other children, they may need some practical assistance and tips on how to
overcome some of the issues that arise due to the difficulties faced by their child. It is the
parents responsibility to inform professionals on the areas where they believe they need
more help and support.
Parental participation in decision-making
Professionals should allow parents to be more involved in activities and decisions regarding
the education and care of their child. For example, professionals should not make drastic
changes in the treatment that they follow before consulting with the parents. This is a good
way to ensure cooperation and to minimise conflicts in parent-professional relationship. Pa
rents will be able to make an informed choice regarding the future of their own child. There
fore, a common purpose or shared concern or mutual interest should be established in order
for the relationship between the interested parties to be productive. Both parents and profes
sionals should be involved in brainstorming regarding potential ideas, plans, or actions that
could enhance the development of the child. Parents should make an effort to follow and
understand the progress of their child in order to be able to make a decision. This could in
clude reading books, notes, or reports regarding the condition of their child and the treat
ment that is implemented.
Parents as therapists
Professionals may train parents to use some behavioral techniques that will allow them to
teach their child, complementing thus and supporting the work of professionals. If parents
feel confident enough, they may want to assume an active role in furthering their childs
learning. However, professionals should be aware that parents may not have enough time
to be actively involved in the education of their child if they have a full-time job or other
children to look after. Therefore, at the beginning of the partnership professionals and pa
rents should reach an agreement on the amount of time that parents can spend with their
child on a weekly basis. Professionals should encourage each member of the family to con
tribute to the treatment of the child with autism, which may need special assistance to par
ticipate in family outings and activities. This can be achieved by encouraging parents to
communicate with each other and express openly their concerns and needs.
Parental briefing
Professionals should inform parents from the beginning about the cost of the treatment, seek
their consent when contemplating the acquisition of new material, and brief them about the
progress of their child, even if the news are not particularly encouraging or reassuring. It
would be a good idea for professionals to keep notes of the meeting with the parents, so that
they can refer to them in the future and keep track of the progress of their child.
Disclosure of information to parents or third parties
551
552
Professionals could verbally inform parents about the progress of their child but access to
records may be prohibited due to legal issues related to their confidentiality professionals
are called to make individual decisions according to each situation. Parents who advocate
their right to have access to the records should be equally responsible in their own record
keeping. Professionals should inform parents of any other professionals with whom they
discuss the case of their child and elicit their consent before doing so.
Family discord
In case of disagreement between the parents regarding the treatment of their child, profes
sionals should stay neutral and avoid making alliances with one parent or colluding consis
tently with one parents preferences. If professionals believe that there are many pressing
issues among the family members, they should encourage them to see a counsellor. Parents
should realize that professionals working with their child may not have the necessary
knowledge and training to deal with these issues.
Negotiation of parent-professional disagreement
When a disagreement arises, both parents and professionals should try to resolve it. They
must express their opinions and feelings openly, keeping in mind that they have the childs
best interest in mind. If it is impossible to resolve the disagreement, it might be advisable to
discontinue the partnership.
Author details
Efrosini Kalyva
Psychology Department, The International Faculty of the University of Sheffield, CITY
College, Thessaloniki, Greece
References
[1] Seligman M, Darling RB. Ordinary Families, Special Children: A Systems Approach
to Childhood Disability. 2nd ed. New York: The Guilford Press; 1997.
[2] Swain J, Walker C. Parent-Professional Power Relations: Parents and Professionals
Perspectives. Disability and Society 2003;18(4) 547-560.
[3] Feinberg E, Beyer J, Moses P. Beyond Mediation: Strategies for Appropriate Early
Dispute Resolution in Special Education. Unpublished manuscript. National Center
on Alternative Dispute Resolution (CADRE): Eugene, OR; 2002.
http://dx.doi.org/10.5772/53966
[4] Minuchin S. Families and Family Therapy. Cambridge, MA: Harvard University
Press; 1974.
[5] Elman NS. Family Therapy. In Seligman M. (ed.) The Family with a Handicapped
Child. 2nd ed. Boston: Allyn & Bacon; 1991, p369-406.
[6] Turnbull AP, Summers JA, Brotherson MJ. Family Life Cycle: Theoretical and Empir
ical Implications and Future Directions for Families with Mentally Retarded Mem
bers. In Sowers J. (ed.) Making our Way: Promoting Self-Competence among
Children and Youth with Disabilities. Baltimore: Brookes; 1986, p45-66.
[7] Weiss S. Stressors Experienced by Family Caregivers of Children with Pervasive De
velopmental Disorders. Child Psychiatry and Human Development 1991;21(2)
203-216.
[8] Siklos S, Kerns KA. Assessing Needs for Social Support in Parents of Children with
Autism and Down Syndrome. Journal of Autism and Developmental Disorders
2006;36(7) 921-933.
[9] Grissom M. From their own perspective: An Ethnographic Study of Families with
Children with Autism. Dissertations Abstracts International: The Sciences and Engi
neering. 2005;65 3745.
[10] Pakenham KI, Samios C, Sofronoff K. Adjustment in Mothers of Children with As
perger Syndrome: An Application of the ABCX Model of Family Adjustment. Au
tism 2005;9(2) 191-212.
[11] Turnbull AP, Turnbull HR. Families, Professionals, and Exceptionality: Collaborating
for Empowerment. 4th ed. Columbus, OH: Merrill; 2001.
[12] Turnbull AP, Patterson JM, Behr SK, Murphy DL, Maquis JG, Blue-Banning MJ. Cog
nitive Coping, Families, and Disability. Baltimore: Brookes; 1993.
[13] Turnbull AP, Turnbull HR. Families, Professionals and Exceptionality: A Special
Partnership. 3rd ed.Upper Saddle River: Merrill; 1997.
[14] Bromley J, Hare D, Davison K, Emerson E. Mothers Supporting a Child with Autistic
Spectrum Disorders: Social Support, Mental Health Status and Satisfaction with Serv
ices. Autism 2004;8(3) 409-423.
[15] Parette P, Chuang SJL, Huer MB. First Generation Chinese American Families Atti
tudes Regarding Disabilities and Educational Interventions. Focus on Autism and
Other Developmental Disabilities 2004;19(1) 114-123.
[16] Gena A. Family and Child with Autism: Parental Reactions and Adjustment. In Gena
A, Kalogeropoulou E, Mavropoulou S, Nikolaou A, Notas S, Papageorgiou V. (eds.)
The Autism Spectrum: Cooperation between family and professionals. Trikala: The
Association of Parents and Friends of Children with Autism; 2006, p45-88.
[17] Gena A. Autism and Pervasive Developmental Disorders. Athens: Author; 2002.
553
554
[18] King Gerlach E. Part 1. The Beginning: How Parents Move Forward and Make
Choices after Diagnosis. Exceptional Parent Magazine, New York: www.discov
ery.org-www.thecenterfordiscovery.org; 2002.
[19] Rolland JS. Mastering Family Challenges in Series Illness & Disability. In Walsh F.
(ed.) Normal Family Processes. 2nd ed. New York: Guildford Press; 1993, p444-473.
[20] Adelman H, Taylor L. Addressing Barriers to Learning: Beyond School-Linked Serv
ices and Full Service Schools. American Journal of Orthopsychiatry 1997a; 67(3)
408-421.
[21] Adelman HS, Taylor L. Toward a Scale-up Model for Replicating New Approaches
to Schooling. Journal of Educational Psychology Consultation 1997b;5(2)197-230.
[22] Childrens Aid Society. Building a Community School. New York: Author; 1997.
[23] McKnight J. The Careless Society: Community and its Counterfeits. New York: Basic
Books, 1995.
[24] Osher TW, deFur E, Nava C, Spencer S, Toth-Dennis D. New Roles for Families in
Systems of Care. Washington, DC: American Institutes of Research, Center for Effec
tive Collaboration and Practice; 1999.
[25] Bennett J, Grimly LK. Parenting in the Global Community. A Cross-Cultural/Interna
tional Perspective. In Fine M, Lee S. (eds.) Handbook of Diversity in Parent Educa
tion: The Changing Faces of Parenting and Parent Education. San Diego, CA:
Academic Press; 2001, p96-132.
[26] Fristad MA, Goldberg-Arnold JS, Gavazzi SM. Multi-Family Psychoeducation
Groups in the Treatment of Children with Mood Disorders. Journal of Marital Family
Therapy 2003;29(4) 491-504.
[27] Duchanowski AJ, Kurash K, Friedman RM. Community-Based Interventions in a
System of Care and Outcomes of Framework. In Burns BJ, Hoagwood K. (eds.) Com
munity Treatment for Youth: Evidence-Based Interventions for Severe Emotional and
Behavioral Disorders. New York: Oxford University Press; 2002, p16-38.
[28] Friesen BJ, Huff B. Family Perspectives on Systems of Care. In Stroul B. (ed.) Chil
drens Mental Health: Creating Systems of Care in a Changing Society. Baltimore:
Paul H. Brookes; 1996, p41-67.
[29] Ruffolo MC, Kuhn MT, Evans ME. Developing a Parent-Professional Team Leader
ship Model in Group Work: Work with Families with Children Experiencing Behav
ioral and Emotional Problems. Social Work 2006;51(1) 39-47.
[30] Bruner C. Thinking Collaboratively: Ten Questions and Answers to Help Policy
Makers Improve Childrens Services. Washington, DC: Education and Human Serv
ices Consortium; 1991.
http://dx.doi.org/10.5772/53966
[31] Cunningham CC, Davis H. Early Parenting Counseling. In Craft M, Bichnell J, Hol
lins S. (eds.) Mental Handicap: A Multidisciplinary Approach. London: Bailliere Tin
dall; 1985, p69-88.
[32] Marteau TM, Johnston M, Baum JD, Bloch S. Goals of Treatment in Diabetes: A Com
parison of Doctors and Parents of Children with Diabetes. Journal of Behavioral
Medicine1987;10(1) 33-48.
[33] Betz M, OConnell L. Changing Doctor-Patient Relationships and the Rise in Concern
for Accountability. Social Problems 1983;31(1) 84-95.
[34] Pugh G, DeAth E. Working Towards Partnership in Early Years. London: National
Childrens Bureau; 1989.
[35] Mittler P, McConachie H. Parents, Professionals and Mentally Handicapped People:
Approaches to Partnership. Beckenham: Croom Helm; 1983.
[36] Mittler P, Mittler H. The Transitional Relationship. In Mittler P, McConachie H.
(eds.) Parents, Professionals and Mentally Handicapped People: Approaches to Part
nership. Beckenham: Croom Helm; 1983, p221-240.
[37] Turnbull AP, Turnbull HR. Parent Involvement in the Education of Handicapped
Children: A Critique. Mental Retardation1982;20(2) 115-122.
[38] Davis PB, May JE. Involving Fathers in Early Intervention and Family Support Pro
grams: Issues and Strategies. Child Health Care 1991;20(1) 87-92.
[39] Appleton PL, Minchom PE. Models of Parent Partnership and Child Development
Centers. Child: Care, Health and Development 1991;17(1) 27-38.
[40] Dale P. Parent Report Assessment of Language and Communication. In Cole K, Dale
P, Thal D. (eds.) Assessment of Communication and Language. Baltimore, MD: Paul
H. Brookes; 1996, p161-182.
[41] McConkey R. Working with Parents: A Practical Guide for Teachers and Therapists.
London: Croom Helm; 1986.
[42] New C, David M. For the Childrens Sake: Making Childcare More than Womens
Business. Harmondsworth: Penguin; 1985.
[43] Ayer S, Alaszewski A. Community Care and the Mentally Handicapped: Services for
Mothers and their Mentally Handicapped Children. London: Croom Helm; 1984.
[44] Glendenning C. Parents and their Disabled Children. London: Routledge and Kegan
Paul; 1983.
[45] Feinberg E, Vacca J. The Drama and the Trauma of Creating Policies on Autism: Crit
ical Issues to Consider in the New Millennium. Focus on Autism and Other Develop
mental Disabilities 2000;15(2) 130-138.
[46] Hannam C. Parents and Mentally Handicapped Children. Harmondsworth: Penguin;
1975.
555
556
[47] Quine L, Rutter DR. First Diagnosis of Severe Mental and Physical Disability: A
Study of Doctor-Patient Communication. Journal of Child Psychology and Psychia
try 1994;35(7) 1273-1287.
[48] Friend M, Cook L. Interactions: Collaborative Skills for School Professionals. White
Plains, NY: Longman; 1992.
[49] Fine MJ. The Handbook of Family-School Intervention: A Systems Perspective. Bos
ton: Allyn & Bacon; 1991.
[50] Kalyva E. Autism: Educational and Therapeutic Approaches. London: Sage; 2011.
[51] Hecimovic A, Gregory S. The Evolving Role, Impact, and Needs of Families. In Zager
D. (ed.) Autism Spectrum Disorders: Identification, Education, and Treatment. 3rd
ed. Mahwah, NJ: Lawrence Erlbaum Associates; 2005, p111-142.
[52] Lovaas OI. Behavioral Treatment and Normal Educational and Intellectual Function
ing in Young Autistic Children. Journal of Consulting and Clinical Psychology
1987;5(1) 3-9.
[53] Schopler E, Mesibov GB, Hearsey KA. Structured Teaching in the TEACCH System.
In Schopler E, Mesibov GB. (eds.), Learning and Cognition in Autism. New York:
Plenum; 1995, p243-268.
[54] Hardy N, Sturmey P. Portage Guide to Early Education, III: A Rapid Training and
Feedback System to Teach and Maintain Mothers' Teaching Skills. Educational Psy
chology 1994;14(3) 345-358.
[55] Ruble LA, Dalrymple NJ. COMPASS: A Parent-Teacher Collaborative Model for Stu
dents with Autism. Focus on Autism and Other Developmental Disabilities
2002;17(1) 76-83.
[56] Friesen BJ. Creating Change for Children with Serious Emotional Disorders: A Na
tional Strategy. In Mizrahi T, Morrison J. (eds.). Community Organizations and So
cial Administration: Advances, Trends and Emerging Principles. New York:
Haworth Press; 1993, p127-146.
[57] Kohler F. Examining the Services Received by Young Children with Autism and
their Families: A Survey of Parent Responses. Focus on Autism and Other Develop
mental Disabilities 1999;14(2) 150-158.
[58] Johnson HC. Family Issues and Interventions. In Johnson HC. (ed.) Child Mental
Health in the 1990s: Curricula for Graduate and Undergraduate Professional Educa
tion. Washington, DC: U.S. Department of Health and Human Services, Public
Health Service, National Institute of Mental Health; 1993, p85-101.
[59] Read J, Clements L. Disabled Children and the Law: Research, the Law and Good
Practice. London: Jessica Kingsley Publishers; 2001.
http://dx.doi.org/10.5772/53966
[60] Soodak LC, Erwin EJ, Winton P, et al. Implementing Inclusive Early Childhood Edu
cation: A Call for Professional Empowerment. Topics in Early Childhood Special Ed
ucation 2002;22(1) 91-102.
[61] Collins B, Collins T. Parent-Professional Relationships in the Treatment of Seriously
Emotionally Disturbed Children and Adolescents. Social Work 1990;35(5) 522-527.
[62] Smith DE, Griffith AI. Coordinating the Uncoordinated: Mothering, Schooling and
the Family Wage. Perspectives of Social Problems 1990;2(1) 25-43.
[63] Crawford T, Simonoff E. Parental Views about Services for Children Attending
Schools for the Emotionally and Behaviourally Disturbed (EBD): A Qualitative Anal
ysis. Child: Care, Health and Development 2003;29(6) 481-491.
[64] Francell C, Conn V, Gray D. Families' Perceptions of Burden of Care for Chronic
Mentally Ill Relatives. Hospital of Community Psychology 1988;39(12) 1296-1937.
[65] Tarico V, Low B, Trupin E, Forsyth-Stephens A. Children's Mental Health Services: A
Parent Perspective. Community and Mental Health Journal 1989;25(3) 313-326.
[66] Johnson HC, Renaud E. Professional Beliefs about Parents of Children with Mental
and Emotional Disabilities: A Cross-Discipline Comparison. Journal of Emotional
and Behavioral Disorders 1995;5(2) 149-161.
[67] Randall P, Parker J. Supporting the Families of Children with Autism. Chichester:
Wiley; 1999.
[68] Hartman A, Laird J. Family-Centered Social Work Practice. New York: Free Press;
1983.
[69] Bennett WS, Hokenstad MC. Full-Time People Workers and Conceptions of the Pro
fessional. In Halmos P, (ed.) Professionalism and Social Change. Keele: University of
Keele Press; 1973, p36-58.
[70] Handy CB. Understanding Organizations. Harmondsworth: Penguin; 1985.
[71] Cone JD, Delawyer DD, Wolfe VV. Assessing Parent Participation: The Parent/Fami
ly Involvement Index. Exceptional Children 1985;51(3) 417-424.
[72] Smets AC. Family and Staff Attitudes toward Family Involvement in the Treatment
of Hospitalized Chronic Patients. Hospital Community Psychiatry 1982;33(6)
573-575.
[73] Brand S. Making Parent Involvement a Reality: Helping Teachers Develop Partner
ships with Parents. Young Children 1996;51(1) 76-81.
[74] Katz L, Bauch J. The Peabody family involvement initiative: Preparing preservice
teachers for family/school collaboration. The School Community Journal 1999;9(1)
49-69.
[75] Tichenor M. Teacher Education and Parent Involvement: Reflections from Preservice
Teachers. Journal of Instructional Psychology 1997;24(2) 233-240.
557
558
[76] Dinnebeil LA, Hale LM, Rule S. A Qualitative Analysis of Parents and Service Coor
dinators Descriptions of Variables that Influence Collaborative Relationships. Topics
in Early Childhood Special Education 1996:19(4) 322-347.
[77] Dunst CJ, Trivette CM, Johanson C. Parent-Professional Collaboration and Partner
ship. In Dunst CJ, Trivette CM, Deal AG. (eds.) Supporting and Strengthening Fami
lies. Cambridge, MA: Brookline Books; 1994, p197-211.
[78] Summers JA, Hoffman L, Marquis J, Turnbull A, Poston D, Lord Nelson L. Measur
ing the Quality of Family-Professional Partnerships in Special Education Services.
Exceptional Children 2005;72(1) 65-81.
[79] Stevenson O, Parsloe P. Community Care and Empowerment. York. Joseph Row
ntree Foundation; 1993.
[80] Loxley A. Collaboration in Health and Welfare: Working with Difference. London.
Jessica Kingsley Publishers; 1997.
[81] Malin N. Services for People with Learning Disabilities. London: Routledge; 1995.
[82] Goble R. Multi-Professional Education in Europe. In Leathard A, (ed.) Going InterProfessional: Working Together for Health and Welfare. London: Routledge; 1994,
p157-194.
[83] Wistow G. Hospital Discharge and Community Care: Early Days. Leeds: Nuffield In
stitute for Health; 1993.
[84] Roberts RN, Rule S, Innocenti MS. Strengthening the Family-Professional Partner
ship in Services for Young Children. Baltimore: Brookes; 1998.
[85] Epstein JL. School, Family, and Community Partnership: Preparing Educators and
Improving Schools. Boulder, CO: Westview Press; 2001.
[86] Osher TW, Osher DM. The Paradigm Shift to True Collaboration with Families. Jour
nal of Child and Family Studies 2002;11(1) 47-60.
[87] Bruder MB. Family-Centered Early Intervention: Clarifying our Values for the New
Millennium. Topics in Early Childhood Special Education 2000;20(1) 105-115.
[88] Trivette CM, Dunst CJ, Boyd K, Hamby D. Family-Oriented Program Models, Help
Giving Practices, and Parental Control Appraisals. Exceptional Children 1995;62(2)
237-248.
[89] Applequist KL, Bailey DB. Navajo Caregivers Perceptions of Early Intervention
Services. Journal of Early Intervention Services 2000;23(1) 47-61.
[90] McWilliam RA, Tocci L, Harbin GL. Family-Centered Services: Service Providers
Discourse and Behavior. Topics in Early Childhood Special Education 1998;18(2)
206-221.
http://dx.doi.org/10.5772/53966
[91] Park J, Turnbull AP. Service Integration in Early Intervention: Determining Interper
sonal and Structural Factors for its Success. Infants and Young Children 2003;16(1)
48-58.
[92] Parette HP, Brotherson MJ, Huer MB. (2000). Giving Families a Voice in Augmenta
tive and Alternative Communication Decision-Making. Education and Training in
Mental Retardation and Developmental Disabilities 2000;35(2) 77-90.
[93] Soodak L, Erwin E. Valued Member or Tolerated Participant: Parents Experiences in
Inclusive Early Childhood Settings. Journal of the Association of Parents with Severe
Handicaps 2000;25(1) 29-41.
[94] Park J, Turnbull AP. Families Speak Out: What are Quality Indicators of Professio
nals in Working with Children with Problem Behavior? Journal of Positive Behavio
ral Intervention 2002;4(2) 118-123.
[95] McWilliam R, Maxwell K, Sloper K. Beyond Involvement: Are Elementary Schools
Ready to be Family Centered? School Psychology Review 1999;28(3) 378-394.
[96] Rainforth B, York J, Macdonald C. Collaborative Teams for Students with Severe Dis
abilities: Integrating Therapy and Educational Services. Baltimore: Brooks; 1992.
[97] Salembier GB, Furney KS. Speaking up for your Childs Future. Exceptional Parent
1998;28(1) 62-64.
[98] Sanders M. Improving School, Family and Community Partnerships in Urban Mid
dle Schools. Middle School Journal 1999;31(1): 35-41.
[99] Blue-Banning MJ, Turnbull AP, Pereira L. Group Action Planning as a Support Strat
egy for Hispanic Families: Parent and Professional Perspectives. Mental Retardation
2000;38(2) 262-275.
[100] Allen RL, Perry CG. Toward Developing Standards and Measurements for FamilyCentered Practice in Family Support Programs. In Singer GHS, Powers LE, Olson
AL. (ed.) Redefining Family Support: Innovations in Public-Private Partnerships. Bal
timore: Brookes; 1996. p57-86.
[101] Dunst CJ. Revisiting Rethinking Early Intervention. Topics in Early Childhood
Special Education 2000;20(1) 95-104.
[102] Kalyanpur M, Harry B. Culture in Special Education. Baltimore: Brookes; 1999.
[103] Lynch EW, Hanson MJ. Developing Cross-Cultural Competence: A Guide for Work
ing with Children and Families. 2nd ed. Baltimore: Brookes; 1998.
[104] Sileo TW, Prater MA. Preparing Professionals for Partnerships with Parents of Stu
dents with Disabilities: Textbook Considerations Regarding Cultural Diversity. Ex
ceptional Children 1998;64(5) 513-528.
[105] Blue-Banning MJ, Summers JA, Frankland C, Nelson LGL, Beegle G. Dimensions of
Parent-Professional Partnerships. Exceptional Children 2004;70(1) 167-184.
559
560
[106] Lord Nelson LG, Summers JA, Turnbull AP. Boundaries in Family-Professional Rela
tionships. Remedial and Special Education 2004;25(3) 153-165.
[107] Ruble L, Sears L. Diagnostic Assessment of Autistic Disorder. In Huebner R. (ed.)
Autism and Related Disorders: A Sensorimotor Approach to Management. Mary
land: Aspen; 2000, p41-59.
[108] Ruble LA, Dalrymple NJ. An Alternative View of Outcome in Autism. Focus on Au
tism and Other Developmental Disabilities 1996;11(1) 3-14.
[109] McWilliam R, Young H, Harville K. Satisfaction and Struggles: Family Perceptions of
Early Intervention Services. Journal of Early Intervention 1995;19(1) 43-60.
[110] Murphy DL, Lee IM, Turnbull AP, Turbiville V. The Family-Centered Program Rat
ing Scale: An Instrument for Program Evaluation and Changes. Journal of Early In
tervention 1995;19(1) 24-42.
[111] McNaughton D. Measuring Parent Satisfaction with Early Childhood Intervention
Programs: Current Practice, Problems, and Future Perspectives. Topics in Early
Childhood Special Education 1994;10(1) 1-15.
[112] Lake JF, Billingsley BS. An Analysis of Factors that Contribute to Parent-School Con
flict in Special Education. Remedial and Special Education 2000;21(4) 240-251.
[113] Minke K, Scott M. Parent Professional Relationships in Early Intervention: A Qualita
tive Investigation. Topics in Early Childhood Special Education 1995;15(3) 335-346.
[114] Dominique B, Cuttler B, McTarnaghan J. The Experience of Autism in the Lives of
Families. In Wetherby AM, Prizant BM. (eds). Autism Spectrum Disorders: A Trans
actional Developmental Perspective. Baltimore: Brooks; 2000, p369-394.
[115] Lambie R. Working with Families of at Risk and Special Needs Students: A Systems
Change Model. Focus on Exceptional Children 2000;32(1) 1-22.
[116] Powers M. Children with Autism: A Parents Guide. 2nd ed. Bethesda, MD: Wood
bine House; 2000.
[117] Katz L. Dispositions: Definitions and Implications for Early Childhood Practices.
New York: ERIC; 1993.
[118] Stoner JB, Bock SJ, Thompson JR, Angell ME, Heyl BS, Crowley EP. Welcome to our
World: Parent Perceptions of Interactions between Parents of Young Children with
ASD and Education Professionals. Focus on Autism and Other Developmental Disa
bilities 2005;20(1) 39-51.
[119] Bartolo PA. Communicating a Diagnosis of Developmental Disability to Parents:
Multiprofessional Negotiation Frameworks. Child: Care, Health and Development
2002;28(1) 65-71.
[120] Buckman R, Kason Y. How to Break Bad News: A Practical Protocol for Health Pro
fessionals. London: Macmillan; 1992.
http://dx.doi.org/10.5772/53966
[121] Siegel B. Coping with the Diagnosis of Autism. In Cohen DJ, Volkmar FR. (eds.)
Handbook of Autism and Pervasive Developmental Disorders. New York: Wiley;
1997, p460-483.
[122] Cottrell DJ, Summers K. Communicating an Evolutionary Diagnosis of Disability to
Parents. Child: Care, Health and Development 1990;16(2) 211-218.
[123] Cohen DJ, Volkmar FR. Handbook of Autism and Pervasive Developmental Disor
ders. New York: Wiley; 1997.
[124] Freeman WJ. Neurohumoral Brain Dynamics of Social Group Formation: Implica
tions for Autism. In Carter CH, Lederhendler H, Kirkpatrick B. (eds.) The Integrative
Neurobiology of Affiliation. New York: Annals of the New York Academy of Scien
ces; 1997, p501-503.
[125] Abrams EZ, Goodman JF. Diagnosing Developmental Problems in Children: Parents
and Professionals Negotiate Bad News. Journal of Pediatric Psychology 1998; 23(1)
87-98.
[126] Gill VT, Maynard DW. On "Labelling" in Actual Interaction: Delivering and Receiv
ing Diagnoses of Developmental Disabilities. Social Problems 1995;42(1) 11-37.
[127] Maynard DW. Bearing Bad News in Clinical Settings. In Dervin B. (ed.) Progress in
Communication Sciences. Norwood, N.J.: Ablex; 1991, p143-172.
[128] Bailey D, Scarborough A, Hebbeler K. Families First Experiences with Early Inter
vention. Menlo Park, CA: SRI International; 2003.
[129] King G, King S, Rosenbaum P, Goffin R. Family-Centered Caregiving and Well-Being
of Parents of Children with Disabilities. Journal of Pediatric Psychology 1999;24(1)
41-53.
[130] Thompson L, Lobb C, Elling R, Herman S, Jurkiewicz T, Hulleza C. Pathways to
Family Empowerment: Effects of Family-Centered Delivery of Early Intervention
Services. Exceptional Children 1997;64(1) 99-113.
[131] Laws G, Millward L. Predicting Parents Satisfaction with the Education of their
Child with Down Syndrome. Education Research 2001;43(2) 209-226.
[132] Rao SS. Perspectives of an African American Mother on Parent-Professional Relation
ships in Special Education. Mental Retardation 2000;38(3) 475-488.
[133] Park J, Turnbull AP. Cross-Cultural Competency and Special Education: Perception
and Experiences of Korean Parents of Children with Special Needs. Education and
Training in Mental Retardation and Developmental Disabilities 2001;36(2) 133-147.
[134] Able-Boone H, Goodwin I, Sandall S, Gordon N, Martin D. Consumer-Based Early
Intervention Services. Journal of Early Intervention 1992;16(2) 201-209.
[135] Covert SB. Whatever it Takes! Excellence in Family Support: When Families Experi
ence a Disability. St. Augustine, FL: Training Resource Network, Inc; 1995.
561
562
[136] Karp D. Speaking of Sadness: Depression, Disconnection, and the Meanings of Ill
ness. Oxford: Oxford University Press; 1996.
[137] Goldstein H. On Boundaries. Family and Society Journal of Contemporary History
1999;80(5) 435-438.
[138] Strom-Gottfied, K. Professional Boundaries: An Analysis of Violations by Social
Workers. Family and Society Journal of Contemporary History 1999;80(4) 439-449.
[139] British Psychological Society. Code of Ethics and Conduct. Leicester: Author; 2009.
[140] American Psychiatric Association. Diagnostic and Statistical Manual for Mental Dis
orders. 4th ed. text revision. Washington, DC: American Psychiatric Association; 2000.
[141] Health and Care Professions Council. Fitness to Practice. http://www.hpc-uk.org/
aboutus/committees/ftp/ (accessed 15 June 2008).
[142] Cournoyer DE, Johnson HC. Measuring Parents Perceptions of Mental Health Pro
fessionals. Research in Social Work and Practice 1991;1(3) 399-415.
[143] Johnson HC, Cournoyer DE. Measuring Worker Cognitions about Parents of Chil
dren with Mental and Emotional Disabilities. Journal of Emotional and Behavioral
Disorders 1994;2(1) 99-108.
[144] Darling RB, Baxter C. Families in Focus: Socio-Logical Methods in Early Intervention.
Austin, TX: Pro-Ed; 1996.
[145] Gowen JW, Christy DS, Sparling J. Informational Needs of Parents of Young Chil
dren with Special Needs. Journal of Early Intervention 1993;17(2) 194-210.
[146] Hassall R, Rose J, McDonald J. Parenting Stress in Mothers of Children with an Intel
lectual Disability: The Effects of Parental Cognitions in Relation to Child Characteris
tics and Family Support. Journal of Intellectual Disability Research 2005;49(6)
405-418.
[147] Summers JA, Gavin K, Hall T, Nelson J. Family and School Partnerships: Building
Bridges in General and Special Education. In Obiakor FE, Utley A, Rotatori AF.
(eds.). Advances in Special Education: Psychology of Effective Education for Learn
ers with Exceptionalities. Stamford, CT: JAI Press; 2003, p417-445.
[148] Muscott HS. Exceptional Partnerships: Listening to the Voices of Families. Prevent
ing School Failure 2002;42(1) 66-69.
[149] Dillenburger K, Keenan M, Gallagher S, McElhinney M. Parent Education and
Home-Based Behaviour Analytic Intervention: An Examination of Parents Percep
tions and Emotions. Journal of Intellectual and Developmental Disabilities 2004;29(1)
119-130.
[150] Longenecker H. Parental Stress - ABA and Traditional Special Education Programs.
http://rsaffran.tripod.com/longenecker.html. (accessed 28 June 2006).
http://dx.doi.org/10.5772/53966
[151] Laborde PR, Seligman M. Counseling Parents with Children with Disabilities. In Se
ligman M. (ed.) The Family with a Handicapped Child. 2nd ed. Boston: Allyn & Ba
con; 1991, p337-369.
[152] Moscovici S. Social Change and Influence. London: Academic Press; 1978.
[153] Field S, Hoffman A. The Importance of Family Involvement for Promoting Self-De
termination in Adolescents with Autism and Other Developmental Disabilities. Fo
cus on Autism and Other Developmental Disabilities 1999;14(1) 36-41.
[154] Renty J, Roeyers H. Quality of Life in High-Functioning Adults with Autism Spec
trum Disorder: The Predictive Value of Disability and Support Characteristics. Au
tism 2006;10(5) 511-524.
[155] Avramidis E, Kalyva E. Research Methods in Special Needs: Theory and Practice.
Athens: Papazisis; 2006.
[156] Kalantzi-Azizi A, Besevengkis E. Issues of Training and Sensitization of Mental
Health Professionals Working with Children and Adolescents; 2000.
563
Chapter 24
Early Intensive Behavioural Intervention in

Autism Spectrum Disorders
Olive Healy and Sinad Lydon
http://dx.doi.org/10.5772/54274
1. Introduction
Autism spectrum disorder (ASD) is a developmental disorder characterised and diagnosed
by behavioural symptoms that mark impairments in social and communication behaviour
along with a restricted range of activities and interests. ASD is considered a heterogeneous
and complex disorder impacting many areas of development including intellectual, commu
nication, social, emotional, and adaptive (Makrygianni & Reed, 2010). This disorder can
present considerable challenges to both the individual and their family across their lifespan.
A myriad of intervention approaches have been highlighted to treat this condition. Some in
clude therapies that have been developed by parents independent of any particular discipline
(e.g., Son-Rise Program and Hanen). Others are based on biological approaches (e.g., special
and restricted diets, secretin) or alternative medicine (e.g., homeopathy, chelation therapy).
Some more prevalent treatment approaches are available and differ in their etiological, meth
odological and philosophical interpretation of ASD. These include for example, Applied Be
haviour Analysis (ABA; sometimes referred to as behaviour therapy), Treatment and
Education of Autistic and related Communication Handicapped Children (TEACCH), Picture
Exchange Communication System (PECS), sensory integration therapy, occupational therapy,
music therapy, auditory integration therapy and speech therapy. Despite the considerable
number of various treatment approaches to ASD available to parents and professionals, the
majority of empirical support relating to many of these programs remains at the level of de
scription (Makrygianni & Reed, 2010; Matson & Smith, 2008), and for many of these proposed
interventions there is limited or no evidence provided to demonstrate any effective outcomes
with their use (Metz, Mulick, & Butter, 2005; Mulloy et al. 2010; Lang et al. 2012).
Despite the many debates that exist amongst researchers and practitioners with regard to effi
cacy of intervention approaches, one consensual fact that is recognised across the board is that
2013 Healy and Lydon; licensee InTech. This is an open access article distributed under the terms of the
568
early intervention is the best response to the treatment of ASD. Providing treatment of symp
toms immediately will result in more favourable treatment outcomes (Dawson, 2008; Howlin,
Magiati & Charmin, 2009; Reichow & Wolery, 2009). Many have argued that this early inter
vention will allow greater opportunities for a young child to move towards a more typical de
velopmental trajectory because of malleability or plasticity of the developing young brain (see
for example Dawson 2008). From a learning theory account, teaching new behaviour or re
placement behaviour to a very young child presenting with behavioural deficits or excesses,
will result in desirable consequences that impacts behavioural repertoires and learning history
from the outset. In this way early intervention for the condition may affect the onset of addi
tional secondary problem behaviours which are often not seen at diagnosis. As such these may
be minimised or even prevented (Mundy, Sullivan & Mastergeorge, 2009).
While a consensus that early intervention for ASD exists amongst researchers in this field,
many argue that the actual approach applied during this critical period may be pivotal in
producing the greatest outcomes and ensuring the best chance of attaining a typical devel
opmental trajectory. Over the past four decades, interventions based on the science of ABA
have been thoroughly evaluated and shown to produce effective outcomes in targeting
many of the challenges presented within this condition. Moreover, behavioural interven
tions drawn from this science can produce substantial gains in cognitive, adaptive and social
behaviours in this population (Dillenberger, 2011). Indeed, this approach is internationally
recognised as the most effective basis for treatment for children with ASD (Larsson, 2005).
Improving the core symptoms of ASD is a common goal for parents and professionals. Re
ports of large improvements in this condition have been documented. For example Smith
(1999) provided a summary of published peer-reviewed studies involving seven independ
ent groups of researchers documenting dramatic gains when early intervention was applied.
Importantly however, in all studies reviewed, interventions were underpinned by ABA
methodology and theory and were intensive involving a range of 15 to 40 hours per week
across studies. This approach to autism treatment, known as Early Intensive Behavioural In
tervention (EIBI) has generated much discussion and excitement, and continues to gather
momentum impressing on policy makers the urgency of effective and substantiated provi
sion for individuals and families affected by the condition.
Studies on EIBI have reported the following gains: (1) average increases of approximately 20
points in IQ (e.g., Harris, Handleman, Gordon, Kristoff, & Fuentes, 1991; Lovaas, 1987;
Sheinkopf & Siegal, 1998) (2) increases in standardised test scores (Anderson, Avery, DiPie
tro, Edwards, & Christian, 1987; Birnbrauer & Leach, 1993; Hoyson, Jamison, & Strain, 1984;
McEachin, Smith, & Lovaas, 1993; Strauss et al. 2012), (3) increased gains in adaptive behav
iour (Eldevik et al., 2012; Strauss et al., 2012); (4) improved language scores (Eldevik et al.,
2012; Strauss et al. 2012); (5) the need for less supports in school (Fenske, Zalenski, Krantz, &
McClannahan, 1985; Lovaas, 1987), (6) reduced autism symptomotology (Eikeseth et al,.
2012) and (7) decreased challenging behaviour (Fava et al., 2012). Dillenberger (2011) refers
to the increasing evidence of clinical, social and financial efficiency of intensive behavioural
intervention in autism treatment which has resulted in legally enshrining such interven
tion in North America. For example, the Autism Treatment Acceleration Act (2010) requires
Early Intensive Behavioural Intervention in Autism Spectrum Disorders

http://dx.doi.org/10.5772/54274
that health insurers cover the diagnosis and treatment of autism spectrum disorders, includ
ing access to ABA therapy.
2. What constitutes EIBI?

EIBI is based on the scientifically applied principles of learning and behaviour, and has the dis
cipline of behaviour analysis (Cooper, Heron, & Heward, 2007) at its core. The approach gener
ally targets preschool children and is provided intensively, often in a 1:1 student/teacher ratio,
for 20-50 hours per week. Dawson (2008) and Green (1996) summarise many of the common
and conspicuous features of successful EIBI programs. These include the following:
1.
the EIBI program should be initiated as early as 2 years and before the age of four;
2.
intensive delivery of the program involving a minimum of 25 hours per week for at
least two years;
3.
application of a comprehensive curriculum or various curricula, focusing on imitation,

language, toy play, social interaction, motor, and adaptive behaviour targets;
4.
the curricula and their implementation should show sensitivity to typical developmen
tal sequences;
5.
generalisation strategies should be incorporated to ensure new skills are practiced and
demonstrated in novel environments outside those in which they were taught;
6.
use of supportive and empirically validated teaching strategies and data-driven deci
sion protocols (notably those of Applied Behaviour Analysis);
7.
implementation of behavioural strategies to reduce or eliminate major interfering be

haviours that are an impediment to learning new skills and repertoires (noncompliance,
inattention, impulsivity, tantrum, aggression and self-injurious behaviours are exam
ples of some of the most critical of these behaviours).
8.
a functional analytic approach to treating problem behaviours;
9.
continual parental involvement and tailored parent education;
10. progressive and gradual transition to increasingly naturalistic environments;

11. qualified and highly trained staff delivering the program and
12. the provision of supervision by qualified over-viewers resulting in ongoing review and
systematic progression of the program.
According to Dawson (2008): When these features are present, results are remarkable for up to
50% of children (p.790).
It is important to note that EIBI draws from the bedrock of a science- Applied Behaviour
Analysis (ABA). This science constitutes over 300 procedures (Greer, 2002; Steege, Mace,
Perry, and Longenecker, 2007) each of which have been tested and demonstrated to produce
569
570
behaviour change. The careful selection and application of these procedures to treat the be
havioural symptoms of autism delivered within the scientific framework of ABA (outlined
in Baer, Wolf & Risley, 1968; 1987) is what defines an EIBI approach. It is critical to recognise
how ABA and EIBI are interwoven because the science of ABA and the various behaviour
change strategies therein, have a very long history of substantiated documentation (see for
example Matson, Benavidez, Compton, Paclawskyj, & Baglio, 1996, who reviewed behavior
ally based treatments for autism over a 16-year span).
3. History of EIBI
The history of this early intervention approach to autism has been well documented over
the last three decades. For example, Matson and Smith (2008) trace the origins of this ap
proach in autism treatment to what they refer to as a seminal paper (p.61) published as
early as 1973 by Lovaas, Koegel, Simmons, and Long (1973). Matson and Smith argue that
this paper demonstrated a visionary conceptual framework for early intervention with ASD.
The true significance of the study was the authors efforts to formulate an overarching treatment of children with autism on a
multitude of behaviours including self-stimulation/stereotypies, echolalia, appropriate verbal behaviour, social behaviour, appropri
ate play, intelligence quotient (IQ), and adaptive behaviour (Matson & Smith, 2008, pp. 61-62).
Trends in EIBI, to this day, are based on this original template involving the delivery of idio
syncratic treatment packages constituting evidence-based behavioural interventions to tar
get core symptoms as well as expansive groups of behaviours. Numerous studies have been
published since this seminal paper in 1973 examining EIBI outcomes in autism. One of the
most distinguished and considered published papers which resulted in the acclamation of
EIBI involved that of Lovaas (1987). This well-reviewed study which reported an average
difference of 31 points on IQ test scores between the ASD treatment group and control
group, and classified nine of 19 (47%) participants as having achieved recovery (defined as
post-intervention IQ in the normal range). To this current day, the findings of this study
have caused much debate among researchers with criticisms focusing on particular meth
odological limitations (see for example, Gresham and MacMillan 1998; Short & Mesibov,
1989). We will return to this study in a later section.
To date, a substantial number of studies have been conducted and published to demonstrate
the effectiveness of EIBI in autism treatment. Moreover, six illustrative review papers and
one mega-analysis (a combination of all of the data into one single analysis) have been
published (see below), each providing somewhat varying angles in exploring the outcomes.
Steady growing rates of publications on the findings of EIBI in autism have been evidenced
and concise descriptions of methodology have appeared to improve in most recent years,
particularly with respect to the inclusion of controlno treatment groups and random as
signment of participants across experimental conditions.
The current chapter will provide a synopsis of EIBI studies published between 1987-2012.
Systematic searches were conducted using the following databases: Scopus, Psychology &
Behavioral Sciences Collection, and PsycINFO

http://dx.doi.org/10.5772/54274
The searches were carried out using the terms early intensive behavioural intervention
AND autism, and intensive behavioural intervention AND autism. The inclusion criteria
were largely in line with those of Reichow (2012). Studies were reviewed if they included a
treatment group who received EIBI and an alternate-treatment control group who received
either no treatment, a different treatment or EIBI provided at different intensity levels. Only
studies including children with ASD were reviewed. Each study was required to involve
original research that was written in English and published in a peer reviewed journal. In
the interest of clarity we grouped published investigations under the following headings:
Studies published before 2000 (4 studies), studies published from 2000-2010 (12 studies) and
studies published between 2011-2012 (5 studies). We provide a summary of factors associat
ed with each published paper including intake characteristics of participants, outcome
measures employed, specific treatment characteristics and group differences following inter
vention. The following sections provide a synopsis of all studies identified.
4. Studies published before 2000 (4 Studies)

Lovaas (1987) conducted the first evaluation of EIBI for children with Autism. The outcomes
of 19 children receiving EIBI, for a minimum of 40 hours per week, were compared to those
of two control groups. The first control group, consisting of 19 children, received low inten
sity (10 hours or less) behavioural intervention and the second control group, consisting of
21 children, received TAU. After two years of treatment, 47% of the EIBI group achieved IQ
scores in the normal range and were enabled to integrate fully into mainstream educational
settings while only 2% of children in the control group achieved similar outcomes. In this
case, almost half of children in the EIBI appeared to recover from their diagnosis of autism.
Birnbauer and Leach (1992) compared the outcomes of nine children receiving EIBI and five
children in a control group (no treatment). Children in the EIBI group received an average of
18.7 hours of EIBI per week delivered by trained volunteers in their homes. Children in the EIBI
group achieved significantly higher non-verbal IQ scores and language levels. Four of the nine
children in the EIBI group achieved IQ scores within the normal range following treatment.
Smith et al. (1997) compared the outcomes of 11 children receiving EIBI to 10 children who
received a low intensity behaviour intervention. Children in the high intensity EIBI group
received at least 30 hours of clinician-delivered treatment each week while the low intensity
group received 10 hours of clinician-delivered behavioural intervention each week. At fol
low-up, the children in the EIBI group showed greater increases in IQ and expressive lan
guage than children in the control group.
Sheinkopf and Siegel (1998) evaluated the outcomes of 11 children receiving EIBI and 11
children receiving Treatment as Usual (TAU). EIBI was delivered by parents, supervised by
clinicians, for 27 hours each week. Children in the control group received 11.1 hours of TAU
in a school setting each week. Following treatment, the EIBI group achieved significantly
higher IQ scores and significantly lower scores on a measure of symptom severity than the
control group.
571
572
Study
Intake Characteristics
Outcome
Treatment Characteristics
Group
Group
Age
M, F
IQ
VABS
EL
RL
Measures
Model
Hr/wk
Lovaas et al.
Tx
19
34.6
62.7
Intellectual
UCLA
40
24+
(1987)
19
40.9
57.0
Functioning;
UCLA
10
24+
group
21
<42
60.0
Academic
TAU
24+
achieved
Treatment
Differences
Duration
47% of the Tx
Placement;
normal
Diagnostic
functioning as
Recovery
compared to
2% of the C
groups.
Birnbauer &
Tx
38.1
5,4
51.3
46.1
Intellectual
Leach (1993)
33.2
5,0
54.5
51.5
Functioning;
UCLA
18.7
21.6
24
Adaptive
Functioning;
Language
Functioning;
Psychopathology
Smith et al.
Tx
11
36
11,0
28
50.3
Intellectual
UCLA
30+
35
Mean IQ
(1997)
10
38
8,10
27
Functioning;
UCLA
10
26
increased by 8
Speech; Behaviour
points in the Tx
Problems
group, but
decreased by 3
points in the C
group. The Tx
group also
made
significantly
more progress
with their
speech.
Sheinkopf &
Tx
11
33.8
62.8
Intellectual
UCLA
27.0
15.7
The Tx group
Siegel (1998)
11
35.3
61.7
Functioning; DSM
TAU
11.1
18
presented with
Symptomatology
significantly
higher IQ
following
treatment.
Symptom
severity was
also
significantly
lower in the Tx
group.
Table 1. Summary of EIBI studies Pre-2000, M, F (male, female), VABS (Vineland Adaptive Behaviour Scale), EL
(Expressive Language), RL (Receptive Language)

http://dx.doi.org/10.5772/54274
5. Studies published from 2000-2010 (12 Studies)

Ben-Itzchak et al. (2008) compared the outcomes of 44 children with autism receiving 45 hours
of EIBI weekly and 37children with other developmental disabilities receiving TAU. After one
year, the children in the EIBI group made significantly greater gains in IQ than the control
group. The authors also analysed whether EIBI outcomes were affected by initial cognitive lev
el. Children were categorised as being of normal, borderline, or impaired IQ. They found that
baseline cognitive levels did not predict changes in autism symptoms. However, IQ increases
due to treatment were correlated with reductions in autism symptoms.
Remington et al. (2007) compared the outcomes of 23 children who received 25.6 hours of
EIBI with a control group in which 21 children received an average of 15.3 hours of interven
tion weekly. After two years of treatment, children in the EIBI group made showed signifi
cantly greater increases in mental age, intellectual functioning, language functioning,
adaptive functioning and positive social behaviours.
Reed et al. (2007a) compared the impact of high-intensity and low-intensity home-based EI
BI. The high-intensity group was composed of 14 children who each received 30.4 hours of
intervention per week. There were 13 children in the low-intensity group who each received
an average of 12.6 hours of intervention weekly. The high-intensity group made significant
ly greater gains on measures of intellectual and educational functioning. However, the chil
dren in the low-intensity EIBI group did show significant improvements in educational
functioning at follow-up.
Reed et al. (2007b) compared the outcomes of children who had received EIBI, eclectic in
tervention, or portage. The 12 children in the EIBI group received an average of 30.4 hours
of home-based intervention each week, the 20 children in the eclectic group received a
mean of 12.7 hours per week, and the 16 children in portage group received 8.5 hours of
weekly intervention. At follow-up, the EIBI group outperformed both groups on measures
of educational functioning while both the EIBI group and the eclectic group scored signifi
cantly higher on measures of intellectual functioning than the portage group.
Given the previous considerations, the current study directly compared the impact of exist
ing ABA, special nursery placements, and portage programs on a variety of aspects of the
children's abilities. The latter two were selected because special nursery placement is a com
monly occurring program offered to children with ASD, which has received little direct as
sessment in terms of its effectiveness. Portage was chosen as, again, it is increasingly offered
to children with ASD (see Reed et al., 2000; Smith, 2000). The portage intervention also al
lows comparison of a very intensive intervention (ABA) with a less intensive intervention
(portage) in a community-based setting. This comparison formed part of the original clinicbased study conducted by Lovaas (1987), and the current comparison allows assessment of
the generalization to a community-based sample. However, the intensity of hours of treat
ment delivery varied greatly between the three interventions and this can make it difficult to
tease out whether it was the nature of the intervention or simply the duration of treatment
that accounted for the differences in outcomes reported.
573
574
Magiati et al. (2007) conducted a prospective comparison of 28 children who received 32.4
hours EIBI each week and 16 children who received 25.6 hours of autism-specific nursery pro
vision each week. The EIBI group received parent-delivered intervention with training and su
pervision provided by clinicians. At follow-up, both groups achieved similar outcomes
although the EIBI group scored significantly higher on the VABS Daily Living Skills subscale.
Eldevik et al. (2006) retrospectively compared the outcomes of 13 children receiving EIBI
and 15 children receiving eclectic intervention. The EIBI group typically received 12.5
hours of intervention each week. Parent training was also provided to increase maintenance
and generalisation of skills. The control group received 12 hours of intervention each week.
The EIBI group outperformed the control group on measures of IQ, language functioning,
and communication at the follow-up. They also presented with less symptoms of pathology
than children in the control group.
Eikeseth et al. (2007) compared the outcomes of 13 children who received 28 hours of EIBI
weekly with 12 children who received 29.1 hours of eclectic intervention each week. At
follow-up, the children who had received EIBI showed significantly greater improvements
in IQ, adaptive functioning, and presented with less social and behaviour problems.
Cohen et al. (2006) compared the outcomes of 21 children receiving 35-40 hours of EIBI per
week to a control group of 21 children receiving eclectic interventions. Parents imple
menting EIBI received training so that they could use behavioural techniques in the home
setting. Following the treatment phase, the EIBI group achieved significantly higher scores
on measures of IQ, adaptive functioning, and receptive language. 17 children from the EIBI
group transitioned to mainstream education settings as compared to 1 child from the control
group.
Sallows and Graupner (2005) compared the effects of clinic-directed EIBI and parent-direct
ed EIBI. This study was the only study we found in our search that directly compared the
mode of EIBI delivery. All others either employed an alternate treatment comparison or a
control-no treatment comparison. The 13 children in the clinic-directed EIBI group received
an average of 37.6 hours of intervention weekly while the10 children in the parent-directed
EIBI group typically received 31.6 hours of intervention. Both groups received a UCLAbased intervention (often referred to Lovaas therapy based on the original study in 1987).
The groups made similar gains on outcome measures suggesting that the less costly parentdirected intervention was equally effective. It was found that 48% of participants showed
rapid learning, achieved normal scores on outcome measures, and, at follow-up, were suc
ceeding in mainstream classrooms. Pre-treatment imitation, language, daily living skills,
and socialization were found to be predictive of outcome.
Howard et al. (2005) compared the effects of EIBI, intensive eclectic intervention, and low-in
tensity eclectic intervention. The 29 children assigned to the EIBI group received 25-40 hours
of EIBI each week and their parents received training so that teaching could extend to the home
setting. The 16 children in the intensive eclectic intervention group received 25-30 hours of
intervention each week, while the 16 children in the low-intensity eclectic group received 15
hours of intervention each week. The EIBI group achieved significantly higher scores on meas
ures of intellectual functioning, visual spatial skills, language functioning and adaptive func
tioning. The outcomes of the two eclectic control groups did not differ.

http://dx.doi.org/10.5772/54274
Study
Outcome Measures
Group
Age
M, F
IQ
VABS
EL
RL
Smith et al.
Tx
15
36.1
12, 3
50.5
63.4
41.9
37.3
(2000)
13
35.8
11, 2
50.7
65.2
45.6
38.3
Treatment
Group
Differences
Model
Hr/wk
Intellectual
UCLA
24.5
33.4
The Tx group
Functioning; Visual-
UCLA
15-20
24
made significantly
Duration
Spatial Skills;
greater gains in
Language
IQ, visual-spatial
Functioning;
skills, and
Adaptive
language
Functioning;
development. The
Socioemotional
Tx group tended
Functioning;
to make greater
Academic
academic
Achievement; Class
achievements and
Placement; Progress
to be in less
in Treatment; Parent
restrictive
Evaluation
academic
placements.
Eikeseth et al
Tx
13
66.3
8, 5
61.9
55.8
45.1
49.0
Intellectual
UCLA
28.0
12.2
(2002).
12
65.0
11, 1
65.2
60.0
51.2
50.4
Eclectic
29.1
13.6
The Tx group
achieved
Spatial Skills;
significantly
Language
higher scores that
Functioning;
the C group on all
Adaptive
measures, except
Functioning
the VABS
socialization
subscale and the
daily living
subscale. Children
in the Tx group
had significantly
fewer disruptive
behaviours than
the C group at
follow-up.
Howard et al.
Tx
29
30.9
25, 4
58.5
70.5
(2005)
16
37.4
13, 3
53.7
69.8
16
34.6
16, 0
59.9
71.6
51.9
52.2
Intellectual
EIBI
25-40
14.2
The outcomes of
43.9
45.4
48.8
49.0
Eclectic
25-30
13.3
the two eclectic C
Spatial Skills;
Eclectic
15
14.8
groups did not
Language
differ. The Tx
Functioning;
group performed
Adaptive
significantly
Functioning
better on all
measures, except
motor skills than
the C groups.
575
576
Study
Outcome Measures
Group
Age
M, F
IQ
VABS
EL
RL
Tx
13
35.0
11, 2
50.9
59.5
47.9
38.9
Model
Hr/wk
UCLA
37.6
Treatment
Group
Differences
Duration
Sallows &
Intellectual
48
Both Tx groups
Graupner
Functioning;
performed
(2005)
Language
similarly on all
Functioning;
outcome
Adaptive
measures.
Functioning; Social
Functioning;
Academic
Functioning
Cohen et al.
Tx
21
30.2
18, 3
61.6
69.8
52.9
51.7
Intellectual
UCLA
35-40
36
The Tx group
(2006)
21
33.2
17, 4
59.4
70.6
52.8
52.7
Eclectic
made significantly
Spatial Skills;
greater gains in
Language
IQ, receptive
Functioning;
language, and
Adaptive
adaptive
Functioning;
functioning. 17
Academic
children from the
Placement
Tx group were
included in
mainsteam
education settings
as compared to 1
child in the C
group.
Eldevik et al.
Tx
13
53.0
10, 3
41.0
52.5
33.8
37.3
Intellectual
UCLA
12.5
20.3
(2006)
15
49.0
14, 1
47.2
52.5
41.6
33.2
Functioning;
Eclectic
12.0
21.4
The Tx group
significantly
Language
outperformed the
Functioning;
C group on
Adaptive
intellectual
Functioning; Visual
functioning,
Spatial Skills;
language
Pathology; Degree
functioning, and
of Intellectual
the
Disability
communication
subscale of the
VABS. The Tx
group also
showed
significantly less
pathology at the
follow-up

http://dx.doi.org/10.5772/54274
Study
Outcome Measures
Group
Age
M, F
IQ
VABS
EL
RL
Eikeseth et al.
Tx
13
66.3
8, 5
61.9
55.8
45.1
49.0
(2007)
12
65.0
11, 1
65.2
60.0
51.2
50.4
Model
Hr/wk
Treatment
Intellectual
UCLA
28.0
31.4
Functioning;
Eclectic
29.1
33.3
Group
Differences
Duration
Adaptive
The Tx group
showed
significantly
Functioning;
greater
Socioemotional
improvements in
Functioning
IQ, adaptive
functioning, social
behaviour, and
aggressive
behaviour.
Magiati et al.
Tx
28
38.0
27, 1
83.0
59.6
2.2 (r)
4.9 (r)
Visual-Spatial Skills;
UCLA
32.4
25.5
(2007)
16
42.5
12, 4
65.2
55.4
1.7 (r)
2.9 (r)
Intellectual
Eclectic
25.6
26.0
Functioning;
Both groups
showed
comparable
Adaptive
improvements.
Functioning;
However, the Tx
Language
group achieved
Functioning; Play
significantly
Skills; Autism
higher scores on
Symptomatology
the VABS Daily

Living Skills
subscales. Large
intra-group
variation in
response to
treatment was
observed.
Reed et al.
Tx
14
42.9
14, 0
60.1
59.3
Autism
EIBI
30.4
9-10
The Tx group
(2007a)
13
40.8
13, 0
56.6
56.5
Symptomatology;
EIBI
12.6
9-10
made significantly
Developmental
greater gains on
Functioning;
intellectual
Intellectual
functioning and
Functioning;
educational
Adaptive
functioning,
Functioning
although the C
group did show
significant
improvements on
educational
functioning.
Reed et al.
Tx
12
40
11, 1
56.8
58.2
Autism
EIBI
30.4
Those in the Tx
(2007b)
20
43
18, 2
57.8
53.0
Symptomatology;
Eclectic
12.7
group made
16
38
53.4
58.6
Developmental
Portage
8.5
significantly
577
578
Study
Group
Age
M, F
IQ
Outcome Measures
VABS
EL
RL
Model
Hr/wk
Treatment
Group
Differences
Duration
Functioning;
greater gains than
Intellectual
the portage
Functioning;
group on
Adaptive
intellectual
Functioning;
functioning and
Comorbid Problems
made greater
gains than both C
groups on
educational
functioning.
Remington et
Tx
23
35.7
61.4
114.8 (r)
Intellectual
EIBI
25.6
24
al. (2007)
21
38.4
62.3
113.6 (r)
Functioning;
TAU
15.3
24
The Tx group
showed
Language
significantly
Functioning;
greater increases
Adaptive
in mental age,
Functioning;
intellectual
Behaviour;
functioning,
Nonverbal Social
language
Communication;
functioning,
Parental Wellbeing
adaptive
functioning, and
positive social
behaviours.
Ben-Itzchak
Tx
44
27.3
43, 1
74.8
et al. (2008)
37
24.2
23, 14
71.0
Intellectual
EIBI
45
12
Functioning; Autism
TAU
12
The Tx group
made significantly
Symptomatology (Tx
greater gains in IQ
group only)
than the C group.
Table 2. Summary of EIBI studies 2000-2010, M, F (male, female), VABS (Vineland Adaptive Behaviour Scale), EL
(Expressive Language), RL (Receptive Language), (r) (raw scores)
Eikeseth et al. (2002) compared the outcomes of EIBI and eclectic treatment for children
with autism after one year of intervention. The 13 children in the EIBI group received an
average of 28 hours of intervention each week in a school setting. Parents were trained for a
minimum of four hours each week for three months so that they were able to extend their
childs treatment to the home setting. Children in the eclectic group received an average
of 29.1 hours of intervention each week. Following treatment, the EIBI group outperformed
the control group on measures of intellectual functioning, visual-spatial skills, and language
functioning. They also engaged in fewer disruptive behaviours than the eclectic group.
However, the eclectic group showed significantly greater increases in adaptive function
ing than the EIBI group.

http://dx.doi.org/10.5772/54274
Smith et al. (2000) evaluated the outcomes of children with autism or pervasive develop
mental disorder not otherwise specified who were assigned to an EIBI group or parentdelivered behavioural intervention group. The 15 children in the EIBI group received, on
average, 24.5 hours of intervention each week delivered by trained student therapists
while parents were included in five hours of teaching each week. The 13 children in the
parent-delivered behaviour received 15-20 hours of intervention each week. Their parents
received bi-weekly training for 3-9 months and a minimum of one hour of supervision
each week. At the end of the treatment phase, the EIBI group performed significantly
better than the parent-trained group on measures of intellectual functioning, visual-spa
tial skills, language, and academic functioning. The groups did not differ on measures of
adaptive functioning or challenging behaviours. Children with pervasive developmental
disorder not otherwise specified tended to respond better to treatment than children
with autism.
6. Studies published between 2011-2012 (5 Studies)

Strauss et al. (2012) compared the outcomes of 24 children receiving 35 hours of EIBI
each week and 20 children receiving 12 hours of a mixed eclectic intervention each
week after six months of treatment. EIBI was delivered by staff and by parents, follow
ing initial comprehensive parent training. At follow-up, the EIBI group outperformed the
control group on IQ measures, early language measures, and also showed greater reduc
tions in autism severity. Both groups made significant gains in adaptive behaviour and
receptive language. However, it was found that the eclectic intervention led to signifi
cant reductions in parental stress while parental stress in the EIBI group did not change
over the course of treatment.
Flanagan et al. (2012) conducted a retrospective comparison of the outcomes of 61 children
receiving EIBI for over two years and 61 children, matched on chronological age, who were
on a treatment waitlist. Children in the EIBI group received, on average, 25.8 hours of treat
ment each week, typically at community treatment centres, and parent training was availa
ble and encouraged. The EIBI group made significantly greater gains in intellectual
functioning and adaptive function, and scored lower on a measure of autism symptomatolo
gy. Furthermore, younger age at treatment onset, and higher adaptive skills, were found to
predict better EIBI treatment outcomes.
Eldevik et al. (2012) analysed the outcomes of 31 children receiving EIBI in a mainstream
pre-school and 12 children receiving TAU in the form of an eclectic mix of interventions.
The EIBI group typically received 13.6 hours of intervention each week and parents were en
couraged to use behavioural procedures at home to promote generalisation and mainte
nance. The TAU group received a minimum of five hours of treatment each week. After two
years, the EIBI group achieved significantly greater scores on measures of intellectual and
adaptive functioning.
579
580
Study
Group
Age
M, F
IQ
Outcome
VABS
EL
RL
Measures
Model
Hr/wk
Group Differences
Treatment
Duration
Fava et al.
(2011)
Tx
C
12
10
52.0
43.7
10,2
9,1
62.1
69.1
63.3
44.3
33.7
29.0
48.6
84.5
Autism
Symptomatology;
EIBI
Eclectic
14
12
6
6
Intellectual
Tx group showed
significant changes
in autism severity,
Functioning;
intellectual
Adaptive
functioning,
Functioning;
adaptive behaviour
Language
(except for on the
Functioning;
VABS socialization
Challenging
subscale), and on
Behaviours;
ADHD
Comorbid
symptomatology. A
Psychopathology;
significant decrease
Parental Stress
in challenging
behaviours was also
observed. The C
group showed
significant changes
on all subscales of
the VABS. Parents
of children in the C
group reported
significantly less
stress.
Eikeseth et
al. 2012
Tx
C
35
24
47
53
29, 6
20, 4
67
63.6
Adaptive
Functioning;
UCLA
Eclectic
23
-
12
12
Tx group scored
significantly higher
Autism
on all VABS
Symtomatology
subscales. The Tx
group showed
significant
reductions in autism
symptomatology
Eldevik et
al. (2012)
Tx
C
31
12
42.2
46.2
25, 6
8, 4
51.7
51.6
62.5
58.9
Intellectual
Functioning;
EIBI
13.6
25.1
TAU
5+
24.6
Adaptive
The Tx group made

significantly larger
gains on intellectual
Functioning;
functioning and
adaptive behaviour.
Flanagan et
al. 2012
Tx
79
42.93
69, 10
55.38
Autism
EIBI
25.81
27.84
The Tx group made
Symptomatology;
significantly more
Adaptive
gains on all VABS

http://dx.doi.org/10.5772/54274
Study
Group
Age
M, F
IQ
VABS
Outcome
EL
RL
Measures
Model
Hr/wk
Group Differences
Treatment
Duration
Control
63
42.79
53, 10
55.49
Functioning;
Waitlist
Intellectual
Control
17.01
subscales. They
achieved
Functioning
significantly higher
IQ scores and
scored significantly
lower on a measure
of autism
symptomatology.
Strauss et
al. 2012
Tx
C
23
20
55.67
41.94
22, 2
19, 1
58
66.91
78.33
66.92
32.95
16.88
52.60
47.87
Autism
Symptomatology;
EIBI
Eclectic
35
12
6
6
Tx group showed
significantly greater
Intellectual
gains in intellectual
Functioning;
functioning,
Adaptive
expressive
Functioning;
language, and
Language
social interactions.
Functioning;
They showed
Challenging
significantly greater
Behaviours;
reductions in autism
Parental Stress
symptomatology
and challenging
behaviour. Both
groups made
significant gains in
receptive language
and adaptive
behaviour. Parents
in the Tx group
were significantly
more stressed.
Table 3. Summary of EIBI studies between2011-2012, M, F (male, female), VABS (Vineland Adaptive Behaviour Scale),
EL (Expressive Language), RL (Receptive Language)
Eikeseth et al. (2012) examined the outcomes of 35 children receiving EIBI and 24 children
receiving TAU after one year of treatment. Children in the EIBI group received 23 hours of
intervention per week, on average, and parent training was provided. Children in the
eclectic group were attending special education settings where teachers incorporated a va
riety of interventions. The children in the EIBI group made significantly greater gains in
adaptive functioning. They also demonstrated reduced autism symptomatology.
581
582
Fava et al. (2011) compared the outcomes of 12 children receiving EIBI and 10 children re
ceiving eclectic intervention after six months of treatment. EIBI was delivered by trained
therapists, in a clinic-based setting, and by intensively trained and supervised parents, in a
home-based setting, with children receiving 14 hours per week on average. Children in the
eclectic group typically received approximately 12 hours per week. After six months of in
tervention, the EIBI group showed significantly greater increases in intellectual functioning,
and significantly greater decreases in autism symptomatology and challenging behaviour.
Both groups, however, showed significant gains in adaptive functioning. Parents in the
eclectic group showed significant reductions in stress over the course of treatment while
no changes in parental stress were observed for the EIBI group.
7. Challenges to EIBI
Ongoing analysis of the outcomes of EIBI in comparison to other treatment programs is
clearly continuing to capture the interest of many researchers with five studies alone dem
onstrating outcomes between 2011 and 2012. Indeed, given the growing international recog
nition of EIBI as the recommended approach to autism intervention, this ongoing
investigation and demonstration of effects is vital. Such demonstrations and continuous rig
or in testing this approach with children with autism diagnoses, substantiates the view that
intensive early intervention using the scientific precision of behaviour analysis, can be a
very powerful intervention (Howlin, 2010; Granpeesheh, Tarbox & Dixon, 2009).
However, despite publication of the numerous studies outlined above, criticism of meth
odological stringency and dependent variables analysed within and across them, has
been documented.
Remarkably, despite thousands of ABA-EIBI studies on specific core deficits, and related challenging behaviours and skills, and
EIBI studies as well, some researchers still question the efficacy of these methods (Matson, Tureck, Turygin, Beighley &
Rieske, 2012, p.1413).
One of the most pronounced criticisms of EIBI research for some time is that large multi-ele
ment randomized clinical trials are required to provide a definitive scientific demonstration of
its effectiveness in autism treatment (Spreckley & Boyd, 2009). We, and others, (e.g., Keenan &
Dillenberger, 2011; Matson et al. 2012) do not support this view and we encourage the reader to
examine an excellent rebuttal of the reasons that the gold standard, randomized controlled tri
al in research evaluation, is in actual fact inappropriate for the design and evaluation of indi
vidualised treatment protocols (see Keenan &Dillenberger, 2011 for a thorough analysis).
One criticism presented in relation to the overall interpretation of the studies outlined in this
chapter involves the issue that large idiosyncratic differences occur across children diag
nosed with autism. Because of the extensive discrepant features and their expression across
the condition, Howlin (2010) stresses the need to determine which components of the inter

http://dx.doi.org/10.5772/54274
vention work best for specific individuals and under what set of circumstances. Smith et al.
(2010) also suggest that ongoing research is necessary in identifying key moderating varia
bles in EIBI outcomes. Specifically, they pose the question of what are the most effective
components, and the amount of such components, in producing marked changes in core au
tism symptoms and additional problems. Other researchers have also emphasised this point
(Alessandri, Thorp, Mundy, & Tuchman, 2005; Granpeesheh et al. (2009). For some, deter
mining predictor variables such as personal characteristics affecting outcomes has been a fo
cus. For example, Itzchak and Zachor (2009) demonstrated that the presence of an
intellectual disability and significantly delayed adaptive skills in young children with au
tism was a major risk factor and a predictor of weaker outcomes for EIBI. They also showed
that children who were 30 months of age or younger responded significantly better to early
intervention. A more recent study by Perry et al. (2011) showed that variables including
younger age and higher intellectual functioning at onset of intervention were predictors of
greater positive effects. Not surprisingly, Perry et al. (2011) also found that duration of inter
vention was a predictor of positive outcomes for young children undergoing EIBI- the lon
ger the child participated in the intervention, the better the outcome.
While EIBI programs provide strong adherence to the framework and foundational princi
ples of learning within ABA, some investigators have followed a particular "brand name"
approach (Healy, Leader & Reed, 2010). There are a number of different ABA approaches
that have been outlined in a variety of sources (some examples include: Greer, Keohane &
Healy, 2002; Koegel & Koegel, 2006; Lovaas, 1981; Lovaas & Smith, 1989; Sundberg & Mi
chael, 2001). Often this branding can lead to obfuscation for the reader in interpreting
what type of EIBI/ABA program is best. However, these approaches are all built on the
same bedrock sharing important common features- intensity in program delivery (up to 40
hours weekly for at least three years), one-to-one teaching where the individual requires
such intensive instruction, and discrete-trial reinforcement-based methods (in both massed
trial formats and natural environmental teaching opportunities) incorporated within the sci
entific stringency of a behaviour analytic framework (Matson et al. 2012).
Magiati and Howlin (2001) have argued that many of the EIBI studies employ different
measurements across participants and at baseline and follow up thereby compromising
interpretation and reliability. For example, Eikeseth et al. (2002) and Howard et al. (2005)
did not use the same tests at baseline and at follow up phases. Inconsistencies in partici
pant characteristics across groups (lack of matching: (e.g., Eldevik, Eikeseth, Jahr, &
Smith, 2006; Fenske, Zalenski, Krantz, & McClannahan, 1985) have also been critiqued
within the studies. In addition, different investigators examined various settings for EIBIsome were clinic-based (Ben-Itzchak et al., 2007; Eldevik et al., 2006) others were com
munity-based (Cohen et al., 2006; Eikeseth et al. 2002; Eikeseth et al., 2007; Eikeseth et
al., 2012; Eldevik et al., 2012; Flanagan et al., 2012; Howard et al. 2005; Magiati et al.,
2007), while others were home-based (Reed et al., 2007a; Reed et al., 2007b; Remington et
al., 2007; Sheinkopf & Siegel, 1998;Smith et al., 2000). This variation in measures/settings
across studies may provide challenges in the generalisation of intervention outcomes to
different environments (Mudford et al., 2009).
583
584
However, we believe that it is critical to be able to assess the effectiveness of EIBI across par
ticipants who may reflect different tracts on the spectrum i.e., those with more severe core
autism symptoms, presence of challenging behaviours, less linguistically able; impaired IQ;
co-morbid or co-occurring problems etc. In this sense it appears important to utilise a wide
range of instruments in the assessment procedure, not only to examine autism severity but
also measures of intellectual functioning, adaptive behaviour, challenging behaviour, comorbid psychopathology and educational functioning.
Treatment integrity including initial training of therapists and parents along with continual
supervision is often not reported in studies yet many authors have written on the impor
tance of adherence to the scientific rigor of ABA (Symes, Remington, Brown & Hastings,
2006). While many of the studies reviewed referred to training either for therapists or pa
rents, detail on the fidelity of treatment delivery was not measured. Where some have inves
tigated adherence to strict training protocols, highly effective outcomes can be demonstrated
using EIBI (see McGarrell, Healy, Leader, OConnor & Kenny, 2009).
Critiques of the initial results reported by Lovaas (1987) concerning the effectiveness of EIBI
were dominant amongst the most vociferous arbiters, especially given that exact replication
of such results is not evident to date. Indeed, this is one of the greatest challenges faced by
many EIBI researchers. The children undergoing EIBI treatment in the Lovaas study made
remarkable gains of up to 30 IQ points and were not noticeably different from neuro typical
developing children after 3 years of the intervention. Replications of this original study have
certainly attempted to address the methodological criticisms by incorporating more rigorous
experimental design including random assignment to groups (Sallows and Graupner 2005;
Smith et al. 2000). However, studies to date have yet to achieve the extent of the outcomes
reported by Lovaas (1987).
It is clear that over time the methodological criticisms of the earlier studies have been ad
dressed by more recent investigators. Some of the recent published studies have employed
larger small sample sizes, comparison groups, random assignment of the children to groups,
matched characteristics across groups and standardising measures used for assessment be
tween and within children (e.g., Flanagan et al., 2012)
Certainly, consistency in measures at baseline and follow-up has improved with most of the
studies published between 2011-2012 implementing the same measures at entry and output
for the majority of variables measured (Eikeseth, et al., 2012, Eldevik, et al, 2012; Fava et al.,
2011; Flanagan et al., 2012; Strauss et al., 2012). Furthermore, it is worth noting that most re
cent studies on EIBI are employing a more extensive battery of measures to assess the effects
of EIBI- in addition to IQ and adaptive behaviour which was the focus of earlier research.
For example, Fava et al. (2011) and Strauss et al. (2012) measured autism symptomatology,
language functioning, challenging behaviour, comorbid psychopathology, and parental
stress as outcomes of EIBI. Eikeseth et al. (2012) and Flanagan et al. (2012) also examined au
tism symptomatology as a dependent variable. This focus on increasing evaluation of treat
ment outcomes is a welcome development in EIBI research. Examining the impact of EIBI on
the core symptoms of autism, challenging behaviours and comorbid psychopathology pro
vides an exciting avenue for future research.

http://dx.doi.org/10.5772/54274
While some authors have provided criticism in response to their interpretation of the EIBI
outcome studies summarised within this chapter (e.g., Shea, 2004), others have acknowl
edged the long-term effects of such an intervention resulting from the best empirically vali
dated interventions (e.g., Granpeesheh, Tarbox & Dixon, 2009).
Prior to 2009 six EIBI descriptive review papers were published each analysing meth
odologies, variables and outcomes from different perspectives (e.g., Eikeseth 2009;
Granpeesheh et al. 2009; Howlin, Magiati & Charman, 2009; Matson and Smith 2008;
Reichow & Wolery, 2009; Rogers and Vismara, 2008). As well as these research re
views, Eldevik et al. (2010) gathered individual participant data from 16 group design
studies on behavioural intervention for children with autism, resulting in individual
participant data for 309 participants in an EIBI group, 39 participants in an alternate
treatment comparison group, and 105 in a control group-no treatment group. Their
analysis revealed that more children who underwent behavioral intervention achieved
significantly greater change in IQ and adaptive behaviour compared with the compari
son and control groups (see Eldevik et al. 2010). We encourage the reader to examine
these papers in order to discern the conventional acclaim of EIBI as an acknowledged
intervention for ASD.
More importantly, since 2009 EIBI research for young children with ASD has been subject to
six meta-analytic reviews (Eldevik et al. 2009; Makrygianni and Reed 2010; Reichow and
Wolery 2009; Peters-Scheffer, Didden, Korzilius & Sturmey, 2011; Spreckley and Boyd 2009;
Virues-Ortega, 2010). A meta-analysis is a particular type of statistical method for integrat
ing results from many individual studies. This type of statistic can be useful for obtaining an
overall estimate of whether or not an intervention is effective and, if so, what the size of the
benefits are (i.e., the effect size). The overwhelming findings from five of the six meta-analy
ses conducted between 2009 to 2012 (Eldevik et al. 2009; Makrygianni and Reed 2010; PetersScheffer et al., 2011; Reichow & Wolery 2009; Virues-Ortega 2010) concluded that EIBI was
an effective intervention strategy for many children with ASD, accelerating development,
improving IQ and adaptive skills compared to those receiving no intervention or alternate
diverse standard care treatments.
Most recently, Reichow (2012) presented an overview of the five meta-analyses on EIBI for
young children with ASD. He concluded that the collective and accumulating evidence sup
porting EIBI from meta-analytic studies cannot be dismissed. Reichows impressive dissec
tion of the investigations of EIBI to date achieves the following assertion:
Furthermore, the current evidence on the effectiveness of EIBI meets the threshold and criteria for the highest levels of evidencebased treatments across definitions Collectively, EIBI is the comprehensive treatment model for individuals with ASDs with the
greatest amount of empirical support and should be given strong consideration when deciding deciding treatment options for
young children with ASDs (Reichow, 2012, p. 518.)
585
586
8. Screening for ASD and EIBI provision

It is accepted in the field of autism that there now exists enough evidence to recognise
the disorder at a very early age (Feldman et al. 2012; Matson, Boisjoli, Rojahn, & Hess,
2009). While many screening instruments exist for the disorder, the most thoroughly ex
amined of these is the BISCUIT (Matson et al., 2009; Matson, Fodstad, & Mahan, 2009;
Matson, Fodstad, Mahan, & Sevin, 2009; Matson, Wilkins, Sevin, et al., 2009; Matson,
Wilkins, Sharp, et al., 2009). In addition to providing clinicians with a measure of the
very early signs of autism symptomology, the BISCUIT also provides a measure of emo
tional/behavioural disorders and comorbid psychopathology. We believe that providing
EIBI to young infants showing early signs of autism, before the condition is fully mani
fest, will target core skills by accelerating developmental sequences, halting deteriorating
behavioural repertoires, and preventing additional secondary problems. Provision of EIBI
at the time when symptoms are initially detected, may in tandem, alter the course of ear
ly behavioural and brain development increasing the likelihood that children attain a
rate of typical development (Dawson, 2008).
We advocate for the need to screen children for this disorder during routine health and de
velopmental checks. Screening in Ireland is currently haphazard and often depends on a pa
rent showing concern for some area of their childs development. In particular, prevention
entails detecting infants at risk before the full diagnostic criteria are present and it has been
recognised that early signs may emerge as soon as 9 months in infants with siblings who
have ASD (Ozonoff et al. 2010; Zwaigenbaum et al. 2005). Screening these biologically at
risk children in early infancy should allow greater access to the effective methods demon
strated by EIBI. We strongly believe that the availability of both standardised screening
techniques and EIBI provision to such children will impact on a more promising prognosis
in the long-term.
9. The benefits of EIBI

There is no doubt that the cost of an intensive and accomplished EIBI program is expensive.
For example, cost analysis studies revealed that the average annual cost of an EIBI program
in North America to be $33,000 per year with the average duration being three years (Jacob
son, Mulick & Green, 1998). However, further analysis of this cost-effectiveness and saving
over time has also been provided. For instance, the Autism Society of America reported in
2008 that the cost of lifelong care could be reduced by up to as much as two thirds with ear
ly diagnosis and EIBI.
Dillenberger (2011) provides a synopsis of recent cost-benefit analyses showing the savings
that can be achieved by implementation of EIBI in autism treatment. She puts forward the
following:
1.
in Ontario, Canada, an estimated annual CA$ 45 million can be saved if EIBI is made
available to all children diagnosed with ASD (see Motiwala et al., 2006);

http://dx.doi.org/10.5772/54274
2.
in Texas, USA, a total of US$ 208,500 per child is saved by the education system
through the use of EIBI (see Chasson, Harris & Neely (2007);
3.
and in Pennsylvania, USA, average savings per child are estimated even higher to range
from US$ 274,700 to US$ 282,690 (see also Chasson, Harris & Neely (2007).
Based on these cost-saving analyses increasing change has been shown in policy regard
ing the role of EIBI in early intervention. For example, the state of Ontario in Canada,
has legislated to make EIBI services available for all children diagnosed with ASD (Perry
& Condillac, 2003). In the USA, 32 States have passed legislation to ensure that ABAbased interventions are either state-funded or provided through medical insurance com
panies (Dillenberger, 2011; Market Watch, 2012). It remains to be seen whether
government policy in the United Kingdom or Ireland will catch up with that of Canada
and the USA and provide government funded EIBI once children are deemed at risk for
or indeed presenting with this condition. Interestingly, the use of trained volunteers to
deliver EIBI has been shown to produce effective outcomes (Birnbrauer & Leach, 1993)
and may be an option for some parents/services to consider when cost is an issue. Many
university students who train on third level post-graduate programmes in Applied Be
haviour Analysis could make strong contributions in a voluntary capacity, to EIBI in au
tism treatment, as part of their ongoing accreditation process as Board Certified
Behaviour Analysts with the international certification body (Behaviour Analyst Certifica
tion Board). Alternatively providing parents of children with autism with training in
behavioural interventions (demonstrated by Sallows and Graupner, 2005) can result in
cost-saving and important positive outcomes for children with autism.
10. Controversies related to EIBI efficacy

The published studies outlined in this chapter highlight the possible positive outcomes for
young children diagnosed with autism. EIBI continues to be investigated internationally as a
treatment intervention for this condition and as a result of these investigations attracts many
critics and controversies. In the past, some authors have criticised a behavioural approach to
autism intervention with regard to robotic teaching and behaviour patterns that lack gen
eralisation to naturalistic settings (Jordan, Jones & Murray, 1998; Shea, 2004) along with the
use of negative consequences in acquisition teaching and behaviour reduction (Carr, Robin
son & Palumbo, 1990). Others have highlighted the concerns with regard to claims of re
coveryor a cure for autism (Offit, 2008). However, the improvements shown over the last
decade in EIBI refinement and provision, particularly with regard to training and regulatory
protocols with its delivery (Behavior Analyst Certification Board, 2012) has addressed
many of these issues. Indeed, professional training in behaviour analysis and behavioural
intervention has never been as well regulated as it is today.
No doubt there are still many issues that continue to require analysis in the EIBI and autism
field of research. We would like to draw the readers attention to a recent publication by
Matson and Smith (2008) providing an analysis of the current status of intensive behavioural
587
588
intervention for young children with autism. We believe that this paper provides an excel
lent summary of the criticisms provided on EIBI and we will highlight these here. Firstly,
many of the studies providing analysis of EIBI outcomes fail to report the severity of ASD
across participants and groups. This makes it difficult to decipher which children will show
greatest susceptibility to the intervention. Those with greater severity of symptoms may
show slower progress or less gains. It has been reported that a milder degree of autism is
related to better prognosis (e.g., Bartak & Rutter, 1976) and therefore it is essential that varia
bles at intervention onset include such a measure. Secondly, Matson and Smith (2008) high
light the fact that researchers often do not take into account the additional, co-morbid,
problems that present with autism (e.g., ADHD symptoms or anxiety disorders). Psychopa
thological problems can co-occur with the condition and may exacerbate the challenges and
deficits for many children. The impact this can have on treatment susceptibility is underre
ported and often not addressed in treatment research. For example, only two studies in our
review provided outcome measures of co-morbid psychopathology (Birnbrauer & Leach,
1993; Fava, 2011). Matson and Smith (2008) provide a strong argument for the assessment of
psychopathology before, during, and after EIBI, to determine ongoing changes in child pro
files or to address any required adjustments to the delivery of EIBI (e.g., increasing or de
creasing the duration of intervention, removing skills acquisition teaching from artificial
environments, less emphasis on massed trial instruction etc.). Perhaps not enough attention
has been given to these issues in EIBI research. The young age of onset of EIBI and the inten
sity of the intervention may have undesired side effects such as anxiety, stress, burn out
or indeed refusal to participate. Other controversial issues involving EIBI include parent and
sibling involvement which can often induce stress and family strain when highly intensive
intervention is provided within the family home. The negative side effects of this kind of in
tensive intervention certainly warrant separate analysis.
Unfortunately, like any professional practice or therapeutic intervention, there will be those
who claim to provide EIBI without adhering to the scientific demonstrations of what is, and
is not, effective within an intervention protocol. We have heard of anecdotal accounts of the
applications of behavioural interventions in autism treatment that are outdated and often
lack individualisation. Treatment fidelity is often a major problem in the field and often au
thors fail to demonstrate or report adherence to effective and current practice in many of the
published studies on EIBI. Such problems can lend support to a negative view of the use of
EIBI with young children with autism diagnoses.
An analysis of changes in adaptive functioning of young children has become an added fo
cus of EIBI studies in more recent years. Traditionally, studies tended to focus on changes in
intellectual and social functioning and language and communication abilities. Some authors
have criticised EIBI for overly focusing on cognitive skills with 1:1 teacher/student ratios
and a focus on desk-top instruction and intensive drills (e.g., Shea, 2004). Increasingly, EI
BI curricula and instructional protocols have grown to ensure inclusion of adaptive skills
teaching and acquisition of novel skills in natural environments. Studies evaluating out
comes of EIBI have also focused more on adaptive functioning changes as a result of the in
tervention. In 2002, Eikseth et al. reported greater increases in adaptive functioning in a

http://dx.doi.org/10.5772/54274
group of young children who received eclectic intervention than those receiving EIBI. Fur
thermore, Fava et al. (2011) and Strauss et al. (2012) showed that both groups receiving EIBI
and eclectic intervention showed significant gains in adaptive functioning. Two more re
cent studies by Eldevik et al.(2012) and Eikseth et al., (2012) reported the opposite findings
to Eikseth et al. (2002) in relation to adaptive functioning when comparing both interven
tions.
Another variable that has been increasingly analysed in early intervention autism research
includes parental stress. Interestingly, two comparison studies (Fava et al., 2011; Strauss et
al., 2012) showed significant reductions in parental stress for those parents whose children
were receiving eclectic intervention. The same effect was not shown for parents of chil
dren receiving EIBI. This is another important area of analysis particularly in light of the de
mands that EIBI places on parents and family.
11. Conclusion
EIBI as an approach to autism treatment is one of the most intensively analysed interven
tions in paediatric clinical psychology (Matson & Smith, 2008).
Substantial objective evidence for EIBI has been demonstrated at an experimental, descrip
tive and meta-analytic level of analysis (Reichow, 2012). We support the contention of many
authors in the field of autism treatment, that EIBI prevails by adhering to a principle of evi
dence-based practice, incorporating standardised objective measurement of outcomes along
with implementation of robust experimental design. This robust demonstration of effective
ness is driving policy change on the international stage and some authors (e.g., Dawson,
2008) suggest that one of the most important goals of investigations in the domains of au
tism and behaviour analysis research, is to become more effective communicators of scientif
ic findings to the general public/government bodies/advocacy groups/related professionals,
not only to harvest their support, but to ensure the dissemination of accurate and effective
intervention to so many who require it.
Author details
Olive Healy and Sinad Lydon
National University of Ireland, Galway
References
[1] Alessandri, M., Thorp, D., Mundy, P., & Tuchman, R. F. (2005). Can we cure autism?
From outcome to intervention. Revista de Neurologia, 40, S131S136.
589
590
[2] Anderson, S. R., Avery, D. L., DiPietro, E. K., Edwards, G. L., & Christian, W. P.
(1987). Intensive home-based early intervention with autistic children. Education and
Treatment of Children, 10, 353366.
[3] Autism Treatment Acceleration Act (ATAA). (2010). Summary of the Autism Treat
ment Acceleration Act of 2009 (ATAA) (S. 819 and H.R. 2413) Retrieved from http://
autismtreatmentaccelerationact.org/4.html.
[4] Behavior Analyst Certification Board (2012). http://www.bacb.com.
[5] Baer, D. M., Wolf, M. M. & Risley, T. R. (1968). Some current dimensions of applied
behavior analysis. Journal of Applied Behavior Analysis, 1, 91-97.
[6] Baer, D. M., Wolf, M. M. & Risley, T. R. (1987). Some still-current dimensions of ap
plied behavior analysis. Journal of Applied Behavior Analysis, 20, 313-317.
[7] Ben-Itzchak, E., Lahat, E., Burgin, R., & Zachor, A. D. (2008). Cognitive, behavior and
intervention outcome in young children with autism. Research in Developmental Disa
bilities, 29, 447-458.
[8] Birnbrauer, J. S., & Leach, D. J. (1993). The Murdoch early intervention program after
2 years. Behaviour Change, 10, 63-74.
[9] Carr, E.G., Robinson, S., & Palumbo, L.W. (1990). The wrong issue: Aversive versus
nonaversive treatment. The right issue: Functional versus non-functional treatment.
In A. Repp & N. Singh (Eds.), Perspectives on the use of nonaversive and aversive
interventions for persons with developmental disabilities (pp. 361-379). Sycamore,
IL: Sycamore Publishing Co.
[10] Chasson, G. S., Harris, G. E., & Neely, W. J. (2007). Cost comparison of early inten
sive behavioural intervention and special education for children with autism. Journal
of Child and Family Studies, 16, 401413.
[11] Cohen, H., Amerine-Dickens, M., & Smith, T. (2006). Early intensive behavioral treat
ment: Replication of the UCLA model in a community setting. Developmental and Be
havioral Pediatrics, 27, S145-S155.
[12] Cooper, J. O., Heron, T. E., & Heward, W. L. (2007). Applied behavior analysis (2nd ed.).
Upper Saddle River, NJ: Prentice Hall.
[13] Dawson, G. (2008). Early behavioral intervention, brain plasticity, and the prevention
of autism spectrum disorder. Development and Psychopathology 20, 775803.
[14] Dillenberger, K. (2011). The Emperors new clothes: Eclecticism in autism treatment.
Research in Autism Spectrum Disorders, 5, 11191128.
[15] Eikeseth, S. (2009). Outcome of comprehensive psycho-educational interventions for
young children with autism. Research in Developmental Disabilities, 30, 158178.
[16] Eikeseth, S., Hayward, D., Gale, C., Gitlesen, J. P., & Eldevik, S. (2009). Intensity of
supervision and outcome for preschool aged children receiving early and intensive

http://dx.doi.org/10.5772/54274
behavioral interventions: A preliminary study. Research in Autism Spectrum Disorders,

3, 67-73. doi: 10.1016/j.rasd.2008.04.003
[17] Eikeseth, S., Klintwall, L., Jahr, E., & Karlsson, P. (2012). Outcome for children with
autism receiving early and intensive behavioral intervention in mainstream pre
school and kindergarten settings. Research in Autism Spectrum Disorders, 6, 829-835.
[18] Eikeseth, S., Smith, T., Jahr, E., & Eldevik, S. (2002). Intensive behavioral treatment at
school for 4- to 7- year old children with autism: A 1-year comparison controlled
study. Behavior Modification, 26, 49-68.
[19] Eikeseth, S., Smith, T., Jahr, E., & Eldevik, S. (2007). Outcome for children with au
tism who began intensive behavioral treatment between ages 4 and 7: A comparison
controlled study. Behavior Modification, 31, 264-278.
[20] Eldevik, S., Hastings, R. P., Hughes, C., Jahr, E., Eikeseth, S., & Cross, S. (2009). Metaanalysis of early intensive behavioral intervention for children with autism. Journal of
Clinical Child and Adolescent Psychology, 38, 439450.
[21] Eldevik, S., Eikeseth, S., Jahr, E., & Smith, T. (2006). Effects of low-intensity behavio
ral treatment for children with autism and mental retardation. Journal of Autism and
Developmental Disorders, 36, 211-224.
[22] Eldevik, S., Hastings, R. P., Jahr, E., & Hughes, J. C. (2012). Outcomes of behavioral
interventions for children with autism in mainstream pre-school settings. Journal of
Autism and Developmental Disorders, 42, 210-220.
[23] Eldevik, S., Hastings, R. P., Hughes, J. C., Jahr, E., Eikeseth, S., & Cross, S. (2010) Us
ing participant data to extend the evidence base for intensive behavioral intervention
for children with autism. American Journal on Intellectual and Developmental Disabilities,
115, 381405.
[24] Fava, L., & Strauss, K. (2011). Cross-setting complementary staff and parent-mediat
ed Early Intensive Behavioral Intervention for young children with autism: Are
search-based comprehensive approach. Research in Autism Spectrum Disorders, 5, 512
522.
[25] Fava, L., Strauss, K., Valeri, G., DElia, L., Arima, S., & Vicari, S. (2011). The effective
ness of a cross-setting complementary staff- and parent-mediated early intensive be
havioral intervention for young children with ASD. Research in Autism Spectrum
Disorders, 5, 1479-1492.
[26] Feldman M.A., Ward R.A., Savona D., Regehr, K., Parker, K., Hudson, M., Penning,
H. & Holden, J.J.A. (2012). Development and initial validation of a parent report
measure of the behavioral development of infants at risk for autism spectrum disor
ders. Journal of Autism and Developmental Disorders, 42, 13-22.
[27] Fenske, E. C., Zalenski, S., Krantz, P. J., & McClannahan, L. E. (1985). Age at interven
tion and treatment outcome for autistic children in a comprehensive intervention
program. Analysis and Intervention in Developmental Disabilities, 5, 4958.
591
592
[28] Flanagan, H. E., Perry, A., & Freeman, N. L. (2012). Effectiveness of large-scale com
munity-based intensive behavioral intervention: A waitlist comparison study explor
ing outcomes and predictors. Research in Autism Spectrum Disorders, 6, 673-682.
[29] Granpeesheh, D., Tarbox, J., & Dixon, D. R. (2009). Applied behavior analytic inter
ventions for children with autism: A description and review of treatment research.
Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychia
trist, 21, 162173.
[30] Green, G. (1996). Early behavioral intervention for autism: What does research tell
us? In C. Maurice, G. Green, & S. Luce (Eds.). Behavioral intervention for young children
with autism: A manual for parents and professionals (pp. 29- 44). Austin, TX: PRO-ED.
[31] Greer, R.D. (2002). Designing teaching strategies: an applied behavior analysis systems ap
proach. Academic Press: Dan Diego, CA.
[32] Greer, R. D., Keohane, D. D. & Healy, O. (2002). Quality and applied behavior analy
sis. The Behavior Analyst Today, 3 (2), 120-132. www.behavior-analyst-today.org.
[33] Gresham, F.M. & MacMillan, D.L. (1998). Early intervention project: Can its claims be
substantiated and its effects replicated? Journal of Autism and Developmental Disorders,
28. 5-13.
[34] Harris, S. L., Handleman, J. S., Gordon, R., Kristoff, B., & Fuentes, F. (1991). Changes
in cognitive and language functioning of preschool children with autism. Journal of
Autism and Developmental Disorders, 21, 281290.
[35] Healy, O., Leader, G., & Reed, P. (2009). Applied Behavior Analysis and the Treat
ment of Autism Spectrum Disorders in the Republic of Ireland. In Leon V. Berhardt
(Ed.) Advances in Medicine and Biology, Volume 8. Nova Science Publishers.
[36] Howlin, P. (2010). Evaluating psychological treatments for children with autismspectrum disorders. Advances in Psychiatric Treatment, 16, 133140.
[37] Hoyson, M., Jamieson, B., & Strain, P. S. (1984). Individualized group instruction of
normally developing and autistic-like children: The LEAP Curriculum Model. Journal
of the Division for Early Childhood, 8, 157-172.
[38] Howard, J. S, Sparkman, C. R., Cohen, H. G., Green, G., & Stanislaw, H. (2005). A
comparison of intensive behavior analytic and eclectic treatment for young children
with autism. Research in Developmental Disabilities, 26, 359-383.
[39] Howlin, P., Magiati, I., & Charman, T. (2009). A systematic review of early intensive
behavioural interventions (EIBI) for children with autism. American Journal on Intellec
tual and Developmental Disabilities, 114, 2341.
[40] Jacobson, J. W., Mulick, J. A., & Green, G. (1998). Cost-benefit estimates for early in
tensive behavioral intervention for young children with autism: General model and
single state case. Behavioral Interventions, 13, 201-226.

http://dx.doi.org/10.5772/54274
[41] Jordan R, Jones G, Murray D. (1998). Educational Interventions for Children with
Autism: A literature review of recent and current research. School of Education, Uni
versity of Birmingham, UK.
[42] Keenan, M. & Dillenberger, K. (2011). When all you have is a hammer : RCTs and
hegemony in science. Research on Autism Spectrum Disorders, 1-13.
[43] Kelley, E., Naigles, L., & Fein, D. (2010). An in-depth examination of optimal out
come children with a history of autism spectrum disorders. Research in Autism Spec
trum Disorders, 4, 526-538.
[44] Klintwall, L., & Eikeseth, S. (2012). Number and controllability of reinforcers as pre
dictors of individual outcome for children with autism receiving early and intensive
behavioral intervention: A preliminary study. Research in Autism Spectrum Disorders,
6, 493-499.
[45] Koegel, Robert L. and Lynn Kern Koegel (2006). Pivotal Response Treatments for Au
tism: Communication, Social, and Academic Development. Baltimore, Md.: Paul H.
Brookes.
[46] Kovshoff, H., Hastings, R. P., & Remington, B. (2011). Two-year outcomes for chil
dren with autism after the cessation of early intensive behavioral intervention. Behav
ior Modification, 35, 427-450.
[47] Lang, R., OReilly, M., Healy, O., Rispoli, M., Lydon, H., Streusand, W., Davis, T.,
Kang, S., Sigafoos, J., Lancioni, G., Didden, R., & Giesbers, S. (2012). Sensory integra
tion therapy for autism spectrum disorders: A systematic review. Research in Autism
Spectrum Disorders, 6, 1004-1018
[48] Larsson, E. (2005). Resources for parents. In M. Keenan, M. Henderson, K.P. Kerr, &
K. Dillenburger. Applied behaviour analysis and autism. Building a future together (pp.
255-287). London: Jessica Kingsley Publishers.
[49] Lovaas, O. I. (1981). Teaching developmentally disabled children: The me book. Baltimore:
University Park.
[50] Lovaas, O. I. (1987). Behavioral treatment and normal educational and intellectual
functioning in young autistic children. Journal of Consulting and Clinical Psychology,
55, 3-9.
[51] Lovaas, O. I., Koegel, R., Simmons, J. Q., & Long, J. S. (1973). Some generalization
and follow-up measures on autistic children in behavior therapy. Journal of Applied
Behavior Analysis, 6, 131166.
[52] Lovaas, O. I., & Smith, T. (1989). A comprehensive behavioraltheory of autistic chil
dren: Paradigm for research andtreatment. Journal of Behavior Therapy and Experi
mental Psychiatry, 20, 1729.
593
594
[53] Love, J. R., Carr, J. E., Almason, S. M., & Petursdottir, A. I. (2009). Early and intensive
behavioral intervention for autism: A survey of clinical practices. Research in Autism
Spectrum Disorders, 3, 421-428.
[54] Magiati, I., Charman, T., & Howlin, P. (2007). A two-year prospective follow-up
study of community-based early intensive behavioural intervention and specialist
nursery provision for children with autism spectrum disorders. Journal of Child Psy
chology and Psychiatry, 48, 803-812.
[55] Magiati, I., & Howlin, P. (2001). Monitoring the progress of preschool children with
autism enrolled in early intervention programmers. Autism, 5, 399406.
[56] Market Watch (2012). http://www.marketwatch.com/story/department-of-defenseand-tri-care-ordered-to-provide-applied-behavioral-therapy-to-autistic-children-ofmilitary-dependents-2012-07-26.
[57] Makrygianni, M. K., & Reed, P. (2010). A meta-analytic review of the effectiveness of
behavioural early intervention programs for children with autism spectrum disor
ders. Research in Autism Spectrum Disorders, 4, 577593.
[58] Matson, J. L. Benavidez, D. A., Compton, L. S., Paclawskyj, T. R., & Baglio, C. S.
(1996). Behavioral treatment for autistic persons: A review of research from 1980 to
the present. Research in Developmental Disabilities, 17, 433466.
[59] Matson, J. L., Boisjoli, J., Rojahn, J., & Hess, J. (2009). A factor analysis of challenging
behaviors assessed with the Baby and Infant Screen for Children with aUtIsm Traits
(BISCUIT-Part 3). Research in Autism Spectrum Disorders, 3, 714722.
[60] Matson, J. L., Fodstad, J. C., & Mahan, S. (2009). Cutoffs, norms, and patterns of co
morbid difficulties in children with developmental disabilities on the Baby Infant
Screen for Children with aUtIsm Traits (BISCUIT-Part 2). Research in Developmental
Disabilities, 30, 12211228.
[61] Matson, J. L., Fodstad, J. C., Mahan, S., & Sevin, J. A. (2009). Cutoffs, norms, and pat
terns of comorbid difficulties in children with ASD on the Baby Infant Screen for
Children with aUtIsm Traits (BISCUIT-Part 2). Research in Autism Spectrum Disorders,
3, 977988.
[62] Matson, J. L., Wilkins, J., Sevin, J. A., Knight, C., Boisjoli, J. A., & Sharp, B. (2009). Re
liability and item content of the Baby and Infant Screen for Children with aUtIsm
Traits (BISCUIT): Part 13. Research in Autism Spectrum Disorders, 3, 336344.
[63] Matson, J. L., & Smith, K. R. M. (2008). Current status of intensive behavioral inter
ventions for young children with autism and PDD-NOS. Research in Autism Spectrum
Disorders, 2, 6074.
[64] Matson, J.L., Tureck, K., Turygin, N., Beighley, J., Rieske, R. (2012). Trends and topics
in Early Intensive Behavioral Interventions for toddlers with autism. Research in Au
tism Spectrum Disorders, 6, 14121417.

http://dx.doi.org/10.5772/54274
[65] McEachin, J. J., Smith, T., & Lovaas, O. I. (1993). Long-term outcome for children
with autism who received early intensive behavioral treatment. American Journal on
Mental Retardation, 97, 359391.
[66] McGarrell, M., Healy, O., Leader, G., OConnor, J., & Kenny, N. (2009). Six reports of
children with autism spectrum disorder following intensive behavioural interven
tions using the Preschool Inventory of Repertoires for Kindergarten (PIRRK). Re
search in Autism Spectrum Disorders, 3, 767782.
[67] Metz, Mulick, J., and Butter, E. (2005). Autism: A late-20th-century fad magnet. In J.
W. Jacobson, R. M. Foxx, and J. A. Mulick (Eds.), Controversial therapies for developmen
tal disabilities: Fad, fashion, and science in professional practice. Mahwah, New Jersey:
Lawrence Erlbaum Associates.
[68] Motiwala, S. S., Gupta, S., Lilly, M. B., Ungar, W. J., & Coyte, P. C. (2006). The costeffectiveness of expanding intensive behavioural intervention to all autistic children
in Ontario. Health Policy, 1, 135151.
[69] Mudford, O., et al., (2009). Technical review of published research on applied behav
iour analysis interventions for people with autism spectrum disorders: Auckland
Uniservices Ltd. Wellington, New Zealand: Ministry of Education.
[70] Mulloy, A., Lang, R., OReilly, M., Sigafoos, J., Lancioni, G., & Rispoli, M. (2010). Glu
ten-free and casein-free diets in the treatment of autism spectrum disorders: A sys
tematic review. Research in Autism Spectrum Disorders, 4, 328-339.
[71] Mundy, P., Sullivan, L., & Mastergeorge, A. (2009). A parallel and distributed-proc
essing model of joint attention, social cognition and autism. Autism research, 2, 221.
[72] Offit, Paul (2008). Autisms False Prophets: Bad Science, Risky Medicine, and the Search for
a Cure. Columbia University Press: New York.
[73] Ozonoff, S., Iosif, A.-M., Baguio, F., Cook, I. C., Hill, M. M., Hutman, T., et al. (2010).
A prospective study of the emergence of early behavioral signs of autism. Journal of
the American Academy of Child & Adolescent Psychiatry, 49(3), 258268.
[74] Perry, A., & Condillac, R. (2003). Evidence-based practices for children and adolescents
with autism spectrum disorders: Review of the literature and practice guide. Ontario, Cana
da: Childrens Mental Health Ontario.
[75] Perry, A., Cummings, A., Geier, J. D., Freeman, N. L., Hughes, S., Managhan, T., et al.
(2011). Predictors of outcome for children receiving intensive behavioral intervention
in a large community-based program. Research in Autism Spectrum Disorders, 5, 592
603.
[76] Peters-Scheffer, N., Didden, R., Korzilius, H., & Matson, J. (2012). Cost comparison of
early intensive behavioral intervention and treatment as usual for children with au
tism spectrum disorder in the Netherlands. Research in Developmental Disabilities, 33,
1763-1772.
595
596
[77] Reed, P., Osborne, L. A., & Corness, M. (2007a). Brief report: Relative effectiveness of
different home-based behavioral approaches to early teach intervention. Journal of
Autism and Developmental Disorders, 37, 1815-1821.
[78] Reed, P., Osborne, L. A., & Corness, M. (2007b). The real-world effectiveness of early
teaching interventions for children with autism spectrum disorder. Exceptional Chil
dren, 73, 417-433.
[79] Reichow, B. (2012). Overview of Meta-Analyses on Early Intensive Behavioral Inter
vention for Young Children with Autism Spectrum Disorders. Journal of Autism and
Developmental Disorders, 42, 512520.
[80] Reichow, B., & Wolery, M. (2009). Comprehensive synthesis of early intensive behav
ioral interventions for young children with autism based on the UCLA Young Au
tism Project model. Journal of Autism and Developmental Disorders, 39, 2341.
[81] Remington, B., Hastings, R. P., Kovshoff, H., degli Espinosa, F., Jahr, E., Brown, T. &
Ward, N. (2007). Early intensive behavioral intervention: Outcomes for children with
autism and their parents after two years. American Journal on Mental Retardation, 112,
418-438.
[82] Rogers, S. J., & Vismara, L. A. (2008). Evidence-based comprehensive treatments for
early autism. Journal of Clinical Child and Adolescent Psychology, 37, 838.
[83] Sallows, G. O., & Graupner, T. D. (2005). Intensive behavioral treatment for children
with autism: Four-year outcome and predictors. American Journal on Mental Retarda
tion, 110, 417-438.
[84] Schopler, E., Short, A., & Mesibov, G. (1989). Relation of behavioral treatment to nor
mal functioning: Comment on Lovaas. Journal of Consulting and Clinical Psycholo
gy, 57, 162-164.
[85] Sheinkopf, S. J., & Siegel, B. (1998). Home-baseed behavioral treatment of young chil
dren with autism. Journal of Autism and Developmental Disorders, 28, 15-23.
[86] Schreibman, L. (2000). Intensive behavioral/psychoeducational treatments for autism:
Research needs and future directions. Journal of Autism and Developmental Disorders,
30, 373378.
[87] Shea, V. (2004). A perspective on the research literature related to early intensive be
havioral intervention (Lovaas) for young children with autism. Autism, 8, 349367.
[88] Smith, T. (1999). Outcome of early intervention for children with autism. Clinical Psy
chology: Science and Practice, 6, 3349.
[89] Smith, T., Eikeseth, S., Klevstrand, M., & Lovaas, O. I. (1997). Intensive behavioral
treatment for preschoolers with severe mental retardation and pervasive develop
mental disorder. American Journal on Mental Retardation, 102, 238-249.
[90] Smith, T., Eikeseth, S., Sallows, G. O., & Graupner, T. D. (2010). Efficacy of applied
behavior analysis in autism. The Journal of Pediatrics, 155, 151152.

http://dx.doi.org/10.5772/54274
[91] *Smith, T., Groen, A. D., & Wynn, J. W. (2000). Randomized trial of intensive early
intervention for children with pervasive developmental disorder. American Journal on
Mental Retardation, 105, 269-285.
[92] Spreckley, M., & Boyd, R. (2009). Efficacy of applied behavioral intervention in pre
school children with autism for improving cognitive, language, and adaptive behav
ior: A systematic review and meta-analysis. The Journal of Pediatrics, 154, 338344.
[93] Steege, M. W., Mace, C., Perry, L., & Longenecker, H. (2007). Applied behavior analy
sis: Beyond discrete trial teaching. Psychology in the Schools, 44, 9199.
[94] Strauss, K., Vicari, S., Valeri, G., DElia, L., Arima, S., & Fava, L. (2012). Parent inclu
sion in early intensive behavioral intervention: The influence of parental stress, pa
rent treatment fidelity and parent-mediated generalization of behavior targets on
child outcomes. Research in Developmental Disabilities, 33, 688-703.
[95] Sundberg, M. L., & Michael, J. (2001). The value of Skinners analysis of verbal be
havior for teaching children with autism. Behavior Modification, 25, 698-724.
[96] Symes, M. D., Remington, B., & Brown, T. (2006). Early intensive intervention for
children with autism: Therapists perspective on achieving procedural fidelity. Re
search in Developmental Disabilities, 27, 3042.
[97] Virues-Ortega, J. (2010). Applied behavior analytic intervention for autism in early
childhood: Meta-analysis, meta-regression and dose-response meta-analysis of multi
ple outcomes. Clinical Psychology Review, 30, 387399.
[98] Zwaigenbaum, L., Bryson, S., Rogers, T., Roberts, W., Brian, J., & Szatmari, P. (2005).
Behavioral manifestations of autism in the first year of life. International Journal of
Developmental Neuroscience, 23, 143152.
597
Chapter 25
Feeding Issues Associated with

the Autism Spectrum Disorders
Genevive Nadon, Debbie Feldman and Erika Gisel
http://dx.doi.org/10.5772/53644
1. Introduction
Feeding issues are prevalent in young children. Feeding will be defined here as the process of in
gesting food and drink in social environments where such activities take place. Estimates of
problems may range from 13 to 50% in typically developing children, but may be as high as 80%
in children with developmental disabilities [1-7]. In 1 to 10% of these children problems may be
come chronic and may affect their health and development [1, 8]. Anatomical, metabolic, gastro
intestinal, motor or sensory problems may be the cause of or may contribute to some of these
feeding problems [8]. A global medical assessment is necessary when feeding problems persist,
because some medical symptoms may not be recognized as associated with feeding at first sight,
such as asthma. Even if the association remains unclear, a high prevalence of asthmatic children,
particularly with nocturnal asthma, have gastro-esophageal reflux (GER) [9]. Both feeding and
eating, the processing of food and drink in the mouth and swallowing, are also known as activi
ties of daily living (ADL) and studies examining the specific problems of children with Autism
Spectrum Disorders (ASD), found that 46 to 89% have feeding problems [10-18].
While these studies are important to determine the nature and extent of such problems, re
sults have to be interpreted with caution. First, small and heterogeneous sample sizes do not
permit generalization to the entire population of children with ASD. There is also no consen
sus regarding the terminology and definitions used to describe these problems, i.e. feeding
problem, eating problem, food refusal, selective/picky eating, mealtime problems, etc Fur
thermore, authors use different instruments to measure these problems. Caregiver question
naires are the most commonly used tools for this purpose; however, their psychometric
properties are not well established. Further, observational studies of these subjects eating
skills or self-reports from them are lacking. This makes it difficult to compare studies or to
replicate their results.
2013 Nadon et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
600
Despite these methodological limitations, it is clear that feeding problems constitute a fre
quent and significant preoccupation for many parents of children with ASD [18]. In support
of such concerns, some studies found that children with ASD are more susceptible to feed
ing problems than children with other developmental disabilities [19-23]. There is as yet no
defined etiology for feeding problems in children with ASD neither is there for the pediatric
population in general. Significant associations have been found between oral-motor, gastro
intestinal and sensory problems in children with ASD [19, 24-26]. According to Skinner [27],
individuals responses to environmental stimuli shape their behaviors and this interaction
constitutes the foundation for learning. When feeding is described as a struggle in the family
environment, behavioral approaches such as escape extinction and positive reinforcement
are used by professionals and gradually assumed by the caregiver. However, feeding prob
lems may also arise from a limited ability to communicate or from poor social and cognitive
skills. Eating skills and mealtime manners are learned by observation and imitation, yet
these associations have not been correlated with ASD. More recent studies have found simi
larities between anorexia nervosa (AN) and ASD, on the basis of global processing deficits,
inflexible style of thinking, communication difficulties and impairment of interpersonal
functioning and social interactions [28-30]. Hence, treatment approaches used for AN might
also be suitable for ASD.
Considering the impact feeding problems can have on childrens health, the stress experi
enced by parents, as well as the impact on social participation of child and family, it will be
crucial to continue documenting feeding problems in this group, to better understand them
and thereby, offer better treatment. Similarly, it will be just as important to provide profes
sionals with better guidelines to evaluate feeding problems, as well as to appreciate the con
sequences they have on family function.
2. Essentials of diagnosis
The severity of pediatric feeding problems can range from mild to severe. Despite this wide
range, there are no clear indicators to determine which problems will be transient and those
that will persist over the long term and may have an impact on childrens health [1]. The
DSM-IV-TR, a classification for psychiatric disorders, describes criteria for feeding disorder of
infancy and early childhood; however, this particular diagnosis is rarely used in research or
clinical practice. There are several reasons for this. A majority of the children who are refer
red for feeding problems, in general, do not meet all of the criteria outlined in the DSM-IVTR (Table 1) [7, 31]. For example, children do not qualify even if they have severe feeding
problems but normal weight (e.g. eating foods of poor nutritional value; eating only purees
or being tube fed) [7]. It is also not clear which medical or mental conditions, including ASD,
would exclude a child from a diagnosis of feeding disorder of infancy and early childhood. Other
diagnostic classifications and screening criteria appear promising. These are: Feeding Behav
ior Disorder [32, 33], Avoidant/Restrictive Food Intake Disorder [34] and Feeding Disorder [35-37],
the Wolfson Diagnostic Criteria [38] and the framework proposed by Davies et al.[39].
Feeding Issues Associated with the Autism Spectrum Disorders

http://dx.doi.org/10.5772/53644
Criterion A. Feeding disturbance as manifested by persistent failure to eat adequately with significant failure to gain
weight or significant loss of weight over at least 1 month.
Criterion B. The disturbance is not due to an associated gastrointestinal or other general medical condition (e.g.
esophageal reflux).
Criterion C. The disturbance is not better accounted for by another mental disorder (e.g., Rumination Disorder) or by
lack of available food.
Criterion D. The onset is before age 6 years.
Table 1. Diagnostic Criteria for Feeding Disorder of Infancy or Early Childhood from the DSM-IV-TR [31]
2.1. DC: 0-3R and Proposed DSM-V

Feeding Behavior Disorder [32] applies when the child does not regulate his feeding in ac
cordance with physiological feelings of hunger or fullness and comprises six categories to
be described below. The future DSM-V [34] Avoidant/Restrictive Food Intake Disorder will in
clude a description of three main subtypes that will map onto the first three categories of the
DC:0-3R [32]. The reader is referred to the APA DSM-V website for further details on the
inclusion criteria [34]. A clarification has been made to consider severe feeding problems,
when they exceed what is normally expected with a concurrent medical condition or anoth
er mental disorder, which may include ASD [34]. The criterion has been further modified to
also include children that do not loose or fail to gain weight.
2.1.1. Infantile anorexia
The central problem of infantile anorexia is a lack of appetite, as manifested by a lack of
interest in eating and food refusal, and issues of control and autonomy that may exist be
tween the parent and the child [33, 35]. Parent recall indicates that the child will be easily
distracted by environmental stimuli, which interfere with nursing from the bottle or
breast from the very first weeks of life. Later, children in this category never complain of
hunger and are satisfied with only a few bites. Parents worry when their child does not
eat enough and often try different strategies to encourage their child to eat. Early on dis
traction manoeuvres may work, but they do not last, and parents are forced to invent new
strategies to entice their child to eat. They may coax the child and sometimes use forcefeeding. Despite these efforts the child does not eat enough to maintain normal growth,
which may later lead to malnutrition, but will come to attention when the child does not
follow his expected growth curve.
2.1.2. Sensory food aversions
In contrast to infantile anorexia, children with sensory based feeding problems are not lacking
in appetite and eat an adequate diet as long as it meets their preferences which are consis
tent and stable over time [33]. These food preferences may be based on food texture, taste,
smell, temperature or appearance. Sensory aversions may range from mild to severe, with
some children refusing only a few items and others a whole food category. The varying in
601
602
tensities of these aversive reactions may lead to food refusals that may get generalized to
foods with similar characteristics or to all new foods. Some children are so sensitive to the
sensory characteristics of the rejected food that they will not eat any other food that comes
in contact with the refused food, or refuse that certain foods be placed in their line of vision,
or refuse to eat when others, seated next to them, eat a food that has been rejected or it may
trigger an aversive reaction (Figure 1). What distinguishes Sensory Food Aversions from nor
mal food preferences is the degree of severity of the food refusal and the presence of nutri
tional deficiencies or oral-motor delays arising from a lack of exposure to more demanding
food textures [33]. Some studies have shown a significant relationship between food selec
tivity or mealtime problems and problems with sensory modulation [26, 40].
Figure 1. Children learn about food through exploration with their senses
2.1.3. Feeding disorders associated with insults to the gastrointestinal tract

This diagnosis, later renamed posttraumatic feeding disorders by Chatoor [33], has a sudden
onset and results in severe food refusal. Young children with this diagnosis refuse to be fed,
and often cry, hyper-extend their trunk and refuse to open their mouth when food is of
fered. Posttraumatic feeding problems are the result of a traumatic event or chronic, repeat
ed traumatic events that affect the oropharynx or the esophagus. The event may have been
aspiration of solid food into the trachea, related to force-feeding, due to medical procedures,
such as placement of a nasogastric tube or enteral feeding. The refusal of food may manifest
itself in different ways, depending on the type of feeding that is associated with the trauma.
Depending further on the situation where the trauma occurred, such as the location or the
positioning associated with feeding, the child may show signs of anxiety and marked dis
tress at the approach of the bottle or the spoon, or when the food is placed in the mouth.
Fear will override any sense of hunger and the effects on the childs health may vary, de
pending on the duration and extent of the food refusal, and the adequacy and adaptations
made for nutritional compensation. If the food refusal extends over a prolonged period of
time, delay in oral-motor skills, or overall development may be the result [33].

http://dx.doi.org/10.5772/53644
2.1.4. Feeding disorder associated with concurrent medical conditions

The DC: 0-3R [32] also lists feeding problems that are associated with medical conditions
whereas the DSM-V [34] will only deal with mental health issues, not medical problems.
Children with medical conditions and associated feeding problems are able to initiate eat
ing; however, they may soon show signs of distress and/or fatigue and may not be able to
finish their meal [33]. This inability may vary according to the severity of the medical condi
tion. Heart and respiratory problems, as well as allergies and gastro-esophageal reflux are
frequently associated with this type of feeding disability. Resolving the medical issues often
improves the feeding related problems, although the latter may not always be eliminated
completely. Several symptoms such as gagging, lack of appetite, food refusals, weight loss
or growth faltering, may also be found in conjunction with other medical diagnoses. It is es
sential therefore, that children with feeding problems be carefully examined for associated
medical problems.
2.1.5. Feeding disorder of state regulation
This feeding disorder is characterized by its onset in infancy, difficulty in establishing a qui
et alert state necessary for feeding, weight loss, and absence of any medical condition that
could explain these problems. This disturbance in state regulation, similar to disturbances in
sleep or crying, will not be included in the next issue of the DSM-V [34]. Feeding is the first
competent motor skill of infants [41] and is also an early indicator of self-regulation [33].
Therefore, specific aspects of feeding problems that also coincide with the behavior charac
teristics of ASD, might become red flags for its diagnosis. Infants must be alert and able to
maintain a calm state during feeding right from birth, i.e. the infant should not fall asleep at
the onset of feeding, be too agitated or too distressed to feed [33]. Infants triple their body
weight in the first year of life [41]. Therefore, a child who does not gain weight will not be
able to maintain his established growth curve, or tends to cross over into a lower growth
curve, which is interpreted as losing weight. Mother and infant are mutual caregivers
[42]; the child who engages the mother visually, smiles or babbles and gains weight pro
vides feedback to the mother that she is doing a good job, whereas a child who is colicky,
cries, arches away from the mother and does not seem to eat enough causes the mother to
worry and to try to compensate. She may feed the child more frequently than a child who
eats well and she will also feed the child longer to compensate for the emerging weight loss
[43]. The recent development of the P.O.P.S.I.C.L.E Center Infant and Child Feeding Ques
tionnaire (Parent Organized Partnerships Supporting Infants and Children Learning to
Eat), an age-specific questionnaire available on the web, gives parents information regard
ing typical feeding development and helps them identify whether referral to a health profes
sional (feeding specialist) is indicated [44]. Future studies will need to determine whether
the constellation of early weight loss, lack of reciprocity, and distractibility during feeding
may be an early indicator of ASD.
603
604
2.1.6. Feeding disorder of caregiver-infant reciprocity

Feeding disorders of caregiver-infant reciprocity have their onset in the infants first year of
life and may come to attention through a problem that needs medical attention. The infants
developmental progression shows growth retardation and a lack of age appropriate engage
ment with the primary caregiver. Careful examination of the child-family relationships often
point toward child neglect that may have its origin in the caregivers history. These difficult
problems will need to be addressed in conjunction with the original feeding problems of the
infant [33]. In the DSM-V, this problem will be classifiable under a V code (i.e. a relational
problem) [34].
2.2. Feeding Disorders as classified by Dovey and collaborators
The classification by Dovey et al. [35, 36] is built on an older classification by Chatoor and
Ganiban [45]. Of the five types of feeding disorder, which will be further described below,
four are similar to the classifications mentioned above. Learning-dependant food refusal is add
ed and will include many children seen briefly in clinical practice. In their decision-making
model [36, 37], Autism-Related Food Refusal is mentioned as a distinct category, but not fur
ther elaborated. In an earlier paper Dovey et al. [35] briefly describe feeding problems asso
ciated with ASD and touch upon the importance of the cognitive and social aspects of these
problems. However, at that time, the authors seemed to include Autism-Related Food Refusal
in their selective food refusal category. For clarity we will present a brief definition of the Au
tism-Related Food Refusal as a sixth category in this chapter.
2.2.1. Medical complications-related food refusal
Similar to the Feeding Disorder Associated with Concurrent Medical Conditions [32], food refusal
is associated with one or more medical conditions. Medical professionals (e.g. gastroenterol
ogist, general practitioner, health visitor, etc.) are needed to address these issues. The child
may lack developmentally appropriate experiences with food because of major medical in
terventions that may have required nasogastric tube feeding which is often followed by gas
trostomy feeding until the medical issues are resolved. Periods of longer than 1 week of tube
feeding put the child at risk for oral deprivation, i.e. they deprive the child of the daily
practice of oral behaviors which in turn seem to have a detrimental effect on the associated
brain development [46, 47]. If it occurs in infancy children will experience great difficulty in
making the transition to oral feeding. If children have had oral feeding experience before in
tubation there will be a transition time where they will have to learn to eat again, but the
transition will be shorter than in infants who have not had any feeding experience [46].
Dovey et al. [35] describe these children as not interested in eating but generally as happy to
explore and play with food. Food refusal can also be present due to an association of food
and/or eating with pain or discomfort. Many children who were tub-fed for extended peri
ods will require additional support when making the transition to oral feeding [48].

http://dx.doi.org/10.5772/53644
2.2.2. Learning-dependent food refusal

According to Dovey et al. [35], the feeding disorder defined in this category is complete
ly dependent on the childs experience with it (eating). Children in this category may
have temper tantrums when new foods are offered to them and the usual response of the
parent is to take their plate away and replace it with something they know their child will
eat. Eventually, parents adapt the family menu to better fit their childs preferences and
avoid unfamiliar foods or ones they know will trigger aversive reactions. Children be
tween 2 and 6 years of age often refuse to taste new foods, which generally improves as
the children get older. Food refusal based on novelty is called food neophobia and is con
sidered an evolved behavior from human ancestry that protects the organisms from poi
soning, at a time when children begin to leave their parents supervision and gain more
autonomy [35]. Repeated exposure, a positive experience and social influence will help
children to overcome food neophobia. Therefore, caregiver education will be the first
strategy to use when a learning dependent feeding disorder is suspected and rapid
change can be expected.
2.2.3. Selective food refusal
Initially the picture of the selective child will be similar to learning dependent food refusal
but for various reasons will evolve into a significant decrease in dietary variety. Here, expo
sure and social facilitation will have little to no effect on food acceptance and the child will
not play with food. His diet will rely mostly on hedonic foods, e.g. foods that have a high
salt, sugar and fat content. The child may eventually develop gastrointestinal problems as a
result of a lack of fiber in his diet. Similar to Chatoors Sensory Food Aversion category [33],
these children have some sensory sensitivities, both tactile and/or oral defensiveness. En
largement of dietary variety is a long process for children in this category and needs collabo
ration of parents, other caregivers and professionals. Dovey et al. [35] suggest that children
in this category be referred for diagnostic work-up because of the high prevalence of senso
ry problems in the ASD population.
2.2.4. Appetite-awareness-autonomy-based food refusal
This category is the same as Infantile Anorexia described earlier by Chatoor and her col
leagues [33] and is included in the above classification. The reader is referred to it for fur
ther details.
2.2.5. Fear-based food refusal
Fear-Based Food Refusal is also called Food Phobia. This category is identical to Posttrau
matic Feeding Disorders of Infancy [33]. Some authors believe that, for many of these chil
dren, food phobia might be associated with a more general anxiety or affective disorder [49].
Food refusal in this category can be distinguished from other categories by the intensity of
the emotional reaction when the child is asked to eat the target food.
605
606
2.2.6. Autism-related food refusal

Dovey et al. [35] describe children with ASD and feeding problems as having seemingly
illogical rules around what constitutes an acceptable meal. We are not aware of any stud
ies that have examined these childrens rationale for their eating behaviors and the cogni
tive decisions that have led to them. Although, we do not know whether Dovey and
collaborators have studied these, they acknowledge that these children must make deci
sions whether to eat something or not. This constitutes an important gap in our under
standing of these childrens feeding behavior and has important consequences on how we
treat them. We observe childrens behaviors and decide to manipulate them without un
derstanding the underlying rationale that has led to these behaviors. An interpretation
based on the hyper-systematization theory of Baron-Cohen et al. [50] will be discussed in
the intervention section of this chapter. Meanwhile, perhaps one approach would be to
study adults with autism and/or higher functioning children with ASD where some com
munication and insight is present, in order to access this very challenging domain. Even
here, we must be sensitive to the fact that many other domains of ADL might be affected,
besides eating, and that children and their family must be treated holistically.
2.3. The Wolfson group diagnostic criteria of infantile feeding disorders
The Wolfson Group, a collaboration of medical professionals from Israel, has studied infan
tile feeding problems for a number of years [38, 51, 52] and has shown considerable success
in discriminating between infantile feeding disorders (non-organic) and medically based
feeding problems (organic). Levine et al. [38] compared the diagnostic criteria of the Wolf
son group to DC: 0-3R [32], and the DSM-IV [31] classifications in a group of children refer
red for food refusal. Results discriminated 100%, 77% and 47% respectively. The Wolfson
criteria (Table 2) successfully identified a substantial proportion of treatable patients that the
two other existing classifications could not identify [38].
1. Persistent food refusal "/>1 month

2. Absence of obvious organic disease leading to food refusal or lack of response to medical treatment of an organic
disease
3. Age of onset <2 years, age at presentation <6 years
4. Presence of at least one of the following:
a. Pathological feeding or
b. Anticipatory gagging
Table 2. The Wolfson Diagnostic Criteria

http://dx.doi.org/10.5772/53644
2.4. Davies and collaborators framework for classification

Finally, another convincing argument for a reconceptualization of diagnostic criteria of feed
ing problems has been advanced by Davies and collaborators [39], suggesting that feeding
problems are the result of a relational disorder of the child in his social context. The authors
propose that feeding problems be diagnosed along 6 axes that define 1) a feeding disorder
between parent and child, characterized by the childs persistent failure to eat foods in ac
cordance with his developmental stage and the cultural or sub-cultural expectations. 2) a
character/developmental disorder of parent and/or child, where the feeding relationship
may be disrupted due to the caregivers own psychopathology or life demands, and/or
where the child may have a difficult temperament or medical and developmental issues that
interfere with feeding, 3) This axis describes medical disorders of parent and/or child, that
need to be addressed before feeding problems can be resolved 4) psychosocial stressors need
to be identified through use of the multi-axial diagnosis, to reflect the multi-determined na
ture of feeding disorders 5) global functioning of parent and child will be examined sepa
rately for each, and 6) the global parent-infant relationship is classified through assessment
of the quality of the parent-child relationship.
2.5. Parent reported feeding problems
A systematic literature review of feeding problems reported by parents, shows that many
symptoms are similar to those associated with sensory feeding problems [4, 5, 10, 11, 14, 17,
20, 26, 53-55]. The peculiar ways in which sensory input is treated by persons with ASD are
well documented in the literature [56-59]. The most frequently mentioned problems are tex
ture, color, and smell selectivity, refusal of new foods, and food refusals in general. These
problems were not associated with weight loss in a study comparing body mass index be
tween typically developing children and those with ASD [60]. One study even reported a
large proportion of children with ASD to be obese [61].
Parents perception of their childs feeding problem often leads them to seek professional
advice. In terms of nutritional deficiency, results vary widely [62-64]. Application of stand
ards of reference with different criteria for severity levels may explain these discrepancies
[65]. Furthermore, none of the studies reviewed so far have exclusively studied children
with clinically significant feeding problems. Within a normally distributed population one
would expect some children with, but the majority to be without nutritional deficiencies.
Thus, it is not yet possible to determine whether or not children with ASD and severe feed
ing problems would also have nutritional deficiencies. Some case studies and larger studies
report negative health effects due to selective eating or restrictive diets [66, 67]. Therefore, it
is always advisable to refer a child to a qualified nutritional expert when the child presents
with selective eating.
Some parents report problems with chewing and abnormal drooling even after the childs
developmental age has been taken into account [13, 68]. Nadon et al. [13] compared children
with ASD and their typically developing siblings of the same mean age and found that only
the children with ASD had problems with eating related drooling, chewing, moving their
tongue or swallowing. While parents interpreted these problems as a source of their childs
607
608
feeding problem, this study showed that these motor behaviors were associated with tactile
sensitivity but independent of mental retardation, attention deficit disorder or hyperactivity
that is often present in these children [13]. These oral-motor problems are often overlooked,
because it is generally a small group when compared to the whole population of children
with ASD. However, careful evaluation may be particularly helpful for this group of chil
dren, because specific treatments exist, and have been shown to be effective for other neuro
logically based feeding problems [41].
Anticipatory behavior is an early indicator of social engagement. Kanner [69] noted that in
fants who later were described as autistic did not reach out to an adult who was engaged
in picking them up. Brisson and colleagues [70] made use of this characteristic by studying
anticipatory behavior associated with feeding. The authors performed a retrospective re
view of home movies of infants, 3 to 6 months of age, who were later diagnosed with au
tism, expecting that they would perform poorly on opening their mouth (the anticipatory
behavior) in response to an approaching spoon. Results were compared to an age matched
typically developing group. While typically developing children, as a group, achieved 79%
correct responses, only 46% of the children with autism did so. There was a clear learning
curve in both groups, with younger infants showing fewer mouth opening responses than
the older ones, and a larger proportion of typically developing infants opening their mouth
to an approaching spoon than did infants with autism. These results are consistent with pa
rent descriptions that infants were easily distracted when feeding, right from birth, and this
behavior may indeed become an early diagnostic indicator, in conjunction with other behav
iors that characterize the ASDs.
3. Evaluation
Feeding at mealtimes occurs as the result of the interaction between a childs body functions
and structures, his health condition and some contextual factors (i.e. environmental factors
as well as personal factors). An illustration of these interactions, using the model of the In
ternational Classification of Functioning, Disability and Health (ICF) is illustrated in Figure
2. The complexity of these interactions may be the reason why many investigators devel
oped their own assessment tool, because existing ones did not adequately cover the domains
to meet the authors needs [71]. To have a complete picture of a childs problems, it is neces
sary to combine various methods of evaluation and to collaborate with professionals who
have different domains of expertise.
There are a number of methods and feeding assessments, with varying content as well as
different psychometric properties (e.g. caregiver questionnaires, interviews, child observa
tions). The following review will be selective and is not intended to be exhaustive. For a
more complete review the reader is referred to Nadon et al. [71] and Seiverling, Williams
and Sturmey [72]. Other evaluations may be performed using standardized assessments if
the childs condition suggests additional problems.

http://dx.doi.org/10.5772/53644
Figure 2. Adapted from the International Classification of Functioning, Disability and Health (ICF)
3.1. Parent questionnaires

Parent questionnaires with interview formats are commonly used [71-74]. These have the
advantage that they can cover an extended period of the childs life. As well, documenting
the feeding history during the first year of life, and again around 18 months when most of
the problems become apparent, sheds light on the evolution of the presenting problems. Pa
rents can provide a more complete picture of the childs feeding behaviors because they usu
ally provide their childs daily meals. The advantage for the evaluator is that he is not
dependent on a single meal observation that may not be representative of the daily routine
in the home. It is also very important to get to know parents motivation for consultation,
their perception of the problems and their priorities for resolving them. It is important like
wise, to learn what strategies parents have tried to solve the feeding problems and how the
child reacted to them [75]. A detailed description of the childs food preferences is in order
to determine the adequacy of the nutritional content. As well, common sensory characteris
tics of his preferred and non-preferred foods need to be assessed (color, texture, consistency,
taste, smell, appearance,) to better understand the nature of the problem and assist in the
formulation of a treatment plan [76]. A sensory profile of the child is essential and, to under
stand his way of communicating, his motor abilities, learning strategies, and his cognitive
and sensory information processing. It is also important to assess whether the child has a
minimal understanding of negotiation, and what his play skills and interests are. These abil
ities will determine how best to approach his treatment.
609
610
3.2. Mealtime behavior questionnaires

The Childrens Eating Behavior Inventory (CEBI-R) [77] covers eating and behavioral prob
lems at mealtimes in 2 groups: typically developing children (non-clinic) and a clinic
group, aged 2 to 12 years. It uses a 5 point Likert scale to identify whether a problem oc
curs between never and always , and a dichotomized scale for parents to note
whether the behavior is perceived as a problem or not. Construct validity was demon
strated by significant differences between the two groups in total eating problems and the
number of items perceived as problematic. Internal reliability or item consistency ranged
from.58 to.76 using Cronbachs alpha, and test-retest reliability was 84 (parent score) and
87 (total eating problems).
The Brief Autism Mealtime Behavior Inventory (BAMBI) [73] measures the frequency of meal
time behavior problems in children with ASD between the ages of 3 and 11 years. The BAM
BI contains 18 questions based on a 3 factor structure that identifies limited variety of foods
(8 items), food refusals (5 items) and autistic behaviors (5 items). The BAMBI has good inter
nal consistency.88, high inter-rater 0.78 and test-retest reliability 0.87, as well as strong con
struct and criterion-related validity [73].
The Behavioral Pediatric Feeding Assessment Scale (BPFAS) is a 35 item, standardized caregiver
report inventory that was developed for children with feeding problems, 9 months to 8
years of age, but who are otherwise typically developing. The tool has a 5-point Likert scale
and caregivers indicate how frequently children show a behavior, i.e. never happens to
always happens , parents frequency of feelings or strategies is noted and a total frequen
cy is computed. Higher scores indicate more problems. Internal consistency of the BPFAS is.
88. Test-re-test reliability for the total score is.78 in both normal and clinical samples. The
BPFAS was shown to have adequate reliability and validity [78].
The 31-item Parent Mealtime Action Scale (PMAS) [75] measures parents actions regarding
their childs mealtime behaviors in nine dimensions: snack limits, positive persuasion, daily
fruit and vegetable availability, use of rewards, insistence on eating, snack modeling, special
meals, fat reduction and many food choices. Parents also provide three-point ratings (1 =
never, 2 = sometimes, 3 = always) how often they use each of these actions in a typical week.
The clinician then provides specific recommendations to caregivers regarding actions they
can implement to improve their childs feeding. The PMAS was developed with a sample of
over 2000 typically developing children [75] but a recent study [79] examined its applicabil
ity with a clinical sample including 49 children with ASD. Mean internal reliability was.62
and convergent validity was demonstrated with expected associations between parent meal
time actions measured by the PMAS and some childrens feeding problems. The five PMAS
dimensions most associated with childrens feeding problems were snack limits, insistence
on eating, fat reduction, many food choices, and special meals [79].
The Feeding Demands Questionnaire is a parent report questionnaire that measures parents
belief how their child should eat [80]. Mothers of 3 to 7-year old children completed the 8item Feeding Demands Questionnaire, the Child Feeding Questionnaire, measures of de
pression and fear of fat. The Feeding Demands Questionnaire revealed 3 factors: anger/

http://dx.doi.org/10.5772/53644
frustration, food amount demandingness, and food type demandingness, for which sub
scales were computed. The Feeding Demands Questionnaire showed acceptable internal
consistency (.70 to.86). The authors concluded that different demand beliefs influence differ
ent feeding practices.
About Your Childs Eating (AYCE) [81] was developed to document positive mealtime envi
ronment, parent aversion to mealtime and child resistance to eating in a sample of typically
developing and a group of chronically ill children, aged 8 to 16 years. The AYCE is scored
on a Likert scale from never to nearly every time describing the frequency of the
childs mealtime behaviors, the caregivers interaction with the child and the caregivers re
action to the meal. While the constructs evaluated would seem to be similar in a group of
younger children, validity for the ASD diagnostic group remains to be determined. The
AYCE internal consistency is -.24 for child resistance, positive mealtime environment.55,
and parent aversion -.37. There is also evidence for convergent validity with the Family Envi
ronment measure. Other psychometric properties still need to be developed.
The Eating Profile [13] covers eleven domains (145 items): 1) dietary history of the child, 2) child
health, 3) family dietary history, 4) mealtime behaviors of the child, 5) food preferences, 6) au
tonomy with respect to eating, 7) behaviors outside of mealtimes, 8) impact on daily life, 9)
strategies used to resolve difficulties encountered at mealtimes, 10) communication abilities of
the child and 11) socio-economic factors of the family. The psychometric properties of this
questionnaire have been studied to a limited degree [13, 82]. It was used to compare sibling
mealtime behavior (ASD vs typically developing) in the same family. It showed that although
typically developing children also had some mealtime problems (mean of 5.0), children in the
same social and physical environment but with ASD, had significantly more such problems
(mean of 13.0) than their siblings. Lack of variety of foods, i.e. less than 20 items, an inadequate
number of meals, not eating at the table, or not staying seated during the meal, as well as show
ing some oral-motor deficits were the most significant differences between the two groups [13].
Even after developmentally related behaviors were excluded the difference between the num
ber of mealtime problems in the two groups persisted. These results suggest that the impact of
the diagnosis on mealtime behavior is greater than that of the environment.
3.3. Nutritional assessments
The Youth/Adolescent Questionnaire (YAQ) [83] is a self-report inventory for food frequency
with 148 items to determine the nutritional intake of 9 to 18 year-olds and the average food
serving frequency of six food groups. It provides an estimate of the average serving frequen
cy per day for 6 food groups as well as the average intake over one year. In a validation
study a correlation of.54 was achieved between the YAQ and 24-hour food recall interviews
[83]. Test-retest reliability ranged from.26 to.58 for nutrients and from.39 to.57 for food
groups. A modified version of the YAQ was used with children with ASD to quantify food
refusal and food selectivity (i.e. High-Frequency Single Food Intake) on a daily basis [64].
Although food frequency questionnaires are known to commonly over-report dietary intake
[84], they are useful to analyze childrens preferences as it is required when using graduated
exposure therapies.
611
612
Food records are routinely used by nutritionists to measure energy intake. A systematic
review [84] suggests that the 24-hour multiple pass recall conducted over at least a 3-day
period that includes weekdays and weekend days, using parents as reporters is the most
accurate method for children aged 4 to 11 years and that weighted food records provid
ed the best estimates of Estimated Intake for younger children aged 0.5 to 4 years. Cor
nish [54] used a three day food record to study a small group of children with ASD,
aged 3 to 16 years where 8 had followed a gluten and/or casein free diet for various
lengths (1 to 6 months) and 29 consumed a regular diet. Caregivers filled out a 3-day di
ary of all foods and drinks consumed. Nutrient intakes in 12 children were lower than
recommended in Lower Reference Nutrient Intake for zinc, calcium, iron, vitamin A, B12
and riboflavin in the regular diet group and in 4 for zinc and calcium in the diet group
although these differences were not statistically significant between the 2 groups. The
median daily energy intake was 93% of Estimated Average Requirements (EAR) in both
groups, and did not differ in the contribution of proteins, fats, or carbohydrates. Fruit
and vegetable intake was higher and consumption of starches was lower in the diet
group. The author notes that parents who followed the exclusion diet found that it iso
lated the family socially, food substitutes were difficult to find and costly, meals re
quired longer preparation time, and it was very difficult for the child to make the
change to the new diet.
3.4. Direct observations
Observation of the childs mealtime routine in his familiar environment provides insight
into the familys daily life and the accommodations made for coping with problems [74].
The family may be so enmeshed in this routine that it does not always realize how it
has adapted to the childs problem and to what extent the childs behavior or the envi
ronmental setting may contribute to the maintenance of problems. By making several vis
its to the home and by changing different variables (person, environment, social
demands, sensory stimuli, liked vs non-liked foods) the observer gets a clearer picture
of the situation. If possible the evaluator should have a discussion with the child regard
ing his global understanding of eating and his recognition of any problems. If a home
visit is not possible, the parent/caregiver should come to the clinic and bring some of the
childs liked and non-liked foods. Familiar plates or utensils can also be brought. Evalua
tion will then focus on oral-motor skills, reaction to foods, intensity of food aversions,
and acceptability of food modifications. A systematic presentation of foods was used by
Ahearn et al. [10] for children with ASD. However, a major criticism with this type of
evaluation is that it does not measure the severity or the problem experienced in the
home, because the context is far from what the child is used to. It is more likely measur
ing the childs reaction to novelty or the influence of different contexts.
The Multidisciplinary Feeding Profile (MFP) was developed by Kenny and collaborators
[85] with a group of 18 children, 6 to 18 years of age, who had neurological disabilities
and were dependent feeders. The evaluation is divided into six sections covering: I)
Physical/Neurological factors such as posture, tone and reflex activity, 2) Oral-Facial

http://dx.doi.org/10.5772/53644
Structure, consisting of an evaluation of the face and mouth at rest to identify variations
from normal, using surface anatomy exclusively, 3) Oral-Facial Sensory Inputs: a subjec
tive evaluation of sensory and reflex motor activity produced by stimulation of selected
cranial nerves, 4) Oral-Facial Motor Function: a series of voluntary oral facial postures
such as puckering the lips or deviating the jaw to the right or left, 5) Ventilation/Phona
tion: a subjective evaluation of breathing and sound production and 6) Functional Feed
ing Assessment: an evaluation of oral-motor skills during specific feeding tasks
examining spoon feeding, biting, chewing, cup- and straw drinking and swallowing.
Overall rater agreement, among 3 raters, was 0.83, and overall rater consistency was
0.90. Other psychometric properties such as validity, item consistency and test-retest reli
ability still need to be determined. As well, examination of the suitability for the popula
tion with ASD will be needed.
The Schedule of Oral-Motor Assessment (SOMA) by Reilly et al. [86] measures the oral-motor
and feeding skills of children 8 to 24 months of age. A sample of 127 children constituted the
original sample, 90% were typically developing and 10% were children with cerebral palsy.
Differently textured foods and liquids are offered to the child in a pre-determined order: liq
uid, puree, semi-solids, solids, biscuits and dried fruit and scored in 6 sections. Scores are
based on the quality of oral-motor, mandible, lip and tongue movements. Inter-rater reliabil
ity was 0.75 and internal consistency 0.85 [87]. The predictive validity was > 95% and sensi
tivity >.85 [88]. The age range of the SOMA makes it particularly attractive for use with
young children because of the benefits of early intervention [41]. While a diagnosis of ASD
may only be confirmed by two years or later, feeding problems are often recognized by pa
rents from the first year. Treatment of feeding problems is not dependent on the diagnosis
of ASD. Therefore, early intervention may prevent aggravation of feeding problems with
time when not treated promptly.
4. Treatment
Treatment must take the complete evaluation into account, including the interaction of the
person with his familiar environment. Feeding cannot be treated as an isolated problem and
the strategies employed should not be limited to mealtimes only. To illustrate: the stress a
child experiences during mealtime may decrease his appetite or decrease his tolerance for
tactile or olfactory stimuli. Also, if functional analysis reveals environmental contributions
to the feeding problems, like inappropriate parental strategies to cope with behavioral issues
during mealtime, treatment needs to include these routines as well.
Whether the treatment approach will be interdisciplinary or trans-disciplinary [19, 89]
collaboration between different professionals is desirable, given the complex nature of
feeding problems and the many factors to be considered [21, 39, 90, 91]. The degree of
involvement may vary, depending on the expertise of the individuals involved, the etiol
ogy of the problem to be addressed or the relationship the professionals have with the
parents [89, 90].
613
614
4.1. Parent education

When professionals help parents recognize the source of the feeding problem, the course
of its evolution, and what contributes to its maintenance, the parent can become the pro
fessionals strongest ally, because parents know their child best. Engagement is better
when parent and professional come to an agreement regarding treatment goals and pa
rent involvement is essential in a family-centered approach to treatment [92]. If the child
is still young, one would anticipate that the child will become more food selective around
the age of two or three years, as seen in typical development, and that this stage will be
more challenging for a child with ASD. When parents first learn of the childs diagnosis,
it may be wise to show them a number of coping strategies (Table 3), in order to prepare
them for the developmental food refusals, or to prevent some problems from getting
worse. Particular attention must be paid to prevent intrusive feeding and to assure the
child is regularly exposed to variation in the menu and presentation of foods [38, 93]. Pa
rents actions and their relationship with their child influence the course of mealtimes.
Eating is not only about food. At the table members of the family enjoy each others com
pany, the meal, exchange feelings and family/cultural values. When mealtimes are not
pleasurable and some members do not feel respected with regard to their needs and
choices, the relationship may become affected. When the strategies chosen by the parent
affect the relationship and contribute to the maintenance of a feeding problem, alterna
tives may be suggested and modeling used, to demonstrate different actions and attitudes
in response to the childs behaviors. Regardless which treatment approach is chosen, pa
rents must learn it and the transfer to different social environments must be carefully
planned. It is hoped that regular follow-up with the family can be established, so that pa
rent support is ensured and that changes can be made when needed.
Never force feed children

Never require that children empty their plate
Schedule regular meal times, to establish a cycle of hunger and satiety
Include activities before and after meals, to establish an anticipated routine.
Use adapted communication and/or visual cues to establish clear expectations
Limit the amount of liquids (especially juice and milk), because very small amounts can decrease appetite.
Each child needs a designated seat at the table.
Avoid commercial containers to facilitate the use of other brands
Praise good behavior.
Change constituents of menus regularly.
Introduce changes that are big enough to be recognized, but small enough that they will be tolerated.
Adapt portion size to the age of the child and to his average appetite.
Plan for generalizations
Table 3. Principles of feeding

http://dx.doi.org/10.5772/53644
4.2. Nutritional supplementation

Feeding problems may be long-term problems. This is one reason why nutritional supple
ments may be useful to ensure that the childs health is not compromised [94]. This will re
quire a nutritionists evaluation, to determine whether supplementation or modification of
the existing diet is indicated. These changes have to be made carefully and follow-up is
needed to ensure that they dont suppress the childs appetite or interfere with digestion.
Another option is to introduce supplements in small quantities after each meal, or before
bedtime. Modification of preferred recipes or the introduction of nutritional supplements to
a child who refuses any change to his established mealtime routine may present a major
challenge and considerable risk. It is best to try such changes under professional supervision
because, if done wrong, children may eliminate another food from their already limited rep
ertoire. To increase the chance of success, it will be best not to change the sensory properties
of preferred foods and to present modifications as similar as possible to the taste and texture
of preferred foods [76]. Fading and desensitizing techniques are usually best for introducing
food supplements [94]. These will be described below.
4.3. Behavioral treatment approaches
Behavioral treatments must be based on a functional analysis in order to determine which
behaviors contribute to the maintenance of feeding problems and what function these be
haviors serve (avoidance, attention seeking, pleasure seeking, obtaining a reward). Quali
fied professionals must supervise interventions so that no undesirable behaviors are
reinforced [95].
A number of studies have shown the effectiveness of behavioral interventions for increasing
acceptance of new foods [15, 16, 96]. However, there are only a few studies demonstrating
that acceptance of new foods generalizes to other foods or other environments and that pref
erences of the child have been taken into account [97, 98]. Different types of behavioral inter
ventions are often used in varying combinations [8, 97]. Positive reinforcement, for example,
consists of rewarding the child when he shows the desired response. Sequential presenta
tion is a form of positive reinforcement. In this type of intervention acceptance of a non-pre
ferred food is immediately followed by a preferred food. In simultaneous presentation the
new, non-preferred food is presented together with the preferred food. Although not men
tioned in the literature, clinical practice requires great care with this approach. If parents re
port that their child can detect the slightest change to a familiar recipe, or reacts negatively
to different commercial brands when they look exactly alike, the child may be hypersensi
tive to flavors. When new foods are hidden in what is familiar to the child, they are often
detected by the child. The danger of this approach is, that if the child has limited communi
cation abilities, he may not understand what happened to his food and thus, may refuse to
ever eat it again for fear that this problem will repeat itself. It is best not to use this method
without the knowledge of the child. First, the caregiver will want to decrease the risk that
the child would eliminate one of his preferred foods from an already limited repertoire. Sec
ond, the child should be aware that a new food is being introduced, if we want to gradually
diminish anxiety toward this food and new foods in general.
615
616
In food fading a similar approach is used. The intensity of the taste or texture is decreased by
mixing the new food with something that the child likes. For instance, one can mix a tea
spoon of home-made applesauce in a cup of commercial applesauce. If the child tolerates it,
one can add a second teaspoonful at the next meal, and so on. If the child reacts mostly to
visual changes he may be a good candidate for this particular approach.
Antecedent manipulation aims likewise at modifying the characteristics of a novel food or its
presentation (e.g. texture, bite size, utensil, etc.), to make it more acceptable to the child and
to fit the oral-motor skills of the child [8].
Escape extinction is used when the functional analysis shows that problem behaviors during
a meal result in avoidance of encountering or having to eat a certain food. Physical guidance
and non-withdrawal of the spoon are the general methods used for this situation [15]. The
spoon is presented to the child and kept near his mouth until the food is accepted. Physical
guidance consists of exerting slight pressure on the chin, to elicit opening of the mouth. Bad
behavior is ignored. This approach is very difficult to accept for parents because it can be
very taxing emotionally for both parent and child. Professional supervision is strongly rec
ommended, to prevent post-traumatic feeding problems or adverse effects on the parentchild relationship. We do not recommend using this approach on a long-term basis but
rather for specific identified behavioral problems.
4.4. Treatment based on the theory of sensory integration
Sensory modulation describes a component of the theory of sensory integration [99]. It is de
fined as the ability of adjusting responses to the degree, nature, or intensity of the sensory
environment [100]. Sensory modulation disorders (SMD) describe responses that are incon
sistent, inflexible and fail to meet the demands and expectations of the environment or a
task [100, 101]. One or more sensory systems may be involved, such as touch, vision, hear
ing, proprioception, vestibular, smell and taste. According to Miller et al. [101], there are
three subtypes of SMD; over-responsivity, under-responsivity, and seeking/craving. Chil
dren who are over-responsive react to sensory input more rapidly, and with greater intensi
ty and duration than the majority of their peers [101]. Over-responsivity can lead to
avoidance or aggressive behavior, to escape discomfort caused by sensory input. Tactile de
fensiveness is part of this subtype and is probably the most documented SMD [40, 99, 100,
102-104]. Under-responsivity describes slower, less intense responses to sensory stimuli
[101]. Children in this subtype are difficult to engage, they seem lethargic and lack the inner
drive to explore their environment or initiate social contact. Sensory seeking/craving is de
fined as an intense, insatiable desire for sensory input [100]. Available inputs are not
enough for children in this subcategory. They need input of greater intensity. They may take
risks and engage in socially unacceptable behaviors, and may have unusual olfactory or gus
tatory preferences.
People, in general, react differently to intrinsic (e.g. hunger, pain) or extrinsic (e.g. texture,
taste of food) sensations. Reaction thresholds and sensory preferences are part of each indi
viduals unique characteristics. However, these are not easy to measure objectively. Some in
vestigators do measure them, but their tools are not readily available to the clinician [105].

http://dx.doi.org/10.5772/53644
Through analysis of a persons emotional as well as physiologic and autonomic reactions,

professionals make a decision whether these constitute a SMD or not. The impact of this sen
sory excitatory state on activities of daily living, or on general development, must be signifi
cant in order to constitute a problem. The association of SMD with feeding problems has
been documented by some investigators [26, 40, 106-108].
Analysis of the sensory components associated with meals is essential. For a child to func
tion optimally at meal times, he has to be in a calm and alert state. The clinician assesses the
childs overall level of arousal prior to mealtime and may intervene to ensure an optimal
state for eating. Exploration and tactile desensitization activities may be recommended, such
as exploration of new foods through touch, smell, and taste [109, 110]. Some investigators
have found a correlation between anxiety and over-responsivity; heightened sensitivity to
sensory information mediates the impact of anxiety on selective eating [106]. If the childs
anxiety level is too high, it is appropriate to start tactile exploration of familiar foods or
items outside the eating domain. Manipulating foods with subtle differences in texture,
smell, temperature and taste can help the child feel more comfortable in their presence and
is often a preliminary step before accepting them to eat. When these exercises are done play
fully they are often less stressful for the child and facilitate participation. Finally, all compo
nents of a meal, e.g. utensils used or food textures, must be included in the analysis and can
be modified to better suit the childs sensory profile. Despite the extensive use of these tech
niques in the clinical environment, research using appropriate controls is still lacking to cor
roborate results from anecdotal reports [8].
4.5. Graduated exposure food therapy
Graduated exposure food therapy is similar to systematic desensitization, a type of behavio
ral therapy used for specific phobias and other anxiety disorders. Treatment consists of sys
tematic and gradual exposure to the fear producing stimulus (food), the learning and
application of coping strategies, observation of the development of tolerance and mainte
nance of the engagement of the child; finally, acceptance without adverse reaction, so that
the targeted food eventually becomes an integral part of the childs diet. Another goal of de
sensitization is to gradually eliminate the fear/anxiety that is associated with eating and to
replace it with more positive sentiments such as pleasure. Graduated exposure may com
mence with two types of hierarchy: 1) introducing foods that share some sensory properties
with the childs preferred food (e.g. visual, taste, texture) as suggested by Fraker et al. [76] in
Food Chaining or 2) increasing the foods proximity, e.g. tolerating the presence of the
food on the table - on the plate observing it - touching it smelling it - tasting it chewing
it and, finally, swallowing it [110, 111]. It may be necessary to use both types of hierarchy
when introducing a target food. Change can take a long time and it is important that the
child does not refuse foods that he previously accepted which can happen when familiar
food is modified without his knowledge.
Objective : Introduction of meat
617
618
a. Kraft Dinner (the childs preferred food)

b. Other pasta, but with the Kraft cheese mixture
c. Pasta with home-made cheese mixture
d. Pasta with pink sauce
e. Pasta with tomato sauce
f. Pasta with meat sauce
Table 4. Example of Desensitization Based on Sensory Properties as in Food Chaining [76]
In Food Chaining [76], the childs food preferences are analyzed in detail to establish a
point of departure from which professionals can enlarge the childs food repertoire (Table
4). No studies were found to support the effectiveness of this approach for children with
ASD [112]. Nevertheless, it is currently in use in North American clinical environments and
several documents addressed to parents and professionals mention it [76, 110, 113]. Hier
archical exposure, based on proximity, associated with individualized positive reinforce
ment showed promising results for some children with ASD [98]. Validation is needed with
a more representative sample of the ASD population [98]. Graduated exposure may be used
in combination with other approaches, mentioned earlier, to determine which foods may be
easier to introduce first, to structure the progression of treatment, and to ensure that treat
ment does not progress too rapidly. Some use these strategies in combination with other
trans-disciplinary interventions in group therapies as a means of exploring foods through
games [111, 114]. This may be an interesting approach for children who have good symbolic
play and imitation skills. Other authors have used graduated exposure with more cognitivebehavioral methods, such as in a competition table or a diary to describe the childs prog
ress, or with positive reinforcement or strategies to decrease stress [115]. All children in this
last study were 7 years old or older. Some had autistic features, but none had a definitive
diagnosis of autism. A self/auto-evaluation scale for the child who has fair insight, as well as
an observation scale, are suggested by the authors of Food Chaining to rate reactions when
exposed to a new food [76].
4.6. Cognitive approach
Sensory hypersensitivities are very prevalent in ASD [56, 116, 117]. Baron-Cohen et al. [50]
suggest that excellent attention to detail observed in ASD results from this sensory hyper
sensitivity and that it leads to hyper-systemizing, an exceptional capacity to recognize re
peating patterns in stimuli; i.e. recognition of the rules that define a system. This theory
explains savantism as well as non-social features of autism, like narrow interests, or re
sistance to change. When applied to feeding, some food selectivity or illogical rules, like
wanting food prepared exactly the same way every day, may be the expression of a
strong systemizing capacity; i.e. sameness helps the child build concepts. According to
Baron-Cohen et al. [50] a concept is a system and helps to define what items to include as
members of the system. Therefore, a childs concept of French fries may rely on visual
systemizing (i.e. visual properties of the food are used to categorize: homogeneous light
brown, thin and long, in a specific container), or alternatively on social/environmental sys

http://dx.doi.org/10.5772/53644
temizing (i.e. categorizing according to who is present or when it is eaten: French fries
are eaten after swimming class, at McDonalds, with dad). Because the child with ASD is
also hypersensitive, a minor change in cooking duration, a different tablemat, is immedi
ately detected and the presence of this new feature (often more than one, considering all
the variations possible during mealtime) may no longer allow the child to include the
new food in his concept of French fries. This interpretation of autism-related feeding
problems could explain amelioration of feeding problems as children with ASD get older,
as well as miraculously resolved feeding problems observed sometimes in clinic or re
ported by parents. When the child understands and has a better global conceptualization
of food and mealtime situations, his feeding issues may resolve very rapidly. Other ap
proaches such as sensory integration and graduated exposure may be complementary, be
cause the first addresses sensory hypersensitivity, which leads to hyper-systemization,
and the second supports how changes can be introduced. According to Baron-Cohen et al.
[50], changing one variant at a time is better to support the child in building general con
cepts. Another avenue may be inspired by cognitive remediation therapy used for chil
dren and adolescents with anorexia nervosa but it would have to be adapted to ASD, and
maybe also focus more on food concepts and feeding situations [118].
Developing a teaching method to learn global concepts of food and eating specific to ASD
may be needed. Baron-Cohen et al. [119] found an autism-friendly way to teach emotions
to children with ASD which may potentially be adapted to the feeding domain. Eating and
the socialization associated with it, touches a spectrum of emotions. Children with ASD
seem to only recognize like vs dislike and not the broader spectrum of tolerate, appreciate,
enjoy, love, or crave. Understanding these may also help them to explore and eat a larger
number of foods.
4.7. Adaptation of commonly used tools/approaches to ASD
To achieve acceptable table manners, Social Storiestm [120] may be used to describe a meal
time situation, a skill or a food concept, that includes expected table manners, and aims at
helping the individual with ASD better understand social expectations at mealtimes. A So
cial Storytm may be illustrated such that it explains to the child how meals are set up, why
one has to eat, or even to explain what table manners are and what is expected at home or
outside the home (i.e. formal and informal rules). This type of intervention was shown to be
effective in a young boy with Asperger syndrome, for decreasing unacceptable table man
ners, such as spilling food and increasing desirable behaviors such as mouth wiping [121].
The TEACCH approach seeks to promote understanding and independence by adapting the
environment to better fit the learning style of children with ASD [122]. Visual supports used
in TEACCH to enhance predictability and understanding of a task would also be appropri
ate for eating. For example, one would place only a tiny amount of a new food on the childs
plate, if the goal is only to taste the food. To help the child understand the sequence of the
meal, one could place a visual sequence next to the plate, to illustrate what he is expected to
do, how/when the meal will end and what will happen after the meal (e.g. sit at the table eat foods on your plate - drink beverage from your glass - wipe your hands - return to play).
619
620
Use of alternative and augmentative communication such as the Picture Exchange Communi
cation System (PECS) [123] may enhance communication and understanding of social set
tings between the child and members of the family at mealtimes.
5. Discussion
Much progress has been made in our ability to discriminate between constellations of ap
parently similar feeding behaviors, and thereby establish differential diagnoses for chil
dren with ASD and feeding problems [33-35, 38, 39]. However, each new insight gained
seems to beg new questions that call for an answer. The evaluation and treatment for
these feeding problems has experienced a similar evolution. We will discuss these in the
same order as the chapter has been presented so far, starting with diagnoses, followed by
evaluation and treatment.
5.1. Differential diagnoses
One of the basic needs for the classification of a problem is the use of a nomenclature that is
understood and used consistently by the professionals who work in the same domain. There
is still no universal consensus what defines a feeding problem, eating problem, food refusal,
selective/picky eating, mealtime problems etc., in terms of their characteristics, duration,
and severity. It may be the source of confusion and disagreement in the interpretation of re
sults from research. Therefore, such a classification would do much to advance the field, by
minimizing the need for defining terms by individual investigators in the course of their
work. Consensus building of this type is usually called upon by nationally recognized pro
fessional organizations which in the case of feeding problems will need to ensure that as
broad a spectrum of professionals is represented in the discussions and formulation of such
a classification of this complex topic.
Several classification systems are currently in use. These may contribute to some of the in
consistencies of results, but each makes a unique contribution, and so, a comparison may be
helpful to conclude the discussion on differential diagnoses. The DC: 0-3R [32], the proposed
DSM-V [34] and Dovey et al. [35] classifications have several advantages over the current
DSM-IV-TR classification. These are the addition of the constructs of appetite, self-regula
tion, and the sensory and post-traumatic feeding problems. Despite these advances, there
will always be children who will not exactly fit these new definitions. It must also be noted
that the authors of these classifications do not exclude the possibility that a child may
present with more than one diagnosis at a time. Nonetheless, there are still gaps. For exam
ple, much attention has been paid to nutritional deficiencies and weight loss, whereas nor
mal weight gain or over-weight due to hyper-caloric diets associated with high hedonic
value from sugars, fats and salt are not yet covered. These diets are quickly becoming an
important societal problem. Certain symptoms and diagnostic criteria sometimes overlap
and standardized tools are not yet available, especially for sensory food aversions [124]. The
recognition of sensory based feeding problems is new and studies will be needed to validate

http://dx.doi.org/10.5772/53644
criteria for sensory based food aversions. It is also not yet clear whether some of these feed
ing problems are specific to the population with ASD, if they are an associated condition or
a learned behavior complicated by their diagnosis.
5.2. Evaluation
In the section on evaluation we noted that the age ranges of evaluations vary from infancy
to late adolescence. New assessments may be needed if the age range for a particular do
main is not yet available. While a diagnosis of ASD is often not confirmed until a child is 3
to 4 years old, feeding problems are prevalent and often come to attention in infancy [70].
Treatment of a feeding problem does not depend on a diagnosis of ASD. Therefore, it can be
dealt with as early as it comes to attention. Such an approach may prevent the serious longterm consequences in terms of weight gain and brain development [46]. Whether early feed
ing behaviors may become predictors for a diagnosis of ASD will need further study.
However, inclusion of feeding evaluation at the time of the diagnostic work-up is highly rec
ommended for the many reasons that have been stated throughout this chapter.
We proposed the International Classification of Functioning (ICF; WHO) as the model for eval
uation, in order to ensure that the interactions between the childs body functions and struc
tures, his health condition, and some contextual factors (i.e. environmental as well as
personal factors) will be included in the global evaluation. As of this writing no standar
dized evaluation exists that covers all domains of this model. Some evaluations may cover
some domains, e.g. activity/participation and environment, or personal factors and activity/
participation and so, feeding assessments based on all domains have to be accomplished by
using several evaluations that in combination cover these domains. Another problem is that
some of these evaluations have been developed for typically developing children or children
with other diagnoses, and will need to be validated for children with ASD. As stated in the
discussion of differential diagnoses, collaboration by an interdisciplinary team to develop a
tool comprising all three domains would move the field forward substantially.
Many of the evaluation tools reviewed above are questionnaires and may have satisfacto
ry psychometric properties [73, 77, 78], while others have only limited psychometric prop
erties [13, 85] and need further development. Questionnaires offer the advantage of
describing the childs usual abilities. These behaviors are described by a person who is fa
miliar with the child, usually a parent or teacher, and reflects the observers perception of
the childs performance. Direct observations of the childs performance in his familiar en
vironment are still lacking. This constitutes a significant gap in the treating professionals
knowledge, because the treatment plan will be based on results obtained from a question
naire or from contexts unfamiliar to the child.
Evaluation of childrens nutritional state is based on caloric and nutrient sufficiency of the
diet. These are commonly evaluated by food frequency questionnaires, and by 1, or 3-day
food records [84]. Food intake is very individual, depending on the childs age and activi
ty level, as well as the cultural environment of the family unit. To judge intake adequacy,
results are compared to established national standards such as Estimated Average Require
ments, or National Recommended Intake Standards (NRIS). Evaluation of nutrient adequacy
621
622
(vitamins and micronutrients) should be part of a nutritional evaluation. A particular chal

lenge is the peculiar eating habits of children with ASD; they may be of normal weight,
hence pose no major medical problem, but their diet may consist predominantly of sug
ars, fats and salt. Such diets may also eventually lead to obesity. To assist parents in their
daily mealtime struggles a number of evaluations also focus on parent perceptions of their
successes and difficulties [80, 81]. We are not aware of any standardized dietary evalua
tion for children with ASD.
Although some standardized sensory evaluations exist [125-127], they cover sensory reac
tions in many domains of ADL and so, only a few items deal directly with feeding and
eating. Hence, the greatest need in this area is an assessment that will fully cover the sen
sory domains associated with feeding and eating. Preliminary data are available from a
study by Tessier [124], but now need to be subjected to a full psychometric evaluation.
Common sensory characteristics should include color, texture, consistency, taste, smell,
shape, size of a bite, and appearance which may have an influence on the variety of foods
eaten. A study of how language and social skills affect feeding ability and the cognitive
aspects that are involved for or against eating a certain food may be appropriate to in
clude, since meals are social events. We are also still lacking self-report studies from indi
viduals with ASD who may help us understand the challenges they associate with eating.
An update of evaluation guidelines or even new guidelines for clinicians and researchers
may well arise from the research suggested in this section and would immediately benefit
the population we are trying to serve.
5.3. Treatment
A combination of treatment strategies, based on a holistic evaluation is, in our opinion, the
most promising approach to intervention. Regardless which treatment approaches are chos
en, intervention based on the contextual factors suggested by the ICF will facilitate the trans
fer to different environments, maintenance of the gains over time and hopefully further
improvement. Early parent education may be critical to prevent the establishment of feeding
problems but will need further study.
We have seen that careful manipulation of foods, the mealtime environment or the nutrient
content of the diet may lead to some success in the acceptance of a new food, but one of the
challenges remaining is that success with one food or domain does not necessarily general
ize to other foods or domains. Such progress will probably only happen once childrens cog
nitive decisions/intuitive reactions for acceptance/rejection of foods will be more clearly
understood. We have suggested that one approach may be to study the more highly func
tioning children with ASD or Aspergers syndrome where some communication skills and
insight are present. It may also be helpful to begin work by letting the child determine his
food preference to facilitate co-operation.
Typically developing children also go through food jags, i.e. phases where they will only eat
a limited variety of foods over an extended period of time. One of the authors (E.G.) recalls a
parent telling her that his three-year-old son ate only pasta for three months and once he
had his fill he returned to eating the well balanced family diet. What this fill was, the pa

http://dx.doi.org/10.5772/53644
rent could not tell, but it upset the family considerably. Therefore, the definition of what
is normal or abnormal at different stages of development has not yet been adequately de
fined. Despite the extensive use of behavioral and sensory integration techniques in the clin
ical environment, research using appropriate controls is still lacking to corroborate results
from anecdotal reports [8]. Most of the behavioral approaches are patient centered and so,
may not take the whole family unit into account. This point has been particularly empha
sized by Davies et al. [39]. With an activity that is so family/culture centered as mealtimes
are, a further challenge will be to integrate the family into our treatment approaches.
6. Conclusion
This literature review has illustrated how common feeding problems are in children with
ASD. However, it is not yet definitively established whether these problems are different
from the general pediatric population. There is no consensus yet on the terminology to be
used to describe these problems, on evaluation methods, and use of different diagnostic
classification systems. This makes comparisons of different studies very difficult at present.
Some feeding problems are similar to the sensory problems described in the DC: 0-3R. This
would justify the use of the sensory integration approach, as well as hierarchic desensitiza
tion in the treatment of children with ASD and feeding problems. Updating guidelines for
diagnoses and clinical practice will contribute to knowledge translation from research to
general practice. Preventive approaches, and teaching parents how to handle feeding prob
lems also seems promising. Further research is needed to support these beginnings.
Author details
Genevive Nadon1, Debbie Feldman1 and Erika Gisel1,2
1 Universit de Montral and Center for Interdisciplinary Rehabilitation Research, Montreal,
Quebec, Canada
2 Faculty of Medicine, School of Physical & Occupational Therapy, McGill University, Canada
References
[1] Aldridge VK, Dovey TM, Martin CI, Meyer C. Identifying clinically relevant feeding
problems and disorders. Journal of Child Health Care 2010;14 261-270.
[2] Bryant-Waugh R, Markham L, Kreipe RE, Walsh BT. Feeding and eating disorders in
childhood. International Journal of Eating Disorders 2010;43 98-111.
623
624
[3] Carruth BR, Ziegler PJ, Gordon A, Barr SI. Prevalence of picky eaters among infants
and toddlers and their caregivers' decisions about offering a new food. Journal of the
American Dietetic Association 2004;104 s57-64.
[4] Field D, Garland M, Williams K. Correlates of specific childhood feeding problems.
Journal of Paediatrics and Child Health 2003;39 299-304.
[5] Manikam R, Perman JA. Pediatric Feeding Disorders. Journal of Clinical Gastroenter
ology 2000;30 34-46.
[6] Mascola AJ, Bryson SW, Agras WS. Picky Eating during Childhood: A longitudinal
study to age 11 years. Eating Behavior 2010;11 253-257.
[7] Williams KE, Riegel K, Kerwin ML. Feeding Disorder of Infancy or Early Childhood:
How often is it seen in feeding programs? Children's Health Care 2009;38 123-136.
[8] Sharp WG, Jaquess DL, Morton JF, Herzinger CV. Pediatric feeding disorders: a
quantitative synthesis of treatment outcomes. Clinical Child and Family Psychology
Review 2010;13 348-365.
[9] Molle LD, Goldani HAS, Fagondes SC, Vieira VG, Barros SGS, Silva PS, et al. Noctur
nal reflux in children and adolescents with persistent asthma and gastroesophageal
reflux. Journal of Asthma 2009;46 347-350.
[10] Ahearn WH, Castine T, Nault K, Green G. An assessment of food acceptance in chil
dren with autism or pervasive developmental disorder-not otherwise specified. Jour
nal of Autism and Developmental Disorders 2001;31 505-511.
[11] Martins Y, Young RL, Robson DC. Feeding and eating behaviors in children with au
tism and typically developing children. Journal of Autism and Developmental Disor
ders 2008;38 1878-1887.
[12] Ledford JR, Gast DL. Feeding problems in children with Autism Spectrum Disorders:
A review. Focus on Autism and Other Developmental Disabilities 2006;21 153-166.
[13] Nadon G, Ehrmann Feldman D, Dunn W, Gisel E. Mealtime problems in children
with autism spectrum disorder and their typically developing siblings: A comparison
study. Autism 2011;15 98-113.
[14] Schreck KA, Williams K, Smith AF. A comparison of eating behaviors between chil
dren with and without autism. Journal of Autism and Developmental Disorders
2004;34 433-438.
[15] Volkert VM, Vaz PCM, Piazza CC. Recent studies on feeding problems in children
with Autism. Journal of Applied Behavior Analysis 2010;43 155-159.
[16] Williams KE, Seiverling L. Eating problems in children with Autism Spectrum Disor
ders. Topics in Clinical Nutrition 2010;25 27-37.
[17] Williams PG, Dalrymple N, Neal J. Eating habits of children with autism. Pediatric
Nursing 2000;26 259-264.

http://dx.doi.org/10.5772/53644
[18] Rogers LG, Magill-Evans J, Rempel GR. Mothers challenges in feeding their children
with Autism Spectrum DisorderManaging more than just picky eating. Journal of
Developmental and Physical Disabilities 2011;24 19-33.
[19] Cermak SA, Curtin C, Bandini LG. Food selectivity and sensory sensitivity in chil
dren with autism spectrum disorders. Journal of the American Dietetic Association
2010;110 238-246.
[20] Collins MSR, Kyle R, Smith S, Laverty A, Roberts S, Eaton-Evans J. Coping with the
usual family diet: Eating behaviour and food choices of children with Down's Syn
drome, Autistic Spectrum Disorders or Cri du Chat Syndrome and comparison
groups of siblings. Journal of Learning Disabilities 2003;7 137-155.
[21] Provost B, Crowe TK, Osbourn PL, McClain C, Skipper BJ. Mealtime behaviors of
preschool children: Comparison of children with Autism Spectrum Disorder and
children with typical development. Physical & Occupational Therapy in Pediatrics
2010;30 220-233.
[22] Schmitt L, Heiss CJ, Campbell EE. A Comparison of nutrient intake and eating be
haviors of boys with and without Autism. Topics in Clinical Nutrition 2008;23 23-31.
[23] Williams KE, Gibbons BG, Schreck KA. Comparing selective eaters with and without
developmental disabilities. Journal of Developmental and Physical Disabilities
2005;17 299-309.
[24] Badalyan V, Schwartz RH. Feeding problems and GI dysfunction in children with
Asperger Syndrome or Pervasive Developmental Disorder not Otherwise Specified:
Comparison with their siblings. Open Journal of Pediatrics 2011;1 51-63.
[25] Page J, Boucher J. Motor impairments in children with Autistic Disorder. Child Lan
guage Teaching and Therapy 1998;14 233-259.
[26] Nadon G, Ehrmann Feldman D, Dunn W, Gisel E. Association of sensory processing
and eating problems in children with Autism Spectrum Disorders. Autism Research
and Treatment DOI:10.1155/2011/541926, 2011. Article ID541926, 8 pages.
[27] Skinner B. The operational analysis of psychological terms. Behavioral and Brain Sci
ences 1984;7 547-553.
[28] Coombs E, Brosnan M, Bryant-Waugh R, Skevington SM. An investigation into the
relationship between eating disorder psychopathology and autistic symptomatology
in a non-clinical sample. British Journal of Clinical Psychology 2011;50 326-338.
[29] Oldershaw A, Treasure J, Hambrook D, Tchanturia K, Schmidt U. Is anorexia nervo
sa a version of autism spectrum disorders? European Eating Disorders Review
2011;19 462-474.
[30] Pepin G, Stagnitti K. Come play with me: An argument to link Autism Spectrum Dis
orders and Anorexia Nervosa through early childhood pretend play. Eating Disor
ders: The Journal of Treatment and Prevention 2012;20 254-259.
625
626
[31] American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disor
ders: DSM-IV-TR. Washington, DC: American Psychiatric Publishing, Inc.; 2000.
[32] ZERO TO THREE. Diagnostic Classification of Mental Health and Developmental
Disorders of Infancy and Early Childhood: Revised edition (DC: 0-3R). Washington,
DC: Zero To Three; 2005.
[33] Chatoor I. Diagnosis and Treatment of Feeding Disorders in Infants, Toddlers, and
Young Children. Washington, DC: Zero To Three; 2009.
[34] American Psychiatric Association. DSM-V Development. Avoidant/Restrictive Food
Intake Disorder. http://www.dsm5.org/ProposedRevisions/Pages/proposedrevi
sion.aspx?rid=110: American Psychiatric Association (accessed 24 August 2012).
[35] Dovey TM, Farrow CV, Martin CI, Isherwood E, Halford JCG. When does food refus
al require professional intervention? Current Nutrition and Food Science 2009;5
160-171.
[36] Dovey TM, Isherwood E, Aldridge VK, Martin CI. Typology of feeding disorders
based on a single assessment system. Infant, Child, and Adolescent Nutrition 2010;2
52-61.
[37] Southall A, Martin C. Decision-making model. Feeding problems in children: A prac
tical guide, Second edition. Oxford, New York: Radcliffe Publishing; 2010. p. 314-315.
[38] Levine A, Bachar L, Tsangen Z, Mizrachi A, Levy A, Dalal I, et al. Screening criteria
for diagnosis of Infantile Feeding Disorders as a cause of poor feeding or food refus
al. Journal of Pediatric Gastroenterology and Nutrition 2011;52 563-568.
[39] Davies W, Satter E, Berlin KS, Sato AF, Silverman AH, Fischer EA, et al. Reconceptu
alizing feeding and feeding disorders in interpersonal context: The case for a rela
tional disorder. Journal of Family Psychology 2006;20 409-417.
[40] Smith AM, Roux S, Naidoo NTR, Venter DJL. Food choices of tactile defensive chil
dren. Nutrition 2005;2114-2119.
[41] Gisel E. Interventions and outcomes for children with dysphagia. Developmental
Disabilities Research Reviews 2008;14 165-173.
[42] Anderson GC. The mother and her newborn: Mutual caregivers. Journal of Obstetric,
Gynecologic, & Neonatal Nursing 1977;6 50-57.
[43] Ramsay M, Gisel E, McCusker J, Bellavance F, Platt R. Infant sucking ability, Nonorganic failure to thrive, maternal characteristics, and feeding practices: A prospec
tive cohort study. Developmental Medicine and Child Neurology 2002;44 405-414.
[44] P.O.P.S.I.C.L.E.Center. P.O.P.S.I.C.L.E. Center Infant and Child Feeding Question
naire. http://www.popsicle.org: P.O.P.S.I.C.L.E. Center (accessed 18 August 2012).
[45] Chatoor I, Ganiban J. Food refusal by infants and young children: Diagnosis and
treatment. Cognitive and Behavioral Practice 2003;10 138-146.

http://dx.doi.org/10.5772/53644
[46] Senez C, Guys J, Mancini J, Paredes AP, Lena G, Choux M. Weaning children from
tube to oral feeding. Child's Nervous System 1996;12 590-594.
[47] Dunitz-Scheer M, Levine A, Roth Y, Kratky E, Beckenbach H, Braegger C, et al. Pre
vention and treatment of tube dependency in infancy and early childhood. Infant,
Child, and Adolescent Nutrition 2009;1 73-82.
[48] Daveluy W, Guimber D, Mention K, Lescut D, Michaud L, Turck D, et al. Home en
teral nutrition in children: An 11-year experience with 416 patients. Clinical Nutri
tion 2005;24 48-54.
[49] McNally RJ. Choking phobia: A review of the literature. Comprehensive Psychiatry
1994;35 83-89.
[50] Baron-Cohen S, Ashwin E, Ashwin C, Tavassoli T, Chakrabarti B. Talent in autism:
Hyper-systemizing, hyper-attention to detail and sensory hypersensitivity. Philo
sophical Transactions of the Royal Society B: Biological Sciences 2009;364 1377-1383.
[51] Levy Y, Levy A, Zangen T, Kornfeld L, Dalal I, Samuel E, et al. Diagnostic clues for
identification of nonorganic vs organic causes of food refusal and poor feeding. Jour
nal of Pediatric Gastroenterology and Nutrition 2009;48 355-362.
[52] Zangen T, Ciarla C, Zangen S, Di Lorenzo C, Flores AF, Cocjin J, et al. Gastrointesti
nal motility and sensory abnormalities may contribute to food refusal in medically
fragile toddlers. Journal of Pediatric Gastroenterology and Nutrition 2003;37 287-293.
[53] Cornish E. A balanced approach towards healthy eating in autism. Journal of Human
Nutrition and Dietetics 1998;11 501-509.
[54] Cornish E. Gluten and casein free diets in autism: A study of the effects on food
choice and nutrition. Journal of Human Nutrition and Dietetics 2002;15 261-269.
[55] Kerwin MLE, Eicher PS, Gelsinger J. Parental report of eating problems and gastroin
testinal symptoms in children with Pervasive Developmental Disorders. Children's
Health Care 2005;34 217-234.
[56] Baranek GT, David FJ, Poe MD, Stone WL, Watson LR. Sensory Experiences Ques
tionnaire: Discriminating sensory features in young children with autism, develop
mental delays, and typical development. Journal of Child Psychology and Psychiatry
2006;47 591-601.
[57] Leekam SR, Nieto C, Libby SJ, Wing L, Gould J. Describing the sensory abnormalities
of children and adults with Autism. Journal of Autism and Developmental Disorders
2007;37 894-910.
[58] Harrison J, Hare DJ. Brief Report: Assessment of sensory abnormalities in people
with Autistic Spectrum Disorders. Journal of Autism and Developmental Disorders
2004;34 727-730.
627
628
[59] Jones R, Quigney C, Huws J. First-Hand Accounts of Sensory Perceptual Experiences

in Autism: A qualitative analysis. Journal of Intellectual and Developmental Disabili
ty 2003;28 112-121.
[60] Emond A, Emmett P, Steer C, Golding J. Feeding symptoms, dietary patterns, and
growth in young children with Autism Spectrum Disorders. Pediatrics 2010;126 e337e342.
[61] Ho HH, Eaves LC, Peabody D. Nutrient intake and obesity in children with Autism.
Focus on Autism and Other Developmental Disabilities 1997;12 187-192.
[62] Levy SE, Souders MC, Ittenbach RF, Giarelli E, Mulberg AE, Pinto-Martin JA. Rela
tionship of dietary intake to gastrointestinal symptoms in children with Autistic
Spectrum Disorders. Biological Psychiatry 2007;61 492-497.
[63] Geraghty ME, Depasquale GM, Lane AE. Nutritional intake and therapies in Autism
- a spectrum of what we know : Part 1. Infant, Child, & Adolescent Nutrition 2010;2
62-69.
[64] Bandini LG, Anderson SE, Curtin C, Cermak S, Evans EW, Scampini R, et al. Food
selectivity in children with Autism Spectrum Disorders and typically developing
children. Journal of Pediatrics 2010;157 259-264.
[65] Altenburger JL. The quality of nutritional intakes in children with Autism. MS thesis,
Ohio State University, OH; 2010.
[66] Hediger ML, England LJ, Molloy CA, Yu KF, Manning-Courtney P, Mills JL. Re
duced bone cortical thickness in boys with Autism or Autism Spectrum Disorder.
Journal of Autism and Developmental Disorders 2008;38 848-856.
[67] McAbee GN, Prieto DM, Kirby J, Santilli AM, Setty R. Permanent visual loss due to
dietary vitamin A deficiency in an autistic adolescent. Journal of Child Neurology
2009;24 1288-1289.
[68] Dailey SA. Oral motor skills in children with food refusal behaviors. PhD thesis, The
University of Iowa, IA; 2009.
[69] Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2 217-250.
[70] Brisson J, Warreyn P, Serres J, Foussier S, Adrien-Louis J. Motor anticipation failure
in infants with Autism: A retrospective analysis of feeding situations. Autism 2012;16
420-429.
[71] Nadon G, Ehrmann Feldman D, Gisel E. [Review of assessment methods used to
evaluate feeding in children with pervasive developmental disorder] in French. Ar
chives de Pediatrie 2008;15 1332-1348.
[72] Seiverling L, Williams K, Sturmey P. Assessment of feeding problems in children
with Autism Spectrum Disorders. Journal of Developmental and Physical Disabilities
2010;22 401-413.

http://dx.doi.org/10.5772/53644
[73] Lukens CT, Linscheid TR. Development and validation of an inventory to assess
mealtime behavior problems in children with autism. Journal of Autism and Devel
opmental Disorders 2008;38 342-352.
[74] Evans-Morris S, Dunn Klein M. Mealtime Assessment. In: Evans-Morris S, Dunn
Klein M. (eds.) Pre-Feeding Skills. Austin, TX: Pro-Ed. 2000. p. 157-186.
[75] Hendy HM, Williams KE, Riegel K, Paul C. Parent mealtime actions that mediate as
sociations between children's fussy-eating and their weight and diet. Appetite
2010;54 191-195.
[76] Fraker C, Fishbein M, Walbert L, Cox S. Food Chaining: The proven 6-step plan to
stop picky eating, solve feeding problems and expand your child's diet. Cambridge,
MA: Da Capo Press; 2007.
[77] Archer LA, Rosenbaum PL, Streiner DL. The children's eating behavior inventory:
Reliability and validity results. Journal of Pediatric Psychology 1991;16 629-642.
[78] Crist W, Napier-Phillips A. Mealtime behaviors of young children: A comparison of
normative and clinical data. Journal of Developmental & Behavioral Pediatrics
2001;22 279.
[79] Williams KE, Hendy HM, Seiverling LJ, Can SH. Validation of the parent mealtime
action scale (PMAS) when applied to children referred to a hospital-based feeding
clinic. Appetite 2011;56 553-557.
[80] Faith MS, Storey M, Kral TVE, Pietrobelli A. The Feeding Demands Questionnaire:
Assessment of parental demand cognitions concerning parent-child feeding rela
tions. Journal of the American Dietetic Association 2008;108 624-630.
[81] Davies W, Ackerman LK, Davies CM, Vannatta K, Noll RB. About Your Child's Eat
ing: Factor structure and psychometric properties of a feeding relationship measure.
Eating Behaviors 2007;8 457-463.
[82] Nadon G. Le profil alimentaire des enfants prsentant un trouble envahissant du d
veloppement: un lien avec lge et le diagnostic. MSc Thesis, Universit de Montral,
Montreal: 2007.
[83] Rockett HRH, Breitenbach M, Frazier AL, Witschi J, Wolf AM, Field AE, et al. Valida
tion of a youth/adolescent food frequency questionnaire. Preventive Medicine
1997;26 808-816.
[84] Burrows TL, Martin RJ, Collins CE. A systematic review of the validity of dietary as
sessment methods in children when compared with the method of doubly labeled
water. Journal of the American Dietetic Association 2010;110 1501-1510.
[85] Kenny DJ, Koheil RM, Greenberg J, Reid D, Milner M, Moran R, et al. Development
of a multidisciplinary feeding profile for children who are dependent feeders. Dys
phagia 1989;4 16-28.
629
630
[86] Reilly S, Skuke D, Wolke D. SOMA: The schedule of Oral Motor Assessment. Lon
don: Whurr Publisher; 2000.
[87] Reilly S, Skuse D, Mathisen B, Wolke D. The objective rating of oral-motor functions
during feeding. Dysphagia 1995;10 177-191.
[88] Skuse D, Stevenson J, Reilly S, Mathisen B. Schedule for oral-motor assessment (SO
MA): Methods of validation. Dysphagia 1995;10 192-202.
[89] Bruns DA, Thompson SD. Feeding challenges in young children: Toward a best prac
tices model. Infants and Young Children 2010;23 93-102.
[90] Twachtman-Reilly J, Amaral SC, Zebrowski PP. Addressing feeding disorders in
children on the autism spectrum in school-based settings: Physiological and behavio
ral issues. Language, Speech, and Hearing Services in Schools 2008;39 261-272.
[91] Geraghty ME, Bates-Wall J, Ratliff-Schaub K, Lane AE. Nutritional interventions and
therapies in Autism - a spectrum of what we know: Part 2. Infant, Child, and Adoles
cent Nutrition 2010;2 120-133.
[92] Angell A. Selective eaters and tactile sensitivity: A review of classification and treat
ment methods that address anxiety and support a child's need for a sense of control.
Infant, Child, and Adolescent Nutrition 2010;2 299-303.
[93] Schreck KA, Williams K. Food preferences and factors influencing food selectivity for
children with Autism Spectrum Disorders. Research in Developmental Disabilities
2006;27 353-363.
[94] Williams KE, Foxx RM. Treating Eating Problems of Children with Autism Spectrum
Disorders and Developmental Disabilities. Austin, Texas: Pro-ED Inc.; 2007.
[95] Kodak T, Piazza CC. Assessment and behavioral treatment of feeding and sleeping
disorders in children with Autism Spectrum Disorders. Child and Adolescent Psy
chiatric Clinics of North America 2008;17: 887-905, x-xi.
[96] Matson JL, Fodstad JC. Issues in identifying the etiology of food refusal in young
children. Journal of Pediatric Gastroenterology and Nutrition 2009;48 274-275.
[97] Kozlowski AM, Matson JL, Fodstad JC, Moree BN. Feeding therapy in a child with
Autistic Disorder: Sequential food presentation. Clinical Case Studies 2011;10
236-246.
[98] Koegel RL, Bharoocha AA, Ribnick CB, Ribnick RC, Bucio MO, Fredeen RM, et al.
Using individualized reinforcers and hierarchical exposure to increase food flexibili
ty in children with Autism Spectrum Disorders. Journal of Autism and Developmen
tal Disorders 2011;42 1574-1581.
[99] Ayres AJ. Sensory Integration and the Child. Los Angeles, CA: Western Psychologi
cal Services; 1979.
[100] Schaaf R, Schoen S, Smith Roley S, Lane S, Koomar J, May-Benson T. A Frame of ref
erence for sensory integration. In: Kramer P & Hinojosa J. (eds.) Frames of Reference

http://dx.doi.org/10.5772/53644
for Pediatric Occupational Therapy. Baltimore, MD: Wolters Kluwer Lippincott Wil
liams & Wilkins; 2010. p. 99-186.
[101] Miller LJ, Anzalone ME, Lane SJ, Cermak SA, Osten ET. Concept evolution in senso
ry integration: A proposed nosology for diagnosis. 2007.
[102] Baranek GT, Foster LG, Berkson G. Tactile defensiveness and stereotyped behaviors.
The American Journal of Occupational Therapy 1997;51 91-95.
[103] Ghanizadeh A. Sensory processing problems in children with ADHD, a systematic
review. Psychiatry Investigation 2011;8 89.
[104] Dovey TM, Staples PA, Gibson EL, Halford JCG. Food neophobia and picky/fussy
eating in children: A review. Appetite 2008;50 181-193.
[105] Reynolds S, Lane SJ. Diagnostic validity of sensory over-responsivity: A review of
the literature and case reports. Journal of Autism and Developmental Disorders
2008;38 516-529.
[106] Farrow CV, Coulthard H. Relationships between sensory sensitivity, anxiety and se
lective eating in children. Appetite 2012;58 842-846.
[107] Naish KR, Harris G. Food Intake Is Influenced by Sensory Sensitivity. PloS one
2012;7:e43622.
[108] Coulthard H, Blissett J. Fruit and vegetable consumption in children and their moth
ers. Moderating effects of child sensory sensitivity. Appetite 2009;52 410-415.
[109] Flanagan MA. Improving Speech and Eating Skills in Children with Autism Spec
trum Disorders: An Oral-Motor Program for Home and School. Shawnee Mission,
Kansas: Autism Asperger Publishing Company; 2008.
[110] Ernsperger L, Stegen-Hanson T. Just Take a Bite: Easy, Effective Answers to Food
Aversions and Eating Challenges! Arlington, VA: Future Horizons Inc; 2004.
[111] Toomey K, Nyhoff A, Lester A. Picky Eaters vs. Problem Feeders: The SOS Approach
to Feeding: Conference Proceedings, February 2007, Manchester, NH: Education Re
sources Inc. 2007.
[112] Cox S, Fraker C, Walbert L, Fishbein M. Food chaining: A systematic approach for
the treatment of children with eating aversion. Journal of Pediatric Gastroenterology
and Nutrition 2004;39 S51.
[113] Fraker C, Walbert L. Treatment of selective eating and dysphagia using pre-chaining
and food chaining therapy programs. Perspectives on swallowing and swallowing
disorders. Dysphagia 2011;20 75-81.
[114] Toomey KA, Ross ES. SOS approach to feeding. Perspectives on swallowing and
swallowing disorders. Dysphagia 2011;20 82-87.
[115] Nicholls D, Christie D, Randall L, Lask B. Selective eating: Symptom, disorder or nor
mal variant. Clinical Child Psychology and Psychiatry 2001;6 257-270.
631
632
[116] Lane AE, Dennis SJ, Geraghty ME. Brief report: Further evidence of sensory subtypes
in Autism. Journal of Autism and Developmental Disorders 2011;41 826-831.
[117] Lane AE, Young RL, Baker AEZ, Angley MT. Sensory processing subtypes in Au
tism: Association with adaptive behavior. Journal of Autism and Developmental Dis
orders 2009;40 112-122.
[118] Lindvall C, Owen I, Lask B. Cognitive Remediation Therapy (CRT) for Children and
Adolescents with Eating Disorders: Resource Pack. 2011.
[119] Baron-Cohen S, Golan O, Ashwin E. Can emotion recognition be taught to children
with Autism Spectrum conditions? Philosophical Transactions of the Royal Society B:
Biological Sciences 2009;364 3567-3574.
[120] Gray C. The New Social Story Book: 10th Anniversary Edition. Arlington, VA: Future
Horizons Inc.; 2010.
[121] Bledsoe R, Myles BS, Simpson RL. Use of a social story intervention to improve meal
time skills of an adolescent with Asperger syndrome. Autism 2003;7 289-295.
[122] Mesibov GB, Shea V, Schopler E. The TEACCH Approach to Autism Spectrum Dis
orders. New York: Kluwer Academic/Plenum; 2005.
[123] Bondy A, Frost L. The Picture Exchange Communication System. Behavior Modifica
tion 2001;25 725-44.
[124] Tessier MJ. Marqueurs prcoces des problmes sensoriels chez le jeune enfant pr
sentant des problmes d'alimentation. MSc thesis, Universit de Montral, Montreal;
2011.
[125] Dunn W. The Sensory Profile Manual. San Antonio TX: Psychological Corporation;
1999.
[126] Miller-Kuhaneck H, Henry DA, Glennon TJ, Mu K. Development of the sensory
processing measureSchool: Initial studies of reliability and validity. The American
Journal of Occupational Therapy 2007;61 170-175.
[127] Parham L, Ecker C, Kuhaneck HM, Henry D, Glennon T. Sensory Processing Meas
ure. Los Angeles, CA: Western Psychological Services; 2006.
Chapter 26
Clinical Approach in Autism:

Management and Treatment
Rudimar Riesgo, Carmem Gottfried and
Michele Becker
http://dx.doi.org/10.5772/54784
1. Introduction
The terms Autism and ASD (Autism Spectrum Disorders) can be interchangeable in the clinical
setting, and have been used to describe one of the most intriguing neurobehavioral syndromes,
that include the so-called triad of Wing: problems in communication, social skills, and
restrict repertoire of interests. However, it is somewhat difficult to precisely define autism,
because of the imprecise boundaries between different kinds of ASD as well as the fact that
there is no biological marker to date (Gottfried and Riesgo 2011).
By definition, in autism the social deficits are characterized by lack of interest in spontaneously
sharing feelings, different levels of communication deficits, difficulties in imaginative plays,
restrictive repertoire of interests, non-functional routine fixations, as well as stereotypies and
other motor alterations, such as flapping with hands, circular movements and others (Nikolov,
Jonker, and Scahill 2006; Gadia, Tuchman, and Rotta 2004).
While the criteria of the DSM-V (Diagnostic and Statistical Manual of Mental Disorders Fifth
Edition) are not yet published, we still have to use the older version. According with the
DSMIV criteria, there are five clinical situations that could be encompassed by the term
PDD (Pervasive Developmental Disorders) or ASD (Autism Spectrum Disorders) with the
same meaning of PDD or autism (Association 2002).
Although it will change in the near future, the five current clinical ASD diagnosis admitted by
DSM-IV-TR (Gadia et al., 2004) are: a) Autistic Disorder; b) Asperger Disorder (AD); c) Rett
Disorder; d) Childhood Disintegrative Disorder; e) PDD-NOS (Pervasive Developmental
Disorder Not Otherwise Specified).
2013 Riesgo et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
634
According with DSM-IV-TR, and in agreement with previous epidemiological data, our group
found that the most prevalent ASD is the PDD-NOS, followed by Autistic Disorder, and then
by Asperger Disorder. Accordingly, the Rett Disorder and the Childhood Disintegrative
Disorder for sure are less frequently seen in the clinical practice (Longo et al. 2009).
The increasing levels of prevalence in ASD probably is due to several reasons, such as the
changes in diagnostic criteria, the high level of awareness, the underestimation of former data,
the massive information exchange regarding ASD, the public strategies, etc. The first descrip
tion of autism was made by Hans Asperger, in 1938. In 1943, when Leo Kanner described a
sample with 11 children, autism was a rare condition affecting not more than 4 in 10.000
children (Kanner 1943).
However, childhood autism is much more frequent and is identified in at least one in each 100
children nowadays. For instance, a recent paper describes prevalence of 2.6% of ASD in
children aging from seven to twelve years of age (Kim et al. 2011).
Autism and ASD certainly have different kinds of approaches. These neurobehavioral
syndromes can be addressed, for example, both from the clinical and from the experimental
field. To our knowledge, at least in the academic environment, the best approach could be the
translational type because it made us able to rapidly build a bridge between the experimental
and the clinical field (Gottfried and Riesgo 2011).
Obviously, the earlier results usually came from the experimental research for several reasons.
In general, the time spent in each one experiment can be shorter compared to clinical research;
the environmental variables can be in part controlled, etc. By the other side, clinical research
can be more time consuming and potentially more complicated to be performed. There is no
doubt that both approaches are not mutually exclusive. Actually they are complementary.
Strictly speaking from the clinical perspective in autism, we can divide the clinical approach
into two basic and complementary issues. The first one is the general management, including
the confirmation of the correct diagnosis, the determination of the intensity of the compromise,
and the evaluation of intensity level of eventual core behavioral symptoms. The last one
encompasses several treatment options, which includes psychopharmacotherapy and differ
ent types of non-medical treatments.
As the first cases of autism were described in the early 40s, now we have adults with ASD. That
is the reason to keep in mind how ASD symptoms usually change during lifetime. As time pass,
different symptoms change differently and it is crucial to clinicians to know these differences.
In this context, the present chapter aimed to review (i) the general management of ASD from
the clinical perspective; (ii) the lifetime changes in ASD symptoms; and (iii) the evidence-based
treatment options.
2. General management of ASD from the clinical perspective

The general management of ASD from the clinical perspective encompasses both interventions
in the family/environment as well as interventions addressed to the patient. Ideally, after
Clinical Approach in Autism: Management and Treatment

http://dx.doi.org/10.5772/54784
diagnosis confirmation, the best initial approach could be done by an interdisciplinary team
including professionals coming from medicine, psychology and social sciences.
Obviously, before initiating any kind of intervention, several steps must be done as follows.
First of all, the final diagnosis must be confirmed by a careful anamnesis as well doublechecked using the DSM-IV criteria as well as a reliable clinical instrument such as Autism
Diagnosis Interview-Revised (ADI-R) (Becker et al. 2012). The ADI-R is frequently used as a
gold standard instrument for publication purposes, but it is problematic in the clinical practice
for several reasons, such as it can miss same ASD cases as well as it need at least two hours to
be completed. Then, the intensity of the ASD could be defined both from the clinical perspec
tive and by one instrument such as CARS (Pereira, Riesgo, and Wagner 2008). Another critical
issue is to delimitate if there is any associated mental disability and its degree of intensity. As
clinicians, we know the prognostic importance of an unaffected intelligence in ASD patients.
The second step includes the definition of the parents doubts, fears, and degree of awareness.
Usually, after diagnosis confirmation, parents became stressed. Not infrequently they go to
internet in order to search every kind of available information regarding autism. Because some
information coming from internet can be inaccurate, at this point, it is very important to clarify
which are the evidence-based types of therapies to date.
The third step could be the delimitation of environmental variables that needs to be addressed,
starting from the home and family. Neighborhood and school needs to be evaluated both in
terms of potential stressors and also because they can facilitates choosing a given type of
therapy on an individual basis.
The next step is done by the identification of the target behaviors needing treatment. After core
symptoms definition in each case, the different professional specialties that need to be involved
are selected. In general, the team includes a physician specialized in ASD patients as well as
one speech therapist and others professionals arising from health care and/or education with
experience in children with ASD.
3. How ASD symptoms change during lifetime

All professionals who treat children and adolescents, both coming from health care as well as
from education must know how behaviors can normally change during the normal neuro
psychological development. In other words: there is an ontogenetic evolution on each one of
the behavioral manifestations in the normally developed children.
For example: in terms of gender versus behavior, usually hyperactivity is more prevalent in
normal boys when compared with normal girls. The humor control, the language skills and
the social competence usually improves in normally developed children as long as time passes.
Usually, normal girls tend to improve faster their language skills and their social competence
when compared with normal boys. This knowledge is crucial to identify how different
behavioral symptoms change during lifetime in ASD patients.
635
636
When the issue is childhood autism symptoms, there are no major problems in terms of
information, because of most of the available publications are directed to pediatric patients.
As a consequence, adult ASD symptoms are less frequently accessed in the available literature.
Researchers had noted that the prevalence of adult ASD may be underestimating and most of
these patients reach adulthood without any diagnosis or treatment. This is especially true to
patients with Asperger. (Szatmari et al. 1995; Arora et al. 2011).
More recently, an increasing interest is observed in prevalence and clinical presentation of
ASD in adults. The few available prospective studies indicate a diagnostic stability through
life (Billstedt, Gillberg, and Gillberg 2005), and near of 80% of individuals with ASD diagnosed
in childhood continues to present scores within this spectrum during adolescence and
adulthood (Rutter, Greenfeld, and Lockyer 1967).
It is important to mention the difficulties in making diagnosis of ASD in adult patients,
because many of them have no information regarding their first years of life. If the diag
nosis of ASD is hard to be made in adults, then the prognosis is equally affected. The
prognostic studies in adults with ASD had includes patients with very different levels of
cognitive, linguistic, social, and behavioral functioning (Howlin et al. 2004). Additionally,
most of available the prognostic studies in adult ASD use small samples, which make
impossible to obtain definitive conclusions.
Where searching literature regarding how ASD symptoms change during lifetime, a paucity
of published information is promptly identified. Although the lack of publications, at least two
different timelines could be identified in ASD patients: a) how ASD core symptoms change as
time pass; b) how ASD-associated symptoms change with time.
3.1. How ASD core symptoms change during lifetime
The three core symptoms of ASD, the so-called triad of Wing are the following: social deficits,
communication deficits, and restrict and repetitive behavior.
The social deficits persist as an important problem in adolescence and adult age and usually
are accessed by the Autism Diagnostic Interview (ADI) and also by the Vineland Adaptive
Behavior Scale (VABS). Our group translated into Brazilian Portuguese the ADI-R, considered
the gold-standard in autism diagnosis and is extremely useful identifying social deficits
(Becker et al. 2012). One study found that only 16.7% of adults with autism presented high
scores in social domain of VABS. Additionally, more than half of patients had no social contact
at all and one third showed strange social contact (Howlin, Mawhood, and Rutter 2000). In
general, social deficits do not improve significantly as time pass.
The communication skills tend to improve. As a group, ASD patients tend to keep al
most unchanged the idiosyncratic use of language as well as the inappropriate patterns
of communication in adulthood. More recent research had shown that more than half of
ASD patients present language below the level of ten years of age, when adults. When
comparing ASD versus AD patients with similar age and cognition, it is identified a

http://dx.doi.org/10.5772/54784
slight superiority in language skills in the AD patient group (Mawhood, Howlin, and
Rutter 2000; Howlin et al. 2004).
The restrictive repertoire of activities and interests do not change in intensity as long as time
passes, but certainly the type of interest do change during lifetime. Only few studies address
the restrictive repertoire of interests. According with Rutter and colleagues (1967), in a cohort
study, although some improvement was identified, all of patients with repetitive behaviors
during infancy continued presenting it 10 years later, with a trend to increasing frequency and
intensity of such symptoms (Rutter, Greenfeld, and Lockyer 1967). Subsequent research
showed that near of 90% of adolescents and adults with autism persisted with restrictive
repertoire of activities and interests (Seltzer et al. 2003; Howlin et al. 2004).
Another recurrent preoccupation in ASD follow up is regarding the Intellectual Quotient (IQ).
Although some studies revealed lifelong IQ stability, it seem to have a performance IQ decline
and a verbal IQ increase as time pass. In reality, there is a paucity of studies regarding IQ
changes lifelong in ASD patients. In patients with verbal and performance IQ above 70, these
changes seem to be less intense (Howlin et al. 2004).
Core symptom
Social deficits
In adolescence
In adulthood
Persistence of social deficits. A
Persistence of social deficits. A discrete improvement can
discrete improvement can occur
occur
Communication deficits Can improve, but some deficits
Can improve, but some deficits persists
persists
Restrict repetitive
Increase in frequency and
Persists in 90%. Uncommon concerns and complex
behavior
complexity
stereotypies can decrease. The focus of interests can vary
Table 1. How ASD core symptoms change during lifetime.
3.2. How ASD-associated symptoms change with time

There are few epidemiologic studies of the ASD-associated comorbidities changes as time pass.
Consequently, to date any estimate need to be taken with caution.
In general, the comorbidities found in classic autism are different from the identified in
Asperger patients, which is probably associated with cognition. As a result, classic autism is
more associated to violent behavior, and psychosis. By the other side, Asperger disorder can
be more linked to anxiety and/or depression.
The more prevalent psychiatric diagnosis in ASD patients is depression that seems to become
more intense with age and frequently associated with anxiety (Howlin, Mawhood, and Rutter
2000). In our experience, the dyad depression/anxiety is more frequent in intelligencepreserved ASD patients, such as those with Asperger disorder. Additionally, anxiety seems to
increase in stress situations and also during lifetime (Gottfried and Riesgo 2011). Because of
their ability to identify their own difficulties (Cederlund, Hagberg, and Gillberg 2010), patients
with Asperger are more prone to became depressed.
637
638
The second more frequent psychiatric disorder in ASD patients is probably bipolar disorder
(Howlin, Mawhood, and Rutter 2000). Young ASD children experience more difficulties in
mood stabilization. In addition, moods changes occur more rapidly in children when com
pared with adults. As a result, in very young ASD children the humor can change almost
instantaneously.
The prevalence of bipolar disorders as a whole can reach up to 33% in ASD patients (Abramson
et al. 1992). Obsessive and compulsive symptoms are frequently identified in ASD, although
is difficult to distinguish the pure obsessive-compulsive disorder from bizarre concerns
common in patients with autism (Howlin, Mawhood, and Rutter 2000).
Adults with Asperger disorder can experience occasional episodes of psychosis, such as
persecutory ideas, auditory hallucinations, paranoid idea or delusional thoughts. But schizo
phrenia is not common and must remain as a differential diagnosis (Howlin, Mawhood, and
Rutter 2000). The abovementioned episodes of psychosis can be identified in up to 15% of
Asperger patients after adolescence (Hofvander et al. 2009).
Hyperactivity is a frequent symptom in children with ASD, is more prevalent in boys than in
girls, and can decrease as time passes. Although the concomitant aggressiveness itself usually
decrease with aging, the consequences of aggressiveness can be worse with age increasing in
patients with autism because of their increase of muscle strength. An overlap between ADHD
and ASD is relatively common in childhood, but this association is rarely described in
manuscripts with ASD adults (Stahlberg et al. 2004).
3.3. Prognosis for ASD patients in adulthood
Although there are no doubts regarding a substantial improvement in the management of
autism in the last three decades, unfortunately even nowadays a minority of adults with autism
is able to work, to live independently, as well to develop appropriate social skills. Most of these
patients still live with their parents or other caregivers (Howlin et al. 2004).
It is known by far that the most important prognostic value is defined by the cognitive
functioning in childhood. In this sense, the clinical problem eventually is to access intelligence
in non-verbal ASD children. According with literature, children with autism and IQ above 70
had better global prognosis in adulthood (Howlin et al. 2004).
The ability to acquire functional language until the age of six years is also another prognostic
landmark (Howlin et al. 2004). Better language and more preserved cognition are the two
probably reasons to explain the best prognosis in Asperger disorder when compared with
classical forms of autism.
4. Psychopharmacological treatment of ASD patients

Since to date there is no specific medication developed to autism itself, the psychopharmaco
logic approach is addressed to some core symptoms, such as hyperactivity, anxiety, depres

http://dx.doi.org/10.5772/54784
sion, etc. Actually, medication is frequently required to decrease the noise surrounding
autism, including a wide range of maladaptive behaviors and/or associated problems
(Benvenuto et al. 2012). To our knowledge, psychopharmacotherapy can eventually improve
adhesion to non-medical treatment of ASD patients (Gottfried and Riesgo 2011).
In our experience, we usually identify 2-5 ASD associated symptoms and/or diagnosis,
including epilepsy. We have found disruptive behavior more frequently in ASD patients with
cognitive impairment, as well as symptoms related with depression and/or anxiety in pre
served intelligence ASD children (Gottfried and Riesgo 2011). Other related symptoms are:
aggression, self-injury, impulsivity, decreased attention, anxiety, depression, and sleep
disruption, among others.
Because ASD are chronic and markedly impairing situations in many cases, there is justifiably
a high desire for effective treatments. By the other side, it is important to mention that there is
a paucity of well conducted evidence-based studies of medications used in ASD patients. Not
infrequently, this desire leads to premature enthusiasm for agents and interventions that
appear promising in early reports but later do not withstand the rigor of randomized controlled
trial (RTC).
Another critical issue is the co-occurrence of epilepsy in ASD patients which is almost twenty
times more frequent when ASD patients are compared with children with typical develop
ment. The management of combined epilepsy can represent a challenge for clinicians. Several
anti-epileptic drugs can determine an exacerbation of behavioral symptoms, and some
psychotropic medications used in ASD patients may lower the seizure threshold (Benvenuto
et al. 2012). In our experience, risperidone can be safely used up to 3mg/Kg/day, and higher
doses can lead to seizures in susceptible patients. That is the reason why we prefer to perform
an electroencephalogram before using psychoactive drugs in ASD children (Gottfried and
Riesgo 2011). Therefore, its mandatory to search a treatment strategy with the minor negative
impact on this subgroup of patients
It should be noted that most psychotropic use in ASD is actually off-label, as currently
there are only two medications approved for use in ASD children by the FDA (Food and
Drug Administration). These drugs are risperidone and aripiprazole, which are effective
to associated behaviors, but not to autism itself. The general principles for the pharmaco
therapy in ASD are similar to the used in other neuropsychiatric conditions (Weinssman
and Bridgemohan 2012).
In summary, the use of psychotropic medications, alone or in combination, should follow some
guidelines, such as: be focused on specific targets, be used at the minimum effective dosage,
as well as be used for short period of time (Benvenuto et al. 2012). Ideally, medications should
be initiated only after behavioral and educational interventions are in place.
4.1. Disruptive behaviors
Disruptive behaviors in ASD children may include irritability, aggression, explosive outbursts
(tantrums), and/or self-injury. These symptoms can be identified in almost two thirds of ASD
patients and certainly have the biggest impact on the care of affected individuals, as well as
639
640
marked distress for their families (Benvenuto et al. 2012; Kanne and Mazurek 2011). Although
behavioral and environmental approaches are recommended as the initial treatment, more
severe or even dangerous behaviors usually result in requests for urgent pharmacologic
intervention (Kaplan and McCracken 2012; Weinssman and Bridgemohan 2012). In our
experience, this type of symptoms is more frequently found in intelligence disabled ASD
patients (Gottfried and Riesgo 2011).
In the past, conventional neuroleptic agents such as haloperidol have been used in disruptive
behaviors of autistic patients (Benvenuto et al. 2012; Miral et al. 2008; Kaplan and McCracken
2012). Our group showed that risperidone is superior when compared with haloperidol in one
experimental research using hippocampal cells (Quincozes-Santos et al. 2010). Additionally,
in the clinical research, at least one study proved that risperidone is more effective than
haloperidol in ASD patients (Miral et al. 2008). There are two RTC suggesting that haloperidol
is effective in disruptive behaviors of ASD children (Campbell et al. 1982; Miral et al. 2008),
but sedation and other side effects including dyskinesia and extrapyramidal symptoms limits
its use (Weinssman and Bridgemohan 2012).
As a result, to date atypical antipsychotic seem to be more helpful in treatment of disruptive
behaviors. Currently, risperidone and aripiprazole are the only second-generation antipsy
chotic drugs that have shown to decrease disruptive behaviors in large-scale, controlled,
double-blind studies (Benvenuto et al. 2012; Kaplan and McCracken 2012; Weinssman and
Bridgemohan 2012).
Before the approval by FDA in 2006, risperidone was carefully studied by the NIMH Research
Units on Pediatric Psychopharmacology (RUPP) Autism Network. A multiphasic trial
comparing risperidone with placebo was performed by RUPP for the treatment of aggressive
behaviors in patients aged 5 to 17 years with ASD. There was an initial double-blind, 8-week
RCT study (McCracken et al. 2002).
The studies found that risperidone, in mean doses of 2,08mg/d, was effective for reducing
moderate to severe tantrums, aggression, and self-injurious behavior in children with autism.
There wasnt evidence of side effects such as dyskinesia or dystonia. However, the observed
weight gain of 5,6kg for the risperidone group was more than twice the expected weight gain
over a 6-month period (McCracken et al. 2002; Kaplan and McCracken 2012).
Risperidone was approved by the FDA in 2006 for the treatment of disruptive symptoms in
children and adolescents aged from 5 to 16 years with autism, with a maximum recommended
dose of 3 mg/d. In our experience, risperidone was initially used in dose up to 6 mg/d. As time
pass, we noted that if no response was obtained with 3mg/d, no more increments were useful.
Coincidentally, this daily regimen seems to be the seizure threshold in susceptible patients
(Gottfried and Riesgo 2011).
Aripiprazole was approved by the FDA for the treatment of disruptive behavior in ASD
patients aged 6 to 17 years in 2009. Two large controlled studies documented the short-term
efficacy of aripiprazole at 5, 10 or 15 mg/d for severe aggression and irritability in young
subjects with autistic disorder. The most commonly reported adverse events were drowsiness
and weight gain, with extrapyramidal symptoms mostly in the fixed-dose study, but these

http://dx.doi.org/10.5772/54784
events rarely led to treatment discontinuation (Marcus et al. 2009; Owen et al. 2009). Aripi
prazole dosing and response can vary considerably; the usual recommended clinical dose for
maintenance is between 5 and 15 mg/d (Kaplan and McCracken 2012).
Other atypical antipsychotics lack large-scale controlled studies. Small open-label reports
suggest variable benefits of olanzapine (Potenza et al. 1999), clozapine (Beherec et al. 2011),
and ziprasidone (Malone et al. 2007), which have possible support, versus quetiapine, which
has not appeared to be beneficial. Other medications of different classes have been used, such
as alpha-2 agonists, mood stabilizers, beta blockers, SSRI (selective serotonin reuptake
inhibitors), all of them without evidence-based studies of efficacy in disruptive behavior to
date (Weinssman and Bridgemohan 2012).
Probably due the co-occurrence of epilepsy in ASD, the use of some antiepileptic drugs has
been used in the management of maladaptive behaviors (Gottfried and Riesgo 2011). Dival
proex sodium has been demonstrated to be efficient not only in decreasing irritability/
aggression, but also in improving of repetitive behaviors, social relatedness and mood
instability (Hollander et al. 2006; Hollander et al. 2010).
Adjunctive topiramate therapies can decrease irritability, hyperactivity and inattention
(Hardan, Jou, and Handen 2004; Mazzone and Ruta 2006). Moreover, the combination of
topiramate with risperidone has been proved superior to risperidone monotherapy in
reducing irritability and severe disruptive symptoms (Rezaei et al. 2010). In our experience,
this specific combination would be helpful in preventing or at least decreasing the weight gain
due to risperidone usage in ASD patients.
Although preliminary data of open-label studies showed that levetiracetam may reduce
hyperactivity, impulsivity, mood instability and aggression in autistic children, a RCT suggest
that levetiracetam does not improve behavioral disturbances of ASD (Weinssman and
Bridgemohan 2012), as well lamotrigine (Belsito et al. 2001).
4.2. Hyperactivity and inattention symptoms
These symptoms are frequently identified in ASD patients. Inattention, hyperactivity and
impulsivity may be related to comorbid ADHD (attention deficit hyperactivity disorder) and/
or to baseline anxiety of these children (Murray 2010; Rommelse et al. 2010; Benvenuto et al.
2012) Weinssman & Bridgemohan, 2012). It is known that children with ASD and ADHD have
more clinical impairments than children with ASD alone (Gadow, DeVincent, and Pomeroy
2006; Kaplan and McCracken 2012).
The potentially useful drugs for inattention and hyperactivity in ASD could be stimulants,
alpha-2 adrenergic agonists, atypical antipsychotics as well as anticonvulsant mood stabilizers.
To date, there is strong evidence that both stimulants and risperidone are effective for
hyperactivity. If the inattention and/or hyperactivity behaviors are due to anxiety, SSRI may
be a useful choice (Weinssman and Bridgemohan 2012).
Psychoestimulants and other medications used in typically developing children with
ADHD have been evaluated as a therapeutic option for treatment of ADHD symptoms
641
642
in patients with ASD. The largest trial undertaken by RUPP Autism Network has dem
onstrated that methylphenidate (MPH) was reasonably efficacious in patient with both
ASD and ADHD (RUPP 2005). Convergent evidence from different studies confirms a
positive effect on social behaviors (joint attention, response to bids for joint attention,
self-regulation, and regulated affective sate), hyperactivity, inattention and impulsiveness
(Di Martino et al. 2004; Jahromi et al. 2009). However, response rate to MPH is lower in
ASD children compared with children with ADHD without ASD (Weinssman and
Bridgemohan 2012). In ASD children, MPH should be started at the lowest dosage ant ti
trated slowly because of these patients are more prone to experience side effects.
As the same observed with MPH, atomoxetine has initially demonstrated a lower efficacy in
ASD patients with ADHD than in ADHD children without autism (Posey et al. 2007; Charnsil
2011). Nevertheless, more recent studies showed significant reductions in ADHD symptoms
in high-functioning ASD boys (Zeiner, Gjevik, and Weidle 2011).
Regarding the use of antipsychotic drugs in inattentive/hyperactive ASD patients, secondary
analyses from large RTCs demonstrated that risperidone and aripiprazole are associated with
large reduction of hyperactivity in children with ASD (McCracken et al. 2002; Owen et al.
2009; Weinssman and Bridgemohan 2012).
Despite the small number of RCT, another option is the use of alpha-2 agonists drugs in
ASD children with inattention, hyperactivity, and impulsivity. The use of guanfacine in
autistic children has showed modest improvement in the domains of hyperactivity, inat
tention, insomnia, and tics (Scahill et al. 2006; Handen, Sahl, and Hardan 2008; Weinss
man and Bridgemohan 2012). Clonidine is effective in reducing sleep disorders of
children with ASD, with a consequent daily improvement of attention deficits, hyperac
tivity, mood instability and aggressiveness (Jaselskis et al. 1992; Ming et al. 2008). How
ever, only two RCT have been conducted for this class of agent (Weinssman and
Bridgemohan 2012).
4.3. Stereotypy and repetitive behaviors
One of the core symptoms in ASD children is perseverative or repetitive behaviors usually
associated with difficulties in change interests, which can interfere in the quality of life of
patients and parents. Stereotypies and repetitive behaviors are not unique to ASD and can be
found in other developmental disorders, although clinicians and researchers agree that these
tend to be more frequent in ASD (Kaplan & McCracken, 2012; Leekam et al., 2011). By the other
hand, difficulties in changing interests, in the context of a developmental disorder, is one of
the hallmarks of autism.
Before use of medication, behavioral therapies should be performed. In our experience, poor
cognitive performance can be one of the limitations to behavioral therapy. If the child is
mentally disabled, the non-medical approach can be unsuccessful. In this situation, when these
symptoms are intense enough to cause impairments to academic performance and/or inter
personal relationships, pharmacologic treatment is often considered.

http://dx.doi.org/10.5772/54784
Because of the similarity of this cluster of autistic symptoms to anxiety as well as other
serotonin-related disorders such as obsessive compulsive disorder has led clinicians to use and
researchers to investigate the efficacy of SSRI in the treatment of repetitive behaviors and
rigidity. Other possibilities in terms of medication include clomipramine, atypical antipsy
chotics and valproate (Weinssman & Bridgemohan, 2012).
To date, although the lack of high quality evidence that SSRI are effective to stereotypy and
repetitive behaviors, we still use this class of medication in clinical practice. In a meta-analysis
of published trials with different classes of antidepressants, including SSRI and tricyclic
antidepressants, the small benefit of these drugs on repetitive behavior disappeared after
statistical adjustment (Carrasco et al., 2012).
Other types of SSRI were tested in ASD children with stereotypy and repetitive behaviors, for
example: fluvoxamine, sertraline, paroxetine, citalopram and escitalopram. There is one
unpublished trial of fluvoxamine, which was poorly tolerated by children (McDougle et al.,
1996). There are no RCT of sertraline and paroxetine in ASD children (Weinssman & Bridge
mohan, 2012). The largest published trial of citalopram (mean dose 16mg/d) found no effect
at all on repetitive or compulsive behavior but found a possible effect on challenging behaviors
(King et al., 2009). Others RCT didnt show strengths of evidence for effect of citalopram or
escitalopram to reduce repetitive or challenging behavior (McPheeters et al., 2011).
Concerning antipsychotic drugs, in the RUPP studies, stereotypies and repetitive behaviors
were examined as secondary outcomes and then risperidone achieved levels of statistical
significance in reduction of repetitive behavior (McDougle et al., 2005). Similarly, aripiprazole
studies showed that the agent significantly improved repetitive behaviors over placebo
(Marcus et al., 2009; Owen et al., 2009).
There is only one small RCT which shows the efficacy of valproate in repetitive behaviors of
ASD children (Hollander et al., 2006). Our group avoids the usage of valproate in such
symptoms. In summary, from the clinical point of view, it is hard to improve stereotypy and
repetitive behaviors with pharmacotherapy. As a matter of fact, sometimes these symptoms
can be more uncomfortable to parents than patients.
4.4. Mood instability
In clinical practice, mood instability is more difficult to control in ASD patients compared with
typically developed children (Gottfried & Riesgo, 2011). Different drugs have been used,
including antipsychotics, SSRI, and lithium. The problem is that none of these medications
have been studied with RCT specifically for mood regulation in ASD pediatric patients
(Weinssman & Bridgemohan, 2012).
If mood lability is associated with disruptive behavior, the best choice could be atypical
antipsychotics. If this symptom is associated with depression and or anxiety, the use of
SSRI could be considered. It is important to remember the higher possibilities of behavio
ral activation in ASD patients after SSRI use, leading to hypomaniac states in susceptible
children.
643
644
4.5. Sleep disorders

Sleep disorders can be identified years before an unequivocal diagnosis of autism. Not
infrequently, we face with sleep complaints in very young babies who lately will develop the
whole clinical picture compatible with ASD. By the other hand, sleep disorders occur more
frequently in ASD patients compared with developing children (Benvenuto et al., 2012; Miano
& Ferri, 2010).
Sleep disorders tend to be under-recognized valued in the ASD patient group, probably
because they can be considered less disabling than aggression and repetitive behaviors;
however, ongoing abnormal sleep patterns are very disruptive to the overall quality of family
life and interfere with patient daytime functioning. Parents frequently ask for medication and
then physicians are confronted with the lack of FAD-approved treatments for this problem
(Kaplan & McCracken, 2012; Weinssman & Bridgemohan, 2012).
Before use of medication, is important to ensure appropriate sleep hygiene as well as to use
behavioral intervention. Pharmacology is recommended only when psychosocial treatments
fail. Melatonin administration in ASDs is reported to be safe, well tolerated and efficient in
improving sleep parameters and daytime behavior, and in decreasing of parental stress
(Malow et al., 2011; Rossignol & Frye, 2011).
Core symptoms
Medications
Level of evidence
Aggressiveness
Risperidone*
Large scale double blind RCT
Irritability
Aripiprazole*
Large scale double blind RCT
elf-injury
Olanzapine
Double blind RCT
Other disruptive behaviors
Clozapine
Small open label reports
Ziprazidone
Valproic acid
RCT
Topiramate
RCT
Hyperactivity
Metilfenidate
Crossover RCT
Inattention
Atomoxetine
Crossover RCT
Risperidone*
Large scale double blind RCT**
Aripiprazole*
Guanfacine
RCT
Clonidine
Repetitive behavior
Risperidone*
Stereotypies
Aripiprazole*
Fluoxetine
RCT
Valproic acid
RCT
Melatonin
RCT
Sleep disorders
*FDA-approved medications for ASD children; **Secondary analysis; RCT = randomized controlled trials
Table 2. Psychopharmacological treatment in ASD patients

http://dx.doi.org/10.5772/54784
5. Non-medical treatment of ASD patients

The treatment of ASD evolves professionals coming from different area and usually is
characterized by comprehensive and intense programs encompassing both patients and
families. Early identification is critically important to ensure that families have the op
portunity to reap the many unique benefits that may arise from early intervention ef
forts. For example, intervention efforts that occur early during a childs development
may have the advantage of increasing brain plasticity, which may enhance outcomes
(LeBlanc & Gillis, 2012).
In our experience, children with low intensity ASD treats, when early-treated can eventually
get out from de ASD diagnosis when accessed by CARS, a rating scale of autism symptoms
(Gottfried & Riesgo, 2011).
The non-medical intervention programs are directed to the core social, communication and
cognitive issues in autism. The objectives of each one program are selected according with the
specific abilities and difficulties as well as the actual neurodevelopmental phase of the ASD
patient. As a result, this kind of intervention needs to be customized (Dawson & Burner,
2011; LeBlanc & Gillis, 2012).
In general, the following types of therapy can be used both isolate or in different combi
nations: behavioral, occupational, speech therapy as well as psychopedagogic therapy.
Although the non-medical treatments for ASD patients can be different from each other,
they usually had the same goals, such as to give the child the best degree of independ
ent functioning as well as to improve quality of life from the patient and family (Myers
& Johnson, 2007).
There is a consensus that facing a suspicious case of ASD in children the treatment must be
promptly initiated, independently of the type of non-medical treatment, because of the brain
plasticity in the developing child (LeBlanc & Gillis, 2012; Lord & McGee, 2001).
Besides the large number of non-medical type of treatment, there are some of them with good
level of evidence. According with the National Autism Centers Standard Report, after a
systematic review of literature available from 1957 to 2007, at least 11 treatment methods for
ASD were considered with good level of evidence.
Additionally, there are some problems in evaluating the efficacy of non-medical treatments in
ASD patients. For example, the small sample sizes, the different methodologies, the difficulty
in the outcome measures, etc.
5.1. Behavioral treatment
The therapies involving behavioral and educational strategies are the main components of the
non-medical treatments of ASD children. The only psychoeducational treatment that meets
the criteria as well-established and efficacious intervention for ASD to date is the behavior
treatment (Dawson & Burner, 2011; LeBlanc & Gillis, 2012).
645
646
There is consensual that behavioral therapy must be intensive with at least 25 hours per
week, all year long. There are two main types of behavioral treatments: interventionists
and non-interventionists. Among the first group of available therapies, there are three
principal methods: a) Applied Behavior Analysis (ABA); b) Treatment and Educational of
Autistic and related Communication-handicapped Children (TEACCH); c) developmen
tal/relationship-based therapy (Floortime). Some of these strategies use combinations of
different models and are denominated integrative models. To date, there is no evidence
that integrative models are better than the original models (Weinssman & Bridgemohan,
2012). By the other side, one example of non-interventionist behavioral therapy is the
Picture Exchange Charts System (PECS).
5.1.1. ABA (Applied Behavior Analysis)
Aims to teach the absent child skills through the introduction of these skills in stages. Usually,
each one of the skills is individually showed, presenting it coupled with an indication or
instruction. When necessary, any support that is offered should be removed as soon as
possible. (Ospina et al., 2008; Warren et al., 2011). In the clinical setting, we have identified
problems in terms of improvement from the classroom as well as a trend to overestimate the
efficacy of ABA.
5.1.2. Treatment and Educational of Autistic and related Communication-handicapped Children
(TEACCH)
Use structured activities and environment to help ASD patients to improve compromised area.
The model is adapted to each one child and addresses environment organization as well as
predicable routines in order to adapt the environment to make it easier for the child to
understand it, and understand what is expected of her. TEACCH programs are usually given
in a classroom, but can also be made at home. Parents work with professionals as co-therapists
for techniques that can be continued at home. It is used by psychologists, special education
teachers, speech therapists and trained professionals (Myers & Johnson, 2007).
5.1.3. Floortime
The main objective is to teach fundamental skills expected to the level of development which
were not acquired in a given ASD patient age, but to date the efficacy evidences are still
inconclusive (Ospina et al., 2008). Our group is conducting an evidence-based research to find
out if this treatment is reliable.
5.1.4. Picture Exchange Communication System (PECS)
This non-interventionist behavioral therapy enables non-verbal children to communicate
by using figures. PECS can be used at home, in the classroom or in several others envi
ronments (Bondy & Frost, 2001). A meta-analysis showed that PECS is a promising inter
vention (Ganz et al., 2012).

http://dx.doi.org/10.5772/54784
Psychoeducational
Example
treatments
ABA*
TEACCH
Interventional Models
Denver model
Floortime
Specific behaviors
another
Well established
PECS
Promising results
Social skills instruction
Parental role
Well established
Insufficient evidence to recommend one over
Focal behavior intervention
Communication
Integrative Models
Effectiveness
Promising results
Focal behavior intervention
Insufficient evidence to recommend one over

another
Parent-mediated intervention
Inconsistent results
programs
Small size studies
Sensory integration therapy

Occupational therapy
Inconsistent results
Little research
*Suggested by Autism Center Guidelines

Table 3. psychoeducational treatment of ASD patients
5.2. Complementary and alternative therapies

Complementary and alternative medicine (CAM) encompasses different kinds of medical and
healthcare systems, practices, and products usually not considered to be a part of the conven
tional medicine. There are several proposed CAM systems to treat ASD children, but to date
still without recognized efficacy by FDA. As a result, they are considered off label. Interest
ingly, more than 70% of ASD patients are treated by CAM (Rossignol, 2009).
It is important to note that the definition of CAM is slightly different when used in ASD when
compared with other medical disorders. That difference is due the fact of many of the psy
choeducational therapies used in ASD children, although not considered conventional medical
therapies; they are well accepted methods treating this group of patients.
In terms of scientific support, there are three main groups of CAM: a) promising treatments;
b) treatments with some degree of scientific evidence; c) treatments with no scientific proved
efficacy to date (Rossignol, 2009).
5.2.1. Promising CAM
These types of treatment showed the highest level of evidence and include music therapy,
naltrexone, and acetyl-cholinesterase inhibitors (Rossignol, 2009). Concerning music therapy,
there is evidence that it is able to improve social interaction as well as communication skills
(Gold et al., 2006; Kim et al., 2008). Our group conducted a RCT using music therapy in ASD
patients and we identified the promising effect of this treatment (Gattino et al., 2011). There is
647
648
a comprehensive RCT been done testing the efficacy of music therapy in ASD patients
(Geretsegger et al., 2012).
5.2.2. CAM with little evidence
This group of therapies may include the use of carnitine, ocytocin, vitamin C, tetrahydrobiop
terin, adrenergic alfa-2 agonists, hyperbaric oxygen therapy, immune-modulatory treatment,
and anti-inflammatory treatment (Rossignol 2009). Caution is needed with the hyperbaric
oxygen therapy because of the potential adverse effects, such as barotrauma, reversible
myopia, oxygen toxicity, and seizures (Weinssman & Bridgemohan, 2012).
5.2.3. CAM with no proved efficacy to date
Several of the proposed CAM for ASD had no proved efficacy to date, for example: use of
carnosine, multi-vitamin and mineral complexes, piracetam, omega-3 fatty acids, selective
diets, vitamin B6, magnesium, chelation, cyproheptadine, glutamate antagonists, acupunc
ture, auditory integration training, massage, neuro-feedback, and others (Rossignol, 2009).
6. Clinical recommendations in ASD

The following clinical recommendations can be done as a result of more than twenty years of
personal clinical practice in Child Neurology dealing with ASD children, among other
neuropediatric situations. For instance, our Child Neurology Unit (http://www.ufrgs.br/
neuropediatria) usually makes more than 16,000 neuropediatric evaluations per year.
From the clinical point of view, it is important to remember the ongoing changes in DSM
criteria for ASD diagnosis. To date, we still deal with five different diagnosis of autism,
according with DSM-IV criteria. Even after modifications due the new DSM-V classification,
ASD children will remain as a heterogeneous group, making difficult the exact clinical
diagnosis.
It is important to remember that ASD diagnosis can be catastrophic to parents. As a result, an
incorrect diagnosis would be even worse. That is the reason to be careful in terms of making
ASD diagnosis as well as to make a double check if diagnosis is really correct.
After finishing a list of the prominent symptoms, the next step is to decide if they are intense
enough to deserve treatment, which is not easy. Some symptoms seem to be more unpleasant
to parents than the ASD child. At this point, there is no guideline to follow, and the previous
clinical experience is extremely helpful.
Usually the non-medical treatment is started earlier than the use of medications. It is important
to remember the relevance of evidence-based CAM, since there are a great number of proposed
non-medical treatments.
In general, medications are used in addition to non-medical treatments. The best medica
tion approach would be monotherapy, but it is not always possible in the real clinical

http://dx.doi.org/10.5772/54784
world. Another critical problem in terms of psychopharmacotherapy is the paucity of

well-conducted RCT, as pointed before in this chapter, especially in the table 2. To date,
there are only two FDA-approved antipsychotic medications for ASD in children: risperi
done and aripiprazole.
Risperidone was approved by FDA in 2006. The usual dose varies from 1 to 3mg/day. In our
practice, 3mg/day of risperidone seems to be the cutoff dose in terms of seizure susceptibility.
We have identified patients who experienced seizures with doses higher than 3mg/day.
Aripiprazole was FDA-approved in 2009 and the daily dose is up to 15mg.
Because of ASD patients are almost twenty times more prone to have epilepsy when compared
with normally developing children, and because of many of the drugs used in autism can
decrease the seizure threshold in susceptible children, it is important to assure that there is a
previous normal EEG before prescribing psychopharmacotherapy.
7. Conclusions and future remarks

The clinical approach includes a general management as well as two types of not excluding
treatment strategies: one with medication and another without medication. From the clinical
point of view, these two types of treatment are, in fact, complementary.
In the clinical practice, numerous types of treatment have been proposed and there is ur
gent need to choose any one of them in short period of time. Searching literature, a lack
of well conducted RCT was identified. As a result, caution is the best form to approach
ASD cases.
Future perspectives in the treatment of ASD probably will include immunomodulation,
quantic biochemistry, stem cell therapy and other forms of approach after careful RCT attesting
its efficiency.
Author details
Rudimar Riesgo1,2, Carmem Gottfried1,3 and Michele Becker1,2
1 Translational Research Group in Autism, (UFRGS) Federal University of Rio Grande do
Sul, Porto Alegre, RS, Brazil
2 Child Neurology Unit, HCPA (Clinical Hospital of Porto Alegre), UFRGS, Porto Alegre,
RS, Brazil
3 Neuroglial Plasticity Laboratory, Department of Biochemistry, Postgraduate Program of
Biochemistry, Institute of Basic Health Sciences, UFRGS, Porto Alegre, RS, Brazil
649
650
References
[1] Abramson, R. K.,Wright, H.H., Cuccaro, M.L., Lawrence, L.G., Babb, S., Pencarinha, D.,
Marstelle, F., & Harris, E.C. 1992. Biological liability in families with autism. Journal of
the American Academy of Child and Adolescent Psychiatry, 31, 2, pp. 370-1.
[2] Arora, M., Praharaj, S.K., Sarkhel, S., & Sinha, V.K. 2011. Asperger disorder in adults.
Southern Medical Journal, 104, 4, pp. 264-8.
[3] Association, American Psychiatric, ed. 2002. Manual Diagnstico e Estatstico de
Transtornos Mentais: DSM-IV-TR. Artmed, Porto Alegre.
[4] Becker, M. M., Wagner, M.B., Bosa, C.A., Schmidt, C., Longo, D., Papaleo, C., & Riesgo,
R.S. 2012. Translation and validation of Autism Diagnostic Interview-Revised (ADI-R)
for autism diagnosis in Brazil. Arquivos de Neuro-Psiquiatria, 70, 3, pp. 185-90.
[5] Beherec, L., Lambrey, S., Quilici, G., Rosier, A., Falissard, B., & Guillin, O. 2011.
Retrospective review of clozapine in the treatment of patients with autism spectrum
disorder and severe disruptive behaviors. Journal of Clinical Psychopharmacology, 31,
3, pp. 341-4.
[6] Belsito, K. M., Law, P.A., Kirk, K.S., Landa, R.J., & Zimmerman, A.W. 2001. Lamotrigine
therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial.
Journal of Autism and Developmental Disorders, 31, 2, pp. 175-81.
[7] Benvenuto, A., Battan, B., Porfirio, M.C., & Curatolo, P. 2012. Pharmacotherapy of
autism spectrum disorders. Brain & Development, http://dx.doi.org/10.1016/j.brain
dev.2012.03.015.
[8] Billstedt, E., Gillberg, I.C., & Gillberg, C. 2005. Autism after adolescence: populationbased 13- to 22-year follow-up study of 120 individuals with autism diagnosed in
childhood. Journal of Autism and Developmental Disorders, 35, 3, pp. 351-60.
[9] Bondy, A., & Frost, L. 2001. The Picture Exchange Communication System. Behavior
Modification, 25, 5, pp. 725-44.
[10] Campbell, M., Anderson, L.T., Small, A.M., Perry, R., Green,W.H., & Caplan, R. 1982.
The effects of haloperidol on learning and behavior in autistic children. Journal of
Autism and Developmental Disorders, 12, 2, pp. 167-75.
[11] Carrasco, M.,Volkmar, F.R., & Bloch, M.H. 2012. Pharmacologic treatment of repetitive
behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics, 129,
5, pp. e1301-10.
[12] Cederlund, M., Hagberg, B., & Gillberg, C. 2010. Asperger syndrome in adolescent and
young adult males. Interview, self- and parent assessment of social, emotional, and
cognitive problems. Research in Developmental Disabilities, 31, 2, pp. 287-98.

http://dx.doi.org/10.5772/54784
[13] Center, National Autism. 2009. The National Autism Center's National Standards
Report [cited 08/23/2012. Available from www.nationalautismcenter.org/pdf/NAC
%20Standards%20Report.pdf
[14] Charnsil, C. 2011. Efficacy of atomoxetine in children with severe autistic disorders and
symptoms of ADHD: an open-label study. Journal of Attention Disorders, 15, 8, pp.
684-9
[15] Dawson, G., & Burner, K. 2011. Behavioral interventions in children and adolescents
with autism spectrum disorder: a review of recent findings. Current Opinion in
Pediatrics, 23, 6, pp. 616-20.
[16] Di Martino, A., Melis, G., Cianchetti, C., & Zuddas, A. 2004. Methylphenidate for
pervasive developmental disorders: safety and efficacy of acute single dose test and
ongoing therapy: an open-pilot study. Journal of Child and Adolescent Psychophar
macology, 14, 2, pp. 207-18.
[17] Gadia, C. A., Tuchman, R., & Rotta, N. T. 2004. Autism and pervasive developmental
disorders. Jornal de Pediatria (Rio J), 80, 2, pp. S83-94.
[18] Gadow, K. D., DeVincent, C. J., & Pomeroy, J. 2006. ADHD symptom subtypes in
children with pervasive developmental disorder. Journal of Autism and Developmen
tal Disorders, 36, 2, pp. 271-83.
[19] Ganz, J. B., Davis, J.L., Lund, E.M., Goodwyn, F.D., & Simpson, R.L. 2012. Meta-analysis
of PECS with individuals with ASD: investigation of targeted versus non-targeted
outcomes, participant characteristics, and implementation phase. Research in Devel
opmental Disabilities, 33, 2, pp. 406-18.
[20] Gattino, G., Riesgo, R., Longo, D., Leite, J.L., & Faccini, L.S. 2011. Effect of relational
music therapy of communication of children with autism: a randomized controlled
study. Nordic Journal of Music Therapy, 20, 2, pp.142-154.
[21] Geretsegger, M., Holck, U., & Gold, C. 2012. Randomised controlled trial of improvi
sational music therapy's effectiveness for children with autism spectrum disorders
(TIME-A): study protocol. BMC Pediatrics, 5, 12, pp. 2.
[22] Gold, C., Wigram, T., & Elefant, C. 2006. Music therapy for autistic spectrum disorder.
Cochrane database of systematic reviews, 2, CD004381.
[23] Gottfried, C., & Riesgo, R. 2011. Antipsychotics in the treatment of autism. In Autism
spectrum disorders: from genes to environment, T. Williams, Intech: Rijeka. pp.23-46
[24] Handen, B.L., Sahl, R., & Hardan, A.Y. 2008. Guanfacine in children with autism
and/or intellectual disabilities. Journal of Developmental and Behavioral Pediatrics, 29,
4, pp. 303-8.
[25] Hardan, A.Y., Jou, R.J., & Handen, B.L. 2004. A retrospective assessment of topiramate
in children and adolescents with pervasive developmental disorders. Journal of Child
and Adolescent Psychopharmacology, 14, 3, pp. 426-32.
651
652
[26] Hofvander, B., Delorme, R., Chaste, P., Nyden, A., Wentz, E., Stahlberg, O., Herbrecht,
E., Stopin, A., Anckarsater, H., Gillberg, C., Rastam, M., & Leboyer, M. 2009. Psychiatric
and psychosocial problems in adults with normal-intelligence autism spectrum
disorders. BMC Psychiatry, 9, pp. 35.
[27] Hollander, E., Chaplin, W., Soorya, L., Wasserman, S., Novotny, S., Rusoff, J., Feirsen,
N., Pepa, L., & Anagnostou, E. 2010. Divalproex sodium vs placebo for the treatment
of irritability in children and adolescents with autism spectrum disorders. Neuropsy
chopharmacology : official publication of the American College of Neuropsychophar
macology, 35, 4, pp. 990-8.
[28] Hollander, E., Soorya, L.,Wasserman, S., Esposito, K., Chaplin, W., & Anagnostou, E.
2006. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism
spectrum disorder. The international journal of neuropsychopharmacology / official
scientific journal of the Collegium Internationale Neuropsychopharmacologicum, 9, 2,
pp. 209-13.
[29] Howlin, P., Goode, S., Hutton, J., & Rutter, M. 2004. Adult outcome for children with
autism. Journal of child psychology and psychiatry, and allied disciplines, 45, 2, pp.
212-29.
[30] Howlin, P., Mawhood, L., & Rutter, M. 2000. Autism and developmental receptive
language disorder--a follow-up comparison in early adult life. II: Social, behavioural,
and psychiatric outcomes. Journal of child psychology and psychiatry, and allied
disciplines, 41,5, pp. 561-78.
[31] Jahromi, L.B., Kasari, C.L., McCracken, J.T., Lee, L.S., Aman, M.G., McDougle, C.J.,
Scahill, L., Tierney, E., Arnold, L.E., Vitiello, B., Ritz, L., Witwer, A., Kustan, E.,
Ghuman, J., & Posey, D.J. 2009. Positive effects of methylphenidate on social commu
nication and self-regulation in children with pervasive developmental disorders and
hyperactivity. Journal of Autism and Developmental Disorders, 39, 3, pp. 395-404.
[32] Jaselskis, C.A., Cook, E.H., Fletcher, Jr., K.E., & Leventhal, B.L.1992. Clonidine treat
ment of hyperactive and impulsive children with autistic disorder. Journal of Clinical
Psychopharmacology, 12, 5, pp. 322-7.
[33] Kanne, S.M., & Mazurek, M.O. 2011. Aggression in children and adolescents with ASD:
prevalence and risk factors. Journal of Autism and Developmental Disorders, 41, 7, pp.
926-37.
[34] Kanner, L. 1943. Autistic disturbances of affective contact. Nervous Child, 2, pp.
217-250.
[35] Kaplan, G., & McCracken, J.T. 2012. Psychopharmacology of autism spectrum disor
ders. Pediatric Clinics of North America, 59, 1, pp. 175-87.
[36] Kim, J., Wigram, T., & Gold, C. 2008. The effects of improvisational music therapy on
joint attention behaviors in autistic children: a randomized controlled study. Journal
of Autism and Developmental Disorders, 38, 9, pp. 1758-66.

http://dx.doi.org/10.5772/54784
[37] Kim, Y.S., Leventhal, B.L., Koh,Y.J., Fombonne, E., Laska, E., Lim, E.C., Cheon, K.A.,
Kim, S.J., Kim, Y.K., Lee, H., Song, D.H., & Grinker, R.R. 2011. Prevalence of autism
spectrum disorders in a total population sample. The American Journal of Psychiatry,
168, 9, pp. 904-12.
[38] King, B.H., Hollander, E., Sikich, L., McCracken, J.T., Scahill, L., Bregman, J.D.,
Donnelly, C.L., Anagnostou, E., Dukes, K., Sullivan, L., Hirtz, D.,Wagner, A., & Ritz,
L. 2009. Lack of efficacy of citalopram in children with autism spectrum disorders and
high levels of repetitive behavior: citalopram ineffective in children with autism.
Archives of General Psychiatry, 66, 6, pp. 583-90.
[39] LeBlanc, L.A., & Gillis, J.M. 2012. Behavioral interventions for children with autism
spectrum disorders. Pediatric Clinics of North America, 59, 1, pp. 147-64.
[40] Leekam, S.R., Prior, M.R., & Uljarevic, M. 2011. Restricted and repetitive behaviors in
autism spectrum disorders: a review of research in the last decade. Psychological
Bulletin, 137, 4, pp. 562-93.
[41] Longo, D., Schuler-Faccini, L., Brandalize, A.P., Riesgo, R.S., & Bau, C.H. 2009. Influ
ence of the 5-HTTLPR polymorphism and environmental risk factors in a Brazilian
sample of patients with autism spectrum disorders. Brain Res, 1267, pp. 9-17.
[42] Lord, C., & McGee, J.P. eds. 2001. Educating children with autism. Washington, DC:
National Academy Press.
[43] Malone, R.P., Delaney, M.A., Hyman, S.B., & Cater, J.R. 2007. Ziprasidone in adoles
cents with autism: an open-label pilot study. Journal of Child and Adolescent Psycho
pharmacolog, 17, 6, pp. 779-90.
[44] Malow, B., Adkins, K.W., McGrew, S.G., Wang, L., Goldman, S.E., Fawkes, D., &
Burnette, C. 2011. Melatonin for sleep in children with autism: a controlled trial
examining dose, tolerability, and outcomes. Journal of Autism and Developmental
Disorders, 42, 8, pp. 1729-37.
[45] Marcus, R.N., Owen, R., Kamen, L., Manos, G., McQuade, R.D., Carson, W.H., & Aman,
M.G. 2009. A placebo-controlled, fixed-dose study of aripiprazole in children and
adolescents with irritability associated with autistic disorder. Journal of the American
Academy of Child and Adolescent Psychiatry, 48, 11, pp. 1110-9.
[46] Mawhood, L., Howlin, P., & Rutter, M. 2000. Autism and developmental receptive
language disorder--a comparative follow-up in early adult life. I: Cognitive and
language outcomes. Journal of child psychology and psychiatry, and allied disciplines,
41, 5, pp. 547-59.
[47] Mazzone, L., & Ruta, L. 2006. Topiramate in children with autistic spectrum disorders.
Brain & Development, 28, 10, pp. 668.
[48] McCracken, J.T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M.G., Arnold, L.E.,
Lindsay, R., Nash, P., Hollway, J., McDougle, C.J., Posey, D., Swiezy, N., Kohn, A.,
653
654
Scahill, L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E.,
Ghuman, J., Gonzalez, N.M., Grados, M.,Vitiello, B., Ritz, L., Davies, M., Robinson, J.,
& McMahon, D. 2002. Risperidone in children with autism and serious behavioral
problems. The New England Journal of Medicine, 347, 5, pp. 314-21.
[49] McDougle, C.J., Naylor, S.T., Cohen, D.J., Volkmar, F.R., Heninger, G.R., & Price, L.H.
1996. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic
disorder. Archives of General Psychiatry, 53, 11, pp. 1001-8.
[50] McDougle, C.J., Scahill, L., Aman, M.G., McCracken, J.T., Tierney, E., Davies, M.,
Arnold, L.E., Posey, D.J., Martin, A., Ghuman, J.K., Shah, B., Chuang, S.Z., Swiezy, N.B.,
Gonzalez, N.M., Hollway, J., Koenig, K., McGough, J.J., Ritz, L., &Vitiello, B. 2005.
Risperidone for the core symptom domains of autism: results from the study by the
autism network of the research units on pediatric psychopharmacology. The American
Journal of Psychiatry,62, 6, pp. 1142-8.
[51] McPheeters, M.L., Warren, Z., Sathe, N., Bruzek, J.L., Krishnaswami, S., Jerome, R.N.,
& Veenstra-Vanderweele,V. 2011. A systematic review of medical treatments for
children with autism spectrum disorders. Pediatrics, 127, 5, pp. e1312-21.
[52] Miano, S., & Ferri, R. 2010. Epidemiology and management of insomnia in children
with autistic spectrum disorders. Paediatric Drugs, 12, 2, pp. 75-84.
[53] Ming, X., Gordon, E., Kang, N., & Wagner, G.C. 2008. Use of clonidine in children with
autism spectrum disorders. Brain & Development, 30, 7, pp. 454-60.
[54] Miral, S., Gencer, O., Inal-Emiroglu, F.N., Baykara, B., Baykara, A., & Dirik, E. 2008.
Risperidone versus haloperidol in children and adolescents with AD : a randomized,
controlled, double-blind trial. European Child & Adolescent Psychiatry, 17, 1, pp. 1-8.
[55] Murray, M.J. 2010. Attention-deficit/Hyperactivity Disorder in the context of Autism
spectrum disorders. Current Psychiatry Reports, 12, 5, pp. 382-8.
[56] Myers, S. M., & Johnson, C.P. 2007. Management of children with autism spectrum
disorders. Pediatrics, 120, 5, pp. 1162-82.
[57] Nikolov, R., Jonker, J., & Scahill, L. 2006. Autistic disorder: current psychopharmaco
logical treatments and areas of interest for future developments. Revista Brasileira de
Psiquiatria, 28, Suppl 1, pp. S39-46.
[58] Ospina, M.B., Krebs Seida, J., Clark, B., Karkhaneh, M., Hartling, L., Tjosvold, L.,
Vandermeer, B., & Smith, V. 2008. Behavioural and developmental interventions for
autism spectrum disorder: a clinical systematic review. PloS one, 3,11, pp. e3755.
[59] Owen, R., Sikich, L., Marcus, R.N., Corey-Lisle, P., Manos, G., McQuade, R.D., Car
son,W.H., & Findling, R.L. 2009. Aripiprazole in the treatment of irritability in children
and adolescents with autistic disorder. Pediatrics, 124, 6, pp. 1533-40.

http://dx.doi.org/10.5772/54784
[60] Pereira, A., Riesgo, R.S., & Wagner, M.B. 2008. Childhood autism: translation and
validation of the Childhood Autism Rating Scale for use in Brazil. Jornal de Pediatria
(Rio J), 84, 6, pp. 487-94.
[61] Piven, J., Harper, J., Palmer, P., & Arndt, S. 1996. Course of behavioral change in autism:
a retrospective study of high-IQ adolescents and adults. Journal of the American
Academy of Child and Adolescent Psychiatry, 35, 4, pp. 523-9.
[62] Posey, D.J., Aman, M.G., McCracken, J.T., Scahill, L., Tierney, E., Arnold, L.E., Vitiello,
B., Chuang, S.Z., Davies, M., Ramadan,Y., Witwer, A.N., Swiezy, N.B., Cronin, P., Shah,
B., Carroll, D.H., Young, C., Wheeler, C., & McDougle, C.J. 2007. Positive effects of
methylphenidate on inattention and hyperactivity in pervasive developmental
disorders: an analysis of secondary measures. Biological Psychiatry, 61, 4, pp. 538-44.
[63] Potenza, M.N., Holmes, J.P., Kanes, S.J., & McDougle, C.J. 1999. Olanzapine treatment
of children, adolescents, and adults with pervasive developmental disorders: an openlabel pilot study. Journal of Clinical Psychopharmacology, 19,1, pp. 37-44.
[64] Quincozes-Santos, A., Bobermin, L.D., Tonial, R.P., Bambini-Junior, V., Riesgo, R., &
Gottfried, C. 2010. Effects of atypical (risperidone) and typical (haloperidol) antipsy
chotic agents on astroglial functions. European Archives of Psychiatry and Clinical
Neuroscience, 260, 6, pp. 475-81.
[65] Rezaei, V., Mohammadi, M.R., Ghanizadeh, A., Sahraian, A., Tabrizi, M., Rezazadeh,
S.A., & Akhondzadeh, S. 2010. Double-blind, placebo-controlled trial of risperidone
plus topiramate in children with autistic disorder. Progress in Neuro-Psychopharma
cology & Biological Psychiatry, 34, 7, pp. 1269-72.
[66] Rommelse, N.N., Franke, B.,Geurts, H.M., Hartman, C.A., & Buitelaar, J.K. 2010. Shared
heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder.
European Child & Adolescent Psychiatry, 19, 3, pp. 281-95.
[67] Rossignol, D.A. 2009. Novel and emerging treatments for autism spectrum disorders:
a systematic review. Annals of Clinical Psychiatry : official journal of the American
Academy of Clinical Psychiatrists, 21,4, pp. 213-36.
[68] Rossignol, D.A., & Frye, R.E. 2011. Melatonin in autism spectrum disorders: a system
atic review and meta-analysis. Developmental Medicine and Child Neurology, 53, 9,
pp. 783-92.
[69] RUPP. 2005. Randomized, controlled, crossover trial of methylphenidate in pervasive
developmental disorders with hyperactivity. Archives of General Psychiatry, 62, 11,
pp. 1266-74.
[70] Rutter, M., Greenfeld, D., & Lockyer, L. 1967. A five to fifteen year follow-up study of
infantile psychosis. II. Social and behavioural outcome. The British Journal of Psychia
try : the journal of mental science, 113, 504, pp. 1183-99.
[71] Scahill, L., Aman, M.G., McDougle, C.J., McCracken, J.T., Tierney, E., Dziura, J., Arnold,
L.E., Posey, D., Young, C., Shah, B., Ghuman, J., Ritz, L., & Vitiello, B. 2006. A prospec
655
656
tive open trial of guanfacine in children with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology, 16, 5, pp. 589-98.
[72] Seltzer, M.M., Krauss, M.W., Shattuck, P.T., Orsmond, G., Swe, A., & Lord, C. 2003. The
symptoms of autism spectrum disorders in adolescence and adulthood. Journal of
Autism and Developmental Disorders, 33, 6, pp. 565-81.
[73] Stahlberg, O., Soderstrom, H., Rastam, M., & Gillberg, C. 2004. Bipolar disorder,
schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD
and/or autism spectrum disorders. Journal of Neural Transmission, 111, 7, pp. 891-902.
[74] Szatmari, P., Archer, L., Fisman, S., Streiner, D.L., and Wilson, F. 1995. Asperger's
syndrome and autism: differences in behavior, cognition, and adaptive functioning.
Journal of the American Academy of Child and Adolescent Psychiatry, 34, 12, pp.
1662-71.
[75] Warren, Z., McPheeters, M. L., Sathe, N., Foss-Feig, J.H., Glasser, A., & VeenstraVanderweele, J. 2011. A systematic review of early intensive intervention for autism
spectrum disorders. Pediatrics, 127, 5, pp. e1303-11.
[76] Weinssman, L., & Bridgemohan, C. 2012. (last updated: 06/05/2012) Autism spectrum
disorder in children and adolescents: pharmacologic interventions. In, Up To Date,
acessed on 08/30/2012, Available from http://www.uptodate.com/contents-autismspectrum-disorders-in -children-and-adolescents-pharmacological-interventions
[77] Zeiner, P., Gjevik, E., and Weidle, B. 2011. Response to atomoxetine in boys with highfunctioning autism spectrum disorders and attention deficit/hyperactivity disorder.
Acta Paediatrica, 100, 9, pp. 1258-61.
Chapter 27
Building an Alternative Communication System

for Literacy of Children with Autism (SCALA)
with Context-Centered Design of Usage
Liliana Maria Passerino and Maria Rosangela Bez
http://dx.doi.org/10.5772/54547
1. Introduction
Human language is a system of linguistic symbols acquired through a long ontological process
of cultural learning [1]. It serves two functional aspects, communication and cognition [2]. The
communicative function of language emerges in the indicative function and allows the
establishment of the communication process through choice and combination of symbols [2],
whereas, the cognitive function of language allows the representation of beliefs and intentions
through linguistic symbols; thus, acts on ones own mental states and that of others [1]. Our
view of autism and the way it affect communication is discussed along those lines.
As our conception of language development, it is assumed that communicating is more
than speaking. Communicating means skillfully using a powerful tool of mediation1:hu
man language. In addition, human language is taken here with all its possible modes of
expression, including verbal and non-verbal symbols. Communication is neither regarded
as a linear process of direct use of a symbolic system (language) nor as a process of lan
guage acquisition of grammatical and phonetic items. The complex process behind lan
guage acquisition includes social, cultural, historical, and intersubjective dimensions and
is interactional in essence. Interaction, the fuel for development, occurs within scenes of
joint attention, in which interacting agents intentionally use linguistic symbols to express
intentions, beliefs and representations from their own perspective in several ways [3].
These are the premises underlying our research.
1 From a sociohistorical perspective, mediation is regarded as a scene of joint attention [1] between two or more
subjects intentionally using tools and signs (such as language) to promote a process of appropriation with
differentiated responsibility and competence among participants.
2013 Passerino and Bez; licensee InTech. This is an open access article distributed under the terms of the
658
Human primates natural trend to understand others as intentional agents with goals and
perceptions is the basis for the engagement in collaborative activities and joint attention [1].
Different from other primates, humans have developed a specific capacity to share attention
and establish a unique type of social interaction. Hence, scenes of joint attention constitute
social interactional processes in which: 1) agents are reciprocally responsible; 2) there is a
shared goal, that is, each partner is aware of the goal to be achieved together; and, 3) partici
pants coordinate their plans of action and intentions mutually so that each participant can
anticipate the roles in the interaction and potentially help others with their role if necessary2 [4].
Scenes of joint attention contribute with the locus for the negotiation needed for the construc
tion of intersubjective and perspectivated meanings [1]. This is what characterizes the process
of communication as a relational and systemic phenomenon. Subjects are actively involved in
interaction with a particular dynamics of implicit or explicit rules over which none of the
subjects have complete control.
Such intersubjective and perspectivated construction of meanings reveals the uniqueness of
human language as, upon the specific use of a particular linguistic symbol, it carries a local,
historical and social meaning jointly constructed. This is also to say that in each interaction,
participants quickly update possible meanings.
By extension, learning a language is a process situated relationally, historically and culturally.
In each interactional process where two individuals engage, there is an intersubjective
reconstruction of the perspectives of the others in the representation of their own intentions
and beliefs, which requires interacting individuals to select, filter and reconfigure symbols,
according to the context, intentions, beliefs and mental representations of co-participants in
the communication process.
Communication implies reorganization and coordination of social, cultural and mental
representations of subjects in interaction. It is precisely by means of linguistic symbols, namely
signs, that it is possible to build and share meanings. That dialectical dimension of the use/
understanding/acquisition of a sign is a feature of the linguistic symbol which always involves
two dimensions, language and thought. As a consequence, the attainment of a linguistic
symbol constitutes a real and complex act of thought, represented by the word. It is not simply
acquired by memorization or association [2].
Language acquisition is realized through the use of the symbol in actions of mediation (triadic)
by which participants negotiate and construct meaning in an intersubjective way, because "[...]
the meaning of a word is given through the process of verbal and social interaction with adults.
Children do not build their own concepts freely. They derive them through the process of
understanding the speech of others " [5] (p. 121). It is precisely within those triadic scenes,
called joint attention scenes [1], that the interlocutors share some Aspect of their context3 and
where intersubjectivity occurs [4]. It is also important to note that interlocutors may reach
different levels intersubjectivity depending on the extent of their exchanges [5, 6].
2 Especially in interactions between subjects with different levels of experience or knowledge about the situation.
3 The context refers to the way objects and events are represented and meant in a situation [6].
Building an Alternative Communication System for Literacy of Children with Autism (SCALA) with Context-Centered
Design of Usage
http://dx.doi.org/10.5772/54547
Besides intersubjectivity, linguistic symbols require an ability to understand perspectiva

tion. Understanding a symbol is a prerequisite to understanding the intentions, beliefs
and background knowledge of others, as well as a particular perspective about an object
or event that is incorporated into the symbol [1]. Human ability to adopt different per
spectives for the same symbol or to treat different objects as if they were the same for
some communicative purpose is only possible because all of those perspectives are incor
porated into the symbol. So, this perspectivated nature of linguistic symbols sets forth an
endless array of possibilities to manipulate the attention of others with implications for
the nature of its cognitive representation [1].
2. Communication in autism: Some considerations

Autism belongs in the group of Pervasive Developmental Disorders (PDDs). Literature
highlights a triad of elements [7] for the identification of the disorder: behavior, social
interaction, and language and communication [8]. In the presence of autism, such elements
portray qualitative features which prove to be peculiar or bear deficits. This session aims at
discussing the characteristics related to communication and language in autism in more detail
without deepening other inter-related aspects of the syndrome (such as interaction and
behavior). Presenting a state of the art of on autism is not intended here, but rather, a brief
review of some researches concerning language use and communication.
The field of language and communication in autism presents a great potential for researches.
Although there have been many recent studies on autism, there is a gap in what concerns
language and communication. So far, emphasis has been on aspects of social interaction,
diagnostic and prevalence.
It is widely known that there are certain deficits in communication, such as, the absence of
expressive body cues (in non-verbal communication), deficits in understanding colloquial
exchanges, and speech that is not adjusted the context (in verbal communication). Several
elements in the speech of a subject with autism account for it being regarded as strange,
unproductive, monotonous and unusual, such as a) the difficulty in using pronouns properly,
particularly, with pronoun inversions; b) the repetition of questions which have already been
answered or of fixed sentences in a mediated echolalic process; c) the literal understanding of
metaphors or idiomatic slangs; and, d) the difficulty in using predicative abbreviations4 [9].
In a study involving with neurotypical, mentally impaired and children with autism, the kind
of gestures children use to communicate have been analyzed [10] and three main categories
of gestures emerged: deictic (pointing); instrumental, to organize others behavior; and,
expressive, to share emotions. The study reveals that while typical and mentally impaired
children use the three types of gestures, the group of children with autism only uses deictic
4 Predicative abbreviations consist of replacind the subject of a sentence so that the predicative remains as a hidden
subject. For example: Laura always buys bread at the grocery at the corner. She takes a bag and some change her mother
leaves on the fridge. The second statement has a predicative abbreviation. It contains the action and the subject is implicit
(WERTSCH, 1988).
659
660
and instrumental gestures. Besides that, other studies have established that children with
autism face difficulties when it comes to using time and space pragmatic markers [11, 12],
expressing mental states [13, 14], using adequate expressions and gestures [15], organizing
more complex and if-so statements [16].
As for stories and narratives, the greatest difficulty for children with autism seems to lie in the
ability to follow a narrative with multiple characters and organize each characters specific
traits and personality. It is also hard for them to follow a characters way of thinking and to
put themselves into the characters position [9, 10, 17, 18].
Such deficits in symbolization affect communication because it requires an active use of
symbols for representation, especially, when situations involve more abstract elements such
as feelings and emotions. Narratives demand the narrator to organize information for a
potential listener and to select relevant aspects from the listeners perspective. Researchers
have tried to explain such deficits for understanding narratives through the Theory of Mind
[11, 13, 14, 16, 19, 20]. In those researches, it is hypothesized that people with autism fail to
read other peoples state of minds and understand their intentions, beliefs and emotions.
From another perspective, problems in communication could be associated with joint attention
[1] or mutual imitation [21]. A recent research, consistent with previous studies, has focused
adults diagnosed with high functioning autism or Aspergers syndrome [22]. It has not found
deviation in phonology and syntax or deficits in the subjects ability to understand and extract
the plot of narratives. There was significant difference in the use of referents, though. As a
consequence, narratives have been less coherent and less organized. Just as in [9], the research
has identified pronominal inconsistencies, preference for simple and unbound sentences,
disregard for the relationship of a specific event with what happened previously, and limited
use of time expressions.
In another research [22], however, subjects are able to apprehend the structure of the story and
follow the main plot as they mention all the relevant events of the narrative. Such outcome
confirms that adults diagnosed with high functioning autism or Aspergers syndrome do not
present difficulties with morphosyntactic aspects but rather a limited perception of a charac
ters intentions and inner states in the story, that is, in pragmatics of communication.
Other study, aiming at the identification of the symbolic understanding of images with three
children aged 7 to 9 years old [23], has shown it is possible to use functional communication
successfully. In that study, non-verbal children not employing any type of visual/symbolic
communication previously have undergone a process of systematic visual literacy consisting
of understanding family, people, actions and sequences. Each category has been composed by
a set of 10 symbols (or photographs); and, after nine weeks the proposal of intervention has
shown positive results as children begin using the images to communicate requests, define
tasks and other communicative activities. Such research adds to other of the kind focusing
functional communication in autism [24].
Functional communication has started in the 90s with the Picture Exchange Communication
System (PECS). PECS is an Alternative Communication (AC) system with a behavioral
methodology for children with social communication deficits. Its main goal is to teach
Design of Usage
http://dx.doi.org/10.5772/54547
functional communication by means of hierarchical organization, basic principles of behavior

such as modeling, differential reinforcement, stimulus control, control transference of stimulus
through delayed strategies of questions [23].
PECS is one of several psychoeducational programs for people with autism available nowa
days [25]. It seeks to stimulate spontaneous communication through potential reinforcers,
images and physical exchanges. The system is organized into six hierarchical phases inter
wined with a method of behavior analysis and teaching. Although PECS seems functionally
efficient, our critique is targeted at the strong behavioral control imposed by the system and
its disregard for prerequisite abilities for language use, such as joint attention, imitation or
visual contact as previously discussed.
Summing up, it is important to note that even children with autism who do not evidence
language impairment might benefit from communication support systems at times, as a way
to compensate for their lack of understanding of language semantics or pragmatics [26]. Is such
cases, where speech is not present, the use of alternative communication systems can promote
and develop processes to facilitate communication (facilitated communication). This way, the
use of technology may contribute to the sociocognitive development of those subjects [27]; and,
alternative communication systems may assist them in developing meaningful communica
tion [9, 17, 23].
3. Alternative communication: Methodology and resource in an approach

to autism
Alternative communication (AC) in one of the most important areas within the field known
as Assistive Technology. It encompasses technical aids for communication, be it to comple
ment, supplement or provide alternatives to make the communicative process happen.
There are several systems of AC. These provide a vast repertoire of representative elements,
such as photographs, drawings and pictograms. Support for those systems may require either
low (concrete material) or high (computational systems) technological devices. The importance
of AC lies in the communicative strategies and techniques to promote subjects autonomy for
communicative instances so; it is secondary whether support is mediatic or not.
Given the impact language development on human development, subjects presenting deficits
in communication can benefit from the use of AC systems as application of techniques and
technology go beyond its instrumental character to enhance the development of abilities to
use linguistic symbols intentionally. Considering that in the case of autism, communication
deficits may exhibit alterations in language use, form or content in pragmatic level, and to a
lesser extent, in syntactic, morphosyntactic, phonological or phonetic level, the importance of
employing an AC system is more concerned with adequate reception and production proc
esses, and those play an inter-related role [28].
Although the use of AC dates from the 90s, researches are recent. One of the first works was
the adaptation and standardization of the PECS [29, 30]. It is also worthy of note the research
661
662
on language development and meaning construction supported by AC with three children

with autism [31], which revealed relevant outcomes.
More recent studies [32, 33, 34, 35] have involved the use of AC with Global Development
Disorders (autism and Cornelia-Langes syndrome). Those studies have also come to impor
tant results, particularly, when AC processes are supported by digital technologies.
According to the studies cited above, there is significant improvement in communication
processes both in enunciation and pragmatics for subjects with autism when an AC sys
tem acts as tool of mediation between subjects in interaction. We believe that when AC
is adapted to the needs of subjects with autism, it serves as a factor of facilitation and
proximity because it contributes with an alternative for communication and establishes a
bridge between people.
AC systems may function as bridge for human communication. However, it cannot be naively
assumed that a technological support can stand on its own. On the contrary, an AC resource
must be clearly founded on a methodology epistemologically grounded. The AC system
presented in the following session (SCALA) is constituted of technological, human and social
elements which are interwined to build an integral relationship, as highlighted by a researcher
when stating that [...] more important than [...] any resource to intermediate dialogue, it is time,
attention to listen and dedication granted to one another [36] (p. 139).
Two versions of SCALA have been developed by our team: web and tablet. Development has
started in 2009 and the version for tablets is currently undergoing experimentation in a study
with three children aged 4 diagnosed with autism.
4. Technology and autism: SCALA project

Researches on the use of technological applications for subjects with autism is frequent in the
literature. One of the first studies involving technology and autism used computer-aided
instruction (CAI) to stimulate the language development of children with autism [37]. Other
studies have been published reporting the positive effects of technological applications in the
process of teaching how to read and write [38, 39, 44], problem-solving [40, 41], social inter
action [27, 42], and, cognition and learning [27, 39, 43].
Improvement of language use and childrens learning how to read and write have been
reported by [38] and [44]. In Brazil, the first study dates from 1975 [45]. It has been developed
in the Laboratory of Artificial Intelligence of Edinburgh with a seven-year-old child with
autism, with the use of Logo5. It has pointed out the use of Logo facilitated the process of
interaction of the child with other people because [...] the turtle assumed the role of mediator
in the interaction of D. with other people and served as an object to help the development of
mental schemes [...]" [45] (p. 73).
5 LOGO is a computational tool in which a student controls an icon represented by a turtle through simple commands.
Designed by Seymour Papert in the 70s, it was the first computational tool especially projected to be constructivist and
grounded on Genetic Epistemology.
Design of Usage
http://dx.doi.org/10.5772/54547
Other positive outcomes of the studies above include gains in communication and moti
vation. Such correlations are often observed in a structured and communicative environ
ment supported by technology and organized for interventions with subjects with autism
[27]. Even when more guided [38] or more flexible [45] softwares are employed, results
are productive. Such outcome could be traced back to the pedagogical strategy adopted
by the teacher, who acts as a more experienced partner because the use of computers,
particularly in virtual learning environments designed to adapt to the subjects interests
and needs, becomes relevant and important tools of mediation as advocated under a so
ciohistorical conception [3].
Once strategies are added to the flexibility, adaptation and complexification processes inherent
to digital technologies, they help to promote sociocognitive development of participants.
Nevertheless, it is necessary to establish strategies for different learning environments,
learning situations and subjects in interaction so that the introduction of technology can
contribute with its qualitative differential for the enhancement of social interaction of subjects
with autism [46]. In doing so, researches corroborate that the use of technologies can help
people with autism communicate and interact [47].
Mobile devices also represent a possibility for the use of applications to assist users as well.
Their utility extends into day by day activities as they are easy to handle, can be used in
different places and allow connectivity to other devices. Connectivity in particular can be quite
useful to enable communication and learning in groups and, as a consequence, can help foster
the integration of subjects in their social environment [48].
On sociability, a recent study with high functioning autism and Aspergers syndrome
adults users of online social networks has found that the structuring features of comput
er-mediated communication (CMC) help and promote their participation in social interac
tional processes [49]. Similar results have been identified in a study focusing chat room
interaction [27]. In addition, a research by [50] highlights that engagement in mediated
communication may not only foster participation, but also enhance learning of social
rules of turn taking and dialog maintenance when supported by intelligent computation
al systems. Despite the likely advantages of CMC, it is important to consider its poten
tial limitations and complications when it intensifies problems associated with trust,
secrecy, inflexibility and perspectivation [51].
Turn-taking, which underlies unstructured social talk, poses a challenge which can be even
greater if some sensorial hypersensibility (to lights, sounds, smell and touch) is associated with
the syndrome. In those cases, communication controlled by a computational device may play
a role in the maintenance of social relationship and management of feelings of loneliness and
depression [52].
Adults with Aspergers may reveal intense isolation and difficulties to initiate social in
teraction [53]. They often lack a model of behavior socially acceptable and, as a result,
may behave in a way that impacts their communication with other people negatively.
Hence, alternative means of communication, like CMC, and other platforms easily availa
663
664
ble such as Orkut, Facebook, and other social networks, can be useful for the promotion
of interaction of people with autism [27, 49, 50].
CMC offers users with autism control over their environment as well as over problems
with prosody and intonation [49]. A study developed by e-mail with adults with Asperg
ers Syndrome has found that visual anonymity, time flexibility and the permanence al
lowed by the internet help diminish the social and emotional pressures of interpersonal
communication as well as the cognitive complexity of the processes involved [49]. In par
ticular, the authors state that online communities provide a space for interchanges and
talks for people with similar interests or problems, so people with autism do benefit from
those possibilities and structuring characteristics of CMC. In their study, 16 adults with
high functioning autism or Aspergers syndrome have been interviewed on their daily ac
tivities and participation in social networks and attested that CMC tends to be beneficial
for the initiation of social interactions more than half of the interviewees participated in
some type of social network. However, limitations and drawbacks in the interactions in
social networks have been reported as well, which often refer to initiation of contact,
maintenance of interaction for long periods and issues of security and trust. As a result,
those users seek to interact with people already known from other spaces6.
In spite of the benefits reported in studies, few address AC in technological systems with nonverbal subjects with autism. We know that communication with subjects with autism can
resemble the Tower of Babel and challenges are greater when subjects are non-verbal7. In
this case, we are in a rather complex situation which requires the adoption of strategies and
resources to climb up the tower. In the researches presented here, we notice that the use of
technology is promising for the processes of communication and interaction. That brings us
to some important questions: is it possible to identify the same benefits when allying the
potential of CMC with AC? And, if so, how to use AC with mobile devices with non-verbal
children with autism?
In this specific research node (AC, technology and autism), there are few studies on mobile
devices for AC that focus people with the syndrome. In the literature review, in addition to
the work of our research group, we found a research with the system Sc@ut [47]. Sc@ut is an
AC system adapted to be a communicator for Pocket PC and Nintendo DS. According to the
authors, the use of the system in groups of children with autism has shown an improvement
in the behavior of subjects in oral language. With some subjects, the models of communication
provided by the system were used to train social skills and daily life activities8 [48]. The studies
developed by our research group are reported in the following session.
6 This is typical within other social groups investigated. In general, confidence is stronger and more consistent
among stigmatized group minorities [54].
7 Researches point out that a third of children with autism are non-verbal. Such proportion fells to 14 to 20% when they
receive early intervention [55].
8 Another product under development by [47] is a platform for the creation of pedagogic activities for Ipad and Iphone.
Activities are diverse including navigation, association, memory games, puzzles, sequencing, visual and aural perception,
vocabulary, visuo-spatial coordination, among others. However, this product (Picaa) has not been tested with children
with autism yet.
Design of Usage
http://dx.doi.org/10.5772/54547
5. Development centered in contexts of use

Since 2009, when we started the development of SCALA, we have aimed at supporting
language development of children with autism presenting deficits in communication. The
epistemological basis of the sociohistorical theory, which we adopt, implies a conceptual reorganization of the software development process known as User-Centered Design (UCD). In
UCD, the objective goes beyond subject-object interaction and focuses on designing strategies
to allow interaction and communication between children with autism and other interlocutors
[32, 34, 56]. SCALA is composed of three modules: board, narratives and free communication
and follows a UCD approach.
From a sociohistorical perspective and the theoretical premises already presented, our
approach not only contemplates the subject with disabilities, but that subject in interaction,
which broadens our focus of investigation to (a) the social contexts in which (b) cultural
practices of communication and literacy are developed by (c) different participants through
(d) mediating actions.
The general guidelines of the UCD consider the macro context of human development in social
interaction as the basis for the analysis of cases. Characteristics and needs of individuals cannot
be understood apart from the contexts in which they belong. As a consequence, the develop
ment of assistive technology goes beyond a functional view of the human being. In spite of so,
we do not ignore functional aspects in our proposal, we consider them within the cultural
spectrum in which the AC is to operate. Each individual "inhabits" many contexts in which is
more or less active in face of different cultural practices. In some cases, those practices happen
within a triadic mediated action (individual-mediator-object) which entails learning and
development. So, our focus of analysis is always the individual in relation with his/her different
contexts. On its turn, each context impacts our relationships, consequently, the mediations that
are possible. In time, we do not regard the cultural context as something that limits the
individual, but as an element that shapes the relationship. This is why it is of importance to
consider social contexts in the development of technology that will be employed as a qualita
tive resource and psychological tool in the mediating action.
Context, under such conception, exceeds the notion of physical space. It constitutes a condition
that represents the action and is crossed by a space-time dimension. This dimension includes
not only physical space but social space, and four types of time: a) present, which is the
microgenetic time, i.e., the time now, b) lived, which refers to human history, or the ontogenetic
time c) historical, which refers to ones personal story and is related to culture; and, at last, d)
future, which is a projection, what one imagines will happen, ones own expectations and that
of others, the wishes, the intentions that projects oneself to the future. Those four times frames
pervade contexts and are constantly updated, so, they must be taken into consideration when
we project assistive technology systems.
The analysis of the different frames of time starts with the present one microgenetic and
through it, the others are recovered. An ethnographic approach is central in that analysis
because informants provides information about lived and historical time that allows us to
665
666
project into the future [57]. As ethnographic research is strongly based on discourse, therefore,
discourse itself is a powerful informant. Because discourse is imbued with subjectivity, a report
of memories and expectations, it may be argued that it does not provide a wholly truthful
account. However, as subjectivity is an important aspect within the sociohistorical research,
triangulation of the data is adopted as a regulating mechanism [58].
The configuration of contexts underlies sociohistorical research. The nature of contexts is a
discursive one, in which language emerges and allows us to analyze various elements: persons,
situations, cultural practices and mediating actions within those practices (Figure 1) in relation
to time. Thus, context cannot be regarded as a static element as it plays a role in the interaction
too. Besides the agents (people) subject A1, subject A2 , overlapping contexts need to be
included in the analysis of contexts of use.
The overview of contexts constitutes the macro level of investigation necessary to deepen the
understanding of the phenomenon of communication within educational spaces. In the micro
level, triads (subject-mediator, non-verbal subject and mediating actions) represent the starting
point for the understanding of the processes of mediation with technologies. Such methodo
logical perspective supports the development of technological resources (for instance, SCALA)
in a differentiated way, that is, different from traditional processes of development and
different from processes based on UCD, which involve users in the process of development
and take their needs, expectations and experiences into consideration.
In SCALA, there is not a single model of user but a diverse range of agents involved with many
peculiarities that differ in expectations and experiences, this is why we propose a broader view.
We are not only interested in the user, as in the UCD, but in the peculiarities and specificities
of the various agents in interaction as well. Our focus encompasses the action implied in the
interaction, the cultural practices in which agents and technological resources are embedded.
Besides UCD, another proposal is the Activity-Centered Design (ACD). ACD focuses the
activity that is performed and, as in the UCD, tries to create a model of activity. Considering
that literacy practices cannot be thought of as an activity but as a set of practices that vary
across different situations, we propose a Context-Centered Design (CCD). In this sort of
development, differentiated sociohistorical contexts provide the guidelines to orient system
development. In other words, what people do in different contexts, with different objectives
and scenarios is what guides this project development. Figure 1 shows a scheme of CCD.
Three multi-case researches underlie SCALA developed. The first research allowed us to
identify mediation strategies and validate the methodological proposal for intervention with
communication with children with ASD [33]. The second case study was concerned with the
interaction and intervention with a child aged 5-6 diagnosed with ASD and presenting defi
cits in communication. This case study was a follow-up to the previous one and derived
strategies for the development of communication with the use of a first prototype in this
phase [35]. Interventions allowed a broader understanding of the process of use implemen
tation of AC with children with autism, and provided input on how a tool for such purpose
should be developed.
Design of Usage
http://dx.doi.org/10.5772/54547
Interaction
(mediation)
667
Analysis
Micro level
F
F
E
Time
S
L
Macro
level
E
L
Language: Tools + Symbol
F = Family Context
E = School Context
L = Lab Context S = Subject
A1
A2
An
People
Contexts (Time)
o Present
o Lived
o Historical
o Future
Language
Interaction (teacher/
researcher)
Arrows
=
Contexts
(time)
Analysis
Synthesis
Figure 1. Scheme of Context-Centered Design (CCD)
Figure 1. Scheme of Context-Centered Design (CCD)
Three multi-case researches underlie SCALA developed. The first research allowed us to identify mediation strategies and valid
Requirements,
like touch screens
andintervention
the adaptation
of the sizewith
of children
the figures
among
the methodological
proposal for
with communication
with ASD
[33]. other
The second case study w
concerned
with the contributed
interaction andtointervention
with
a childofaged
5-6 diagnosed
ASD now
and presenting deficits
aspects, have
significantly
the second
version
SCALA.
A new with
version,
communication. This case study was a follow-up to the previous one and derived strategies for the development of communicat
considering mobile devices and fast connection with the internet is under development
with the use of a first prototype in this phase [35]. Interventions allowed a broader understanding of the process of
(2011-2012)implementation
and has been
informed
by the
currently
subjects
from be developed.
of AC
with children
withthird
autism,study,
and provided
input involving
on how a toolthree
for such
purpose should
three different cultural contexts. From the family context, the study took into consideration
Requirements, like touch screens and the adaptation of the size of the figures among other aspects, have significantly contributed
daily interactions,
hygiene, leisure time, among other information. Besides family, other
the second version of SCALA. A new version, now considering mobile devices and fast connection with the internet is un
contexts include
school
and laboratory.
proposal
thestudy,
controlled
to investigate
development (2011-2012)
and has beenThe
informed
by the of
third
currentlycontext
involvingis
three
subjects from three different cultu
From the
context,
the study with
took into
consideration
hygiene,
interactioncontexts.
with peers
by family
inserting
3 children
autism
in the daily
sameinteractions,
social space
andleisure
at time, among ot
information. Besides family, other contexts include school and laboratory. The proposal of the controlled context is to investig
present time.
interaction with peers by inserting 3 children with autism in the same social space and at present time.
As it is possible to observe, development and investigation imbricate in a spiral process where

As it is possible to observe, development and investigation imbricate in a spiral process where each process repeats itself reach
each process
repeats itself reaching greater complexity, and thus, improving the system which
greater complexity, and thus, improving the system which proceeds development according to the principles of CCD. To deve
proceeds development
according
the the
principles
of CCD. To ofdevelop
SCALA,
the one of their teachers
SCALA, on the one
hand, we to
address
needs of communication
non-verbal
children, on
the expectations
mediatorsthe
of educative
and count onof
thenon-verbal
intense participation
of family
to use and adaptofthose
strategies and resour
hand, we address
needs ofpractices
communication
children,
the expectations
their
[32, 34, 59, 60]. On the other hand, research trajectory involves several investigation projects developed by the research group
different spaces and moments, with points of intersection and team consolidation through regular meetings to keep investigat
668
teachers as mediators of educative practices and count on the intense participation of family
to use and adapt those strategies and resources [32, 34, 59, 60]. On the other hand, research
trajectory involves several investigation projects developed by the research group in different
spaces and moments, with points of intersection and team consolidation through regular
meetings to keep investigation on track. Spiral development starts from a deep analysis of
existing systems9 adding to the results of the multi-case researches, which gradually informs
the construction of requirements for the system and is constantly adjusted.
From a technological standpoint SCALA has as its main features, a module for building
communication boards, a module for the construction of stories, and a module for free
communication. It also encompasses common application features such as the ability to import
files, edit sounds, save, export, and manage the various files generated by the system (Figure
2). The menu on the left to the user presents the categories of images that can be used with all
the three modules and the horizontal menu bar displays the features.
From a predefined layout one can fill each card by clicking on the categories of images. Each
image has a caption pattern which can be edited. For each card it is possible to record sounds
and hear them. If the user does not want to record a sound, a speech synthesizer will read the
caption (otherwise, the sound recorded by the user will be supplied).
In addition to the existing images in the system, it is possible to add personal images allowing
customization and adaptation to the sociohistorical context of the user. Finally, the last feature
designed was the animation of actions. This feature was introduced as empirical studies have
shown evidence that animated actions may be more suitable to forge understanding of
metaphorical and symbolic elements with autism [46, 61, 62].
SCALA is currently available for two platforms (web e android), which allows its use with
mobile devices. In the next session, some preliminary results are presented.
(a) board module
(b) story module
(c) story module (editing)
Figure 2. Board and Story modules in the version for Android for tablets
9 The main softwares available in the market have been explored, for example, Amplisoft, Boardmaker,and other free
systems whose traits concerning interaction and narrative building were relevant to think about the systems require
ments. A complete synthesis of such assessment was developed by [35] as part of her masters research.
Design of Usage
http://dx.doi.org/10.5772/54547
6. Development and preliminary results

In the session, an extract of some preliminary results of our research is presented. It comprises
the period of time raging from August 2011 to May 2012. The subjects are three non-verbal
children diagnosed with autism aged 4 years old. Three contexts have been taken into account:
family, school and laboratory, but, in this report, we mainly focus on the interactions in the
context of the laboratory, so, just a few considerations about other contexts are referred.
Interactions have been planned upon the methodology of mediating actions, with particular
focus on the promotion of scenes of joint attention in order to accomplish communication and
social interaction of the subjects involved. Those interactions happened simultaneously with
the three subjects once a week in the laboratory. Interactions in the laboratory took place
weekly and duration was flexible in the beginning10 to adapt to the needs of individuals. In
addition, there were visits to each subjects home and school followed by observation and
initial guidance to mothers and school personnel. This way, the subjects contexts encompass
ing greater social experiences and participation were accessed. The first contact was with the
mothers, school and teachers with the distribution of some instruments for data collection11 to
help set up an initial profile of the subjects.
The interventions of the researcher in the three contexts do not follow a linear fashion. Visits
are scheduled according to opportunity and the needs identified in the course of the research.
Interventions are filmed for later analysis and to subsidize reconstruction and development
of new possibilities of interactional arrangements so as to contribute to subjects development
across contexts.
Besides the scenes of joint attention, which have been promoted as part of the methodol
ogy of intervention, subjects had the opportunity to interact with physical AC materials
as instruments of mediation of those scenes. Then, during the first weeks, AC material
employing both low and high technology was used along with other resources, as Pre
sented in the figure 3.
Mediating actions had a focus on the triadic interactions of the mediator with subjects and
objects acting as instruments of mediation to further expand the interactions with the other
subjects. With the first interventions in the lab, it was possible to establish bonds with the
children and get to know their needs and potential. Furthermore, with the help of their mothers
and school teachers, it was possible to outline a descriptive profile of their forms of commu
nication, social interaction and initial potentialities.
In spite of the same diagnosis, the three children have very distinctive characteristics within
the symptoms of the syndrome and are accompanied by diverse professionals in therapeutic
interventions. They are referred to as Case 1, 2 and 3 in the table 1.
10 In the beginning, meetings were shorter and gradually increased in time.
11 Open interviews, anamnesis and consent forms
669
670
Figure 3. Example of AC material of low and high technology
Case 1
Boy, 3.10 y.o., living with his parents and two older sisters; attends nursery (level 3) school in
the afternoon.
Some abnormality in his development was noticed at the age of 1.3 y. o. as he did not show
any vocabulary. ASD was diagnosed at the age of 1.9 by a team of professionals (pediatrician,
neuropsychologist and a psychiatrist).
Communication
Makes some sounds, makes meaningful facial expressions (looks) to pay attention, when he
is called, to get to know the environment and closes his eyes in protest. He smiles to
demonstrate satisfaction and joy and cries, grumbles and mumbles to show contrariety.
Body expressions involve pointing and touching what he wants with his finger and waving.
Is starting AC with speech therapist.
Communicates spontaneously through gestures in order to have his wishes realized.
Does not present stereotyped behavior.
Social interaction and Accepts touch.

understanding
Understands the meaning of the objects and his own existence.

Demonstrates understanding of other people without engaging in turn taking.
Interacts when is requested to by sitting at a table.
Can interact with objects and other people for short or medium periods of time.
Potencialities
Can deal with changes in routine.
preferences
Does not react contradictorily in the presence of people who are strange to him.
Is fascinated by lights, fans, drains and objects that spin. Appreciates looking at the mirror.
Use communicative gestures through meaningful facial and bodily expressions.
Can hold a pencil, paints with some limitation, scribbles.
Uses his index finger to point at things he wants.
Can eat with independence and can put on shoes without shoelaces.
Design of Usage
http://dx.doi.org/10.5772/54547
Case 1
the afternoon.
Is in the process of toilet training and learning to dress and undress with independence.
Case 2
Boy, 4.2 y.o. lives with parents and a brother. Some abnormality in his development was
noticed at the age of 2.3 y.o.. ASD was diagnosed at the age of 2.3 by a neuropediatrician
and psychologist. Attends nursery school in the afternoon.
Communication
Presents some language delay. It is difficult to understand what he says. Uses a proper
language. Understands speech but does not engage in turn taking.
Facial expressions are observed when he is upset, cries and grumbles to show contrariety.
Does not sustain visual contact. Knocks his head to call attention or squeezes his arms and
legs. Moves his hands and fingers in a strange way.
To get what he wants, uses other peoples arm or hand. Pointing is not part of his routine.
Has difficulty in sitting still or remaining in an activity.
Likes to scribbles, but with no apparent meaning.
Does not use any form of alternative communication.
Social interaction and Resists to be touched. Contact is accepted only by family members.
understanding
Limited understanding of the meanings of objects or people.

Does not get attached to his environment or shows a sense of belonging.
Interaction is restricted to objects when they are interesting to him and gets attached to
them.
Potencialities
Appreciates music, fascination for lights, mirrors and bright eyes.
preferences
Hyposensitive in relation to senses, laughs for no apparent reason, shows good

coordination.
Likes to jump, lie on the floor and run.
Food compulsiveness needs to be managed.
Depends on other people to dress, undress and for hygiene.
Case 3
Boy, 3.5 y.o. lives with parents. Some abnormality in his development was noticed at the
age of 1.3 y.o.., neurologist attested ASD. Uses anti-psychotic (Resperidal) and anticonvulsive medication. Attends nursery school in the afternoon..
Communication
Oral communication is expressed through few grumbles.

Communicates through gestures with people who are familiar to him. To get what he
wants, uses other peoples arm or hand. Does not point at objects.
Facial expressions are observed when he is displeased, cries and grumbles to show
contrariety. Frustration is expressed through aggression (beating himself and others, pulling
ones hair, bites).
Shows great difficulty in demonstrating what he wants to communicate.
Does not use any form of alternative communication.
671
672
Case 1
the afternoon.
Social interaction and Does not accept physical contact and does not make eye contact.
understanding
Elects small spaces to stay.

In some moments, he seems to unplug and becomes apathetic to everything and
everyone
Does not accept the mediation of the researcher and in rare moments, it happens with
some object he is interested in.
Potencialities
Loud noises call his attention, shows fascination for lights, interest in small details of
preferences
objects.
Keeps a fixed and strange look at his fingers and hands.
Often puts objects in his mouth.
Faces difficulty to run, jump, climb and go down the stairs.
Exaggerated attachment and attraction to certain objects, likes to spin them and does not
use games properly.
Changes in routine are not well accepted. Sometimes he is too active and other times too
passive. Is afraid of wide spaces and symmetric floor.
Table 1. Initial profile of communication, social interaction and potentialities of subjects.
As can be noticed, only one of the subjects used the pointing function. Due to that, initial
sessions focused on actions to make that gesture meaningful. SCALA software was used in
two versions with symbols and boards with tablets. In the beginning, there was a great need
to associate concrete material with the symbols in the boards and, afterwards, the gesture of
pointing emerged with the fascination for the tablet technology.
The subject from case 2 accepts to be touched and soon learns to point. He also increases
lateral visual contact. Although we accomplished only a few instances of mediation, he
started interacting with the technological tool and increased attention span through the
observation of details. On its turn, subject 1 improves pointing and eye contact and starts
participating in scenes of joint attention in response to the employed mediating actions
(mediator-subject-object). He soon shows great autonomy in dealing with the tablet. At
last, subject 3 required more time to accept some physical contact and to fix his eyes on
the activities proposed. Pointing was initially motivated by the sound produced by this
touch on the screen.
Together with SCALA, several free applications have been tried with the children (Figure 4).
Applications were picked according to the profile of each of the subjects and that was important
to promote the appropriation and understanding of the technology, as seen in Figure 5, along
with the use of AC boards (Figure 6).
Design of Usage
http://dx.doi.org/10.5772/54547
Figure 4. Using different tablet applications
Figure 5. Using tablets with subjects with autism
With the use of tablets, we could notice attention spans increased for all the subjects. Speech
was also prompted in all mediations. So, subjects range of vocabulary has increased. Subject
1 showed easiness with the technology and the participation as an intentional agent in
mediated actions. He is currently producing more words with two syllables and participating
in scenes of joint attention in the mediations with other subjects.
673
674
Although subject 2 demonstrates he prefers to interact with the equipment on his own, he also
starts participating in scenes of joint attention in the mediated actions. In some few instances,
he initiates interactions with the other subjects spontaneously. It is possible to notice the
verbalization of some isolated words and that he accepts being touched and demonstrates
affection through hugs and kisses.
Subject 3, through mediating actions accepts touch and demonstrates affection through kisses
and hugs. Aggression is only expressed when he feels some pain. His interactions with the
object increase and he starts participating in some mediating actions with the researcher. Only
one word was said after great insistence, but the symbols of alternative communication start
being understood, which is likely to contribute to his way of communication soon.
Figure 6. the use of SCALA with subjects with autism in the tablet and a board with symbols
The first image of Figure 3 shows one of the subjects interacting with AC software SCALA.
The second shows a board constructed with the software and meant to be used in the mediated
actions. The third image is a board adopting low-technology with printed material.
Apart from the work in the laboratory, mothers were asked to use alternative communication
at home. As needs came up, mothers turned to us and together we constructed boards. A tablet
was purchased by two families (subjects 1 and 2), so the children started using it in family
contexts too. As for schools, the teachers of subjects 1 and 2 have requested some boards to
use in that environment too, but we perceived a lack of understanding about how to integrate
AC in the school context. Therefore, we are providing two training courses, for teachers and
assistants and for the school team.
The results referred here are preliminary as the project stretches until 2013. However, they are
consistent with previous research [27, 33, 50, 63] showing relevant outcomes for the social and
Design of Usage
http://dx.doi.org/10.5772/54547
cognitive development of subjects with autism through the use of digital learning environment
as instruments of mediation. Just as the present study, they have also adopted a sociohistorical
view where mediating actions widen the level of development through the use of symbols and
tools in a way that the zone of proximal development is adjusted until internalization of
concepts is complete.
In fact, we can consider the significant improvement in both social interaction and cognitive
development of subjects with autism with the introduction of technology from a sociohistorical
perspective as it allows more flexible adaptive and abstraction processes with increasing levels
of complexity.
7. Conclusion
To sum up, it is important to highlight that developing assistive technology for alternative
communication as proposed in this chapter, that is with Context-Centered Design, implicates
a multidimensional process involving technological innovations, pedagogic mediation,
cultural practices and contexts, as well as, specific formations pervaded by critical analysis to
favor the creation of new technologies with differentiated theoretical and methodological
proposals.
The introduction of alternative communication can go far beyond the specialized spaces in the
scope of Health and Education, such as the rooms of multifunctional resources12, for instance.
For those who need it, alternative communication is a tool to be used in varied social spaces
and systematically in daily life.
Acknowledgements
We would like to thank
CAPES (Coordination for higher Education Staff Development), which through PROESP
(Special Education Support Program), has funded graduate students involved in this
project;
CNPq (National Counsel of Technological and Scientific Development) for research
scholarships to undergraduate students and grants to research professors;
FAPERGS (Foundation of Research Support of Rio Grande do Sul) for the financial support
through through the Edict Pesquisador Gacho 2009 that funded the development of phases
II and III of SCALA Project; and
12 Rooms of multifunctional resources are equipped with diverse assistive technologies applications that are distributed
by the Ministry of Education to regular public schools that serve students with disabilities or special needs through a
specialized educational support outside school hours.
675
676
PROPESQ/UFRGS (Research Dean Office of Federal University of Rio Grande do Sul) for
the infrastructure and financial support to SCALA project.
Project funded by CAPES and FAPERGS. Article developed from researches funded by CAPES
(PROESP program), CNPq (Grant for Productivity in Technological Development and
Innovative Extension) and FAPERGS (Gaucho Researcher Edict 2010).
Author details
Liliana Maria Passerino1 and Maria Rosangela Bez2
1 Graduate Program in Education (PPGEDU) and Computer Science and Education (PGIE)
and the Interdisciplinary Center of Technologies in Education - CINTED/UFRGS, Computer
Science and Education, Brazil
2 Interdisciplinary Center of Technologies in Education - CINTED/UFRGS, Brazil
References
[1] Tomasello, M. Origens culturais da aquisio do conhecimento humano. So Paulo:
Martins Fontes, 2003.
[2] Vygotsky, L. S. A Construo do Pensamento e da Linguagem (texto integral traduzido
do russo). So Paulo: Martins Fontes, 2001.
[3] Vygotsky, L. S. Formao Social da Mente. 6.ed.- So Paulo: Martins Fontes, 1988.
[4] Tomasello, M; Carpenter, M. The Emergence of Social Cognition in Three Young
Chimpanzees. Monogr Soc Res Child Dev. 2005;70(1):vii-132.
[5] Wertsch, J. Vygotsky y la formacin social de la mente. Serie Cognicin y desarrollo
humano. Barcelona: Ed. Paids, 1988.
[6] Wertsch,J. La Mente en Accin. Buenos Aires: Aique, 1999.
[7] Wing, L. El Autismo en nios y adultos: Una gua para la famlia. Buenos Aires.
Argentina: Paids, 1998.
[8] Rivire, A. Coleccin Estructura y Procesos. Serie Pensamiento, Psicopatologia y
Psiquiatra. Madrid, 2001.
[9] Jordan, R. & Powell, S. Understanding and Teaching Children with Autism. West
Sussex, England: John Wiley&Sons, 1995.
Design of Usage
http://dx.doi.org/10.5772/54547
[10] Peeters, T. Autism: From Theoretical Understanding to Educational Intervention.

Whurr Publishers, 1998.
[11] Bruner, J., & Feldman, C. Theory of mind and the problem of autism. In S. Baron-Cohen,
H. Tager-Flsberg & D. Cohen (Eds.), Understanding other minds: Perspectives from
autism. Oxford: Oxford University Press, 1993.
[12] Loveland, K. & Tunali, B. Narrative language in autism and the theory of mind
hypothesis: A wider perspective. In S. Baron-Cohen, H. Tager-Flusberg, and D. Cohen
(Eds.), Understanding other minds: Perspectives from autism, pp. 247-266, Oxford
University Press, 1993.
[13] Baron-Cohen, S. Without a theory of mind one cannot participate in a conversation.
Cognition, 1988b, 29, 8384.
[14] Baron-Cohen, S. Autismo: uma alterao cognitiva especfica de cegueira mental.
Revista Portuguesa de Pedagogia, Ano XXIV, 1990, p.407-430.
[15] Loveland, K. A., Mcevoy, R. E., Tunali, B., & Kelley, M. L. Narrative story telling in
autism and Downs syndrome. British Journal of Developmental Psychology, 1990, 8,
923.
[16] Tager-Flusberg, H., & Sullivan, K. Attributing mental states to story characters: A
comparison of narratives produced by autistic and mentally retarded individuals.
Applied Psycholinguistics, 1995, 16, 241256.
[17] Sigman, M. & Capps, L. Nios y Nias autistas. Srie Bruner. Madrid: Morata, 2000.
[18] Hobson, P.R. El autismo y el desarrollo de la Mente. Madrid: Alianza Editorial, 1993.
[19] Baron-Cohen, S. Perceptual role taking and protodeclarative pointing in autism. British
Journal of Developmental Psychology, 1989, 7, 113127.
[20] Happ, F. An advance test of theory of mind: understanding of story characters
thoughts and feeling by able autistic, mentally handicapped, and normal children and
adults. Journal f Autism and Development Disorders, 1994, 24, 129154.
[21] Meltzoff, A. N., & Gopnik, A. (1993). The role of imitation in understanding persons
and developing a theory of mind. In: S. Baron-Cohen, H. Tager-Flusberg, & D. J. Cohen
(Eds), Understanding other minds. Oxford Medical Publications, 1993, p. 335366.
[22] Colle, L.; Baron-Cohen, S.; Whellwrigth, S; van der Lely, H. Narrative Discourse in
Adults with High-Functioning Autism or Asperger Syndrome. Journal Autism Dev
Disord. 2008, 38:2840 DOI 10.1007/s10803-007-0357-5.
[23] Cihak, D. Teaching students with autism to read pictures. Research in Autism Spectrum
Disorders 1(2007) 318329.
[24] Bondy, A., & Frost, L. The picture exchange communication system. Focus on Autistic
Behavior, 1994, 9, 119.
677
678
[25] Bergeson, T.; Heuschel, M.; Harmon, B.; Gill, D.; Colwell, M.L. Los aspectos pedag
gicos de los trastornos del espectro autista. Office of Superintendent of Public Instruc
tion, (OSPI), 2003. Disponvel on-line em: http://www.k12.wa.us.
[26] Bosa, C. Intervenes psicoeducacionais. Revista Brasileira de Psiquiatria. 2006;28(Supl
I):S47-53.
[27] Passerino, L, M. & Santarosa, L. Autism and Digital Learning Environments: processes
of interaction and mediation. Computers and Education, v. 51, p. 385-402, 2008.
[28] Passerino, L. M. A Comunicao Aumentativa e Alternativa no espao do Atendimento
Educacional Especializado: trajetrias imbricadas de investigao e desenvolvimento
tecnolgico. In: Anais VI Seminrio Nacional de Pesquisa em Educao especial:
Prticas Pedaggicas na educao Especial: multiplicidade do atendimento educacio
nal especializado, 2011. v. 1. p. 1-17.
[29] Walter, C. A adaptao do sistema PECS de comunicao para o Brasil: uma comuni
cao alternativa para pessoas com autismo infantil. In: Marquezine MC, Almeida MA,
Tanaka EDO, Mori N, Shimazaki, E., organizadores. Perspectivas multidiciplinares em
educao especial. Londrina:Ed UEL. 1998. p.277-80.
[30] Walter, C. Os efeitos da adaptao do PECS associada ao Curriculum funcional em
pessoas com autismo infantil [dissertao]. So Carlos (SP): Universidade Federal de
So Carlos; 2000.
[31] Orr, S. E. A constituio da linguagem de alunos autistas apoiada em Comunicao
Suplementar Alternativa. Tese de Doutorado. Piracicaba: UNIMEP, 2006.
[32] Bez, M. R.; Passerino, L. M. Applying Alternative and Augmentative Communication
to an inclusive group. In: WCCE 2009 - Education and Technology for a Better World
Monday, 2009, Bento Gonalves. WCCE 2009 Proceedings - Education and Technology
for a Better World Monday. Germany : IFIP WCCE, 2009. v. 1. p. 164-174.
[33] Bez, M. R. Comunicao Aumentativa e Alternativa para sujeitos com Transtornos
Globais do Desenvolvimento na promoo da expresso e intencionalidade por meio
de Aes Mediadoras. Dissertao. Programa de Ps-Graduao em Educao Faculdade de Educao. Universidade Federal Do Rio Grande Do Sul. Porto Alegre,
2010.
[34] Avila, B. G; Passerino, L. M. Comunicao Aumentativa e Alternativa e Autismo:
desenvolvendo estratgias por meio do SCALA. In:Anais VI Seminrio Nacional de
Pesquisa em Educao especial: Prticas Pedaggicas na educao Especial: multipli
cidade do atendimento educacional especializado, 2011. v. 1. p. 1-10
[35] Avila, B. G. Comunicao Aumentativa e Alternativa para o Desenvolvimento da
Oralidade de Pessoas com Autismo. Dissertao de Mestrado. PPGEDU/UFRGS. 2011.
[36] Walter, C. O PECS adaptado no ensino regular: ma opo de comunicao alternativa
para alunos com autismo. In: Nunes, L. Quiterio, P; Walter, C.; Schimer, C.;Braun, P.
Design of Usage
http://dx.doi.org/10.5772/54547
(Org.) Comunicar preciso: em busca das melhores prticas na educao do aluno com
deficincia. Marilia: ABPEE, 2011 [192 p.] (p. 127-140).
[37] Colby, K. M. The Rationale for Computer-Based Treatment of Language Difficulties in
Nonspeaking Autistic Children, Journal of Autism and Childhood Schizophrenia 1973,
3: 25460.
[38] Heimann, M., Nelson, K.E., Tjus, T. & Gillberg, C. Increasing reading and communi
cation skills in children with autism through an interactive multimedia computer
program. Journal of Autism and Developmental Disorders, 1995, 25(5):459-80.
[39] Tjus, T.; Heimann, M. & Nelson, K. E. Gains in Literacy through the Use of a Specially
Developed Multimedia Computer Strategy: Positive Findings from Thirteen Children
with Autism, Autism 1998, 2: 13956
[40] Jordan, R. & Powell, S. Improving Thinking in Autistic Children Using Computer
Presented Activities. Communication, 1990, 24: 235.
[41] Jordan, R. & Powell, S. Teaching Autistic Children to Think More Effectively, Com
munication, 1990b, 24: Wiley&Sons, 1995.
[42] Parsons, S; Chell, P.; Leonard, A. Do adolescents with autistic spectrum disorders
adhere to social conventions in virtual environments?. SAGE Publications and The
National Autistic Society, 2005, Vol 9(1) 95117.
[43] Bernard-Opiz, V.; Ross, K.; Tuttas, M.L. Computer assisted instruction for autistic
children. Annals of the Academy of Medicine, 1990, v. 19, p. 611-616.
[44] Nelson, K. E., Heimann, M. & Tjus, T. Theoretical and Applied Insights from Multi
media Facilitation of Communication Skills in Children with Autism, Deaf Children,
and Children with Other Disabilities. In: Adamson, L. & Romski, M. (eds) Communi
cation and Language Acquisition: Discoveries from Atypical Development. Baltimore,
MD: Brookes, 1997, p. 295-325.
[45] Valente, J. A. Informtica na Educao Especial. In: VALENTE, J. A. (Org.) Liberando
a Mente: Computadores na Educao Especial. Campinas, SP: Unicamp. 1991. 62-79.
[46] Passerino, L. M. Pessoas com autismo em ambientes digitais de aprendizagem : estudo
dos processos de interao social e mediao. 2005. Universidade Federal do Rio
Grande do Sul. Faculdade de Educao. Programa de Ps-Graduao em Informtica
na Educao. Disponvel em http://hdl.handle.net/10183/13081.
[47] Rodrguez-Frtiz, M. J., Fernndez-Lopez, A., Rodriguez, M. L. Mobile Communica
tion and Learning Applications for Autistic People. IN: Williams, Tim (Ed.) Autism
Spectrum Disorders From Genes to Environment. Rieka, Croatia: Intechweb.org, 2011
(p. 349-362).
[48] Rodrguez-Frtiz, M. J., Gonzlez, J. L., Fernndez, A., Entrena, M., Hornos, M. J., Prez,
A., Carrillo, A. & Barragn, L. Sc@ut: Developing Adapted Communicators for Special
679
680
Education. Procedia - Social and Behavioral Sciences, 2009, 1 (1), pp. 1348-1352.
Elsevier.
[49] Burke, M. and Kraut, R. Mopping up: modeling wikipedia promotion decisions. Proc.
CSCW ACM (2008), 27- 36.Colby, K. M. (1973). The Rationale for Computer-Based
Treatment of Language Difficulties in Nonspeaking Autistic Children, Journal of
Autism and Childhood Schizophrenia 3: 25460
[50] Rabello , R. S.; Passerino, L. M.; Vicari, R. M.; Silveira, R. A. Interao e Autismo: Uso
de Agentes Inteligentes para Detectar Dficits de Comunicao em Ambientes Sncro
nos. Revista Brasileira de Informtica na Educao (2011) v. 19, n. 01.
[51] Seltzer, M.M., Krauss, M.W., Shattuck, P.T., Orsmond, G., Swe, A., & Lord, C. The
Symptoms of Autism Spectrum Disorders in Adolescence and Adulthood. Journal of
Autism and Developmental Disorders 33, 6 (2003), 565-581.
[52] Lainhart, J.E. and Folstein, S.E. Affective disorders in people with autism: a review of
published cases. Journal of Autism and Developmental Disorders 24, 5 (1994), 587-601.
[53] Muller, E., Schuler, A., and Yates, G.B. Social challenges and supports from the
perspective of individuals with Asperger syndrome and other autism spectrum
disabilities. Autism, 2008, 12, 2, 173.
[54] Passerino, L & Montardo, S. P. Incluso social via acessibilidade digital: proposta de
incluso digital para Pessoas com Necessidades Especiais (PNE). E-Comps (Braslia),
2007, v. 8, p. 1-18.
[55] Thunberg, G.; Ahlsn, E.; Sandberg, A. D. Autism, communication and use of a speechgenerating device in different environments a case study, Journal of Assistive
Technologies, 2011, Vol. 5 Iss: 4, pp.181 - 198Tjus, T.;
[56] Passerino, L. M.; Avila, B. G.; Bez, M. R. SCALA: um Sistema de Comunicao Alter
nativa para o Letramento de Pessoas com Autismo. RENOTE. Revista Novas Tecnolo
gias na Educao, v. 1, p. 1-10, 2010.
[57] Goetz, J. P. Etnography and qualitative design in educational research. Orlando, EUA:
Academic Press, 1984.
[58] Yin, R. K. Case study research, design and methods, 3rd ed. Newbury Park: Sage
Publications, 2003.
[59] Rodrigues, G. F. E se os outros puderem me entender? Os sentidos da Comunicao
Alternativa e Suplementar produzidos por educadores especiais. 2011. Dissertao
(mestrado) - Universidade Federal do Rio Grande do Sul. Faculdade de Educao.
Programa de Ps-Graduao em Educao, Porto Alegre, BR-RS, 2011.
[60] Rodrigues, G. F.; Passerino, L. Formao permanente de professores e Comunicao
Alternativa: uma aproximao necessria. In: I Seminrio de Polticas Pblicas de
incluso escolar no Rio Grande do Sul, 2010, Porto Alegre. Anais do I Seminrio de
Polticas Pblicas de incluso escolar no Rio Grande do Sul, 2010. p. 01-18.
Design of Usage
http://dx.doi.org/10.5772/54547
[61] Barth, C; Passerino, L.M.; Santarosa, L. M. C. Descobrindo emoes: software para

estudo da teoria da mente em sujeitos com autismo. CINTED. Porto Alegre, v.3, n.1,
2005. Disponvel em: <http://www.cinted.ufrgs.br/>. Acesso em: 20 de mai. 2007.
[62] Barakova, E.; Gillessen, J.; Feijs, L. Social training of autistic children with interactive
intelligent agents. Journal of Integrative Neuroscience, Vol. 8, No. 1 (2009) 2334
[63] Bez, M. R. ; Passerino, L. M. Tecnologias Assistivas, salas de recursos e Incluso escolar
a partir da perspectiva scio-histrica. In: VI Seminrio Regional de Formao de
gestores e Educadores do Programa Educao Inclusiva: Direito Diversidade, 2010,
Uruguaiana. VI Seminrio Regional de Formao de gestores e Educadores do Progra
ma Educao Inclusiva: Direito Diversidade. Uruguaiana: Prefeitura Municipal de
Uruguaiana, 2010. v. 1. p. 31-40.
681
Chapter 29
Early Intervention of Autism:

A Case for Floor Time Approach
Rubina Lal and Rakhee Chhabria
http://dx.doi.org/10.5772/54378
1. Introduction
Autism is a developmental disorder that affects a childs perception of the world and
how the child learns from his or her experiences. Even among the most complex disabili
ties, autism remains an enigma. Autism is the frequently occurring form of a group of
disorders known as Autism Spectrum Disorders (ASD). The term Autism Spectrum Dis
orders (ASD) covers diagnostic labels which include Autistic Disorder, High Functioning
Autism, Asperger's Syndrome, and Pervasive Developmental Disorder Not Otherwise
Specified (PDD-NOS).
Autism Society of America [1] defines autism as a complex developmental disability that
typically appears during the first three years of life and is the result of a neurological disor
der that affects the normal functioning of the brain, impacting development in the areas of
social interaction and communication skills. Autism has also been defined as a neurological
disorder characterized by qualitative impairment in social interaction and communication as
well as the presence of restricted, repetitive, and stereotyped patterns of behaviors, interests
and activities [2]. Children with ASD share the social and communicative symptoms which
are the core of autism, but they vary in severity of symptoms and in level of functioning.
The first three years of life are critical to a child's development. Parents take their child
to the pediatrician, during this period for general health check up, screening and vacci
nations. Although child with autism can be screened by 18 months by a pediatrician, pa
rents often are the first ones to suspect behavioral deviations in their child. The mean
age for such screening is approximately 15 months and in some cases it can be as early
as 11 months [3]. According to the parents, children manifest patterns of extreme reactiv
ity, either by getting upset when new stimulus is shown or by completely ignoring it.
The infants often fail to copy verbal behavior of others and do not babble by 12 months.
2013 Lal and Chhabria; licensee InTech. This is an open access article distributed under the terms of the
692
Research reports a significant difference between age-matched infants with autism and
typically developing infants with respect to visual attention to social stimuli, smile fre
quency, vocalization, object exploration engagement, facial expression, use of convention
al gesture, and pointing to indicate interest [4].
Identifying autism in toddlers is a recent practice. A large number of children have been di
agnosed reliably at 2 years. Professionals can now predict autism from the behaviors ob
served in a child younger than 2 years. Providing therapeutic intervention at this age would
improve developmental and adaptive outcomes. The global trend in early intervention of
autism is to provide training to parents so they can help the children develop in key areas of
social responsiveness, attention skills, early communication skills, and interactive behavior.
2. Autism and social behavior

Difficulties in social relationships and interactions have been the defining features of autism.
Hence, the need to understand the nature of these difficulties and to find effective treat
ments for them has been central to autism research and educational practices [5]. Unlike
neuro-typical children who learn how to be social and interactive by watching how others
talk, play and relate to each other, enjoy the give-and-take of social engagement and initiate,
maintain and respond to interactions with others, children with autism often do not show
the expected development of early social interaction skills. They are often socially avoidant,
socially indifferent and awkward. Autistic children avoid social contact by having a tantrum
or running away from people who attempt to interact with them. They seek social contact
with people only when they want something. Factors that may affect development of social
behavior are described below.
Theory of Mind: Many children with autism also show profound empathy deficits. They
develop a limited appreciation or no appreciation at all, of other people's feelings and
ideas. They don't recognize and respond to faces as do normal children, and they thus do
not learn that each face belongs to an individual separate person. To the severely autistic
child, his/her own feelings and ideas are the only feelings and ideas that appear to exist.
Autistic children may have no reaction to another person's crying, for example. They may
have no idea that their words and actions affect other people. Many autistic children are
completely unaware of their surroundings and other people in their surroundings. It is
impossible for some autistic children to take another person's perspective without delib
erate training. For individuals with autism, it does not come naturally to consider other
peoples perspective. This makes it difficult for them to understand how others think and
feel [6]. Clinicians and researchers call this inability to consider others perspective as def
icit in theory of mind. Theory of mind, the ability to attribute mental states to self and oth
ers in order to understand and predict behavior, is an area of weakness among
individuals in the autism spectrum. The development of theory of mind begins in infancy,
as does the shift from the typical course that is seen in children with autism spectrum dis
orders. While the peak in theory of mind development occurs in typical children from the
Early Intervention of Autism: A Case for Floor Time Approach

http://dx.doi.org/10.5772/54378
age of 3 to 4, mental state understanding in individuals within the autism spectrum often
continues to be conspicuously absent throughout the lifespan and leads to significant so
cial and communicative challenges.
Play Behavior: Play is considered a key social behavior. Children play, regardless of age,
so this is a behavior that is typically found in the behavioral repertoires of all children. To
teach play to children with autism is to teach them skills that other typically developing
children have and give them a common ground, a common language to engage with oth
ers. Play phases occur in developmental stages that typically developing children go
through, so play is not only for fun, but for a purpose. Children learn about social interac
tion and language through play. As children with autism have trouble in symbol use and
joint attention, understanding anothers perspective, participating in pretend play and us
ing imitative skills are difficult for many of them. They are more self-centered than self
ish. When involved in joint play, there can be a tendency to impose or dictate the activity.
Social contact is tolerated as long as other children play their game according to their
rules. Children with ASD play in a bubble and can resent other children intruding into
their activity. They prefer to be left alone and continue their activity uninterrupted. There
is a strong preference to interact with adults who are far more interesting, knowledgeable
and more tolerant and accommodating to their lack of social awareness. It is often hard
for them to enter into play with other children, maintain that play, and be appropriate.
The children do not see themselves as members of a particular group and follow own in
terest rather than that of other children in the group. In fact, while other children have
mastered the rules of simple childhood games, these children may not understand what is
expected of them in team sports. They are often not interested in competitive sports or
team games. Even understanding basic turn-taking may elude them. Most of them are un
able to comprehend how or why one would have a sense of satisfaction in knowing that
ones opponents felt inferior.
Comprehending Emotions: Inability to empathize with people may be misinterpreted as a
complete lack of the ability to care for others. It is more often a lack of understanding of
emotions. The child is either confused by the emotions of others or has difficulty express
ing own feelings. The child does not display the anticipated range and depth of facial ex
pression. As interaction continues, one is aware that the child is not recognizing or
responding to changes in the other persons facial expression or body language. Hands
may be moved to describe graphically what to do with objects or express anger or frustra
tion, but gestures or body language based on an appreciation of another persons
thoughts and feelings- e.g. embarrassment, consolation or pride- are conspicuously di
minished or absent [7]. Subtle clues may not be recognized by a child with Aspergers
Syndrome. The child can then be confused and offended when criticized for not comply
ing with the signals of hidden intention. Not only are there problems with the under
standing of the emotional expressions of others, but the childs own expression of
emotions are unusual, and tend to lack subtlety and precision. A complete stranger may
be given a kiss on the lips, or distress is expressed quite out of proportion to the situation.
Sometimes they cannot express their anger appropriately. When they are anxious or
693
694
stressed, they may not be able to let others know how they are feeling and may react vio
lently or aggressively. Additionally, appropriate social interaction in autism is hampered
by a tendency to become fascinated by special interest that dominates the childs time and
conversation, and the imposition of routines that must be completed. The interest is a soli
tary pursuit and not that evinced by age peers. A lack of completion of the activity in a
routine can lead to distress and anxiety. Researches indicate that insistence on completing
an activity in a particular way may be the childs attempt to find patterns and look for
rules and organization within environment [8]. Once a pattern has emerged it must be
maintained. Thus, establishment of a routine ensures that there is no opportunity for
change. As social situations are inherently dynamic, this adherence to routine and limited
interest deeply impacts the child's ability to be socially active in appropriate manner.
3. Early intervention
Early intervention (EI) is a system of services provided to children who are disabled, have
delayed development or are at risk of delayed development, from birth until about five
years of age. To help children with autism it is essential to focus on the earliest years of de
velopment, since this is a critically important time for early learning which powerfully af
fects the childs future life course.
Early intervention, also known as early childhood education, provides a support system for
children with developmental disabilities and their families. Early intervention may start as
soon as it is evident that the child has a developmental disability or is at risk of acquiring it.
The early intervention services ensure that infants and pre-school children develop the core
skills in physical, cognitive, communication, socio-emotional and self help domains. Early
intervention (EI) services are coordinated so that they enable child's growth and develop
ment and support families during the critical early years. For the family, such services help
in overcoming the feelings of isolation, stress and frustration, and reduce the cost of provid
ing for special education, rehabilitation and health care needs of the child. EI services follow
a multidisciplinary approach, with a variety of therapists and teachers working in collabora
tion to improve the child's prognosis in every area of development.
To help children with autism it is essential to focus on the earliest years of development,
since this is a critically important time for early learning which powerfully affects the childs
future life course. The children are actively engaged in an instructional program three to
five times a week, through the year. It involves planned intervention organized around rela
tively brief periods of time for the very young children so that they may receive sufficient
adult attention. Since children with autism find it difficult to work in large groups, the EI
services for them should follow a structured program of one-on-one training or training in
small groups to help attain individual goals.
EI is the most dynamic and critical period in the treatment of autism for one very simple
reason: the younger they are, the more 'elastic' their brains are [9]. Recognizing and diagnos
ing autism before pre-school age has been uncommon until the last few years. But increas

http://dx.doi.org/10.5772/54378
ingly autism is being identified very early in development. It has been shown that diagnosis
can be valid and reliable at 2 years of age, and signs can be recognizable and predictive of
autism even from early in the second year of life. In future it is likely that autism will be
diagnosed for most children in the toddler age period [18 - 30 months). Very early therapeu
tic intervention is likely to improve developmental and adaptive outcomes. Trials of early
intervention need to focus on training parents to work with their very young children in the
key areas of social responsiveness, attention skills, early communication skills, and interac
tive play. The findings of a study by Ivar Lovaas [10] on early behavioral intervention of
children with autism in 1987 showed a significant gain in IQ and that 49% of children who
received EI were mainstreamed in regular classrooms.
The guidelines for best practice in early intervention for children with autism [11] recom
mend the following:
Preparation: All children on entering intervention programs should have had a compre
hensive, multidisciplinary diagnostic assessment from an interdisciplinary team of experi
enced clinicians and based on national and internationally agreed criteria. Diagnostic
evaluations should include interviews with parents/care givers to review the childs de
velopmental history, family history, previous assessments and interventions; collection of
information from all professionals involved in the care of the child; paediatric, psycholog
ical, and speech pathology examinations to assess communication, relevant health condi
tions including motor skills, vision, and hearing, and any associated problems such as
intellectual disability and anxiety. Additionally, direct observation of the child is impor
tant in the assessment of cognitive, social, and communicative (verbal & nonverbal) do
mains, fine and gross motor, and adaptive functioning using both standardised tests and
informal procedures.
Timing: Intervention should begin as early as possible in the childs life. Since a child at
risk of autism can be screened by 16 months the intervention may start immediately.
Process: All children should have an Individual Family Service Plan (IFSP), for their edu
cation, designed to best fit their and their family's needs and strengths, developed in con
sultation with parents, and reviewed and revised regularly in light of the childs progress
and ongoing needs.
Intensity: Ideally the intervention should be provided for 20 hours a week for two years,
with continuing support into, and through the school age years.
Content and Focus: The content should be autism specific and include teaching joint at
tention skills, play, and imitation skills; building communication through Alternative and
Augmentative Communication (AAC) techniques such as pictures, symbols and signs;
developing social interaction and daily living skills; and management of sensory issues
and challenging behaviors.
Settings: The intervention should be delivered in various settings, individually and with
peers. Implementation should happen both at the centre and at home. Including age peers
695
696
with no disability enhances the quality but it should be done so that peer interaction is
adequately supported.
Program Design and Methods: A high degree of structure in the program is essential, i.e.
well organized, regular and predictable, focused on specific objectives, and consistently
managed. A supportive teaching environment with modeling, prompting, praise, shap
ing, and generalization strategies will maximize learning.
Challenging Behaviors: A functional approach to modifying challenging behaviors in
cludes positive behavior support that consists of teaching alternative appropriate behav
ior and communication skills to replace challenging behaviors.
Personnel: Teachers and therapists should be adequately trained in working with chil
dren with autism and have knowledge and skills required for their special needs.
Family Collaboration: Parents need information about autism and services, especially at
key times like first diagnosis and school entry. Programs should include parent involve
ment, such as provision of support, counseling, and parent education to help the child
with play, social, and communication skills development, and with management of chal
lenging and repetitive behaviors
Research and Evaluation of Program: Evaluation of treatment outcomes should be built
into EI programs using systematic assessment of the childs social, cognitive, and adap
tive functioning before, during, and at the end of the program. Regular and systematic
documentation of program process and outcome helps in evaluation.
Collaboration with family or parents is a component of best EI practices. Parents of children
who have autism play an important role; they are critical components of the intervention
process, without whom gains are unlikely to be maintained. The involvement of parents in
implementing intervention strategies designed to help their autistic children has a history
stretching back at least three decades [12]. Parental involvement is an integral part of the
success of early intervention programs for children with autism. The collaboration between
the parent and the professional working with the child in the program is critical to the effec
tiveness of programs.
Traditionally, the EI for autism has been premised on the use of applied behavioral methods
such as discrete trials. However, at times parents find the structure, organization and proto
col of behavioral intervention difficult to implement and maintain. Consequently, the pro
gram receives inadequate follow up in the child's home. There is a need for interventions
that do not require a rigid structure and ensure parental involvement. Hence, in the recent
years, EI practices for autism have seen a shift from behavioral methods to developmental
approaches.
4. Developmental approach
In a developmental approach, development of a child with autism is compared with the de
velopmental sequence seen in non-disabled children. Early childhood assessment tools are

http://dx.doi.org/10.5772/54378
used to determine the patterns of typical development. The skills that the child demon
strates are indicative of his or developmental level. The intervention goals are set for the
skills the child failed or partially accomplished during assessment. A developmental ap
proach to intervention is also referred to as child centered approach in which the adult fol
lows the child's lead. It uses materials and activities that suit the child's level in a given area
of development. The materials are provided to the child, and the adult facilitates the child'
interaction with them so that the child moves towards achieving the pre-set developmental
goal. But it is the child's initiative with the material or activities that serves as guideline for
the adult's interaction. For example, if a child picks up a toy, the adult may show what can
be done with it by demonstration and prompts. Child's preferences decide what should be
selected as material, and the adult plays a supportive role to encourage the child's interac
tion with the material. Unlike the behavioral methods, developmental approach does not re
quire the child to interact with material or carry out an activity in a pre-specified structured
manner. The consequences of such interactive behaviors are reinforcements that occur natu
rally in child's environment. The reinforcements may be internal, such as, happiness at being
able to complete a task successfully.
5. The DIR model and floor time

The Developmental, Individual, Relationship-based (DIR) Model, designed by Stanley
Greenspan in 1989, provides a framework to understand the functional emotional develop
ment and unique profile of every child, and a guide to create emotionally meaningful learn
ing interactions that promote critical functional emotional developmental capacities. The
objectives of the DIR Model are to build healthy foundations for social, emotional, and intel
lectual capacities rather than focusing on skills and isolated behaviors [13]. The DIR de
scribes six milestones as crucial to a child's development. Parents and professionals involved
with the child must comprehend how the milestones affect a child's emotional and intellec
tual growth. The six milestones, namely, Self regulation and interest, Intimacy, Two-way
communication, Complex communication, Emotional ideas, and Emotional thinking, are ex
plained below. Individual difference is the unique biologically-based ways each child takes
in, regulates, responds to, and comprehends sensations such as sound, touch, and the plan
ning and sequencing of actions and ideas. While children may be very hyper sensitive to
touch and sound, others may be hypo sensitive, and still others seek out these sensations.
Relationship is described as the learning relationships with caregivers, educators, therapists,
peers, and others who tailor their affect based interactions to the childs individual differen
ces and developmental capacities to enable progress in mastering the essential foundations.
Floor time, is central to the DIR model of early intervention. It enables professionals and pa
rents to assess and implement intervention programs that address the unique developmen
tal needs of children with autism. The major element of this approach entails that (a)
professionals do floor time with the child (b) parents observe floor time being done with
their child, and (c) parents change their style of relating to the child with regard to a given
milestone. Floor time is a systematic way of working with a child with autism to help him or
697
698
her climb the developmental ladder. Floor time intervention aims at taking the child back to
the first milestones that the child may have missed in the process of development. With the
help of the therapists and parents the child works towards achieving the milestones. This is
done through intensive one to one sessions for which parents share equal responsibility
with the therapists. According to the DIR/Floor time framework, due to individual process
ing differences, children with autism do not master the early developmental milestones that
are the foundations of learning. Floor time [14] describes six core developmental stages that
children with autism have often missed or not mastered:
Regulation and interest in the world: Infants try and process what they see, hear, and feel.
They respond to pleasant face and soothing voice. They learn to enjoy, understand and,
use the pleasant feelings and sensations to calm themselves. This helps them learn to take
in and respond appropriately to the world around them. This ultimately develops the
ability to self regulate.
Engagement and relationship: Babies learn to bond with their parents very soon. They
recognize the parents' face and voice, and want to touch them or be close to them. They
enjoy being cuddled and loved by their parents. This process of bonding also builds a re
lationship of trust between babies and their parents. This trusting relationship enables the
child to become a well-adjusted adult later in his or her life. It also forms a stable base for
all future relationships. The baby learns that relationships with people can be joyful.
Two-way communication: Once relationship with parents is developed, the baby realizes
that he or she can have an impact on parents. The baby's smile can produce a smile from
the parents. If the baby reaches out to mother, she picks him or her up. The baby learns
that adults can understand and respond to its communication intents and feelings. A dy
ad of communication starts slowly. When the baby looks at the mother and reaches out to
her the mother responds by giving eye contact and a hug. In turn the baby may smile,
vocalize or touch the mother. Thus a non-verbal dialogue or a two-way communication
process may be completed. The baby soon transfers this new ability to other things in the
environment. He bangs a toy, it makes a noise, and if he drops his bottle, it breaks. His
actions can have an impact not only on his parents but others too. Hence, two-way com
munication helps babies to learn about them and about the world.
Complex communication: The non-verbal two way communication slowly becomes com
plex in nature. While earlier the baby was initiating or responding to a communication by
a simple gesture of reaching out or smiling, now he may run towards the mother, and
squeal with pleasure. Anger and displeasure may be expressed by pulling, kicking and
grabbing or throwing things. Similarly, hugs and kisses are used to express affection.
Since, the baby is ambulatory by now, he may take the parent by hand and show them
what he wants. Complex communication ability also aid development of creativity. The
toddler adds his own ideas to the games that parents play with him. This leads to the
emergence of the child's own personality.
Emotional ideas: Play is a fertile ground for ideas. Using toys and playthings, a child cre
ates a world where toys play roles. So, a teddy is a friend, a doll is a baby and a shoe box

http://dx.doi.org/10.5772/54378
is a car garage. This idea-filled play provides a strong basis for language development.
Besides learning to label things, the child now uses dialogue during play with help of the
parents. Eventually, he is able to manipulate the ideas to meet his needs. When hungry,
he can ask for food; if he needs help he can call his mother instead of crying. He learns
about object permanence - that although not visible to him, object do not disappear.
Hence, he can feel secure thinking about his parents even when they are not with him.
With this ability to use symbols, the child moves on to a higher level of communication
and awareness.
Emotional thinking: When he reaches this stage, a child is ready to connect various ideas
into a logical sequence. While in the previous stage he was able to carry out symbolic ac
tivities, such as dressing a doll, and banging a toy car into another to simulate a crash, the
child is now able to think emotionally. He may dress up the doll for a car ride. At this
stage, the child is able to express a wide range of emotions, and through this learns to rec
ognize self. The child now comprehends concept of space and time at a personal level. For
example, the child understands that grandmother's house is different from his own, or
that if he grabs another child's toys, his own favorite car may later be taken away by that
child. The child, by this time, is fully verbal and can use words to express ideas and feel
ings.
5.1. Floor time method
A typical floor time session is conducted in a child's naturalistic environment and requires
the therapist or parent to sit on the floor and work with the child. The purpose is to help the
child achieve the stages of development, by taking him back to the milestones that he may
have missed. During a session, the parent or therapist follows the child's lead. This helps in
establishing relationship between the child and the adult. It is this relationship that slowly
enables the child to develop the basic social, emotional and communication abilities. During
a floor time session the child learns to engage with others, initiate actions, make own wishes
and desires known and the realization that his actions can elicit responses from others. Floor
time creates opportunities for children to have dialogues, which are called circles of commu
nication, first without words and later with them, and eventually to imagine and think.
Since floor time sessions are child-centered, the activities are motivating to the child as it is
he who has chosen them. Additionally, the selecting the child's natural environment for the
session also contributes to calming him and improving his comfort level. A floor time ses
sion follows the steps given below.
1.
Observation: Before starting a session, the adult observes the child. This requires watch
ing the child while he is in the room, observing what interests him, assessing his level of
interaction is he running around or is he sitting quietly. This observation helps the
adult determine the child's current emotional state.
2.
Approach: Once the adult understands the child's level of emotional functioning, he or
she joins the child in whatever the child is doing. If the child sits and merely twirls a
toy, the adult follows this play behavior. However, the adult adds value to it by label
699
700
ing the activity in gestures and words. The adult also uses appropriate facial expression
and tone of voice to convey own enjoyment in what the child is doing. Such measures
enable the adult to open the circle of communication with the child
3.
Child's Lead: During a floor time session, the child is the director or leader of activities.
The adult's role is to follow the child. The aim here is to support the child's activities
and initiatives, and through this to take him to a higher level of emotional functioning.
4.
Expand Ideas: As the sessions progress, the adult builds on the child's play initiatives.
Now the adult associates daily experiences with the experiences during the play activi
ties. For example, the adult may say "give teddy a bath, like mommy gives you". This
planned expansion and addition to child's activities help in development of emotional
ideas.
5.
Close Circle of Communication: Once the adult engages the child at a level the child
currently enjoys, enters the child's activities, and follows the child's lead, he or she now
attempts to move the child from a mutually shared engagement toward more increas
ingly complex interactions, a process known as "opening and closing circles of commu
nication." In a circle of communication, the adult opens the circle by approaching the
child, and the child closes the circle by giving a reaction to the adult's comments and
gestures. During session many circles may open and close in quick successions as the
adult interacts with the child. The process leads to two-way communication.
6. Research support for floor time

The Floor time approach examines the functional developmental capacities of children in the
context of their unique biological profile and their family relationships and interactive pat
terns. A longitudinal study [15] was conducted to determine if children with ASD could
overcome the core deficits in social behavior and become empathetic and reflective with
floor time intervention. A follow-up study of 16 children diagnosed with (ASD) revealed
that with the DIR/Floor time approach, a subgroup of children with ASD can become empa
thetic, creative, and reflective, with healthy peer relationships and solid academic skills. This
suggests that some children with ASD can master the core deficits and reach levels of devel
opment formerly thought unattainable with a family-oriented approach that focuses on the
building blocks of relating, communicating, and thinking [16].
In another study undertaken by Greenspan and Weider [15] where the progress of 200 chil
dren who had earlier received Floor time sessions, was reviewed showed that majority of
the children learned to relate and engage with warmth, trust and intimacy; they were able to
interact, read and respond to social signals; a subgroup of children developed the capacity
for imaginative play, creative use of language and reflective thinking. This sub group was
included in mainstream schools where the children developed meaningful relationships
with peers.

http://dx.doi.org/10.5772/54378
Josefi and Ryan [17] conducted a case study on a 6 year old boy with severe autism. Video
recordings of 16 sessions of play therapy with the child were analyzed qualitatively and
quantitatively. The study concluded that this child was able to enter into a therapeutic rela
tionship and demonstrated attachment behavior towards the therapist. Key areas of im
provement were in the childs development of autonomy and pretend play, while ritualistic
behaviors showed only mild improvement. Changes were also noted in the boys behavior
at home of increased independence and empathy. One implication of this preliminary re
search is that non-directive play therapy may enhance and accelerate emotional/social de
velopment of children with severe autism.
Children with ASD differ from one anotherin the ways they engage, relate, and communi
cate and in the ways they respond to sensations, and plan and sequence their actions. These
differences mean that each child requires an intervention approach tailored to his unique
ness, an intervention that must also consider the home setting. According to Costa and Wit
ten [18] the goals of such a program, regardless of the approach used, must be to strengthen
the childs core deficits, namely: building the foundations for relating, communicating and
thinking. The DIR/Floor time Model is especially beneficial to children with ASD and other
developmental and/or emotional challenges.
Solomon et al [19] published an evaluation of The PLAY Project Home Consultation, a wide
ly disseminated program that trains parents of children with autism spectrum disorders in
the DIR/Floor time model. Sixty- eight children, 2 to 6 years old (average 3.7 years) complet
ed an 812 month program where parents were encouraged to deliver 15 hours per week of
1:1 interaction. Pre/post ratings of videotapes by blind raters using the Functional Emotional
Assessment Scale (FEAS) showed significant increases in child subscale scores. That is, 45.5
percent of children made good to very good functional developmental progress. Overall pa
rents satisfaction with program was 90 percent.
7. Method
The study was experimental in nature and employed a pre-test post-test control group ex
perimental design. It was conducted on children with ASD residing in Mumbai, India. The
objectives were to determine the efficacy of floor time approach for developing social behav
ior in pre-school children with ASD, and to compare the levels of social skill achievement by
children who received floor time intervention with those who did not.
7.1. Subjects
Children with ASD within the age group of 3 to 6 years were randomly selected from five
pre-schools and intervention clinics located across the city and suburban areas of Mumbai.
A total of 26 children participated in the experiment. After selection the children were ran
domly assigned to treatment and control groups so that both groups had 13 children each.
701
702
7.2. Instruments
The Behavioral Scale for Social Skills (BSFS) and Floor time intervention were the primary
instruments used in the study. They were developed for the purpose of the research. A brief
description of both is given below.
Behavioural Scale for Social Skills: The BSFS was used as a measure at both pre and post
tests. The instrument measured social behaviour under 4 domains
a.
Turn taking: This is one of the bases for development of social skills and inferring oth
ers' intentions correctly [20]. Turn taking includes use of play material with an adult
and with peers.
b.
Two-way communication: As a child enjoys intimacy in a safe and calm manner, he re

alizes he can have an impact on others. The child expresses a feeling or intention, and
his partner responds. This is the beginning of communication. Two-way communica
tion enables the child to enjoy intimacy and initiate interaction through gestures at first
and then with words.
c.
Understanding of cause and effect: This is a basis for development of thinking skills.
The ability to see the relationship between an event and the factors leading to it helps a
child decode the world around him. Understanding of cause and effect relationship im
proves by providing the child the opportunity to explore the environment.
d.
Emotional thinking: According to Greenspan, emotional thinking is the ability to build

bridges between ideas to make them reality-based and logical. Ideas are linked together
into logical sequences and play, and imagination is also more rational.
The BSFS had a total of 20 items. Each item was measured on a 4-point scale based on the
category of response, namely, correct response; response with verbal prompt; response with
gestural prompt; and response with physical prompt. Whereas correct responses were scor
ed as 4, responses with physical prompts were scored as 1. The selection of items under each
sub head of BSFS was done after detailed discussions with developmental psychologists,
pre-school teachers, and many parents. In addition, several observations of pre-school chil
dren with and without ASD were also made for selection of items. The instrument was pilot
tested on children with ASD belonging to the same age group as the subjects.
Floor time Intervention: Floor time is a comprehensive program for infants, young chil
dren, and families with a variety of developmental challenges including ASD. The pro
gram aims at enhancing the functional emotional developmental levels and creating those
learning relationships that will help the child move ahead in social skills acquisition.
Floor time can be tailored to suit the individual needs of children with ASD. Floor time
approach was used for treatment in the study. As stated earlier, Floor time approach
helps an infant/young child reach the 6 milestones crucial for development of social be
havior, namely, self regulation; intimacy; two way communication; complex communica
tion; emotional ideas,; and emotional thinking. However, in this study, the treatment was
directed toward achievement of 4 milestones Turn taking (a component skill in intima
cy), Two way communication, Understanding of cause and effect relationship (an impor

http://dx.doi.org/10.5772/54378
tant skill for problem solving that enhances complex communication), and Emotional
thinking. Various activities were developed for the purpose of enhancing the target skills.
Some of the activities are mentioned below.
a.
Turn taking: Here the activities selected were done with the authors and then done with
peers. Such activities as building block tower, bead stringing, rolling a ball, and throw
ing ball in a bucket were used for teaching turn taking skills to children.
b.
Two-way communication: Training a child to respond to his name, reach out to a play
thing, and respond to non-verbal communication such as gestures, facial expressions
etc was undertaken to develop the ability for two way communication.
c.
Cause and effect: A series of simple activities were done to explain the relationship be
tween an outcome and its cause. Tapping a spoon on a surface, shaking a bell, pressing
a toy to produce sound or movement, squeezing a wet sponge, opening a transparent
box to obtain a desirable object within, etc. were undertaken to help the children estab
lish the connection between a cause and its effect.
d.
Emotional thinking: Pretend play was primarily used for this purpose. Hence, pretend
play such as talking on telephone, dressing or feeding the doll (where the authors
would at times play out the doll's emotions in the right tone of voice), and playing a
shopkeeper etc. were included. The focus was on recognition of emotions. Thus, flash
cards of happy and sad faces were used too during the pretend play so that the child
was able to understand what did it mean when the 'doll' was 'crying' or the the shop
keeper was 'happy'.
7.3. Procedure
The intervention started after assessing the children's baseline behavior on BSFS. The 26
children were then randomly assigned to experimental and control groups so that both
groups had 13 children each. As per the recommended floor time protocol, the researchers
observed each child in the experimental group to determine his or her current emotional
level, before the commencement of intervention. Each child in the experimental group re
ceived 20 sessions of floor time intervention. Each session was of 30 minutes duration. Each
session included at least one activity relevant to the pre selected social skills. The sessions
started by getting the child's attention by showing a desired object. The researchers used
word and simple phrases to describe each activity. The activities were done as given below,
and parents were encouraged to observe the sessions.
Building a block tower began by demonstrating how to make a tower from the four
blocks provided on the floor. The child was then asked to lay a block over the one put by
the adult. Subsequently, the adult would put another block over it. The adult would then
prompt the child to take his or her turn to put a block on top. The activity was repeated
with a peer. Now the peer would take the adult's role. The adult would call out each
child's name and say ' your turn now ', as they put one block over the other to make a
block tower.
703
704
A number of colorful beads were placed on the floor along with a string for the bead
stringing activity. The task was first demonstrated, and then used to encourage the child
to take turn with an adult and later with a peer in slipping a bead through the string.
The ' ball rolling ' activity was done by rolling the ball to a child and asking him or her o
roll it back to the adult. In case of 5 or 6 year old children, a slight variation was made.
The activity was introduced with a peer. Both the child and peer were asked to take turns
in throwing the ball to the adult and to each other.
Throwing the ball in the bucket required that the child identify the bucket first. Subse
quently, the task was demonstrated before the child taking turn with the adult and with
peer to throw a ball in the bucket.
Cause and effect activities such as ringing a bell (to produce sound), squeezing a sponge
(for water to drip), and opening a box (to get what is inside) were demonstrated and sub
sequently, taught with prompts and cues. Some fun activities such as blowing soap bub
bles were also included as soap bubbles excited the children.
Calling out the child's name, seeking his attention by showing a preferred object or toy
helped in initiating two-way communication. Preferred activities served a dual purpose.
They could get the child's attention, but they were also helpful in teaching the child a way
to communicate. The adult would have a picture of the preferred activity or toy. The child
would be asked to point or pick up the picture in order to get the activity. The adult also
used facial expression cards to help the child understand what each expression meant.
Pretend play was a strong medium for teaching emotional thinking. Pretend play was en
couraged using a variety of toys such as dolls, telephone, car, kitchen set, and doctor set
etc. The adult would pretend to call the child, and ask the child to pick up the phone and
say something. While the child was holding the doll, the adult would prompt him or her
to hug and kiss the doll. If the child put the doll away, the adult would convey in appro
priate tone and affect how sad the doll was feeling. The child would then be prompted to
hold the doll again.
Taking the lead from the child, the adult would stand at the window if the child was
standing there. The adult would then softly describe what they could both see.
Though all activities were pre-planned, the adult would at times digress to include activi
ties that suited the need of the child on a given day.
While the experimental group children received floor time intervention, the children in the
control group received the usual early intervention sessions provided in their educational
settings. Post intervention, BSFS was administered again.
Figures 1 to 7 illustrate some of the floor time activities done with the children.

http://dx.doi.org/10.5772/54378
Figure 1. Block tower activity
Figure 2. Picture matching
705
706
Figure 3. Getting a child's attention
Figure 4. Pretend play with doll

http://dx.doi.org/10.5772/54378
Figure 5. Teaching facial expression
Figure 6. Choice of play things
707
708
Figure 7. Activity with peer
8. Results
The study was conducted to establish the efficacy of floor time for development of social
behavior in pre-school children with ASD. The children who received intervention
showed a qualitative change in their interactive behavior. A comparison of their compo
site mean score on BSFS at baseline with that at post intervention showed a significant
difference. The data was analyzed using t-test, as the selection of children was random.
Table 1 presents the details.
Mean
df
t-value
Significance
Pre test
34.92
13
12
9.56
p< .0001
Post test
48.38
13
Table 1. Comparison of Composite Mean Scores on BSFS at Pre and Post Tests
The statistical analysis of data indicated the overall effectiveness of floor time. The average
score on BSFS at baseline [34.92] increased post intervention [48.38]. This increase was sig
nificant as evident from the obtained t-value [9.56, p<.0001]. That the intervention was effec
tive for all children in the group may be seen from Figure 8 which shows the performance of
each child at pre and post intervention conditions
Table 1.
Comparison of Composite Mean Scores on BSFS at Pre and Post Tests
The statistical analysis of data indicated the overall effectiveness of floor time. The average score on BSFS at baseline [34.92]
increased post intervention [48.38]. This increase was significant as evident from the obtained
Early Intervention of Autism: A Case for Floor Time Approach 709
http://dx.doi.org/10.5772/54378
t-value [9.56, p<.0001]. That the intervention was effective for all children in the group may be seen from Figure 8 which shows the
performance of each child at pre and post intervention conditions
70
60
50
40
30
20
10
0
1
pre test
10
11
12
13
post test
Figure 8. Comparison of individual performance on BSFS
From Figure 8 it is evident that floor time intervention enhanced the social behavior of children, though some gained more from
From Figure
8 it This
is evident
thatbefloor
enhanced
the social
behavior
of chil
the treatment
than others.
variance may
due totime
initial intervention
intra group differences
in the children's
functioning
levels.
dren, though some gained more from the treatment than others. This variance may be due
Children's scores on selected components of BSFS of turn taking, two way communication, cause and effect and emotional thinking
to initial intra group differences in the children's functioning levels.
were analyzed individually. On Turn taking skill, the baseline mean [12,38] was significantly lower than the mean score [17.69]
Children's scores on selected components of BSFS of turn taking, two way communication,
cause and effect and emotional thinking were analyzed individually. On Turn taking skill,
the baseline mean [12,38] was significantly lower than the mean score [17.69] post interven
tion. The derived t-value [5.02] was statistically significant (p<.0002]. An illustration of each
postchild's
intervention.
The derived on
t-value
was statistically
significant by
(p<.0002].
An9.illustration of each child's performance on
performance
turn[5.02]
taking
skill is provided
Figure
turn taking skill is provided by Figure 9.
30
25
20
15
10
5
0
1
6
pre test
10
11
12
13
post test
Figure 9. Comparison of individual performance on turn taking
It is evident from Figure 9 that the treatment was effective for all children in the experimental group. All of them gained
It is evident
Figure
that the
treatment
was effective
for all children
in the experimen
significantly,
except from
child no.
7 who 9
showed
a marginal
improvement
only. The children's
ability to understand
the relationship
between
cause andAll
its effect
also improved.
mean performance
on this
subno.
skill 7post
intervention
[13.30]
was higherim
than the
tal group.
of them
gained Their
significantly,
except
child
who
showed
a marginal
baseline [8.61]. The derived t-value was significant [7.17, p<.0001]. Each child's performance on cause and effect is depicted in
provement
only.
The
children's
ability
to
understand
the
relationship
between
cause
and
its
figure 10. The data indicates the effectiveness of floor time as a method to develop the understanding of cause and effect
relationship in children with ASD.
18
16
14
12
15
10
710
Recent Advances
in Autism Spectrum Disorders - Volume I
5
0
1
10
11
12
13
effect also improved. Their mean performance

on
this sub skill post intervention [13.30] was
pre test
post test
higher than the baseline [8.61]. The derived t-value was significant [7.17, p<.0001]. Each
child's performance on cause and effect is depicted in figure 10. The data indicates the effec
tiveness of floor time as a method to develop the understanding of cause and effect relation
ship in children with ASD.
significantly, except child no. 7 who showed a marginal improvement only. The children's ability to understand the relationship
between cause and its effect also improved. Their mean performance on this sub skill post intervention [13.30] was higher than the
18
16
14
12
10
8
6
4
2
0
1
6
Pre test
10
11
12
13
Post test
Figure 10. comparioson of individual performance on cause and effect relationship
When performances on two-way communication skills were compared, a similar trend was evident. The mean score at baseline
[6.31]
was lower
than that post intervention
[8.69]
and the difference was
statistically
significant (t=5.72,
p<.0001].trend
Individually
When
performances
on two-way
communication
skills
were compared,
a similar
was too,
children improved as may be seen from figure 11. All children gained on the ability for two-way communication.
evident. The mean score at baseline [6.31] was lower than that post intervention [8.69] and
the difference was statistically significant (t=5.72, p<.0001]. Individually too, children im
proved as may be seen from figure 11. All children gained on the ability for two-way com
munication.
Lastly, when the data from BSFS were analyzed for performance on emotional thinking, a
significant gain was seen in this area too. The difference between baseline mean score [7.38]
and post intervention mean score [8.84] was significant (t-value=3.5, p<.004]. Though this
difference was significant when means were compared, individually all children did not
gain from the intervention. Whereas most children showed an enhancement in emotional
thinking from pre to post intervention, performance of some remained the same as what it
was at baseline. Figure 12 presents the data on emotional thinking. Since, emotional think
ing is the last and the most complex of the six milestones; it is possible that these children
required more time to achieve this skill than what was given during the 20 sessions of inter
vention. However, these children improved their performance on the earlier sub-skills of
turn taking, two-way communication and understanding of cause and effect relationship.
14
12

http://dx.doi.org/10.5772/54378
10
711
8
14
6
12
4
10
2
8
0
1
Pre test
10
11
12
13
Post test
4
Figure 11. Comparison of individual performance on two-way communication
2
Lastly, when the data0from BSFS were analyzed for performance on emotional thinking, a significant gain was seen in this area too.
The difference between baseline
and
1
2mean 3score [7.38]
4
5 post
6 intervention
7
8 mean
9 score
10[8.84]11was significant
12
13 (t-value=3.5, p<.004].
Though this difference was significant when means were compared, individually all children did not gain from the intervention.
Pre test
Post test
Whereas most children showed an enhancement in emotional
thinking
from pre to post intervention, performance of some
remained the same as what it was at baseline. Figure 12 presents the data on emotional thinking. Since, emotional thinking is the
last and
most complex
of theperformance
six milestones;
it is possible
that these children required more time to achieve this skill than what
Figure
11.the
Comparison
of individual
on two-way
communication
Figure
11. Comparison
of individual performance
on two-way communication
was given during the 20 sessions of intervention. However, these children improved their performance on the earlier sub-skills of
turn taking,
understanding
of causeon
and
effect relationship.
Lastly,
whentwo-way
the data communication
from BSFS wereand
analyzed
for performance
emotional
thinking, a significant gain was seen in this area too.
The difference between baseline mean score [7.38] and post intervention mean score [8.84] was significant (t-value=3.5, p<.004].
Though this difference
was significant when means were compared, individually all children did not gain from the intervention.
14
Whereas most children showed an enhancement in emotional thinking from pre to post intervention, performance of some
12
last and the most complex of the six milestones; it is possible that these children required more time to achieve this skill than what
10
turn taking, two-way
communication and understanding of cause and effect relationship.
8
14
6
12
4
10
2
8
0
6
Pre test
10
11
12
13
Post test
2
Figure 12. Comparison
of individual performance on emotional thinking
Figure 12. Comparison of individual performance on emotional thinking
The second objective

of the study was to compare the performance of children in the experimental group with that of those in
0 objective of the study was to compare the performance of children in the experi
The second
control group. As mentioned
selected
from
1
2earlier,3the participant
4
5 children
6 were7 randomly
8
9
10 5 pre-schools
11
12 and13intervention clinics.
mental
group
that of
those in
control
group.
As mentioned
earlier,The
thestudy,
participant
chil
Hence,
when the
studywith
commenced
all children
were
on some
kind of early
intervention program.
in effect, determined
Pre test
Post test
the dren
efficacywere
of floor
time in comparison
early
intervention
In order
to do this,
the post
intervention
randomly
selected with
fromother
5 pre-schools
andstrategies.
intervention
clinics.
Hence,
when
the
performance on BSFS by both groups was analyzed. The mean score of experimental group was compared with that of control
study commenced all children were on some kind of early intervention program. The study,
group.12.
The
data analysis
is presented
in Table
Figure
Comparison
of individual
performance
on2.emotional thinking
in effect, determined the efficacy of floor time in comparison with other early intervention
Mean
Nthe performance
df
t-value
Significance
strategies.
In of
order
to do
the post
intervention
performance
on
BSFS
by with
boththat
groups
the study
wasthis,
to compare
of children
in the experimental
group
of those in
Experimental
48.38
13children were
24 randomly
p<.0.005
control
group.
As mentioned
participant
selected
from 5 pre-schools
clinics.
was
analyzed.
The earlier,
meanthe
score
of experimental
group 3.08
was compared
with and
thatintervention
of control
Hence, when the study commenced all children were on some kind of early intervention program. The study, in effect, determined
group.
The
data
analysis
is
presented
in
Table
2.
the efficacy of floor time in comparison with other early intervention strategies. In order to do this, the post intervention
group. The data analysis is presented in Table 2.
Experimental
Mean
48.38
N
13
df
24
t-value
3.08
Significance
p<.0.005
712
Mean
df
t-value
Significance
Experimental
48.38
13
24
3.08
p<.0.005
Control
37.46
13
Table 2. Comparison of Post test performance of experimental and control groups
Comparison of post intervention mean scores of experimental and control groups showed a
significant difference between the two, in favour of the experimental group. The resultant tvalue [3.08] was statistically significant (p<.005]. This indicated that in comparison to other
measures for early intervention, floor time was more effective in development of social be
Control
37.46
13
havior of children with ASD. Figure 13 provides a graphic representation of this difference
Table 2.
Comparison of Post test performance of experimental and control groups
Comparison of post intervention mean scores of experimental and control groups showed a significant difference between the two,
in favour of the experimental group. The resultant t- value [3.08] was statistically significant (p<.005]. This indicated that in
comparison to other measures for early intervention, floor time was more effective in development of social behavior of children
with ASD. Figure 13 provides a graphic representation of this difference
70
60
50
40
30
20
10
0
1
Experimental
10
11
12
13
Control
Figure 13. Comparison of post intervention performance of experimental and control groups
It is evident from Figure 13 that except for child no. 3 and child no. 5, all children in experiment group achieved higher scores on
is evident
from
thatchildren's
exceptscored
for child
no. 3 higher
and child
no. control
5, all children
inAexperi
BSFSItthan
the control
groupFigure
children.13
Most
significantly
than their
group peers.
comparative
analysis
of both
group's
mean performance
on each on
sub BSFS
skill i.e.than
turn taking
(TT), two-way
communication
(TWC),children's
cause and effect
ment
group
achieved
higher scores
the control
group
children. Most
(C&E), and emotional thinking (ET), within BSFS is presented in Figure 14.
scored significantly higher than their control group peers. A comparative analysis of both
group's
mean performance on each sub skill i.e. turn taking (TT), two-way communication
20
(TWC),
cause and effect (C&E), and emotional thinking (ET), within BSFS is presented in
18
16 14.
Figure
14
The12 children who received floor time intervention performed better on an average than
10 who were in the control group. However, the performance gap between the two
those
8
groups was not uniform across all sub skills. On emotional thinking skill, the average per
6
formance
of both groups was nearly same with control group's mean less than 2 points be
4
low2that of experimental group.
0
TT
TWC
Experimental
C&E
Control
ET
Figure 14. Comparison of experimental and control group on sub skills of BSFS
The children who received floor time intervention performed better on an average than those who were in the control group.
However, the performance gap between the two groups was not uniform across all sub skills. On emotional thinking skill, the
It is evident from Figure 13 that except for child no. 3 and childEarly
no. 5,
all childrenof
inAutism:
experiment
group
higher
scores on
713
Intervention
A Case
for achieved
Floor Time
Approach
BSFS than the control group children. Most children's scored significantly higher than their
control group peers. A comparative
http://dx.doi.org/10.5772/54378
analysis of both group's mean performance on each sub skill i.e. turn taking (TT), two-way communication (TWC), cause and effect
20
18
16
14
12
10
8
6
4
2
0
TT
TWC
Experimental
C&E
Control
ET
average performance of both groups was nearly same with control group's mean less than 2 points below that of experimental
group.
9. Discussion
9. Discussion
Unlike neuro-typical children who learn how to be social and interactive by watching
how
others talk,
play
each and
other,
enjoybythe
give-and-take
of play
social
Unlike
neuro-typical
children
whoand
learnrelate
how to to
be social
interactive
watching
how others talk,
andengage
relate to each
other,
enjoy and
the give-and-take
of social engagement
and initiate,
maintain and respond
to interactions
with others,
ment
initiate, maintain
and respond
to interactions
with others,
children
with children
autismwith
autism
oftendo
do not
the expected
development
of early social of
interaction
skills. Promoting
the social
development
of infants
often
notshow
show
the expected
development
early social
interaction
skills.
Promoting
and toddlers with ASD is one of the primary goals of early intervention services, as is facilitating the ability of young children with
the social development of infants and toddlers with ASD is one of the primary goals of
early intervention services, as is facilitating the ability of young children with social de
lays to develop appropriate friendships. With early and intensive intervention, the seem
ingly pervasive social skill deficits of many children with ASD can be remediated[21]. To
successfully target these important skills, intervention efforts, even within early interven
tion, should include: (a) regular access to typical peers, (b) thoughtful planning of mean
ingful social situations embedded throughout the day, (c) the use of social toys, (d)
multiple-setting opportunities (home inclusive, community-based) to practice emerging
social skills, and (e) intensive data collection in order to make midcourse corrections to
existing intervention plans [22]. Poor social skills are an impediment to childs success in
classroom, and can also be the cause of behavioral problem. Accordingly, teaching social
skills is a common educational objective for children who have autism [23]. However,
while teaching variables such as age, developmental and functional levels and sensory
profile of each should be considered. Floor time which is based on the developmental
approach takes care of the childs developmental level and emphasizes building the mile
stones that the child may have missed during his or her period of growth. Rather than
focusing on teaching a child to speak a few words to interact, Greenspan suggests that
the childs gestural system should be worked upon first for language to flow in natural
ly rather than by rote, thus focusing on the developmental ladder. As the child climbs
the developmental ladder he or she becomes more and more regulated and forms a
714
sense of self. In the study the authors chose age and functionally appropriate activities
for helping a child achieve the given milestones for social behavior. The individual ses
sions during which the adult followed the child's lead, prompted and encouraged the
child effort to participate, and provided the opportunity to practice the skill with a peer
contributed to the significant increase in each child's performance from pre to post inter
vention on BSFS.
According to the Colorado guidelines [24] early intervention strategies must involve build
ing of positive relationships between adults (parents and caregivers) and the infant or tod
dler. The intent should be to teach the child that parents and caregivers can be relied on as
stable, secure, and safe figures that provide nurturance, comfort, pleasure and guidance. De
veloping attachments is a challenge for a young child with ASD, so special efforts are re
quired, even when signs of a childs interest are not apparent. This might require that a
parent or caregiver identify the activities, objects, settings, and interactions that the child
finds pleasurable and provide those events and items to the child contingent on a social in
teraction behavior (rather than non-contingently in a manner meant to keep a child satisfied
without social interaction). A tickle game might be initiated with a child and then interrupt
ed by the caregiver with the expectation that the child look at the adult or repeat a gesture to
continue. A key objective of efforts to form positive relationships is to ensure that the inter
actions are pleasurable and that they are associated with the child receiving input that is
consistent with needs and interests. Importantly, successful efforts to form strong, positive
bonds when a child is very young result in a subsequent relationship in which an adult has
considerable influence over a childs behavior and this influence can be essential for the
guidance and instruction that the adult (parent or other caregiver) must provide on an ongo
ing basis. The floor time intervention addressed the issues mentioned above. Activities se
lected were simple and manageable for the children. Most activities were demonstrated
before the child was required to participate. For children with autism, visually organized
tasks are easier to learn [25]. During intervention the adult often provided model/picture of
a task to be done e.g. block tower, completed puzzle, picture and symbol cards etc. Interven
tion sessions were built around child's motivation and interests. Most early intervention
programs for children with ASD are based on behavioral approach and use discrete trial
training. Though evaluations have shown acquisition of learning and behavioral develop
ment in several children [26], behavioral approach does not suit all children and families.
Strict protocol of timing, intensity, structure, and quality of therapist training influences the
success of behavioral interventions. In contrast, floor time encourages naturalistic interac
tions to develop the core skills. It takes into account the inherent bonding and affection pa
rents have for the child, and guides the parent to modify and channelize their interactions to
suit the developmental level of the child. As stated earlier, the children selected for the
study attended pre-school and intervention clinics. Thus control group children also re
ceived early intervention while floor time intervention was given to the experimental group.
However, the experimental group children performed better on selected social skills at the
end of the intervention period. The significantly higher achievement of social skills by ex
perimental group children may be attributed to the child-centric naturalistic interactions
that occurred during the floor time intervention.

http://dx.doi.org/10.5772/54378
10. Conclusion
Early intervention is very important for enhancing the development of infants and toddlers
with disabilities, and they are especially crucial in determining the future language, social
and behavioral outcomes of very young children with ASD [27]. A primary consideration of
programs for young children with ASD is to provide an environment that is designed to
prevent problem behaviors, promote engagement and participation, and facilitate successful
interactions with typically developing peers. Getting the child to engage with materials and
activities may prevent challenging behavior occurrence and promote appropriate social be
havior [28]. Results of this research support the above findings. Floor time principles state
that development begins with a shared world between the caregiver and the young child.
The goal is to help the child with ASD emerge from its own world and enter this shared
world in order to develop his or her functional and emotional capacities. Floor time achieves
this by encouraging child to engage in age and level appropriate play activities with adults
and later with peers. The outcomes indicate the effectiveness of Floor time as a method for
early intervention of children with autism. The findings of the study may be useful for fami
lies who are in need of evidence based and suitable early intervention for children with
ASD.
Acknowledgements
The authors wish to thank the children who participated in this study, and are grateful to
the childrens parents, teachers, therapists, and administrators of the schools and interven
tion clinics for their support.
Author details
Department of Special Education, SNDT Women's University, Mumbai, India
References
[1] Autism Society of America (2006). Defining Autism. Available from http://
www.autismsociety.org (accessed May. 8, 2012)
[2] American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental
Disorders (4th ed. TR). Washington DC
[3] Young, R. Brewer, N. Pattison, C. (2003). Parental identification of early behaviora
labnormalities in children with autistic disorder. Autism, 7, 125-143.
715
716
[4] Volkmar, F. Chawarska, K. Klin, A. (2005). Autism in infancy and early childhood.
Annual Review of Psychology, 56, 315-36.
[5] Lal, R. and Ganesan, K. (2011) Children with Autism Spectrum Disorders:Social Sto
ries and Self Management of Behaviour British Journal of Educational Research1(1):
36-48, 2011SCIENCEDOMAIN international
[6] Richard, G. J. (2000). The source for treatment methodologies in autism. East Moline,
IL: Lingui Systems
[7] Attwood, T. (1988). Aspergers syndrome: A guide for parents and professionals.
London. Jessica Kinsley.
[8] Baron-Cohen, S. (2003a). The essential difference: The truth about the male and fe
male brain. New York: Basic Books
[9] Martin, N. (2009) Art as an early intervention tool for children with autism. Jessica
Kinsley Publishers, PA.USA
[10] Lovaas OI. Behavioral treatment and normal educational and intellectual functioning
in youngautistic children. J Consult Clin Psychol. 1987;55(1):39
[11] Prior,M & Robert, J. (2006) Early Intervention for Children with Autism Spectrum
Disorders: for Best Practices http://www.health.gov.au/internet/main/publishing.nsf/
content/D9F44B55D7698467CA257280007A98BD/$File/autbro.pdf (accessed June 20,
2012)
[12] Diggle, T.T.J, and McConachie, H.H.R. (2009) Parent-mediated early intervention for
young children with autism spectrum disorder (Review) http://onlineli
brary.wiley.com/doi/10.1002/14651858.CD003496/pdf/standard (accessed on August,
2012)
[13] http://www.icdl.com/DIRFloortime.shtml (accessed on Sept. 1, 2012)
[14] Greenspan, S.I., and Wieder, S. (1998). The child with special needs. Encouraging in
tellectual and emotional growth. Perseus Publishing, Massachusetts
[15] Wieder, S. and Greenspan, S.I., (2005). Can children with autism master the core defi
cits and become empathetic,creative, and reflective?:A Ten to Fifteen Year Follow-Up
of a Subgroup of Children with Autism Spectrum Disorders (ASD) Who Received a
Comprehensive Developmental, Individual-Difference, Relationship-Based (DIR)Ap
proach. Journal of Developmental and Learning Disorders Vol 9: 39-60
[16] Greenspan, S.I., and Wieder, S. (1997b). developmental patters and outcomes in in
fants and children with disorders in relating and communicating: A chart review of
200 children with autistic spectrum diagnoses. Journal of Developmental and Learn
ing Disorders. 1: 87-141
[17] Josefi, O.,Ryan, V (2004). Non-directive play therapy for young children with autism:
A case study Children. Clinical Child Psychology & Psychiatry. Vol 9 (4), 533-51.

http://dx.doi.org/10.5772/54378
[18] Costa G & Witten MR(2009). Pervasive Developmental Disorders. In Mowder, Ru

binson & Yasik (Eds), EvidenceBased Practice in Infant and Early Childhood Psy
chology. Wiley.
[19] Solomon, R., J. Necheles, C. Ferch, and D. Bruckman (2007) Pilot study of a parent
training program for young children with autism: The P.L.A.Y. Project Home Con
sultation program. Autism 11, no. 3 205224.
[20] Nadel, J.: Early imitation and a sense of agency. In: Proceedings of the 4th interna
tional workshop on epigenetic robots (2004) http://tivipe.com/TVPresearch/
62430115.pdf (accessed on Sept.19, 2012)
[21] McGee, G., Daly, T. & Jacobs, H.A. (1993). Walden preschool. In S. L. Harris & J.S.
Handleman (Eds.), Preschooleducation programs for children with autism. Austin,
TX:Pro-Ed.
[22] Strain, P. S., & Danko, C. D. (1995). Caregivers encouragement of positive interaction
between preschoolers with autism and their siblings. Journal of Emotional and Be
havioral Disorders, 3, 212.
[23] Weiss, M.J., & Harris, S.L. (2001). Teaching social skills to people with autism. Jour
nal of Behavior Modification. 25, 785-802
[24] Early Intervention Colorado Autism Guidelines for Infants and Toddlers (2010). De
veloped by the Universityof Colorado Denver, PELE Center, under contract with the
Colorado Department of Human Services, Division for Developmental Disabilities.
www.eicolorado.org (accessed on July 2,2012)
[25] Lal, R. and Shahane, A. (2011). TEACCH Intervention for autism. In T.Williams (Ed.)
Autism Spectrum Disorders-From Genes to Environment. In Tech, Croatia
[26] Lal, R and Lobo, S. (2007). Discrete trial training and development of pre learning
skills in intellectually impaired children with autism. Journal of Rehabilitation Coun
cil of India. 3, 1&2: 15-23
[27] National Resource Council, (2002). Educating Children with Autism. National Aca
demic Press, Washington
[28] Strain, P., & Schwartz, I. (2009). Positive behavior support and early intervention for
young children with autism: Case studies on the efficacy of proactive treatment of
problem behavior. In W. Sailor, G. Dunlap, G. Sugai, & R.H. Horner (Eds). Hand
book of positive behavior support (pp. 107123). New York
717
Chapter 30
Early Communication Intervention for

Children with Autism Spectrum Disorders
Gunilla Thunberg
http://dx.doi.org/10.5772/54881
1. Introduction
The main purpose of this chapter is to present the results of a review of communication
interventions for children aged 0-6 years with autism spectrum disorders and to formulate
recommendations for an evidence-based practice. The study, including 20 reviews and 27
primary studies, specifically focus interventions targeting children with diagnosis within the
autism spectrum being on an early communicative level.
2. Communication in children with Autism Spectrum Disorders (ASD)

2.1. Difficulties with communication and language as part of the spectrum
Major advances have been made over the two past decades in understanding the socialcommunication difficulties of children with ASD, resulting in greater emphasis on early socialcommunication features in the diagnostic criteria. Most parents of children with autism first
begin to be concerned that something is not quite right in their childs development because
of early delays or regressions in the development of speech [1]. Problems with communication,
in terms of both understanding and expression, are often said to be one of the main causes of
the severe behaviour problems that are common among persons with severe autism and
mental retardation [2]. The lack of meaningful, spontaneous speech by age five has been
associated with poor adult outcomes [3,4,5,6]. Certainly, communication and communication
problems are at the heart of what ASD is all about.
Although all persons diagnosed with autism have problems with communication, their type
and degree vary a lot and the work of identifying different subgroups has just begun. It has
2013 Thunberg; licensee InTech. This is an open access article distributed under the terms of the Creative
720
been estimated that between one-third [7] and one-half [8] of children and adults with autism
have no speech. However, more recent research results indicate that the proportion of nonspeaking children with ASD is much smaller, approximately 14% to 20%, among those who
received very early intervention [9].
Two phenotypes of speaking children with ASD were identified by Tager-Flusberg and Joseph
[10]: children with normal linguistic abilities (phonological skills, vocabulary, syntax, and
morphology) and children with impaired language that is similar to the phenotype found in
specific language impairment. Another potential subgroup may experience verbal dyspraxia
or dyspraxia of speech [11; 12; 13]. Voluntary motor control is disturbed in children with
dyspraxia, which also affects their ability to imitate. The new research on the role of the mirror
neurons in the parietal and frontal lobes may provide some answers on the relationships
between motor control and imitation but also on the possible link with the development of
intersubjectivity [11].
In spite of the heterogeneity of language abilities in children with ASD, social-communication
or pragmatic impairments are universal across all ages and ability levels [14]. According to
Wetherby [15], the social-communication deficits in children with ASD can be organized into
two major areas: (1) the capacity for joint attention and (2) the capacity for symbol use. Since
joint attention emerges before words, this deficit may be more fundamental and a number of
longitudinal studies provide evidence of a relationship between joint attention and language
outcomes [16, 17]. According to Wetherby [15] p. 11, deficits in initiating and responding to
joint attention have a cascading effect on language development since language learning
occurs within the context of the modelling by the caregiver of words that refer to objects and
words that are jointly regarded. Wetherby [15] states that deficits in imitation and observa
tional learning are other main causes of the problems with symbol use experienced by children
with ASD. Learning shared meanings, imitating and using conventional behaviours, and being
able to decontextualize meaning from the context constitute the symbolic deficits in children
with ASD [13].
2.2. Development of communication and language in children with ASD
Because autism is usually not diagnosed until age three or four, there is relatively little
information about language in very young children with autism [10]. Retrospective studies
using parent reports and/or videotapes collected during infancy, together with studies of
children considered likely to develop autism, show severely delayed language acquisition with
respect to both receptive and expressive skills [18, 19, 20]. Another typical phenomenon
described by 25% of parents of children with ASD is language loss after initially developing
some words [21]. Lord, Schulman, and DiLavore [22] found that this language regression is
unique to autism and does not occur in other children with developmental delays. Chawarska
et al. [21] hypothesize that these early-acquired speech-like productions are lost by children
with ASD because the link between these expressions and a network of symbolic communi
cation fails. There is significant variability in the rate at which language progresses among
children with ASD who do acquire speech.
Early Communication Intervention for Children with Autism Spectrum Disorders

http://dx.doi.org/10.5772/54881
The few longitudinal studies of language acquisition in children with ASD suggest that
progress within each domain of language follows similar pathways as it does in typical
ly developing children [9, 12]. However, the speech of children with ASD is also charac
terized by some typical deviations. One of the most salient aspects is the occurrence of
echolalia, which can be either immediate or delayed. Although some echolalia seems to
be self-stimulating, both types of echolalia can serve communicative purposes for the
speaker [12]. At an early stage of language development, this may be the only way in
which the child can actually produce speech. Tager-Flusberg et al. (1990) found that,
over the course of development, echolalia rapidly declined for all the children with ASD
and Downs syndrome in their study. Another prominent feature of language in children
with ASD is general problems with deixis, which are most often manifested as pronoun
confusion [10]. Features such as vocal quality, intonation and stress patterns often result
in problems for persons with ASD, although there is a lack of research in this field. Tak
en together, the findings suggest that the difficulties are due not only to problems in so
cial intent but also to problems affecting a more basic aspect of vocalization [12].
Less research attention has focused on the comprehension skills of individuals with ASD
although deviations in response to language and comprehension have been found to be
strong indicators of ASD [18]. According to Tager-Flusberg et al. [14], it seems that ASD
children not only may have limited ability to integrate linguistic input with real-world
knowledge but also may lack knowledge about social events used by normally develop
ing children to buttress emerging language skills and to acquire increasingly advanced
linguistic structures [12, p. 350].
The pragmatic aspects of language have been studied in numerous ways. Children with
autism share important similarities across different language levels [12]. The speech acts
that are missing or rarely used in the conversations of children with autism often con
cern social, rather than regulatory, uses of language [22]. Ramberg, Ehlers, Nydn, Jo
hansson, and Gillberg [24] found that children with ASD were impaired in taking turns
during dyadic conversations. A higher proportion of initiations rather than responses
was found in a study [25]. Although the basic intention to communicate often exists, the
person with autism has impaired skill in participating in communicative activities involv
ing joint reference or shared topics [12, p. 354].
3. Interventions to support communication and language development in

children with ASD
3.1. History and different theoretical approaches
The first reports on language interventions were published in the mid-1960s. The intervention
at that time built on the operant tradition developed by Skinner during the 1950s. The teaching
sessions in this method, referred to as discrete trial teaching or didactic teaching, are marked
by a high level of adult control and direction, massed-practice periods for preselected tasks,
721
722
and precise antecedent, teaching, and reinforcement practices. The learner is in a responder
role, and the teacher has a directive role [11]. The strength of the didactic behavioural approach
is primarily that it has demonstrated efficacy in many studies, using a variety of treatment
settings and treatment deliverers, with both single-subject and group designs [11]. Limitations
on this approach as a language-training method were recognized early on, with the childrens
lack of generalization being a core problem [26].
The pragmatic understanding of communication was fully developed after the operant
teaching methods were first developed [11]. The current scientific understanding of commu
nication and language development stems from the 1970s and 1980s, when it was demon
strated that language develops from the preverbal social exchanges of infants with important
others (Bates, 1976). According to Rogers [11 p. 149], current research, building primarily on
the work of Wetherby [13, 15, 23], Prizant [13], and Mundy, Sigman and Kasari [17], has
demonstrated that young children with autism lacked these early building blocks of commu
nication, involving social initiative, joint attention, social and emotional reciprocity, and the
use of gestures to co-ordinate social exchanges.
In 1968, an important study was published by Hart and Risley [27]. Very positive results were
obtained with an intervention in which the principles of operant teaching were applied in the
childs natural environment. The term incidental teaching was used for this approach, in
which the natural environment is deliberately structured to highlight the function of the
targeted language form. This intervention produced much better results with respect to
maintenance and generalization and stimulated development and research in the field [11].
According to Rogers [11, p. 153], the effectiveness of this approach results from four factors:
(1) child language functions to achieve child-chosen goals and child-chosen reinforcers, which
strengthen their power; (2) the focus is on child communication skills that are functional in all
settings; (3) the social functions of language are highlighted; (4) emphasis on child motivation
and natural reinforcers adds a positive element to the interactions, which may enhance
memory for learning.
The third major approach in the field of communication intervention for children with ASD is
the developmental pragmatic approach. The most elaborated programme for treatment, the
SCERTS (Social-Communication, Emotional Regulation, Transactional Support) model [28]
focuses on functional communication. This approach bears many resemblances to the behav
ioural naturalistic teaching methods. More emphasis is, however, placed on developing
nonverbal behaviours prior to verbal communication and on the use of Augmentative and
Alternative Communication (AAC) systems to assist in the development of verbal communi
cation [11]. Today many models combine behavioural techniques and social-interactionist
approaches, such as Enhanced Milieu Teaching, developed by Kaiser and colleagues [29], The
Denver Early Start [30], Caregiver Mediated Joint Engagement Intervention for Toddlers with
Autism [31], Focus parent training for toddlers with autism [32]. The strength of the develop
mental model is its strong basis in the science of communication development. Its weaknesses
include the lack of treatment manuals and the fact that it requires considerable knowledge on
the part of the therapist [11].

http://dx.doi.org/10.5772/54881
3.2. Early communication intervention

3.2.1. Why early communication intervention?
Several new research findings point to the importance of an early start of communication
intervention. The most essential of these are:
Difficulties in understanding and expressing communication is very closely linked to the
development of challenging behaviors in individuals with autism [2].
Communication and language are pivotal for the development of several other cognitive
constructs or competencies, such as:
Reading and writing.
Theory of Mind [33].
Communication ability predicts outcome with respect to functioning and quality of life in
adults with autism spectrum disorders [3].
The severity of communication difficulties in preschool-aged children is correlated to the
perceived level of stress in their parents [34].
Communication is one of the most important factors for the participation in daily activities
of young disabled children [35].
According to several guidelines, among these NRC (National Research Council) in the
United States, functional communication and social interaction should be prioritized in early
intervention programs given to children with ASD.
Furthermore, interactional research done on children with communicative impairments
and their parents has shown that the responsive communication style that characterizes
parents of typically developing children is often replaced by a more directive style in pa
rents of children with communicative impairments. Besides this impact on quality, quan
tity is also affected, in that the rate of communication occasions in these families tend to
decrease. This adds a cumulative negative effect on the communication development due
to less stimulation and experience [36]. Research has also shown that children with ASD
whose parents used a responsive style during preschool years in general had better com
munication and languages skills when they were followed up as teen-agers [37].
3.2.2. Early communication intervention methods or programs
There are many intervention programs for children with ASD that focus on communica
tion. Some of these are more specifically aimed at communication whilst others include
communication and language as a part of a comprehensive early intervention program.
Some programs (indirect interventions) focus on the parent or partner usually by guid
ing and teaching parents, individually or in groups (courses). Other intervention pro
grams focus more on the training of the child (direct interventions). Today it is common
723
724
that early intervention programs include both indirect and direct aspects: education and
tutoring of parents and training of the child.
Another dimension of great importance in early communication intervention concerns
the degree of child focus. To have a child focus means that the motivation of the child
and the developmental level is decisive in what is done during intervention. The adult
follows the lead of the child and the place for training is where the child is, often the
floor. In this way its not necessary to use reinforcements or rewards since the child is
already interested and motivated. To get the child to train and focus the intended skills
or functions different behavioural techniques are often used. At the other end of this di
mension we find the more traditional didactic training situation where the adult trainer
or therapist follows and uses a predefined set of activities and materials during a train
ing session. The specific behavioural techniques; prompts and reinforcements used dur
ing the session are often also specified or planned. The child is expected to follow the
lead of the adult and it is typical that the training is held the child and the adult sitting
face-to-face at a table. It is more typical that child-focused interventions are provided
during daily activities in the natural environment of the child; at home and/or in preeschool, whilst didactic training is provided at a clinic, at least during the introduction of
new materials and training activities.
Still another difference between programs that might be seen as a dimension is the degree to
which augmentative and alternative communication (AAC) is included. In some programs
these strategies, in the form of manual signs, symbols and pictures and speech-generating
devices (SGDs, today often Apps used on an iPad, smartphone or other platform), are included
already from the start to promote communication and build language, whilst in other pro
grams AAC strategies are not included, but instead seen as a last resort when training of speech
has failed.
3.2.2.1. Education and tutoring of parents and staff
The most common intervention of this type is parental education. The internationally most
wide-spread parental education programs most probably are the courses developed by the
Canadian Hanen Centre [38]. The course being developed for children within the autism
spectrum is called More Than Words and includes eight group sessions for the parents and
three home-visits by the Speech-language pathologist. During these visits the interaction
between the child and the parent is videotaped and the parents are given feed-back and further
guidance how to improve communication and use of the strategies being taught during the
course. The Hanen courses is a developmental approach and teaches responsive strategies to
the parents adding some behavioural techniques to stimulate communication learning within
the frames of child-focused natural interaction in the home [38]. A new parental course called
ComAlong has been developed in Sweden and now is spreading in northern Europe [39].
ComAlong include eight group sessions focusing on responsive strategies and environmental
teaching but also puts a large focus on the use of augmentative communication strategies in

http://dx.doi.org/10.5772/54881
the home setting [39]. The parents are provided with picture boards so they can use aided
language modeling in their homes [39, 40].
3.2.2.2. Comprehensive intervention programs
Training of communication, language and speech is most often an important part in the
different comprehensive programs, addressing different skills and problems, that has been
developed for young children within the autism spectrum. Some of these are built on behav
ioural theories, others on developmental pragmatic approaches. There seems to be a trend that
the programs being developed and researched during the last decade, specifically for young
children with autism, are more eclectic. The background theories are often described as
developmental pragmatic whilst ABA (Applied Behavior Analysis) techniques are used to
strengthen the teaching practices. Most often these comprehensive programs include both
direct training to the child and indirect intervention parts in that parents and/or staff in the
close network of the child are given education, training and/or guidance.
3.2.2.3. Augmentative and Alternative Communication AAC
AAC comprises different methods and modes of communication such as body communication,
concrete objects, manual signs, graphic symbols or speech-generating devices. Historically,
the first studies describing AAC techniques being used for individuals with autism appeared
in the 1970s; they reported on the use of sign language to improve communication [41]. These
studies appeared at the same time as the unsatisfactory results of spoken-language-training
programmes were being published. Studies by, for example, Lovaas et al. [26] reported little
change after many hours of intensive treatment, and the results were particularly poor for the
children whose comprehension and vocal skills were most impaired [41]. Initially, most
signing programmes were built on formal sign language systems, but it became evident that
these were often too complex and abstract, and so specially adapted systems were developed
and implemented. Sign-based programmes spread rapidly in schools for children with autism
in many countries.
During the 80s and the 90s a gradual change in AAC intervention for persons with autism,
was seen, as visual-graphic communication was more in focus. Mirenda and Erickson [42]
explain that the shift away from the use of signing to visual-graphic communication occurred
as a result of research findings in three main areas: imitation, iconicity, and intelligibility. In
addition to the evidence of a generalized imitation deficit in autism, there were also studies
showing that some children with ASD had extremely poor sign imitation skills [43] due to
difficulties with motor planning, control and execution [44]. According to Howlin [41], the
shift from the use of manual signs to visual methods was also due to the fact that visual
methods had proven to be effective in enhancing general skill acquisition, mainly within the
TEACCH programme (Treatment of Education of Autistic and related Communicationhandicapped CHildren; [45]) developed during the 1970s. A variety of symbol systems were
also developed, beginning with Blissymbolics and Rebus followed by Pictogram and Picture
Communication Symbols. The improvements in computer technology made these symbol sets
easily available in the form of practical software packages. The development of digital cameras
725
726
during the 1990s also increased the possibility of including personal photos in AAC systems,
which, according to clinical reports, seemed to increase motivation and facilitate understand
ing of pictures, particularly for individuals with ASD [46].
There are, however, also reports of problems in teaching symbols to children with ASD, mainly
in teaching them to use the pictures spontaneously and for communicative functions other
than requesting [41]. It was precisely these problems that led Bondy and Frost [47] to develop
the method called Picture Exchange Communication System (PECS). PECS is a systematic
approach to communication training specifically developed for children with autism. The
elements that make PECS different from other visual-graphic techniques are the use of the
concrete hand-to-hand exchange of the picture and also the highly prescriptive user manual
with its six levels to follow in sequence.
Historically, the use of speech output technologies with individuals with ASD has not been a
matter of course [48]. Computer technology was introduced into educational settings for
children with autism late, not only in North America, but also in other countries. Professionals
feared that people with ASD would become even more aloof if they were encouraged to sit in
front of a computer screen. Concerning speech-generating devices (SGDs), a common view
was that they would only stimulate echolalia in children with ASD, and that there would be
too much noise in the classroom. By the end of the 1990s, scepticism had decreased. This was
probably due to reports of some studies of successful computer-assisted instruction (CAI)
carried out. The introduction of app technology has meant a revolution to the field of speechgenerating devices and the first studies of the effects of apps are now being published.
4. Evidence-Based Practice EBP

The term evidence-based used as a prefix and a denominator of interventions and methods
comes from medicine. The term evidence based means that the choices of interventions and as
sessments are based on a research literature not simply professional experience or previous
practice. Evidence-based practice has been important within the area of early communication
intervention. The behavioural intervention tradition with its roots in the research clinic has pro
duced a lot of high-quality research during the years. Other types of interventions has been less
researched and sometimes have used methods and produced data that are different so that com
parisons of effects are hard or impossible to do. This has also led to an interesting discussion of
how to do EPB within the field of communication intervention. Ralph W. Schlosser, professor at
NorthEastern University, USA, has been of great importance in this respect. Partly because he is
spreading knowledge about evidence-based practise (EBP) and due to the many thorough com
pilations of research that he has done, but also in demonstrating the problems and shortcom
ings using EBP in relation to the field of augmentative communication intervention [49]. One of
these problems concerns the use of the Randomized Controlled Trial or Study (RCT) as the gold
en standard, as RCTs are almost non-existent within the AAC field. There are many reasons to
this but the main ones are that (1) children with communicative disabilities are so heterogene
ous and (2) that randomization is extremely difficult to put through due to ethical reasons.

http://dx.doi.org/10.5772/54881
Schlosser has therefore suggested an alternative evidence hierarchy placing the meta-analysis
on top [49, 50]. Schlosser and several other prominent authors within the field of communica
tion intervention research designs recommend the use of well-controlled single-subject re
search designs that can form the base for systematic meta-analyses.
5. Method
5.1. EBP-group
The review of research within the field of early communication intervention that is presented
in this study was initiated by the Swedish association of Habilitation directors as part of a
project concerning EBP that was started 2002. Within the frames of this project several reports
have been produced with respect to interventions for children and adults with disability. The
author of this chapter was appointed scientific leader for a group of five speech-language
pathologists and one special educator in Sweden, that applied for taking part in the project.
The group has worked together during recurrent two-day-sessions and in between, work has
also been done separately and in pairs.
5.2. EBP-method and search question
The group decided to use the EBP-model of Ralph Schlosser [49]. As mentioned above the hier
archy of evidence of Schlosser is a bit different compared to the traditional ones, in that it places
the meta-analysis on top of the hierarchy beside the RCT-study. Schlosser also includes per
spectives of the stakeholder and the influence of environment into his model of EBP and defines
EBP as follows: The integration of best and current research evidence with clinical/educational
expertise and relevant stakeholder perspectives to facilitate decisions for assessment and inter
vention that are deemed effective and efficient for a given stakeholder. The classical model of
formulation of a evidence question shortened PICO - Problem, Intervention, Comparison, Out
come - has accordingly been revised into PESICO - Problem, Environment, Stakeholders, Inter
vention, Comparison, Outcome [49]. The question that was formulated in this review was: A
young child with severe communicative disability, living with his/her parents and being placed
in a pree-school group: which intervention is most effective; indirect or direct interventions.
5.3. Procedure
When the clinical question had been formulated the group identified search terms to use. These
were: Early Intervention, Communication, Communication Disability/ies, Direct intervention,
Indirect intervention, Early childhood, Kindergarten, Pree-school, AAC, Augmentative Com
munication, Alternative Communication, Early Communication, Language, Meta-analysis,
Review. The terms were searched separately and in combinations using four scientific data bas
es: PubMed, PsycInfo, CINAHL and ERIC. It was seen that CINAHL generated significantly
more results than the other three. All abstract were browsed and the studies considered as rele
vant were downloaded. The reference lists of these studies led to some new findings. A few
727
728
studies and book chapters were found through the groups different contacts and readings of
literature. The studies were read and reviewed using a protocol and a manual that was devel
oped. The factors that were examined in each study were: Research methods, participants, envi
ronment, intervention, results, evidence grading and a final category called notes. This column
included judgements of (a) ICF domain/s that the study involved, (b) validity: internal, external,
social and ecological, (c) importance of discussion and suggestions of future studies.
Each study was first reviewed by two group members separately and then discussed and
graded by the group altogether. The group graded the studies according to three systems:
Schlosser [49], Nordenstrm [51] and Golper [52]. Schlossers system was seen as the most
important for this study due to the fact that it was developed for the field of communication
intervention for people with disability. Nordenstrm represent the classical medical evidence
hierarchy whilst the Golper was included for its ambition to catch or grade the level or depth
of evaluation that the study represents.
System
Level
Definition
Schlosser
Meta-analyses of SSRD /RCT
Well designed non-RCT group study

SSRD one intervention
SSRD several interventions
Subgroups to/variants of the types above
Nordenstrm
Narrative quantitative reviews (except of meta-analyses)
Narrative reviews
Pre- experimental group studies (i.e. before-after) and case studies
Expertise: educational books, journals, expert opinion
Strong scientific evidence (meta-analysis, well-done and large RCT)
Moderate evidence (smaller or non-randomized studies, cross-sectional

studies, case studies, cohort studies)
Week evidence (expert opinion, concensus reports, case studies and other
descriptive reports)
Golper
Non-existent scientific evidence (No studies of sufficient quality exists).
Phase I
Hypotheses about treatment efficacy are being developed for later testing.
Often this involves experimental manipulations to test potential benefits
or activity of a particular treatment.
Phase II
The goals are to formulate and standardize protocols, validate

measurement instruments, optimise dosage of treatment, and so on.
Includes case reports and small group studies with no control groups or
treatment comparisons.
Phase III
Treatment efficacy of a specified protocol is formally tested either with

SSRD or group studies with controls such as control groups or treatment
comparisons.
Table 1. Systems for evidence-grading being used in this study. SSRD=Singel Subject Research Design,
RCT=Randomized Controlled Study

http://dx.doi.org/10.5772/54881
Author&year
Study design
Intervention
Evidence grading
Aldred, Green & Adams, 2004 [54]
RCT
Education and guidance of parents in
Schlosser: 1
the use of responsive strategies
Nordenstrm
Golper. III
Callenberg och Ganebratt, 2009 [56]
Pre-experimental
ComAlong parental education;
Schlosser: 5
group-study
responsive strategies and AAC
Nordenstrm: B
Pilot RCT
Focus parent training; joint attention
Golper. II
Drew, Baird, Baron-Cohen, Cox,
Slonims, Wheelwright, Swettenham,
Schlosser: 1
Nordenstrm: A
Berry & Charman, 2002 [32]
Golper. III
Elder, Valcante, Yarandi, White & Elder, Large-scale SSRD
Education and guidance of fathers:
Schlosser: 2
2005 [57]
imitation and responsive strategies
Nordenstrm: B
Golper. III
Ferm, Andersson, Broberg, Liljegren &
Group study; mixed
Parents and course leaders experiences Schlosser: 5
Thunberg, 2011 [55]
methods
of the ComAlong augmentative and
Nordenstrm: B
alternative communication early
Golper. II
intervention course
Girolametto, Sussman & Weitzmann,
Case study,
Hanen More than Words parental
Schlosser: 5
2007 [58]
Interaction analyses
education and guidance: responsive
Nordenstrm: C
strategies
Golper. III
PECS training of pree-school teachers
Schlosser: 1
(and also some older children)
Nordenstrm: A
Howlin, Gordon, Pascoe, Wade &
RCT
Charman, 2007 [59]
Golper. III
Jonsson, Kristoffersson, Ferm &
Pre-experimental
Schlosser: 5
Thunberg, 2011 [40]
group study; mixed
Nordenstrm: B
methods
Karlsson & Melltorp, 2006 [62]
Golper. II
Pilot group study,
Schlosser: 5
mixed methods
Nordenstrm: B
Group study, small
Schlosser: 5
control group
Nordenstrm: B
McConachie, Randle, Hammal &
Controlled group
Hanen More than Words parental
Schlosser: 2
LeCouteur, 2005 [61]
study
education and guidance: responsive
Nordenstrm: B
strategies
Golper: III
Focus parent training; joint attention
Schlosser: 1
Golper. I
Lennartsson och Srensson, 2010 [60]
Golper. II
Oosterling et al., 2010 [63]
RCT
Nordenstrm: A
Golper. III
Seung, Ashwell, Elder & Valcante, 2006 Group study
Verbal outcomes after training of
Schlosser: 2
[64]
fathers as analyzed by video
Nordenstrm: B
interactions
Golper. III
Evaluation of the parental plus progam
Schlosser: 5
including responsive strategies
Nordenstrm: B
Sharry, Guerin, Griffin & Drumm, 2005

[65]
Group study
Golper. II
Table 2. Studies of education and guidance to parents or staff
729
730
The results were analysed and grouped primarily according to the formulated search question
but also according to the identified areas of intervention and methods being evaluated in the
studies. Building on these results, recommendations and a model for early communicative
intervention was suggested. These results were documented in a report being published on
the website of the Association of Swedish Habilitation directors [53]. A new literature search
using the same procedure as described above led to some revision of results and recommen
dations in a new version of the report that was recently published [53].
The results that will be shared in this book chapter concerns the studies that specifically
involved children on the autism spectrum, which in total involved about half of the studies,
or exactly 47 studies. The data from both literature searches was used: 30 studies from the
review published in 2011 and 16 studies from the updated version of 2012.
6. Results
The number of studies that were included in the review totalled 106. Of these, 39 were reviews,
while the other 67 were primary studies. 46 of the studies involved children diagnosed within
the autism spectrum. This means that about half the research on interventions for children
with communicative disabilities have focused children with ASD. 31 of the studies were
included in the report published 2011 while 14 were added in the review done 2012. 20 of the
publications were reviews while 27 were primary studies. There were comparatively more
primary studies, often of high research quality, to be found in the more recent search (2012).
Only publications where the children were clearly described as having ASD were included in
this review. There were most probably even more studies of the 106 that included children
with ASD since sometimes participants were described according to type and/or severity of
disability (such as severe communicative disability), and not diagnose..
6.1. Indirect interventions Education and guidance to parents
14 primary studies were found. The evidence is moderately to strong since there are also some
studies with a high level of scientific control. Many of the studies were noted as showing high
validity with respect to external validity as well as social and ecological validity. In several
studies the parents were involved in the evaluation procedure and measures of natural
interactions were included.
In general the results of education and guidance to parents and staff are very positive al
though this review shows that there seems to be a lack of research when it comes to ed
ucation and guidance of staff. Only one study was found where pree-school teachers
were educated and guided how to use the PECS-method [32]. The results of the parental
interventions indicate that they are effective in that positive results can be seen very
quickly with respect to different areas and with comparatively little amount of interven
tion. This is also probably one of the reasons behind the trend that parental education
seems to be included as a part of the more recently developed intervention programs. In
the second literature search in this study more interventions were found that included

http://dx.doi.org/10.5772/54881
guidance of parents (for example 31, 63, 74, 75, 81). Several of these interventions includ
ed education that was combined with home-visits when the therapist interacted with and
trained the child during natural play situations. The parents observed these play activi
ties and the therapists use of behavioural strategies, which were then discussed an prac
ticed during the sessions. The results of these comprehensive programs are included in
the section of direct interventions below (table 3), but it is important to also recognize
the fairly large amount of indirect instruction in these programs.
In several studies of the interventions more specifically aimed at parental education, it
was seen that the parents use of responsive strategies increased [54, 58, 60, 61, 62] and
some studies showed that interaction between the parent and the child was positively af
fected [57, 58, 62, 65]. Some studies report that the development of communication and
language in the child seems to be increased when the parents are provided with educa
tion and guidance [32, 54, 56, 61, 62, 64]. Several studies have tried to measure parental
stress and other family related parameters that are expected to be affected, also out from
parental interviews [54, 55, 56, 61, 65]. Most studies failed in proving effects in this re
spect, at least on a level of statistical significance. In some studies the researchers specu
late that the questionnaires given before and after an intervention seems to fail in
catching an effect. In qualitative studies parents report that they can see the problems of
the child more clearly after the course and can be more open about the family problems
[55]. This means that items related to family issues even might get worse comparing
questionnaires filled in blindly before-after intervention.
So far very little is known of the long-term effects of indirect intervention. The few studies
with this focus show that the effects seem to fade over time. Both clinicians and researchers
hypothesize that there probably is a need to do follow-ups and/or provide booster interven
tions to maintain the intervention effects over time. There are also indications that the effects
of a parental education on the development of the child seems to be further enhanced when
the education is complemented with direct intervention to the child.
6.2. Direct interventions Provision of training of the child
19 studies were found of which 10 were reviews (1 meta-analysis) and the rest primary studies.
The scientific level of evidence varies, but the recently published primary studies being of high
quality certainly strengthen evidence in the area of direct communication intervention.
Direct interventions or training of the child has proved to have a positive impact on the
development of the child with ASD as is stated in most, but not so sure in all, of the studies in
the table. Exactly what is described to be affected differs in different studies, depending on the
focus of the study, but to a large extent also on what have been measured in a particular study.
It is more common that classical didactic programs report outcomes within the function- or
activity-domain, often by the use of measures of intelligence (IQ) or language (different
language tests). The child-directed naturalistic interventions more often describe outcomes in
terms of activity or participation and use data of communication or interaction from video
analyses, parental questionnaires and interviews.
731
732
Author&year
Study design
Intervention
Evidence grading
Charman, 2010 [76]
Review
Review of developmental approaches to
Schlosser: 4
understanding and treating autism
Nordenstrm: C
Golper. I
Corsello, 2005 [66]
Review
Review and discussion of interventions 0-3
Schlosser: 4
years
Nordenstrm: C
Golper. I
Dawson et al, 2010 [30]
RCT
Study of the effects of : The Early Start
Schlosser: 1
Denver Model for toddlers with ASD
Nordenstrm: A
Golper. III
Delprato, 2001 [67]
Review
Comparison of discrete trial interventions
Schlosser: 4
and naturalistic language interventions
Nordenstrm: B
Golper. II
Diggle & McConachie, 2009
Review
Review of parent-mediated intervention/
Schlosser: 3
[68]
Cochrane-report
training of children with ASD
Nordenstrm: B
Fernell et al, 2011 [77]
Comparative group
Comparison of effects of 1) intensity and
Schlosser: 2
study
form of intervention 2) intelligence on
Nordenstrm: B
adaptive behaviour on children with ASD
Golper. II-III
Review and comparison of communication
Schlosser: 4
intervention to children with ASD
Nordenstrm: B
Golper. III
Goldstein, 2002 [69]
Review
Golper. II
Kasari et al (2010) [31]
RCT
Study of the outcomes of an intervention for
Schlosser: 1
joint attention
Nordenstrm: A
Golper: III
Kasari, Paparella & Freeman,
Randomized group
Comparison of interventions for play and
Schlosser: 2
2008 [70]
study
joint attention in children with ASD
Nordenstrm: A
McConkey et al, (2010) [74]
Controlled group study
Evaluation of the impact of home-based
Schlosser: 2
intervention to promote communication
Nordenstrm: B
Golper. III
Golper. III
McConnell, 2002 [71]
Paul & Roth , 2011 [78]
Rogers, 2006 [11]
Schuit et al, 2011 [79]
Review
Review of interventions to promote social
Schlosser: 4
interaction in young children in educational
Nordenstrm: B
settings
Golper. I
Narrative review/
Characterizing and Predicting Outcomes of
Schlosser: 6
expertise
Communication Delays in Infants and
Nordenstrm: C
Toddlers: Implications for Clinical Practice.
Golper. I
Review of and historic description of
Schlosser: 6
communication intervention to young
Nordenstrm: C
children with ASD
Golper. I
Controlled group study
Evaluation of a program aimed at stimulate
Schlosser: 5
(small groups)
language learning in disabled children
Nordenstrm: B
Meta-analysis
Meta-analysis of discrete-trial-interventions
Schlosser: 1
for children with ASD
Nordenstrm: A
Review
Golper. III
Spreckley & Boyd, 2009 [80]
Golper. III

http://dx.doi.org/10.5772/54881
Author&year
Study design
Intervention
Evidence grading
Vismara et al, 2009 [81]
Group study Non-
Evaluation of the effects of start-kit of 12
Schlosser: 2
concurrent multiple
individual sessions teaching parents
Nordenstrm: B
baseline design
communicative strategies
Golper. I
RCT (small groups)
Evaluation of Autism 1-2-3-progam
Schlosser: 1
Wong & Kwang, 2010 [75]
Nordenstrm: B
Golper. III
Woods & Wetherby, 2003 [72]
Yoder & Stone, 2006 [73]
Review, clinical report
Review of methods of identification and
Schlosser: 4
intervention for young children at risk of
Nordenstrm: C
ACD
Golper. II
Randomized
Comparison of RPMT and PECS on spoken
Schlosser: 2
comparison
communication
Nordenstrm: B
Golper. III
Table 3. Studies of direct interventions and comprehensive programs
As mentioned in earlier paragraphs generalization and maintenance has been a big issue
within the field of communication and language intervention for years. Generally the childfocused interventions show better generalization and maintenance in younger children with
ASD [67, 72, 76]. These studies discuss that the use of the inborn motivation of the child and
the use of natural context and natural play context make the difference all according to current
theories of development of cognition and communication. Proponents of didactic training hold
that the use of learned words and phrases might be a start of a positive social spiral where the
child gets more response and is treated differently. Some reviews come to the conclusion that
we still do not have enough evidence to tell which type of program is best, didactic or childfocused, but that the important factors seem to be early start and intensity [66, 69]. According
to the meta-analysis of six RCT studies of didactic interventions [80] these however fail in
reporting better outcomes than the control groups when it comes to cognition, language and
adaptive functioning. Generally the children in didactic training programs also were older [68].
Didactic training in its intensive and comprehensive form seems less effective on younger
children and children at early communicative levels [77]. The involvement of the parents in
recurrent didactic training activities in the home is also questioned in some studies [68]. There
are indications of a high degree of stress in these parents and a comparative study showed that
parental stress was lowered when the training was done by others and furthermore that the
results with respect to communication development was enhanced [68].
Several recent studies report outcomes from eclectic comprehensive interventions [30, 31, 74].
These programs are built upon current theories of cognitive, communicative and neurophy
siological development but also adds knowledge from the behaviourist tradition or rather
Applied Behavior Analysis (ABA) in optimizing the learning situation. More concretely this
means that these programs are child-focused in that it makes use of the childs motivation and
interests and focus the communication between the parent and the child and are often
implemented in the home setting, sometimes after some introductory sessions on a clinic. An
analysis of the childs communication development forms the decision of what is going to be
focused during interaction. Prelinguistic competencies such as imitation, joint attention and
733
734
use of symbol play and symbols are seen as basic and pivotal. The behavioural techniques are
used to arrange the environment and chose strategies to refine and enhance learning in the
natural interaction. The trainer serve as model to the parent and then guide and coach the
parent, often in the home.
The majority of the primary studies in the table above report excellent outcomes [30, 31 70, 73,
74, 75, 81]. In general the research quality of evaluations of these interventions were high since
many were of RCT type or Randomized Group studies. External, social and ecological validity
was also considered as generally high partly due to the use of more interactional data and
information from the stakeholders. The studies show that these interventions seem to be very
effective in proving positive outcomes with respect to interaction, parental communication
style and child development. Some of these intervention programs are of comparatively low
intensity and short, which is interesting and important, as high intensity traditionally have
been said to be essential to success in children with autism
Some articles compare interventions and discuss recommendations with respect to different
needs of the child or family. A comparison of the AAC-method PECS and RPMT (a compre
henesive program containing parental education in the use of responsive strategies and
training of the child and guidance to parents in their home) showed interesting results with
respect to communication outcomes in the children [73]. The children at the earliest commu
nicative stage, not yet being interested in objects, seem to develop more with RPMT. At the
next communicative stage when the children has an interest of objects, an understanding of
cause and effect and some emergent understanding of joint attention PECS is more effective.
When joint attention is more established the Prelinguistic Mileu Teching strategies (behavioral
techniques implemented in natural interaction) in the RPMT seems to be more operant. It was
also seen that the PMT-training had better effect for those children whose mothers used a
responsive communication style. The focus on development of joint attention is emphasized
as the primary goal in this study with a successive introduction of symbol play as joint attention
is being established [73].
Finally, one review studies the effect of different types of interventions to promote social
interaction in pree-school settings and conclude that there is good evidence that it is important
to work both with the child with disability as well as with his/her friends in the school
environment [71].
6.3. AAC intervention
The field of AAC is a fairly new field of knowledge that has gradually grown as there is a
increasing interest in functional communication and in ensuring the communicative rights of
individuals with disability. There has also been an explosion of available communication
technologies and methods that can support and improve communication for individuals with
autism. We have probably and hopefully only seen the dawn of these new options. It is also
possible to see that we are moving from using one technique or approach at the time to working
with multimodal techniques or approaches where different tools and methods combined with
an understanding of communication and use of interactional strategies build a total system of
communication.

http://dx.doi.org/10.5772/54881
Author&year
Study design
Intervention
Evidence grading
Binger, Berens, Kent-Walsh &Taylor,
Review
The impact of AAC-intervention on use
Schlosser: 4
of AAC, symbolic gestures and speech
Nordenstrm: B
2008 [82]
Golper. II
Bopp, Brown & Mirenda, 2004 [83]
Review
Review of FCT and use of visual
Schlosser: 4
strategies and discussion of the role of
Nordenstrm: B
speech-language pathologist in
Golper. I
working with challenging behaviors

Brady, 2000 [84]
Case study
Study of the impact of use of SGDs on
Schlosser: 5
the understanding of speech
Nordenstrm: C
Golper. I
Branson & Demcak, 2009 [85]
Meta-analysis
Evaluation of AAC interventions for
Schlosser: 1
toddlers and infants with disability
Nordenstrm: A
Golper. III
Ganz, Simpson & Corbin-Newsome,
SSRD Multiple
Impact of PECS on requesting and
Schlosser: 2
2008 [86]
baseline
speech
Nordenstrm: B
Mancil et al(2009) [95]
SSRD multiple
Study of the effects of a picture-
Schlosser: 2
baseline
exhange-intervention using milieu
Nordenstrm: B
teaching in the home
Golper. III
The impact of AAC-interventions on
Schlosser: 1
speech development
Nordenstrm: B
Golper. III
Millar, Light & Schlosser 2006 [87]
Meta-analysis
Golper. I
Papparella & Kasari, 2004 [88]
Preston & Carter, 2009 [89]
Review
Meta-analysis
Study of the relationship between joint
Schlosser:4
attention and language manual
Nordenstrm: C
signing
Golper. I
Study of the effects of PECS
Schlosser: 1
Nordenstrm: B
Golper. III
Schlosser &, 2006 [90]
Quantitative review
The impact of AAC on children with
Schlosser: 4
developmental disabilites
Nordenstrm: B
Golper. II
Schlosser & Wendt, 2008 [91]
Meta-analysis
Effects of different types of AAC on
Schlosser: 1
speech in children with ASD
Nordenstrm: B
Golper: II
Sigafoos, Drasgow, Reichle, OReilly &
Review
Tait, 2004 [92]
Study of the effectiveness of training of
Schlosser: 4
rejecting using AAC
Nordenstrm: B
Golper. I
Snell, Chen, Lih-Huan & Hoover, 2006
Review
[94]
Review of AAC-interventions to children Schlosser: 4

with severe communicative disabilities
Nordenstrm: B
Golper. I
van der Meer et al, 2011 [93]
Controlled group
Evaluation of a program using AAC (not Schlosser: 5
study
further described)
Nordenstrm: B
Golper. II
Table 4. Studies of education and guidance to parents
735
736
The research base with respect to AAC used by young children with autism has grown in
recent years. This research mostly consists of singe-subject-design studies and case studies,
with very few controlled group studies being done. On the other hand there are some welldone meta-analyses published that compile results from singe-subject research studies. Due
to the difficulties of conducting RCT studies within the field of AAC-intervention the metaanlyses are important and can be seen as the golden standard. In total 14 studies were identified
as focusing the use of AAC and of these 10 were reviews or meta-analyses.
In conclusion, meta-analyses and other studies show that AAC-interventions are cost-effective
and give fast results and furthermore tend to stimulate speech development [82, 84, 85, 86, 87,
91]. The best results seem to be reached when the social network surrounding a child is given
support and resources, to be able to use responsive strategies and provide communication
opportunities and direct training using AAC in natural daily interactions. AAC intervention
should be started as soon as communication difficulties are displayed or suspected since AAC
promotes communication, language and speech. AAC-intervention has also been proved to
effectively decrease challenging behaviour [83]. There is today no mode of AAC that is known
to be better than any other for young children with autism. Instead multimodal approaches
seem to be the most effective [93]. However, graphic AAC seem to be acquired at a faster rate
and also easier to generalize to other situations [90]. PECS has been proved to be an effective
AAC method, specifically at early stages of communication and with respect to the first three
phases of the method [89].
Figure 1. Model for early communication intervention

http://dx.doi.org/10.5772/54881
7. Conclusion
The conclusion of this chapter is presented in the form of eight recommendations and of a
model for early communication intervention answering the question that was initially
formulated in this study: A young child with autism and severe communicative disability,
living with his/her parents and being placed in a pree-school group: which intervention is
most effective; indirect or direct interventions?
1.
A combination of indirect and direct interventions. There is strong evidence that the
combination of education and guidance to the parents and direct child-focused interven
tion to the child in a naturalistic context leads to good outcomes with respect to several
parameters such as: development of communication and language, interaction between
the parent and the child where the parent uses a responsive communication pattern,
2.
Parental education should include knowledge of and training in the use of responsive
strategies and behavioural/environmental teaching techniques within the frames of
natural interaction in the home. Several studies show that parents change their commu
nicative style after a few education sessions and that this positively affect the interaction
pattern with the child and enhance language development in the child. Guidance or
coaching of the parents in natural interactions in the home environment is included in
most of the recently presented studies and show very good results in short time.
3.
Direct interventions provided to children on early communicative stage should be

child-focused and implemented in daily natural interactions. The intervention should
focus imitation, joint attention and symbol use (speech, symbols, manual signs). Didactic
intervention is not effective for young children since maintenance and generalization of
training is low.
4.
Interventions need to be continuous and include follow-ups and possibilities of

booster-intervention. The few long-term follow up-studies all show that interventions (of
different type) tend to wear off by time. The recent published studies show that lowintensity interventions also could yield good results. The engagement of the parent also
might be an important success factor.
5.
Children at early communicative stages should be provided with AAC as early as

possible. There is no age-limit or prerequisites that need to met before AAC is introduced.
There is strong evidence that AAC decreases challenging behaviour. There is moderate
to strong evidence that AAC facilitates development of speech.
6.
AAC-intervention should ideally be multimodal. All modes of AAC are effective. There
is some evidence that symbols (specifically combined with speech output) are learned
faster than manual signs and that iconic symbols are learned faster.
7.
PECS (Picture Exchange Communication System) is an effective AAC-method for

children at early communicative stages. There is strong evidence that PECS has a positive
effect on interaction and behaviour and that functional communication is increased.
737
738
8.
The AAC-modes should be used and modelled by the childs communication part
ners (aided language stimulation or modelling) to promote learning and spontaneous use
of the symbols.
These recommendations means that the child in our formulated question should be provided
with intervention according to the model below.
Acknowledgements
Parts of chapter two, three and four was first published in the authors thesis [96]. Thanks to
my collegues in the ebp-group: Lena Nilsson, Maria Nolemo, Barbara Eberhart, Jessica
Forsberg, Ruth Breivik and Anna Fldt.
Author details
Gunilla Thunberg*
DART Centre for AAC and Assistive Technology, Sahlgrenska University Hospital, Sweden
References
[1] Short C, Schopler E. Factors relating to age of onset in autism. Journal of Autism and
Developmental Disorders 1988 ;18 207216.
[2] Carr EG, Levin L, McConnachie G, Carlson JI, Kemp DC, Smith CE. Communicationbased intervention for problem behavior. Baltimore, MD: Paul H. Brookes Publish
ing; 1997.
[3] Billstedt E. Children with autism grow up: Use of the DISCO (Diagnostic Interview
for Social and COmmunication disorders) in population cohorts. Gteborg: Gteborg
University; 2007.
[4] Billstedt E, Gillberg IC, Gillberg C. Autism after adolescence: Population-based
13-22-year follow-up study of 120 individuals with autism diagnosed in childhood.
Journal of Autism and Developmental Disorders 2005 ; 35, 351360.
[5] Howlin P, Goode S, Hutton J, Rutter M. Adult outcomes for children with autism.
Journal of Child Psychology and Psychiatry, 2004; 45, 212229.
[6] Shea V, Mesibov G. Adolescents and adults with autism. In F. Volkmar, R. Paul, A.
Klin & D. Cohen (Eds.), Handbook of autism and pervasive developmental disorders
(pp. 288311). Hoboken, NJ: John Wiley & Sons; 2005.

http://dx.doi.org/10.5772/54881
[7] Bryson S. Brief report: Epidemiology of autism. Journal of Autism and Developmen
tal Disorders 1996; 26, 165167.
[8] Bryson S, Clark BS, Smith TM. First report of a Canadian epidemiological study of
autistic syndromes. Journal of Child Psychology and Psychiatry 1988; 29, 433445.
[9] Lord C, Risi S, Pickles. Trajectory of language development in autism spectrum dis
orders. In R. M & S. Warren (Eds.), Developmental language disorders: From pheno
types to etiologies (pp. 729). Mahwah, NJ: Lawrence Erlbaum; 2004.
[10] Tager-Flusberg H., Joseph RM. Identifying neurocognitive phenotypes in autism.
Philosophical Transactions of the Royal Society of London, Series B: Biological Scien
ces 2003; 358, 303314.
[11] Rogers S. Evidence-based interventions for language development in young children
with autism. In T. Charman & W. Stone (Eds.) Social and communication develop
ment in autism spectrum disorders (pp. 143179). New York: The Guildford Press ;
2006.
[12] Tager-Flusberg H, Paul R, Lord C. Language and communication in autism. In F.
Volkmar, R. Paul, A. Klin & D. Cohen (Eds.) Handbook of autism and pervasive de
velopmental disorders (Vol. 1, pp. 335364). Hoboken, NJ: John Wiley & Sons ; 2005.
[13] Wetherby A M, Prizant BM, Schuler AL. Understanding the nature of communica
tion and language impairments. In AM Wetherby & BM Prizant (Eds.), Autism spec
trum disorders: A transactional developmental perspective pp. 109141. Baltimore,
MD: Paul H. Brookes Publishing; 2000.
[14] Tager-Flusberg H, Joseph R, Folstein S. Current directions in research on autism.
Mental Retardation and Developmental Disabilities Research Reviews 2001; 7, 2129.
[15] Wetherby AM. Understanding and measuring social communication in children with
autism spectrum disorders. In T. Charman & W. Stone (Eds.), Social and communica
tion development in autism spectrum disorders (pp. 334). New York: The Guildford
Press: 2006.
[16] Charman T, Baron-Cohen S, Swettenham J, Baird G, Drew A, Cox A. Predicting lan
guage outcome in infants with autism and pervasive developmental disorder. Inter
national Journal of Language and Communication Disorders 2003; 38, 265285.
[17] Mundy P, Sigman M, Kasari C. A longitudinal study of joint attention and language
development in autistic children. Journal of Speech and Hearing Research 1990; 38,
157167.
[18] Dahlgren SO, Gillberg C. Symptoms in the first two years of life: A preliminary pop
ulation study of infantile autism. European Archives of Psychiatric and Neurological
Science 1989; 283, 169174.
739
740
[19] Osterling J, Dawson G. Early recognition of children with autism: A study of first
birthday home videotapes. Journal of Autism and Developmental Disorders 1994; 24,
247258.
[20] Watson LR, Baranek GT, Crais ER, Reznick SJ, Dykstra J, Perryman T. The first year
inventory: Retrospective parent responses to a questionnaire designed to identify
one-year olds at risk for autism. Journal of Autism and Developmental Disorders
2007: 37, 4961.
[21] Chawarska K, Paul R, Klin A, Hannigen S, Dichtel L E, Volkmar F. Parental recogni
tion of developmental problems in toddlers with autism spectrum disorders. Journal
of Autism and Developmental Disorders 2007; 37, 6272.
[22] Lord C, Schulman C, DiLavore P. Regression and word loss in autistic spectrum dis
orders. Journal of Child Psychology and Psychiatry 2004; 45, 936955.
[23] Wetherby AM. Ontogeny of communicative functions in autism. Journal of Autism
and Developmental Disorders 1986; 16, 295316.
[24] Ramberg C, Ehlers S, Nydn A, Johansson M, Gillberg C. Language and pragmatic
functions in school-age children on the autism spectrum. European Journal of Disor
ders of Communication 1996; 31, 387413.
[25] Bishop D, Hartley J, Weir F. Why and when do some language-impaired children
seem talkative? A study of initiation in conversation of children with semantic-prag
matic disorders. Journal of Autism and Developmental Disorders 1994 ; 24, 177197.
[26] Lovaas OI, Koegel RL, Simmons JQ, Long JS. Some generalization and follow-up
measures on autistic children in behaviour therapy. Journal of Applied Behavior
Analysis 1973; 6, 131166.
[27] Hart BM, Risley TR. Establishing use of descriptive adjectives in the spontaneous
speech of disadvantaged preschool children. Journal of Applied Behavior Analysis
1968; 1, 109120.
[28] Prizant BM, Wetherby AM, Rydell P. Communication intervention issues for chil
dren with autism spectrum disorders. In A. M. Wetherby & B. M. Prizant (Eds.), Au
tism spectrum disorders: A transactional developmental perspective. Baltimore, MD:
Paul H. Brookes Publishing; 2000.
[29] Hancock TB, Kaiser AP. The effects of trainer-implemented enhanced milieu-teach
ing on the social communication of children with autism. Topics in Early Childhood
Special Education 2002; 22, 2954.
[30] Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, Donaldson A, Varley
J. Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The
Early Start Denver Model. Pediatrics 2010; 125; e17.

http://dx.doi.org/10.5772/54881
[31] Kasari C, Gulsrud AC, Wong C, Kwon S, Locke J. Randomized controlled caregiver
mediated joint engagement intervention for toddlers with autism. Journal of Autism
and Developmental disorders 2010; 40, 1045-1056.
[32] Drew A, Baird G, Baron-Cohen S, Cox A, Slonims V, Wheelwright S, Swettenham J,
Berry B, Charman T. A pilot randomised control trial of a parent training interven
tion for pre-school children with autism: preliminary findings and methodological
challenges. European Child & Adolescent Psychiatry 2002; 11(6) s. 266-272.
[33] Dahlgren S, Dahlgren-Sandberg A. The non-specificity of theory of mind deficits:
Evidence from children with communicative disabilities. European Journal of Cogni
tive psychology 2004; 15, 129-155.
[34] Ello LM, Donovan SJ. Assessment of the relationship between parenting stress and a
child's ability to functionally communicate. Research on Social Work Practice
2005;15(6), 531-544.
[35] Wilder J, Granlund M. Behaviour style and interaction between seven children with
multiple disabilities and their caregivers. Child: care, health and development 2003;
29, 559-567.
[36] Warren S, Brady N, Sterling A, Fleming K, Marquis J. Maternal responsivity predicts
language development in young children with fragile X syndrome. American Journal
on Intellectual Disabilities 2010;115 (1), 54-75.
[37] Siller M, Sigman M. The behaviors of parents of children with autism predict the
subsequent development of their childrens communication. Journal of Autism and
Developmental Disorders 2002; 32, 77-89.
[38] Hanen centre. http://www.hanen.org (accessed 23 October 2012).
[39] AKKtiv. http://www.akktiv.se (accessed 23 October 2012).
[40] Jonsson A, Kristoffersson L, Ferm U, Thunberg G. The ComAlong communication
boards: Parents use and experiences of aided language stimulation. Augmentative
and Alternative Communication 2011; 27 (2), 103116.
[41] Howlin P. Augmentative and alternative communication systems for children with
autism. InT. Charman & W. Stone (Eds.), Social and communication development in
autism spectrum disorders (pp. 236266). New York: The Guildford Press: 2006.
[42] Mirenda P, Erickson KA. Augmentative communication and literacy. In B. M. Prizant
& A. M. Wetherby (Eds.), Autism spectrum disorders: A transactional developmental
perspective (pp. 369394). Baltimore, MD: Paul H. Brookes Publishing. 2000.
[43] Yoder PJ, Layton TL. Speech following sign language training in autistic children
with minimal verbal language. Journal of Autism and Developmental Disorders
1988: 18, 217230.
741
742
[44] Seal BC, Bonvillian JD. Sign language and motor functioning in students with autistic
disorders. Journal of Autism and Developmental Disorders 1997; 27, 437466.
[45] Schopler E, Reichler R, Lansing M. Teaching strategies for parents and professionals.
Austin, TX: PRO-ED Inc: 1980.
[46] Danielsson H, Jnsson, B. Pictures as language. Paper presented at the International
Conference on Language and Visualisation, Stockholm: 2001.
[47] Bondy A, Frost L. The Picture Exchange Communication System. Focus on Autistic
Behavior, 1994: 9, 119.
[48] Schlosser RW, Blischak DM. Is there a role for speech output in interventions for per
sons with autism. Focus on Autism and Other Developmental Disabilities 2001;16,
170176.
[49] Schlosser RW. The Efficacy of Augmentative and Alternative Communication: To
wards Evidence-Based Practice. Baltimore: Paul Brookes: 2003.
[50] Schlosser RW, Raghavendra P. Evidence-Based Practice in Augmentative andAlter
native Communication. Augmentative and Alternative Communication 2004; 20,
1-21.
[51] Nordenstrm J. Evidensbaserad medicin: I Sherlock Holmes fotspr. Stockholm: Kar
olinska University Press; 2006.
[52] Golper LAC, Wertz RT, Frattali CM, Yorkston K, Myers P, Katz.R, Beeson P, Ken
nedy MRT, Bayles K, Wambaugh J. Evidence-based practice guidelines for the man
agement of communication disorders inneurologically impaired individuals: Project
introduction. ANCDS: 2001.
[53] Sveriges habiliteringschefer [Swedish habilitation directors]. http://www.sverigesha
biliteringschefer.se (accessed 23 october 2012).
[54] Aldred C, Green J, Adams C. A new social intervention for children with autism: pi
lot randomised controlled treatment study suggesting effectiveness. Journal of Child
Psychology and Psychiatry 2004;45(1) 1420-1430.
[55] Ferm U, Andersson M, Broberg M, Liljegren T, Thunberg G. Parents and course lead
ers experiences of the ComAlong augmentative and alternative communication ear
ly intervention course. Disability Studies Quarterly: Mediated Communication 2011;
31(4) http://dsq-sds.org
[56] Callenberg A, Ganebratt P. Utvrdering av AKKtiv frldrautbildning: frldrars
bedmningar av barnens kommunikativa utveckling. [Evaluation of ComAlong pa
rental course: parents views and development in children]. Unpublished masters
thesis in Speech-language Pathology, University of Gothenburg: Department of Neu
roscience and Physiology, Gothenburg: 2009.

http://dx.doi.org/10.5772/54881
[57] Elder JH, Valcante G, Yarandi H, White D, Elder TH. Evaluating In-Home Training
for Fathers of Children With Autism Using Single-Subject Experimentation and
Group Analysis Methods. Nursing Research 2009; vol 54 no 1.
[58] Girolametto L, Sussman F, Weitzmann E. Using case study methods to investigate
the effects of interactive intervention for children with autism spectrum disorders.
Journal of Communication Disorders 2007; 40, 470-492.
[59] Howlin P, Gordon K, Pasco G, Wade A, Charman T. The effectiveness of Picture Ex
change Communication System (PECS) training for teachers of children with autism:
a pragmatic, group randomised controlled trial. J Child Psychol Psychiatry. 2007;
48(5):473-81.
[60] Lennartsson E, Srensson K. Frldrars stt att kommunicera med sina barn fre och
efter KomIgng kommunikationskurs. [Parental communication style before and af
ter ComAlong parental course]. Unpublished masters thesis in Speech-language
Pathology, University of Gothenburg: Department of Neuroscience and Physiology,
Gothenburg: 2010.
[61] McConachie H, Randle V, Hammal D, Le Couteur A. A controlled trial of training
course for parents of children with suspected autism spectrum disorders. The Journal
of Pediatrics 2005; 14, 335-40.
[62] Karlsson E, Melltorp M. Utvrdering av AKKtiv: Tidig intervention till frldrar som
har barn med omfattande kommunikationssvrigheter. [Evaluation of ComAlong:
Early intervention to parents of children with communicative disability]. Unpublish
ed masters thesis in Speech-language Pathology, University of Gothenburg: Depart
ment of Neuroscience and Physiology, Gothenburg: 2006.
[63] Oosterling I, Visser J, Swinkels S, Rommelse N, Donders, R, Woudenberg T, Roos S,
van der Gaag RJ, Biotelaar J. Randomized controlled trial of the Focus parent training
for toddlers with autism: 1-year outcome. Journal of Autism and Developmental Dis
orders 2010; 40, 1447-1458.
[64] Seung HK, Ashwell S, Elder JH, Valcante G. (2006). Verbal communication outcomes
in children with autism after in-home father training. Journal of Intellectual Disabili
ty Research, 2, (50), 139-150.
[65] Sharry J, Guerin S, Griffin C, Drumm, M. (2005). An evaluation of the Parents Plus
Early Years Programme: A video-based early intervention for parents of pre-school
children with behavioural and developmental difficulties. Clinical Child Psychology
and Psychiatry, 10, 319.
[66] Corsello CM. Early Intervention in Autism. Infants & Young Children 2005; 18(2)
74-85.
743
744
[67] Delprato, D. J., (2001) Comparisons of Discrete-Trial and Normalized Behavioral

Language Intervention for Young Children with Autism. Journal of Autism and De
velopmental Disorders, 31, 315-325.
[68] Diggle TTJ, McConachie HHR. Parent-mediated early intervention for young chil
dren with autism spectrum disorder (Review). The Cochrane Library 2009, Issue 4.
[69] Goldstein H. Communication Intervention for Children with Autism: A Review of
Treatment Efficacy. Journal of Autism and Development Disorders 2002; 32(5),
373-396.
[70] Kasari C, Papparella T, Freeman S. Language Outcome in Autism: Randomized
Comparison of Joint Attention and Play Interventions. Journal of Consulting and
Clinical Psychology 2008; 76(1) 125-137.
[71] McConnell S. Intervention to Facilitate Social Interaction for Young Children with
Autism: Review of Available Research and Recommendations for Educational Inter
vention and Future Research. Journal of Autism and Developmental Disorders 2002;
32(5) 351-372.
[72] Woods J, Wetherby A. Early Indentification of and Intervention for Infant and Tod
dlers Who Are at Risk for Autism Spectrum Disorder, Language, Speech and Hear
ing in Schools, 2003; 34 180-193.
[73] Yoder P. Stone WL. A Randomized Comparison of the Effect of Two Prelinguistic
Communication Interventions on the Acquisition of Spoken Communication in Pre
schoolers With ASD. Journal of Speech, Language and Hearing Research 2006; 49
698-771.
[74] McConkey R, Truesdale-Kennedy M, Crawford H, McGreevy E, Reavey M, Cassidy
A. Preeschoolers with autism spectrum disorders: evaluating the impact of homebased intervention to promote their communication. Early Child Development and
Care 2010; 180(3) 299-315.
[75] Wong VCN, Kwan QK. Randomized Controlled Trial for Early Intervention for Au
tism: A Pilot Study of the Autism 1-2-3 Project. Journal of Developmental Disorder
2010; 40 677-688.
[76] Charman, T. (2010). Developmental Approaches to Understanding and Treating Au
tism. Folia Phoniatrica et Logopaedica, 62, 166-177.
[77] Fernell E, Hedvall , Westerlund J, Hglund Carlsson L, Eriksson M, Barnevik Ols
son M, Holm A, Norrelgen F, Kjellmer L, Gillberg C. Early Intervention in 208 Swed
ish preschoolers with autism spectrum disorder. A prospective naturalistic study
Research in developmental Disabilities 2011; 32 2092-2101.
[78] Paul R, Roth FP. Characterizing and Predicting Outcomes of Communication Delays
in Infants and Toddlers: Implications for Clinical Practice. Language, Speech, and
Hearing Services in Schools, 42, 331-340.

http://dx.doi.org/10.5772/54881
[79] Van der Schuit M, Segers E, Van Balkom H. Verhoeven L. Early language interven
tion for children with intellectual disabilities: A neurocognitive perspective. Research
in Developmental Disabilities 2011; 32 705-712.
[80] Spreckley M, Boyd R. Efficacy of Applied Behavioural intervention in preschool chil
dren with autism for improving cognitive, language and adaptive behaviour. A sys
tematic review and meta-analysis. J Pediatr 2009; 154 338-344.
[81] Vismara LA, Colombi C, Rogers SJ. Can one hour per week of therapy lead to lasting
changes in young children with autism? Autism 2009; 13(1) 93-115.
[82] Binger C, Berens J, Kent-Walsh J, Taylor S. The Effects of Aided AAC Interventions
on AAC Use, Speech, and Symbolic Gestures. Seminars och Speech and language
2008; 29 101-111.
[83] Bopp K, Brown K. Mirenda P. Speech-Language Pathologists Roles in the Delivery
of Positive Behaviour Support for Individuals With Developmental Disabilities.
American Journal of Speech-Language Pathology 2004; 13 5-19.
[84] Brady NC. (2000). Improved Comprehension of Object Names Following Voice Out
put Communication Aid Use: Two case Studies. Augmentative and Alternative Com
munication, 16, 197-204.
[85] Branson D Demchak M. The use of Augmentative and Alternative Communication
Methods with Infants and Toddlers with Disabilities: A Research Review. Augmen
tative and Alternative Communication 2009; 25 274-286.
[86] Ganz JB, Simpson RL, Corbin-Newsome J. The impact of the Picture Excange Com
munication System om requesting and speech development in preschoolers with au
tism spectrum disorders and similar characteristics. Research in Autism Spectrum
Disorders 2008; 2 157-169.
[87] Millar DC, Light JC Schlosser RW. The Impact of Augmentative and Alternative
Communication Intervention on the Speech Production of Individuals with Develop
mental Disabilities: A Research Review. Journal of Speech, Language and Hearing
Research 2006; 49 248-264.
[88] Papparella T. Kasari C. Joint Attention Skills and Language Development in Special
Needs Populations Translating Research to Practice. Infants and Young Children
2004; 17(3) 269280.
[89] Preston D. Carter M. A Review of the Efficacy of the Picture Exchange Communica
tion System Intervention. Journal of Autism and Developmental Disorders 2009; 39
1471-1486.
[90] Schlosser R. Sigafoos J. Augmentative and Alternative communication interventions
for persons with developmental disabilities: narrative review of comparative singlesubject experimental studies Research in Developmental Disabilities 2006; 27 1-29.
745
746
[91] Schlosser R. Wendt O. Effects of Augmentative and Alternative Communication In

tervention on Speech Production in Children With Autism: A Systematic Review.
American Journal of Speech-Language Pathology 2008; 17 212-223.
[92] Sigafoos J, Drasgow E, Reichle J, OReilly M, Green V, Tait K. Forum on Intervention
Strategies for Severe Disabilities Tutorial: Teaching Communicative Rejecting to
Children With Severe Disabilities. American Journal of Speech-Language Pathology
2004; 13 31-42
[93] van der Meer L, Sigafoos J, OReilly M. Lancioni, G. Assessing preferences for AAC
options in communication interventions for individuals with developmental disabili
ties: A review of the literature. Research in Developmental Disabilities 2011; 32 1422
1431.
[94] Snell M, Chen L-Y & Hoover K. Teaching Augmentative and Alternative Communi
cation to Students With Severe Disabilities: A Review of Intervention Research
1997-2003. Research and Practice for Persons with Severe Disabilities 2006; 3, 203-214.
[95] Mancil RG, Conroy AC, Haydon TF. Effects of a Modified Milieu Therapy Interven
tion on the Social Communicative Behaviours of Young Children with Autism Spec
trum Disorders. Journal of Autism and Developmental Disorders 2009; 39 149-163.
[96] Thunberg, G. Using speech-generating devices at home. A study of children with au
tism spectrum disorders at different stages of communication development. Gothen
burg Monographs in Linguistics 34. Gteborg, Sweden: Gteborg University: 2007.
Chapter 32
Critical Evaluation of the

Concept of Autistic Creativity
Viktoria Lyons and Michael Fitzgerald
http://dx.doi.org/10.5772/54465
1. Introduction
Autism Spectrum Disorders (ASD) are neurodevelopmental conditions that are associated
with an astonishing combination of cognitive strengths and weaknesses with a substantial
minority of individuals displaying some exceptional creative abilities, reaching genius pro
portions in some rare cases. Creativity is a multifactorial construct and neuroscience is only
beginning to unravel some of the cognitive components involved in the creative process. In
this chapter we contrast neuroscientific evidence from creativity research with models at
tempting to explain talent and creativity in ASD. Although there are no agreed definitions
for creativity the formulation put forward by Griffiths [1] Creativity is a mental journey be
tween ideas or concepts that involves either a novel route or a novel destination (p.6)
seems to fit the picture very well. Various explanations and theories have been put forward
to account for creativity ranging from unconscious mechanisms, cognitive processes, special
abilities and personal traits to links with genetic processes and psychopathology.
The classical portrait of autism is that of rigid, stereotyped behaviours, a preference for
sameness and a resulting lack of imagination. Therefore, the prevalent view is that creativity
and imaginative thought are extremely difficult or impossible for individuals with ASD.
There is substantial research evidence that almost all forms of imagination are impaired in
autism including lack of pretend play, pragmatic language, comprehension and construc
tion of narrative, theory of mind and experimental tests of creativity [2-6]. A significant chal
lenge to this perceived lack of creativity is the enormous achievements that some people
with ASD show in creative and scientific fields. Some theorists and clinicians have therefore
challenged the view of impoverished creativity in ASD [7-12].
In this review the focus is on a subgroup of individuals on the autistic spectrum who dis
play exceptional creative talents and abilities. The features of ASD that favour creativity in
2013 Lyons and Fitzgerald; licensee InTech. This is an open access article distributed under the terms of the
772
clude narrow interests, great persistence, ability to see details within a whole, a fascination
with facts (rather than people) and having savant type talents. While social imagination is
impaired, autistic imagination of the Einsteinian type is amplified.
2. Nature of autistic intelligence and creativity

Autistic intelligence as described by Hans Asperger [13] is a sort of intelligence hardly
touched by tradition and culture unconventional, unorthodox, strangely pure and origi
nal, akin to the intelligence of pure creativity. As pointed out by Einstein To raise new
questions, new possibilities, to regard old problems from a new angle, requires imagination
and makes real advance in science [14 p. 40].
Individuals with ASD show great variation in IQ ranging from severe intellectual impair
ment to superior ability. In addition, intelligence as measured by traditional intelligence
tests reveals a different intellectual profile in ASD than in the neurotypical population
with peaks on Block Design and troughs in Comprehension that appears to be robust
across IQ levels [15]. Individuals with ASD also generally display atypical cognitive
processes when performing these tasks. More recent studies [16,17] revealed further evi
dence for a different nature of autistic intelligence including fast information processing
despite poor measured IQ.
The relationship between intelligence and creativity is unclear and ranges from suggestions
of totally distinct psychological entities to overlapping constructs to different labels for the
same thing [18]. Guilford [19] in his 1950 landmark paper Creativity asserted that creative
talent could not be understood in terms of intelligence. Within the creativity literature, as
noted by Lubart [20] the dominant view is that certain intellectual abilities may be particu
larly useful in creative work, but no intellectual ability is devoted only to creativity (p.288).
Good general intelligence, domain-specific knowledge and special skills are necessary ingre
dients for creativity; however, these components alone are not sufficient for explaining crea
tive processes [21].
Gardners [22] model of multiple intelligences holds that intelligence is a collection of differ
ent intellectual capacities including linguistic, logical-mathematical, musical, bodily kinaes
thetic, spatial intelligence and two forms of personal intelligence, - one oriented towards the
understanding of other persons, the other towards an understanding of self. Autistic intelli
gence tends to be concentrated in the areas of music and logical-mathematical and spatial
abilities. By nature, individuals with autism are extremely logical and analytical, and their
thinking is concrete which makes them good mathematicians though lesser poets. The ex
ception may be a minority of gifted individuals with ASD who have special literary talents
as suggested by Ilona Roth [23] in her analysis of autism spectrum poets including Donna
Williams, Tito Mukhopadhyay and Wendy Lawson. Roth makes the point that poetry, with
its dependence on intensely abstract, symbolic, and free-flowing forms of expression (p.
161) might be particularly suited to the autistic cognitive style.
Critical Evaluation of the Concept of Autistic Creativity

http://dx.doi.org/10.5772/54465
Many features of Asperger syndrome enhance creativity, but the ability to focus deeply on a
topic and to take endless pains is characteristic. Hans Asperger [24] emphasized the intensi
ty with which special interests are pursued already in his first lecture about children with
autistic psychopathology. It appears that these unique qualities of concentration and also
perception as discussed in subsequent paragraphs in individuals with ASD may give rise to
extraordinary creative abilities. Exceptionally gifted people like for example the animal sci
entist and author Temple Grandin [25] declares that her autism, as manifested in her acute
visual/spatial mind and in her powers of concentration is what has made her success possi
ble (p.188). People with Asperger syndrome live very much in their intellects, and certain
forms of creativity benefit greatly from this [26]. Apart from good concrete intelligence addi
tional characteristics of a gifted person with ASD include, ability to disregard social conven
tions, unconcern about the opinions of others and a sometimes-childlike naivety and
inquisitiveness.
According Nancy Andreasen [27], who made a significant contribution to research on
creativity, the personality traits that characterize creative individuals include openness
to experience, adventuresomeness, rebelliousness, individualism, persistence, curiosity,
simplicity, the ability to see things in a different and novel way, indifference to social
conventions, dislike of externally imposed rules, driven by own set of rules derived from
within and a childlike manner (p.30-32). Not surprisingly, the above two descriptions
are strikingly similar.
3. Cognitive processes involved in creativity

Creativity is a multidimensional construct and cognitive neuroscience is only beginning to
understand the many cognitive components involved in creative thinking including the neu
ral substrates underlying these processes [for a review see 28]. Theories of creativity in gen
eral suggest that creativity is linked to attentional capacity [29] and associative or divergent
thinking processes [30]. Mendelsohn [31] emphasised the specific role of defocused atten
tion or a widened attentional ability in highly creative individuals, which is in contrast with
the extremely narrow focus of attention ascribed to individuals with autism [e.g. 32]. Like
wise, divergent thinking, which involves the production of a variety of responses [33] and
assumes to depend on extensively connected neural networks also conflicts with the well re
ported neural underconnectivity and enhanced local networks found in autism. As pointed
out by Nettle [34] different domains of creativity require different cognitive profiles, with
poetry and art associated with divergent thinking, schizophrenia and affective disorder, and
mathematics associated with convergent thinking and autism (p.1). It appears that other
concepts of information processing need to be considered when attempting to elucidate the
specific and unique mechanisms underlying autistic creativity. In the words of Allan Snyder
[35] The fact that genius might fall within the autistic spectrum challenges our deepest no
tions of creativity. Are there radically different routes to creativity: normal and autistic? (p.
1403).
773
774
The main current interpretation of special gifts and savant skills associated with autism in
clude cognitive and psychological theories as well as various other models.
4. Savant syndrome and creativity

According to Treffert [36]: Savant syndrome is a rare, but extraordinary condition in which
persons with serious mental disabilities, including autistic disorder, have some island of
genius which stands in marked, incongruous contrast to overall handicap (p.1351). Savant
skills are found more commonly in ASD than in any other group [37] and are generally at
tributed to low-functioning autism but can also occur in individuals with normal and very
high intelligence.
Theories put forward to explain savant skills strongly suggest a relationship with repetitive,
obsessional and restricted behaviour [38]. Savants generally exhibit circumscribed interests
usually within their skill area [39], which leads to considerable rehearsal, practice and train
ing. Savant skills are also strongly associated with rote memory [40]. Pring [41] in her analy
sis of memory characteristics in savants argued against the rote memory explanation and
instead proposed the existence of complex long-term memory structures in savants. In gen
eral, memory is considered an essential cognitive component of savant skills. In addition, re
searchers have suggested a role for implicit or unintentional, learning in savant skill
development [42,43]. Results of neuropsychological examinations of a calendar-calculating
savant indicated that good memory, superior mental calculation and knowledge of calendar
are the underlying elements for this specific talent [44]. Taken together, the classical portrait
of the autistic savant is largely imitative and not very creative and some writers [e.g. 45] ar
gued that true creativity is missing in savants there are no savant geniuses about. Their
mental limitations disallow and preclude an awareness of innovative developments (p.
177). In contrast, other theorists [46,47] believe that savants, particularly those with Asperg
er syndrome with above average intelligence levels [48] can be extremely creative. Mottron
et al [49] write that Savant performance cannot be reduced to uniquely efficient rote memo
ry skills . and encompasses not only the ability for strict recall, requiring pattern comple
tion, but also the ability to produce creative, new material within the constraints of a
previously integrated structure (p.1388).
Various pathological conditions such as frontotemporal dementia, dominant-hemisphere
strokes, head injuries and infections may also result in the emergence of savant like abilities
[e.g. 50]. Of particular interest is the fact that individuals with these diverse types of disor
ders and emerging savant skills also develop cognitive features and behavioural traits,
which are characteristic of autism [51].

http://dx.doi.org/10.5772/54465
5. Cognitive and psychological theories and explanations underlying

special gifts and talents and savant skills in ASD
The development of special gifts and talents in ASD has been associated in general with the
ability to process local information. These abilities include detail-focused cognitive style
(weak coherence) [52], enhanced perceptual functioning [53], an accentuated capacity for
systemizing [54], privileged access to low-level perceptual processes [55] and various other
psychological and physiological states.
5.1. Weak central coherence
A different cognitive style, the weak central coherence theory (WCC) proposed by Uta Frith
[56] and Frith and Happ [57] has been suggested as an explanation for certain special abili
ties found in ASD. This exceptional part-based processing style is demonstrated in the supe
rior ability individuals with ASD show on tasks such as block design and embedded figures
resulting from deficits in integration processes that serve to draw information together as a
meaningful whole [see 58]. According to Frith [59], the WCC particularly addresses the spe
cial gifts and talents and acute perceptual abilities in autism (e.g. hypersensitivity, visual
and auditory abilities) and can explain the achievements of individuals with ASD syndrome
in art, science, music, and many other areas. Local coherence, which is defined by close at
tention to mechanical or physical patterns, is exemplified in the work of Temple Grandin
[60]. Atypical attentional mechanisms and abnormal neural connectivity have been suggest
ed as possible cognitive and neural mechanisms underlying WCC.
5.2. Enhanced perceptual functioning
Also located at the level of perception is the model proposed by Mottron and Burack
[61] and Mottron et al [62] which are based on enhanced perceptual functioning (EPF)
suggesting that people with autism have an overdevelopment of low-level perceptual
abilities at the expense of high-level processing mechanisms. This theory provides a con
vincing account of special abilities in ASD such as peaks of ability in visual and audito
ry modalities and also indicates that a variety of cognitive processes are required for the
development of savant abilities. For example, Mottron et al [63] propose that enhanced
detection of patterns, including similarity within and among patterns is contributing to
creativity evident in savants. As far as neural correlates for their theory is concerned the
authors suggest the notion of brain plasticity and an overfunctioning of brain regions in
volved in perception in autism [64].
EPF and WCC are similar in emphasizing detail focused processing bias and superior local
processing. Superiority in local coherence may be specific to autistic creativity and as argued
by Mills [65] produces an imaginative faculty defined by close attention to mechanical or
physical patterns not psychological or social rules (p.126).
775
776
5.3. Systemizing theory

This above interpretation appears to be in line with the systemizing theory put forward
by Baron-Cohen et al. [66] which emphasises the superior ability in recognizing repeating
patterns in stimuli (e.g. numerical, spatial, mechanical, auditory systemizing). The system
izing theory, in contrast to the WCC model, predicts that individuals with ASD have a
strong central coherence as indicated by their excellent skills in integrating information in
areas such as astronomy and physics. This ability, however, does not apply to non-systemiz
able fields such as fiction. Similar to the WCC the systemizing model also posits excellent
attention to detail in perception and memory. Baron-Cohen et al [67] further suggest that
this excellent attention to detail is a consequence of sensory hypersensitivity found in indi
viduals with ASD. Belmonte et al [68] posited that local overconnectivity in the posterior
sensory parts of the cortex is responsible for the sensory magnification in ASD.
5.4. Low level information processing
The work of Synder et al. [69] also provides an understanding of certain forms of creativity.
According to Snyder and Mitchell [70] outstanding savant skills might be accomplished by
accessing early stages of information processing. Their controversial model predicts the pos
sibility of accessing non-conscious information by artificially disinhibiting the inhibiting net
works associated with concept formation, using transcranial magnetic brain stimulation
(TMS). By means of this method Snyder et al. [71] propose that this process will open the
door for restoration of perfect pitch, for recalling detail... and even enhancing creativity. A
recent EEG study [72] attributing increased visual detail perception in autism to neural ab
normalities related to low-level visual processing potentially supports this theory.
Snyderss theory [73] furthermore suggests the possibility that savant skills may be latent in
everyone, but a form of cortical disinhibition or atypical hemispheric imbalance is re
quired in order to access them (p. 1399). In support for his theory Snyder quotes the emer
gence of savant skills in individuals without any previous history for talents due to a variety
of illnesses.
Snyders model explains many of the talents and characteristics associated with Asperger
geniuses including their childlike view of the world and lack of preconceptions, which is
beneficial for developing new and original theories and perspectives. For example, Ludwig
Wittgenstein, who had Asperger syndrome did spend little time reading other philosophers
and felt most of them were wrong anyhow. He didnt want to cloud his mind with false
theories [74].
5.5. Primary process thought and disinhibition syndrome, reduced self-awareness
Flow
Theories of creativity [75, 76] also highlight the importance of primary process thought as
found in dreaming, free association and psychosis in creative processes. Einstein suggested
that creative scientists are the ones with access to their dreams. Occasionally, a dream will
actually provide the solution to a problem, as cited by Gregory [77] (p.226). Many mathe

http://dx.doi.org/10.5772/54465
maticians are intuitive thinkers and rely on the unconscious mind to a large extent, like for
example the genius mathematician Poincar [78]. Freudian theory holds that primary proc
esses or primitive thinking which creative persons have more access to are based on their
weak defence mechanisms of repression. Individuals with Asperger syndrome have very
weak defence mechanisms thus allowing them access to early childhood memories [79].
Low levels of repression or inhibition are associated with creativity and a number of theo
rists [80, 81] have suggested that creativity is a disinhibition syndrome, i.e. highly creative
individuals lack cognitive inhibition. Neural correlates of cognitive disinhibition are the
frontal lobes and research indicates that creative individuals show less frontal-lobe activity
during verbal association tasks [82]. Deficits in inhibition have been documented in autism
[83] as well as in Attention Deficit Hyperactivity Disorder (ADHD) [84] a neurodevelop
mental disorder that is associated with increased creativity.
Also relevant in this context maybe the concept of flow proposed by the psychologist
Cskszentmihlyi [85]. The notion of flow indicates a familiar state of reduced self-aware
ness where temporal concerns (time, food, ego-self, etc) are ignored during periods where
the individual is fully immersed in a task or process. According to Cskszentmihlyi flow
is characterised by a feeling of great absorption, engagement and fulfilment and thought to
be inherently reinforcing and rewarding [86]. As alerted to in the chapter Atypical Sense of
Self in Autism Spectrum Disorders: A Neuro-cognitive Perspective (this book) [87] dimin
ished self-awareness which is a characteristic of individuals with ASD and associated with
right hemisphere dysfunction might be advantageous in the development of special talents
in ASD as quoted by Happ and Vital [88] (p.1373).
To conclude, although no single theory can explain the cognitive mechanisms underlying
savant skill development, prodigious memory, atypical perception and excellent attention to
detail are fundamentally associated with savant like talents in individual with ASD.
6. Neural basis of creativity in non-clinical populations
The study of the neural basis of creativity is an area greatly neglected by scientific research
and despite methodological difficulties associated with investigating creativity any account
of creativity must include explanations about the neural correlates of creativity [89].
Neuroscientific approaches aiming to determine the physiological basis of creative thought,
are assuming that creativity is a measurable trait. Creativity can be interpreted as physiolog
ical changes that are required for creative problem solving focussing on EEG measures of
cortical activation [90]. Theories of creativity in general postulate that low levels of cortical
activation contribute to creative inspiration. Imaging data [91] suggest that great creativity
not only requires a high level of specialized knowledge (stored in temporal and parietal
lobes) and divergent thinking (mediated by the frontal lobes) but also co-activation and
communication between areas of the brain that normally do not show strong connections.
Highly creative individuals also possess the ability to modulate neurotransmitters [92, 93]
such as the norepinephrine system (located in the frontal lobes), indicated by a reduction of
cerebral levels of norepinephrine during creative periods. Support for the role of frontal
777
778
areas in a fluid analogy-making task comes from an fMRI study [94] indicating bilateral neu
ral activations. A study measuring differences in cerebral blood flow between highly crea
tive individuals and controls during a verbal task of creative thinking [95] implicated a
neural network consisting of right and left fronto-temporal, parietal, and cerebellar regions
in highly creative performances. These areas are involved in cognition, emotion, working
memory and response to novelty.
7. Neural basis of creativity in ASD

We are not aware of any studies investigating directly the neural basis of creativity in au
tism apart from studies exploring savant skills in autism. Some of these support the Left
Hemisphere (LH) dysfunction/ and Right Hemisphere (RH) compensation theory [e.g. 96] as
indicated by hemispheric asymmetry. Research evidence of neuroanatomical abnormalities
including atypical minicolumnar organization in ASD [97,98] as well as neural hypotheses
about abnormal connectivity [e.g. 99] support this theory.
7.1. Hemispheric asymmetry
Cerebral asymmetry refers to the lack of structural symmetry in left and right hemispheres
in humans. Atypical cerebral asymmetry, a deviation from the normal pattern of cerebral
asymmetry has been associated with special cognitive talents [100] and creativity [101] as
cited by Smalley et al. [102]. For example, the capability for making distal or global verbal
associations is one factor contributing to creativity and according to Brugger and Graves
[103] the basis for this type of verbal creativity is cerebral laterality in which an individual
has a relative weakening of left hemisphere dominance and strengthening of availability of
right hemisphere processing [104] p. 138.
Atypical cerebral asymmetry has been associated with autism, dyslexia and ADHD [105],
neurodevelopmental disorders considered to share regions of linkage overlap [106]. In addi
tion, creativity in psychiatric populations is often associated with atypical cerebral asymme
try [107] and a RH bias [108].
Research evidence for atypical cerebral asymmetry in autism (e.g. increased size of some RH
cortical structures) and reversed lateralization of language has been well documented [e.g.
109]. An imaging study by Herbert et al [110] found a sizeable right-asymmetry increase
in subjects with autism. Individuals with autism had twice as much right-as left-asymmetri
cal cortex than the control sample. This finding was interpreted as a consequence of early
abnormal brain growth abnormalities. According to the hypothesis put forward by Gesch
wind and Galaburda [111] the immaturity of the LH in utero makes it more susceptible to
damage, which could result in a compensatory overdevelopment of the RH caused by neu
ral migration and thus resulting in an anomalous RH-dominance. As the RH develops earli
er than the LH, accelerated early brain development in autism may lead to anomalous
lateralization of cognitive functions as suggested by Herbert et al [112].

http://dx.doi.org/10.5772/54465
7.2. Right hemisphere processing and creativity

Savant skills are linked to the RH [113], which is dominant for attention, visuospatial and
emotional function. Various authors [114-115] have suggested that autistic savants have
atypical LH dysfunction with RH compensation. Based on research evidence including
imaging studies Treffert [116] speculated that one mechanism in some savants, whether
congenital or acquired is left brain dysfunction with right brain compensation. The notion
of paradoxical functional facilitation as described by Kapur [117] denotes loss of function
in one damaged brain area and enhanced function of another area, which as emphasized by
Treffert is central to explaining savant syndrome (p.1356).
RH skills can be characterized as non-symbolic, artistic, concrete and directly perceived in
contrast to LH skills that are more sequential, logical, and symbolic. For example musical,
artistic, visual or spatial abilities (mathematics) are primarily RH skills.
The association between RH and creativity is based on research evidence demonstrating that
the RH is more involved in production of mental images than the LH, perception and pro
duction of music, e.g. the right inferior frontal gyrus is known to be involved in musical
pitch encoding and melodic pitch memory [118]. EEG studies show that highly creative indi
viduals show more right than left-hemisphere activation during experimental studies [119],
indicating that during the creative process creative individuals rely more on the RH. Lesion
studies as well as unimpaired population studies have demonstrated that the RH is superior
to the LH at noticing anomalies in objects [120]. Individuals with autism are well known for
detecting even the smallest changes in the environment.
In sum, several lines of evidence suggest that atypical cerebral asymmetry which is a highly
heritable trait [121] is associated with autism and linked to certain aspects of creativity. It is
also likely that some of the structural brain abnormalities evidenced in autism are related to
the special cognitive functioning that encourages great creativity. Neurological brain differ
ences have been reported in the literature on creativity [122].
7.3. Neuroanatomical abnormalities in autism
Converging neuroscientific evidence has suggested that the neuropathology of ASD is wide
ly distributed, involving impaired connectivity throughout the brain. Neuroanatomical ab
normalities in autism include increase in cortical thickness [123], and increase in head and
brain size [124]. Accelerated growth in brain size in early childhood in autism has been
documented by a range of studies [125], which may be consistent with the asymmetric cere
bral lateralization in autism as discussed above. The increased brain volumes in autism are
believed to be the result of insufficient or abnormal prenatal pruning, which together with
genetic factors are most likely to underlie these growth abnormalities [126]. In addition,
there is evidence of higher birth weight [127] and faster body growth [128] as well as in
creased levels of growth hormones [129] in autism. These altered brain growth rates are con
sidered to have a strong influence on patterns of brain connectivity and cerebral
lateralization [130, 131] and differential cognitive functioning. For example, the increased
hippocampus size in autism [132] may be associated with enhanced visual-spatial, mathe
779
780
matical and mechanistic processing in autism as well as savant abilities such as calculation
and memory. Imaging data of a reduced size of corpus callosum in autism [133] is consistent
with the reduced interhemispheric brain connectivity reported in autistic individuals [134].
Neural underconnectivity [e.g. 135] provides support for the weak central coherence theo
ry which postulates enhanced local and decreased global information processing in autism.
Research on patterns of cortical connectivity also indicates that a specific minicolumnar phe
notype found in autism may be beneficial for information processing and/or focused atten
tion and may also offer an explanation for the savant abilities autism [136, 137].
To conclude, although neural mechanisms underlying savant skill and development are
not well established, associating creativity with hemisphere lateralization and anatomical
abnormalities in autism is supported by empirical evidence and also has some explanato
ry potential. Additional areas to explore are genetic factors and creativity found in other
pathological conditions.
8. Nature versus nurture

Is great creativity a fortunate combination of specific traits, or do creativity genes exist?
As speculated by Smalley et al [138] genes that increase ones risk for certain psychiatric or
learning disorders may also be enhancer genes for creativity (and intuition) (p.82). Ac
cording to Gardner [139] it is extremely unlikely that there is such a thing as a poetry gene
or a music gene since complex human behaviours typically have a polygenic basis (p.
175). Without doubt ASD have a polygenic basis and genetic factors not only contribute to
specific skills but also to traits such as persistence, the capacity for concentration for extend
ed periods, and curiosity about certain types of stimulation. Lykken et al [140] describe the
concept of emergenesis, an extreme form of epitasis, in which a unique combination of genes
may lead to qualitative shifts in capacity or ability that may apply to extremely gifted indi
viduals with ASD.
The relationship between inherited talent and/or extensive practice is a very contentious as
pect of superior ability in specific skills. The view propounded by Howe [141] emphasizing
the overwhelming role of practice in the acquirement of special skills, is largely rejected by a
majority of theorists who argue for the role of innate talent [142-144]. Special talents are es
sentially innate in predisposing to cognitive or physical qualities and are the key to under
standing geniuses from Einstein to Mozart [145]. For example, research evidence from twin
data [146] suggests a genetic basis for detail-focused cognitive style predisposing to talent in
ASD. It is configuration of genes and variations in genetic inputs that are critical to the suc
cess in persons of great creativity. It is our belief that there are significant genetic underpin
nings to creativity of genius proportions, which of course could not be expressed without
environmental factors.

http://dx.doi.org/10.5772/54465
9. Novelty, ADHD and creativity

The majority of theoretical conceptions of creativity agree that the main component of crea
tivity is its novelty, uniqueness or unusualness that undoubtedly applies to the creativity
displayed by gifted individuals with ASD. Novelty or sensation seeking behaviour is also
strongly associated with ADHD. A significant degree of comorbidity between autism and
ADHD has been documented [e.g. 147] in the literature. Although reported to have poor at
tention and concentration and being poor academic performers individuals with ADHD
have a capacity to hyperfocus, which allows them to produce great works of art. For exam
ple the poetry of Lord Byron, who had ADHD [148] is an example for a work of genius in
this area. As pointed out above, both autism and ADHD are associated with atypical cere
bral asymmetry which is a highly heritable and complex phenotype linked to creativity and
sharing regions of linkage overlap [149,150].
10. Psychopathology
There is a very close relationship between creativity (especially in literature and arts) and
psychopathology, particularly mood disorder [151, 152]. An association of biochemical fac
tors in psychosis and creativity has been suggested by Folley et al [153] indicating the nora
drenergic system. This model also provides possible links between attention, divergent
thinking, and arousal based on mechanisms that interact with structural and neurochemical
systems of the brain and has the potential to explain the novelty seeking behaviour implicat
ed in ADHD but may have less explanatory power as far as autism is concerned. According
to Sternberg and Lubart [154] creativity and novelty must be coupled with appropriateness
for something to be considered creative. Although schizotypal thought most likely leads to
an increase in novel ideas, they may not always be appropriate.
In contrast, the nature of creativity displayed by individuals with ASD is associated with the
distinctiveness of the autistic brain and its unique neural connectivity. In this context Tem
ple Grandin [155] has stated, it is likely that genius is an abnormality (p178-179). Howev
er, she also believes that autistic intelligence is necessary in order to add diversity and
creativity to the world: It is possible that persons with bits of these traits are more creative,
are possibly even geniusesIf science eliminated these genes, maybe the whole world
would be taken over by accountants (p.124).
11. Conclusion
The results of our evaluation suggest that many features of ASD are advantageous for
great creativity. Creativity is an extremely complex and multifaceted construct and no
cognitive theory or model of brain function has so far been able to fully account for it.
We suggest that the distinctive gifts of perception, attention, memory and information
781
782
processing combined with personality attributes can give rise to the extraordinary crea
tivity seen in some individuals with ASD. It is our view that progress in elucidating the
neural basis of autism may hold promises for a better understanding of autistic creativi
ty and creativity in general. Autism Spectrum Disorders are mainly portrayed as nega
tive phenomena, as a curse, but if they were an integral part of the mindset of highly
creative individuals such as Einstein and Darwin who possessed autistic traits they could
be regarded in some aspects as a gift [156].
Author details
Viktoria Lyons* and Michael Fitzgerald
Trinity College Dublin, Ireland
References
[1] Griffiths TD. Scientific Commentary. Capturing Creativity. Brain 2008;131: 6-7.
[2] Baird G, Cox A, Charman, T, Baron-Cohen S. et al. A Screening Instrument for Au
tism at 18 Months of Age: A Six-Year Follow-up Study. Journal of the American
Academy of Child and Adolescent Psychiatry 2000; 39: 694-702.
[3] Happ F. Communicative Competence and Theory of Mind in Autism: A Test of
Relevance Theory. Cognition 1993;48: 101-119.
[4] Bruner J, Feldman C. Theories of Mind and the Problem of Autism. In: Baron-Cohen
S, Tager-Flusberg H, Cohen DJ. (eds) Understanding Other Minds: Perspectives from
Autism. Oxford: Oxford University Press; 1993. p 267-291.
[5] Baron-Cohen S. Theory of Mind and Autism: a Review. Special Issue of The Interna
tional Review of Mental Retardation 2001; 23: 169.
[6] Craig J, Baron-Cohen S. Creativity and Imagination in Autism and Asperger Syn
drome. Journal of Autism and Developmental Disorders 1999;29: 319-326
[7] Fitzgerald M. Autism and Creativity: Is there a link between autism in men and ex
ceptional ability? New York: Brunner Routledge; 2004.
[8] Fitzgerald M. The Genesis of Artistic Creativity. London: Jessica Kingsley; 2005.
[9] Fitzgerald M, James I. The Mind of the Mathematician. Baltimore: John Hopkins
Press; 2007.

http://dx.doi.org/10.5772/54465
[10] Sacks O. An Anthropologist on Mars: Seven Paradoxical Tales. New York: Knopf;
1995.
[11] Treffert DA. The savant syndrome: an extraordinary condition. A synopsis: past,
present, future. In: Happ F, Frith U. (eds.) Autism and talent. Philosophical transac
tions of The Royal Society 2009; vol. 364 (1522) p1351-1358.
[12] Mottron L, Dawson M, Soulires I. Enhanced perception in savant syndrome: pat
terns, structure and creativity. In: Happ F, Frith U. (eds.) Autism and talent. Philo
sophical transactions of The Royal Society 2009; vol. 364 (1522) p1385-1392.
[13] Asperger H. Die autistischen Psychopathen im Kindesalter. Archiv fuer Psychiatrie
und Nervenkrankheiten 1944;11: 76-136.
[14] Jay E. Problem finding: understanding its nature and mechanism. Qualifying paper,
Harvard Graduate School of Education, Cambridge, M.A.; 1989.
[15] Lincoln AJ, Allen MH, Kilman A. The assessment and interpretation of intellectual
abilities in people with Autism. In: Schopler E, Mesibov GB (eds.). Learning and cog
nition in autism. New York: Plenum Press; 1995. p89-117.
intelligence. Psychological Science 2007;18: 657-662.
[17] Scheuffgen K, Happ F, Anderson M, Frith U. High intelligence, low IQ Speed of
processing and measured IQ in children with autism. Developmental Psychopatholo
gy 2000;12: 83-90.
[18] Sternberg RJ, OHara LA. Intelligence and Creativity. In: Sternberg RJ. (ed.) Hand
book of Intelligence. Cambridge: Cambridge University Press; 2000.
[19] Guilford JP. Creativity. American Psychologist 1950;5: 444-454.
[20] Lubart T. In Search of Creative Intelligence. In: Sternberg J, Lautrey J, Lubart TI (eds.)
Models of intelligence: international perspectives. Washington: APA; 2004.
[21] Heilman KM, Nadeau SE, Beversdorf DO. Creative Innovation: Possible Brain Mech
anism. Neurocase 2003;9: 369-379.
[22] Gardner H. Frames of mind: The theory of multiple intelligences. New York: Basic;
1983.
[23] Roth I. Imagination and the Awareness of Self in Autistic Spectrum Poets. In: Osteen
M. (ed.) Autism and Representation. New York: Routledge; 2008.
[24] Asperger H. Das psychisch abnorme Kind. Wiener Klinische Wochenzeitschrift
1938;49: 1314-1317.
[25] Grandin, T. Thinking in Pictures: and Other Reports from my Life with Autism. New
York: Doubleday; 1995.
[26] Fitzgerald & James, 2007.
783
784
[27] Andreasen NC. The Creating Brain. The Neuroscience of Genius. New York: Dana
Press; 2005.
[28] Abraham A, Windmann S. Creative cognition: The diverse operations and the pros
pect of applying a cognitive neuroscience perspective. Methods 2007; 22: 38-8.
[29] Mendelsohn GA. Associative and attentional processes in creative performance. Jour
nal of Personality 1976;44: 341-369.
[30] Guilford JP. The nature of human intelligence. New York: McGraw-Hill; 1967.
[31] Mendelsohn 1976.
[32] Townsend J, Courchesne E. Parietal damage and narrow spotlight spatial attention.
Journal of Cognitive Neuroscience 1994;6: 220-232.
[33] Torrance EP. The Torrance Tests of Creative Thinking: Technical-norms manual. Ben
senville, IL: Scholastic Testing Service; 1974.
[34] Nettle D. Schizotypy and mental health amongst poets, visual artists, and mathema
ticians. Journal of Research in Personality 2006;40: 876-890.
[35] Snyder A. Explaining and inducing savant skills: privileged access to lower level,
less-processed information. In: Happ F, Frith U. (eds.) Autism and talent. Philo
[36] Treffert 2009.
[37] Howlin P, Goode S, Hutton J, Rutter M. Savant skills in autism: psychometric ap
proaches and parental reports. In: Happ F, Frith U. (eds.) Autism and talent. Philo
[38] OConnor N, Hermelin B. Talents and preoccupations in idiot-savants. Psychological
Medicine 1991;21: 959-964.
[39] OConnor & Hermelin, 1991.
[40] Hill AL. Savants: Mentally retarded individuals with special skills. In Ellis N. (ed.)
International review of research in mental retardation. New York: Academic Press;
1978. (9) p277-298.
[41] Pring L. Memory characteristics in individuals with savant skills. In: Boucher J,
Bowler D. (eds.) Memory in Autism. Cambridge: Cambridge University Press; 2008.
[42] Treffert D. Extraordinary people: understanding idiot savants. New York: Harper
and Row; 1989.
[43] Hermelin B. Bright splinters of the mind: a personal story of research with autistic
savants. London: Jessica Kingsley Press; 2001.
[44] Wallace GL, Happ F, Giedd JN. A case study of a multiply talented savant with an
autism spectrum disorder: neuropsychological functioning and brain morphometry.

http://dx.doi.org/10.5772/54465
In: Happ F, Frith U. (eds.) Autism and talent. Philosophical transactions of The Roy
al Society 2009; vol. 364 (1522) p1425-1432.
[45] Hermelin 2001.
[46] Treffert 2009.
[47] Mottron, Dawson & Soulires 2009.
[48] Fitzgerald 2005.
[50] Seeley WW, Matthews BR, Crawford RK, Gorno-Tempini ML, Foti D, Mackenzie IR,
Miller BL. Unravelling Bolro: progressive aphasia, transmodal creativity and the
right posterior neocortex. Brain 2008;131: 39-49.
[51] Heaton P. Wallace GL. Annotation: The savant syndrome. Journal of Child Psycholo
gy and Psychiatry 2004;45: 899-911.
[52] Frith U, Happ F. Autism: beyond theory of mind. Cognition 1994;50: 115-132.
hyper-systemizing, hyper-attention to detail and sensory hypersensitivity. In: Happ
F, Frith U. (eds.) Autism and talent. Philosophical transactions of The Royal Society
2009; vol. 364 (1522) p1377-1384.
[55] Snyder AW, Mitchell DJ. Is integer arithmetic fundamental to mental processing? the
minds secret arithmetic. London: Proceedings of the Royal Society 1999;266: 587-592.
[56] Frith U. Autism: Explaining the Enigma. Oxford: Blackwell; 1989.
[57] Frith & Happ 1994.
[58] Happ F, Frith U. The Weak Coherence Account: detail-focused Cognitive style in
Autism Spectrum Disorders. Journal of Autism and Developmental Disorders
2006;36: 5-25.
[59] Frith, U. (2004). Emanuel Miller lecture: Confusions and controversies about Asperg
er Syndrome. Journal of Child Psychology and Psychiatry 2004;45: 672-686, p. 680.
[60] Grandin 1995.
[61] Mottron L, Burack JA. Enhanced perceptual functioning in the development of au
tism. In: Burack JA, Charman T, Yirmiya N, Zelazo PR. (eds.) The development of
autism: Perspectives from theory and research. New Jersey: Lawrence Erlbaum; 2001.
[62] Mottron L, Dawson M, Soulires I, Hubert B, Burack J. Enhanced Perceptual func
tioning in Autism: An Update, and eight Principles of Autistic Perception. Journal of
Autism and Developmental Disorders 2006;3: 27-43.
785
786
[64] Mottron & Burack 2001.

[65] Mills B. Autism and the Imagination. In: Osteen M. (ed.) Autism and Representation.
New York: Routledge; 2008.
[66] Baron-Cohen S, Richler J, Bisarya D, Gurunathan N, Wheelwright S. The systemizing
quotient: an investigation of adults with Asperger syndrome or high-functioning au
tism and normal sex differences. In: Frith U, Hill E. (eds.) Autism: Mind and Brain.
Oxford: Oxford University Press; 2004. p161-186.
[67] Baron-Cohen et al. 2009.
[68] Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, Webb SJ.
Autism and abnormal development of brain connectivity. Journal of Neuroscience
2004;24: 9228-31.
[69] Snyder AW, Bossomaier T, Mitchell DJ. Concept Formation: Object Attributes Dy
namically Inhibited from Conscious Awareness. Journal of Integrative Neuroscience
2004;(3) 1: 3146.
[70] Snyder & Mitchell 1999.
[71] Snyder et al 2004.
[72] Vandenbroucke MWG, Scholte HS, van Engeland H, Lamme VAF, Kemner C. A neu
ral substrate for atypical low-level visual processing in autism spectrum disorder.
Brain 2008, 131(4): 1013-1024.
[73] Snyder 2009.
[75] Freud S. Creative writers and daydreaming. In: Strachey J. (ed. & trans.) Standard
edition of the complete psychological works of Sigmund Freud. London: Hogarth
Press; 1959. (9) p141-153.
[76] Kris E. Psychoanalytic explorations in art. New York: International Universities
Press; 1952.
[77] Gregory FL. The Oxford Companion to the Mind. Oxford: Oxford University Press;
2004.
[79] Lyons V, Fitzgerald, M. Early Memory and Autism. Letter to the Editor. Journal of
Autism and Developmental Disorders 2005;35: 683.
[80] Eysenck H. Genius: The natural history of creativity. Cambridge: Cambridge Univer
sity Press; 1995.
[81] Martindale C. Personality, situation, and creativity. In: Glover JA, Running RR, Rey
nolds CR (eds.) Handbook of creativity. New York: Plenum; 1989. p211-228.

http://dx.doi.org/10.5772/54465
[82] Hudspith S. The neurological correlates of creative thought. Unpublished PhD. Dis
sertation, University of Southern California, Los Angeles, CA; 1985.
[83] Johnson KA, Robertson IH, Kelly SP. et al. Dissociation in performance of children
with ADHD and high-functioning autism on a task of sustained attention. Neuropsy
chologia 2007;45: 2234-2245.
[84] Ozonoff, S. Components of executive function in autism and other disorders. In: Rus
sell J. (ed.) Autism as an Executive Disorder. Oxford: Oxford University Press; 1997.
[85] Cskszentmihlyi M. Flow: the psychology of optimal experience. Ney York: Harper
and Row; 1990.
[86] Cskszentmihlyi M, Lefevre J. Optimal experience in work and leisure. Journal of
Personal and Social Psychology 1989;56: 815-822.
[87] Lyons V, Fitzgerald M. Atypical Sense of Self in Autism Spectrum Disorders: A Neu
ro-cognitive Perspective. In: ..
[88] Happ F, Vital P. What aspects of autism predispose to talent? In: Happ F, Frith U.
(eds.) Autism and talent. Philosophical transactions of The Royal Society 2009; vol.
364 (1522): p1369-1376.
[89] Zeki S. Essays on science and society. Artistic creativity and the brain. Science
2001;293: 51-2.
[90] Martindale C. Creative imagination and neural activity. In: Kunzendorf R, Sheikh A.
(eds.) Psychophysiology of mental imagery: Theory, research, and application. Ami
tyville, NY: Baywood; 1990. p89-108.
[91] Heilman, Nadeau & Beversdorf, 2003.
[92] Beversdorf DQ, Hughes JD, Steinberg BA, Lewis LD, Heilman KM. Noradrenergic
modulation of cognitive flexibility in problem solving. Neuroreport 1999;10: 2763-7.
[93] Folley BS, Doop ML, Park S. Psychoses and creativity: is the missing link a biological
mechanism related to phospholipids turnover? Prostaglandins, Leukotrienes and Es
sential Fatty Acids 2003;69: 467-476.
[94] Gaeke JG, Hansen PC. Neural correlates of intelligence as revealed by fMRI of fluid
analogies. Neuroimage 2005;26: 555-64.
[95] Chavez-Eakle RA, Graff-Guerrero A, Garcia-Reyna JC, Vaugier V, Cruz-Fuentes D.
Cerebral blood flow associated with creative performance: a comparative study.
Neuroimage 2007;38: 519-28.
[96] Rimland B. Infantile Autism: the Syndrome and its implications for a neural theory
of behavior. New York: Appleton-Century-Crofts; 1978.
[97] Casanova MF, Switala AE, Trippe J, Fitzgerald M. Comparative minicolumnar
morphometry of three distinguished scientists. Autism, The International Journal of
Research and Practice 2007;11: 55-569.
787
788
[98] Casanova M, Trippe J. Radial cytoarchitecture and patterns of cortical connectivity in

autism. In: Happ F, Frith U. (eds.) Autism and talent. Philosophical transactions of
The Royal Society 2009; vol. 364 (1522) p1433-1436.
[99] Belmonte et al 2004.
[100] Geschwind N, Miller BL. Molecular approaches to cerebral laterality: development
and neurodegeneration. American Journal of Medical Genetics 2001;101: 379-381.
[101] Brugger P, Graves R.E. Right hemispatial inattention and magical ideation. European
Archive for Psychiatry Clinical Neuroscience 1997;247: 55-57.
[102] Smalley SL, Loo SK, Yang MH, Cantor RM. Toward Localizing Genes Underlying
Cerebral Asymmetry and Mental Health. American Journal of Medical Genetics Part
B (Neuropsychiatric Genetics) 2004;135B: 79-84.
[103] Brugger & Graves, 1997.
[104] Weinstein S, Graves RE. Are creativity and schizotypy products of a right hemi
sphere bias? Brain Cognition 2002;49: 138-151.
[105] Smalley et al 2004.
[106] Smalley SL, Kustanovich V, Minassian S, Stone JL, Ogdie MN. et al. Genetic linkage
of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region impli
cated in autism. American Journal Human Genetics 2002;71: 959-963.
[107] Overby LA III, Harris AE, Leek MR. Perceptual asymmetry in schizophrenia and af
fective disorder: Implications from a right hemisphere task. Neuropsychologia
1989;27: 861-870.
[108] Weinstein & Graves 2002.
[109] Bigler ED, Mortensen S, Neeley ES, Ozonoff S, Krasny, L, Johnson M, Lu J, Provencal
SL, McMahon W, Lainhart, JE. Superior temporal gyrus, language function, and au
tism. Developmental Neuropsychology 2007;31: 217-38.
[110] Herbert MR, Ziegler DA, Deutsch CK, OBrien LM, Kennedy DN, Filipek PA, Bar
kardjiev AI, Hodgson J, Takeoka M, Makris N, Caviness Jr VS. Brain asymmetries in
autism and developmental language disorder: a nested whole-brain analysis. Brain
2005;28: 213-226.
[111] Geschwind N, Galaburda AM. Cerebral Lateralization: Biological Mechanisms, Asso
ciations, and Pathology. Cambridge: MIT Press; 1987.
[112] Herbert et al 2005.
[113] Treffert D. The idiot savant: a review of the syndrome. American Journal of Psychia
try 2000; 45: 563-572.
[114] Miller BL, Boone K, Cummings LR, Mishkin F. Emergence of artistic talent in frontotemporal dementia. Neurology 1998;51: 978-982.

http://dx.doi.org/10.5772/54465
[115] Sacks O. Musicophilia: tales of music and the brain. New York: Knopf Publishing
Group; 2007.
[116] Treffert 2009.
[117] Kapur N. Paradoxical functional facilitation in brain-behaviour research: a critical re
view. Brain 1996;119 1775-1790.
[118] Hyde K, Zatorre R, GriffithsTD, Lerch JP, Peretz I. Morphometry of the amusic brain:
A two-site study. Brain 2006;129:2562-70.
[119] Martindale C, Hines D, Mitchell L, Covello E. EEG alpha asymmetry and creativity.
Personality and Individual Differences 1984;5: 77-86.
[120] Smith SD, Dixon MJ, Tays WJ, Bulman-Fleming MB. Anomaly detection in the right
hemisphere: The influence of visuospatial factors. Brain Cognition 2004;55: 458-62.
[121] Geschwind DH, Miller BL, DeCarli C, Carmelli D. Heritability of lobar brain volumes
in twins supports genetic models of cerebral laterality and handedness. Proceedings
of the National Academy of Sciences USA 2002;99: 3176-3181
[122] Herrmann N. The creative brain. Lake Lure, N.C: Applied Creative Services; 1988.
[123] Hardan AY, Muddasani S, Vemulapalli M, Keshavan MS, Minshew NJ. An MRI
study of increased cortical thickness in autism. American Journal of Psychiatry
2006;163: 1290-92.
[124] Dissanayake C, Bui QM, Huggins R, Loesch DZ. Growth in stature and head circum
ference in high-functioning autism and Asperger disorder during the first 3 years of
life. Development and Psychopathology 2006;18: 381-93.
[125] Courchesne E, Pierce K. Brain overgrowth in autism during a critical time in devel
opment: Implications for frontal pyramidal neuron and interneuron development
and connectivity. International Journal of Developmental Neuroscience 2005; 23:
153-70.
[126] Courchesne E. Brain development in autism: Early overgrowth followed by prema
ture arrest of growth. Mental retardation and Developmental Disabilities. Research
Reviews 2004;10 106-11.
[127] Mraz KD, Green J, Dumont-Mathieu T, Makin S, Fein D. Correlates of head circum
ference growth in infants later diagnosed with autism spectrum disorders. Journal of
Child Neurology 2007;22: 700-13.
[128] Dissanayake et al 2006.
[129] Mills JL, Hediger ML, Molloy CA, et al. Elevated levels of growth-related hormones
in autism and autism spectrum disorder. Clinical Endocrinology 2007;67: 230-37.
brain. Behavioral and Brain Sciences 2008;31: 284-320.
789
790
[131] Turner KC, Frost L, Linsenbardt D, McIlroy JR, Mller RA. Atypically diffuse func
tional connectivity between caudate nuclei and cerebral cortex. Behavioural and
Brain Functions 2006;2 34.
[132] Schumann KC, Hamstra J, Goodlin-Jones BL, Lotspeich LJ, et al. The amygdala is en
larged in children but nor adolescents with autism; the hippocampus is enlarged at
all ages. Journal of Neuroscience 2004; 25: 6392-6401.
[133] Egaas B, Courchesne E, Saitoh O. Reduced size of corpus callosum in autism. Ar
chives of Neurology 1995; 52: 794-801.
[135] Just MA, Cherkassky VL, Keller TA. Kana, RK, Minshew N. (Functional and Ana
tomical Cortical Underconnectivity in autism: Evidence from a fMRI Study of an Ex
ecutive function task and Corpus Callosum Morphometry. Cerebral Cortex 2007;17:
951-961.
[136] Casanova et al 2007.
[139] Gardner H. Extraordinary Minds. New York: Basic Books; 1997.
[140] Lykken DT. The mechanism of emergenesis. Genes, Brain & Behavior 2006;5:
306-310.
[141] Howe MA. Genius Explained. Cambridge: Cambridge University Press; 1999.
[142] Happ F, Frith U. The beautiful otherness of the autistic mind. Introduction. app F,
Frith U. (eds.) Autism and talent. Philosophical transactions of The Royal Society
2009; vol. 364 (1522) p.1345-1350.
[146] Happ &Vital 2009.
[147] Goldstein S. Schwebach AJ. A comorbidity of pervasive developmental disorder and
Attention Deficit Hyperactivity Disorder: results of a retrospective chart review.
Journal of Autism & Developmental Disorders 2004;34 (3): 329-339.
[148] Fitzgerald M. Did Lord Byron have Attention Deficit Hyperactivity Disorder? Jour
nal of Medical Biography 2001;9: 31-33.

http://dx.doi.org/10.5772/54465
[151] Andreasen NC. Creativity and mental illness: prevalence rates in writers and their
first-degree relatives. American Journal of Psychiatry 1987;144: 1288-1292.
[152] Andreasen NC 1987.
[153] Folley et al 2003.
[154] Sternberg RJ, Lubart TI. Defying the crowd: Cultivating creativity in a culture of con
formity. New York: Free Press; 1995.
[155] Grandin 1995.
[156] Lyons V, Fitzgerald M. Asperger Syndrome. A Gift or a Curse? New York: Nova Sci
ence Publishers; 2005.
791
Chapter 29

http://dx.doi.org/10.5772/54378
1. Introduction
692


http://dx.doi.org/10.5772/54378
693
694

http://dx.doi.org/10.5772/54378
mend the following:
and ongoing needs.
695
696
approaches.

http://dx.doi.org/10.5772/54378

697
698

http://dx.doi.org/10.5772/54378
and awareness.
ings.
1.
2.
699
700
3.
4.
ideas.
5.

with peers.

http://dx.doi.org/10.5772/54378
7. Method
7.1. Subjects
701
702
7.2. Instruments
a.
and with peers.
b.

c.
d.


http://dx.doi.org/10.5772/54378
a.
b.
c.
d.
keeper was 'happy'.
7.3. Procedure
block tower.
703
704

http://dx.doi.org/10.5772/54378
705
706

http://dx.doi.org/10.5772/54378
707
708
8. Results
Mean
df
t-value
Significance
Pre test
34.92
13
12
9.56
p< .0001
Post test
48.38
13
Table 1.
http://dx.doi.org/10.5772/54378
70
60
50
40
30
20
10
0
1
pre test
10
11
12
13
post test
From Figure
8 it This
is evident
thatbefloor
enhanced
the social
behavior
of chil
the treatment
than others.
variance may
due totime
in the children's
functioning
levels.
postchild's
intervention.
The derived on
t-value
was statistically
significant by
(p<.0002].
performance
turn[5.02]
taking
skill is provided
Figure
30
25
20
15
10
5
0
1
6
pre test
10
11
12
13
post test
It is evident
Figure
that the
treatment
was effective
for all children
in the experimen
significantly,
except from
child no.
7 who 9
showed
a marginal
improvement
the relationship
between
cause andAll
its effect
also improved.
mean performance
on this
subno.
skill 7post
intervention
[13.30]
was higherim
than the
tal group.
of them
gained Their
significantly,
except
child
who
showed
a marginal
provement
only.
The
children's
ability
to
understand
the
relationship
between
cause
and
its
18
16
14
12
15
10
710
Recent Advances
5
0
1
10
11
12
13

on
pre test
post test
18
16
14
12
10
8
6
4
2
0
1
6
Pre test
10
11
12
13
Post test
[6.31]
was lower
[8.69]
statistically
p<.0001].trend
Individually
When
performances
on two-way
communication
skills
were compared,
a similar
was too,
munication.
14
12

http://dx.doi.org/10.5772/54378
10
711
8
14
6
12
4
10
2
8
0
1
Pre test
10
11
12
13
Post test
4
2
and
1
2mean 3score [7.38]
4
5 post
6 intervention
7
8 mean
9 score
12
13 (t-value=3.5, p<.004].
Pre test
Post test
thinking
last and
most complex
of theperformance
six milestones;
it is possible
Figure
11.the
Comparison
of individual
on two-way
communication
Figure
11. Comparison
turn taking,
understanding
of causeon
and
Lastly,
whentwo-way
from BSFS wereand
analyzed
for performance
emotional
14
12
10
8
14
6
12
4
10
2
8
0
6
Pre test
10
11
12
13
Post test
2

The second
selected
from
1
4
5 children
6 were7 randomly
8
9
10 5 pre-schools
11
mental
group
that of
those in
control
group.
As mentioned
earlier,The
thestudy,
participant
chil
Hence,
when the
studywith
commenced
all children
were
on some
kind of early
Pre test
Post test
the dren
efficacywere
of floor
time in comparison
early
intervention
In order
to do this,
the post
intervention
randomly
selected with
fromother
5 pre-schools
andstrategies.
intervention
clinics.
Hence,
when
the
group.12.
The
data analysis
is presented
in Table
Figure
Comparison
of individual
performance
Mean
Nthe performance
df
t-value
Significance
strategies.
In of
order
to do
the post
intervention
performance
on
BSFS
by with
boththat
groups
the study
wasthis,
to compare
of children
in the experimental
group
of those in
Experimental
48.38
13children were
24 randomly
p<.0.005
control
group.
As mentioned
participant
selected
from 5 pre-schools
clinics.
was
analyzed.
The earlier,
meanthe
score
of experimental
group 3.08
was compared
with and
thatintervention
of control
group.
The
data
analysis
is
presented
in
Table
2.
Experimental
Mean
48.38
N
13
df
24
t-value
3.08
Significance
p<.0.005
712
Mean
df
t-value
Significance
Experimental
48.38
13
24
3.08
p<.0.005
Control
37.46
13
Control
37.46
13
Table 2.
70
60
50
40
30
20
10
0
1
Experimental
10
11
12
13
Control
is evident
from
thatchildren's
exceptscored
for child
no. 3 higher
and child
no. control
5, all children
inAexperi
BSFSItthan
the control
groupFigure
children.13
Most
significantly
than their
group peers.
comparative
analysis
of both
group's
mean performance
on each on
sub BSFS
skill i.e.than
turn taking
(TT), two-way
communication
(TWC),children's
cause and effect
ment
group
achieved
higher scores
the control
group
children. Most
group's
20
(TWC),
18
16 14.
Figure
14
those
8
6
formance
4
0
TT
TWC
Experimental
C&E
Control
ET
no. 5,
all childrenof
inAutism:
experiment
group
higher
scores on
713
Intervention
A Case
for achieved
Floor Time
Approach
http://dx.doi.org/10.5772/54378
20
18
16
14
12
10
8
6
4
2
0
TT
TWC
Experimental
C&E
Control
ET
group.
9. Discussion
9. Discussion
how
others talk,
play
each and
other,
enjoybythe
give-and-take
of play
social
Unlike
neuro-typical
children
whoand
learnrelate
how to to
be social
interactive
watching
how others talk,
andengage
relate to each
other,
enjoy and
the give-and-take
and initiate,
to interactions
with others,
ment
initiate, maintain
and respond
to interactions
with others,
children
with children
autismwith
autism
oftendo
do not
the expected
development
of early social of
interaction
skills. Promoting
the social
development
of infants
often
notshow
show
the expected
development
early social
interaction
skills.
Promoting
714
vention on BSFS.

http://dx.doi.org/10.5772/54378
10. Conclusion
ASD.
Acknowledgements
Author details
References
715
716
IL: Lingui Systems
2012)
2012)

http://dx.doi.org/10.5772/54378

chology. Wiley.
TX:Pro-Ed.
cil of India. 3, 1&2: 15-23
717
Chapter 29

http://dx.doi.org/10.5772/54378
1. Introduction
692


http://dx.doi.org/10.5772/54378
693
694

http://dx.doi.org/10.5772/54378
mend the following:
and ongoing needs.
695
696
approaches.

http://dx.doi.org/10.5772/54378

697
698

http://dx.doi.org/10.5772/54378
and awareness.
ings.
1.
2.
699
700
3.
4.
ideas.
5.

with peers.

http://dx.doi.org/10.5772/54378
7. Method
7.1. Subjects
701
702
7.2. Instruments
a.
and with peers.
b.

c.
d.


http://dx.doi.org/10.5772/54378
a.
b.
c.
d.
keeper was 'happy'.
7.3. Procedure
block tower.
703
704

http://dx.doi.org/10.5772/54378
705
706

http://dx.doi.org/10.5772/54378
707
708
8. Results
Mean
df
t-value
Significance
Pre test
34.92
13
12
9.56
p< .0001
Post test
48.38
13
Table 1.
http://dx.doi.org/10.5772/54378
70
60
50
40
30
20
10
0
1
pre test
10
11
12
13
post test
From Figure
8 it This
is evident
thatbefloor
enhanced
the social
behavior
of chil
the treatment
than others.
variance may
due totime
in the children's
functioning
levels.
postchild's
intervention.
The derived on
t-value
was statistically
significant by
(p<.0002].
performance
turn[5.02]
taking
skill is provided
Figure
30
25
20
15
10
5
0
1
6
pre test
10
11
12
13
post test
It is evident
Figure
that the
treatment
was effective
for all children
in the experimen
significantly,
except from
child no.
7 who 9
showed
a marginal
improvement
the relationship
between
cause andAll
its effect
also improved.
mean performance
on this
subno.
skill 7post
intervention
[13.30]
was higherim
than the
tal group.
of them
gained Their
significantly,
except
child
who
showed
a marginal
provement
only.
The
children's
ability
to
understand
the
relationship
between
cause
and
its
18
16
14
12
15
10
710
Recent Advances
5
0
1
10
11
12
13

on
pre test
post test
18
16
14
12
10
8
6
4
2
0
1
6
Pre test
10
11
12
13
Post test
[6.31]
was lower
[8.69]
statistically
p<.0001].trend
Individually
When
performances
on two-way
communication
skills
were compared,
a similar
was too,
munication.
14
12

http://dx.doi.org/10.5772/54378
10
711
8
14
6
12
4
10
2
8
0
1
Pre test
10
11
12
13
Post test
4
2
and
1
2mean 3score [7.38]
4
5 post
6 intervention
7
8 mean
9 score
12
13 (t-value=3.5, p<.004].
Pre test
Post test
thinking
last and
most complex
of theperformance
six milestones;
it is possible
Figure
11.the
Comparison
of individual
on two-way
communication
Figure
11. Comparison
turn taking,
understanding
of causeon
and
Lastly,
whentwo-way
from BSFS wereand
analyzed
for performance
emotional
14
12
10
8
14
6
12
4
10
2
8
0
6
Pre test
10
11
12
13
Post test
2

The second
selected
from
1
4
5 children
6 were7 randomly
8
9
10 5 pre-schools
11
mental
group
that of
those in
control
group.
As mentioned
earlier,The
thestudy,
participant
chil
Hence,
when the
studywith
commenced
all children
were
on some
kind of early
Pre test
Post test
the dren
efficacywere
of floor
time in comparison
early
intervention
In order
to do this,
the post
intervention
randomly
selected with
fromother
5 pre-schools
andstrategies.
intervention
clinics.
Hence,
when
the
group.12.
The
data analysis
is presented
in Table
Figure
Comparison
of individual
performance
Mean
Nthe performance
df
t-value
Significance
strategies.
In of
order
to do
the post
intervention
performance
on
BSFS
by with
boththat
groups
the study
wasthis,
to compare
of children
in the experimental
group
of those in
Experimental
48.38
13children were
24 randomly
p<.0.005
control
group.
As mentioned
participant
selected
from 5 pre-schools
clinics.
was
analyzed.
The earlier,
meanthe
score
of experimental
group 3.08
was compared
with and
thatintervention
of control
group.
The
data
analysis
is
presented
in
Table
2.
Experimental
Mean
48.38
N
13
df
24
t-value
3.08
Significance
p<.0.005
712
Mean
df
t-value
Significance
Experimental
48.38
13
24
3.08
p<.0.005
Control
37.46
13
Control
37.46
13
Table 2.
70
60
50
40
30
20
10
0
1
Experimental
10
11
12
13
Control
is evident
from
thatchildren's
exceptscored
for child
no. 3 higher
and child
no. control
5, all children
inAexperi
BSFSItthan
the control
groupFigure
children.13
Most
significantly
than their
group peers.
comparative
analysis
of both
group's
mean performance
on each on
sub BSFS
skill i.e.than
turn taking
(TT), two-way
communication
(TWC),children's
cause and effect
ment
group
achieved
higher scores
the control
group
children. Most
group's
20
(TWC),
18
16 14.
Figure
14
those
8
6
formance
4
0
TT
TWC
Experimental
C&E
Control
ET
no. 5,
all childrenof
inAutism:
experiment
group
higher
scores on
713
Intervention
A Case
for achieved
Floor Time
Approach
http://dx.doi.org/10.5772/54378
20
18
16
14
12
10
8
6
4
2
0
TT
TWC
Experimental
C&E
Control
ET
group.
9. Discussion
9. Discussion
how
others talk,
play
each and
other,
enjoybythe
give-and-take
of play
social
Unlike
neuro-typical
children
whoand
learnrelate
how to to
be social
interactive
watching
how others talk,
andengage
relate to each
other,
enjoy and
the give-and-take
and initiate,
to interactions
with others,
ment
initiate, maintain
and respond
to interactions
with others,
children
with children
autismwith
autism
oftendo
do not
the expected
development
of early social of
interaction
skills. Promoting
the social
development
of infants
often
notshow
show
the expected
development
early social
interaction
skills.
Promoting
714
vention on BSFS.

http://dx.doi.org/10.5772/54378
10. Conclusion
ASD.
Acknowledgements
Author details
References
715
716
IL: Lingui Systems
2012)
2012)

http://dx.doi.org/10.5772/54378

chology. Wiley.
TX:Pro-Ed.
cil of India. 3, 1&2: 15-23
717
Chapter 32

http://dx.doi.org/10.5772/54465
1. Introduction
772


http://dx.doi.org/10.5772/54465
inquisitiveness.

1403).
773
774

high intelligence.

http://dx.doi.org/10.5772/54465

775
776

of illnesses.
theories [74].
Flow

http://dx.doi.org/10.5772/54465
777
778


http://dx.doi.org/10.5772/54465

779
780

viduals with ASD.

http://dx.doi.org/10.5772/54465

10. Psychopathology
11. Conclusion
781
782
Author details
References
Press; 2007.

http://dx.doi.org/10.5772/54465
1995.
gy 2000;12: 83-90.
1983.
1938;49: 1314-1317.
783
784
Press; 2005.
[36] Treffert 2009.
Medicine 1991;21: 959-964.
1978. (9) p277-298.
and Row; 1989.

http://dx.doi.org/10.5772/54465
al Society 2009; vol. 364 (1522) p1425-1432.
[45] Hermelin 2001.
[46] Treffert 2009.
2009; vol. 364 (1522) p1377-1384.
[57] Frith & Happ 1994.
2006;36: 5-25.
[60] Grandin 1995.
785
786

2004;24: 9228-31.
2004;(3) 1: 3146.
Brain 2008, 131(4): 1013-1024.
[73] Snyder 2009.
Press; 1959. (9) p141-153.
Press; 1952.
2004.
sity Press; 1995.

http://dx.doi.org/10.5772/54465
chologia 2007;45: 2234-2245.
and Row; 1990.
364 (1522): p1369-1376.
2001;293: 51-2.
Neuroimage 2007;38: 519-28.
787
788

1989;27: 861-870.
2005;28: 213-226.
try 2000; 45: 563-572.

http://dx.doi.org/10.5772/54465
Group; 2007.
view. Brain 1996;119 1775-1790.
2006;163: 1290-92.
153-70.
Reviews 2004;10 106-11.
789
790
951-961.
306-310.
2009; vol. 364 (1522) p.1345-1350.
[146] Happ &Vital 2009.

http://dx.doi.org/10.5772/54465
[155] Grandin 1995.
791
Chapter 31
Atypical Sense of Self in Autism Spectrum Disorders: A

Neuro-Cognitive Perspective
http://dx.doi.org/10.5772/53680
1. Introduction
1.1. Self Definitions and concepts
The concept of self is notoriously difficult to define and different notions and theories of the
self have been proposed by a variety of disciplines all interpreting concepts of self and iden
tity in various ways. We adopt the definition advanced by neuroscientists Kircher and Da
vid [1] who interpret the self as the commonly shared experience, that we know we are the
same person across time, that we are the author of our thoughts/actions, and that we are dis
tinct from the environment (p.2). In cognitive neuroscience literature, operational defini
tions of the self are used which are measurable by experimental methods including self
recognition, self and other differentiation, body awareness, awareness of other minds,
awareness of self as expressed in language and important concepts such as autobiographical
memory and self narrative. There is significant interest in the role of the self and possible
abnormalities associated with the self, as causally implicated in autism. In this paper we re
view developmental perspectives of self and self-related functions with reference to their
neuroanatomical basis and investigate the possible causes for atypical self-development in
Autism Spectrum Disorders (ASD).
2. Review of studies investigating the self in ASD

The question whether individuals with ASD have a different sense of self than people with
out ASD, i.e. neurotypicals has fascinated researchers and clinicians for decades. Kanner
[2] in 1943 already noted self-deficits in the children he described, including their difficulties
in maintaining a constant self-concept, and associated problems of adapting their fragile
750
self-concept to changing environments. Asperger [3] (1974, p. 2026) refers to a disturbance

and a weakness of the self in children with autistic psychopathy. Psychoanalytic theories
considered autism as a disorder of the self [4] based on the lack of ability in establishing sta
ble internal representations of themselves and of others. The German psychiatrist Lutz [5]
(1968) interpreted autism as a disturbance of self-consciousness, self-related activities and
self-perception. Powell and Jordan [6] (1993) suggested that individuals with ASD lack an
experiencing self that provides a personal dimension for ongoing events. This is consistent
with Friths [7] suggestion of an absent self in autism. Hobson [8] put forward a develop
mental account of the self in autism emphasising impaired interpersonal relatedness, inter
subjectivity and its far-reaching consequences for the development of the self. In a recent
study investigating whether children with autism show abnormal self-other connectedness,
Hobson and Meyer [9] found a failure in autism to identify with another person. These au
thors suggest that this process of identifying with others is crucial for a normal development
of self-other relationship and the basis for understanding other minds.
3. Atypical development of self-related processes in ASD

There is general consensus among developmental theorists [e.g. 10,11] that early interper
sonal communication is central to the establishment of the self in normal development. A
large body of research literature indicates that early processes underlying self-other
awareness are impaired or delayed in autism including gaze following, abnormal re
sponse to sound and deficits in attention [12], showing of objects, responding and orient
ing to own name [13], looking at others faces [14], pretend play, protodeclarative
pointing and gaze monitoring [15], empathy and imitation [16], joint-attention behaviour
[17], affect and personal relatedness [18,19].
3.1. Self recognition and awareness
The ability to recognize ones own face in the mirror is considered a test for self-aware
ness. Self-recognition as measured by mirror tests [20] in 18 months old children has
been depicted as a developmental milestone in self-conception and described as the ach
ievement of a cognitive self [21]. Not only is self recognition essential for developing a
concept of self, and self-other differentiation, it is also a prerequisite for later developing
theory of mind abilities, as a stable self concept is the basis for being able to read the
mental states of others. Research data on self-recognition reveals that autistic childrens
responses to their mirror images are qualitatively different from those of normal children
[22]. Children with ASD have deficits of self-awareness as measured by a self-recogni
tion test [23] they show little interest in their own mirror images and have been descri
bed as relatively face inexperienced [24].
The prefrontal cortex, especially the Right Hemisphere (RH) plays a critical role in the
recognition of ones own face [25] as evidenced by functional imaging studies. Face per
ception studies in individuals with ASD suggest abnormal functioning in the fusiform
Atypical Sense of Self in Autism Spectrum Disorders: A Neuro-Cognitive Perspective

http://dx.doi.org/10.5772/53680
face area as well as amygdala, brain regions associated with the social brain (e.g. 26,27]
involving the RH.
3.2. Self/other differentiation
The ability to differentiate between self and other is also essential for the development of
self-awareness, which appears to be impaired in autism. In particular, the recognition of a
separate existence of other people seems to be delayed in children with autism [28,29]. At
tentional abnormalities, such as tunnel vision, the tendency to think in a monotropic man
ner have been suggested by some as the cause of self-other problems in ASD [30]. Donna
Williams [31] interprets monoprocessing as the inability to process simultaneously informa
tion of oneself and others.
In neurotypicals the middle cingulate cortex and ventromedial prefrontal cortex are in
volved in self/other processing. In contrast, atypical neural responses have been reported in
individuals with ASD. A recent fMRI study [32] investigating the attribution of behavioural
outcomes to either oneself or others while playing an interactive trust game revealed a lack
of brain activity in the cingulate cortex indicating diminished self responses in individuals
with ASD. However, other responses, attributing actions to other people were intact. Previ
ous research data using trust games [33] had demonstrated that cingulate cortex activation
is consistent with self-response patterns generated during interpersonal exchanges. Chiu et
al. [34] interpreted their data in terms of a deficit in ASD in monitoring their own intentions
in social interactions and thus contributing to impaired theory of mind abilities, lack of in
trospection and self-referential processing. Of particular interest is the fact that the im
paired self-responses in the ASD group correlated with their behavioural symptom
severity, i.e. the lesser activity along cingulated cortex the more serious were their behaviou
ral symptoms. Similar results have been reported by Lombardo et al. [35] also demonstrat
ing atypical neural responses from the middle cingulate cortex during a self-referential
processing task. This study also provided a link between these deficits and early social im
pairments in autism. In addition, these authors also demonstrated reduced functional con
nectivity between ventromedial prefrontal cortex and lower level regions (e.g.
somatosensory cortex) in individuals with ASD during these selfrepresentation tasks.
Previous studies identified the right inferior parietal lobe, along with frontopolar and soma
tosensory regions [36,37] as critical for distinguishing between self and other. Additional da
ta [e.g. 38] demonstrate that SI and SII cortices, which contribute to the mirror-neuron
system, are also crucial for preserving a sense of self.
3.3. Body awareness, sense of agency
Knowing oneself and knowing ones body are closely related concepts. In his review on
body image and the self, Goldenberg [39] argues that the acquisition of body image is not
innate but acquired through experiences of ones own and other bodies. Likewise, Jordan
and Powell [40] believe that a body concept develops from interacting with others. Anecdo
tal reports indicate that some children and adults with autism have an insecure body image
751
752
or totally lack body awareness. Russell [41] suggested that the body schemas of persons
with autism are poorly specified resulting in an atypical experience of agency. A sense of
agency is a central aspect of human self-consciousness and refers to the experience of oneself
as the agent of ones actions. Based on his executive function account of impaired action
monitoring Russell [42] put forward the hypothesis that individuals with autism are im
paired in distinguishing between self and others. In contrast, a recent study by Williams and
Happ [43] suggests that individuals with ASD are aware of their agency as indicated by
their ability to monitor their own actions.
Support for a dominant role of the right hemisphere in the above processes is substantial.
The right posterior parietal lobe is generally associated with spatial and bodily awareness
[44,45]. Activation of right inferior parietal lobe correlates with a sense of ownership in ac
tion execution [46]. Additional research evidence [47] based on transcranial magnetic stimu
lation (TMS) supports the significance of the right temporo-parietal junction in the
maintenance of a coherent sense of ones body.
3.4. Theory of mind, emotions and self-awareness
An essential component of self-awareness is the ability to be aware of other minds. A multi
tude of studies have provided evidence that theory of mind is lacking or delayed in ASD, or
develops differently than in neurotypicals [for a substantive review see 48]. Deficits in mind
reading may also affect the ability to reflect on ones own mental states [49] resulting in di
minished self-awareness. There is some evidence suggesting that the ability to think about
ones own thoughts depends on the same cognitive and neural processes as mindreading
[50]. Equally, emotions play an important role in self-awareness. The development of the ca
pacity to experience, communicate and regulate emotions is considered to be the most im
portant event in infancy [51]. One of the main characteristics of autism is lack of empathy
and emotional engagement with others [52,53]. Children with autism have difficulties with
interpreting emotions, are deficient in processing their own emotional experiences and pay
little attention to emotional stimuli in general [e.g. 54-57]. Due to this inability to empathize
and emotionally engage with others individuals with ASD are totally focussed on their own
interests and concerns.
A network of structures important for theory of mind processing includes the superior tem
poral sulcus and the adjacent temporo-parietal junction, the temporal poles and the medial
prefrontal cortex [58; see also 59 for a review). Research evidence implicated the RH in theo
ry of mind reasoning across various tasks [60, 61]. The neural substrates for emotions and
empathy are complex [62] involving amygdala, ventral medial prefrontal cortex. Recent
imaging studies point to an involvement of a mirror neuron circuit for empathy [63,64].
3.5. Egocentrism/Allocentrism
In apparent contrast to the mentalizing impairment even among very high functioning indi
viduals with ASD is their often-documented increased sense of self or total focus on the self
[65,66,67] that is also reflected in numerous biographical accounts. The term autism is de

http://dx.doi.org/10.5772/53680
rived from the Greek word autos (self) and since Kanners time this focus on the self as
atypical applies to all individuals with ASD. Extreme egocentricity was one of the diagnostic
criteria for Asperger Syndrome proposed by Gillberg & Gillberg [68]. Frith and de Vigne
mont [69] suggest that there are differences to reading other minds depending on whether
the other person can be understood using an egocentric or an allocentric standpoint. From
an egocentric point of view other people are understood only relative to the self whereas
from an allocentric stance the mental state of a person is independent from the self. These
theorists suggest that individuals with ASD suffer from an imbalance between both point of
views, they are unable to connect an egocentric to an allocentric stance and can only adopt
extreme forms of either [70]. This very detailed analysis of mindreading further illustrates
the different and unique aspects of awareness of self and others in individuals with ASD.
3.6. Self awareness across time
Awareness that we are the same person across time, also defined as temporally extended
self-awareness [71] is an essential part of ones self-concept. Although the results of two re
cent studies [72,73] indicate that individuals with ASD have undiminished temporally ex
tended self-awareness as assessed by the delayed self-recognition task, this task may not
adequately measure self-awareness as suggested by Lind & Bowler [74]. Indirect evidence
suggests that temporally extended self-awareness is impaired in ASD based on their prob
lems with theory of mind as well as some aspects of temporal cognition [75]. Alternative ex
planations are the autobiographic memory difficulties [76] and also the well-documented
language impairments in ASD. Language is a medium with which we monitor ourselves
and it allows us to experience past, present and future [77].
3.7. Language and awareness of self
Conceptions about oneself and others develop from an early age and depend largely on the
emergence of language. At around 18 months of age children start referring to themselves as
I and begin using the word you for others, indicating a further development in their selfother awareness. According to Kircher and David [78] the symbolic presentation of the self
in language is the personal pronoun I. Language difficulties such as pronoun reversal, use
of third person perspective, impoverished inner speech, and impaired narrative have a neg
ative effect on mental processes and also restrict certain aspects of self-awareness.
There is substantial clinical and research evidence of impaired pragmatic language use in
children with ASD as indicated by pronoun reversal errors (I/me/you) [79-82] reflecting
general difficulties with their sense of self, as well as problems in self-other differentiation.
Peeters et al. [83] suggested that the reason children with autism sometimes communicate
from a third-person perspective instead of a first- vis--vis second person perspective is that
in contrast to typically developing children they possess a non-social basis of self-other cate
gorization. Use of a third person perspective also has consequences for attribution of mental
states, and mentalizing ability in general. As argued by Northoff and Heinzel [84] a third
person perspective is an indication of a fragmented image of self and other. Adults with
753
754
ASD also appear to have difficulties with first person pronoun usage [85]. Of particular in
terest might be the fact, that Hans Asperger often used to refer to himself from a third per
son perspective [86].
A fundamental role in self-awareness is attributed to inner speech [87] that is impaired in
ASD [88]. When asked about the nature of their thoughts, a group of adults with Asperger
syndrome reported mainly images and actions as their only inner experience and made no
reference to inner speech or emotions [89]. Many individuals with ASD are visual thinkers
and rely heavily on visualization to process information [90].
A recent fMRI study [91] provided evidence of underintegration of language and imag
ing in autism by showing that individuals with ASD are more reliant on visualization to
support language comprehension. These authors suggest that cortical underconnectivity
is the reason for the lack of synchronization between linguistic and imaginal processing
in autism. Supporting these findings are the results of an imaging study on daydream
ing [92] indicating that autistic individuals do not daydream about themselves or other
people. This study also points to a link between daydreaming and the construction of self
and self-awareness.
In summary, language is of fundamental significance to self-awareness and necessary for
forming a clear identity of self and others. Another important dimension in the formation of
the self that is also dependent on language is autobiographical memory as well as the con
struct of a narrative self.
3.8. Autobiographical memory
Many influential theorists [93,94] associate the development of self with the emergence of
autobiographical or episodic memory. The components necessary for a fully functioning
autobiographical memory are a basic memory system, spoken or signed language, under
standing and production of narrative, temporal understanding, self-awareness and theory
of mind [95]. Autobiographical memory not only depends on these cognitive constructs
but is also specifically concerned with events that have specific meaning to the individu
al. This personal significance evolves through emotions and motivations that are con
structed in interaction with others. Autobiographical disturbances can arise from
combined deficits in the realms of memory, emotion and self-related processing which
are intricately connected, both behaviourally and neurologically [96].
The majority of components that make up an autobiographic memory system are im
paired in autism. There is significant evidence that individuals with ASD have circum
scribed episodic memory impairments, e.g. they have an impaired recall for personally
experienced events [97-101]. As suggested by Millward et al [102] individuals with ASD
remember real-life episodes less well than other people because they have no experienc
ing self. Wheeler et al [103] in their investigation of episodic memory in autism conclud
ed that remembering of personal events requires the highest form of consciousness,
autonoetic consciousness (self-knowing), which is dependent of self-awareness.

http://dx.doi.org/10.5772/53680
The prevailing view is that episodic memory is created in the neocortex and subsequently
stored in the medial-temporal lobes and after a time becomes independent and is distribut
ed in neocortical networks [104]. Whereas the left temporal lobe is dominant for the acquisi
tion of new verbal information, episodic information involves mainly the right fontal lobes
[105, 106]. Neuroimaging studies provide evidence for right frontal involvement in the proc
essing of autobiographic memories [e.g. 107]. The RH is especially important for memories
with emotional contents.
3.9. The narrative self
Many theorists [e.g. 108, 109] have highlighted the importance of the narrative self and ar
gued that the autobiographical self is a similar construct as the narrative self. Individuals
create their own identity by constructing autobiographical narratives or life stories [110].
The benefits of a personal or narrative self are significant; a narrative mediates self-under
standing and creates coherence out of lifes experiences. Narrative emerges early in develop
ment and narrative and self are inseparable [111]. The creation of a narrative self depends on
various cognitive capacities, including working memory, self-awareness, episodic memory
and reflective metacognition, a sense of agency, the ability to attribute action to oneself to
gether with a capacity for temporal integration of events, a fully functioning pronoun sys
tem, an ability to differentiate between self and non-self as well as a sense of ones own body
that is based on proprioceptive-motor processes [112].
The mechanisms responsible for each of the above dimensions are impaired in autism and
as a consequence individuals with ASD have great difficulties in constructing a self-narra
tive. If autobiographical material cannot be provided, the narrative is disoriented and con
fused and in many cases is no narrative at all but only confabulation [113], which is often the
case in autism. As a result, the narrative of individuals with ASD, and the self that is repre
sented in this narrative, is quite vague and not representing the true self. Research evidence
confirms deficits in narrative abilities in individuals with ASD [114-116].
Language and symbolic functions are localized in the left hemisphere, whereas narrative
abilities are considered to be a function of the right hemisphere. There is a significant evi
dence for RH contribution to social language and many of the functions associated with au
tobiographic memory specifically those with emotional contents. In addition, narrative
organisation depends on coordination of activity among various brain regions [117] and as
suggested by Belmonte [118] malfunction in neural connectivity may be the underlying
problem with autistic narrative.
To summarize, there is substantial evidence that the main components of self-awareness in
cluding self recognition, self-other differentiation, body awareness, theory of mind, inter
subjectivity, emotion processing, language (pronoun reversal, inner speech, third person
perspective), autobiographical memory and narrative self are impaired in ASD. Our review
of neural substrates underlying these processes has highlighted the significance of the Right
Hemisphere.
755
756
4. Self neuropathology in ASD

From a neural point of view the self can be viewed as a complex and dynamic representa
tion consisting of multiple brain networks [119, 120]. The origins of self begin in infancy and
over the first several years of life normally developing children acquire an understanding of
different dimensions of self and other. Deviant development in autism is likely to result in a
cascade of developmental impairments including dysfunctional self-related processes as
outlined above. Various brain regions have been indicated in the pathogenesis of autism in
cluding frontal lobes [e.g., 121] cerebellum [122], parietal lobes [123], hippocampus [124] and
amygdala [125]. The extent of anatomical and functional abnormalities in autism points to a
possible core dysfunction in neural processing. In addition, the vast amount of potential ge
netic risk factors suggests that multiple or all-emerging functional brain areas are affected
during early development [126]. This theory is supported by widespread growth abnormali
ties in the brain of children with autism [127, 128].
In the following sections we will explore three neural theories implicated in the develop
ment of an atypical or different sense of self in individuals with ASD. Apart from the in
volvement of the RH in self-related processes a dysfunctional mirror neuron system as
well as abnormal connectivity may have a role to play in the atypical developmental tra
jectories in ASD.
4.1. Right hemisphere hypothesis
The prefrontal cortex plays a vital role in the development of the self as it generates a sense
of self and facilitates many links with other parts of the brain. Cognitive neuroscience stud
ies have shown that the RH plays a special role in personal relatedness, which is intimately
linked to the development of the self. Based largely on recent neuroimaging research evi
dence an increasing number of cognitive neuroscientists have emphasized the specific role
of the RH in self-related functions [129-132]. Specifically the right dorsomedial prefrontal
cortex seems to play a critical role in the development of models of the self [133]. This has
been confirmed by several imaging studies, including a recent study of self-evaluation [134].
As described in the previous paragraphs there is substantial research evidence that the RH
may be dominant for self-awareness and self-related functions. The psychiatrist and philoso
pher Iain McGilchrist [135] provided an extensive exploration of the dominance of the RH in
self-related processes.
Elsewhere, Lyons and Fitzgerald [136] put forward the theory that RH impairment leads to
a dysfunctional self-development in ASD. There is substantial research evidence linking As
perger syndrome to right hemisphere dysfunction [e.g. 137, 138]. The RH is dominant in the
first years of human life when the major brain development during critical periods takes
place. Results of a cerebral metabolism study in children (aged between 18 days to 12 years)
showed that the RH is prominently activated, suggesting that the RH develops earlier than
the LH [139]. The RH in implicated during early social interactions [140] including early at
tachment processes [141], maternal face and voice recognition [142] as well as the ability to
view others in a similar way as the self [143]. The developing self depends on relations with

http://dx.doi.org/10.5772/53680
others and these early experiences are vital for the maturation of the right brain system. Sub
stantial behavioural evidence of infants who later developed autism is supporting the theo
ry of disrupted intersubjective behaviour. We argue that impairments in neurobiology
affecting particularly the RH both cause and interact with defects in personal relatedness
and later developing self processes.
4.2. Abnormal connectivity
The Abnormal Neural Connectivity Theory proposes that autism is a distributed systemwide brain disorder that restricts the coordination and integration among various brain
areas. The original positron emission tomography (PET) study by Horwitz et al. [144] found
reduced correlations among frontal cortex, parietal and other brain regions and suggested
that autism involves impairment in functional connectivity between frontal cortex and other
brain systems. More recent studies proposed that autism is a disorder of neural undercon
nectivity [145], overconnectivity [146, 147] or both under and overconnectivity in which lo
cal connectivity may be relatively dense whereas long-range connectivity between brain
regions may be reduced or abnormally patterned [146-151].
Studies of the cerebral cortex in autism show abnormalities of synaptic and columnar struc
ture. Cortical minicolumns are fundamental units of cerebral cortical information process
ing. Examination of neurons revealed abnormalities in the size of cortical minicolumns
particularly in the frontal and temporal lobes in ASD [152, 153] that could alter overall levels
of connectivity within the brain. These findings are in accordance with the observed white
matter abnormalities reported particularly in people with ASD [154]. A recent study using
functional connectivity MRI (fcMRI) [155] provided further evidence of atypical enhanced
functional connectivity suggesting that abnormal connectivity may be linked to develop
mental brain growth disturbances in autism.
These studies suggest that connectivity among diverse brain areas may be the core problem
in autism. In autism the network connectivity through which various brain areas communi
cate with each other are limited, particularly the connections to the frontal cortex [156]
which is dominant for self-related processing particularly in the RH. The network model of
the self proposed by Stuss et al. [157] suggests that the self is hierarchically organized, with
the highest level of the self involved in self-awareness being subserved by frontal lobes. Ear
ly developmental impairments in minicolumnar microcircuitry in the frontal cortex in au
tism could be the reason for the deficits found in higher order frontal processes [158] which
are likely to result in fragmented self awareness and identity formation in autism.
4.3. Mirror neuron system
Another recent neural theory of autism suggests that a dysfunctional mirror neuron system
may be fundamental to the aetiology of autism [159, 160]. The existence of mirror neurons in
humans has been demonstrated by a number of EEG and imaging studies [e.g. 161]. Mirror
neurons are activated in relation both to specific actions performed by self and matching ac
tions performed by others, providing a potential bridge between minds [162] and might
757
758
have a role to play in self related processes. Mirror neurons may enable us to understand the
actions of others by mapping the actions of other people to our own motor system and so
allow a shared representation of actions. In addition to understanding the action of others
this so-called mirroring might also allow the automatic experience of the intention and
emotion of the other person as suggested by Kaplan and Iacoboni [163].
Research has demonstrated that mirror neuron activity correlates with empathy [164] and
social competence in general [165]. It has been suggested that mirror neurons are a prerequi
site for the normal development of self-recognition, imitation, theory of mind, empathy, in
tersubjectivity and language [166, 167]. Furthermore, mirror neurons are likely to play a
central role in self-awareness. To quote Ramachandran and Oberman [168] they may enable
humans to see themselves as others see them, which may be an essential ability for selfawareness and introspection (p.41). Developmental data suggest that there is higher imita
tive behaviour in children that can self-recognise, possibly facilitated by mirror neurons, in
contrast to those who cannot [169]. Providing support for a RH hypothesis in self-related
functions are recent imaging studies [170, 171] indicating that a frontoparietal mirror net
work is associated with self-recognition processes.
Several recent functional brain-imaging studies have found evidence of mirror neuron dys
function in individuals with ASD in social mirroring tasks [172], motor facilitation [173], and
imitation [174]. A fMRI study [175] revealed that individuals with autism showed a different
pattern of brain activity during cognitive tasks relating to self-referential processing. The au
thors concluded that a core deficit in autism might be related to the construction of a sense
of self in its relation with others. Echoing Hobson [176] Iacoboni [177] suggests that primary
intersubjectivity is the basis for the development of the neural systems associated with inter
nal and external self-related processes. Failure or abnormal development of a fully function
ing mirror neuron system in the autistic infant is likely to result in a cascade of
developmental impairments including dysfunctional self-related processes.
5. Conclusion
The centrality of an impaired sense of self in autism has been the focus of research for many
decades. The development of self-awareness is a complex process that involves integration
of information from many sources and coordination across the brain systems involved in
self-related concepts. A sense of self emerges from the activity of the brain in interaction
with other selves. There is substantial evidence that early deficits in self-development in
cluding impaired relations with others result in a fragmented and atypical sense of self in
ASD. In this review we have presented evidence that a great majority of self-related process
es that are mediated to a significant extent by the right hemisphere are impaired in individ
uals with ASD. Additional lines of investigation indicate that an unintegrated sense of self
in autism is also potentially associated with abnormal functional connectivity and an im
paired mirror neuron system. Consequences of this atypical sense of self are the well-docu
mented impairments individuals with ASD experience in the social and communication

http://dx.doi.org/10.5772/53680
domain. In contrast, there have been suggestions that this different sense of self might be a
contributory factor to the significant talents and special skills present in a majority of indi
viduals with ASD. Happ & Vital [178] put forward the notion that diminished self-aware
ness in ASD might be advantageous in the development of these special gifts.
Author details
Viktoria Lyons1 and Michael Fitzgerald2
1 Blackrock, Co. Dublin, Ireland
2 Trinity College Dublin, Ireland
References
[1] Kircher T, David AS. Introduction: The Self And Neuroscience. In: Kircher T, David
A.S. (eds) The Self in Neuroscience and Psychiatry, Cambridge: Cambridge Universi
ty Press; 2003. p2.
[2] Kanner L. Autistic Disturbances of Affective Contact. Nervous Child 1943;2: 217-50.
[3] Asperger H. Frhkindlicher Autismus, Medizinische Klinik 1974;69: 2024-27.
[4] Cohen DJ. The pathology of the Self in primary childhood autism and Gilles de la
Tourette Syndrome. Psychiatric Clinics of North America 1980; 3 (3): 383-402.
[5] Lutz J. Zum Verstaendnis Des Autismus Infantum Als Einer Ich-Bewusstseins-, IchAktivitaets- Und Ich-Einpraegungsstoerung. Acta Paedopsychiatrica 1968; 35, 161.
[6] Powell S, Jordan R. Being Subjective About Autistic Thinking And Learning To
Learn. Educational Psychology 1993;13: 359-370.
[7] Frith U. Autism: Explaining The Enigma. Oxford: Blackwell; 1989, 2nd Edition; 2003.
[8] Hobson RP. On The Origins Of Self And The Case Of Autism. Development And
Psychopathology 1990;2: 163-81.
[9] Hobson RP, Meyer JA. Foundations For Self And Other: A Study In Autism. Devel
opmental Science 2005;8: 481-91.
[10] Stern DN. The Interpersonal World Of The Infant. New York: Basic Books; 1985.
[11] Neisser U. Five kinds of self-knowledge. Philosophical Psychology 1988;1(1): 35-58.
759
760
[12] Dahlgren SO, Gillberg C. Symptoms in the first two years of life. A preliminary pop
Science 1989; 283: 169-74.
[13] Nadig AS, Ozonoff S, Young GS, Rozga A, Sigman M, Rogers SJ. A Prospective
Study Of Response To Name In Infants At Risk For Autism. Archives Pediatric Ado
lescent Medicine 2007;161: 378-83.
[14] Osterling J, Dawson G. Early Recognition Of Children With Autism: A Study Of First
Birthday Home Videotapes. Journal Of Autism And Developmental Disorders
1994;24: 247-53.
[15] Baron-Cohen S, Cos A, Bird G, Swettenham J, Nightingale N, Morgan K, Drew A.
Charman T. Psychological markers in the detection of autism in infancy in a large
population. British Journal of Psychiatry 1996;16: 158-63.
[16] Dawson G, Adams A. Imitation and social responsiveness in autistic children. Jour
nal of Abnormal Child Psychology 1984;12 (2): 209-26.
[17] Mundy P, Crowson M. Joint Attention And Early Communication: Implications For
Intervention With Autism. Journal Of Autism And Developmental Disorders 1997;6:
653-76.
[18] Hobson RP. Autism And The Development Of Mind. Hillsdale, NJ: Lawrence Erl
baum; 1993.
[19] Hobson, 1990.
[20] Gallup GG. Jr. Chimpanzees: Self-Recognition. Science 1970;167: 86-87.
[21] Lewis M., Ramsay D. Intentions, Consciousness And Pretend Play. In: Zelazo PD,
Astington JW, Olson DR (eds) Developing Theories Of Intention: Social Understand
ing And Self-Control. Mahwah, NJ: Erlbaum; 1999. p77-94,
[22] Dawson G, McKissick FC. Self-recognition in autistic children. Journal of Autism and
Developmental Disorders 1984;17: 383-94.
[23] Keenan JP, Christiana W, Malcolm S, Johnson A. Mirror-Self Recognition In Autism
And Aspergers Syndrome: Implications For Neurological Correlates. Poster Pre
sented At The Eleventh Annual Cognitive Neuroscience Society Meeting, San Fran
cisco. CA., April 2004.
[24] Pierce K., Muller R-A., Ambrose J., Allen G., Courchesne E. Face Processing Occurs
Outside The Fusiform Face Area In Autism: Evidence From Functional MRI. Brain
2001;124: 2059-73.
[25] Keenan JP, McCutcheon NB, Pascual-Leone A. Functional Magnetic Resonance Imag
ing And Event Related Potential Suggest Right Prefrontal Activation For Self-Related
Processing. Brain And Cognition 2001;47: 87-91.

http://dx.doi.org/10.5772/53680
[26] Critchley HD, Daly EM, Bullmore ET. Et Al. The functional neuroanatomy of social
behavior. Changes in cerebral blood flow when people with autistic disorder process
facial expressions. Brain 2000;123: 2203-12.
[27] Pierce et al., (2001).
[28] Hobson (1990).
[29] Hobson & Meyer (2005).
[30] Murray D, Lesser M. Lawson W. Attention, Monotropism And The Diagnostic Crite
ria For Autism. Autism. The International Journal Of Research And Practice 2005;9
(2): 139-56.
[31] Williams D. Autism And Sensing. The Unlost Instinct. London: Jessica Kingsley;
1998.
[32] Chiu PH, Kayali MA, Kishida KT, Tomlin D, Klinger LG, Klinger MR, Montague PR.
Self Responses along cingulate cortex reveal quantitative neural phenotype for highfunctioning autism. Neuron 2008;57: 463-73.
[33] Tomlin D, Kayali M A, King-Casas B, Anen D, Camerer CF, Et Al. Agent-Specific Re
sponses In The Cingulated Cortex During Economic Exchanges. Science 2006;5776:
1047-50.
[34] Chiu et al. (2008).
[35] Lombardo MV, Chakrabarti B, Bullmore ET, Sadek SA, Pasco G, Wheelwright SJ,
Suckling J, MRC AIMS Consortium, Baron-Cohen S. (2009). Atypical Neural SelfRepresentation in Autism. Brain 2009. http://brain.oxfordjournals.org/cgi/content/
abstract/awp306v1(accessed 19 January 2010)
[36] Ruby P, Decety J. How Would You Feel Versus How Do You Think She Would Feel?
A Neuroimaging Study On Perspective-Taking With Social Emotions. Journal Of
Cognitive Neuroscience 2003;16: 988-99.
[37] Decety J, Sommerville JA. Shared representations between self and other: A social
cognitive neuroscience view. Trends in Cognitive Science 2003;7: 527-33.
[38] Avikainen S, Forss N, Hair R. Modulated activation of the human SI and SII cortices
during observation of hand actions. Neuron 2002;15: 640-6.
[39] Goldenberg G. Body Image And The Self. In: Feinberg TE, Keenan JP (eds.) The Lost
Self. Pathologies Of The Brain And Identity. Oxford: Oxford University Press; 2005.
p81-99.
[40] Jordan R, Powell S. Understanding And Teaching Children With Autism. Chichester:
Wiley; 1995.
[41] Russell J. How Executive Disorders Can Bring About An Inadequate Theory Of
Mind. In: Russell J (Ed.) Autism As An Executive Disorder. Oxford: Oxford Univer
sity Press. 1997.p281.
761
762
[42] Russell (1997).

[43] Williams D, Happ F. Pre-Conceptual Aspects Of Self-Awareness In Autism Spec
trum Disorder: The Case Of Action Monitoring. Journal Of Autism And Develop
mental Disorders 2009;39: 251-9.
[44] Mesulam MM. Principles Of Behavioral And Cognitive Neurology (2nd Ed.), Oxford:
Oxford University Press; 2000.
[45] Devinsky O. Right Cerebral Hemisphere Dominance for a Sense of Corporeal and
Emotional Self. Epilepsy & Behaviour 2000;1: 60-73.
[46] Farrer C, Franck N, Georgieff N, Frith CD, Decety J, Et Al. Modulating The Experi
ence Of Agency: A Positron Emission Tomography Study. Neuroimage 2003;18:
324-33.
[47] Tsakiris M, Constantine M, Haggard P. The Role Of Right Temporo-Parietal Junction
In Maintaining A Coherent Sense Of Ones Body. Neuropsychologia 2008;46:
3014-18.
[48] Saxe R, Baron-Cohen, S. Editorial: The Neuroscience Of Theory Of Mind. In: R. Saxe
R, Baron-Cohen S. (eds.) Theory Of Mind. A Special Issue Of The Journal Social Neu
roscience. Hove: Psychology Press; 2007.
[49] Frith U, Happ F. Theory Of Mind And Self Consciousness: What It Is Like To Be
Autistic? Mind & Language 1999;14: 1-22.
[50] Happ F. Theory Of Mind And The Self. In: Ledoux J, Debiec J, Moss H. (eds) The
Self: From Soul To Brain, Annals Of The New York Academy Of Sciences 2003;1001:
134-144.
[51] Schore AN. Affect Dysregulation And Disorders of The Self. New York: Ww. Norton
& Company; 2003.
[52] Baron-Cohen S. Wheelwright S. The Empathy quotient: An investigation of adults
with Asperger syndrome or high functioning autism, and normal sex differences.
Journal of Autism and Developmental Disorders 2004;34: 163-75.
[53] Hobson (1993).
[54] Hobson RP. The Autistic Childs Appraisal Of Expressions Of Emotion. Journal Of
Child Psychology And Psychiatry 1986; 27: 321-42.
[55] Yirmiya N., Sigman M., Kasari C., Mundy P. Empathy And Cognition In High Func
tioning Children With Autism. Child Development 1992;63: 150-60.
[56] Baron-Cohen S., Wheelwright S., Joliffe T. Is there a language of the eyes? Evidence
from normal adults and adults with autism or Asperger syndrome. Visual Cognition
1997;4: 311-31.
[57] Gaigg SB, Bowler DM. Free Recall And Forgetting Of Emotionally Arousing Words
In Autism Spectrum Disorder. Neuropsychologia 2008;46: 2336-43.

http://dx.doi.org/10.5772/53680
[58] Frith CD, Frith U. The Neural Basis Of Mentalizing. Neuron 2006;50: 531-34.
[59] Saxe & Baron-Cohen (2007).
[60] Happ F., Brownell H., Winner E. Acquired Theory Of Mind Impairments Following
Right Hemisphere Stroke. Cognition 1999;70: 211-40.
[61] Shamay-Tsoory SG, Tomer R, Berger BD., Goldsher D,Aharon-Peretz, J. Impaired
Affective Theory Of Mind Is Associated With Right Ventromedial Prefrontal Dam
age. Cognitive And Behavioural Neurology 2005;18: 55-67.
[62] Chakrabarti B, Bullmore E, Baron-Cohen S. (2007) Empathizing with basic emotions:
Common and discrete neural substrates. In: Saxe R, Baron-Cohen S. (eds) Theory of
Mind. A special issue of the Journal Social Neuroscience. Hove: Psychology Press;
2007. p. 364-384.
[63] Keysers C., Perrett I. Demystifying Social Cognition: A Hebbian Perspective. Trends
In Cognitive Science 2004;8: 501-7.
[64] Rizzolatti G, Craighero L. The Mirror-Neuron Sys tem. Annual Reviews Of Neuro
science 2004; 27: 169-92.
[65] Kanner (1943).
[66] Asperger H. Die autistischen Psychopathen im Kindesalter. Archiv fr Psychiatrie
and Nervenkrankheiten 1944;117: 78-136.
[67] Baron-Cohen, S. (2005) Autism Autos: Literally, a Total Focus on the Self? In:
Feinberg TE., Keenan JP (eds.) The Lost Self. Pathologies of the Brain and Identity.
Oxford: Oxford University Press. p166-80.
[68] Gillberg IC, Gillberg C. Asperger Syndrome Some Epidemiological Considerations:
A Research Note. Journal Of Child Psychology And Psychiatry 1989;30: 631-38.
[69] Frith U, De Vignemont, F. Egocentrism, Allocentrism, And Asperger Syndrome.
Consciousness And Cognition 2005;14: 719-38.
[70] Frith U, De Vignemont F. (2005)
[71] Moore C, Lemmon K. The Self In Time: Developmental Perspectives. Hillsdale, NJ,
Usa: Erlbaum; 2001.
[72] Nielsen M., Suddendorf T., Dissanayake C. Imitation And Self-Recognition In Au
tism. In: Rogers S., Williams JW. (Eds) Imitation And The Development Of The Social
Mind: Autism And Typical Development. New York: Guilford Press; 2006. p138-56.
[73] Lind SE, Bowler DM. Delayed Self-Recognition In Children With Autism Spectrum
Disorder. Journal Of Autism And Developmental Disorders 2009;39 (4): 643-650.
[74] Lind SE, Bowler DM. (2009).
763
764
[75] Boucher J, Pons F, Lind S, Williams D. Temporal cognition in children with autistic
spectrum disorders: Tests of diachronic thinking. Journal of Autism and Develop
[76] Lind SE, Bowler DM. Episodic Memory And Autonoetic Consciousness In Autistic
Spectrum Disorders: The Roles Of Self-Awareness, Representational Abilities And
Temporal Cognition. In: Boucher J, Bowler DM. (eds), Memory In Autism: Theory
And Evidence. Cambridge: Cambridge University Press; 2008. p166-188.
[77] Beitman BD, Nair J, Viamontes GI. Why Self-Awareness? In: Beitman BD, J. Nair J.
(eds.) Self-Awareness Deficits in Psychiatric Patients. Neurobiology, Assessment,
and Treatment. New York: W.W. Norton & Company; 2004. p3-23.
[78] Kircher T, David AS. (2003) p3.
[79] Kanner L. (1943).
[80] Tager-Flusberg, H. Current Theory And Research On Language And Communica
tion In Autism. Journal Of Autism And Developmental Disorders 1996;26: 169-172.
[81] Hobson (1990).
[82] Jordan R, Powell S. (1995).
[83] Peeters G, Grobben G, Hendrickx,A., Van Den Eede S, Verlinden K. Self-Other And
Third-Person Categorization In Normal And Autistic Children. Developmental Sci
ence 2003. 6: 166-172.
[84] Northoff G, Heinzel A. The Self In Philosophy, Neuroscience And Psychiatry: An
Epistemic Approach, In: T. Kircher T., David A. (eds.) The Self In Neuroscience And
Psychiatry. Cambridge: Cambridge University Press; 2003. p40-55.
[85] Lombardo MV, Barnes JL, Wheelwright SJ, Baron-Cohen S. Self-Referential Cogni
tion And Empathy In Autism. PloS One 2007,2: e883.
[86] Lyons V, Fitzgerald M. Asperger Syndrome A Gift Or A Curse? New York: Nova
Science Publishers; 2007.
[87] Siegrist M. Inner Speech As A Cognitive Process Mediating Self-Consciousness And
Inhibiting Self-Deception. Psychology Report 1995;76: 259-265.
[88] Whitehouse A.JO, Maybery MT, Durkin K. Inner Speech Impairments In Autism.
Journal Of Child Psychology And Psychiatry 2006;47: 857-65.
[89] Hurlburt R, Happ F, Frith U. Sampling The Form Of Inner Experience In Three
Adults With Aspergers Syndrome. Psychological Medicine 1994;24: 385-95.
[90] Grandin T. Thinking In Pictures: And Other Reports From My Life With Autism.
New York: Vintage Books; 1995.

http://dx.doi.org/10.5772/53680
[91] Kana RK, Keller TA, Cherkassky VL, Minshew NJ, Just MA. Sentence Comprehen
sion In Autism: Thinking In Pictures With Decreased Functional Connectivity. Brain
2006;129: 2484-93.
[92] Kennedy DP, Redcay E, Courchesne E. Failing To Deactivate: Resting Functional Ab
normalities In Autism. Proceedings Of The National Academy Of Science USA
2006;103: 8275-80.
[93] Perner J. Episodic Memory: Essential Distinctions And Developmental Implications.
In: Moore C, Lemmon K.(Eds.) The Self In Time: Developmental Perspectives. Hill
sdale NJ: Erlbaum; 2001. p181-202.
[94] Wheeler MA. Episodic Memory And Autonoetic Awareness. In: Tulving E, Craik
FIM. (eds.) Oxford Handbook Of Memory. New York: Oxford University Press; 2000.
p597-625.
[95] Nelson K, Fivush R. The Emergence Of Autobiographical Memory: A Social Cultural
Developmental Theory. Psychological Review 2004;111: 486-511.
[96] Fujiwara E, Markowitsch HJ. Autobiographical Disorders. In: Feinberg TE, Keenan
JP. (eds.) The Lost Self. Pathologies Of The Brain And Identity, Oxford: Oxford Uni
versity Press; 2005. p65-80.
[97] Bowler DM, Gardiner JM, Grice SJ. Episodic memory and remembering in adults
with Asperger syndrome. Journal of Autism and Developmental Disorders 2000;30:
295-304, p. 295.
[98] Millward C, Powell S, Messer D, Jordan R. Recall For Self And Other In Autism:
Childrens Memory For Events Experienced By Themselves And Their Peers. Journal
For Autism And Developmental Disorders 2000;30: 15-28.
[99] Gardiner, J. M. Bowler, D. M, Grice SJ. Further Evidence Of Preserved Priming And
Impaired Recall In Adults With Aspergers Syndrome. Journal Of Autism And De
velopmental Disorder 2003;33 (3) 250-69.
[100] Crane L, Goddard L. Episodic and semantic autobiographical memory in adults with
Autism Spectrum Disorders. Journal of Autism and Developmental Disorders 2008;
38: 498-506.
[101] Boucher J, Bowler DM (eds) Memory in autism: theory and evidence. Cambridge:
Cambridge University Press; 2008.
[102] Millward et al. (2000).
[103] Wheeler MA, Stuss DT, Tulving, E Toward A Theory Of Episodic Memory: The
Frontal Lobes And Autonoetic Consciousness. Psychological Bulletin 1997;121:
331-54.
[104] Fink GR. In Search Of Ones Own Past: The Neural Bases Of Autobiographical Mem
ories. Brain 2003;126: 1509-10.
765
766
[105] Shallice T, Fletcher P, Frith C, Grasby P, Frackowiak R, Dolan R. Brain Regions Asso
ciated With Acquisition And Retrieval Of Verbal Episodic Memory. Nature 1994;368:
633-35.
[106] Tulving E, Kapur S, Craik F, Moskovitch M, Houle S. Hemispheric Encoding/Retriev
al Asymmetry In Episodic Memory: Positron Emission Tomography Findings. Pro
ceedings Of The National Academy Of Science USA 1994;91: 2016-20.
[107] Fink GR, Markowitsch HJ, Reinkemeier M, Bruckbauer T, Kessler J, Heiss W-D. Cere
bral Representation Of Ones Own Past: Neural Networks Involved In Autobio
graphical Memory, Journal of Neuroscience 1996;16: 4275-82.
[108] Bruner J. Kalmar DA. Narrative and metanarrative in the construction of self. In: Fer
rari M, Sternberg RJ. (eds.) Self-Awareness: Its Nature and Development. New York:
Guilford Press; 1988.
[109] Dennett D. Consciousness Explained. Boston: Little, Brown; 1991.
[110] Schechtman M. The Constitution Of Selves. Ithaca: Cornell University Press; 1996.
[111] Ochs E, Capps L. Narrating The Self. Annual Review Of Anthropology 1996;25:
19-43.
[112] Gallagher S. Self-Narrative In Schizophrenia. In: Kircher T, David A. (eds.) The Self
In Neuroscience And Psychiatry. Cambridge: Cambridge University Press; 2003.
p336-360.
[113] Gallagher (2003).
[114] Loveland K. Mcevoy R, Tunali B, Kelley ML. Narrative Story Telling In Autism And
Downs Syndrome. British Journal of Developmental Psychology 1990;8: 9-23.
[115] Losh M, Capps L. Narrative Ability In Highfunctioning Children With Autism Or
Aspergers Syndrome. Journal of Autism and Developmental Disorders 2003;33:
239-51.
[116] Colle L, Baron-Cohen S, Wheelwright S, Van Der Lely HK. Narrative discourse in
adults with high-functioning Autism or Asperger Syndrome. Journal of Autism and
[117] Tononi G, Sporns O, Edelman GM. Reentry And The Problem Of Integrating Multi
ple Cortical Areas: Simulation Of Dynamic Integration In The Visual System. Cere
bral Cortex 1992; 2: 310-35.
[118] Belmonte M. Human, but more so: What the autistic brain tells us about the process
of narrative. In: Osteen M. (ed.) Autism and representation. London: Routledge;
2008. p166-79.
[119] Viamontes GI, Beitman BD, Viamontes CT, Viamontes JA. Neural Circuits For SelfAwareness. Evolutionary Origins And Implementation In The Human Brain. In: Beit

http://dx.doi.org/10.5772/53680
man BD, Nair J. (eds) Self-Awareness Deficits In Psychiatric Patients. Neurobiology,

Assessment, And Treatment. New York: W.W. Norton & Company; 2004. p24-111.
[120] Decety & Somerville (2003).
[121] Aylward EH, Minshew NJ, Field, K, Sparks BF, Singh N. Effects of age on brain vol
ume and head circumference in autism. Neurology 2002;59: 175-83.
[122] Courchesne E, Townsend J, Akshoomoff NA,Et al. A new finding: impairment in
shifting attention in autistic and cerebellar patients. In: Broman SH, Grafman J. (eds)
Atypical cognitive deficits in developmental disorders: implications for brain func
tion. Hillsdale, N.J.: Lawrence Erlbaum Associates; 1994. p101-137.
[123] Courchesne E, Press G, Yeung-Courchesne, R. Parietal lobe abnormalities detected
with MR in patients with infantile autism. American Journal of Roentgeneology
1993;160: 387-393.
[124] Saitoh O, Karnds,CM, Courchesne E. Development Of Hippocampal Formation
From 2 To 42 Years: MRI Evidence Of Smaller Area Dentate In Autism. Brain
2001;124: 1317-24.
[125] Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA., Augustine AM, Yates KO,
Barta PE, Pearlson GD. MRI volumes of amygdala and hippocampus in non-mental
ly retarded autistic adolescents and adults. Neurology 1999;53: 2145-50.
[126] Mller RA. The Study Of Autism As A Distributed Disorder. Mental Retardation
And Developmental Disabilities Research Review 2007;13(1): 85-95.
[127] Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA. et al. Unusual brain
growth patterns in early life in patients with autistic disorder: an MRI study. Neurol
ogy 2001;57: 245-54.
[128] Carper RA, Courchesne E. Localized enlargement of the frontal lobe in early autism.
Biological Psychiatry 2005;57 (2): 126-33.
[129] Fossati P, Hevenor S, Graham SJ. Et Al. In Search Of The Emotional Self: An fMRI
Study Using Positive And Negative Emotional Words. American Journal Of Psychia
try 2003;160: 1938-45.
[130] Keenan JP, Gallup GG, Jr., Falk D. The Face In The Mirror: The Search For The Ori
gins Of Consciousness. New York: Harper Collins; 2003.
[131] Kircher & David (2001).
[132] Decety & Somervie (2003).
[133] Mega MS, Cummings JL. Frontal Subcortical Circuits: Anatomy And Function. In:
Salloway SP, Malloy PF, Duffy JD. (Eds) The Frontal Lobes and Neuropsychiatric Ill
ness. Washington, DC: American Psychiatric Publishing; 2001. p15-32.
[134] Fossati et al. (2003).
767
768
[135] McGilchrist I. The Master And His Emissary. The Divided Brain And The Making Of
The Western World. New Haven and London: Yale University Press; 2010.
[136] Lyons V, Fitzgerald, M. Did Hans Asperger (1906-1980) Have Asperger Syndrome?
Journal Of Autism And Developmental Disorder 2007;37: 2020-21.
[137] Klin A, Volkmar F, Sparrow, S, Cicchetti DV, Rourke BP. Validity and Neuropsycho
logical Characterization of Asperger Syndrome: Convergence with Nonverbal Learn
ing Disabilities Syndrome. Journal of Child Psychology and Psychiatry 1995; 36,
1127-1140.
[138] Gunter HL, Ghaziuddin M, Ellis HE. Asperger Syndrome: Test Of Right Hemisphere
Functioning And Interhemispheric Communication. Journal Of Autism And Devel
opmental Disorders 2002;32: 263-81.
[139] Chiron C, Jambaque I, Nabbout R, Lounes R, Syrota A., Dulac O. The right brain
hemisphere is dominant in human infants. Brain 1997;120: 1057-1065.
ciations, And Pathology. Boston: MIT Press; 1987.
[141] Schore AN. The Experience-Dependent Maturation Of A Regulatory System In The
Orbital Prefrontal Cortex And The Origin Of Developmental Psychopathology. De
velopment and Psychopathology 1996;8: 59-87.
[142] Fernald A. Intonation And Communicative Interest In Mothers Speech To Infants: Is
The Melody The Message? Child Development 1989;60: 1497-1510.
[143] Meltzoff AN, Brooks R. Like Me As A Building Block For Understanding Other
Minds: Bodily Acts, Attention And Intention. In Malle BF, Et Al (Eds) Intentions And
Intentionality: Foundations For Social Cognition. Boston: MIT Press; 2001. p171-192.
[144] Horwitz, B, Rumsey JM, Grady C.L, Rapoport SI. The Cerebral Metabolic Landscape
In Autism. Intercorrelations Of Regional Glucose Utilization. Archives Of Neurology
1988; 45: 749-755.
[145] Just MA, Cherkassky VL, Keller TA, Minshew N. Cortical Activation And Synchroni
zation During Sentence Comprehension In High-Functioning Autism: Evidence Of
Underconnectivity. Brain 2004;127 (8): 1811-21.
[146] Casanova MF. White matter volume increase and minicolumns in autism. Annals of
Neurology 2004;56: 453-54.
[147] Mizuno A, Villalobos ME, Davies MM, Dahl BC, Mller RA. Partially Enhanced Tala
mocortical Functional Connectivity In Autism. Brain Research 2006;1104 (1): 160-174.
[148] Courchesne E, Pierce K. Why the frontal cortex in autism might be talking only to
itself: local overconnectivity but long-distance disconnection. Current Opinion in
Neurobiology 2005;15: 225-30.

http://dx.doi.org/10.5772/53680
[149] Belmonte M, Cook JEH, Anderson G, Rubinstein J, Greenough W, et al. Autism as a

disorder of neural information processing: direction for research and targets for ther
apy. Molecular Psychiatry 2004a;9: 646-63.
[150] Kana et al. (2006).
[151] Just et al. (2007).
[152] Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Minicolumnar pathology in au
tism. Neurology 2002a;58: 428-32.
[153] Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Aspergers syndrome and corti
cal neuropathology. Journal of Child Neurology 2002b;17: 142-45.
[154] Keller TA., Kana RK, Just MA. A Developmental Study Of The Structural Integrity
Of White Matter In Autism. Neuroreport 2007;18: 23-27.
[155] Turner KC, Frost L, Linsenbardt D, Mcilroy JR, Mller RA. Atypically Diffuse Func
tional Connectivity Between Caudate Nuclei And Cerebral Cortex. Behavioural And
Brain Functions 2006;2: 34.
[156] Just MA., Cherkassky VL, Keller TA., Kana RK, Minshew N. Functional And Ana
tomical Cortical Underconnectivity In Autism: Evidence From A FMRI Study Of An
Executive Function Task And Corpus Callosum Morphometry. Cerebral Cortex
2007;17: 951-61.
[157] Stuss DT, Picton TW, Alexander MP. Consciousness, Self-Awareness And The Fron
tal Lobes. In: Salloway SP, Malloy PF (eds.) The Frontal Lobes And Neuropsychiatric
Illness. Washington, DC: American Psychiatric Publishing; 2001. P101-109.
[158] Courchesne & Pierce (2005).
[159] Williams JHG, Whiten A., Suddendorf T, Perrett DI. Imitation, Mirror Neurons And
Autism. Neuroscience & Biobehavioral Reviews 2001;25: 287-95.
[160] Oberman LM, Ramachandran VS. The Simulating Social Mind: The Role Of The Mir
ror Neuron System And Simulation In The Social And Communicative Deficits In
Autism Spectrum Disorders. Psychological Bulletin 2007;133(2): 310-27.
[161] Rizolatti & Craighero (2004).
[162] Williams et al. (2001).
[163] Kaplan JT, Iacoboni M. Getting A Grip On Other Minds: Mirror Neurons, Intention
Understanding, And Cognitive Empathy. In: Saxe R, Baron-Cohen S. (eds.) Theory
Of Mind. A Special Issue Of The Journal Social Neuroscience. Hove: Psychology
Press; 2007. P175-183.
[164] Pfeifer J, Iacoboni M, Mazziotta JC, Dapretto M. Mirror neuron system activity corre
lates with empathy and interpersonal competence in children. Social Neuroscience
2006; 6 (3-4): 175-83.
769
770
[165] Kaplan & Iacoboni (2007).

[166] Oberman & Ramachandran (2007).
[167] Gallese V. The Roots Of Empathy: The Shared Hypothesis And The Neural Basis Of
Intersubjectivity. Psychopathology 2003;36: 171-80.
[168] Ramachandran VS, Oberman LM. Broken Mirrors: A Theory Of Autism. Scientific
American 2006; November, 39-45.
[169] Asendorpf JB, Baudonniere PM. Self-awareness and Other-awareness: Mirror selfrecognition and synchronic imitation among unfamiliar peers. Developmental Psy
chology 1993;29: 88-95.
[170] Uddin LQ, Kaplan JT, Molnar-Szakacs I, Zaidel E, Iacoboni M. Self-Face Recognition
Activates A Frontoparietal Mirror Network In The Right Hemisphere: An Event-Re
lated fMRI Study. Neuroimage 2005; 25: 926-35.
[171] Uddin LQ, Molnar-Szakacs I, Zaidel E, Iacoboni M. Rtms To The Right Inferior Parie
tal Area Disrupts Self-Other Discrimination. Social Cognitive And Affective Neuro
science 2006; 1, 65-71.
[172] Dapretto M, Davies MS, Pfeifer JH, Scott AA, Sigman,M. Bookheimer SY, Iacoboni
M. Understanding emotions in others: mirror neuron dysfunction in children with
autism spectrum disorders. Nature Neuroscience 2006;9(1): 28-30.
[173] Theoret H, Halligan E, Kobyashi M, Fregni F, Tager-Flusberg H, Pascual-Leone A.
Impaired Motor Facilitation During Action Observation In Individuals With Autism
Spectrum Disorder. Current Biology 2005;15: 84-85.
[174] Nishitani NA, Vikainen S, Hari R. Abnormal Imitation-Related Cortical Activation
Sequences In Aspergers Syndrome. Annals Of Neurology 2004;55: 558-62.
[175] Kennedy et al. (2006).
[176] Hobson RP. The Intersubjective Foundations Of Thought. In Braten S. (ed.) Intersub
jective Communication And Emotion In Early Ontogeny. Cambridge: Cambridge
University Press; 1998. p283-296.
[177] Iacoboni, M. Failure To Deactivate In Autism: The Constitution Of Self And Other.
Retrieved October 7, 2006, From http://www.awares.org/conferences/
[178] Happ F, Vital P. What Aspects Of Autism Predispose To Talent?, In: Happ F,
Frith U.(eds.) Autism And Talent. London: Philosophical Transactions of The Royal
Society; 2009. p1369-1376.
Chapter 31
Atypical Sense of Self in Autism Spectrum Disorders: A

Neuro-Cognitive Perspective
http://dx.doi.org/10.5772/53680
1. Introduction
1.1. Self Definitions and concepts
The concept of self is notoriously difficult to define and different notions and theories of the
self have been proposed by a variety of disciplines all interpreting concepts of self and iden
tity in various ways. We adopt the definition advanced by neuroscientists Kircher and Da
vid [1] who interpret the self as the commonly shared experience, that we know we are the
same person across time, that we are the author of our thoughts/actions, and that we are dis
tinct from the environment (p.2). In cognitive neuroscience literature, operational defini
tions of the self are used which are measurable by experimental methods including self
recognition, self and other differentiation, body awareness, awareness of other minds,
awareness of self as expressed in language and important concepts such as autobiographical
memory and self narrative. There is significant interest in the role of the self and possible
abnormalities associated with the self, as causally implicated in autism. In this paper we re
view developmental perspectives of self and self-related functions with reference to their
neuroanatomical basis and investigate the possible causes for atypical self-development in
Autism Spectrum Disorders (ASD).
2. Review of studies investigating the self in ASD

The question whether individuals with ASD have a different sense of self than people with
out ASD, i.e. neurotypicals has fascinated researchers and clinicians for decades. Kanner
[2] in 1943 already noted self-deficits in the children he described, including their difficulties
in maintaining a constant self-concept, and associated problems of adapting their fragile
750
self-concept to changing environments. Asperger [3] (1974, p. 2026) refers to a disturbance

and a weakness of the self in children with autistic psychopathy. Psychoanalytic theories
considered autism as a disorder of the self [4] based on the lack of ability in establishing sta
ble internal representations of themselves and of others. The German psychiatrist Lutz [5]
(1968) interpreted autism as a disturbance of self-consciousness, self-related activities and
self-perception. Powell and Jordan [6] (1993) suggested that individuals with ASD lack an
experiencing self that provides a personal dimension for ongoing events. This is consistent
with Friths [7] suggestion of an absent self in autism. Hobson [8] put forward a develop
mental account of the self in autism emphasising impaired interpersonal relatedness, inter
subjectivity and its far-reaching consequences for the development of the self. In a recent
study investigating whether children with autism show abnormal self-other connectedness,
Hobson and Meyer [9] found a failure in autism to identify with another person. These au
thors suggest that this process of identifying with others is crucial for a normal development
of self-other relationship and the basis for understanding other minds.
3. Atypical development of self-related processes in ASD

There is general consensus among developmental theorists [e.g. 10,11] that early interper
sonal communication is central to the establishment of the self in normal development. A
large body of research literature indicates that early processes underlying self-other
awareness are impaired or delayed in autism including gaze following, abnormal re
sponse to sound and deficits in attention [12], showing of objects, responding and orient
ing to own name [13], looking at others faces [14], pretend play, protodeclarative
pointing and gaze monitoring [15], empathy and imitation [16], joint-attention behaviour
[17], affect and personal relatedness [18,19].
3.1. Self recognition and awareness
The ability to recognize ones own face in the mirror is considered a test for self-aware
ness. Self-recognition as measured by mirror tests [20] in 18 months old children has
been depicted as a developmental milestone in self-conception and described as the ach
ievement of a cognitive self [21]. Not only is self recognition essential for developing a
concept of self, and self-other differentiation, it is also a prerequisite for later developing
theory of mind abilities, as a stable self concept is the basis for being able to read the
mental states of others. Research data on self-recognition reveals that autistic childrens
responses to their mirror images are qualitatively different from those of normal children
[22]. Children with ASD have deficits of self-awareness as measured by a self-recogni
tion test [23] they show little interest in their own mirror images and have been descri
bed as relatively face inexperienced [24].
The prefrontal cortex, especially the Right Hemisphere (RH) plays a critical role in the
recognition of ones own face [25] as evidenced by functional imaging studies. Face per
ception studies in individuals with ASD suggest abnormal functioning in the fusiform

http://dx.doi.org/10.5772/53680
face area as well as amygdala, brain regions associated with the social brain (e.g. 26,27]
involving the RH.
3.2. Self/other differentiation
The ability to differentiate between self and other is also essential for the development of
self-awareness, which appears to be impaired in autism. In particular, the recognition of a
separate existence of other people seems to be delayed in children with autism [28,29]. At
tentional abnormalities, such as tunnel vision, the tendency to think in a monotropic man
ner have been suggested by some as the cause of self-other problems in ASD [30]. Donna
Williams [31] interprets monoprocessing as the inability to process simultaneously informa
tion of oneself and others.
In neurotypicals the middle cingulate cortex and ventromedial prefrontal cortex are in
volved in self/other processing. In contrast, atypical neural responses have been reported in
individuals with ASD. A recent fMRI study [32] investigating the attribution of behavioural
outcomes to either oneself or others while playing an interactive trust game revealed a lack
of brain activity in the cingulate cortex indicating diminished self responses in individuals
with ASD. However, other responses, attributing actions to other people were intact. Previ
ous research data using trust games [33] had demonstrated that cingulate cortex activation
is consistent with self-response patterns generated during interpersonal exchanges. Chiu et
al. [34] interpreted their data in terms of a deficit in ASD in monitoring their own intentions
in social interactions and thus contributing to impaired theory of mind abilities, lack of in
trospection and self-referential processing. Of particular interest is the fact that the im
paired self-responses in the ASD group correlated with their behavioural symptom
severity, i.e. the lesser activity along cingulated cortex the more serious were their behaviou
ral symptoms. Similar results have been reported by Lombardo et al. [35] also demonstrat
ing atypical neural responses from the middle cingulate cortex during a self-referential
processing task. This study also provided a link between these deficits and early social im
pairments in autism. In addition, these authors also demonstrated reduced functional con
nectivity between ventromedial prefrontal cortex and lower level regions (e.g.
somatosensory cortex) in individuals with ASD during these selfrepresentation tasks.
Previous studies identified the right inferior parietal lobe, along with frontopolar and soma
tosensory regions [36,37] as critical for distinguishing between self and other. Additional da
ta [e.g. 38] demonstrate that SI and SII cortices, which contribute to the mirror-neuron
system, are also crucial for preserving a sense of self.
3.3. Body awareness, sense of agency
Knowing oneself and knowing ones body are closely related concepts. In his review on
body image and the self, Goldenberg [39] argues that the acquisition of body image is not
innate but acquired through experiences of ones own and other bodies. Likewise, Jordan
and Powell [40] believe that a body concept develops from interacting with others. Anecdo
tal reports indicate that some children and adults with autism have an insecure body image
751
752
or totally lack body awareness. Russell [41] suggested that the body schemas of persons
with autism are poorly specified resulting in an atypical experience of agency. A sense of
agency is a central aspect of human self-consciousness and refers to the experience of oneself
as the agent of ones actions. Based on his executive function account of impaired action
monitoring Russell [42] put forward the hypothesis that individuals with autism are im
paired in distinguishing between self and others. In contrast, a recent study by Williams and
Happ [43] suggests that individuals with ASD are aware of their agency as indicated by
their ability to monitor their own actions.
Support for a dominant role of the right hemisphere in the above processes is substantial.
The right posterior parietal lobe is generally associated with spatial and bodily awareness
[44,45]. Activation of right inferior parietal lobe correlates with a sense of ownership in ac
tion execution [46]. Additional research evidence [47] based on transcranial magnetic stimu
lation (TMS) supports the significance of the right temporo-parietal junction in the
maintenance of a coherent sense of ones body.
3.4. Theory of mind, emotions and self-awareness
An essential component of self-awareness is the ability to be aware of other minds. A multi
tude of studies have provided evidence that theory of mind is lacking or delayed in ASD, or
develops differently than in neurotypicals [for a substantive review see 48]. Deficits in mind
reading may also affect the ability to reflect on ones own mental states [49] resulting in di
minished self-awareness. There is some evidence suggesting that the ability to think about
ones own thoughts depends on the same cognitive and neural processes as mindreading
[50]. Equally, emotions play an important role in self-awareness. The development of the ca
pacity to experience, communicate and regulate emotions is considered to be the most im
portant event in infancy [51]. One of the main characteristics of autism is lack of empathy
and emotional engagement with others [52,53]. Children with autism have difficulties with
interpreting emotions, are deficient in processing their own emotional experiences and pay
little attention to emotional stimuli in general [e.g. 54-57]. Due to this inability to empathize
and emotionally engage with others individuals with ASD are totally focussed on their own
interests and concerns.
A network of structures important for theory of mind processing includes the superior tem
poral sulcus and the adjacent temporo-parietal junction, the temporal poles and the medial
prefrontal cortex [58; see also 59 for a review). Research evidence implicated the RH in theo
ry of mind reasoning across various tasks [60, 61]. The neural substrates for emotions and
empathy are complex [62] involving amygdala, ventral medial prefrontal cortex. Recent
imaging studies point to an involvement of a mirror neuron circuit for empathy [63,64].
3.5. Egocentrism/Allocentrism
In apparent contrast to the mentalizing impairment even among very high functioning indi
viduals with ASD is their often-documented increased sense of self or total focus on the self
[65,66,67] that is also reflected in numerous biographical accounts. The term autism is de

http://dx.doi.org/10.5772/53680
rived from the Greek word autos (self) and since Kanners time this focus on the self as
atypical applies to all individuals with ASD. Extreme egocentricity was one of the diagnostic
criteria for Asperger Syndrome proposed by Gillberg & Gillberg [68]. Frith and de Vigne
mont [69] suggest that there are differences to reading other minds depending on whether
the other person can be understood using an egocentric or an allocentric standpoint. From
an egocentric point of view other people are understood only relative to the self whereas
from an allocentric stance the mental state of a person is independent from the self. These
theorists suggest that individuals with ASD suffer from an imbalance between both point of
views, they are unable to connect an egocentric to an allocentric stance and can only adopt
extreme forms of either [70]. This very detailed analysis of mindreading further illustrates
the different and unique aspects of awareness of self and others in individuals with ASD.
3.6. Self awareness across time
Awareness that we are the same person across time, also defined as temporally extended
self-awareness [71] is an essential part of ones self-concept. Although the results of two re
cent studies [72,73] indicate that individuals with ASD have undiminished temporally ex
tended self-awareness as assessed by the delayed self-recognition task, this task may not
adequately measure self-awareness as suggested by Lind & Bowler [74]. Indirect evidence
suggests that temporally extended self-awareness is impaired in ASD based on their prob
lems with theory of mind as well as some aspects of temporal cognition [75]. Alternative ex
planations are the autobiographic memory difficulties [76] and also the well-documented
language impairments in ASD. Language is a medium with which we monitor ourselves
and it allows us to experience past, present and future [77].
3.7. Language and awareness of self
Conceptions about oneself and others develop from an early age and depend largely on the
emergence of language. At around 18 months of age children start referring to themselves as
I and begin using the word you for others, indicating a further development in their selfother awareness. According to Kircher and David [78] the symbolic presentation of the self
in language is the personal pronoun I. Language difficulties such as pronoun reversal, use
of third person perspective, impoverished inner speech, and impaired narrative have a neg
ative effect on mental processes and also restrict certain aspects of self-awareness.
There is substantial clinical and research evidence of impaired pragmatic language use in
children with ASD as indicated by pronoun reversal errors (I/me/you) [79-82] reflecting
general difficulties with their sense of self, as well as problems in self-other differentiation.
Peeters et al. [83] suggested that the reason children with autism sometimes communicate
from a third-person perspective instead of a first- vis--vis second person perspective is that
in contrast to typically developing children they possess a non-social basis of self-other cate
gorization. Use of a third person perspective also has consequences for attribution of mental
states, and mentalizing ability in general. As argued by Northoff and Heinzel [84] a third
person perspective is an indication of a fragmented image of self and other. Adults with
753
754
ASD also appear to have difficulties with first person pronoun usage [85]. Of particular in
terest might be the fact, that Hans Asperger often used to refer to himself from a third per
son perspective [86].
A fundamental role in self-awareness is attributed to inner speech [87] that is impaired in
ASD [88]. When asked about the nature of their thoughts, a group of adults with Asperger
syndrome reported mainly images and actions as their only inner experience and made no
reference to inner speech or emotions [89]. Many individuals with ASD are visual thinkers
and rely heavily on visualization to process information [90].
A recent fMRI study [91] provided evidence of underintegration of language and imag
ing in autism by showing that individuals with ASD are more reliant on visualization to
support language comprehension. These authors suggest that cortical underconnectivity
is the reason for the lack of synchronization between linguistic and imaginal processing
in autism. Supporting these findings are the results of an imaging study on daydream
ing [92] indicating that autistic individuals do not daydream about themselves or other
people. This study also points to a link between daydreaming and the construction of self
and self-awareness.
In summary, language is of fundamental significance to self-awareness and necessary for
forming a clear identity of self and others. Another important dimension in the formation of
the self that is also dependent on language is autobiographical memory as well as the con
struct of a narrative self.
3.8. Autobiographical memory
Many influential theorists [93,94] associate the development of self with the emergence of
autobiographical or episodic memory. The components necessary for a fully functioning
autobiographical memory are a basic memory system, spoken or signed language, under
standing and production of narrative, temporal understanding, self-awareness and theory
of mind [95]. Autobiographical memory not only depends on these cognitive constructs
but is also specifically concerned with events that have specific meaning to the individu
al. This personal significance evolves through emotions and motivations that are con
structed in interaction with others. Autobiographical disturbances can arise from
combined deficits in the realms of memory, emotion and self-related processing which
are intricately connected, both behaviourally and neurologically [96].
The majority of components that make up an autobiographic memory system are im
paired in autism. There is significant evidence that individuals with ASD have circum
scribed episodic memory impairments, e.g. they have an impaired recall for personally
experienced events [97-101]. As suggested by Millward et al [102] individuals with ASD
remember real-life episodes less well than other people because they have no experienc
ing self. Wheeler et al [103] in their investigation of episodic memory in autism conclud
ed that remembering of personal events requires the highest form of consciousness,
autonoetic consciousness (self-knowing), which is dependent of self-awareness.

http://dx.doi.org/10.5772/53680
The prevailing view is that episodic memory is created in the neocortex and subsequently
stored in the medial-temporal lobes and after a time becomes independent and is distribut
ed in neocortical networks [104]. Whereas the left temporal lobe is dominant for the acquisi
tion of new verbal information, episodic information involves mainly the right fontal lobes
[105, 106]. Neuroimaging studies provide evidence for right frontal involvement in the proc
essing of autobiographic memories [e.g. 107]. The RH is especially important for memories
with emotional contents.
3.9. The narrative self
Many theorists [e.g. 108, 109] have highlighted the importance of the narrative self and ar
gued that the autobiographical self is a similar construct as the narrative self. Individuals
create their own identity by constructing autobiographical narratives or life stories [110].
The benefits of a personal or narrative self are significant; a narrative mediates self-under
standing and creates coherence out of lifes experiences. Narrative emerges early in develop
ment and narrative and self are inseparable [111]. The creation of a narrative self depends on
various cognitive capacities, including working memory, self-awareness, episodic memory
and reflective metacognition, a sense of agency, the ability to attribute action to oneself to
gether with a capacity for temporal integration of events, a fully functioning pronoun sys
tem, an ability to differentiate between self and non-self as well as a sense of ones own body
that is based on proprioceptive-motor processes [112].
The mechanisms responsible for each of the above dimensions are impaired in autism and
as a consequence individuals with ASD have great difficulties in constructing a self-narra
tive. If autobiographical material cannot be provided, the narrative is disoriented and con
fused and in many cases is no narrative at all but only confabulation [113], which is often the
case in autism. As a result, the narrative of individuals with ASD, and the self that is repre
sented in this narrative, is quite vague and not representing the true self. Research evidence
confirms deficits in narrative abilities in individuals with ASD [114-116].
Language and symbolic functions are localized in the left hemisphere, whereas narrative
abilities are considered to be a function of the right hemisphere. There is a significant evi
dence for RH contribution to social language and many of the functions associated with au
tobiographic memory specifically those with emotional contents. In addition, narrative
organisation depends on coordination of activity among various brain regions [117] and as
suggested by Belmonte [118] malfunction in neural connectivity may be the underlying
problem with autistic narrative.
To summarize, there is substantial evidence that the main components of self-awareness in
cluding self recognition, self-other differentiation, body awareness, theory of mind, inter
subjectivity, emotion processing, language (pronoun reversal, inner speech, third person
perspective), autobiographical memory and narrative self are impaired in ASD. Our review
of neural substrates underlying these processes has highlighted the significance of the Right
Hemisphere.
755
756
4. Self neuropathology in ASD

From a neural point of view the self can be viewed as a complex and dynamic representa
tion consisting of multiple brain networks [119, 120]. The origins of self begin in infancy and
over the first several years of life normally developing children acquire an understanding of
different dimensions of self and other. Deviant development in autism is likely to result in a
cascade of developmental impairments including dysfunctional self-related processes as
outlined above. Various brain regions have been indicated in the pathogenesis of autism in
cluding frontal lobes [e.g., 121] cerebellum [122], parietal lobes [123], hippocampus [124] and
amygdala [125]. The extent of anatomical and functional abnormalities in autism points to a
possible core dysfunction in neural processing. In addition, the vast amount of potential ge
netic risk factors suggests that multiple or all-emerging functional brain areas are affected
during early development [126]. This theory is supported by widespread growth abnormali
ties in the brain of children with autism [127, 128].
In the following sections we will explore three neural theories implicated in the develop
ment of an atypical or different sense of self in individuals with ASD. Apart from the in
volvement of the RH in self-related processes a dysfunctional mirror neuron system as
well as abnormal connectivity may have a role to play in the atypical developmental tra
jectories in ASD.
4.1. Right hemisphere hypothesis
The prefrontal cortex plays a vital role in the development of the self as it generates a sense
of self and facilitates many links with other parts of the brain. Cognitive neuroscience stud
ies have shown that the RH plays a special role in personal relatedness, which is intimately
linked to the development of the self. Based largely on recent neuroimaging research evi
dence an increasing number of cognitive neuroscientists have emphasized the specific role
of the RH in self-related functions [129-132]. Specifically the right dorsomedial prefrontal
cortex seems to play a critical role in the development of models of the self [133]. This has
been confirmed by several imaging studies, including a recent study of self-evaluation [134].
As described in the previous paragraphs there is substantial research evidence that the RH
may be dominant for self-awareness and self-related functions. The psychiatrist and philoso
pher Iain McGilchrist [135] provided an extensive exploration of the dominance of the RH in
self-related processes.
Elsewhere, Lyons and Fitzgerald [136] put forward the theory that RH impairment leads to
a dysfunctional self-development in ASD. There is substantial research evidence linking As
perger syndrome to right hemisphere dysfunction [e.g. 137, 138]. The RH is dominant in the
first years of human life when the major brain development during critical periods takes
place. Results of a cerebral metabolism study in children (aged between 18 days to 12 years)
showed that the RH is prominently activated, suggesting that the RH develops earlier than
the LH [139]. The RH in implicated during early social interactions [140] including early at
tachment processes [141], maternal face and voice recognition [142] as well as the ability to
view others in a similar way as the self [143]. The developing self depends on relations with

http://dx.doi.org/10.5772/53680
others and these early experiences are vital for the maturation of the right brain system. Sub
stantial behavioural evidence of infants who later developed autism is supporting the theo
ry of disrupted intersubjective behaviour. We argue that impairments in neurobiology
affecting particularly the RH both cause and interact with defects in personal relatedness
and later developing self processes.
4.2. Abnormal connectivity
The Abnormal Neural Connectivity Theory proposes that autism is a distributed systemwide brain disorder that restricts the coordination and integration among various brain
areas. The original positron emission tomography (PET) study by Horwitz et al. [144] found
reduced correlations among frontal cortex, parietal and other brain regions and suggested
that autism involves impairment in functional connectivity between frontal cortex and other
brain systems. More recent studies proposed that autism is a disorder of neural undercon
nectivity [145], overconnectivity [146, 147] or both under and overconnectivity in which lo
cal connectivity may be relatively dense whereas long-range connectivity between brain
regions may be reduced or abnormally patterned [146-151].
Studies of the cerebral cortex in autism show abnormalities of synaptic and columnar struc
ture. Cortical minicolumns are fundamental units of cerebral cortical information process
ing. Examination of neurons revealed abnormalities in the size of cortical minicolumns
particularly in the frontal and temporal lobes in ASD [152, 153] that could alter overall levels
of connectivity within the brain. These findings are in accordance with the observed white
matter abnormalities reported particularly in people with ASD [154]. A recent study using
functional connectivity MRI (fcMRI) [155] provided further evidence of atypical enhanced
functional connectivity suggesting that abnormal connectivity may be linked to develop
mental brain growth disturbances in autism.
These studies suggest that connectivity among diverse brain areas may be the core problem
in autism. In autism the network connectivity through which various brain areas communi
cate with each other are limited, particularly the connections to the frontal cortex [156]
which is dominant for self-related processing particularly in the RH. The network model of
the self proposed by Stuss et al. [157] suggests that the self is hierarchically organized, with
the highest level of the self involved in self-awareness being subserved by frontal lobes. Ear
ly developmental impairments in minicolumnar microcircuitry in the frontal cortex in au
tism could be the reason for the deficits found in higher order frontal processes [158] which
are likely to result in fragmented self awareness and identity formation in autism.
4.3. Mirror neuron system
Another recent neural theory of autism suggests that a dysfunctional mirror neuron system
may be fundamental to the aetiology of autism [159, 160]. The existence of mirror neurons in
humans has been demonstrated by a number of EEG and imaging studies [e.g. 161]. Mirror
neurons are activated in relation both to specific actions performed by self and matching ac
tions performed by others, providing a potential bridge between minds [162] and might
757
758
have a role to play in self related processes. Mirror neurons may enable us to understand the
actions of others by mapping the actions of other people to our own motor system and so
allow a shared representation of actions. In addition to understanding the action of others
this so-called mirroring might also allow the automatic experience of the intention and
emotion of the other person as suggested by Kaplan and Iacoboni [163].
Research has demonstrated that mirror neuron activity correlates with empathy [164] and
social competence in general [165]. It has been suggested that mirror neurons are a prerequi
site for the normal development of self-recognition, imitation, theory of mind, empathy, in
tersubjectivity and language [166, 167]. Furthermore, mirror neurons are likely to play a
central role in self-awareness. To quote Ramachandran and Oberman [168] they may enable
humans to see themselves as others see them, which may be an essential ability for selfawareness and introspection (p.41). Developmental data suggest that there is higher imita
tive behaviour in children that can self-recognise, possibly facilitated by mirror neurons, in
contrast to those who cannot [169]. Providing support for a RH hypothesis in self-related
functions are recent imaging studies [170, 171] indicating that a frontoparietal mirror net
work is associated with self-recognition processes.
Several recent functional brain-imaging studies have found evidence of mirror neuron dys
function in individuals with ASD in social mirroring tasks [172], motor facilitation [173], and
imitation [174]. A fMRI study [175] revealed that individuals with autism showed a different
pattern of brain activity during cognitive tasks relating to self-referential processing. The au
thors concluded that a core deficit in autism might be related to the construction of a sense
of self in its relation with others. Echoing Hobson [176] Iacoboni [177] suggests that primary
intersubjectivity is the basis for the development of the neural systems associated with inter
nal and external self-related processes. Failure or abnormal development of a fully function
ing mirror neuron system in the autistic infant is likely to result in a cascade of
developmental impairments including dysfunctional self-related processes.
5. Conclusion
The centrality of an impaired sense of self in autism has been the focus of research for many
decades. The development of self-awareness is a complex process that involves integration
of information from many sources and coordination across the brain systems involved in
self-related concepts. A sense of self emerges from the activity of the brain in interaction
with other selves. There is substantial evidence that early deficits in self-development in
cluding impaired relations with others result in a fragmented and atypical sense of self in
ASD. In this review we have presented evidence that a great majority of self-related process
es that are mediated to a significant extent by the right hemisphere are impaired in individ
uals with ASD. Additional lines of investigation indicate that an unintegrated sense of self
in autism is also potentially associated with abnormal functional connectivity and an im
paired mirror neuron system. Consequences of this atypical sense of self are the well-docu
mented impairments individuals with ASD experience in the social and communication

http://dx.doi.org/10.5772/53680
domain. In contrast, there have been suggestions that this different sense of self might be a
contributory factor to the significant talents and special skills present in a majority of indi
viduals with ASD. Happ & Vital [178] put forward the notion that diminished self-aware
ness in ASD might be advantageous in the development of these special gifts.
Author details
Viktoria Lyons1 and Michael Fitzgerald2
1 Blackrock, Co. Dublin, Ireland
2 Trinity College Dublin, Ireland
References
[1] Kircher T, David AS. Introduction: The Self And Neuroscience. In: Kircher T, David
A.S. (eds) The Self in Neuroscience and Psychiatry, Cambridge: Cambridge Universi
ty Press; 2003. p2.
[2] Kanner L. Autistic Disturbances of Affective Contact. Nervous Child 1943;2: 217-50.
[3] Asperger H. Frhkindlicher Autismus, Medizinische Klinik 1974;69: 2024-27.
[4] Cohen DJ. The pathology of the Self in primary childhood autism and Gilles de la
Tourette Syndrome. Psychiatric Clinics of North America 1980; 3 (3): 383-402.
[5] Lutz J. Zum Verstaendnis Des Autismus Infantum Als Einer Ich-Bewusstseins-, IchAktivitaets- Und Ich-Einpraegungsstoerung. Acta Paedopsychiatrica 1968; 35, 161.
[6] Powell S, Jordan R. Being Subjective About Autistic Thinking And Learning To
Learn. Educational Psychology 1993;13: 359-370.
[7] Frith U. Autism: Explaining The Enigma. Oxford: Blackwell; 1989, 2nd Edition; 2003.
[8] Hobson RP. On The Origins Of Self And The Case Of Autism. Development And
Psychopathology 1990;2: 163-81.
[9] Hobson RP, Meyer JA. Foundations For Self And Other: A Study In Autism. Devel
opmental Science 2005;8: 481-91.
[10] Stern DN. The Interpersonal World Of The Infant. New York: Basic Books; 1985.
[11] Neisser U. Five kinds of self-knowledge. Philosophical Psychology 1988;1(1): 35-58.
759
760
[12] Dahlgren SO, Gillberg C. Symptoms in the first two years of life. A preliminary pop
Science 1989; 283: 169-74.
[13] Nadig AS, Ozonoff S, Young GS, Rozga A, Sigman M, Rogers SJ. A Prospective
Study Of Response To Name In Infants At Risk For Autism. Archives Pediatric Ado
lescent Medicine 2007;161: 378-83.
[14] Osterling J, Dawson G. Early Recognition Of Children With Autism: A Study Of First
Birthday Home Videotapes. Journal Of Autism And Developmental Disorders
1994;24: 247-53.
[15] Baron-Cohen S, Cos A, Bird G, Swettenham J, Nightingale N, Morgan K, Drew A.
Charman T. Psychological markers in the detection of autism in infancy in a large
population. British Journal of Psychiatry 1996;16: 158-63.
[16] Dawson G, Adams A. Imitation and social responsiveness in autistic children. Jour
nal of Abnormal Child Psychology 1984;12 (2): 209-26.
[17] Mundy P, Crowson M. Joint Attention And Early Communication: Implications For
Intervention With Autism. Journal Of Autism And Developmental Disorders 1997;6:
653-76.
[18] Hobson RP. Autism And The Development Of Mind. Hillsdale, NJ: Lawrence Erl
baum; 1993.
[19] Hobson, 1990.
[20] Gallup GG. Jr. Chimpanzees: Self-Recognition. Science 1970;167: 86-87.
[21] Lewis M., Ramsay D. Intentions, Consciousness And Pretend Play. In: Zelazo PD,
Astington JW, Olson DR (eds) Developing Theories Of Intention: Social Understand
ing And Self-Control. Mahwah, NJ: Erlbaum; 1999. p77-94,
[22] Dawson G, McKissick FC. Self-recognition in autistic children. Journal of Autism and
[23] Keenan JP, Christiana W, Malcolm S, Johnson A. Mirror-Self Recognition In Autism
And Aspergers Syndrome: Implications For Neurological Correlates. Poster Pre
sented At The Eleventh Annual Cognitive Neuroscience Society Meeting, San Fran
cisco. CA., April 2004.
[24] Pierce K., Muller R-A., Ambrose J., Allen G., Courchesne E. Face Processing Occurs
Outside The Fusiform Face Area In Autism: Evidence From Functional MRI. Brain
2001;124: 2059-73.
[25] Keenan JP, McCutcheon NB, Pascual-Leone A. Functional Magnetic Resonance Imag
ing And Event Related Potential Suggest Right Prefrontal Activation For Self-Related
Processing. Brain And Cognition 2001;47: 87-91.

http://dx.doi.org/10.5772/53680
[26] Critchley HD, Daly EM, Bullmore ET. Et Al. The functional neuroanatomy of social
behavior. Changes in cerebral blood flow when people with autistic disorder process
facial expressions. Brain 2000;123: 2203-12.
[27] Pierce et al., (2001).
[28] Hobson (1990).
[29] Hobson & Meyer (2005).
[30] Murray D, Lesser M. Lawson W. Attention, Monotropism And The Diagnostic Crite
ria For Autism. Autism. The International Journal Of Research And Practice 2005;9
(2): 139-56.
[31] Williams D. Autism And Sensing. The Unlost Instinct. London: Jessica Kingsley;
1998.
[32] Chiu PH, Kayali MA, Kishida KT, Tomlin D, Klinger LG, Klinger MR, Montague PR.
Self Responses along cingulate cortex reveal quantitative neural phenotype for highfunctioning autism. Neuron 2008;57: 463-73.
[33] Tomlin D, Kayali M A, King-Casas B, Anen D, Camerer CF, Et Al. Agent-Specific Re
sponses In The Cingulated Cortex During Economic Exchanges. Science 2006;5776:
1047-50.
[34] Chiu et al. (2008).
[35] Lombardo MV, Chakrabarti B, Bullmore ET, Sadek SA, Pasco G, Wheelwright SJ,
Suckling J, MRC AIMS Consortium, Baron-Cohen S. (2009). Atypical Neural SelfRepresentation in Autism. Brain 2009. http://brain.oxfordjournals.org/cgi/content/
abstract/awp306v1(accessed 19 January 2010)
[36] Ruby P, Decety J. How Would You Feel Versus How Do You Think She Would Feel?
A Neuroimaging Study On Perspective-Taking With Social Emotions. Journal Of
Cognitive Neuroscience 2003;16: 988-99.
[37] Decety J, Sommerville JA. Shared representations between self and other: A social
cognitive neuroscience view. Trends in Cognitive Science 2003;7: 527-33.
[38] Avikainen S, Forss N, Hair R. Modulated activation of the human SI and SII cortices
during observation of hand actions. Neuron 2002;15: 640-6.
[39] Goldenberg G. Body Image And The Self. In: Feinberg TE, Keenan JP (eds.) The Lost
Self. Pathologies Of The Brain And Identity. Oxford: Oxford University Press; 2005.
p81-99.
[40] Jordan R, Powell S. Understanding And Teaching Children With Autism. Chichester:
Wiley; 1995.
[41] Russell J. How Executive Disorders Can Bring About An Inadequate Theory Of
Mind. In: Russell J (Ed.) Autism As An Executive Disorder. Oxford: Oxford Univer
sity Press. 1997.p281.
761
762
[42] Russell (1997).

[43] Williams D, Happ F. Pre-Conceptual Aspects Of Self-Awareness In Autism Spec
trum Disorder: The Case Of Action Monitoring. Journal Of Autism And Develop
[44] Mesulam MM. Principles Of Behavioral And Cognitive Neurology (2nd Ed.), Oxford:
Oxford University Press; 2000.
[45] Devinsky O. Right Cerebral Hemisphere Dominance for a Sense of Corporeal and
Emotional Self. Epilepsy & Behaviour 2000;1: 60-73.
[46] Farrer C, Franck N, Georgieff N, Frith CD, Decety J, Et Al. Modulating The Experi
ence Of Agency: A Positron Emission Tomography Study. Neuroimage 2003;18:
324-33.
[47] Tsakiris M, Constantine M, Haggard P. The Role Of Right Temporo-Parietal Junction
In Maintaining A Coherent Sense Of Ones Body. Neuropsychologia 2008;46:
3014-18.
[48] Saxe R, Baron-Cohen, S. Editorial: The Neuroscience Of Theory Of Mind. In: R. Saxe
R, Baron-Cohen S. (eds.) Theory Of Mind. A Special Issue Of The Journal Social Neu
roscience. Hove: Psychology Press; 2007.
[49] Frith U, Happ F. Theory Of Mind And Self Consciousness: What It Is Like To Be
Autistic? Mind & Language 1999;14: 1-22.
[50] Happ F. Theory Of Mind And The Self. In: Ledoux J, Debiec J, Moss H. (eds) The
Self: From Soul To Brain, Annals Of The New York Academy Of Sciences 2003;1001:
134-144.
[51] Schore AN. Affect Dysregulation And Disorders of The Self. New York: Ww. Norton
& Company; 2003.
[52] Baron-Cohen S. Wheelwright S. The Empathy quotient: An investigation of adults
with Asperger syndrome or high functioning autism, and normal sex differences.
Journal of Autism and Developmental Disorders 2004;34: 163-75.
[53] Hobson (1993).
[54] Hobson RP. The Autistic Childs Appraisal Of Expressions Of Emotion. Journal Of
Child Psychology And Psychiatry 1986; 27: 321-42.
[55] Yirmiya N., Sigman M., Kasari C., Mundy P. Empathy And Cognition In High Func
tioning Children With Autism. Child Development 1992;63: 150-60.
[56] Baron-Cohen S., Wheelwright S., Joliffe T. Is there a language of the eyes? Evidence
from normal adults and adults with autism or Asperger syndrome. Visual Cognition
1997;4: 311-31.
[57] Gaigg SB, Bowler DM. Free Recall And Forgetting Of Emotionally Arousing Words
In Autism Spectrum Disorder. Neuropsychologia 2008;46: 2336-43.

http://dx.doi.org/10.5772/53680
[58] Frith CD, Frith U. The Neural Basis Of Mentalizing. Neuron 2006;50: 531-34.
[59] Saxe & Baron-Cohen (2007).
[60] Happ F., Brownell H., Winner E. Acquired Theory Of Mind Impairments Following
Right Hemisphere Stroke. Cognition 1999;70: 211-40.
[61] Shamay-Tsoory SG, Tomer R, Berger BD., Goldsher D,Aharon-Peretz, J. Impaired
Affective Theory Of Mind Is Associated With Right Ventromedial Prefrontal Dam
age. Cognitive And Behavioural Neurology 2005;18: 55-67.
[62] Chakrabarti B, Bullmore E, Baron-Cohen S. (2007) Empathizing with basic emotions:
Common and discrete neural substrates. In: Saxe R, Baron-Cohen S. (eds) Theory of
Mind. A special issue of the Journal Social Neuroscience. Hove: Psychology Press;
2007. p. 364-384.
[63] Keysers C., Perrett I. Demystifying Social Cognition: A Hebbian Perspective. Trends
In Cognitive Science 2004;8: 501-7.
[64] Rizzolatti G, Craighero L. The Mirror-Neuron Sys tem. Annual Reviews Of Neuro
science 2004; 27: 169-92.
[65] Kanner (1943).
[66] Asperger H. Die autistischen Psychopathen im Kindesalter. Archiv fr Psychiatrie
and Nervenkrankheiten 1944;117: 78-136.
[67] Baron-Cohen, S. (2005) Autism Autos: Literally, a Total Focus on the Self? In:
Feinberg TE., Keenan JP (eds.) The Lost Self. Pathologies of the Brain and Identity.
Oxford: Oxford University Press. p166-80.
[68] Gillberg IC, Gillberg C. Asperger Syndrome Some Epidemiological Considerations:
A Research Note. Journal Of Child Psychology And Psychiatry 1989;30: 631-38.
[69] Frith U, De Vignemont, F. Egocentrism, Allocentrism, And Asperger Syndrome.
Consciousness And Cognition 2005;14: 719-38.
[70] Frith U, De Vignemont F. (2005)
[71] Moore C, Lemmon K. The Self In Time: Developmental Perspectives. Hillsdale, NJ,
Usa: Erlbaum; 2001.
[72] Nielsen M., Suddendorf T., Dissanayake C. Imitation And Self-Recognition In Au
tism. In: Rogers S., Williams JW. (Eds) Imitation And The Development Of The Social
Mind: Autism And Typical Development. New York: Guilford Press; 2006. p138-56.
[73] Lind SE, Bowler DM. Delayed Self-Recognition In Children With Autism Spectrum
Disorder. Journal Of Autism And Developmental Disorders 2009;39 (4): 643-650.
[74] Lind SE, Bowler DM. (2009).
763
764
[75] Boucher J, Pons F, Lind S, Williams D. Temporal cognition in children with autistic
spectrum disorders: Tests of diachronic thinking. Journal of Autism and Develop
[76] Lind SE, Bowler DM. Episodic Memory And Autonoetic Consciousness In Autistic
Spectrum Disorders: The Roles Of Self-Awareness, Representational Abilities And
Temporal Cognition. In: Boucher J, Bowler DM. (eds), Memory In Autism: Theory
And Evidence. Cambridge: Cambridge University Press; 2008. p166-188.
[77] Beitman BD, Nair J, Viamontes GI. Why Self-Awareness? In: Beitman BD, J. Nair J.
(eds.) Self-Awareness Deficits in Psychiatric Patients. Neurobiology, Assessment,
and Treatment. New York: W.W. Norton & Company; 2004. p3-23.
[78] Kircher T, David AS. (2003) p3.
[79] Kanner L. (1943).
[80] Tager-Flusberg, H. Current Theory And Research On Language And Communica
tion In Autism. Journal Of Autism And Developmental Disorders 1996;26: 169-172.
[81] Hobson (1990).
[82] Jordan R, Powell S. (1995).
[83] Peeters G, Grobben G, Hendrickx,A., Van Den Eede S, Verlinden K. Self-Other And
Third-Person Categorization In Normal And Autistic Children. Developmental Sci
ence 2003. 6: 166-172.
[84] Northoff G, Heinzel A. The Self In Philosophy, Neuroscience And Psychiatry: An
Epistemic Approach, In: T. Kircher T., David A. (eds.) The Self In Neuroscience And
Psychiatry. Cambridge: Cambridge University Press; 2003. p40-55.
[85] Lombardo MV, Barnes JL, Wheelwright SJ, Baron-Cohen S. Self-Referential Cogni
tion And Empathy In Autism. PloS One 2007,2: e883.
[86] Lyons V, Fitzgerald M. Asperger Syndrome A Gift Or A Curse? New York: Nova
Science Publishers; 2007.
[87] Siegrist M. Inner Speech As A Cognitive Process Mediating Self-Consciousness And
Inhibiting Self-Deception. Psychology Report 1995;76: 259-265.
[88] Whitehouse A.JO, Maybery MT, Durkin K. Inner Speech Impairments In Autism.
Journal Of Child Psychology And Psychiatry 2006;47: 857-65.
[89] Hurlburt R, Happ F, Frith U. Sampling The Form Of Inner Experience In Three
Adults With Aspergers Syndrome. Psychological Medicine 1994;24: 385-95.
[90] Grandin T. Thinking In Pictures: And Other Reports From My Life With Autism.
New York: Vintage Books; 1995.

http://dx.doi.org/10.5772/53680
[91] Kana RK, Keller TA, Cherkassky VL, Minshew NJ, Just MA. Sentence Comprehen
sion In Autism: Thinking In Pictures With Decreased Functional Connectivity. Brain
2006;129: 2484-93.
[92] Kennedy DP, Redcay E, Courchesne E. Failing To Deactivate: Resting Functional Ab
normalities In Autism. Proceedings Of The National Academy Of Science USA
2006;103: 8275-80.
[93] Perner J. Episodic Memory: Essential Distinctions And Developmental Implications.
In: Moore C, Lemmon K.(Eds.) The Self In Time: Developmental Perspectives. Hill
sdale NJ: Erlbaum; 2001. p181-202.
[94] Wheeler MA. Episodic Memory And Autonoetic Awareness. In: Tulving E, Craik
FIM. (eds.) Oxford Handbook Of Memory. New York: Oxford University Press; 2000.
p597-625.
[95] Nelson K, Fivush R. The Emergence Of Autobiographical Memory: A Social Cultural
Developmental Theory. Psychological Review 2004;111: 486-511.
[96] Fujiwara E, Markowitsch HJ. Autobiographical Disorders. In: Feinberg TE, Keenan
JP. (eds.) The Lost Self. Pathologies Of The Brain And Identity, Oxford: Oxford Uni
versity Press; 2005. p65-80.
[97] Bowler DM, Gardiner JM, Grice SJ. Episodic memory and remembering in adults
with Asperger syndrome. Journal of Autism and Developmental Disorders 2000;30:
295-304, p. 295.
[98] Millward C, Powell S, Messer D, Jordan R. Recall For Self And Other In Autism:
Childrens Memory For Events Experienced By Themselves And Their Peers. Journal
For Autism And Developmental Disorders 2000;30: 15-28.
[99] Gardiner, J. M. Bowler, D. M, Grice SJ. Further Evidence Of Preserved Priming And
Impaired Recall In Adults With Aspergers Syndrome. Journal Of Autism And De
velopmental Disorder 2003;33 (3) 250-69.
[100] Crane L, Goddard L. Episodic and semantic autobiographical memory in adults with
Autism Spectrum Disorders. Journal of Autism and Developmental Disorders 2008;
38: 498-506.
[101] Boucher J, Bowler DM (eds) Memory in autism: theory and evidence. Cambridge:
Cambridge University Press; 2008.
[102] Millward et al. (2000).
[103] Wheeler MA, Stuss DT, Tulving, E Toward A Theory Of Episodic Memory: The
Frontal Lobes And Autonoetic Consciousness. Psychological Bulletin 1997;121:
331-54.
[104] Fink GR. In Search Of Ones Own Past: The Neural Bases Of Autobiographical Mem
ories. Brain 2003;126: 1509-10.
765
766
[105] Shallice T, Fletcher P, Frith C, Grasby P, Frackowiak R, Dolan R. Brain Regions Asso
ciated With Acquisition And Retrieval Of Verbal Episodic Memory. Nature 1994;368:
633-35.
[106] Tulving E, Kapur S, Craik F, Moskovitch M, Houle S. Hemispheric Encoding/Retriev
al Asymmetry In Episodic Memory: Positron Emission Tomography Findings. Pro
ceedings Of The National Academy Of Science USA 1994;91: 2016-20.
[107] Fink GR, Markowitsch HJ, Reinkemeier M, Bruckbauer T, Kessler J, Heiss W-D. Cere
bral Representation Of Ones Own Past: Neural Networks Involved In Autobio
graphical Memory, Journal of Neuroscience 1996;16: 4275-82.
[108] Bruner J. Kalmar DA. Narrative and metanarrative in the construction of self. In: Fer
rari M, Sternberg RJ. (eds.) Self-Awareness: Its Nature and Development. New York:
Guilford Press; 1988.
[109] Dennett D. Consciousness Explained. Boston: Little, Brown; 1991.
[110] Schechtman M. The Constitution Of Selves. Ithaca: Cornell University Press; 1996.
[111] Ochs E, Capps L. Narrating The Self. Annual Review Of Anthropology 1996;25:
19-43.
[112] Gallagher S. Self-Narrative In Schizophrenia. In: Kircher T, David A. (eds.) The Self
In Neuroscience And Psychiatry. Cambridge: Cambridge University Press; 2003.
p336-360.
[113] Gallagher (2003).
[114] Loveland K. Mcevoy R, Tunali B, Kelley ML. Narrative Story Telling In Autism And
Downs Syndrome. British Journal of Developmental Psychology 1990;8: 9-23.
[115] Losh M, Capps L. Narrative Ability In Highfunctioning Children With Autism Or
Aspergers Syndrome. Journal of Autism and Developmental Disorders 2003;33:
239-51.
[116] Colle L, Baron-Cohen S, Wheelwright S, Van Der Lely HK. Narrative discourse in
adults with high-functioning Autism or Asperger Syndrome. Journal of Autism and
[117] Tononi G, Sporns O, Edelman GM. Reentry And The Problem Of Integrating Multi
ple Cortical Areas: Simulation Of Dynamic Integration In The Visual System. Cere
bral Cortex 1992; 2: 310-35.
[118] Belmonte M. Human, but more so: What the autistic brain tells us about the process
of narrative. In: Osteen M. (ed.) Autism and representation. London: Routledge;
2008. p166-79.
[119] Viamontes GI, Beitman BD, Viamontes CT, Viamontes JA. Neural Circuits For SelfAwareness. Evolutionary Origins And Implementation In The Human Brain. In: Beit

http://dx.doi.org/10.5772/53680
man BD, Nair J. (eds) Self-Awareness Deficits In Psychiatric Patients. Neurobiology,

Assessment, And Treatment. New York: W.W. Norton & Company; 2004. p24-111.
[120] Decety & Somerville (2003).
[121] Aylward EH, Minshew NJ, Field, K, Sparks BF, Singh N. Effects of age on brain vol
ume and head circumference in autism. Neurology 2002;59: 175-83.
[122] Courchesne E, Townsend J, Akshoomoff NA,Et al. A new finding: impairment in
shifting attention in autistic and cerebellar patients. In: Broman SH, Grafman J. (eds)
Atypical cognitive deficits in developmental disorders: implications for brain func
tion. Hillsdale, N.J.: Lawrence Erlbaum Associates; 1994. p101-137.
[123] Courchesne E, Press G, Yeung-Courchesne, R. Parietal lobe abnormalities detected
with MR in patients with infantile autism. American Journal of Roentgeneology
1993;160: 387-393.
[124] Saitoh O, Karnds,CM, Courchesne E. Development Of Hippocampal Formation
From 2 To 42 Years: MRI Evidence Of Smaller Area Dentate In Autism. Brain
2001;124: 1317-24.
[125] Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA., Augustine AM, Yates KO,
Barta PE, Pearlson GD. MRI volumes of amygdala and hippocampus in non-mental
ly retarded autistic adolescents and adults. Neurology 1999;53: 2145-50.
[126] Mller RA. The Study Of Autism As A Distributed Disorder. Mental Retardation
And Developmental Disabilities Research Review 2007;13(1): 85-95.
[127] Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA. et al. Unusual brain
growth patterns in early life in patients with autistic disorder: an MRI study. Neurol
ogy 2001;57: 245-54.
[128] Carper RA, Courchesne E. Localized enlargement of the frontal lobe in early autism.
Biological Psychiatry 2005;57 (2): 126-33.
[129] Fossati P, Hevenor S, Graham SJ. Et Al. In Search Of The Emotional Self: An fMRI
Study Using Positive And Negative Emotional Words. American Journal Of Psychia
try 2003;160: 1938-45.
[130] Keenan JP, Gallup GG, Jr., Falk D. The Face In The Mirror: The Search For The Ori
gins Of Consciousness. New York: Harper Collins; 2003.
[131] Kircher & David (2001).
[132] Decety & Somervie (2003).
[133] Mega MS, Cummings JL. Frontal Subcortical Circuits: Anatomy And Function. In:
Salloway SP, Malloy PF, Duffy JD. (Eds) The Frontal Lobes and Neuropsychiatric Ill
ness. Washington, DC: American Psychiatric Publishing; 2001. p15-32.
[134] Fossati et al. (2003).
767
768
[135] McGilchrist I. The Master And His Emissary. The Divided Brain And The Making Of
The Western World. New Haven and London: Yale University Press; 2010.
[136] Lyons V, Fitzgerald, M. Did Hans Asperger (1906-1980) Have Asperger Syndrome?
Journal Of Autism And Developmental Disorder 2007;37: 2020-21.
[137] Klin A, Volkmar F, Sparrow, S, Cicchetti DV, Rourke BP. Validity and Neuropsycho
logical Characterization of Asperger Syndrome: Convergence with Nonverbal Learn
ing Disabilities Syndrome. Journal of Child Psychology and Psychiatry 1995; 36,
1127-1140.
[138] Gunter HL, Ghaziuddin M, Ellis HE. Asperger Syndrome: Test Of Right Hemisphere
Functioning And Interhemispheric Communication. Journal Of Autism And Devel
opmental Disorders 2002;32: 263-81.
[139] Chiron C, Jambaque I, Nabbout R, Lounes R, Syrota A., Dulac O. The right brain
hemisphere is dominant in human infants. Brain 1997;120: 1057-1065.
ciations, And Pathology. Boston: MIT Press; 1987.
[141] Schore AN. The Experience-Dependent Maturation Of A Regulatory System In The
Orbital Prefrontal Cortex And The Origin Of Developmental Psychopathology. De
velopment and Psychopathology 1996;8: 59-87.
[142] Fernald A. Intonation And Communicative Interest In Mothers Speech To Infants: Is
The Melody The Message? Child Development 1989;60: 1497-1510.
[143] Meltzoff AN, Brooks R. Like Me As A Building Block For Understanding Other
Minds: Bodily Acts, Attention And Intention. In Malle BF, Et Al (Eds) Intentions And
Intentionality: Foundations For Social Cognition. Boston: MIT Press; 2001. p171-192.
[144] Horwitz, B, Rumsey JM, Grady C.L, Rapoport SI. The Cerebral Metabolic Landscape
In Autism. Intercorrelations Of Regional Glucose Utilization. Archives Of Neurology
1988; 45: 749-755.
[145] Just MA, Cherkassky VL, Keller TA, Minshew N. Cortical Activation And Synchroni
zation During Sentence Comprehension In High-Functioning Autism: Evidence Of
Underconnectivity. Brain 2004;127 (8): 1811-21.
[146] Casanova MF. White matter volume increase and minicolumns in autism. Annals of
Neurology 2004;56: 453-54.
[147] Mizuno A, Villalobos ME, Davies MM, Dahl BC, Mller RA. Partially Enhanced Tala
mocortical Functional Connectivity In Autism. Brain Research 2006;1104 (1): 160-174.
[148] Courchesne E, Pierce K. Why the frontal cortex in autism might be talking only to
itself: local overconnectivity but long-distance disconnection. Current Opinion in
Neurobiology 2005;15: 225-30.

http://dx.doi.org/10.5772/53680
[149] Belmonte M, Cook JEH, Anderson G, Rubinstein J, Greenough W, et al. Autism as a

disorder of neural information processing: direction for research and targets for ther
apy. Molecular Psychiatry 2004a;9: 646-63.
[150] Kana et al. (2006).
[151] Just et al. (2007).
[152] Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Minicolumnar pathology in au
tism. Neurology 2002a;58: 428-32.
[153] Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Aspergers syndrome and corti
cal neuropathology. Journal of Child Neurology 2002b;17: 142-45.
[154] Keller TA., Kana RK, Just MA. A Developmental Study Of The Structural Integrity
Of White Matter In Autism. Neuroreport 2007;18: 23-27.
[155] Turner KC, Frost L, Linsenbardt D, Mcilroy JR, Mller RA. Atypically Diffuse Func
tional Connectivity Between Caudate Nuclei And Cerebral Cortex. Behavioural And
Brain Functions 2006;2: 34.
[156] Just MA., Cherkassky VL, Keller TA., Kana RK, Minshew N. Functional And Ana
tomical Cortical Underconnectivity In Autism: Evidence From A FMRI Study Of An
Executive Function Task And Corpus Callosum Morphometry. Cerebral Cortex
2007;17: 951-61.
[157] Stuss DT, Picton TW, Alexander MP. Consciousness, Self-Awareness And The Fron
tal Lobes. In: Salloway SP, Malloy PF (eds.) The Frontal Lobes And Neuropsychiatric
Illness. Washington, DC: American Psychiatric Publishing; 2001. P101-109.
[158] Courchesne & Pierce (2005).
[159] Williams JHG, Whiten A., Suddendorf T, Perrett DI. Imitation, Mirror Neurons And
Autism. Neuroscience & Biobehavioral Reviews 2001;25: 287-95.
[160] Oberman LM, Ramachandran VS. The Simulating Social Mind: The Role Of The Mir
ror Neuron System And Simulation In The Social And Communicative Deficits In
Autism Spectrum Disorders. Psychological Bulletin 2007;133(2): 310-27.
[161] Rizolatti & Craighero (2004).
[162] Williams et al. (2001).
[163] Kaplan JT, Iacoboni M. Getting A Grip On Other Minds: Mirror Neurons, Intention
Understanding, And Cognitive Empathy. In: Saxe R, Baron-Cohen S. (eds.) Theory
Of Mind. A Special Issue Of The Journal Social Neuroscience. Hove: Psychology
Press; 2007. P175-183.
[164] Pfeifer J, Iacoboni M, Mazziotta JC, Dapretto M. Mirror neuron system activity corre
lates with empathy and interpersonal competence in children. Social Neuroscience
2006; 6 (3-4): 175-83.
769
770
[165] Kaplan & Iacoboni (2007).

[166] Oberman & Ramachandran (2007).
[167] Gallese V. The Roots Of Empathy: The Shared Hypothesis And The Neural Basis Of
Intersubjectivity. Psychopathology 2003;36: 171-80.
[168] Ramachandran VS, Oberman LM. Broken Mirrors: A Theory Of Autism. Scientific
American 2006; November, 39-45.
[169] Asendorpf JB, Baudonniere PM. Self-awareness and Other-awareness: Mirror selfrecognition and synchronic imitation among unfamiliar peers. Developmental Psy
chology 1993;29: 88-95.
[170] Uddin LQ, Kaplan JT, Molnar-Szakacs I, Zaidel E, Iacoboni M. Self-Face Recognition
Activates A Frontoparietal Mirror Network In The Right Hemisphere: An Event-Re
lated fMRI Study. Neuroimage 2005; 25: 926-35.
[171] Uddin LQ, Molnar-Szakacs I, Zaidel E, Iacoboni M. Rtms To The Right Inferior Parie
tal Area Disrupts Self-Other Discrimination. Social Cognitive And Affective Neuro
science 2006; 1, 65-71.
[172] Dapretto M, Davies MS, Pfeifer JH, Scott AA, Sigman,M. Bookheimer SY, Iacoboni
M. Understanding emotions in others: mirror neuron dysfunction in children with
autism spectrum disorders. Nature Neuroscience 2006;9(1): 28-30.
[173] Theoret H, Halligan E, Kobyashi M, Fregni F, Tager-Flusberg H, Pascual-Leone A.
Impaired Motor Facilitation During Action Observation In Individuals With Autism
Spectrum Disorder. Current Biology 2005;15: 84-85.
[174] Nishitani NA, Vikainen S, Hari R. Abnormal Imitation-Related Cortical Activation
Sequences In Aspergers Syndrome. Annals Of Neurology 2004;55: 558-62.
[175] Kennedy et al. (2006).
[176] Hobson RP. The Intersubjective Foundations Of Thought. In Braten S. (ed.) Intersub
jective Communication And Emotion In Early Ontogeny. Cambridge: Cambridge
University Press; 1998. p283-296.
[177] Iacoboni, M. Failure To Deactivate In Autism: The Constitution Of Self And Other.
Retrieved October 7, 2006, From http://www.awares.org/conferences/
[178] Happ F, Vital P. What Aspects Of Autism Predispose To Talent?, In: Happ F,
Frith U.(eds.) Autism And Talent. London: Philosophical Transactions of The Royal
Society; 2009. p1369-1376.
Chapter 32

http://dx.doi.org/10.5772/54465
1. Introduction
772


http://dx.doi.org/10.5772/54465
inquisitiveness.

1403).
773
774

high intelligence.

http://dx.doi.org/10.5772/54465

775
776

of illnesses.
theories [74].
Flow

http://dx.doi.org/10.5772/54465
777
778


http://dx.doi.org/10.5772/54465

779
780

viduals with ASD.

http://dx.doi.org/10.5772/54465

10. Psychopathology
11. Conclusion
781
782
Author details
References
Press; 2007.

http://dx.doi.org/10.5772/54465
1995.
gy 2000;12: 83-90.
1983.
1938;49: 1314-1317.
783
784
Press; 2005.
[36] Treffert 2009.
Medicine 1991;21: 959-964.
1978. (9) p277-298.
and Row; 1989.

http://dx.doi.org/10.5772/54465
al Society 2009; vol. 364 (1522) p1425-1432.
[45] Hermelin 2001.
[46] Treffert 2009.
2009; vol. 364 (1522) p1377-1384.
[57] Frith & Happ 1994.
2006;36: 5-25.
[60] Grandin 1995.
785
786

2004;24: 9228-31.
2004;(3) 1: 3146.
Brain 2008, 131(4): 1013-1024.
[73] Snyder 2009.
Press; 1959. (9) p141-153.
Press; 1952.
2004.
sity Press; 1995.

http://dx.doi.org/10.5772/54465
chologia 2007;45: 2234-2245.
and Row; 1990.
364 (1522): p1369-1376.
2001;293: 51-2.
Neuroimage 2007;38: 519-28.
787
788

1989;27: 861-870.
2005;28: 213-226.
try 2000; 45: 563-572.

http://dx.doi.org/10.5772/54465
Group; 2007.
view. Brain 1996;119 1775-1790.
2006;163: 1290-92.
153-70.
Reviews 2004;10 106-11.
789
790
951-961.
306-310.
2009; vol. 364 (1522) p.1345-1350.
[146] Happ &Vital 2009.

http://dx.doi.org/10.5772/54465
[155] Grandin 1995.
791

Advances Autism PDF

Uploaded by

Copyright:

Available Formats

Advances Autism PDF

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Advances Autism PDF

Uploaded by

Copyright:

Available Formats

Chapter 1

Promoting Early Identification of Autism in the Primary

Recent Advances in Autism Spectrum Disorders - Volume I

2. Raising Public Awareness about Autism

Portrayals of ASD in the media

Cultural representations of ASD

Recent Advances in Autism Spectrum Disorders - Volume I

Financial barriers to successful awareness campaigns

Influencing the information environment. The LSAE campaign developed a comprehensive

Recent Advances in Autism Spectrum Disorders - Volume I

3. Implementing autism-specific screening

Parental compliance with the preventive pediatric healthcare schedule

The Medical Expenditure Panel Survey provides nationally representative information on

Recent Advances in Autism Spectrum Disorders - Volume I

Competing priorities, time, and reimbursement constraints

Availability of high-quality screening instruments

Limited parent literacy

Need for practice-wide system change

Recent Advances in Autism Spectrum Disorders - Volume I

Figure 2. Breakthrough Series Model

4. Communicating concerns about autism to parents

Recent Advances in Autism Spectrum Disorders - Volume I

Limited, outdated, or incorrect information on ASD and effective interventions

Doubts about the accuracy of ASD-specific screening tests

Expectations about parental reactions

Lack of experience in delivering bad news in uncertain situations

Primary care providers may be reluctant to administer population-wide screening measures

Recent Advances in Autism Spectrum Disorders - Volume I

5. Supporting parents between referral and onset of services

Comprehensive early intervention programs, consistent with the NRC recommendations or

Parents need to be reminded about the referrals

Recent Advances in Autism Spectrum Disorders - Volume I

Parents need to be educated about ASD

An additional lesson learned by clinics implementing an effective referral-tracking system

Early Intervention administrators need to be informed that ASD is suspected

Recent Advances in Autism Spectrum Disorders - Volume I

*Address all correspondence to: [email protected]

Recent Advances in Autism Spectrum Disorders - Volume I

Recent Advances in Autism Spectrum Disorders - Volume I

Recent Advances in Autism Spectrum Disorders - Volume I

cation Skills and Occupational Stress in Oncology: A Randomised Study. Br J Cancer

Recent Advances in Autism Spectrum Disorders - Volume I

Indicators of Autism in Iranian Children

Recent Advances in Autism Spectrum Disorders - Volume I

2. Identifying children with autism in different cultures

Indicators of Autism in Iranian Children

3. Screening and assessing children for autism

Recent Advances in Autism Spectrum Disorders - Volume I

through a detailed, structured interview with parents. However a multi-disciplinary as

Indicators of Autism in Iranian Children

Recent Advances in Autism Spectrum Disorders - Volume I

Indicators of Autism in Iranian Children

Recent Advances in Autism Spectrum Disorders - Volume I

Uses gestures instead of speech or uses signs to

Makes high-pitched sounds (e.g. eee-eee-eee) or 65.4%

other vocalizations for self-stimulation

Does not imitate other people when imitation is 65.0%

Withdraws, remains aloof or acts stand-offish in

required or desirable such as in games or learning